PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Lohman, D				Lohman, Diederik			Retreat From Human Rights and Adverse Consequences for Health	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lohman, Diederik] Human Rights Watch, 350 Fifth Ave,34th Floor, New York, NY 10118 USA		Lohman, D (corresponding author), Human Rights Watch, 350 Fifth Ave,34th Floor, New York, NY 10118 USA.	lohmand@hrw.org						Al Jazeera, 2017, D RODRIGUEZ NO HUMAN; Human RightsWatch, 2017, MANN HEAV HLTH ED PA; Human RightsWatch, 2017, HOSP HLTH WORK ATT U; Human RightsWatch, 2018 WORLD REP; Ministry of People's Power for Health (Venezuela), 2016, EPIDEMIOLOGICAL B; Ministry of People's Power for Health (Venezuela), 2015, EPIDEMIOLOGICAL B; Safeguarding Health in Conflict, 2017, IMP MUST END ATT HLT	7	2	2	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 6	2018	319	9					861	862		10.1001/jama.2018.0271	http://dx.doi.org/10.1001/jama.2018.0271			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY3FW	29346483				2022-12-28	WOS:000426705100009
J	Venkatesh, B; Finfer, S; Cohen, J; Rajbhandari, D; Arabi, Y; Bellomo, R; Billot, L; Correa, M; Glass, P; Harward, M; Joyce, C; Li, Q; McArthur, C; Perner, A; Rhodes, A; Thompson, K; Webb, S; Myburgh, J				Venkatesh, B.; Finfer, S.; Cohen, J.; Rajbhandari, D.; Arabi, Y.; Bellomo, R.; Billot, L.; Correa, M.; Glass, P.; Harward, M.; Joyce, C.; Li, Q.; McArthur, C.; Perner, A.; Rhodes, A.; Thompson, K.; Webb, S.; Myburgh, J.		ADRENAL Trial Investigators; Australian-New Zealand Intensive C	Adjunctive Glucocorticoid Therapy in Patients with Septic Shock	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CRITICALLY-ILL PATIENTS; SEVERE SEPSIS; CORTICOSTEROID TREATMENT; CORTICOTROPIN TEST; ADULTS; HYDROCORTISONE; DEFINITIONS; MORTALITY; TRIAL	BACKGROUND Whether hydrocortisone reduces mortality among patients with septic shock is unclear. METHODS We randomly assigned patients with septic shock who were undergoing mechanical ventilation to receive hydrocortisone (at a dose of 200 mg per day) or placebo for 7 days or until death or discharge from the intensive care unit (ICU), whichever came first. The primary outcome was death from any cause at 90 days. RESULTS From March 2013 through April 2017, a total of 3800 patients underwent randomization. Status with respect to the primary outcome was ascertained in 3658 patients (1832 of whom had been assigned to the hydrocortisone group and 1826 to the placebo group). At 90 days, 511 patients (27.9%) in the hydrocortisone group and 526 (28.8%) in the placebo group had died (odds ratio, 0.95; 95% confidence interval [CI], 0.82 to 1.10; P = 0.50). The effect of the trial regimen was similar in six prespecified subgroups. Patients who had been assigned to receive hydrocortisone had faster resolution of shock than those assigned to the placebo group (median duration, 3 days [interquartile range, 2 to 5] vs. 4 days [interquartile range, 2 to 9]; hazard ratio, 1.32; 95% CI, 1.23 to 1.41; P<0.001). Patients in the hydrocortisone group had a shorter duration of the initial episode of mechanical ventilation than those in the placebo group (median, 6 days [interquartile range, 3 to 18] vs. 7 days [interquartile range, 3 to 24]; hazard ratio, 1.13; 95% CI, 1.05 to 1.22; P< 0.001), but taking into account episodes of recurrence of ventilation, there were no significant differences in the number of days alive and free from mechanical ventilation. Fewer patients in the hydrocortisone group than in the placebo group received a blood transfusion (37.0% vs. 41.7%; odds ratio, 0.82; 95% CI, 0.72 to 0.94; P =0.004). There were no significant between-group differences with respect to mortality at 28 days, the rate of recurrence of shock, the number of days alive and out of the ICU, the number of days alive and out of the hospital, the recurrence of mechanical ventilation, the rate of renal-replacement therapy, and the incidence of new-onset bacteremia or fungemia. CONCLUSIONS Among patients with septic shock undergoing mechanical ventilation, a continuous infusion of hydrocortisone did not result in lower 90-day mortality than placebo.	[Venkatesh, B.; Finfer, S.; Rajbhandari, D.; Billot, L.; Correa, M.; Glass, P.; Harward, M.; Li, Q.; Thompson, K.; Myburgh, J.] Univ New South Wales, George Inst Global Hlth, Sydney, NSW, Australia; [Myburgh, J.] Univ Sydney, St George Clin Sch, St George Hosp, Sydney, NSW, Australia; [Venkatesh, B.; Finfer, S.; Myburgh, J.] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia; [Finfer, S.] Royal North Shore Hosp, Sydney, NSW, Australia; [Venkatesh, B.; Joyce, C.] Univ Queensland, Princess Alexandra Hosp, Brisbane, Qld, Australia; [Cohen, J.] Univ Queensland, Royal Brisbane & Womens Hosp, Brisbane, Qld, Australia; [Venkatesh, B.; Cohen, J.] Wesley Hosp, Brisbane, Qld, Australia; [Bellomo, R.] Univ Melbourne, Austin Hosp, Melbourne, Vic, Australia; [Bellomo, R.] Univ Melbourne, Sch Med, Melbourne, Vic, Australia; [Bellomo, R.] Monash Univ, Australian & New Zealand Res Ctr, Melbourne, Vic, Australia; [Bellomo, R.; Webb, S.; Myburgh, J.] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic, Australia; [Webb, S.] Univ Western Australia, Royal Perth Hosp, Perth, WA, Australia; [Webb, S.] Univ Western Australia, Sch Med & Pharmacol, Perth, WA, Australia; [Arabi, Y.] King Saud Bin Abdulaziz Univ Hlth Sci, King Abdullah Int Med Res Ctr, Riyadh, Saudi Arabia; [McArthur, C.] Auckland City Hosp, Dept Crit Care Med, Auckland, New Zealand; [Perner, A.] Univ Copenhagen, Rigshosp, Copenhagen, Denmark; [Rhodes, A.] St Georges Univ London, St Georges Univ Hosp NHS Fdn Trust, London, England	George Institute for Global Health; University of New South Wales Sydney; University of Sydney; St George Hospital; University of Sydney; University of Sydney; Royal North Shore Hospital; University of Queensland; Royal Brisbane & Women's Hospital; University of Queensland; Wesley Hospital; Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; University of Melbourne; Monash University; Monash University; Royal Perth Hospital; University of Western Australia; University of Western Australia; King Saud Bin Abdulaziz University for Health Sciences; King Abdullah International Medical Research Center (KAIMRC); Auckland City Hospital; Rigshospitalet; University of Copenhagen; St Georges University London	Venkatesh, B (corresponding author), Wesley Hosp, Dept Intens Care, 451 Coronat Dr, Brisbane, Qld 4066, Australia.	bvenkatesh@georgeinstitute.org.au	Billot, Laurent/Y-1241-2019; Madsen, Martin/ABA-5798-2021; Rhodes, Andrew/G-4265-2011; Whitehouse, Tony/AAC-1215-2020; Arabi, Yaseen/ABF-3316-2020; Mellinghoff, Johannes/V-4844-2019; Presneill, Jeffrey/B-4894-2012	Billot, Laurent/0000-0002-4975-9793; Madsen, Martin/0000-0003-0186-8971; Rhodes, Andrew/0000-0002-8737-574X; Whitehouse, Tony/0000-0002-4387-3421; Arabi, Yaseen/0000-0001-5735-6241; Mellinghoff, Johannes/0000-0002-5455-8953; Venkatesh, Bala/0000-0002-3234-5244; Knowles, Serena/0000-0002-5028-3825; Finfer, Simon/0000-0002-2785-5864; Glass, Parisa/0000-0002-1334-7156; Ziegenfuss, Marc/0000-0002-1488-2994; Myburgh, John/0000-0003-4088-7016; Bompoint, Severine/0000-0001-5226-4321; Saxena, Manoj/0000-0002-0385-6731; Presneill, Jeffrey/0000-0001-7177-7667; Thompson, Kelly/0000-0003-2304-8931; Barlow-Armstrong, Jewel/0000-0001-7350-0397; Whitehead, Christina/0000-0003-4561-7082; Perner, Anders/0000-0002-4668-0123; Micallef, Sharon/0000-0002-8496-2324; COHEN, Jeremy/0000-0002-1356-8506; Rajbhandari, Dorrilyn/0000-0001-8883-0428; Madsen, Martin/0000-0001-5832-2262	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	Funded by the National Health and Medical Research Council of Australia and others	Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; Annane D, 2005, CURR OPIN CRIT CARE, V11, P449, DOI 10.1097/01.ccx.0000176691.95562.43; Annane D, 2002, JAMA-J AM MED ASSOC, V288, P862, DOI 10.1001/jama.288.7.862; Annane D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002243.pub3; Annane D, 2010, JAMA-J AM MED ASSOC, V303, P341, DOI 10.1001/jama.2010.2; Annane D, 2009, JAMA-J AM MED ASSOC, V301, P2362, DOI 10.1001/jama.2009.815; Beale R, 2010, CRIT CARE, V14, DOI 10.1186/cc9044; Billot L, 2017, CRIT CARE RESUSC, V19, P183; BONE RC, 1987, NEW ENGL J MED, V317, P653, DOI 10.1056/NEJM198709103171101; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Briegel J, 2009, INTENS CARE MED, V35, P2151, DOI 10.1007/s00134-009-1627-9; Brock GN, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-144; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P1351, DOI 10.1056/NEJM199505183322008; Cooper DJ, 2017, NEW ENGL J MED, V377, P1858, DOI 10.1056/NEJMoa1707572; Finfer S, 2004, INTENS CARE MED, V30, P589, DOI 10.1007/s00134-004-2157-0; Fleischmann C, 2016, AM J RESP CRIT CARE, V193, P259, DOI 10.1164/rccm.201504-0781OC; HOLM S, 1979, SCAND J STAT, V6, P65; Ibarra-Estrada Miguel A, 2017, World J Crit Care Med, V6, P65, DOI 10.5492/wjccm.v6.i1.65; Keh D, 2003, AM J RESP CRIT CARE, V167, P512, DOI 10.1164/rccm.200205-446OC; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Liu V, 2014, JAMA-J AM MED ASSOC, V312, P90, DOI 10.1001/jama.2014.5804; Loisa P, 2007, CRIT CARE, V11, DOI 10.1186/cc5696; Machado FR, 2017, LANCET INFECT DIS, V17, P1180, DOI 10.1016/S1473-3099(17)30322-5; Myburgh JA, 2008, INTENS CARE MED, V34, P2226, DOI 10.1007/s00134-008-1219-0; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Reinhart K, 2017, NEW ENGL J MED, V377, P414, DOI 10.1056/NEJMp1707170; Rhee C, 2017, JAMA-J AM MED ASSOC, V318, P1241, DOI 10.1001/jama.2017.13836; Rhodes A, 2017, INTENS CARE MED, V43, P304, DOI 10.1007/s00134-017-4683-6; Ripatti S, 2000, BIOMETRICS, V56, P1016, DOI 10.1111/j.0006-341X.2000.01016.x; SCHUMER W, 1976, ANN SURG, V184, P333, DOI 10.1097/00000658-197609000-00011; Shi LJ, 2001, ARCH BIOCHEM BIOPHYS, V394, P145, DOI 10.1006/abbi.2001.2519; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; SPRUNG CL, 1984, NEW ENGL J MED, V311, P1137, DOI 10.1056/NEJM198411013111801; Venkatesh B, 2005, ANAESTH INTENS CARE, V33, P201, DOI 10.1177/0310057X0503300208; Venkatesh B, 2013, CRIT CARE RESUSC, V15, P83; Venkatesh B, 2015, CLIN ENDOCRINOL, V83, P289, DOI 10.1111/cen.12702; Volbeda M, 2015, INTENS CARE MED, V41, P1220, DOI 10.1007/s00134-015-3899-6; WAGNER RL, 1984, NEW ENGL J MED, V310, P1415, DOI 10.1056/NEJM198405313102202	39	451	482	3	85	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 1	2018	378	9					797	808		10.1056/NEJMoa1705835	http://dx.doi.org/10.1056/NEJMoa1705835			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FX7GP	29347874	Green Accepted, Bronze			2022-12-28	WOS:000426256300005
J	Ravi, D; Ghasemiesfe, M; Korenstein, D; Cascino, T; Keyhani, S				Ravi, Divya; Ghasemiesfe, Mehrnaz; Korenstein, Deborah; Cascino, Thomas; Keyhani, Salomeh			Associations Between Marijuana Use and Cardiovascular Risk Factors and Outcomes A Systematic Review	ANNALS OF INTERNAL MEDICINE			English	Review							BODY-MASS INDEX; CANNABIS USE; MYOCARDIAL-INFARCTION; INSULIN-RESISTANCE; ISCHEMIC-STROKE; MORTALITY; DISEASE; OBESITY; HEALTH	Background: Marijuana use is increasing in the United States, and its effect on cardiovascular health is unknown. Purpose: To review harms and benefits of marijuana use in relation to cardiovascular risk factors and clinical outcomes. Data Sources: PubMed, MEDLINE, EMBASE, PsycINFO, and the Cochrane Library between 1 January 1975 and 30 September 2017. Study Selection: Observational studies that were published in English, enrolled adults using any form of marijuana, and reported on vascular risk factors (hyperglycemia, diabetes, dyslipidemia, and obesity) or on outcomes (stroke, myocardial infarction, cardiovascular mortality, and all-cause mortality in cardiovascular cohorts). Data Extraction: Study characteristics and quality were assessed by 4 reviewers independently; strength of evidence for each outcome was graded by consensus. Data Synthesis: 13 and 11 studies examined associations between marijuana use and cardiovascular risk factors and clinical outcomes, respectively. Although 6 studies suggested a metabolic benefit from marijuana use, they were based on crosssectional designs and were not supported by prospective studies. Evidence examining the effect of marijuana on diabetes, dyslipidemia, acute myocardial infarction, stroke, or cardiovascular and all-cause mortality was insufficient. Although the current literature includes several long-term prospective studies, they are limited by recall bias, inadequate exposure assessment, minimal marijuana exposure, and a predominance of low-risk cohorts. Limitation: Poor-or moderate-quality data, inadequate assessment of marijuana exposure and minimal exposure in the populations studied, and variation in study design. Conclusion: Evidence examining the effect of marijuana on cardiovascular risk factors and outcomes, including stroke and myocardial infarction, is insufficient.	[Ravi, Divya] Wright Ctr Grad Med Educ, 111 North Washington Ave, Scranton, PA 18503 USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; [Ghasemiesfe, Mehrnaz; Keyhani, Salomeh] San Francisco VA Med Ctr, 4150 Clement St, San Francisco, CA 94121 USA; [Korenstein, Deborah] Mem Sloan Kettering Canc Ctr, 485 Lexington Ave,2nd Floor, New York, NY 10017 USA; [Cascino, Thomas] Univ Michigan, Div Cardiol, 1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA	University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); San Francisco VA Medical Center; Memorial Sloan Kettering Cancer Center; University of Michigan System; University of Michigan	Ravi, D (corresponding author), Wright Ctr Grad Med Educ, 111 North Washington Ave, Scranton, PA 18503 USA.	divyaravi.88@gmail.com		Cascino, Thomas/0000-0003-3779-0790	National Heart, Lung, and Blood Institute [PROSPERO: CRD42016051297]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130484] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Heart, Lung, and Blood Institute. (PROSPERO: CRD42016051297)	Bancks MP, 2015, DIABETOLOGIA, V58, P2736, DOI 10.1007/s00125-015-3740-3; Barber PA, 2013, STROKE, V44, P2327, DOI 10.1161/STROKEAHA.113.001562; Berard AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0037882; Berkman N. D., 2013, AHRQ PUBLICATION, V13; Centers for Disease Control and Prevention, HEART DIS FACTS; Centers for Disease Control and Prevention National Center for Health Statistics, 2017, UND CAUS DEATH 1999; Chen A, 2015, NATL PUBLIC RADIO; Coskun ZM, 2014, ACTA HISTOCHEM, V116, P112, DOI 10.1016/j.acthis.2013.05.013; Danielsson AK, 2016, J DIABETES RES, V2016, DOI 10.1155/2016/6278709; Falkstedt D, 2017, STROKE, V48, P265, DOI 10.1161/STROKEAHA.116.015565; Frost L, 2013, AM HEART J, V165, P170, DOI 10.1016/j.ahj.2012.11.007; GAONI Y, 1964, J AM CHEM SOC, V86, P1646, DOI 10.1021/ja01062a046; Hayatbakhsh MR, 2010, AM J DRUG ALCOHOL AB, V36, P350, DOI 10.3109/00952990.2010.500438; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Katoor A, 2016, MARIJUANA CORONARY H; Keyhani S, 2015, GRANTOME; Khiabani HZ, 2008, EUR J INTERN MED, V19, P608, DOI 10.1016/j.ejim.2007.06.031; Levendal RA, 2012, PHYTOMEDICINE, V19, P575, DOI 10.1016/j.phymed.2012.02.001; Maccarrone M, 2015, TRENDS PHARMACOL SCI, V36, P277, DOI 10.1016/j.tips.2015.02.008; Marist Institute for Public Opinion, 2017, YAH NEWS MAR POLL WE; Mittleman MA, 2001, CIRCULATION, V103, P2805; Mukamal KJ, 2008, AM HEART J, V155, P465, DOI 10.1016/j.ahj.2007.10.049; Mukhopadhyay Partha, 2008, Congest Heart Fail, V14, P330, DOI 10.1111/j.1751-7133.2008.00016.x; Muniyappa R, 2013, DIABETES CARE, V36, P2415, DOI 10.2337/dc12-2303; National Academies of Sciences Engineering and Medicine, 2017, HLTH EFF CANN CANN C; National Institute of Health, 2015, PREV MAR US US AD DO; Ngueta G, 2015, OBESITY, V23, P290, DOI 10.1002/oby.20973; Niu CG, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004099; Nugent SM, 2017, ANN INTERN MED, V167, P319, DOI 10.7326/M17-0155; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Penner EA, 2013, AM J MED, V126, P583, DOI 10.1016/j.amjmed.2013.03.002; PERMUTT MA, 1976, AM J PSYCHIAT, V133, P220; PROSPERO, 2020, INT PROSPECTIVE REGI; Rajavashisth TB, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000494; Reichenbach ZW, 2015, CLIN THER, V37, P2267, DOI 10.1016/j.clinthera.2015.07.023; Reis JP, 2017, AM J PUBLIC HEALTH, V107, P601, DOI 10.2105/AJPH.2017.303654; Rodondi N, 2006, AM J CARDIOL, V98, P478, DOI 10.1016/j.amjcard.2006.03.024; Rumalla K, 2016, J STROKE CEREBROVASC, V25, P452, DOI 10.1016/j.jstrokecerebrovasdis.2015.10.019; Singla S, 2012, CLIN CARDIOL, V35, P329, DOI 10.1002/clc.21962; Substance Abuse and Mental Health Services Administration and Office of Applied Studies, 2010, NAT EST DRUG REL EM; Svizenska I, 2008, PHARMACOL BIOCHEM BE, V90, P501, DOI 10.1016/j.pbb.2008.05.010; Szalavitz M, 2017, MARIJUANA NEXT DIABE; Thompson CA, 2015, ANN EPIDEMIOL, V25, P486, DOI 10.1016/j.annepidem.2015.01.013; Vidot DC, 2014, J ADDICT DIS, V33, P1, DOI 10.1080/10550887.2014.882718; Warren M, 2005, J ADDICT DIS, V24, P95, DOI 10.1300/J069v24n03_08; Wells G., 2014, NEWCASTLE OTTAWA SCA; Welsh J, 2014, BUSINESS INSIDER; Williams MJA, 1998, HEART, V79, P191, DOI 10.1136/hrt.79.2.191; Wolff V, 2011, STROKE, V42, P1778, DOI 10.1161/STROKEAHA.110.610915; WU TC, 1988, NEW ENGL J MED, V318, P347, DOI 10.1056/NEJM198802113180603; Yankey BA, 2018, EUR J PREV CARDIOL, V25, P42, DOI 10.1177/2047487317740426	51	55	55	6	24	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 6	2018	168	3					187	+		10.7326/M17-1548	http://dx.doi.org/10.7326/M17-1548			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV0CU	29357394	Green Accepted			2022-12-28	WOS:000424224300007
J	Morscher, RJ; Ducker, GS; Li, SHJ; Mayer, JA; Gitai, Z; Sperl, W; Rabinowitz, JD				Morscher, Raphael J.; Ducker, Gregory S.; Li, Sophia Hsin-Jung; Mayer, Johannes A.; Gitai, Zemer; Sperl, Wolfgang; Rabinowitz, Joshua D.			Mitochondrial translation requires folate-dependent tRNA methylation	NATURE			English	Article							ANTICODON WOBBLE NUCLEOTIDE; SERINE HYDROXYMETHYLTRANSFERASE; HYPERTROPHIC CARDIOMYOPATHY; LACTIC-ACIDOSIS; MUTATIONS; IDENTIFICATION; METABOLISM; DEFECT; CHAIN; BIOSYNTHESIS	Folates enable the activation and transfer of one-carbon units for the biosynthesis of purines, thymidine and methionine(1-3). Antifolates are important immunosuppressive4 and anticancer agents(5). In proliferating lymphocytes(6) and human cancers(7,8), mitochondrial folate enzymes are particularly strongly upregulated. This in part reflects the need for mitochondria to generate one-carbon units and export them to the cytosol for anabolic metabolism(2,9). The full range of uses of folate-bound one-carbon units in the mitochondrial compartment itself, however, has not been thoroughly explored. Here we show that loss of the catalytic activity of the mitochondrial folate enzyme serine hydroxymethyltransferase 2 (SHMT2), but not of other folate enzymes, leads to defective oxidative phosphorylation in human cells due to impaired mitochondrial translation. We find that SHMT2, presumably by generating mitochondrial 5,10-methylenetetrahydrofolate, provides methyl donors to produce the taurinomethyluridine base at the wobble position of select mitochondrial tRNAs. Mitochondrial ribosome profiling in SHMT2-knockout human cells reveals that the lack of this modified base causes defective translation, with preferential mitochondrial ribosome stalling at certain lysine (AAG) and leucine (UUG) codons. This results in the impaired expression of respiratory chain enzymes. Stalling at these specific codons also occurs in certain inborn errors of mitochondrial metabolism. Disruption of whole-cell folate metabolism, by either folate deficiency or antifolate treatment, also impairs the respiratory chain. In summary, mammalian mitochondria use folate-bound one-carbon units to methylate tRNA, and this modification is required for mitochondrial translation and thus oxidative phosphorylation.				joshr@princeton.edu	Gitai, Zemer/AAI-6989-2021; Rabinowitz, Joshua/GPP-4019-2022	Rabinowitz, Joshua/0000-0002-1247-4727; Ducker, Gregory/0000-0002-8651-6846; Morscher, Raphael Johannes/0000-0003-3378-9266; Li, Sophia Hsin-Jung/0000-0001-8972-6921	US National Institutes of Health (NIH) [R01CA163591, DP1DK113643]; StandUp to Cancer [SU2C-AACR-DT-20-16]; American Cancer Society [PF-15-190-01-TBE]; Paracelsus Medical University Salzburg [E-12/15/076-MAY]; NIH [DP1AI124669]; NATIONAL CANCER INSTITUTE [R01CA163591] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [DP1AI124669] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP1DK113643, F31DK113653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM107384] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); StandUp to Cancer; American Cancer Society(American Cancer Society); Paracelsus Medical University Salzburg; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Pan, W. Lu, L. Chen, L. Parsons, W. Wang and T. Srikumar, and all members of the Rabinowitz laboratory. This work was supported by funding to J.D.R. from the US National Institutes of Health (NIH) (R01CA163591 and DP1DK113643) and StandUp to Cancer (SU2C-AACR-DT-20-16). G.S.D. was supported by a postdoctoral fellowship (PF-15-190-01-TBE) from the American Cancer Society. J.A.M. was supported by the science fund of the Paracelsus Medical University Salzburg (E-12/15/076-MAY). Z.G. was supported by the NIH (DP1AI124669).	Afgan E, 2016, NUCLEIC ACIDS RES, V44, pW3, DOI 10.1093/nar/gkw343; Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anderson DD, 2011, P NATL ACAD SCI USA, V108, P15163, DOI 10.1073/pnas.1103623108; [Anonymous], 2013, NAT PROTOCOLS, V8, P2281; Balakrishnan R, 2014, NUCLEIC ACIDS RES, V42, P13370, DOI 10.1093/nar/gku1098; Bao XR, 2016, ELIFE, V5, DOI 10.7554/eLife.10575; Bern Marshall, 2012, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1320s40; Birsoy K, 2015, CELL, V162, P540, DOI 10.1016/j.cell.2015.07.016; BROWN SS, 1965, BIOCHEM J, V97, pC34, DOI 10.1042/bj0970034C; Calvo SE, 2010, ANNU REV GENOM HUM G, V11, P25, DOI 10.1146/annurev-genom-082509-141720; Chabner BA, 2005, NAT REV CANCER, V5, P65, DOI 10.1038/nrc1529; Clasquin MF., 2012, CURRENT PROTOCOLS BI, V37, p14.11.1, DOI [10.1002/0471250953.bi1411s37, DOI 10.1002/0471250953.BI1411S37]; Clayton D. A, 2014, COLD SPRING HARB PRO; Contestabile R, 2000, BIOCHEMISTRY-US, V39, P7492, DOI 10.1021/bi000032z; Couvillion MT, 2016, NATURE, V533, P499, DOI 10.1038/nature18015; Danson MJ, 2001, METHOD ENZYMOL, V331, P3; Del Campo C, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005613; Doherty EA, 2001, NAT STRUCT BIOL, V8, P339, DOI 10.1038/86221; Dorfer V, 2014, J PROTEOME RES, V13, P3679, DOI 10.1021/pr500202e; Ducker GS, 2017, CELL METAB, V25, P27, DOI 10.1016/j.cmet.2016.08.009; Ducker GS, 2016, CELL METAB, V23, P1140, DOI 10.1016/j.cmet.2016.04.016; Dunn J. G., 2016, PLASTID POSITIONAL L; Dunn JG, 2013, ELIFE, V2, DOI 10.7554/eLife.01179; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Feichtinger RG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-149; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Fu Y, 2010, ANGEW CHEM INT EDIT, V49, P8885, DOI 10.1002/anie.201001242; Garrison Erik., 2012, HAPLOTYPE BASED VARI, DOI DOI 10.48550/ARXIV.1207.3907; GARROW TA, 1993, J BIOL CHEM, V268, P11910; Ghezzi D, 2012, AM J HUM GENET, V90, P1079, DOI 10.1016/j.ajhg.2012.04.011; Gohil VM, 2010, NAT BIOTECHNOL, V28, P249, DOI 10.1038/nbt.1606; Grim J, 2003, CLIN PHARMACOKINET, V42, P139, DOI 10.2165/00003088-200342020-00003; Hahne F, 2016, METHODS MOL BIOL, V1418, P335, DOI 10.1007/978-1-4939-3578-9_16; Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9; Ingolia NT, 2012, NAT PROTOC, V7, P1534, DOI 10.1038/nprot.2012.086; Iurescia S, 1996, PROTEIN EXPRES PURIF, V7, P323, DOI 10.1006/prep.1996.0046; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kim D, 2015, NATURE, V520, P363, DOI 10.1038/nature14363; Kirino Y, 2005, P NATL ACAD SCI USA, V102, P7127, DOI 10.1073/pnas.0500563102; Kopajtich R, 2014, AM J HUM GENET, V95, P708, DOI 10.1016/j.ajhg.2014.10.017; KOZAK M, 1983, MICROBIOL REV, V47, P1; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; LOVE MI, 2014, GENOME BIOL, V15, DOI DOI 10.1186/S13059-014-0550-8; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; Mayr JA, 2007, AM J HUM GENET, V80, P478, DOI 10.1086/511788; Mayr JA, 2015, J INHERIT METAB DIS, V38, P629, DOI 10.1007/s10545-015-9831-y; Moukadiri I, 2009, NUCLEIC ACIDS RES, V37, P7177, DOI 10.1093/nar/gkp762; Mullen AR, 2012, NATURE, V481, P385, DOI 10.1038/nature10642; Nakahigashi K, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1115; Nilsson R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4128; Ogata T, 2009, J ORG CHEM, V74, P2585, DOI 10.1021/jo802697r; Oh E, 2011, CELL, V147, P1295, DOI 10.1016/j.cell.2011.10.044; Putz J, 2007, RNA, V13, P1184, DOI 10.1261/rna.588407; R Development Core Team, 2009, R LANG ENV STAT COMP; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Renwick SB, 1998, STRUCTURE, V6, P1105, DOI 10.1016/S0969-2126(98)00112-9; Ron-Harel N, 2016, CELL METAB, V24, P104, DOI 10.1016/j.cmet.2016.06.007; Rooijers K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3886; Rouskin S, 2014, NATURE, V505, P701, DOI 10.1038/nature12894; RUSTIN P, 1994, CLIN CHIM ACTA, V228, P35, DOI 10.1016/0009-8981(94)90055-8; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Sasarman F, 2012, METHODS MOL BIOL, V837, P207, DOI 10.1007/978-1-61779-504-6_14; Schilling B, 2012, MOL CELL PROTEOMICS, V11, P202, DOI 10.1074/mcp.M112.017707; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Songe-Moller L, 2010, MOL CELL BIOL, V30, P1814, DOI 10.1128/MCB.01602-09; Spivak M, 2009, J PROTEOME RES, V8, P3737, DOI 10.1021/pr801109k; Sullivan LB, 2015, CELL, V162, P552, DOI 10.1016/j.cell.2015.07.017; Suzuki T, 2014, NUCLEIC ACIDS RES, V42, P7346, DOI 10.1093/nar/gku390; Szebenyi DME, 2004, BIOCHEMISTRY-US, V43, P6865, DOI 10.1021/bi049791y; Tibbetts AS, 2010, ANNU REV NUTR, V30, P57, DOI 10.1146/annurev.nutr.012809.104810; Tischner C, 2015, HUM MOL GENET, V24, P2247, DOI 10.1093/hmg/ddu743; Tucker EJ, 2011, CELL METAB, V14, P428, DOI 10.1016/j.cmet.2011.07.010; Van Haute L, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12039; Wang YL, 2000, TRENDS BIOCHEM SCI, V25, P300, DOI 10.1016/S0968-0004(00)01561-9; Yasukawa T, 2000, J BIOL CHEM, V275, P4251, DOI 10.1074/jbc.275.6.4251; Yasukawa T, 2000, FEBS LETT, V467, P175, DOI 10.1016/S0014-5793(00)01145-5; Zheng GQ, 2013, MOL CELL, V49, P18, DOI 10.1016/j.molcel.2012.10.015	80	132	138	2	72	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 1	2018	554	7690					128	+		10.1038/nature25460	http://dx.doi.org/10.1038/nature25460			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7QX	29364879	Green Accepted			2022-12-28	WOS:000424048900044
J	Ezekiel, S				Ezekiel, Sarah			WHAT YOUR PATIENT IS THINKING "Where there is life, there is hope"	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												ezekiel.sarah@googlemail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2018	360								j5920	10.1136/bmj.j5920	http://dx.doi.org/10.1136/bmj.j5920			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU2WT	29367349	Bronze, Green Published			2022-12-28	WOS:000423711400003
J	Kuehn, BM				Kuehn, Bridget M.			CMS Cancels Mandatory Hip and Cardiac Payment Bundles	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					332	332		10.1001/jama.2017.21303	http://dx.doi.org/10.1001/jama.2017.21303			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362780				2022-12-28	WOS:000423405300005
J	Diaz, S; Pascual, U; Stenseke, M; Martin-Lopez, B; Watson, RT; Molnar, Z; Hill, R; Chan, KMA; Baste, IA; Brauman, KA; Polasky, S; Church, A; Lonsdale, M; Larigauderie, A; Leadley, PW; van Oudenhoven, APE; van der Plaat, F; Schroter, M; Lavorel, S; Aumeeruddy-Thomas, Y; Bukvareva, E; Davies, K; Demissew, S; Erpul, G; Failler, P; Guerra, CA; Hewitt, CL; Keune, H; Lindley, S; Shirayama, Y				Diaz, Sandra; Pascual, Unai; Stenseke, Marie; Martin-Lopez, Berta; Watson, Robert T.; Molnar, Zsolt; Hill, Rosemary; Chan, Kai M. A.; Baste, Ivar A.; Brauman, Kate A.; Polasky, Stephen; Church, Andrew; Lonsdale, Mark; Larigauderie, Anne; Leadley, Paul W.; van Oudenhoven, Alexander P. E.; van der Plaat, Felice; Schroter, Matthias; Lavorel, Sandra; Aumeeruddy-Thomas, Yildiz; Bukvareva, Elena; Davies, Kirsten; Demissew, Sebsebe; Erpul, Gunay; Failler, Pierre; Guerra, Carlos A.; Hewitt, Chad L.; Keune, Hans; Lindley, Sarah; Shirayama, Yoshihisa			Assessing nature's contributions to people	SCIENCE			English	Editorial Material							ECOSYSTEM SERVICES; IPBES; FRAMEWORK					sandra.diaz@unc.edu.ar; unai.pascual@bc3research.org	Martin-Lopez, Berta/R-9397-2017; Stenseke, Marie/K-2278-2019; Chan, Kai M A/C-1682-2009; Pascual, Unai/O-7946-2019; Keune, Hans/AAC-7084-2019; Bukvareva, Elena N/J-5492-2014; van Oudenhoven, Alexander/J-4146-2019; Hill, Rosemary/A-6954-2011; Polasky, Stephen/AAC-5341-2019; Guerra, Carlos/AAR-4414-2021; Díaz, Sandra/ABE-7349-2020; Hewitt, Chad L/J-2105-2019; Schröter, Matthias/B-8883-2017; Diaz, Sandra/Q-9804-2018; Brauman, Kate A/ABD-5349-2021	Martin-Lopez, Berta/0000-0003-2622-0135; Chan, Kai M A/0000-0002-7804-3276; Pascual, Unai/0000-0002-5696-236X; Keune, Hans/0000-0002-1531-944X; Bukvareva, Elena N/0000-0003-0023-7270; van Oudenhoven, Alexander/0000-0002-3258-2565; Hill, Rosemary/0000-0002-7426-3132; Díaz, Sandra/0000-0003-0012-4612; Hewitt, Chad L/0000-0002-6859-6512; Schröter, Matthias/0000-0003-0207-7311; Brauman, Kate A/0000-0002-8099-285X; Davies, Kirsten/0000-0002-6940-4359; Molnar, Zsolt/0000-0001-5454-4714; Guerra, Carlos/0000-0003-4917-2105; Davies, Kelvin/0000-0001-7790-3003; failler, pierre/0000-0002-9225-9399	Consejo Nacional de Investigaciones Cientificas y Tecnicas; Universidad Nacional de Cordoba; Fondo para la Investigacion Cientifica y Tecnologica; Basque Foundation for Science, IKERBASQUE; AHRC [AH/J006866/1, AH/I507655/1] Funding Source: UKRI	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Universidad Nacional de Cordoba; Fondo para la Investigacion Cientifica y Tecnologica; Basque Foundation for Science, IKERBASQUE; AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	We acknowledge the following experts participating in IPBES assessments: C. Anderson, P. Balvanera, B. Baptiste, N. Bennas, F. Berkes, M. Carneiro da Cunha, C. Chenu, M.-C. Cornier-Salem, B. Czucz, P. Elias, B. Erasmus, S. Fennessy, J. Fisher, C. Furst, S. Jacobs, O. Osano, D. Pacheco, M. Potts, S. Preston, A. Purvis, A. Rajwanshi, J. Rice, M. Rosales-Benites, C. S. Seixas, M. Solan, J. Tassin, W. Townsend, G. von Maltitz, T. Yahara, C.-Y. Yao, and Y.-C. Youn. We thank C. Broshi, M. Colloff, H.T. Ngo, and D. Singer for useful input during the development of this work; V. Falczuk for help with the bibliography; and Y. Estrada for preparing the figures. S.D. was partially supported by the Consejo Nacional de Investigaciones Cientificas y Tecnicas, Universidad Nacional de Cordoba, and Fondo para la Investigacion Cientifica y Tecnologica. U.P. was supported by the Basque Foundation for Science, IKERBASQUE.	Berkes F., 2012, SACRED ECOLOGY, V3; Brondizio ES, 2016, SCIENCE, V352, P1272, DOI 10.1126/science.aaf5122; Chan KMA, 2012, BIOSCIENCE, V62, P744, DOI 10.1525/bio.2012.62.8.7; Comberti C, 2015, GLOBAL ENVIRON CHANG, V34, P247, DOI 10.1016/j.gloenvcha.2015.07.007; Diaz S, 2015, CURR OPIN ENV SUST, V14, P1, DOI 10.1016/j.cosust.2014.11.002; IPBES, 2016, SUMMARY POLICYMAKERS; Lele S, 2013, CONSERV SOC, V11, P343, DOI 10.4103/0972-4923.125752; Norgaard RB, 2010, ECOL ECON, V69, P1219, DOI 10.1016/j.ecolecon.2009.11.009; Pascual U, 2017, CURR OPIN ENV SUST, V26-27, P7, DOI 10.1016/j.cosust.2016.12.006; Pascual U, 2014, BIOSCIENCE, V64, P1027, DOI 10.1093/biosci/biu146; Polasky S, 2009, ANNU REV RESOUR ECON, V1, P409, DOI 10.1146/annurev.resource.050708.144110; Roue M, 2017, KNOWLEDGES OF NATURE, V9; [No title captured]	13	1071	1099	51	504	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					270	272		10.1126/science.aap8826	http://dx.doi.org/10.1126/science.aap8826			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT6BB	29348221	Green Submitted, Green Accepted			2022-12-28	WOS:000423236700017
J	Wadman, M				Wadman, Meredith			Rochester roiled by fallout from sexual harassment case Report supports university's handling of explosive charges involving linguist T. Florian Jaeger, but president bows out	SCIENCE			English	News Item																			0	0	0	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					262	263		10.1126/science.359.6373.262	http://dx.doi.org/10.1126/science.359.6373.262			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6BB	29348218				2022-12-28	WOS:000423236700014
J	Dendukuri, N; Schiller, I; de Groot, J; Libman, M; Moons, K; Reitsma, J; van Smeden, M				Dendukuri, Nandini; Schiller, Ian; de Groot, Joris; Libman, Michael; Moons, Karel; Reitsma, Johannes; van Smeden, Maarten			Concerns about composite reference standards in diagnostic research	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CLINICAL CASE DEFINITIONS; ACID AMPLIFICATION TESTS; INTRATHORACIC TUBERCULOSIS; CHLAMYDIA-TRACHOMATIS; ACCURACY; CLASSIFICATION; CHILDREN; ABSENCE	Composite reference standards are used to evaluate the accuracy of a new test in the absence of a perfect reference test. A composite reference standard defines a fixed, transparent rule to classify subjects into disease positive and disease negative groups based on existing imperfect tests. The accuracy of the composite reference standard itself has received limited attention. We show that increasing the number of tests used to define a composite reference standard can worsen its accuracy, leading to underestimation or overestimation of the new test's accuracy. Further, estimates based on composite reference standards vary with disease prevalence, indicating that they may not be comparable across studies. These problems can be attributed to the fact that composite reference standards make a simplistic classification and then ignore the uncertainty in this classification. Latent class models that adjust for the accuracy of the different imperfect tests and the dependence between them should be pursued to make better use of data	[Dendukuri, Nandini; Schiller, Ian] McGill Univ, Hlth Ctr, Res Inst, Div Clin Epidemiol, Montreal, PQ, Canada; [de Groot, Joris; Moons, Karel; Reitsma, Johannes; van Smeden, Maarten] Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Libman, Michael] McGill Univ, Hlth Ctr, Div Infect Dis, Montreal, PQ, Canada	McGill University; Utrecht University; Utrecht University Medical Center; McGill University	Dendukuri, N (corresponding author), McGill Univ, Hlth Ctr, Res Inst, Div Clin Epidemiol, Montreal, PQ, Canada.	nandini.dendukuri@mcgill.ca	van Smeden, Maarten/Y-7034-2019	van Smeden, Maarten/0000-0002-5529-1541; Reitsma, Johannes/0000-0003-4026-4345	Canadian Institutes of Health Research [89857]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by funding from the Canadian Institutes of Health Research (Grant number 89857).	Albert PS, 2004, BIOMETRICS, V60, P427, DOI 10.1111/j.0006-341X.2004.00187.x; Alonzo TA, 1999, STAT MED, V18, P2987, DOI 10.1002/(SICI)1097-0258(19991130)18:22<2987::AID-SIM205>3.3.CO;2-2; Baughman AL, 2008, CLIN VACCINE IMMUNOL, V15, P106, DOI 10.1128/CVI.00223-07; Black CM, 2002, J CLIN MICROBIOL, V40, P3757, DOI 10.1128/JCM.40.10.3757-3763.2002; Ferrante di Ruffano L, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e686; Graham SM, 2015, CLIN INFECT DIS, V61, pS179, DOI 10.1093/cid/civ581; Graham SM, 2012, J INFECT DIS, V205, pS199, DOI 10.1093/infdis/jis008; Green SM, 2014, ANN EMERG MED, V64, P286, DOI 10.1016/j.annemergmed.2014.01.016; Hadgu A, 2005, EPIDEMIOLOGY, V16, P604, DOI 10.1097/01.ede.0000173042.07579.17; Hatherill M, 2010, B WORLD HEALTH ORGAN, V88, P312, DOI 10.2471/BLT.09.062893; Pepe MS, 2006, STAT EVALUATION MED; Reitsma JB, 2009, J CLIN EPIDEMIOL, V62, P797, DOI 10.1016/j.jclinepi.2009.02.005; Schiller I, 2016, STAT MED, V35, P1454, DOI 10.1002/sim.6803; Schumacher SG, 2016, AM J EPIDEMIOL, V184, P690, DOI 10.1093/aje/kww094; Shrier LA, 2004, AM J OBSTET GYNECOL, V190, P654, DOI 10.1016/j.ajog.2003.09.063; TorranceRynard VL, 1997, STAT MED, V16, P2157, DOI 10.1002/(SICI)1097-0258(19971015)16:19<2157::AID-SIM653>3.0.CO;2-X; US Food and Drug Administration, 2016, DRAFT GUID INF DIS N; Xie XQ, 2017, RES SYNTH METHODS, V8, P321, DOI 10.1002/jrsm.1243; Yin QQ, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/310194	19	16	16	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 18	2018	360								j5779	10.1136/bmj.j5779	http://dx.doi.org/10.1136/bmj.j5779			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT5QZ	29348126	Bronze, Green Submitted			2022-12-28	WOS:000423209600004
J	Fairchild, AL; Lee, JS; Bayer, R; Curran, J				Fairchild, Amy L.; Lee, Ju Sung; Bayer, Ronald; Curran, James			E-Cigarettes and the Harm-Reduction Continuum	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fairchild, Amy L.; Lee, Ju Sung] Texas A&M Univ, Sch Publ Hlth, College Stn, TX 77843 USA; [Bayer, Ronald] Columbia Univ, Mailman Sch Publ Hlth, New York, NY USA; [Curran, James] Emory Univ, Rollins Sch Publ Hlth, Atlanta, GA 30322 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Columbia University; Emory University; Rollins School Public Health	Fairchild, AL (corresponding author), Texas A&M Univ, Sch Publ Hlth, College Stn, TX 77843 USA.		Fairchild, Amy/F-1811-2018	Fairchild, Amy/0000-0002-1292-7212; Lee, Jusung/0000-0002-9099-3899				[Anonymous], 2017, SCI REG PUBL HLTH; Fairchild AL, 2015, SCIENCE, V347, P375, DOI 10.1126/science.1260761; Frieden T., 2016, CDC TELEBRIEFING NEW; Gottlieb S, 2017, ADV MED NICOTINE REP; Gottlieb S, 2017, NEW ENGL J MED, V377, P1111, DOI 10.1056/NEJMp1707409	5	42	42	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2018	378	3					216	219		10.1056/NEJMp1711991	http://dx.doi.org/10.1056/NEJMp1711991			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT1IJ	29342380				2022-12-28	WOS:000422888400005
J	Yang, ZJ; Wei, JJ; Sobolev, YI; Grzybowski, BA				Yang, Zhijie; Wei, Jingjing; Sobolev, Yaroslav I.; Grzybowski, Bartosz A.			Systems of mechanized and reactive droplets powered by multi-responsive surfactants	NATURE			English	Article							ACTIVE CONTROL; NANOPARTICLES; EMULSIONS; SHEAR	Although 'active' surfactants, which are responsive to individual external stimuli such as temperature(1), electric(2,3) or magnetic(4) fields, light(5,6), redox processes(6,7) or chemical agents(8), are well known, it would be interesting to combine several of these properties within one surfactant species. Such multi-responsive surfactants could provide ways of manipulating individual droplets and possibly assembling them into larger systems of dynamic reactors(9,10). Here we describe surfactants based on functionalized nanoparticle dimers that combine all of these and several other characteristics. These surfactants and therefore the droplets that they cover are simultaneously addressable by magnetic, optical and electric fields. As a result, the surfactant-covered droplets can be assembled into various hierarchical structures, including dynamic ones, in which light powers the rapid rotation of the droplets. Such rotating droplets can transfer mechanical torques to their non-nearest neighbours, thus acting like systems of mechanical gears. Furthermore, droplets of different types can be merged by applying electric fields and, owing to interfacial jamming(11,12), can form complex, non-spherical, 'patchy' structures with different surface regions covered with different surfactants. In systems of droplets that carry different chemicals, combinations of multiple stimuli can be used to control the orientations of the droplets, inter-droplet transport, mixing of contents and, ultimately, sequences of chemical reactions. Overall, the multi-responsive active surfactants that we describe provide an unprecedented level of flexibility with which liquid droplets can be manipulated, assembled and reacted.	[Yang, Zhijie; Wei, Jingjing; Sobolev, Yaroslav I.; Grzybowski, Bartosz A.] IBS, Ctr Soft & Living Matter, Ulsan 44919, South Korea; [Grzybowski, Bartosz A.] Ulsan Natl Inst Sci & Technol, Dept Chem, Ulsan 44919, South Korea	Institute for Basic Science - Korea (IBS); Ulsan National Institute of Science & Technology (UNIST)	Grzybowski, BA (corresponding author), IBS, Ctr Soft & Living Matter, Ulsan 44919, South Korea.; Grzybowski, BA (corresponding author), Ulsan Natl Inst Sci & Technol, Dept Chem, Ulsan 44919, South Korea.	nanogrzybowski@gmail.com	Grzybowski, Bartosz A/H-5741-2017	Grzybowski, Bartosz/0000-0001-6613-4261; Wei, Jingjing/0000-0002-2197-8062; Sobolev, Yaroslav I./0000-0002-2194-1630; Yang, Zhijie/0000-0002-5012-9852	Institute for Basic Science Korea [IBS-R020-D1]	Institute for Basic Science Korea	We acknowledge support from the Institute for Basic Science Korea, project code IBS-R020-D1.	Brown P, 2012, ANGEW CHEM INT EDIT, V51, P2414, DOI 10.1002/anie.201108010; Cui MM, 2013, SCIENCE, V342, P460, DOI 10.1126/science.1242852; Dommersnes P, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3066; Eastoe J, 2005, SOFT MATTER, V1, P338, DOI 10.1039/b510877m; Gallardo BS, 1999, SCIENCE, V283, P57, DOI 10.1126/science.283.5398.57; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Griffin W.C., 1949, J SOC COSMET CHEM, V1, P311; Gross AF, 2012, DALTON T, V41, P5458, DOI 10.1039/c2dt30174a; Ha JW, 1998, J COLLOID INTERF SCI, V206, P195, DOI 10.1006/jcis.1998.5676; Jiang S, 2010, ADV MATER, V22, P1060, DOI 10.1002/adma.200904094; Lach S, 2016, CHEM SOC REV, V45, P4766, DOI 10.1039/c6cs00242k; Liu YX, 2006, SCIENCE, V313, P958, DOI 10.1126/science.1128142; Maglia G, 2009, NAT NANOTECHNOL, V4, P437, DOI [10.1038/NNANO.2009.121, 10.1038/nnano.2009.121]; Meguro K., 1987, NONIONIC SURFACTANTS, P927; Nudurupati S, 2010, SOFT MATTER, V6, P1157, DOI 10.1039/b912723b; Paven M, 2016, ADV FUNCT MATER, V26, P3199, DOI 10.1002/adfm.201600034; Pontani LL, 2013, SOFT MATTER, V9, P7150, DOI 10.1039/c3sm51137e; Prasad M, 2016, LANGMUIR, V32, P5796, DOI 10.1021/acs.langmuir.6b00468; Rosslee C, 2000, CURR OPIN COLLOID IN, V5, P81, DOI 10.1016/S1359-0294(00)00035-2; Rozynek Z, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4945; Shardt O, 2013, LANGMUIR, V29, P6201, DOI 10.1021/la304919p; Shi WL, 2006, NANO LETT, V6, P875, DOI 10.1021/nl0600833; Subramaniam AB, 2005, NATURE, V438, P930, DOI 10.1038/438930a; Vanapalli SA, 2001, FOOD HYDROCOLLOID, V15, P507, DOI 10.1016/S0268-005X(01)00057-1; Villar G, 2013, SCIENCE, V340, P48, DOI 10.1126/science.1229495; Wu BH, 2009, NANO RES, V2, P975, DOI 10.1007/s12274-009-9102-z; Wykes MSD, 2016, SOFT MATTER, V12, P4584, DOI 10.1039/c5sm03127c; Yu H, 2005, NANO LETT, V5, P379, DOI 10.1021/nl047955q; Zarzar LD, 2015, NATURE, V518, P520, DOI 10.1038/nature14168	29	112	115	26	450	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2018	553	7688					313	318		10.1038/nature25137	http://dx.doi.org/10.1038/nature25137			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT9MB	29320473				2022-12-28	WOS:000423475100046
J	Seegert, L				Seegert, Liz			US POLICY A year in health and healthcare under President Trump	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												liz@lizseegert.com						Abutaleb Y, 2017, REUTERS; [Anonymous], 2018, COMMUNICATION   0105; [Anonymous], 2003, BACK DRAWING BOARD F; [Anonymous], 2015, CNN POLITICS; [Anonymous], 2017, US WITHDR PAR CLIM A; Centers for Medicare and Medicaid Services, 2017, WHAT IS PAT PAP; Chow L., 2017, EPA PULLS SCI TALK C; Diamond J., 2015, CNN POLITICS    0730; Edney A, 2017, TRUMP CALLS DRUG PRI; HHS secretary Tom Price resigns, 2017, WASH POST; Howe A., 2017, GORSUCH ABORTION REL; LENZER J, 2017, BMJ-BRIT MED J, V358, DOI DOI 10.1136/BMJ.J423328903925; Lucia K, 2017, PRESIDENT TRUMPS EXE; Nichols C., 2017, TRUE CAMPAIGN TRUMP; Park E., 2017, CBO SEVERE HARM TRUM; Schipani V., 2016, CANDIDATES CLIMATE C; Snyder L, 2015, MEDICAID FINANCING D; Sobel L, 2017, NEW REGULATIONS BROA; Valverde M., 2017, D TRUMP DECLARES PUB; White House, 2017, COMMUNICATION   0601; White House, 2017, DJ TRUMP IS TAKING A; White House, 2017, PRESIDENT TRUMP CUTS	22	0	0	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 16	2018	360								k192	10.1136/bmj.k192	http://dx.doi.org/10.1136/bmj.k192			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT5PN	29339373				2022-12-28	WOS:000423205800006
J	Bae, C; Jara-Oseguera, A; Swartz, KJ				Bae, Chanhyung; Jara-Oseguera, Andres; Swartz, Kenton J.			TRPM channels come into focus	SCIENCE			English	Editorial Material							ELECTRON CRYOMICROSCOPY; REVEALS; ACTIVATION; MECHANISM; VOLTAGE		[Bae, Chanhyung; Jara-Oseguera, Andres; Swartz, Kenton J.] NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Swartz, KJ (corresponding author), NINDS, Mol Physiol & Biophys Sect, Porter Neurosci Res Ctr, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA.	kenton.swartz@nih.gov		Jara Oseguera, Andres/0000-0001-5921-9320; Bae, Chanhyung/0000-0003-3407-2857	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002945] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Autzen HE, 2018, SCIENCE, V359, P228, DOI 10.1126/science.aar4510; Bandell M, 2006, NAT NEUROSCI, V9, P493, DOI 10.1038/nn1665; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; Guo JT, 2017, NATURE, V552, P205, DOI 10.1038/nature24997; de Vega MJP, 2016, J MED CHEM, V59, P10006, DOI 10.1021/acs.jmedchem.6b00305; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Mathar I, 2014, HANDB EXP PHARMACOL, V222, P461, DOI 10.1007/978-3-642-54215-2_18; Minke B, 2010, J NEUROGENET, V24, P216, DOI 10.3109/01677063.2010.514369; MONTELL C, 1985, SCIENCE, V230, P1040, DOI 10.1126/science.3933112; Swartz KJ, 2008, NATURE, V456, P891, DOI 10.1038/nature07620; Whicher JR, 2016, SCIENCE, V353, P664, DOI 10.1126/science.aaf8070; Winkler PA, 2017, NATURE, V552, P200, DOI 10.1038/nature24674; Yin Y, 2018, SCIENCE, V359, P237, DOI 10.1126/science.aan4325; Zhang F, 2016, ELIFE, V5, DOI 10.7554/eLife.16409	15	5	6	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					160	161		10.1126/science.aar6205	http://dx.doi.org/10.1126/science.aar6205			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS5EO	29326261				2022-12-28	WOS:000419816600023
J	Carlton, JM				Carlton, Jane M.			Malaria parasite evolution in a test tube	SCIENCE			English	Editorial Material							PLASMODIUM-FALCIPARUM; RESISTANCE; LINEAGE; FUTURE		[Carlton, Jane M.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA	New York University	Carlton, JM (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.	jane.carlton@nyu.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI089676] Funding Source: NIH RePORTER; NIAID NIH HHS [U19 AI089676] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Barrick JE, 2013, NAT REV GENET, V14, P827, DOI 10.1038/nrg3564; Blasco B, 2017, NAT MED, V23, P917, DOI 10.1038/nm.4381; Carlton JMR, 2001, TRENDS PARASITOL, V17, P236, DOI 10.1016/S1471-4922(01)01899-2; Cowell AN, 2018, SCIENCE, V359, P191, DOI 10.1126/science.aan4472; Ghorbal M, 2014, NAT BIOTECHNOL, V32, P819, DOI 10.1038/nbt.2925; Hunt P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-499; Imwong M, 2017, LANCET INFECT DIS, V17, P1022, DOI 10.1016/S1473-3099(17)30524-8; Maddamsetti R, 2017, GENOME BIOL EVOL, V9, P1072, DOI 10.1093/gbe/evx064; Olszewski KL, 2009, CELL HOST MICROBE, V5, P191, DOI 10.1016/j.chom.2009.01.004; Perkins SL, 2014, J PARASITOL, V100, P11, DOI 10.1645/13-362.1; Wagner JC, 2014, NAT METHODS, V11, P915, DOI [10.1038/NMETH.3063, 10.1038/nmeth.3063]; WHO, 2016, WORLD MAL REP 2016; WILLIAMSON J, 1947, ANN TROP MED PARASIT, V41, P278, DOI 10.1080/00034983.1947.11685333; Zumla A, 2016, LANCET INFECT DIS, V16, pE47, DOI 10.1016/S1473-3099(16)00078-5	15	4	4	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					159	160		10.1126/science.aar4189	http://dx.doi.org/10.1126/science.aar4189			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS5EO	29326260	Green Accepted			2022-12-28	WOS:000419816600022
J	Cowell, AN; Istvan, ES; Lukens, AK; Gomez-Lorenzo, MG; Vanaerschot, M; Sakata-Kato, T; Flannery, EL; Magistrado, P; Owen, E; Abraham, M; LaMonte, G; Painter, HJ; Williams, RM; Franco, V; Linares, M; Arriaga, I; Bopp, S; Corey, VC; Gnadig, NF; Coburn-Flynn, O; Reimer, C; Gupta, P; Murithi, JM; Moura, PA; Fuchs, O; Sasaki, E; Kim, SW; Teng, CH; Wang, LT; Akidil, A; Adjalley, S; Willis, PA; Siegel, D; Tanaseichuk, O; Zhong, Y; Zhou, YY; Llinas, M; Ottilie, S; Gamo, FJ; Lee, MCS; Goldberg, DE; Fidock, DA; Wirth, DF; Winzeler, EA				Cowell, Annie N.; Istvan, Eva S.; Lukens, Amanda K.; Gomez-Lorenzo, Maria G.; Vanaerschot, Manu; Sakata-Kato, Tomoyo; Flannery, Erika L.; Magistrado, Pamela; Owen, Edward; Abraham, Matthew; LaMonte, Gregory; Painter, Heather J.; Williams, Roy M.; Franco, Virginia; Linares, Maria; Arriaga, Ignacio; Bopp, Selina; Corey, Victoria C.; Gnadig, Nina F.; Coburn-Flynn, Olivia; Reimer, Christin; Gupta, Purva; Murithi, James M.; Moura, Pedro A.; Fuchs, Olivia; Sasaki, Erika; Kim, Sang W.; Teng, Christine H.; Wang, Lawrence T.; Akidil, Asli; Adjalley, Sophie; Willis, Paul A.; Siegel, Dionicio; Tanaseichuk, Olga; Zhong, Yang; Zhou, Yingyao; Llinas, Manuel; Ottilie, Sabine; Gamo, Francisco-Javier; Lee, Marcus C. S.; Goldberg, Daniel E.; Fidock, David A.; Wirth, Dyann F.; Winzeler, Elizabeth A.			Mapping the malaria parasite druggable genome by using in vitro evolution and chemogenomics	SCIENCE			English	Article							PLASMODIUM-FALCIPARUM MALARIA; MULTIDRUG-RESISTANCE; ANTIMALARIAL-DRUG; CLINICAL CANDIDATE; LIFE-CYCLE; TRANSPORTER; REVEALS; BINDING; PROTEIN; GENE	Chemogenetic characterization through in vitro evolution combined with whole-genome analysis can identify antimalarial drug targets and drug-resistance genes. We performed a genome analysis of 262 Plasmodium falciparum parasites resistant to 37 diverse compounds. We found 159 gene amplifications and 148 nonsynonymous changes in 83 genes associated with drug-resistance acquisition, where gene amplifications contributed to one-third of resistance acquisition events. Beyond confirming previously identified multidrug-resistance mechanisms, we discovered hitherto unrecognized drug target-inhibitor pairs, including thymidylate synthase and a benzoquinazolinone, farnesyltransferase and a pyrimidinedione, and a dipeptidylpeptidase and an arylurea. This exploration of the P. falciparum resistome and druggable genome will likely guide drug discovery and structural biology efforts, while also advancing our understanding of resistance mechanisms available to the malaria parasite.	[Cowell, Annie N.; Flannery, Erika L.; Abraham, Matthew; LaMonte, Gregory; Williams, Roy M.; Corey, Victoria C.; Reimer, Christin; Gupta, Purva; Fuchs, Olivia; Sasaki, Erika; Kim, Sang W.; Teng, Christine H.; Wang, Lawrence T.; Ottilie, Sabine; Winzeler, Elizabeth A.] Univ Calif San Diego, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Istvan, Eva S.; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Istvan, Eva S.; Goldberg, Daniel E.] Washington Univ, Sch Med, Dept Mol Biol, St Louis, MO 63110 USA; [Lukens, Amanda K.; Sakata-Kato, Tomoyo; Magistrado, Pamela; Bopp, Selina; Wirth, Dyann F.] Harvard TH Chan Sch Publ Hlth, Dept Immunol & Infect Dis, 665 Huntington Ave, Boston, MA 02115 USA; [Lukens, Amanda K.; Wirth, Dyann F.] Broad Inst, Infect Dis Program, 415 Main St, Cambridge, MA 02142 USA; [Gomez-Lorenzo, Maria G.; Franco, Virginia; Linares, Maria; Arriaga, Ignacio; Gamo, Francisco-Javier] GlaxoSmithKline, Malaria Discovery Performance Unit, Tres Cantos Med Dev Campus,Severo Ochoa 2, Madrid 28760, Spain; [Vanaerschot, Manu; Gnadig, Nina F.; Coburn-Flynn, Olivia; Murithi, James M.; Moura, Pedro A.; Lee, Marcus C. S.; Fidock, David A.] Columbia Univ Coll Phys & Surg, Dept Microbiol & Immunol, 630 W 168th St, New York, NY 10032 USA; [Owen, Edward; Painter, Heather J.; Llinas, Manuel] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA; [Akidil, Asli; Adjalley, Sophie; Lee, Marcus C. S.] Wellcome Sanger Inst, Malaria Programme, Wellcome Genome Campus, Hinxton CB10 1SA, Cambs, England; [Willis, Paul A.] Med Malaria Venture, POB 1826,20 Route Prebois, CH-1215 Geneva 15, Switzerland; [Siegel, Dionicio; Winzeler, Elizabeth A.] UCSD, Skaggs Sch Pharm & Pharmaceut Sci, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Tanaseichuk, Olga; Zhong, Yang; Zhou, Yingyao] Novartis Res Fdn, Genom Inst, 10675 John J Hopkins Dr, San Diego, CA 92121 USA; [Fidock, David A.] Columbia Univ Coll Phys & Surg, Div Infect Dis, 630 W 168th St, New York, NY 10032 USA	University of California System; University of California San Diego; Washington University (WUSTL); Washington University (WUSTL); Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; GlaxoSmithKline; Columbia University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Wellcome Trust Sanger Institute; University of California System; University of California San Diego; Novartis; Columbia University	Winzeler, EA (corresponding author), Univ Calif San Diego, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ewinzeler@ucsd.edu	Linares, Maria/Q-4106-2017; Winzeler, Elizabeth/AAP-6752-2020; Vanaerschot, Manu/B-6812-2013	Linares, Maria/0000-0003-3180-6560; Winzeler, Elizabeth/0000-0002-4049-2113; Vanaerschot, Manu/0000-0002-9141-2347; Bopp, Selina/0000-0002-9412-9766; Lee, Marcus/0000-0002-4973-0915; Fidock, David/0000-0001-6753-8938; Reimer, Christin/0000-0002-6288-0109; Owen, Edward/0000-0001-7331-4658; Lukens, Amanda/0000-0002-9560-7643; Gomez Lorenzo, Maria de Gracia/0000-0003-2065-1145	Bill and Melinda Gates Foundation [OPP1040406, OPP1119049]; National Institutes of Health [P50GM085764]; National Institute of Allergy and Infectious Diseases (NIAID) [R01AI103058, R01AI50234]; UCSD Division of Infectious Diseases institutional NIAID training grant [T32AI007036]; NIAID National Research Service Award fellowship [F32AI102567]; UCSD Genetics Training Program through National Institute of General Medical Sciences [T32GM008666]; A.P. Giannini Post-Doctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI050234, R01AI090141, R01AI103058, R01AI050234, T32AI007036, R01AI099105] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085764, T32GM008666, T32GM007198] Funding Source: NIH RePORTER	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); UCSD Division of Infectious Diseases institutional NIAID training grant; NIAID National Research Service Award fellowship; UCSD Genetics Training Program through National Institute of General Medical Sciences; A.P. Giannini Post-Doctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Bill and Melinda Gates Foundation (OPP1040406 and OPP1119049), the National Institutes of Health (P50GM085764), and the National Institute of Allergy and Infectious Diseases (NIAID; R01AI103058 and R01AI50234). Whole-genome sequencing was performed at the Institute for Genomic Medicine Genomic Center, UCSD. We thank the Penn State Metabolomics Core Facility (University Park, PA) for critical analytical expertise. A.C. received support from the UCSD Division of Infectious Diseases institutional NIAID training grant (T32AI007036). E.L.F. received support from a NIAID National Research Service Award fellowship (F32AI102567). V.C. received support from a UCSD Genetics Training Program through an institutional training grant from the National Institute of General Medical Sciences (T32GM008666). G.M.L. is supported by an A.P. Giannini Post-Doctoral Fellowship. The authors declare no competing financial interests. The red blood cells used in this work were sourced ethically, and their research use was in accord with the terms of the informed consents. All relevant sequence data that were not previously published have been deposited in the National Center for Biotechnology Information (NCBI) Sequence Read Archive (SRA) database with accession code SRP096299. Previously published sequences are deposited in the NCBI SRA with the accession codes listed in table S3. This work is licensed under a Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. This license does not apply to figures/photos/artwork or other content included in the article that is credited to a third party; obtain authorization from the rights holder before using such material.	Allman Erik L, 2016, Antimicrob Agents Chemother, V60, P6635, DOI 10.1128/AAC.01224-16; Almawi AW, 2017, PROG BIOPHYS MOL BIO, V127, P105, DOI 10.1016/j.pbiomolbio.2016.12.003; Alper SL, 2013, MOL ASPECTS MED, V34, P494, DOI 10.1016/j.mam.2012.07.009; Alvarez-Ortega C, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00007; Amato R, 2016, ELIFE, V5, DOI 10.7554/eLife.08714; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Baragana B, 2015, NATURE, V522, P315, DOI 10.1038/nature14451; Jimenez-Diaz MB, 2014, P NATL ACAD SCI USA, V111, pE5455, DOI 10.1073/pnas.1414221111; Blasco B, 2017, NAT MED, V23, P917, DOI 10.1038/nm.4381; Bopp SER, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003293; Borrmann S, 2013, SCI REP-UK, V3, DOI 10.1038/srep03318; Boss C, 2016, CHEMMEDCHEM, V11, P1995, DOI 10.1002/cmdc.201600298; Campbell TL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001165; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Corey VC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11901; Coyne S, 2010, ANTIMICROB AGENTS CH, V54, P4389, DOI 10.1128/AAC.00155-10; Dharia NV, 2010, GENOME RES, V20, P1534, DOI 10.1101/gr.105163.110; Eastman RT, 2007, MOL BIOCHEM PARASIT, V152, P66, DOI 10.1016/j.molbiopara.2006.11.012; Flannery EL, 2015, ACS CHEM BIOL, V10, P413, DOI 10.1021/cb500616x; Flannery EL, 2013, J MED CHEM, V56, P7761, DOI 10.1021/jm400325j; Gamo FJ, 2010, NATURE, V465, P305, DOI 10.1038/nature09107; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; Gasnier B, 2004, PFLUG ARCH EUR J PHY, V447, P756, DOI 10.1007/s00424-003-1091-2; Geertsma ER, 2015, NAT STRUCT MOL BIOL, V22, P803, DOI 10.1038/nsmb.3091; Glenn MP, 2006, J MED CHEM, V49, P5710, DOI 10.1021/jm060081v; Guiguemde WA, 2010, NATURE, V465, P311, DOI 10.1038/nature09099; Guler JL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003375; Henry RI, 2007, BIOCHEM BIOPH RES CO, V363, P288, DOI 10.1016/j.bbrc.2007.08.116; Hoepfner D, 2012, CELL HOST MICROBE, V11, P654, DOI 10.1016/j.chom.2012.04.015; Istvan ES, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14240; Istvan ES, 2011, P NATL ACAD SCI USA, V108, P1627, DOI 10.1073/pnas.1011560108; Kato N, 2016, NATURE, V538, P344, DOI 10.1038/nature19804; Kavishe RA, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-205; Kenthirapalan S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10519; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Kuhen KL, 2014, ANTIMICROB AGENTS CH, V58, P5060, DOI 10.1128/AAC.02727-13; LaMonte G, 2016, MBIO, V7, DOI 10.1128/mBio.00696-16; Lim MYX, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.166, 10.1038/nmicrobiol.2016.166]; McNamara CW, 2013, NATURE, V504, P248, DOI 10.1038/nature12782; Meister S, 2011, SCIENCE, V334, P1372, DOI 10.1126/science.1211936; Menard D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002489; Modrzynska K, 2017, CELL HOST MICROBE, V21, P11, DOI 10.1016/j.chom.2016.12.003; Mok S, 2014, MOL MICROBIOL, V91, P918, DOI 10.1111/mmi.12505; Mu JB, 2010, NAT GENET, V42, P268, DOI 10.1038/ng.528; Nair S, 2007, MOL BIOL EVOL, V24, P562, DOI 10.1093/molbev/msl185; Nair S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000243; Ng CL, 2016, MOL MICROBIOL, V101, P381, DOI 10.1111/mmi.13397; Paul S, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00143; Paulusma CC, 2005, BBA-MOL BASIS DIS, V1741, P11, DOI 10.1016/j.bbadis.2005.04.006; Plouffe D, 2008, P NATL ACAD SCI USA, V105, P9059, DOI 10.1073/pnas.0802982105; Riechmann JL, 1998, BIOL CHEM, V379, P633; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Rottmann M, 2010, SCIENCE, V329, P1175, DOI 10.1126/science.1193225; Santos JM, 2017, CELL HOST MICROBE, V21, P731, DOI 10.1016/j.chom.2017.05.006; Schweizer HP, 2001, FEMS MICROBIOL LETT, V202, P1, DOI 10.1111/j.1574-6968.2001.tb10772.x; Sonoiki E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14574; Spangenberg T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062906; Teo SM, 2012, BIOINFORMATICS, V28, P2711, DOI 10.1093/bioinformatics/bts535; Thorvaldsdottir H, 2013, BRIEF BIOINFORM, V14, P178, DOI 10.1093/bib/bbs017; Wang F, 2011, MOL BIOCHEM PARASIT, V175, P10, DOI 10.1016/j.molbiopara.2010.08.004; Wang ZL, 2016, SCI REP-UK, V6, DOI 10.1038/srep33891; Wendler JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096486; White NJ, 2014, NEW ENGL J MED, V371, P403, DOI 10.1056/NEJMoa1315860; Witkowski B, 2017, LANCET INFECT DIS, V17, P174, DOI [10.1016/S1473-3099(16)30415-7, 10.1016/s1473-3099(16)30415-7]; Yu Min, 2008, Cell Host Microbe, V4, P567, DOI 10.1016/j.chom.2008.11.001; Yuvaniyama J, 2003, NAT STRUCT BIOL, V10, P357, DOI 10.1038/nsb921	69	119	123	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					191	+		10.1126/science.aan4472	http://dx.doi.org/10.1126/science.aan4472			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS5EO	29326268	Green Submitted, Green Published, Green Accepted			2022-12-28	WOS:000419816600041
J	Frattini, V; Pagnotta, SM; Tala; Fan, JJ; Russo, MV; Lee, SB; Garofano, L; Zhang, J; Shi, PG; Lewis, G; Sanson, H; Frederick, V; Castano, AM; Cerulo, L; Rolland, DCM; Mall, R; Mokhtari, K; Elenitoba-Johnson, KSJ; Sanson, M; Huang, X; Ceccarelli, M; Lasorella, A; Iavarone, A				Frattini, Veronique; Pagnotta, Stefano M.; Tala; Fan, Jerry J.; Russo, Marco V.; Lee, Sang Bae; Garofano, Luciano; Zhang, Jing; Shi, Peiguo; Lewis, Genevieve; Sanson, Heloise; Frederick, Vanessa; Castano, Angelica M.; Cerulo, Luigi; Rolland, Delphine C. M.; Mall, Raghvendra; Mokhtari, Karima; Elenitoba-Johnson, Kojo S. J.; Sanson, Marc; Huang, Xi; Ceccarelli, Michele; Lasorella, Anna; Iavarone, Antonio			A metabolic function of FGFR3-TACC3 gene fusions in cancer	NATURE			English	Article							STATISTICAL-MODEL; MASS-SPECTROMETRY; MYELOID-LEUKEMIA; PROTEIN; GLIOMA; PROLIFERATION; INHIBITION; LANDSCAPE; TOPOLOGY; TUMORS	Chromosomal translocations that generate in-frame oncogenic gene fusions are notable examples of the success of targeted cancer therapies(1-3). We have previously described gene fusions of FGFR3-TACC3 (F3-T3) in 3% of human glioblastoma cases(4). Subsequent studies have reported similar frequencies of F3-T3 in many other cancers, indicating that F3-T3 is a commonly occuring fusion across all tumour types(5,6). F3-T3 fusions are potent oncogenes that confer sensitivity to FGFR inhibitors, but the downstream oncogenic signalling pathways remain unknown(2,4-6). Here we show that human tumours with F3-T3 fusions cluster within transcriptional subgroups that are characterized by the activation of mitochondrial functions. F3-T3 activates oxidative phosphorylation and mitochondrial biogenesis and induces sensitivity to inhibitors of oxidative metabolism. Phosphorylation of the phosphopeptide PIN4 is an intermediate step in the signalling pathway of the activation of mitochondrial metabolism. The F3-T3-PIN4 axis triggers the biogenesis of peroxisomes and the synthesis of new proteins. The anabolic response converges on the PGC1 alpha coactivator through the production of intracellular reactive oxygen species, which enables mitochondrial respiration and tumour growth. These data illustrate the oncogenic circuit engaged by F3-T3 and show that F3-T3-positive tumours rely on mitochondrial respiration, highlighting this pathway as a therapeutic opportunity for the treatment of tumours with F3-T3 fusions. We also provide insights into the genetic alterations that initiate the chain of metabolic responses that drive mitochondrial metabolism in cancer.	[Frattini, Veronique; Pagnotta, Stefano M.; Tala; Russo, Marco V.; Lee, Sang Bae; Garofano, Luciano; Zhang, Jing; Shi, Peiguo; Lewis, Genevieve; Sanson, Heloise; Frederick, Vanessa; Castano, Angelica M.; Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Inst Canc Genet, Med Ctr, New York, NY 10032 USA; [Pagnotta, Stefano M.; Garofano, Luciano; Cerulo, Luigi; Ceccarelli, Michele] Univ Sannio, Dept Sci & Technol, I-82100 Benevento, Italy; [Fan, Jerry J.; Huang, Xi] Hosp Sick Children, Program Dev & Stem Cell Biol, Arthur & Sonia Labatt Brain Tumour Res Ctr, Toronto, ON M5G 1A4, Canada; [Fan, Jerry J.; Huang, Xi] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Garofano, Luciano; Cerulo, Luigi; Ceccarelli, Michele] BIOGEM Ist Ric Genet G Salvatore, I-83031 Campo Reale, Ariano Irpino, Italy; [Rolland, Delphine C. M.; Elenitoba-Johnson, Kojo S. J.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Mall, Raghvendra] Hamad Bin Khalifa Univ, QCRI, Doha, Qatar; [Mokhtari, Karima; Sanson, Marc] UPMC Univ Paris 06, Sorbonne Univ, UMR S 1127, CNRS,UMR 7225,ICM,Inserm U1127, F-75013 Paris, France; [Mokhtari, Karima] Grp Hosp Pitie Salpetriere, AP HP, Lab Neuropathol R Escourolle, F-75013 Paris, France; [Mokhtari, Karima; Sanson, Marc] AP HP, Onconeurotek, F-75013 Paris, France; [Sanson, Marc] Hop La Pitie Salpetriere, AP HP, Serv Neurol 2, F-75013 Paris, France; [Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10032 USA; [Lasorella, Anna] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10032 USA; [Iavarone, Antonio] Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA	Columbia University; University of Sannio; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Pennsylvania; Pennsylvania Medicine; Qatar Foundation (QF); Hamad Bin Khalifa University-Qatar; Qatar Computing Research Institute; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Columbia University; Columbia University; Columbia University	Lasorella, A; Iavarone, A (corresponding author), Columbia Univ, Inst Canc Genet, Med Ctr, New York, NY 10032 USA.; Lasorella, A; Iavarone, A (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10032 USA.; Lasorella, A (corresponding author), Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10032 USA.; Iavarone, A (corresponding author), Columbia Univ, Dept Neurol, Med Ctr, New York, NY 10032 USA.	al2179@cumc.columbia.edu; ai2102@cumc.columbia.edu	Rolland, Delphine/ABG-2497-2021; Ceccarelli, Michele/AGP-1739-2022; Huang, Xi/C-2409-2017; Garofano, Luciano/ABI-7602-2022; Mall, Raghvendra/I-9470-2019	Huang, Xi/0000-0002-7177-7525; Garofano, Luciano/0000-0001-8582-0865; Mall, Raghvendra/0000-0003-1779-3150; LEE, SANG BAE/0000-0002-4031-8051; PAGNOTTA, Stefano Maria/0000-0002-8298-9777; Elenitoba-Johnson, Kojo/0000-0002-1082-1545; Iavarone, Antonio/0000-0002-0683-4634; Rolland, Delphine/0000-0002-7801-6534; Russo, Marco Vincenzo/0000-0002-5148-1305; Fan, Jerry/0000-0002-2381-5427	NIH [R01CA101644, U54CA193313, R01CA131126, R01CA178546, R01CA179044, R01CA190891, R01NS061776]; Chemotherapy Foundation; Ontario Institute for Cancer Research (OICR) Brain Translational Research Initiative; American Brain Tumor Association (ABTA); Cancer Biology Taining Grant [T32CA009503]; Italian Association for Cancer Research (AIRC) fellowship; SickKids Garron Family Cancer Centre Pitblado Discovery;  [NRF-2013R1A6A3A03063888]; NATIONAL CANCER INSTITUTE [T32CA009503, R01CA190891, R01CA178546, R01CA179044, R01CA131126, R01CA101644, U54CA193313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061776] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chemotherapy Foundation; Ontario Institute for Cancer Research (OICR) Brain Translational Research Initiative; American Brain Tumor Association (ABTA); Cancer Biology Taining Grant; Italian Association for Cancer Research (AIRC) fellowship(Fondazione AIRC per la ricerca sul cancro); SickKids Garron Family Cancer Centre Pitblado Discovery; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. Scuoppo for donation of the pLCiG2 plasmid and support with the gRNA design, E. Chen for identification of PIN4 immunocomplexes and H. Li for high-content microscopy. This work was supported by NIH R01CA101644, U54CA193313 and R01CA131126 to A.L.; R01CA178546, U54CA193313, R01CA179044, R01CA190891, R01NS061776 and The Chemotherapy Foundation to A. I.; SickKids Garron Family Cancer Centre Pitblado Discovery and Ontario Institute for Cancer Research (OICR) Brain Translational Research Initiative to X.H.; American Brain Tumor Association (ABTA) and a Cancer Biology Taining Grant (T32CA009503) fellowship to V.Fra.; a NRF-2013R1A6A3A03063888 fellowship to S.B.L.; an Italian Association for Cancer Research (AIRC) fellowship to M.V.R.	Ajaz Saima, 2015, Methods Mol Biol, V1264, P117, DOI 10.1007/978-1-4939-2257-4_12; Ali MAM, 2016, MOL DIAGN THER, V20, P315, DOI 10.1007/s40291-016-0208-1; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Carlsson G, 2009, B AM MATH SOC, V46, P255, DOI 10.1090/S0273-0979-09-01249-X; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Ceccarelli M, 2016, CELL, V164, P550, DOI 10.1016/j.cell.2015.12.028; Costa R, 2016, ONCOTARGET, V7, P55924, DOI 10.18632/oncotarget.10482; Devarakonda S, 2011, P NATL ACAD SCI USA, V108, P18678, DOI 10.1073/pnas.1113813108; Di Stefano AL, 2015, CLIN CANCER RES, V21, P3307, DOI 10.1158/1078-0432.CCR-14-2199; Fenyo D, 2003, ANAL CHEM, V75, P768, DOI 10.1021/ac0258709; Fermin D, 2011, PROTEOMICS, V11, P1340, DOI 10.1002/pmic.201000650; Frattini V, 2013, NAT GENET, V45, P1141, DOI 10.1038/ng.2734; Gerber DE, 2010, CANCER CELL, V18, P548, DOI 10.1016/j.ccr.2010.11.033; Haibo He, 2009, IEEE Transactions on Knowledge and Data Engineering, V21, P1263, DOI 10.1109/TKDE.2008.239; Han J, 2013, NAT CELL BIOL, V15, P481, DOI 10.1038/ncb2738; Isserlin Ruth, 2014, F1000Res, V3, P141, DOI 10.12688/f1000research.4536.1; Iyer MK, 2011, BIOINFORMATICS, V27, P2903, DOI 10.1093/bioinformatics/btr467; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Kessner D, 2008, BIOINFORMATICS, V24, P2534, DOI 10.1093/bioinformatics/btn323; Lasorella A, 2005, MOL CELL BIOL, V25, P3563, DOI 10.1128/MCB.25.9.3563-3574.2005; Lasorella A, 2017, NEURO-ONCOLOGY, V19, P475, DOI 10.1093/neuonc/now240; Lee SB, 2016, NATURE, V529, P172, DOI 10.1038/nature16475; Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lum PY, 2013, SCI REP-UK, V3, DOI 10.1038/srep01236; MacLean B, 2006, BIOINFORMATICS, V22, P2830, DOI 10.1093/bioinformatics/btl379; Malina A, 2014, METHOD ENZYMOL, V546, P193, DOI 10.1016/B978-0-12-801185-0.00010-6; Mall R., 2017, PREPRINT; Merico D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013984; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nicolau M, 2011, P NATL ACAD SCI USA, V108, P7265, DOI 10.1073/pnas.1102826108; Nielson JL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9581; Niola F, 2013, J CLIN INVEST, V123, P405, DOI 10.1172/JCI63811; Pedrioli PGA, 2010, METHODS MOL BIOL, V604, P213, DOI 10.1007/978-1-60761-444-9_15; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Read RD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003253; Read RD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000374; Risso D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-480; Rizvi AH, 2017, NAT BIOTECHNOL, V35, P551, DOI 10.1038/nbt.3854; Rolland D, 2014, AM J PATHOL, V184, P1331, DOI 10.1016/j.ajpath.2014.01.036; Roweis ST, 2000, SCIENCE, V290, P2323, DOI 10.1126/science.290.5500.2323; RUTKA JT, 1987, ACTA NEUROPATHOL, V75, P92, DOI 10.1007/BF00686798; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Singh Gurjeet, 2007, EUR S POINT BAS GRAP, DOI [10.2312/SPBG/SPBG07/091-100, DOI 10.2312/SPBG/SPBG07/091-100]; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Smith JJ, 2013, NAT REV MOL CELL BIO, V14, P803, DOI 10.1038/nrm3700; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Sonoda Y, 2001, CANCER RES, V61, P4956; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Stransky N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5846; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tiefenbock SK, 2010, EMBO J, V29, P171, DOI 10.1038/emboj.2009.330; Uchida T, 1999, FEBS LETT, V446, P278, DOI 10.1016/S0014-5793(99)00239-2; Uchida T, 2003, CHEM BIOL, V10, P15, DOI 10.1016/S1074-5521(02)00310-1; Vazquez F, 2013, CANCER CELL, V23, P287, DOI 10.1016/j.ccr.2012.11.020; XIONG WC, 1994, GENE DEV, V8, P981, DOI 10.1101/gad.8.8.981; Yeh ES, 2007, NAT REV CANCER, V7, P381, DOI 10.1038/nrc2107; Yoshihara K, 2015, ONCOGENE, V34, P4845, DOI 10.1038/onc.2014.406; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727; Zhu SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046724	61	86	88	3	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2018	553	7687					222	+		10.1038/nature25171	http://dx.doi.org/10.1038/nature25171			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4WL	29323298	Green Accepted, Green Submitted			2022-12-28	WOS:000419794800040
J	Reich, DS; Lucchinetti, CF; Calabresi, PA				Reich, Daniel S.; Lucchinetti, Claudia F.; Calabresi, Peter A.			Multiple Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							OPTICAL COHERENCE TOMOGRAPHY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CENTRAL-NERVOUS-SYSTEM; GRAY-MATTER ATROPHY; BRAIN ATROPHY; CORTICAL DEMYELINATION; DISEASE-ACTIVITY; MYELOID CELLS; WHITE-MATTER; DOUBLE-BLIND		[Reich, Daniel S.] NINDS, Translat Neuroradiol Sect, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Calabresi, Peter A.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Calabresi, Peter A.] Johns Hopkins Sch Med, Dept Neurosci, Baltimore, MD USA; [Lucchinetti, Claudia F.] Mayo Clin, Dept Neurol, Rochester, MN USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Mayo Clinic	Reich, DS (corresponding author), NINDS, 10 Ctr Dr,MSC 1400,Bldg 10,Rm 5C103, Bethesda, MD 20892 USA.	daniel.reich@nih.gov	Calabresi, Peter A./AAF-2288-2019; Filippi, Massimo/K-1755-2018; Rocca, Maria Assunta/K-1619-2018; Reich, Daniel S./E-5701-2010	Filippi, Massimo/0000-0002-5485-0479; Rocca, Maria Assunta/0000-0003-2358-4320; Reich, Daniel S./0000-0002-2628-4334; Calabresi, Peter/0000-0002-7776-6472	Novartis; Sanofi-Synthelabo; Biogen; Mallinkrodt; Alexion; Biogen Idec; Med-Immune; Teva; Annexon; AbbVie; Merck; Vaccinex; Vertex; Disarm Therapeutics; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003119, R37NS041435] Funding Source: NIH RePORTER	Novartis(Novartis); Sanofi-Synthelabo; Biogen(Biogen); Mallinkrodt; Alexion; Biogen Idec(Biogen); Med-Immune(AstraZenecaMedimmune); Teva(Teva Pharmaceutical Industries); Annexon; AbbVie(AbbVie); Merck(Merck & Company); Vaccinex; Vertex(Vertex Pharmaceuticals); Disarm Therapeutics; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Dr. Reich reports having cooperative research and development agreements with Vertex Pharmaceuticals, holding a patent (US9607392) on a system and method of automatically detecting tissue abnormalities, and having a pending patent (PCT/US2013/033334) on a method of analyzing multisequence MRI data for analyzing brain abnormalities in a patient; Dr. Lucchinetti, receiving grant support from Novartis, Sanofi-Synthelabo, Biogen, Mallinkrodt, and Alexion; and Dr. Calabresi, receiving grant support, paid to his institution, and consulting fees from Biogen Idec, grant support paid to his institution from Novartis, Med-Immune, Teva, and Annexon, and consulting fees from AbbVie, Merck, Vaccinex, Vertex, and Disarm Therapeutics. No other potential conflict of interest relevant to this article was reported.	Absinta M, 2016, J CLIN INVEST, V126, P2597, DOI 10.1172/JCI86198; Absinta M, 2016, NAT REV NEUROL, V12, P358, DOI 10.1038/nrneurol.2016.59; Absinta M, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000145; Absinta M, 2015, NEUROLOGY, V85, P18, DOI 10.1212/WNL.0000000000001587; Adelman Gabriel, 2013, J Med Econ, V16, P639, DOI 10.3111/13696998.2013.778268; Aguzzi A, 2013, SCIENCE, V339, P156, DOI 10.1126/science.1227901; Altmann DR, 2009, NEUROLOGY, V72, P595, DOI 10.1212/01.wnl.0000335765.55346.fc; Arnason BGW, 1999, NEUROLOGY, V53, P457, DOI 10.1212/wnl.53.3.457; Ascherio A, 2016, SEMIN NEUROL, V36, P103, DOI 10.1055/s-0036-1579693; Azevedo CJ, 2015, NEUROL-NEUROIMMUNOL, V2, DOI 10.1212/NXI.0000000000000102; Berer K, 2017, P NATL ACAD SCI USA, V114, P10719, DOI 10.1073/pnas.1711233114; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bergles DE, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a020453; Bo L, 2003, J NEUROPATH EXP NEUR, V62, P723, DOI 10.1093/jnen/62.7.723; Brownlee WJ, 2017, LANCET, V389, P1336, DOI 10.1016/S0140-6736(16)30959-X; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Carbajal KS, 2015, J IMMUNOL, V195, P2552, DOI 10.4049/jimmunol.1501097; Cekanaviciute E, 2017, P NATL ACAD SCI USA, V114, P10713, DOI 10.1073/pnas.1711235114; Chang A, 2000, J NEUROSCI, V20, P6404, DOI 10.1523/JNEUROSCI.20-17-06404.2000; Chataway J, 2014, LANCET, V383, P2213, DOI 10.1016/S0140-6736(13)62242-4; Cree BAC, 2016, ANN NEUROL, V80, P499, DOI 10.1002/ana.24747; De Stefano N, 2010, NEUROLOGY, V74, P1868, DOI 10.1212/WNL.0b013e3181e24136; DeLuca GC, 2006, BRAIN, V129, P1507, DOI 10.1093/brain/awl074; Dimou L, 2015, GLIA, V63, P1429, DOI 10.1002/glia.22859; Farh KKH, 2015, NATURE, V518, P337, DOI 10.1038/nature13835; Feigin VL, 2017, LANCET NEUROL, V16, P877, DOI 10.1016/S1474-4422(17)30299-5; Fisher E, 2016, MULT SCLER J, V22, P668, DOI 10.1177/1352458515599072; Fox RJ, 2016, CONTEMP CLIN TRIALS, V50, P166, DOI 10.1016/j.cct.2016.08.009; Fox RJ, 2012, MULT SCLER J, V18, P1534, DOI 10.1177/1352458512458169; Franklin RJM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020594; Gaitan MI, 2011, ANN NEUROL, V70, P22, DOI 10.1002/ana.22472; Gilmore CP, 2009, MULT SCLER, V15, P180, DOI 10.1177/1352458508096876; Giovannoni G, 2015, MULT SCLER RELAT DIS, V4, P329, DOI 10.1016/j.msard.2015.04.006; Green AJ, 2010, BRAIN, V133, P1591, DOI 10.1093/brain/awq080; Guerau-de-Arellano M, 2012, J NEUROIMMUNOL, V248, P32, DOI 10.1016/j.jneuroim.2011.10.006; HARRIS JO, 1991, ANN NEUROL, V29, P548, DOI 10.1002/ana.410290515; Housley WJ, 2015, CLIN IMMUNOL, V161, P51, DOI 10.1016/j.clim.2015.06.015; Jarius S, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0929-z; Kantarci OH, 2016, ANN NEUROL, V79, P288, DOI 10.1002/ana.24564; Kaunzner UW, 2017, CURR TREAT OPTION NE, V19, DOI 10.1007/s11940-017-0454-5; Kearney H, 2015, NAT REV NEUROL, V11, P327, DOI 10.1038/nrneurol.2015.80; Keegan M, 2005, LANCET, V366, P579, DOI 10.1016/S0140-6736(05)67102-4; Kipp M, 2012, MULT SCLER RELAT DIS, V1, P15, DOI 10.1016/j.msard.2011.09.002; Kitic M, 2017, ACTA NEUROPATHOL, V134, P325, DOI 10.1007/s00401-017-1735-5; Kuhle J, 2016, MULT SCLER J, V22, P1550, DOI 10.1177/1352458515623365; Kutzelnigg A, 2005, BRAIN, V128, P2705, DOI 10.1093/brain/awh641; Kwong B, 2017, NAT IMMUNOL, V18, P1117, DOI 10.1038/ni.3816; Lassmann H, 2014, GLIA, V62, P1816, DOI 10.1002/glia.22597; Lassmann H, 2012, NAT REV NEUROL, V8, P647, DOI 10.1038/nrneurol.2012.168; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Linden JR, 2015, MBIO, V6, DOI 10.1128/mBio.02513-14; Liu W, 2014, ANN NEUROL, V76, P370, DOI 10.1002/ana.24213; Lucchinetti C, 2000, ANN NEUROL, V47, P707, DOI 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q; Lucchinetti CF, 2011, NEW ENGL J MED, V365, P2188, DOI 10.1056/NEJMoa1100648; Ludwin SK, 2016, MULT SCLER J, V22, P1114, DOI 10.1177/1352458516643396; Maggi P, 2014, ANN NEUROL, V76, P594, DOI 10.1002/ana.24242; Mahad DH, 2015, LANCET NEUROL, V14, P183, DOI 10.1016/S1474-4422(14)70256-X; Martinez-Lapiscina EH, 2016, LANCET NEUROL, V15, P574, DOI 10.1016/S1474-4422(16)00068-5; Metz I, 2014, ANN NEUROL, V75, P728, DOI 10.1002/ana.24163; Michel L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00636; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Mishra MK, 2016, NAT REV NEUROL, V12, P539, DOI 10.1038/nrneurol.2016.110; Montalban X, 2017, NEW ENGL J MED, V376, P209, DOI 10.1056/NEJMoa1606468; Muraro PA, 2017, NAT REV NEUROL, V13, P391, DOI 10.1038/nrneurol.2017.81; Nandoskar A, 2017, DRUGS, V77, P885, DOI 10.1007/s40265-017-0726-0; Nikic I, 2011, NAT MED, V17, P495, DOI 10.1038/nm.2324; Okuda DT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090509; Peterson JW, 2001, ANN NEUROL, V50, P389, DOI 10.1002/ana.1123; Petzold A, 2017, LANCET NEUROL, V16, P797, DOI 10.1016/S1474-4422(17)30278-8; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Rawji KS, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00047; Reich DS, 2015, MULT SCLER J, V21, P1693, DOI 10.1177/1352458515569098; Rovira A, 2015, NAT REV NEUROL, V11, P471, DOI 10.1038/nrneurol.2015.106; Ruckh JM, 2012, CELL STEM CELL, V10, P96, DOI 10.1016/j.stem.2011.11.019; Ryu JK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9164; Saidha S, 2015, ANN NEUROL, V78, P801, DOI 10.1002/ana.24487; Schlaeger R, 2014, ANN NEUROL, V76, P568, DOI 10.1002/ana.24241; Segal BM, 2008, LANCET NEUROL, V7, P796, DOI 10.1016/S1474-4422(08)70173-X; Serafini B, 2004, BRAIN PATHOL, V14, P164, DOI 10.1111/j.1750-3639.2004.tb00049.x; Signori A, 2016, MULT SCLER RELAT DIS, V6, P57, DOI 10.1016/j.msard.2016.01.007; Solomon AJ, 2016, NEUROLOGY, V87, P1393, DOI 10.1212/WNL.0000000000003152; Sormani MP, 2014, ANN NEUROL, V75, P43, DOI 10.1002/ana.24018; Sormani MP, 2013, LANCET NEUROL, V12, P669, DOI 10.1016/S1474-4422(13)70103-0; Syc SB, 2012, BRAIN, V135, P521, DOI 10.1093/brain/awr264; Thompson AJ, 2017, LANCET NEUROL; Traboulsee A, 2016, AM J NEURORADIOL, V37, P394, DOI 10.3174/ajnr.A4539; Tran JQ, 2014, NEUROL-NEUROIMMUNOL, V1, DOI 10.1212/NXI.0000000000000018; Trapp BD, 1998, NEW ENGL J MED, V338, P278, DOI 10.1056/NEJM199801293380502; van der Valk P, 2009, CURR OPIN NEUROL, V22, P207, DOI 10.1097/WCO.0b013e32832b4c76; Zhang T, 2015, EUR J NEUROL, V22, P990, DOI 10.1111/ene.12698; Zivadinov R, 2013, RADIOLOGY, V268, P831, DOI 10.1148/radiol.13122424	91	1002	1025	29	286	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 11	2018	378	2					169	180		10.1056/NEJMra1401483	http://dx.doi.org/10.1056/NEJMra1401483			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS7IR	29320652	Green Accepted			2022-12-28	WOS:000419971600010
J	Atri, A; Frolich, L; Ballard, C; Tariot, PN; Molinuevo, JL; Boneva, N; Windfeld, K; Raket, LL; Cummings, JL				Atri, Alireza; Frolich, Lutz; Ballard, Clive; Tariot, Pierre N.; Molinuevo, Jose Luis; Boneva, Neli; Windfeld, Kristian; Raket, Lars L.; Cummings, Jeffrey L.			Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease Three Randomized Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							5-HT6 RECEPTOR ANTAGONIST; DOUBLE-BLIND; RATING-SCALE; SB-742457; DONEPEZIL; SEROTONIN; VALIDITY; MODERATE	IMPORTANCE New therapeutic approaches for Alzheimer disease (AD) are needed. OBJECTIVE To assess whether idalopirdine, a selective 5-hydroxytryptamine-6 receptor antagonist, is effective for symptomatic treatment of mild to moderate AD. DESIGN, SETTING, AND PARTICIPANTS Three randomized clinical trials that included 2525 patients aged 50 years or older with mild to moderate AD (study 1: n = 933 patients at 119 sites; study 2: n = 858 at 158 sites; and study 3: n = 734 at 126 sites). The 24-week studies were conducted from October 2013 to January 2017; final follow-up on January 12, 2017. INTERVENTIONS Idalopirdine (10, 30, or 60 mg/d) or placebo added to cholinesterase inhibitor treatment (donepezil in studies 1 and 2; donepezil, rivastigmine, or galantamine in study 3). MAIN OUTCOMES AND MEASURES Primary end point in all 3 studies: change in cognition total score (range, 0-70; a lower score indicates less impairment) from baseline to 24 weeks measured by the 11-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-Cog); key secondary end points: Alzheimer's Disease Cooperative Study-Clinical Global Impression of Change Scale and 23-item Activities of Daily Living Inventory scores. Dose group efficacy required a significant benefit over placebo for the primary end point and 1 or more key secondary end points. Safety data and adverse event profiles were recorded. RESULTS Among 2525 patients randomized in the 3 trials (mean age, 74 years; mean baseline ADAS-Cog total score, 26; between 62% and 65% of participants were women), 2254 (89%) completed the studies. In study 1, the mean change in ADAS-Cog total score between baseline and 24 weeks was 0.37 for the 60-mg dose of idalopirdine group, 0.61 for the 30-mg dose group, and 0.41 for the placebo group (adjusted mean difference vs placebo, 0.05 [95% CI, -0.88 to 0.98] for the 60-mg dose group and 0.33 [95% CI, -0.59 to 1.26] for the 30-mg dose group). In study 2, the mean change in ADAS-Cog total score between baseline and 24 weeks was 1.01 for the 30-mg dose of idalopirdine group, 0.53 for the 10-mg dose group, and 0.56 for the placebo group (adjusted mean difference vs placebo, 0.63 [95% CI, -0.38 to 1.65] for the 30-mg dose group; given the gated testing strategy and the null findings at the 30-mg dose, statistical comparison of the 10-mg dose was not performed). In study 3, the mean change in ADAS-Cog total score between baseline and 24 weeks was 0.38 for the 60-mg dose of idalopirdine group and 0.82 for the placebo group (adjusted mean difference vs placebo, -0.55 [95% CI, -1.45 to 0.36]). Treatment-emergent adverse events occurred in between 55.4% and 69.7% of participants in the idalopirdine groups vs between 56.7% and 61.4% of participants in the placebo groups. CONCLUSIONS AND RELEVANCE In patients with mild to moderate AD, the use of idalopirdine compared with placebo did not improve cognition over 24 weeks of treatment. These findings do not support the use of idalopirdine for the treatment of AD.	[Atri, Alireza] Calif Pacific Med Ctr, Ray Dolby Brain Hlth Ctr, Davies Campus,45 Castro St,Ste 220, San Francisco, CA 94114 USA; [Atri, Alireza] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Atri, Alireza] Harvard Med Sch, Boston, MA USA; [Frolich, Lutz] Heidelberg Univ, Med Fac Mannheim, Cent Inst Mental Hlth, Heidelberg, Germany; [Ballard, Clive] Univ Exeter, Med Sch, Exeter, Devon, England; [Tariot, Pierre N.] Banner Alzheimers Inst, Phoenix, AZ USA; [Molinuevo, Jose Luis] Hosp Clin & Univ, IDIBAPS, Alzheimers Dis & Other Cognit Disorders Unit, Barcelona, Spain; [Molinuevo, Jose Luis] Pasqual Maragall Fdn, Barcelonasseta Brain Res Ctr, Barcelona, Spain; [Boneva, Neli; Windfeld, Kristian; Raket, Lars L.] H Lundbeck & Co AS, Valby, Denmark; [Windfeld, Kristian] Genmab, Copenhagen, Denmark; [Cummings, Jeffrey L.] Cleveland Clin, Lou Ruvo Ctr Brain Hlth, Las Vegas, NV USA	California Pacific Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Central Institute of Mental Health; Ruprecht Karls University Heidelberg; University of Exeter; Banner Research; Banner Health; Banner Alzheimer's Institute; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Lundbeck Corporation; Genmab; Cleveland Clinic Foundation	Atri, A (corresponding author), Calif Pacific Med Ctr, Ray Dolby Brain Hlth Ctr, Davies Campus,45 Castro St,Ste 220, San Francisco, CA 94114 USA.	atria@cpmcri.org	Cummings, Jeffrey/AAC-5947-2019; Raket, Lars Lau/GSD-4232-2022; Molinuevo, Jose Luis/HCH-3881-2022; Raket, Lars Lau/GQY-8428-2022; Frölich, Lutz/AAA-6940-2019	Cummings, Jeffrey/0000-0001-8944-4158; Raket, Lars Lau/0000-0001-7099-2314; Frölich, Lutz/0000-0003-1494-0813; Molinuevo, Jose Luis/0000-0003-0485-6001; Ballard, Clive/0000-0003-0022-5632	H. Lundbeck A/S	H. Lundbeck A/S	This research was supported by funding from H. Lundbeck A/S.	Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Ayele BT, 2014, J BIOPHARM STAT, V24, P211, DOI 10.1080/10543406.2013.859148; Birks J, 2006, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001190.pub2, 10.1002/14651858.CD001190.pub3]; Bretz F, 2009, STAT MED, V28, P586, DOI 10.1002/sim.3495; Farlow MR, 2010, CLIN THER, V32, P1234, DOI 10.1016/j.clinthera.2010.06.019; Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; Geldenhuys WJ, 2011, CNS DRUGS, V25, P765, DOI 10.2165/11590190-000000000-00000; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Ramirez MJ, 2013, ALZHEIMERS RES THER, V5, DOI 10.1186/alzrt169; Rodriguez JJ, 2012, PROG NEUROBIOL, V99, P15, DOI 10.1016/j.pneurobio.2012.06.010; Lorke DE, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-36; Maher-Edwards G, 2010, CURR ALZHEIMER RES, V7, P374, DOI 10.2174/156720510791383831; Maher-Edwards Gareth, 2015, Alzheimers Dement (N Y), V1, P23, DOI 10.1016/j.trci.2015.04.001; Maher-Edwards G, 2011, INT J GERIATR PSYCH, V26, P536, DOI 10.1002/gps.2562; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Posner K, 2011, AM J PSYCHIAT, V168, P1266, DOI 10.1176/appi.ajp.2011.10111704; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; S Schneider L, 2000, Dialogues Clin Neurosci, V2, P111; Schmidt E, 2014, ALZHEIMERS DEMENT, V10, pP925; Schneider LS, 1997, ALZ DIS ASSOC DIS, V11, pS22; Upton N, 2008, NEUROTHERAPEUTICS, V5, P458, DOI 10.1016/j.nurt.2008.05.008; US Department of Health and Human Services, GUID IND EXP RESP RE; US Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research (CDER) Center for Biologics Evaluation and Research (CBER), GUID IND DRUG IND LI; US Department of Health and Human Services; US Food and Drug Administration, ICH HARM TRIP GUID E; Wilkinson D, 2014, LANCET NEUROL, V13, P1092, DOI 10.1016/S1474-4422(14)70198-X	25	95	100	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2018	319	2					130	142		10.1001/jama.2017.20373	http://dx.doi.org/10.1001/jama.2017.20373			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS4PR	29318278	Green Published, Bronze			2022-12-28	WOS:000419775500013
J	Gallagher, KC				Gallagher, Kathleen C.			She Smiled as She Walked Away	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gallagher, Kathleen C.] Vanderbilt Univ, Sch Med, 2215 Garland Ave,Light Hall, Nashville, TN 37212 USA	Vanderbilt University	Gallagher, KC (corresponding author), Vanderbilt Univ, Sch Med, 2215 Garland Ave,Light Hall, Nashville, TN 37212 USA.	kathleen.c.gallagher@vanderbilt.edu							0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2018	319	2					121	122		10.1001/jama.2017.19760	http://dx.doi.org/10.1001/jama.2017.19760			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS4PR	29318281				2022-12-28	WOS:000419775500009
J	Seo, GH; Kim, TH; Chung, JH				Seo, Gi Hyeon; Kim, Tae Hyuk; Chung, Jae Hoon			Antithyroid Drugs and Congenital Malformations A Nationwide Korean Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							AMERICAN THYROID ASSOCIATION; SENSITIVITY-ANALYSIS; EARLY-PREGNANCY; BIRTH-DEFECTS; HYPERTHYROIDISM; PROPYLTHIOURACIL; THYROTOXICOSIS; METHIMAZOLE; POPULATION; MANAGEMENT	Background: Untreated or insufficiently treated Graves disease in pregnancy may pose risks to both mother and fetus. Antithyroid drugs (ATDs) are the treatment mainstay, but the potential teratogenic effect of these drugs has prompted clinicians to question the safe management of this vulnerable population. Objective: To examine the association between maternal prescriptions for ATDs and congenital malformations in live births. Design: Nationwide cohort study. Setting: Korean National Health Insurance database. Participants: A cohort of 2 886 970 completed pregnancies linked to live-born infants in 2 210 253 women between 2008 and 2014. Intervention: Maternal prescriptions for ATDs in the first trimester. Measurements: The risk for overall and organ-specific congenital malformations in offspring, with logistic regression models used to control for potential confounders. Results: 12 891 pregnancies (0.45%) were exposed to ATDs during the first trimester. The prevalence of malformations in exposed offspring was 7.27%, compared with 5.94% in offspring of women who were not prescribed ATDs during pregnancy (P < 0.001) (adjusted odds ratio, 1.19 [95% Cl, 1.12 to 1.28]). Absolute increases in the prevalence of congenital malformations per 1000 live births were 8.81 cases (Cl, 3.92 to 13.70 cases) for propylthiouracil alone, 17.05 cases (Cl, 1.94 to 32.15 cases) for methimazole (MMI) alone, and 16.53 cases (CI, 4.73 to 28.32 cases) for propylthiouracil and MMI, compared with pregnancies without ATD prescriptions. In the MMI group, a high cumulative dose (> 495 mg) during the first trimester was associated with an increased risk for malformations compared with a low dose (1 to 126 mg) (adjusted odds ratio, 1.87 [CI, 1.06 to 3.30]). Limitation: The study used a prescription claims database to assess ATD exposure. Conclusion: Exposure to ATDs during the first trimester was associated with increased risk for congenital malformations, particularly for pregnancies in which women received prescriptions for MMI or both ATDs.	[Kim, Tae Hyuk; Chung, Jae Hoon] Sungkyunkwan Univ, Sch Med, Div Endocrinol & Metab, Dept Med,Thyroid Ctr,Samsung Med Ctr, 81 Irwon Ro, Seoul 06351, South Korea; [Seo, Gi Hyeon] Hlth Insurance Review & Assessment Serv, 60 Hyeoksin Ro Bangok Dong, Wonju 26465, Gangwon Do, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center	Seo, GH (corresponding author), Sungkyunkwan Univ, Sch Med, Div Endocrinol & Metab, Dept Med,Thyroid Ctr,Samsung Med Ctr, 81 Irwon Ro, Seoul 06351, South Korea.	thyroid@skku.edu	Seo, Gihyeon/AGG-1178-2022	Seo, Gihyeon/0000-0001-7414-0258; Kim, Tae Hyuk/0000-0002-7975-2437				Alexander EK, 2017, THYROID, V27, P315, DOI 10.1089/thy.2016.0457; Andersen SL, 2016, J CLIN ENDOCR METAB, V101, P1606, DOI 10.1210/jc.2015-4274; Andersen SL, 2014, EUR THYROID J, V3, P164, DOI 10.1159/000365101; Andersen SL, 2013, J CLIN ENDOCR METAB, V98, P4373, DOI 10.1210/jc.2013-2831; [Anonymous], 2016, Diabetes Care, V39 Suppl 1, pS4, DOI 10.2337/dc16-S003; Bahn RS, 2011, THYROID, V21, P593, DOI 10.1089/thy.2010.0417; Bahn Rebecca S, 2009, Thyroid, V19, P673, DOI 10.1089/thy.2009.0169; Brunstrom M, 2015, LANCET, V385, P1394, DOI 10.1016/S0140-6736(15)60715-2; Citrome L, 2013, INT J CLIN PRACT, V67, P407, DOI 10.1111/ijcp.12142; Clementi M, 2010, J CLIN ENDOCR METAB, V95, pE337, DOI 10.1210/jc.2010-0652; Cooper DS, 2013, LANCET DIABETES ENDO, V1, P238, DOI 10.1016/S2213-8587(13)70086-X; Cooper DS, 2005, NEW ENGL J MED, V352, P905, DOI 10.1056/NEJMra042972; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; Glinoer D, 2012, CURR OPIN ENDOCRINOL, V19, P402, DOI 10.1097/MED.ObOl3e3283565b49; KALTER H, 1983, NEW ENGL J MED, V308, P424, DOI 10.1056/NEJM198302243080804; Kim DS, 2010, SOC WORK PUBLIC HLTH, V25, P127, DOI 10.1080/19371910903070333; Kim HJ, 2001, AM J GASTROENTEROL, V96, P165; Korelitz JJ, 2013, THYROID, V23, P758, DOI 10.1089/thy.2012.0488; Labadzhyan A, 2014, J CLIN TRANSL ENDOCR, V1, P140, DOI 10.1016/j.jcte.2014.07.008; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; Laurberg P, 2014, EUR J ENDOCRINOL, V171, pR13, DOI 10.1530/EJE-14-0135; Laurberg P, 2009, EUR J ENDOCRINOL, V160, P1, DOI 10.1530/EJE-08-0663; Lazarus JH, 2013, WERNER INGBARS THYRO; Li HX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126610; Localio AR, 2017, ANN INTERN MED, V167, P285, DOI 10.7326/M17-1485; Matthews T J, 2015, Natl Vital Stat Rep, V64, P1; MILHAM S, 1972, TERATOLOGY, V5, P125, DOI 10.1002/tera.1420050117; Mortimer RH, 1997, J CLIN ENDOCR METAB, V82, P3099, DOI 10.1210/jc.82.9.3099; Muller CJ, 2014, INT J EPIDEMIOL, V43, P962, DOI 10.1093/ije/dyu029; Napier C, 2015, CLIN ENDOCRINOL, V82, P475, DOI 10.1111/cen.12577; Organisation for Economic Co-operation and Development, 2015, OECD HLTH CAR RES; Rivkees SA, 2013, J CLIN ENDOCR METAB, V98, P4332, DOI 10.1210/jc.2013-3549; Sadler T.W., 2012, LANGMANS MEDICAL EMB, V12th; Seo GH, 2015, THYROID, V25, P927, DOI 10.1089/thy.2014.0557; Statistics Korea, 2016, FIN RES BIRTH STAT 2; Taylor PN, 2012, EUR THYROID J, V1, P176, DOI 10.1159/000342920; U. S. Food and Drug Administration, 2009, INF HEALTHC PROF PRO; Vaccarella S, 2015, THYROID, V25, P1127, DOI 10.1089/thy.2015.0116; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; WING DA, 1994, AM J OBSTET GYNECOL, V170, P90; Yoshihara A, 2012, J CLIN ENDOCR METAB, V97, P2396, DOI 10.1210/jc.2011-2860	41	48	56	0	17	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 20	2018	168	6					405	+		10.7326/M17-1398	http://dx.doi.org/10.7326/M17-1398			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FZ8AM	29357398				2022-12-28	WOS:000427827400015
J	Albers, GW; Marks, MP; Kemp, S; Christensen, S; Tsai, JP; Ortega-Gutierrez, S; McTaggart, RA; Torbey, MT; Kim-Tenser, M; Leslie-Mazwi, T; Sarraj, A; Kasner, SE; Ansari, SA; Yeatts, SD; Hamilton, S; Mlynash, M; Heit, JJ; Zaharchuk, G; Kim, S; Carrozzella, J; Palesch, YY; Demchuk, AM; Bammer, R; Lavori, PW; Broderick, JP; Lansberg, MG				Albers, G. W.; Marks, M. P.; Kemp, S.; Christensen, S.; Tsai, J. P.; Ortega-Gutierrez, S.; McTaggart, R. A.; Torbey, M. T.; Kim-Tenser, M.; Leslie-Mazwi, T.; Sarraj, A.; Kasner, S. E.; Ansari, S. A.; Yeatts, S. D.; Hamilton, S.; Mlynash, M.; Heit, J. J.; Zaharchuk, G.; Kim, S.; Carrozzella, J.; Palesch, Y. Y.; Demchuk, A. M.; Bammer, R.; Lavori, P. W.; Broderick, J. P.; Lansberg, M. G.		DEFUSE 3 Investigators	Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ACUTE ISCHEMIC-STROKE; HEALTH-CARE PROFESSIONALS; ENDOVASCULAR THROMBECTOMY; EARLY MANAGEMENT; INFARCT SIZE; DEFUSE 2; REPERFUSION; TIME; OUTCOMES; THERAPY	BACKGROUND Thrombectomy is currently recommended for eligible patients with stroke who are treated within 6 hours after the onset of symptoms. METHODS We conducted a multicenter, randomized, open-label trial, with blinded outcome assessment, of thrombectomy in patients 6 to 16 hours after they were last known to be well and who had remaining ischemic brain tissue that was not yet infarcted. Patients with proximal middle-cerebral-artery or internal-carotid-artery occlusion, an initial infarct size of less than 70 ml, and a ratio of the volume of ischemic tissue on perfusion imaging to infarct volume of 1.8 or more were randomly assigned to endovascular therapy (thrombectomy) plus standard medical therapy (endovascular-therapy group) or standard medical therapy alone (medical-therapy group). The primary outcome was the ordinal score on the modified Rankin scale (range, 0 to 6, with higher scores indicating greater disability) at day 90. RESULTS The trial was conducted at 38 U.S. centers and terminated early for efficacy after 182 patients had undergone randomization (92 to the endovascular-therapy group and 90 to the medical-therapy group). Endovascular therapy plus medical therapy, as compared with medical therapy alone, was associated with a favorable shift in the distribution of functional outcomes on the modified Rankin scale at 90 days (odds ratio, 2.77; P<0.001) and a higher percentage of patients who were functionally independent, defined as a score on the modified Rankin scale of 0 to 2 (45% vs. 17%, P<0.001). The 90-day mortality rate was 14% in the endovascular-therapy group and 26% in the medical-therapy group (P=0.05), and there was no significant between-group difference in the frequency of symptomatic intracranial hemorrhage (7% and 4%, respectively; P=0.75) or of serious adverse events (43% and 53%, respectively; P=0.18). CONCLUSIONS Endovascular thrombectomy for ischemic stroke 6 to 16 hours after a patient was last known to be well plus standard medical therapy resulted in better functional outcomes than standard medical therapy alone among patients with proximal middle-cerebral-artery or internal-carotid-artery occlusion and a region of tissue that was ischemic but not yet infarcted.	[Albers, G. W.; Kemp, S.; Christensen, S.; Tsai, J. P.; Hamilton, S.; Mlynash, M.; Lansberg, M. G.] Stanford Univ, Dept Neurol, Sch Med, Stanford, CA 94305 USA; [Albers, G. W.; Kemp, S.; Christensen, S.; Tsai, J. P.; Hamilton, S.; Mlynash, M.; Lansberg, M. G.] Stanford Univ, Dept Neurol Sci, Sch Med, Stanford, CA 94305 USA; [Marks, M. P.; Heit, J. J.; Zaharchuk, G.] Stanford Univ, Dept Diagnost Radiol, Sch Med, Stanford, CA 94305 USA; [Bammer, R.] Stanford Univ, Dept Radiol, Sch Med, Stanford, CA 94305 USA; [Lavori, P. W.] Stanford Univ, Dept Biomed Data Sci, Sch Med, Stanford, CA 94305 USA; [Kim-Tenser, M.] Univ Southern Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA USA; [Ortega-Gutierrez, S.] Univ Iowa, Ames, IA USA; [Ortega-Gutierrez, S.] Univ Iowa, Dept Anesthesia, Ames, IA USA; [Ortega-Gutierrez, S.] Univ Iowa, Dept Neurosurg, Ames, IA USA; [Ortega-Gutierrez, S.] Univ Iowa, Dept Radiol, Ames, IA USA; [McTaggart, R. A.] Brown Univ, Dept Diagnost Imaging, Warren Alpert Sch Med, Providence, RI 02912 USA; [McTaggart, R. A.] Brown Univ, Dept Neurol, Warren Alpert Sch Med, Providence, RI 02912 USA; [McTaggart, R. A.] Brown Univ, Dept Neurosurg, Warren Alpert Sch Med, Providence, RI 02912 USA; [McTaggart, R. A.] Rhode Isl Hosp, Providence, RI USA; [Torbey, M. T.] Ohio State Univ, Dept Neurol, Columbus, OH 43210 USA; [Torbey, M. T.] Ohio State Univ, Dept Neurosurg, Columbus, OH 43210 USA; [Carrozzella, J.; Broderick, J. P.] Univ Cincinnati, Gardner Neurosci Inst, Cincinnati, OH USA; [Carrozzella, J.; Broderick, J. P.] Univ Cincinnati, Coll Med, Dept Neurol & Rehabil Med, Cincinnati, OH USA; [Leslie-Mazwi, T.] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Leslie-Mazwi, T.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Sarraj, A.] Univ Texas Hlth Sci Ctr Houston, Dept Neurol, Houston, TX 77030 USA; [Kasner, S. E.] Univ Penn, Sch Med, Dept Neurol, Philadelphia, PA 19104 USA; [Ansari, S. A.] Northwestern Univ, Dept Radiol, Feinberg Sch Med, Chicago, IL 60611 USA; [Ansari, S. A.] Northwestern Univ, Dept Neurol, Feinberg Sch Med, Chicago, IL 60611 USA; [Ansari, S. A.] Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Yeatts, S. D.; Palesch, Y. Y.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC USA; [Kim, S.] NYU, Sch Med, Dept Neurol, New York, NY USA; [Demchuk, A. M.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB, Canada; [Demchuk, A. M.] Univ Calgary, Cumming Sch Med, Hotchkiss Brain Inst, Dept Radiol, Calgary, AB, Canada	Stanford University; Stanford University; Stanford University; Stanford University; Stanford University; University of Southern California; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Brown University; Brown University; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; University of Texas System; University of Texas Health Science Center Houston; University of Pennsylvania; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Medical University of South Carolina; New York University; University of Calgary; University of Calgary	Albers, GW (corresponding author), Stanford Stroke Ctr, 780 Welch Rd,Suite 350, Palo Alto, CA 94304 USA.	albers@stanford.edu	Demchuk, Andrew M/E-1103-2012	Demchuk, Andrew M/0000-0002-4930-7789; Lansberg, Maarten/0000-0002-3545-6927; Hsia, Amie/0000-0002-0214-9736; Derdeyn, Colin/0000-0002-5932-2683; , Dorothea/0000-0001-9893-989X; Tirschwell, David/0000-0002-8059-2901; Heit, Jeremy/0000-0003-1055-8000; Ortega-Gutierrez, Santiago/0000-0002-3408-1297; Albers, Gregory/0000-0003-0263-4632	National Institute of Neurological Disorders and Stroke [U10NS086487, U01NS092076]; Alberta Innovates [201300690] Funding Source: researchfish; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U01NS092076, U01NS086872, U10NS086487] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Alberta Innovates; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported by grants (U10NS086487 and U01NS092076) from the National Institute of Neurological Disorders and Stroke. The RAPID software platform was provided to all sites by iSchemaView.	Albers GW, 2017, INT J STROKE, V12, P896, DOI 10.1177/1747493017701147; Albers GW, 2016, ANN NEUROL, V79, P76, DOI 10.1002/ana.24543; Albers GW, 2015, STROKE, V46, P2786, DOI 10.1161/STROKEAHA.115.010710; Campbell BCV, 2015, NEW ENGL J MED, V372, P1009, DOI 10.1056/NEJMoa1414792; Federau C, 2016, RADIOLOGY, V280, P184, DOI 10.1148/radiol.2015151586; Fransen PSS, 2016, JAMA NEUROL, V73, P190, DOI 10.1001/jamaneurol.2015.3886; Goyal M, 2016, LANCET, V387, P1723, DOI 10.1016/S0140-6736(16)00163-X; Jauch EC, 2013, STROKE, V44, P870, DOI 10.1161/STR.0b013e318284056a; Khatri P, 2014, LANCET NEUROL, V13, P567, DOI 10.1016/S1474-4422(14)70066-3; Lai TL, 2014, CONTEMP CLIN TRIALS, V39, P191, DOI 10.1016/j.cct.2014.09.001; Lansberg MG, 2017, ANN NEUROL, V81, P849, DOI 10.1002/ana.24953; Lansberg MG, 2012, LANCET NEUROL, V11, P860, DOI 10.1016/S1474-4422(12)70203-X; Nogueira RG, 2018, NEW ENGL J MED, V378, P11, DOI 10.1056/NEJMoa1706442; Powers WJ, 2015, STROKE, V46, P3020, DOI 10.1161/STR.0000000000000074; Saver JL, 2016, JAMA-J AM MED ASSOC, V316, P1279, DOI 10.1001/jama.2016.13647; Saver JL, 2015, NEW ENGL J MED, V372, P2285, DOI 10.1056/NEJMoa1415061; Straka M, 2010, J MAGN RESON IMAGING, V32, P1024, DOI 10.1002/jmri.22338; Wheeler HM, 2015, INT J STROKE, V10, P723, DOI 10.1111/ijs.12436; Wheeler HM, 2013, STROKE, V44, P681, DOI 10.1161/STROKEAHA.111.000135; Zaidat OO, 2013, STROKE, V44, P2650, DOI 10.1161/STROKEAHA.113.001972	20	2271	2410	18	207	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2018	378	8					708	718		10.1056/NEJMoa1713973	http://dx.doi.org/10.1056/NEJMoa1713973			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW8VA	29364767	Green Accepted			2022-12-28	WOS:000425613900008
J	Wilson, AM; Hubel, TY; Wilshin, SD; Lowe, JC; Lorenc, M; Dewhirst, OP; Artlam-Brooks, HLAB; Diack, R; Ennitt, EB; Golabek, KA; Woledge, RC; McNutt, JW; Urtin, NAC; West, TG				Wilson, Alan M.; Hubel, Tatjana Y.; Wilshin, Simon D.; Lowe, John C.; Lorenc, Maja; Dewhirst, Oliver P.; Artlam-Brooks, Hattie L. A. B.; Diack, Rebecca; Ennitt, Emily B.; Golabek, Krystyna A.; Woledge, Roger C.; McNutt, J. Weldon; Urtin, Nancy A. C.; West, Timothy G.			Biomechanics of predator-prey arms race in lion, zebra, cheetah and impala	NATURE			English	Article							ELITE SPRINTING ATHLETE; MUSCLE MOMENT ARMS; FUNCTIONAL-ANATOMY; PELVIC LIMB; ACINONYX-JUBATUS; THORACIC LIMB; POWER OUTPUT; POSTCRANIAL MUSCLES; TRADE-OFFS; HIND-LIMB	The fastest and most manoeuvrable terrestrial animals are found in savannah habitats, where predators chase and capture running prey. Hunt outcome and success rate are critical to survival, so both predator and prey should evolve to be faster and/or more manoeuvrable. Here we compare locomotor characteristics in two pursuit predator-prey pairs, lion-zebra and cheetah-impala, in their natural savannah habitat in Botswana. We show that although cheetahs and impalas were universally more athletic than lions and zebras in terms of speed, acceleration and turning, within each predator-prey pair, the predators had 20% higher muscle fibre power than prey, 37% greater acceleration and 72% greater deceleration capacity than their prey. We simulated hunt dynamics with these data and showed that hunts at lower speeds enable prey to use their maximum manoeuvring capacity and favour prey survival, and that the predator needs to be more athletic than its prey to sustain a viable success rate.	[Wilson, Alan M.; Hubel, Tatjana Y.; Wilshin, Simon D.; Lowe, John C.; Lorenc, Maja; Dewhirst, Oliver P.; Artlam-Brooks, Hattie L. A. B.; Diack, Rebecca; Woledge, Roger C.; Urtin, Nancy A. C.; West, Timothy G.] Univ London, Royal Vet Coll, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England; [Ennitt, Emily B.] Univ Botswana, Okavango Res Inst, Maun, Botswana; [Golabek, Krystyna A.; McNutt, J. Weldon] Botswana Predator Conservat Trust, Private Bag 13, Maun, Botswana	University of London; University of London Royal Veterinary College; University of Botswana	Wilson, AM (corresponding author), Univ London, Royal Vet Coll, Struct & Mot Lab, Hatfield AL9 7TA, Herts, England.	awilson@rvc.ac.uk		Lorenc, Maja/0000-0003-2665-0135; Wilson, Alan/0000-0001-9914-3455; Bartlam-Brooks, Hattie/0000-0002-1507-1712	EPSRC [EP/H013016/1]; BBSRC [BB/J018007/1]; ERC [323041]; RVC Ethics & Welfare Committee [RVC 2013 1233]; Biotechnology and Biological Sciences Research Council [BB/J018007/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/H013016/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC(European Research Council (ERC)European Commission); RVC Ethics & Welfare Committee; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank S. Amos for fabricating collars, N. Jordan and G. Gilfillan, M. Claase and N. Terry and BPCT research assistants for working with us in the study area and M. Flyman (DWNP) for his support and enthusiasm; J. Usherwood, R. Bomphrey and A. R. Wilson for comments on the manuscript; EPSRC (EP/H013016/1), BBSRC (BB/J018007/1) and ERC (323041) for funding. The Botswana Predator Conservation Trust was supported by private donors, Tusk Trust and the Cincinnati Zoo. Work was approved by RVC Ethics & Welfare Committee (RVC 2013 1233) and Botswana Department of Wildlife and National Parks Research Permits were held by J.W.M. and A.M.W. (EWT 8/36/4 plus additions) and a Botswana Veterinary Registration held by A.M.W. Tissue shipping was covered by CITES, Botswana export, Botswana National Veterinary Laboratory approval, South African transit and UK DEFRA import permits.	ABBOTT BC, 1952, J PHYSIOL-LONDON, V117, P380, DOI 10.1113/jphysiol.1952.sp004755; Alexander RM., 2003, PRINCIPLES ANIMAL LO; Barclay CJ, 2010, J PHYSIOL-LONDON, V588, P3819, DOI 10.1113/jphysiol.2010.192799; Bartlam-Brooks HLA, 2013, ECOL EVOL, V3, P2795, DOI 10.1002/ece3.676; Benton MJ, 2009, SCIENCE, V323, P728, DOI 10.1126/science.1157719; Bro-Jorgensen J, 2013, EVOLUTION, V67, P3371, DOI 10.1111/evo.12233; Broekhuis F, 2013, J ANIM ECOL, V82, P1097, DOI 10.1111/1365-2656.12077; Carrier DR, 2011, P NATL ACAD SCI USA, V108, P18631, DOI 10.1073/pnas.1105277108; Carrier DR, 1998, J EXP BIOL, V201, P3185; Combes SA, 2013, INTEGR COMP BIOL, V53, P787, DOI 10.1093/icb/ict072; Crook TC, 2008, J ANAT, V212, P144, DOI 10.1111/j.1469-7580.2007.00848.x; CROW MT, 1982, J GEN PHYSIOL, V79, P147, DOI 10.1085/jgp.79.1.147; Cuff AR, 2016, J ANAT, V229, P142, DOI 10.1111/joa.12474; Cuff AR, 2016, J ANAT, V229, P128, DOI 10.1111/joa.12477; Curtin NA, 2005, P ROY SOC B-BIOL SCI, V272, P581, DOI 10.1098/rspb.2004.2982; Curtin NA, 2015, J EXP BIOL, V218, P2856, DOI 10.1242/jeb.121897; Daley M.A., 2016, UNDERSTANDING MAMMAL, P277; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Dewhirst OP, 2017, J EXP BIOL, V220, P341, DOI 10.1242/jeb.146035; Domenici P, 2008, CURR BIOL, V18, P1792, DOI 10.1016/j.cub.2008.09.062; Domenici P, 2011, J EXP BIOL, V214, P2474, DOI 10.1242/jeb.053801; ESTES RD, 1991, BEHAV GUIDE AFRICAN; GETZ WM, 1981, J OPTIMIZ THEORY APP, V34, P383, DOI 10.1007/BF00934679; Gunn H. M, 1988, P 2 ICEEP EQ EX PHSY, P253; Hill A. V., 1950, Science Progress London, V38, P209; Holland R., 2014, MUCH MEAT EXPECT BEE; HOWLAND HC, 1974, J THEOR BIOL, V47, P333, DOI 10.1016/0022-5193(74)90202-1; Hubel TY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11034; Hubel TY, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11033; Hudson PE, 2011, J ANAT, V218, P375, DOI 10.1111/j.1469-7580.2011.01344.x; Hudson PE, 2011, J ANAT, V218, P363, DOI 10.1111/j.1469-7580.2010.01310.x; Irschick DJ., 2015, ANIMAL ATHLETES ECOL, DOI [10.1093/acprof:oso/9780199296545.001.0001/acprof-9780199296545, DOI 10.1093/ACPROF:OSO/9780199296545.001.0001/ACPROF-9780199296545]; Jindrich DL, 2007, J EXP BIOL, V210, P1378, DOI 10.1242/jeb.001545; Kalman RE., 1960, T ASME J BASIC ENG, V82, P35, DOI [10.1115/1.3662552, DOI 10.1115/1.3662552]; Kohn TA, 2013, J EXP BIOL, V216, P960, DOI 10.1242/jeb.078485; Lindstedt SL, 2001, NEWS PHYSIOL SCI, V16, P256, DOI 10.1152/physiologyonline.2001.16.6.256; McGuigan MP, 2003, J EXP BIOL, V206, P1325, DOI 10.1242/jeb.00254; MENDEZ J, 1960, METABOLISM, V9, P184; MERZ AW, 1974, AIAA J, V12, P259, DOI 10.2514/3.49215; Moore TY, 2015, INTEGR COMP BIOL, V55, P1188, DOI 10.1093/icb/icv074; Nowak R.M., 1999, WALKERS MAMMALS WORL, V1; Pasi BM, 2003, J EVOLUTION BIOL, V16, P324, DOI 10.1046/j.1420-9101.2003.00512.x; Payne RC, 2005, J ANAT, V206, P557, DOI 10.1111/j.1469-7580.2005.00420.x; Payne RC, 2004, J ANAT, V205, P479, DOI 10.1111/j.0021-8782.2004.00353.x; Pinheiro J. C., 2000, MIXED EFFECTS MODELS, P3, DOI DOI 10.1007/0-387-22747-4_1; Ranatunga KW, 1998, EXP PHYSIOL, V83, P371, DOI 10.1113/expphysiol.1998.sp004120; RAUCH HE, 1965, AIAA J, V3, P1445, DOI 10.2514/3.3166; Roberts TJ, 2010, J APPL PHYSIOL, V109, P396, DOI 10.1152/japplphysiol.01272.2009; ROME LC, 1990, J PHYSIOL-LONDON, V431, P173, DOI 10.1113/jphysiol.1990.sp018325; SACKS RD, 1982, J MORPHOL, V173, P185, DOI 10.1002/jmor.1051730206; SCHALLER G B, 1972, P480; Schaller N. U, 2008, THESIS; Schmidt-Nielsen K., 1965, DESERT ANIMALS PHYSL; SEOW CY, 1991, J GEN PHYSIOL, V97, P541, DOI 10.1085/jgp.97.3.541; Shahar R, 2001, AM J VET RES, V62, P928, DOI 10.2460/ajvr.2001.62.928; Sikes RS, 2016, J MAMMAL, V97, P663, DOI 10.1093/jmammal/gyw078; Smith NC, 2006, J ANAT, V209, P765, DOI 10.1111/j.1469-7580.2006.00658.x; Tan HL, 2011, P ROY SOC B-BIOL SCI, V278, P2105, DOI 10.1098/rspb.2010.2395; Titterton D., 2004, STRAPDOWN INERTIAL N, V207; Usherwood JR, 2005, NATURE, V438, P753, DOI 10.1038/438753a; Van Valen L., 1973, EVOL THEORY REV, V1, P1, DOI DOI 10.1038/344864A0; Webster EL, 2014, J ANAT, V225, P317, DOI 10.1111/joa.12208; West TG, 2013, J EXP BIOL, V216, P2974, DOI 10.1242/jeb.083667; Williams SB, 2008, J ANAT, V213, P361, DOI [10.1111/j.1469-7580.2008.00961.x, 10.1111/j.1469-7580.2008.00962.x]; Williams SB, 2007, J ANAT, V210, P472, DOI 10.1111/j.1469-7580.2007.00704.x; Williams SB, 2007, J ANAT, V210, P491, DOI 10.1111/j.1469-7580.2007.00703.x; Williams SB, 2009, BIOL LETTERS, V5, P610, DOI 10.1098/rsbl.2009.0360; Wilson AM, 2013, NATURE, V498, P185, DOI 10.1038/nature12295; Wilson AM, 2001, NATURE, V414, P895, DOI 10.1038/414895a; Wilson JW, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0620; Wynn ML, 2015, J EXP BIOL, V218, P433, DOI 10.1242/jeb.111682	71	75	75	10	159	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 8	2018	554	7691					183	+		10.1038/nature25479	http://dx.doi.org/10.1038/nature25479			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1OE	29364874	Green Accepted			2022-12-28	WOS:000424332600028
J	Myers-Smith, IH; Myers, JH				Myers-Smith, Isla H.; Myers, Judith H.			Comment on "Precipitation drives global variation in natural selection"	SCIENCE			English	Editorial Material							CLIMATE; TIME	Siepielski et al. (Reports, 3 March 2017, p. 959) claim that "precipitation drives global variation in natural selection." This conclusion is based on a meta-analysis of the relationship between climate variables and natural selection measured in wild populations of invertebrates, plants, and vertebrates. Three aspects of this analysis cause concern: (i) lack of within-year climate variables, (ii) low and variable estimates of covariance relationships across taxa, and (iii) a lack of mechanistic explanations for the patterns observed; association is not causation.	[Myers-Smith, Isla H.] Univ Edinburgh, Sch GeoSci, Edinburgh EH9 3FF, Midlothian, Scotland; [Myers, Judith H.] Univ British Columbia, Biodivers Res Ctr, Vancouver, BC V6T 1Z4, Canada	University of Edinburgh; University of British Columbia	Myers-Smith, IH (corresponding author), Univ Edinburgh, Sch GeoSci, Edinburgh EH9 3FF, Midlothian, Scotland.	isla.myers-smith@ed.ac.uk	Myers-Smith, Isla H/D-1529-2013	Myers-Smith, Isla H/0000-0002-8417-6112	NERC [NE/M016323/1] Funding Source: UKRI; Natural Environment Research Council [NE/M016323/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Begueria S, 2016, INT J CLIMATOL, V36, P3413, DOI 10.1002/joc.4561; Centre for Environmental Data Analysis, 2013, CRU TS3 21 CLIM RES; Franks SJ, 2007, P NATL ACAD SCI USA, V104, P1278, DOI 10.1073/pnas.0608379104; Karger D. N., 2016, ARXIV160700217; Kimball S, 2012, OECOLOGIA, V169, P319, DOI 10.1007/s00442-011-2199-2; Macias-Fauria M, 2014, NAT CLIM CHANGE, V4, P845, DOI 10.1038/nclimate2372; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parmesan C, 2013, ECOL LETT, V16, P58, DOI 10.1111/ele.12098; Scheffers BR, 2012, TRENDS ECOL EVOL, V27, P501, DOI 10.1016/j.tree.2012.05.008; SCHLUTER D, 1986, EVOLUTION, V40, P221, DOI 10.1111/j.1558-5646.1986.tb00465.x; Siepielski AM, 2017, SCIENCE, V355, P959, DOI 10.1126/science.aag2773; Siepielski AM, 2009, ECOL LETT, V12, P1261, DOI 10.1111/j.1461-0248.2009.01381.x; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Thackeray SJ, 2016, NATURE, V535, P241, DOI 10.1038/nature18608; Weiland FCS, 2015, J HYDROL, V529, P1095, DOI 10.1016/j.jhydrol.2015.08.061	15	5	5	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374							eaan5028	10.1126/science.aan5028	http://dx.doi.org/10.1126/science.aan5028			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT6SD	29371441				2022-12-28	WOS:000423283200001
J	Tucker, MA; Bohning-Gaese, K; Fagan, WF; Fryxell, JM; Van Moorter, B; Alberts, SC; Ali, AH; Allen, AM; Attias, N; Avgar, T; Bartlam-Brooks, H; Bayarbaatar, B; Belant, JL; Bertassoni, A; Beyer, D; Bidner, L; van Beest, FM; Blake, S; Blaum, N; Bracis, C; Brown, D; de Bruyn, PJN; Cagnacci, F; Calabrese, JM; Camilo-Alves, C; Chamaille-Jammes, S; Chiaradia, A; Davidson, SC; Dennis, T; DeStefano, S; Diefenbach, D; Douglas-Hamilton, I; Fennessy, J; Fichtel, C; Fiedler, W; Fischer, C; Fischhoff, I; Fleming, CH; Ford, AT; Fritz, SA; Gehr, B; Goheen, JR; Gurarie, E; Hebblewhite, M; Heurich, M; Hewison, AJM; Hof, C; Hurme, E; Isbell, LA; Janssen, R; Jeltsch, F; Kaczensky, P; Kane, A; Kappeler, PM; Kauffman, M; Kays, R; Kimuyu, D; Koch, F; Kranstauber, B; LaPoint, S; Leimgruber, P; Linnell, JDC; Lopez-Lopez, P; Markham, AC; Mattisson, J; Medici, EP; Mellone, U; Merrill, E; Mourao, GD; Morato, RG; Morellet, N; Morrison, TA; Diaz-Munoz, SL; Mysterud, A; Nandintsetseg, D; Nathan, R; Niamir, A; Odden, J; O'Hara, RB; Oliveira-Santos, LGR; Olson, KA; Patterson, BD; de Paula, RC; Pedrotti, L; Reineking, B; Rimmler, M; Rogers, TL; Rolandsen, CM; Rosenberry, CS; Rubenstein, DI; Safi, K; Said, S; Sapir, N; Sawyer, H; Schmidt, NM; Selva, N; Sergiel, A; Shiilegdamba, E; Silva, JP; Singh, N; Solberg, EJ; Spiegel, O; Strand, O; Sundaresan, S; Ullmann, W; Voigt, U; Wall, J; Wattles, D; Wikelski, M; Wilmers, CC; Wilson, JW; Wittemyer, G; Zieba, F; Zwijacz-Kozica, T; Mueller, T				Tucker, Marlee A.; Boehning-Gaese, Katrin; Fagan, William F.; Fryxell, John M.; Van Moorter, Bram; Alberts, Susan C.; Ali, Abdullahi H.; Allen, Andrew M.; Attias, Nina; Avgar, Tal; Bartlam-Brooks, Hattie; Bayarbaatar, Buuveibaatar; Belant, Jerrold L.; Bertassoni, Alessandra; Beyer, Dean; Bidner, Laura; van Beest, Floris M.; Blake, Stephen; Blaum, Niels; Bracis, Chloe; Brown, Danielle; de Bruyn, P. J. Nico; Cagnacci, Francesca; Calabrese, Justin M.; Camilo-Alves, Constanca; Chamaille-Jammes, Simon; Chiaradia, Andre; Davidson, Sarah C.; Dennis, Todd; DeStefano, Stephen; Diefenbach, Duane; Douglas-Hamilton, Iain; Fennessy, Julian; Fichtel, Claudia; Fiedler, Wolfgang; Fischer, Christina; Fischhoff, Ilya; Fleming, Christen H.; Ford, Adam T.; Fritz, Susanne A.; Gehr, Benedikt; Goheen, Jacob R.; Gurarie, Eliezer; Hebblewhite, Mark; Heurich, Marco; Hewison, A. J. Mark; Hof, Christian; Hurme, Edward; Isbell, Lynne A.; Janssen, Rene; Jeltsch, Florian; Kaczensky, Petra; Kane, Adam; Kappeler, Peter M.; Kauffman, Matthew; Kays, Roland; Kimuyu, Duncan; Koch, Flavia; Kranstauber, Bart; LaPoint, Scott; Leimgruber, Peter; Linnell, John D. C.; Lopez-Lopez, Pascual; Markham, A. Catherine; Mattisson, Jenny; Medici, Emilia Patricia; Mellone, Ugo; Merrill, Evelyn; Mourao, Guilherme de Miranda; Morato, Ronaldo G.; Morellet, Nicolas; Morrison, Thomas A.; Diaz-Munoz, Samuel L.; Mysterud, Atle; Nandintsetseg, Dejid; Nathan, Ran; Niamir, Aidin; Odden, John; O'Hara, Robert B.; Oliveira-Santos, Luiz Gustavo R.; Olson, Kirk A.; Patterson, Bruce D.; de Paula, Rogerio Cunha; Pedrotti, Luca; Reineking, Bjorn; Rimmler, Martin; Rogers, Tracey L.; Rolandsen, Christer Moe; Rosenberry, Christopher S.; Rubenstein, Daniel I.; Safi, Kamran; Said, Sonia; Sapir, Nir; Sawyer, Hall; Schmidt, Niels Martin; Selva, Nuria; Sergiel, Agnieszka; Shiilegdamba, Enkhtuvshin; Silva, Joao Paulo; Singh, Navinder; Solberg, Erling J.; Spiegel, Orr; Strand, Olav; Sundaresan, Siva; Ullmann, Wiebke; Voigt, Ulrich; Wall, Jake; Wattles, David; Wikelski, Martin; Wilmers, Christopher C.; Wilson, John W.; Wittemyer, George; Zieba, Filip; Zwijacz-Kozica, Tomasz; Mueller, Thomas			Moving in the Anthropocene: Global reductions in terrestrial mammalian movements	SCIENCE			English	Article							HOME-RANGE SIZE; MIGRATION; FRAGMENTATION; LANDSCAPE; DISTANCE; FOREST; ROADS; DEER	Animal movement is fundamental for ecosystem functioning and species survival, yet the effects of the anthropogenic footprint on animal movements have not been estimated across species. Using a unique GPS-tracking database of 803 individuals across 57 species, we found that movements of mammals in areas with a comparatively high human footprint were on average one-half to one-third the extent of their movements in areas with a low human footprint. We attribute this reduction to behavioral changes of individual animals and to the exclusion of species with long-range movements from areas with higher human impact. Global loss of vagility alters a key ecological trait of animals that affects not only population persistence but also ecosystem processes such as predator-prey interactions, nutrient cycling, and disease transmission.	[Tucker, Marlee A.; Boehning-Gaese, Katrin; Bracis, Chloe; Fritz, Susanne A.; Hof, Christian; Nandintsetseg, Dejid; Mueller, Thomas] Senckenberg Gesell Naturforsch, Senckenberg Biodivers & Climate Res Ctr, D-60325 Frankfurt, Main, Germany; [Tucker, Marlee A.; Boehning-Gaese, Katrin; Bracis, Chloe; Fritz, Susanne A.; Nandintsetseg, Dejid; Mueller, Thomas] Goethe Univ, Dept Biol Sci, D-60438 Frankfurt, Main, Germany; [Fagan, William F.; Calabrese, Justin M.; Fleming, Christen H.; Gurarie, Eliezer; Hurme, Edward] Univ Maryland, Dept Biol, College Pk, MD 20742 USA; [Fagan, William F.] Univ Maryland, SESYNC, Annapolis, MD 21401 USA; [Fryxell, John M.] Univ Guelph, Dept Integrat Biol, Guelph, ON N1G 2W1, Canada; [Van Moorter, Bram; Kaczensky, Petra; Linnell, John D. C.; Mattisson, Jenny; Rolandsen, Christer Moe; Solberg, Erling J.; Strand, Olav] Norwegian Inst Nat Res, POB 5685 Torgard, NO-7485 Trondheim, Norway; [Alberts, Susan C.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Alberts, Susan C.] Duke Univ, Dept Evolut Anthropol, Durham, NC 27708 USA; [Ali, Abdullahi H.] Hirola Conservat Programme, Garissa, Kenya; [Allen, Andrew M.; Singh, Navinder] Swedish Univ Agr Sci, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden; [Allen, Andrew M.] Radboud Univ Nijmegen, Dept Anim Ecol & Physiol, Inst Water & Wetland Res, NL-6500 GL Nijmegen, Netherlands; [Attias, Nina] Univ Fed Mato Grosso do Sul, Ecol & Conservat Grad Program, Campo Grande, MS, Brazil; [Avgar, Tal; Merrill, Evelyn] Univ Alberta, Dept Biol Sci, Edmonton, AB, Canada; [Bartlam-Brooks, Hattie] Univ London, Royal Vet Coll, Struct & Motion Lab, London NW1 0TU, England; [Bayarbaatar, Buuveibaatar; Olson, Kirk A.; Shiilegdamba, Enkhtuvshin] Wildlife Conservat Soc, Mongolia Program, Ulaanbaatar, Mongolia; [Belant, Jerrold L.] Mississippi State Univ, Forest & Wildlife Res Ctr, Carnivore Ecol Lab, Box 9690, Mississippi State, MS USA; [Bertassoni, Alessandra] Sao Paulo State Univ, Anim Biol Postgra Program, BR-15054000 Sao Jose Do Rio Preto, SP, Brazil; [Beyer, Dean] Michigan Dept Nat Resources, 1990 US 41 South, Marquette, MI 49855 USA; [Bidner, Laura; Isbell, Lynne A.] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [van Beest, Floris M.; Schmidt, Niels Martin] Aarhus Univ, Dept Biosci, DK-4000 Roskilde, Denmark; [Blake, Stephen; Davidson, Sarah C.; Fiedler, Wolfgang; LaPoint, Scott; Safi, Kamran; Wikelski, Martin] Max Planck Inst Ornithol, Vogelwarte Radolfzell, D-78315 Radolfzell am Bodensee, Germany; [Blake, Stephen] Wildlife Conservat Soc, Bronx, NY 10460 USA; [Blaum, Niels; Jeltsch, Florian; Ullmann, Wiebke] Univ Potsdam, Plant Ecol & Nat Conservat, D-14476 Potsdam, Germany; [Brown, Danielle] Middle Tennessee State Univ, Dept Biol, Murfreesboro, TN 37132 USA; [de Bruyn, P. J. Nico] Univ Pretoria, Dept Zool & Entomol, Mammal Res Inst, ZA-0028 Gauteng, South Africa; [Cagnacci, Francesca] Fdn Edmund Mach, Res & Innovat Ctr, Dept Biodivers & Mol Ecol, I-38010 San Michele All Adige, TN, Italy; [Cagnacci, Francesca] Harvard Univ, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Calabrese, Justin M.; Fleming, Christen H.; Leimgruber, Peter; Mueller, Thomas] Natl Zool Pk, Smithsonian Conservat Biol Inst, Front Royal, VA USA; [Camilo-Alves, Constanca] Univ Evora, Depat Fitotecn, P-7002554 Evora, Portugal; [Camilo-Alves, Constanca] Univ Evora, ICAAM, Inst Mediterranean Agr & Environm Sci, Evora, Portugal; [Chamaille-Jammes, Simon] Univ Montpellier, Univ Paul Valery Montpellier, CNRS,EPHE, Ctr Ecol Fonctionnelle & Evolut,UMR 5175, F-34293 Montpellier 5, France; [Chiaradia, Andre] Phillip Isl Nat Parks, Cowes, Vic, Australia; [Chiaradia, Andre] Monash Univ, Sch Biol Sci, Melbourne, Vic, Australia; [Davidson, Sarah C.] Ohio State Univ, Dept Civil Environm & Geodet Engn, Columbus, OH 43210 USA; [Dennis, Todd] Fiji Natl Univ, Dept Biol, POB 5529, Natabua, Lautoka, Fiji; [DeStefano, Stephen; Wattles, David] Univ Massachusetts, US Geol Survey, Massachusetts Cooperat Fish & Wildlife Res Unit, Amherst, MA 01003 USA; [Diefenbach, Duane] Penn State Univ, US Geol Survey, Penn Cooperat Fish & Wildlife Res Unit, University Pk, PA 16802 USA; [Douglas-Hamilton, Iain] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Fennessy, Julian] Giraffe Conservat Fdn, POB 86099, Eros, Namibia; [Fichtel, Claudia; Kappeler, Peter M.; Koch, Flavia] German Primate Ctr, Behav Ecol & Sociobiol Unit, D-37077 Gottingen, Germany; [Fischer, Christina] Tech Univ Munich, Dept Ecol & Ecosyst Management, Restorat Ecol, D-85354 Freising Weihenstephan, Germany; [Fischhoff, Ilya] Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA; [Ford, Adam T.] Univ British Columbia, Irving K Barber Sch Arts & Sci, Unit 2, Biol, Okanagan Campus, Kelowna, BC V1V 1V7, Canada; [Gehr, Benedikt; Kranstauber, Bart] Univ Zurich, Dept Evolutionary Biol & Environm Studies, CH-8057 Zurich, Switzerland; [Goheen, Jacob R.] Univ Wyoming, Dept Zool & Physiol, Laramie, WY 82071 USA; [Gurarie, Eliezer] Univ Washington, Sch Environm & Forest Sci, Seattle, WA 98195 USA; [Hebblewhite, Mark] Univ Montana, Coll Forestry & Conservat, Dept Ecosyst & Conservat Sci, Wildlife Biol Program, Missoula, MT 59812 USA; [Heurich, Marco] Bavarian Forest Natl Pk, Dept Conservat & Res, D-94481 Grafenau, Germany; [Heurich, Marco] Albert Ludwigs Univ Freiburg, Wildlife Ecol & Management, D-79106 Freiburg, Germany; [Hewison, A. J. Mark; Morellet, Nicolas] Univ Toulouse, INRA, CEFS, Castanet Tolosan, France; [Isbell, Lynne A.] Univ Calif Davis, Anim Behav Grad Grp, Davis, CA 95616 USA; [Janssen, Rene] Bionet Natr Onderzoek, NL-6171 EL Stein, Netherlands; [Kaczensky, Petra] Univ Vet Med Vienna, Res Inst Wildlife Ecol, A-1160 Vienna, Austria; [Kane, Adam] Univ Coll Cork, Sch Biol Earth & Environm Sci, Cork, Ireland; [Kauffman, Matthew] Univ Wyoming, US Geol Survey, Dept Zool & Physiol, Wyoming Cooperat Fish & Wildlife Res Unit, Laramie, WY USA; [Kays, Roland] North Carolina Museum Nat Sci, Raleigh, NC 27601 USA; [Kays, Roland] North Carolina State Univ, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Kimuyu, Duncan] Karatina Univ, Dept Nat Resource Management, POB 195710101, Karatina, Kenya; [Koch, Flavia] Univ Lethbridge, Dept Psychol, Lethbridge, AB T1K 3M4, Canada; [LaPoint, Scott] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Lopez-Lopez, Pascual] Univ Valencia, Terr Vertebrates Grp, Cavanilles Inst Biodivers & Evolutionary Biol, E-46980 Valencia, Spain; [Markham, A. Catherine] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; [Medici, Emilia Patricia] TSG, SSC, IUCN, Rua Licuala 622,Damha 1,Campo Grande, BR-79046150 Mato Grosso Sul, Brazil; [Medici, Emilia Patricia] IPE Inst Pesquisas Ecol Inst Ecol Res, Caixa Postal 47, BR-12960000 Sao Paulo, Brazil; [Mellone, Ugo] Univ Alicante, Dept Ciencias Ambient & Recursos Natur, Vertebrates Zool Res Grp, Alicante, Spain; [Mourao, Guilherme de Miranda] Embrapa Pantanal, BR-79320900 Corumba, MS, Brazil; [Morato, Ronaldo G.; de Paula, Rogerio Cunha] Chico Mendes Inst Conservat Biodivers, Natl Res Ctr Carnivores Conservat, BR-12952011 Atiba, SP, Brazil; [Morrison, Thomas A.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Glasgow, Lanark, Scotland; [Diaz-Munoz, Samuel L.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA; [Diaz-Munoz, Samuel L.] Univ Calif Davis, Dept Microbiol & Mol Genet, Davis, CA 95616 USA; [Mysterud, Atle] Univ Oslo, Dept Biosci, Ctr Ecol & Evolutionary Synth, NO-0316 Oslo, Norway; [Nathan, Ran] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Ecol Evolut & Behav, Movement Ecol Lab, IL-91904 Jerusalem, Israel; [Odden, John] Norwegian Inst Nat Res, NO-0349 Oslo, Norway; [O'Hara, Robert B.] Norwegian Univ Sci & Technol NTNU, Dept Math Sci & Ctr Biodivers Dynam, N-7491 Trondheim, Norway; [Oliveira-Santos, Luiz Gustavo R.] Univ Fed Mato Grosso do Sul, Dept Ecol, BR-79070900 Campo Grande, MS, Brazil; [Patterson, Bruce D.] Field Museum Nat Hist, Integrat Res Ctr, Chicago, IL 60605 USA; [Pedrotti, Luca] Consorzio Parco Nazl Stelvio, Bormio, Sondrio, Italy; [Reineking, Bjorn] Univ Grenoble Alpes, Irstea, UR LESSEM, BP 76, F-38402 St Martin Dheres, France; [Reineking, Bjorn] Univ Bayreuth, BayCEER, D-95447 Bayreuth, Germany; [Rimmler, Martin] Natl Park Schwarzwald, D-77889 Seebach, Germany; [Rogers, Tracey L.] Univ New South Wales, Evolut & Ecol Res Ctr, Sydney, NSW 2052, Australia; [Rogers, Tracey L.] Univ New South Wales, Sch Biol Earth & Environm Sci, Sydney, NSW 2052, Australia; [Rosenberry, Christopher S.] Penn Game Commiss, Harrisburg, PA 17110 USA; [Rubenstein, Daniel I.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Safi, Kamran; Wikelski, Martin] Univ Konstanz, Dept Biol, D-78467 Constance, Germany; [Said, Sonia] Off Natl Chasse & Faune Sauvage, Studies & Expertise DRE, F-01330 Birieux, France; [Sapir, Nir] Univ Haifa, Dept Evolutionary & Environm Biol, IL-3498838 Haifa, Israel; [Sawyer, Hall] Western Ecosyst Technol Inc, Laramie, WY 82070 USA; [Schmidt, Niels Martin] Aarhus Univ, Arctic Res Ctr, DK-8000 Aarhus C, Denmark; [Selva, Nuria; Sergiel, Agnieszka] Polish Acad Sci, Inst Nat Conservat, PL-31120 Krakow, Poland; [Silva, Joao Paulo] Univ Porto, CIBIO InBIO Associate Lab, P-4485661 Vairao, Portugal; [Silva, Joao Paulo] Univ Lisbon, Inst Super Agron, InBIO Associate Lab, Ctr Appl Ecol Prof Baeta Neves, P-1349017 Lisbon, Portugal; [Silva, Joao Paulo] Univ Lisbon, Fac Ciencias, Ctr Ecol Evolut & Environm Changes, P-1749016 Lisbon, Portugal; [Spiegel, Orr] Univ Calif Davis, Dept Environm Sci & Policy, Davis, CA 95616 USA; [Sundaresan, Siva] Jackson Hole Conservat, Jackson, WY 83001 USA; [Voigt, Ulrich] Univ Vet Med Hannover, Inst Terr & Aquat Wildlife Res, D-30173 Hannover, Germany; [Wilmers, Christopher C.] Univ Calif Santa Cruz, Environm Studies Dept, Ctr Integrated Spatial Res, Santa Cruz, CA 95060 USA; [Wilson, John W.] Univ Pretoria, Dept Zool & Entomol, ZA-0028 Hatfield, South Africa; [Wittemyer, George] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO 80523 USA; [Zieba, Filip; Zwijacz-Kozica, Tomasz] Tatra Natl Pk, PL-34500 Zakopane, Poland	Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Goethe University Frankfurt; University System of Maryland; University of Maryland College Park; University of Guelph; Norwegian Institute Nature Research; Duke University; Duke University; Swedish University of Agricultural Sciences; Radboud University Nijmegen; Universidade Federal de Mato Grosso do Sul; University of Alberta; University of London; University of London Royal Veterinary College; Mississippi State University; Universidade Estadual Paulista; University of California System; University of California Davis; Aarhus University; Max Planck Society; Wildlife Conservation Society; University of Potsdam; Middle Tennessee State University; University of Pretoria; Fondazione Edmund Mach; Harvard University; Smithsonian Institution; Smithsonian National Zoological Park & Conservation Biology Institute; University of Evora; University of Evora; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Monash University; University System of Ohio; Ohio State University; Fiji National University (FNU); United States Department of the Interior; United States Geological Survey; University of Massachusetts System; University of Massachusetts Amherst; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; United States Department of the Interior; United States Geological Survey; University of Oxford; Deutsches Primatenzentrum (DPZ); Technical University of Munich; Cary Institute of Ecosystem Studies; University of British Columbia; University of Zurich; University of Wyoming; University of Washington; University of Washington Seattle; University of Montana System; University of Montana; University of Freiburg; INRAE; University of California System; University of California Davis; University of Veterinary Medicine Vienna; University College Cork; United States Department of the Interior; United States Geological Survey; University of Wyoming; University of North Carolina; North Carolina State University; University of Lethbridge; Columbia University; University of Valencia; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Universitat d'Alacant; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); University of Glasgow; New York University; University of California System; University of California Davis; University of Oslo; Hebrew University of Jerusalem; Norwegian Institute Nature Research; Norwegian University of Science & Technology (NTNU); Universidade Federal de Mato Grosso do Sul; Field Museum of Natural History (Chicago); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); INRAE; University of Bayreuth; University of New South Wales Sydney; University of New South Wales Sydney; Princeton University; University of Konstanz; University of Haifa; Aarhus University; Polish Academy of Sciences; Universidade do Porto; Universidade de Lisboa; Universidade de Lisboa; University of California System; University of California Davis; University of Veterinary Medicine Hannover, Foundation; University of California System; University of California Santa Cruz; University of Pretoria; Colorado State University	Tucker, MA; Mueller, T (corresponding author), Senckenberg Gesell Naturforsch, Senckenberg Biodivers & Climate Res Ctr, D-60325 Frankfurt, Main, Germany.; Tucker, MA; Mueller, T (corresponding author), Goethe Univ, Dept Biol Sci, D-60438 Frankfurt, Main, Germany.; Mueller, T (corresponding author), Natl Zool Pk, Smithsonian Conservat Biol Inst, Front Royal, VA USA.	tucker.marlee@gmail.com; thomas.mueller@senckenberg.de	Silva, João P/L-6745-2013; Buuveibaatar, Bayarbaatar/AAY-9092-2020; Fiedler, Wolfgang/AAG-4510-2021; Oliveira-Santos, Luiz Gustavo Rodrigues/F-9562-2012; Mysterud, Atle/AAQ-2864-2020; van Beest, Floris M./C-6745-2019; Sergiel, Agnieszka/AAH-8965-2020; Schmidt, Niels Martin/G-3843-2011; Rogers, Tracey L/C-3419-2008; Chiaradia, Andre/AAG-4928-2022; Allen, Andrew M./A-5983-2017; Avgar, Tal/W-9520-2019; Chiaradia, Andre/AFK-6634-2022; Odden, John/F-6088-2019; Fritz, Susanne/M-9872-2014; Patterson, Bruce D/O-5068-2019; Belant, Jerrold/HDM-7749-2022; Hebblewhite, Mark/AAI-8101-2020; Bayarbaatar, Buuveibaatar/AAS-5963-2020; Calabrese, Justin/B-9131-2012; Safi, Kamran/B-2079-2008; Sapir, Nir/V-9634-2019; Camilo-Alves, Constança/AAE-5299-2021; Leimgruber, Peter/O-1304-2015; Mourão, Guilherme M/C-3319-2013; López-López, Pascual/C-1039-2011; Hof, Christian/J-8888-2014; Hewison, Aidan J Mark/AGJ-3300-2022; Cagnacci, Francesca/L-7377-2013; Fischer, Christina/B-5568-2011; Tucker, Marlee/M-9546-2019; Linnell, John/V-4177-2019; Niamir, Aidin/G-5779-2011; O'Hara, Bob/A-7499-2008; Spiegel, Orr/D-4035-2011; Wittemyer, George/AFQ-1840-2022; hebblewhite, mark/G-6164-2013; Gurarie, Eliezer/AGI-0958-2022; De Bruyn, P.J.N./E-4176-2010; Morellet, Nicolas/AAC-3278-2019; Selva, Nuria/J-6970-2013; Heurich, Marco/O-4653-2014; Nathan, Ran/A-9380-2008; Mattisson, Jenny/X-4750-2019; Böhning-Gaese, Katrin/W-2601-2019; Kane, Adam/H-6449-2013; Wilson, John/E-9601-2011; Mueller, Thomas/A-1740-2014; DE PAULA, ROGERIO/S-2182-2017	Silva, João P/0000-0002-1956-5779; Fiedler, Wolfgang/0000-0003-1082-4161; Oliveira-Santos, Luiz Gustavo Rodrigues/0000-0001-9632-5173; Mysterud, Atle/0000-0001-8993-7382; van Beest, Floris M./0000-0002-5701-4927; Sergiel, Agnieszka/0000-0002-3455-4218; Schmidt, Niels Martin/0000-0002-4166-6218; Chiaradia, Andre/0000-0002-6178-4211; Allen, Andrew M./0000-0002-0119-2425; Avgar, Tal/0000-0002-8764-6976; Chiaradia, Andre/0000-0002-6178-4211; Odden, John/0000-0002-6275-8648; Fritz, Susanne/0000-0002-4085-636X; Patterson, Bruce D/0000-0002-2249-7260; Hebblewhite, Mark/0000-0001-5382-1361; Calabrese, Justin/0000-0003-0575-6408; Safi, Kamran/0000-0002-8418-6759; Sapir, Nir/0000-0002-2477-0515; Leimgruber, Peter/0000-0002-3682-0153; Mourão, Guilherme M/0000-0002-8300-4191; López-López, Pascual/0000-0001-5269-652X; Hof, Christian/0000-0002-7763-1885; Hewison, Aidan J Mark/0000-0002-2276-4154; Cagnacci, Francesca/0000-0002-4954-9980; Fischer, Christina/0000-0001-7784-1105; Tucker, Marlee/0000-0001-7535-3431; Linnell, John/0000-0002-8370-5633; Niamir, Aidin/0000-0003-4511-3407; O'Hara, Bob/0000-0001-9737-3724; Spiegel, Orr/0000-0001-8941-3175; Gurarie, Eliezer/0000-0002-8666-9674; De Bruyn, P.J.N./0000-0002-9114-9569; Selva, Nuria/0000-0003-3389-201X; Heurich, Marco/0000-0003-0051-2930; Nathan, Ran/0000-0002-5733-6715; Mattisson, Jenny/0000-0001-6032-5307; Böhning-Gaese, Katrin/0000-0003-0477-5586; Bartlam-Brooks, Hattie/0000-0002-1507-1712; Gehr, Benedikt/0000-0002-1044-9296; Blaum, Niels/0000-0001-6807-5162; Morato, Ronaldo/0000-0002-8304-9779; Kane, Adam/0000-0002-2830-5338; Bertassoni, Alessandra/0000-0002-4806-579X; Kimuyu, Duncan/0000-0001-6077-4970; Rogers, Tracey/0000-0002-7141-4177; Wilson, John/0000-0002-7230-1449; Morellet, Nicolas/0000-0002-4274-7044; Mueller, Thomas/0000-0001-9305-7716; Kranstauber, Bart/0000-0001-8303-780X; Rolandsen, Christer Moe/0000-0002-5628-0385; Bayarbaatar, Buuveibaatar/0000-0003-1803-0745; Reineking, Bjorn/0000-0001-5277-9181; Hurme, Edward/0000-0002-2936-2449; DE PAULA, ROGERIO/0000-0003-1943-8320; Kaczensky, Petra/0000-0001-5428-1176; SAID, Sonia/0000-0003-1485-8297; Voigt, Ulrich/0000-0002-9505-4612; Kays, Roland/0000-0002-2947-6665; Alberts, Susan/0000-0002-1313-488X	Robert Bosch Foundation; Direct For Biological Sciences [1564380] Funding Source: National Science Foundation	Robert Bosch Foundation; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Supported by the Robert Bosch Foundation and additional funding sources (see supplementary text). The data reported in this paper are available at datadryad.org (doi:10.5061/dryad.st350). M.A.T., T.M., K.B.-G., W.F.F., J.M.F., and B.V.M. conceived the manuscript; M.A.T. and T.M. conducted the analyses and wrote the first manuscript draft. Co-authors contributed data sets and assisted with writing the final version of the manuscript.	Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Barnosky AD, 2012, NATURE, V486, P52, DOI 10.1038/nature11018; Bauer S, 2014, SCIENCE, V344, P54, DOI 10.1126/science.1242552; Benitez-Lopez A, 2010, BIOL CONSERV, V143, P1307, DOI 10.1016/j.biocon.2010.02.009; Fahrig L, 2007, FUNCT ECOL, V21, P1003, DOI 10.1111/j.1365-2435.2007.01326.x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Gilchrist JS, 2002, CAN J ZOOL, V80, P1795, DOI 10.1139/Z02-113; Graham MD, 2009, ANIM CONSERV, V12, P445, DOI 10.1111/j.1469-1795.2009.00272.x; Hanski I, 2000, NATURE, V404, P755, DOI 10.1038/35008063; Hassell JM, 2017, TRENDS ECOL EVOL, V32, P55, DOI 10.1016/j.tree.2016.09.012; Hein AM, 2012, ECOL LETT, V15, P104, DOI 10.1111/j.1461-0248.2011.01714.x; JEDRZEJEWSKA B, 1994, J APPL ECOL, V31, P664, DOI 10.2307/2404157; Jerina K, 2012, J MAMMAL, V93, P1139, DOI 10.1644/11-MAMM-A-136.1; Jetz W, 2004, SCIENCE, V306, P266, DOI 10.1126/science.1102138; Jones JD, 2014, ECOL APPL, V24, P1769, DOI 10.1890/13-2092.1; Kamler JF, 2003, J MAMMAL, V84, P989, DOI 10.1644/BJK-033; Lenz J, 2011, P ROY SOC B-BIOL SCI, V278, P2257, DOI 10.1098/rspb.2010.2383; Lundberg J, 2003, ECOSYSTEMS, V6, P87, DOI 10.1007/s10021-002-0150-4; MCNAB BK, 1986, ECOL MONOGR, V56, P1, DOI 10.2307/2937268; Morellet N, 2013, J ANIM ECOL, V82, P1326, DOI 10.1111/1365-2656.12105; Mueller T, 2011, GLOBAL ECOL BIOGEOGR, V20, P683, DOI 10.1111/j.1466-8238.2010.00638.x; Pettorelli N, 2011, CLIM RES, V46, P15, DOI 10.3354/cr00936; Prange S, 2004, J MAMMAL, V85, P483, DOI 10.1644/BOS-121; Rowcliffe JM, 2012, METHODS ECOL EVOL, V3, P653, DOI 10.1111/j.2041-210X.2012.00197.x; Said S, 2005, LANDSCAPE ECOL, V20, P1003, DOI 10.1007/s10980-005-7518-8; Sawyer H, 2013, J APPL ECOL, V50, P68, DOI 10.1111/1365-2664.12013; Teitelbaum CS, 2015, ECOL LETT, V18, P545, DOI 10.1111/ele.12435; Tigas LA, 2002, BIOL CONSERV, V108, P299, DOI 10.1016/S0006-3207(02)00120-9; Tucker MA, 2014, GLOBAL ECOL BIOGEOGR, V23, P1105, DOI 10.1111/geb.12194; Venter O, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12558	30	503	513	45	350	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					466	469		10.1126/science.aam9712	http://dx.doi.org/10.1126/science.aam9712			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6SD	29371471	Green Published, Green Accepted, Green Submitted			2022-12-28	WOS:000423283200049
J	Slomka, S; Pilpel, Y				Slomka, Shai; Pilpel, Yitzhak			Meiotic Recombination: Genetics' Good Old Scalpel	CELL			English	Editorial Material							MUTATIONS; EVOLUTION	In the era of genome engineering, a new study returns to classical genetics to decipher genotype-phenotype relationships in unprecedented throughput and with unprecedented accuracy. Capitalizing on natural variation in yeast strains and frequent meiotic recombination, She and Jarosz (2018) dissect and map to nucleotide resolution, simple and complex determinants of diverse phenotypic traits.	[Slomka, Shai; Pilpel, Yitzhak] Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Pilpel, Y (corresponding author), Weizmann Inst Sci, Dept Mol Genet, IL-76100 Rehovot, Israel.	pilpel@weizmann.ac.il			Minerva Center for Live Emulation of Evolution in the Lab	Minerva Center for Live Emulation of Evolution in the Lab	We thank the Minerva Center for Live Emulation of Evolution in the Lab for grant support.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Barbieri EM, 2017, CELL, V171, P1453, DOI 10.1016/j.cell.2017.10.034; Evangelou E, 2013, NAT REV GENET, V14, P379, DOI 10.1038/nrg3472; Levin-Reisman I, 2017, SCIENCE, V355, P826, DOI 10.1126/science.aaj2191; Li C, 2016, SCIENCE, V352, P837, DOI 10.1126/science.aae0568; Sadhu MJ, 2016, SCIENCE, V352, P1113, DOI 10.1126/science.aaf5124; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Segura J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1945; She R, 2018, CELL, V172, P478, DOI 10.1016/j.cell.2017.12.015	9	0	0	0	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2018	172	3					391	392		10.1016/j.cell.2018.01.017	http://dx.doi.org/10.1016/j.cell.2018.01.017			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FT9BS	29373827	Bronze			2022-12-28	WOS:000423447600002
J	Friedman, DJ; Piccini, JP; Wang, TR; Zheng, JY; Malaisrie, C; Holmes, DR; Suri, RM; Mack, MJ; Badhwar, V; Jacobs, JP; Gaca, JG; Chow, SC; Peterson, ED; Brennan, JM				Friedman, Daniel J.; Piccini, Jonathan P.; Wang, Tongrong; Zheng, Jiayin; Malaisrie, Chris; Holmes, David R.; Suri, Rakesh M.; Mack, Michael J.; Badhwar, Vinay; Jacobs, Jeffrey P.; Gaca, Jeffrey G.; Chow, Shein-Chung; Peterson, Eric D.; Brennan, J. Matthew			Association Between Left Atrial Appendage Occlusion and Readmission for Thromboembolism Among Patients With Atrial Fibrillation Undergoing Concomitant Cardiac Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							STROKE PREVENTION; WARFARIN; CLOSURE; THERAPY; SOCIETY; ANTICOAGULATION; METAANALYSIS; MANAGEMENT; LIGATION; MEDICARE	IMPORTANCE The left atrial appendage is a key site of thrombus formation in atrial fibrillation (AF) and can be occluded or removed at the time of cardiac surgery. There is limited evidence regarding the effectiveness of surgical left atrial appendage occlusion (S-LAAO) for reducing the risk of thromboembolism. OBJECTIVE To evaluate the association of S-LAAO vs no receipt of S-LAAO with the risk of thromboembolism among older patients undergoing cardiac surgery. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study of a nationally representative Medicare-linked cohort from the Society of Thoracic Surgeons Adult Cardiac Surgery Database (2011-2012). Patients aged 65 years and older with AF undergoing cardiac surgery (coronary artery bypass grafting [CABG], mitral valve surgery with or without CABG, or aortic valve surgery with or without CABG) with and without concomitant S-LAAO were followed up until December 31, 2014. EXPOSURES S-LAAO vs no S-LAAO. MAIN OUTCOMES AND MEASURES The primary outcome was readmission for thromboembolism (stroke, transient ischemic attack, or systemic embolism) at up to 3 years of follow-up, as defined by Medicare claims data. Secondary end points included hemorrhagic stroke, all-cause mortality, and a composite end point (thromboembolism, hemorrhagic stroke, or all-cause mortality). RESULTS Among 10 524 patients undergoing surgery (median age, 76 years; 39% female; median CHA(2)DS(2)-VASc score, 4), 3892 (37%) underwent S-LAAO. Overall, at a mean follow-up of 2.6 years, thromboembolism occurred in 5.4%, hemorrhagic stroke in 0.9%, all-cause mortality in 21.5%, and the composite end point in 25.7%. S-LAAO, compared with no S-LAAO, was associated with lower unadjusted rates of thromboembolism (4.2% vs 6.2%), all-cause mortality (17.3% vs 23.9%), and the composite end point (20.5% vs 28.7%) but no significant difference in rates of hemorrhagic stroke (0.9% vs 0.9%). After inverse probability-weighted adjustment, S-LAAO was associated with a significantly lower rate of thromboembolism (subdistribution hazard ratio [HR], 0.67; 95% CI, 0.56-0.81; P<.001), all-cause mortality (HR, 0.88; 95% CI, 0.79-0.97; P=.001), and the composite end point (HR, 0.83; 95% CI, 0.76-0.91; P<.001) but not hemorrhagic stroke (subdistribution HR, 0.84; 95% CI, 0.53-1.32; P=.44). S-LAAO, compared with no S-LAAO, was associated with a lower risk of thromboembolism among patients discharged without anticoagulation (unadjusted rate, 4.2% vs 6.0%; adjusted subdistribution HR, 0.26; 95% CI, 0.17-0.40; P<.001), but not among patients discharged with anticoagulation (unadjusted rate, 4.1% vs 6.3%; adjusted subdistribution HR, 0.88; 95% CI, 0.56-1.39; P=.59). CONCLUSIONS AND RELEVANCE Among older patients with AF undergoing concomitant cardiac surgery, S-LAAO, compared with no S-LAAO, was associated with a lower risk of readmission for thromboembolism over 3 years. These findings support the use of S-LAAO, but randomized trials are necessary to provide definitive evidence.	[Friedman, Daniel J.; Piccini, Jonathan P.; Peterson, Eric D.] Duke Clin Res Inst, Durham, NC USA; [Friedman, Daniel J.; Piccini, Jonathan P.; Peterson, Eric D.; Brennan, J. Matthew] Duke Univ, Sch Med, Durham, NC USA; [Wang, Tongrong; Zheng, Jiayin; Chow, Shein-Chung] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Malaisrie, Chris] Northwestern Univ, Div Cardiac Surg, Chicago, IL 60611 USA; [Holmes, David R.] Mayo Clin, Div Cardiovasc Dis, Rochester, MN USA; [Suri, Rakesh M.] Cleveland Clin Fdn, Thorac & Cardiovasc Surg, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Mack, Michael J.] Baylor Univ, Div Cardiovasc Surg, Dallas, TX USA; [Badhwar, Vinay] West Virginia Univ, Dept Cardiovasc & Thorac Surg, Morgantown, WV USA; [Jacobs, Jeffrey P.] Hopkins All Childrens Heart Inst, St Petersburg, FL USA; [Gaca, Jeffrey G.] Duke Univ, Div Cardiovasc & Thorac Surg, Durham, NC USA	Duke University; Duke University; Duke University; Northwestern University; Mayo Clinic; Cleveland Clinic Foundation; Baylor University; West Virginia University; Duke University	Brennan, JM (corresponding author), Duke Univ, Sch Med, Div Cardiol, 2400 Pratt St,Room 0311 Terrace Level, Durham, NC 27705 USA.	j.matthew.brennan@dm.duke.edu	Peterson, Eric David/ABF-5033-2021; Badhwar, Vinay/AHC-0815-2022		US Food and Drug Administration [1U01FD004591-01]; Burroughs Welcome Fund [1014158]; National Institutes of Health [HL069749-13]; FOOD AND DRUG ADMINISTRATION [U01FD004591] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069749] Funding Source: NIH RePORTER	US Food and Drug Administration; Burroughs Welcome Fund(Burroughs Wellcome Fund); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOOD AND DRUG ADMINISTRATION(United States Department of Health & Human Services); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funding for this study was made possible, in part, by grant 1U01FD004591-01 from the US Food and Drug Administration, which was awarded to Dr Brennan. Additional funding was provided through an Innovation in Regulatory Science Award from Burroughs Welcome Fund (1014158) awarded to Dr Brennan. Dr Friedman is funded by T32 training grant HL069749-13 from the National Institutes of Health.	Bennett-Guerrero E, 2010, JAMA-J AM MED ASSOC, V304, P1568, DOI 10.1001/jama.2010.1406; Blackshear JL, 1996, ANN THORAC SURG, V61, P755, DOI 10.1016/0003-4975(95)00887-X; Brennan JM, 2012, J AM COLL CARDIOL, V60, P971, DOI 10.1016/j.jacc.2012.05.029; Dharmarajan K, 2013, JAMA-J AM MED ASSOC, V309, P355, DOI 10.1001/jama.2012.216476; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Harder VS, 2010, PSYCHOL METHODS, V15, P234, DOI 10.1037/a0019623; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Holmes DR, 2009, LANCET, V374, P534, DOI 10.1016/S0140-6736(09)61343-X; Holmes DR, 2015, J AM COLL CARDIOL, V65, P2614, DOI 10.1016/j.jacc.2015.04.025; Holmes DR, 2014, J AM COLL CARDIOL, V64, P1, DOI 10.1016/j.jacc.2014.04.029; Hsu JC, 2016, JAMA CARDIOL, V1, P55, DOI 10.1001/jamacardio.2015.0374; Jacobs JP, 2016, ANN THORAC SURG, V101, P33, DOI 10.1016/j.athoracsur.2015.08.055; Jacobs JP, 2010, ANN THORAC SURG, V90, P1150, DOI 10.1016/j.athoracsur.2010.05.042; January CT, 2014, J AM COLL CARDIOL, V64, P2246, DOI [10.1016/j.jacc.2014.03.022, 10.1016/j.jacc.2014.03.021, 10.1161/CIR.0000000000000041, 10.1161/CIR.0000000000000142]; KANNEL WB, 1998, AM J CARDIOL, V82; Katz ES, 2000, J AM COLL CARDIOL, V36, P468, DOI 10.1016/S0735-1097(00)00765-8; Kirchhof P, 2016, EUR HEART J, V37, P2893, DOI 10.1093/eurheartj/ehw210; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Melduni RM, 2017, CIRCULATION, V135, P366, DOI 10.1161/CIRCULATIONAHA.116.021952; Ottenbacher KJ, 2014, JAMA-J AM MED ASSOC, V311, P604, DOI 10.1001/jama.2014.8; Park-Hansen J., 2017, ESC C 2017 AUG 28 BA; Prasad V, 2013, JAMA-J AM MED ASSOC, V309, P241, DOI 10.1001/jama.2012.96867; Ruff CT, 2014, LANCET, V383, P955, DOI 10.1016/S0140-6736(13)62343-0; Society of Thoracic Surgeons, AD CARD SURG DAT COL; Tsai YC, 2015, EUR J CARDIO-THORAC, V47, P847, DOI 10.1093/ejcts/ezu291; Whitlock R, 2014, ANN CARDIOTHORAC SUR, V3, P45, DOI 10.3978/j.issn.2225-319X.2013.12.06; Zapolanski A, 2013, INNOVATIONS, V8, P371, DOI 10.1097/IMI.0000000000000022	27	90	94	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					365	374		10.1001/jama.2017.20125	http://dx.doi.org/10.1001/jama.2017.20125			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362794	Green Accepted, Bronze, Green Published			2022-12-28	WOS:000423405300022
J	Patel, JJ				Patel, Jayshil J.			The Things We Say	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Patel, Jayshil J.] Med Coll Wisconsin, Div Pulm & Crit Care Med, 9200 W Wisconsin Ave,Ste E5200, Milwaukee, WI 53226 USA	Medical College of Wisconsin	Patel, JJ (corresponding author), Med Coll Wisconsin, Div Pulm & Crit Care Med, 9200 W Wisconsin Ave,Ste E5200, Milwaukee, WI 53226 USA.	jpatel2@mcw.edu						Gwynne NM, 2014, GWYNNES GRAMMAR ULTI, P5; Mukherjee S., 2015, THE LAWS OF MED; Tiemstra J, 2009, ACAD MED, V84, P723, DOI 10.1097/ACM.0b013e3181a43e28	3	1	1	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					341	342		10.1001/jama.2017.20545	http://dx.doi.org/10.1001/jama.2017.20545			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362799				2022-12-28	WOS:000423405300016
J	Du, YS; Xin, L; Shi, Y; Zhang, TH; Wu, NC; Dai, L; Gong, DY; Brar, G; Shu, S; Luo, JD; Reiley, W; Tseng, YW; Bai, HY; Wu, TT; Wang, JR; Shu, YL; Sun, R				Du, Yushen; Xin, Li; Shi, Yuan; Zhang, Tian-Hao; Wu, Nicholas C.; Dai, Lei; Gong, Danyang; Brar, Gurpreet; Shu, Sara; Luo, Jiadi; Reiley, William; Tseng, Yen-Wen; Bai, Hongyan; Wu, Ting-Ting; Wang, Jieru; Shu, Yuelong; Sun, Ren			Genome-wide identification of interferon-sensitive mutations enables influenza vaccine design	SCIENCE			English	Article							I INTERFERON; VIRUS-VACCINES; A VIRUS; LIVE; POLYMERASE; GENERATION; IMMUNITY; INNATE; NS1; METAANALYSIS	In conventional attenuated viral vaccines, immunogenicity is often suboptimal. Here we present a systematic approach for vaccine development that eliminates interferon (IFN)-modulating functions genome-wide while maintaining virus replication fitness. We applied a quantitative high-throughput genomics system to influenza A virus that simultaneously measured the replication fitness and IFN sensitivity of mutations across the entire genome. By incorporating eight IFN-sensitive mutations, we generated a hyper-interferon-sensitive (HIS) virus as a vaccine candidate. HIS virus is highly attenuated in IFN-competent hosts but able to induce transient IFN responses, elicits robust humoral and cellular immune responses, and provides protection against homologous and heterologous viral challenges. Our approach, which attenuates the virus and promotes immune responses concurrently, is broadly applicable for vaccine development against other pathogens.	[Du, Yushen; Shi, Yuan; Zhang, Tian-Hao; Dai, Lei; Gong, Danyang; Brar, Gurpreet; Shu, Sara; Luo, Jiadi; Tseng, Yen-Wen; Wu, Ting-Ting; Wang, Jieru; Sun, Ren] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Du, Yushen; Sun, Ren] Zhejiang Univ, Canc Inst, Sch Med, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310058, Zhejiang, Peoples R China; [Xin, Li; Bai, Hongyan; Shu, Yuelong] Minist Hlth Peoples Republ China, Collaborat Innovat Ctr Diag & Treatment Infect Di, Chinese Ctr Dis Control & Prevent, Key Lab Med Virol & Viral Dis,Natl Inst Viral Dis, Beijing 102206, Peoples R China; [Zhang, Tian-Hao; Wu, Nicholas C.; Sun, Ren] Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA; [Luo, Jiadi; Wang, Jieru] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15224 USA; [Luo, Jiadi] Cent S Univ, Dept Pathol, Xiangya Hosp 2, Changsha 410005, Hunan, Peoples R China; [Reiley, William] Trudeau Inst, Saranac Lake, NY 12983 USA; [Shu, Yuelong] Sun Yat Sen Univ, Sch Publ Hlth Shenzhen, Guangzhou 510275, Guangdong, Peoples R China	University of California System; University of California Los Angeles; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; Zhejiang University; Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases; University of California System; University of California Los Angeles; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University; Trudeau Institute; Sun Yat Sen University	Du, YS; Sun, R (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.; Du, YS; Sun, R (corresponding author), Zhejiang Univ, Canc Inst, Sch Med, Collaborat Innovat Ctr Diag & Treatment Infect Di, Hangzhou 310058, Zhejiang, Peoples R China.; Sun, R (corresponding author), Univ Calif Los Angeles, Mol Biol Inst, Los Angeles, CA 90095 USA.	lily.duyushen@gmail.com; rsun@mednet.ucla.edu	Wu, Nicholas/H-3822-2015	Wu, Nicholas/0000-0002-9078-6697; Zhang, Tian-hao/0000-0002-4422-5581; Brar, Gurpreet/0000-0001-9499-3135; Shu, Sara/0000-0002-7419-7251	Whitcome Fellowship; Burroughs Wellcome Fund; NIH [CA177322, DE023591, HL113655]; National Science Fund for Distinguished Young Scholars [81525017]; National Science and Technology Major Project [2015ZX09101044]; NATIONAL CANCER INSTITUTE [P01CA177322] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL113655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE023591] Funding Source: NIH RePORTER	Whitcome Fellowship; Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Science and Technology Major Project; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	We greatly appreciate the communication with A. te Velthuis and E. Fodor, who found that the same and similar mutations in PB2 produce mini viral RNAs (mvRNAs), which bind to RIG-I and induce IFN production. Using their method, we were able to detect these mvRNAs produced by our PB2 mutants. We thank Q. Zhou, A. York, and S. Bensinger for THP1 cells with specific gene knockouts and for discussions. We thank S. Park and S. Dubinett for the immortalized HSAECs and HBECs. Support was provided by the Whitcome Fellowship, the Burroughs Wellcome Fund, and the NIH (grants CA177322 and DE023591) to Y.D. and R.S.; the NIH (grant HL113655) to J.W.; the National Science Fund for Distinguished Young Scholars (grant 81525017) to Y. Shu; and National Science and Technology Major Project (grant 2015ZX09101044) to L.X. The sequencing data are deposited in the NIH Sequence Read Archive with accession numbers PRJNA383938, PRJNA254185, PRJNA318707, and PRJNA285135.	Carragher DM, 2008, J IMMUNOL, V181, P4168, DOI 10.4049/jimmunol.181.6.4168; Crouse J, 2015, NAT REV IMMUNOL, V15, P231, DOI 10.1038/nri3806; Darvishian M, 2014, LANCET INFECT DIS, V14, P1228, DOI 10.1016/S1473-3099(14)70960-0; Doud MB, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006271; Du YS, 2016, MBIO, V7, DOI 10.1128/mBio.01801-16; Elena SF, 2006, EMBO REP, V7, P168, DOI 10.1038/sj.embor.7400636; Gamblin SJ, 2004, SCIENCE, V303, P1838, DOI 10.1126/science.1093155; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Graef KM, 2010, J VIROL, V84, P8433, DOI 10.1128/JVI.00879-10; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hale BG, 2010, FUTURE MICROBIOL, V5, P23, DOI [10.2217/fmb.09.108, 10.2217/FMB.09.108]; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Huber JP, 2011, IMMUNOLOGY, V132, P466, DOI 10.1111/j.1365-2567.2011.03412.x; Iwasaki A, 2014, NAT REV IMMUNOL, V14, P315, DOI 10.1038/nri3665; Jin H, 2004, J VIROL, V78, P995, DOI 10.1128/JVI.78.2.995-998.2004; Krammer F, 2015, NAT REV DRUG DISCOV, V14, P167, DOI 10.1038/nrd4529; Le Bon A, 2002, CURR OPIN IMMUNOL, V14, P432, DOI 10.1016/S0952-7915(02)00354-0; Le Bon A, 2001, IMMUNITY, V14, P461, DOI 10.1016/S1074-7613(01)00126-1; Maassab HF, 1999, REV MED VIROL, V9, P237, DOI 10.1002/(SICI)1099-1654(199910/12)9:4&lt;237::AID-RMV252&gt;3.0.CO;2-G; Memoli MJ, 2016, MBIO, V7, DOI 10.1128/mBio.00417-16; Mossler C, 2013, VACCINE, V31, P6194, DOI 10.1016/j.vaccine.2013.10.061; Mueller S, 2010, NAT BIOTECHNOL, V28, P723, DOI 10.1038/nbt.1636; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; Perez-Cidoncha M, 2014, J VIROL, V88, P4632, DOI 10.1128/JVI.00014-14; Pflug A, 2014, NATURE, V516, P355, DOI 10.1038/nature14008; Reich S, 2014, NATURE, V516, P361, DOI 10.1038/nature14009; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Si LL, 2016, SCIENCE, V354, P1170, DOI 10.1126/science.aah5869; Steel J, 2009, J VIROL, V83, P1742, DOI 10.1128/JVI.01920-08; Talon J, 2000, P NATL ACAD SCI USA, V97, P4309, DOI 10.1073/pnas.070525997; Tricco AC, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-153; Visher E, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005856; Wang LL, 2017, CELL HOST MICROBE, V21, P334, DOI 10.1016/j.chom.2017.02.007; Welsh RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002352; Wu CY, 2017, P NATL ACAD SCI USA, V114, P280, DOI 10.1073/pnas.1617174114; Wu NC, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-015-2358-7; Wu NC, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005310; Wu NC, 2014, J VIROL, V88, P10157, DOI 10.1128/JVI.01494-14; Wu Nicholas C, 2014, Sci Rep, V4, P4942, DOI 10.1038/srep04942	40	51	56	3	92	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					290	+		10.1126/science.aan8806	http://dx.doi.org/10.1126/science.aan8806			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6BB	29348231				2022-12-28	WOS:000423236700031
J	Hanna, FWF; Issa, BG; Sim, J; Keevil, B; Fryer, AA				Hanna, Fahmy W. F.; Issa, Basil G.; Sim, Julius; Keevil, Brian; Fryer, Anthony A.			CLINICAL UPDATES Management of incidental adrenal tumours	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PHEOCHROMOCYTOMA; PREVALENCE; SOCIETY; PARAGANGLIOMA; GUIDELINES; DIAGNOSIS; LESIONS; MASSES; PET		[Hanna, Fahmy W. F.] Staffordshire Univ, Univ Hosp North Midlands, Endocrinol & Metab, Stoke On Trent, Staffs, England; [Issa, Basil G.] Univ Hosp South Manchester, Manchester, Lancs, England; [Sim, Julius] Keele Univ, Keele Med Sch, Healthcare Res, Keele, Staffs, England; [Keevil, Brian] Univ Hosp South Manchester, Clin Biochem, Manchester, Lancs, England; [Fryer, Anthony A.] Keele Univ, Univ Hosp North Midlands, Inst Appl Clin Sci, Clin Biochem, Stoke On Trent, Staffs, England	Staffordshire University; Wythenshawe Hospital NHS Foundation Trust; Keele University; Wythenshawe Hospital NHS Foundation Trust; Keele University	Hanna, FWF (corresponding author), Staffordshire Univ, Univ Hosp North Midlands, Endocrinol & Metab, Stoke On Trent, Staffs, England.	Fahmy.hanna@uhns.nhs.uk		hanna, fahmy/0000-0001-5800-1442; Issa, Basil/0000-0001-5681-2698; Fryer, Anthony/0000-0001-8678-0404				Adachi J, 2003, INTERNAL MED, V42, P714, DOI 10.2169/internalmedicine.42.714; [Anonymous], 2002, NIH Consens State Sci Statements, V19, P1; Arlt W, 2011, J CLIN ENDOCR METAB, V96, P3775, DOI 10.1210/jc.2011-1565; BAERT D, 1995, ACTA CLIN BELG, V50, P310, DOI 10.1080/17843286.1995.11718468; Bancos I, 2016, EUR J ENDOCRINOL, V175, pR65, DOI 10.1530/EJE-16-0297; Barzon L, 2003, EUR J ENDOCRINOL, V149, P273, DOI 10.1530/eje.0.1490273; Barzon L, 1999, J CLIN ENDOCR METAB, V84, P520, DOI 10.1210/jc.84.2.520; Becherer A, 2001, CANCER BIOTHER RADIO, V16, P289, DOI 10.1089/108497801753131363; Bovio S, 2006, J ENDOCRINOL INVEST, V29, P298, DOI 10.1007/BF03344099; Caoili EM, 2002, RADIOLOGY, V222, P629, DOI 10.1148/radiol.2223010766; Chang CA, 2016, CANCER IMAGING, V16, DOI 10.1186/s40644-016-0084-2; Dennedy MC, 2016, J CLIN ENDOCR METAB; Else T, 2014, ENDOCR REV, V35, P282, DOI 10.1210/er.2013-1029; Fassnacht M, 2016, EUR J ENDOCRINOL, V175, pG1, DOI 10.1530/EJE-16-0467; Funder JW, 2016, J CLIN ENDOCR METAB, V101, P1889, DOI 10.1210/jc.2015-4061; Grumbach MM, 2003, ANN INTERN MED, V138, P424, DOI 10.7326/0003-4819-138-5-200303040-00013; Haider MA, 2004, RADIOLOGY, V231, P711, DOI 10.1148/radiol.2313030676; Kapoor A, 2011, CUAJ-CAN UROL ASSOC, V5, P241, DOI 10.5489/cuaj.11135; KLOOS RT, 1995, ENDOCR REV, V16, P460, DOI 10.1210/er.16.4.460; Lenders JWM, 2014, J CLIN ENDOCR METAB, V99, P1915, DOI 10.1210/jc.2014-1498; Mansmann G, 2004, ENDOCR REV, V25, P309, DOI 10.1210/er.2002-0031; Mantero F, 2000, J CLIN ENDOCR METAB, V85, P637, DOI 10.1210/jc.85.2.637; Mayer SK, 1997, J PEDIATR SURG, V32, P911, DOI 10.1016/S0022-3468(97)90649-7; Shin YR, 2015, AM J ROENTGENOL, V205, P554, DOI 10.2214/AJR.15.14467; SUTTON MGS, 1981, MAYO CLIN PROC, V56, P354; Terzolo M, 2011, EUR J ENDOCRINOL, V164, P851, DOI 10.1530/EJE-10-1147; Young WF, 2000, ENDOCRIN METAB CLIN, V29, P159, DOI 10.1016/S0889-8529(05)70122-5; Young WF, 2007, NEW ENGL J MED, V356, P601, DOI 10.1056/NEJMcp065470; Yun MJ, 2001, J NUCL MED, V42, P1795; Zeiger MA, 2009, ENDOCR PRACT, V15, P450, DOI 10.4158/EP.15.5.450	30	14	14	1	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 18	2018	360								j5674	10.1136/bmj.j5674	http://dx.doi.org/10.1136/bmj.j5674			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT5QZ	29348269	Green Accepted			2022-12-28	WOS:000423209600001
J	Voelker, R				Voelker, Rebecca			Regulatory Pathway for 3D Printing	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2018	319	3					220	220		10.1001/jama.2017.20643	http://dx.doi.org/10.1001/jama.2017.20643			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT3BY	29340662				2022-12-28	WOS:000423022300006
J	Shen, K; Zhang, L; Chen, XD; Liu, LM; Zhang, DL; Han, Y; Chen, JY; Long, JL; Luque, R; Li, YW; Chen, BL				Shen, Kui; Zhang, Lei; Chen, Xiaodong; Liu, Lingmei; Zhang, Daliang; Han, Yu; Chen, Junying; Long, Jilan; Luque, Rafael; Li, Yingwei; Chen, Banglin			Ordered macro-microporous metal-organic framework single crystals	SCIENCE			English	Article							ZEOLITE; ARCHITECTURES; STABILITY; STRATEGY; GROWTH; ARRAYS; OXIDES	We constructed highly oriented and ordered macropores within metal-organic framework (MOF) single crystals, opening up the area of three-dimensional-ordered macro-microporous materials (that is, materials containing both macro-and micropores) in single-crystalline form. Our methodology relies on the strong shaping effects of a polystyrene nanosphere monolith template and a double-solvent-induced heterogeneous nucleation approach. This process synergistically enabled the in situ growth of MOFs within ordered voids, rendering a single crystal with oriented and ordered macro-microporous structure. The improved mass diffusion properties of such hierarchical frameworks, together with their robust single-crystalline nature, endow them with superior catalytic activity and recyclability for bulky-molecule reactions, as compared with conventional, polycrystalline hollow, and disordered macroporous ZIF-8.	[Shen, Kui; Zhang, Lei; Chen, Xiaodong; Chen, Junying; Long, Jilan; Li, Yingwei] South China Univ Technol, Sch Chem & Chem Engn, Guangzhou 510640, Guangdong, Peoples R China; [Liu, Lingmei; Han, Yu] KAUST, Phys Sci & Engn Div, Adv Membranes & Porous Mat Ctr, Thuwal 239556900, Saudi Arabia; [Zhang, Daliang] KAUST, Imaging & Characterizat Core Lab, Thuwal 239556900, Saudi Arabia; [Luque, Rafael] Univ Cordoba, Dept Quim Organ, Edificio Marie Curie,Carretera Nacl 4-A,Km 396, E-14014 Cordoba, Spain; [Chen, Banglin] Univ Texas San Antonio, Dept Chem, One UTSA Circle, San Antonio, TX 78249 USA	South China University of Technology; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; Universidad de Cordoba; University of Texas System; University of Texas at San Antonio (UTSA)	Li, YW (corresponding author), South China Univ Technol, Sch Chem & Chem Engn, Guangzhou 510640, Guangdong, Peoples R China.; Chen, BL (corresponding author), Univ Texas San Antonio, Dept Chem, One UTSA Circle, San Antonio, TX 78249 USA.	liyw@scut.edu.cn; banglin.chen@utsa.edu	Zhang, Lei/A-4182-2013; Chen, Banglin/F-5461-2010; Zhang, Daliang/B-3358-2018; Han, Yu/GZA-9220-2022; Luque, Rafael/F-9853-2010; Li, Yingwei/M-6479-2014; Han, Yu/N-2036-2015	Zhang, Lei/0000-0002-6385-5773; Chen, Banglin/0000-0001-8707-8115; Zhang, Daliang/0000-0003-3494-7000; Luque, Rafael/0000-0003-4190-1916; Li, Yingwei/0000-0003-1527-551X; Han, Yu/0000-0003-1462-1118; Shen, Kui/0000-0002-4132-4533; Chen, Junying/0000-0003-3881-7238	National Natural Science Foundation of China [21606087, 21436005, 51621001, 21576095, 21606088]; Fundamental Research Funds for the Central Universities [2017PY004, 2017MS069]; Guangdong Natural Science Foundation [2014A030310445, 2016A050502004, 2017A030312005]; Welch Foundation [AX-1730]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Welch Foundation(The Welch Foundation)	We thank the National Natural Science Foundation of China (grants 21606087, 21436005, 51621001, 21576095, and 21606088), the Fundamental Research Funds for the Central Universities (grants 2017PY004 and 2017MS069), the Guangdong Natural Science Foundation (grants 2014A030310445, 2016A050502004, and 2017A030312005), and the Welch Foundation (grant AX-1730) for financial support. K.S. thanks D. Tong for help with the schematic design and Y. Zhao for GFP preparation. K.S., Y.L., and B.C. conceived the idea and designed the experiments. K.S. synthesized the materials and carried out most of the structural characterization. Y.H., L.L., and D.Z. performed the HRTEM images and analyzed the results. K.S., L.Z., X.C., J.C., and J.L. performed the catalytic tests and some structural characterization. K.S., Y.L., B.C., and R.L. cowrote the paper. All authors discussed and commented on the manuscript. All data are reported in the main text and supplementary materials. K.S. and Y.L. are inventors on a patent/patent application (201710819873.9) held/submitted by South China University of Technology that covers the method for preparing ordered macroporous MOF single crystals.	Cai GR, 2017, ANGEW CHEM INT EDIT, V56, P563, DOI 10.1002/anie.201610914; Choi M, 2006, NAT MATER, V5, P718, DOI 10.1038/nmat1705; Cravillon J, 2011, CHEM MATER, V23, P2130, DOI 10.1021/cm103571y; Crossland EJW, 2013, NATURE, V495, P215, DOI 10.1038/nature11936; Davis ME, 2002, NATURE, V417, P813, DOI 10.1038/nature00785; Eddaoudi M, 2002, SCIENCE, V295, P469, DOI 10.1126/science.1067208; Furukawa S, 2014, CHEM SOC REV, V43, P5700, DOI 10.1039/c4cs00106k; Han S, 2015, CRYST GROWTH DES, V15, P5568, DOI 10.1021/acs.cgd.5b01218; Holland BT, 1998, SCIENCE, V281, P538, DOI 10.1126/science.281.5376.538; Huang XC, 2006, ANGEW CHEM INT EDIT, V45, P1557, DOI 10.1002/anie.200503778; Inagaki S, 2002, NATURE, V416, P304, DOI 10.1038/416304a; Krishna R, 2012, CHEM SOC REV, V41, P3099, DOI 10.1039/c2cs15284c; Li JR, 2009, CHEM SOC REV, V38, P1477, DOI 10.1039/b802426j; Li LM, 2016, CRYST GROWTH DES, V16, P2700, DOI 10.1021/acs.cgd.5b01817; Li Z, 2013, CHEM MATER, V25, P1761, DOI 10.1021/cm400260g; Lin S, 2015, SCIENCE, V349, P1208, DOI 10.1126/science.aac8343; Na K, 2011, SCIENCE, V333, P328, DOI 10.1126/science.1204452; Park KS, 2006, P NATL ACAD SCI USA, V103, P10186, DOI 10.1073/pnas.0602439103; Reboul J, 2012, NAT MATER, V11, P717, DOI [10.1038/NMAT3359, 10.1038/nmat3359]; Sun LB, 2012, J AM CHEM SOC, V134, P126, DOI 10.1021/ja209698f; Tietze LF, 1996, CHEM REV, V96, P115, DOI 10.1021/cr950027e; Valtchev V, 2013, CHEM REV, V113, P6734, DOI 10.1021/cr300439k; Wu YN, 2011, ANGEW CHEM INT EDIT, V50, P12518, DOI 10.1002/anie.201104597; Yang PD, 1998, NATURE, V396, P152; Yang PD, 1998, SCIENCE, V282, P2244, DOI 10.1126/science.282.5397.2244; Yue YF, 2013, J AM CHEM SOC, V135, P9572, DOI 10.1021/ja402694f	26	610	623	174	2354	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					206	+		10.1126/science.aao3403	http://dx.doi.org/10.1126/science.aao3403			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS5EO	29326271				2022-12-28	WOS:000419816600044
J	McCulloch, P; Feinberg, J; Philippou, Y; Kolias, A; Kehoe, S; Lancaster, G; Donovan, J; Petrinic, T; Agha, R; Pennell, C				McCulloch, Peter; Feinberg, Joshua; Philippou, Yiannis; Kolias, Angelos; Kehoe, Sean; Lancaster, Gillian; Donovan, Jenny; Petrinic, Tatjana; Agha, Riaz; Pennell, Christopher			Progress in clinical research in surgery and IDEAL	LANCET			English	Article							SURGICAL RESEARCH; EXPLORATION; INNOVATION; FRAMEWORK; TRIALS; HEALTH	The quality of clinical research in surgery has long attracted criticism. High-quality randomised trials have proved difficult to undertake in surgery, and many surgical treatments have therefore been adopted without adequate supporting evidence of efficacy and safety. This evidence deficit can adversely affect research funding and reimbursement decisions, lead to slow adoption of innovations, and permit widespread adoption of procedures that offer no benefit, or cause harm. Improvement in the quality of surgical evidence would therefore be valuable. The Idea, Development, Exploration, Assessment, and Long-term Follow-up (IDEAL) Framework and Recommendations specify desirable qualities for surgical studies, and outline an integrated evaluation pathway for surgery, and similar complex interventions. We used the IDEAL Recommendations to assess methodological progress in surgical research over time, assessed the uptake and influence of IDEAL, and identified the challenges to further methodological progress.Comparing studies from the periods 2000-04 and 2010-14, we noted apparent improvement in the use of standard outcome measures, adoption of Consolidated Standards of Reporting Trials (CONSORT) standards, and assessment of the quality of surgery and of learning curves, but no progress in the use of qualitative research or reporting of modifications during procedure development. Better education about research, integration of rigorous evaluation into routine practice and training, and linkage of such work to awards systems could foster further improvements in surgical evidence. IDEAL has probably contributed only slightly to the improvements described to date, but its uptake is accelerating rapidly. The need for the integrated evaluation template IDEAL offers for surgery and other complex treatments is becoming more widely accepted.	[McCulloch, Peter; Philippou, Yiannis] Univ Oxford, Nuffiled Dept Surg Sci, Oxford, England; [Feinberg, Joshua; Pennell, Christopher] Maimonides Hosp, Dept Surg, Brooklyn, NY 11219 USA; [Kolias, Angelos] Univ Cambridge, Sch Clin Med, Div Neurosurg, Cambridge, England; [Kehoe, Sean] Univ Birmingham, Inst Canc & Genom, Birmingham, W Midlands, England; [Lancaster, Gillian] Keele Univ, Inst Primary Care & Hlth Sci, Newcastle, NSW, Australia; [Donovan, Jenny] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Petrinic, Tatjana] Oxford Univ Hosp Fdn Trust, Cairns Lib, Oxford, England; [Agha, Riaz] Guys & St Thomas NHS Fdn Trust, Plast Surg Dept, London, England	University of Oxford; Maimonides Medical Center; University of Cambridge; University of Birmingham; University of Bristol; Oxford University Hospitals NHS Foundation Trust; University of Oxford; Guy's & St Thomas' NHS Foundation Trust	McCulloch, P (corresponding author), Univ Oxford, John Radcliffe Hosp, Nuffield Dept Surg Sci, Oxford OX3 9DU, England.	peter.mcculloch@nds.ox.ac.uk	Paez, Arsenio/AAC-7767-2019	Paez, Arsenio/0000-0002-7984-514X; Kolias, Angelos/0000-0003-3992-0587; McCulloch, Peter/0000-0002-3210-8273; Philippou, Yiannis/0000-0002-5335-5871	MRC [MR/K025643/1] Funding Source: UKRI; Medical Research Council [MR/K025643/1] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Barkun JS, 2009, LANCET, V374, P1089, DOI 10.1016/S0140-6736(09)61083-7; Beard D, 2018, PHYS THER, V98, P108, DOI 10.1093/ptj/pzx103; Bell PRF, 1996, LANCET, V347, P1479, DOI 10.1016/S0140-6736(96)91715-8; Bhangu A, 2013, LANCET, V382, P1091, DOI 10.1016/S0140-6736(13)62013-9; Ergina PL, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f3011; Heikens JT, 2013, SURG INNOV, V20, P459, DOI 10.1177/1553350612468959; Horton R, 1996, LANCET, V347, P984, DOI 10.1016/S0140-6736(96)90137-3; Levay C, 2016, J INTERN MED, V279, P160, DOI 10.1111/joim.12438; Levin L, 2013, VALUE HEALTH, V16, pA264, DOI 10.1016/j.jval.2013.03.1357; Marshall DA, 2014, CLIN ORTHOP RELAT R, V472, P2217, DOI 10.1007/s11999-014-3556-3; McCulloch P, 2002, BRIT MED J, V324, P1448, DOI 10.1136/bmj.324.7351.1448; McCulloch P, 2009, LANCET, V374, P1105, DOI 10.1016/S0140-6736(09)61116-8; Mirheydar HS, 2013, WORLD J UROL, V31, P455, DOI 10.1007/s00345-012-1015-x; Pennell CP, 2016, BRIT J SURG, V103, P607, DOI 10.1002/bjs.10115; Rogers E., 2003, DIFFUSION INNOVATION, VFifth; Ruckley CV, 1996, LANCET, V347, P1479; Sampietro-Colom L, 2016, HOSP BASED HLTH TECH, P3; Sedrakyan A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2372; SOLOMON MJ, 1994, SURGERY, V115, P707; Verkooijen HM, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00059	20	38	46	0	9	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 7	2018	392	10141					88	94		10.1016/S0140-6736(18)30102-8	http://dx.doi.org/10.1016/S0140-6736(18)30102-8			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL9OL	29361334	Green Submitted, Green Accepted			2022-12-28	WOS:000437665000037
J	Hultcrantz, M; Bjorkholm, M; Dickman, PW; Landgren, O; Derolf, AR; Kristinsson, SY; Andersson, TML				Hultcrantz, Malin; Bjorkholm, Magnus; Dickman, Paul W.; Landgren, Ola; Derolf, Asa R.; Kristinsson, Sigurdur Y.; Andersson, Therese M. L.			Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms A Population-Based Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							TYROSINE KINASE JAK2; POLYCYTHEMIA-VERA; ESSENTIAL THROMBOCYTHEMIA; PRIMARY MYELOFIBROSIS; COAGULATION ACTIVATION; MUTATION; SURVIVAL; DIAGNOSIS; PLATELET; DISEASE	Background: Patients with myeloproliferative neoplasms (MPNs) are reported to be at increased risk for thrombotic events. However, no population-based study has estimated this excess risk compared with matched control participants. Objective: To assess risk for arterial and venous thrombosis in patients with MPNs compared with matched control participants. Design: Matched cohort study. Setting: Population-based setting in Sweden from 1987 to 2009, with follow-up to 2010. Patients: 9429 patients with MPNs and 35 820 matched control participants. Measurements: The primary outcomes were rates of arterial and venous thrombosis. Flexible parametric models were used to calculate hazard ratios (HRs) and cumulative incidence with 95% CIs. Results: The HRs for arterial thrombosis among patients with MPNs compared with control participants at 3 months, 1 year, and 5 years were 3.0 (95% CI, 2.7 to 3.4), 2.0 (CI, 1.8 to 2.2), and 1.5 (CI, 1.4 to 1.6), respectively. The corresponding HRs for venous thrombosis were 9.7 (CI, 7.8 to 12.0), 4.7 (CI, 4.0 to 5.4), and 3.2 (CI, 2.9 to 3.6). The rate was significantly elevated across all age groups and was similar among MPN subtypes. The 5-year cumulative incidence of thrombosis in patients with MPNs showed an initial rapid increase followed by gentler increases during follow-up. The HR for venous thrombosis decreased during more recent calendar periods. Limitation: No information on individual laboratory results or treatment. Conclusion: Patients with MPNs across all age groups have a significantly increased rate of arterial and venous thrombosis compared with matched control participants, with the highest rates at and shortly after diagnosis. Decreases in the rate of venous thrombosis over time likely reflect advances in clinical management.	Karolinska Univ Hosp, Stockholm, Sweden; [Dickman, Paul W.; Andersson, Therese M. L.] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Hultcrantz, Malin; Bjorkholm, Magnus; Derolf, Asa R.] Karolinska Univ Hosp Solna, Dept Med, Div Hematol, SE-17176 Stockholm, Sweden; [Landgren, Ola] Mem Sloan Kettering Canc Ctr, Dept Med, Myeloma Serv, 1275 York Ave, New York, NY 10065 USA; [Kristinsson, Sigurdur Y.] Univ Iceland, Fac Med, Hringbraut 101, IS-101 Reykjavik, Iceland; Landspitali Natl Univ Hosp, Reykjavik, Iceland	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Memorial Sloan Kettering Cancer Center; University of Iceland; Landspitali National University Hospital	Hultcrantz, M (corresponding author), Karolinska Univ Hosp Solna, Dept Med, Div Hematol, SE-17176 Stockholm, Sweden.	malin.hultcrantz@ki.se; therese.m-l.andersson@ki.se	Dickman, Paul W/B-4572-2013; Andersson, Therese M-L/E-7107-2016	Dickman, Paul W/0000-0002-5788-3380; Andersson, Therese M-L/0000-0001-8644-9041; Hultcrantz, Malin/0000-0002-9045-6495	Cancer Research Foundations of Radiumhemmet, Blodcancerfonden; Swedish Research Council; Adolf H. Lundin Charitable Foundation; Memorial Sloan Kettering Cancer Center [P30 CA008748]; Stockholm County Council and Karolinska Institutet; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Cancer Research Foundations of Radiumhemmet, Blodcancerfonden; Swedish Research Council(Swedish Research CouncilEuropean Commission); Adolf H. Lundin Charitable Foundation; Memorial Sloan Kettering Cancer Center; Stockholm County Council and Karolinska Institutet; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	By the Cancer Research Foundations of Radiumhemmet, Blodcancerfonden, the Swedish Research Council, the regional agreement on medical training and clinical research between Stockholm County Council and Karolinska Institutet, the Adolf H. Lundin Charitable Foundation, and a Memorial Sloan Kettering Cancer Center Core Grant (P30 CA008748).	Alvarez-Larran A, 2008, ANN HEMATOL, V87, P269, DOI 10.1007/s00277-007-0386-3; Barbui T, 2016, BLOOD REV, V30, P453, DOI 10.1016/j.blre.2016.06.001; Barbui T, 2015, AM J HEMATOL, V90, P434, DOI 10.1002/ajh.23970; Barbui T, 2014, BLOOD, V124, P3021, DOI 10.1182/blood-2014-07-591610; Barbui T, 2013, BLOOD, V122, P2176, DOI 10.1182/blood-2013-03-460154; Barbui T, 2012, BLOOD, V120, P5128, DOI 10.1182/blood-2012-07-444067; Barbui T, 2011, J CLIN ONCOL, V29, P3179, DOI 10.1200/JCO.2010.34.5298; Barbui T, 2011, J CLIN ONCOL, V29, P761, DOI 10.1200/JCO.2010.31.8436; Barbui T, 2010, BLOOD, V115, P778, DOI 10.1182/blood-2009-08-238956; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; BERLIN NI, 1975, SEMIN HEMATOL, V12, P339; Bjorkholm M, 2014, BEST PRACT RES CL HA, V27, P141, DOI 10.1016/j.beha.2014.07.003; Bjorkholm M, 2011, J CLIN ONCOL, V29, P2410, DOI 10.1200/JCO.2011.34.7542; Campbell PJ, 2012, BLOOD, V120, P1409, DOI 10.1182/blood-2012-04-424911; Carobbio A, 2011, BLOOD, V117, P5857, DOI 10.1182/blood-2011-02-339002; Cervantes F, 2009, BLOOD, V113, P2895, DOI 10.1182/blood-2008-07-170449; Falanga A, 2007, EXP HEMATOL, V35, P702, DOI 10.1016/j.exphem.2007.01.053; Finazzi G, 2013, CURR HEMATOL MALIG R, V8, P307, DOI 10.1007/s11899-013-0176-z; Harrison CN, 2005, NEW ENGL J MED, V353, P33, DOI 10.1056/NEJMoa043800; Hinchliffe SR, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-13; Hultcrantz M, 2015, J CLIN ONCOL, V33, P2288, DOI 10.1200/JCO.2014.57.6652; Hultcrantz M, 2012, J CLIN ONCOL, V30, P2995, DOI 10.1200/JCO.2012.42.1925; Jaffe ES, 2001, WHO CLASSIFICATION T; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kiladjian JJ, 2008, BLOOD, V112, P3065, DOI 10.1182/blood-2008-03-143537; Klampfl T, 2013, NEW ENGL J MED, V369, P2379, DOI 10.1056/NEJMoa1311347; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Landolfi R, 2004, NEW ENGL J MED, V350, P114, DOI 10.1056/NEJMoa035572; Landolfi R, 2007, BLOOD, V109, P2446, DOI 10.1182/blood-2006-08-042515; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Ludvigsson JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-450; Marchioli R, 2005, J CLIN ONCOL, V23, P2224, DOI 10.1200/JCO.2005.07.062; Marchioli R, 2013, NEW ENGL J MED, V368, P22, DOI 10.1056/NEJMoa1208500; Murphy S, 1997, SEMIN HEMATOL, V34, P29; Nangalia J, 2013, NEW ENGL J MED, V369, P2391, DOI 10.1056/NEJMoa1312542; Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270; Robertson B, 2007, J THROMB HAEMOST, V5, P1679, DOI 10.1111/j.1538-7836.2007.02626.x; Samuelson BT, 2016, BLOOD COAGUL FIBRIN, V27, P648, DOI 10.1097/MBC.0000000000000446; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Socialstyrelsen, 2009, HJARTSJ OPPN JAMF UT; Socialstyrelsen, 2010, DODS HIST PROD TILLF; Socialstyrelsen, 2014, CANC SVER 2013 NYA D; Statistics Sweden, 2010, TAB SVER BEF 2009; Statistics Sweden, 1994, BEF 1993; Stein BL, 2013, LEUKEMIA LYMPHOMA, V54, P1989, DOI 10.3109/10428194.2012.759656; Swerdlow SH, 2008, WHO CLASSIFICATION T; Tefferi A, 2013, LEUKEMIA, V27, P1874, DOI 10.1038/leu.2013.163; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Vannucchi AM, 2013, SEMIN THROMB HEMOST, V39, P496, DOI 10.1055/s-0033-1343890; Verstovsek S, 2016, HAEMATOLOGICA, V101, P821, DOI 10.3324/haematol.2016.143644	50	120	121	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2018	168	5					317	+		10.7326/M17-0028	http://dx.doi.org/10.7326/M17-0028			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY2GD	29335713	Green Accepted			2022-12-28	WOS:000426632600004
J	Wood, RA; Bauza, M; Krupic, J; Burton, S; Delekate, A; Chan, D; O'Keefe, J				Wood, Ruth A.; Bauza, Marius; Krupic, Julija; Burton, Stephen; Delekate, Andrea; Chan, Dennis; O'Keefe, John			The honeycomb maze provides a novel test to study hippocampal-dependent spatial navigation	NATURE			English	Article							ENTORHINAL CORTEX; RATS; REPRESENTATION; MEMORY; CELLS; MAP	Here we describe the honeycomb maze, a behavioural paradigm for the study of spatial navigation in rats. The maze consists of 37 platforms that can be raised or lowered independently. Place navigation requires an animal to go to a goal platform from any of several start platforms via a series of sequential choices. For each, the animal is confined to a raised platform and allowed to choose between two of the six adjacent platforms, the correct one being the platform with the smallest angle to the goal-heading direction. Rats learn rapidly and their choices are influenced by three factors: the angle between the two choice platforms, the distance from the goal, and the angle between the correct platform and the direction of the goal. Rats with hippocampal damage are impaired in learning and their performance is affected by all three factors. The honeycomb maze represents a marked improvement over current spatial navigation tests, such as the Morris water maze(1-3), because it controls the choices of the animal at each point in the maze, provides the ability to assess knowledge of the goal direction from any location, enables the identification of factors influencing task performance and provides the possibility for concomitant singlecell recording.				j.okeefe@ucl.ac.uk	Bauza, Marius/AAB-6403-2019	Bauza, Marius/0000-0003-3514-8382; Krupic, Julija/0000-0001-6299-1629; Burton, Stephen/0000-0002-0788-1897; O'Keefe, John/0000-0001-5697-4881	Wellcome Trust; Gatsby Charitable Foundation; Kavli Foundation Dream Team project; Isaac Newton Trust; Cambridge NIHR Biomedical Research Centre; Medical Research Council [MR/M018067/1] Funding Source: researchfish; MRC [MR/M018067/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Gatsby Charitable Foundation; Kavli Foundation Dream Team project; Isaac Newton Trust; Cambridge NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank M. Bertelli, A. Hastings, D. Howett, N. Khan, P. Mumford, A. O'Leary, B. Potter, S. Richards and R. Wu for their contribution to this work, and D. Farquharson and D. Halpin for their input to the design, building and testing of maze prototypes. This work was supported by grants from the Wellcome Trust and the Gatsby Charitable Foundation to J.O. R.A.W. is an MRC Clinical Research Training Fellow, J.K. is a Wellcome Trust/Royal Society Sir Henry Dale Fellow and is supported by the Kavli Foundation Dream Team project and the Isaac Newton Trust. D.C. is funded by the Cambridge NIHR Biomedical Research Centre and by the Wellcome Trust.	BARNES CA, 1979, J COMP PHYSIOL PSYCH, V93, P74, DOI 10.1037/h0077579; Dudchenko PA, 2001, BEHAV NEUROSCI, V115, P850, DOI 10.1037//0735-7044.115.4.850; EICHENBAUM H, 1990, J NEUROSCI, V10, P3531; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; MORRIS RGM, 1982, NATURE, V297, P681, DOI 10.1038/297681a0; MORRIS RGM, 1981, LEARN MOTIV, V12, P239, DOI 10.1016/0023-9690(81)90020-5; Moser MB, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021808; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; O'Keefe J., 1996, LANGUAGE SPACE, P277; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKeefe J., 2007, HIPPOCAMPUS BOOK, P471; OKeefe J, 1991, BRAIN SPACE, P273, DOI DOI 10.1016/j.neuron.2015.06.011; OLTON DS, 1978, BRAIN RES, V139, P295, DOI 10.1016/0006-8993(78)90930-7; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; RANCK J B JR, 1984, Society for Neuroscience Abstracts, V10, P599; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; TAUBE JS, 1990, J NEUROSCI, V10, P420	19	19	20	6	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2018	554	7690					102	+		10.1038/nature25433	http://dx.doi.org/10.1038/nature25433			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7QX	29364869	Green Submitted, Green Accepted			2022-12-28	WOS:000424048900039
J	Cho, A				Cho, Adrian			PARTICLE PHYSICS Muon's magnetism could point to new physics	SCIENCE			English	News Item																			0	1	1	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					381	381		10.1126/science.359.6374.381	http://dx.doi.org/10.1126/science.359.6374.381			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6SD	29371450				2022-12-28	WOS:000423283200022
J	Hurley, R				Hurley, Richard			THE BMJ CHARITY APPEAL CHRISTMAS 2017 The BMJ charity appeal Christmas 2017: help Medecins Sans Frontieres help child refugees worldwide	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												rhurley@bmj.com						Al-Kilani L., 2017, ONE REFUGEE ANOTHER; Feinmann J, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5926; Feinmann J, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5535; Gattinger M., 2018, CAN EUROPE BE MORE T; HURLEY R, 2017, BMJ-BRIT MED J, V359, DOI DOI 10.1136/BMJ.J572229233810; MSF Serbia, 2017, GAM OF VIOL; Unicef, 2017, CHILD IS CHILD PROT	7	0	0	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2018	360								k349	10.1136/bmj.k349	http://dx.doi.org/10.1136/bmj.k349			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU2WT	29367270				2022-12-28	WOS:000423711400014
J	Abascal-Palacios, G; Ramsay, EP; Beuron, F; Morris, E; Vannini, A				Abascal-Palacios, Guillermo; Ramsay, Ewan Phillip; Beuron, Fabienne; Morris, Edward; Vannini, Alessandro			Structural basis of RNA polymerase III transcription initiation	NATURE			English	Article							CRYSTAL-STRUCTURE; FACTOR-TFIIIB; ACTIVE-SITE; DNA; VISUALIZATION; SUBUNIT; COMPLEX; PROTEIN; BDP1; TERMINATION	RNA polymerase (Pol) III transcribes essential non-coding RNAs, including the entire pool of transfer RNAs, the 5S ribosomal RNA and the U6 spliceosomal RNA, and is often deregulated in cancer cells. The initiation of gene transcription by Pol III requires the activity of the transcription factor TFIIIB to form a transcriptionally active Pol III preinitiation complex (PIC). Here we present electron microscopy reconstructions of Pol III PICs at 3.4-4.0 angstrom and a reconstruction of unbound apo-Pol III at 3.1 angstrom. TFIIIB fully encircles the DNA and restructures Pol III. In particular, binding of the TFIIIB subunit Bdp1 rearranges the Pol III-specific subunits C37 and C34, thereby promoting DNA opening. The unwound DNA directly contacts both sides of the Pol III cleft. Topologically, the Pol III PIC resembles the Pol II PIC, whereas the Pol I PIC is more divergent. The structures presented unravel the molecular mechanisms underlying the first steps of Pol III transcription and also the general conserved mechanisms of gene transcription initiation.	[Abascal-Palacios, Guillermo; Ramsay, Ewan Phillip; Beuron, Fabienne; Morris, Edward; Vannini, Alessandro] Inst Canc Res, London SW7 3RP, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Vannini, A (corresponding author), Inst Canc Res, London SW7 3RP, England.	Alessandro.Vannini@icr.ac.uk		Morris, Edward/0000-0003-3544-0041; Vannini, Alessandro/0000-0001-7212-5425; Abascal-Palacios, Guillermo/0000-0002-6805-5927; Ramsay, Ewan/0000-0003-4670-4145	Marie Sklodowska-Curie Intra-European Fellowship (EU project) [655238]; Cancer Research UK (CR-UK) [C12209/A16749]; Biotechnology and Biological Sciences Research Council (BBSRC) New Investigator Award [BB/K014390/1]; Cancer Research UK Programme Foundation (CR-UK) [C47547/A21536]; Wellcome Trust Investigator Award [200818/Z/16/Z]; Biotechnology and Biological Sciences Research Council [BB/K014390/1] Funding Source: researchfish; Cancer Research UK [16749, 21536] Funding Source: researchfish; BBSRC [BB/K014390/1] Funding Source: UKRI	Marie Sklodowska-Curie Intra-European Fellowship (EU project); Cancer Research UK (CR-UK)(Cancer Research UK); Biotechnology and Biological Sciences Research Council (BBSRC) New Investigator Award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK Programme Foundation (CR-UK); Wellcome Trust Investigator Award(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank N. Cronin at the Institute of Cancer Research for help with yeast fermentation; C. Richardson for the computing infrastructure; C. Plaschka (MRC-LMB, Cambridge) for advice during data processing; and the staff at beamline M03 of the Diamond Light Source synchrotron (UK) for help with EM data collection (EM15629, EM16599 and EM166601). We acknowledge support and the use of resources of iNEXT, in particular C. Sachse and W. Hagen for EM data collection at EMBL Heidelberg (PID1956 and 2180). G.A.-P. is a recipient of a Marie Sklodowska-Curie Intra-European Fellowship (EU project 655238). E.M. is supported by Cancer Research UK (CR-UK C12209/A16749). A.V. is supported by a Biotechnology and Biological Sciences Research Council (BBSRC) New Investigator Award (BB/K014390/1), a Cancer Research UK Programme Foundation (CR-UK C47547/A21536) and a Wellcome Trust Investigator Award (200818/Z/16/Z).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arimbasseri AG, 2015, MOL CELL, V58, P1124, DOI 10.1016/j.molcel.2015.04.002; Barski A, 2010, NAT STRUCT MOL BIOL, V17, P629, DOI 10.1038/nsmb.1806; Brun I, 1997, EMBO J, V16, P5730, DOI 10.1093/emboj/16.18.5730; Carter R, 2010, MOL BIOL EVOL, V27, P1035, DOI 10.1093/molbev/msp316; Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716; Cloutier TE, 2001, P NATL ACAD SCI USA, V98, P9581, DOI 10.1073/pnas.161292298; Dauwerse JG, 2011, NAT GENET, V43, P20, DOI 10.1038/ng.724; Dieci G, 2000, J MOL BIOL, V299, P601, DOI 10.1006/jmbi.2000.3783; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engel C, 2017, CELL, V169, P120, DOI 10.1016/j.cell.2017.03.003; Fairley JA, 2012, MOL CELL, V45, P541, DOI 10.1016/j.molcel.2011.11.030; Filer D., 2017, NATURE; Geiger SR, 2010, MOL CELL, V39, P583, DOI 10.1016/j.molcel.2010.07.028; Goodarzi H, 2016, CELL, V165, P1416, DOI 10.1016/j.cell.2016.05.046; Gouge J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00126-1; Gouge J, 2015, CELL, V163, P1375, DOI 10.1016/j.cell.2015.11.005; Han Y, 2017, ELIFE, V6, DOI 10.7554/eLife.27414; Harismendy O, 2003, EMBO J, V22, P4738, DOI 10.1093/emboj/cdg466; Hausner W, 2001, J BACTERIOL, V183, P3025, DOI 10.1128/JB.183.10.3025-3031.2001; He Y, 2016, NATURE, V533, P359, DOI 10.1038/nature17970; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Hoffmann NA, 2015, NATURE, V528, P231, DOI 10.1038/nature16143; Hu HL, 2015, MOL CELL BIOL, V35, P2831, DOI 10.1128/MCB.00263-15; Huet J, 1997, J BIOL CHEM, V272, P18341, DOI 10.1074/jbc.272.29.18341; Ishiguro A, 2002, MOL CELL BIOL, V22, P3264, DOI 10.1128/MCB.22.10.3264-3275.2002; Jun SH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6132; Juo ZS, 2003, NATURE, V422, P534, DOI 10.1038/nature01534; Kassavetis GA, 2005, P NATL ACAD SCI USA, V102, P15406, DOI 10.1073/pnas.0507653102; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; Kassavetis GA, 1999, EMBO J, V18, P5042, DOI 10.1093/emboj/18.18.5042; KASSAVETIS GA, 1992, J MOL BIOL, V226, P47, DOI 10.1016/0022-2836(92)90123-2; Kassavetis GA, 2001, EMBO J, V20, P2823, DOI 10.1093/emboj/20.11.2823; Kassavetis GA, 2010, J BIOL CHEM, V285, P2695, DOI 10.1074/jbc.M109.074013; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Moqtaderi Z, 2010, NAT STRUCT MOL BIOL, V17, P635, DOI 10.1038/nsmb.1794; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plaschka C, 2016, NATURE, V533, P353, DOI 10.1038/nature17990; Punjani A, 2017, NAT METHODS, V14, P290, DOI [10.1038/nmeth.4169, 10.1038/NMETH.4169]; Rijal K, 2013, NUCLEIC ACIDS RES, V41, P139, DOI 10.1093/nar/gks985; Rohou A, 2015, J STRUCT BIOL, V192, P216, DOI 10.1016/j.jsb.2015.08.008; Sadian Y, 2017, EMBO J, V36, P2698, DOI 10.15252/embj.201796958; Schulz S, 2016, P NATL ACAD SCI USA, V113, pE1816, DOI 10.1073/pnas.1515817113; SHAABAN SA, 1995, MOL CELL BIOL, V15, P1467; Shin JY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119931; Tagami S, 2010, NATURE, V468, P978, DOI 10.1038/nature09573; Thiffault I, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8623; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Vannini A, 2010, CELL, V143, P59, DOI 10.1016/j.cell.2010.09.002; Weixlbaumer A, 2013, CELL, V152, P431, DOI 10.1016/j.cell.2012.12.020; Wu CC, 2011, MOL CELL BIOL, V31, P2715, DOI 10.1128/MCB.05151-11; Zhang Y, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-40; Zhang Y, 2012, SCIENCE, V338, P1076, DOI 10.1126/science.1227786; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	56	82	84	1	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2018	553	7688					301	+		10.1038/nature25441	http://dx.doi.org/10.1038/nature25441			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT9MB	29345637				2022-12-28	WOS:000423475100043
J	Bi, YC; Mann, E; Whitfield, C; Zimmer, J				Bi, Yunchen; Mann, Evan; Whitfield, Chris; Zimmer, Jochen			Architecture of a channel-forming O-antigen polysaccharide ABC transporter	NATURE			English	Article							CRYSTAL-STRUCTURES; LIPOPOLYSACCHARIDE; BINDING; BIOSYNTHESIS; PHENIX; TOOLS; MODEL	O-antigens are cell surface polysaccharides of many Gram-negative pathogens that aid in escaping innate immune responses(1). A widespread O-antigen biosynthesis mechanism involves the synthesis of the lipid-anchored polymer on the cytosolic face of the inner membrane, followed by transport to the periplasmic side where it is ligated to the lipid A core to complete a lipopolysaccharide molecule(2). In this pathway, transport to the periplasm is mediated by an ATP-binding cassette (ABC) transporter, called Wzm-Wzt. Here we present the crystal structure of the Wzm-Wzt homologue from Aquifex aeolicus in an open conformation. The transporter forms a transmembrane channel that is sufficiently wide to accommodate a linear polysaccharide. Its nucleotide-binding domain and a periplasmic extension form 'gate helices' at the cytosolic and periplasmic membrane interfaces that probably serve as substrate entry and exit points. Site-directed mutagenesis of the gates impairs in vivo O-antigen secretion in the Escherichia coli prototype. Combined with a closed structure of the isolated nucleotide-binding domains, our structural and functional analyses suggest a processive O-antigen translocation mechanism, which stands in contrast to the classical alternating access mechanism of ABC transporters.	[Bi, Yunchen; Zimmer, Jochen] Univ Virginia, Sch Med, Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA; [Mann, Evan; Whitfield, Chris] Univ Guelph, Dept Mol & Cell Biol, Guelph, ON N1G 2W1, Canada	University of Virginia; University of Guelph	Zimmer, J (corresponding author), Univ Virginia, Sch Med, Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.	jochen_zimmer@virginia.edu		Mann, Evan/0000-0003-4685-7264; Zimmer, Jochen/0000-0002-8423-2882	federal funds from the National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; National Institute of General Medical Sciences from National Institutes of Health (NIH) [P41 GM103403]; NIH-ORIP HEI grant [S10 RR029205]; DOE Office of Science by Argonne National Laboratory [DE-AC02-06CH11357]; NIH grant [5R01GM110143]; Alexander Graham Bell Canada Graduate Scholarship from Natural Sciences and Engineering Research Council; Canadian Institutes of Health Research; Canada Research Chair; DOE Office of Science by Brookhaven National Laboratory [DE-SC0012704]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM110143, P41GM103403] Funding Source: NIH RePORTER	federal funds from the National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute of General Medical Sciences from National Institutes of Health (NIH); NIH-ORIP HEI grant; DOE Office of Science by Argonne National Laboratory(United States Department of Energy (DOE)); NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alexander Graham Bell Canada Graduate Scholarship from Natural Sciences and Engineering Research Council; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); DOE Office of Science by Brookhaven National Laboratory(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Morgan and G. Lipkowitz for cloning the full-length Wzm-Wzt transporter, S. Johnson for help with Wzm-WztN purification, C. Caffalette for comments on the manuscript, O. Pornillos for access to SEC-MALS, and the staff at the APS Southeast Regional (SER)- and GM/CA-CAT as well as NSLS-II AMX and FMX beam lines. GM/CA@APS has been funded in whole or in part with federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). The Northeastern Collaborative Access Team beam lines are funded by the National Institute of General Medical Sciences from the National Institutes of Health (NIH) (P41 GM103403). The Pilatus 6M detector on the 24-ID-C beam line is funded by a NIH-ORIP HEI grant (S10 RR029205). Data for this research was also in part collected at the SER Collaborative Access Team beam line at the Advanced Photon Source, Argonne National Laboratory. This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract number DE-AC02-06CH11357; and the AMX and FMX beamlines of the National Synchrotron Light Source II, a US DOE Office of Science User Facility operated for the DOE Office of Science by Brookhaven National Laboratory under contract number DE-SC0012704. Y.B. and J.Z. were supported by NIH grant 5R01GM110143. E.M. is a recipient of an Alexander Graham Bell Canada Graduate Scholarship from the Natural Sciences and Engineering Research Council. C.W. was supported by funding from the Canadian Institutes of Health Research. C.W. is a recipient of a Canada Research Chair.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Caboni M, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1004749; Cowtan KD, 1999, PROG BIOPHYS MOL BIO, V72, P245, DOI 10.1016/S0079-6107(99)00008-5; Cowtan K, 2010, ACTA CRYSTALLOGR D, V66, P470, DOI 10.1107/S090744490903947X; Cuthbertson L, 2005, J BIOL CHEM, V280, P30310, DOI 10.1074/jbc.M504371200; Cuthbertson L, 2007, P NATL ACAD SCI USA, V104, P19529, DOI 10.1073/pnas.0705709104; DeLano W.L, PYMOL MOL GRAPHICS S; Divne C, 1998, J MOL BIOL, V275, P309, DOI 10.1006/jmbi.1997.1437; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Goebel EM, 2008, INFECT IMMUN, V76, P1774, DOI 10.1128/IAI.01629-07; HITCHCOCK PJ, 1983, J BACTERIOL, V154, P269, DOI 10.1128/JB.154.1.269-277.1983; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Hug I, 2011, GLYCOBIOLOGY, V21, P138, DOI 10.1093/glycob/cwq148; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kos V, 2009, J BIOL CHEM, V284, P2947, DOI 10.1074/jbc.M807213200; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee JY, 2016, NATURE, V533, P561, DOI 10.1038/nature17666; Lin DYW, 2015, NATURE, V523, P425, DOI 10.1038/nature14623; Liston SD, 2017, BBA-MOL CELL BIOL L, V1862, P1394, DOI 10.1016/j.bbalip.2016.10.008; Locher KP, 2016, NAT STRUCT MOL BIOL, V23, P487, DOI 10.1038/nsmb.3216; Mann E, 2016, J BIOL CHEM, V291, P9748, DOI 10.1074/jbc.M116.719344; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meyer JEW, 1997, PROTEIN SCI, V6, P1084, DOI 10.1002/pro.5560060515; Morgan JLW, 2016, NATURE, V531, P329, DOI 10.1038/nature16966; Morgan JLW, 2013, NATURE, V493, P181, DOI 10.1038/nature11744; Nicholls RA, 2012, ACTA CRYSTALLOGR D, V68, P404, DOI 10.1107/S090744491105606X; Oldham ML, 2011, P NATL ACAD SCI USA, V108, P15152, DOI 10.1073/pnas.1108858108; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Perez C, 2015, NATURE, V524, P433, DOI 10.1038/nature14953; Qian HW, 2017, CELL, V169, P1228, DOI 10.1016/j.cell.2017.05.020; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; Schirner K, 2011, ACS CHEM BIOL, V6, P407, DOI 10.1021/cb100390w; Skurnik M, 2003, CARBOHYD RES, V338, P2521, DOI 10.1016/S0008-6215(03)00305-7; Spiwok V, 2017, MOLECULES, V22, DOI 10.3390/molecules22071038; TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X; van der Es D, 2017, CHEM SOC REV, V46, P1464, DOI 10.1039/c6cs00270f; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whitfield C., 2017, ESSENTIALS GLYCOBIOL, P265; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	40	59	60	7	73	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2018	553	7688					361	+		10.1038/nature25190	http://dx.doi.org/10.1038/nature25190			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT9MB	29320481	Green Accepted			2022-12-28	WOS:000423475100056
J	Blustein, J; Weinstein, BE; Freeman, JCML				Blustein, Jan; Weinstein, Barbara E.; Freeman, Joshua Chodosh Michael L.			Tackling hearing loss to improve the care of older adults	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HEALTH-CARE; NOISE; COMMUNICATION		[Blustein, Jan] NYU, Robert F Wagner Grad Sch Publ Serv, Hlth Policy & Med, Dept Hlth Policy, 295 Lafayette St, New York, NY 10003 USA; [Weinstein, Barbara E.] CUNY, Grad Ctr, Dept Audiol, Audiol, New York, NY USA; [Freeman, Joshua Chodosh Michael L.] NYU, Med Sch, Dept Med, Div Geriatr & Palliat Care, New York, NY USA	New York University; City University of New York (CUNY) System; New York University	Blustein, J (corresponding author), NYU, Robert F Wagner Grad Sch Publ Serv, Hlth Policy & Med, Dept Hlth Policy, 295 Lafayette St, New York, NY 10003 USA.	jan.blustein@wagner.nyu.edu		Chodosh, Joshua/0000-0001-7784-4306				Angeli J, 2007, SOUND CONTROL IMPROV; Centers for Disease Control and Prevention, 2010, 2010 NAT HOSP DISCH; Centers for Disease Control and Prevention, 2010, 2010 NAT HOSP AMB CA; Chapman S, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h184; Cohen JM, 2017, J AM GERIATR SOC, V65, P1642, DOI 10.1111/jgs.14860; Cudmore V, 2017, JAMA OTOLARYNGOL, V143, P1054, DOI 10.1001/jamaoto.2017.1248; Doyle C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001570; Fook L, 2000, POSTGRAD MED J, V76, P92, DOI 10.1136/pmj.76.892.92; Genther DJ, 2013, JAMA-J AM MED ASSOC, V309, P2322, DOI 10.1001/jama.2013.5912; Goman AM, 2016, AM J PUBLIC HEALTH, V106, P1820, DOI 10.2105/AJPH.2016.303299; Henshaw H, 2015, LANCET, V386, P2140, DOI 10.1016/S0140-6736(15)01048-X; Iezzoni LI, 2004, ANN INTERN MED, V140, P356, DOI 10.7326/0003-4819-140-5-200403020-00011; Kracht JM, 2007, J ACOUST SOC AM, V121, P2673, DOI 10.1121/1.2714921; Lewsen B., 1997, J SPEECH LANGUAGE PA, V21, P149; Mamo SK, 2017, AM J GERIAT PSYCHIAT, V25, P91, DOI 10.1016/j.jagp.2016.08.019; Matters Hearing, 2015, HEAR MATT; Mick P, 2014, J AM GERIATR SOC, V62, P2207, DOI 10.1111/jgs.13113; National Academies of Sciences, 2016, ENG MED HEAR HLTH CA; Orellana D, 2007, J ACOUST SOC AM, V121, P1996, DOI 10.1121/1.2642309; Pope DS, 2013, RES NURS HEALTH, V36, P228, DOI 10.1002/nur.21540; Pryce H, 2012, AGE AGEING, V41, P40, DOI 10.1093/ageing/afr112; Roter D, 2013, ENCY BEHAV MED, P622; Salandin A, 2011, J ACOUST SOC AM, V130, P3754, DOI 10.1121/1.3655884; Smith AK, 2016, J PAIN SYMPTOM MANAG, V52, P254, DOI 10.1016/j.jpainsymman.2016.02.007; Smith AK, 2015, J PALLIAT MED, V18, P559, DOI 10.1089/jpm.2014.0367; STEWART MA, 1995, CAN MED ASSOC J, V152, P1423; Tye-Murray N, 2004, FDN AURAL REHABILITA; Vollmer Charlene, 2007, Nursing, V37, P26; Wilson BS, 2017, LANCET, V390, P2503, DOI 10.1016/S0140-6736(17)31073-5; World Health Organization, GRAD HEAR IMP; World Health Organization, 2012, HEAR LOSS PERS 65 OL	31	20	21	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 18	2018	360								k21	10.1136/bmj.k21	http://dx.doi.org/10.1136/bmj.k21			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT5QZ	29348197	Green Published			2022-12-28	WOS:000423209600005
J	Patel, MS; Volpp, KG; Asch, DA				Patel, Mitesh S.; Volpp, Kevin G.; Asch, David A.			Nudge Units to Improve the Delivery of Health Care	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							DEFAULT OPTIONS; ACTIVE CHOICE; RECORD; TESTS; RATES		[Patel, Mitesh S.] Univ Penn, Penn Med Nudge Unit, LDI Ctr Hlth Incent & Behav Econ,Wharton Sch, Penn Med Ctr Hlth Care Innovat,Perelman Sch Med, Philadelphia, PA 19104 USA; Crescenz Vet Affairs Med Ctr, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine	Patel, MS (corresponding author), Univ Penn, Penn Med Nudge Unit, LDI Ctr Hlth Incent & Behav Econ,Wharton Sch, Penn Med Ctr Hlth Care Innovat,Perelman Sch Med, Philadelphia, PA 19104 USA.			Asch, David/0000-0002-7970-286X	NATIONAL INSTITUTE ON AGING [P30AG034546] Funding Source: NIH RePORTER; NIA NIH HHS [P30 AG034546] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Halpern SD, 2007, NEW ENGL J MED, V357, P1340, DOI 10.1056/NEJMsb071595; Patel MS, 2017, J GEN INTERN MED, V32, P790, DOI 10.1007/s11606-017-4046-6; Patel MS, 2016, HEALTHCARE-J DEL SCI, V4, P340, DOI 10.1016/j.hjdsi.2016.04.005; Patel MS, 2016, JAMA INTERN MED, V176, P847, DOI 10.1001/jamainternmed.2016.1691; Sedrak MS, 2017, JAMA INTERN MED, V177, P939, DOI 10.1001/jamainternmed.2017.1144	5	124	124	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2018	378	3					214	216		10.1056/NEJMp1712984	http://dx.doi.org/10.1056/NEJMp1712984			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT1IJ	29342387	Green Accepted			2022-12-28	WOS:000422888400004
J	Carey, TS; Kinlaw, A				Carey, Timothy S.; Kinlaw, Alan			Review: In primary care, CRP testing, shared decision making, and procalcitonin reduce antibiotic prescribing for ARI	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Carey, Timothy S.; Kinlaw, Alan] Univ N Carolina, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Carey, TS (corresponding author), Univ N Carolina, Chapel Hill, NC 27599 USA.			Kinlaw, Alan/0000-0002-4279-8685				Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; Levine DM, 2016, JAMA INTERN MED, V176, P1778, DOI 10.1001/jamainternmed.2016.6217	2	2	3	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2018	168	2					JC11	JC11		10.7326/ACPJC-2018-168-2-011	http://dx.doi.org/10.7326/ACPJC-2018-168-2-011			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU8IN	29335723				2022-12-28	WOS:000424096600011
J	Jakobsen, GS; Smastuen, MC; Sandbu, R; Nordstrand, N; Hofso, D; Lindberg, M; Hertel, JK; Hjelmesaeth, J				Jakobsen, Gunn Signe; Smastuen, Milada Cvancarova; Sandbu, Rune; Nordstrand, Njord; Hofso, Dag; Lindberg, Morten; Hertel, Jens Kristoffer; Hjelmesaeth, Joran			Association of Bariatric Surgery vs Medical Obesity Treatment With Long- term Medical Complications and Obesity- Related Comorbidities	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GASTRIC BYPASS-SURGERY; LIFE-STYLE INTERVENTION; CARDIOVASCULAR OUTCOMES; ABDOMINAL-PAIN; RISK-FACTORS; OPEN-LABEL; FOLLOW-UP; WEIGHT; MULTICENTER; SYMPTOMS	IMPORTANCE The association of bariatric surgery and specialized medical obesity treatment with beneficial and detrimental outcomes remains uncertain. OBJECTIVE To compare changes in obesity-related comorbidities in patients with severe obesity (body mass index >= 40 or >= 35 and at least 1 comorbidity) undergoing bariatric surgery or specialized medical treatment. DESIGN, SETTING, AND PARTICIPANTS Cohort study with baseline data of exposures from November 2005 through July 2010 and follow-up data from 2006 until death or through December 2015 at a tertiary care outpatient center, Vestfold Hospital Trust, Norway. Consecutive treatment-seeking adult patients (n = 2109) with severe obesity assessed (221 patients excluded and 1888 patients included). EXPOSURES Bariatric surgery (n = 932, 92% gastric bypass) or specialized medical treatment (n = 956) including individual or group-based lifestyle intervention programs. MAIN OUTCOMES AND MEASURES Primary outcomes included remission and new onset of hypertension based on drugs dispensed according to the Norwegian Prescription Database. Prespecified secondary outcomes included changes in comorbidities. Adverse events included complications retrieved from the Norwegian Patient Registry and a local laboratory database. RESULTS Among 1888 patients included in the study, the mean (SD) age was 43.5 (12.3) years (1249 women [66%]; mean [SD] baseline body mass index, 44.2 [6.1]; 100% completed follow-up at a median of 6.5 years [range, 0.2-10.1]). Surgically treated patients had a greater likelihood of hypertension remission and lesser likelihood for new-onset hypertension. Surgically treated patients also had a greater likelihood of diabetes remission, risk of new-onset depression, treatment initiation with opioids, and greater risk of undergoing at least 1 additional gastrointestinal surgical procedure. The proportion of patients with low ferritin levels was significantly greater in the surgical group (26% vs 12%, P < .001). [GRAPHOCS]. CONCLUSIONS AND RELEVANCE Among patients with severe obesity followed up for a median of 6.5 years, bariatric surgery compared with medical treatmentwas associated with a clinically important increased risk for complications, aswell as lower risks of obesity-related comorbidities. The risk for complications should be considered in the decision-making process.	[Jakobsen, Gunn Signe; Smastuen, Milada Cvancarova; Sandbu, Rune; Nordstrand, Njord; Hofso, Dag; Hertel, Jens Kristoffer; Hjelmesaeth, Joran] Vestfold Hosp Trust, Morbid Obes Ctr, Boks 2168, N-3103 Tonsberg, Norway; [Sandbu, Rune] Vestfold Hosp Trust, Dept Surg, Tonsberg, Norway; [Lindberg, Morten] Vestfold Hosp Trust, Dept Lab Med, Tonsberg, Norway; [Hjelmesaeth, Joran] Univ Oslo, Dept Endocrinol Morbid Obes & Prevent Med, Inst Clin Med, Oslo, Norway	University of Oslo	Hjelmesaeth, J (corresponding author), Vestfold Hosp Trust, Morbid Obes Ctr, Boks 2168, N-3103 Tonsberg, Norway.; Hjelmesaeth, J (corresponding author), Vestfold Hosp Trust, Dept Med, Endocrinol Sect, N-3103 Tonsberg, Norway.	joran.hjelmeseth@siv.no	Lindberg, Morten/AAP-5362-2021; Lindberg, Morten/L-4457-2018	Lindberg, Morten/0000-0002-5568-7810; 	Vestfold Hospital Trust	Vestfold Hospital Trust	Dr Jakobsen was funded by Vestfold Hospital Trust.	Adams TD, 2017, NEW ENGL J MED, V377, P1143, DOI 10.1056/NEJMoa1700459; Adams TD, 2012, JAMA-J AM MED ASSOC, V308, P1122, DOI 10.1001/2012.jama.11164; Booth H, 2015, J AFFECT DISORDERS, V174, P644, DOI 10.1016/j.jad.2014.12.050; Booth H, 2014, LANCET DIABETES ENDO, V2, P963, DOI 10.1016/S2213-8587(14)70214-1; Bruze G, 2017, SURG OBES RELAT DIS, V13, P962, DOI 10.1016/j.soard.2017.01.004; Carlsson LMS, 2012, NEW ENGL J MED, V367, P695, DOI 10.1056/NEJMoa1112082; Dawes AJ, 2016, JAMA-J AM MED ASSOC, V315, P150, DOI 10.1001/jama.2015.18118; Douglas IJ, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001925; Ettehad D, 2016, LANCET, V387, P957, DOI 10.1016/S0140-6736(15)01225-8; Fischer L, 2014, SURG OBES RELAT DIS, V10, P516, DOI 10.1016/j.soard.2014.02.040; Furu K, 2010, BASIC CLIN PHARMACOL, V106, P86, DOI 10.1111/j.1742-7843.2009.00494.x; Gjevestad E, 2015, OBESITY, V23, P37, DOI 10.1002/oby.20880; Gloy VL, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5934; Gribsholt SB, 2016, JAMA SURG, V151, P504, DOI 10.1001/jamasurg.2015.5110; Heymsfield SB, 2017, NEW ENGL J MED, V376, P254, DOI 10.1056/NEJMra1514009; Hofso D, 2010, EUR J ENDOCRINOL, V163, P735, DOI 10.1530/EJE-10-0514; Hogestol IK, 2017, OBES SURG, V27, P1438, DOI 10.1007/s11695-016-2499-z; Ikramuddin S, 2013, JAMA-J AM MED ASSOC, V309, P2240, DOI 10.1001/jama.2013.5835; Jakobsen GS, 2010, OBES SURG, V20, P1142, DOI 10.1007/s11695-009-0053-y; Jensen MD, 2014, OBESITY, V22, pS5, DOI 10.1002/oby.20821; Kalarchian MA, 2007, AM J PSYCHIAT, V164, P328, DOI 10.1176/appi.ajp.164.2.328; King WC, 2017, SURG OBES RELAT DIS, V13, P1337, DOI 10.1016/j.soard.2017.04.003; Marso SP, 2016, NEW ENGL J MED, V375, P311, DOI 10.1056/NEJMoa1603827; Mingrone G, 2015, LANCET, V386, P964, DOI 10.1016/S0140-6736(15)00075-6; Mitchell JE, 2014, OBESITY, V22, P1799, DOI 10.1002/oby.20738; Ovrebo B, 2017, CLIN OBES, V7, P183, DOI 10.1111/cob.12190; Pierik AS, 2017, SURG OBES RELAT DIS, V13, P1743, DOI 10.1016/j.soard.2017.05.027; Puzziferri N, 2014, JAMA-J AM MED ASSOC, V312, P934, DOI 10.1001/jama.2014.10706; Risstad H, 2015, JAMA SURG, V150, P352, DOI 10.1001/jamasurg.2014.3579; Schauer PR, 2017, NEW ENGL J MED, V376, P641, DOI 10.1056/NEJMoa1600869; Sox HC, 2016, JAMA-J AM MED ASSOC, V316, P1205, DOI 10.1001/jama.2016.11409; Stenberg E, 2016, LANCET, V387, P1397, DOI 10.1016/S0140-6736(15)01126-5; Taylor F, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004816.pub5; Valderhaug Tone G, 2016, BMC Obes, V3, P51; Wadden TA, 2014, OBESITY, V22, P5, DOI 10.1002/oby.20662; World Health Organization, OB OV; Zhang J, 1998, JAMA-J AM MED ASSOC, V280, P1690, DOI 10.1001/jama.280.19.1690; Zinman B, 2015, NEW ENGL J MED, V373, P2117, DOI 10.1056/NEJMoa1504720	38	180	186	2	21	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2018	319	3					291	301		10.1001/jama.2017.21055	http://dx.doi.org/10.1001/jama.2017.21055			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT3BY	29340680	Green Published, Bronze			2022-12-28	WOS:000423022300021
J	Peterli, R; Wolnerhanssen, BK; Peters, T; Vetter, D; Kroll, D; Borbely, Y; Schultes, B; Beglinger, C; Drewe, J; Schiesser, M; Nett, P; Bueter, M				Peterli, Ralph; Wolnerhanssen, Bettina Karin; Peters, Thomas; Vetter, Diana; Kroll, Dino; Borbely, Yves; Schultes, Bernd; Beglinger, Christoph; Drewe, Jurgen; Schiesser, Marc; Nett, Philipp; Bueter, Marco			Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss in Patients With Morbid Obesity The SM-BOSS Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BARIATRIC SURGERY; BARRETTS-ESOPHAGUS; METAANALYSIS; OUTCOMES; IMPROVEMENT; VALIDATION; REFLUX; INDEX	IMPORTANCE Sleeve gastrectomy is increasingly used in the treatment of morbid obesity, but its long-term outcome vs the standard Roux-en-Y gastric bypass procedure is unknown. OBJECTIVE To determine whether there are differences between sleeve gastrectomy and Roux-en-Y gastric bypass in terms of weight loss, changes in comorbidities, increase in quality of life, and adverse events. DESIGN, SETTING, AND PARTICIPANTS The Swiss Multicenter Bypass or Sleeve Study (SM-BOSS), a 2-group randomized trial, was conducted from January 2007 until November 2011 (last follow-up in March 2017). Of 3971 morbidly obese patients evaluated for bariatric surgery at 4 Swiss bariatric centers, 217 patients were enrolled and randomly assigned to sleeve gastrectomy or Roux-en-Y gastric bypass with a 5-year follow-up period. INTERVENTIONS Patients were randomly assigned to undergo laparoscopic sleeve gastrectomy (n = 107) or laparoscopic Roux-en-Y gastric bypass (n = 110). MAIN OUTCOMES AND MEASURES The primary end point was weight loss, expressed as percentage excess body mass index (BMI) loss. Exploratory end points were changes in comorbidities and adverse events. RESULTS Among the 217 patients (mean age, 45.5 years; 72% women; mean BMI, 43.9) 205 (94.5%) completed the trial. Excess BMI loss was not significantly different at 5 years: for sleeve gastrectomy, 61.1%, vs Roux-en-Y gastric bypass, 68.3%(absolute difference, -7.18%; 95% CI, -14.30% to -0.06%; P = .22 after adjustment for multiple comparisons). Gastric reflux remission was observed more frequently after Roux-en-Y gastric bypass (60.4%) than after sleeve gastrectomy (25.0%). Gastric reflux worsened (more symptoms or increase in therapy) more often after sleeve gastrectomy (31.8%) than after Roux-en-Y gastric bypass (6.3%). The number of patients with reoperations or interventions was 16/101 (15.8%) after sleeve gastrectomy and 23/104 (22.1%) after Roux-en-Y gastric bypass. CONCLUSIONS AND RELEVANCE Among patients with morbid obesity, there was no significant difference in excess BMI loss between laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass at 5 years of follow-up after surgery.	[Peterli, Ralph] St Clara Hosp, Dept Surg, Kleinriehenstr 30, CH-4016 Basel, Switzerland; [Wolnerhanssen, Bettina Karin; Beglinger, Christoph] St Clara Hosp, Dept Clin Res, Basel, Switzerland; [Wolnerhanssen, Bettina Karin] Univ Hosp Basel, Dept Biomed, Basel, Switzerland; [Peters, Thomas] St Clara Hosp, Dept Internal Med, Basel, Switzerland; [Vetter, Diana; Bueter, Marco] Univ Hosp, Dept Visceral & Transplantat Surg, Zurich, Switzerland; [Kroll, Dino; Borbely, Yves; Nett, Philipp] Univ Hosp Bern, Dept Surg, Bern, Switzerland; [Schultes, Bernd] Swiss Med & Surg Ctr, St Gallen, Switzerland; [Drewe, Jurgen] Univ Hosp, Dept Pharmacol & Toxicol, Basel, Switzerland; [Schiesser, Marc] Kantonsspital, Dept Surg, St Gallen, Switzerland	University of Basel; University of Zurich; University Zurich Hospital; University of Bern; University Hospital of Bern; Kantonsspital Aarau AG (KSA); Kantonsspital St. Gallen	Peterli, R (corresponding author), St Clara Hosp, Dept Surg, Kleinriehenstr 30, CH-4016 Basel, Switzerland.	ralph.peterli@claraspital.ch	Drewe, Juergen/ABF-8204-2021	Drewe, Juergen/0000-0001-5178-7825; Peterli, Ralph/0000-0002-0038-9795; Wolnerhanssen, Bettina/0000-0003-3134-2743; Borbely, Yves/0000-0003-1997-0675; Kroll, Dino/0000-0001-8736-6619	Swiss National Science Foundation [32003B-120020, 320030-138439]; Ethicon Endo Surgery USA	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Ethicon Endo Surgery USA	This study was funded by the Swiss National Science Foundation (grants 32003B-120020 and 320030-138439) and Ethicon Endo Surgery USA.	Aghajani E, 2017, SURG ENDOSC, V31, P3743, DOI 10.1007/s00464-017-5415-2; Anaparthy R, 2013, CLIN GASTROENTEROL H, V11, P1430, DOI 10.1016/j.cgh.2013.05.007; Angrisani L, 2017, OBES SURG, V27, P2279, DOI 10.1007/s11695-017-2666-x; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; Brethauer SA, 2015, OBES SURG, V25, P587, DOI 10.1007/s11695-015-1645-3; Buchwald H., 2004, JAMA (Journal of the American Medical Association), V292, P1724, DOI 10.1001/jama.292.14.1724; Buchwald H, 2009, AM J MED, V122, P248, DOI 10.1016/j.amjmed.2008.09.041; EYPASCH E, 1995, BRIT J SURG, V82, P216, DOI 10.1002/bjs.1800820229; Felsenreich DM, 2017, OBES SURG, V27, P3092, DOI 10.1007/s11695-017-2748-9; Genco A, 2017, SURG OBES RELAT DIS, V13, P568, DOI 10.1016/j.soard.2016.11.029; Helmio M, 2014, SCAND J SURG, V103, P175, DOI 10.1177/1457496913509984; Karamanakos SN, 2008, ANN SURG, V247, P401, DOI 10.1097/SLA.0b013e318156f012; Kehagias I, 2011, OBES SURG, V21, P1650, DOI 10.1007/s11695-011-0479-x; Keidar A, 2013, DIABETOLOGIA, V56, P1914, DOI 10.1007/s00125-013-2965-2; Li JF, 2016, OBES SURG, V26, P429, DOI 10.1007/s11695-015-1996-9; Moorehead MK, 2003, OBES SURG, V13, P684, DOI 10.1381/096089203322509237; Oria HE, 1998, OBES SURG, V8, P487, DOI 10.1381/096089298765554043; Osland E, 2017, SURG ENDOSC, V31, P1952, DOI 10.1007/s00464-016-5202-5; PASS 15 Power Analysis and Sample Size Software, 2017, NCSSCOM SOFTWARE PAS; Peterli R, 2013, ANN SURG, V258, P690, DOI 10.1097/SLA.0b013e3182a67426; Peterli R, 2012, OBES SURG, V22, P740, DOI 10.1007/s11695-012-0622-3; Peterli R, 2009, ANN SURG, V250, P234, DOI 10.1097/SLA.0b013e3181ae32e3; Rubino F, 2016, DIABETES CARE, V39, P861, DOI 10.2337/dc16-0236; Schauer PR, 2017, NEW ENGL J MED, V376, P1997, DOI 10.1056/NEJMc1703377; Schneider J, 2016, SURG OBES RELAT DIS, V12, P563, DOI 10.1016/j.soard.2015.07.002; Shoar S, 2017, SURG OBES RELAT DIS, V13, P170, DOI 10.1016/j.soard.2016.08.011; Steinert RE, 2013, OBESITY, V21, pE660, DOI 10.1002/oby.20522; Stenberg E, 2017, BRIT J SURG, V104, P562, DOI 10.1002/bjs.10448; Stokes L, 2014, JAMA-J AM MED ASSOC, V312, P180, DOI 10.1001/jama.2014.8295; Wang MC, 2015, AM SURGEON, V81, P166; Woelnerhanssen B, 2011, SURG OBES RELAT DIS, V7, P561, DOI 10.1016/j.soard.2011.01.044; Yang JG, 2015, BMC SURG, V15, DOI 10.1186/s12893-015-0074-5; Yu JJ, 2015, OBES SURG, V25, P143, DOI 10.1007/s11695-014-1460-2; Zhang Y, 2014, OBES SURG, V24, P1617, DOI 10.1007/s11695-014-1258-2	34	548	564	6	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2018	319	3					255	265		10.1001/jama.2017.20897	http://dx.doi.org/10.1001/jama.2017.20897			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT3BY	29340679	Green Published, Green Accepted, Bronze			2022-12-28	WOS:000423022300018
J	Shubeck, S; Dimick, JB; Telem, DA				Shubeck, Sarah; Dimick, Justin B.; Telem, Dana A.			Long-term Outcomes Following Bariatric Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							WEIGHT		[Shubeck, Sarah] Inst Healthcare Policy & Innovat, Natl Clinician Scholars Program, Ann Arbor, MI USA; [Shubeck, Sarah; Dimick, Justin B.; Telem, Dana A.] Univ Michigan, Dept Surg, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Telem, DA (corresponding author), Univ Michigan, Dept Surg, 1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	dtelem@med.umich.edu		Shubeck, Sarah/0000-0001-8831-2428	National Clinician Scholars Program at the Institute for Healthcare Policy and Innovation, University of Michigan	National Clinician Scholars Program at the Institute for Healthcare Policy and Innovation, University of Michigan	Dr Shubeck is supported by the National Clinician Scholars Program at the Institute for Healthcare Policy and Innovation, University of Michigan.	Adams TD, 2017, NEW ENGL J MED, V377, P1143, DOI 10.1056/NEJMoa1700459; Cardoso L, 2017, DIABETES OBES METAB, V19, P1223, DOI 10.1111/dom.12922; Cauchi R., MOST STATES HAVE EXP; Chang SH, 2014, JAMA SURG, V149, P275, DOI 10.1001/jamasurg.2013.3654; Courcoulas AP, 2018, JAMA SURG, V153, P427, DOI 10.1001/jamasurg.2017.5025; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Flum DR, 2005, JAMA-J AM MED ASSOC, V294, P1903, DOI 10.1001/jama.294.15.1903; Loveman E, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15020; Opozda M, 2017, SURG OBES RELAT DIS, V13, P1887, DOI 10.1016/j.soard.2017.07.013; Primomo JA, 2016, SURG OBES RELAT DIS, V12, P1725, DOI 10.1016/j.soard.2016.08.016	10	24	25	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2018	319	3					302	303		10.1001/jama.2017.20521	http://dx.doi.org/10.1001/jama.2017.20521			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT3BY	29340664				2022-12-28	WOS:000423022300022
J	Becker, MA; Vaxenburg, R; Nedelcu, G; Sercel, PC; Shabaev, A; Mehl, MJ; Michopoulos, JG; Lambrakos, SG; Bernstein, N; Lyons, JL; Stoferle, T; Mahrt, RF; Kovalenko, MV; Norris, DJ; Raino, G; Efros, AL				Becker, Michael A.; Vaxenburg, Roman; Nedelcu, Georgian; Sercel, Peter C.; Shabaev, Andrew; Mehl, Michael J.; Michopoulos, John G.; Lambrakos, Samuel G.; Bernstein, Noam; Lyons, John L.; Stoferle, Thilo; Mahrt, Rainer F.; Kovalenko, Maksym V.; Norris, David J.; Raino, Gabriele; Efros, Alexander L.			Bright triplet excitons in caesium lead halide perovskites	NATURE			English	Article							INITIO MOLECULAR-DYNAMICS; DARK-EXCITON; QUANTUM; RASHBA; NANOCRYSTALS; EMISSION; LUMINESCENCE; TRANSITION; BLINKING; LIFETIME	Nanostructured semiconductors emit light from electronic states known as excitons(1). For organic materials, Hund's rules(2) state that the lowest-energy exciton is a poorly emitting triplet state. For inorganic semiconductors, similar rules(3) predict an analogue of this triplet state known as the 'dark exciton'(4). Because dark excitons release photons slowly, hindering emission from inorganic nanostructures, materials that disobey these rules have been sought. However, despite considerable experimental and theoretical efforts, no inorganic semiconductors have been identified in which the lowest exciton is bright. Here we show that the lowest exciton in caesium lead halide perovskites (CsPbX3, with X = Cl, Br or I) involves a highly emissive triplet state. We first use an effective-mass model and group theory to demonstrate the possibility of such a state existing, which can occur when the strong spin-orbit coupling in the conduction band of a perovskite is combined with the Rashba effect(5-10). We then apply our model to CsPbX3 nanocrystals(11), and measure size-and composition-dependent fluorescence at the single-nanocrystal level. The bright triplet character of the lowest exciton explains the anomalous photon-emission rates of these materials, which emit about 20 and 1,000 times faster(12) than any other semiconductor nanocrystal at room(13-16) and cryogenic(4) temperatures, respectively. The existence of this bright triplet exciton is further confirmed by analysis of the fine structure in low-temperature fluorescence spectra. For semiconductor nanocrystals, which are already used in lighting(17), lasers(18) and displays(19), these excitons could lead to materials with brighter emission. More generally, our results provide criteria for identifying other semiconductors that exhibit bright excitons, with potential implications for optoelectronic devices.	[Becker, Michael A.; Stoferle, Thilo; Mahrt, Rainer F.; Raino, Gabriele] IBM Res Zurich, Saumerstr 4, CH-8803 Ruschlikon, Switzerland; [Becker, Michael A.; Norris, David J.] Swiss Fed Inst Technol, Dept Mech & Proc Engn, Opt Mat Engn Lab, CH-8092 Zurich, Switzerland; [Vaxenburg, Roman; Shabaev, Andrew] George Mason Univ, Computat Mat Sci Ctr, Fairfax, VA 22030 USA; [Nedelcu, Georgian; Kovalenko, Maksym V.; Raino, Gabriele] Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Inst Inorgan Chem, CH-8093 Zurich, Switzerland; [Nedelcu, Georgian; Kovalenko, Maksym V.] Empa, Swiss Fed Labs Mat Sci & Technol, Lab Thin Films & Photovolta, CH-8600 Dubendorf, Switzerland; [Sercel, Peter C.] CALTECH, TJ Watson Lab Appl Phys, Pasadena, CA 91125 USA; [Mehl, Michael J.] US Naval Acad, Annapolis, MD 21402 USA; [Michopoulos, John G.; Lambrakos, Samuel G.; Bernstein, Noam; Lyons, John L.; Efros, Alexander L.] Naval Res Lab, Ctr Computat Mat Sci, Washington, DC 20375 USA	International Business Machines (IBM); Swiss Federal Institutes of Technology Domain; ETH Zurich; George Mason University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); California Institute of Technology; United States Department of Defense; United States Navy; United States Naval Academy; United States Department of Defense; United States Navy; Naval Research Laboratory	Raino, G (corresponding author), IBM Res Zurich, Saumerstr 4, CH-8803 Ruschlikon, Switzerland.; Norris, DJ (corresponding author), Swiss Fed Inst Technol, Dept Mech & Proc Engn, Opt Mat Engn Lab, CH-8092 Zurich, Switzerland.; Kovalenko, MV; Raino, G (corresponding author), Swiss Fed Inst Technol, Dept Chem & Appl Biosci, Inst Inorgan Chem, CH-8093 Zurich, Switzerland.; Kovalenko, MV (corresponding author), Empa, Swiss Fed Labs Mat Sci & Technol, Lab Thin Films & Photovolta, CH-8600 Dubendorf, Switzerland.; Efros, AL (corresponding author), Naval Res Lab, Ctr Computat Mat Sci, Washington, DC 20375 USA.	mvkovalenko@ethz.ch; dnorris@ethz.ch; rainog@ethz.ch; sasha.efros@nrl.navy.mil	Mahrt, Rainer F./J-5407-2014; Norris, David J/F-4022-2010; LYONS, JOHN L/AAV-2491-2021; Kovalenko, Maksym V/B-6844-2008	Mahrt, Rainer F./0000-0002-9772-1490; Norris, David J/0000-0002-3765-0678; Kovalenko, Maksym V/0000-0002-6396-8938; Mehl, Michael/0000-0001-9402-6591; Becker, Michael A./0000-0003-2042-9384; Stoferle, Thilo/0000-0003-0612-7195; Sercel, Peter/0000-0002-1734-3793; Raino, Gabriele/0000-0002-2395-4937	European Union's Horizon-2020 programme through Marie-Sklodowska Curie ITN network PHONSI [H2020-MSCA-ITN-642656]; US Office of Naval Research (ONR) through core funding of the Naval Research Laboratory; ONR [N0001416WX01849]; Center for Advanced Solar Photophysics (CASP), an Energy Frontier Research Center (EFRC) - BES, OS, US DOE; European Research Council under the European Union's Seventh Framework Programme/ERC grant [339905, 306733]	European Union's Horizon-2020 programme through Marie-Sklodowska Curie ITN network PHONSI; US Office of Naval Research (ONR) through core funding of the Naval Research Laboratory; ONR(Office of Naval Research); Center for Advanced Solar Photophysics (CASP), an Energy Frontier Research Center (EFRC) - BES, OS, US DOE; European Research Council under the European Union's Seventh Framework Programme/ERC grant(European Research Council (ERC))	We thank F. Krieg for providing large CsPbBr<INF>3</INF> nanocrystals, S. Yakunin and J. Jagielski for assistance with absolute quantum-yield measurements, and E. Ivchenko, M. Glazov and E. Rashba for discussions. M.A.B., G.R., T.S., M.V.K. and R.F.M. acknowledge the European Union's Horizon-2020 programme through the Marie-Sklodowska Curie ITN network PHONSI (H2020-MSCA-ITN-642656) and the Swiss State Secretariat for Education Research and Innovation (SERI). J.G.M., S.G.L., N.B., J.L.L. and Al.L.E. acknowledge support from the US Office of Naval Research (ONR) through the core funding of the Naval Research Laboratory. R.V. was funded by ONR grant N0001416WX01849. A. S. acknowledges support from the Center for Advanced Solar Photophysics (CASP), an Energy Frontier Research Center (EFRC) funded by BES, OS, US DOE. D.J.N. and M.V.K. acknowledge partial financial support from the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC grant agreement number 339905 (QuaDoPS Advanced Grant) and number 306733 (NANOSOLID Starting Grant), respectively.	Bir G. L., 1974, SYMMETRY STRAIN INDU; Bischof TS, 2014, NANO LETT, V14, P6787, DOI 10.1021/nl502180w; BLOCHL PE, 1994, PHYS REV B, V50, P17953, DOI 10.1103/PhysRevB.50.17953; Cottingham P, 2016, CHEM COMMUN, V52, P5246, DOI 10.1039/c6cc01088a; Crooker SA, 2003, APPL PHYS LETT, V82, P2793, DOI 10.1063/1.1570923; Dang C, 2012, NAT NANOTECHNOL, V7, P335, DOI [10.1038/nnano.2012.61, 10.1038/NNANO.2012.61]; Dery H, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.125431; Du H, 2002, NANO LETT, V2, P1321, DOI 10.1021/nl025785g; Even J, 2013, J PHYS CHEM LETT, V4, P2999, DOI 10.1021/jz401532q; Fu M, 2017, NANO LETT, V17, P2895, DOI 10.1021/acs.nanolett.7b00064; Galland C, 2011, NATURE, V479, P203, DOI 10.1038/nature10569; Hund F, 1925, Z PHYS, V33, P345, DOI 10.1007/BF01328319; Isarov M, 2017, NANO LETT, V17, P5020, DOI 10.1021/acs.nanolett.7b02248; Kane E. O., 1966, SEMICONDUCT SEMIMET, V1, P75; Kepenekian M, 2015, ACS NANO, V9, P11557, DOI 10.1021/acsnano.5b04409; Kim M, 2014, P NATL ACAD SCI USA, V111, P6900, DOI 10.1073/pnas.1405780111; Kim TH, 2011, NAT PHOTONICS, V5, P176, DOI 10.1038/NPHOTON.2011.12; KRESSE G, 1994, PHYS REV B, V49, P14251, DOI 10.1103/PhysRevB.49.14251; KRESSE G, 1993, PHYS REV B, V48, P13115, DOI 10.1103/PhysRevB.48.13115; Kresse G., 1993, THESIS; Krukau AV, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2404663; Mehl MJ, 2017, COMP MATER SCI, V136, pS1, DOI 10.1016/j.commatsci.2017.01.017; Mosconi E, 2017, J PHYS CHEM LETT, V8, P2247, DOI 10.1021/acs.jpclett.7b00328; NIRMAL M, 1995, PHYS REV LETT, V75, P3728, DOI 10.1103/PhysRevLett.75.3728; ONODERA Y, 1967, J PHYS SOC JPN, V22, P833, DOI 10.1143/JPSJ.22.833; Perdew JP, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.136406; Protesescu L, 2015, NANO LETT, V15, P3692, DOI 10.1021/nl5048779; Raino G, 2016, ACS NANO, V10, P2485, DOI 10.1021/acsnano.5b07328; RASHBA EI, 1962, SOV PHYS-SOL STATE, V4, P759; Rodina AV, 2016, J EXP THEOR PHYS+, V122, P554, DOI 10.1134/S1063776116030183; Scholes GD, 2006, NAT MATER, V5, P683, DOI 10.1038/nmat1714; Shirasaki Y, 2013, NAT PHOTONICS, V7, P13, DOI 10.1038/nphoton.2012.328; Smyder JA, 2014, PHYS CHEM CHEM PHYS, V16, P25723, DOI 10.1039/c4cp01395f; Wuister SF, 2004, ANGEW CHEM INT EDIT, V43, P3029, DOI 10.1002/anie.200353532; Yaffe O, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.136001; Yakunin S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9056; Zheng F, 2015, NANO LETT, V15, P7794, DOI 10.1021/acs.nanolett.5b01854	39	538	538	57	952	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2018	553	7687					189	+		10.1038/nature25147	http://dx.doi.org/10.1038/nature25147			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4WL	29323292	Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000419794800033
J	Giladi, A; Amit, I				Giladi, Amir; Amit, Ido			Single-Cell Genomics: A Stepping Stone for Future Immunology Discoveries	CELL			English	Review							MONONUCLEAR PHAGOCYTE SYSTEM; INNATE LYMPHOID-CELLS; RNA-SEQ; GENE-EXPRESSION; SPATIAL RECONSTRUCTION; IMMUNE-SYSTEM; EPIGENETIC HETEROGENEITY; CHROMATIN ACCESSIBILITY; LINEAGE COMMITMENT; DIFFERENTIATION	The immunology field has invested great efforts and ingenuity to characterize the various immune cell types and elucidate their functions. However, accumulating evidence indicates that current technologies and classification schemes are limited in their ability to account for the functional heterogeneity of immune processes. Single-cell genomics hold the potential to revolutionize the way we characterize complex immune cell assemblies and study their spatial organization, dynamics, clonal distribution, pathways, function, and crosstalks. In this Perspective, we consider recent and forthcoming technological and analytical advances in single-cell genomics and the potential impact of those advances on the future of immunology research and immunotherapy.	[Giladi, Amir; Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Amit, I (corresponding author), Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel.	ido.amit@weizmann.ac.il	t, lf/AAJ-4924-2020		Chan Zuckerberg Initiative; Howard Hughes Medical Institute International Scholar Award; European Research Council [724471-HemTree2.0]; Melanoma Research Alliance Established Investigator Award [509044]; Israel Science Foundation [703/15]; Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Helen and Martin Kimmel Award for Innovative Investigation; Minerva Stiftung research grant; Israeli Ministry of Science, Technology, and Space; David and Fela Shapell Family Foundation; NeuroMac DFG (German Research Foundation)/Transregional Collaborative Research Center Grant; Abramson Family Center for Young Scientists	Chan Zuckerberg Initiative; Howard Hughes Medical Institute International Scholar Award(Howard Hughes Medical Institute); European Research Council(European Research Council (ERC)European Commission); Melanoma Research Alliance Established Investigator Award; Israel Science Foundation(Israel Science Foundation); Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; Helen and Martin Kimmel Award for Innovative Investigation; Minerva Stiftung research grant; Israeli Ministry of Science, Technology, and Space(Ministry of Science, Technology and Space (MOST), Israel); David and Fela Shapell Family Foundation; NeuroMac DFG (German Research Foundation)/Transregional Collaborative Research Center Grant(German Research Foundation (DFG)); Abramson Family Center for Young Scientists	I. A. is supported by the Chan Zuckerberg Initiative; the Howard Hughes Medical Institute International Scholar Award; European Research Council Consolidator Grant 724471-HemTree2.0; a Melanoma Research Alliance Established Investigator Award (509044); the Israel Science Foundation (703/15); the Ernest and Bonnie Beutler Research Program of Excellence in Genomic Medicine; the Helen and Martin Kimmel Award for Innovative Investigation; a Minerva Stiftung research grant; the Israeli Ministry of Science, Technology, and Space; the David and Fela Shapell Family Foundation; the NeuroMac DFG (German Research Foundation)/Transregional Collaborative Research Center Grant; and the Abramson Family Center for Young Scientists. The authors declare patent applications relating to several parts of this Perspective.	Achim K, 2015, NAT BIOTECHNOL, V33, P503, DOI 10.1038/nbt.3209; Amit I, 2011, NAT REV IMMUNOL, V11, P873, DOI 10.1038/nri3109; Bain CC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11852; Bjorklund AK, 2016, NAT IMMUNOL, V17, P451, DOI 10.1038/ni.3368; Brennecke P, 2015, NAT IMMUNOL, V16, P933, DOI 10.1038/ni.3246; Brennecke P, 2013, NAT METHODS, V10, P1093, DOI [10.1038/nmeth.2645, 10.1038/NMETH.2645]; Brestoff JR, 2015, CELL, V161, P146, DOI 10.1016/j.cell.2015.02.022; Brodin P, 2015, CELL, V160, P37, DOI 10.1016/j.cell.2014.12.020; Buenostro JD, 2015, NATURE, V523, P486, DOI 10.1038/nature14590; Butler A., 2017, INTEGRATED ANAL SING; Camp JG, 2017, NATURE, V546, P533, DOI 10.1038/nature22796; Cheow LF, 2016, NAT METHODS, V13, P833, DOI 10.1038/nmeth.3961; Cusanovich DA, 2015, SCIENCE, V348, P910, DOI 10.1126/science.aab1601; Deng QL, 2014, SCIENCE, V343, P193, DOI 10.1126/science.1245316; Devitt A, 2011, J LEUKOCYTE BIOL, V90, P447, DOI 10.1189/jlb.0211095; Dey SS, 2015, NAT BIOTECHNOL, V33, P285, DOI 10.1038/nbt.3129; Dixit A, 2016, CELL, V167, P1853, DOI 10.1016/j.cell.2016.11.038; FULWYLER MJ, 1965, SCIENCE, V150, P910, DOI 10.1126/science.150.3698.910; Gaublomme JT, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.009; GOHDE W, 1971, ARZNEI-FORSCHUNG, V21, P1656; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gosselin D, 2014, CELL, V159, P1327, DOI 10.1016/j.cell.2014.11.023; Grun D, 2015, NATURE, V525, P251, DOI 10.1038/nature14966; Gury-BenAri M, 2016, CELL, V166, P1231, DOI 10.1016/j.cell.2016.07.043; Habib N, 2016, SCIENCE, V353, P925, DOI 10.1126/science.aad7038; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; Halpern KB, 2017, NATURE, V542, P352, DOI 10.1038/nature21065; Han A, 2014, NAT BIOTECHNOL, V32, P684, DOI 10.1038/nbt.2938; Hashimshony T, 2012, CELL REP, V2, P666, DOI 10.1016/j.celrep.2012.08.003; Hoppe PS, 2014, NAT CELL BIOL, V16, P919, DOI 10.1038/ncb3042; Hume DA, 2008, MUCOSAL IMMUNOL, V1, P432, DOI 10.1038/mi.2008.36; Islam S, 2014, NAT METHODS, V11, P163, DOI [10.1038/nmeth.2772, 10.1038/NMETH.2772]; Jaitin DA, 2016, CELL, V167, P1883, DOI 10.1016/j.cell.2016.11.039; Jaitin DA, 2014, SCIENCE, V343, P776, DOI 10.1126/science.1247651; Junker JP, 2016, BIORXIV; Keren-Shaul H, 2017, CELL, V169, P1276, DOI 10.1016/j.cell.2017.05.018; Kharchenko PV, 2014, NAT METHODS, V11, P740, DOI [10.1038/NMETH.2967, 10.1038/nmeth.2967]; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Lackey DE, 2016, NAT REV ENDOCRINOL, V12, P15, DOI 10.1038/nrendo.2015.189; Lavin Y, 2017, CELL, V169, P750, DOI 10.1016/j.cell.2017.04.014; Lavin Y, 2014, CELL, V159, P1312, DOI 10.1016/j.cell.2014.11.018; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Lonnberg T, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aal2192; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Matcovitch-Natan O, 2016, SCIENCE, V353, DOI 10.1126/science.aad8670; McKenna A, 2016, SCIENCE, V353, DOI 10.1126/science.aaf7907; Medaglia C, 2017, SCIENCE, V358, P1622, DOI 10.1126/science.aao4277; Meredith M, 2015, NAT IMMUNOL, V16, P942, DOI 10.1038/ni.3247; Mooijman D, 2016, NAT BIOTECHNOL, V34, P852, DOI 10.1038/nbt.3598; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Nestorowa S, 2016, BLOOD, V128, pE20, DOI 10.1182/blood-2016-05-716480; PAPALEXI E, 2017, NAT REV IMMUNOL; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Perie L, 2015, CELL, V163, P1655, DOI 10.1016/j.cell.2015.11.059; Perli SD, 2016, SCIENCE, V353, DOI 10.1126/science.aag0511; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Ramskold D, 2012, NAT BIOTECHNOL, V30, P777, DOI 10.1038/nbt.2282; Saeys Y, 2016, NAT REV IMMUNOL, V16, P449, DOI 10.1038/nri.2016.56; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Satija R, 2014, TRENDS IMMUNOL, V35, P219, DOI 10.1016/j.it.2014.03.004; Schlitzer A, 2015, NAT IMMUNOL, V16, P718, DOI 10.1038/ni.3200; Schroeder T, 2010, CELL STEM CELL, V6, P203, DOI 10.1016/j.stem.2010.02.006; Schwartz M, 2013, J NEUROSCI, V33, P17587, DOI 10.1523/JNEUROSCI.3241-13.2013; Setty M, 2016, NAT BIOTECHNOL, V34, P637, DOI 10.1038/nbt.3569; Shah S, 2016, NEURON, V92, P342, DOI 10.1016/j.neuron.2016.10.001; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shalek AK, 2013, NATURE, V498, P236, DOI 10.1038/nature12172; Sharma P, 2015, CELL, V161, P205, DOI 10.1016/j.cell.2015.03.030; Smallwood SA, 2014, NAT METHODS, V11, P817, DOI [10.1038/nmeth.3035, 10.1038/NMETH.3035]; Spitzer MH, 2015, SCIENCE, V349, DOI 10.1126/science.1259425; Stegle O, 2015, NAT REV GENET, V16, P133, DOI 10.1038/nrg3833; STEINMAN RM, 1973, J EXP MED, V137, P1142, DOI 10.1084/jem.137.5.1142; Stoll S, 2002, SCIENCE, V296, P1873, DOI 10.1126/science.1071065; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Tanay A, 2017, NATURE, V541, P331, DOI 10.1038/nature21350; Tauber AI, 2003, NAT REV MOL CELL BIO, V4, P897, DOI 10.1038/nrm1244; Tirosh I, 2016, SCIENCE, V352, P189, DOI 10.1126/science.aad0501; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; Treutlein B, 2014, NATURE, V509, P371, DOI 10.1038/nature13173; VANFURTH R, 1972, B WORLD HEALTH ORGAN, V46, P845; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Vremec D, 1997, J IMMUNOL, V159, P565; Wagner A, 2016, NAT BIOTECHNOL, V34, P1145, DOI 10.1038/nbt.3711; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Zeisel A., 2015, CELL TYPES MOUSE COR, P1; Zepp JA, 2017, CELL, V170, P1134, DOI 10.1016/j.cell.2017.07.034; Zhou F, 2016, NATURE, V533, P487, DOI 10.1038/nature17997; Zhu JF, 2010, ANNU REV IMMUNOL, V28, P445, DOI 10.1146/annurev-immunol-030409-101212	91	94	99	4	47	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					14	21		10.1016/j.cell.2017.11.011	http://dx.doi.org/10.1016/j.cell.2017.11.011			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29328909	Bronze			2022-12-28	WOS:000419840100006
J	Kaufmann, E; Sanz, J; Dunn, JL; Khan, N; Mendonca, LE; Pacis, A; Tzelepis, F; Pernet, E; Dumaine, A; Grenier, JC; Mailhot-Leonard, F; Ahmed, E; Belle, J; Besla, R; Mazer, B; King, IL; Nijnik, A; Robbins, CS; Barreiro, LB; Divangahi, M				Kaufmann, Eva; Sanz, Joaquin; Dunn, Jonathan L.; Khan, Nargis; Mendonca, Laura E.; Pacis, Alain; Tzelepis, Fanny; Pernet, Erwan; Dumaine, Anne; Grenier, Jean-Christophe; Mailhot-Leonard, Florence; Ahmed, Eisha; Belle, Jad; Besla, Rickvinder; Mazer, Bruce; King, Irah L.; Nijnik, Anastasia; Robbins, Clinton S.; Barreiro, Luis B.; Divangahi, Maziar			BCG Educates Hematopoietic Stem Cells to Generate Protective Innate Immunity against Tuberculosis	CELL			English	Article							MYCOBACTERIUM-TUBERCULOSIS; AIRBORNE TUBERCULOSIS; EXPRESSION ANALYSIS; GENOMIC FEATURES; CALMETTE-GUERIN; IFN-GAMMA; INFECTION; IDENTIFICATION; PROGENITORS; POPULATIONS	The dogma that adaptive immunity is the only arm of the immune response with memory capacity has been recently challenged by several studies demonstrating evidence for memory-like innate immune training. However, the underlying mechanisms and location for generating such innate memory responses in vivo remain unknown. Here, we show that access of Bacillus Calmette-Guerin (BCG) to the bone marrow (BM) changes the transcriptional landscape of hematopoietic stem cells (HSCs) and multipotent progenitors (MPPs), leading to local cell expansion and enhanced myelopoiesis at the expense of lymphopoiesis. Importantly, BCG-educated HSCs generate epigenetically modified macrophages that provide significantly better protection against virulent M. tuberculosis infection than naive macrophages. By using parabiotic and chimeric mice, as well as adoptive transfer approaches, we demonstrate that training of the monocyte/macrophage lineage via BCG-induced HSC reprogramming is sustainable in vivo. Our results indicate that targeting the HSC compartment provides a novel approach for vaccine development.	[Kaufmann, Eva; Dunn, Jonathan L.; Khan, Nargis; Mendonca, Laura E.; Tzelepis, Fanny; Pernet, Erwan; Ahmed, Eisha; Mazer, Bruce; King, Irah L.; Divangahi, Maziar] McGill Univ, Hlth Ctr, McGill Int TB Ctr,Dept Pathol, Meakins Christie Labs,Dept Med,Dept Microbiol & I, Montreal, PQ H4A 3J1, Canada; [Sanz, Joaquin; Pacis, Alain] Univ Montreal, Dept Biochem, Fac Med, Montreal, PQ H3T 1J4, Canada; [Sanz, Joaquin; Pacis, Alain; Dumaine, Anne; Grenier, Jean-Christophe; Mailhot-Leonard, Florence; Barreiro, Luis B.] CHU St Justine, Res Ctr, Dept Genet, Montreal, PQ H3T 1C5, Canada; [Belle, Jad; Nijnik, Anastasia] McGill Univ, Complex Traits Grp, Dept Physiol, Montreal, PQ H3G 0B1, Canada; [Besla, Rickvinder; Robbins, Clinton S.] Univ Toronto, Dept Immunol, Toronto, ON M5G 1L7, Canada; [Barreiro, Luis B.] Univ Montreal, Fac Med, Dept Pediat, Montreal, PQ H3T 1C5, Canada	McGill University; Universite de Montreal; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; McGill University; University of Toronto; Universite de Montreal	Divangahi, M (corresponding author), McGill Univ, Hlth Ctr, McGill Int TB Ctr,Dept Pathol, Meakins Christie Labs,Dept Med,Dept Microbiol & I, Montreal, PQ H4A 3J1, Canada.; Barreiro, LB (corresponding author), CHU St Justine, Res Ctr, Dept Genet, Montreal, PQ H3T 1C5, Canada.; Barreiro, LB (corresponding author), Univ Montreal, Fac Med, Dept Pediat, Montreal, PQ H3T 1C5, Canada.	luis.barreiro@umontreal.ca; maziar.divangahi@mcgill.ca	Barreiro, Luis/I-7772-2015; Nijnik, Anastasia/W-2697-2019; Sanz, Joaquín/AAA-4010-2019	Sanz, Joaquín/0000-0002-2980-9685; Kaufmann, Eva/0000-0001-7965-9200; Barreiro, Luis/0000-0001-9456-367X; Grenier, Jean-Christophe/0000-0001-7937-5160; Belle, Jad/0000-0001-8944-9792; Pernet, Erwan/0000-0003-3595-4755; Robbins, Clinton/0000-0001-9848-1495	Canadian Institute of Health Research (CIHR) Foundation Grant [FDN-143273]; CIHR [301538, 232519]; Fonds de Recherche du Quebec-Sante (FRQS) Award; Canada Research Chair [950-228993]; German Research Foundation (DFG); FRQS; CIHR	Canadian Institute of Health Research (CIHR) Foundation Grant; CIHR(Canadian Institutes of Health Research (CIHR)); Fonds de Recherche du Quebec-Sante (FRQS) Award; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); German Research Foundation (DFG)(German Research Foundation (DFG)); FRQS; CIHR(Canadian Institutes of Health Research (CIHR))	We thank Dr. Marcel Behr for providing BCG-GFP and Maitane Gutierrez for assistance with figures. We thank Dr. Michael Reed for help with BCG realtime PCR. We thank Ioannis Ragoussis for access to the 10X machine and Yu Chang Wang for technical support with scRNA-seq library preparation. We thank John Marioni for advice on single- cell data analyses. This work was supported by the Canadian Institute of Health Research (CIHR) Foundation Grant (FDN-143273) to M.D. and the CIHR operating grants (301538 and 232519) to L.B.B.M.D. holds a Fonds de Recherche du Quebec-Sante (FRQS) Award. L.B.B. is a Canada Research Chair (950-228993). E.K. is a recipient of a postdoctoral research fellowship from the German Research Foundation (DFG). J.S. was supported by FRQS and by the CIHR through a Banting Postdoctoral Fellowship. A.P. was supported by a fellowship from FRQS. We thank Calcul Quebec and Compute Canada for access to the supercomputer Briaree from the University of Montreal.	Alter A, 2010, HUM GENET, V127, P337, DOI 10.1007/s00439-009-0775-x; ANACKER RL, 1972, Z IMMUNITATSFORSCH, V143, P363; Baldridge MT, 2010, NATURE, V465, P793, DOI 10.1038/nature09135; BARCLAY W R, 1970, Infection and Immunity, V2, P574; BARCLAY WR, 1973, AM REV RESPIR DIS, V107, P351; Behar SM, 2010, NAT REV MICROBIOL, V8, P668, DOI 10.1038/nrmicro2387; Belyaev NN, 2010, NAT IMMUNOL, V11, P477, DOI 10.1038/ni.1869; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Boring L, 1997, J CLIN INVEST, V100, P2552, DOI 10.1172/JCI119798; Breese MR, 2013, BIOINFORMATICS, V29, P494, DOI 10.1093/bioinformatics/bts731; Brewer TF, 2000, CLIN INFECT DIS, V31, pS64, DOI 10.1086/314072; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Burberry A, 2014, CELL HOST MICROBE, V15, P779, DOI 10.1016/j.chom.2014.05.004; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Calaminus SDJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051361; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Comas I, 2010, NAT GENET, V42, P498, DOI 10.1038/ng.590; CURTIS HM, 1984, LANCET, V1, P145; Dabney A, 2010, QVALUE Q VALUE ESTIM; Das B, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004912; Di Rosa F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00051; Divangahi M., 2017, AM J RESP CRIT CARE; Divangahi M, 2010, NAT IMMUNOL, V11, P751, DOI 10.1038/ni.1904; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Downey J, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006326; Ensan S, 2016, NAT IMMUNOL, V17, P159, DOI 10.1038/ni.3343; Garly ML, 2003, VACCINE, V21, P2782, DOI 10.1016/S0264-410X(03)00181-6; HART PD, 1977, BRIT MED J, V2, P293, DOI 10.1136/bmj.2.6082.293; Hermesh T, 2010, CELL HOST MICROBE, V7, P343, DOI 10.1016/j.chom.2010.04.006; King KY, 2011, NAT REV IMMUNOL, V11, P685, DOI 10.1038/nri3062; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Kolb-Maurer A, 2002, BLOOD, V100, P3703, DOI 10.1182/blood-2002-03-0898; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Lu RQ, 2008, TRENDS IMMUNOL, V29, P487, DOI 10.1016/j.it.2008.07.006; Lun Aaron T L, 2016, F1000Res, V5, P2122; Manz MG, 2014, NAT REV IMMUNOL, V14, P302, DOI 10.1038/nri3660; Nakorn TN, 2003, P NATL ACAD SCI USA, V100, P205, DOI 10.1073/pnas.262655099; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Pacis A, 2015, GENOME RES, V25, P1801, DOI 10.1101/gr.192005.115; Pai M, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.76; Pique-Regi R, 2011, GENOME RES, V21, P447, DOI 10.1101/gr.112623.110; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Reed MB, 2007, J BACTERIOL, V189, P2583, DOI 10.1128/JB.01670-06; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Satija R, 2015, NAT BIOTECHNOL, V33, P495, DOI 10.1038/nbt.3192; Sharpe S, 2016, TUBERCULOSIS, V101, P174, DOI 10.1016/j.tube.2016.09.004; Tameris MD, 2013, LANCET, V381, P1021, DOI 10.1016/S0140-6736(13)60177-4; TRIBOULEY J, 1978, CR SOC BIOL, V172, P902; Wang HM, 2001, MOL CELL, V8, P817, DOI 10.1016/S1097-2765(01)00366-5; Wilson NK, 2015, CELL STEM CELL, V16, P712, DOI 10.1016/j.stem.2015.04.004; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Young NS, 2008, CURR OPIN HEMATOL, V15, P162, DOI 10.1097/MOH.0b013e3282fa7470; Zeng WH, 2006, BLOOD, V107, P167, DOI 10.1182/blood-2005-05-1884; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao X, 2010, STEM CELLS, V28, P122, DOI 10.1002/stem.252; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	63	506	528	11	106	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					176	+		10.1016/j.cell.2017.12.031	http://dx.doi.org/10.1016/j.cell.2017.12.031			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29328912	Bronze			2022-12-28	WOS:000419840100018
J	Vuong, LN; Dang, VQ; Ho, TM; Huynh, BG; Ha, DT; Pham, TD; Nguyen, LK; Norman, RJ; Mol, BW				Vuong, Lan N.; Dang, Vinh Q.; Ho, Tuong M.; Huynh, Bao G.; Ha, Duc T.; Pham, Toan D.; Nguyen, Linh K.; Norman, Robert J.; Mol, Ben W.			IVF Transfer of Fresh or Frozen Embryos in Women without Polycystic Ovaries	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-VITRO FERTILIZATION; ASSISTED REPRODUCTIVE TECHNOLOGY; IMPAIRED ENDOMETRIAL RECEPTIVITY; TRIAL COMPARING FRESH; LOW-BIRTH-WEIGHT; CHILDREN BORN; PERINATAL OUTCOMES; COHORT; SINGLE; VITRIFICATION	BACKGROUND Among women who are undergoing in vitro fertilization (IVF), the transfer of frozen embryos has been shown to result in a higher rate of live birth than the transfer of fresh embryos in those with infertility associated with the polycystic ovary syndrome. It is not known whether frozen-embryo transfer results in similar benefit in women with infertility that is not associated with the polycystic ovary syndrome. METHODS We randomly assigned 782 infertile women without the polycystic ovary syndrome who were undergoing a first or second IVF cycle to receive either a frozen embryo or a fresh embryo on day 3. In the frozen-embryo group, all grade 1 and 2 embryos had been cryopreserved, and a maximum of two embryos were thawed on the day of transfer in the following cycle. In the fresh-embryo group, a maximum of two fresh embryos were transferred in the stimulated cycle. The primary outcome was ongoing pregnancy after the first embryo transfer. RESULTS After the first completed cycle, ongoing pregnancy occurred in 142 of 391 women (36.3%) in the frozen-embryo group and in 135 of 391 (34.5%) in the fresh-embryo group (risk ratio in the frozen-embryo group, 1.05; 95% confidence interval [CI], 0.87 to 1.27; P = 0.65). Rates of live birth after the first transfer were 33.8% and 31.5%, respectively (risk ratio, 1.07; 95% CI, 0.88 to 1.31). CONCLUSIONS Among infertile women without the polycystic ovary syndrome who were undergoing IVF, the transfer of frozen embryos did not result in significantly higher rates of ongoing pregnancy or live birth than the transfer of fresh embryos.	[Vuong, Lan N.] Univ Med & Pharm Ho Chi Minh City, Dept Obstet & Gynecol, 217 Hong Bang St,Dist 5, Ho Chi Minh City, Vietnam; [Vuong, Lan N.; Dang, Vinh Q.; Ho, Tuong M.; Huynh, Bao G.; Pham, Toan D.; Nguyen, Linh K.] My Duc Hosp, IVFMD, Ho Chi Minh City, Vietnam; [Ho, Tuong M.] Vietnam Natl Univ, Sch Med, Res Ctr Genet & Reprod Hlth, Ho Chi Minh City, Vietnam; [Ha, Duc T.] Natl Hosp Can Tho, Can Tho, Vietnam; [Norman, Robert J.; Mol, Ben W.] Robinson Res Inst, Dept Med, Adelaide, SA, Australia; [Norman, Robert J.] Fertil South Australia, Adelaide, SA, Australia; [Mol, Ben W.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	Hochiminh City University of Medicine & Pharmacy; HOPE Research Center, My Duc Hospital; Vietnam National University Hochiminh City; Robinson Research Institute; South Australian Health & Medical Research Institute (SAHMRI)	Vuong, LN (corresponding author), Univ Med & Pharm Ho Chi Minh City, Dept Obstet & Gynecol, 217 Hong Bang St,Dist 5, Ho Chi Minh City, Vietnam.	lanvuong@ump.edu.vn	Vinh, Dang Quang/N-6816-2019; Norman, Robert J/A-1155-2007	Vinh, Dang Quang/0000-0001-5205-8210; Norman, Robert J/0000-0002-3118-3896; Ho, Tuong/0000-0003-3528-7358	My Duc Hospital, Ho Chi Minh City, Vietnam	My Duc Hospital, Ho Chi Minh City, Vietnam	Supported by My Duc Hospital, Ho Chi Minh City, Vietnam.	AbdelHafez FF, 2010, REPROD BIOMED ONLINE, V20, P209, DOI 10.1016/j.rbmo.2009.11.013; Alpha Scientists in Reproductive Medicine and ESHRE Special Interest Group of Embryology, 2011, Hum Reprod, V26, P1270, DOI 10.1093/humrep/der037; [Anonymous], 2015, QUEENSL CLIN GUID HY; [Anonymous], 2014, 2014 FIN CLIN SUMM R; Belva F, 2008, HUM REPROD, V23, P2227, DOI 10.1093/humrep/den254; Bhattacharya S, 2001, LANCET, V357, P2075, DOI 10.1016/S0140-6736(00)05179-5; Chen ZJ, 2016, NEW ENGL J MED, V375, P523, DOI 10.1056/NEJMoa1513873; Debrock S, 2015, HUM REPROD, V30, P1820, DOI 10.1093/humrep/dev134; Evans J, 2014, HUM REPROD UPDATE, V20, P808, DOI 10.1093/humupd/dmu027; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Healy DL, 2010, HUM REPROD, V25, P265, DOI 10.1093/humrep/dep376; Henningsen AKA, 2011, FERTIL STERIL, V95, P959, DOI 10.1016/j.fertnstert.2010.07.1075; Ishihara O, 2014, FERTIL STERIL, V101, P128, DOI 10.1016/j.fertnstert.2013.09.025; Loutradi KE, 2008, FERTIL STERIL, V90, P186, DOI 10.1016/j.fertnstert.2007.06.010; Maheshwari A, 2012, FERTIL STERIL, V98, P368, DOI 10.1016/j.fertnstert.2012.05.019; McLernon DJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6945; Pelkonen S, 2014, HUM REPROD, V29, P1552, DOI 10.1093/humrep/deu088; Pelkonen S, 2010, HUM REPROD, V25, P914, DOI 10.1093/humrep/dep477; Pinborg A, 2014, HUM REPROD, V29, P618, DOI 10.1093/humrep/det440; Pinborg A, 2010, FERTIL STERIL, V94, P1320, DOI 10.1016/j.fertnstert.2009.05.091; Sazonova A, 2012, HUM REPROD, V27, P1343, DOI 10.1093/humrep/des036; Shapiro BS, 2013, FERTIL STERIL, V99, P389, DOI 10.1016/j.fertnstert.2012.09.044; Shapiro BS, 2011, FERTIL STERIL, V96, P516, DOI 10.1016/j.fertnstert.2011.02.059; Shapiro BS, 2011, FERTIL STERIL, V96, P344, DOI 10.1016/j.fertnstert.2011.05.050; Shih W, 2008, HUM REPROD, V23, P1644, DOI 10.1093/humrep/den150; STEPTOE PC, 1978, LANCET, V2, P366; Sterling L, 2016, FERTIL STERIL, V105, P791, DOI 10.1016/j.fertnstert.2015.11.019; Lan VTN, 2013, REPROD BIOMED ONLINE, V27, P390, DOI 10.1016/j.rbmo.2013.07.008; WADA I, 1994, HUM REPROD, V9, P543, DOI 10.1093/oxfordjournals.humrep.a138542; Wang YA, 2005, FERTIL STERIL, V83, P1650, DOI 10.1016/j.fertnstert.2004.12.033; Wennerholm UB, 1997, HUM REPROD, V12, P1819, DOI 10.1093/humrep/12.8.1819; Wennerholm UB, 2013, HUM REPROD, V28, P2545, DOI 10.1093/humrep/det272; Wikland M, 2010, HUM REPROD, V25, P1699, DOI 10.1093/humrep/deq117	33	129	136	10	52	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 11	2018	378	2					137	147		10.1056/NEJMoa1703768	http://dx.doi.org/10.1056/NEJMoa1703768			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS7IR	29320655	Bronze			2022-12-28	WOS:000419971600007
J	Wang, TG; Heianza, Y; Sun, DJY; Huang, T; Ma, WJ; Rimm, EB; Manson, JE; Hu, FB; Willett, WC; Qi, L				Wang, Tiange; Heianza, Yoriko; Sun, Dianjianyi; Huang, Tao; Ma, Wenjie; Rimm, Eric B.; Manson, Joann E.; Hu, Frank B.; Willett, Walter C.; Qi, Lu			Improving adherence to healthy dietary patterns, genetic risk, and long term weight gain: gene-diet interaction analysis in two prospective cohort studies	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; PHYSICAL-ACTIVITY; MEDITERRANEAN DIET; OBESITY; REPRODUCIBILITY; ASSOCIATION; CONSUMPTION; VALIDITY; QUALITY; PREDISPOSITION	OBJECTIVE To investigate whether improving adherence to healthy dietary patterns interacts with the genetic predisposition to obesity in relation to long term changes in body mass index and body weight. DESIGN Prospective cohort study. SETTING Health professionals in the United States. PARTICIPANTS 8828 women from the Nurses' Health Study and 5218 men from the Health Professionals Follow-up Study. EXPOSURE Genetic predisposition score was calculated on the basis of 77 variants associated with body mass index. Dietary patterns were assessed by the Alternate Healthy Eating Index 2010 (AHEI-2010), Dietary Approach to Stop Hypertension (DASH), and Alternate Mediterranean Diet (AMED). MAIN OUTCOME MEASURES Five repeated measurements of four year changes in body mass index and body weight over follow-up (1986 to 2006). RESULTS During a 20 year follow-up, genetic association with change in body mass index was significantly attenuated with increasing adherence to the AHEI-2010 in the Nurses' Health Study (P= 0.001 for interaction) and Health Professionals Follow-up Study (P= 0.005 for interaction). In the combined cohorts, four year changes in body mass index per 10 risk allele increment were 0.07 (SE 0.02) among participants with decreased AHEI-2010 score and -0.01 (0.02) among those with increased AHEI-2010 score, corresponding to 0.16 (0.05) kg versus -0.02 (0.05) kg weight change every four years (P< 0.001 for interaction). Viewed differently, changes in body mass index per 1 SD increment of AHEI-2010 score were -0.12 (0.01), -0.14 (0.01), and -0.18 (0.01) (weight change: -0.35 (0.03), -0.36 (0.04), and -0.50 (0.04) kg) among participants with low, intermediate, and high genetic risk, respectively. Similar interaction was also found for DASH but not for AMED. CONCLUSIONS These data indicate that improving adherence to healthy dietary patterns could attenuate the genetic association with weight gain. Moreover, the beneficial effect of improved diet quality on weight management was particularly pronounced in people at high genetic risk for obesity.	[Wang, Tiange; Heianza, Yoriko; Sun, Dianjianyi; Qi, Lu] Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA; [Wang, Tiange] Shanghai Jiao Tong Univ, Sch Med, Rui Jin Hosp, Shanghai Inst Endocrine & Metab Dis, Shanghai, Peoples R China; [Huang, Tao] Peking Univ, Hlth Sci Ctr, Sch Publ Hlth, Dept Epidemiol & Biostat, Beijing, Peoples R China; [Ma, Wenjie; Rimm, Eric B.; Manson, Joann E.; Willett, Walter C.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Rimm, Eric B.; Hu, Frank B.; Willett, Walter C.; Qi, Lu] Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA; [Rimm, Eric B.; Manson, Joann E.; Hu, Frank B.; Willett, Walter C.; Qi, Lu] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA; [Rimm, Eric B.; Manson, Joann E.; Hu, Frank B.; Willett, Walter C.; Qi, Lu] Harvard Med Sch, Boston, MA 02115 USA; [Manson, Joann E.] Brigham & Womens Hosp, Dept Med, Div Prevent Med, 75 Francis St, Boston, MA 02115 USA	Tulane University; Shanghai Jiao Tong University; Peking University; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Qi, L (corresponding author), Tulane Univ, Sch Publ Hlth & Trop Med, Dept Epidemiol, New Orleans, LA 70112 USA.; Qi, L (corresponding author), Harvard TH Chan Sch Publ Hlth, Dept Nutr, Boston, MA 02115 USA.; Qi, L (corresponding author), Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.; Qi, L (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	lqi1@tulane.edu			National Institutes of Health [R01 CA49449, UM1 CA186107, UM1 CA167552]; National Heart, Lung, and Blood Institute [HL071981, HL034594, HL126024, HL35464]; National Institute of Diabetes and Digestive and Kidney Diseases [DK091718, DK100383, DK078616]; National Eye Institute [EY015473]; National Human Genome Research Institute [U01 HG004728]; National Institute of Health [CA87969, CA49449, CA55075, CA167552]; National Natural Science Foundation of China [81500610]; American Heart Association Scientist Development Award [0730094N]; NATIONAL CANCER INSTITUTE [UM1CA167552, UM1CA186107, R01CA049449, U01CA167552] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY015473] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071981] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100383, R01DK078616] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Heart Association Scientist Development Award(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The cohorts were supported by grants R01 CA49449, UM1 CA186107, and UM1 CA167552 from the National Institutes of Health. This study was supported by grants from the National Heart, Lung, and Blood Institute (HL071981, HL034594, HL126024, HL35464), the National Institute of Diabetes and Digestive and Kidney Diseases (DK091718, DK100383, DK078616), the National Eye Institute (EY015473), the National Human Genome Research Institute (U01 HG004728), and the National Institute of Health (CA87969, CA49449, CA55075, CA167552). TW is supported by the National Natural Science Foundation of China (81500610). LQ is supported by the American Heart Association Scientist Development Award (0730094N). All investigators are independent from funders.	Ainsworth BE, 2000, MED SCI SPORT EXER, V32, pS498, DOI 10.1097/00005768-200009001-00009; Brunkwall L, 2016, AM J CLIN NUTR, V104, P809, DOI 10.3945/ajcn.115.126052; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; Cornelis MC, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002033; Ezzati M, 2013, NEW ENGL J MED, V369, P954, DOI 10.1056/NEJMra1203528; Feliciano EMC, 2016, OBESITY, V24, P2176, DOI 10.1002/oby.21589; FESKANICH D, 1993, J AM DIET ASSOC, V93, P790, DOI 10.1016/0002-8223(93)91754-E; Fung TT, 2008, ARCH INTERN MED, V168, P713, DOI 10.1001/archinte.168.7.713; Fung TT, 2015, J NUTR, V145, P1850, DOI 10.3945/jn.114.208785; Fung TT, 2009, CIRCULATION, V119, P1093, DOI 10.1161/CIRCULATIONAHA.108.816736; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Jensen MK, 2011, CIRC-CARDIOVASC GENE, V4, P549, DOI 10.1161/CIRCGENETICS.111.960393; Kant AK, 2005, INT J OBESITY, V29, P950, DOI 10.1038/sj.ijo.0802980; Kant AK, 2004, J AM DIET ASSOC, V104, P615, DOI 10.1016/j.jada.2004.01.010; Livingstone KM, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4707; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Moustafa JSES, 2013, NAT REV ENDOCRINOL, V9, P402, DOI 10.1038/nrendo.2013.57; Qi L, 2008, NUTR REV, V66, P684, DOI 10.1111/j.1753-4887.2008.00128.x; Qi L, 2010, HUM MOL GENET, V19, P2706, DOI 10.1093/hmg/ddq156; Qi QB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g1610; Qi QB, 2012, NEW ENGL J MED, V367, P1387, DOI 10.1056/NEJMoa1203039; Rimm E B, 1990, Epidemiology, V1, P466, DOI 10.1097/00001648-199011000-00009; RIMM EB, 1992, AM J EPIDEMIOL, V135, P1114, DOI 10.1093/oxfordjournals.aje.a116211; RIMM EB, 1991, LANCET, V338, P464, DOI 10.1016/0140-6736(91)90542-W; SALVINI S, 1989, INT J EPIDEMIOL, V18, P858, DOI 10.1093/ije/18.4.858; Smith JD, 2015, J NUTR, V145, P2527, DOI 10.3945/jn.115.214171; Sotos-Prieto M, 2017, NEW ENGL J MED, V377, P143, DOI [10.1056/NEJMoa1613502, 10.1056/nejmoa1613502]; Sotos-Prieto M, 2015, CIRCULATION, V132, P2212, DOI 10.1161/CIRCULATIONAHA.115.017158; Swinburn BA, 2004, PUBLIC HEALTH NUTR, V7, P123, DOI 10.1079/PHN2003585; Tobias DK, 2016, INT J OBESITY, V40, P1748, DOI 10.1038/ijo.2016.156; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; US Department of Health and Human Services (US DHHS) and USDA, 2015, 2015 2020 DIET GUID, V8th; Wang TG, 2017, DIABETES, V66, P2704, DOI 10.2337/db17-0071; Wang TG, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0862-0; Wiggs JL, 2011, HUM MOL GENET, V20, P4707, DOI 10.1093/hmg/ddr382; WILLETT WC, 1987, NEW ENGL J MED, V316, P22, DOI 10.1056/NEJM198701013160105; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; Xiang LW, 2016, AM J CLIN NUTR, V103, P1162, DOI 10.3945/ajcn.115.123448	39	83	85	2	42	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2018	360								j5644	10.1136/bmj.j5644	http://dx.doi.org/10.1136/bmj.j5644			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS9MW	29321156	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000422743300011
J	Cohen, JD; Li, L; Wang, YX; Thoburn, C; Afsari, B; Danilova, L; Douville, C; Javed, AA; Wong, F; Mattox, A; Hruban, RH; Wolfgang, CL; Goggins, MG; Dal Molin, M; Wang, TL; Roden, R; Klein, AP; Ptak, J; Dobbyn, L; Schaefer, J; Silliman, N; Popoli, M; Vogelstein, JT; Browne, JD; Schoen, RE; Brand, RE; Tie, J; Gibbs, P; Wong, HL; Mansfield, AS; Jen, J; Hanash, SM; Falconi, M; Allen, PJ; Zhou, S; Bettegowda, C; Diaz, LA; Tomasetti, C; Kinzler, KW; Vogelstein, B; Lennon, AM; Papadopoulos, N				Cohen, Joshua D.; Li, Lu; Wang, Yuxuan; Thoburn, Christopher; Afsari, Bahman; Danilova, Ludmila; Douville, Christopher; Javed, Ammar A.; Wong, Fay; Mattox, Austin; Hruban, Ralph. H.; Wolfgang, Christopher L.; Goggins, Michael G.; Dal Molin, Marco; Wang, Tian-Li; Roden, Richard; Klein, Alison P.; Ptak, Janine; Dobbyn, Lisa; Schaefer, Joy; Silliman, Natalie; Popoli, Maria; Vogelstein, Joshua T.; Browne, James D.; Schoen, Robert E.; Brand, Randall E.; Tie, Jeanne; Gibbs, Peter; Wong, Hui-Li; Mansfield, Aaron S.; Jen, Jin; Hanash, Samir M.; Falconi, Massimo; Allen, Peter J.; Zhou, Shibin; Bettegowda, Chetan; Diaz, Luis A., Jr.; Tomasetti, Cristian; Kinzler, Kenneth W.; Vogelstein, Bert; Lennon, Anne Marie; Papadopoulos, Nickolas			Detection and localization of surgically resectable cancers with a multi-analyte blood test	SCIENCE			English	Article							CIRCULATING TUMOR DNA; LUNG-CANCER; QUANTIFICATION; BIOMARKERS; MUTATIONS; EVOLUTION	Earlier detection is key to reducing cancer deaths. Here, we describe a blood test that can detect eight common cancer types through assessment of the levels of circulating proteins and mutations in cell-free DNA. We applied this test, called CancerSEEK, to 1005 patients with nonmetastatic, clinically detected cancers of the ovary, liver, stomach, pancreas, esophagus, colorectum, lung, or breast. CancerSEEK tests were positive in a median of 70% of the eight cancer types. The sensitivities ranged from 69 to 98% for the detection of five cancer types (ovary, liver, stomach, pancreas, and esophagus) for which there are no screening tests available for average-risk individuals. The specificity of CancerSEEK was greater than 99%: only 7 of 812 healthy controls scored positive. In addition, CancerSEEK localized the cancer to a small number of anatomic sites in a median of 83% of the patients.	[Cohen, Joshua D.; Wang, Yuxuan; Douville, Christopher; Wong, Fay; Mattox, Austin; Klein, Alison P.; Ptak, Janine; Dobbyn, Lisa; Schaefer, Joy; Silliman, Natalie; Popoli, Maria; Zhou, Shibin; Bettegowda, Chetan; Diaz, Luis A., Jr.; Kinzler, Kenneth W.; Vogelstein, Bert; Papadopoulos, Nickolas] Johns Hopkins Univ, Sch Med, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21205 USA; [Cohen, Joshua D.; Wang, Yuxuan; Douville, Christopher; Mattox, Austin; Ptak, Janine; Silliman, Natalie; Vogelstein, Bert] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Cohen, Joshua D.; Wang, Yuxuan; Thoburn, Christopher; Douville, Christopher; Wong, Fay; Mattox, Austin; Hruban, Ralph. H.; Goggins, Michael G.; Wang, Tian-Li; Roden, Richard; Klein, Alison P.; Ptak, Janine; Dobbyn, Lisa; Schaefer, Joy; Silliman, Natalie; Popoli, Maria; Zhou, Shibin; Bettegowda, Chetan; Diaz, Luis A., Jr.; Tomasetti, Cristian; Kinzler, Kenneth W.; Vogelstein, Bert; Lennon, Anne Marie; Papadopoulos, Nickolas] Johns Hopkins Univ, Sch Med, Sidney Kimmel Canc Ctr, Baltimore, MD 21205 USA; [Cohen, Joshua D.; Wang, Yuxuan; Douville, Christopher; Wong, Fay; Mattox, Austin; Hruban, Ralph. H.; Goggins, Michael G.; Dal Molin, Marco; Klein, Alison P.; Ptak, Janine; Dobbyn, Lisa; Schaefer, Joy; Silliman, Natalie; Popoli, Maria; Zhou, Shibin; Bettegowda, Chetan; Diaz, Luis A., Jr.; Kinzler, Kenneth W.; Vogelstein, Bert; Lennon, Anne Marie; Papadopoulos, Nickolas] Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA; [Cohen, Joshua D.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Baltimore, MD 21205 USA; [Li, Lu; Tomasetti, Cristian] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA; [Afsari, Bahman; Danilova, Ludmila; Tomasetti, Cristian] Johns Hopkins Med Inst, Dept Oncol, Div Biostat & Bioinformat, Baltimore, MD 21287 USA; [Javed, Ammar A.; Wolfgang, Christopher L.; Lennon, Anne Marie] Johns Hopkins Med Inst, Dept Surg, Baltimore, MD 21287 USA; [Hruban, Ralph. H.; Goggins, Michael G.; Wang, Tian-Li; Roden, Richard] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21287 USA; [Goggins, Michael G.; Lennon, Anne Marie] Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21287 USA; [Goggins, Michael G.; Lennon, Anne Marie] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21287 USA; [Klein, Alison P.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Vogelstein, Joshua T.] Johns Hopkins Univ, Sch Med, Inst Computat Med, Baltimore, MD 21205 USA; [Browne, James D.] Johns Hopkins Univ, Whiting Sch Engn, Dept Comp Sci, Baltimore, MD 21218 USA; [Schoen, Robert E.; Brand, Randall E.] Univ Pittsburgh, Dept Med, 930 Scaife Hall, Pittsburgh, PA 15260 USA; [Schoen, Robert E.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15260 USA; [Tie, Jeanne; Gibbs, Peter; Wong, Hui-Li] Walter & Eliza Hall Inst Med Res, Div Syst Biol & Personalized Med, Parkville, Vic 3021, Australia; [Tie, Jeanne; Gibbs, Peter] Univ Melbourne, Fac Med Dent & Hlth Sci, Melbourne, Vic 3010, Australia; [Tie, Jeanne; Gibbs, Peter] Western Hlth, Dept Med Oncol, Melbourne, Vic 3021, Australia; [Tie, Jeanne; Gibbs, Peter] Peter MacCallum Canc Ctr, Dept Med Oncol, Melbourne, Vic 3000, Australia; [Mansfield, Aaron S.] Mayo Clin, Dept Oncol, Div Med Oncol, Rochester, MN 55902 USA; [Jen, Jin] Mayo Clin, Dept Lab Med & Pathol, Div Expt Pathol, Rochester, MN 55902 USA; [Hanash, Samir M.] Univ Texas MD Anderson Canc Ctr, Sheikh Ahmed Ctr Pancreat Canc Res, Houston, TX 77030 USA; [Falconi, Massimo] Res Hosp, San Raffaele Sci Inst, Dept Surg, Div Pancreat Surg, I-20132 Milan, Italy; [Allen, Peter J.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Diaz, Luis A., Jr.] Mem Sloan Kettering Canc Ctr, Div Solid Tumor Oncol, New York, NY 10065 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Walter & Eliza Hall Institute; University of Melbourne; Peter Maccallum Cancer Center; Mayo Clinic; Mayo Clinic; University of Texas System; UTMD Anderson Cancer Center; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Kinzler, KW; Vogelstein, B; Papadopoulos, N (corresponding author), Johns Hopkins Univ, Sch Med, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21205 USA.; Vogelstein, B (corresponding author), Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA.; Tomasetti, C; Kinzler, KW; Vogelstein, B; Lennon, AM; Papadopoulos, N (corresponding author), Johns Hopkins Univ, Sch Med, Sidney Kimmel Canc Ctr, Baltimore, MD 21205 USA.; Kinzler, KW; Vogelstein, B; Lennon, AM; Papadopoulos, N (corresponding author), Johns Hopkins Univ, Sch Med, Sol Goldman Pancreat Canc Res Ctr, Baltimore, MD 21205 USA.; Tomasetti, C (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD 21205 USA.; Tomasetti, C (corresponding author), Johns Hopkins Med Inst, Dept Oncol, Div Biostat & Bioinformat, Baltimore, MD 21287 USA.; Lennon, AM (corresponding author), Johns Hopkins Med Inst, Dept Surg, Baltimore, MD 21287 USA.; Lennon, AM (corresponding author), Johns Hopkins Med Inst, Dept Med, Baltimore, MD 21287 USA.; Lennon, AM (corresponding author), Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21287 USA.	ctomasetti@jhu.edu; bertvog@gmail.com; kinzlke@jhmi.edu; npapado1@jhmi.edu	Wolfgang, Christopher/HGD-0863-2022; Vogelstein, Joshua/AAG-5489-2019; Javed, Ammar A/AAE-2870-2020; Thoburn, Christopher J/U-9170-2017; Falconi, Massimo/K-2194-2016; Mansfield, Aaron/AAQ-8298-2021; Danilova, Ludmila/K-2781-2018	Vogelstein, Joshua/0000-0003-2487-6237; Javed, Ammar A/0000-0002-5463-5250; Thoburn, Christopher J/0000-0001-7743-9183; Falconi, Massimo/0000-0001-9654-7243; Mansfield, Aaron/0000-0002-9483-6903; Cohen, Joshua/0000-0003-1158-5668; Diaz, Luis/0000-0002-7079-8914; Wang, Yuxuan/0000-0002-2932-6042; Tie, Jeanne/0000-0001-9244-2057; Lennon, Anne Marie/0000-0001-8957-3945; Danilova, Ludmila/0000-0003-2813-3094; Douville, Christopher/0000-0002-2510-4151	Lustgarten Foundation for Pancreatic Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; Conrad N. Hilton Foundation; Commonwealth Fund; John Templeton Foundation; Clinomics Program; Mayo Clinic Center for Individualized Medicine; Mayo Clinic Biobank; Sol Goldman Center for Pancreatic Cancer Research; Michael Rolfe Pancreatic Cancer Research Foundation; Benjamin Baker Scholarship; Gray Foundation; Marcus Foundation; Honorable Tina Brozman Foundation; Burroughs Wellcome Career Award for Medical Scientists; Doris Duke Charitable Foundation [2014107]; National Institutes of Health [P50-CA62924, P50-CA102701, CA06973, CA152753, GM-07309, U01CA200469, U01CA152753]; NATIONAL CANCER INSTITUTE [P50CA102701, U01CA200469, P30CA006973, F32CA069731, P50CA062924, U01CA152753] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007309, R01GM073095, T32GM008752] Funding Source: NIH RePORTER	Lustgarten Foundation for Pancreatic Cancer Research; Virginia and D. K. Ludwig Fund for Cancer Research; Conrad N. Hilton Foundation; Commonwealth Fund; John Templeton Foundation; Clinomics Program; Mayo Clinic Center for Individualized Medicine; Mayo Clinic Biobank; Sol Goldman Center for Pancreatic Cancer Research; Michael Rolfe Pancreatic Cancer Research Foundation; Benjamin Baker Scholarship; Gray Foundation; Marcus Foundation; Honorable Tina Brozman Foundation; Burroughs Wellcome Career Award for Medical Scientists(Burroughs Wellcome Fund); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank our patients for their courage and generosity. We are grateful to C. Blair and K. Judge for expert technical and administrative assistance. We thank H. Ren, J. Olson, M. Hathcok, H. Zeh, A. Singhi, S. Crippa, M. Ryan, and L. Ryan for their assistance with this study. This work was supported by the Lustgarten Foundation for Pancreatic Cancer Research; The Virginia and D. K. Ludwig Fund for Cancer Research; The Conrad N. Hilton Foundation; The Commonwealth Fund; The John Templeton Foundation; the Clinomics Program; Mayo Clinic Center for Individualized Medicine; the Mayo Clinic Biobank; The Sol Goldman Center for Pancreatic Cancer Research; The Michael Rolfe Pancreatic Cancer Research Foundation; The Benjamin Baker Scholarship; The Gray Foundation; S. Wojcicki and D. Troper; The Marcus Foundation; The Honorable Tina Brozman Foundation; The Burroughs Wellcome Career Award for Medical Scientists; The Doris Duke Charitable Foundation (2014107); and National Institutes of Health grants P50-CA62924, P50-CA102701, CA06973, CA152753, GM-07309, U01CA200469, and U01CA152753. N.P., S.Z., K.W.K., L.D., and B.V. are founders of Personal Genome Diagnostics and PapGene. B.V. and K.W.K are on the Scientific Advisory Board of SysmexInostics. B.V. is also on the Scientific Advisory Boards of Exelixis GP. R.H.H. is on the Board of Directors of MiDiagnostics. These companies and others have licensed technologies from Johns Hopkins, and N.P., K.W.K., L.D., B.V, and R.H.H. receive equity or royalties from these licenses. The terms of these arrangements are being managed by Johns Hopkins University in accordance with its conflict of interest policies. L.D. is on the Board of Directors of Jounce Therapeutics and is a Scientific Advisor for Genocea, Cell Design Labs, and Merck. A.S.M. is a consultant for Abbvie, Genentech, Bristol-Myers Squibb, and Trovagene. B.V., N.P., and K.W.K. are inventors on a patent (U.S. 20140227705 A1) held by Johns Hopkins University that covers basic aspects of the SafeSeqS technology used in this paper. B.V., K.W.K., N.P., J.D.C., C.T., and A.M.L. are inventors on a patent application to be submitted by Johns Hopkins University that covers other aspects of SafeSeqS as well as the multi-analyte approach described in this paper. All data needed to evaluate the conclusions in the paper are present in the paper and/or the supplementary materials. Contact C.T. for questions about the algorithms; A.M.L. for questions about clinically related issues; K.W.K about the sequencing analyses; B.V. about experimental procedures; and N.P. about the overall design of the study.	Abbosh C, 2017, NATURE, V545, P446, DOI 10.1038/nature22364; [Anonymous], 2010, TREATM TUB GUID; Bardelli A, 2017, CANCER CELL, V31, P172, DOI 10.1016/j.ccell.2017.01.002; Beddowes E, 2017, BREAST, V34, pS31, DOI 10.1016/j.breast.2017.06.024; Benson AB, 2017, J NATL COMPR CANC NE, V15, P370, DOI 10.6004/jnccn.2017.0036; Bettegowda C, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007094; Bozic I, 2013, ELIFE, V2, DOI 10.7554/eLife.00747; Cohen JD, 2017, P NATL ACAD SCI USA, V114, P10202, DOI 10.1073/pnas.1704961114; Cree IA, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3693-7; Dawson SJ, 2013, NEW ENGL J MED, V368, P1199, DOI 10.1056/NEJMoa1213261; Diehl F, 2005, P NATL ACAD SCI USA, V102, P16368, DOI 10.1073/pnas.0507904102; Forbes SA, 2017, NUCLEIC ACIDS RES, V45, pD777, DOI 10.1093/nar/gkw1121; Forshew T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003726; Haber DA, 2014, CANCER DISCOV, V4, P650, DOI 10.1158/2159-8290.CD-13-1014; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kinde I, 2011, P NATL ACAD SCI USA, V108, P9530, DOI 10.1073/pnas.1105422108; Liotta Lance A, 2003, Clin Adv Hematol Oncol, V1, P460; MOERTEL CG, 1995, ANN INTERN MED, V122, P321, DOI 10.7326/0003-4819-122-5-199503010-00001; Patz EF, 2007, J CLIN ONCOL, V25, P5578, DOI 10.1200/JCO.2007.13.5392; Phallen J, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aan2415; Pinsky PF, 2017, NEW ENGL J MED, V376, P1285, DOI 10.1056/NEJMsb1616281; Semrad TJ, 2015, ANN SURG ONCOL, V22, pS855, DOI 10.1245/s10434-015-4610-4; Siegel RL, 2017, CA-CANCER J CLIN, V67, P7, DOI 10.3322/caac.21387; Vogelstein B, 2015, NEW ENGL J MED, V373, P1895, DOI 10.1056/NEJMp1508811; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wang H, 2016, EXPERT REV PROTEOMIC, V13, P99, DOI 10.1586/14789450.2016.1122529; Wang YX, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8507; World Health Organization, 2016, CONS GUID US ANT DRU; Yachida S, 2012, CLIN CANCER RES, V18, P6339, DOI 10.1158/1078-0432.CCR-12-1215	30	1424	1478	44	501	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2018	359	6378					926	+		10.1126/science.aar3247	http://dx.doi.org/10.1126/science.aar3247			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX0QX	29348365	Green Accepted			2022-12-28	WOS:000425752600047
J	Charo, RA; Sipp, D				Charo, R. Alta; Sipp, Douglas			Rejuvenating Regenerative Medicine Regulation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Charo, R. Alta] Univ Wisconsin, Law Sch, Madison, WI 53706 USA; [Sipp, Douglas] RIKEN, Ctr Dev Biol, Kobe, Hyogo, Japan; [Sipp, Douglas] Keio Univ, Sch Med, Keio Global Res Inst, Tokyo, Japan; [Sipp, Douglas] RIKEN, Ctr Adv Intelligence Project, Tokyo, Japan	University of Wisconsin System; University of Wisconsin Madison; RIKEN; Keio University; RIKEN	Charo, RA (corresponding author), Univ Wisconsin, Law Sch, Madison, WI 53706 USA.		Sipp, Douglas/C-9218-2017	Sipp, Douglas/0000-0002-5979-0938; Charo, Robin Alta/0000-0003-3710-1043				Institute of Medicine National Research Council, 2014, STEM CELL THER OPP E; Turner L, 2016, CELL STEM CELL, V19, P154, DOI 10.1016/j.stem.2016.06.007	2	21	23	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2018	378	6					504	505		10.1056/NEJMp1715736	http://dx.doi.org/10.1056/NEJMp1715736			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV1OX	29320637				2022-12-28	WOS:000424335200005
J	Kauffman, KM; Hussain, FA; Yang, J; Arevalo, P; Brown, JM; Chang, WK; VanInsberghe, D; Elsherbini, J; Sharma, RS; Cutler, MB; Kelly, L; Polz, MF				Kauffman, Kathryn M.; Hussain, Fatima A.; Yang, Joy; Arevalo, Philip; Brown, Julia M.; Chang, William K.; VanInsberghe, David; Elsherbini, Joseph; Sharma, Radhey S.; Cutler, Michael B.; Kelly, Libusha; Polz, Martin F.			A major lineage of non-tailed dsDNA viruses as unrecognized killers of marine bacteria	NATURE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; SINGLE-STRANDED-DNA; TOOL; WEB; ORIGINS; GENOMES; VISUALIZATION; PURIFICATION; PERFORMANCE; PREDICTION	The most abundant viruses on Earth are thought to be double-stranded DNA (dsDNA) viruses that infect bacteria(1). However, tailed bacterial dsDNA viruses (Caudovirales), which dominate sequence and culture collections, are not representative of the environmental diversity of viruses(2,3). In fact, non-tailed viruses often dominate ocean samples numerically4, raising the fundamental question of the nature of these viruses. Here we characterize a group of marine dsDNA non-tailed viruses with short 10-kb genomes isolated during a study that quantified the diversity of viruses infecting Vibrionaceae bacteria. These viruses, which we propose to name the Autolykiviridae, represent a novel family within the ancient lineage of double jelly roll (DJR) capsid viruses. Ecologically, members of the Autolykiviridae have a broad host range, killing on average 34 hosts in four Vibrio species, in contrast to tailed viruses which kill on average only two hosts in one species. Biochemical and physical characterization of autolykiviruses reveals multiple virion features that cause systematic loss of DJR viruses in sequencing and culture-based studies, and we describe simple procedural adjustments to recover them. We identify DJR viruses in the genomes of diverse major bacterial and archaeal phyla, and in marine water column and sediment metagenomes, and find that their diversity greatly exceeds the diversity that is currently captured by the three recognized families of such viruses. Overall, these data suggest that viruses of the non-tailed dsDNA DJR lineage are important but often overlooked predators of bacteria and archaea that impose fundamentally different predation and gene transfer regimes on microbial systems than on tailed viruses, which form the basis of all environmental models of bacteria-virus interactions.				libusha.kelly@einstein.yu.edu; mpolz@mit.edu	Kauffman, Anne Kathryn/AAY-5689-2021; Polz, Martin/ABE-7199-2020; Kauffman, Kathryn/AAF-2946-2021	Yang, Joy/0000-0002-3385-9490; Arevalo, Philip/0000-0003-1237-2314; Polz, Martin/0000-0002-4975-2946; Kelly, Libusha/0000-0002-7303-1022; Kauffman, Kathryn/0000-0002-1997-947X; VanInsberghe, David/0000-0002-1933-8103	National Science Foundation [OCE 1435993]; NSF GRFP; WHOI Ocean Ventures Fund; Directorate For Geosciences [1435868] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM087237] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NSF GRFP(National Science Foundation (NSF)NSF - Office of the Director (OD)); WHOI Ocean Ventures Fund; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. King, P. Weigele, J. Daily and J. Chodera for comments and suggestions; T. Soni and members of the Polz laboratory for assistance with sampling; S. Labrie for guidance in viral genome extractions and sequencing library preparation, and C. Haase-Pettingell for assistance with density gradients; N. Watson for electron microscopy; and R. Ratzlaff for discussions and the suggestion of electron microscopy of virus plaques in agar overlay. This work was supported by grants from the National Science Foundation OCE 1435993 to M.F.P. and L.K., the NSF GRFP to F.A.H. and the WHOI Ocean Ventures Fund to K.M.	Adriaenssens EM, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040070; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Anantharaman K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13219; Anantharaman K, 2016, PEERJ, V4, DOI 10.7717/peerj.1607; Andrews-Pfannkoch C, 2010, APPL ENVIRON MICROB, V76, P5039, DOI 10.1128/AEM.00204-10; Bateman A, 2017, NUCLEIC ACIDS RES, V45, pD158, DOI 10.1093/nar/gkw1099; Bates D. M., 2010, LME4 MIXED EFFECTS M; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Baym M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128036; Benson DA, 2014, NUCLEIC ACIDS RES, V42, pD32, DOI [10.1093/nar/gkp1024, 10.1093/nar/gkt1030, 10.1093/nar/gks1195, 10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Benson SD, 2004, MOL CELL, V16, P673, DOI 10.1016/j.molcel.2004.11.016; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Biller SJ, 2014, SCIENCE, V343, P183, DOI 10.1126/science.1243457; Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207; Brum JR, 2015, SCIENCE, V348, DOI 10.1126/science.1261498; Brum JR, 2015, NAT REV MICROBIOL, V13, P147, DOI 10.1038/nrmicro3404; Brum JR, 2013, ISME J, V7, P1738, DOI 10.1038/ismej.2013.67; Capella-Gutierrez S, 2009, BIOINFORMATICS, V25, P1972, DOI 10.1093/bioinformatics/btp348; Castro-Mejia JL, 2015, MICROBIOME, V3, DOI 10.1186/s40168-015-0131-4; Clark K, 2016, NUCLEIC ACIDS RES, V44, pD67, DOI 10.1093/nar/gkv1276; Clerissi C, 2014, APPL ENVIRON MICROB, V80, P3150, DOI 10.1128/AEM.00123-14; Csardi G., 2006, INTERJOURNALCOMPLEX, V1695, P1, DOI DOI 10.3724/SP.J.1087.2009.02191; D'Herelle F, 1929, Yale J Biol Med, V1, P195; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; ESPEJO RT, 1968, VIROLOGY, V34, P738, DOI 10.1016/0042-6822(68)90094-9; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Finn RD, 2015, NUCLEIC ACIDS RES, V43, pW30, DOI 10.1093/nar/gkv397; Ghai R, 2010, ISME J, V4, P1154, DOI 10.1038/ismej.2010.44; Grazziotin AL, 2017, NUCLEIC ACIDS RES, V45, pD491, DOI 10.1093/nar/gkw975; Guidi L, 2016, NATURE, V532, P465, DOI 10.1038/nature16942; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Guy L, 2010, BIOINFORMATICS, V26, P2334, DOI 10.1093/bioinformatics/btq413; Hehemann JH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12860; Henn MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009083; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Huerta-Cepas J, 2017, MOL BIOL EVOL, V34, P2115, DOI 10.1093/molbev/msx148; Huerta-Cepas J, 2016, MOL BIOL EVOL, V33, P1635, DOI 10.1093/molbev/msw046; Huerta-Cepas J, 2016, NUCLEIC ACIDS RES, V44, pD286, DOI 10.1093/nar/gkv1248; Hunt DE, 2008, SCIENCE, V320, P1081, DOI 10.1126/science.1157890; Hurwitz BL, 2013, ENVIRON MICROBIOL, V15, P1428, DOI 10.1111/j.1462-2920.2012.02836.x; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; International Committee on Taxonomy of Viruses, 2016, ICTV MAST SPEC LIST; Iranzo J, 2016, MBIO, V7, DOI 10.1128/mBio.00978-16; John SG, 2011, ENV MICROBIOL REP, V3, P195, DOI 10.1111/j.1758-2229.2010.00208.x; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Kivela HM, 1999, VIROLOGY, V262, P364, DOI 10.1006/viro.1999.9838; Koonin EV, 2015, VIROLOGY, V479, P2, DOI 10.1016/j.virol.2015.02.039; Krishnamurthy SR, 2017, VIRUS RES, V239, P136, DOI 10.1016/j.virusres.2017.02.002; Krupovic M, 2008, NAT REV MICROBIOL, V6, P941, DOI 10.1038/nrmicro2033; Krupovic M, 2008, VIROLOGY, V375, P292, DOI 10.1016/j.virol.2008.01.043; Krupovic M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-236; Krupovic M, 2017, P NATL ACAD SCI USA, V114, pE2401, DOI 10.1073/pnas.1621061114; Krupovic M, 2011, MICROBIOL MOL BIOL R, V75, P610, DOI 10.1128/MMBR.00011-11; Labonte JM, 2013, ISME J, V7, P2169, DOI 10.1038/ismej.2013.110; Lawrence J., 2010, MANUAL AQUATIC VIRAL, P166, DOI DOI 10.4319/MAVE.2010.978-0-9845591-0-7.166; Lefort V, 2017, MOL BIOL EVOL, V34, P2422, DOI 10.1093/molbev/msx149; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Li WZ, 2015, NUCLEIC ACIDS RES, V43, pW580, DOI 10.1093/nar/gkv279; Marchler-Bauer A, 2017, NUCLEIC ACIDS RES, V45, pD200, DOI 10.1093/nar/gkw1129; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Mizuno CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003987; Peralta B, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001667; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pietila MK, 2013, P NATL ACAD SCI USA, V110, P10604, DOI 10.1073/pnas.1303047110; R Development Core Team, 2009, R LANG ENV STAT COMP; Rasband W.S., 1997, IMAGEJ; Roux S, 2016, PEERJ, V4, DOI 10.7717/peerj.2777; Saren AM, 2005, J MOL BIOL, V350, P427, DOI 10.1016/j.jmb.2005.04.059; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; SILBERT JA, 1969, VIROLOGY, V39, P666, DOI 10.1016/0042-6822(69)90005-1; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Steward GF, 2013, ISME J, V7, P672, DOI 10.1038/ismej.2012.121; Sun L, 2014, NATURE, V505, P432, DOI 10.1038/nature12816; Sunagawa S, 2015, SCIENCE, V348, DOI 10.1126/science.1261359; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Vega Yon G., 2015, RGEXF BUILD IMPORT E; Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; WOMMACK KE, 1992, APPL ENVIRON MICROB, V58, P2965, DOI 10.1128/AEM.58.9.2965-2970.1992; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Xue H, 2015, MBIO, V6, DOI 10.1128/mBio.00552-15; Zaremba-Niedzwiedzka K, 2017, NATURE, V541, P353, DOI 10.1038/nature21031	91	96	98	3	98	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 1	2018	554	7690					118	+		10.1038/nature25474	http://dx.doi.org/10.1038/nature25474			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7QX	29364876				2022-12-28	WOS:000424048900042
J	Mann, A				Mann, Adam			SPACE Heavy-lift rocket poised to boost space science	SCIENCE			English	News Item																			0	2	2	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					376	377		10.1126/science.359.6374.376	http://dx.doi.org/10.1126/science.359.6374.376			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6SD	29371446				2022-12-28	WOS:000423283200018
J	Stringer, C; Galway-Witham, J				Stringer, Chris; Galway-Witham, Julia			When did modern humans leave Africa?	SCIENCE			English	Editorial Material							ISRAEL		[Stringer, Chris; Galway-Witham, Julia] Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England	Natural History Museum London	Stringer, C (corresponding author), Nat Hist Museum, Dept Earth Sci, London SW7 5BD, England.	c.stringer@nhm.ac.uk; j.galway-witham@nhm.ac.uk			Calleva Foundation; Human Origins Research Fund	Calleva Foundation; Human Origins Research Fund	Authors are supported by the Calleva Foundation and the Human Origins Research Fund.	Breeze PS, 2016, QUATERNARY SCI REV, V144, P155, DOI 10.1016/j.quascirev.2016.05.012; Freidline SE, 2012, J HUM EVOL, V62, P225, DOI 10.1016/j.jhevol.2011.11.005; Hershkovitz I, 2018, SCIENCE, V359, P456, DOI 10.1126/science.aap8369; Hershkovitz I, 2011, AM J PHYS ANTHROPOL, V144, P575, DOI 10.1002/ajpa.21446; Martinon-Torres M, 2017, CURR ANTHROPOL, V58, pS434, DOI 10.1086/694449; Mercier N, 2003, J HUM EVOL, V45, P401, DOI 10.1016/j.jhevol.2003.09.004; Nielsen R, 2017, NATURE, V541, P302, DOI 10.1038/nature21347; Posth C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16046; Shea J. J., 2007, RETHINKING HUMAN REV; Stringer C, 2017, NATURE, V546, P212, DOI 10.1038/546212a	10	10	11	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					389	390		10.1126/science.aas8954	http://dx.doi.org/10.1126/science.aas8954			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT6SD	29371454	Green Submitted			2022-12-28	WOS:000423283200026
J	Kuehn, BM				Kuehn, Bridget M.			Tick Bite Linked to Red Meat Allergy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	4	4	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					332	332		10.1001/jama.2017.20802	http://dx.doi.org/10.1001/jama.2017.20802			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362779				2022-12-28	WOS:000423405300004
J	Cox, PM; Huntingford, C; Williamson, MS				Cox, Peter M.; Huntingford, Chris; Williamson, Mark S.			Emergent constraint on equilibrium climate sensitivity from global temperature variability	NATURE			English	Article							ENERGY BUDGET CONSTRAINTS	Equilibrium climate sensitivity (ECS) remains one of the most important unknowns in climate change science. ECS is defined as the global mean warming that would occur if the atmospheric carbon dioxide (CO2) concentration were instantly doubled and the climate were then brought to equilibrium with that new level of CO2. Despite its rather idealized definition, ECS has continuing relevance for international climate change agreements, which are often framed in terms of stabilization of global warming relative to the pre-industrial climate. However, the 'likely' range of ECS as stated by the Intergovernmental Panel on Climate Change (IPCC) has remained at 1.5-4.5 degrees Celsius for more than 25 years(1). The possibility of a value of ECS towards the upper end of this range reduces the feasibility of avoiding 2 degrees Celsius of global warming, as required by the Paris Agreement. Here we present a new emergent constraint on ECS that yields a central estimate of 2.8 degrees Celsius with 66 per cent confidence limits (equivalent to the IPCC 'likely' range) of 2.2-3.4 degrees Celsius. Our approach is to focus on the variability of temperature about long-term historical warming, rather than on the warming trend itself. We use an ensemble of climate models to define an emergent relationship(2) between ECS and a theoretically informed metric of global temperature variability. This metric of variability can also be calculated from observational records of global warming(3), which enables tighter constraints to be placed on ECS, reducing the probability of ECS being less than 1.5 degrees Celsius to less than 3 per cent, and the probability of ECS exceeding 4.5 degrees Celsius to less than 1 per cent.	[Cox, Peter M.; Williamson, Mark S.] Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England; [Huntingford, Chris] Ctr Ecol & Hydrol, Wallingford OX10 8BB, Oxon, England	University of Exeter; UK Centre for Ecology & Hydrology (UKCEH)	Cox, PM (corresponding author), Univ Exeter, Coll Engn Math & Phys Sci, Exeter EX4 4QF, Devon, England.	p.m.cox@exeter.ac.uk	Huntingford, Christopher/A-4307-2008; Cox, Peter Michae;/B-3299-2012	Huntingford, Christopher/0000-0002-5941-7770; Cox, Peter Michae;/0000-0002-0679-2219	European Research Council (ERC) ECCLES project [742472]; EU Horizon 2020 Research Programme CRESCENDO project [641816]; EPSRC; NERC CEH National Capability fund; NERC [ceh020013, NE/F005997/1, NE/I006702/1, NE/H000224/1, ceh020006] Funding Source: UKRI; Natural Environment Research Council [NE/H000224/1, NE/I006702/1, ceh020006, NE/F005997/1, ceh020013] Funding Source: researchfish	European Research Council (ERC) ECCLES project(European Research Council (ERC)); EU Horizon 2020 Research Programme CRESCENDO project; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC CEH National Capability fund; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was supported by the European Research Council (ERC) ECCLES project, grant agreement number 742472 (P.M.C.); the EU Horizon 2020 Research Programme CRESCENDO project, grant agreement number 641816 (P.M.C. and M.S.W.); the EPSRC-funded ReCoVER project (M.S.W.); and the NERC CEH National Capability fund (C.H.). We also acknowledge the World Climate Research Programme's Working Group on Coupled Modelling, which is responsible for CMIP, and we thank the climate modelling groups (listed in Extended Data Table 1 of this paper) for producing and making available their model output.	Andrews T, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL051607; Annan JD, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025259; Armour KC, 2017, NAT CLIM CHANGE, V7, P331, DOI [10.1038/nclimate3278, 10.1038/NCLIMATE3278]; Caldeira K, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/3/034039; Cowtan K, 2014, Q J ROY METEOR SOC, V140, P1935, DOI 10.1002/qj.2297; Cox PM, 2013, NATURE, V494, P341, DOI 10.1038/nature11882; Flato G., 2013, CLIMATE CHANGE 2013, P741; Forster P. M., 2013, J GEOPHYS RES ATMOS, V118; Forster PM, 2016, ANNU REV EARTH PL SC, V44, P85, DOI 10.1146/annurev-earth-060614-105156; Geoffroy O, 2013, J CLIMATE, V26, P1841, DOI 10.1175/JCLI-D-12-00195.1; Gregory JM, 2016, GEOPHYS RES LETT, V43, P3911, DOI 10.1002/2016GL068406; Gregory JM, 2002, J CLIMATE, V15, P3117, DOI [10.1175/1520-0442(2002)015<3117:AOBEOT>2.0.CO;2, 10.1175/1520-0442(2002)015&lt;3117:AOBEOT&gt;2.0.CO;2]; Hall A, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025127; HASSELMANN K, 1976, TELLUS, V28, P473, DOI 10.1111/j.2153-3490.1976.tb00696.x; Kiehl JT, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031383; Knutti R, 2017, NAT GEOSCI, V10, P727, DOI 10.1038/NGEO3017; LEITH CE, 1975, J ATMOS SCI, V32, P2022, DOI 10.1175/1520-0469(1975)032<2022:CRAFD>2.0.CO;2; Lenton TM, 2008, P NATL ACAD SCI USA, V105, P1786, DOI 10.1073/pnas.0705414105; Lewis N, 2015, CLIM DYNAM, V45, P1009, DOI 10.1007/s00382-014-2342-y; MacMynowski DG, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL048623; Marvel K, 2016, NAT CLIM CHANGE, V6, P386, DOI [10.1038/NCLIMATE2888, 10.1038/nclimate2888]; Morice CP, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD017187; Otto A, 2013, NAT GEOSCI, V6, P415, DOI 10.1038/ngeo1836; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Sherwood SC, 2014, NATURE, V505, P37, DOI 10.1038/nature12829; Taylor KE, 2012, B AM METEOROL SOC, V93, P485, DOI 10.1175/BAMS-D-11-00094.1; Tignor M., 2013, CLIMATE CHANGE 2013; Wenzel S, 2016, NATURE, V538, P499, DOI 10.1038/nature19772	28	154	160	15	206	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2018	553	7688					319	+		10.1038/nature25450	http://dx.doi.org/10.1038/nature25450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT9MB	29345639	Green Accepted, Green Submitted			2022-12-28	WOS:000423475100047
J	Margolis, DM; Garcia, JV				Margolis, David M.; Garcia, J. Victor			Countering HIV - Three's the Charm?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ANTIBODY	Two proof-of-principle studies using a hybrid simian model of HIV infection showed that broadly neutralizing monoclonal antibodies can prevent infection.	[Margolis, David M.; Garcia, J. Victor] Univ North Carolina Chapel Hill, Univ North Carolina UNC HIV Cure Ctr, UNC Ctr AIDS Res, Chapel Hill, NC 27599 USA; [Margolis, David M.; Garcia, J. Victor] Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC 27599 USA; [Margolis, David M.; Garcia, J. Victor] Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Margolis, David M.] Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Margolis, DM (corresponding author), Univ North Carolina Chapel Hill, Univ North Carolina UNC HIV Cure Ctr, UNC Ctr AIDS Res, Chapel Hill, NC 27599 USA.; Margolis, DM (corresponding author), Univ North Carolina Chapel Hill, Dept Med, Chapel Hill, NC 27599 USA.; Margolis, DM (corresponding author), Univ North Carolina Chapel Hill, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA.; Margolis, DM (corresponding author), Univ North Carolina Chapel Hill, Dept Epidemiol, Chapel Hill, NC 27599 USA.		Margolis, David M./Y-2468-2019	Margolis, David M./0000-0001-5714-0002				Julg B, 2017, SCI TRANSL MED, V9; Kelsoe G, 2017, IMMUNOL REV, V275, P79, DOI 10.1111/imr.12508; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Margolis DM, 2017, J INFECT DIS, V215, pS111, DOI 10.1093/infdis/jiw618; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Xu L, 2017, SCIENCE, V358, P85, DOI 10.1126/science.aan8630	6	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2018	378	3					295	297		10.1056/NEJMcibr1712494	http://dx.doi.org/10.1056/NEJMcibr1712494			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT1IJ	29342376	Green Submitted			2022-12-28	WOS:000422888400016
J	Patel, T; Patel, V				Patel, Tejas; Patel, Vihas			Review: In adults, contrast-enhanced CT is not linked to acute kidney injury or mortality vs noncontrast CT	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Patel, Tejas] Icahn Sch Med Mt Sinai, New York, NY 10029 USA; [Patel, Vihas] Zucker Sch Med Hofstra Northwell, New Hyde Pk, NY USA	Icahn School of Medicine at Mount Sinai	Patel, T (corresponding author), Icahn Sch Med Mt Sinai, New York, NY 10029 USA.							[Anonymous], CONS GUID PREV CONTR; Eckardt KU, 2012, KIDNEY INT SUPPL, V2, P7, DOI 10.1038/kisup.2012.8; McCullough PA, 2016, J AM COLL CARDIOL, V68, P1465, DOI 10.1016/j.jacc.2016.05.099	3	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2018	168	2					JC10	JC10		10.7326/ACPJC-2018-168-2-010	http://dx.doi.org/10.7326/ACPJC-2018-168-2-010			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU8IN	29335722				2022-12-28	WOS:000424096600010
J	Kupferschmidt, K				Kupferschmidt, Kai			TAMING THE MONSTERS OF TOMORROW	SCIENCE			English	Editorial Material																			0	2	3	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					152	155		10.1126/science.359.6372.152	http://dx.doi.org/10.1126/science.359.6372.152			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS5EO	29326256				2022-12-28	WOS:000419816600019
J	Freeman, SA; Vega, A; Riedl, M; Collins, RF; Ostrowski, PP; Woods, EC; Bertozzi, CR; Tammi, MI; Lidke, DS; Johnson, P; Mayor, S; Jaqaman, K; Grinstein, S				Freeman, Spencer A.; Vega, Anthony; Riedl, Magdalena; Collins, Richard F.; Ostrowski, Phillip P.; Woods, Elliot C.; Bertozzi, Carolyn R.; Tammi, Markku I.; Lidke, Diane S.; Johnson, Pauline; Mayor, Satyajit; Jaqaman, Khuloud; Grinstein, Sergio			Transmembrane Pickets Connect Cyto- and Pericellular Skeletons Forming Barriers to Receptor Engagement	CELL			English	Article							FLUID-MOSAIC MODEL; PLASMA-MEMBRANE; HYALURONAN-BINDING; ANCHORED PROTEINS; CORTICAL ACTIN; ERM PROTEINS; DIFFUSION; PHAGOCYTOSIS; TRACKING; POLARIZATION	Phagocytic receptors must diffuse laterally to become activated upon clustering by multivalent targets. Receptor diffusion, however, can be obstructed by transmembrane proteins ("pickets'') that are immobilized by interacting with the cortical cytoskeleton. The molecular identity of these pickets and their role in phagocytosis have not been defined. We used single-molecule tracking to study the interaction between Fc gamma receptors and CD44, an abundant transmembrane protein capable of indirect association with F-actin, hence likely to serve as a picket. CD44 tethers reversibly to formin-induced actin filaments, curtailing receptor diffusion. Such linear filaments predominate in the trailing end of polarized macrophages, where receptor mobility was minimal. Conversely, receptors were most mobile at the leading edge, where Arp2/3-driven actin branching predominates. CD44 binds hyaluronan, anchoring a pericellular coat that also limits receptor displacement and obstructs access to phagocytic targets. Force must be applied to traverse the pericellular barrier, enabling receptors to engage their targets.	[Freeman, Spencer A.; Riedl, Magdalena; Collins, Richard F.; Ostrowski, Phillip P.; Grinstein, Sergio] Hosp Sick Children, Program Cell Biol, Peter Gilgan Ctr Res & Learning, Toronto, ON M5G 0A4, Canada; [Vega, Anthony; Jaqaman, Khuloud] Univ Texas Southwestern Med Ctr Dallas, Dept Biophys, Dallas, TX 75390 USA; [Woods, Elliot C.; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Woods, Elliot C.; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Mol Biol, Berkeley, CA 94720 USA; [Woods, Elliot C.; Bertozzi, Carolyn R.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Tammi, Markku I.] Univ Eastern Finland, Inst Biomed, Kuopio 70210, Finland; [Lidke, Diane S.] Univ New Mexico, Sch Med, Dept Pathol, Canc Res Facil, Albuquerque, NM 87131 USA; [Johnson, Pauline] Univ British Columbia, Dept Microbiol & Immunol, Vancouver, BC V6T 1Z3, Canada; [Mayor, Satyajit] Tata Inst Fundamental Res, Cellular Org & Signaling, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India; [Grinstein, Sergio] St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5C 1N8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of Eastern Finland; University of New Mexico; University of British Columbia; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto	Grinstein, S (corresponding author), Hosp Sick Children, Program Cell Biol, Peter Gilgan Ctr Res & Learning, Toronto, ON M5G 0A4, Canada.; Grinstein, S (corresponding author), St Michaels Hosp, Keenan Res Ctr, Li Ka Shing Knowledge Inst, Toronto, ON M5C 1N8, Canada.	sergio.grinstein@sickkids.ca	Johnson, Pauline/G-9659-2019; Tammi, Markku/AAQ-7878-2021	Johnson, Pauline/0000-0001-7367-4653; Vega, Anthony/0000-0002-4464-6482; Woods, Elliot/0000-0003-2920-8334; Jaqaman, Khuloud/0000-0003-3471-1911	CPRIT training grant [RP140110]; Banting fellowship of the Canadian Institutes of Health Research (CIHR); Human Frontiers Science Program [RGP0027/2012]; Sigrid Juselius Foundation; Cancer Center of Eastern Finland; NSERC; NIH/NIGMS [MIRA R35GM119619]; CPRIT recruitment award [R1216]; UTSW Endowed Scholars Program; CIHR [FDN-143202]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM085273, R35GM119619, R01GM059907] Funding Source: NIH RePORTER	CPRIT training grant; Banting fellowship of the Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Human Frontiers Science Program(Human Frontier Science Program); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Cancer Center of Eastern Finland; NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); CPRIT recruitment award; UTSW Endowed Scholars Program; CIHR(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. C. Valley for cloning of the HA-tagged transmembrane actin-binding proteins. S.A.F. is supported by a Banting fellowship of the Canadian Institutes of Health Research (CIHR). A.V. is supported by a CPRIT training grant RP140110. D.S.L. and S.M. were supported by the Human Frontiers Science Program (grant RGP0027/2012). M.L.T. is supported by the Sigrid Juselius Foundation, and the Cancer Center of Eastern Finland. P.J. was supported by NSERC. K.J. is supported by NIH/NIGMS MIRA R35GM119619, CPRIT recruitment award R1216, and by the UTSW Endowed Scholars Program. S.G. is supported by grant FDN-143202 from the CIHR.	ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Botelho RJ, 2000, J CELL BIOL, V151, P1353, DOI 10.1083/jcb.151.7.1353; Faure S, 2004, NAT IMMUNOL, V5, P272, DOI 10.1038/ni1039; Fehon RG, 2010, NAT REV MOL CELL BIO, V11, P276, DOI 10.1038/nrm2866; Ferrari R, 2001, PHYSICA D, V154, P111, DOI 10.1016/S0167-2789(01)00234-2; Freeman SA, 2016, CELL, V164, P128, DOI 10.1016/j.cell.2015.11.048; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Ghosh M, 2004, SCIENCE, V304, P743, DOI 10.1126/science.1094561; Gowrishankar K, 2012, CELL, V149, P1353, DOI 10.1016/j.cell.2012.05.008; Haggie PM, 2006, MOL BIOL CELL, V17, P4937, DOI 10.1091/mbc.E06-08-0670; Jaqaman K, 2011, CELL, V146, P593, DOI 10.1016/j.cell.2011.06.049; Kalay Z, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.022724; Kultti A, 2006, J BIOL CHEM, V281, P15821, DOI 10.1074/jbc.M512840200; Kusumi A, 1996, CURR OPIN CELL BIOL, V8, P566, DOI 10.1016/S0955-0674(96)80036-6; Kusumi A, 2012, ANNU REV CELL DEV BI, V28, P215, DOI 10.1146/annurev-cellbio-100809-151736; Lammermann T, 2008, NATURE, V453, P51, DOI 10.1038/nature06887; LAURENT TC, 1992, FASEB J, V6, P2397, DOI 10.1096/fasebj.6.7.1563592; Lee-Sayer SSM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00150; Lesley J, 2000, J BIOL CHEM, V275, P26967; Lomakin AJ, 2015, NAT CELL BIOL, V17, P1435, DOI 10.1038/ncb3246; Masters TA, 2013, P NATL ACAD SCI USA, V110, P11875, DOI 10.1073/pnas.1301766110; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Nakada C, 2003, NAT CELL BIOL, V5, P626, DOI 10.1038/ncb1009; Paszek MJ, 2014, NATURE, V511, P319, DOI 10.1038/nature13535; Pienimaki JP, 2001, J BIOL CHEM, V276, P20428, DOI 10.1074/jbc.M007601200; Rilla K, 2008, J HISTOCHEM CYTOCHEM, V56, P901, DOI 10.1369/jhc.2008.951665; Saha S, 2015, MOL BIOL CELL, V26, P4033, DOI 10.1091/mbc.E15-06-0397; Schwartz SL, 2015, ACS CHEM BIOL, V10, P539, DOI 10.1021/cb5005146; Segura I, 2004, J MICROBIOL METH, V56, P83, DOI 10.1016/j.mimet.2003.09.004; Serrador JM, 1998, BLOOD, V91, P4632, DOI 10.1182/blood.V91.12.4632.412k17_4632_4644; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; TAMMI R, 1994, PROG HISTOCHEM CYTOC, V29, P1; Trimble WS, 2015, J CELL BIOL, V208, P259, DOI 10.1083/jcb.201410071	34	98	98	1	31	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					305	+		10.1016/j.cell.2017.12.023	http://dx.doi.org/10.1016/j.cell.2017.12.023			23	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29328918	Green Accepted, Bronze			2022-12-28	WOS:000419840100027
J	Talarek, E; Marczynska, M				Talarek, Ewa; Marczynska, Magdalena			Cowpox Virus Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Talarek, Ewa; Marczynska, Magdalena] Med Univ Warsaw, Warsaw, Poland	Medical University of Warsaw	Talarek, E (corresponding author), Med Univ Warsaw, Warsaw, Poland.	ewa.talarek@wum.edu.pl	Talarek, Ewa/P-2278-2018; Marczynska, Magdalena/V-6904-2018	Talarek, Ewa/0000-0002-3466-0782; Marczynska, Magdalena/0000-0001-5731-6346					0	3	3	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 11	2018	378	2					181	181		10.1056/NEJMicm1702548	http://dx.doi.org/10.1056/NEJMicm1702548			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FS7IR	29320650				2022-12-28	WOS:000419971600011
J	Rubin, R				Rubin, Rita			High Cost of Investigating Measles Cases	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2018	319	2					114	114		10.1001/jama.2017.20423	http://dx.doi.org/10.1001/jama.2017.20423			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS4PR	29318286				2022-12-28	WOS:000419775500004
J	Lescroart, F; Wang, XN; Lin, XH; Swedlund, B; Gargouri, S; Sanchez-Danes, A; Moignard, V; Dubois, C; Paulissen, C; Kinston, S; Gottgens, B; Blanpain, C				Lescroart, Fabienne; Wang, Xiaonan; Lin, Xionghui; Swedlund, Benjamin; Gargouri, Souhir; Sanchez-Danes, Adriana; Moignard, Victoria; Dubois, Christine; Paulissen, Catherine; Kinston, Sarah; Gottgens, Berthold; Blanpain, Cedric			Defining the earliest step of cardiovascular lineage segregation by single-cell RNA-seq	SCIENCE			English	Article							PROGENITOR SPECIFICATION; HEART DEVELOPMENT; MAMMALIAN HEART; MESP1; DIFFERENTIATION; HETEROGENEITY; RESTRICTION; EXPRESSION; REGULATOR; REVEALS	Mouse heart development arises from Mesp1-expressing cardiovascular progenitors (CPs) that are specified during gastrulation. The molecular processes that control early regional and lineage segregation of CPs have been unclear. We performed single-cell RNA sequencing of wild-type and Mesp1-null CPs in mice. We showed that populations of Mesp1 CPs are molecularly distinct and span the continuum between epiblast and later mesodermal cells, including hematopoietic progenitors. Single-cell transcriptome analysis of Mesp1-deficient CPs showed that Mesp1 is required for the exit from the pluripotent state and the induction of the cardiovascular gene expression program. We identified distinct populations of Mesp1 CPs that correspond to progenitors committed to different cell lineages and regions of the heart, identifying the molecular features associated with early lineage restriction and regional segregation of the heart at the early stage of mouse gastrulation.	[Lescroart, Fabienne; Lin, Xionghui; Swedlund, Benjamin; Gargouri, Souhir; Sanchez-Danes, Adriana; Dubois, Christine; Paulissen, Catherine; Blanpain, Cedric] Univ Libre Bruxelles, Lab Stem Cells & Canc, B-1070 Brussels, Belgium; [Wang, Xiaonan; Moignard, Victoria; Kinston, Sarah; Gottgens, Berthold] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England; [Wang, Xiaonan; Moignard, Victoria; Kinston, Sarah; Gottgens, Berthold] Univ Cambridge, Wellcome & Med Res Council, Cambridge Stem Cell Inst, Cambridge, England; [Blanpain, Cedric] Univ Libre Bruxelles, WELBIO, B-1070 Brussels, Belgium	Universite Libre de Bruxelles; University of Cambridge; University of Cambridge; Universite Libre de Bruxelles; WELBIO	Blanpain, C (corresponding author), Univ Libre Bruxelles, Lab Stem Cells & Canc, B-1070 Brussels, Belgium.; Gottgens, B (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 0XY, England.; Gottgens, B (corresponding author), Univ Cambridge, Wellcome & Med Res Council, Cambridge Stem Cell Inst, Cambridge, England.; Blanpain, C (corresponding author), Univ Libre Bruxelles, WELBIO, B-1070 Brussels, Belgium.	bg200@cam.ac.uk; cedric.blanpain@ulb.ac.be	Blanpain, Cedric/ABD-8392-2021; lescroart, fabienne/AAE-4486-2022	Gottgens, Berthold/0000-0001-6302-5705; Lin, Xionghui/0000-0001-7488-1435; Swedlund, Benjamin/0000-0002-8264-9342; Wang, Xiaonan/0000-0003-3759-778X; Lescroart, Fabienne/0000-0003-4942-7921; Sanchez-Danes, Adriana/0000-0001-7895-9973	Fonds de la Recherche Scientifique (FNRS); European Molecular Biology Organization long-term fellowship; Leducq Fondation; Wellcome; Bloodwise; Cancer Research UK; National Institute of Diabetes and Digestive and Kidney Diseases; FNRS; Universite Libre de Bruxelles Foundation; European Research Council; Bettencourt Schueller Foundation; Leducq Fondation as part of the network "22q11.2 deletion syndrome: Novel approaches to understand cardiopharyngeal pathogenesis"; Cancer Research UK [21762] Funding Source: researchfish; Medical Research Council [MC_PC_12009, MR/M008975/1] Funding Source: researchfish; MRC [MR/M008975/1] Funding Source: UKRI; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK106766] Funding Source: NIH RePORTER	Fonds de la Recherche Scientifique (FNRS)(Fonds de la Recherche Scientifique - FNRS); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); Leducq Fondation; Wellcome; Bloodwise; Cancer Research UK(Cancer Research UK); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); FNRS(Fonds de la Recherche Scientifique - FNRS); Universite Libre de Bruxelles Foundation; European Research Council(European Research Council (ERC)European Commission); Bettencourt Schueller Foundation; Leducq Fondation as part of the network "22q11.2 deletion syndrome: Novel approaches to understand cardiopharyngeal pathogenesis"; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the Light Microscopy Facility for help with confocal imaging and F. Hamey for help with SPRING analysis. F.L. has been supported by the Fonds de la Recherche Scientifique (FNRS), the European Molecular Biology Organization long-term fellowship, and the Leducq Fondation. Work in the Gottgens laboratory is supported by grants from the Wellcome, Bloodwise, Cancer Research UK, National Institute of Diabetes and Digestive and Kidney Diseases, and core support grants by the Wellcome to the Wellcome-Medical Research Council Cambridge Stem Cell Institute. C.B. is an investigator of WELBIO. Work in C.B.'s laboratory was supported by the FNRS, the Universite Libre de Bruxelles Foundation, the European Research Council, the Bettencourt Schueller Foundation (C.B. and F.L.), and the Leducq Fondation as part of the network "22q11.2 deletion syndrome: Novel approaches to understand cardiopharyngeal pathogenesis."	Barnes RM, 2010, DEV DYNAM, V239, P3086, DOI 10.1002/dvdy.22428; Behrens T, 2016, BMC CANCER, V16, DOI 10.1186/s12885-016-2432-9; Bertrand N, 2011, DEV BIOL, V353, P266, DOI 10.1016/j.ydbio.2011.02.029; Bondue A, 2008, CELL STEM CELL, V3, P69, DOI 10.1016/j.stem.2008.06.009; Bondue A, 2011, J CELL BIOL, V192, P751, DOI 10.1083/jcb.201007063; Bondue A, 2010, CIRC RES, V107, P1414, DOI 10.1161/CIRCRESAHA.110.227058; Buckingham M, 2005, NAT REV GENET, V6, P826, DOI 10.1038/nrg1710; Chan SSK, 2016, BIOCHEM BIOPH RES CO, V474, P469, DOI 10.1016/j.bbrc.2016.04.139; DeLaughter DM, 2016, DEV CELL, V39, P480, DOI 10.1016/j.devcel.2016.10.001; Devine WP, 2014, ELIFE, V3, DOI 10.7554/eLife.03848; Fre S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025785; Harel I, 2012, P NATL ACAD SCI USA, V109, P18839, DOI 10.1073/pnas.1208690109; Harel I, 2009, DEV CELL, V16, P822, DOI 10.1016/j.devcel.2009.05.007; Huynh T, 2007, GENESIS, V45, P470, DOI 10.1002/dvg.20317; Kattman SJ, 2011, CELL STEM CELL, V8, P228, DOI 10.1016/j.stem.2010.12.008; Kume T, 2001, GENE DEV, V15, P2470, DOI 10.1101/gad.907301; Lescroart F, 2014, NAT CELL BIOL, V16, P829, DOI 10.1038/ncb3024; Lindsley RC, 2008, CELL STEM CELL, V3, P55, DOI 10.1016/j.stem.2008.04.004; MacGrogan D, 2010, CURR TOP DEV BIOL, V92, P333, DOI 10.1016/S0070-2153(10)92011-5; Martello G, 2014, ANNU REV CELL DEV BI, V30, P647, DOI 10.1146/annurev-cellbio-100913-013116; Martin-Puig S, 2008, CELL STEM CELL, V2, P320, DOI 10.1016/j.stem.2008.03.010; Palencia-Desai S, 2011, DEVELOPMENT, V138, P4721, DOI 10.1242/dev.064998; Saga Y, 1999, DEVELOPMENT, V126, P3437; Schultheiss TM, 1997, GENE DEV, V11, P451, DOI 10.1101/gad.11.4.451; Scialdone A, 2016, NATURE, V535, P289, DOI 10.1038/nature18633; Weinreb C, 2018, BIOINFORMATICS, V34, P1246, DOI 10.1093/bioinformatics/btx792	26	130	133	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380					1177	1181		10.1126/science.aao4174	http://dx.doi.org/10.1126/science.aao4174			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ3RU	29371425	Green Accepted, Green Submitted			2022-12-28	WOS:000435215200001
J	Carey, RM; Whelton, PK				Carey, Robert M.; Whelton, Paul K.			The 2017 American College of Cardiology/American Heart Association Hypertension Guideline: A Resource for Practicing Clinicians	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							BLOOD-PRESSURE; GLOBAL BURDEN		[Carey, Robert M.] Univ Virginia Hlth Syst, POB 801414, Charlottesville, VA 22908 USA; [Whelton, Paul K.] Tulane Univ, Sch Publ Hlth & Trop Med, New Orleans, LA USA; Tulane Univ, Sch Med, 1430 Tulane Ave, New Orleans, LA 70112 USA; [Whelton, Paul K.] Tulane Sch Med, 1440 Canal St, New Orleans, LA 70112 USA	University of Virginia; Tulane University; Tulane University; Tulane University	Carey, RM (corresponding author), Univ Virginia Hlth Syst, POB 801414, Charlottesville, VA 22908 USA.							Carey RM, 2018, ANN INTERN MED, V168, P351, DOI 10.7326/M17-3203; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; Greenland P, 2018, JAMA-J AM MED ASSOC, V319, P117, DOI 10.1001/jama.2017.19675; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Muntner P, 2018, CIRCULATION, V137, P109, DOI 10.1161/CIRCULATIONAHA.117.032582; Whelton Paul K, 2018, Hypertension, V71, pe13, DOI [10.1016/j.jash.2018.06.010, 10.1161/HYP.0000000000000065]; Whelton PK, 2017, HYPERTENSION, DOI 10.1016/j.jacc.2017.11.006	8	19	20	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2018	168	5					359	+		10.7326/M18-0025	http://dx.doi.org/10.7326/M18-0025			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY2GD	29357396				2022-12-28	WOS:000426632600009
J	Doron, S; Melamed, S; Ofir, G; Leavitt, A; Lopatina, A; Keren, M; Amitai, G; Sorek, R				Doron, Shany; Melamed, Sarah; Ofir, Gal; Leavitt, Azita; Lopatina, Anna; Keren, Mai; Amitai, Gil; Sorek, Rotem			Systematic discovery of antiphage defense systems in the microbial pangenome	SCIENCE			English	Article							ESCHERICHIA-COLI; PHAGE INFECTIONS; PROTEIN FAMILIES; DNA; BACTERIA; GENOMES; RESTRICTION; RESISTANCE; PREDICTION; EVOLUTION	The arms race between bacteria and phages led to the development of sophisticated antiphage defense systems, including CRISPR-Cas and restriction-modification systems. Evidence suggests that known and unknown defense systems are located in "defense islands" in microbial genomes. Here, we comprehensively characterized the bacterial defensive arsenal by examining gene families that are clustered next to known defense genes in prokaryotic genomes. Candidate defense systems were systematically engineered and validated in model bacteria for their antiphage activities. We report nine previously unknown antiphage systems and one antiplasmid system that are widespread in microbes and strongly protect against foreign invaders. These include systems that adopted components of the bacterial flagella and condensin complexes. Our data also suggest a common, ancient ancestry of innate immunity components shared between animals, plants, and bacteria.				rotem.sorek@weizmann.ac.il		Doron, Shany/0000-0002-8392-6110; Melamed, Sarah/0000-0002-0604-3605; Ofir, Gal/0000-0002-8307-9388; Lopatina, Anna/0000-0002-3484-6819	Israel Science Foundation [1360/16]; Israel Science Foundation (I-CORE grant) [1796/12]; European Research Council (ERC) [ERC-CoG 681203]; Abisch-Frenkel Foundation; David and Fela Shapell Family Foundation; Benoziyo Advancement of Science grant; Minerva Foundation; Pasteur-Weizmann Council	Israel Science Foundation(Israel Science Foundation); Israel Science Foundation (I-CORE grant); European Research Council (ERC)(European Research Council (ERC)); Abisch-Frenkel Foundation; David and Fela Shapell Family Foundation; Benoziyo Advancement of Science grant; Minerva Foundation; Pasteur-Weizmann Council	We thank H. Sberro, O. Zuqert, O. Cohen, S. Mintzer, R. Shenhav, Z. Erez, D. Dar, M. Voichek, and N. Tal for useful discussion during the course of this study. We also thank M. Voichek for assistance with RNA-seq and S. Silverman for help with phage isolation. R. S. was supported, in part, by the Israel Science Foundation (personal grant 1360/16 and I-CORE grant 1796/12), the European Research Council (ERC) (grant ERC-CoG 681203), the Abisch-Frenkel Foundation, the David and Fela Shapell Family Foundation, the Benoziyo Advancement of Science grant, the Minerva Foundation, and the Pasteur-Weizmann Council. Assembled phage genomes and raw reads were deposited in the European Nucleotide Archive (ENA) under study accession PRJEB23070.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Alva V, 2016, NUCLEIC ACIDS RES, V44, pW410, DOI 10.1093/nar/gkw348; Anantharaman V, 2012, MOL BIOSYST, V8, P3142, DOI 10.1039/c2mb25239b; Baker AE, 2017, J BACTERIOL, V199, DOI 10.1128/JB.00088-17; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Baym M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128036; BLAIR DF, 1990, CELL, V60, P439, DOI 10.1016/0092-8674(90)90595-6; Burch-Smith TM, 2007, PLOS BIOL, V5, P501, DOI 10.1371/journal.pbio.0050068; Burroughs AM, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv1267; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Caplan JL, 2008, CELL, V132, P449, DOI 10.1016/j.cell.2007.12.031; Chen I, 2005, SCIENCE, V310, P1456, DOI 10.1126/science.1114021; Couillault C, 2004, NAT IMMUNOL, V5, P488, DOI 10.1038/ni1060; Cui HT, 2015, ANNU REV PLANT BIOL, V66, P487, DOI 10.1146/annurev-arplant-050213-040012; Danilova O, 2007, MOL MICROBIOL, V65, P1485, DOI 10.1111/j.1365-2958.2007.05881.x; Dar D, 2016, SCIENCE, V352, DOI 10.1126/science.aad9822; Depardieu F, 2016, CELL HOST MICROBE, V20, P471, DOI 10.1016/j.chom.2016.08.010; Dy RL, 2014, ANNU REV VIROL, V1, P307, DOI 10.1146/annurev-virology-031413-085500; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Essuman K, 2017, NEURON, V93, P1334, DOI 10.1016/j.neuron.2017.02.022; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fliegert R, 2007, BIOCHEM SOC T, V35, P109, DOI 10.1042/BST0350109; Fortier Louis-Charles, 2009, V501, P203, DOI 10.1007/978-1-60327-164-6_19; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Goldfarb T, 2015, EMBO J, V34, P169, DOI 10.15252/embj.201489455; Gonzalez-Garcia VA, 2015, J BIOL CHEM, V290, P10038, DOI 10.1074/jbc.M114.614222; Haering CH, 2016, CELL, V164, P326, DOI 10.1016/j.cell.2015.12.026; Hirano T, 2005, PHILOS T R SOC B, V360, P507, DOI 10.1098/rstb.2004.1606; Hosking ER, 2006, J MOL BIOL, V364, P921, DOI 10.1016/j.jmb.2006.09.035; Hoskisson PA, 2007, CURR OPIN MICROBIOL, V10, P396, DOI 10.1016/j.mib.2007.04.003; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Koonin EV, 2017, ANNU REV MICROBIOL, V71, P233, DOI 10.1146/annurev-micro-090816-093830; Kropinski Andrew M., 2009, V501, P69, DOI 10.1007/978-1-60327-164-6_7; Krupovic M, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-36; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Li L, 2003, GENOME RES, V13, P2178, DOI 10.1101/gr.1224503; Makarova KS, 2015, NAT REV MICROBIOL, V13, P722, DOI 10.1038/nrmicro3569; Makarova KS, 2013, NUCLEIC ACIDS RES, V41, P4360, DOI 10.1093/nar/gkt157; Makarova KS, 2011, J BACTERIOL, V193, P6039, DOI 10.1128/JB.05535-11; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-29; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Markowitz VM, 2012, NUCLEIC ACIDS RES, V40, pD115, DOI 10.1093/nar/gkr1044; Mazzocco Amanda, 2009, V501, P81, DOI 10.1007/978-1-60327-164-6_9; MOLINEUX IJ, 1991, NEW BIOL, V3, P230; Murray NE, 2000, MICROBIOL MOL BIOL R, V64, P412, DOI 10.1128/MMBR.64.2.412-434.2000; Nimma S, 2017, CURR OPIN STRUC BIOL, V43, P122, DOI 10.1016/j.sbi.2016.12.014; Ofir G, 2018, NAT MICROBIOL, V3, DOI 10.1038/s41564-017-0051-0; Oliveira PH, 2014, NUCLEIC ACIDS RES, V42, P10618, DOI 10.1093/nar/gku734; Pancer Z, 2006, ANNU REV IMMUNOL, V24, P497, DOI 10.1146/annurev.immunol.24.021605.090542; Petrushenko ZM, 2011, MOL MICROBIOL, V81, P881, DOI 10.1111/j.1365-2958.2011.07763.x; Radeck J, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-29; SING WD, 1990, J GEN MICROBIOL, V136, P1807, DOI 10.1099/00221287-136-9-1807; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Stern A, 2011, BIOESSAYS, V33, P43, DOI 10.1002/bies.201000071; Stern A, 2010, TRENDS GENET, V26, P335, DOI 10.1016/j.tig.2010.05.008; Swarts DC, 2014, NAT STRUCT MOL BIOL, V21, P743, DOI 10.1038/nsmb.2879; Swarts DC, 2014, NATURE, V507, P258, DOI 10.1038/nature12971; Thiaville JJ, 2016, P NATL ACAD SCI USA, V113, pE1452, DOI 10.1073/pnas.1518570113; Titok MA, 2003, PLASMID, V49, P53, DOI 10.1016/S0147-619X(02)00109-9; Tock MR, 2005, CURR OPIN MICROBIOL, V8, P466, DOI 10.1016/j.mib.2005.06.003; van Dongen S, 2012, METHODS MOL BIOL, V804, P281, DOI 10.1007/978-1-61779-361-5_15; WILSON GA, 1968, J BACTERIOL, V95, P1439, DOI 10.1128/JB.95.4.1439-1449.1968; Wommack K. Eric, 2009, V501, P3, DOI 10.1007/978-1-60327-164-6_1; Yamaguchi Y, 2011, ANNU REV GENET, V45, P61, DOI 10.1146/annurev-genet-110410-132412; Zhang Y, 2016, MOL BIOL EVOL, V33, P2692, DOI 10.1093/molbev/msw154	67	364	393	27	180	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2018	359	6379							eaar4120	10.1126/science.aar4120	http://dx.doi.org/10.1126/science.aar4120			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GJ3UD	29371424	Green Accepted			2022-12-28	WOS:000435223400001
J	Surana, NK; Kasper, DL				Surana, Neeraj K.; Kasper, Dennis L.			Moving beyond microbiome-wide associations to causal microbe identification (vol 552, pg 244, 2017)	NATURE			English	Correction																		Surana NK, 2017, NATURE, V552, P244, DOI 10.1038/nature25019	1	1	1	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2018	554	7692					394	394		10.1038/nature25471	http://dx.doi.org/10.1038/nature25471			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW0PD	29342144	Bronze			2022-12-28	WOS:000424996300047
J	Gibcus, JH; Samejima, K; Goloborodko, A; Samejima, I; Naumova, N; Nuebler, J; Kanemaki, MT; Xie, LF; Paulson, JR; Earnshaw, WC; Mirny, LA; Dekker, J				Gibcus, Johan H.; Samejima, Kumiko; Goloborodko, Anton; Samejima, Itaru; Naumova, Natalia; Nuebler, Johannes; Kanemaki, Masato T.; Xie, Linfeng; Paulson, James R.; Earnshaw, William C.; Mirny, Leonid A.; Dekker, Job			A pathway for mitotic chromosome formation	SCIENCE			English	Article							SISTER-CHROMATID RESOLUTION; CONDENSIN-I; METAPHASE CHROMOSOMES; VERTEBRATE CELLS; TOPOISOMERASE-II; SCAFFOLD ATTACHMENT; CHROMOKINESIN KIF4A; MAMMALIAN-CELLS; LOOP EXTRUSION; HUMAN GENOME	Mitotic chromosomes fold as compact arrays of chromatin loops. To identify the pathway of mitotic chromosome formation, we combined imaging and Hi-C analysis of synchronous DT40 cell cultures with polymer simulations. Here we show that in prophase, the interphase organization is rapidly lost in a condensin-dependent manner, and arrays of consecutive 60-kilobase (kb) loops are formed. During prometaphase, similar to 80-kb inner loops are nested within similar to 400-kb outer loops. The loop array acquires a helical arrangement with consecutive loops emanating from a central "spiral staircase" condensin scaffold. The size of helical turns progressively increases to similar to 12 megabases during prometaphase. Acute depletion of condensin I or II shows that nested loops form by differential action of the two condensins, whereas condensin II is required for helical winding.	[Gibcus, Johan H.; Naumova, Natalia; Dekker, Job] Univ Massachusetts, Dept Biochem & Mol Pharmacol, Program Syst Biol, Med Sch, 368 Plantation St, Worcester, MA 01605 USA; [Samejima, Kumiko; Samejima, Itaru; Earnshaw, William C.] Univ Edinburgh, Wellcome Ctr Cell Biol, Kings Bldg, Edinburgh EH9 3BF, Midlothian, Scotland; [Goloborodko, Anton; Nuebler, Johannes; Mirny, Leonid A.] MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Goloborodko, Anton; Nuebler, Johannes; Mirny, Leonid A.] MIT, Dept Phys, Cambridge, MA 02139 USA; [Kanemaki, Masato T.] Res Org Informat & Syst, Div Mol Cell Engn, Natl Inst Genet, Yata 1111, Mishima, Shizuoka 4118540, Japan; [Kanemaki, Masato T.] SOKENDAI, Dept Genet, Mishima, Shizuoka 4118540, Japan; [Xie, Linfeng; Paulson, James R.] Univ Wisconsin, Dept Chem, 800 Algoma Blvd, Oshkosh, WI 54901 USA; [Dekker, Job] Univ Massachusetts, Howard Hughes Med Inst, Med Sch, 368 Plantation St, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Edinburgh; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; University of Wisconsin System; Howard Hughes Medical Institute; University of Massachusetts System; University of Massachusetts Worcester	Dekker, J (corresponding author), Univ Massachusetts, Dept Biochem & Mol Pharmacol, Program Syst Biol, Med Sch, 368 Plantation St, Worcester, MA 01605 USA.; Earnshaw, WC (corresponding author), Univ Edinburgh, Wellcome Ctr Cell Biol, Kings Bldg, Edinburgh EH9 3BF, Midlothian, Scotland.; Mirny, LA (corresponding author), MIT, Inst Med Engn & Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.; Mirny, LA (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.; Dekker, J (corresponding author), Univ Massachusetts, Howard Hughes Med Inst, Med Sch, 368 Plantation St, Worcester, MA 01605 USA.	bill.earnshaw@ed.ac.uk; leonid@MIT.edu; job.dekker@umassmed.edu	Mirny, Leonid/ABE-8083-2020; Earnshaw, William/AAY-7438-2020; Kanemaki, Masato/Q-3246-2019; Gibcus, Johan/F-3550-2012	Mirny, Leonid/0000-0002-0785-5410; Kanemaki, Masato/0000-0002-7657-1649; Gibcus, Johan/0000-0002-0851-7560; Xie, Linfeng/0000-0002-7025-2671; Nuebler, Johannes/0000-0002-5404-1604; Samejima, Itaru/0000-0003-1860-5772; Earnshaw, William/0000-0002-7191-0621; Goloborodko, Anton/0000-0002-2210-8616	National Human Genome Research Institute [HG003143]; NIH Common Fund [DK107980]; NSF [1504942]; National Institute of General Medical Sciences [GM114190]; Wellcome [107022]; Wellcome Trust [203149]; Japan Society for the Promotion of Science KAKENHI [16K15095]; Mochida Memorial Foundation for Medical and Pharmaceutical Research; SGH Foundation; Sumitomo Foundation; Canon Foundation; NATIONAL CANCER INSTITUTE [U54CA193419] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003143] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK107980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114190] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIH Common Fund(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Wellcome; Wellcome Trust(Wellcome TrustEuropean Commission); Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Mochida Memorial Foundation for Medical and Pharmaceutical Research; SGH Foundation; Sumitomo Foundation; Canon Foundation(Canon Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Human Genome Research Institute (HG003143) and the NIH Common Fund (DK107980) to J.D. and L.A.M. J.D. is an investigator of the Howard Hughes Medical Institute. Work in the Mirny lab was also supported by the NSF (Physics of Living Systems grant 1504942) and the National Institute of General Medical Sciences (grant GM114190). Work in the Earnshaw lab was funded by Wellcome, of which W.C.E. is a Principal Research Fellow (grant 107022). The Wellcome Centre for Cell Biology is supported by core funding from the Wellcome Trust (grant 203149). M.T.K. was supported by a Japan Society for the Promotion of Science KAKENHI grant (16K15095), as well as research grants from the Mochida Memorial Foundation for Medical and Pharmaceutical Research, the SGH Foundation, The Sumitomo Foundation, and The Canon Foundation.	Abe S, 2011, GENE DEV, V25, P863, DOI 10.1101/gad.2016411; ADOLPH KW, 1977, P NATL ACAD SCI USA, V74, P4937, DOI 10.1073/pnas.74.11.4937; Alipour E, 2012, NUCLEIC ACIDS RES, V40, P11202, DOI 10.1093/nar/gks925; Baranetzky J., 1880, BOT ZTG, V38, P281; Belmont AS, 1999, CURR OPIN CELL BIOL, V11, P307, DOI 10.1016/S0955-0674(99)80041-6; BELMONT AS, 1987, J CELL BIOL, V105, P77, DOI 10.1083/jcb.105.1.77; Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Booth DG, 2016, MOL CELL, V64, P790, DOI 10.1016/j.molcel.2016.10.009; COCKERILL PN, 1986, CELL, V44, P273, DOI 10.1016/0092-8674(86)90761-0; CRAIG JM, 1993, BIOESSAYS, V15, P349, DOI 10.1002/bies.950150510; Crane E, 2015, NATURE, V523, P240, DOI 10.1038/nature14450; DELATOUR EB, 1988, CELL, V55, P937, DOI 10.1016/0092-8674(88)90239-5; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; EARNSHAW WC, 1985, J CELL BIOL, V100, P1716, DOI 10.1083/jcb.100.5.1716; EARNSHAW WC, 1983, J CELL BIOL, V96, P84, DOI 10.1083/jcb.96.1.84; Eltsov M, 2008, P NATL ACAD SCI USA, V105, P19732, DOI 10.1073/pnas.0810057105; Fudenberg G, 2016, CELL REP, V15, P2038, DOI 10.1016/j.celrep.2016.04.085; GASSER SM, 1986, EMBO J, V5, P511, DOI 10.1002/j.1460-2075.1986.tb04240.x; Georgatos SD, 1997, J CELL SCI, V110, P2129; Gerlich D, 2006, CURR BIOL, V16, P333, DOI 10.1016/j.cub.2005.12.040; Goloborodko A, 2016, ELIFE, V5, DOI 10.7554/eLife.14864; Goloborodko A, 2016, BIOPHYS J, V110, P2162, DOI 10.1016/j.bpj.2016.02.041; Green LC, 2012, J CELL SCI, V125, P1591, DOI 10.1242/jcs.097790; Hirota T, 2004, J CELL SCI, V117, P6435, DOI 10.1242/jcs.01604; Hochegger H, 2007, J CELL BIOL, V178, P257, DOI 10.1083/jcb.200702034; Holland AJ, 2012, P NATL ACAD SCI USA, V109, pE3350, DOI 10.1073/pnas.1216880109; Hudson DF, 2003, DEV CELL, V5, P323, DOI 10.1016/S1534-5807(03)00199-0; Hughes B. D., 1995, RANDOM WALKS RANDOM, VI; Imakaev M, 2012, NAT METHODS, V9, P999, DOI [10.1038/NMETH.2148, 10.1038/nmeth.2148]; Kim JH, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3537; Kobe B, 1999, STRUCTURE, V7, pR91, DOI 10.1016/S0969-2126(99)80060-4; Kustatscher G, 2014, NAT PROTOC, V9, P2090, DOI 10.1038/nprot.2014.142; KUWADA Y., 1939, Cytologia, V10, P213, DOI 10.1508/cytologia.10.213; Liang ZY, 2015, CELL, V161, P1124, DOI 10.1016/j.cell.2015.04.030; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202; Maeshima K, 2003, DEV CELL, V4, P467, DOI 10.1016/S1534-5807(03)00092-3; Maritan A, 2000, NATURE, V406, P287, DOI 10.1038/35018538; Marko JF, 1997, MOL BIOL CELL, V8, P2217, DOI 10.1091/mbc.8.11.2217; MARSDEN MPF, 1979, CELL, V17, P849, DOI 10.1016/0092-8674(79)90325-8; Mazumdar M, 2004, J CELL BIOL, V166, P613, DOI 10.1083/jcb.200401142; MIRKOVITCH J, 1988, J MOL BIOL, V200, P101, DOI 10.1016/0022-2836(88)90336-1; Moore LL, 2001, J CELL BIOL, V153, P1199, DOI 10.1083/jcb.153.6.1199; Nagano T, 2017, NATURE, V547, P61, DOI 10.1038/nature23001; Nagasaka K, 2016, NAT CELL BIOL, V18, P692, DOI 10.1038/ncb3353; Nasmyth K, 2001, ANNU REV GENET, V35, P673, DOI 10.1146/annurev.genet.35.102401.091334; Naumova N, 2013, SCIENCE, V342, P948, DOI 10.1126/science.1236083; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; Nishino Y, 2012, EMBO J, V31, P1644, DOI 10.1038/emboj.2012.35; Nora EP, 2017, CELL, V169, P930, DOI 10.1016/j.cell.2017.05.004; Nora EP, 2012, NATURE, V485, P381, DOI 10.1038/nature11049; OHNUKI Y, 1968, CHROMOSOMA, V25, P402, DOI 10.1007/BF02327721; Ohta S, 2016, MOL CELL PROTEOMICS, V15, P2802, DOI 10.1074/mcp.M116.057885; Ohta S, 2010, CELL, V142, P810, DOI 10.1016/j.cell.2010.07.047; Okada Masahiro, 2006, Subcell Biochem, V40, P91; Ono T, 2004, MOL BIOL CELL, V15, P3296, DOI 10.1091/mbc.E04-03-0242; Ono T, 2003, CELL, V115, P109, DOI 10.1016/S0092-8674(03)00724-4; Ou HD, 2017, SCIENCE, V357, DOI 10.1126/science.aag0025; Paturej J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601478; PAULSON JR, 1977, CELL, V12, P817, DOI 10.1016/0092-8674(77)90280-X; PIENTA KJ, 1984, J CELL SCI, P123; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; RATTNER JB, 1985, CELL, V42, P291, DOI 10.1016/S0092-8674(85)80124-0; RIGGS AD, 1990, PHILOS T R SOC B, V326, P285, DOI 10.1098/rstb.1990.0012; ROBBINS E, 1964, J CELL BIOL, V21, P429, DOI 10.1083/jcb.21.3.429; SAITOH Y, 1994, CELL, V76, P609, DOI 10.1016/0092-8674(94)90502-9; Samejima K, 2008, P NATL ACAD SCI USA, V105, P2457, DOI 10.1073/pnas.0712083105; Samejima K, 2018, J CELL SCI, V131, DOI 10.1242/jcs.210187; Samejima K, 2012, J CELL BIOL, V199, P755, DOI 10.1083/jcb.201202155; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Schwarzer W, 2017, NATURE, V551, P51, DOI 10.1038/nature24281; Shintomi K, 2017, SCIENCE, V356, P1284, DOI 10.1126/science.aam9702; Shintomi K, 2011, GENE DEV, V25, P1464, DOI 10.1101/gad.2060311; Sonoda E, 2001, P NATL ACAD SCI USA, V98, P8388, DOI 10.1073/pnas.111006398; Strukov YG, 2003, J CELL BIOL, V162, P23, DOI 10.1083/jcb.200303098; Takahashi M, 2016, GENE DEV, V30, P1931, DOI 10.1101/gad.282855.116; Terakawa T, 2017, SCIENCE, V358, P672, DOI 10.1126/science.aan6516; Wilkins BJ, 2014, SCIENCE, V343, P77, DOI 10.1126/science.1244508; WOODCOCK CLF, 1984, J CELL BIOL, V99, P42, DOI 10.1083/jcb.99.1.42; Yanagida M, 2009, NAT REV MOL CELL BIO, V10, P489, DOI 10.1038/nrm2712; Yoshimura SH, 2016, J CELL SCI, V129, P3963, DOI 10.1242/jcs.185710; Zhang T, 2016, CHROMOSOME RES, V24, P243, DOI 10.1007/s10577-016-9519-7; Zhiteneva A, 2017, OPEN BIOL, V7, DOI 10.1098/rsob.170076	84	306	308	8	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					652	+	eaao6135	10.1126/science.aao6135	http://dx.doi.org/10.1126/science.aao6135			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GN1WA	29348367	Green Published, Green Submitted, Green Accepted			2022-12-28	WOS:000438784100002
J	Daley, J				Daley, Jennifer			Ensuring Timely Access to Quality Care for US Veterans	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Daley, Jennifer] Cigna Corp, Newton, MA USA		Daley, J (corresponding author), Jennifer Daley MD & Associates, 5 Candlewick Close, Lexington, MA 02421 USA.	jenniferdaleymd@gmail.com			Department of Veterans Affairs	Department of Veterans Affairs(US Department of Veterans Affairs)	The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Daley reported that she is an employee of Cigna Corp and that she has received personal fees from the Department of Veterans Affairs for serving on its Special Medical Advisory group.	Blay E, 2017, JAMA INTERN MED, V177, P882, DOI 10.1001/jamainternmed.2017.0605; Congressional Budget Office, 2014, COMMUNICATION; Farmer CM, 2016, BALANCING DEMAND SUP; Office of Suicide Prevention, 2016, SUIC VET OTH AM 2001; Office of the Inspector General, 2014, REV ALL PAT DEATHS P; Office of the Inspector General, 2014, REV PAT WAIT TIM SCH; United States Government Accountability Office, 2017, HIGH RISK SER PROGR, P627	7	9	9	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2018	319	5					439	440		10.1001/jama.2017.20743	http://dx.doi.org/10.1001/jama.2017.20743			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CW	29344616				2022-12-28	WOS:000424224500008
J	Boehnke, KF				Boehnke, Kevin F.			Cheating on my mentor	SCIENCE			English	Editorial Material								For the first 2 years of my Ph.D. program, my primary adviser was always available when I needed help, promptly responding to emails and meeting with me when questions arose. But that abruptly changed when he went on sabbatical and left the country. My emails were rarely answered, and our scheduled meetings were often canceled. I did what I could to push my research forward on my own, but I felt I was floundering. I grew frustrated and uncertain about my future, even questioning whether I wanted to pursue a research career. After sufficient wallowing in self-pity, however, I decided to take matters into my own hands by seeking the support that I needed.	[Boehnke, Kevin F.] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Boehnke, KF (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.	SciCareerEditor@aaas.org	Boehnke, Kevin/AAM-9429-2020	Boehnke, Kevin/0000-0003-3696-3979					0	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					486	486		10.1126/science.359.6374.486	http://dx.doi.org/10.1126/science.359.6374.486			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT6SD	29371472				2022-12-28	WOS:000423283200051
J	Dai, XH; Gong, DY; Lim, HY; Jih, J; Wu, TT; Sun, R; Zhou, ZH				Dai, Xinghong; Gong, Danyang; Lim, Hanyoung; Jih, Jonathan; Wu, Ting-Ting; Sun, Ren; Zhou, Z. Hong			Structure and mutagenesis reveal essential capsid protein interactions for KSHV replication	NATURE			English	Article							KAPOSIS-SARCOMA; DNA-SEQUENCES; PARTICLE; IDENTIFICATION; HERPESVIRUSES; ORGANIZATION; EXPRESSION; MICROSCOPY; STABILITY; MECHANISM	Kaposi's sarcoma-associated herpesvirus (KSHV) causes Kaposi's sarcoma(1,2), a cancer that commonly affects patients with AIDS3 and which is endemic in sub-Saharan Africa(4). The KSHV capsid is highly pressurized by its double-stranded DNA genome, as are the capsids of the eight other human herpesviruses(5). Capsid assembly and genome packaging of herpesviruses are prone to interruption(6-9) and can therefore be targeted for the structure-guided development of antiviral agents. However, herpesvirus capsids-comprising nearly 3,000 proteins and over 1,300 A in diameter-present a formidable challenge to atomic structure determination(10) and functional mapping of molecular interactions. Here we report a 4.2 A resolution structure of the KSHV capsid, determined by electron-counting cryo-electron microscopy, and its atomic model, which contains 46 unique conformers of the major capsid protein (MCP), the smallest capsid protein (SCP) and the triplex proteins Tri1 and Tri2. Our structure and mutagenesis results reveal a groove in the upper domain of the MCP that contains hydrophobic residues that interact with the SCP, which in turn crosslinks with neighbouring MCPs in the same hexon to stabilize the capsid. Multiple levels of MCP-MCP interaction-including six sets of stacked hairpins lining the hexon channel, disulfide bonds across channel and buttress domains in neighbouring MCPs, and an interaction network forged by the N-lasso domain and secured by the dimerization domain-define a robust capsid that is resistant to the pressure exerted by the enclosed genome. The triplexes, each composed of two Tri2 molecules and a Tri1 molecule, anchor to the capsid floor via a Tri1 N-anchor to plug holes in the MCP network and rivet the capsid floor. These essential roles of the MCP N-lasso and Tri1 N-anchor are verified by serial-truncation mutageneses. Our proof-of-concept demonstration of the use of polypeptides that mimic the smallest capsid protein to inhibit KSHV lytic replication highlights the potential for exploiting the interaction hotspots revealed in our atomic structure to develop antiviral agents.	[Dai, Xinghong; Lim, Hanyoung; Jih, Jonathan; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Dai, Xinghong; Sun, Ren; Zhou, Z. Hong] Univ Calif Los Angeles, CNSI, Los Angeles, CA 90095 USA; [Dai, Xinghong; Gong, Danyang; Wu, Ting-Ting; Sun, Ren] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Zhou, ZH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.; Sun, R; Zhou, ZH (corresponding author), Univ Calif Los Angeles, CNSI, Los Angeles, CA 90095 USA.; Sun, R (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	RSun@mednet.ucla.edu; Hong.Zhou@UCLA.edu	Zhou, Z Hong/HDN-0747-2022	Jih, Jonathan/0000-0001-5169-0919; Dai, Xinghong/0000-0002-4102-3175	National Institutes of Health (NIH) [DE025567, GM071940, AI094386, CA091791, CA177322]; Clinical and Translational Science Institute core voucher award from UCLA's National Center for Advancing Translational Science [UL1TR000124]; UCLA; NIH [1S10OD018111, 1U24GM116792]; NSF [DBI-1338135, DMR-1548924]; NATIONAL CANCER INSTITUTE [P01CA177322, R01CA091791] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001881, UL1TR000124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI094386] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071940, U24GM116792] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018111] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Clinical and Translational Science Institute core voucher award from UCLA's National Center for Advancing Translational Science; UCLA(University of California System); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This project was supported in part by grants from the National Institutes of Health (NIH) (DE025567, GM071940, AI094386, CA091791 and CA177322) and indirectly through a Clinical and Translational Science Institute core voucher award (UL1TR000124) from UCLA's National Center for Advancing Translational Science. We acknowledge the use of instruments at the Electron Imaging Center for Nanomachines supported by UCLA and by instrumentation grants from the NIH (1S10OD018111, 1U24GM116792) and NSF (DBI-1338135, DMR-1548924).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Akita F, 2007, J MOL BIOL, V368, P1469, DOI 10.1016/j.jmb.2007.02.075; Aksyuk AA, 2015, MBIO, V6, DOI 10.1128/mBio.01525-15; Baker ML, 2005, J VIROL, V79, P14967, DOI 10.1128/JVI.79.23.14967-14970.2005; Bauer DW, 2013, J AM CHEM SOC, V135, P11216, DOI 10.1021/ja404008r; Boshoff C, 2002, NAT REV CANCER, V2, P373, DOI 10.1038/nrc797; Bowman BR, 2003, EMBO J, V22, P757, DOI 10.1093/emboj/cdg086; Brulois KF, 2012, J VIROL, V86, P9708, DOI 10.1128/JVI.01019-12; Chan SR, 2000, J VIROL, V74, P10920, DOI 10.1128/JVI.74.23.10920-10929.2000; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chatlynne LG, 1999, SEMIN CANCER BIOL, V9, P175, DOI 10.1006/scbi.1998.0089; Dai X., 2014, BIOPROTOC, V4, pe1193, DOI [10.21769/BioProtoc.1193, DOI 10.21769/BIOPROTOC.1193, 10.21769/bioprotoc.1193.]; Dai XH, 2015, P NATL ACAD SCI USA, V112, pE649, DOI 10.1073/pnas.1420317112; Dai XH, 2014, J VIROL, V88, P12694, DOI 10.1128/JVI.01509-14; Dai XH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003525; Deres K, 2003, SCIENCE, V299, P893, DOI 10.1126/science.1077215; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fokine A, 2005, P NATL ACAD SCI USA, V102, P7163, DOI 10.1073/pnas.0502164102; Gilbert C, 2002, DRUG RESIST UPDATE, V5, P88, DOI 10.1016/S1368-7646(02)00021-3; Gong DY, 2016, CELL HOST MICROBE, V20, P642, DOI 10.1016/j.chom.2016.10.004; Gong D, 2014, J VIROL, V88, P11369, DOI 10.1128/JVI.00793-14; Helgstrand Charlotte, 2003, Journal of Molecular Biology, V334, P885, DOI 10.1016/j.jmb.2003.09.035; Henson BW, 2009, J VIROL, V83, P3877, DOI 10.1128/JVI.01733-08; Huet A, 2016, NAT STRUCT MOL BIOL, V23, P531, DOI 10.1038/nsmb.3212; Kivioja T, 2000, J STRUCT BIOL, V131, P126, DOI 10.1006/jsbi.2000.4279; Kucukelbir A, 2014, NAT METHODS, V11, P63, DOI [10.1038/nmeth.2727, 10.1038/NMETH.2727]; Lander GC, 2008, STRUCTURE, V16, P1399, DOI 10.1016/j.str.2008.05.016; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Liang YY, 2002, J STRUCT BIOL, V137, P292, DOI 10.1016/S1047-8477(02)00014-X; Lin SF, 1997, J VIROL, V71, P3069, DOI 10.1128/JVI.71.4.3069-3076.1997; Liu HR, 2008, J STRUCT BIOL, V161, P64, DOI 10.1016/j.jsb.2007.09.016; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8; MOORE PS, 1995, NEW ENGL J MED, V332, P1181, DOI 10.1056/NEJM199505043321801; Myoung J, 2011, J VIROL METHODS, V174, P12, DOI 10.1016/j.jviromet.2011.03.012; Parent KN, 2010, STRUCTURE, V18, P390, DOI 10.1016/j.str.2009.12.014; Perkins EM, 2008, J VIROL, V82, P7201, DOI 10.1128/JVI.00423-08; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; Sticht J, 2005, NAT STRUCT MOL BIOL, V12, P671, DOI 10.1038/nsmb964; Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010; Sutter M, 2008, NAT STRUCT MOL BIOL, V15, P939, DOI 10.1038/nsmb.1473; Ternois F, 2005, NAT STRUCT MOL BIOL, V12, P678, DOI 10.1038/nsmb967; Wikoff WR, 2000, SCIENCE, V289, P2129, DOI 10.1126/science.289.5487.2129; Yu XK, 2017, SCIENCE, V356, DOI 10.1126/science.aam6892; Yu XK, 2015, ELIFE, V4, DOI 10.7554/eLife.07901; Zhang XF, 2013, ADV ENERGY MATER, V3, P1299, DOI 10.1002/aenm.201300269; Zhang XK, 2010, J STRUCT BIOL, V172, P400, DOI 10.1016/j.jsb.2010.05.006; Zhang X, 2011, J STRUCT BIOL, V175, P253, DOI 10.1016/j.jsb.2011.05.004; Zhang X, 2010, CELL, V141, P472, DOI 10.1016/j.cell.2010.03.041; Zhou ZH, 2014, STRUCTURE, V22, P1385, DOI 10.1016/j.str.2014.05.019; ZHOU ZH, 1995, NAT STRUCT BIOL, V2, P1026, DOI 10.1038/nsb1195-1026; Zlotnick A, 2002, J VIROL, V76, P4848, DOI 10.1128/JVI.76.10.4848-4854.2002	53	29	29	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2018	553	7689					521	+		10.1038/nature25438	http://dx.doi.org/10.1038/nature25438			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU6OE	29342139	Green Accepted			2022-12-28	WOS:000423971100044
J	Dzau, VJ; Kirch, DG; Nasca, TJ				Dzau, Victor J.; Kirch, Darrell G.; Nasca, Thomas J.			To Care Is Human - Collectively Confronting the Clinician-Burnout Crisis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dzau, Victor J.; Kirch, Darrell G.; Nasca, Thomas J.] Natl Acad Med, Action Collaborat Clinician Well Being & Resilien, Washington, DC 20001 USA; [Dzau, Victor J.] Natl Acad Med, Washington, DC 20001 USA; [Kirch, Darrell G.] Assoc Amer Med Coll, Washington, DC USA; [Nasca, Thomas J.] Accreditat Council Grad Med Educ, Chicago, IL USA	National Academies of Sciences, Engineering & Medicine; National Academies of Sciences, Engineering & Medicine; Association of American Medical Colleges	Dzau, VJ (corresponding author), Natl Acad Med, Action Collaborat Clinician Well Being & Resilien, Washington, DC 20001 USA.; Dzau, VJ (corresponding author), Natl Acad Med, Washington, DC 20001 USA.							Andrew L. B., 2017, MEDSCAPE; Dyrbye LN, 2017, BURNOUT HLTH CARE PR, DOI 10.31478/201707b; Institutes of Medicine, 1999, ERR IS HUMAN BUILDIN; National Academy of Medicine, 2017, ACT COLL CLIN WELL B	4	123	123	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 25	2018	378	4					312	314		10.1056/NEJMp1715127	http://dx.doi.org/10.1056/NEJMp1715127			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT5ZX	29365296				2022-12-28	WOS:000423233400002
J	Slomski, A				Slomski, Anita			Bariatric Surgery Controls Blood Pressure	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					333	333		10.1001/jama.2017.21380	http://dx.doi.org/10.1001/jama.2017.21380			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362792				2022-12-28	WOS:000423405300009
J	Ferrier-Barbut, I; Pfau, T				Ferrier-Barbut, Igor; Pfau, Tilman			Quantum liquids get thin	SCIENCE			English	Editorial Material									[Ferrier-Barbut, Igor] Univ Stuttgart, Phys Inst, Stuttgart, Germany; Univ Stuttgart, Ctr Integrated Quantum Sci & Technol, Stuttgart, Germany	University of Stuttgart; University of Stuttgart	Ferrier-Barbut, I (corresponding author), Univ Stuttgart, Phys Inst, Stuttgart, Germany.	i.ferrier-barbut@physik.uni-stuttgart.de	Ferrier-Barbut, Igor/J-8759-2016; Pfau, Tilman/G-1774-2011	Ferrier-Barbut, Igor/0000-0002-4707-0474; Pfau, Tilman/0000-0003-3272-3468				BARKER JA, 1976, REV MOD PHYS, V48, P587, DOI 10.1103/RevModPhys.48.587; Cabrera CR, 2018, SCIENCE, V359, P301, DOI 10.1126/science.aao5686; Chomaz L, 2016, PHYS REV X, V6, DOI 10.1103/PhysRevX.6.041039; Edler D, 2017, PHYS REV LETT, V119, DOI 10.1103/PhysRevLett.119.050403; Ferrier-Barbut I, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.215301; Petrov DS, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.100401; Petrov DS, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.155302; Schmitt M, 2016, NATURE, V539, P259, DOI 10.1038/nature20126; Semeghini G., 2017, ARXIV171010890; Toennies JP, 2001, PHYS TODAY, V54, P31, DOI 10.1063/1.1359707	10	14	14	2	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					274	275		10.1126/science.aar3785	http://dx.doi.org/10.1126/science.aar3785			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT6BB	29348223				2022-12-28	WOS:000423236700019
J	Siddiqui, J; Krishnan, AS				Siddiqui, Juveria; Krishnan, Anant S.			Butterfly Glioma	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material								An 83-year-old woman presented to the emergency department with weakness, slurred speech, and urinary incontinence. MRI showed a symmetric, bifrontal lesion that extended across the corpus callosum and resembled a butterfly. A biopsy was performed and glioblastoma was diagnosed.	[Siddiqui, Juveria; Krishnan, Anant S.] Barts Hlth NHS Trust, London, England	Barts Health NHS Trust	Siddiqui, J (corresponding author), Barts Hlth NHS Trust, London, England.	juveria@doctors.org.uk							0	3	3	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2018	378	3					281	281		10.1056/NEJMicm1704713	http://dx.doi.org/10.1056/NEJMicm1704713			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT1IJ	29342386				2022-12-28	WOS:000422888400012
J	Friedrich, MJ				Friedrich, M. J.			Possible Biomarkers of Deadly Ebola	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2018	319	3					219	219		10.1001/jama.2017.20420	http://dx.doi.org/10.1001/jama.2017.20420			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT3BY	29340690				2022-12-28	WOS:000423022300002
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: We need another vote	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				BMA, 2017, EU SURV; Fahy N, 2017, LANCET, V390, P2110, DOI 10.1016/S0140-6736(17)31926-8; Forster K., 2017, NHS FACES UNPRECEDEN; NHS Digital, 2017, HCHS STAFF NHS TRUST; Royal College of Physicians, 2017, BREX WHAT DOES IT ME	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2018	360								j5919	10.1136/bmj.j5919	http://dx.doi.org/10.1136/bmj.j5919			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT5PG	29335279	Bronze, Green Published			2022-12-28	WOS:000423205100012
J	Marteau, TM				Marteau, Theresa M.			The art of medicine Changing minds about changing behaviour	LANCET			English	Editorial Material									[Marteau, Theresa M.] Univ Cambridge, Behav & Hlth Res Unit, Cambridge Biomed Campus, Cambridge CB2 0SR, England	University of Cambridge	Marteau, TM (corresponding author), Univ Cambridge, Behav & Hlth Res Unit, Cambridge Biomed Campus, Cambridge CB2 0SR, England.	tm388@cam.ac.uk							0	26	27	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 13	2018	391	10116					116	117		10.1016/S0140-6736(17)33324-X	http://dx.doi.org/10.1016/S0140-6736(17)33324-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT0EG	29353612	Green Submitted			2022-12-28	WOS:000422793400015
J	Danjo, T; Toyoizumi, T; Fujisawa, S				Danjo, Teruko; Toyoizumi, Taro; Fujisawa, Shigeyoshi			Spatial representations of self and other in the hippocampus	SCIENCE			English	Article							MEDIAL ENTORHINAL CORTEX; PLACE CELLS; EPISODIC MEMORY; SINGLE NEURONS; SOCIAL MEMORY; THETA-RHYTHM; DYNAMICS; NAVIGATION; RATS; MAP	An animal's awareness of its location in space depends on the activity of place cells in the hippocampus. How the brain encodes the spatial position of others has not yet been identified. We investigated neuronal representations of other animals' locations in the dorsal CA1 region of the hippocampus with an observational T-maze task in which one rat was required to observe another rat's trajectory to successfully retrieve a reward. Information reflecting the spatial location of both the self and the other was jointly and discretely encoded by CA1 pyramidal cells in the observer rat. A subset of CA1 pyramidal cells exhibited spatial receptive fields that were identical for the self and the other. These findings demonstrate that hippocampal spatial representations include dimensions for both self and nonself.	[Danjo, Teruko; Fujisawa, Shigeyoshi] RIKEN Brain Sci Inst, Lab Syst Neurophysiol, 2-1 Hirosawa, Wako, Saitama 3510198, Japan; [Toyoizumi, Taro] RIKEN Brain Sci Inst, Lab Neural Computat & Adaptat, 2-1 Hirosawa, Wako, Saitama 3510198, Japan	RIKEN; RIKEN	Fujisawa, S (corresponding author), RIKEN Brain Sci Inst, Lab Syst Neurophysiol, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	fujisawa@brain.riken.jp	Fujisawa, Shigeyoshi/N-6439-2015; Toyoizumi, Taro/G-5632-2015	Fujisawa, Shigeyoshi/0000-0003-3963-4281; Toyoizumi, Taro/0000-0001-5444-8829	Japan Society for the Promotion of Science (KAKENHI) [16K14561, 16H01290, 15H05876, 16H01519]; Grants-in-Aid for Scientific Research [16H01519, 15H05871] Funding Source: KAKEN	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank A. Amarasingham for helpful suggestions on data analysis and T. J. McHugh and C. Yokoyama for comments on the manuscript. This work was supported by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (KAKENHI) nos. 16K14561 and 16H01290 to T.D. and 15H05876 and 16H01519 to S.F. All data necessary to support the paper's conclusions are present in the paper and the supplementary materials.	Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Buzsaki G, 2013, NAT NEUROSCI, V16, P130, DOI 10.1038/nn.3304; Deshmukh SS, 2013, HIPPOCAMPUS, V23, P253, DOI 10.1002/hipo.22101; Dragoi G, 2006, NEURON, V50, P145, DOI 10.1016/j.neuron.2006.02.023; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Frank LM, 2000, NEURON, V27, P169, DOI 10.1016/S0896-6273(00)00018-0; Fujisawa S, 2008, NAT NEUROSCI, V11, P823, DOI 10.1038/nn.2134; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; Hitti FL, 2014, NATURE, V508, P88, DOI 10.1038/nature13028; Ho SA, 2008, NEUROSCIENCE, V157, P254, DOI 10.1016/j.neuroscience.2008.09.004; Kropff E, 2015, NATURE, V523, P419, DOI 10.1038/nature14622; Lee I, 2004, NATURE, V430, P456, DOI 10.1038/nature02739; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; Mehta MR, 2002, NATURE, V417, P741, DOI 10.1038/nature00807; Mou X, 2016, ELIFE, V5, DOI 10.7554/eLife.18022; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Okuyama T, 2016, SCIENCE, V353, P1536, DOI 10.1126/science.aaf7003; Quiroga RQ, 2005, NATURE, V435, P1102, DOI 10.1038/nature03687; Ravassard P, 2013, SCIENCE, V340, P1342, DOI 10.1126/science.1232655; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Robinson NTM, 2017, NEURON, V94, P677, DOI 10.1016/j.neuron.2017.04.003; TAUBE JS, 1990, J NEUROSCI, V10, P420; TOLMAN EC, 1948, PSYCHOL REV, V55, P189, DOI 10.1037/h0061626; Wills TJ, 2005, SCIENCE, V308, P873, DOI 10.1126/science.1108905; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Wirth S, 2003, SCIENCE, V300, P1578, DOI 10.1126/science.1084324; Wood ER, 2000, NEURON, V27, P623, DOI 10.1016/S0896-6273(00)00071-4; Wood ER, 1999, NATURE, V397, P613, DOI 10.1038/17605; Zhang KC, 1998, J NEUROPHYSIOL, V79, P1017, DOI 10.1152/jn.1998.79.2.1017	35	88	88	7	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					213	+		10.1126/science.aao3898	http://dx.doi.org/10.1126/science.aao3898			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS5EO	29326273				2022-12-28	WOS:000419816600046
J	Goremychkin, EA; Park, H; Osborn, R; Rosenkranz, S; Castellan, JP; Fanelli, VR; Christianson, AD; Stone, MB; Bauer, ED; McClellan, KJ; Byler, DD; Lawrence, JM				Goremychkin, Eugene A.; Park, Hyowon; Osborn, Raymond; Rosenkranz, Stephan; Castellan, John-Paul; Fanelli, Victor R.; Christianson, Andrew D.; Stone, Matthew B.; Bauer, Eric D.; McClellan, Kenneth J.; Byler, Darrin D.; Lawrence, Jon M.			Coherent band excitations in CePd3: A comparison of neutron scattering and ab initio theory	SCIENCE			English	Article							MEAN-FIELD THEORY; INFINITE DIMENSIONS; LATTICE; DYNAMICS	In common with many strongly correlated electron systems, intermediate valence compounds are believed to display a crossover from a high-temperature regime of incoherently fluctuating local moments to a low-temperature regime of coherent hybridized bands. We show that inelastic neutron scattering measurements of the dynamic magnetic susceptibility of CePd3 provides a benchmark for ab initio calculations based on dynamical mean field theory. The magnetic response is strongly momentum dependent thanks to the formation of coherent f-electron bands at low temperature, with an amplitude that is strongly enhanced by local particle-hole interactions. The agreement between experiment and theory shows that we have a robust first-principles understanding of the temperature dependence of f-electron coherence.	[Goremychkin, Eugene A.] Joint Inst Nucl Res, Frank Lab Neutron Phys, Dubna 141980, Moscow Region, Russia; [Park, Hyowon; Osborn, Raymond; Rosenkranz, Stephan; Castellan, John-Paul] Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA; [Park, Hyowon] Univ Illinois, Dept Phys, Chicago, IL 60607 USA; [Castellan, John-Paul] Karlsruhe Inst Technol, Inst Solid State Phys, D-76021 Karlsruhe, Germany; [Fanelli, Victor R.] Oak Ridge Natl Lab, Instrument & Source Div, Oak Ridge, TN 37831 USA; [Christianson, Andrew D.; Stone, Matthew B.] Oak Ridge Natl Lab, Quantum Condensed Matter Div, Oak Ridge, TN 37831 USA; [Bauer, Eric D.; McClellan, Kenneth J.; Byler, Darrin D.; Lawrence, Jon M.] Los Alamos Natl Lab, Los Alamos, NM 87545 USA; [Lawrence, Jon M.] Univ Calif Irvine, Dept Phys & Astron, Irvine, CA 92697 USA	Joint Institute for Nuclear Research - Russia; United States Department of Energy (DOE); Argonne National Laboratory; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Helmholtz Association; Karlsruhe Institute of Technology; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Oak Ridge National Laboratory; United States Department of Energy (DOE); Los Alamos National Laboratory; University of California System; University of California Irvine	Osborn, R (corresponding author), Argonne Natl Lab, Div Mat Sci, Argonne, IL 60439 USA.	rosborn@anl.gov	Rosenkranz, Stephan/E-4672-2011; Spectrometer, Merlin/AAC-8401-2020; Goremychkin, Eugene/L-8413-2017; Fanelli, Victor R/A-4375-2015; Stone, Matthew/G-3275-2011; Instrument, Merlin/AAB-5400-2020; Osborn, Raymond/E-8676-2011	Rosenkranz, Stephan/0000-0002-5659-0383; Goremychkin, Eugene/0000-0003-0856-3951; Fanelli, Victor R/0000-0002-8496-2244; Stone, Matthew/0000-0001-7884-9715; Osborn, Raymond/0000-0001-9565-3140	Russian Foundation for Basic Research [16-02-01086]; Materials Sciences and Engineering Division, Office of Basic Energy Sciences, U.S. Department of Energy; Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Materials Sciences and Engineering Division, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE))	The research at the Joint Institute for Nuclear Research was supported by the Russian Foundation for Basic Research project 16-02-01086. The research at Argonne National Laboratory and Los Alamos National Laboratory was supported by the Materials Sciences and Engineering Division, Office of Basic Energy Sciences, U.S. Department of Energy. The research at Oak Ridge National Laboratory's Spallation Neutron Source was supported by the Scientific User Facilities Division, Office of Basic Energy Sciences, U.S. Department of Energy. Neutron experiments were performed at the Spallation Neutron Source, Oak Ridge National Laboratory, and the ISIS Pulsed Neutron Source, Rutherford Appleton Laboratory. We gratefully acknowledge the computing resources provided on Blues, a high-performance computing cluster operated by the Laboratory Computing Resource Center at Argonne National Laboratory. We are also grateful for useful discussions with P. Riseborough. Files containing the data sets used in this paper are available for download from http://dx.doi.org/doi:10.18126/M2C914. Four-dimensional inelastic neutron scattering data from ARCS are stored in HDF5 files, conforming to the NeXus standard (www.nexusformat.org), which can be viewed using the open-source application, NeXpy (http://nexpy.github.io/nexpy/). The data can be compared with DFT+DMFT calculations, produced using the Wien2K+DMFT package (31), which are also stored in NeXus files. Inelastic neutron scattering data from MERLIN are available as RAR archives, containing files produced by the Horace suite of MATLAB programs (http://horace.isis.rl.ac.uk/), which can be used to extract cuts and slices through the 4D data.	Abernathy DL, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.3680104; Balcar E., 1989, THEORY MAGNETIC NEUT; Bewley RI, 2006, PHYSICA B, V385-86, P1029, DOI 10.1016/j.physb.2006.05.328; Blaha P., 2001, WIEN2K; BRANDOW BH, 1988, PHYS REV B, V37, P250, DOI 10.1103/PhysRevB.37.250; Burdin S, 2000, PHYS REV LETT, V85, P1048, DOI 10.1103/PhysRevLett.85.1048; Choi HC, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.016402; Christianson AD, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.117206; Coldea R, 2001, PHYS REV LETT, V86, P5377, DOI 10.1103/PhysRevLett.86.5377; COOKE JF, 1982, PHYS REV B, V26, P4410, DOI 10.1103/PhysRevB.26.4410; Cornelius AL, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.117201; Dai PC, 2015, REV MOD PHYS, V87, P855, DOI 10.1103/RevModPhys.87.855; Deng XY, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.086401; Ewings RA, 2016, NUCL INSTRUM METH A, V834, P132, DOI 10.1016/j.nima.2016.07.036; Fanelli VR, 2014, J PHYS-CONDENS MAT, V26, DOI 10.1088/0953-8984/26/22/225602; Georges A, 1996, REV MOD PHYS, V68, P13, DOI 10.1103/RevModPhys.68.13; JARRELL M, 1992, PHYS REV LETT, V69, P168, DOI 10.1103/PhysRevLett.69.168; Kaminski A, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.207003; Klein M, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.186407; Kotliar G, 2006, REV MOD PHYS, V78, P865, DOI 10.1103/RevModPhys.78.865; LAWRENCE JM, 1985, PHYS REV LETT, V54, P2537, DOI 10.1103/PhysRevLett.54.2537; LAWRENCE JM, 1981, REP PROG PHYS, V44, P1, DOI 10.1088/0034-4885/44/1/001; LOONG CK, 1988, PHYS REV B, V38, P7365, DOI 10.1103/PhysRevB.38.7365; Mo SK, 2012, PHYS REV B, V85, DOI 10.1103/PhysRevB.85.241103; Murani AP, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.206405; Park H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.137007; Riseborough PS, 2016, REP PROG PHYS, V79, DOI 10.1088/0034-4885/79/8/084501; Sakai O, 2010, J PHYS SOC JPN, V79, DOI 10.1143/JPSJ.79.114701; Shim JH, 2007, SCIENCE, V318, P1615, DOI 10.1126/science.1149064; Sinha S. K., 1984, TECH REP; Weber F, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.057001	31	27	27	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					186	190		10.1126/science.aan0593	http://dx.doi.org/10.1126/science.aan0593			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS5EO	29326267	Green Submitted			2022-12-28	WOS:000419816600040
J	Wagner, CE				Wagner, Catherine E.			Improbable Big Birds	SCIENCE			English	Editorial Material							HOMOPLOID HYBRID SPECIATION; ADAPTIVE RADIATION; CICHLID FISH; HYBRIDIZATION		[Wagner, Catherine E.] Univ Wyoming, Dept Bot, 1000 East Univ Ave, Laramie, WY 82071 USA; [Wagner, Catherine E.] Univ Wyoming, Biodivers Inst, 1000 East Univ Ave, Laramie, WY 82071 USA	University of Wyoming; University of Wyoming	Wagner, CE (corresponding author), Univ Wyoming, Dept Bot, 1000 East Univ Ave, Laramie, WY 82071 USA.; Wagner, CE (corresponding author), Univ Wyoming, Biodivers Inst, 1000 East Univ Ave, Laramie, WY 82071 USA.	catherine.wagner@uwyo.edu	Wagner, Catherine/F-4692-2012	Wagner, Catherine/0000-0001-8585-6120				Brawand D, 2014, NATURE, V513, P375, DOI 10.1038/nature13726; Buerkle CA, 2000, HEREDITY, V84, P441, DOI 10.1046/j.1365-2540.2000.00680.x; Dasmahapatra KK, 2012, NATURE, V487, P94, DOI 10.1038/nature11041; Grant P. R., 2014, 40 YERAS EVOLUTION D; Gross BL, 2005, J HERED, V96, P241, DOI 10.1093/jhered/esi026; Lamichhaney S, 2018, SCIENCE, V359, P224, DOI 10.1126/science.aao4593; Lamichhaney S, 2015, NATURE, V518, P371, DOI 10.1038/nature14181; Meier JI, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14363; Meyer JR, 2016, SCIENCE, V354, P1301, DOI 10.1126/science.aai8446; Schluter D., 2000, ECOLOGY ADAPTIVE RAD; Schumer M, 2014, EVOLUTION, V68, P1553, DOI 10.1111/evo.12399; Seehausen O, 2004, TRENDS ECOL EVOL, V19, P198, DOI 10.1016/j.tree.2004.01.003	12	4	4	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					157	159		10.1126/science.aar4796	http://dx.doi.org/10.1126/science.aar4796			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS5EO	29326259				2022-12-28	WOS:000419816600021
J	Serra-Garcia, M; Peri, V; Susstrunk, R; Bilal, OR; Larsen, T; Villanueva, LG; Huber, SD				Serra-Garcia, Marc; Peri, Valerio; Susstrunk, Roman; Bilal, Osama R.; Larsen, Tom; Villanueva, Luis Guillermo; Huber, Sebastian D.			Observation of a phononic quadrupole topological insulator	NATURE			English	Article							EDGE STATES; PHASE	The modern theory of charge polarization in solids(1,2) is based on a generalization of Berry's phase(3). The possibility of the quantization of this phase(4,5) arising from parallel transport in momentum space is essential to our understanding of systems with topological band structures(6-10). Although based on the concept of charge polarization, this same theory can also be used to characterize the Bloch bands of neutral bosonic systems such as photonic(11) or phononic crystals(12,13). The theory of this quantized polarization has recently been extended from the dipole moment to higher multipole moments(14). In particular, a two-dimensional quantized quadrupole insulator is predicted to have gapped yet topological one-dimensional edge modes, which stabilize zero-dimensional in-gap corner states(14). However, such a state of matter has not previously been observed experimentally. Here we report measurements of a phononic quadrupole topological insulator. We experimentally characterize the bulk, edge and corner physics of a mechanical metamaterial (a material with tailored mechanical properties) and find the predicted gapped edge and in-gap corner states. We corroborate our findings by comparing the mechanical properties of a topologically non-trivial system to samples in other phases that are predicted by the quadrupole theory. These topological corner states are an important stepping stone to the experimental realization of topologically protected wave guides(12,15) in higher dimensions, and thereby open up a new path for the design of metamaterials(16,17).	[Serra-Garcia, Marc; Peri, Valerio; Susstrunk, Roman; Bilal, Osama R.; Huber, Sebastian D.] ETH, Inst Theoret Phys, CH-8093 Zurich, Switzerland; [Bilal, Osama R.] CALTECH, Div Engn & Appl Sci, Pasadena, CA 91125 USA; [Larsen, Tom; Villanueva, Luis Guillermo] Ecole Polytech Fed Lausanne, Adv NEMS Grp, CH-1015 Lausanne, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; California Institute of Technology; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Huber, SD (corresponding author), ETH, Inst Theoret Phys, CH-8093 Zurich, Switzerland.	sebastian.huber@phys.ethz.ch	Bilal, Osama/AAF-3550-2021; Peri, Valerio/AAE-8122-2020; Huber, Sebastian/L-8987-2013; Villanueva, Luis Guillermo/C-4904-2009	Bilal, Osama/0000-0003-3803-5084; Peri, Valerio/0000-0002-0727-3808; Huber, Sebastian/0000-0003-3558-351X; Villanueva, Luis Guillermo/0000-0003-3340-2930; Larsen, Tom/0000-0002-3472-7182	Swiss National Science Foundation; NCCR QSIT; Marie Curie fellowship; ETH postdoctoral fellowship [FEL-2615-2]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NCCR QSIT; Marie Curie fellowship(European Commission); ETH postdoctoral fellowship	We acknowledge financial support from the Swiss National Science Foundation and the NCCR QSIT. T.L. acknowledges support from a Marie Curie fellowship and O.R.B. from the ETH postdoctoral fellowship FEL-2615-2.	Benalcazar WA, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.245115; Benalcazar WA, 2017, SCIENCE, V357, P61, DOI 10.1126/science.aah6442; Bernevig BA, 2006, SCIENCE, V314, P1757, DOI 10.1126/science.1133734; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Chiu CK, 2016, REV MOD PHYS, V88, DOI 10.1103/RevModPhys.88.035005; Coulais C, 2016, NATURE, V535, P529, DOI 10.1038/nature18960; Fidkowski L, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.036601; Fu L, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.195312; Hafezi M, 2013, NAT PHOTONICS, V7, P1001, DOI [10.1038/NPHOTON.2013.274, 10.1038/nphoton.2013.274]; Hsieh D, 2008, NATURE, V452, P970, DOI 10.1038/nature06843; Huber SD, 2016, NAT PHYS, V12, P621, DOI 10.1038/nphys3801; Imhof S., 2017, PREPRINT; Kane CL, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.146802; KINGSMITH RD, 1993, PHYS REV B, V47, P1651, DOI 10.1103/PhysRevB.47.1651; Konig M, 2007, SCIENCE, V318, P766, DOI 10.1126/science.1148047; Lang N, 2017, NPJ QUANTUM INFORM, V3, DOI 10.1038/s41534-017-0047-x; Liu ZY, 2000, SCIENCE, V289, P1734, DOI 10.1126/science.289.5485.1734; Lu L, 2016, NAT PHYS, V12, P626, DOI 10.1038/nphys3796; Matlack K. H., 2018, NAT MAT; Moore JE, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.121306; Nash LM, 2015, P NATL ACAD SCI USA, V112, P14495, DOI 10.1073/pnas.1507413112; Peterson C. W., 2017, PREPRINT; Qi XL, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.195424; Rechtsman MC, 2013, NATURE, V496, P196, DOI 10.1038/nature12066; Susstrunk R, 2015, SCIENCE, V349, P47, DOI 10.1126/science.aab0239; Susstrunk R, 2016, P NATL ACAD SCI USA, V113, pE4767, DOI 10.1073/pnas.1605462113; Taherinejad M, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.115102; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; VONKLITZING K, 1980, PHYS REV LETT, V45, P494, DOI 10.1103/PhysRevLett.45.494; Xiao M, 2015, NAT PHYS, V11, P240, DOI 10.1038/NPHYS3228; Xu SY, 2015, SCIENCE, V349, P613, DOI 10.1126/science.aaa9297	31	478	482	27	310	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 15	2018	555	7696					342	+		10.1038/nature25156	http://dx.doi.org/10.1038/nature25156			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FZ3HG	29334685	Green Accepted, Green Submitted			2022-12-28	WOS:000427477100030
J	Zhang, DL; Zhu, YH; Liu, LM; Ying, XR; Hsiung, CE; Sougrat, R; Li, K; Han, Y				Zhang, Daliang; Zhu, Yihan; Liu, Lingmei; Ying, Xiangrong; Hsiung, Chia-En; Sougrat, Rachid; Li, Kun; Han, Yu			Atomic-resolution transmission electron microscopy of electron beam-sensitive crystalline materials	SCIENCE			English	Article							METAL-ORGANIC FRAMEWORK; CRYO-EM; DAMAGE; RECONSTRUCTION; NANOCRYSTALS; TEMPERATURE; GRAPHENE; SURFACE; TEM	High-resolution imaging of electron beam-sensitive materials is one of the most difficult applications of transmission electron microscopy (TEM). The challenges are manifold, including the acquisition of images with extremely low beam doses, the time-constrained search for crystal zone axes, the precise image alignment, and the accurate determination of the defocus value. We develop a suite of methods to fulfill these requirements and acquire atomic-resolution TEM images of several metal organic frameworks that are generally recognized as highly sensitive to electron beams. The high image resolution allows us to identify individual metal atomic columns, various types of surface termination, and benzene rings in the organic linkers. We also apply our methods to other electron beam-sensitive materials, including the organic-inorganic hybrid perovskite CH3NH3PbBr3.	[Zhang, Daliang; Sougrat, Rachid; Li, Kun] KAUST, Imaging & Characterizat Core Lab, Thuwal 239556900, Saudi Arabia; [Zhu, Yihan; Liu, Lingmei; Ying, Xiangrong; Hsiung, Chia-En; Han, Yu] KAUST, Adv Membranes & Porous Mat Ctr, Phys Sci & Engn Div, Thuwal 239556900, Saudi Arabia; [Han, Yu] KAUST, KAUST Catalysis Ctr, Phys Sci & Engn Div, Thuwal 239556900, Saudi Arabia; [Zhu, Yihan] Zhejiang Univ Technol, Dept Chem Engn, Hangzhou 310014, Zhejiang, Peoples R China	King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; King Abdullah University of Science & Technology; Zhejiang University of Technology	Zhang, DL; Li, K (corresponding author), KAUST, Imaging & Characterizat Core Lab, Thuwal 239556900, Saudi Arabia.; Han, Y (corresponding author), KAUST, Adv Membranes & Porous Mat Ctr, Phys Sci & Engn Div, Thuwal 239556900, Saudi Arabia.; Han, Y (corresponding author), KAUST, KAUST Catalysis Ctr, Phys Sci & Engn Div, Thuwal 239556900, Saudi Arabia.	daliang.zhang@kaust.edu.sa; kun.li@kaust.edu.sa; yu.han@kaust.edu.sa	Han, Yu/GZA-9220-2022; Han, Yu/N-2036-2015; Zhang, Daliang/B-3358-2018	Han, Yu/0000-0003-1462-1118; Zhang, Daliang/0000-0003-3494-7000; Li, Kun/0000-0001-7054-0756; Sougrat, Rachid/0000-0001-6476-1886	King Abdullah University of Science and Technology [URF/1/2570-01, FCC/1/1972-19]	King Abdullah University of Science and Technology(King Abdullah University of Science & Technology)	We thank M. Pan and O. Terasaki for helpful discussions. This work was supported by King Abdullah University of Science and Technology through Competitive Research Grant (URF/1/2570-01) and Center Competitive Funding (FCC/1/1972-19). HRTEM images presented in this paper and the two programs used for zone-axis alignment and image alignment are archived in a data repository (https://zenodo.org/record/1133206) for verification purposes only. Interested readers can download the programs after agreeing with the terms and conditions stated there. D.Z., Y.Z., K.L., and Y.H. are inventors on United States Provisional patent applications (62/490,967 and 62/490,968) submitted by King Abdullah University of Science and Technology that cover the methods for crystal zone-axis alignment and image alignment.	Brivio F, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.155204; Cavka JH, 2008, J AM CHEM SOC, V130, P13850, DOI 10.1021/ja8057953; Chui SSY, 1999, SCIENCE, V283, P1148, DOI 10.1126/science.283.5405.1148; Cravillon J, 2009, CHEM MATER, V21, P1410, DOI 10.1021/cm900166h; Duden T, 2011, ULTRAMICROSCOPY, V111, P1574, DOI 10.1016/j.ultramic.2011.08.003; Egerton RF, 2012, MICROSC RES TECHNIQ, V75, P1550, DOI 10.1002/jemt.22099; Farha OK, 2010, NAT CHEM, V2, P944, DOI [10.1038/nchem.834, 10.1038/NCHEM.834]; Furukawa H, 2013, SCIENCE, V341, P974, DOI 10.1126/science.1230444; Garcia A, 2014, ULTRAMICROSCOPY, V146, P33, DOI 10.1016/j.ultramic.2014.05.004; Guan LH, 2008, NANO LETT, V8, P459, DOI 10.1021/nl072396j; Hashimoto A, 2004, NATURE, V430, P870, DOI 10.1038/nature02817; Jia CL, 2003, SCIENCE, V299, P870, DOI 10.1126/science.1079121; Jin L, 2008, J STRUCT BIOL, V161, P352, DOI 10.1016/j.jsb.2007.10.007; Lebedev OI, 2005, CHEM MATER, V17, P6525, DOI 10.1021/cm051870o; Li H, 1999, NATURE, V402, P276, DOI 10.1038/46248; Li XM, 2013, NAT METHODS, V10, P584, DOI 10.1038/nmeth.2472; Merk A, 2016, CELL, V165, P1698, DOI 10.1016/j.cell.2016.05.040; Meyer JC, 2011, NAT MATER, V10, P209, DOI 10.1038/NMAT2941; Snaith HJ, 2014, J PHYS CHEM LETT, V5, P1511, DOI 10.1021/jz500113x; Susi T, 2012, ACS NANO, V6, P8837, DOI 10.1021/nn303944f; Tress W, 2015, ENERG ENVIRON SCI, V8, P995, DOI 10.1039/c4ee03664f; Ugurlu O, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.113408; Valenzano L, 2011, CHEM MATER, V23, P1700, DOI 10.1021/cm1022882; Wan W, 2012, ULTRAMICROSCOPY, V115, P50, DOI 10.1016/j.ultramic.2012.01.013; Wei J, 2014, J PHYS CHEM LETT, V5, P3937, DOI 10.1021/jz502111u; Wiktor C, 2012, MICROPOR MESOPOR MAT, V162, P131, DOI 10.1016/j.micromeso.2012.06.014; Zandbergen HW, 1996, ULTRAMICROSCOPY, V64, P231, DOI 10.1016/0304-3991(96)00015-0; Zhu LK, 2013, CRYSTENGCOMM, V15, P9356, DOI 10.1039/c3ce41122b; Zhu YH, 2017, NAT MATER, V16, P532, DOI [10.1038/nmat4852, 10.1038/NMAT4852]; Zou X. D., 2011, ELECT CRYSTALLOGRAPH, P177	30	239	244	61	559	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					675	+		10.1126/science.aao0865	http://dx.doi.org/10.1126/science.aao0865			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2FH	29348363	Green Submitted			2022-12-28	WOS:000425117700038
J	Grohme, MA; Schloissnig, S; Rozanski, A; Pippel, M; Young, GR; Winkler, S; Brandl, H; Dahl, A; Powell, S; Hiller, M; Myers, E; Rink, JC				Grohme, Markus Alexander; Schloissnig, Siegfried; Rozanski, Andrei; Pippel, Martin; Young, George Robert; Winkler, Sylke; Brandl, Holger; Dahl, Andreas; Powell, Sean; Hiller, Michael; Myers, Eugene; Rink, Jochen Christian			The genome of Schmidtea mediterranea and the evolution of core cellular mechanisms	NATURE			English	Article							PLANARIAN STEM-CELLS; REGENERATION; CHECKPOINT; ANEUPLOIDY; REPAIR; TIME	The planarian Schmidtea mediterranea is an important model for stem cell research and regeneration, but adequate genome resources for this species have been lacking. Here we report a highly contiguous genome assembly of S. mediterranea, using long-read sequencing and a de novo assembler (MARVEL) enhanced for low-complexity reads. The S. mediterranea genome is highly polymorphic and repetitive, and harbours a novel class of giant retroelements. Furthermore, the genome assembly lacks a number of highly conserved genes, including critical components of the mitotic spindle assembly checkpoint, but planarians maintain checkpoint function. Our genome assembly provides a key model system resource that will be useful for studying regeneration and the evolutionary plasticity of core cell biological mechanisms.	[Grohme, Markus Alexander; Rozanski, Andrei; Winkler, Sylke; Brandl, Holger; Dahl, Andreas; Hiller, Michael; Myers, Eugene; Rink, Jochen Christian] Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany; [Schloissnig, Siegfried; Pippel, Martin; Powell, Sean] Heidelberg Inst Theoret Studies, Schloss Wolfsbrunnenweg 35, D-69118 Heidelberg, Germany; [Young, George Robert] Francis Crick Inst, 1 Midland Rd, London NW1 1AT, England; [Dahl, Andreas] Tech Univ Dresden, BIOTEC Ctr Regenerat Therapies Dresden, Deep Sequencing Grp, Cluster Excellence, Fetscherstr 105, D-01307 Dresden, Germany; [Hiller, Michael] Max Planck Inst Phys Komplexer Syst, Nothnitzer Str 38, D-01187 Dresden, Germany	Max Planck Society; Heidelberg Institute for Theoretical Studies; Francis Crick Institute; Technische Universitat Dresden; Max Planck Society	Myers, E; Rink, JC (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.; Schloissnig, S (corresponding author), Heidelberg Inst Theoret Studies, Schloss Wolfsbrunnenweg 35, D-69118 Heidelberg, Germany.	siegfried.schloissnig@h-its.org; myers@mpi-cbg.de; rink@mpi-cbg.de	Henry, Ian/J-7328-2019; Grohme, Markus/ABH-4373-2020; Dahl, Andreas/E-3783-2017; Powell, Sean/B-2374-2009; Young, George/C-6733-2009; Pippel, Martin/AGA-8156-2022	Henry, Ian/0000-0002-7134-3110; Grohme, Markus/0000-0002-4250-5600; Dahl, Andreas/0000-0002-2668-8371; Powell, Sean/0000-0002-0994-5911; Young, George/0000-0002-1203-588X; Pippel, Martin/0000-0002-8134-5929; Rozanski, Andrei/0000-0001-9082-2240	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program [649024]; Max Planck Society; Francis Crick Institute [FC001162]; Cancer Research UK; UK Medical Research Council; Wellcome Trust; The Francis Crick Institute [10162] Funding Source: researchfish	European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program(European Research Council (ERC)); Max Planck Society(Max Planck SocietyFoundation CELLEX); Francis Crick Institute; Cancer Research UK(Cancer Research UK); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute	We thank J.-H. Lee for multiple sequence alignments; T. Boothe and M. V. Farre for karyotyping; A. Hejnol, A. Desai and J. Mansfeld for critical reading of the manuscript; and DoveTail Genomics staff for graphical support. We thank the following MPI-CBG facilities for their support: DNA sequencing, Scientific computing and Light microscopy. We thank V. Benes and the EMBL GeneCore and A. Dahl and the Deep Sequencing Group (SFB 655/BIOTEC) for RNA sequencing, and S. von Kannen, H. Andreas, S. Clausing and N. Gscheidel for technical support. This project received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation program (grant agreement number 649024) and the Max Planck Society. G.R.Y. was supported by the Francis Crick Institute under award FC001162 (J. P. Stoye). The Crick Institute receives its core funding from Cancer Research UK, the UK Medical Research Council and the Wellcome Trust.	Brandl H, 2016, NUCLEIC ACIDS RES, V44, pD764, DOI 10.1093/nar/gkv1148; Cantarel BL, 2008, GENOME RES, V18, P188, DOI 10.1101/gr.6743907; Ceccaldi R, 2016, TRENDS CELL BIOL, V26, P52, DOI 10.1016/j.tcb.2015.07.009; Collins JJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003396; Eid J, 2009, SCIENCE, V323, P133, DOI 10.1126/science.1162986; Grudniewska M, 2016, ELIFE, V5, DOI 10.7554/eLife.20607; Guo LH, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-016-0019; Kang H, 2009, DEV DYNAM, V238, P1111, DOI 10.1002/dvdy.21928; Koren S, 2017, GENOME RES, V27, P722, DOI 10.1101/gr.215087.116; Lai AG, 2018, DEV BIOL, V433, P218, DOI 10.1016/j.ydbio.2017.07.023; Laumer CE, 2015, ELIFE, V4, DOI 10.7554/eLife.05503; Macas J, 2007, GENE, V390, P108, DOI 10.1016/j.gene.2006.08.007; MCWHINNIE MA, 1957, BIOL BULL, V112, P371, DOI 10.2307/1539130; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nishimura O, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143525; Nowoshilow S, 2018, NATURE, V554, P50, DOI 10.1038/nature25458; Onal P, 2012, EMBO J, V31, P2755, DOI 10.1038/emboj.2012.110; Putnam NH, 2016, GENOME RES, V26, P342, DOI 10.1101/gr.193474.115; Rancati G, 2008, CELL, V135, P879, DOI 10.1016/j.cell.2008.09.039; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rink JC, 2013, DEV GENES EVOL, V223, P67, DOI 10.1007/s00427-012-0426-4; Robb SMC, 2015, GENESIS, V53, P535, DOI 10.1002/dvg.22872; Salo E, 2012, INT J DEV BIOL, V56, P1, DOI 10.1387/ijdb.123495es; Santaguida S, 2015, NAT REV MOL CELL BIO, V16, P473, DOI 10.1038/nrm4025; Schockaert ER, 2008, HYDROBIOLOGIA, V595, P41, DOI 10.1007/s10750-007-9002-8; Sekelsky J, 2017, GENETICS, V205, P471, DOI 10.1534/genetics.116.186759; Silio V, 2015, DEV CELL, V35, P600, DOI 10.1016/j.devcel.2015.11.012; Stubenhaus BM, 2016, ELIFE, V5, DOI 10.7554/eLife.14175; Tsai IJ, 2013, NATURE, V496, P57, DOI 10.1038/nature12031; van Hooff JJE, 2017, EMBO REP, V18, P1559, DOI 10.15252/embr.201744102; Wagner DE, 2011, SCIENCE, V332, P811, DOI 10.1126/science.1203983; Wasik K, 2015, P NATL ACAD SCI USA, V112, P12462, DOI 10.1073/pnas.1516718112; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wurtzel O, 2015, DEV CELL, V35, P632, DOI 10.1016/j.devcel.2015.11.004	35	104	107	1	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2018	554	7690					56	+		10.1038/nature25473	http://dx.doi.org/10.1038/nature25473			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7QX	29364871	hybrid, Green Accepted, Green Published, Green Submitted			2022-12-28	WOS:000424048900030
J	Herbst, RS; Morgensztern, D; Boshoff, C				Herbst, Roy S.; Morgensztern, Daniel; Boshoff, Chris			The biology and management of non-small cell lung cancer	NATURE			English	Review							GROWTH-FACTOR RECEPTOR; OPEN-LABEL; EGFR-MUTATION; ACQUIRED-RESISTANCE; 1ST-LINE TREATMENT; STAGE IV; AMERICAN SOCIETY; PD-1 BLOCKADE; SINGLE-ARM; PHASE-III	Important advancements in the treatment of non-small cell lung cancer (NSCLC) have been achieved over the past two decades, increasing our understanding of the disease biology and mechanisms of tumour progression, and advancing early detection and multimodal care. The use of small molecule tyrosine kinase inhibitors and immunotherapy has led to unprecedented survival benefits in selected patients. However, the overall cure and survival rates for NSCLC remain low, particularly in metastatic disease. Therefore, continued research into new drugs and combination therapies is required to expand the clinical benefit to a broader patient population and to improve outcomes in NSCLC.	[Herbst, Roy S.; Boshoff, Chris] Yale Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA; [Morgensztern, Daniel] Washington Univ, Sch Med, St Louis, MO USA; [Boshoff, Chris] Pfizer Inc, New York, NY 10017 USA	Yale University; Washington University (WUSTL); Pfizer	Herbst, RS; Boshoff, C (corresponding author), Yale Sch Med, Yale Canc Ctr, New Haven, CT 06510 USA.; Boshoff, C (corresponding author), Pfizer Inc, New York, NY 10017 USA.	roy.herbst@yale.edu; chris.boshoff@pfizer.com			Yale SPORE in Lung Cancer [P50CA196530]	Yale SPORE in Lung Cancer	We would like to thank L. Chen and A. M. Incassati for editorial assistance. R. Herbst is supported by the Yale SPORE in Lung Cancer (P50CA196530).	Abbosh C, 2017, NATURE, V545, P446, DOI 10.1038/nature22364; Ahrendt SA, 2003, J NATL CANCER I, V95, P961, DOI 10.1093/jnci/95.13.961; Alberg AJ, 2013, CHEST, V143, pE1, DOI 10.1378/chest.12-2345; Antonia SJ, 2017, NEW ENGL J MED, V377, P1919, DOI 10.1056/NEJMoa1709937; Awad MM, 2016, J CLIN ONCOL, V34, P721, DOI 10.1200/JCO.2015.63.4600; Awad MM, 2013, NEW ENGL J MED, V368, P2395, DOI 10.1056/NEJMoa1215530; Bezu L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00187; Blakely CM, 2017, NAT GENET, V49, P1693, DOI 10.1038/ng.3990; Borghaei H, 2015, NEW ENGL J MED, V373, P1627, DOI 10.1056/NEJMoa1507643; Brahmer J, 2015, NEW ENGL J MED, V373, P123, DOI 10.1056/NEJMoa1504627; Brandon TH, 2015, J CLIN ONCOL, V33, P952, DOI 10.1200/JCO.2014.59.4465; Camidge DR, 2014, NAT REV CLIN ONCOL, V11, P473, DOI 10.1038/nrclinonc.2014.104; Carbone DP, 2017, NEW ENGL J MED, V376, P2415, DOI 10.1056/NEJMoa1613493; Cardarella S, 2013, CLIN CANCER RES, V19, P4532, DOI 10.1158/1078-0432.CCR-13-0657; Chang CH, 2015, CELL, V162, P1229, DOI 10.1016/j.cell.2015.08.016; Chen DS, 2017, NATURE, V541, P321, DOI 10.1038/nature21349; Chi A, 2017, RADIOTHER ONCOL, V123, P346, DOI 10.1016/j.radonc.2017.05.007; COLEY WB, 1991, CLIN ORTHOP RELAT R, P3; Collisson EA, 2014, NATURE, V511, P543, DOI 10.1038/nature13385; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Curran WJ, 2011, J NATL CANCER I, V103, P1452, DOI 10.1093/jnci/djr325; Davies KD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082236; DILLMAN RO, 1990, NEW ENGL J MED, V323, P940, DOI 10.1056/NEJM199010043231403; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Drilon A, 2017, CANCER DISCOV, V7, P963, DOI 10.1158/2159-8290.CD-17-0507; Drilon A, 2016, LANCET ONCOL, V17, P1653, DOI 10.1016/S1470-2045(16)30562-9; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Facchinetti F, 2017, CANCER TREAT REV, V55, P83, DOI 10.1016/j.ctrv.2017.02.010; Frampton GM, 2015, CANCER DISCOV, V5, P850, DOI 10.1158/2159-8290.CD-15-0285; Fukuoka M, 2003, J CLIN ONCOL, V21, P2237, DOI 10.1200/JCO.2003.10.038; Fukuoka M, 2011, J CLIN ONCOL, V29, P2866, DOI 10.1200/JCO.2010.33.4235; Gainor JF, 2016, CANCER DISCOV, V6, P1118, DOI 10.1158/2159-8290.CD-16-0596; Garon EB, 2015, NEW ENGL J MED, V372, P2018, DOI 10.1056/NEJMoa1501824; Garon EB, 2014, LANCET, V384, P665, DOI 10.1016/S0140-6736(14)60845-X; Gautschi O, 2017, J CLIN ONCOL, V35, P1403, DOI 10.1200/JCO.2016.70.9352; Gettinger S, 2017, CANCER DISCOV, V7, P1420, DOI 10.1158/2159-8290.CD-17-0593; Goldstraw P, 2016, J THORAC ONCOL, V11, P39, DOI 10.1016/j.jtho.2015.09.009; Hackshaw AK, 1997, BMJ-BRIT MED J, V315, P980, DOI 10.1136/bmj.315.7114.980; Hammerman PS, 2012, NATURE, V489, P519, DOI 10.1038/nature11404; Hanna N, 2017, J CLIN ONCOL, V35, P3484, DOI 10.1200/JCO.2017.74.6065; Hays JT, 2008, NEW ENGL J MED, V359, P2018, DOI 10.1056/NEJMct0800146; Hellmann MD, 2017, LANCET ONCOL, V18, P31, DOI [10.1016/S1470-2045(16)30624-6, 10.1016/s1470-2045(16)30624-6]; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Herbst RS, 2016, LANCET ONCOL, V17, P1464, DOI 10.1016/S1470-2045(16)30524-1; Herbst RS, 2016, LANCET, V387, P1540, DOI 10.1016/S0140-6736(15)01281-7; Herbst RS, 2015, CLIN CANCER RES, V21, P1514, DOI 10.1158/1078-0432.CCR-13-3473; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Hida T, 2017, LANCET, V390, P29, DOI 10.1016/S0140-6736(17)30565-2; Hirsch FR, 2017, LANCET, V389, P299, DOI 10.1016/S0140-6736(16)30958-8; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Holmgaard RB, 2013, J EXP MED, V210, P1389, DOI 10.1084/jem.20130066; Hyman D.M., 2017, J CLIN ONCOL, V35, DOI DOI 10.1200/JC0.2017.35.15_SUPPL.LBA2501; Hyman DM, 2015, NEW ENGL J MED, V373, P726, DOI 10.1056/NEJMoa1502309; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Janne PA, 2015, NEW ENGL J MED, V372, P1689, DOI 10.1056/NEJMoa1411817; Jia Y, 2016, NATURE, V534, P129, DOI 10.1038/nature17960; Kazandjian D, 2016, ONCOLOGIST, V21, P634, DOI 10.1634/theoncologist.2015-0507; Kim DW, 2017, J CLIN ONCOL, V35, P2490, DOI 10.1200/JCO.2016.71.5904; Kim ES, 2011, CANCER DISCOV, V1, P44, DOI 10.1158/2159-8274.CD-10-0010; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kohno T, 2012, NAT MED, V18, P375, DOI 10.1038/nm.2644; Koyama S, 2016, CANCER RES, V76, P999, DOI 10.1158/0008-5472.CAN-15-1439; Kris MG, 2017, J CLIN ONCOL, V35, P2960, DOI 10.1200/JCO.2017.72.4401; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; Kris MG, 2003, JAMA-J AM MED ASSOC, V290, P2149, DOI 10.1001/jama.290.16.2149; Kwak EL, 2010, NEW ENGL J MED, V363, P1693, DOI 10.1056/NEJMoa1006448; Langer CJ, 2016, LANCET ONCOL, V17, P1497, DOI 10.1016/S1470-2045(16)30498-3; Lawler SE, 2017, JAMA ONCOL, V3, P841, DOI 10.1001/jamaoncol.2016.2064; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lemmon MA, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a020768; Liang H., 2017, ANN SURG; Lim SM, 2017, J CLIN ONCOL, V35, P2613, DOI 10.1200/JCO.2016.71.3701; Lin JJ, 2017, CANCER DISCOV, V7, P137, DOI 10.1158/2159-8290.CD-16-1123; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Marchetti A, 2011, J CLIN ONCOL, V29, P3574, DOI 10.1200/JCO.2011.35.9638; Mazieres J, 2016, ANN ONCOL, V27, P281, DOI 10.1093/annonc/mdv573; Mazieres J, 2013, J CLIN ONCOL, V31, P1997, DOI 10.1200/JCO.2012.45.6095; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Mok TS, 2017, NEW ENGL J MED, V376, P629, DOI 10.1056/NEJMoa1612674; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Morgensztern D, 2010, J THORAC ONCOL, V5, P29, DOI 10.1097/JTO.0b013e3181c5920c; Niederst MJ, 2015, CLIN CANCER RES, V21, P3924, DOI 10.1158/1078-0432.CCR-15-0560; Okabe T, 2007, CANCER RES, V67, P2046, DOI 10.1158/0008-5472.CAN-06-3339; Oxnard GR, 2016, J CLIN ONCOL, V34, P3375, DOI 10.1200/JCO.2016.66.7162; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Paik PK, 2015, CANCER DISCOV, V5, P842, DOI 10.1158/2159-8290.CD-14-1467; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Paz-Ares L, 2017, ANN ONCOL, V28, P270, DOI 10.1093/annonc/mdw611; Peters S, 2017, NEW ENGL J MED, V377, P829, DOI 10.1056/NEJMoa1704795; Planchard D, 2016, LANCET ONCOL, V17, P984, DOI 10.1016/S1470-2045(16)30146-2; Planchard D, 2016, LANCET ONCOL, V17, P642, DOI 10.1016/S1470-2045(16)00077-2; Reck M, 2017, NEW ENGL J MED, V377, P849, DOI 10.1056/NEJMra1703413; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Robinson DR, 2017, NATURE, V548, P297, DOI 10.1038/nature23306; Romero R, 2017, NAT MED, V23, P1362, DOI 10.1038/nm.4407; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Sahin U, 2017, NATURE, V547, P222, DOI 10.1038/nature23003; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Sequist LV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002003; Shahab L, 2017, ANN INTERN MED, V166, P390, DOI 10.7326/M16-1107; Sharma P., 2017, NAT MED, V23, P1362; Sharma SV, 2007, NAT REV CANCER, V7, P169, DOI 10.1038/nrc2088; Shaw AT, 2017, LANCET ONCOL, V18, P1590, DOI 10.1016/S1470-2045(17)30680-0; Shaw AT, 2016, LANCET ONCOL, V17, P234, DOI 10.1016/S1470-2045(15)00488-X; Shaw AT, 2014, NEW ENGL J MED, V371, P1963, DOI 10.1056/NEJMoa1406766; Shaw AT, 2014, NEW ENGL J MED, V370, P2537, DOI 10.1056/NEJMc1404894; Shaw AT, 2013, NEW ENGL J MED, V368, P2385, DOI 10.1056/NEJMoa1214886; Shepherd FA, 2005, NEW ENGL J MED, V353, P123, DOI 10.1056/NEJMoa050753; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]; Soria JC, 2017, N ENGL J MED; Soria JC, 2017, LANCET, V389, P917, DOI 10.1016/S0140-6736(17)30123-X; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Thatcher N, 2015, LANCET ONCOL, V16, P763, DOI 10.1016/S1470-2045(15)00021-2; Thress KS, 2015, NAT MED, V21, P560, DOI 10.1038/nm.3854; Tian L, 2017, NATURE, V544, P250, DOI 10.1038/nature21724; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Uchibori K, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14768; Vineis P, 2005, BRIT MED J, V330, P277, DOI 10.1136/bmj.38327.648472.82; Voron T, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00070; Wheeler DL, 2010, NAT REV CLIN ONCOL, V7, P493, DOI 10.1038/nrclinonc.2010.97; Wu YL, 2017, LANCET ONCOL, V18, P1454, DOI 10.1016/S1470-2045(17)30608-3; Yang JCH, 2015, LANCET ONCOL, V16, P141, DOI 10.1016/S1470-2045(14)71173-8; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958; Zhang JJ, 2014, SCIENCE, V346, P256, DOI 10.1126/science.1256930; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Zitvogel L, 2013, IMMUNITY, V39, P74, DOI 10.1016/j.immuni.2013.06.014	139	1829	1907	68	712	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2018	553	7689					446	454		10.1038/nature25183	http://dx.doi.org/10.1038/nature25183			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU6OE	29364287				2022-12-28	WOS:000423971100031
J	Honig, LS; Vellas, B; Woodward, M; Boada, M; Bullock, R; Borrie, M; Hager, K; Andreasen, N; Scarpini, E; Liu-Seifert, H; Case, M; Dean, RA; Hake, A; Sundell, K; Hoffmann, VP; Carlson, C; Khanna, R; Mintun, M; DeMattos, R; Selzler, KJ; Siemers, E				Honig, Lawrence S.; Vellas, Bruno; Woodward, Michael; Boada, Merce; Bullock, Roger; Borrie, Michael; Hager, Klaus; Andreasen, Niels; Scarpini, Elio; Liu-Seifert, Hong; Case, Michael; Dean, Robert A.; Hake, Ann; Sundell, Karen; Hoffmann, Vicki Poole; Carlson, Christopher; Khanna, Rashna; Mintun, Mark; DeMattos, Ronald; Selzler, Katherine J.; Siemers, Eric			Trial of Solanezumab for Mild Dementia Due to Alzheimer's Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							A-BETA BURDEN; AMYLOID HYPOTHESIS; CLINICAL-TRIALS; RATING-SCALE; BAPINEUZUMAB; MODEL	BACKGROUND Alzheimer's disease is characterized by amyloid-beta (A beta) plaques and neurofibrillary tangles. The humanized monoclonal antibody solanezumab was designed to increase the clearance from the brain of soluble A beta, peptides that may lead to toxic effects in the synapses and precede the deposition of fibrillary amyloid. METHODS We conducted a double-blind, placebo-controlled, phase 3 trial involving patients with mild dementia due to Alzheimer's disease, defined as a Mini-Mental State Examination (MMSE) score of 20 to 26 (on a scale from 0 to 30, with higher scores indicating better cognition) and with amyloid deposition shown by means of florbetapir positron-emission tomography or A beta 1-42 measurements in cerebrospinal fluid. Patients were randomly assigned to receive solanezumab at a dose of 400 mg or placebo intravenously every 4 weeks for 76 weeks. The primary outcome was the change from baseline to week 80 in the score on the 14-item cognitive subscale of the Alzheimer's Disease Assessment Scale (ADAS-cog14; scores range from 0 to 90, with higher scores indicating greater cognitive impairment). RESULTS A total of 2129 patients were enrolled, of whom 1057 were assigned to receive solanezumab and 1072 to receive placebo. The mean change from baseline in the ADAS-cog14 score was 6.65 in the solanezumab group and 7.44 in the placebo group, with no significant between-group difference at week 80 (difference, -0.80; 95% confidence interval, -1.73 to 0.14; P = 0.10). As a result of the failure to reach significance with regard to the primary outcome in the prespecified hierarchical analysis, the secondary outcomes were considered to be descriptive and are reported without significance testing. The change from baseline in the MMSE score was -3.17 in the solanezumab group and -3.66 in the placebo group. Adverse cerebral edema or effusion lesions that were observed on magnetic resonance imaging after randomization occurred in 1 patient in the solanezumab group and in 2 in the placebo group. CONCLUSIONS Solanezumab at a dose of 400 mg administered every 4 weeks in patients with mild Alzheimer's disease did not significantly affect cognitive decline.	[Honig, Lawrence S.] Columbia Univ, Med Ctr, Dept Neurol, New York, NY USA; [Honig, Lawrence S.] Columbia Univ, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, New York, NY USA; [Vellas, Bruno] Univ Toulouse III Paul Sabatier, INSERM, CHU Toulouse, Gerontopole,Unite Mixte Rech,Unite 1027, Toulouse, France; [Woodward, Michael] Austin Hlth Continuing Care Clin Serv Unit, Heidelberg, Vic, Australia; [Woodward, Michael] Univ Melbourne, Melbourne, Vic, Australia; [Boada, Merce] Fundacio ACE, Alzheimer Res Ctr, Barcelona, Spain; [Boada, Merce] Inst Catala Neurociencies Aplicades, Memory Clin, Barcelona, Spain; [Bullock, Roger] Victoria Hosp, Kingshill Res Ctr, Swindon, Wilts, England; [Borrie, Michael] Western Univ, Schulich Sch Med & Dent, Div Geriatr Med, London, ON, Canada; [Hager, Klaus] Diakovere Henriettenstift, Clin Med Elderly, Hannover, Germany; [Andreasen, Niels] Karolinska Univ Hosp, Karolinska Inst, Alzheimers Dis Res Ctr, Huddinge, Sweden; [Andreasen, Niels] Karolinska Univ Hosp, Clin Trial Unit, Geriatr Clin, Huddinge, Sweden; [Scarpini, Elio] Univ Milan, Fdn Ca Granda,Dino Ferrari Ctr, Ist Ricovero & Cura Carattere Sci,Neurol Unit, Osped Policlin,Dept Pathophysiol & Transplantat, Milan, Italy; [Liu-Seifert, Hong; Case, Michael; Hake, Ann; Sundell, Karen; Hoffmann, Vicki Poole; Carlson, Christopher; Khanna, Rashna; Mintun, Mark; DeMattos, Ronald; Selzler, Katherine J.; Siemers, Eric] Eli Lilly, Indianapolis, IN USA; [Dean, Robert A.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Mintun, Mark] Avid Radiopharmaceut, Philadelphia, PA USA	Columbia University; Columbia University; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; University of Melbourne; Western University (University of Western Ontario); Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; Eli Lilly; Indiana University System; Indiana University Bloomington	Honig, LS (corresponding author), Columbia Univ, Coll Phys & Surg, Med Ctr, Taub Inst Res Alzheimers Dis & Aging Brain, 630 W 168th St P&S Unit 16, New York, NY 10032 USA.	lh456@cumc.columbia.edu	Iwata, Atsushi/AAH-8924-2019; Borrie, Michael/G-3280-2011	Iwata, Atsushi/0000-0001-7308-5314; 	Eli Lilly; Bristol-Myers Squibb; Eisai; Forum Pharmaceuticals; Lundbeck; Fujirebio; AbbVie; Axovant; Biogen; C2N Diagnostics; Genentech; Janssen-Johnson Johnson; Merck; Pfizer; Roche; TauRx; vTv Therapeutics; Pierre Fabre; Regeneron; AstraZeneca; LPG Systems; Alzheon; MSD; Otsuka; Sanofi; Nestle; Transition Therapeutics; Takeda Pharmaceutical; Cognition Therapeutics (CogRx); Nutricia; Buck Institute for Research on Aging; Servier; Prana Biotechnology; Takeda Pharmaceutical-Zinfandel Pharmaceuticals; Novartis; Araclon Biotech; Grifols; Krka; Dr. Willmar Schwabe Pharmaceuticals; Janssen; Kyowa Hakko Kirin; Piramal; Fundacio La Caixa; Bioiberica; Mediti Pharma; Seqirus	Eli Lilly(Eli Lilly); Bristol-Myers Squibb(Bristol-Myers Squibb); Eisai(Eisai Co Ltd); Forum Pharmaceuticals; Lundbeck(Lundbeck Corporation); Fujirebio; AbbVie(AbbVie); Axovant; Biogen(Biogen); C2N Diagnostics; Genentech(Roche HoldingGenentech); Janssen-Johnson Johnson(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Merck(Merck & Company); Pfizer(Pfizer); Roche(Roche Holding); TauRx; vTv Therapeutics; Pierre Fabre; Regeneron(Regeneron); AstraZeneca(AstraZeneca); LPG Systems; Alzheon; MSD; Otsuka(Otsuka Pharmaceutical); Sanofi; Nestle(Nestle SA); Transition Therapeutics; Takeda Pharmaceutical(Takeda Pharmaceutical Company Ltd); Cognition Therapeutics (CogRx); Nutricia(Danone Nutricia); Buck Institute for Research on Aging; Servier(Servier); Prana Biotechnology; Takeda Pharmaceutical-Zinfandel Pharmaceuticals(Takeda Pharmaceutical Company Ltd); Novartis(Novartis); Araclon Biotech; Grifols; Krka; Dr. Willmar Schwabe Pharmaceuticals; Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Kyowa Hakko Kirin(Kyowa Kirin Ltd); Piramal; Fundacio La Caixa(La Caixa FoundationEuropean Commission); Bioiberica; Mediti Pharma(Dexcel Pharma); Seqirus	Supported by Eli Lilly.; Dr. Honig reports receiving grant support and consulting fees from Bristol-Myers Squibb, Eisai, Forum Pharmaceuticals, and Lundbeck, grant support and travel support from Eli Lilly, consulting fees from Fujirebio, and grant support from AbbVie, AstraZeneca, Axovant, Biogen, C2N Diagnostics, Genentech, Janssen-Johnson & Johnson, Merck, Pfizer, Roche, TauRx, and vTv Therapeutics; Dr. Vellas, receiving grant support from AbbVie, Pierre Fabre, Regeneron, AstraZeneca, LPG Systems, and Alzheon, grant support and consulting fees from Eli Lilly, Lundbeck, MSD, Otsuka, Roche, Sanofi, and Nestle, and consulting fees from Biogen, Transition Therapeutics, and Takeda Pharmaceutical; Dr. Woodward, receiving grant and travel support and consulting fees from Cognition Therapeutics (CogRx), Nutricia, Merck, Eli Lilly, and Lundbeck, consulting fees and travel support from Seqirus, and grant support from Bristol-Myers Squibb, Eisai, Forum Pharmaceuticals, AbbVie, AstraZeneca, Axovant, Biogen, Buck Institute for Research on Aging, Servier, Sanofi, Genentech, Janssen-Johnson & Johnson, Pfizer, Roche, Prana Biotechnology, Takeda Pharmaceutical-Zinfandel Pharmaceuticals, Novartis, TauRx, and vTv Therapeutics; Dr. Boada, receiving consulting fees, lecture fees, and grant support from Araclon Biotech and Grifols, consulting fees and grant support from Eli Lilly, MSD, Nutricia, and Roche, lecture fees and grant support from Krka, consulting fees and lecture fees from Dr. Willmar Schwabe Pharmaceuticals, consulting fees from AstraZeneca, Janssen, Kyowa Hakko Kirin, and Servier, and grant support from Piramal, Biogen, Fundacio La Caixa, and Bioiberica; Dr. Bullock, serving on an advisory board for Eli Lilly; Dr. Borrie, receiving consulting fees and fees for serving on an advisory board from Eli Lilly and Roche, consulting fees from Mediti Pharma, and grant support from Bristol-Myers Squibb, Eisai, Forum Pharmaceuticals, Lundbeck, Biogen, Genentech, Janssen-Johnson & Johnson, Merck, and Pfizer; Dr. Scarpini, receiving fees for serving on an advisory board for Eli Lilly; Dr. Liu-Seifert, Mr. Case, Dr. Hake, Dr. Khanna, and Dr. Selzler, being employed by and being shareholders in Eli Lilly; Dr. Dean, Ms. Sundell, Dr. Poole Hoffmann, Dr. Carlson, and Dr. Siemers, being formerly employed by and holding stock in Eli Lilly; Dr. Mintun, being employed by Eli Lilly and Avid Radiopharmaceuticals; and Dr. DeMattos, being employed by Eli Lilly and holding a patent (U.S. patent number, 7195761 B2) for humanized antibodies that sequester amyloid-beta peptide, for which no royalties have been received. No other potential conflict of interest relevant to this article was reported.	Bateman RJ, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt59; BERG L, 1992, ANN NEUROL, V31, P242, DOI 10.1002/ana.410310303; DeMattos RB, 2001, P NATL ACAD SCI USA, V98, P8850, DOI 10.1073/pnas.151261398; Dodart JC, 2002, NAT NEUROSCI, V5, P452, DOI 10.1038/nn842; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galasko D, 2004, J AM GERIATR SOC, V52, P1070, DOI 10.1111/j.1532-5415.2004.52303.x; Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hardy J, 2017, BRAIN, V140, P853, DOI 10.1093/brain/awx059; Harrison JR, 2016, BRIT J PSYCHIAT, V208, P1, DOI 10.1192/bjp.bp.115.167569; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Jucker M, 2013, NATURE, V501, P45, DOI 10.1038/nature12481; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mohs RC, 1997, ALZ DIS ASSOC DIS, V11, pS13; O'Bryant SE, 2008, ARCH NEUROL-CHICAGO, V65, P1091, DOI 10.1001/archneur.65.8.1091; Ostrowitzki S, 2012, ARCH NEUROL-CHICAGO, V69, P198, DOI 10.1001/archneurol.2011.1538; PFEFFER RI, 1982, J GERONTOL, V37, P323, DOI 10.1093/geronj/37.3.323; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; Salloway S, 2009, NEUROLOGY, V73, P2061, DOI 10.1212/WNL.0b013e3181c67808; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; SELKOE DJ, 1991, NEURON, V6, P487, DOI 10.1016/0896-6273(91)90052-2; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Siemers ER, 2016, ALZHEIMERS DEMENT, V12, P110, DOI [10.1016/j.jalz.2015.06.1893, 10.1016/j.dadm.2016.02.006]; Sperling R, 2012, LANCET NEUROL, V11, P241, DOI 10.1016/S1474-4422(12)70015-7; Wessels AM, 2015, J PREZ ALZ DIS, V2, P227	27	536	546	3	117	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 25	2018	378	4					321	330		10.1056/NEJMoa1705971	http://dx.doi.org/10.1056/NEJMoa1705971			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT5ZX	29365294	Bronze, Green Published			2022-12-28	WOS:000423233400005
J	Murayama, Y; Samora, CP; Kurokawa, Y; Iwasaki, H; Uhlmann, F				Murayama, Yasuto; Samora, Catarina P.; Kurokawa, Yumiko; Iwasaki, Hiroshi; Uhlmann, Frank			Establishment of DNA-DNA Interactions by the Cohesin Ring	CELL			English	Article							SISTER-CHROMATID COHESION; SACCHAROMYCES-CEREVISIAE; FISSION YEAST; SMC5/6 COMPLEX; WAPL CONTROLS; S-PHASE; REPLICATION; ASSOCIATION; ACETYLATION; MAINTENANCE	The ring-shaped structural maintenance of chromosome (SMC) complexes are multi-subunit ATPases that topologically encircle DNA. SMC rings make vital contributions to numerous chromosomal functions, including mitotic chromosome condensation, sister chromatid cohesion, DNA repair, and transcriptional regulation. They are thought to do so by establishing interactions between more than one DNA. Here, we demonstrate DNA-DNA tethering by the purified fission yeast cohesin complex. DNA-bound cohesin efficiently and topologically captures a second DNA, but only if that is single-stranded DNA (ssDNA). Like initial double-stranded DNA (dsDNA) embrace, second ssDNA capture is ATP-dependent, and it strictly requires the cohesin loader complex. Second-ssDNA capture is relatively labile but is converted into stable dsDNA-dsDNA cohesion through DNA synthesis. Our study illustrates second-DNA capture by an SMC complex and provides a molecular model for the establishment of sister chromatid cohesion.	[Murayama, Yasuto; Iwasaki, Hiroshi; Uhlmann, Frank] Tokyo Inst Technol, Inst Innovat Res, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528550, Japan; [Samora, Catarina P.; Uhlmann, Frank] Francis Crick Inst, Chromosome Segregat Lab, 1 Midland Rd, London NW1 1AT, England; [Kurokawa, Yumiko] Tokyo Inst Technol, Educ Acad Computat Life Sci, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528550, Japan; [Murayama, Yasuto; Kurokawa, Yumiko] Natl Inst Genet, Ctr Frontier Res, Chromosome Biochem Lab, 1111 Yata, Mishima, Shizuoka 4118540, Japan; [Murayama, Yasuto] SOKENDAI Grad Univ Adv Studies, Dept Genet, 1111 Yata, Mishima, Shizuoka 4118540, Japan	Tokyo Institute of Technology; Francis Crick Institute; Tokyo Institute of Technology; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan	Murayama, Y (corresponding author), Tokyo Inst Technol, Inst Innovat Res, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528550, Japan.; Murayama, Y (corresponding author), Natl Inst Genet, Ctr Frontier Res, Chromosome Biochem Lab, 1111 Yata, Mishima, Shizuoka 4118540, Japan.; Murayama, Y (corresponding author), SOKENDAI Grad Univ Adv Studies, Dept Genet, 1111 Yata, Mishima, Shizuoka 4118540, Japan.	ystmurayama@nig.ac.jp	Iwasaki, Hiroshi/Y-7946-2018	Iwasaki, Hiroshi/0000-0002-0153-6873; Uhlmann, Frank/0000-0002-3527-6619	Japan Society for the Promotion of Science (JSPS) [16H06160, 16H01404]; Tomizawa Jun-Ichi & Keiko Fund of the Molecular Biology Society of Japan; JSPS [15H059749]; European Research Council [670412]; Francis Crick Institute - Cancer Research UK [FC001198]; UK Medical Research Council [FC001198]; Wellcome Trust [FC001198]; The Francis Crick Institute [10198] Funding Source: researchfish	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Tomizawa Jun-Ichi & Keiko Fund of the Molecular Biology Society of Japan; JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); European Research Council(European Research Council (ERC)European Commission); Francis Crick Institute - Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); The Francis Crick Institute	We would like to thank A. Marston for yeast strains; K. Shirahige for the acetylSmc3 antibody; J. Diffley for plasmids to overexpress RPA; and T. Toda, C. Bouchoux, and our laboratory members for discussion and critical reading of the manuscript. This work was supported by a grant-in-aid for young scientist (A)(16H06160), grant-in-aid for scientific research on innovative areas (16H01404) from the Japan Society for the Promotion of Science (JSPS) and the Tomizawa Jun-Ichi & Keiko Fund of the Molecular Biology Society of Japan to Y.M. H.I. was supported by a grant-in-aid for scientific research on innovative areas (15H059749) from JSPS. C.P.S. and F.U. were supported by the European Research Council (grant agreement no. 670412) and The Francis Crick Institute, which receives its core funding from Cancer Research UK (FC001198), the UK Medical Research Council (FC001198), and the Wellcome Trust (FC001198).	Abe T, 2016, ONCOTARGET, V7, P67934, DOI 10.18632/oncotarget.11982; Akai Y, 2011, OPEN BIOL, V1, DOI 10.1098/rsob.110023; Alt A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14011; Amberg DC., 2005, METHODS YEAST GENETI; Beckouet F, 2016, MOL CELL, V61, P563, DOI 10.1016/j.molcel.2016.01.026; Ben-Shahar TR, 2008, SCIENCE, V321, P563, DOI 10.1126/science.1157774; Bernard P, 2006, CURR BIOL, V16, P875, DOI 10.1016/j.cub.2006.03.037; Borges V, 2013, CHROMOSOMA, V122, P121, DOI 10.1007/s00412-013-0396-y; Chao WCH, 2015, CELL REP, V12, P719, DOI 10.1016/j.celrep.2015.06.071; Cuylen S, 2011, NAT STRUCT MOL BIOL, V18, P894, DOI 10.1038/nsmb.2087; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Fernius J, 2013, CURR BIOL, V23, P599, DOI 10.1016/j.cub.2013.02.022; Fernius J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000629; Feytout A, 2011, MOL CELL BIOL, V31, P1771, DOI 10.1128/MCB.01284-10; FOIANI M, 1994, MOL CELL BIOL, V14, P923, DOI 10.1128/MCB.14.2.923; Forsburg SL, 2006, YEAST, V23, P173, DOI 10.1002/yea.1347; Furuya K, 1998, GENE DEV, V12, P3408, DOI 10.1101/gad.12.21.3408; Hadjur S, 2009, NATURE, V460, P410, DOI 10.1038/nature08079; Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098; Hanna JS, 2001, MOL CELL BIOL, V21, P3144, DOI 10.1128/MCB.21.9.3144-3158.2001; Hirano T, 2016, CELL, V164, P847, DOI 10.1016/j.cell.2016.01.033; Jeppsson K, 2014, NAT REV MOL CELL BIO, V15, P601, DOI 10.1038/nrm3857; Kanno T, 2015, CELL REP, V12, P1471, DOI 10.1016/j.celrep.2015.07.048; Kouzine F, 2013, CELL, V153, P988, DOI 10.1016/j.cell.2013.04.033; Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040; Kurokawa Y, 2008, PLOS BIOL, V6, P836, DOI 10.1371/journal.pbio.0060088; Ladurner R, 2014, CURR BIOL, V24, P2228, DOI 10.1016/j.cub.2014.08.011; Lengronne A, 2006, MOL CELL, V23, P787, DOI 10.1016/j.molcel.2006.08.018; Lindroos HB, 2006, MOL CELL, V22, P755, DOI 10.1016/j.molcel.2006.05.014; Liu JL, 2008, ANNU REV GENOM HUM G, V9, P303, DOI 10.1146/annurev.genom.9.081307.164211; Lopez-Serra L, 2013, CURR BIOL, V23, P64, DOI 10.1016/j.cub.2012.11.030; Michaelis C, 1997, CELL, V91, P35, DOI 10.1016/S0092-8674(01)80007-6; Murayama Y, 2015, CELL, V163, P1628, DOI 10.1016/j.cell.2015.11.030; Murayama Y, 2014, NATURE, V505, P367, DOI 10.1038/nature12867; Nasmyth K, 2011, NAT CELL BIOL, V13, P1170, DOI 10.1038/ncb2349; Niki H, 2016, SCI REP-UK, V6, DOI 10.1038/srep29469; Onn I, 2011, P NATL ACAD SCI USA, V108, P12198, DOI 10.1073/pnas.1107504108; Peters JM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011130; Samora CP, 2016, MOL CELL, V63, P371, DOI 10.1016/j.molcel.2016.05.036; Strom L, 2007, SCIENCE, V317, P242, DOI 10.1126/science.1140649; Sutani T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8815; Tanaka K, 2001, EMBO J, V20, P5779, DOI 10.1093/emboj/20.20.5779; Tittel-Elmer M, 2012, MOL CELL, V48, P98, DOI 10.1016/j.molcel.2012.07.004; Tomonaga T, 2000, GENE DEV, V14, P2757, DOI 10.1101/gad.832000; Unal E, 2007, SCIENCE, V317, P245, DOI 10.1126/science.1140637; Uhlmann F, 2000, CELL, V103, P375, DOI 10.1016/S0092-8674(00)00130-6; Uhlmann F, 2016, NAT REV MOL CELL BIO, V17, P399, DOI 10.1038/nrm.2016.30; Unal E, 2008, SCIENCE, V321, P566, DOI 10.1126/science.1157880; Van Driessche B, 2005, YEAST, V22, P1061, DOI 10.1002/yea.1293; Wilhelm L, 2015, ELIFE, V4, DOI 10.7554/eLife.06659; Yeeles JTP, 2015, NATURE, V519, P431, DOI 10.1038/nature14285; Zhang NG, 2008, J CELL BIOL, V183, P1019, DOI 10.1083/jcb.200801157	52	72	73	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2018	172	3					465	+		10.1016/j.cell.2017.12.021	http://dx.doi.org/10.1016/j.cell.2017.12.021			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FT9BS	29358048	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000423447600008
J	Raff, M				Raff, Martin			Ben Barres (1954-2017) A passionate neuroscientist and advocate of equal opportunity in the sciences	SCIENCE			English	Biographical-Item									[Raff, Martin] UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England	MRC Laboratory Molecular Biology; University of London; University College London	Raff, M (corresponding author), UCL, MRC Lab Mol Cell Biol, London WC1E 6BT, England.	m.raff@ucl.ac.uk							0	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					280	280		10.1126/science.aas9270	http://dx.doi.org/10.1126/science.aas9270			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6BB	29348227				2022-12-28	WOS:000423236700023
J	Kraut, JA; Mullins, ME				Kraut, Jeffrey A.; Mullins, Michael E.			Toxic Alcohols	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ETHYLENE-GLYCOL; DIETHYLENE GLYCOL; ANION-GAP; METHANOL INTOXICATION; ANTIFREEZE INGESTION; PRACTICE GUIDELINES; CLINICAL-FEATURES; AMERICAN-ACADEMY; CALCIUM-OXALATE; DIGLYCOLIC ACID	Poisonings by the toxic alcohols (methanol, ethylene glycol, isopropanol, diethylene glycol, and propylene glycol) are potentially fatal. This review summarizes the mechanisms of toxicity, methods of diagnosis, and current recommendations for treatment.	[Kraut, Jeffrey A.] Vet Hlth Adm Greater Los Angeles VHAGLA Healthcar, Med Serv, Los Angeles, CA USA; [Kraut, Jeffrey A.] Vet Hlth Adm Greater Los Angeles VHAGLA Healthcar, Res Serv, Los Angeles, CA USA; [Kraut, Jeffrey A.] Vet Hlth Adm Greater Los Angeles VHAGLA Healthcar, Div Nephrol, Los Angeles, CA USA; [Kraut, Jeffrey A.] Univ Calif Los Angeles, David Geffen Sch Med, Biochim Membranes Lab, Los Angeles, CA 90095 USA; [Mullins, Michael E.] Washington Univ, Sch Med, Div Emergency Med, St Louis, MO USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Washington University (WUSTL)	Kraut, JA (corresponding author), VHAGLA Healthcare Syst, Div Nephrol, 11301 Wilshire Blvd,Bldg 500,Rm 6018, Los Angeles, CA 90073 USA.	jkraut@ucla.edu		Mullins, Michael E./0000-0001-8605-0217				Abramson S, 2000, CURR OPIN NEPHROL HY, V9, P695, DOI 10.1097/00041552-200011000-00017; Alhamad Tarek, 2013, J Nephropathol, V2, P139, DOI 10.12860/JNP.2013.23; Ammar KA, 1996, AM J KIDNEY DIS, V27, P130, DOI 10.1016/S0272-6386(96)90040-2; [Anonymous], 2009, ANT FOM HIGHL PRESCR; Anseeuw K, 2008, EUR J EMERG MED, V15, P107, DOI 10.1097/MEJ.0b013e3282f3c13b; Barceloux DG, 1999, J TOXICOL-CLIN TOXIC, V37, P537; Barceloux DG, 2002, J TOXICOL-CLIN TOXIC, V40, P415; Beatty L, 2013, EMERG MED INT, V2013, DOI 10.1155/2013/638057; BENNETT IL, 1953, MEDICINE, V32, P431, DOI 10.1097/00005792-195312000-00002; Borron SW, 1999, LANCET, V354, P831; Borron SW, 1997, VET HUM TOXICOL, V39, P26; Brent J, 1999, NEW ENGL J MED, V340, P832, DOI 10.1056/NEJM199903183401102; Brent J, 2010, CLIN TOXICOL, V48, P401, DOI 10.3109/15563650.2010.495347; Brent J, 2009, NEW ENGL J MED, V360, P2216, DOI 10.1056/NEJMct0806112; Brophy PD, 2000, AM J KIDNEY DIS, V35, P958, DOI 10.1016/S0272-6386(00)70270-8; CANTARELL MC, 1987, ANN INTERN MED, V106, P478, DOI 10.7326/0003-4819-106-3-478_2; Casavant MJ, 2001, PEDIATRICS, V107, P113, DOI 10.1542/peds.107.1.113; Devoti E, 2015, AM J KIDNEY DIS, V65, P603, DOI 10.1053/j.ajkd.2014.07.032; DORWART WV, 1975, CLIN CHEM, V21, P190; Eder AF, 1998, CLIN CHEM, V44, P168; Ghannoum M, 2014, SEMIN DIALYSIS, V27, P395, DOI 10.1111/sdi.12237; Guo CG, 2007, TOXICOL LETT, V173, P8, DOI 10.1016/j.toxlet.2007.06.010; Hack JB, 2007, ACAD EMERG MED, V14, P1130, DOI 10.1197/j.aem.2007.07.017; Haviv YS, 1998, AM J NEPHROL, V18, P436, DOI 10.1159/000013366; Hirsch DJ, 2001, KIDNEY INT, V60, P2021, DOI 10.1046/j.1523-1755.2001.00003.x; Hodgman M, 2017, J MED TOXICOL, V13, P153, DOI 10.1007/s13181-017-0598-4; Hovda KE, 2005, CLIN NEPHROL, V64, P190; Hovda KE, 2005, J ANAL TOXICOL, V29, P586, DOI 10.1093/jat/29.6.586; Hovda KE, 2005, J INTERN MED, V258, P181, DOI 10.1111/j.1365-2796.2005.01521.x; Hovda KE, 2004, INTENS CARE MED, V30, P1842, DOI 10.1007/s00134-004-2373-7; Hovda KE, 2007, CLIN TOXICOL, V45, P516, DOI 10.1080/15563650701354150; Hunderi OH, 2006, SCAND J UROL NEPHROL, V40, P70, DOI 10.1080/00365590500190755; IBERTI TJ, 1990, CRIT CARE MED, V18, P275, DOI 10.1097/00003246-199003000-00005; JACOBSEN D, 1986, MED TOXICOL ADV DRUG, V1, P309, DOI 10.1007/BF03259846; JACOBSEN D, 1988, MED TOXICOL ADV DRUG, V3, P418, DOI 10.1007/BF03259893; Jorens PG, 2004, J TOXICOL-CLIN TOXIC, V42, P163, DOI 10.1081/CLT-120030942; Juenke JM, 2011, AM J CLIN PATHOL, V136, P318, DOI 10.1309/AJCPOB9YPQIYKGLJ; Kapitein B, 2014, ANN PHARMACOTHER, V48, P940, DOI 10.1177/1060028014529744; Karayel F, 2010, AM J FOREN MED PATH, V31, P34, DOI 10.1097/PAF.0b013e3181c160d9; Krasowski MD, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-1; Kraut JA, 2015, CLIN TOXICOL, V53, P589, DOI 10.3109/15563650.2015.1056880; Kraut JA, 2013, CLIN J AM SOC NEPHRO, V8, P2018, DOI 10.2215/CJN.04040413; Kraut JA, 2011, AM J KIDNEY DIS, V58, P480, DOI 10.1053/j.ajkd.2011.05.018; Krautt JA, 2008, CLIN J AM SOC NEPHRO, V3, P208, DOI 10.2215/CJN.03220807; Ku E, 2009, AM J KIDNEY DIS, V54, P385, DOI 10.1053/j.ajkd.2009.05.006; Landry GM, 2011, TOXICOL SCI, V124, P35, DOI 10.1093/toxsci/kfr204; Latus J, 2012, CLIN KIDNEY J, V5, P120, DOI 10.1093/ckj/sfs009; Lepik KJ, 2009, ANN EMERG MED, V53, P439, DOI 10.1016/j.annemergmed.2008.05.008; MAHIEU P, 1989, HUM TOXICOL, V8, P135, DOI 10.1177/096032718900800209; McMartin K, 2016, BRIT J CLIN PHARMACO, V81, P505, DOI 10.1111/bcp.12824; McMartin K, 2009, CLIN TOXICOL, V47, P859, DOI 10.3109/15563650903344793; McQuade DJ, 2014, ANN CLIN BIOCHEM, V51, P167, DOI 10.1177/0004563213506697; Megarbane B, 2005, INTENS CARE MED, V31, P189, DOI 10.1007/s00134-004-2521-0; Megarbane B, 2001, INTENS CARE MED, V27, P1370, DOI 10.1007/s001340101011; Mowry JB, 2016, CLIN TOXICOL, V54, P924, DOI 10.1080/15563650.2016.1245421; Mullins ME, 1998, J TOXICOL-CLIN TOXIC, V36, P315, DOI 10.3109/15563659809028027; PAPPAS AA, 1991, J TOXICOL-CLIN TOXIC, V29, P11, DOI 10.3109/15563659109038593; Parsa T, 2005, AM J EMERG MED, V23, P787, DOI 10.1016/j.ajem.2005.02.051; Peces R, 2008, NEFROLOGIA, V28, P413; Pillai U, 2014, AM J THER, V21, pE106, DOI 10.1097/MJT.0b013e31824c407d; Rastogi A, 2008, AM J KIDNEY DIS, V52, P181, DOI 10.1053/j.ajkd.2007.12.010; Reddy NJ, 2010, CLIN TOXICOL, V48, P967, DOI 10.3109/15563650.2010.532803; Rietjens SJ, 2014, NETH J MED, V72, P73; Roberts DM, 2015, CRIT CARE MED, V43, P461, DOI 10.1097/CCM.0000000000000708; Robinson CN, 2017, CLIN TOXICOL, V55, P196, DOI 10.1080/15563650.2016.1271128; Rooney SL, 2016, J MED TOXICOL, V12, P172, DOI 10.1007/s13181-015-0516-6; Schep LJ, 2009, CLIN TOXICOL, V47, P525, DOI 10.1080/15563650903086444; Shin JM, 2008, TRANSL RES, V152, P194, DOI 10.1016/j.trsl.2008.07.002; Slaughter RJ, 2014, CLIN TOXICOL, V52, P470, DOI 10.3109/15563650.2014.914527; Sosa NR, 2014, ANN EMERG MED, V64, P38, DOI 10.1016/j.annemergmed.2013.12.011; Thanacoody RHK, 2016, CLIN TOXICOL, V54, P134, DOI 10.3109/15563650.2015.1116044; Van hee P, 2004, CLIN CHEM LAB MED, V42, P1341, DOI 10.1515/CCLM.2004.252; Verelst S, 2009, CLIN TOXICOL, V47, P236, DOI 10.1080/15563650802432954; WACKER WEC, 1965, J AMER MED ASSOC, V194, P1231, DOI 10.1001/jama.194.11.1231; Wiles D, 2014, NETH J MED, V72, P383; World Health Organization, 2013, WHO MOD LIST ESS MED; Zakharov S, 2016, ANN EMERG MED, V68, P52, DOI 10.1016/j.annemergmed.2016.01.010; Zakharov S, 2015, CLIN TOXICOL, V53, P797, DOI 10.3109/15563650.2015.1059946; Zakharov S, 2014, KIDNEY INT, V86, P199, DOI 10.1038/ki.2014.60; Zar T, 2007, SEMIN DIALYSIS, V20, P217, DOI 10.1111/j.1525-139X.2007.00280.x	80	71	75	4	33	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2018	378	3					270	280		10.1056/NEJMra1615295	http://dx.doi.org/10.1056/NEJMra1615295			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT1IJ	29342392				2022-12-28	WOS:000422888400011
J	Powell, LM; Maciejewski, ML				Powell, Lisa M.; Maciejewski, Matthew L.			Taxes and Sugar-Sweetened Beverages	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HEALTH; FOOD		[Powell, Lisa M.] Univ Illinois, Sch Publ Hlth, Hlth Policy & Adm, Chicago, IL USA; [Powell, Lisa M.] Univ Illinois, Inst Hlth Res & Policy, Chicago, IL USA; [Maciejewski, Matthew L.] Durham Vet Affairs Med Ctr, Ctr Hlth Serv Res Primary Care, Durham, NC 27705 USA; [Maciejewski, Matthew L.] Duke Univ, Sch Med, Dept Populat Hlth Sci, Durham, NC 27705 USA; [Maciejewski, Matthew L.] Duke Univ, Sch Med, Dept Med, Div Gen Internal Med, Durham, NC 27705 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Durham VA Medical Center; Duke University; Duke University	Maciejewski, ML (corresponding author), Durham Vet Affairs Med Ctr, 411 W Chapel Hill St,Ste 600, Durham, NC 27705 USA.; Maciejewski, ML (corresponding author), Duke Univ, Med Ctr, Ctr Hlth Serv Res Primary Care, 411 W Chapel Hill St,Ste 600, Durham, NC 27705 USA.	matthew.maciejewski@va.gov			University of Alabama at Birmingham; NIDA; Veterans Affairs; Centers for Disease Control and Prevention; Bloomberg Philanthropies; World Health Organization; Pan American Health Organization	University of Alabama at Birmingham; NIDA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Veterans Affairs(US Department of Veterans Affairs); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Bloomberg Philanthropies; World Health Organization(World Health Organization); Pan American Health Organization	The authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Maciejewski reported receiving personal fees from the University of Alabama at Birmingham for a workshop presentation; grants from NIDA and the Veterans Affairs; a contract from NCQA to Duke University for research; and that his spouse owns stock in Amgen. Dr Powell reported that her research is currently funded by the Centers for Disease Control and Prevention and Bloomberg Philanthropies. In 2017, she also received consulting fees and travel support from the World Health Organization and the Pan American Health Organization.	Colchero MA, 2017, J NUTR, V147, P1552, DOI 10.3945/jn.117.251892; Colchero MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144408; Guerrero-Lopez CM, 2017, PREV MED, V105, pS43, DOI 10.1016/j.ypmed.2017.09.001; Powell LM, 2013, OBES REV, V14, P110, DOI 10.1111/obr.12002; Rehm CD, 2016, JAMA-J AM MED ASSOC, V315, P2542, DOI 10.1001/jama.2016.7491; Rosinger A, 2017, MMWR-MORBID MORTAL W, V66, P181; Silver LD, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002283	7	17	18	2	35	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2018	319	3					229	230		10.1001/jama.2017.19522	http://dx.doi.org/10.1001/jama.2017.19522			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT3BY	29340686				2022-12-28	WOS:000423022300012
J	Acuto, M				Acuto, Michele			Global science for city policy	SCIENCE			English	Editorial Material							CITIES; URBAN; TIME		[Acuto, Michele] Univ Melbourne, Melbourne Sch Design, Parkville, Vic 3010, Australia; [Acuto, Michele] UCL, London WC1E 6BT, England	University of Melbourne; University of London; University College London	Acuto, M (corresponding author), Univ Melbourne, Melbourne Sch Design, Parkville, Vic 3010, Australia.; Acuto, M (corresponding author), UCL, London WC1E 6BT, England.	m.acuto@ucl.ac.uk		Acuto, Michele/0000-0003-4320-0531	EPSRC [EP/N005600/1] Funding Source: UKRI	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Acuto M, 2016, NATURE, V537, P611, DOI 10.1038/537611a; Bunnell T, 2010, INT J URBAN REGIONAL, V34, P415, DOI 10.1111/j.1468-2427.2010.00988.x; Fluckiger Y, 2016, NATURE, V531, P448, DOI 10.1038/531448c; Kitchin R, 2014, GEOJOURNAL, V79, P1, DOI 10.1007/s10708-013-9516-8; McGoey L., 2012, NO SUCH THING FREE G; McPhearson T, 2016, NATURE, V538, P165, DOI 10.1038/538165a; Satterthwaite D., 2013, REDUCING URBAN POVER; Solecki W, 2013, ENVIRONMENT, V55, P12, DOI 10.1080/00139157.2013.748387; Swiss Re, 2013, MIND RISK; Townsend A, 2015, PUBLIC CULTURE, V27, P201, DOI 10.1215/08992363-2841808; Turekian V, 2017, SCIENCE, V357, P735, DOI 10.1126/science.aao6889; [No title captured]	12	27	28	3	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					165	166		10.1126/science.aao2728	http://dx.doi.org/10.1126/science.aao2728			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS5EO	29326264	Green Submitted			2022-12-28	WOS:000419816600026
J	Waller, WH				Waller, William H.			My second life as a teacher	SCIENCE			English	Editorial Material																			0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					246	246		10.1126/science.359.6372.246	http://dx.doi.org/10.1126/science.359.6372.246			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS5EO	29326276	hybrid			2022-12-28	WOS:000419816600052
J	Bassler, D; Shinwell, ES; Hallman, M; Jarreau, PH; Plavka, R; Carnielli, V; Meisner, C; Engel, C; Koch, A; Kreutzer, K; van den Anker, JN; Schwab, M; Halliday, HL; Poets, CF				Bassler, Dirk; Shinwell, Eric S.; Hallman, Mikko; Jarreau, Pierre-Henri; Plavka, Richard; Carnielli, Virgilio; Meisner, Christoph; Engel, Corinna; Koch, Alexander; Kreutzer, Karen; van den Anker, Johannes N.; Schwab, Matthias; Halliday, Henry L.; Poets, Christian F.		Neonatal European Study Inhaled St	Long-Term Effects of Inhaled Budesonide for Bronchopulmonary Dysplasia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BIRTH-WEIGHT INFANTS; GLUCOCORTICOIDS; PREVENTION; STEROIDS; NEUROSIS; TRIAL	BACKGROUND The long-term effects on neurodevelopment of the use of inhaled glucocorticoids in extremely preterm infants for the prevention or treatment of bronchopulmonary dysplasia are uncertain. METHODS We randomly assigned 863 infants (gestational age, 23 weeks 0 days to 27 weeks 6 days) to receive early (within 24 hours after birth) inhaled budesonide or placebo. The prespecified secondary long-term outcome was neurodevelopmental disability among survivors, defined as a composite of cerebral palsy, cognitive delay (a Mental Development Index score of <85 [1 SD below the mean of 100] on the Bayley Scales of Infant Development, Second Edition, with higher scores on the scale indicating better performance), deafness, or blindness at a corrected age of 18 to 22 months. RESULTS Adequate data on the prespecified composite long-term outcome were available for 629 infants. Of these infants, 148 (48.1%) of 308 infants assigned to budesonide had neurodevelopmental disability, as compared with 165 (51.4%) of 321 infants assigned to placebo (relative risk, adjusted for gestational age, 0.93; 95% confidence interval [CI], 0.80 to 1.09; P = 0.40). There was no significant difference in any of the individual components of the prespecified outcome. There were more deaths in the budesonide group than in the placebo group (82 [19.9%] of 413 infants vs. 58 [14.5%] of 400 infants for whom vital status was available; relative risk, 1.37; 95% CI, 1.01 to 1.86; P = 0.04). CONCLUSIONS Among surviving extremely preterm infants, the rate of neurodevelopmental disability at 2 years did not differ significantly between infants who received early inhaled budesonide for the prevention of bronchopulmonary dysplasia and those who received placebo, but the mortality rate was higher among those who received budesonide.	[Bassler, Dirk] Univ Zurich, Univ Hosp Zurich, Dept Neonatol, Frauen Klin Str 10, CH-8091 Zurich, Switzerland; [van den Anker, Johannes N.] Univ Basel, Childrens Hosp, Div Pediat Pharmacol & Pharmacometr, Basel, Switzerland; [Shinwell, Eric S.] Bar Ilan Univ, Fac Med Galilee, Ziv Med Ctr, Ramat Gan, Israel; [Hallman, Mikko] Univ Oulu, Oulu Univ Hosp, Dept Children & Adolescents, Oulu, Finland; [Hallman, Mikko] Univ Oulu, PEDEGO Res Unit, Med Res Ctr Oulu, Oulu, Finland; [Jarreau, Pierre-Henri] Univ Paris 05, AP HP, Dept Hosp Univ Risques & Grossesse, Serv Med & Reanimat Neonatales Port Royal,Hop Coc, Paris, France; [Plavka, Richard] Charles Univ Prague, Gen Fac Hosp, Prague, Czech Republic; [Plavka, Richard] 1st Fac Med Prague, Prague, Czech Republic; [Carnielli, Virgilio] Polytech Univ Marche, Salesi Childrens Hosp, Ancona, Italy; [Meisner, Christoph] Univ Childrens Hosp Tubingen, Inst Clin Epidemiol & Appl Biometry, Tubingen, Germany; [Engel, Corinna] Univ Childrens Hosp, Ctr Pediat Clin Studies, Tubingen, Germany; [Koch, Alexander; Kreutzer, Karen; Poets, Christian F.] Univ Childrens Hosp, Dept Neonatol, Tubingen, Germany; [Schwab, Matthias] Univ Hosp Tubingen, Dept Clin Pharmacol, Tubingen, Germany; [Schwab, Matthias] Univ Hosp Tubingen, Dept Pharm & Biochem, Tubingen, Germany; [Schwab, Matthias] Univ Tubingen, Tubingen, Germany; [Schwab, Matthias] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [van den Anker, Johannes N.] Sophia Childrens Univ Hosp, Erasmus Med Ctr, Intens Care & Dept Pediat Surg, Rotterdam, Netherlands; [van den Anker, Johannes N.] Childrens Natl Hlth Syst, Div Clin Pharmacol, Washington, DC USA; [Halliday, Henry L.] Queens Univ Belfast, Inst Clin Sci, Dept Child Hlth, Belfast, Antrim, North Ireland	University of Zurich; University Zurich Hospital; University of Basel; Bar Ilan University; Ziv Medical Center; University of Oulu; University of Oulu; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Charles University Prague; General University Hospital Prague; Charles University Prague; Marche Polytechnic University; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; TUBINGEN UNIVERSITY CHILDRENS HOSPITAL; University of Hamburg; University Medical Center Hamburg-Eppendorf; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Children's National Health System; Queens University Belfast	Bassler, D (corresponding author), Univ Zurich, Univ Hosp Zurich, Dept Neonatol, Frauen Klin Str 10, CH-8091 Zurich, Switzerland.	dirk.bassler@usz.ch	Schwab, Matthias/ABH-7449-2020; nobile, stefano/G-9775-2017; Plavka, Richard/K-2222-2017; Mur, Sébastien/AFV-8068-2022; Hallman, Niilo/AHD-9810-2022; Metsvaht, Tuuli/H-6897-2015; Lano, Aulikki/J-6328-2015; Zlatohlavkova, Blanka/K-5821-2017	nobile, stefano/0000-0002-5304-1485; Mur, Sébastien/0000-0001-6620-7467; scaramuzzo, rosa teresa/0000-0002-1765-1972; Metsvaht, Tuuli/0000-0003-3206-3092; Lano, Aulikki/0000-0003-1708-4514; Zlatohlavkova, Blanka/0000-0002-2131-1786; Bassler, Dirk/0000-0003-2358-4419; Yaari, Maya/0000-0002-0052-7094	European Union [HEALTH-F5-2009-223060]; Chiesi Farmaceutici	European Union(European Commission); Chiesi Farmaceutici(Chiesi Pharmaceuticals Inc)	Supported by a grant (HEALTH-F5-2009-223060) from the European Union and by Chiesi Farmaceutici. Chiesi Farmaceutici provided the study drugs free of charge, and Trudell Medical International, Canada, provided the spacers (AeroChamber mini) free of charge.	Bassler D, 2017, J MATERN-FETAL NEO M, V30, P2372, DOI 10.1080/14767058.2016.1248937; Bassler D, 2015, NEW ENGL J MED, V373, P1497, DOI 10.1056/NEJMoa1501917; Bassler D, 2010, NEONATOLOGY, V97, P52, DOI 10.1159/000227294; Bassler D, 2009, PEDIATRICS, V123, P313, DOI 10.1542/peds.2008-0377; Bott L, 2006, PEDIATR RES, V60, P340, DOI 10.1203/01.pdr.0000232793.90186.ca; Doyle LW, 2006, PEDIATRICS, V118, P108, DOI 10.1542/peds.2005-2522; Doyle LW, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001146.pub4; Doyle LW, 2009, SEMIN FETAL NEONAT M, V14, P391, DOI 10.1016/j.siny.2009.08.004; Halliday HL, 2009, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD001145.pub2, 10.1002/14651858.CD001146.pub2]; Jangaard K A, 2002, Paediatr Child Health, V7, P13; Job S, 2015, ARCH DIS CHILD-FETAL, V100, pF371, DOI 10.1136/archdischild-2014-308060; Koch A, 2017, NEONATOLOGY, V112, P110, DOI 10.1159/000468507; Maas C, 2010, NEONATOLOGY, V98, P404, DOI 10.1159/000316978; Nakamura T, 2016, ARCH DIS CHILD FETAL; Ogawa R, 2015, PEDIATR INT, V57, P189, DOI 10.1111/ped.12584; Palisano R, 1997, DEV MED CHILD NEUROL, V39, P214, DOI 10.1111/j.1469-8749.1997.tb07414.x; Schmidt B, 2003, JAMA-J AM MED ASSOC, V289, P1124, DOI 10.1001/jama.289.9.1124; Schmidt B, 2015, NEW ENGL J MED, V373, P1566, DOI 10.1056/NEJMe1509243; Shah VS, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001969.pub4; Shinwell ES, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-2511; Slaughter JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106838; Stoll BJ, 2015, JAMA-J AM MED ASSOC, V314, P1039, DOI 10.1001/jama.2015.10244; Yi S.H., 1993, MANUAL BAYLEY SCALES	23	64	69	0	29	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 11	2018	378	2					148	157		10.1056/NEJMoa1708831	http://dx.doi.org/10.1056/NEJMoa1708831			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS7IR	29320647	Green Published, Bronze			2022-12-28	WOS:000419971600008
J	Bekkering, S; Arts, RJW; Novakovic, B; Kourtzelis, I; van der Heijden, CDCC; Li, Y; Popa, CD; ter Horst, R; van Tuijl, J; Netea-Maier, RT; de Veerdonk, FLV; Chavakis, T; Joosten, LAB; van der Meer, JWM; Stunnenberg, H; Riksen, NP; Netea, MG				Bekkering, Siroon; Arts, Rob J. W.; Novakovic, Boris; Kourtzelis, Ioannis; van der Heijden, Charlotte D. C. C.; Li, Yang; Popa, Calin D.; ter Horst, Rob; van Tuijl, Julia; Netea-Maier, Romana T.; de Veerdonk, Frank L. van; Chavakis, Triantafyllos; Joosten, Leo A. B.; van der Meer, Jos W. M.; Stunnenberg, Henk; Riksen, Niels P.; Netea, Mihai G.			Metabolic Induction of Trained Immunity through the Mevalonate Pathway	CELL			English	Article							HYPER-IGD SYNDROME; HYPERIMMUNOGLOBULINEMIA-D; INFLAMMATORY ATTACKS; CYTOKINE PRODUCTION; KINASE; EXPRESSION; STATINS; MEMORY; CELLS; REINFECTION	Innate immune cells can develop long-term memory after stimulation by microbial products during infections or vaccinations. Here, we report that metabolic signals can induce trained immunity. Pharmacological and genetic experiments reveal that activation of the cholesterol synthesis pathway, but not the synthesis of cholesterol itself, is essential for training of myeloid cells. Rather, the metabolite mevalonate is the mediator of training via activation of IGF1-R and mTOR and subsequent histone modifications in inflammatory pathways. Statins, which block mevalonate generation, prevent trained immunity induction. Furthermore, monocytes of patients with hyper immunoglobulin D syndrome (HIDS), who are mevalonate kinase deficient and accumulate mevalonate, have a constitutive trained immunity phenotype at both immunological and epigenetic levels, which could explain the attacks of sterile inflammation that these patients experience. Unraveling the role of mevalonate in trained immunity contributes to our understanding of the pathophysiology of HIDS and identifies novel therapeutic targets for clinical conditions with excessive activation of trained immunity.	[Bekkering, Siroon; Arts, Rob J. W.; van der Heijden, Charlotte D. C. C.; ter Horst, Rob; van Tuijl, Julia; de Veerdonk, Frank L. van; Joosten, Leo A. B.; van der Meer, Jos W. M.; Riksen, Niels P.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 GA Nijmegen, Netherlands; [Bekkering, Siroon] Acad Med Ctr, Dept Expt Vasc Med, Amsterdam, Netherlands; [Novakovic, Boris; Stunnenberg, Henk] Radboud Univ Nijmegen, Fac Sci, Dept Mol Biol, NL-6525 GA Nijmegen, Netherlands; [Kourtzelis, Ioannis; Chavakis, Triantafyllos] Tech Univ Dresden, Med Fac, Inst Clin Chem & Lab Med, Fetscherstr 74, D-01307 Dresden, Germany; [Popa, Calin D.] Radboud Univ Nijmegen, Med Ctr, Dept Rheumatol, NL-6525 GA Nijmegen, Netherlands; [Joosten, Leo A. B.] Univ Med & Pharm Iuliu Hatieganu, Dept Med Genet, Cluj Napoca, Romania; [Netea, Mihai G.] Univ Bonn, Life & Med Sci Inst LIMES, Dept Genom & Immunoregulat, D-53115 Bonn, Germany; [Li, Yang] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, Nijmegen, Netherlands; [Netea-Maier, Romana T.] Radboud Univ Nijmegen, Div Endocrinol, Dept Med, Geert Grootepl 8, Nijmegen, Netherlands	Radboud University Nijmegen; University of Amsterdam; Academic Medical Center Amsterdam; Radboud University Nijmegen; Technische Universitat Dresden; Radboud University Nijmegen; Iuliu Hatieganu University of Medicine & Pharmacy; University of Bonn; University of Groningen; Radboud University Nijmegen	Riksen, NP; Netea, MG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 GA Nijmegen, Netherlands.; Netea, MG (corresponding author), Univ Bonn, Life & Med Sci Inst LIMES, Dept Genom & Immunoregulat, D-53115 Bonn, Germany.	niels.riksen@radboudumc.nl; mihai.netea@radboudumc.nl	Li, Yang/HGT-8446-2022; Horst, Rob Ter/G-3536-2016; Chavakis, Triantafyllos/ABE-8845-2020; Bekkering, Siroon/T-3694-2017; van de Veerdonk, Frank L/C-7256-2008; Popa, Calin D/E-2998-2016; Netea, Mihai/N-5155-2014; van der Meer, Jos W.M./C-8521-2013; Stunnenberg, Hendrik G./D-6875-2012; Netea-Maier, R.T./L-4543-2015; Riksen, Niels P/G-8260-2015; Arts, Rob JW/P-8678-2015; Novakovic, Boris/D-8018-2013; Joosten, Leo AB/H-3138-2015	Li, Yang/0000-0003-4022-7341; Horst, Rob Ter/0000-0003-0576-5873; Bekkering, Siroon/0000-0003-1149-466X; van de Veerdonk, Frank L/0000-0002-1121-4894; van der Meer, Jos W.M./0000-0001-5120-3690; Stunnenberg, Hendrik G./0000-0002-0066-1576; Riksen, Niels P/0000-0001-9197-8124; Arts, Rob JW/0000-0002-6649-7190; Novakovic, Boris/0000-0002-5623-9008; Joosten, Leo AB/0000-0001-6166-9830; Kourtzelis, Ioannis/0000-0003-3006-8885	ERC [310372]; Netherlands Organization for Scientific Research (NWO); NHMRC (Australia) CJ Martin Early Career Fellowship; Netherlands Heart Foundation [2012T051]; Romanian Ministry of European Funds (HINT) [P_37_762]; European Union [667837]; Ipsen Pharmaceuticals; ERC (DEMETINL); IN-CONTROL CVON grant [CVON2012-03]	ERC(European Research Council (ERC)European Commission); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); NHMRC (Australia) CJ Martin Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Netherlands Heart Foundation(Netherlands Heart Foundation); Romanian Ministry of European Funds (HINT); European Union(European Commission); Ipsen Pharmaceuticals(Ipsen); ERC (DEMETINL); IN-CONTROL CVON grant	The authors thank A. Simon for her contribution in collecting the patient samples. M.G.N. is supported by an ERC Consolidator Grant (#310372) and a Spinoza grant of the Netherlands Organization for Scientific Research (NWO). B.N. is supported by an NHMRC (Australia) CJ Martin Early Career Fellowship. N.P.R. is supported by a Dr. Dekker grant from the Netherlands Heart Foundation (2012T051). L.A.B.J. is supported by a Competitiveness Operational Programme grant of the Romanian Ministry of European Funds (HINT, P_37_762). N.P.R., M.G.N., and L.A.B.J. received funding from the European Union's Horizon 2020 research and innovation program under grant agreement no. 667837. R.T.N.-M. received funding for this study from an unrestricted grant from Ipsen Pharmaceuticals. T.C. was supported by the ERC (DEMETINL). This study was also partly supported by an IN-CONTROL CVON grant (CVON2012-03).	Akula MK, 2016, NAT IMMUNOL, V17, P922, DOI 10.1038/ni.3487; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arts RJW, 2016, CELL METAB, V24, P807, DOI 10.1016/j.cmet.2016.10.008; Arts RJW, 2016, CELL REP, V17, P2562, DOI 10.1016/j.celrep.2016.11.011; Arts RJW, 2015, J LEUKOCYTE BIOL, V98, P129, DOI 10.1189/jlb.6AB0914-416R; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Bekkering S, 2016, CLIN VACCINE IMMUNOL, V23, P926, DOI 10.1128/CVI.00349-16; Bekkering S, 2014, ARTERIOSCL THROM VAS, V34, P1731, DOI 10.1161/ATVBAHA.114.303887; Bodar EJ, 2011, ANN RHEUM DIS, V70, P2155, DOI 10.1136/ard.2011.149922; Bodar EJ, 2005, NETH J MED, V63, P260; Borriello F, 2017, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00680; Buffen K, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004485; Chang CL, 2014, INT SYMP INTEGR CIRC, P1, DOI 10.1109/ISICIR.2014.7029491; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Christ A, 2018, CELL, V172, P162, DOI 10.1016/j.cell.2017.12.013; De Loecker I, 2012, ANN INTENSIVE CARE, V2, DOI 10.1186/2110-5820-2-19; Demirkaya E, 2007, CLIN RHEUMATOL, V26, P1757, DOI 10.1007/s10067-006-0501-1; Drenth JPH, 1999, NAT GENET, V22, P178, DOI 10.1038/9696; Drenth JPH, 1996, J IMMUNOL, V157, P400; Dricu A, 1997, GLYCOBIOLOGY, V7, P625, DOI 10.1093/glycob/7.5.625; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Hoffmann P, 2006, NEW ENGL J MED, V355, P2705, DOI 10.1056/NEJMc062714; Houten SM, 1999, NAT GENET, V22, P175, DOI 10.1038/9691; Houten SM, 2003, J BIOL CHEM, V278, P5736, DOI 10.1074/jbc.M206564200; Huang Da Wei, 2009, Curr Protoc Bioinformatics, VChapter 13, DOI 10.1002/0471250953.bi1311s27; King ZA, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004321; Kleinnijenhuis J, 2012, P NATL ACAD SCI USA, V109, P17537, DOI 10.1073/pnas.1202870109; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee S, 2008, MOL ENDOCRINOL, V22, P1312, DOI 10.1210/me.2008-0012; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li Q, 2011, CANCER RES, V71, P6899, DOI 10.1158/0008-5472.CAN-11-1523; Li Y, 2016, NAT MED, V22, P952, DOI 10.1038/nm.4139; Merx MW, 2005, CIRCULATION, V112, P117, DOI 10.1161/CIRCULATIONAHA.104.502195; Milutinovic B, 2016, SEMIN IMMUNOL, V28, P328, DOI 10.1016/j.smim.2016.05.004; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Murray PJ, 2015, CELL METAB, V22, P190, DOI 10.1016/j.cmet.2015.06.014; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Novakovic B, 2016, CELL, V167, P1354, DOI 10.1016/j.cell.2016.09.034; Park YH, 2016, NAT IMMUNOL, V17, P914, DOI 10.1038/ni.3457; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Repnik U, 2003, J IMMUNOL METHODS, V278, P283, DOI 10.1016/S0022-1759(03)00231-X; Shendi HM, 2014, JCR-J CLIN RHEUMATOL, V20, P103, DOI 10.1097/01.RHU.0000442576.41537.de; Simon A, 2004, CLIN PHARMACOL THER, V75, P476, DOI 10.1016/j.clpt.2004.01.012; Stoffels M, 2015, RHEUMATOLOGY, V54, P363, DOI 10.1093/rheumatology/keu341; Tascilar K, 2016, ARTHRITIS RHEUMATOL, V68, P2603, DOI 10.1002/art.39774; Thurnher M, 2015, SCI SIGNAL, V8, DOI 10.1126/scisignal.2005970; Turro E, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r13; van Tits LJH, 2011, ATHEROSCLEROSIS, V214, P345, DOI 10.1016/j.atherosclerosis.2010.11.018; VANDERMEER JWM, 1984, LANCET, V1, P1087; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Xu SW, 2010, CYTOTECHNOLOGY, V62, P473, DOI 10.1007/s10616-010-9290-0; Yu HH, 2012, LIPIDS, V47, P249, DOI 10.1007/s11745-011-3635-0	56	332	352	15	99	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					135	+		10.1016/j.cell.2017.11.025	http://dx.doi.org/10.1016/j.cell.2017.11.025			21	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29328908	Bronze			2022-12-28	WOS:000419840100015
J	[Anonymous]				[Anonymous]			Images of the year (vol 552, pg 308, 2017)	NATURE			English	Correction																		ABDALLAH J, 2017, NATURE, V552, P308	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2018	553	7687					140	140		10.1038/d41586-018-00384-z	http://dx.doi.org/10.1038/d41586-018-00384-z			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4WL	29323307	Bronze			2022-12-28	WOS:000419794800011
J	Ambrogio, C; Kohler, J; Zhou, ZW; Wang, HY; Paranal, R; Li, JQ; Capelletti, M; Caffarra, C; Li, S; Lv, Q; Gondi, S; Hunter, JC; Lu, J; Chiarle, R; Santamaria, D; Westover, KD; Janne, PA				Ambrogio, Chiara; Kohler, Jens; Zhou, Zhi-Wei; Wang, Haiyun; Paranal, Raymond; Li, Jiaqi; Capelletti, Marzia; Caffarra, Cristina; Li, Shuai; Lv, Qi; Gondi, Sudershan; Hunter, John C.; Lu, Jia; Chiarle, Roberto; Santamaria, David; Westover, Kenneth D.; Janne, Pasi A.			KRAS Dimerization Impacts MEK Inhibitor Sensitivity and Oncogenic Activity of Mutant KRAS	CELL			English	Article							CELL LUNG-CANCER; RAS FORMS DIMERS; WILD-TYPE RAS; THERAPEUTIC STRATEGY; PROLIFERATION; DOCETAXEL; PROTEINS; SURVIVAL; SITE	The mechanism by which the wild-type KRAS allele imparts a growth inhibitory effect to oncogenic KRAS in various cancers, including lung adenocarcinoma (LUAD), is poorly understood. Here, using a genetically inducible model of KRAS loss of heterozygosity (LOH), we show that KRAS dimerization mediates wild-type KRAS-dependent fitness of human and murine KRAS mutant LUAD tumor cells and underlies resistance to MEK inhibition. These effects are abrogated when wild-type KRAS is replaced by KRAS(D154Q), a mutant that disrupts dimerization at the alpha 4-alpha 5 KRAS dimer interface without changing other fundamental biochemical properties of KRAS, both in vitro and in vivo. Moreover, dimerization has a critical role in the oncogenic activity of mutant KRAS. Our studies provide mechanistic and biological insights into the role of KRAS dimerization and highlight a role for disruption of dimerization as a therapeutic strategy for KRAS mutant cancers.	[Ambrogio, Chiara; Kohler, Jens; Paranal, Raymond; Li, Jiaqi; Capelletti, Marzia; Caffarra, Cristina; Li, Shuai; Janne, Pasi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA; [Zhou, Zhi-Wei; Gondi, Sudershan; Hunter, John C.; Lu, Jia; Westover, Kenneth D.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Zhou, Zhi-Wei; Gondi, Sudershan; Hunter, John C.; Lu, Jia; Westover, Kenneth D.] Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA; [Wang, Haiyun; Lv, Qi] Tongji Univ, Sch Life Sci & Technol, Shanghai 200092, Peoples R China; [Chiarle, Roberto] Boston Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Chiarle, Roberto] Harvard Med Sch, Boston, MA 02115 USA; [Chiarle, Roberto] Univ Turin, Dept Mol Biotechnol & Hlth Sci, I-10126 Turin, Italy; [Santamaria, David] Univ Bordeaux, INSERM, U1218, ACT Lab,IECB, F-33600 Pessac, France; [Janne, Pasi A.] Dana Farber Canc Inst, Belfer Ctr Appl Canc Sci, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Tongji University; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of Turin; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Harvard University; Dana-Farber Cancer Institute	Ambrogio, C; Janne, PA (corresponding author), Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02215 USA.; Westover, KD (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA.; Westover, KD (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Radiat Oncol, Dallas, TX 75390 USA.; Janne, PA (corresponding author), Dana Farber Canc Inst, Belfer Ctr Appl Canc Sci, Boston, MA 02215 USA.	chiara_ambrogio@dfci.harvard.edu; kenneth.westover@utsouthwestern.edu; pasi_janne@dfci.harvard.edu	Köhler, Jens/AAK-1541-2021; Santamaria, David/D-3930-2011; Westover, Ken/AAZ-1795-2020; caffarra, cristina/I-2361-2018; Capelletti, Marzia/L-6317-2016	Santamaria, David/0000-0002-4711-3569; Westover, Ken/0000-0003-3653-5923; caffarra, cristina/0000-0003-4582-353X; Capelletti, Marzia/0000-0001-5095-7060; Wang, Haiyun/0000-0001-8364-8328; Kohler (MD), Jens/0000-0002-9922-6469	Stand Up To Cancer-American Cancer Society Lung Cancer Dream Team Translational Research Grant [SU2C-AACR-DT17-15]; Gadzooks Fund; Cammarata Family Foundation Research Fund; US Department of Defense [W81XWH-16-1-0106]; Cancer Prevention and Research Institute of Texas [RP140233]; National Natural Science Foundation of China [31571363, 31771469]; German Cancer Aid Foundation [70111755]; AstraZeneca	Stand Up To Cancer-American Cancer Society Lung Cancer Dream Team Translational Research Grant; Gadzooks Fund; Cammarata Family Foundation Research Fund; US Department of Defense(United States Department of Defense); Cancer Prevention and Research Institute of Texas; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); German Cancer Aid Foundation; AstraZeneca(AstraZeneca)	This work was supported by a Stand Up To Cancer-American Cancer Society Lung Cancer Dream Team Translational Research Grant (SU2C-AACR-DT17-15 to P.A.J.), the Gadzooks Fund (to P.A.J.), the Cammarata Family Foundation Research Fund (to P.A.J.), the US Department of Defense (W81XWH-16-1-0106 to K.D.W.), the Cancer Prevention and Research Institute of Texas (RP140233 to K.D.W.), the National Natural Science Foundation of China (31571363 and 31771469 to H.W.) and a Mildred-Scheel postdoctoral fellowship from the German Cancer Aid Foundation (70111755 to J.K.). Stand Up To Cancer is a program of the Entertainment Industry Foundation. Research grants are administered by the American Association for Cancer Research, the scientific partner of SU2C. The authors would like to acknowledge the data from CGP project, which is hosted by the European Bioinformatics Institute under accession number EGAD00001001039. The authors would like to thank Mariano Barbacid and Matthias Drosten for sharing the Ras-less cells, Patricia Nieto for helpful discussion and technical contribution for BRAF/CRAF co-IP experiments, and Eric Smith for generating the graphical abstract. P.A.J. has served as a consultant for and has received sponsored research funding from AstraZeneca.	Albeck JG, 2013, MOL CELL, V49, P249, DOI 10.1016/j.molcel.2012.11.002; Ambrogio C, 2016, NAT MED, V22, P270, DOI 10.1038/nm.4041; Ambrogio C, 2014, CANCER RES, V74, P5978, DOI 10.1158/0008-5472.CAN-14-1606; Blumenschein GR, 2015, ANN ONCOL, V26, P894, DOI 10.1093/annonc/mdv072; Brant R, 2017, CLIN CANCER RES, V23, P1471, DOI 10.1158/1078-0432.CCR-16-0021; Burgess MR, 2017, CELL, V168, P817, DOI 10.1016/j.cell.2017.01.020; Castellano E, 2013, CANCER CELL, V24, P617, DOI 10.1016/j.ccr.2013.09.012; Chapman PB, 2014, CANCER CELL, V26, P603, DOI 10.1016/j.ccell.2014.10.017; Drosten M, 2010, EMBO J, V29, P1091, DOI 10.1038/emboj.2010.7; Garnett MJ, 2012, NATURE, V483, P570, DOI 10.1038/nature11005; Guldenhaupt J, 2012, BIOPHYS J, V103, P1585, DOI 10.1016/j.bpj.2012.08.043; Guerra C, 2003, CANCER CELL, V4, P111, DOI 10.1016/S1535-6108(03)00191-0; Harrison RA, 2016, J MOL BIOL, V428, P4723, DOI 10.1016/j.jmb.2016.10.017; He LS, 2003, CYTOM PART A, V55A, P71, DOI 10.1002/cyto.a.10073; Hunter JC, 2015, MOL CANCER RES, V13, P1325, DOI 10.1158/1541-7786.MCR-15-0203; Hunter JC, 2014, P NATL ACAD SCI USA, V111, P8895, DOI 10.1073/pnas.1404639111; Janne PA, 2017, JAMA-J AM MED ASSOC, V317, P1844, DOI 10.1001/jama.2017.3438; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; K_ohler J., 2017, CURRMED CHEM, V24, P1; Kim J, 2016, NATURE, V538, P114, DOI 10.1038/nature19771; Lavoie H, 2015, NAT REV MOL CELL BIO, V16, P281, DOI 10.1038/nrm3979; Lin WC, 2014, P NATL ACAD SCI USA, V111, P2996, DOI 10.1073/pnas.1321155111; Lito P, 2014, CANCER CELL, V25, P697, DOI 10.1016/j.ccr.2014.03.011; Manchado E, 2016, NATURE, V534, P647, DOI 10.1038/nature18600; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Miller Mark Steven, 2012, Frontiers in Genetics, V2, P100, DOI 10.3389/fgene.2011.00100; Muratcioglu S, 2015, STRUCTURE, V23, P1325, DOI 10.1016/j.str.2015.04.019; Nan XL, 2015, P NATL ACAD SCI USA, V112, P7996, DOI 10.1073/pnas.1509123112; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Puyol M, 2010, CANCER CELL, V18, P63, DOI 10.1016/j.ccr.2010.05.025; Samatar AA, 2014, NAT REV DRUG DISCOV, V13, P928, DOI 10.1038/nrd4281; Simanshu DK, 2017, CELL, V170, P17, DOI 10.1016/j.cell.2017.06.009; Singh A, 2005, FASEB J, V19, P161, DOI 10.1096/fj.04-2584hyp; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Spencer-Smith R, 2017, NAT CHEM BIOL, V13, P62, DOI [10.1038/nchembio.2231, 10.1038/NCHEMBIO.2231]; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; To MD, 2008, NAT GENET, V40, P1240, DOI 10.1038/ng.211; Westcott PMK, 2015, NATURE, V517, P489, DOI 10.1038/nature13898; Wood K, 2016, JAMA ONCOL, V2, P805, DOI 10.1001/jamaoncol.2016.0405; Wu H, 2013, CELL, V153, P287, DOI 10.1016/j.cell.2013.03.013; Xiong Y, 2017, ACS MED CHEM LETT, V8, P61, DOI 10.1021/acsmedchemlett.6b00373; Young A, 2013, CANCER DISCOV, V3, P112, DOI 10.1158/2159-8290.CD-12-0231; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721; Zhao YJ, 2014, NAT REV CLIN ONCOL, V11, P385, DOI 10.1038/nrclinonc.2014.83; Zhou Y, 2015, BBA-MOL CELL RES, V1853, P841, DOI 10.1016/j.bbamcr.2014.09.008; Zhu ZH, 2014, CANCER DISCOV, V4, P452, DOI 10.1158/2159-8290.CD-13-0646	46	149	151	3	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					857	+	868.e15	10.1016/j.cell.2017.12.020	http://dx.doi.org/10.1016/j.cell.2017.12.020			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29336889	Bronze			2022-12-28	WOS:000424648800023
J	Dickel, DE; Ypsilanti, AR; Pla, R; Zhu, YW; Barozzi, I; Mannion, BJ; Khin, YS; Fukuda-Yuzawa, Y; Plajzer-Frick, I; Pickle, CS; Lee, EA; Harrington, AN; Pham, QT; Garvin, TH; Kato, M; Osterwalder, M; Akiyama, JA; Afzal, V; Rubenstein, JLR; Pennacchio, LA; Visel, A				Dickel, Diane E.; Ypsilanti, Athena R.; Pla, Ramon; Zhu, Yiwen; Barozzi, Iros; Mannion, Brandon J.; Khin, Yupar S.; Fukuda-Yuzawa, Yoko; Plajzer-Frick, Ingrid; Pickle, Catherine S.; Lee, Elizabeth A.; Harrington, Anne N.; Pham, Quan T.; Garvin, Tyler H.; Kato, Momoe; Osterwalder, Marco; Akiyama, Jennifer A.; Afzal, Veena; Rubenstein, John L. R.; Pennacchio, Len A.; Visel, Axel			Ultraconserved Enhancers Are Required for Normal Development	CELL			English	Article							ONE-STEP GENERATION; RNA-SEQ DATA; HUMAN GENOME; ARX; GENE; MICE; EXPRESSION; DIFFERENTIATION; TELENCEPHALON; INTERNEURONS	Non-coding "ultraconserved'' regions containing hundreds of consecutive bases of perfect sequence conservation across mammalian genomes can function as distant-acting enhancers. However, initial deletion studies in mice revealed that loss of such extraordinarily constrained sequences had no immediate impact on viability. Here, we show that ultraconserved enhancers are required for normal development. Focusing on some of the longest ultraconserved sites genome wide, located near the essential neuronal transcription factor Arx, we used genome editing to create an expanded series of knockout mice lacking individual or combinations of ultraconserved enhancers. Mice with single or pair-wise deletions of ultraconserved enhancers were viable and fertile but in nearly all cases showed neurological or growth abnormalities, including substantial alterations of neuron populations and structural brain defects. Our results demonstrate the functional importance of ultraconserved enhancers and indicate that remarkably strong sequence conservation likely results from fitness deficits that appear subtle in a laboratory setting.	[Dickel, Diane E.; Zhu, Yiwen; Barozzi, Iros; Mannion, Brandon J.; Fukuda-Yuzawa, Yoko; Plajzer-Frick, Ingrid; Pickle, Catherine S.; Lee, Elizabeth A.; Harrington, Anne N.; Pham, Quan T.; Garvin, Tyler H.; Kato, Momoe; Osterwalder, Marco; Akiyama, Jennifer A.; Afzal, Veena; Pennacchio, Len A.; Visel, Axel] Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, 1 Cyclotron Rd, Berkeley, CA 94720 USA; [Ypsilanti, Athena R.; Pla, Ramon; Khin, Yupar S.; Rubenstein, John L. R.] Univ Calif San Francisco, UCSF Weill Inst Neurosci, Neurosci Program, Dept Psychiat, San Francisco, CA 94158 USA; [Ypsilanti, Athena R.; Pla, Ramon; Khin, Yupar S.; Rubenstein, John L. R.] Univ Calif San Francisco, Nina Ireland Lab Dev Neurobiol, San Francisco, CA 94158 USA; [Pennacchio, Len A.; Visel, Axel] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Pennacchio, Len A.] Univ Calif Berkeley, Comparat Biochem Program, Berkeley, CA 94720 USA; [Visel, Axel] Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California San Francisco; University of California System; University of California San Francisco; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Berkeley; University of California System; University of California Merced	Dickel, DE; Pennacchio, LA; Visel, A (corresponding author), Lawrence Berkeley Natl Lab, Environm Genom & Syst Biol Div, 1 Cyclotron Rd, Berkeley, CA 94720 USA.; Pennacchio, LA; Visel, A (corresponding author), US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA.; Pennacchio, LA (corresponding author), Univ Calif Berkeley, Comparat Biochem Program, Berkeley, CA 94720 USA.; Visel, A (corresponding author), Univ Calif Merced, Sch Nat Sci, Merced, CA 95343 USA.	dedickel@lbl.gov; lapennacchio@lbl.gov; avisel@lbl.gov	Osterwalder, Marco/AAU-4478-2021; Pla, Ramon/AAA-9243-2020; Visel, Axel/A-9398-2009; Ferriz, Ramon Pla/ABF-5635-2020; Barozzi, Iros/GLQ-8907-2022; Osterwalder, Marco/T-1817-2018	Pla, Ramon/0000-0003-4115-149X; Visel, Axel/0000-0002-4130-7784; Barozzi, Iros/0000-0003-0690-3473; Pennacchio, Len/0000-0002-8748-3732; Osterwalder, Marco/0000-0002-1969-2313; Mannion, Brandon/0000-0002-1149-3790; Ypsilanti, Athena/0000-0002-0310-7693; Fukuda-Yuzawa, Yoko/0000-0002-9887-9820; Dickel, Diane/0000-0001-5497-6824	NIH [S10RR029668, S10RR027303, R01HG003988, R24HL123879, UM1HL098166, NINDS R01NS34661, NIMH R37MH049428]; U.S. Department of Energy [DE-AC02-05CH11231]; Laboratory Directed Research and Development Program of Lawrence Berkeley National Laboratory; Fondation Fyssen; Swiss National Science Foundation (SNSF); NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029668, S10RR027303] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL131003, UM1HL098166, R24HL123879] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [UM1HG009421, R01HG003988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH049428, R37MH049428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS034661, R01NS099099] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Energy(United States Department of Energy (DOE)); Laboratory Directed Research and Development Program of Lawrence Berkeley National Laboratory; Fondation Fyssen; Swiss National Science Foundation (SNSF)(Swiss National Science Foundation (SNSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank qb3 MacroLab for plasmid pML6B and J. Doudna (University of California Berkeley) for plasmid pMJ920 and for advice on Cas9/CRISPR-mediated genome editing. This work used the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, which is supported by NIH grants S10RR029668 and S10RR027303. Research was conducted at the E.O. Lawrence Berkeley National Laboratory and performed under U.S. Department of Energy contract DE-AC02-05CH11231, University of California. This work was supported by NIH grants to L.A.P. and A.V. (R01HG003988, R24HL123879, and UM1HL098166) and to J.L.R.R. (NINDS R01NS34661 and NIMH R37MH049428). The single-cell RNA sequencing work was supported by the Laboratory Directed Research and Development Program of Lawrence Berkeley National Laboratory (to D.E.D.). A.R.Y. was supported by a grant from Fondation Fyssen. M.O. was supported by a Swiss National Science Foundation (SNSF) fellowship.	ADAMS JC, 1981, J HISTOCHEM CYTOCHEM, V29, P775, DOI 10.1177/29.6.7252134; Ahituv N, 2007, PLOS BIOL, V5, P1906, DOI 10.1371/journal.pbio.0050234; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen YJJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep45656; Chiang CWK, 2008, GENETICS, V180, P2277, DOI 10.1534/genetics.108.096537; Colasante G, 2008, J NEUROSCI, V28, P10674, DOI 10.1523/JNEUROSCI.1283-08.2008; Colasante G, 2015, CEREB CORTEX, V25, P322, DOI 10.1093/cercor/bht222; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; Colombo E, 2007, J NEUROSCI, V27, P4786, DOI 10.1523/JNEUROSCI.0417-07.2007; Crawley J. N., 2007, WHAT WRONG MY MOUSE; DELRIO JA, 1994, DEV BRAIN RES, V81, P247, DOI 10.1016/0165-3806(94)90311-5; Dickel DE, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12923; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Ester M., 1996, KDD-96 Proceedings. Second International Conference on Knowledge Discovery and Data Mining, P226; Finak G, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0844-5; Gecz J, 2006, CURR OPIN GENET DEV, V16, P308, DOI 10.1016/j.gde.2006.04.003; GOULD E, 1991, BRAIN RES BULL, V27, P767, DOI 10.1016/0361-9230(91)90209-3; Harmston N, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0021; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Johnson KD, 2012, J CLIN INVEST, V122, P3692, DOI 10.1172/JCI61623; Kiselev VY, 2017, NAT METHODS, V14, P483, DOI [10.1038/NMETH.4236, 10.1038/nmeth.4236]; Kitamura K, 2002, NAT GENET, V32, P359, DOI 10.1038/ng1009; KOTHARY R, 1989, DEVELOPMENT, V105, P707; Kvon EZ, 2016, CELL, V167, P633, DOI 10.1016/j.cell.2016.09.028; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Marsh ED, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0265-8; Martin M., 2011, EMBNET J, V17, P10, DOI [10.14806/ej.17.1.200, DOI 10.14806/EJ.17.1.200]; McLean C, 2008, GENOME RES, V18, P1743, DOI 10.1101/gr.080184.108; Motenko H, 2015, MAMM GENOME, V26, P325, DOI 10.1007/s00335-015-9573-z; Nolte MJ, 2014, EVOL DEV, V16, P207, DOI 10.1111/ede.12084; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Sandelin A, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-99; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Stanco A, 2014, NEURON, V84, P940, DOI 10.1016/j.neuron.2014.10.040; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Visel A, 2013, CELL, V152, P895, DOI 10.1016/j.cell.2012.12.041; Wang B, 2017, NAT METHODS, V14, P414, DOI 10.1038/nmeth.4207; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	49	101	103	1	41	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2018	172	3					491	+		10.1016/j.cell.2017.12.017	http://dx.doi.org/10.1016/j.cell.2017.12.017			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FT9BS	29358049	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000423447600010
J	Narula, R; Tinaz, S				Narula, Reshma; Tinaz, Sule			Creutzfeldt-Jakob Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Narula, Reshma; Tinaz, Sule] Yale New Haven Med Ctr, 20 York St, New Haven, CT 06504 USA	Yale University	Narula, R (corresponding author), Yale New Haven Med Ctr, 20 York St, New Haven, CT 06504 USA.	reshma.narula@yale.edu							0	2	2	1	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 25	2018	378	4							e7	10.1056/NEJMicm1710121	http://dx.doi.org/10.1056/NEJMicm1710121			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT5ZX	29365304				2022-12-28	WOS:000423233400012
J	Abalem, MF; Rao, PK; Rao, RC				Abalem, Maria Fernanda; Rao, P. Kumar; Rao, Rajesh C.			Nystagmus and Platinum Hair	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ALBINISM		[Abalem, Maria Fernanda] Univ Sao Paulo, Fac Med, Dept Ophthalmol, Sao Paulo, Brazil; [Abalem, Maria Fernanda; Rao, Rajesh C.] Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, 1000 Wall St,Brehm Room 8326, Ann Arbor, MI 48105 USA; [Rao, P. Kumar] Washington Univ, Sch Med, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Rao, Rajesh C.] Univ Michigan, Dept Pathol, Ann Arbor, MI 48109 USA	Universidade de Sao Paulo; University of Michigan System; University of Michigan; Washington University (WUSTL); University of Michigan System; University of Michigan	Rao, RC (corresponding author), Univ Michigan, WK Kellogg Eye Ctr, Dept Ophthalmol & Visual Sci, 1000 Wall St,Brehm Room 8326, Ann Arbor, MI 48105 USA.	rajeshr@med.umich.edu	Rao, Rajesh C./N-1107-2017	Rao, Rajesh C./0000-0002-5776-8366	National Institutes of Health [K08EY026654]; Research to Prevent Blindness; Leonard G. Miller Ophthalmic Research Fund at the Kellogg Eye Center; Grossman Research Fund; Barbara Dunn Research Fund; Roz Greenspon Research Fund; Beatrice & Reymont Paul Foundation; March Hoops to Beat Blindness; NATIONAL EYE INSTITUTE [K08EY026654] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Leonard G. Miller Ophthalmic Research Fund at the Kellogg Eye Center; Grossman Research Fund; Barbara Dunn Research Fund; Roz Greenspon Research Fund; Beatrice & Reymont Paul Foundation; March Hoops to Beat Blindness; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	Dr R. C. Rao is supported by Career Development Awards from the National Institutes of Health (K08EY026654) and Research to Prevent Blindness and has received grant funding from the Leonard G. Miller Ophthalmic Research Fund at the Kellogg Eye Center, Grossman Research Fund, Barbara Dunn Research Fund, Roz Greenspon Research Fund, Beatrice & Reymont Paul Foundation, and March Hoops to Beat Blindness.	El-Chemaly S, 2016, CLIN CHEST MED, V37, P505, DOI 10.1016/j.ccm.2016.04.012; Gronskov K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-43; Huurneman B, 2013, STRABISMUS, V21, P216, DOI 10.3109/09273972.2013.833954; Introne W, 1999, MOL GENET METAB, V68, P283, DOI 10.1006/mgme.1999.2927; Kamaraj B, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/905472; Mancini AJ, 1998, J AM ACAD DERMATOL, V38, P295, DOI 10.1016/S0190-9622(98)70568-7; Martinez-Garcia M, 2013, J DERMATOL, V40, P319, DOI 10.1111/1346-8138.12170; Okulicz JF, 2003, J EUR ACAD DERMATOL, V17, P251, DOI 10.1046/j.1468-3083.2003.00767.x; Schwering MS, 2015, GRAEF ARCH CLIN EXP, V253, P655, DOI 10.1007/s00417-015-2943-0; WITKOP CJ, 1979, ALA J MED SCI, V16, P327	10	2	2	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					399	400		10.1001/jama.2017.20673	http://dx.doi.org/10.1001/jama.2017.20673			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362773				2022-12-28	WOS:000423405300026
J	Grundy, Q; Dunn, AG; Bourgeois, FT; Coiera, E; Bero, L				Grundy, Quinn; Dunn, Adam G.; Bourgeois, Florence T.; Coiera, Enrico; Bero, Lisa			Prevalence of Disclosed Conflicts of Interest in Biomedical Research and Associations With Journal Impact Factors and Altmetric Scores	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Grundy, Quinn; Bero, Lisa] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia; [Dunn, Adam G.; Coiera, Enrico] Macquarie Univ, Ctr Hlth Informat, Sydney, NSW, Australia; [Bourgeois, Florence T.] Boston Childrens Hosp, Computat Hlth Informat Program, Boston, MA USA	University of Sydney; Macquarie University; Harvard University; Boston Children's Hospital	Grundy, Q (corresponding author), Univ Sydney, Charles Perkins Ctr, Hub, D17,Level 6, Sydney, NSW 2006, Australia.	quinn.grundy@sydney.edu.au	; Dunn, Adam/E-6828-2011	Coiera, Enrico/0000-0002-6444-6584; Dunn, Adam/0000-0002-1720-8209; Bero, Lisa/0000-0003-1893-6651	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work received no specific funding. Dr Grundy is supported by a postdoctoral fellowship from the Canadian Institutes of Health Research.	Ahn R, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.i6770; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Drazen JM, 2015, NEW ENGL J MED, V372, P1853, DOI 10.1056/NEJMe1503623; Dunn Adam G, 2016, Res Integr Peer Rev, V1; Friedman LS, 2004, J GEN INTERN MED, V19, P51, DOI 10.1111/j.1525-1497.2004.30617.x; Steinbrook R, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2942	6	37	37	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					408	409		10.1001/jama.2017.20738	http://dx.doi.org/10.1001/jama.2017.20738			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362787	Bronze, Green Published			2022-12-28	WOS:000423405300030
J	Brat, GA; Agniel, D; Beam, A; Yorkgitis, B; Bicket, M; Homer, M; Fox, KP; Knecht, DB; McMahill-Walraven, CN; Palmer, N; Kohane, I				Brat, Gabriel A.; Agniel, Denis; Beam, Andrew; Yorkgitis, Brian; Bicket, Mark; Homer, Mark; Fox, Kathe P.; Knecht, Daniel B.; McMahill-Walraven, Cheryl N.; Palmer, Nathan; Kohane, Isaac			Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PRESCRIBING PATTERNS; UNITED-STATES; RISK-FACTORS; CHRONIC PAIN; ABUSE; ANALGESICS; DEPENDENCE; DRUG; RECIPIENTS; MORTALITY	OBJECTIVE To quantify the effects of varying opioid prescribing patterns after surgery on dependence, overdose, or abuse in an opioid naive population. DESIGN Retrospective cohort study. SETTING Surgical claims from a linked medical and pharmacy administrative database of 37 651 619 commercially insured patients between 2008 and 2016. PARTICIPANTS 1 015 116 opioid naive patients undergoing surgery. MAIN OUTCOME MEASURES Use of oral opioids after discharge as defined by refills and total dosage and duration of use. The primary outcome was a composite of misuse identified by a diagnostic code for opioid dependence, abuse, or overdose. RESULTS 568 612 (56.0%) patients received postoperative opioids, and a code for abuse was identified for 5906 patients (0.6%, 183 per 100 000 person years). Total duration of opioid use was the strongest predictor of misuse, with each refill and additional week of opioid use associated with an adjusted increase in the rate of misuse of 44.0% (95% confidence interval 40.8% to 47.2%, P< 0.001), and 19.9% increase in hazard (18.5% to 21.4%, P< 0.001), respectively. CONCLUSIONS Each refill and week of opioid prescription is associated with a large increase in opioid misuse among opioid naive patients. The data from this study suggest that duration of the prescription rather than dosage is more strongly associated with ultimate misuse in the early postsurgical period. The analysis quantifies the association of prescribing choices on opioid misuse and identifies levers for possible impact.	[Brat, Gabriel A.; Agniel, Denis; Beam, Andrew; Homer, Mark; Palmer, Nathan; Kohane, Isaac] Harvard Med Sch, Countway Lib, Dept Biomed Informat, Boston, MA 02215 USA; [Brat, Gabriel A.] Beth Israel Deaconess Med Ctr, Dept Surg, 330 Brookline Ave, Boston, MA 02215 USA; [Yorkgitis, Brian] Univ Florida, Dept Surg, Jacksonville, FL USA; [Yorkgitis, Brian] Univ Florida, Coll Med, Div Acute Care Surg, Jacksonville, FL USA; [Bicket, Mark] Johns Hopkins Univ, Dept Anesthesia & Crit Care Med, Baltimore, MD USA; [Fox, Kathe P.; Knecht, Daniel B.; McMahill-Walraven, Cheryl N.] Aetna, Dept Analyt & Behav Change, Blue Bell, PA USA	Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; State University System of Florida; University of Florida; State University System of Florida; University of Florida; Johns Hopkins University	Brat, GA (corresponding author), Harvard Med Sch, Countway Lib, Dept Biomed Informat, Boston, MA 02215 USA.; Brat, GA (corresponding author), Beth Israel Deaconess Med Ctr, Dept Surg, 330 Brookline Ave, Boston, MA 02215 USA.	gbrat@bidmc.harvard.edu		Bicket, Mark/0000-0001-9406-5953; Beam, Andrew/0000-0002-6657-2787	National Institute of General Medical Sciences of the National Institutes of Health [T32GM075774]	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Aetna for donating the dataset. MB was supported by the National Institute of General Medical Sciences of the National Institutes of Health (award No T32GM075774).	ACS, 2015, ACS NAT SURG QUAL IM; Bateman BT, 2016, JAMA INTERN MED, V176, P583, DOI 10.1001/jamainternmed.2016.0544; Bedard NA, 2017, J ARTHROPLASTY; Bicket MC, 2017, JAMA SURG, V152, P1066, DOI 10.1001/jamasurg.2017.0831; Bohnert ASB, 2011, JAMA-J AM MED ASSOC, V305, P1315, DOI 10.1001/jama.2011.370; Brummett CM, 2017, JAMA SURG, V152, DOI 10.1001/jamasurg.2017.0504; Calcaterra SL, 2016, J GEN INTERN MED, V31, P478, DOI 10.1007/s11606-015-3539-4; Cerner Corporation, 2016, MULT LEX; Ciesielski T, 2016, AM J MED, V129, P699, DOI 10.1016/j.amjmed.2016.02.014; Clarke Hance, 2014, BMJ, V348, pg1251, DOI 10.1136/bmj.g1251; Dasgupta N, 2016, PAIN MED, V17, P85, DOI 10.1111/pme.12907; Deyo RA, 2017, J GEN INTERN MED, V32, P21, DOI 10.1007/s11606-016-3810-3; Dunn KM, 2010, ANN INTERN MED, V152, P85, DOI 10.7326/0003-4819-152-2-201001190-00006; Edlund MJ, 2014, CLIN J PAIN, V30, P557, DOI 10.1097/AJP.0000000000000021; Edlund MJ, 2010, DRUG ALCOHOL DEPEN, V112, P90, DOI 10.1016/j.drugalcdep.2010.05.017; Elzey MJ, 2016, PAIN PHYSICIAN, V19, P215; Frieden TR, 2016, NEW ENGL J MED, V374, P1501, DOI 10.1056/NEJMp1515917; Gomes T, 2011, ARCH INTERN MED, V171, P686, DOI 10.1001/archinternmed.2011.117; Hill MV, 2018, ANN SURG, V267, P468, DOI 10.1097/SLA.0000000000002198; Hill MV, 2017, ANN SURG, V265, P709, DOI 10.1097/SLA.0000000000001993; Jena AB, 2016, JAMA INTERN MED, V176, P990, DOI 10.1001/jamainternmed.2016.2737; Kehlet H, 2006, LANCET, V367, P1618, DOI 10.1016/S0140-6736(06)68700-X; Ladha KS, 2016, ANESTHESIOLOGY, V124, P837, DOI 10.1097/ALN.0000000000001034; Lenguerrand E, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149306; McCarty D, 2014, PRESENTATION TO FDA; Medicaid C for M and, 2014, OP MORPH EQ CONV FAC, P1; Menendez ME, 2015, CLIN ORTHOP RELAT R, V473, P2402, DOI 10.1007/s11999-015-4173-5; Miller M, 2015, JAMA INTERN MED, V175, P608, DOI 10.1001/jamainternmed.2014.8071; Morrison RS, 2003, PAIN, V103, P303, DOI 10.1016/S0304-3959(02)00458-X; Mosher HJ, 2016, PAIN MED, V17, P1282, DOI 10.1093/pm/pnw058; Passik Steven D, 2006, J Pain Palliat Care Pharmacother, V20, P5; Paulozzi LJ, 2015, MMWR SURVEILL SUMM, V64, P1, DOI 10.15585/mmwr.ss6409a1; Paulozzi Leonard J., 2011, Morbidity and Mortality Weekly Report, V60, P60; Ronan MV, 2016, HEALTH AFFAIR, V35, P832, DOI 10.1377/hlthaff.2015.1424; Rudd RA, 2016, MMWR-MORBID MORTAL W, V64, P1378, DOI 10.15585/mmwr.mm6450a3; Strassels SA, 2002, ANESTH ANALG, V94, P130, DOI 10.1097/00000539-200201000-00025; Sullivan MD, 2015, PHARMACOEPIDEM DR S, V24, P893, DOI 10.1002/pds.3821; Sun EC, 2016, JAMA INTERN MED, V176, P1286, DOI 10.1001/jamainternmed.2016.3298; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Volkow ND, 2016, NEW ENGL J MED, V374, P1253, DOI 10.1056/NEJMra1507771; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1299, DOI 10.1001/jama.2011.401; Waljee JF, 2017, ANN SURG, V265, P728, DOI 10.1097/SLA.0000000000001904; Waljee JF, 2016, PLAST RECONSTR SURG, V137, p355E, DOI 10.1097/01.prs.0000475788.52446.7b; Waxman BP, 2015, ANZ J SURG, V85, P210, DOI 10.1111/ans.13026; Wilkerson Richard Gentry, 2016, Emerg Med Clin North Am, V34, pe1, DOI 10.1016/j.emc.2015.11.002; Wu CL, 2011, LANCET, V377, P2215, DOI 10.1016/S0140-6736(11)60245-6; Wunsch Hannah, 2016, JAMA, V315, P1654, DOI 10.1001/jama.2016.0130	47	280	283	0	27	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 17	2018	360								j5790	10.1136/bmj.j5790	http://dx.doi.org/10.1136/bmj.j5790			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT5QK	29343479	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000423208100002
J	Henning, AN; Klebanoff, CA; Restifo, NP				Henning, Amanda N.; Klebanoff, Christopher A.; Restifo, Nicholas P.			Silencing stemness in T cell differentiation	SCIENCE			English	Editorial Material							LINEAGE RELATIONSHIP; EFFECTOR		[Henning, Amanda N.; Restifo, Nicholas P.] NCI, Ctr Cell Based Therapy, NIH, Bethesda, MD 20892 USA; [Henning, Amanda N.; Restifo, Nicholas P.] NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Klebanoff, Christopher A.] MSKCC, Ctr Cell Engn, New York, NY 10065 USA; [Klebanoff, Christopher A.] MSKCC, Dept Med, New York, NY 10065 USA; [Klebanoff, Christopher A.] MSKCC, Parker Inst Canc Immunotherapy, New York, NY 10065 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Restifo, NP (corresponding author), NCI, Ctr Cell Based Therapy, NIH, Bethesda, MD 20892 USA.; Restifo, NP (corresponding author), NCI, Ctr Canc Res, NIH, Bethesda, MD 20892 USA.	restifon@mail.nih.gov	Restifo, Nicholas Phillip/Z-1614-2019; Restifo, Nicholas Phillip/M-6549-2019	Klebanoff, Christopher/0000-0001-9645-3896; Restifo, Nicholas P./0000-0003-4229-4580; Henning, Amanda/0000-0002-0935-9963	NATIONAL CANCER INSTITUTE [ZIABC010763] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 BC010763-03] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Crompton JG, 2016, CELL MOL IMMUNOL, V13, P502, DOI 10.1038/cmi.2015.32; Friedmann-Morvinski D, 2014, EMBO REP, V15, P244, DOI 10.1002/embr.201338254; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Gray SM, 2017, IMMUNITY, V46, P596, DOI 10.1016/j.immuni.2017.03.012; Hawkins RD, 2010, CELL STEM CELL, V6, P479, DOI 10.1016/j.stem.2010.03.018; Kakaradov B, 2017, NAT IMMUNOL, V18, P422, DOI 10.1038/ni.3688; Klebanoff CA, 2016, J CLIN INVEST, V126, P318, DOI 10.1172/JCI81217; Ladle BH, 2016, P NATL ACAD SCI USA, V113, P10631, DOI 10.1073/pnas.1524490113; Pace L, 2018, SCIENCE, V359, P177, DOI 10.1126/science.aah6499; Phan AT, 2017, IMMUNITY, V46, P714, DOI 10.1016/j.immuni.2017.04.016; Restifo NP, 2013, CURR OPIN IMMUNOL, V25, P556, DOI 10.1016/j.coi.2013.09.003; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Youngblood B, 2017, NATURE, V552, P404, DOI 10.1038/nature25144	15	13	13	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					163	164		10.1126/science.aar5541	http://dx.doi.org/10.1126/science.aar5541			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS5EO	29326263	Green Accepted			2022-12-28	WOS:000419816600025
J	Zhu, GT; Wang, SC; Huang, ZJ; Zhang, SB; Liao, QG; Zhang, CZ; Lin, T; Qin, M; Peng, M; Yang, CK; Cao, X; Han, X; Wang, XX; van der Knaap, E; Zhang, ZH; Cui, X; Klee, H; Fernie, AR; Luo, J; Huang, SW				Zhu, Guangtao; Wang, Shouchuang; Huang, Zejun; Zhang, Shuaibin; Liao, Qinggang; Zhang, Chunzhi; Lin, Tao; Qin, Mao; Peng, Meng; Yang, Chenkun; Cao, Xue; Han, Xu; Wang, Xiaoxuan; van der Knaap, Esther; Zhang, Zhonghua; Cui, Xia; Klee, Harry; Fernie, Alisdair R.; Luo, Jie; Huang, Sanwen			Rewiring of the Fruit Metabolome in Tomato Breeding	CELL			English	Article							GENOME-WIDE ASSOCIATION; GENE-EXPRESSION; PLANT; DOMESTICATION; BIOSYNTHESIS; REVEALS; TRAIT; LOCI; RICE; IDENTIFICATION	Humans heavily rely on dozens of domesticated plant species that have been further improved through intensive breeding. To evaluate how breeding changed the tomato fruit metabolome, we have generated and analyzed a dataset encompassing genomes, transcriptomes, and metabolomes from hundreds of tomato genotypes. The combined results illustrate how breeding globally altered fruit metabolite content. Selection for alleles of genes associated with larger fruits altered metabolite profiles as a consequence of linkage with nearby genes. Selection of fivemajor loci reduced the accumulation of anti-nutritional steroidal glycoalkaloids in ripened fruits, rendering the fruit more edible. Breeding for pink tomatoes modified the content of over 100 metabolites. The introgression of resistance genes from wild relatives in cultivars also resulted in major and unexpected metabolic changes. The study reveals a multi-omics view of the metabolic breeding history of tomato, as well as provides insights into metabolome- assisted breeding and plant biology.	[Zhu, Guangtao; Liao, Qinggang; Zhang, Chunzhi; Lin, Tao; Qin, Mao; Han, Xu; Huang, Sanwen] Chinese Acad Agr Sci, Genome Anal Lab, Minist Agr, Agr Genom Inst Shenzhen, Shenzhen 518124, Guangdong, Peoples R China; [Wang, Shouchuang; Peng, Meng; Yang, Chenkun; Luo, Jie] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Hubei, Peoples R China; [Wang, Shouchuang; Peng, Meng; Yang, Chenkun; Luo, Jie] Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Wuhan 430070, Hubei, Peoples R China; [Huang, Zejun; Zhang, Shuaibin; Cao, Xue; Wang, Xiaoxuan; Zhang, Zhonghua; Cui, Xia; Huang, Sanwen] Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Hort Crops, Sinodutch Joint Lab Hort Gen, Minist Agr,Inst Vegetables & Flowers, Beijing 100081, Peoples R China; [van der Knaap, Esther] Univ Georgia, Dept Hort, Athens, GA 30602 USA; [Klee, Harry] Univ Florida, Plant Innovat Ctr, Hort Sci, Gainesville, FL 32611 USA; [Fernie, Alisdair R.] Max Planck Inst Mol Plant Physiol, D-144776 Potsdam, Germany; [Fernie, Alisdair R.] Ctr Plant Syst Biol & Biotechnol, Plovdiv 4000, Bulgaria; [Luo, Jie] Hainan Univ, Inst Trop Agr & Forestry, Haikou 572208, Hainan, Peoples R China	Chinese Academy of Agricultural Sciences; Agriculture Genomes Institute at Shenzhen, CAAS; Ministry of Agriculture & Rural Affairs; Huazhong Agricultural University; Huazhong Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Vegetables & Flowers, CAAS; Ministry of Agriculture & Rural Affairs; University System of Georgia; University of Georgia; State University System of Florida; University of Florida; Max Planck Society; Hainan University	Huang, SW (corresponding author), Chinese Acad Agr Sci, Genome Anal Lab, Minist Agr, Agr Genom Inst Shenzhen, Shenzhen 518124, Guangdong, Peoples R China.; Luo, J (corresponding author), Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan 430070, Hubei, Peoples R China.; Luo, J (corresponding author), Huazhong Agr Univ, Natl Ctr Plant Gene Res Wuhan, Wuhan 430070, Hubei, Peoples R China.; Huang, SW (corresponding author), Chinese Acad Agr Sci, Key Lab Biol & Genet Improvement Hort Crops, Sinodutch Joint Lab Hort Gen, Minist Agr,Inst Vegetables & Flowers, Beijing 100081, Peoples R China.; Luo, J (corresponding author), Hainan Univ, Inst Trop Agr & Forestry, Haikou 572208, Hainan, Peoples R China.	jie.luo@mail.hzau.edu.cn; huangsanwen@caas.cn	Huang, Sanwen/ABE-9053-2020; Klee, Harry/A-7912-2008	Huang, Sanwen/0000-0002-8547-5309; zhang, zhonghua/0000-0002-1034-227X; van der Knaap, Esther/0000-0003-4963-7427; Qinggang, Liao/0000-0002-9687-7266; Wang, Shouchuang/0000-0002-5568-816X	China National Key Research and Development Program for Crop Breeding [2016YFD0100307]; National Science Fund for Distinguished Young Scholars [31625021, 31225025]; National Natural Science Foundation of China [31530066, 31530052, 31601756]; "973'' Program [2012CB113900]; PlantaSYST Project by the European Union's Horizon Research and Innovation Programme [SGA-CSA 664621, 739582, 664620]; National Science Foundation [IOS-1539831]; Chinese Academy of Agricultural Science (ASTIP-CAAS); Chinese Academy of Agricultural Science [CAAS-XTCX2016001]; Leading Talents of Guangdong Province Program [00201515]; Shenzhen municipal government (The Peacock Plan) [KQTD2016113010482651]; Dapeng district government	China National Key Research and Development Program for Crop Breeding; National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); "973'' Program(National Basic Research Program of China); PlantaSYST Project by the European Union's Horizon Research and Innovation Programme; National Science Foundation(National Science Foundation (NSF)); Chinese Academy of Agricultural Science (ASTIP-CAAS); Chinese Academy of Agricultural Science; Leading Talents of Guangdong Province Program; Shenzhen municipal government (The Peacock Plan); Dapeng district government	We thank Solab lab members for preparing fruit samples and Dr. Jiabing Ji from the Agricultural Genomics Institute at Shenzhen for his suggestions on the manuscript. We thank Ruowang Li from the University of Pennsylvania for data analysis. The work was supported by China National Key Research and Development Program for Crop Breeding (2016YFD0100307 to S.H.), National Science Fund for Distinguished Young Scholars (31625021 to J.L.; 31225025 to S.H.), National Natural Science Foundation of China (31530066 to S.H.; 31530052 to J.L.; 31601756 to G.Z.), the "973'' Program (2012CB113900 to S.H.), the funding of the PlantaSYST Project by the European Union's Horizon 2020 Research and Innovation Programme (SGA-CSA 664621; 739582 under FPA no. 664620), and National Science Foundation (IOS-1539831 to H.K.). This work was also supported by the Chinese Academy of Agricultural Science (ASTIP-CAAS and CAAS-XTCX2016001), Leading Talents of Guangdong Province Program (00201515 to S.H.), and the Shenzhen municipal (The Peacock Plan KQTD2016113010482651 to S.H.) and Dapeng district governments.	Adato A, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000777; Aflitos S, 2014, PLANT J, V80, P136, DOI 10.1111/tpj.12616; Ballester AR, 2010, PLANT PHYSIOL, V152, P71, DOI 10.1104/pp.109.147322; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Beleggia R, 2016, MOL BIOL EVOL, V33, P1740, DOI 10.1093/molbev/msw050; Butelli E, 2008, NAT BIOTECHNOL, V26, P1301, DOI 10.1038/nbt.1506; Cardenas PD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10654; Carrari F, 2006, PLANT PHYSIOL, V142, P1380, DOI 10.1104/pp.106.088534; Chakrabarti M, 2013, P NATL ACAD SCI USA, V110, P17125, DOI 10.1073/pnas.1307313110; Chen W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12767; Chen W, 2013, MOL PLANT, V6, P1769, DOI 10.1093/mp/sst080; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Fernie AR, 2004, NAT REV MOL CELL BIO, V5, P763, DOI 10.1038/nrm1451; Frary A, 2000, SCIENCE, V289, P85, DOI 10.1126/science.289.5476.85; Friedman M, 2002, J AGR FOOD CHEM, V50, P5751, DOI 10.1021/jf020560c; Grienenberger E, 2009, PLANT J, V58, P246, DOI 10.1111/j.1365-313X.2008.03773.x; Holzinger ER, 2012, PHARMACOGENOMICS, V13, P213, DOI [10.2217/pgs.11.145, 10.2217/PGS.11.145]; Huang ZJ, 2011, THEOR APPL GENET, V123, P465, DOI 10.1007/s00122-011-1599-3; Iijima Y, 2009, J AGR FOOD CHEM, V57, P3247, DOI 10.1021/jf8037902; Itkin M, 2013, SCIENCE, V341, P175, DOI 10.1126/science.1240230; Kalisz S, 2008, HEREDITY, V100, P171, DOI 10.1038/sj.hdy.6800939; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kusano M, 2011, PLANT J, V66, P456, DOI 10.1111/j.1365-313X.2011.04506.x; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li MX, 2012, HUM GENET, V131, P747, DOI 10.1007/s00439-011-1118-2; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Lippert C, 2011, NAT METHODS, V8, P833, DOI [10.1038/nmeth.1681, 10.1038/NMETH.1681]; Luo J, 2015, CURR OPIN PLANT BIOL, V24, P31, DOI 10.1016/j.pbi.2015.01.006; Matsuda F, 2010, PLANT PHYSIOL, V152, P566, DOI 10.1104/pp.109.148031; Michaelson JJ, 2009, METHODS, V48, P265, DOI 10.1016/j.ymeth.2009.03.004; Mu Q, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006930; Muir SR, 2001, NAT BIOTECHNOL, V19, P470, DOI 10.1038/88150; Olsen KM, 2006, GENETICS, V173, P975, DOI 10.1534/genetics.106.056473; Palaisa K, 2004, P NATL ACAD SCI USA, V101, P9885, DOI 10.1073/pnas.0307839101; Peng M, 2016, PLANT CELL, V28, P1533, DOI 10.1105/tpc.16.00265; Retief J D, 2000, Methods Mol Biol, V132, P243; RICK CM, 1994, P NATL ACAD SCI USA, V91, P12877, DOI 10.1073/pnas.91.26.12877; Rio D.C., 2010, COLD SPRING HARBOR P, V2010, ppdb.prot5439, DOI [10.1101/pdb.prot5439, DOI 10.1101/PDB.PROT5439]; Ritchie MD, 2015, NAT REV GENET, V16, P85, DOI 10.1038/nrg3868; Ron M, 2014, PLANT PHYSIOL, V166, P455, DOI 10.1104/pp.114.239392; Saito K, 2010, ANNU REV PLANT BIOL, V61, P463, DOI 10.1146/annurev.arplant.043008.092035; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Sauvage C, 2014, PLANT PHYSIOL, V165, P1120, DOI 10.1104/pp.114.241521; Schwahn K, 2014, J INTEGR PLANT BIOL, V56, P864, DOI 10.1111/jipb.12274; Shabalin AA, 2012, BIOINFORMATICS, V28, P1353, DOI 10.1093/bioinformatics/bts163; Shang Y, 2014, SCIENCE, V346, P1084, DOI 10.1126/science.1259215; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Soyk S, 2017, NAT GENET, V49, P162, DOI 10.1038/ng.3733; Stegle O, 2012, NAT PROTOC, V7, P500, DOI 10.1038/nprot.2011.457; Takagi H, 2013, PLANT J, V74, P174, DOI 10.1111/tpj.12105; Tanksley SD, 2004, PLANT CELL, V16, pS181, DOI 10.1105/tpc.018119; Tieman D, 2017, SCIENCE, V355, P391, DOI 10.1126/science.aal1556; Townsend JA, 2009, NATURE, V459, P442, DOI 10.1038/nature07845; Umemoto N, 2016, PLANT PHYSIOL, V171, P2458, DOI 10.1104/pp.16.00137; van der Knaap E, 2003, THEOR APPL GENET, V107, P139, DOI 10.1007/s00122-003-1224-1; Verlaan MG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003399; Wishart DS, 2007, NUCLEIC ACIDS RES, V35, pD521, DOI 10.1093/nar/gkl923; Wurtzel ET, 2016, SCIENCE, V353, P1232, DOI 10.1126/science.aad2062; Zhang Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9635	63	365	408	71	589	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					249	+		10.1016/j.cell.2017.12.019	http://dx.doi.org/10.1016/j.cell.2017.12.019			25	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29328914	Green Published, Bronze			2022-12-28	WOS:000419840100023
J	Grossman, DC; Curry, SJ; Owens, DK; Barry, MJ; Davidson, KW; Doubeni, CA; Epling, J; Kemper, AR; Krist, AH; Kurth, AE; Landefeld, S; Mangione, CM; Phipps, MG; Silverstein, M; Simon, MA; Tseng, CW				Grossman, David C.; Curry, Susan J.; Owens, Douglas K.; Barry, Michael J.; Davidson, Karina W.; Doubeni, Chyke A.; Epling, Johnw., Jr.; Kemper, Alex R.; Krist, Alex H.; Kurth, Ann E.; Landefeld, Seth; Mangione, Carol M.; Phipps, Maureen G.; Silverstein, Michael; Simon, Melissa A.; Tseng, Chien-Wen		US Preventive Serv Task Force	Screening for Adolescent Idiopathic Scoliosis US Preventive Services Task Force Recommendation Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; NATURAL-HISTORY; FOLLOW-UP; RESEARCH-SOCIETY; BRACE; COHORT; GIRLS; CURVE	IMPORTANCE Adolescent idiopathic scoliosis, a lateral curvature of the spine of unknown cause with a Cobb angle of at least 10 degrees, occurs in children and adolescents aged 10 to 18 years. Idiopathic scoliosis is the most common form and usually worsens during adolescence before skeletal maturity. Severe spinal curvature may be associated with adverse long-term health outcomes (eg, pulmonary disorders, disability, back pain, psychological effects, cosmetic issues, and reduced quality of life). Early identification and effective treatment of mild scoliosis could slow or stop curvature progression before skeletal maturity, thereby improving long-term outcomes in adulthood. OBJECTIVE To update the 2004 US Preventive Services Task Force (USPSTF) recommendation on screening for idiopathic scoliosis in asymptomatic adolescents. EVIDENCE REVIEW The USPSTF reviewed the evidence on the benefits and harms of screening for and treatment of adolescent idiopathic scoliosis. FINDINGS The USPSTF found no direct evidence on screening for adolescent idiopathic scoliosis and health outcomes and no evidence on the harms of screening. The USPSTF found inadequate evidence on treatment with exercise and surgery. It found adequate evidence that treatment with bracingmay slow curvature progression in adolescents with mild or moderate curvature severity (Cobb angle <40 degrees to 50 degrees); however, evidence on the association between reduction in spinal curvature in adolescence and long-term health outcomes in adulthood is inadequate. The USPSTF found inadequate evidence on the harms of treatment. Therefore, the USPSTF concludes that the current evidence is insufficient and that the balance of benefits and harms of screening for adolescent idiopathic scoliosis cannot be determined. CONCLUSIONS AND RECOMMENDATION The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for adolescent idiopathic scoliosis in children and adolescents aged 10 to 18 years. (I statement)	[Grossman, David C.] Kaiser Permanente Washington Hlth Res Inst, Seattle, WA 98101 USA; [Curry, Susan J.] Univ Iowa, Iowa City, IA USA; [Owens, Douglas K.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Owens, Douglas K.] Stanford Univ, Stanford, CA 94305 USA; [Barry, Michael J.] Harvard Med Sch, Boston, MA USA; [Davidson, Karina W.] Columbia Univ, New York, NY USA; [Doubeni, Chyke A.] Univ Penn, Philadelphia, PA 19104 USA; [Epling, Johnw., Jr.] Virginia Tech, Carilion Sch Med, Roanoke, VA USA; [Kemper, Alex R.] Nationwide Childrens Hosp, Columbus, OH USA; [Krist, Alex H.] Fairfax Family Practice Residency, Fairfax, VA USA; [Krist, Alex H.] Virginia Commonwealth Univ, Richmond, VA USA; [Kurth, Ann E.] Yale Univ, New Haven, CT USA; [Landefeld, Seth] Univ Alabama Birmingham, Birmingham, AL USA; [Mangione, Carol M.] Univ Calif Los Angeles, Los Angeles, CA 90024 USA; [Phipps, Maureen G.] Brown Univ, Providence, RI 02912 USA; [Silverstein, Michael] Boston Univ, Boston, MA 02215 USA; [Simon, Melissa A.] Northwestern Univ, Evanston, IL USA; [Tseng, Chien-Wen] Univ Hawaii, Honolulu, HI 96822 USA; [Tseng, Chien-Wen] Pacific Hlth Res & Educ Inst, Honolulu, HI USA	Kaiser Permanente; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Stanford University; Harvard University; Harvard Medical School; Columbia University; University of Pennsylvania; Virginia Polytechnic Institute & State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Virginia Commonwealth University; Yale University; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles; Brown University; Boston University; Northwestern University; University of Hawaii System; Pacific Health Research & Education Institute	Grossman, DC (corresponding author), Kaiser Permanente Washington Hlth Res Inst, Seattle, WA 98101 USA.	david.c.grossman@kp.org	Davidson, Karina/GWC-0996-2022; Davidson, Karina/AAG-2388-2019; Kehoe, Clare/ABC-7984-2020; Epling, John W/J-1097-2019	Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Epling, John W/0000-0001-9445-8669; Kemper, Alex/0000-0001-5491-3997	Agency for Healthcare Research and Quality (AHRQ)	Agency for Healthcare Research and Quality (AHRQ)(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	The USPSTF is an independent, voluntary body. The US Congress mandates that the Agency for Healthcare Research and Quality (AHRQ) support the operations of the USPSTF.	Coillard C, 2014, EUR J PHYS REHAB MED, V50, P479; Danielsson AJ, 2012, SPINE, V37, P755, DOI 10.1097/BRS.0b013e318231493c; Danielsson AJ, 2010, SPINE, V35, P199, DOI 10.1097/BRS.0b013e3181c89f4a; Danielsson AJ, 2001, EUR SPINE J, V10, P278, DOI 10.1007/s005860100309; DUNN J, 2017, SCREENING ADOLESCENT; Dunn J, 2018, JAMA-J AM MED ASSOC, V319, P173, DOI 10.1001/jama.2017.11669; Fong DYT, 2015, SPINE J, V15, P825, DOI 10.1016/j.spinee.2015.01.019; Goldberg C J, 1993, Eur Spine J, V2, P29, DOI 10.1007/BF00301052; GOLDBERG CJ, 1995, SPINE, V20, P1368, DOI 10.1097/00007632-199506000-00007; GOLDBERG CJ, 1993, SPINE, V18, P902, DOI 10.1097/00007632-199306000-00015; Hresko MT, 2015, COMMUNICATION; Karachalios T, 1999, SPINE, V24, P2318, DOI 10.1097/00007632-199911150-00006; Lee CF, 2010, SPINE, V35, pE1492, DOI 10.1097/BRS.0b013e3181ecf3fe; Linker B, 2012, AM J PUBLIC HEALTH, V102, P606, DOI 10.2105/AJPH.2011.300531; Luk KDK, 2010, SPINE, V35, P1607, DOI 10.1097/BRS.0b013e3181c7cb8c; Monticone M, 2014, EUR SPINE J, V23, P1204, DOI 10.1007/s00586-014-3241-y; NACHEMSON AL, 1995, J BONE JOINT SURG AM, V77A, P815, DOI 10.2106/00004623-199506000-00001; Negrini S, 2008, J REHABIL MED, V40, P451, DOI 10.2340/16501977-0195; Negrini S, 2012, SCOLIOSIS SPINAL DIS, V7, DOI 10.1186/1748-7161-7-3; PETERSON LE, 1995, J BONE JOINT SURG AM, V77A, P823, DOI 10.2106/00004623-199506000-00002; Rosenberg Jacob J, 2011, Pediatr Rev, V32, P397, DOI 10.1542/pir.32-9-397; Weinstein SL, 1999, SPINE, V24, P2592, DOI 10.1097/00007632-199912150-00006; Weinstein SL, 2013, SPINE, V38, P1832, DOI 10.1097/01.brs.0000435048.23726.3e; Weinstein SL, 2013, NEW ENGL J MED, V369, P1512, DOI 10.1056/NEJMoa1307337; Wiemann JM, 2014, J PEDIATR ORTHOPED, V34, P603, DOI 10.1097/BPO.0000000000000221; Yawn BP, 1999, JAMA-J AM MED ASSOC, V282, P1427, DOI 10.1001/jama.282.15.1427	26	68	68	7	32	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2018	319	2					165	172		10.1001/jama.2017.19342	http://dx.doi.org/10.1001/jama.2017.19342			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS4PR	29318284	Bronze			2022-12-28	WOS:000419775500016
J	Ofri, D				Ofri, Danielle			The art of medicine In search of a teacher	LANCET			English	Editorial Material									[Ofri, Danielle] NYU, Sch Med, Bellevue Hosp, New York, NY 10016 USA	Bellevue Hospital Center; New York University	Ofri, D (corresponding author), NYU, Sch Med, Bellevue Hosp, New York, NY 10016 USA.	danielle.ofri@nyumc.org		Ofri, Danielle/0000-0001-9865-7104					0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 6	2018	391	10115					22	23		10.1016/S0140-6736(17)33259-2	http://dx.doi.org/10.1016/S0140-6736(17)33259-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR9ZB	29323645				2022-12-28	WOS:000419432300015
J	Carey, RM; Whelton, PK				Carey, Robert M.; Whelton, Paul K.		ACC AHA Hypertension Guideline Wri	Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: Synopsis of the 2017 American College of Cardiology/American Heart Association Hypertension Guideline	ANNALS OF INTERNAL MEDICINE			English	Article							CLINICAL-PRACTICE GUIDELINES; GLOBAL BURDEN; TRIAL	Description: In November 2017, the American College of Cardiology (ACC) and the American Heart Association (AHA) released a clinical practice guideline for the prevention, detection, evaluation, and treatment of high blood pressure (BP) in adults. This article summarizes the major recommendations. Methods: In 2014, the ACC and the AHA appointed a multidisciplinary committee to update previous reports of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The committee reviewed literature and commissioned systematic reviews and meta-analyses on out-of-office BP monitoring, the optimal target for BP lowering, the comparative benefits and harms of different classes of antihypertensive agents, and the comparative benefits and harms of initiating therapy with a single antihypertensive agent or a combination of 2 agents. Recommendations: This article summarizes key recommendations in the following areas: BP classification, BP measurement, screening for secondary hypertension, nonpharmacologic therapy, BP thresholds and cardiac risk estimation to guide drug treatment, treatment goals (general and for patients with diabetes mellitus, chronic kidney disease, and advanced age), choice of initial drug therapy, resistant hypertension, and strategies to improve hypertension control.	[Carey, Robert M.] Univ Virginia Hlth Syst, POB 801414, Charlottesville, VA 22908 USA; [Whelton, Paul K.] Tulane Univ, Sch Publ Hlth & Trop Med, 1440 Canal St, New Orleans, LA 70112 USA; [Whelton, Paul K.] Tulane Sch Med, 1440 Canal St, New Orleans, LA 70112 USA	University of Virginia; Tulane University; Tulane University	Carey, RM (corresponding author), Univ Virginia Hlth Syst, POB 801414, Charlottesville, VA 22908 USA.		Himmelfarb, Cheryl Dennison/V-5660-2019; Stafford, Randall/F-3974-2017; Casey, Donald/AFM-6658-2022	Himmelfarb, Cheryl Dennison/0000-0003-1918-4316; Stafford, Randall/0000-0003-1805-1271; Casey, Donald/0000-0002-3820-598X; Gidding, Samuel/0000-0002-8557-7225				Bangalore S, 2017, AM J MED, V130, P707, DOI 10.1016/j.amjmed.2017.01.004; Berra E, 2016, HYPERTENSION, V68, P297, DOI 10.1161/HYPERTENSIONAHA.116.07464; Bress AP, 2017, DIABETES CARE, V40, P1401, DOI 10.2337/dc17-0885; Bundy JD, 2017, JAMA CARDIOL, V2, P775, DOI 10.1001/jamacardio.2017.1421; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Cushman WC, 2010, NEW ENGL J MED, V362, P1575, DOI 10.1056/NEJMoa1001286; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Forouzanfar MH, 2017, JAMA-J AM MED ASSOC, V317, P165, DOI 10.1001/jama.2016.19043; Gibbons GH, 2013, CIRCULATION, V128, P1716, DOI 10.1161/CIRCULATIONAHA.113.005548; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; Jacobs AK, 2014, CIRCULATION, V130, P1208, DOI 10.1161/CIR.0000000000000090; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Muntner P, 2018, CIRCULATION, V137, P109, DOI 10.1161/CIRCULATIONAHA.117.032582; Perkovic V, 2015, NEW ENGL J MED, V373, P2175, DOI 10.1056/NEJMe1513301; Reboussin DM, 2018, HYPERTENSION, V71, pE116, DOI [10.1161/HYP.0000000000000067, 10.1016/j.jacc.2017.11.004]; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Thomopoulos C, 2016, J HYPERTENS, V34, P613, DOI 10.1097/HJH.0000000000000881; Verdecchia P, 2016, HYPERTENSION, V68, P642, DOI 10.1161/HYPERTENSIONAHA.116.07608; Warwick J, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0328-1; Whelton PK, 2017, HYPERTENSION, DOI 10.1016/j.jacc.2017.11.006; Xie XF, 2016, LANCET, V387, P435, DOI 10.1016/S0140-6736(15)00805-3	21	193	213	2	52	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2018	168	5					351	+		10.7326/M17-3203	http://dx.doi.org/10.7326/M17-3203			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY2GD	29357392				2022-12-28	WOS:000426632600008
J	Sharfstein, JM				Sharfstein, Joshua M.			A New Year's Wish on Opioids	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item									[Sharfstein, Joshua M.] Johns Hopkins Bloomberg Sch Publ Hlth, Publ Hlth Practice & Training, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Sharfstein, JM (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Publ Hlth Practice & Training, Baltimore, MD 21205 USA.	joshua.sharfstein@jhu.edu							0	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2018	319	6					537	538		10.1001/jama.2018.0058	http://dx.doi.org/10.1001/jama.2018.0058			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV9LD	29365013	Bronze			2022-12-28	WOS:000424908400003
J	Stevenson, R; Moore, DE				Stevenson, Robin; Moore, Donald E., Jr.			Ascent to the Summit of the CME Pyramid	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PERFORMANCE; OUTCOMES		[Stevenson, Robin] Journal European CME, Glasgow, Lanark, Scotland; [Moore, Donald E., Jr.] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA	Vanderbilt University	Stevenson, R (corresponding author), Journal European CME, Glasgow, Lanark, Scotland.; Stevenson, R (corresponding author), Univ Manchester, Innovat Ctr, Arch 29 North Campus Incubator,Sackville St, Manchester M60 1QD, Lancs, England.	rstevenson@jecme.eu	Moore, Donald E./ABC-1015-2020	Moore, Donald E./0000-0002-6176-3920				Barber RM, 2017, LANCET, V390, P231, DOI [10.1016/S0140-6736(17)30818-8, 10.1016/s0140-6736(17)30818-8]; Campbell C, 2010, MED TEACH, V32, P657, DOI 10.3109/0142159X.2010.500708; Cervero RM, 2015, J CONTIN EDUC HEALTH, V35, P131, DOI 10.1002/chp.21290; Chetty R, 2016, JAMA-J AM MED ASSOC, V315, P1750, DOI 10.1001/jama.2016.4226; Health Consumer Powerhouse, EUR HLTH CONS IND 20; MILLER GE, 1990, ACAD MED, V65, pS63, DOI 10.1097/00001888-199009000-00045; Moore DE, 2009, J CONTIN EDUC HEALTH, V29, P1, DOI 10.1002/chp.20001	7	15	15	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2018	319	6					543	544		10.1001/jama.2017.19791	http://dx.doi.org/10.1001/jama.2017.19791			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV9LD	29356817				2022-12-28	WOS:000424908400009
J	Mueller, S; Engleitner, T; Maresch, R; Zukowska, M; Lange, S; Kaltenbacher, T; Konukiewitz, B; Ollinger, R; Zwiebel, M; Strong, A; Yen, HY; Banerjee, R; Louzada, S; Fu, BY; Seidler, B; Gotzfried, J; Schuck, K; Hassan, Z; Arbeiter, A; Schonhuber, N; Klein, S; Veltkamp, C; Friedrich, M; Rad, L; Barenboim, M; Ziegenhain, C; Hess, J; Dovey, OM; Eser, S; Parekh, S; Constantino-Casas, F; de la Rosa, J; Sierra, MI; Fraga, M; Mayerle, J; Kloppel, G; Cadinanos, J; Liu, P; Vassiliou, G; Weichert, W; Steiger, K; Enard, W; Schmid, RM; Yang, FT; Unger, K; Schneider, G; Varela, I; Bradley, A; Saur, D; Rad, R				Mueller, Sebastian; Engleitner, Thomas; Maresch, Roman; Zukowska, Magdalena; Lange, Sebastian; Kaltenbacher, Thorsten; Konukiewitz, Bjoern; Oellinger, Rupert; Zwiebel, Maximilian; Strong, Alex; Yen, Hsi-Yu; Banerjee, Ruby; Louzada, Sandra; Fu, Beiyuan; Seidler, Barbara; Goetzfried, Juliana; Schuck, Kathleen; Hassan, Zonera; Arbeiter, Andreas; Schoenhuber, Nina; Klein, Sabine; Veltkamp, Christian; Friedrich, Mathias; Rad, Lena; Barenboim, Maxim; Ziegenhain, Christoph; Hess, Julia; Dovey, Oliver M.; Eser, Stefan; Parekh, Swati; Constantino-Casas, Fernando; de la Rosa, Jorge; Sierra, Marta I.; Fraga, Mario; Mayerle, Julia; Kloeppel, Gunter; Cadinanos, Juan; Liu, Pentao; Vassiliou, George; Weichert, Wilko; Steiger, Katja; Enard, Wolfgang; Schmid, Roland M.; Yang, Fengtang; Unger, Kristian; Schneider, Gunter; Varela, Ignacio; Bradley, Allan; Saur, Dieter; Rad, Roland			Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes	NATURE			English	Article							EXPRESSION; TUMOR; MUTATIONS; CARCINOMA; SUBTYPES; CELLS; MODEL; P53; CLASSIFICATION; AMPLIFICATIONS	The poor correlation of mutational landscapes with phenotypes limits our understanding of the pathogenesis and metastasis of pancreatic ductal adenocarcinoma (PDAC). Here we show that oncogenic dosage-variation has a critical role in PDAC biology and phenotypic diversification. We find an increase in gene dosage of mutant KRAS in human PDAC precursors, which drives both early tumorigenesis and metastasis and thus rationalizes early PDAC dissemination. To overcome the limitations posed to gene dosage studies by the stromal richness of PDAC, we have developed large cell culture resources of metastatic mouse PDAC. Integration of cell culture genomes, transcriptomes and tumour phenotypes with functional studies and human data reveals additional widespread effects of oncogenic dosage variation on cell morphology and plasticity, histopathology and clinical outcome, with the highest Kras(MUT) levels underlying aggressive undifferentiated phenotypes. We also identify alternative oncogenic gains (Myc, Yap1 or Nfkb2), which collaborate with heterozygous Kras(MUT) in driving tumorigenesis, but have lower metastatic potential. Mechanistically, different oncogenic gains and dosages evolve along distinct evolutionary routes, licensed by defined allelic states and/ or combinations of hallmark tumour suppressor alterations (Cdkn2a, Trp53, Tgf beta-pathway). Thus, evolutionary constraints and contingencies direct oncogenic dosage gain and variation along defined routes to drive the early progression of PDAC and shape its downstream biology. Our study uncovers universal principles of Ras-driven oncogenesis that have potential relevance beyond pancreatic cancer.	[Mueller, Sebastian; Engleitner, Thomas; Maresch, Roman; Zukowska, Magdalena; Lange, Sebastian; Kaltenbacher, Thorsten; Oellinger, Rupert; Seidler, Barbara; Schoenhuber, Nina; Klein, Sabine; Veltkamp, Christian; Saur, Dieter; Rad, Roland] Tech Univ Munich, Ctr Translat Canc Res TranslaTUM, D-81675 Munich, Germany; [Mueller, Sebastian; Engleitner, Thomas; Maresch, Roman; Zukowska, Magdalena; Lange, Sebastian; Kaltenbacher, Thorsten; Oellinger, Rupert; Zwiebel, Maximilian; Seidler, Barbara; Goetzfried, Juliana; Schuck, Kathleen; Hassan, Zonera; Arbeiter, Andreas; Schoenhuber, Nina; Klein, Sabine; Veltkamp, Christian; Rad, Lena; Barenboim, Maxim; Eser, Stefan; Schmid, Roland M.; Schneider, Gunter; Saur, Dieter; Rad, Roland] Tech Univ Munich, Dept Med 2, Klinikum Rechts Isar, D-81675 Munich, Germany; [Engleitner, Thomas; Maresch, Roman; Kaltenbacher, Thorsten; Yen, Hsi-Yu; Barenboim, Maxim; Weichert, Wilko; Schmid, Roland M.; Schneider, Gunter; Saur, Dieter; Rad, Roland] German Canc Res Ctr, German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Konukiewitz, Bjoern; Kloeppel, Gunter; Weichert, Wilko; Steiger, Katja] Tech Univ Munich, Inst Pathol, D-81675 Munich, Germany; [Strong, Alex; Banerjee, Ruby; Louzada, Sandra; Fu, Beiyuan; Friedrich, Mathias; Dovey, Oliver M.; de la Rosa, Jorge; Cadinanos, Juan; Liu, Pentao; Vassiliou, George; Yang, Fengtang; Bradley, Allan] Wellcome Trust Sanger Inst, Genome Campus, Cambridge CB10 1SA, England; [Yen, Hsi-Yu; Steiger, Katja] Tech Univ Munich, Comparat Expt Pathol, D-81675 Munich, Germany; [Ziegenhain, Christoph; Parekh, Swati; Enard, Wolfgang] Univ Munich, Dept Biol 2, Anthropol & Human Genom, D-82152 Martinsried, Germany; [Hess, Julia; Unger, Kristian] Helmholtz Zentrum Munchen, Res Unit Radiat Cytogenet, D-85764 Neuherberg, Germany; [Constantino-Casas, Fernando] Univ Cambridge, Dept Vet Med, Cambridge CB3 0ES, England; [de la Rosa, Jorge; Cadinanos, Juan] IMOMA, Oviedo 33193, Spain; [de la Rosa, Jorge] Univ Oviedo, Inst Univ Oncol IUOPA, Fac Med, Dept Bioquim & Biol Mol, Oviedo 33006, Spain; [Sierra, Marta I.; Fraga, Mario] Univ Oviedo, Inst Oncol Asturias IUOPA, HUCA, Oviedo 33011, Spain; [Fraga, Mario] Univ Oviedo, Nanomat & Nanotechnol Res Ctr CINN CSIC, El Entrego 33940, Spain; [Mayerle, Julia] Klinikum LMU Munchen Grosshadern, Med Klin & Poliklin 2, D-81377 Munich, Germany; [Varela, Ignacio] Inst Biomed & Biotecnol Cantabria UC CSIC, Santander 39012, Spain	Technical University of Munich; Technical University of Munich; Helmholtz Association; German Cancer Research Center (DKFZ); Technical University of Munich; Wellcome Trust Sanger Institute; Technical University of Munich; University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Cambridge; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Central University Hospital Asturias; University of Oviedo; Instituto Universitario de Oncologia de Asturias; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigacion en Nanomateriales y Nanotecnologia (CINN); University of Oviedo; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munich; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC)	Rad, R (corresponding author), Tech Univ Munich, Ctr Translat Canc Res TranslaTUM, D-81675 Munich, Germany.; Rad, R (corresponding author), Tech Univ Munich, Dept Med 2, Klinikum Rechts Isar, D-81675 Munich, Germany.; Rad, R (corresponding author), German Canc Res Ctr, German Canc Consortium DKTK, D-69120 Heidelberg, Germany.	roland.rad@tum.de	Varela, Ignacio/G-1699-2016; Ziegenhain, Christoph/AFQ-1711-2022; Lange, Sebastian/S-4635-2019; Yang, Fan/GYU-4249-2022; Mayerle, Julia/W-7907-2019; Barenboim, Maxim/ABE-1253-2021; Fraga, Mario F/H-7824-2017; Saur, Dieter/O-8355-2015; Unger, Kristian/F-3730-2018; Konukiewitz, Björn/AAT-7340-2020; Varela, Ignacio/AAA-7680-2021; Enard, Wolfgang/K-3483-2014; Schuck, Kathleen/AAQ-4664-2021	Varela, Ignacio/0000-0002-0969-506X; Ziegenhain, Christoph/0000-0003-2208-4877; Lange, Sebastian/0000-0003-0406-1401; Barenboim, Maxim/0000-0002-9821-3797; Fraga, Mario F/0000-0001-8450-2603; Saur, Dieter/0000-0001-5874-0210; Unger, Kristian/0000-0002-0374-2320; Varela, Ignacio/0000-0002-0969-506X; Ollinger, Rupert/0000-0002-2292-5982; Louzada Gomes Pereira, Sandra/0000-0003-2245-8453; Mayerle, Julia/0000-0002-3666-6459; Vassiliou, George/0000-0003-4337-8022; Bradley, Allan/0000-0002-2349-8839; de la Rosa, Jorge/0000-0002-0201-2078; Yen, Hsi-Yu/0000-0003-2644-2782; Cadinanos, Juan/0000-0001-7561-7759; Kloppel, Gunter/0000-0002-6688-086X; Yang, Fengtang/0000-0002-3573-2354	German Cancer Consortium Joint Funding Program; Helmholtz Gemeinschaft (PCCC Consortium); German Research Foundation [SFB1243, A13/A14]; European Research Council (ERC CoG) [648521]	German Cancer Consortium Joint Funding Program; Helmholtz Gemeinschaft (PCCC Consortium); German Research Foundation(German Research Foundation (DFG)); European Research Council (ERC CoG)(European Research Council (ERC))	We thank the comparative experimental pathology team for discussions, and A. Selmeier, L. Dajka, O. Seelbach, P. Meyer, T. Schmidt, J. Eichinger and T. Stauber for technical assistance as well as M. Reichert for vector constructs. The work was supported by the German Cancer Consortium Joint Funding Program, the Helmholtz Gemeinschaft (PCCC Consortium), the German Research Foundation (SFB1243; A13/A14) and the European Research Council (ERC CoG number 648521).	Aguirre AJ, 2003, GENE DEV, V17, P3112, DOI 10.1101/gad.1158703; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Bronner I. F., 2014, CURR PROTOC HUM GENE, V80; Campbell PJ, 2010, NATURE, V467, P1109, DOI 10.1038/nature09460; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Feldser DM, 2010, NATURE, V468, P572, DOI 10.1038/nature09535; Friedrich MJ, 2017, NAT PROTOC, V12, P289, DOI 10.1038/nprot.2016.164; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Hamidi T, 2012, J CLIN INVEST, V122, P2092, DOI 10.1172/JCI60144; Heidenblad M, 2002, GENE CHROMOSOME CANC, V34, P211, DOI 10.1002/gcc.10063; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hruban RH, 2006, CANCER RES, V66, P95, DOI 10.1158/0008-5472.CAN-05-2168; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Iacobuzio-Donahue CA, 2009, J CLIN ONCOL, V27, P1806, DOI 10.1200/JCO.2008.17.7188; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jentsch I, 2001, CHROMOSOME RES, V9, P211, DOI 10.1023/A:1016696303479; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Junttila MR, 2010, NATURE, V468, P567, DOI 10.1038/nature09526; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Korbel JO, 2013, CELL, V152, P1226, DOI 10.1016/j.cell.2013.02.023; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Lee CL, 2012, DIS MODEL MECH, V5, P397, DOI 10.1242/dmm.009084; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Makohon-Moore AP, 2017, NAT GENET, V49, P358, DOI 10.1038/ng.3764; Mann KM, 2012, P NATL ACAD SCI USA, V109, P5934, DOI 10.1073/pnas.1202490109; Maresch R, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10770; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Moffitt RA, 2015, NAT GENET, V47, P1168, DOI 10.1038/ng.3398; MOROHOSHI T, 1983, HISTOPATHOLOGY, V7, P645, DOI 10.1111/j.1365-2559.1983.tb02277.x; Nakhai H, 2007, DEVELOPMENT, V134, P1151, DOI 10.1242/dev.02781; Notta F, 2016, NATURE, V538, P378, DOI 10.1038/nature19823; Parekh S, 2016, SCI REP-UK, V6, DOI 10.1038/srep25533; Perez-Mancera PA, 2012, NATURE, V486, P266, DOI 10.1038/nature11114; Rad R, 2015, NAT GENET, V47, P47, DOI 10.1038/ng.3164; Rad R, 2013, CANCER CELL, V24, P15, DOI 10.1016/j.ccr.2013.05.014; Rahib L, 2014, CANCER RES, V74, P2913, DOI 10.1158/0008-5472.CAN-14-0155; REDSTON MS, 1994, CANCER RES, V54, P3025; Rhim AD, 2012, CELL, V148, P349, DOI 10.1016/j.cell.2011.11.025; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653; Schneider G, 2006, EMBO J, V25, P3801, DOI 10.1038/sj.emboj.7601259; Schonhuber N, 2014, NAT MED, V20, P1340, DOI 10.1038/nm.3646; Stathis A, 2010, NAT REV CLIN ONCOL, V7, P163, DOI 10.1038/nrclinonc.2009.236; Stephens PJ, 2011, CELL, V144, P27, DOI 10.1016/j.cell.2010.11.055; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; Waddell N, 2015, NATURE, V518, P495, DOI 10.1038/nature14169; Weber J, 2015, P NATL ACAD SCI USA, V112, P13982, DOI 10.1073/pnas.1512392112; Winter JM, 2008, CLIN CANCER RES, V14, P412, DOI 10.1158/1078-0432.CCR-07-0487; Witkiewicz AK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7744; Yachida S, 2010, NATURE, V467, P1114, DOI 10.1038/nature09515; YAMADA H, 1986, JPN J CANCER RES, V77, P370; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394	63	212	219	1	56	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 1	2018	554	7690					62	+		10.1038/nature25459	http://dx.doi.org/10.1038/nature25459			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7QX	29364867	Green Submitted, Green Accepted			2022-12-28	WOS:000424048900031
J	Shen, QC; Zhang, Q; Shi, Y; Shi, QZ; Jiang, YY; Gu, Y; Li, ZQ; Li, X; Zhao, K; Wang, CM; Li, N; Cao, XT				Shen, Qicong; Zhang, Qian; Shi, Yang; Shi, Qingzhu; Jiang, Yanyan; Gu, Yan; Li, Zhiqing; Li, Xia; Zhao, Kai; Wang, Chunmei; Li, Nan; Cao, Xuetao			Tet2 promotes pathogen infection-induced myelopoiesis through mRNA oxidation	NATURE			English	Article							SEQUENCING DATA; NONCODING RNAS; TRANSCRIPTOME; METHYLATION; CELL; DECAY; GENE; DNA; 5-HYDROXYMETHYLCYTOSINE; INTERLEUKIN-3	Varieties of RNA modification form the epitranscriptome for post-transcriptional regulation(1). 5-Methylcytosine (5-mC) is a sparse RNA modification in messenger RNA (mRNA) under physiological conditions(2). The function of RNA 5-hydroxymethylcytosine (5-hmC) oxidized by ten-eleven translocation (Tet) proteins in Drosophila has been revealed more recently(3,4). However, the turnover and function of 5-mC in mammalian mRNA have been largely unknown. Tet2 suppresses myeloid malignancies mostly in an enzymatic activity-dependent manner(5), and is important in resolving inflammatory response in an enzymatic activityindependent way6. Myelopoiesis is a common host immune response in acute and chronic infections; however, its epigenetic mechanism needs to be identified. Here we demonstrate that Tet2 promotes infection-induced myelopoiesis in an mRNA oxidation-dependent manner through Adar(1)-mediated repression of Socs3 expression at the post-transcription level. Tet2 promotes both abdominal sepsis-induced emergency myelopoiesis and parasite-induced mast cell expansion through decreasing mRNA levels of Socs(3), a key negative regulator of the JAK-STAT pathway that is critical for cytokine-induced myelopoiesis. Tet2 represses Socs3 expression through Adar1, which binds and destabilizes Socs3 mRNA in a RNA editing-independent manner. For the underlying mechanism of Tet2 regulation at the mRNA level, Tet2 mediates oxidation of 5-mC in mRNA. Tet(2) deficiency leads to the transcriptome-wide appearance of methylated cytosines, including ones in the 3 ' untranslated region of Socs(3), which influences double-stranded RNA formation for Adar(1) binding, probably through cytosine methylation-specific readers, such as RNA helicases. Our study reveals a previously unknown regulatory role of Tet2 at the epitranscriptomic level, promoting myelopoiesis during infection in the mammalian system by decreasing 5-mCs in mRNAs. Moreover, the inhibitory function of cytosine methylation on double-stranded RNA formation and Adar1 binding in mRNA reveals its new physiological role in the mammalian system.				caoxt@immunol.org	Li, Xia/AAB-9647-2019; shen, qicong/GYJ-2803-2022		National Natural Science Foundation of China [81788101, 31390431, 91542204, 31670884]; Shanghai Rising-Star Program [17QA1405300]; CAMS Innovation Fund for Medical Science [2016-12M-1-003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Rising-Star Program; CAMS Innovation Fund for Medical Science	We thank R. L. Levine for providing Tet2 knockout mice, and K. Wang and C. Yi for helping with LC-MS analysis of RNA methylation. We thank C. Hu and W. Huang for technician support. This work was supported by grants from the National Natural Science Foundation of China (81788101, 31390431, 91542204, 31670884), the Shanghai Rising-Star Program (17QA1405300) and the CAMS Innovation Fund for Medical Science (2016-12M-1-003).	Aas PA, 2003, NATURE, V421, P859, DOI 10.1038/nature01363; Alvarez-Errico D, 2015, NAT REV IMMUNOL, V15, P7, DOI 10.1038/nri3777; Amort T, 2013, RNA BIOL, V10, P1003, DOI 10.4161/rna.24454; Anantharaman A, 2017, NUCLEIC ACIDS RES, V45, P4189, DOI 10.1093/nar/gkw1304; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Behm-Ansmant I, 2007, EMBO J, V26, P1591, DOI 10.1038/sj.emboj.7601588; Delatte B, 2016, SCIENCE, V351, P282, DOI 10.1126/science.aac5253; Dominissini D, 2013, NAT PROTOC, V8, P176, DOI 10.1038/nprot.2012.148; Edelheit S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003602; Fu LJ, 2014, J AM CHEM SOC, V136, P11582, DOI 10.1021/ja505305z; Fu Y, 2014, NAT REV GENET, V15, P293, DOI 10.1038/nrg3724; Gillen AE, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2675-5; Goll MG, 2006, SCIENCE, V311, P395, DOI 10.1126/science.1120976; Grzechnik P, 2015, GENE DEV, V29, P849, DOI 10.1101/gad.251470.114; He CS, 2016, MOL CELL, V64, P416, DOI 10.1016/j.molcel.2016.09.034; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hu LL, 2013, CELL, V155, P1545, DOI 10.1016/j.cell.2013.11.020; Hussain S, 2013, CELL REP, V4, P255, DOI 10.1016/j.celrep.2013.06.029; Jarmoskaite I, 2014, ANNU REV BIOCHEM, V83, P697, DOI 10.1146/annurev-biochem-060713-035546; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kohli RM, 2013, NATURE, V502, P472, DOI 10.1038/nature12750; Lantz CS, 1998, NATURE, V392, P90, DOI 10.1038/32190; Li XY, 2016, NAT CHEM BIOL, V12, P311, DOI [10.1038/NCHEMBIO.2040, 10.1038/nchembio.2040]; Liang F, 2016, COMPUT BIOL CHEM, V65, P173, DOI 10.1016/j.compbiolchem.2016.09.003; Liddicoat BJ, 2015, SCIENCE, V349, P1115, DOI 10.1126/science.aac7049; Luo YH, 2016, CIRC RES, V118, P944, DOI 10.1161/CIRCRESAHA.115.307674; Moran-Crusio K, 2011, CANCER CELL, V20, P11, DOI 10.1016/j.ccr.2011.06.001; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Peng ZY, 2012, NAT BIOTECHNOL, V30, P253, DOI 10.1038/nbt.2122; Popis MC, 2016, CURR OPIN ONCOL, V28, P65, DOI 10.1097/CCO.0000000000000252; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/nmeth.2330, 10.1038/NMETH.2330]; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Sakurai M, 2017, NAT STRUCT MOL BIOL, V24, P534, DOI 10.1038/nsmb.3403; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Weber GF, 2015, SCIENCE, V347, P1260, DOI 10.1126/science.aaa4268; Yu M, 2012, NAT PROTOC, V7, P2159, DOI 10.1038/nprot.2012.137; Zhang CL, 2011, NAT BIOTECHNOL, V29, P607, DOI 10.1038/nbt.1873; Zhang Q, 2015, NATURE, V525, P389, DOI 10.1038/nature15252; Zhao BXS, 2017, NAT REV MOL CELL BIO, V18, P31, DOI 10.1038/nrm.2016.132	41	109	117	2	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2018	554	7690					123	+		10.1038/nature25434	http://dx.doi.org/10.1038/nature25434			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7QX	29364877				2022-12-28	WOS:000424048900043
J	Saliba, M				Saliba, Michael			Perovskite solar cells must come of age	SCIENCE			English	Editorial Material							HYSTERESIS; CATIONS		[Saliba, Michael] Univ Fribourg, Adolphe Merkle Inst, CH-1700 Fribourg, Switzerland	University of Fribourg	Saliba, M (corresponding author), Univ Fribourg, Adolphe Merkle Inst, CH-1700 Fribourg, Switzerland.	michael.saliba@unifr.ch	Saliba, Michael/I-1945-2016	Saliba, Michael/0000-0002-6818-9781; Lab, Steiner/0000-0002-9834-2716				[Anonymous], BEST RES CELL EFF; Bush KA, 2016, ADV MATER, V28, P3937, DOI 10.1002/adma.201505279; Domanski K, 2017, ENERG ENVIRON SCI, V10, P604, DOI 10.1039/c6ee03352k; Green MA, 2017, ACS ENERGY LETT, V2, P822, DOI 10.1021/acsenergylett.7b00137; Lee JW, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201501310; Matteocci F, 2016, NANO ENERGY, V30, P162, DOI 10.1016/j.nanoen.2016.09.041; Rong YG, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201501066; Saliba M, 2016, SCIENCE, V354, P206, DOI 10.1126/science.aah5557; Shin SS, 2017, SCIENCE, V356, P167, DOI 10.1126/science.aam6620; Snaith HJ, 2014, J PHYS CHEM LETT, V5, P1511, DOI 10.1021/jz500113x; Unger EL, 2014, ENERG ENVIRON SCI, V7, P3690, DOI 10.1039/c4ee02465f	11	110	111	1	187	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					388	389		10.1126/science.aar5684	http://dx.doi.org/10.1126/science.aar5684			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT6SD	29371453				2022-12-28	WOS:000423283200025
J	Laurenti, E; Gottgens, B				Laurenti, Elisa; Goettgens, Berthold			From haematopoietic stem cells to complex differentiation landscapes	NATURE			English	Review							DNA METHYLATION DYNAMICS; GENE-EXPRESSION ANALYSIS; HUMAN CORD BLOOD; IN-VIVO; SELF-RENEWAL; LINEAGE COMMITMENT; PROGENITOR CELLS; BONE-MARROW; MULTIPOTENT PROGENITORS; MEGAKARYOCYTE PROGENITORS	The development of mature blood cells from haematopoietic stem cells has long served as a model for stem-cell research, with the haematopoietic differentiation tree being widely used as a model for the maintenance of hierarchically organized tissues. Recent results and new technologies have challenged the demarcations between stem and progenitor cell populations, the timing of cell-fate choices and the contribution of stem and multipotent progenitor cells to the maintenance of steady-state blood production. These evolving views of haematopoiesis have broad implications for our understanding of the functions of adult stem cells, as well as the development of new therapies for malignant and nonmalignant haematopoietic diseases.	[Laurenti, Elisa; Goettgens, Berthold] Univ Cambridge, Dept Haematol, Cambridge, England; [Laurenti, Elisa; Goettgens, Berthold] Univ Cambridge, Wellcome & MRC Cambridge Stem Cell Inst, Cambridge, England	University of Cambridge; University of Cambridge	Laurenti, E; Gottgens, B (corresponding author), Univ Cambridge, Dept Haematol, Cambridge, England.; Laurenti, E; Gottgens, B (corresponding author), Univ Cambridge, Wellcome & MRC Cambridge Stem Cell Inst, Cambridge, England.	el422@cam.ac.uk; bg200@cam.ac.uk		Laurenti, Elisa/0000-0002-9917-9092; Gottgens, Berthold/0000-0001-6302-5705	Sir Henry Dale fellowship from the Wellcome Trust (WT)/Royal Society; WT; CRUK; Bloodwise; MRC; BBSRC; NIH-NIDDK; BBSRC [BB/P002293/1] Funding Source: UKRI; MRC [MC_PC_16040, G0900951, MR/M008975/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/P002293/1] Funding Source: researchfish; Cancer Research UK [21762] Funding Source: researchfish; Medical Research Council [MR/M008975/1, G0900951, MC_PC_12009] Funding Source: researchfish; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R24DK106766] Funding Source: NIH RePORTER	Sir Henry Dale fellowship from the Wellcome Trust (WT)/Royal Society; WT; CRUK(Cancer Research UK); Bloodwise; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank D. Kent for critical reading of the manuscript. E.L. is supported by a Sir Henry Dale fellowship from the Wellcome Trust (WT)/Royal Society. Research in the Laurenti and Gottgens laboratories is supported by the WT, CRUK, Bloodwise, MRC, BBSRC, NIH-NIDDK, and core support grants by the WT and MRC to the Wellcome-MRC Cambridge Stem Cell Institute.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Ambrosi TH, 2017, CELL STEM CELL, V20, P771, DOI 10.1016/j.stem.2017.02.009; Anjos-Afonso F, 2013, CELL STEM CELL, V13, P161, DOI 10.1016/j.stem.2013.05.025; Baryawno N, 2017, CELL STEM CELL, V20, P590, DOI 10.1016/j.stem.2017.03.025; BECKER AJ, 1963, NATURE, V197, P452, DOI 10.1038/197452a0; Beer PA, 2014, STEM CELL REP, V3, P841, DOI 10.1016/j.stemcr.2014.09.006; Beerman I, 2015, CELL STEM CELL, V16, P613, DOI 10.1016/j.stem.2015.05.009; Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; Benveniste P, 2010, CELL STEM CELL, V6, P48, DOI 10.1016/j.stem.2009.11.014; Benz C, 2012, CELL STEM CELL, V10, P273, DOI 10.1016/j.stem.2012.02.007; Bernitz JM, 2016, CELL, V167, P1296, DOI 10.1016/j.cell.2016.10.022; Biasco L, 2016, CELL STEM CELL, V19, P107, DOI 10.1016/j.stem.2016.04.016; Biezuner T, 2016, GENOME RES, V26, P1588, DOI 10.1101/gr.202903.115; Bock C, 2012, MOL CELL, V47, P633, DOI 10.1016/j.molcel.2012.06.019; Bocker MT, 2011, BLOOD, V117, pE182, DOI 10.1182/blood-2011-01-331926; Boitano AE, 2010, SCIENCE, V329, P1345, DOI 10.1126/science.1191536; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; BRADY G, 1990, Methods in Molecular and Cellular Biology, V2, P17; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Cabezas-Wallscheid N, 2017, CELL, V169, P807, DOI 10.1016/j.cell.2017.04.018; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Cai XW, 2015, CELL STEM CELL, V17, P165, DOI 10.1016/j.stem.2015.06.002; Carrelha J., 2017, NATURE; Catlin SN, 2011, BLOOD, V117, P4460, DOI 10.1182/blood-2010-08-303537; Cavazzana M, 2017, STEM CELLS DEV, V26, P71, DOI 10.1089/scd.2016.0230; Challen GA, 2010, CELL STEM CELL, V6, P265, DOI 10.1016/j.stem.2010.02.002; Chambers Stuart M, 2007, Cell Stem Cell, V1, P578, DOI 10.1016/j.stem.2007.10.003; Chen L, 2014, SCIENCE, V345, P1580, DOI 10.1126/science.1251033; Cheshier SP, 1999, P NATL ACAD SCI USA, V96, P3120, DOI 10.1073/pnas.96.6.3120; Cheung AMS, 2013, BLOOD, V122, P3129, DOI 10.1182/blood-2013-06-508432; Chung SS, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008004; Copley MR, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.98; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Cosgun KN, 2014, CELL STEM CELL, V15, P227, DOI 10.1016/j.stem.2014.06.001; Cross MA, 1997, CURR OPIN GENET DEV, V7, P609, DOI 10.1016/S0959-437X(97)80007-X; DANCEY JT, 1976, J CLIN INVEST, V58, P705, DOI 10.1172/JCI108517; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Dykstra B, 2007, CELL STEM CELL, V1, P218, DOI 10.1016/j.stem.2007.05.015; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Fares I, 2014, SCIENCE, V345, P1509, DOI 10.1126/science.1256337; Farlik M, 2016, CELL STEM CELL, V19, P808, DOI 10.1016/j.stem.2016.10.019; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Geiger H, 2013, NAT REV IMMUNOL, V13, P376, DOI 10.1038/nri3433; Giustacchini A, 2017, NAT MED, V23, P692, DOI 10.1038/nm.4336; Goardon N, 2011, CANCER CELL, V19, P138, DOI 10.1016/j.ccr.2010.12.012; Gorgens A, 2013, CELL REP, V3, P1539, DOI 10.1016/j.celrep.2013.04.025; Goodell MA, 1996, J EXP MED, V183, P1797, DOI 10.1084/jem.183.4.1797; Grinenko T, 2014, J EXP MED, V211, P209, DOI 10.1084/jem.20131115; Grover A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11075; Grun D, 2016, CELL STEM CELL, V19, P266, DOI 10.1016/j.stem.2016.05.010; Guo GJ, 2013, CELL STEM CELL, V13, P492, DOI 10.1016/j.stem.2013.07.017; Haas S, 2015, CELL STEM CELL, V17, P422, DOI 10.1016/j.stem.2015.07.007; Haeckel E, 1868, NATURLICHE SCHOPFUNG; Haghverdi L, 2015, BIOINFORMATICS, V31, P2989, DOI 10.1093/bioinformatics/btv325; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; Herault A, 2017, NATURE, V544, P53, DOI 10.1038/nature21693; Hirche C, 2017, CELL REP, V19, P2345, DOI 10.1016/j.celrep.2017.05.063; Ho TT, 2017, NATURE, V543, P205, DOI 10.1038/nature21388; Hoogenkamp M, 2009, BLOOD, V114, P299, DOI 10.1182/blood-2008-11-191890; Hoppe PS, 2016, NATURE, V535, P299, DOI 10.1038/nature18320; Horton SJ, 2017, NAT CELL BIOL, V19, P1093, DOI 10.1038/ncb3597; Inra CN, 2015, NATURE, V527, P466, DOI 10.1038/nature15530; Ito K, 2016, SCIENCE, V354, P1156, DOI 10.1126/science.aaf5530; Ivanovs A, 2017, DEVELOPMENT, V144, P2323, DOI 10.1242/dev.134866; JACOBSON LO, 1951, SCIENCE, V113, P510, DOI 10.1126/science.113.2940.510; Ji H, 2010, NATURE, V467, P338, DOI 10.1038/nature09367; Kent DG, 2009, BLOOD, V113, P6342, DOI 10.1182/blood-2008-12-192054; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kohn LA, 2012, NAT IMMUNOL, V13, P963, DOI 10.1038/ni.2405; Laurenti E, 2015, CELL STEM CELL, V16, P302, DOI 10.1016/j.stem.2015.01.017; Laurenti E, 2013, NAT IMMUNOL, V14, P756, DOI 10.1038/ni.2615; Laurenti E, 2008, CELL STEM CELL, V3, P611, DOI 10.1016/j.stem.2008.09.005; Lee J, 2017, NAT IMMUNOL, V18, P877, DOI 10.1038/ni.3789; Lefrancais E, 2017, NATURE, V544, P105, DOI 10.1038/nature21706; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Lis R, 2017, NATURE, V545, P439, DOI 10.1038/nature22326; Lu R, 2011, NAT BIOTECHNOL, V29, P928, DOI 10.1038/nbt.1977; Luchsinger LL, 2016, NATURE, V529, P528, DOI 10.1038/nature16500; Majeti R, 2007, CELL STEM CELL, V1, P635, DOI 10.1016/j.stem.2007.10.001; Matatall KA, 2016, CELL REP, V17, P2584, DOI 10.1016/j.celrep.2016.11.031; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Miyawaki K, 2017, BLOOD, V129, P3332, DOI 10.1182/blood-2016-09-741611; Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Moignard V, 2013, NAT CELL BIOL, V15, P363, DOI 10.1038/ncb2709; Morita Y, 2010, J EXP MED, V207, P1173, DOI 10.1084/jem.20091318; Muller-Sieburg CE, 2004, BLOOD, V103, P4111, DOI 10.1182/blood-2003-10-3448; Muller-Sieburg CE, 2002, BLOOD, V100, P1302, DOI 10.1182/blood.V100.4.1302.h81602001302_1302_1309; Naik SH, 2013, NATURE, V496, P229, DOI 10.1038/nature12013; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Narula J, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000771; Nestorowa S, 2016, BLOOD, V128, pE20, DOI 10.1182/blood-2016-05-716480; Nishikawa K, 2003, MOL CELL BIOL, V23, P8295, DOI 10.1128/MCB.23.22.8295-8305.2003; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Okuno Y, 2005, MOL CELL BIOL, V25, P2832, DOI 10.1128/MCB.25.7.2832-2845.2005; Olsson A, 2016, NATURE, V537, P698, DOI 10.1038/nature19348; Pappenheim A., 1896, Virchow's Archiv, Vclxv, P587; Pappenheim A., 1907, FOLIA HAEMATOL, V4, P301; Pei WK, 2017, NATURE, V548, P456, DOI 10.1038/nature23653; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; Pimanda JE, 2007, P NATL ACAD SCI USA, V104, P17692, DOI 10.1073/pnas.0707045104; Pina C, 2012, NAT CELL BIOL, V14, P287, DOI 10.1038/ncb2442; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Psaila B, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0939-7; Qiu JJ, 2014, STEM CELL REP, V2, P473, DOI 10.1016/j.stemcr.2014.01.016; Reinisch A, 2016, NAT MED, V22, P812, DOI 10.1038/nm.4103; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Roch A, 2015, STEM CELLS, V33, P3152, DOI 10.1002/stem.2106; Rodriguez-Fraticelli AE, 2018, NATURE, V553, P212, DOI 10.1038/nature25168; Rufer N, 1999, J EXP MED, V190, P157, DOI 10.1084/jem.190.2.157; Sanada C, 2016, BLOOD, V128, P923, DOI 10.1182/blood-2016-01-693705; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Sawai CM, 2016, IMMUNITY, V45, P597, DOI 10.1016/j.immuni.2016.08.007; Sawen P, 2016, CELL REP, V14, P2809, DOI 10.1016/j.celrep.2016.02.073; Schoedel KB, 2016, BLOOD, V128, P2285, DOI 10.1182/blood-2016-03-706010; Setty M, 2016, NAT BIOTECHNOL, V34, P637, DOI 10.1038/nbt.3569; Signer RAJ, 2014, NATURE, V509, P49, DOI 10.1038/nature13035; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Sontakke P, 2016, LEUKEMIA, V30, P2064, DOI 10.1038/leu.2016.108; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; Steensma DP, 2013, NEW ENGL J MED, V368, P2138, DOI 10.1056/NEJMe1303816; Sugimura R, 2017, NATURE, V545, P432, DOI 10.1038/nature22370; Sun DQ, 2014, CELL STEM CELL, V14, P673, DOI 10.1016/j.stem.2014.03.002; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Swiers G, 2006, DEV BIOL, V294, P525, DOI 10.1016/j.ydbio.2006.02.051; Takizawa H, 2012, BLOOD, V119, P2991, DOI 10.1182/blood-2011-12-380113; Takizawa H, 2011, J EXP MED, V208, P273, DOI 10.1084/jem.20101643; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; Trapnell C, 2014, NAT BIOTECHNOL, V32, P381, DOI 10.1038/nbt.2859; van Galen P, 2014, NATURE, V510, P268, DOI 10.1038/nature13228; van Galen P, 2014, CELL STEM CELL, V14, P94, DOI 10.1016/j.stem.2013.11.021; Vannini N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13125; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Wagner JE, 2016, CELL STEM CELL, V18, P144, DOI 10.1016/j.stem.2015.10.004; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895; Warren L, 2006, P NATL ACAD SCI USA, V103, P17807, DOI 10.1073/pnas.0608512103; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wilson NK, 2015, CELL STEM CELL, V16, P712, DOI 10.1016/j.stem.2015.04.004; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Young K, 2016, J EXP MED, V213, P2259, DOI 10.1084/jem.20160168; Yu VWC, 2016, CELL, V167, P1310, DOI 10.1016/j.cell.2016.10.045; Zou P, 2011, CELL STEM CELL, V9, P247, DOI 10.1016/j.stem.2011.07.003	151	335	340	20	166	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2018	553	7689					418	426		10.1038/nature25022	http://dx.doi.org/10.1038/nature25022			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU6OE	29364285	Green Accepted, Green Submitted			2022-12-28	WOS:000423971100028
J	Sulli, G; Rommel, A; Wang, XJ; Kolar, MJ; Puca, F; Saghatelian, A; Plikus, MV; Verma, IM; Panda, S				Sulli, Gabriele; Rommel, Amy; Wang, Xiaojie; Kolar, Matthew J.; Puca, Francesca; Saghatelian, Alan; Plikus, Maksim V.; Verma, Inder M.; Panda, Satchidananda			Pharmacological activation of REV-ERBs is lethal in cancer and oncogene-induced senescence	NATURE			English	Article							DNA-DAMAGE RESPONSE; CIRCADIAN CLOCK; STEM-CELLS; ALPHA; METABOLISM; AUTOPHAGY; MODULATION; BEHAVIOR; TARGET	The circadian clock imposes daily rhythms in cell proliferation, metabolism, inflammation and DNA damage response(1,2). Perturbations of these processes are hallmarks of cancer3 and chronic circadian rhythm disruption predisposes individuals to tumour development(1,4). This raises the hypothesis that pharmacological modulation of the circadian machinery may be an effective therapeutic strategy for combating cancer. REV-ERBs, the nuclear hormone receptors REV-ERBa (also known as NR1D1) and REV-ERB beta (also known as NR1D2), are essential components of the circadian clock(5,6). Here we show that two agonists of REVERBs- SR9009 and SR9011-are specifically lethal to cancer cells and oncogene-induced senescent cells, including melanocytic naevi, and have no effect on the viability of normal cells or tissues. The anticancer activity of SR9009 and SR9011 affects a number of oncogenic drivers (such as HRAS, BRAF, PIK3CA and others) and persists in the absence of p53 and under hypoxic conditions. The regulation of autophagy and de novo lipogenesis by SR9009 and SR9011 has a critical role in evoking an apoptotic response in malignant cells. Notably, the selective anticancer properties of these REV-ERB agonists impair glioblastoma growth in vivo and improve survival without causing overt toxicity in mice. These results indicate that pharmacological modulation of circadian regulators is an effective antitumour strategy, identifying a class of anticancer agents with a wide therapeutic window. We propose that REV-ERB agonists are inhibitors of autophagy and de novo lipogenesis, with selective activity towards malignant and benign neoplasms.	[Sulli, Gabriele; Panda, Satchidananda] Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA; [Rommel, Amy; Verma, Inder M.] Salk Inst Biol Studies, Lab Genet, La Jolla, CA 92037 USA; [Wang, Xiaojie; Plikus, Maksim V.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA; [Kolar, Matthew J.; Saghatelian, Alan] Salk Inst Biol Studies, Clayton Fdn Labs Peptide Biol, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Puca, Francesca] Univ Texas MD Anderson Canc Ctr, Dept Genom Med, Houston, TX 77030 USA	Salk Institute; Salk Institute; University of California System; University of California Irvine; Salk Institute; University of Texas System; UTMD Anderson Cancer Center	Sulli, G; Panda, S (corresponding author), Salk Inst Biol Studies, Regulatory Biol Lab, La Jolla, CA 92037 USA.	gsulli@salk.edu; satchin@salk.edu		Plikus, Maksim/0000-0002-8845-2559; Kolar, Matthew/0000-0001-8054-9121	AIRC/Marie Curie International Fellowships in Cancer Research [12298]; Istituto Superiore di Sanita; TRAIN 'Training through Research Application Italian iNitiative'; NIH (NIAMS grant) [R01-AR067273, R01-AR069653]; Pew Charitable Trust grant; CIHR postdoctoral fellowship [MFE-123724]; NCI T32 grant; Salk Women in Science; Salk Excellerators Award; Stavros Niarchos Foundation New Frontiers Salk Research Specialist Award; NCI Cancer Center Support Grant P30 [CA014195]; Worldwide Cancer Research grant; American Federation of Aging Research mid-career grant [M14322]; Cancer Center Core Grant [P30 CA014195-38]; H.N. and Frances C. Berger Foundation; Glenn Center for Aging Research; Leona M. and Harry B. Helmsley Charitable Trust [2012-PG-MED002];  [F30 DK112604]; NATIONAL CANCER INSTITUTE [P30CA014195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR069653, R01AR067273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F30DK112604] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007198] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD021815] Funding Source: NIH RePORTER	AIRC/Marie Curie International Fellowships in Cancer Research; Istituto Superiore di Sanita; TRAIN 'Training through Research Application Italian iNitiative'; NIH (NIAMS grant); Pew Charitable Trust grant; CIHR postdoctoral fellowship(Canadian Institutes of Health Research (CIHR)); NCI T32 grant; Salk Women in Science; Salk Excellerators Award; Stavros Niarchos Foundation New Frontiers Salk Research Specialist Award; NCI Cancer Center Support Grant P30; Worldwide Cancer Research grant; American Federation of Aging Research mid-career grant; Cancer Center Core Grant; H.N. and Frances C. Berger Foundation; Glenn Center for Aging Research; Leona M. and Harry B. Helmsley Charitable Trust; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank K. V. Ly, L. Fijany, Y. Soda, M. Soda and M. Schmitt for technical assistance; F. d'Adda di Fagagna, S. Minucci, A. Viale, G. Gargiulo and J. Karlseder for discussion and feedback; the Narita, Gage, Burris, Amati and Shaw laboratories, and F. F. Lang for reagents; and the Salk Institute's Waitt Advanced Biophotonics Center and Gene Targeting and Transfer, and M. Shokhirev and the Razavi Newman Integrative Genomics and Bioinformatics Core. G. S. is supported by the AIRC/Marie Curie International Fellowships in Cancer Research (12298), Istituto Superiore di Sanita, TRAIN 'Training through Research Application Italian iNitiative'. M.V.P. is supported by the NIH (NIAMS grants R01-AR067273 and R01-AR069653) and a Pew Charitable Trust grant. X.W. is supported by a CIHR postdoctoral fellowship (MFE-123724). I.M.V is an American Cancer Society Professor of Molecular Biology. A.R. is supported by the NCI T32 grant, Salk Women in Science, Salk Excellerators Award and the Stavros Niarchos Foundation New Frontiers Salk Research Specialist Award. M.J.K. is supported by F30 DK112604. A.S. is supported by the NCI Cancer Center Support Grant P30 (CA014195 MASS core) and Dr. Frederick Paulsen Chair/Ferring Pharmaceuticals. This work was supported in part by a Worldwide Cancer Research grant and an American Federation of Aging Research mid-career grant M14322 to S.P. Additional support came from a Cancer Center Core Grant (P30 CA014195-38), the H.N. and Frances C. Berger Foundation, the Glenn Center for Aging Research and the Leona M. and Harry B. Helmsley Charitable Trust (grant #2012-PG-MED002).	Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chang JH, 2016, NAT MED, V22, P78, DOI 10.1038/nm.4010; Childs BG, 2017, NAT REV DRUG DISCOV, V16, P718, DOI 10.1038/nrd.2017.116; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Di Micco R, 2011, NAT CELL BIOL, V13, P292, DOI 10.1038/ncb2170; Fu LN, 2002, CELL, V111, P41, DOI 10.1016/S0092-8674(02)00961-3; Fu LN, 2003, NAT REV CANCER, V3, P350, DOI 10.1038/nrc1072; Gorrini C, 2013, NAT REV DRUG DISCOV, V12, P931, DOI 10.1038/nrd4002; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hossain A, 2015, STEM CELLS, V33, P2400, DOI 10.1002/stem.2053; Lam MTY, 2013, NATURE, V498, P511, DOI 10.1038/nature12209; Ma D, 2011, EMBO J, V30, P4642, DOI 10.1038/emboj.2011.322; Marumoto T, 2009, NAT MED, V15, P110, DOI 10.1038/nm.1863; Michaloglou C, 2005, NATURE, V436, P720, DOI 10.1038/nature03890; Peek CB, 2013, SCIENCE, V342, P591, DOI 10.1126/science.1243417; Plikus MV, 2013, P NATL ACAD SCI USA, V110, pE2106, DOI 10.1073/pnas.1215935110; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Quijano C, 2012, CELL CYCLE, V11, P1383, DOI 10.4161/cc.19800; Rubinsztein DC, 2012, NAT REV DRUG DISCOV, V11, P709, DOI 10.1038/nrd3802; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Sancar A, 2010, FEBS LETT, V584, P2618, DOI 10.1016/j.febslet.2010.03.017; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; Svensson RU, 2016, NAT MED, V22, P1108, DOI 10.1038/nm.4181; Vieira E, 2012, ENDOCRINOLOGY, V153, P592, DOI 10.1210/en.2011-1595; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Yu EA, 2011, AGING-US, V3, P479, DOI 10.18632/aging.100323; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	39	183	194	6	93	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2018	553	7688					351	+		10.1038/nature25170	http://dx.doi.org/10.1038/nature25170			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT9MB	29320480	Green Accepted			2022-12-28	WOS:000423475100054
J	Hartmann-Boyce, J; Begh, R; Aveyard, P				Hartmann-Boyce, Jamie; Begh, Rachna; Aveyard, Paul			Electronic cigarettes for smoking cessation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NICOTINE; SMOKERS; REDUCTION; ABSTINENCE; EXPOSURE; TRIAL		[Hartmann-Boyce, Jamie; Begh, Rachna] Univ Oxford, Radcliffe Observ Quarter, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England; [Aveyard, Paul] Univ Oxford, Radcliffe Observ Quarter, Nuffield Dept Primary Care Hlth Sci, Behav Med, Oxford OX2 6GG, England	University of Oxford; University of Oxford	Hartmann-Boyce, J (corresponding author), Univ Oxford, Radcliffe Observ Quarter, Nuffield Dept Primary Care Hlth Sci, Oxford OX2 6GG, England.	Jamie.hartmann-boyce@phc.ox.ac.uk		Aveyard, Paul/0000-0002-1802-4217	National Institute of Health Research; UK Centre for Tobacco and Alcohol Studies; NIHR Biomedical Research Centre, Oxford; NIHR CLAHRC, Oxford; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; Medical Research Council [MR/K023195/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0617-10064, PDF-2016-09-043] Funding Source: researchfish	National Institute of Health Research(National Institute for Health Research (NIHR)); UK Centre for Tobacco and Alcohol Studies; NIHR Biomedical Research Centre, Oxford(National Institute for Health Research (NIHR)); NIHR CLAHRC, Oxford; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	We have read and understood the BMJ policy on declaration of interests and declare the following interests: There was no specific funding for this article. JHB and RB receive support from the National Institute of Health Research. PA is funded by the UK Centre for Tobacco and Alcohol Studies and is supported by the NIHR Biomedical Research Centre, Oxford and the NIHR CLAHRC, Oxford. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. JHB, PA, and RB have no other competing interests to declare.	Action on Smoking and Health (ASH), 2017, US E CIG VAP AD GREA; Begh R, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0505-2; Borup G, 2015, HARM REDUCT J, V12, DOI 10.1186/1477-7517-12-2; Bullen C, 2013, LANCET, V382, P1629, DOI 10.1016/S0140-6736(13)61842-5; Caponnetto P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066317; Cravo AS, 2016, REGUL TOXICOL PHARM, V81, pS1, DOI 10.1016/j.yrtph.2016.10.003; DOLL R, 1994, BRIT MED J, V309, P901, DOI 10.1136/bmj.309.6959.901; Etter JF, 2011, ADDICTION, V106, P2017, DOI 10.1111/j.1360-0443.2011.03505.x; Fagerstrom Karl Olov, 2002, Nicotine Tob Res, V4 Suppl 2, pS73; Farsalinos K, 2016, INTERN EMERG MED, V11, P85, DOI 10.1007/s11739-015-1361-y; Goniewicz ML, 2017, NICOTINE TOB RES, V19, P160, DOI 10.1093/ntr/ntw160; HAJEK P, 1988, JAMA-J AM MED ASSOC, V260, P1593, DOI 10.1001/jama.260.11.1593; Hartmann-Boyce J, 2016, COCHRANE DB SYST REV, V9; Jarvis MJ, 2001, JNCI-J NATL CANCER I, V93, P134, DOI 10.1093/jnci/93.2.134; Lindson-Hawley N, 2016, COCHRANE DB SYST REV, V10; McRobbie H, 2015, CANCER PREV RES, V8, P873, DOI 10.1158/1940-6207.CAPR-15-0058; Meier E, 2017, NICOTINE TOB RES, V19, P176, DOI 10.1093/ntr/ntw157; Pasquereau A, 2017, ADDICTION, V112, P1620, DOI 10.1111/add.13869; Polosa R, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0481-x; Polosa R, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13010108; Polosa R, 2016, DISCOV MED, V21, P99; Pratt SI, 2016, ADDICT BEHAV, V59, P30, DOI 10.1016/j.addbeh.2016.03.009; Public Health England, 2017, HIGH SMOK QUIT SUCC; Public Health England, 2016, E CIG DEV PUBL HLTH; Pulvers K, 2018, NICOTINE TOB RES, V20, P206, DOI 10.1093/ntr/ntw333; Rahman MA, 2014, TOB INDUC DIS, V12, DOI 10.1186/1617-9625-12-21; Rose JE, 2006, PSYCHOPHARMACOLOGY, V184, P274, DOI 10.1007/s00213-005-0250-x; Stead LF, 2012, COCHRANE DB SYST REV, V11; Strasser Andrew A, 2016, Tob Regul Sci, V2, P352; Tobacco Advisory Group of the Royal College of Physicians, 2016, NIC SMOK TOB HARM RE; Tseng TY, 2016, NICOTINE TOB RES, V18, P1937, DOI 10.1093/ntr/ntw017; West R, TRENDS ELECT CIGARET	32	62	64	3	38	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 17	2018	360								j5543	10.1136/bmj.j5543	http://dx.doi.org/10.1136/bmj.j5543			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT5QK	29343486				2022-12-28	WOS:000423208100001
J	Kennedy, AB; Lavie, CJ; Blair, SN				Kennedy, Ann Blair; Lavie, Carl J.; Blair, Steven N.			Fitness or Fatness Which Is More Important?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ALL-CAUSE MORTALITY; CARDIORESPIRATORY FITNESS; OBESITY PARADOX; IMPACT; MEN		[Kennedy, Ann Blair] Univ South Carolina, Sch Med, Div Behav Social & Populat Hlth, Dept Biomed Sci, Greenville, SC USA; [Lavie, Carl J.] Univ Queensland, Sch Med, Dept Cardiovasc Dis, Ochsner Clin Sch, New Orleans, LA USA; [Blair, Steven N.] Univ South Carolina, Arnold Sch Publ Heath, Dept Epidemiol Biostat, 921 Assembly St, Columbia, SC 29208 USA	Ochsner Health System; University of Queensland; University of South Carolina System; University of South Carolina Columbia	Blair, SN (corresponding author), Univ South Carolina, Arnold Sch Publ Heath, Dept Exercise Sci, 921 Assembly St, Columbia, SC 29208 USA.; Blair, SN (corresponding author), Univ South Carolina, Arnold Sch Publ Heath, Dept Epidemiol Biostat, 921 Assembly St, Columbia, SC 29208 USA.	sblair@mailbox.sc.edu	Kennedy, Ann Blair/U-3466-2019	Kennedy, Ann Blair/0000-0002-3518-6314				Barry VW, 2014, PROG CARDIOVASC DIS, V56, P382, DOI 10.1016/j.pcad.2013.09.002; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Clark AL, 2015, AM J CARDIOL, V115, P209, DOI 10.1016/j.amjcard.2014.10.023; Lavie CJ, 2013, MAYO CLIN PROC, V88, P251, DOI 10.1016/j.mayocp.2012.11.020; Lee DC, 2011, CIRCULATION, V124, P2483, DOI 10.1161/CIRCULATIONAHA.111.038422; McAuley PA, 2016, AM J MED, V129, P960, DOI 10.1016/j.amjmed.2016.04.007; McAuley PA, 2012, MAYO CLIN PROC, V87, P443, DOI 10.1016/j.mayocp.2012.01.013; Ortega FB, 2016, CIRC RES, V118, P1752, DOI 10.1161/CIRCRESAHA.115.306883; Roberson LL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-14; Zheng Y, 2017, JAMA-J AM MED ASSOC, V318, P255, DOI 10.1001/jama.2017.7092	10	72	75	0	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2018	319	3					231	232		10.1001/jama.2017.21649	http://dx.doi.org/10.1001/jama.2017.21649			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT3BY	29340689				2022-12-28	WOS:000423022300013
J	Horton, R				Horton, Richard			Offline: From 1918 to 2018-the lessons of influenza	LANCET			English	Editorial Material												richard.horton@lancet.com							0	2	2	0	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 6	2018	391	10115					14	14		10.1016/S0140-6736(18)30009-6	http://dx.doi.org/10.1016/S0140-6736(18)30009-6			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR9ZB	29323640				2022-12-28	WOS:000419432300011
J	Moliterno, AR; Ratchford, EV				Moliterno, Alison R.; Ratchford, Elizabeth V.			Shedding New Light on the Magnitude of Thrombosis Risk in Patients With Myeloproliferative Neoplasms	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CLONAL HEMATOPOIESIS		[Moliterno, Alison R.; Ratchford, Elizabeth V.] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA; [Moliterno, Alison R.] Johns Hopkins Univ, Sch Med, Dept Med, Hematol Div, Ross Res 1025,720 Rutland Ave, Baltimore, MD 21205 USA; [Ratchford, Elizabeth V.] Johns Hopkins Univ, Sch Med, Johns Hopkins Ctr Vasc Med, 10755 Falls Rd,Suite 360, Lutherville Timonium, MD 21093 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Moliterno, AR (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Hematol Div, Ross Res 1025,720 Rutland Ave, Baltimore, MD 21205 USA.	amoliter@jhmi.edu	Ratchford, Elizabeth/AAO-2722-2021	Ratchford, Elizabeth/0000-0002-2244-5604				Cavallari I, 2018, CIRCULATION, V137, P684, DOI 10.1161/CIRCULATIONAHA.117.031062; Hasselbalch HC, 2012, BLOOD, V119, P3219, DOI 10.1182/blood-2011-11-394775; Hinds DA, 2016, BLOOD, V128, P1121, DOI 10.1182/blood-2015-06-652941; Hultcrantz M, 2018, ANN INTERN MED, V168, P317, DOI 10.7326/M17-0028; Jaiswal S, 2014, NEW ENGL J MED, V371, P2488, DOI 10.1056/NEJMoa1408617; Mesa RA, 2017, J NATL COMPR CANC NE, V15, P1193, DOI 10.6004/jnccn.2017.0157; Nielsen C, 2014, HAEMATOLOGICA, V99, P1448, DOI 10.3324/haematol.2014.107631; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Ridker PM, 2013, CURR ATHEROSCLER REP, V15, DOI 10.1007/s11883-012-0295-3; Stein BL, 2015, J NATL COMPR CANC NE, V13, P424, DOI 10.6004/jnccn.2015.0058	10	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2018	168	5					363	+		10.7326/M17-3153	http://dx.doi.org/10.7326/M17-3153			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY2GD	29335737				2022-12-28	WOS:000426632600011
J	Chan, YM; Balza, R; High, FA				Chan, Yee-Ming; Balza, Rene; High, Frances A.			Case 3-2018: A 5-Month-Old Boy with Hypoglycemia	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HYPERCALCEMIA		[Chan, Yee-Ming] Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA; [Balza, Rene] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [High, Frances A.] Massachusetts Gen Hosp, Dept Pediat, Boston, MA 02114 USA; [Chan, Yee-Ming; High, Frances A.] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Balza, Rene] Harvard Med Sch, Dept Radiol, Boston, MA USA	Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Chan, YM (corresponding author), Boston Childrens Hosp, Dept Med, Boston, MA 02115 USA.; Chan, YM (corresponding author), Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA.			Balza, Rene/0000-0002-6517-2490				Bell JJ, 2004, J PEDIATR ENDOCR MET, V17, P629; Ferrara C, 2016, J PEDIATR-US, V168, P212, DOI 10.1016/j.jpeds.2015.09.045; Hwu WL, 1999, J INHERIT METAB DIS, V22, P937, DOI 10.1023/A:1005651809892; Kasapkara CS, 2012, TURKISH J PEDIATR, V54, P35; Kishnani P. S., 2014, Genetics in Medicine, V16, pe1; LEE P, 1994, BRIT J RADIOL, V67, P1062, DOI 10.1259/0007-1285-67-803-1062	6	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 25	2018	378	4					381	389		10.1056/NEJMcpc1706107	http://dx.doi.org/10.1056/NEJMcpc1706107			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT5ZX	29365308				2022-12-28	WOS:000423233400013
J	Hey, SP; Weijer, C; Taljaard, M; Kesselheim, AS				Hey, Spencer Phillips; Weijer, Charles; Taljaard, Monica; Kesselheim, Aaron S.			Research ethics for emerging trial designs: does equipoise need to adapt?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PROTOCOL		[Hey, Spencer Phillips; Kesselheim, Aaron S.] Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA; [Hey, Spencer Phillips; Kesselheim, Aaron S.] Harvard Med Sch, Ctr Bioeth, Boston, MA 02115 USA; [Weijer, Charles] Western Univ, Rotman Inst Philosophy, London, ON, Canada; [Taljaard, Monica] Univ Ottawa, Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Western University (University of Western Ontario); University of Ottawa; Ottawa Hospital Research Institute	Hey, SP (corresponding author), Brigham & Womens Hosp, Dept Med, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA.; Hey, SP (corresponding author), Harvard Med Sch, Ctr Bioeth, Boston, MA 02115 USA.	shey@bwh.harvard.edu	Weijer, Charles/ABC-5433-2020	Weijer, Charles/0000-0002-5510-1074; Taljaard, Monica/0000-0002-3978-8961	Laura and John Arnold Foundation; Canadian Institutes of Health Research	Laura and John Arnold Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Work funded by the Laura and John Arnold Foundation and the Canadian Institutes of Health Research. The funders had no role in the design and conduct of this work; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.	Barker AD, 2009, CLIN PHARMACOL THER, V86, P97, DOI 10.1038/clpt.2009.68; Berry SM, 2015, JAMA-J AM MED ASSOC, V313, P1619, DOI 10.1001/jama.2015.2316; Bilimoria KY, 2016, JAMA SURG, V151, P273, DOI 10.1001/jamasurg.2015.4990; Catenacci DVT, 2015, MOL ONCOL, V9, P967, DOI 10.1016/j.molonc.2014.09.011; Djulbegovic B, 2007, J MED PHILOS, V32, P79, DOI 10.1080/03605310701255719; Donner A, 2000, DESIGN ANAL CLUSTER; FREEDMAN B, 1987, NEW ENGL J MED, V317, P141, DOI 10.1056/NEJM198707163170304; Herbst RS, 2015, CLIN CANCER RES, V21, P1514, DOI 10.1158/1078-0432.CCR-13-3473; Hey SP, 2016, SCIENCE, V353, P448, DOI 10.1126/science.aaf5101; Hey Spencer Phillips, 2015, AMA J Ethics, V17, P1108, DOI 10.1001/journalofethics.2015.17.12.ecas1-1512; McNeil C, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv193; Salman RA, 2014, LANCET, V383, P176, DOI 10.1016/S0140-6736(13)62297-7; Weijer C, 2004, NAT MED, V10, P570, DOI 10.1038/nm0604-570; Weijer C, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001346; Weijer C, 2011, TRIALS, V12, DOI 10.1186/1745-6215-12-100	15	10	10	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2018	360								k226	10.1136/bmj.k226	http://dx.doi.org/10.1136/bmj.k226			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU2XA	29371211				2022-12-28	WOS:000423712100002
J	Jackson, CRM; Bennett, NR; Du, ZX; Cottrell, E; Fei, YW				Jackson, Colin R. M.; Bennett, Neil R.; Du, Zhixue; Cottrell, Elizabeth; Fei, Yingwei			Early episodes of high-pressure core formation preserved in plume mantle	NATURE			English	Article							TUNGSTEN ISOTOPIC EVIDENCE; NOBLE-GAS COMPOSITION; OXIDATION-STATE; LATE ACCRETION; GIANT IMPACTS; EARTHS MANTLE; SILICATE; METAL; SYSTEMATICS; HELIUM	The decay of short-lived iodine (I) and plutonium (Pu) results in xenon (Xe) isotopic anomalies in the mantle that record Earth's earliest stages of formation(1-8). Xe isotopic anomalies have been linked to degassing during accretion(2-4), but degassing alone cannot account for the co-occurrence of Xe and tungsten (W) isotopic heterogeneity in plume-derived basalts(9,10) and their long-term preservation in the mantle. Here we describe measurements of I partitioning between liquid Fe alloys and liquid silicates at high pressure and temperature and propose that Xe isotopic anomalies found in modern plume rocks (that is, rocks with elevated He-3/He-4 ratios) result from I/Pu fractionations during early, high-pressure episodes of core formation. Our measurements demonstrate that I becomes progressively more siderophile as pressure increases, so that portions of mantle that experienced high-pressure core formation will have large I/Pu depletions not related to volatility. These portions of mantle could be the source of Xe and W anomalies observed in modern plume-derived basalts(2-4,9,10). Portions of mantle involved in early high-pressure core formation would also be rich in FeO11,12, and hence denser than ambient mantle. This would aid the long-term preservation of these mantle portions, and potentially points to their modern manifestation within seismically slow, deep mantle reservoirs(13) with high He-3/He-4 ratios.	[Jackson, Colin R. M.; Bennett, Neil R.; Du, Zhixue; Fei, Yingwei] Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA; [Jackson, Colin R. M.; Cottrell, Elizabeth] Smithsonian Inst, Dept Mineral Sci, Natl Museum Nat Hist, Washington, DC 20560 USA	Carnegie Institution for Science; Smithsonian Institution; Smithsonian National Museum of Natural History	Jackson, CRM (corresponding author), Carnegie Inst Sci, Geophys Lab, Washington, DC 20015 USA.; Jackson, CRM (corresponding author), Smithsonian Inst, Dept Mineral Sci, Natl Museum Nat Hist, Washington, DC 20560 USA.	jacksonc3@si.edu	Fei, Yingwei/F-3709-2011	Fei, Yingwei/0000-0001-9955-5353; Du, Zhixue/0000-0002-7716-2994; Cottrell, Elizabeth/0000-0002-9402-9394; Bennett, Neil/0000-0002-0272-7989	National Science Foundation-Earth Sciences [EAR-1128799]; Department of Energy-GeoSciences [DE-FG02-94ER14466]; DOE Office of Science [DE-AC02-06CH11357]; Carnegie Institution for Science; Smithsonian Institution; NSF grants [EAR-1725315, EAR-0738654, EAR-1447311]; Division Of Earth Sciences [1447311] Funding Source: National Science Foundation	National Science Foundation-Earth Sciences(National Science Foundation (NSF)); Department of Energy-GeoSciences(United States Department of Energy (DOE)); DOE Office of Science(United States Department of Energy (DOE)); Carnegie Institution for Science; Smithsonian Institution(Smithsonian Institution); NSF grants(National Science Foundation (NSF)); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Portions of this work were performed at GeoSoilEnviroCARS (The University of Chicago, Sector 13), the Advanced Photon Source, Argonne National Laboratory. GeoSoilEnviroCARS is supported by the National Science Foundation-Earth Sciences (EAR-1128799) and the Department of Energy-GeoSciences (DE-FG02-94ER14466). This research used resources of the Advanced Photon Source, a US Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract number DE-AC02-06CH11357. We acknowledge the support provided by C. Prescher, E. Greenberg, and V. Prakapenka during the experiments conducted at GSECARS and in data reduction. We acknowledge E. Bullock and S. Vitale for their assistance with the electron microscopy, electron microprobe analysis, and focused ion beam recovery. We thank T. Gooding for his assistance in preparing the piston cylinder experiments for analysis. We acknowledge discussions with R. Fischer, R. Parai, S. Parman, J. Tucker and M. Nakajima during the development of the manuscript. C.R.M.J., N.R.B. and Z.D. acknowledge fellowship support from the Carnegie Institution for Science, and C.R.M.J. additionally acknowledges fellowship support from the Smithsonian Institution. The research was also supported by NSF grants to C.R.M.J. (EAR-1725315), to E.C. (EAR-0738654) and to Y.F. (EAR-1447311).	Akahama Y, 2006, J APPL PHYS, V100, DOI 10.1063/1.2335683; ALLEGRE CJ, 1983, NATURE, V303, P762, DOI 10.1038/303762a0; Andrault D, 1998, EUR J MINERAL, V10, P931; Arevalo R, 2008, EARTH PLANET SC LETT, V272, P656, DOI 10.1016/j.epsl.2008.05.031; Armytage RMG, 2013, EARTH PLANET SC LETT, V373, P140, DOI 10.1016/j.epsl.2013.04.031; Bali E, 2012, EARTH PLANET SC LETT, V351, P195, DOI 10.1016/j.epsl.2012.07.032; Basu S, 2008, METALL MATER TRANS B, V39, P447, DOI 10.1007/s11663-008-9148-4; Bouhifd MA, 2013, NAT GEOSCI, V6, P982, DOI [10.1038/NGEO1959, 10.1038/ngeo1959]; Chavrit D, 2016, GEOCHIM COSMOCHIM AC, V183, P106, DOI 10.1016/j.gca.2016.03.014; Chidester BA, 2017, GEOCHIM COSMOCHIM AC, V199, P1, DOI 10.1016/j.gca.2016.11.035; Cottaar S, 2016, GEOPHYS J INT, V207, P1122, DOI 10.1093/gji/ggw324; Cottrell E, 2009, EARTH PLANET SC LETT, V281, P275, DOI 10.1016/j.epsl.2009.02.024; Dalou C, 2017, EARTH PLANET SC LETT, V458, P141, DOI 10.1016/j.epsl.2016.10.026; Dauphas N, 2011, NATURE, V473, P489, DOI 10.1038/nature10077; Du ZX, 2015, REV SCI INSTRUM, V86, DOI 10.1063/1.4929667; Du ZX, 2014, GEOPHYS RES LETT, V41, P8061, DOI 10.1002/2014GL061954; Fiquet G, 2010, SCIENCE, V329, P1516, DOI 10.1126/science.1192448; Fischer RA, 2015, GEOCHIM COSMOCHIM AC, V167, P177, DOI 10.1016/j.gca.2015.06.026; French SW, 2015, NATURE, V525, P95, DOI 10.1038/nature14876; Frost DJ, 2008, PHILOS T R SOC A, V366, P4315, DOI 10.1098/rsta.2008.0147; Harper CL, 1996, GEOCHIM COSMOCHIM AC, V60, P1131, DOI 10.1016/0016-7037(96)00027-0; Heber VS, 2007, GEOCHIM COSMOCHIM AC, V71, P1041, DOI 10.1016/j.gca.2006.11.010; Herzberg C, 2013, NATURE, V493, P393, DOI 10.1038/nature11771; Hirschmann MM, 1998, GEOCHIM COSMOCHIM AC, V62, P883, DOI 10.1016/S0016-7037(98)00028-3; Holland G, 2006, NATURE, V441, P186, DOI 10.1038/nature04761; Jackson MG, 2017, NATURE, V542, P340, DOI 10.1038/nature21023; Jackson MG, 2016, GEOCHIM COSMOCHIM AC, V185, P21, DOI 10.1016/j.gca.2016.02.011; Japan Society for the Promotion of Science (JSPS) and the Nineteenth Committee on Steelmaking, 1988, JSPS STEELM DAT SOUR, P273; Kendrick MA, 2017, NAT GEOSCI, V10, P222, DOI [10.1038/NGEO2902, 10.1038/ngeo2902]; Kendrick MA, 2015, CONTRIB MINERAL PETR, V170, DOI 10.1007/s00410-015-1192-x; Kendrick MA, 2011, NAT GEOSCI, V4, P807, DOI [10.1038/ngeo1270, 10.1038/NGEO1270]; Kilburn MR, 1997, EARTH PLANET SC LETT, V152, P139, DOI 10.1016/S0012-821X(97)00125-8; Kleine T, 2009, GEOCHIM COSMOCHIM AC, V73, P5150, DOI 10.1016/j.gca.2008.11.047; Konig S, 2008, EARTH PLANET SC LETT, V274, P82, DOI 10.1016/j.epsl.2008.07.002; Kruijer TS, 2015, NATURE, V520, P534, DOI 10.1038/nature14360; KURZ MD, 1982, NATURE, V297, P43, DOI 10.1038/297043a0; Li Y, 2016, NAT GEOSCI, V9, P781, DOI [10.1038/ngeo2801, 10.1038/NGEO2801]; Liu JC, 2016, J GEOPHYS RES-SOL EA, V121, P1514, DOI 10.1002/2015JB012701; Ma ZT, 2001, METALL MATER TRANS B, V32, P87, DOI 10.1007/s11663-001-0011-0; MATSUDA J, 1986, GEOCHEM J, V20, P71, DOI 10.2343/geochemj.20.71; MATSUDA J, 1993, SCIENCE, V259, P788, DOI 10.1126/science.259.5096.788; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; McNamara AK, 2005, NATURE, V437, P1136, DOI 10.1038/nature04066; Moreira M, 1998, SCIENCE, V279, P1178, DOI 10.1126/science.279.5354.1178; Moussallam Y, 2016, EARTH PLANET SC LETT, V450, P317, DOI 10.1016/j.epsl.2016.06.031; Mundl A, 2017, SCIENCE, V356, P66, DOI 10.1126/science.aal4179; Ohnishi S, 2017, PHYS CHEM MINER, V44, P445, DOI 10.1007/s00269-017-0871-8; Parai R, 2015, GEOCHEM GEOPHY GEOSY, V16, P719, DOI 10.1002/2014GC005566; Pepin RO, 2006, EARTH PLANET SC LETT, V250, P470, DOI 10.1016/j.epsl.2006.08.014; Peto MK, 2013, EARTH PLANET SC LETT, V369, P13, DOI 10.1016/j.epsl.2013.02.012; Prescher C, 2015, HIGH PRESSURE RES, V35, P223, DOI 10.1080/08957959.2015.1059835; Rizo H, 2016, SCIENCE, V352, P809, DOI 10.1126/science.aad8563; Rubie DC, 2011, EARTH PLANET SC LETT, V301, P31, DOI 10.1016/j.epsl.2010.11.030; Rubie DC, 2004, NATURE, V429, P58, DOI 10.1038/nature02473; Rudge JF, 2010, NAT GEOSCI, V3, P439, DOI 10.1038/NGEO872; SLEEP NH, 1988, GEOPHYS J INT, V95, P437, DOI 10.1111/j.1365-246X.1988.tb06695.x; Smye AJ, 2017, EARTH PLANET SC LETT, V471, P65, DOI 10.1016/j.epsl.2017.04.046; STAUDACHER T, 1988, EARTH PLANET SC LETT, V89, P173, DOI 10.1016/0012-821X(88)90170-7; Sudo M., 1994, NOBLE GAS GEOCHEMIST, P217; Tange Y., 2009, J GEOPHYS RES SOLID, V114; THIBAULT Y, 1995, GEOCHIM COSMOCHIM AC, V59, P991, DOI 10.1016/00167-0379(50)00178-; Tucker JM, 2012, EARTH PLANET SC LETT, V355, P244, DOI 10.1016/j.epsl.2012.08.025; Wade J, 2005, EARTH PLANET SC LETT, V236, P78, DOI 10.1016/j.epsl.2005.05.017; Wade J, 2012, GEOCHIM COSMOCHIM AC, V85, P58, DOI 10.1016/j.gca.2012.01.010; Walter MJ, 2013, EARTH PLANET SC LETT, V365, P165, DOI 10.1016/j.epsl.2013.01.014; WALTER MJ, 1995, SCIENCE, V270, P1186, DOI 10.1126/science.270.5239.1186; Wang ZC, 2013, NATURE, V499, P328, DOI 10.1038/nature12285; Wood BJ, 2006, NATURE, V441, P825, DOI 10.1038/nature04763	73	29	29	5	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2018	553	7689					491	+		10.1038/nature25446	http://dx.doi.org/10.1038/nature25446			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU6OE	29368705				2022-12-28	WOS:000423971100038
J	Flanagin, A; Christiansen, SL; Borden, C; Kyriacou, DN; Sietmann, C; Bryant, L				Flanagin, Annette; Christiansen, Stacy L.; Borden, Chris; Kyriacou, Demetrios N.; Sietmann, Caroline; Bryant, Larry			Editorial Evaluation, Peer Review, and Publication of Research Reports With and Without Supplementary Online Content	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Flanagin, Annette; Christiansen, Stacy L.; Borden, Chris; Kyriacou, Demetrios N.; Sietmann, Caroline; Bryant, Larry] JAMA Network, 330 N Wabash Ave, Chicago, IL 60610 USA		Flanagin, A (corresponding author), JAMA Network, 330 N Wabash Ave, Chicago, IL 60610 USA.	annette.flanagin@jamanetwork.org	Christiansen, Stacy/AAM-1170-2021	Sietmann, Caroline/0000-0002-7523-7526				Borowski C, 2011, J EXP MED, V208, P1337, DOI 10.1084/jem.20111061; Marcus E, 2009, CELL, V139, P11, DOI 10.1016/j.cell.2009.09.021; Maunsell J, 2010, J NEUROSCI, V30, P10599; Pop M, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0668-z; Schriger DL, 2011, ANN EMERG MED, V57, P153, DOI 10.1016/j.annemergmed.2010.10.008; [No title captured]	6	3	3	2	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					410	411		10.1001/jama.2017.20650	http://dx.doi.org/10.1001/jama.2017.20650			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362785	Bronze, Green Published			2022-12-28	WOS:000423405300031
J	Kuehn, BM				Kuehn, Bridget M.			Study Recruitment to Accelerate Precision Medicine	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					332	332		10.1001/jama.2017.21305	http://dx.doi.org/10.1001/jama.2017.21305			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362781				2022-12-28	WOS:000423405300006
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: What's wrong with being honest with the public about NHS pressures?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Aiken Linda H, 2018, BMJ Open, V8, pe019189, DOI 10.1136/bmjopen-2017-019189; Allen V., 2017, MAIL ONLINE; Campbell D, 2018, GUARDIAN; Connolly S., 2017, INDEPENDENT; Donnelly L, 2016, TELEGRAPH; Gainsbury S., 2017, BOTTOM LINE UNDERSTA; Goddard B., 2018, HEREFORD TIMES  0112; Health Education England, WORKF STRAT; King's Fund, 2017, IS NHS PERF NOV 2017; Oliver D, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h6119	10	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 23	2018	360								k265	10.1136/bmj.k265	http://dx.doi.org/10.1136/bmj.k265			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU2WS	29363505	Bronze, Green Published			2022-12-28	WOS:000423711300004
J	Bansak, K; Ferwerda, J; Hainmueller, J; Dillon, A; Hangartner, D; Lawrence, D; Weinstein, J				Bansak, Kirk; Ferwerda, Jeremy; Hainmueller, Jens; Dillon, Andrea; Hangartner, Dominik; Lawrence, Duncan; Weinstein, Jeremy			Improving refugee integration through data-driven algorithmic assignment	SCIENCE			English	Article							ETHNIC ENCLAVES; IMMIGRANTS; OUTCOMES; QUOTAS	Developed democracies are settling an increased number of refugees, many of whom face challenges integrating into host societies. We developed a flexible data-driven algorithm that assigns refugees across resettlement locations to improve integration outcomes. The algorithm uses a combination of supervised machine learning and optimal matching to discover and leverage synergies between refugee characteristics and resettlement sites. The algorithm was tested on historical registry data from two countries with different assignment regimes and refugee populations, the United States and Switzerland. Our approach led to gains of roughly 40 to 70%, on average, in refugees' employment outcomes relative to current assignment practices. This approach can provide governments with a practical and cost-efficient policy tool that can be immediately implemented within existing institutional structures.	[Bansak, Kirk; Hainmueller, Jens; Weinstein, Jeremy] Stanford Univ, Dept Polit Sci, Stanford, CA 94305 USA; [Bansak, Kirk; Ferwerda, Jeremy; Hainmueller, Jens; Dillon, Andrea; Hangartner, Dominik; Lawrence, Duncan; Weinstein, Jeremy] Stanford Univ, Immigrat Policy Lab, Stanford, CA 94305 USA; [Bansak, Kirk; Ferwerda, Jeremy; Hainmueller, Jens; Dillon, Andrea; Hangartner, Dominik; Lawrence, Duncan; Weinstein, Jeremy] ETH, CH-8092 Zurich, Switzerland; [Ferwerda, Jeremy] Dartmouth Coll, Dept Govt, Hanover, NH 03755 USA; [Hainmueller, Jens] Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA; [Hangartner, Dominik] ETH, Ctr Comparat & Int Studies, CH-8092 Zurich, Switzerland; [Hangartner, Dominik] London Sch Econ & Polit Sci, Dept Govt, London WC2A 2AE, England	Stanford University; Stanford University; Swiss Federal Institutes of Technology Domain; ETH Zurich; Dartmouth College; Stanford University; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of London; London School Economics & Political Science	Hainmueller, J (corresponding author), Stanford Univ, Dept Polit Sci, Stanford, CA 94305 USA.; Hainmueller, J (corresponding author), Stanford Univ, Immigrat Policy Lab, Stanford, CA 94305 USA.; Hainmueller, J (corresponding author), ETH, CH-8092 Zurich, Switzerland.; Hainmueller, J (corresponding author), Stanford Univ, Grad Sch Business, Stanford, CA 94305 USA.	jhain@stanford.edu		Dillon, Andrea/0000-0003-2608-9720; Hainmueller, Jens/0000-0001-8214-9041	Ford Foundation; Swiss National Science Foundation; Carnegie Corporation of New York	Ford Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Carnegie Corporation of New York	We acknowledge funding from the Ford Foundation for operational support of the Stanford Immigration Policy Lab, and from the Swiss National Science Foundation and the Carnegie Corporation of New York (J.H.). The funders had no role in the data collection, analysis, decision to publish, or preparation of the manuscript. The U.S. refugee registry data were provided to us under a collaboration research agreement with the Lutheran Immigration and Refugee Service (LIRS). This agreement requires that we do not transfer or disclose the data. Researchers can request access to the data from LIRS. The Swiss ZEMIS database is provided to us under a data use agreement with the Swiss State Secretariat for Migration (SEM), which requires that we do not disclose the individual-level data. Researchers can request access to the ZEMIS data from the SEM. We thank the SEM and LIRS for access to data and guidance, and G. Imbens, D. Laitin, R. Reich, L. Stanczyk, and S. Wager for helpful advice. For replication code, see Harvard Dataverse (doi: 10.7910/DVN/MS8XES). The institutional review boards at Stanford University (IRB-40212) and Dartmouth College (00030198) approved this research. The U.S. resettlement agency that provided the data requested that we not disclose specific locations within the article.	Andersson T., 2016, ASSIGNING REFUGEES L; Beaman LA, 2012, REV ECON STUD, V79, P128, DOI 10.1093/restud/rdr017; Bertsekas D., 1994, RELAX 4 FASTER VERSI; Connor P, 2010, J REFUG STUD, V23, P377, DOI 10.1093/jrs/feq025; Damm AP, 2009, J LABOR ECON, V27, P281, DOI 10.1086/599336; Edin PA, 2003, Q J ECON, V118, P329, DOI 10.1162/00335530360535225; Moraga JFH, 2014, J PUBLIC ECON, V115, P94, DOI 10.1016/j.jpubeco.2014.04.002; Hainmueller J, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600432; Hansen BB, 2006, J COMPUT GRAPH STAT, V15, P609, DOI 10.1198/106186006X137047; Kominers Scott Duke, 2016, REFUGEE RESETTLEMENT; Marbach M., 2017, 1703 STANF ZUR IMM P; Medecins Sans Frontieres, 2013, ILLN MIGR 10 YEARS M; Moraga JFH, 2015, CESIFO ECON STUD, V61, P638, DOI 10.1093/cesifo/ifu037; Smith J, 2016, LANCET GLOB HEALTH, V4, pE85, DOI 10.1016/S2214-109X(15)00243-0	14	89	89	4	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					325	328		10.1126/science.aao4408	http://dx.doi.org/10.1126/science.aao4408			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT6BB	29348237				2022-12-28	WOS:000423236700038
J	Kyle, RA; Larson, DR; Therneau, TM; Dispenzieri, A; Kumar, S; Cerhan, JR; Rajkumar, SV				Kyle, Robert A.; Larson, Dirk R.; Therneau, Terry M.; Dispenzieri, Angela; Kumar, Shaji; Cerhan, James R.; Rajkumar, S. Vincent			Long-Term Follow-up of Monoclonal Gammopathy of Undetermined Significance	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASYMPTOMATIC MULTIPLE-MYELOMA; MALIGNANT-TRANSFORMATION; NATURAL-HISTORY; RISK-FACTOR; PROGRESSION; PREVALENCE; PROGNOSIS; MODELS; MGUS	BACKGROUND Monoclonal gammopathy of undetermined significance (MGUS) occurs in approximately 3% of persons 50 years of age or older. METHODS We studied 1384 patients who were residing in southeastern Minnesota and in whom MGUS was diagnosed at the Mayo Clinic in the period from 1960 through 1994; the median follow-up was 34.1 years (range, 0.0 to 43.6). The primary end point was progression to multiple myeloma or another plasma-cell or lymphoid disorder. RESULTS During 14,130 person-years of follow-up, MGUS progressed in 147 patients (11%), a rate that was 6.5 times (95% confidence interval [CI], 5.5 to 7.7) as high as the rate in the control population. The risk of progression without accounting for death due to competing causes was 10% at 10 years, 18% at 20 years, 28% at 30 years, 36% at 35 years, and 36% at 40 years. Among patients with IgM MGUS, the presence of two adverse risk factors namely, an abnormal serum free light - chain ratio (ratio of kappa to lambda free light chains) and a high serum monoclonal protein (M protein) level (>= 1.5 g per deciliter) was associated with a risk of progression at 20 years of 55%, as compared with 41% among patients who had one adverse risk factor and 19% among patients who had neither risk factor. Among patients with non - IgM MGUS, the risk of progression at 20 years was 30% among those who had the two risk factors, 20% among those who had one risk factor, and 7% among those who had neither risk factor. Patients with MGUS had shorter survival than was expected in the control population of Minnesota residents of matched age and sex (median, 8.1 vs. 12.4 years; P<0.001). CONCLUSIONS Significant differences were noted in the risk of progression between patients with IgM MGUS and those with non-IgM MGUS. Overall survival was shorter among patients with MGUS than was expected in a matched control population.	[Kyle, Robert A.; Dispenzieri, Angela; Kumar, Shaji; Rajkumar, S. Vincent] Mayo Clin, Div Hematol, 200 First St SW, Rochester, MN 55905 USA; [Larson, Dirk R.; Therneau, Terry M.] Mayo Clin, Div Biostat, Rochester, MN USA; [Cerhan, James R.] Mayo Clin, Div Epidemiol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Kyle, RA (corresponding author), Mayo Clin, Div Hematol, 200 First St SW, Rochester, MN 55905 USA.	kyle.robert@mayo.edu	Kumar, Shaji K/A-9853-2008; Rajkumar, S. Vincent/AAV-1834-2021	Kumar, Shaji K/0000-0001-5392-9284; Rajkumar, S. Vincent/0000-0002-5862-1833	National Cancer Institute; NATIONAL CANCER INSTITUTE [R01CA168762, P50CA186781, R01CA107476] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funded by the National Cancer Institute.	Baldini L, 1996, BLOOD, V87, P912, DOI 10.1182/blood.V87.3.912.bloodjournal873912; BERRY G, 1983, BIOMETRICS, V39, P173, DOI 10.2307/2530817; BLADE J, 1992, BRIT J HAEMATOL, V81, P391, DOI 10.1111/j.1365-2141.1992.tb08245.x; Cesana C, 2002, J CLIN ONCOL, V20, P1625, DOI 10.1200/JCO.20.6.1625; COX DR, 1972, J R STAT SOC B, V34, P187; Dispenzieri A, 2010, LANCET, V375, P1721, DOI 10.1016/S0140-6736(10)60482-5; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Katzmann JA, 2013, LEUKEMIA, V27, P208, DOI 10.1038/leu.2012.189; Kyle R, 1997, MANUAL CLIN LAB IMMU, P156; Kyle RA, 2010, LEUKEMIA, V24, P1121, DOI 10.1038/leu.2010.60; KYLE RA, 1978, AM J MED, V64, P814, DOI 10.1016/0002-9343(78)90522-3; Kyle RA, 2002, NEW ENGL J MED, V346, P564, DOI 10.1056/NEJMoa01133202; Kyle RA, 2004, MAYO CLIN PROC, V79, P859, DOI 10.4065/79.7.859; Kyle RA, 2006, NEW ENGL J MED, V354, P1362, DOI 10.1056/NEJMoa054494; KYLE RA, 1992, BLOOD, V79, P1817; Kyle RA, 2007, NEW ENGL J MED, V356, P2582, DOI 10.1056/NEJMoa070389; Kyle RA, 2014, HEMATOL ONCOL CLIN N, V28, P775, DOI 10.1016/j.hoc.2014.06.005; Mangiacavalli S, 2013, EUR J HAEMATOL, V91, P356, DOI 10.1111/ejh.12172; Melton LJ, 1997, NEW ENGL J MED, V337, P1466, DOI 10.1056/NEJM199711133372012; Melton LJ, 1996, MAYO CLIN PROC, V71, P266, DOI 10.4065/71.3.266; PETO R, 1972, J R STAT SOC SER A-G, V135, P185, DOI 10.2307/2344317; Putter H, 2007, STAT MED, V26, P2389, DOI 10.1002/sim.2712; Rajkumar SV, 2014, LANCET ONCOL, V15, pE538, DOI 10.1016/S1470-2045(14)70442-5; Rajkumar SV, 2005, BLOOD, V106, P812, DOI 10.1182/blood-2005-03-1038; Schemper M, 1996, CONTROL CLIN TRIALS, V17, P343, DOI 10.1016/0197-2456(96)00075-X; Surveillance Epidemiology and End Results (SEER) Program, 2014, SEER STAT DAT INC SE; Turesson I, 2014, BLOOD, V123, P338, DOI 10.1182/blood-2013-05-505487; VANDEPOEL MHW, 1995, BRIT J HAEMATOL, V91, P121	28	247	254	2	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2018	378	3					241	249		10.1056/NEJMoa1709974	http://dx.doi.org/10.1056/NEJMoa1709974			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT1IJ	29342381	Bronze, Green Accepted			2022-12-28	WOS:000422888400008
J	Vorlander, MK; Khatter, H; Wetzel, R; Hagen, WJH; Muller, CW				Vorlaender, Matthias K.; Khatter, Heena; Wetzel, Rene; Hagen, Wim J. H.; Mueller, Christoph W.			Molecular mechanism of promoter opening by RNA polymerase III	NATURE			English	Article							TRANSCRIPTION FACTOR IIIB; INITIATION-FACTOR-TFIIIB; TATA-BINDING PROTEIN; I TRANSCRIPTION; ACTIVE-SITE; SUBUNIT; BDP1; BRF1; DNA; VISUALIZATION	RNA polymerase III (Pol III) and transcription factor IIIB (TFIIIB) assemble together on different promoter types to initiate the transcription of small, structured RNAs. Here we present structures of Pol III preinitiation complexes, comprising the 17-subunit Pol III and the heterotrimeric transcription factor TFIIIB, bound to a natural promoter in different functional states. Electron cryo-microscopy reconstructions, varying from 3.7 angstrom to 5.5 angstrom resolution, include two early intermediates in which the DNA duplex is closed, an open DNA complex, and an initially transcribing complex with RNA in the active site. Our structures reveal an extremely tight, multivalent interaction between TFIIIB and promoter DNA, and explain how TFIIIB recruits Pol III. Together, TFIIIB and Pol III subunit C37 activate the intrinsic transcription factor-like activity of the Pol III-specific heterotrimer to initiate the melting of double-stranded DNA, in a mechanism similar to that of the Pol II system.	[Vorlaender, Matthias K.; Khatter, Heena; Wetzel, Rene; Hagen, Wim J. H.; Mueller, Christoph W.] EMBL, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany	European Molecular Biology Laboratory (EMBL)	Muller, CW (corresponding author), EMBL, Struct & Computat Biol Unit, Meyerhofstr 1, D-69117 Heidelberg, Germany.	christoph.mueller@embl.de	Müller, Christoph W/I-7420-2012	Müller, Christoph W/0000-0003-2176-8337; Vorlander, Matthias Kopano/0000-0001-5975-5609; Hagen, Wim/0000-0001-6229-2692	European Research Council Advanced Grant [ERC-2013-AdG340964-POL1PIC]; EMBL International PhD program; European Union's Horizon 2020 program under the Marie Sklodowska-Curie grant [703432]	European Research Council Advanced Grant(European Research Council (ERC)); EMBL International PhD program; European Union's Horizon 2020 program under the Marie Sklodowska-Curie grant	C.W.M. and R.W. acknowledge support from the European Research Council Advanced Grant (ERC-2013-AdG340964-POL1PIC). M.K.V. acknowledges support from the EMBL International PhD program. H.K. acknowledges support from the European Union's Horizon 2020 program under the Marie Sklodowska-Curie grant agreement no. 703432. We thank F. Baudin for help with the transcription assay, A.J. Jakobi for extensive help with setting up LocScaling of cryo-EM maps and model refinement, T. Hoffmann and J. Pecar for setting up the high performance computing for RELION 2.0, and N. A. Hoffmann, J. Kosinski, L. Tafur and Y. Sadian for discussions. We thank A. Vannini for giving us access to the coordinates of PDB entry 5N9G before publication.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; [Anonymous], 2015, PYMOL MOL GRAPHICS S; Arimbasseri AG, 2015, MOL CELL, V58, P1124, DOI 10.1016/j.molcel.2015.04.002; Brun I, 1997, EMBO J, V16, P5730, DOI 10.1093/emboj/16.18.5730; Carter R, 2010, MOL BIOL EVOL, V27, P1035, DOI 10.1093/molbev/msp316; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cloutier TE, 2001, P NATL ACAD SCI USA, V98, P9581, DOI 10.1073/pnas.161292298; Dieci G, 2000, J MOL BIOL, V299, P601, DOI 10.1006/jmbi.2000.3783; Dieci G, 1996, CELL, V84, P245, DOI 10.1016/S0092-8674(00)80979-4; Dieci G, 2003, TRENDS BIOCHEM SCI, V28, P202, DOI 10.1016/S0968-0004(03)00054-9; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Engel C, 2017, CELL, V169, P120, DOI 10.1016/j.cell.2017.03.003; Feklistov A, 2017, SCIENCE, V356, P863, DOI 10.1126/science.aam7858; Felton-Edkins ZA, 2002, J BIOL CHEM, V277, P48182, DOI 10.1074/jbc.M201333200; Goodfellow SJ, 2007, CELL CYCLE, V6, P2323, DOI 10.4161/cc.6.19.4767; Gouge J, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00126-1; Gouge J, 2015, CELL, V163, P1375, DOI 10.1016/j.cell.2015.11.005; Hahn S, 1998, COLD SPRING HARB SYM, V63, P181, DOI 10.1101/sqb.1998.63.181; Han Y, 2017, ELIFE, V6, DOI 10.7554/eLife.27414; He Y, 2016, NATURE, V533, P359, DOI 10.1038/nature17970; He Y, 2013, NATURE, V495, P481, DOI 10.1038/nature11991; Heymann JB, 2007, J STRUCT BIOL, V157, P3, DOI 10.1016/j.jsb.2006.06.006; Hoffmann NA, 2015, NATURE, V528, P231, DOI 10.1038/nature16143; Hu HL, 2015, MOL CELL BIOL, V35, P2831, DOI 10.1128/MCB.00263-15; Ishiguro A, 2002, MOL CELL BIOL, V22, P3264, DOI 10.1128/MCB.22.10.3264-3275.2002; Jakobi AJ, 2017, ELIFE, V6, DOI 10.7554/eLife.27131; Johnson SAS, 2008, J BIOL CHEM, V283, P19184, DOI 10.1074/jbc.M802872200; Juo ZS, 2003, NATURE, V422, P534, DOI 10.1038/nature01534; Kang JJ, 2016, FEBS LETT, V590, P1488, DOI 10.1002/1873-3468.12185; Kassavetis GA, 2005, P NATL ACAD SCI USA, V102, P15406, DOI 10.1073/pnas.0507653102; KASSAVETIS GA, 1990, CELL, V60, P235, DOI 10.1016/0092-8674(90)90739-2; Kassavetis GA, 1999, EMBO J, V18, P5042, DOI 10.1093/emboj/18.18.5042; KASSAVETIS GA, 1992, J MOL BIOL, V226, P47, DOI 10.1016/0022-2836(92)90123-2; Kassavetis GA, 1997, MOL CELL BIOL, V17, P5299, DOI 10.1128/MCB.17.9.5299; Kassavetis GA, 2001, EMBO J, V20, P2823, DOI 10.1093/emboj/20.11.2823; Kassavetis GA, 2006, J BIOL CHEM, V281, P14321, DOI 10.1074/jbc.M601702200; Kassavetis GA, 2010, J BIOL CHEM, V285, P2695, DOI 10.1074/jbc.M109.074013; Keener J, 1998, J BIOL CHEM, V273, P33795, DOI 10.1074/jbc.273.50.33795; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; KHOO B, 1994, GENE DEV, V8, P2879, DOI 10.1101/gad.8.23.2879; Khoo SK, 2014, MOL CELL BIOL, V34, P551, DOI 10.1128/MCB.00910-13; Kimanius D, 2016, ELIFE, V5, DOI 10.7554/eLife.18722; Kumar A, 1997, MOL CELL BIOL, V17, P1868, DOI 10.1128/MCB.17.4.1868; LASSAR AB, 1983, SCIENCE, V222, P740, DOI 10.1126/science.6356356; Liao YL, 2006, MOL CELL BIOL, V26, P5946, DOI 10.1128/MCB.00689-06; Male G, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8387; Moreno-Morcillo M, 2014, ACTA CRYSTALLOGR D, V70, P2570, DOI 10.1107/S1399004714015788; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plaschka C, 2016, NATURE, V533, P353, DOI 10.1038/nature17990; Rani PG, 2004, MOL CELL BIOL, V24, P1709, DOI 10.1128/MCB.24.4.1709-1720.2004; Rijal K, 2013, NUCLEIC ACIDS RES, V41, P139, DOI 10.1093/nar/gks985; Roy K, 2016, GENOME RES, V26, P1363, DOI 10.1101/gr.204776.116; Sadian Y, 2017, EMBO J, V36, P2698, DOI 10.15252/embj.201796958; Sainsbury S, 2013, NATURE, V493, P437, DOI 10.1038/nature11715; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shah SMA, 1999, J BIOL CHEM, V274, P28736, DOI 10.1074/jbc.274.40.28736; Tafur L, 2016, MOL CELL, V64, P1135, DOI 10.1016/j.molcel.2016.11.013; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; White RJ, 2005, NAT REV MOL CELL BIO, V6, P69, DOI 10.1038/nrm1551; Wu CC, 2011, MOL CELL BIOL, V31, P2715, DOI 10.1128/MCB.05151-11; Wu LP, 2003, EUKARYOT CELL, V2, P256, DOI 10.1128/EC.2.2.256-264.2003; Yudkovsky N, 2000, NATURE, V408, P225, DOI 10.1038/35041603; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	64	69	69	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2018	553	7688					295	+		10.1038/nature25440	http://dx.doi.org/10.1038/nature25440			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT9MB	29345638	Green Accepted			2022-12-28	WOS:000423475100042
J	Alberts, MJ				Alberts, Mark J.			Adding patent foramen ovale closure to antiplatelet therapy reduced stroke after cryptogenic stroke	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Alberts, Mark J.] Hartford HealthCare, Hartford, CT 06103 USA; [Alberts, Mark J.] Hartford Hosp, Hartford, CT 06115 USA	Hartford Hospital	Alberts, MJ (corresponding author), Hartford HealthCare, Hartford, CT 06103 USA.; Alberts, MJ (corresponding author), Hartford Hosp, Hartford, CT 06115 USA.							Boyajian R A, 1995, J Neuroimaging, V5, P1	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2018	168	2					JC7	JC7		10.7326/ACPJC-2018-168-2-007	http://dx.doi.org/10.7326/ACPJC-2018-168-2-007			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU8IN	29335719				2022-12-28	WOS:000424096600007
J	Fekete, T				Fekete, Thomas			Review: In suspected influenza, some rapid tests have high sensitivity and high specificity for detecting infection	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Fekete, Thomas] Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Fekete, T (corresponding author), Temple Univ, Lewis Katz Sch Med, Philadelphia, PA 19122 USA.		Fekete, Thomas/AFI-5367-2022					[Anonymous], GUID CLIN US RT PCR	1	0	0	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2018	168	2					JC9	JC9		10.7326/ACPJC-2018-168-2-009	http://dx.doi.org/10.7326/ACPJC-2018-168-2-009			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU8IN	29335721				2022-12-28	WOS:000424096600009
J	Guth, E				Guth, Eve			Counting Calories as an Approach to Achieve Weight Control	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							OBESITY		[Guth, Eve] Jesse Brown Vet Affairs Med Ctr, Chicago, IL USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Guth, E (corresponding author), Jesse Brown VAMC, 820 S Damen Ave, Chicago, IL 60612 USA.	eve.guth@va.gov						Centers for Medicare & Medicaid Services. US Department of Health and Human Services, INT BEH THER IBT OB; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Johnston BC, 2014, JAMA-J AM MED ASSOC, V312, P923, DOI 10.1001/jama.2014.10397; O'Reilly GA, 2014, OBES REV, V15, P453, DOI 10.1111/obr.12156; Pollan M, 2009, DEFENSE OF FOOD; Puzziferri N, 2016, OBESITY, V24, P829, DOI 10.1002/oby.21424; Wadden TA, 2014, JAMA-J AM MED ASSOC, V312, P1779, DOI 10.1001/jama.2014.14173	7	7	7	1	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2018	319	3					225	226		10.1001/jama.2017.21355	http://dx.doi.org/10.1001/jama.2017.21355			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT3BY	29340688				2022-12-28	WOS:000423022300010
J	Pomeranz, JL; Mozaffarian, D; Micha, R				Pomeranz, Jennifer L.; Mozaffarian, Dariush; Micha, Renata			Can the Government Require Health Warnings on Sugar-Sweetened Beverage Advertisements?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Pomeranz, Jennifer L.] NYU, Coll Global Publ Hlth, 715 Broadway,10th Floor, New York, NY 10003 USA; [Mozaffarian, Dariush; Micha, Renata] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA	New York University; Tufts University	Pomeranz, JL (corresponding author), NYU, Coll Global Publ Hlth, 715 Broadway,10th Floor, New York, NY 10003 USA.	jlp284@nyu.edu	Mozaffarian, Dariush/ABC-2822-2020		National Institutes of Health [R01HL130735]; National Heart, Lung, and Blood Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130735] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by grant R01HL130735 from the National Institutes of Health and National Heart, Lung, and Blood Institute (Dr Micha).	Malik VS, 2013, AM J CLIN NUTR, V98, P1084, DOI 10.3945/ajcn.113.058362; Micha R, 2017, JAMA-J AM MED ASSOC, V317, P912, DOI 10.1001/jama.2017.0947; Pan A, 2011, CURR OPIN CLIN NUTR, V14, P385, DOI 10.1097/MCO.0b013e328346df36; Pomeranz JL, 2015, HEALTH AFFAIR, V34, P1986, DOI 10.1377/hlthaff.2015.0616; Rehm CD, 2016, JAMA-J AM MED ASSOC, V315, P2542, DOI 10.1001/jama.2016.7491	5	16	16	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2018	319	3					227	228		10.1001/jama.2017.19209	http://dx.doi.org/10.1001/jama.2017.19209			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT3BY	29340685				2022-12-28	WOS:000423022300011
J	Leonardi, I; Li, X; Semon, A; Li, DL; Doron, I; Putzel, G; Bar, A; Prieto, D; Rescigno, M; McGovern, DPB; Pla, J; Iliev, ID				Leonardi, Irina; Li, Xin; Semon, Alexa; Li, Dalin; Doron, Itai; Putzel, Gregory; Bar, Agnieszka; Prieto, Daniel; Rescigno, Maria; McGovern, Dermot P. B.; Pla, Jesus; Iliev, Iliyan D.			CX3CR1(+) mononuclear phagocytes control immunity to intestinal fungi	SCIENCE			English	Article							CD103(+)CD11B(+) DENDRITIC CELLS; SACCHAROMYCES-CEREVISIAE; CANDIDA-ALBICANS; RECEPTOR CX3CR1; CROHNS-DISEASE; TH17 RESPONSES; POLYMORPHISM; MICE; ASSOCIATION; MACROPHAGES	Intestinal fungi are an important component of the microbiota, and recent studies have unveiled their potential in modulating host immune homeostasis and inflammatory disease. Nonetheless, the mechanisms governing immunity to gut fungal communities (mycobiota) remain unknown. We identified CX3CR1(+) mononuclear phagocytes (MNPs) as being essential for the initiation of innate and adaptive immune responses to intestinal fungi. CX3CR1(+) MNPs express antifungal receptors and activate antifungal responses in a Syk-dependent manner. Genetic ablation of CX3CR1(+) MNPs in mice led to changes in gut fungal communities and to severe colitis that was rescued by antifungal treatment. In Crohn's disease patients, a missense mutation in the gene encoding CX3CR1 was identified and found to be associated with impaired antifungal responses. These results unravel a role of CX3CR1(+) MNPs in mediating interactions between intestinal mycobiota and host immunity at steady state and during inflammatory disease.	[Leonardi, Irina; Li, Xin; Semon, Alexa; Doron, Itai; Bar, Agnieszka; Iliev, Iliyan D.] Weill Cornell Med, Gastroenterol & Hepatol Div, Joan & Sanford I Weill Dept Med, New York, NY 10021 USA; [Leonardi, Irina; Li, Xin; Semon, Alexa; Doron, Itai; Putzel, Gregory; Bar, Agnieszka; Iliev, Iliyan D.] Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY 10021 USA; [Li, Dalin; McGovern, Dermot P. B.] Cedars Sinai Med Ctr, F Widjaja Inflammatory Bowel & Immunobiol Res Ins, Los Angeles, CA 90048 USA; [Prieto, Daniel; Pla, Jesus] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, E-28040 Madrid, Spain; [Rescigno, Maria] European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy; [Iliev, Iliyan D.] Weill Cornell Med, Dept Microbiol & Immunol, New York, NY 10065 USA	Cornell University; Cornell University; Cedars Sinai Medical Center; Complutense University of Madrid; IRCCS European Institute of Oncology (IEO); Cornell University	Iliev, ID (corresponding author), Weill Cornell Med, Gastroenterol & Hepatol Div, Joan & Sanford I Weill Dept Med, New York, NY 10021 USA.; Iliev, ID (corresponding author), Weill Cornell Med, Jill Roberts Inst Res Inflammatory Bowel Dis, New York, NY 10021 USA.; Iliev, ID (corresponding author), Weill Cornell Med, Dept Microbiol & Immunol, New York, NY 10065 USA.	iliev@med.cornell.edu	Prieto, Daniel/P-2038-2017; Pla, Jesús/G-8238-2015; Pla, Jesús/ABG-9609-2020; Leonardi, Irina/AAW-7480-2020; Li, Xin V./ABA-4321-2021	Prieto, Daniel/0000-0003-3931-5790; Pla, Jesús/0000-0003-0897-1963; Leonardi, Irina/0000-0002-0369-7371; Li, Xin V./0000-0002-9444-8214; Semon, Alexa/0000-0002-0551-1446; Li, Dalin/0000-0003-4738-0074	U.S. National Institutes of Health [DK113136, DK098310, AI123819, P01 DK046763, U01 DK062413]; Infect-ERA FUNCOMPATH [PCIN-2014-052]; Ministerio de Economia y Competitividad [BIO2015-6477-P]; Swiss National Science Foundation [P2ZHP3_164850]; Kenneth Rainin Foundation; Jill Roberts Institute for Research in IBD; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI123819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK098310, U01DK062413, R01DK113136, R00DK098310, P01DK046763] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Infect-ERA FUNCOMPATH; Ministerio de Economia y Competitividad(Spanish Government); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Kenneth Rainin Foundation; Jill Roberts Institute for Research in IBD; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by the U.S. National Institutes of Health (grants DK113136, DK098310, and AI123819 to I.D.I; P01 DK046763 and U01 DK062413 to D.P.B.M.), Infect-ERA FUNCOMPATH (PCIN-2014-052 to J.P), Ministerio de Economia y Competitividad (BIO2015-6477-P to J.P.), Swiss National Science Foundation (fellowship P2ZHP3_164850 to I.L), Kenneth Rainin Foundation (Innovator and Breakthrough awards to I.D.I), and support from the Jill Roberts Institute for Research in IBD. The data presented in this study are tabulated in the main text and supplementary materials. Microbiota sequencing data are deposited in National Center for Biotechnology Information (NCBI) Sequence Read Archive (SRA; www.ncbi.nlm.nih.gov/Traces/sra, run numbers SRP124782, SRP124783, SRP124736, and SRP124742). RNA-seq data are deposited in the NCBI Gene Expression Omnibus under accession no. GSE106594.	Atarashi K, 2015, CELL, V163, P367, DOI 10.1016/j.cell.2015.08.058; Aychek T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7525; Brand S, 2006, AM J GASTROENTEROL, V101, P99, DOI 10.1111/j.1572-0241.2005.00361.x; Break TJ, 2015, INFECT IMMUN, V83, P958, DOI 10.1128/IAI.02604-14; Conti HR, 2009, J EXP MED, V206, P299, DOI 10.1084/jem.20081463; Diehl GE, 2013, NATURE, V494, P116, DOI 10.1038/nature11809; Edelson BT, 2011, IMMUNITY, V35, P236, DOI 10.1016/j.immuni.2011.06.012; Iliev ID, 2017, NAT REV IMMUNOL, V17, P635, DOI 10.1038/nri.2017.55; Iliev ID, 2012, SCIENCE, V336, P1314, DOI 10.1126/science.1221789; Kinnebrew MA, 2012, IMMUNITY, V36, P276, DOI 10.1016/j.immuni.2011.12.011; Lionakis MS, 2013, J CLIN INVEST, V123, P5035, DOI 10.1172/JCI71307; Mankai A, 2013, ENDOCR RES, V38, P98, DOI 10.3109/07435800.2012.723293; Mazzini E, 2014, IMMUNITY, V40, P248, DOI 10.1016/j.immuni.2013.12.012; McDermott DH, 2001, CIRC RES, V89, P401, DOI 10.1161/hh1701.095642; Medina-Contreras O, 2011, J CLIN INVEST, V121, P4787, DOI 10.1172/JCI59150; Moatti D, 2001, BLOOD, V97, P1925, DOI 10.1182/blood.V97.7.1925; Niess JH, 2005, SCIENCE, V307, P254, DOI 10.1126/science.1102901; Panea C, 2015, CELL REP, V12, P1314, DOI 10.1016/j.celrep.2015.07.040; Persson EK, 2013, IMMUNITY, V38, P958, DOI 10.1016/j.immuni.2013.03.009; Rescigno M, 2001, NAT IMMUNOL, V2, P361, DOI 10.1038/86373; Riente L, 2004, J RHEUMATOL, V31, P920; Schlitzer A, 2013, IMMUNITY, V38, P970, DOI 10.1016/j.immuni.2013.04.011; Scupham AJ, 2006, APPL ENVIRON MICROB, V72, P793, DOI 10.1128/AEM.72.1.793-801.2006; Sokol H, 2017, GUT, V66, P1039, DOI [10.1136/gutjnl-2015-310746, 10.1136/gutjnl-20]; Standaert-Vitse A, 2006, GASTROENTEROLOGY, V130, P1764, DOI 10.1053/j.gastro.2006.02.009; Tang C, 2015, CELL HOST MICROBE, V18, P183, DOI 10.1016/j.chom.2015.07.003; Trautwein-Weidner K, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005164; Wang TT, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005662; Wheeler ML, 2016, CELL HOST MICROBE, V19, P865, DOI 10.1016/j.chom.2016.05.003; Yang AM, 2017, J CLIN INVEST, V127, P2829, DOI 10.1172/JCI90562	30	144	149	2	51	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					232	+		10.1126/science.aao1503	http://dx.doi.org/10.1126/science.aao1503			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS5EO	29326275	Green Accepted			2022-12-28	WOS:000419816600050
J	Duffy, S; Lee, TH				Duffy, Sean; Lee, Thomas H.			In-Person Health Care as Option B	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Duffy, Sean] Omada Hlth, San Francisco, CA 94111 USA; [Lee, Thomas H.] Press Ganey, Wakefield, MA USA; [Lee, Thomas H.] Harvard Med Sch, Boston, MA USA	Harvard University; Harvard Medical School	Duffy, S (corresponding author), Omada Hlth, San Francisco, CA 94111 USA.							Fletcher H., 2017, TENNESSEAN      0421; Hooton TM, 2012, NEW ENGL J MED, V366, P1028, DOI 10.1056/NEJMcp1104429; Lella A., 2017, SMARTPH PEN SURP 80; Pearl R., 2017, ENGAGING PHYS TELEHE	4	94	96	1	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 11	2018	378	2					104	106		10.1056/NEJMp1710735	http://dx.doi.org/10.1056/NEJMp1710735			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FS7IR	29320653				2022-12-28	WOS:000419971600002
J	Rodriguez-Fraticelli, AE; Wolock, SL; Weinreb, CS; Panero, R; Patel, SH; Jankovic, M; Sun, JL; Calogero, RA; Klein, AM; Camargo, FD				Rodriguez-Fraticelli, Alejo E.; Wolock, Samuel L.; Weinreb, Caleb S.; Panero, Riccardo; Patel, Sachin H.; Jankovic, Maja; Sun, Jianlong; Calogero, Raffaele A.; Klein, Allon M.; Camargo, Fernando D.			Clonal analysis of lineage fate in native haematopoiesis	NATURE			English	Article							SINGLE-CELL TRANSCRIPTOMICS; STEM-CELLS; MULTIPOTENT PROGENITORS; IDENTIFICATION; COMMITMENT; MEGAKARYOCYTES; CLASSIFICATION; SUBPOPULATIONS; HETEROGENEITY; HIERARCHY	Haematopoiesis, the process of mature blood and immune cell production, is functionally organized as a hierarchy, with self-renewing haematopoietic stem cells and multipotent progenitor cells sitting at the very top(1,2). Multiple models have been proposed as to what the earliest lineage choices are in these primitive haematopoietic compartments, the cellular intermediates, and the resulting lineage trees that emerge from them(3-10). Given that the bulk of studies addressing lineage outcomes have been performed in the context of haematopoietic transplantation, current models of lineage branching are more likely to represent roadmaps of lineage potential than native fate. Here we use transposon tagging to clonally trace the fates of progenitors and stem cells in unperturbed haematopoiesis. Our results describe a distinct clonal roadmap in which the megakaryocyte lineage arises largely independently of other haematopoietic fates. Our data, combined with single-cell RNA sequencing, identify a functional hierarchy of unilineage- and oligolineage-producing clones within the multipotent progenitor population. Finally, our results demonstrate that traditionally defined long-term haematopoietic stem cells are a significant source of megakaryocyte-restricted progenitors, suggesting that the megakaryocyte lineage is the predominant native fate of long-term haematopoietic stem cells. Our study provides evidence for a substantially revised roadmap for unperturbed haematopoiesis, and highlights unique properties of multipotent progenitors and haematopoietic stem cells in situ.	[Rodriguez-Fraticelli, Alejo E.; Patel, Sachin H.; Jankovic, Maja; Sun, Jianlong; Camargo, Fernando D.] Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Rodriguez-Fraticelli, Alejo E.; Sun, Jianlong; Camargo, Fernando D.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Wolock, Samuel L.; Weinreb, Caleb S.; Klein, Allon M.] Harvard Med Sch, Dept Syst Biol, Boston, MA 02115 USA; [Panero, Riccardo; Calogero, Raffaele A.] Univ Torino, Dept Clin & Biol Sci, Ctr Mol Biotechnol, I-10126 Turin, Italy; [Sun, Jianlong] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai 201210, Peoples R China	Harvard University; Boston Children's Hospital; Harvard University; Harvard University; Harvard Medical School; University of Turin; ShanghaiTech University	Camargo, FD (corresponding author), Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA.; Camargo, FD (corresponding author), Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA.	Fernando.Camargo@childrens.harvard.edu	Calogero, Raffaele/K-9428-2019; Rodriguez-Fraticelli, Alejo/AAG-7462-2020	Calogero, Raffaele/0000-0002-2848-628X; Rodriguez-Fraticelli, Alejo/0000-0002-4017-8714; camargo, fernando/0000-0002-5630-5909; Wolock, Samuel/0000-0002-2120-4788	National Institutes of Health [HL128850-01A1, P01HL13147]; Burroughs-Wellcome Fund CASI award; Edward J. Mallinckrodt Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL131477, R01HL128850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U54DK110805, P30DK034854] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM080177] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs-Wellcome Fund CASI award; Edward J. Mallinckrodt Fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to members of the Camargo and Klein laboratory for comments. A.R.F. is a Merck Fellow of the Life Sciences Research Foundation and a non-stipendiary European Molecular Biology Organization postdoctoral fellow. This work was supported by National Institutes of Health grants HL128850-01A1 and P01HL13147 to F.D.C. F.D.C. is a Leukemia and Lymphoma Society and a Howard Hughes Medical Institute Scholar. A.M.K. is supported by a Burroughs-Wellcome Fund CASI award, and by the Edward J. Mallinckrodt Fellowship.	Adolfsson J, 2005, CELL, V121, P295, DOI 10.1016/j.cell.2005.02.013; Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599; Buettner F, 2015, NAT BIOTECHNOL, V33, P155, DOI 10.1038/nbt.3102; Busch K, 2015, NATURE, V518, P542, DOI 10.1038/nature14242; Calaminus SDJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051361; Ceredig R, 2009, NAT REV IMMUNOL, V9, P293, DOI 10.1038/nri2525; Debili N, 1996, BLOOD, V88, P1284, DOI 10.1182/blood.V88.4.1284.bloodjournal8841284; Forsberg EC, 2006, CELL, V126, P415, DOI 10.1016/j.cell.2006.06.037; Foudi A, 2009, NAT BIOTECHNOL, V27, P84, DOI 10.1038/nbt.1517; Gekas C, 2013, BLOOD, V121, P4463, DOI 10.1182/blood-2012-09-457929; Haas S, 2015, CELL STEM CELL, V17, P422, DOI 10.1016/j.stem.2015.07.007; Harkey MA, 2007, STEM CELLS DEV, V16, P381, DOI 10.1089/scd.2007.0015; Hennig C., 2017, PREPRINT; Ilicic T, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0888-1; Junker J. P., 2017, PREPRINT; Klein AM, 2015, CELL, V161, P1187, DOI 10.1016/j.cell.2015.04.044; MORRISON SJ, 1994, IMMUNITY, V1, P661, DOI 10.1016/1074-7613(94)90037-X; Morrison SJ, 1997, DEVELOPMENT, V124, P1929; Nishikii H, 2015, STEM CELLS, V33, P2196, DOI 10.1002/stem.1985; Notta F, 2016, SCIENCE, V351, P139, DOI 10.1126/science.aab2116; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Perie L, 2015, CELL, V163, P1655, DOI 10.1016/j.cell.2015.11.059; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; Pronk CJH, 2007, CELL STEM CELL, V1, P428, DOI 10.1016/j.stem.2007.07.005; Raj B., 2017, PREPRINT; Roch A, 2015, STEM CELLS, V33, P3152, DOI 10.1002/stem.2106; Sanada C, 2016, BLOOD, V128, P923, DOI 10.1182/blood-2016-01-693705; Sanjuan-Pla A, 2013, NATURE, V502, P232, DOI 10.1038/nature12495; Sawai CM, 2016, IMMUNITY, V45, P597, DOI 10.1016/j.immuni.2016.08.007; Shekhar K, 2016, CELL, V166, P1308, DOI 10.1016/j.cell.2016.07.054; Sun JL, 2014, NATURE, V514, P322, DOI 10.1038/nature13824; Vannucchi AM, 2000, BLOOD, V95, P2559; Velten L, 2017, NAT CELL BIOL, V19, P271, DOI 10.1038/ncb3493; Wang GP, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn125; Weinreb C., 2016, PREPRINT; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Yamamoto R, 2013, CELL, V154, P1112, DOI 10.1016/j.cell.2013.08.007; Zilionis R, 2017, NAT PROTOC, V12, DOI 10.1038/nprot.2016.154	39	257	260	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2018	553	7687					212	+		10.1038/nature25168	http://dx.doi.org/10.1038/nature25168			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4WL	29323290	Green Accepted, Green Submitted			2022-12-28	WOS:000419794800038
J	Lonning, PE; Berge, EO; Bjornslett, M; Minsaas, L; Chrisanthar, R; Hoberg-Vetti, H; Dulary, C; Busato, F; Bjorneklett, S; Eriksen, C; Kopperud, R; Axcrona, U; Davidson, B; Bjorge, L; Evans, G; Howell, A; Salvesen, HB; Janszky, I; Hveem, K; Romundstad, PR; Vatten, LJ; Tost, J; Dorum, A; Knappskog, S				Lonning, Per E.; Berge, Elisabet O.; Bjornslett, Merete; Minsaas, Laura; Chrisanthar, Ranjan; Hoberg-Vetti, Hildegunn; Dulary, Cecile; Busato, Florence; Bjorneklett, Silje; Eriksen, Christine; Kopperud, Reidun; Axcrona, Ulrika; Davidson, Ben; Bjorge, Line; Evans, Gareth; Howell, Anthony; Salvesen, Helga B.; Janszky, Imre; Hveem, Kristian; Romundstad, Pal R.; Vatten, Lars J.; Tost, Jorg; Dorum, Anne; Knappskog, Stian			White Blood Cell BRCA1 Promoter Methylation Status and Ovarian Cancer Risk	ANNALS OF INTERNAL MEDICINE			English	Article							BREAST-CANCER; DNA METHYLATION; GERMLINE MUTATIONS; PERIPHERAL-BLOOD; SUSCEPTIBILITY GENE; LYNCH SYNDROME; CORD BLOOD; TUMOR; WOMEN; CARCINOMA	Background: The role of normal tissue gene promoter methylation in cancer risk is poorly understood. Objective: To assess associations between normal tissue BRCA1 methylation and ovarian cancer risk. Design: 2 case-control (initial and validation) studies. Setting: 2 hospitals in Norway (patients) and a population-based study (control participants). Participants: 934 patients and 1698 control participants in the initial study; 607 patients and 1984 control participants in the validation study. Measurements: All patients had their blood sampled before chemotherapy. White blood cell (WBC) BRCA1 promoter methylation was determined by using methylation-specific quantitative polymerase chain reaction, and the percentage of methylation-positive samples was compared between population control participants and patients with ovarian cancer, including the subgroup with high-grade serous ovarian cancer (HGSOC). Results: In the initial study, BRCA1 methylation was more frequent in patients with ovarian cancer than control participants (6.4% vs. 4.2%; age-adjusted odds ratio [OR], 1.83 [95% CI, 1.27 to 2.63]). Elevated methylation, however, was restricted to patients with HGSOC (9.6%; OR, 2.91 [CI, 1.85 to 4.56]), in contrast to 5.1% and 4.0% of patients with nonserous and low-grade serous ovarian cancer (LGSOC), respectively. These findings were replicated in the validation study (methylation-positive status in 9.1% of patients with HGSOC vs. 4.3% of control participants-OR, 2.22 [CI 1.40 to 3.52]-4.1% of patients with nonserous ovarian cancer, and 2.7% of those with LGSOC). The results were not influenced by tumor burden, storage time, or WBC subfractions. In separate analyses of young women and newborns, BRCA1 methylation was detected in 4.1% (CI, 1.8% to 6.4%) and 7.0% (CI, 5.0% to 9.1%), respectively. Limitations: Patients with ovarian cancer were recruited at the time of diagnosis in a hospital setting. Conclusion: Constitutively normal tissue BRCA1 promoter methylation is positively associated with risk for HGSOC.	Univ Bergen, Bergen, Norway; Haukeland Hosp, Bergen, Norway; Oslo Univ Hosp, Oslo, Norway; Ctr Natl Rech Genom Humaine, Evry, France; Univ Oslo, Oslo, Norway; Univ Manchester, St Marys Hosp, Manchester, Lancs, England; Univ Hosp South Manchester, Manchester, Lancs, England; Univ Manchester, Manchester, Lancs, England; Norwegian Univ Sci & Technol, Trondheim, Norway; [Lonning, Per E.; Berge, Elisabet O.; Minsaas, Laura; Chrisanthar, Ranjan; Bjorneklett, Silje; Eriksen, Christine; Knappskog, Stian] Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway; [Lonning, Per E.; Berge, Elisabet O.; Minsaas, Laura; Chrisanthar, Ranjan; Bjorneklett, Silje; Eriksen, Christine; Knappskog, Stian] Univ Bergen, Sect Oncol, Dept Clin Sci, N-5020 Bergen, Norway; [Bjornslett, Merete] Oslo Univ Hosp, Inst Canc Res, Norwegian Radium Hosp, Dept Mol Oncol, N-0316 Oslo, Norway; [Axcrona, Ulrika; Davidson, Ben] Univ Oslo, Inst Clin Med, Fac Med, Ullernchausseen 70 Radiumhosp,Box 4950 Nydalen, N-0424 Oslo, Norway; [Axcrona, Ulrika; Davidson, Ben] Oslo Univ Hosp, Dept Pathol, Ullernchausseen 70 Radiumhosp,Box 4950 Nydalen, N-0424 Oslo, Norway; [Hoberg-Vetti, Hildegunn] Haukeland Hosp, Dept Mol Med & Med Genet, N-5021 Bergen, Norway; [Dulary, Cecile; Busato, Florence; Tost, Jorg] CEA Inst Biol Francois Jacob, Ctr Natl Rech Genom Humaine, Lab Epigenet & Environm, Batiment G2,2 Rue Gaston Cremieux,CP 5721, F-91057 Evry, France; [Kopperud, Reidun; Bjorge, Line] Univ Bergen, Dept Clin Sci, Ctr Canc Biomarkers, Dept Obstet & Gynecol,Haukeland Univ Hosp, N-5021 Bergen, Norway; [Evans, Gareth] Univ Manchester, Dept Genom Med, Manchester M13 9WL, Lancs, England; [Evans, Gareth] St Marys Hosp, Div Evolut & Genom Sci, Manchester M13 9WL, Lancs, England; [Howell, Anthony] Univ Manchester, Inst Canc Sci, 555 Wilmslow Rd, Manchester M20 4GJ, Lancs, England; [Howell, Anthony] Christie NHS Fdn Trust, Manchester Canc Res Ctr, Breast Canc Now Unit, 555 Wilmslow Rd, Manchester M20 4GJ, Lancs, England; [Janszky, Imre; Romundstad, Pal R.; Vatten, Lars J.] Norwegian Univ Sci & Technol, Dept Publ Hlth, Boks 8905, N-7491 Tondheim, Norway; [Hveem, Kristian] Norwegian Univ Sci & Technol NTNU, Fac Med, Dept Publ Hlth, KG Jebsen Ctr Genet Epidemiol,HUNT Biobank, Forskningsvegen 2, N-7600 Levanger, Norway; [Dorum, Anne] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Gynecol Oncol, N-0316 Oslo, Norway	University of Bergen; University of Oslo; UDICE-French Research Universities; Universite Paris Saclay; University of Oslo; University of Manchester; Wythenshawe Hospital NHS Foundation Trust; University of Manchester; Norwegian University of Science & Technology (NTNU); University of Bergen; Haukeland University Hospital; University of Bergen; University of Oslo; University of Oslo; University of Oslo; University of Bergen; Haukeland University Hospital; UDICE-French Research Universities; Universite Paris Saclay; University of Bergen; Haukeland University Hospital; University of Manchester; University of Manchester; University of Manchester; Christie NHS Foundation Trust; University of Manchester; Norwegian University of Science & Technology (NTNU); Norwegian University of Science & Technology (NTNU); University of Oslo	Lonning, PE (corresponding author), Haukeland Hosp, Dept Oncol, N-5021 Bergen, Norway.	per.lonning@helse-bergen.no; pal.romundstad@ntnu.no	Bjorge, Line/C-1307-2017; Bjorge, Line/AAD-6179-2021; Evans, D Gareth/AAB-4308-2022; Vatten, Lars/AFK-2073-2022; Hveem, Kristian/AFV-4683-2022; Vatten, Lars/AAF-9380-2022; Tost, Joerg/H-7129-2019	Bjorge, Line/0000-0002-0240-2770; Bjorge, Line/0000-0002-0240-2770; Evans, D Gareth/0000-0002-8482-5784; Tost, Joerg/0000-0002-2683-0817; Howell, Anthony/0000-0002-6233-719X; Knappskog, Stian/0000-0002-4153-1655; Hoberg-Vetti, Hildegunn/0000-0002-9876-576X	Norwegian Cancer Society; Norwegian Health West (Helse Vest; regional funding for medical research); Norwegian Research Council; Bergen Research Foundation; National Institute for Health Research Manchester Biomedical Research Centre	Norwegian Cancer Society(Norwegian Cancer Society); Norwegian Health West (Helse Vest; regional funding for medical research); Norwegian Research Council(Research Council of NorwayEuropean Commission); Bergen Research Foundation; National Institute for Health Research Manchester Biomedical Research Centre(National Institute for Health Research (NIHR))	By the Norwegian Cancer Society, Norwegian Health West (Helse Vest; regional funding for medical research), Norwegian Research Council, and Bergen Research Foundation. Dr. Evans is supported by the National Institute for Health Research Manchester Biomedical Research Centre.	Alsop K, 2012, J CLIN ONCOL, V30, P2654, DOI 10.1200/JCO.2011.39.8545; Bosviel R, 2011, CLIN CHIM ACTA, V412, P1472, DOI 10.1016/j.cca.2011.04.027; Chen Y, 2006, GENET TEST, V10, P281, DOI 10.1089/gte.2006.10.281; Cunningham JM, 2014, SCI REP-UK, V4, DOI 10.1038/srep04026; Denholm R, 2016, BREAST CANCER RES, V18, DOI 10.1186/s13058-016-0751-z; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Evans GR, 2007, J MED GENET, V44, P424, DOI 10.1136/jmg.2006.047753; Fridley BL, 2014, BMC MED GENOMICS, V7, DOI 10.1186/1755-8794-7-21; Friedman E, 2015, BRIT J CANCER, V112, P765, DOI 10.1038/bjc.2015.14; Gazzoli I, 2002, CANCER RES, V62, P3925; Gervin K, 2016, EPIGENETICS-US, V11, P690, DOI 10.1080/15592294.2016.1214782; Hansmann T, 2012, HUM MOL GENET, V21, P4669, DOI 10.1093/hmg/dds308; Hitchins MP, 2011, CANCER CELL, V20, P200, DOI 10.1016/j.ccr.2011.07.003; Hoberg-Vetti H, 2016, EUR J HUM GENET, V24, P881, DOI 10.1038/ejhg.2015.196; Houseman EA, 2014, BIOINFORMATICS, V30, P1431, DOI 10.1093/bioinformatics/btu029; Houseman EA, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-86; Iwamoto T, 2011, BREAST CANCER RES TR, V129, P69, DOI 10.1007/s10549-010-1188-1; Jones MJ, 2015, AGING CELL, V14, P924, DOI 10.1111/acel.12349; King MC, 2003, SCIENCE, V302, P643, DOI 10.1126/science.1088759; Liggett TE, 2011, INT J CANCER, V128, P492, DOI 10.1002/ijc.25363; Ligtenberg MJL, 2009, NAT GENET, V41, P112, DOI 10.1038/ng.283; Little J, 2009, GENET EPIDEMIOL, V33, P581, DOI 10.1002/gepi.20410; Liu XD, 1999, AM J HUM GENET, V64, P1427, DOI 10.1086/302358; Loveday C, 2011, NAT GENET, V43, P879, DOI 10.1038/ng.893; Lynch HT, 2015, NAT REV CANCER, V15, P181, DOI 10.1038/nrc3878; Martino DJ, 2011, EPIGENETICS-US, V6, P1085, DOI 10.4161/epi.6.9.16401; Mavaddat N, 2013, JNCI-J NATL CANCER I, V105, P812, DOI 10.1093/jnci/djt095; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Mihaescu R, 2011, GENOME MED, V3, DOI 10.1186/gm267; Naess O, 2008, INT J EPIDEMIOL, V37, P481, DOI 10.1093/ije/dym217; Norquist BM, 2013, GYNECOL ONCOL, V128, P483, DOI 10.1016/j.ygyno.2012.12.015; Ollikainen M, 2010, HUM MOL GENET, V19, P4176, DOI 10.1093/hmg/ddq336; Pal S, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600584; Qiu L, 2015, CARCINOGENESIS, V36, P94, DOI 10.1093/carcin/bgu231; Rack B, 2010, 33 ANN SAN ANT BREAS, V70, pS6; Rafnar T, 2011, NAT GENET, V43, P1104, DOI 10.1038/ng.955; Rahman N, 2007, NAT GENET, V39, P165, DOI 10.1038/ng1959; Reinius LE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041361; Seynaeve C, 2014, J MED GENET, V51, P98, DOI [10.1136/jmedgenet-2013-101974, DOI 10.1136/JMEDGENET-2013-101974]; Shih AH, 2012, NAT REV CANCER, V12, P599, DOI 10.1038/nrc3343; Snell C, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1858; Song HL, 2014, HUM MOL GENET, V23, P4703, DOI 10.1093/hmg/ddu172; Swerdlow AJ, 1997, LANCET, V350, P1723, DOI 10.1016/S0140-6736(97)05526-8; VanderWeele TJ, 2017, ANN INTERN MED, V167, P268, DOI 10.7326/M16-2607; Wong EM, 2011, CANCER PREV RES, V4, P23, DOI 10.1158/1940-6207.CAPR-10-0212	45	21	21	3	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2018	168	5					326	+		10.7326/M17-0101	http://dx.doi.org/10.7326/M17-0101			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY2GD	29335712				2022-12-28	WOS:000426632600005
J	Gu, B; Swigut, T; Spencley, A; Bauer, MR; Chung, MY; Meyer, T; Wysocka, J				Gu, Bo; Swigut, Tomek; Spencley, Andrew; Bauer, Matthew R.; Chung, Mingyu; Meyer, Tobias; Wysocka, Joanna			Transcription-coupled changes in nuclear mobility of mammalian cis-regulatory elements	SCIENCE			English	Article							MOTION; SEQUENCES; ENHANCERS	To achieve guide RNA (gRNA) multiplexing and an efficient delivery of tens of distinct gRNAs into single cells, we developed a molecular assembly strategy termed chimeric array of gRNA oligonucleotides (CARGO). We coupled CARGO with dCas9 (catalytically dead Cas9) imaging to quantitatively measure the movement of enhancers and promoters that undergo differentiation-associated activity changes in live embryonic stem cells. Whereas all examined functional elements exhibited subdiffusive behavior, their relative mobility increased concurrently with transcriptional activation. Furthermore, acute perturbation of RNA polymerase II activity can reverse these activity-linked increases in loci mobility. Through quantitative CARGO-dCas9 imaging, we provide direct measurements of cis-regulatory element dynamics in living cells and distinct cellular and activity states and uncover an intrinsic connection between cis-regulatory element mobility and transcription.	[Gu, Bo; Swigut, Tomek; Spencley, Andrew; Bauer, Matthew R.; Chung, Mingyu; Meyer, Tobias; Wysocka, Joanna] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Spencley, Andrew] Stanford Univ, Sch Med, Canc Biol Program, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA	Stanford University; Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Wysocka, J (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.; Wysocka, J (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.; Wysocka, J (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA.; Wysocka, J (corresponding author), Stanford Univ, Sch Med, Howard Hughes Med Inst, Stanford, CA 94305 USA.	wysocka@stanford.edu		gu, bo/0000-0002-6711-4139; Meyer, Tobias/0000-0003-4339-3804; Chung, Mingyu/0000-0003-1718-6203; Swigut, Tomek/0000-0002-7649-6781; Spencley, Andrew/0000-0002-7746-6015	NIH R01 grant [GM112720-01]; Ludwig Institute Funds; Henry Fan Stanford Graduate Fellowship; Howard Hughes Medical Institute;  [R35GM127026];  [S10OD018073]; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM107615, R01GM112720, R35GM127026] Funding Source: NIH RePORTER	NIH R01 grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ludwig Institute Funds; Henry Fan Stanford Graduate Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by the Howard Hughes Medical Institute, NIH R01 grant GM112720-01 and Ludwig Institute Funds (to J.W.), R35GM127026 and S10OD018073 (to T.M.), and a Henry Fan Stanford Graduate Fellowship (to B.G.).	Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chen BH, 2016, NUCLEIC ACIDS RES, V44, DOI 10.1093/nar/gkv1533; Chen BH, 2013, CELL, V155, P1479, DOI 10.1016/j.cell.2013.12.001; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Fu Y, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11707; Hayashi K, 2011, CELL, V146, P519, DOI 10.1016/j.cell.2011.06.052; Kalkan T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0540; Levine M, 2010, CURR BIOL, V20, pR754, DOI 10.1016/j.cub.2010.06.070; Long HK, 2016, CELL, V167, P1170, DOI 10.1016/j.cell.2016.09.018; Lucas JS, 2014, CELL, V158, P339, DOI 10.1016/j.cell.2014.05.036; Ma HH, 2016, NAT BIOTECHNOL, V34, P528, DOI 10.1038/nbt.3526; Ma HH, 2015, P NATL ACAD SCI USA, V112, P3002, DOI 10.1073/pnas.1420024112; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Mitsuda SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161288; Nielsen HJ, 2006, MOL MICROBIOL, V61, P383, DOI 10.1111/j.1365-2958.2006.05245.x; Remeseiro S, 2016, WIRES DEV BIOL, V5, P169, DOI 10.1002/wdev.218; Robinett CC, 1996, J CELL BIOL, V135, P1685, DOI 10.1083/jcb.135.6.1685; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; Vazquez J, 2001, CURR BIOL, V11, P1227, DOI 10.1016/S0960-9822(01)00390-6; Vispe S, 2009, MOL CANCER THER, V8, P2780, DOI 10.1158/1535-7163.MCT-09-0549; Weber SC, 2012, P NATL ACAD SCI USA, V109, P7338, DOI 10.1073/pnas.1119505109; Weber SC, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.238102; YANKULOV K, 1995, J BIOL CHEM, V270, P23922, DOI 10.1074/jbc.270.41.23922; Zhang YJ, 2016, ANNU REV BIOPHYS, V45, P117, DOI 10.1146/annurev-biophys-062215-010925	26	165	166	3	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2018	359	6379					1050	1055		10.1126/science.aao3136	http://dx.doi.org/10.1126/science.aao3136			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8SV	29371426	Green Accepted			2022-12-28	WOS:000426366200046
J	Geldmann, J; Gonzalez-Varo, JP				Geldmann, Jonas; Gonzalez-Varo, Juan P.			Conserving honey bees does not help wildlife	SCIENCE			English	Editorial Material							SPILLOVER; CROPS		[Geldmann, Jonas; Gonzalez-Varo, Juan P.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge CB2 3EJ, England	University of Cambridge	Geldmann, J (corresponding author), Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge CB2 3EJ, England.	jg794@cam.ac.uk; jpg62@cam.ac.uk	Geldmann, Jonas/H-8131-2019; González-Varo, Juan P./E-6395-2011	Geldmann, Jonas/0000-0002-1191-7610; González-Varo, Juan P./0000-0003-1439-6475	Individual Marie Sklodowska-Curie Fellowships [H2020-MSCA-IF-2015-706784, H2020-MSCA-IF-2014-656572]	Individual Marie Sklodowska-Curie Fellowships	We thank L.V. Dicks and A. Valido for comments on the manuscript. J.G. (H2020-MSCA-IF-2015-706784) and J.P.G.-V. (H2020-MSCA-IF-2014-656572) were funded by Individual Marie Sklodowska-Curie Fellowships.	Bolton D., 2016, INDEPENDENT DIGITAL; Cane JH, 2017, CONSERV LETT, V10, P205, DOI 10.1111/conl.12263; Furst MA, 2014, NATURE, V506, P364, DOI 10.1038/nature12977; Garibaldi LA, 2013, SCIENCE, V339, P1608, DOI 10.1126/science.1230200; Geslin B, 2017, ADV ECOL RES, V57, P147, DOI 10.1016/bs.aecr.2016.10.007; Gonzalez-Varo JP, 2017, BIOL CONSERV, V212, P376, DOI 10.1016/j.biocon.2017.06.018; Intergovernmental Platform on Biodiversity and Ecosystem Services, 2016, ASS REP INT SCI POL; Lindstrom SAM, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.1641; Magrach A, 2017, NAT ECOL EVOL, V1, P1299, DOI 10.1038/s41559-017-0249-9; Mallinger RE, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189268; The Nature Conservancy, 2017, BEES AND AGR; Torne-Noguera A, 2016, BASIC APPL ECOL, V17, P199, DOI 10.1016/j.baae.2015.11.004; Valido A., 2014, Ecosistemas, V23, P58, DOI 10.7818/ECOS.2014.23-3.08; YouGov, 2014, DECL BEES SEEN MOR S	14	75	79	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					392	393		10.1126/science.aar2269	http://dx.doi.org/10.1126/science.aar2269			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT6SD	29371456				2022-12-28	WOS:000423283200028
J	Koga, Y; Kaneda, T; Saito, Y; Murakami, K; Itami, K				Koga, Yoshito; Kaneda, Takeshi; Saito, Yutaro; Murakami, Kei; Itami, Kenichiro			Synthesis of partially and fully fused polyaromatics by annulative chlorophenylene dimerization	SCIENCE			English	Article							GRAPHENE NANORIBBONS; GEODESIC POLYARENES; CHEMICAL-SYNTHESIS; ARYL; NANOGRAPHENES; MOLECULES; EXTENSION; HECK	Since the discovery by Ullmann and Bielecki in 1901, reductive dimerization (or homocoupling) of aryl halides has been extensively exploited for the generation of a range of biaryl-based functional molecules. In contrast to the single-point connection in these products, edge-sharing fused aromatic systems have not generally been accessible from simple aryl halides via annulation cascades. Here we report a single-step synthesis of fused aromatics with a triphenylene core by the palladium-catalyzed annulative dimerization of structurally and functionally diverse chlorophenylenes through double carbon-hydrogen bond activation. The partially fused polyaromatics can be transformed into fully fused, small graphene nanoribbons, which are otherwise difficult to synthesize. This simple, yet powerful, method allows access to functional p-systems of interest in optoelectronics research.	[Koga, Yoshito; Kaneda, Takeshi; Saito, Yutaro; Murakami, Kei; Itami, Kenichiro] Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Murakami, Kei; Itami, Kenichiro] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Itami, Kenichiro] Nagoya Univ, Itami Mol Nanocarbon Project, Japan Sci & Technol Agcy, Exploratory Res Adv Technol JST ERATO,Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University; Nagoya University; Japan Science & Technology Agency (JST); Nagoya University	Murakami, K; Itami, K (corresponding author), Nagoya Univ, Grad Sch Sci, Chikusa Ku, Nagoya, Aichi 4648602, Japan.; Murakami, K; Itami, K (corresponding author), Nagoya Univ, Inst Transformat Biomol WPI ITbM, Chikusa Ku, Nagoya, Aichi 4648602, Japan.; Itami, K (corresponding author), Nagoya Univ, Itami Mol Nanocarbon Project, Japan Sci & Technol Agcy, Exploratory Res Adv Technol JST ERATO,Chikusa Ku, Nagoya, Aichi 4648602, Japan.	murakami@chem.nagoya-u.ac.jp; itami@chem.nagoya-u.ac.jp	Itami, Kenichiro/B-5110-2011; Murakami, Kei/E-6804-2014	Itami, Kenichiro/0000-0001-5227-7894; Murakami, Kei/0000-0001-5405-3069; Saito, Yutaro/0000-0001-7610-121X	JST ERATO [JPMJER1302]; JSPS KAKENHI [JP15K17821, JP17H04868]; World Premier International Research Center Initiative (WPI)	JST ERATO(Japan Science & Technology Agency (JST)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); World Premier International Research Center Initiative (WPI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by JST ERATO grant number JPMJER1302 (K.I.) and JSPS KAKENHI grant numbers JP15K17821 and JP17H04868 (K.M.). We are grateful to Y. Segawa, H. Ito, and T. Yoshidomi for assistance with x-ray crystal structure analysis and fruitful discussions. We acknowledge Y. Miyauchi and A. Takakura for assistance with Raman measurements, H. Sakamoto and N. Ozaki for assistance with Fourier transform infrared measurements, and K. Kuwata and K. Ito for assistance with high-resolution mass spectrometry measurements. ITbM is supported by the World Premier International Research Center Initiative (WPI). Crystallographic data for compounds 2a, 2p, and 2p' are available free of charge from the Cambridge Crystallographic Data Centre under CCDC identifiers 1518668, 1518669, and 1518670, respectively (www.ccdc.cam.ac.uk/structures/). All authors are inventors on a patent application (PCT/JP2017/020703) submitted by Nagoya University that covers the synthetic methods and molecules included in this paper.	Ackermann L, 2009, ANGEW CHEM INT EDIT, V48, P9792, DOI 10.1002/anie.200902996; Adachi C., 2012, Patent, Patent No. [WO 2012/114745, 2012114745]; BUCHWALD SL, 1986, J AM CHEM SOC, V108, P7411, DOI 10.1021/ja00283a048; Cai JM, 2010, NATURE, V466, P470, DOI 10.1038/nature09211; Campo MA, 2007, J AM CHEM SOC, V129, P6298, DOI 10.1021/ja069238z; Chen L, 2012, ANGEW CHEM INT EDIT, V51, P7640, DOI 10.1002/anie.201201084; Chou PY, 2014, CHEM COMMUN, V50, P6869, DOI 10.1039/c4cc01851f; Grzybowski M, 2013, ANGEW CHEM INT EDIT, V52, P9900, DOI 10.1002/anie.201210238; Hassan J, 2002, CHEM REV, V102, P1359, DOI 10.1021/cr000664r; He J, 2015, CHEM COMMUN, V51, P7245, DOI 10.1039/c5cc00826c; Ito H, 2017, ANGEW CHEM INT EDIT, V56, P11144, DOI 10.1002/anie.201701058; Jiang H, 2016, ORG LETT, V18, P2032, DOI 10.1021/acs.orglett.6b00641; Li CW, 2007, J ORG CHEM, V72, P9203, DOI 10.1021/jo701504m; Mohamed RK, 2016, ANGEW CHEM INT EDIT, V55, P12054, DOI 10.1002/anie.201606330; Mullen K, 2014, ACS NANO, V8, P6531, DOI 10.1021/nn503283d; Narita A, 2014, NAT CHEM, V6, P126, DOI [10.1038/NCHEM.1819, 10.1038/nchem.1819]; Ozaki K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7251; Povie G, 2017, SCIENCE, V356, P172, DOI 10.1126/science.aam8158; Schuler B, 2014, ANGEW CHEM INT EDIT, V53, P9004, DOI 10.1002/anie.201403707; Schwab MG, 2012, J AM CHEM SOC, V134, P18169, DOI 10.1021/ja307697j; Scott LT, 2012, J AM CHEM SOC, V134, P107, DOI 10.1021/ja209461g; Scott LT, 1999, PURE APPL CHEM, V71, P209, DOI 10.1351/pac199971020209; Segawa Y, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2015.2; Segawa Y, 2015, ANGEW CHEM INT EDIT, V54, P66, DOI 10.1002/anie.201403729; SEMMELHACK MF, 1971, J AM CHEM SOC, V93, P5908, DOI 10.1021/ja00751a062; Simpson CD, 2002, CHEM-EUR J, V8, P1424, DOI 10.1002/1521-3765(20020315)8:6<1424::AID-CHEM1424>3.0.CO;2-Z; Togashi K, 2013, CHEM LETT, V42, P651, DOI 10.1246/cl.130150; Togashi K, 2012, J MATER CHEM, V22, P20689, DOI 10.1039/c2jm33669c; Treier M, 2011, NAT CHEM, V3, P61, DOI [10.1038/nchem.891, 10.1038/NCHEM.891]; Tsefrikas VM, 2006, CHEM REV, V106, P4868, DOI 10.1021/cr050553y; Ullmann F, 1901, BER DTSCH CHEM GES, V34, P2174, DOI 10.1002/cber.190103402141; Wang ZH, 2004, J AM CHEM SOC, V126, P7794, DOI 10.1021/ja048580d; Watson DA, 2009, SCIENCE, V325, P1661, DOI 10.1126/science.1178239; Xu LM, 2010, CHEM SOC REV, V39, P712, DOI 10.1039/b809912j	34	97	99	8	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					435	+		10.1126/science.aap9801	http://dx.doi.org/10.1126/science.aap9801			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6SD	29371465				2022-12-28	WOS:000423283200041
J	Siepielski, AM; Morrissey, MB; Buoro, M; Carlson, SM; Caruso, CM; Clegg, SM; Coulson, T; DiBattista, J; Gotanda, KM; Francis, CD; Hereford, J; Kingsolver, JG; Augustine, KE; Kruuk, LEB; Martin, RA; Sheldon, B; Sletvold, N; Svensson, EI; Wade, MJ; MacColl, ADC				Siepielski, Adam M.; Morrissey, Michael B.; Buoro, Mathieu; Carlson, Stephanie M.; Caruso, Christina M.; Clegg, Sonya M.; Coulson, Tim; DiBattista, Joseph; Gotanda, Kiyoko M.; Francis, Clinton D.; Hereford, Joe; Kingsolver, Joel G.; Augustine, Kate E.; Kruuk, Loeske E. B.; Martin, Ryan A.; Sheldon, Ben C.; Sletvold, Nina; Svensson, Erik I.; Wade, Michael J.; MacColl, Andrew D. C.			Response to Comment on "Precipitation drives global variation in natural selection"	SCIENCE			English	Editorial Material								The comment by Myers-Smith and Myers focuses on three main points: (i) the lack of a mechanistic explanation for climate-selection relationships, (ii) the appropriateness of the climate data used in our analysis, and (iii) our focus on estimating climate-selection relationships across (rather than within) taxonomic groups. We address these critiques in our response.	[Siepielski, Adam M.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; [Morrissey, Michael B.] Univ St Andrews, Sch Biol, St Andrews, Fife, Scotland; [Buoro, Mathieu; Carlson, Stephanie M.] Univ Calif Berkeley, Dept Environm Sci Policy & Management, Berkeley, CA 94720 USA; [Caruso, Christina M.] Univ Guelph, Dept Integrat Biol, Guelph, ON, Canada; [Clegg, Sonya M.; Sheldon, Ben C.] Univ Oxford, Edward Grey Inst, Dept Zool, Oxford, England; [Coulson, Tim; Gotanda, Kiyoko M.] Univ Cambridge, Dept Zool, Cambridge, England; [DiBattista, Joseph] Curtin Univ, Dept Environm & Agr, Perth, WA, Australia; [Gotanda, Kiyoko M.] McGill Univ, Redpath Museum, Montreal, PQ, Canada; [Gotanda, Kiyoko M.] McGill Univ, Dept Biol, Montreal, PQ, Canada; [Francis, Clinton D.] Calif Polytech State Univ San Luis Obispo, Dept Biol Sci, San Luis Obispo, CA 93407 USA; [Hereford, Joe] Univ Calif Davis, Dept Evolut & Ecol, Davis, CA 95616 USA; [Kingsolver, Joel G.; Augustine, Kate E.] Univ N Carolina, Dept Biol, Chapel Hill, NC USA; [Kruuk, Loeske E. B.] Australian Natl Univ, Res Sch Biol, Canberra, ACT, Australia; [Martin, Ryan A.] Case Western Reserve Univ, Dept Biol, Cleveland, OH 44106 USA; [Sletvold, Nina] Uppsala Univ, Dept Ecol & Genet, Uppsala, Sweden; [Svensson, Erik I.] Lund Univ, Dept Biol, Lund, Sweden; [Wade, Michael J.] Indiana Univ, Dept Biol, Bloomington, IN USA; [MacColl, Andrew D. C.] Univ Nottingham, Sch Life Sci, Nottingham, England; [Buoro, Mathieu] Univ Pau & Pays Adour, Inst Natl Rech Agron, St Pee Sur Nivelle, France	University of Arkansas System; University of Arkansas Fayetteville; University of St Andrews; University of California System; University of California Berkeley; University of Guelph; University of Oxford; University of Cambridge; Curtin University; McGill University; McGill University; California State University System; California Polytechnic State University San Luis Obispo; University of California System; University of California Davis; University of North Carolina; University of North Carolina Chapel Hill; Australian National University; Case Western Reserve University; Uppsala University; Lund University; Indiana University System; Indiana University Bloomington; University of Nottingham; INRAE; Universite de Pau et des Pays de l'Adour	Siepielski, AM (corresponding author), Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA.	amsiepie@uark.edu	Coulson, Tim/AAL-8148-2021; Svensson, Erik/E-8324-2010; Siepielski, Adam/AAE-4806-2021; Sheldon, Ben C/A-8056-2010; Gotanda, Kiyoko/A-4119-2013; Kruuk, Loeske/AAB-8714-2019; Martin, Ryan/AAF-1314-2019; Kruuk, Loeske E. B./J-3295-2012; MacColl, Andrew/B-7090-2014; DiBattista, Joseph/O-2074-2014; Morrissey, Michael/F-3226-2010	Coulson, Tim/0000-0001-9371-9003; Svensson, Erik/0000-0001-9006-016X; Sheldon, Ben C/0000-0002-5240-7828; Gotanda, Kiyoko/0000-0002-3666-0700; Kruuk, Loeske/0000-0001-8588-1123; Martin, Ryan/0000-0002-7448-5907; Kruuk, Loeske E. B./0000-0001-8588-1123; Carlson, Stephanie/0000-0003-3055-6483; MacColl, Andrew/0000-0003-2102-6130; DiBattista, Joseph/0000-0002-5696-7574; Morrissey, Michael/0000-0001-6209-0177; Buoro, Mathieu/0000-0001-7053-3767	NSF [DEB1620046]	NSF(National Science Foundation (NSF))	We thank I. H. Myers-Smith and J. H. Myers for discussions of the nature of climate data in ecological and evolutionary studies, and an anonymous reviewer for helpful suggestions. Supported by NSF grant DEB1620046 (A.M.S.).	[Anonymous], 2015, SCIENCE, DOI [DOI 10.1126/SCIENCE.AAC4716, DOI 10.1126/science.aac4716]; Campbell D.T., 1999, PRIMER REGRESSION AR; Centre for Environmental Data Analysis, 2013, CRU TS3 21 CLIM RES; Lemoine NP, 2016, ECOLOGY, V97, P2554, DOI 10.1002/ecy.1506; Myers-Smith IH, 2018, SCIENCE, V359, DOI 10.1126/science.aan5028; Parker TH, 2016, TRENDS ECOL EVOL, V31, P711, DOI 10.1016/j.tree.2016.07.002; Siepielski AM, 2017, SCIENCE, V355, P959, DOI 10.1126/science.aag2773; Tseng M., BOTH TEMPERATURE PRE	8	2	3	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374							eaan5760	10.1126/science.aan5760	http://dx.doi.org/10.1126/science.aan5760			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT6SD	29371442				2022-12-28	WOS:000423283200002
J	Jarvis, S; Dassan, P; Piercy, CN				Jarvis, Sheba; Dassan, Pooja; Piercy, Catherine Nelson			10-MINUTE CONSULTATION Managing migraine in pregnancy	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DRUGS		[Jarvis, Sheba; Dassan, Pooja; Piercy, Catherine Nelson] Imperial Coll Healthcare NHS Trust, London W12 0HS, England; [Dassan, Pooja] London North West Healthcare NHS Trust, Dept Neurol, Ealing Hosp, Uxbridge Rd, Southall UB1 3HW, Middx, England; [Piercy, Catherine Nelson] Guys & St Thomas NHS Fdn Trust, London SE1 7EH, England	Imperial College London; Guy's & St Thomas' NHS Foundation Trust	Jarvis, S (corresponding author), Imperial Coll Healthcare NHS Trust, London W12 0HS, England.	sheba.jarvis@imperial.ac.uk						Bergman JEH, 2017, DRUG SAFETY, DOI [10.1007/s40264-017-0627-x29230691, DOI 10.1007/S40264-017-0627-X29230691]; Cassina M, 2010, EXPERT OPIN DRUG SAF, V9, P937, DOI 10.1517/14740338.2010.505601; Flint J, 2016, RHEUMATOLOGY, V55, P1698, DOI 10.1093/rheumatology/kev405; Koren G, 2017, EXPERT OPIN DRUG SAF, V16, P1227, DOI 10.1080/14740338.2017.1361403; Kropp P, 2017, EXPERT REV NEUROTHER, V17, P1059, DOI 10.1080/14737175.2017.1377611; Macgregor E Anne, 2014, Continuum (Minneap Minn), V20, P128, DOI 10.1212/01.CON.0000443841.40933.9e; National Institute of Health and Care Excellence, 2016, HEAD 12S DIAGN MAN; Nelson-Piercy C., 2015, HDB OBSTET MED; Robbins MS, 2015, NEUROLOGY, V85, P1024, DOI 10.1212/WNL.0000000000001954; Scottish Intercollegiate Guidelines Network, 2008, USITC PUBL, V107; Sentilhes L, 2017, NEW ENGL J MED, V377, P2399, DOI [10.1056/NEJMoa1704559, 10.1056/NEJMc1713798]; Skorpen CG, 2016, ANN RHEUM DIS, V75, P795, DOI 10.1136/annrheumdis-2015-208840; Spielmann K, 2017, CEPHALALGIA; Tang YG, 2017, AM J EMERG MED, V35, P1750, DOI 10.1016/j.ajem.2017.08.027; Tietjen GE, 2018, HEADACHE, V58, P173, DOI 10.1111/head.13044; UK Teratology Information Service, 2017, TREATM MIGR PREGN; UK Teratology Information Service, US AM PREGN; Wells RE, 2016, CURR NEUROL NEUROSCI, V16, DOI 10.1007/s11910-016-0634-9; Zacur HA, 2006, HEADACHE, V46, pS49, DOI 10.1111/j.1526-4610.2006.00554.x	19	12	14	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2018	360								k80	10.1136/bmj.k80	http://dx.doi.org/10.1136/bmj.k80			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU2XA	29371217				2022-12-28	WOS:000423712100012
J	Abbasi, J				Abbasi, Jennifer			Shantanu Nundy, MD: The Human Diagnosis Project	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	4	4	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					329	331		10.1001/jama.2017.13897	http://dx.doi.org/10.1001/jama.2017.13897			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362789				2022-12-28	WOS:000423405300003
J	[Anonymous]				[Anonymous]			Adding patent foramen ovale closure to antiplatelet drugs reduced ischemic stroke after cryptogenic stroke	ANNALS OF INTERNAL MEDICINE			English	Editorial Material																			0	0	0	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2018	168	2					JC6	JC6		10.7326/ACPJC-2018-168-2-006	http://dx.doi.org/10.7326/ACPJC-2018-168-2-006			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU8IN	29335718				2022-12-28	WOS:000424096600006
J	Zarocostas, J				Zarocostas, John			Natalia Kanem: lifelong advocate for women's health and rights Profile	LANCET			English	Biographical-Item																		KANEM N, PUBLICATION LIST, P2510	1	0	0	2	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 13	2018	391	10116					115	115		10.1016/S0140-6736(17)33323-8	http://dx.doi.org/10.1016/S0140-6736(17)33323-8			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT0EG	29353611				2022-12-28	WOS:000422793400014
J	Hart, MP; Hobert, O				Hart, Michael P.; Hobert, Oliver			Neurexin controls plasticity of a mature, sexually dimorphic neuron	NATURE			English	Article							CAENORHABDITIS-ELEGANS; SYNAPTIC PLASTICITY; INHIBITORY NEURONS; MATING-BEHAVIOR; VISUAL-CORTEX; C-ELEGANS; NEUROLIGINS; CHANNELS; BALANCE; MALES	During development and adulthood, brain plasticity is evident at several levels, from synaptic structure and function to the outgrowth of dendrites and axons. Whether and how sex impinges on neuronal plasticity is poorly understood. Here we show that the sex-shared GABA (gamma-aminobutyric acid)-releasing DVB neuron in Caenorhabditis elegans displays experience-dependent and sexually dimorphic morphological plasticity, characterized by the stochastic and dynamic addition of multiple neurites in adult males. These added neurites enable synaptic rewiring of the DVB neuron and instruct a functional switch of the neuron that directly modifies a step of male mating behaviour. Both DVB neuron function and male mating behaviour can be altered by experience and by manipulation of postsynaptic activity. The outgrowth of DVB neurites is promoted by presynaptic neurexin and antagonized by postsynaptic neuroligin, revealing a non-conventional activity and mode of interaction of these conserved, human-disease-relevant factors.	[Hart, Michael P.; Hobert, Oliver] Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10032 USA	Columbia University; Howard Hughes Medical Institute	Hart, MP (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Biol Sci, New York, NY 10032 USA.	hartmicp@gmail.com		Hart, Michael/0000-0001-8865-3062	NIH grants from NINDS [F32NS086285, 2R37NS039996]; NIH Office of Research Infrastructure Programs [P40 OD010440]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS086285, R37NS039996] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD010440] Funding Source: NIH RePORTER	NIH grants from NINDS; NIH Office of Research Infrastructure Programs; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank Q. Chen for generating transgenic strains and M. Gendrel for DVB promoter and reporter lines; P. Sengupta, T. G. Drivas, M. Oren-Suissa, and members of the Hobert laboratory for comments on the manuscript; L. R. Garcia and K. Shen for worm strains; and M. VanHoven and D. Colon-Ramos for plasmids. This work was supported by NIH grants from NINDS (M.P.H.:F32NS086285; O.H.:2R37NS039996). O.H. is a Howard Hughes Medical Institute investigator. Some strains were provided by the CGC, funded by NIH Office of Research Infrastructure Programs (P40 OD010440).	Bang ML, 2013, NEUROCHEM RES, V38, P1174, DOI 10.1007/s11064-013-1029-9; Barr MM, 2001, CURR BIOL, V11, P1341, DOI 10.1016/S0960-9822(01)00423-7; Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470; Feinberg EH, 2008, NEURON, V57, P353, DOI 10.1016/j.neuron.2007.11.030; Fu M, 2011, TRENDS NEUROSCI, V34, P177, DOI 10.1016/j.tins.2011.02.001; Garcia LR, 2003, J NEUROSCI, V23, P2696; Garcia LR, 2001, CELL, V107, P777, DOI 10.1016/S0092-8674(01)00600-6; Guo X., NEUROBIOL AGING, V33; Haklai-Topper L, 2011, GENE EXPR PATTERNS, V11, P144, DOI 10.1016/j.gep.2010.10.008; Hobert O, 1999, DEVELOPMENT, V126, P1547; Hobert O, 1999, J CELL BIOL, V144, P45, DOI 10.1083/jcb.144.1.45; Holtmaat A, 2009, NAT REV NEUROSCI, V10, P647, DOI 10.1038/nrn2699; Jarrell TA, 2012, SCIENCE, V337, P437, DOI 10.1126/science.1221762; Jobson MA, 2015, J NEUROSCI, V35, P2803, DOI 10.1523/JNEUROSCI.4557-14.2015; Keck T, 2011, NEURON, V71, P869, DOI 10.1016/j.neuron.2011.06.034; LeBoeuf B, 2017, G3-GENES GENOM GENET, V7, P647, DOI 10.1534/g3.116.036756; LeBoeuf B, 2012, GENETICS, V190, P1025, DOI 10.1534/genetics.111.137455; Lee WCA, 2006, PLOS BIOL, V4, P271, DOI 10.1371/journal.pbio.0040029; Liu YS, 2007, J NEUROSCI, V27, P1411, DOI 10.1523/JNEUROSCI.4320-06.2007; Liu YS, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001326; Mackowiak M, 2014, PHARMACOL REP, V66, P830, DOI 10.1016/j.pharep.2014.04.011; Marik SA, 2014, J NEUROSCI, V34, P1625, DOI 10.1523/JNEUROSCI.4345-13.2014; Maro GS, 2015, NEURON, V86, P1420, DOI 10.1016/j.neuron.2015.05.015; Pizzarelli R, 2011, NEURAL PLAST, V2011, DOI 10.1155/2011/297153; Pokala N, 2014, P NATL ACAD SCI USA, V111, P2770, DOI 10.1073/pnas.1400615111; REINER DJ, 1995, J NEUROSCI, V15, P6094; Vitureira N, 2013, J CELL BIOL, V203, P175, DOI 10.1083/jcb.201306030; WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056; Yin J, 2015, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00439	29	40	41	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2018	553	7687					165	+		10.1038/nature25192	http://dx.doi.org/10.1038/nature25192			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4WL	29323291	Green Accepted			2022-12-28	WOS:000419794800028
J	Tollefson, TT				Tollefson, Travis T.			Apprehending Otherness Through Wonder A Facial Plastic Surgeon's Review of the Book and Movie	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Tollefson, Travis T.] Univ Calif Davis, Otolaryngol Head & Neck Surg, 2521 Stockton Blvd,Ste 7200, Sacramento, CA 95817 USA	University of California System; University of California Davis	Tollefson, TT (corresponding author), Univ Calif Davis, Otolaryngol Head & Neck Surg, 2521 Stockton Blvd,Ste 7200, Sacramento, CA 95817 USA.	tttollefson@gmail.com						Arnold DS, 1992, STUDIES LIT RELIG; Godoy A, 2011, LARYNGOSCOPE, V121, P937, DOI 10.1002/lary.21733; Ishii L, 2009, LARYNGOSCOPE, V119, P459, DOI 10.1002/lary.20132; Ishii LE, 2011, LARYNGOSCOPE, V121, P1138, DOI 10.1002/lary.21764; Palacio, 2012, WONDER	5	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2018	319	7					640	642		10.1001/jama.2017.22109	http://dx.doi.org/10.1001/jama.2017.22109			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW7MQ	29344614				2022-12-28	WOS:000425508400001
J	Linehan, JL; Harrison, OJ; Han, SJ; Byrd, AL; Vujkovic-Cvijin, I; Villarino, AV; Sen, SK; Shaik, J; Smelkinson, M; Tamoutounour, S; Collins, N; Bouladoux, N; Dzutsev, A; Rosshart, SP; Arbuckle, JH; Wang, CR; Kristie, TM; Rehermann, B; Trinchieri, G; Brenchley, JM; O'Shea, JJ; Belkaid, Y				Linehan, Jonathan L.; Harrison, Oliver J.; Han, Seong-Ji; Byrd, Allyson L.; Vujkovic-Cvijin, Ivan; Villarino, Alejandro V.; Sen, Shurjo K.; Shaik, Jahangheer; Smelkinson, Margery; Tamoutounour, Samira; Collins, Nicholas; Bouladoux, Nicolas; Dzutsev, Amiran; Rosshart, Stephan P.; Arbuckle, Jesse H.; Wang, Chyung-Ru; Kristie, Thomas M.; Rehermann, Barbara; Trinchieri, Giorgio; Brenchley, Jason M.; O'Shea, John J.; Belkaid, Yasmine			Non-classical Immunity Controls Microbiota Impact on Skin Immunity and Tissue Repair	CELL			English	Article							CD8(+) T-CELLS; HOMEOSTASIS; MOLECULE; MICE; INFLAMMATION; RECOGNITION; INFECTION; RESPONSES; DEFENSE; BRIDGE	Mammalian barrier surfaces are constitutively colonized by numerous microorganisms. We explored how the microbiota was sensed by the immune system and the defining properties of such responses. Here, we show that a skin commensal can induce T cell responses in a manner that is restricted to non-classical MHC class I molecules. These responses are uncoupled from inflammation and highly distinct from pathogen-induced cells. Commensal-specific T cells express a defined gene signature that is characterized by expression of effector genes together with immunoregulatory and tissue-repair signatures. As such, non-classical MHCI-restricted commensal-specific immune responses not only promoted protection to pathogens, but also accelerated skin wound closure. Thus, the microbiota can induce a highly physiological and pleiotropic form of adaptive immunity that couples antimicrobial function with tissue repair. Our work also reveals that non-classical MHC class I molecules, an evolutionarily ancient arm of the immune system, can promote homeostatic immunity to the microbiota.	[Linehan, Jonathan L.; Harrison, Oliver J.; Han, Seong-Ji; Byrd, Allyson L.; Vujkovic-Cvijin, Ivan; Tamoutounour, Samira; Collins, Nicholas; Bouladoux, Nicolas; Belkaid, Yasmine] NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA; [Byrd, Allyson L.] NHGRI, Translat & Funct Genom Branch, NIH, Bethesda, MD 20892 USA; [Byrd, Allyson L.] Boston Univ, Dept Bioinformat, Boston, MA 02215 USA; [Villarino, Alejandro V.; O'Shea, John J.] NIAMS, Mol Immunol & Inflammat Branch, NIH, Bethesda, MD 20892 USA; [Sen, Shurjo K.; Dzutsev, Amiran; Trinchieri, Giorgio] NCI, Canc & Inflammat Program, NIH, Bethesda, MD 20892 USA; [Shaik, Jahangheer] NIAID, Lab Parasit Dis, NIH, Bethesda, MD 20892 USA; [Smelkinson, Margery] NIAID, Biol Imaging Res Technol Branch, NIH, Bethesda, MD 20892 USA; [Bouladoux, Nicolas] NIAID, Microbiome Program, NIH, Bethesda, MD 20892 USA; [Rosshart, Stephan P.; Rehermann, Barbara] NIDDK, Immunol Sect, Liver Dis Branch, NIH, Bethesda, MD 20892 USA; [Arbuckle, Jesse H.; Kristie, Thomas M.] NIAID, Mol Genet Sect, NIH, Bethesda, MD 20892 USA; [Wang, Chyung-Ru] Northwestern Univ, Dept Microbiol & Immunol, Chicago, IL 60611 USA; [Brenchley, Jason M.] NIAID, Barrier Immun Sect, Lab Parasit Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); Boston University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Northwestern University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Belkaid, Y (corresponding author), NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, Bethesda, MD 20892 USA.	ybelkaid@niaid.nih.gov	Trinchieri, Giorgio/F-9369-2015; Villarino, Alejandro/AAE-3517-2020; Vujkovic-Cvijin, Ivan/AAT-6248-2020; Arbuckle, Jesse H/H-7513-2019; Brenchley, Jason/AAC-5085-2019	Trinchieri, Giorgio/0000-0001-5892-7464; Villarino, Alejandro/0000-0001-8068-2176; Vujkovic-Cvijin, Ivan/0000-0002-8611-4900; Arbuckle, Jesse H/0000-0003-3652-3543; Smelkinson, Margery/0000-0001-7777-5574; Harrison, Oliver/0000-0003-1515-9586; Rehermann, Barbara/0000-0001-6832-9951; Brenchley, Jason/0000-0001-8357-2984	Division of Intramural Research of the NIAID [1ZIAAI0011150 NCI, ZIABC01115309 NIAMS, ZIAAR04115910]; NIDDK [ZIADK05451611]; NIGMS Postdoctoral Research Associate (PRAT) fellowship program; National Psoriasis Foundation Early Career Research Grant; Long-Term EMBO Fellowship; NATIONAL CANCER INSTITUTE [ZIABC011153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001051, ZIAAI000712, ZIAAI001029, ZIAAI001115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [ZIAAR041159, ZICAR041207] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK054508] Funding Source: NIH RePORTER	Division of Intramural Research of the NIAID; NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS Postdoctoral Research Associate (PRAT) fellowship program; National Psoriasis Foundation Early Career Research Grant; Long-Term EMBO Fellowship(European Molecular Biology Organization (EMBO)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Division of Intramural Research of the NIAID, 1ZIAAI0011150 NCI, ZIABC01115309 NIAMS, ZIAAR04115910 and NIDDK ZIADK05451611. J.L.L. was supported by the NIGMS Postdoctoral Research Associate (PRAT) fellowship program. O.J.H. was supported by a National Psoriasis Foundation Early Career Research Grant. S.T. was supported by a Long-Term EMBO Fellowship. We thank the NIAID animal facility staff; the NIAID Microbiome Program gnotobiotic animal facility for the use of germ-free mice; K. Holmes, C. Eigsti, T. Hawley, and E. Stregevsky (NIAID Flow Cytometry facility); O. Schwartz (NIAID Biological Imaging facility), K. Beacht, J. LeGrand, and J. Davis for technical assistance; R. Bosselut for the B2m<SUP>-/-</SUP> mice; and H. Cantor for the Qa-1<SUP>-/-</SUP> mice. We thank the NIH tetramer core facility (Emory University) for provision of fMet peptide: H2-M3 tetramers. We thank all the members of the Belkaid laboratory for critically reading the manuscript and helpful discussions.	Adams EJ, 2013, ANNU REV IMMUNOL, V31, P529, DOI 10.1146/annurev-immunol-032712-095912; An DD, 2014, CELL, V156, P123, DOI 10.1016/j.cell.2013.11.042; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Belkaid Y, 2002, J IMMUNOL, V168, P3992, DOI 10.4049/jimmunol.168.8.3992; Belkaid Y, 2016, NAT REV IMMUNOL, V16, P353, DOI 10.1038/nri.2016.48; Belkaid Y, 2014, SCIENCE, V346, P954, DOI 10.1126/science.1260144; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Beura LK, 2016, NATURE, V532, P512, DOI 10.1038/nature17655; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Byrd AL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4651; Cho H, 2011, P NATL ACAD SCI USA, V108, P13241, DOI 10.1073/pnas.1105118108; Chun T, 2001, J EXP MED, V193, P1213, DOI 10.1084/jem.193.10.1213; Cong YZ, 2009, P NATL ACAD SCI USA, V106, P19256, DOI 10.1073/pnas.0812681106; Conlan S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-7-r64; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Doyle CK, 2003, J IMMUNOL, V171, P836, DOI 10.4049/jimmunol.171.2.836; Eming SA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009337; Fan X, 2016, CELL, V164, P1198, DOI 10.1016/j.cell.2016.02.048; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Godfrey DI, 2015, NAT IMMUNOL, V16, P1114, DOI 10.1038/ni.3298; Hand TW, 2012, SCIENCE, V337, P1553, DOI 10.1126/science.1220961; Honda K, 2016, NATURE, V535, P75, DOI 10.1038/nature18848; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jameson J, 2002, SCIENCE, V296, P747, DOI 10.1126/science.1069639; Kawano M, 2005, J INVEST DERMATOL, V124, P877, DOI 10.1111/j.0022-202X.2005.23693.x; Kerksiek KM, 2001, J IMMUNOL, V166, P1132, DOI 10.4049/jimmunol.166.2.1132; Keyes BE, 2016, CELL, V167, P1323, DOI 10.1016/j.cell.2016.10.052; Lai YP, 2010, J INVEST DERMATOL, V130, P2211, DOI 10.1038/jid.2010.123; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lindahl KF, 1997, ANNU REV IMMUNOL, V15, P851; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Naik S, 2012, SCIENCE, V337, P1115, DOI 10.1126/science.1225152; Nielsen MM, 2017, NAT REV IMMUNOL, V17, P733, DOI 10.1038/nri.2017.101; Pamer EG, 2016, SCIENCE, V352, P535, DOI 10.1126/science.aad9382; Ploss A, 2003, J IMMUNOL, V171, P5948, DOI 10.4049/jimmunol.171.11.5948; Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002; Scharschmidt TC, 2015, IMMUNITY, V43, P1011, DOI 10.1016/j.immuni.2015.10.016; Schenkel JM, 2014, IMMUNITY, V41, P886, DOI 10.1016/j.immuni.2014.12.007; Seaman MS, 2000, J IMMUNOL, V165, P5192, DOI 10.4049/jimmunol.165.9.5192; Torkamani N, 2017, ANAT SCI INT, V92, P151, DOI 10.1007/s12565-016-0359-5; van der Fits L, 2009, J IMMUNOL, V182, P5836, DOI 10.4049/jimmunol.0802999; van Lint A, 2004, J IMMUNOL, V172, P392, DOI 10.4049/jimmunol.172.1.392; Van Rhijn I, 2015, NAT REV IMMUNOL, V15, P643, DOI 10.1038/nri3889; Vugmeyster Y, 1998, P NATL ACAD SCI USA, V95, P12492, DOI 10.1073/pnas.95.21.12492; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279	52	210	214	10	87	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					784	+		10.1016/j.cell.2017.12.033	http://dx.doi.org/10.1016/j.cell.2017.12.033			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29358051	Green Accepted, Bronze			2022-12-28	WOS:000424648800018
J	Mao, KR; Baptista, AP; Tamoutounour, S; Zhuang, LN; Bouladoux, N; Martins, AJ; Huang, YF; Gerner, MY; Belkaid, Y; Germain, RN				Mao, Kairui; Baptista, Antonio P.; Tamoutounour, Samira; Zhuang, Lenan; Bouladoux, Nicolas; Martins, Andrew J.; Huang, Yuefeng; Gerner, Michael Y.; Belkaid, Yasmine; Germain, Ronald N.			Innate and adaptive lymphocytes sequentially shape the gut microbiota and lipid metabolism	NATURE			English	Article							SEGMENTED FILAMENTOUS BACTERIA; LYMPHOID-CELLS; DENDRITIC CELLS; T-CELL; TH17; COLONIZATION; INFLAMMATION; EFFECTOR; IMMUNITY	The mammalian gut is colonized by numerous microorganisms collectively termed the microbiota, which have a mutually beneficial relationship with their host(1-3). Normally, the gut microbiota matures during ontogeny to a state of balanced commensalism marked by the absence of adverse inflammation(4,5). Subsets of innate lymphoid cells (ILCs) and conventional T cells are considered to have redundant functions in containment and clearance of microbial pathogens(6,7), but how these two major lymphoid-cell populations each contribute to shaping the mature commensal microbiome and help to maintain tissue homeostasis has not been determined. Here we identify, using advanced multiplex quantitative imaging methods, an extensive and persistent phosphorylated-STAT3 signature in group 3 ILCs and intestinal epithelial cells that is induced by interleukin (IL)-23 and IL-22 in mice that lack CD4(+) T cells. By contrast, in immune-competent mice, phosphorylated-STAT3 activation is induced only transiently by microbial colonization at weaning. This early signature is extinguished as CD4(+) T cell immunity develops in response to the expanding commensal burden. Physiologically, the persistent IL-22 production from group 3 ILCs that occurs in the absence of adaptive CD4(+) T-cell activity results in impaired host lipid metabolism by decreasing lipid transporter expression in the small bowel. These findings provide new insights into how innate and adaptive lymphocytes operate sequentially and in distinct ways during normal development to establish steady-state commensalism and tissue metabolic homeostasis.	[Mao, Kairui; Baptista, Antonio P.; Germain, Ronald N.] NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Tamoutounour, Samira; Bouladoux, Nicolas; Belkaid, Yasmine] NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Zhuang, Lenan] NIDDK, Lab Endocrinol & Receptor Biol, NIH, Bethesda, MD 20892 USA; [Martins, Andrew J.] NIAID, Syst Genom & Bioinformat Unit, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Huang, Yuefeng] NIAID, Immunol Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Gerner, Michael Y.] Univ Washington, Sch Med, Dept Immunol, Seattle, WA 98109 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Washington; University of Washington Seattle	Mao, KR; Germain, RN (corresponding author), NIAID, Lymphocyte Biol Sect, Lab Syst Biol, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	kairui.mao@nih.gov; rgermain@nih.gov	Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019; Martins, Andrew/AAU-7039-2021; Zhuang, Lenan/GZG-7254-2022	Martins, Andrew/0000-0002-1832-1924; Gerner, Michael/0000-0001-5406-8308; Baptista, Antonio P./0000-0001-8182-8982; Zhuang, Lenan/0000-0001-9561-8396	NIAID K99 award [1K99AI123350-01A1]; Intramural Research Program of NIAID, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000545, ZICAI001233, ZIAAI001133, ZIAAI001034] Funding Source: NIH RePORTER	NIAID K99 award; Intramural Research Program of NIAID, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank Y. Choi and D.M. Kobuley for providing germ free Rag1<SUP>-/-</SUP> mice and performing SFB mono-colonization; M. Oukka and S. K. Durum for providing mice; M. Mack, B. Gao and Y. Umesaki for providing anti-CCR2 antibody, IL-22 adenovirus and SFB faecal pellets; C. Eigsti, V. Nair and J. Davis for cell sorting, scanning electron microscopy and microbiota analysis; J. Zhu for discussions; and members of the Laboratory of Systems Biology for their comments during the course of these studies and input during preparation of this manuscript. Y.H. was supported by an NIAID K99 award (1K99AI123350-01A1). This research was supported by the Intramural Research Program of NIAID, NIH.	Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Bando JK, 2016, NAT IMMUNOL, V17, P783, DOI 10.1038/ni.3484; Belkaid Y, 2014, CELL, V157, P121, DOI 10.1016/j.cell.2014.03.011; Blanton LV, 2016, SCIENCE, V352, DOI 10.1126/science.aad9359; Buonocore S, 2010, NATURE, V464, P1371, DOI 10.1038/nature08949; Caballero S, 2015, ANNU REV IMMUNOL, V33, P227, DOI 10.1146/annurev-immunol-032713-120238; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Eberl G, 2015, NAT IMMUNOL, V16, P1, DOI 10.1038/ni.3059; Fang DF, 2017, J EXP MED, V214, P1861, DOI 10.1084/jem.20170494; Fontenot JD, 2005, NAT IMMUNOL, V6, P1142, DOI 10.1038/ni1263; Gensollen T, 2016, SCIENCE, V352, P539, DOI 10.1126/science.aad9378; Gerner MY, 2015, IMMUNITY, V42, P172, DOI 10.1016/j.immuni.2014.12.024; Gerner MY, 2012, IMMUNITY, V37, P364, DOI 10.1016/j.immuni.2012.07.011; Goto Y, 2014, IMMUNITY, V40, P594, DOI 10.1016/j.immuni.2014.03.005; Guo XH, 2014, IMMUNITY, V40, P25, DOI 10.1016/j.immuni.2013.10.021; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; Ibiza S, 2016, NATURE, V535, P440, DOI 10.1038/nature18644; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Jiang HQ, 2001, INFECT IMMUN, V69, P3611, DOI 10.1128/IAI.69.6.3611-3617.2001; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klose CSN, 2017, NATURE, V549, P282, DOI 10.1038/nature23676; Klose CSN, 2013, NATURE, V494, P261, DOI 10.1038/nature11813; Korn LL, 2014, MUCOSAL IMMUNOL, V7, P1045, DOI 10.1038/mi.2013.121; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Littman DR, 2010, CELL, V140, P845, DOI 10.1016/j.cell.2010.02.021; Liu ZD, 2015, NATURE, V528, P225, DOI 10.1038/nature16169; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Nguyen PM, 2015, J INTERF CYTOK RES, V35, P340, DOI 10.1089/jir.2014.0225; Qiu J, 2013, IMMUNITY, V39, P386, DOI 10.1016/j.immuni.2013.08.002; Renz H, 2012, NAT REV IMMUNOL, V12, P9, DOI 10.1038/nri3112; Sano T, 2015, CELL, V163, P381, DOI 10.1016/j.cell.2015.08.061; Subramanian S, 2015, CELL, V161, P36, DOI 10.1016/j.cell.2015.03.013; Tamoutounour S, 2013, IMMUNITY, V39, P925, DOI 10.1016/j.immuni.2013.10.004; Wang XT, 2014, NATURE, V514, P237, DOI 10.1038/nature13564; Wang YH, 2017, SCIENCE, V357, P913, DOI 10.1126/science.aan0677; Yang Y, 2014, NATURE, V510, P152, DOI 10.1038/nature13279	36	186	193	5	185	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 8	2018	554	7691					255	+		10.1038/nature25437	http://dx.doi.org/10.1038/nature25437			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FV1OE	29364878				2022-12-28	WOS:000424332600042
J	Tavazoie, MF; Pollack, I; Tanqueco, R; Ostendorf, BN; Reis, BS; Gonsalves, FC; Kurth, I; Andreu-Agullo, C; Derbyshire, ML; Posada, J; Takeda, S; Tafreshian, KN; Rowinsky, E; Szarek, M; Waltzman, RJ; Mcmillan, EA; Zhao, CN; Mita, M; Mita, A; Chmielowski, B; Postow, MA; Ribas, A; Mucida, D; Tavazoie, SF				Tavazoie, Masoud F.; Pollack, Ilana; Tanqueco, Raissa; Ostendorf, Benjamin N.; Reis, Bernardo S.; Gonsalves, Foster C.; Kurth, Isabel; Andreu-Agullo, Celia; Derbyshire, Mark L.; Posada, Jessica; Takeda, Shugaku; Tafreshian, Kimia N.; Rowinsky, Eric; Szarek, Michael; Waltzman, Roger J.; Mcmillan, Elizabeth A.; Zhao, Connie; Mita, Monica; Mita, Alain; Chmielowski, Bartosz; Postow, Michael A.; Ribas, Antoni; Mucida, Daniel; Tavazoie, Sohail F.			LXR/ApoE Activation Restricts Innate Immune Suppression in Cancer	CELL			English	Article							LIVER X RECEPTORS; T-CELLS; MYELOID CELLS; METASTATIC MELANOMA; REGULATORY T; PD-1; LXR; CHOLESTEROL; MECHANISMS; CTLA-4	Therapeutic harnessing of adaptive immunity via checkpoint inhibition has transformed the treatment of many cancers. Despite unprecedented long-term responses, most patients do not respond to these therapies. Immunotherapy non-responders often harbor high levels of circulating myeloid-derived suppressor cells (MDSCs)-an immunosuppressive innate cell population. Through genetic and pharmacological approaches, we uncovered a pathway governing MDSC abundance in multiple cancer types. Therapeutic liver-X nuclear receptor (LXR) agonism reduced MDSC abundance in murine models and in patients treated in a first-in-human dose escalation phase 1 trial. MDSC depletion was associated with activation of cytotoxic T lymphocyte (CTL) responses in mice and patients. The LXR transcriptional target ApoE mediated these effects in mice, where LXR/ApoE activation therapy elicited robust anti-tumor responses and also enhanced T cell activation during various immune-based therapies. We implicate the LXR/ApoE axis in the regulation of innate immune suppression and as a target for enhancing the efficacy of cancer immunotherapy in patients.	[Tavazoie, Masoud F.; Pollack, Ilana; Tanqueco, Raissa; Ostendorf, Benjamin N.; Derbyshire, Mark L.; Posada, Jessica; Tafreshian, Kimia N.; Mcmillan, Elizabeth A.; Zhao, Connie; Tavazoie, Sohail F.] Rockefeller Univ, Lab Syst Canc Biol, 1230 York Ave, New York, NY 10021 USA; [Reis, Bernardo S.; Mucida, Daniel] Rockefeller Univ, Lab Mucosal Immunol, 1230 York Ave, New York, NY 10021 USA; [Tavazoie, Masoud F.; Gonsalves, Foster C.; Kurth, Isabel; Andreu-Agullo, Celia; Takeda, Shugaku; Rowinsky, Eric; Szarek, Michael; Waltzman, Roger J.] Rgenix, New York, NY 10065 USA; [Mita, Monica; Mita, Alain] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA; [Chmielowski, Bartosz; Ribas, Antoni] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA; [Postow, Michael A.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Postow, Michael A.] Weill Cornell Med Coll, New York, NY USA; [Szarek, Michael] Downstate Med Ctr, Sch Publ Hlth, Brooklyn, NY USA	Rockefeller University; Rockefeller University; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; Memorial Sloan Kettering Cancer Center; Cornell University; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Tavazoie, MF; Tavazoie, SF (corresponding author), Rockefeller Univ, Lab Syst Canc Biol, 1230 York Ave, New York, NY 10021 USA.; Mucida, D (corresponding author), Rockefeller Univ, Lab Mucosal Immunol, 1230 York Ave, New York, NY 10021 USA.; Tavazoie, MF (corresponding author), Rgenix, New York, NY 10065 USA.	mtavazoie@mail.rockefeller.edu; mucida@mail.rockefeller.edu; stavazoie@mail.rockefeller.edu	Ostendorf, Benjamin Nils/AAA-2109-2022; Szarek, Michael/ABE-1965-2021; Sgarbi Reis, Bernardo/E-3448-2012	Ostendorf, Benjamin Nils/0000-0003-4492-9252; Szarek, Michael/0000-0002-0046-0264; Pollack, Ilana/0000-0001-8274-7818; Sgarbi Reis, Bernardo/0000-0002-6841-116X; Derbyshire, Mark/0000-0002-9180-3567	Howard Hughes Medical Institute; DOD [W81XWH-12-1-0301]; Pershing Square Sohn award; Breast Cancer Research Foundation; NIH [R01CA184804-01A2]; NCI of the NIH [1R44CA206677-01A1]; Deutsche Forschungsgemeinschaft [OS 498/1-1]; NATIONAL CANCER INSTITUTE [R35CA197633, P30CA008748, R44CA206677, P30CA016042, R01CA184804, T32CA009673] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); DOD(United States Department of Defense); Pershing Square Sohn award(Pershing Square Sohn Cancer Research Alliance); Breast Cancer Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI of the NIH; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to members of our laboratory for providing insightful comments on past versions of this manuscript. Apoe null mice were generously provided by Jan Breslow. LXR mutant mice were generously provided by David Mangelsdorf, who also provided insights into LXR biology. The GL261 glioblastoma cell line was kindly provided by Paul Davis. We thank Saeed Tavazoie and David Darst for intellectual and operational guidance in RGX-104 development. We thank Scott Spector for logistical oversight of RGX-104 clinical operations. We thank Lisa Noble, Helen Tian, and Katya Leites for assistance with experiments. We thank Alexander Lesokhin for advice regarding human sample flow cytometry analyses. We thank the Serametrix Corporation for performing timely flow cytometry analysis of patient blood samples. The research of S.F.T. was supported in part by a Faculty Scholar grant from the Howard Hughes Medical Institute and by the DOD Collaborative Scholars and Innovators Award (grant W81XWH-12-1-0301), a Pershing Square Sohn award, a Breast Cancer Research Foundation grant, and NIH grant R01CA184804-01A2. The research reported in this publication was supported by the NCI of the NIH under award 1R44CA206677-01A1. B.N.O. was supported by a Deutsche Forschungsgemeinschaft postdoctoral fellowship (grant OS 498/1-1).	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Andersen V, 2011, WORLD J GASTROENTERO, V17, P197, DOI 10.3748/wjg.v17.i2.197; APFEL R, 1994, MOL CELL BIOL, V14, P7025, DOI 10.1128/MCB.14.10.7025; Bensinger SJ, 2008, CELL, V134, P97, DOI 10.1016/j.cell.2008.04.052; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Curran MA, 2009, CANCER RES, V69, P7747, DOI 10.1158/0008-5472.CAN-08-3289; Davila ML, 2016, CLIN ADV HEMATOL ONC, V14, P802; Dieckmann M, 2010, BIOL CHEM, V391, P1341, DOI 10.1515/BC.2010.129; Durham NM, 2017, J IMMUNOTHER CANCER, V5, DOI 10.1186/s40425-017-0247-0; Evans RM, 2014, CELL, V157, P255, DOI 10.1016/j.cell.2014.03.012; Fontaine C, 2007, CIRC RES, V101, P40, DOI 10.1161/CIRCRESAHA.106.135814; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gros A, 2014, J CLIN INVEST, V124, P2246, DOI [10.1172/JC173639, 10.1172/JCI73639]; Grzes KM, 2017, CELL METAB, V25, P1213, DOI 10.1016/j.cmet.2017.05.012; Han M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095954; Hansson GK, 2001, ANN NY ACAD SCI, V947, P157; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Hong C, 2012, J CLIN INVEST, V122, P337, DOI 10.1172/JCI58393; Huang AC, 2017, NATURE, V545, P60, DOI 10.1038/nature22079; Iwai Y, 2005, INT IMMUNOL, V17, P133, DOI 10.1093/intimm/dxh194; Jeon JY, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4563; KRUMMEL MF, 1995, J EXP MED, V182, P459, DOI 10.1084/jem.182.2.459; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; Lim WA, 2017, CELL, V168, P724, DOI 10.1016/j.cell.2017.01.016; Lin CY, 2015, NAT REV CANCER, V15, P216, DOI 10.1038/nrc3912; Meyer C, 2014, CANCER IMMUNOL IMMUN, V63, P247, DOI 10.1007/s00262-013-1508-5; Nelson ER, 2013, SCIENCE, V342, P1094, DOI 10.1126/science.1241908; Okazaki T, 2007, INT IMMUNOL, V19, P813, DOI 10.1093/intimm/dxm057; Overwijk WW, 1998, J EXP MED, V188, P277, DOI 10.1084/jem.188.2.277; Peggs KS, 2008, IMMUNOL REV, V224, P141, DOI 10.1111/j.1600-065X.2008.00649.x; Pencheva N, 2014, CELL, V156, P986, DOI 10.1016/j.cell.2014.01.038; Plitas G, 2016, CANCER IMMUNOL RES, V4, P721, DOI 10.1158/2326-6066.CIR-16-0193; Sharma P, 2017, CELL, V168, P707, DOI 10.1016/j.cell.2017.01.017; Shipp C, 2016, CELL MOL LIFE SCI, V73, P4043, DOI 10.1007/s00018-016-2278-y; Sinha P, 2007, J IMMUNOL, V179, P977, DOI 10.4049/jimmunol.179.2.977; Tall AR, 2015, NAT REV IMMUNOL, V15, P104, DOI 10.1038/nri3793; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Villa GR, 2016, CANCER CELL, V30, P683, DOI 10.1016/j.ccell.2016.09.008; Waddington KE, 2015, BIOCHEM SOC T, V43, P752, DOI 10.1042/BST20150112; Weber J, 2016, CANCER IMMUNOL RES, V4, P345, DOI 10.1158/2326-6066.CIR-15-0193; Wei SC, 2017, CELL, V170, P1120, DOI 10.1016/j.cell.2017.07.024; Welters MJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8307; White CR, 2014, J LIPID RES, V55, P2007, DOI 10.1194/jlr.R051367; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Wrzesinski C, 2010, J IMMUNOTHER, V33, P1, DOI 10.1097/CJI.0b013e3181b88ffc; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104; Zhang HL, 2011, MEDIAT INFLAMM, V2011, DOI 10.1155/2011/949072	48	202	211	4	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					825	+	840.e18	10.1016/j.cell.2017.12.026	http://dx.doi.org/10.1016/j.cell.2017.12.026			34	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29336888	Green Accepted, Bronze			2022-12-28	WOS:000424648800021
J	Cannon, JW				Cannon, Jeremy W.			Hemorrhagic Shock	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ENDOVASCULAR BALLOON OCCLUSION; DAMAGE CONTROL RESUSCITATION; MASSIVE TRANSFUSION; PLATELET DYSFUNCTION; HYPOTENSIVE PATIENTS; FLUID RESUSCITATION; BRAIN-INJURY; OXYGEN DEBT; TRAUMA; MORTALITY		[Cannon, Jeremy W.] Univ Penn, Perelman Sch Med, Dept Surg, Div Traumatol Surg Crit Care & Emergency Surg, Philadelphia, PA 19104 USA; [Cannon, Jeremy W.] Uniformed Serv Univ Hlth Sci, F Edward Hebert Sch Med, Bethesda, MD USA	University of Pennsylvania; Pennsylvania Medicine; Uniformed Services University of the Health Sciences - USA	Cannon, JW (corresponding author), Div Traumatol Surg Crit Care & Emergency Surg, 51 N 39th St,Med Off Bldg 120, Philadelphia, PA 19104 USA.	jeremy.cannon@uphs.upenn.edu	Cannon, Jeremy/T-3875-2019; Kox, Matthijs/L-4454-2015	Cannon, Jeremy/0000-0002-2969-9316; 				Achneck HE, 2010, ANN SURG, V251, P217, DOI 10.1097/SLA.0b013e3181c3bcca; American College of Surgeons Committee on Trauma, 2012, ADV TRAUM LIF SUPP A, P69; [Anonymous], COCHRANE DATABASE SY; Barbee RW, 2010, SHOCK, V33, P113, DOI 10.1097/SHK.0b013e3181b8569d; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Brown LM, 2011, J TRAUMA, V71, pS337, DOI 10.1097/TA.0b013e318227f67c; Bulger EM, 2014, PREHOSP EMERG CARE, V18, P163, DOI 10.3109/10903127.2014.896962; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Callcut RA, 2013, J TRAUMA ACUTE CARE, V74, P59, DOI 10.1097/TA.0b013e3182788b34; Cannon JW, 2017, J TRAUMA ACUTE CARE, V82, P605, DOI 10.1097/TA.0000000000001333; Carson JL, 2017, NEW ENGL J MED, V377, P1261, DOI 10.1056/NEJMra1612789; Champion HR, 2016, J TRAUMA ACUTE CARE, V81, P420, DOI 10.1097/TA.0000000000001124; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; CHAUDRY IH, 1983, AM J PHYSIOL, V245, pR117, DOI 10.1152/ajpregu.1983.245.2.R117; Chovanes J, 2012, SURG CLIN N AM, V92, P859, DOI 10.1016/j.suc.2012.04.002; Christensen Steffen, 2007, BMC Geriatr, V7, P8, DOI 10.1186/1471-2318-7-8; Cohn SM, 2011, WORLD J SURG, V35, P430, DOI 10.1007/s00268-010-0875-8; Cosgriff N, 1997, J TRAUMA, V42, P857, DOI 10.1097/00005373-199705000-00016; Cotton BA, 2009, J TRAUMA, V67, P389, DOI 10.1097/TA.0b013e3181a8b26f; Duchesne JC, 2010, J TRAUMA, V69, P976, DOI 10.1097/TA.0b013e3181f2abc9; Etchill EW, 2017, CRIT CARE MED, V45, P1311, DOI 10.1097/CCM.0000000000002498; Fortuna G, 2016, J TRAUMA ACUTE CARE, V81, P63, DOI 10.1097/TA.0000000000000996; Gakidou E, 2010, LANCET, V376, P959, DOI 10.1016/S0140-6736(10)61257-3; Gonzalez E, 2016, ANN SURG, V263, P1051, DOI 10.1097/SLA.0000000000001608; Gralnek IM, 2017, NEW ENGL J MED, V376, P1054, DOI 10.1056/NEJMcp1603455; Halmin M, 2016, CRIT CARE MED, V44, P468, DOI 10.1097/CCM.0000000000001410; HIRSHBERG A, 1995, J TRAUMA, V39, P225, DOI 10.1097/00005373-199508000-00007; Hoffman M, 2013, TRANSFUSION, V53, P1594, DOI 10.1111/trf.12201; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holcomb JB, 2013, JAMA SURG, V148, P127, DOI 10.1001/2013.jamasurg.387; Hunt BJ, 2014, NEW ENGL J MED, V370, P847, DOI 10.1056/NEJMra1208626; Hutchings S, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010893; Jenkins DH, 2014, SHOCK, V41, P3, DOI 10.1097/SHK.0000000000000140; Johansson PI, 2017, ANN SURG, V265, P597, DOI 10.1097/SLA.0000000000001751; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kotwal RS, 2016, JAMA SURG, V151, P15, DOI 10.1001/jamasurg.2015.3104; Kragh JF, 2009, ANN SURG, V249, P1, DOI 10.1097/SLA.0b013e31818842ba; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Laine L, 2017, GASTROINTEST ENDOSC, V86, P1028, DOI 10.1016/j.gie.2017.03.1549; Laine L, 2016, NEW ENGL J MED, V374, P2367, DOI 10.1056/NEJMcp1514257; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MacKay EJ, 2017, ANESTH ANALG, V125, P895, DOI 10.1213/ANE.0000000000002312; Maegele M, 2014, SHOCK, V41, P21, DOI 10.1097/SHK.0000000000000088; Maier RV, 2014, J AM COLL SURGEONS, V219, P335, DOI 10.1016/j.jamcollsurg.2014.04.011; Mannucci PM, 2007, NEW ENGL J MED, V356, P2301, DOI 10.1056/NEJMra067742; Meizoso JP, 2016, J TRAUMA ACUTE CARE, V81, P685, DOI 10.1097/TA.0000000000001198; Meyer DE, 2017, J TRAUMA ACUTE CARE, V83, P19, DOI 10.1097/TA.0000000000001531; Mitra B, 2014, SHOCK, V42, P307, DOI 10.1097/SHK.0000000000000219; Moore HB, 2016, J AM COLL SURGEONS, V222, P347, DOI 10.1016/j.jamcollsurg.2016.01.006; Morrison JJ, 2016, J TRAUMA ACUTE CARE, V80, P324, DOI 10.1097/TA.0000000000000913; Nadler R, 2014, SHOCK, V42, P93, DOI 10.1097/SHK.0000000000000178; National Academies of Sciences Engineering and Medicine, 2016, NAT TRAUM CAR SYST I; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Pusateri AE, 2016, TRANSFUSION, V56, pS128, DOI 10.1111/trf.13580; Rasmussen TE, 2016, NEW ENGL J MED, V375, P1612, DOI 10.1056/NEJMp1607636; Raux M, 2015, J VASC SURG, V61, P304, DOI 10.1016/j.jvs.2014.07.098; Rozycki GS, 1998, ANN SURG, V228, P557, DOI 10.1097/00000658-199810000-00012; Ruseckaite R, 2017, VOX SANG, V112, P240, DOI 10.1111/vox.12487; Russo RM, 2016, J AM COLL SURGEONS, V223, P359, DOI 10.1016/j.jamcollsurg.2016.04.037; Salhab M, 2006, VASCULAR, V14, P38, DOI 10.2310/6670.2006.00011; Schochl H, 2014, ANESTH ANALG, V119, P1064, DOI 10.1213/ANE.0b013e318270a6f7; Schroll R, 2015, J TRAUMA ACUTE CARE, V79, P10, DOI 10.1097/TA.0000000000000689; Shackelford SA, 2017, JAMA-J AM MED ASSOC, V318, P1581, DOI 10.1001/jama.2017.15097; Shafi S, 2016, J TRAUMA ACUTE CARE, V81, P780, DOI 10.1097/TA.0000000000001161; Shokoohi H, 2015, CRIT CARE MED, V43, P2562, DOI 10.1097/CCM.0000000000001285; Sihler KC, 2010, CHEST, V137, P209, DOI 10.1378/chest.09-0252; Singletary EM, 2015, CIRCULATION, V132, pS574, DOI 10.1161/CIR.0000000000000269; Spahn DR, 2013, CRIT CARE, V17, DOI 10.1186/cc12685; Spann AP, 2016, BIOPHYS J, V111, P577, DOI 10.1016/j.bpj.2016.06.024; Spinella PC, 2016, CURR OPIN HEMATOL, V23, P536, DOI 10.1097/MOH.0000000000000284; Tesoriero RB, 2017, J TRAUMA ACUTE CARE, V82, P18, DOI 10.1097/TA.0000000000001259; Tisherman SA, 2017, J TRAUMA ACUTE CARE, V83, P803, DOI 10.1097/TA.0000000000001585; Tisherman SA, 2015, ANN SURG, V261, P586, DOI 10.1097/SLA.0000000000000837; Tompkins RG, 2015, J TRAUMA ACUTE CARE, V78, P671, DOI 10.1097/TA.0000000000000568; Wandling MW, 2016, J TRAUMA ACUTE CARE, V81, P931, DOI 10.1097/TA.0000000000001228; White NJ, 2017, J TRAUMA ACUTE CARE, V82, pS41, DOI 10.1097/TA.0000000000001436; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050; Yazer MH, 2016, J TRAUMA ACUTE CARE, V81, P21, DOI 10.1097/TA.0000000000001100; Zhang Q, 2010, NATURE, V464, P104, DOI 10.1038/nature08780	79	274	303	12	72	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 25	2018	378	4					370	379		10.1056/NEJMra1705649	http://dx.doi.org/10.1056/NEJMra1705649			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT5ZX	29365303				2022-12-28	WOS:000423233400009
J	Fauci, AS; Eisinger, RW				Fauci, Anthony S.; Eisinger, Robert W.			PEPFAR-15 Years and Counting the Lives Saved	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fauci, Anthony S.; Eisinger, Robert W.] NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fauci, AS (corresponding author), NIAID, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.							Goosby E, 2012, JAIDS-J ACQ IMM DEF, V60, pS51, DOI 10.1097/QAI.0b013e31825ca721; Office of the Press Secretary, 2003, FACT SHEET PRESIDENT; Office of the U. S. Global AIDS Coordi. nator and the Health Diplomacy, 2017, PEPFAR 2017 ANN REP; United States President's Emergency Plan for AIDS Relief, 2012, J ACQ IMMUN DEF SYND, V60, pS51	4	23	23	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 25	2018	378	4					314	316		10.1056/NEJMp1714773	http://dx.doi.org/10.1056/NEJMp1714773			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT5ZX	29365298	Bronze			2022-12-28	WOS:000423233400003
J	Kopp, F; Mendell, JT				Kopp, Florian; Mendell, Joshua T.			Functional Classification and Experimental Dissection of Long Noncoding RNAs	CELL			English	Review							PROMOTES TRANSCRIPTION TERMINATION; INACTIVE X-CHROMOSOME; GENE-EXPRESSION; HUMAN-CELLS; REGULATORY ELEMENTS; NUCLEAR SPECKLES; PUMILIO PROTEINS; BINDING PROTEINS; CHROMATIN SITES; CIRCULAR RNAS	Over the last decade, it has been increasingly demonstrated that the genomes of many species are pervasively transcribed, resulting in the production of numerous long noncoding RNAs (lncRNAs). At the same time, it is now appreciated that many types of DNA regulatory elements, such as enhancers and promoters, regularly initiate bi-directional transcription. Thus, discerning functional noncoding transcripts from a vast transcriptome is a paramount priority, and challenge, for the lncRNA field. In this review, we aim to provide a conceptual and experimental framework for classifying and elucidating lncRNA function. We categorize lncRNA loci into those that regulate gene expression in cis versus those that perform functions in trans and propose an experimental approach to dissect lncRNA activity based on these classifications. These strategies to further understand lncRNAs promise to reveal new and unanticipated biology with great potential to advance our understanding of normal physiology and disease.	[Kopp, Florian; Mendell, Joshua T.] Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Mendell, Joshua T.] Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA; [Mendell, Joshua T.] Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA; [Mendell, Joshua T.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mendell, JT (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.; Mendell, JT (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Harold C Simmons Comprehens Canc Ctr, Dallas, TX 75390 USA.; Mendell, JT (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Hamon Ctr Regenerat Sci & Med, Dallas, TX 75390 USA.; Mendell, JT (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA.	joshua.mendell@utsouthwestern.edu		Kopp, Florian/0000-0001-9952-635X	Cancer Prevention and Research Institute of Texas [RP160249]; National Institutes of Health [R35CA197311]; German National Academy of Sciences Leopoldina [LPDS 2014-12]; NATIONAL CANCER INSTITUTE [R35CA197311] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German National Academy of Sciences Leopoldina; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Asha Acharya, Mathew Augustine, Ryan Golden, Jaeil Han, Kathryn O'Donnell, Anu Thomas, and Xiaoqiang Zhu for helpful comments on the manuscript. J.T.M. is an Investigator of the Howard Hughes Medical Institute and is also supported by the Cancer Prevention and Research Institute of Texas (RP160249) and the National Institutes of Health (R35CA197311). F.K. is supported by the Leopoldina Fellowship Program (LPDS 2014-12) from the German National Academy of Sciences Leopoldina. We apologize to those whose work we were unable to cite due to space limitations.	Adriaens C, 2016, NAT MED, V22, P861, DOI 10.1038/nm.4135; Allen MA, 2014, ELIFE, V3, DOI 10.7554/eLife.02200; Anderson DM, 2015, CELL, V160, P595, DOI 10.1016/j.cell.2015.01.009; Anderson KM, 2016, NATURE, V539, P433, DOI 10.1038/nature20128; Arun G, 2016, GENE DEV, V30, P34, DOI 10.1101/gad.270959.115; Atianand MK, 2016, CELL, V165, P1672, DOI 10.1016/j.cell.2016.05.075; Bernard D, 2010, EMBO J, V29, P3082, DOI 10.1038/emboj.2010.199; Blume CJ, 2015, LEUKEMIA, V29, P2015, DOI 10.1038/leu.2015.119; Bosson AD, 2014, MOL CELL, V56, P347, DOI 10.1016/j.molcel.2014.09.018; Botcheva K, 2011, CELL CYCLE, V10, P4237, DOI 10.4161/cc.10.24.18383; BROCKDORFF N, 1991, NATURE, V351, P329, DOI 10.1038/351329a0; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Cerase A, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0733-y; Chen CK, 2016, SCIENCE, V354, P468, DOI 10.1126/science.aae0047; Chen LL, 2016, NAT REV MOL CELL BIO, V17, P205, DOI 10.1038/nrm.2015.32; Chu C, 2015, CELL, V161, P404, DOI 10.1016/j.cell.2015.03.025; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; da Rocha ST, 2017, NAT STRUCT MOL BIOL, V24, P197, DOI 10.1038/nsmb.3370; Davidovich C, 2015, MOL CELL, V57, P552, DOI 10.1016/j.molcel.2014.12.017; Denzler R, 2014, MOL CELL, V54, P766, DOI 10.1016/j.molcel.2014.03.045; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dimitrova N, 2014, MOL CELL, V54, P777, DOI 10.1016/j.molcel.2014.04.025; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Eissmann M, 2012, RNA BIOL, V9, P1076, DOI 10.4161/rna.21089; Engreitz JM, 2016, NATURE, V539, P452, DOI 10.1038/nature20149; Engreitz JM, 2014, CELL, V159, P188, DOI 10.1016/j.cell.2014.08.018; Engreitz JM, 2013, SCIENCE, V341, P767, DOI 10.1126/science.1237973; Finn RD, 2016, NUCLEIC ACIDS RES, V44, pD279, DOI 10.1093/nar/gkv1344; Fox AH, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000687; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Gennarino VA, 2015, CELL, V160, P1087, DOI 10.1016/j.cell.2015.02.012; Ghazal G, 2009, MOL CELL, V36, P99, DOI 10.1016/j.molcel.2009.07.029; Groff AF, 2016, CELL REP, V16, P2178, DOI 10.1016/j.celrep.2016.07.050; Gutschner T, 2013, J MOL MED, V91, P791, DOI 10.1007/s00109-013-1028-y; Gutschner T, 2013, CANCER RES, V73, P1180, DOI 10.1158/0008-5472.CAN-12-2850; Guttman M, 2013, CELL, V154, P240, DOI 10.1016/j.cell.2013.06.009; Hacisuleyman E, 2014, NAT STRUCT MOL BIOL, V21, P198, DOI 10.1038/nsmb.2764; Hafner M, 2010, CELL, V141, P129, DOI 10.1016/j.cell.2010.03.009; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Hansen TB, 2011, EMBO J, V30, P4414, DOI 10.1038/emboj.2011.359; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hu WQ, 2012, EMBO REP, V13, P971, DOI 10.1038/embor.2012.145; Hu WQ, 2011, GENE DEV, V25, P2573, DOI 10.1101/gad.178780.111; Huarte M, 2010, CELL, V142, P409, DOI 10.1016/j.cell.2010.06.040; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Ingolia NT, 2014, CELL REP, V8, P1365, DOI 10.1016/j.celrep.2014.07.045; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Joung J, 2017, NATURE, V548, P343, DOI 10.1038/nature23451; Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041; Klann TS, 2017, NAT BIOTECHNOL, V35, P561, DOI 10.1038/nbt.3853; Konig J, 2010, NAT STRUCT MOL BIOL, V17, P909, DOI 10.1038/nsmb.1838; Latos PA, 2012, SCIENCE, V338, P1469, DOI 10.1126/science.1228110; Lee S, 2016, CELL, V164, P69, DOI 10.1016/j.cell.2015.12.017; Li WB, 2016, NAT REV GENET, V17, P207, DOI 10.1038/nrg.2016.4; Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Liu SJ, 2017, SCIENCE, V355, DOI 10.1126/science.aah7111; Mao YTS, 2011, NAT CELL BIOL, V13, P95, DOI 10.1038/ncb2140; Matsumoto A, 2017, NATURE, V541, P228, DOI 10.1038/nature21034; McHugh CA, 2015, NATURE, V521, P232, DOI 10.1038/nature14443; McHugh CA, 2014, GENOME BIOL, V15, DOI 10.1186/gb4152; Mello SS, 2017, GENE DEV, V31, P1095, DOI 10.1101/gad.284661.116; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Michalik KM, 2014, CIRC RES, V114, P1389, DOI 10.1161/CIRCRESAHA.114.303265; Mili S, 2004, RNA, V10, P1692, DOI 10.1261/rna.7151404; Miller MA, 2011, WIRES RNA, V2, P471, DOI 10.1002/wrna.69; Minajigi A., 2015, SCIENCE, P349; Miyagawa R, 2012, RNA, V18, P738, DOI 10.1261/rna.028639.111; Moindrot B, 2015, CELL REP, V12, P562, DOI 10.1016/j.celrep.2015.06.053; Monfort A, 2015, CELL REP, V12, P554, DOI 10.1016/j.celrep.2015.06.067; Nakagawa S, 2014, DEVELOPMENT, V141, P4618, DOI 10.1242/dev.110544; Nakagawa S, 2012, RNA, V18, P1487, DOI 10.1261/rna.033217.112; Nakagawa S, 2011, J CELL BIOL, V193, P31, DOI 10.1083/jcb.201011110; Pauli A, 2012, GENOME RES, V22, P577, DOI 10.1101/gr.133009.111; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Piwecka M, 2017, SCIENCE, V357, DOI 10.1126/science.aam8526; Portoso M, 2017, EMBO J, V36, P981, DOI 10.15252/embj.201695335; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sasaki YTF, 2009, P NATL ACAD SCI USA, V106, P2525, DOI 10.1073/pnas.0807899106; Sauvageau M, 2013, ELIFE, V2, DOI 10.7554/eLife.01749; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Sigova AA, 2015, SCIENCE, V350, P978, DOI 10.1126/science.aad3346; Spector DL, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a000646; Standaert L, 2014, RNA, V20, P1844, DOI 10.1261/rna.047332.114; Sun L, 2013, P NATL ACAD SCI USA, V110, P3387, DOI 10.1073/pnas.1222643110; Sunwoo H, 2009, GENOME RES, V19, P347, DOI 10.1101/gr.087775.108; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Tichon A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12209; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Tsai MC, 2010, SCIENCE, V329, P689, DOI 10.1126/science.1192002; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Wagschal A, 2012, CELL, V150, P1147, DOI 10.1016/j.cell.2012.08.004; West JA, 2014, MOL CELL, V55, P791, DOI 10.1016/j.molcel.2014.07.012; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6; Xing YH, 2017, CELL, V169, P664, DOI 10.1016/j.cell.2017.04.011; Yan XH, 2015, CANCER CELL, V28, P529, DOI 10.1016/j.ccell.2015.09.006; Zhang B, 2012, CELL REP, V2, P111, DOI 10.1016/j.celrep.2012.06.003; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045; Zhao Y, 2016, NUCLEIC ACIDS RES, V44, pD203, DOI 10.1093/nar/gkv1252; Zhu SY, 2016, NAT BIOTECHNOL, V34, P1279, DOI 10.1038/nbt.3715	105	1798	1892	38	516	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2018	172	3					393	407		10.1016/j.cell.2018.01.011	http://dx.doi.org/10.1016/j.cell.2018.01.011			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FT9BS	29373828	Green Accepted, Bronze			2022-12-28	WOS:000423447600003
J	Bouillon, K; Bertrand, M; Bader, G; Lucot, JP; Dray-Spira, R; Zureik, M				Bouillon, Kim; Bertrand, Marion; Bader, Georges; Lucot, Jean-Philippe; Dray-Spira, Rosemary; Zureik, Mahmoud			Association of Hysteroscopic vs Laparoscopic Sterilization With Procedural, Gynecological, and Medical Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							NONVALVULAR ATRIAL-FIBRILLATION; LONG-TERM RISK; TUBAL-STERILIZATION; PULMONARY-EMBOLISM; FRENCH WOMEN; HYSTERECTOMY; SALPINGECTOMY; CONTRACEPTION; SURVIVORSHIP; ANTAGONISTS	IMPORTANCE Safety of hysteroscopic sterilization has been recently questioned following reports of general symptoms such as allergy, tiredness, and depression in addition to associated gynecological results such as pelvic pain, perforation of fallopian tubes or uterus, and unwanted pregnancy. OBJECTIVE To compare the risk of reported adverse events between hysteroscopic and laparoscopic sterilization. DESIGN, SETTING, AND PARTICIPANTS French nationwide cohort study using the national hospital discharge database linked to the health insurance claims database. Women aged 30 to 54 years receiving a first hysteroscopic or laparoscopic sterilization between 2010 and 2014 were included and were followed up through December 2015. EXPOSURES Hysteroscopic sterilization vs laparoscopic sterilization. MAIN OUTCOMES AND MEASURES Risks of procedural complications (surgical and medical) and of gynecological (sterilization failure that includes salpingectomy, second sterilization procedure, or pregnancy; pregnancy; reoperation) and medical outcomes (all types of allergy; autoimmune diseases; thyroid disorder; use of analgesics, antimigraines, antidepressants, benzodiazepines; outpatient visits; sickness absence; suicide attempts; death) that occurred within 1 and 3 years after sterilization were compared using inverse probability of treatment-weighted Cox models. RESULTS Of the 105 357 women included (95.5% of eligible participants; mean age, 41.3 years [SD, 3.7 years]), 71 303 (67.7%) underwent hysteroscopic sterilization, and 34 054 (32.3%) underwent laparoscopic sterilization. During the hospitalization for sterilization, risk of surgical complications for hysteroscopic sterilization was lower: 0.13% for hysteroscopic sterilization vs 0.78% for laparoscopic sterilization (adjusted risk difference [RD], -0.64; 95% CI, -0.67 to -0.60) and was lower for medical complications: 0.06% vs 0.11% (adjusted RD, -0.05; 95% CI, -0.08 to -0.01). During the first year after sterilization, 4.83% of women who underwent hysteroscopic sterilization had a higher risk of sterilization failure than the 0.69% who underwent laparoscopic sterilization (adjusted hazard ratio [HR], 7.11; 95% CI, 5.92 to 8.54; adjusted RD, 4.23 per 100 person-years; 95% CI, 3.40 to 5.22). Additionally, 5.65% of women who underwent hysteroscopic sterilization required gynecological reoperation vs 1.76% of women who underwent laparoscopic sterilization (adjusted HR, 3.26; 95% CI, 2.90 to 3.67; adjusted RD, 4.63 per 100 person-years; 95% CI, 3.38 to 4.75); these differences persisted after 3 years, although attenuated. Hysteroscopic sterilization was associated with a lower risk of pregnancy within the first year of the procedure but was not significantly associated with a difference in risk of pregnancy by the third year (adjusted HR, 1.04; 95% CI, 0.83-1.30; adjusted RD, 0.01 per 100 person-years; 95% CI, -0.04 to 0.07). Risks of medical outcomes were not significantly increased with hysteroscopic sterilization compared with laparoscopic sterilization. CONCLUSIONS AND RELEVANCE Among women undergoing first sterilization, the use of hysteroscopic sterilization was significantly associated with higher risk of gynecological complications over 1 year and over 3 years than was laparoscopic sterilization. Risk of medical outcomes was not significantly increased over 1 year or over 3 years. These findings do not support increased medical risks associated with hysteroscopic sterilization.	[Bouillon, Kim; Bertrand, Marion; Dray-Spira, Rosemary; Zureik, Mahmoud] French Natl Agcy Med & Hlth Prod Safety ANSM, Dept Epidemiol Hlth Prod, 143-147 Blvd Anatole France, F-93285 St Denis, Reunion, France; [Bader, Georges] Poissy Hosp, Dept Obstet & Gynecol & Reprod Med, Poissy, France; [Lucot, Jean-Philippe] Ctr Hosp Bethune, Dept Gynecol & Obstet, Bethune, France; [Zureik, Mahmoud] Univ Versailles St Quentin En Yvelines, Montigny Le Bretonneux, France	Hospital Chi of Poissy Saint Germain; UDICE-French Research Universities; Universite Paris Saclay	Zureik, M (corresponding author), French Natl Agcy Med & Hlth Prod Safety ANSM, Dept Epidemiol Hlth Prod, 143-147 Blvd Anatole France, F-93285 St Denis, Reunion, France.	mahmoud.zureik@ansm.sante.fr	Zureik, Mahmoud/F-7855-2018	Zureik, Mahmoud/0000-0002-8393-4217; Dray-Spira, Rosemary/0000-0001-7646-3667	Boston Scientific	Boston Scientific(Boston Scientific)	All authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Lucot reported receiving personal fees from Boston Scientific. No other disclosures were reported.	Antoun L, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.07.011; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Beziz D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155783; Bouillon K, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004065; Bouillon K, 2015, LANCET HAEMATOL, V2, pE150, DOI 10.1016/S2352-3026(15)00027-7; Chene G, 2016, GYNECOL OBSTET FERTI, V44, P377, DOI 10.1016/j.gyobfe.2016.05.003; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Colas S, 2017, CLIN ORTHOP RELAT R, V475, P2046, DOI 10.1007/s11999-017-5260-6; Colas S, 2015, JAMA SURG, V150, P979, DOI 10.1001/jamasurg.2015.1325; Cooper JM, 2003, OBSTET GYNECOL, V102, P59, DOI 10.1016/S0029-7844(03)00373-9; Dhruva SS, 2015, NEW ENGL J MED, V373, DOI 10.1056/NEJMp1510514; Fernandez H, 2014, EUR J OBSTET GYN R B, V180, P133, DOI 10.1016/j.ejogrb.2014.04.043; GOLDHABER MK, 1993, AM J EPIDEMIOL, V138, P508, DOI 10.1093/oxfordjournals.aje.a116885; Grosdemouge I, 2009, GYNECOL OBSTET FERTI, V37, P389, DOI 10.1016/j.gyobfe.2009.03.024; Kerin JF, 2003, HUM REPROD, V18, P1223, DOI 10.1093/humrep/deg256; Kirchgesner J, 2017, ALIMENT PHARM THER, V45, P37, DOI 10.1111/apt.13835; KJER JJ, 1990, EUR J OBSTET GYN R B, V35, P63, DOI 10.1016/0028-2243(90)90143-O; Lamvu G, 2011, OBSTET GYNECOL, V117, P1175, DOI 10.1097/AOG.0b013e31821646e1; Lemaitre M, 2017, JAMA-J AM MED ASSOC, V318, P1679, DOI 10.1001/jama.2017.16071; Mao J, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5162; Maura G, 2015, CIRCULATION, V132, P1252, DOI 10.1161/CIRCULATIONAHA.115.015710; McCarthy M, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1283; Mino M, 2007, BJOG-INT J OBSTET GY, V114, P763, DOI 10.1111/j.1471-0528.2007.01354.x; Perkins RB, 2016, OBSTET GYNECOL, V128, P843, DOI 10.1097/AOG.0000000000001615; Povedano B, 2012, BJOG-INT J OBSTET GY, V119, P795, DOI 10.1111/j.1471-0528.2012.03292.x; Powell CB, 2017, OBSTET GYNECOL, V130, P961, DOI 10.1097/AOG.0000000000002312; Raguideau F, 2016, JAMA OPHTHALMOL, V134, P415, DOI 10.1001/jamaophthalmol.2015.6205; Raguideau F, 2015, PHARMACOEPIDEM DR S, V24, P526, DOI 10.1002/pds.3763; Rey G, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-33; Rios-Castillo JE, 2013, GYNECOL ENDOCRINOL, V29, P580, DOI 10.3109/09513590.2013.777419; STERGACHIS A, 1990, JAMA-J AM MED ASSOC, V264, P2893, DOI 10.1001/jama.264.22.2893; TEMPLETON AA, 1982, BRIT J OBSTET GYNAEC, V89, P845, DOI 10.1111/j.1471-0528.1982.tb05038.x; Tricotel A, 2015, J THROMB HAEMOST, V13, P1576, DOI 10.1111/jth.13053; Van Drongelen AW, ANALYSIS OF COMPLAIN; Weill A, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2002; Weill A, 2010, PHARMACOEPIDEM DR S, V19, P1256, DOI 10.1002/pds.2044	36	35	36	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					375	387		10.1001/jama.2017.21269	http://dx.doi.org/10.1001/jama.2017.21269			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362796	Green Published, Bronze			2022-12-28	WOS:000423405300023
J	Foa, EB; McLean, CP; Zang, YY; Rosenfield, D; Yadin, E; Yarvis, JS; Mintz, J; Young-McCaughan, S; Borah, EV; Dondanville, KA; Fina, BA; Hall-Clark, BN; Lichner, T; Litz, BT; Roache, J; Wright, EC; Peterson, AL				Foa, Edna B.; McLean, Carmen P.; Zang, Yinyin; Rosenfield, David; Yadin, Elna; Yarvis, Jeffrey S.; Mintz, Jim; Young-McCaughan, Stacey; Borah, Elisa V.; Dondanville, Katherine A.; Fina, Brooke A.; Hall-Clark, Brittany N.; Lichner, Tracey; Litz, Brett T.; Roache, John; Wright, Edward C.; Peterson, Alan L.		STRONG STAR Consortium	Effect of Prolonged Exposure Therapy Delivered Over 2 Weeks vs 8 Weeks vs Present-Centered Therapy on PTSD Symptom Severity in Military Personnel A Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE-BEHAVIORAL THERAPY; PANIC DISORDER; IRAQ WAR; VETERANS; STANDARD; SESSIONS; VICTIMS	IMPORTANCE Effective and efficient treatment is needed for posttraumatic stress disorder (PTSD) in active duty military personnel. OBJECTIVE To examine the effects of massed prolonged exposure therapy (massed therapy), spaced prolonged exposure therapy (spaced therapy), present-centered therapy (PCT), and a minimal-contact control (MCC) on PTSD severity. DESIGN, SETTING, AND PARTICIPANTS Randomized clinical trial conducted at Fort Hood, Texas, from January 2011 through July 2016 and enrolling 370 military personnel with PTSD who had returned from Iraq, Afghanistan, or both. Final follow-up was July 11, 2016. INTERVENTIONS Prolonged exposure therapy, cognitive behavioral therapy involving exposure to trauma memories/reminders, administered as massed therapy (n = 110; 10 sessions over 2 weeks) or spaced therapy (n = 109; 10 sessions over 8 weeks); PCT, a non-trauma-focused therapy involving identifying/discussing daily stressors (n = 107; 10 sessions over 8 weeks); or MCC, telephone calls from therapists (n = 40; once weekly for 4 weeks). MAIN OUTCOMES AND MEASURES Outcomes were assessed before and after treatment and at 2-week, 12-week, and 6-month follow-up. Primary outcome was interviewer-assessed PTSD symptom severity, measured by the PTSD Symptom Scale-Interview (PSS-I; range, 0-51; higher scores indicate greater PTSD severity; MCID, 3.18), used to assess efficacy of massed therapy at 2 weeks posttreatment vs MCC at week 4; noninferiority of massed therapy vs spaced therapy at 2 weeks and 12 weeks posttreatment (noninferiority margin, 50%[2.3 points on PSS-I, with 1-sided a = .05]); and efficacy of spaced therapy vs PCT at posttreatment. RESULTS Among 370 randomized participants, data were analyzed for 366 (mean age, 32.7 [SD, 7.3] years; 44 women [12.0%]; mean baseline PSS-I score, 25.49 [6.36]), and 216 (59.0%) completed the study. At 2 weeks posttreatment, mean PSS-I score was 17.62 (mean decrease from baseline, 7.13) for massed therapy and 21.41 (mean decrease, 3.43) for MCC(difference in decrease, 3.70[95% CI, 0.72 to 6.68]; P=.02). At 2 weeks posttreatment, mean PSS-I score was 18.03 for spaced therapy (decrease, 7.29; difference in means vs massed therapy, 0.79 [1-sided 95% CI, - infinity to 2.29; P=.049 for noninferiority]) and at 12 weeks posttreatment was 18.88 for massed therapy (decrease, 6.32) and 18.34 for spaced therapy (decrease, 6.97; difference, 0.55 [1-sided 95% CI, -infinity to 2.05; P=.03 for noninferiority]). At posttreatment, PSS-I scores for PCT were 18.65 (decrease, 7.31; difference in decrease vs spaced therapy, 0.10 [95% CI, -2.48 to 2.27]; P=.93). CONCLUSIONS AND RELEVANCE Among active duty military personnel with PTSD, massed therapy (10 sessions over 2weeks) reduced PTSD symptom severity more than MCC at 2-week follow-up and was noninferior to spaced therapy (10 sessions over 8 weeks), and there was no significant difference between spaced therapy and PCT. The reductions in PTSD symptom severity with all treatments were relatively modest, suggesting that further research is needed to determine the clinical importance of these findings.	[Foa, Edna B.; McLean, Carmen P.; Zang, Yinyin; Yadin, Elna; Lichner, Tracey] Univ Penn, Sch Med, Dept Psychiat, Philadelphia, PA 19104 USA; [McLean, Carmen P.] VA Palo Alto Hlth Care Syst, Natl Ctr PTSD, Menlo Pk, CA USA; [Rosenfield, David] Southern Methodist Univ, Dept Psychol, Dallas, TX USA; [Yarvis, Jeffrey S.] Carl R Darnall Army Med Ctr, Headquarters, Ft Hood, TX USA; [Mintz, Jim; Young-McCaughan, Stacey; Borah, Elisa V.; Dondanville, Katherine A.; Fina, Brooke A.; Hall-Clark, Brittany N.; Roache, John; Wright, Edward C.; Peterson, Alan L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Psychiat, Sch Med, San Antonio, TX 78229 USA; [Mintz, Jim] Univ Texas Hlth Sci Ctr San Antonio, Sch Med, Dept Epidemiol & Biostat, San Antonio, TX 78229 USA; [Borah, Elisa V.] Univ Texas Austin, Sch Social Work, Austin, TX 78712 USA; [Litz, Brett T.] Boston Univ, Dept Psychol & Brain Sci, VA Boston Healthcare Syst, Massachusetts Vet Epidemiol Res & Informat Ctr, Boston, MA 02215 USA; [Litz, Brett T.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Wright, Edward C.] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Wright, Edward C.] Harvard Med Sch, Boston, MA USA; [Peterson, Alan L.] South Texas Vet Hlth Care Syst, San Antonio, TX USA; [Peterson, Alan L.] Univ Texas San Antonio, Dept Psychol, San Antonio, TX USA	University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Southern Methodist University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Austin; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Texas System; University of Texas at San Antonio (UTSA)	Foa, EB (corresponding author), Univ Penn, Dept Psychiat, 3535 Market St,6th Floor, Philadelphia, PA 19104 USA.	foa@pennmedicine.upenn.edu	Zang, Yinyin/U-6357-2017	Zang, Yinyin/0000-0001-7482-8511; McLean, Carmen/0000-0003-4322-9318; Roache, John/0000-0002-7010-8119; Litz, Brett/0000-0002-0479-8887	DoD through the US Army Medical Research and Materiel Command, Congressionally Directed Medical Research Programs, Psychological Health and Traumatic Brain Injury Research Program [W81XWH-08-02-0111, W81XWH-08-02-109, W81XWH-08-02-0114]; STRONG STAR Consortium	DoD through the US Army Medical Research and Materiel Command, Congressionally Directed Medical Research Programs, Psychological Health and Traumatic Brain Injury Research Program; STRONG STAR Consortium	This study was conducted with support of the DoD through the US Army Medical Research and Materiel Command, Congressionally Directed Medical Research Programs, Psychological Health and Traumatic Brain Injury Research Program awards W81XWH-08-02-0111 (Dr Foa), W81XWH-08-02-109 (Dr Peterson), and W81XWH-08-02-0114 (Dr Litz). Grants were awarded as part of funding for the STRONG STAR Consortium.	Abramowitz JS, 2003, J CONSULT CLIN PSYCH, V71, P394, DOI 10.1037/0022-006X.71.2.394; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Asnaani A, 2014, J ANXIETY DISORD, V28, P310, DOI 10.1016/j.janxdis.2014.01.005; Benjamini Y, 2001, ANN STAT, V29, P1165; Blount TH, 2014, COGN BEHAV PRACT, V21, P89, DOI 10.1016/j.cbpra.2013.05.004; Bohni MK, 2009, ACTA PSYCHIAT SCAND, V120, P187, DOI 10.1111/j.1600-0447.2009.01358.x; Bowalekar Suresh Keshav, 2011, Perspect Clin Res, V2, P115, DOI 10.4103/2229-3485.86868; Deacon B, 2006, BEHAV RES THER, V44, P807, DOI 10.1016/j.brat.2005.05.008; Ehlers A, 2014, AM J PSYCHIAT, V171, P294, DOI 10.1176/appi.ajp.2013.13040552; Enders CK, 2011, PSYCHOL METHODS, V16, P1, DOI 10.1037/a0022640; Feingold A, 2013, REV GEN PSYCHOL, V17, P111, DOI 10.1037/a0030048; Foa E.B., 2019, PROLONGED EXPOSURE T, V2, DOI [10.1093/med-psych/9780190926939.001.0001/med-9780190926939, DOI 10.1093/MED-PSYCH/9780190926939.001.0001/MED-9780190926939]; FOA EB, 1991, J CONSULT CLIN PSYCH, V59, P715, DOI 10.1037/0022-006X.59.5.715; Foa EB, 1999, J CONSULT CLIN PSYCH, V67, P194, DOI 10.1037/0022-006X.67.2.194; Foa EB, 2005, J CONSULT CLIN PSYCH, V73, P953, DOI 10.1037/0022-006X.73.5.953; FOA EB, 1993, J TRAUMA STRESS, V6, P459, DOI 10.1007/BF00974317; FOA EB, 1980, BEHAV RES THER, V18, P333, DOI 10.1016/0005-7967(80)90092-3; Gates MA, 2012, PSYCHOL SERV, V9, P361, DOI 10.1037/a0027649; Hedeker D, 1999, J EDUC BEHAV STAT, V24, P70, DOI 10.3102/10769986024001070; Hedeker D., 2006, LONGITUDINAL DATA AN; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Imel ZE, 2013, J CONSULT CLIN PSYCH, V81, P394, DOI 10.1037/a0031474; Julious SA, 2004, STAT MED, V23, P1921, DOI 10.1002/sim.1783; Kessler RC, 2000, J CLIN PSYCHIAT, V61, P4; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Norman GR, 2003, MED CARE, V41, P582, DOI 10.1097/00005650-200305000-00004; Resick PA, 2017, JAMA PSYCHIAT, V74, P28, DOI 10.1001/jamapsychiatry.2016.2729; Resick PA, 2015, J CONSULT CLIN PSYCH, V83, P1058, DOI 10.1037/ccp0000016; Schnurr PP, 2007, JAMA-J AM MED ASSOC, V297, P820, DOI 10.1001/jama.297.8.820; Selim A, 2009, QUAL LIFE RES, V18, P43, DOI 10.1007/s11136-008-9418-2; Stefanovics EA, 2018, PSYCHIAT QUART, V89, P141, DOI 10.1007/s11126-017-9522-y; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Tuerk PW, 2011, J ANXIETY DISORD, V25, P397, DOI 10.1016/j.janxdis.2010.11.002; Weathers FW, 1993, ANN CONV INT SOC TRA	34	187	190	5	37	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					354	364		10.1001/jama.2017.21242	http://dx.doi.org/10.1001/jama.2017.21242			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT8LW	29362795	Green Published, Bronze			2022-12-28	WOS:000423405300021
J	Lerner, E; Cordes, T; Ingargiola, A; Alhadid, Y; Chung, S; Michalet, X; Weiss, S				Lerner, Eitan; Cordes, Thorben; Ingargiola, Antonino; Alhadid, Yazan; Chung, SangYoon; Michalet, Xavier; Weiss, Shimon			Toward dynamic structural biology: Two decades of single-molecule Forster resonance energy transfer	SCIENCE			English	Review							ALTERNATING-LASER EXCITATION; PROTEIN CONFORMATIONAL DYNAMICS; X-RAY CRYSTALLOGRAPHY; PROMOTER OPEN COMPLEX; RNA-POLYMERASE; FLUORESCENCE SPECTROSCOPY; TRANSCRIPTION BUBBLE; QUANTITATIVE FRET; FOLDING DYNAMICS; BINDING	Classical structural biology can only provide static snapshots of biomacromolecules. Single-molecule Forster resonance energy transfer (smFRET) paved the way for studying dynamics in macromolecular structures under biologically relevant conditions. Since its first implementation in 1996, smFRET experiments have confirmed previously hypothesized mechanisms and provided new insights into many fundamental biological processes, such as DNA maintenance and repair, transcription, translation, and membrane transport. We review 22 years of contributions of smFRET to our understanding of basic mechanisms in biochemistry, molecular biology, and structural biology. Additionally, building on current state-of-the-art implementations of smFRET, we highlight possible future directions for smFRET in applications such as biosensing, high-throughput screening, and molecular diagnostics.	[Lerner, Eitan; Ingargiola, Antonino; Alhadid, Yazan; Chung, SangYoon; Michalet, Xavier; Weiss, Shimon] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Cordes, Thorben] Univ Groningen, Zernike Inst Adv Mat, Mol Microscopy Res Grp, NL-9747 AG Groningen, Netherlands; [Cordes, Thorben] Ludwig Maximilians Univ Munchen, Fac Biol, Phys & Synthet Biol, D-82152 Planegg Martinsried, Germany; [Weiss, Shimon] Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA; [Weiss, Shimon] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of Groningen; University of Munich; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Weiss, S (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA.; Weiss, S (corresponding author), Univ Calif Los Angeles, Dept Physiol, Los Angeles, CA 90095 USA.; Weiss, S (corresponding author), Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA.	sweiss@chem.ucla.edu	Cordes, Thorben/B-8192-2009; weiss, shimon/B-4164-2009; Michalet, Xavier/A-9704-2009; Institute, Zernike/W-7033-2019; Lerner, Eitan/S-5576-2018	Cordes, Thorben/0000-0002-8598-5499; weiss, shimon/0000-0002-0720-5426; Michalet, Xavier/0000-0001-6602-7693; Lerner, Eitan/0000-0002-3791-5277; Ingargiola, Antonino/0000-0002-9348-1397; Chung, SangYoon/0000-0002-0592-4099	NIH [GM069709, GM095904]; NSF [MCB-1244175]; European Research Council [ERC-STG 638536-SM-IMPORT]; Deutsche Forschungsgemeinschaft [GRK2062]; Center for NanoScience; Center for Integrated Protein Science Munich; LMUexcellent; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095904, R01GM069709] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Center for NanoScience; Center for Integrated Protein Science Munich; LMUexcellent; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge contributions and discussions with past and present members of the Weiss lab. We thank M. Segal for editing the manuscript. Supported by NIH grants GM069709 and NSF grant MCB-1244175 (S.W.), NIH grant GM095904 (X.M. and S.W.), and European Research Council grant ERC-STG 638536-SM-IMPORT, grant of the Deutsche Forschungsgemeinschaft within GRK2062, the Center for NanoScience, Center for Integrated Protein Science Munich, and LMUexcellent (T.C.).	Aigrain L, 2015, JOVE-J VIS EXP, DOI 10.3791/52208; Alhadid Y, 2017, PROTEIN SCI, V26, P1278, DOI 10.1002/pro.3160; Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Bae B, 2015, ELIFE, V4, DOI 10.7554/eLife.08504; BETZIG E, 1993, SCIENCE, V262, P1422, DOI 10.1126/science.262.5138.1422; Bharat TAM, 2015, STRUCTURE, V23, P1743, DOI 10.1016/j.str.2015.06.026; Bisaria N, 2015, BIOCHEM SOC T, V43, P172, DOI 10.1042/BST20140268; Blanchard SC, 2009, CURR OPIN STRUC BIOL, V19, P103, DOI 10.1016/j.sbi.2009.01.002; Borsch M, 2013, BIOCHEM SOC T, V41, P1219, DOI 10.1042/BST20130101; Boukobza E, 2001, J PHYS CHEM B, V105, P12165, DOI 10.1021/jp012016x; Brunger AT, 1997, NAT STRUCT BIOL, V4, P862; Chen J, 2012, CURR OPIN STRUC BIOL, V22, P804, DOI 10.1016/j.sbi.2012.09.004; Chen SJ, 2008, ANNU REV BIOPHYS, V37, P197, DOI 10.1146/annurev.biophys.37.032807.125957; Cheng YF, 2015, CELL, V161, P450, DOI 10.1016/j.cell.2015.03.049; Cohen AE, 2006, P NATL ACAD SCI USA, V103, P4362, DOI 10.1073/pnas.0509976103; Cordova JC, 2014, CURR OPIN STRUC BIOL, V28, P142, DOI 10.1016/j.sbi.2014.08.010; Craggs TD, 2012, NAT METHODS, V9, P1157, DOI 10.1038/nmeth.2257; Crawford R, 2013, BIOPHYS J, V105, P2439, DOI 10.1016/j.bpj.2013.09.057; Deniz AA, 2000, P NATL ACAD SCI USA, V97, P5179, DOI 10.1073/pnas.090104997; Deniz AA, 1999, P NATL ACAD SCI USA, V96, P3670, DOI 10.1073/pnas.96.7.3670; Diao JJ, 2011, BIOSCIENCE REP, V31, P457, DOI 10.1042/BSR20110011; Dimura M, 2016, CURR OPIN STRUC BIOL, V40, P163, DOI 10.1016/j.sbi.2016.11.012; Dolino DM, 2016, J BIOL CHEM, V291, P16175, DOI 10.1074/jbc.M116.721274; Ferreon ACM, 2009, P NATL ACAD SCI USA, V106, P5645, DOI 10.1073/pnas.0809232106; Fessl T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks333; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; FUNATSU T, 1995, NATURE, V374, P555, DOI 10.1038/374555a0; Gambin Y, 2010, MOL BIOSYST, V6, P1540, DOI 10.1039/c003024d; Gopich IV, 2009, J PHYS CHEM B, V113, P10965, DOI 10.1021/jp903671p; Gouridis G, 2015, NAT STRUCT MOL BIOL, V22, P57, DOI 10.1038/nsmb.2929; Greenfeld M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030024; Ha T, 1999, P NATL ACAD SCI USA, V96, P9077, DOI 10.1073/pnas.96.16.9077; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Ha T, 2012, ANNU REV PHYS CHEM, V63, P595, DOI 10.1146/annurev-physchem-032210-103340; Ha TJ, 1999, P NATL ACAD SCI USA, V96, P893, DOI 10.1073/pnas.96.3.893; HAAS E, 1984, BIOPHYS J, V46, P429, DOI 10.1016/S0006-3495(84)84040-0; Haas Elisha, 2012, Methods Mol Biol, V895, P467, DOI 10.1007/978-1-61779-927-3_28; Haenni D, 2013, J PHYS CHEM B, V117, P13015, DOI 10.1021/jp402352s; Haney CM, 2015, CURR OPIN CHEM BIOL, V28, P123, DOI 10.1016/j.cbpa.2015.07.007; Hanson JA, 2007, P NATL ACAD SCI USA, V104, P18055, DOI 10.1073/pnas.0708600104; Hellenkamp B, 2017, NAT METHODS, V14, P174, DOI [10.1038/NMETH.4081, 10.1038/nmeth.4081]; Helm Mark, 2009, Biophys Rev, V1, P161, DOI 10.1007/s12551-009-0018-3; Hennig M, 2012, TOP CURR CHEM, V317, P115, DOI 10.1007/128_2011_225; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; HIRSCHFELD T, 1976, APPL OPTICS, V15, P2965, DOI 10.1364/AO.15.002965; Hochreiter B, 2015, SENSORS-BASEL, V15, P26281, DOI 10.3390/s151026281; Hoffmann A, 2011, PHYS CHEM CHEM PHYS, V13, P1857, DOI 10.1039/c0cp01911a; Hohlbein J, 2014, CHEM SOC REV, V43, P1156, DOI 10.1039/c3cs60233h; Hohng S, 2004, BIOPHYS J, V87, P1328, DOI 10.1529/biophysj.104.043935; Hohng S, 2014, CHEM SOC REV, V43, P1007, DOI 10.1039/c3cs60184f; Huang PS, 2016, NATURE, V537, P320, DOI 10.1038/nature19946; Ingargiola A., 2017, BIORXIV; Ingargiola A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175766; Ingargiola A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160716; Ingargiola A, 2016, BIOPHYS J, V110, P26, DOI 10.1016/j.bpj.2015.11.013; Jeschke G, 2012, ANNU REV PHYS CHEM, V63, P419, DOI 10.1146/annurev-physchem-032511-143716; Jia YW, 1999, CHEM PHYS, V247, P69, DOI 10.1016/S0301-0104(99)00127-5; Juette MF, 2016, NAT METHODS, V13, P341, DOI [10.1038/NMETH.3769, 10.1038/nmeth.3769]; Kalinin S, 2012, NAT METHODS, V9, P1218, DOI [10.1038/nmeth.2222, 10.1038/NMETH.2222]; Kalinin S, 2010, J PHYS CHEM B, V114, P6197, DOI 10.1021/jp100025v; Kapanidis AN, 2006, SCIENCE, V314, P1144, DOI 10.1126/science.1131399; Kapanidis AN, 2004, P NATL ACAD SCI USA, V101, P8936, DOI 10.1073/pnas.0401690101; Kim S, 2011, NAT METHODS, V8, P242, DOI 10.1038/NMETH.1569; Kim SE, 2015, J PHYS CHEM B, V119, P6974, DOI 10.1021/acs.jpcb.5b03991; Kim T, 2013, INT J MOL SCI, V14, P4934, DOI 10.3390/ijms14034934; Kinz-Thompson CD, 2015, J PHYS CHEM B, V119, P10888, DOI 10.1021/jp5128805; Klostermeier D, 2011, BIOCHEM SOC T, V39, P611, DOI 10.1042/BST0390611; Konig I, 2015, NAT METHODS, V12, P773, DOI [10.1038/nmeth.3475, 10.1038/NMETH.3475]; Kulzer F, 2004, ANNU REV PHYS CHEM, V55, P585, DOI 10.1146/annurev.physchem.54.011002.103816; Laurence TA, 2005, P NATL ACAD SCI USA, V102, P17348, DOI 10.1073/pnas.0508584102; Le Reste L, 2012, BIOPHYS J, V102, P2658, DOI 10.1016/j.bpj.2012.04.028; Lee NK, 2007, BIOPHYS J, V92, P303, DOI 10.1529/biophysj.106.093211; Lerner E, 2014, BIOPHYS J, V106, P667, DOI 10.1016/j.bpj.2013.11.4500; Lerner E, 2018, J CHEM PHYS, V148, DOI 10.1063/1.5004606; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Liu SX, 2007, P NATL ACAD SCI USA, V104, P12634, DOI 10.1073/pnas.0610597104; Liu SX, 2010, NAT STRUCT MOL BIOL, V17, P1453, DOI 10.1038/nsmb.1937; Long X, 2016, METHODS, V105, P16, DOI 10.1016/j.ymeth.2016.06.009; Lu HP, 2011, PHYS CHEM CHEM PHYS, V13, P6734, DOI 10.1039/c0cp02860f; Mchaourab HS, 2011, STRUCTURE, V19, P1549, DOI 10.1016/j.str.2011.10.009; Medintz IL, 2009, PHYS CHEM CHEM PHYS, V11, P17, DOI 10.1039/b813919a; Meirovitch E, 2010, PROG NUCL MAG RES SP, V56, P360, DOI 10.1016/j.pnmrs.2010.03.002; Michalet X, 2006, CHEM REV, V106, P1785, DOI 10.1021/cr0404343; Michalet X, 2014, IEEE J SEL TOP QUANT, V20, DOI 10.1109/JSTQE.2014.2341568; Min W, 2005, ACCOUNTS CHEM RES, V38, P923, DOI 10.1021/ar040133f; Moerner WE, 2015, FARADAY DISCUSS, V184, P9, DOI 10.1039/c5fd00149h; MOERNER WE, 1989, PHYS REV LETT, V62, P2535, DOI 10.1103/PhysRevLett.62.2535; Munro JB, 2008, BIOPOLYMERS, V89, P565, DOI 10.1002/bip.20961; Muschielok A, 2008, NAT METHODS, V5, P965, DOI 10.1038/nmeth.1259; Nettels D, 2008, J PHYS CHEM B, V112, P6137, DOI 10.1021/jp076971j; Nikic I, 2015, CURR OPIN CHEM BIOL, V28, P164, DOI 10.1016/j.cbpa.2015.07.021; Nir E, 2006, J PHYS CHEM B, V110, P22103, DOI 10.1021/jp063483n; Okumus B, 2004, BIOPHYS J, V87, P2798, DOI 10.1529/biophysj.104.045971; ORRIT M, 1990, PHYS REV LETT, V65, P2716, DOI 10.1103/PhysRevLett.65.2716; Orrit M, 2015, ANGEW CHEM INT EDIT, V54, P8004, DOI 10.1002/anie.201503674; Orrit M, 2014, CHEM SOC REV, V43, P973, DOI 10.1039/c4cs90001d; Person B, 2009, CHEMPHYSCHEM, V10, P1455, DOI 10.1002/cphc.200900109; Peulen TO, 2017, J PHYS CHEM B, V121, P8211, DOI 10.1021/acs.jpcb.7b03441; Pirchi M, 2016, J PHYS CHEM B, V120, P13065, DOI 10.1021/acs.jpcb.6b10726; Pirchi M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1504; Ploetz E, 2016, SCI REP-UK, V6, DOI 10.1038/srep33257; Preus S, 2012, CHEMBIOCHEM, V13, P1990, DOI 10.1002/cbic.201200400; Rahamim G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143732; Renaud JP, 2016, NAT REV DRUG DISCOV, V15, P679, DOI 10.1038/nrd.2016.123; Revyakin A, 2006, SCIENCE, V314, P1139, DOI 10.1126/science.1131398; RIGLER R, 1973, Q REV BIOPHYS, V6, P139, DOI 10.1017/S003358350000113X; RIGLER R, 1993, P SOC PHOTO-OPT INS, V1921, P239, DOI 10.1117/12.146154; Ritter JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011639; Robb NC, 2013, J MOL BIOL, V425, P875, DOI 10.1016/j.jmb.2012.12.015; Robinson A, 2013, NAT REV MICROBIOL, V11, P303, DOI 10.1038/nrmicro2994; Roy R, 2008, NAT METHODS, V5, P507, DOI 10.1038/NMETH.1208; Sakon JJ, 2010, NAT METHODS, V7, P203, DOI [10.1038/nmeth.1421, 10.1038/NMETH.1421]; Sali A, 2015, STRUCTURE, V23, P1156, DOI 10.1016/j.str.2015.05.013; Sasmal DK, 2016, NANOSCALE, V8, P19928, DOI 10.1039/c6nr06794h; Sasmal DK, 2014, J AM CHEM SOC, V136, P12998, DOI 10.1021/ja506231j; Schuler B, 2002, NATURE, V419, P743, DOI 10.1038/nature01060; Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003; Schuler B, 2013, CURR OPIN STRUC BIOL, V23, P36, DOI 10.1016/j.sbi.2012.10.008; Schutz GJ, 1998, BIOPHYS J, V74, P2223, DOI 10.1016/S0006-3495(98)77931-7; Shaw E, 2014, METHOD ENZYMOL, V549, P313, DOI 10.1016/B978-0-12-801122-5.00014-3; SHERA EB, 1990, CHEM PHYS LETT, V174, P553, DOI 10.1016/0009-2614(90)85485-U; Sikic Kresimir, 2010, Open Biochem J, V4, P83, DOI 10.2174/1874091X01004010083; Sinev MA, 1996, BIOCHEMISTRY-US, V35, P6425, DOI 10.1021/bi952687j; Sisamakis E, 2010, METHOD ENZYMOL, V475, P455, DOI 10.1016/S0076-6879(10)75018-7; Spies M, 2017, METHOD ENZYMOL, V582, pXV, DOI 10.1016/S0076-6879(16)30443-8; Stracy M, 2014, FEBS LETT, V588, P3585, DOI 10.1016/j.febslet.2014.05.026; Streets AM, 2014, CURR OPIN BIOTECH, V25, P69, DOI 10.1016/j.copbio.2013.08.013; Sustarsic M, 2015, CURR OPIN STRUC BIOL, V34, P52, DOI 10.1016/j.sbi.2015.07.001; Teng KW, 2016, ELIFE, V5, DOI 10.7554/eLife.20378; Tochio H, 2012, CURR OPIN CHEM BIOL, V16, P609, DOI 10.1016/j.cbpa.2012.10.022; Tomov TE, 2012, BIOPHYS J, V102, P1163, DOI 10.1016/j.bpj.2011.11.4025; Torella JP, 2011, BIOPHYS J, V100, P1568, DOI 10.1016/j.bpj.2011.01.066; Treiber DK, 2001, CURR OPIN STRUC BIOL, V11, P309, DOI 10.1016/S0959-440X(00)00206-2; Uphoff S, 2010, NAT METHODS, V7, P831, DOI [10.1038/NMETH.1502, 10.1038/nmeth.1502]; van de Meent JW, 2014, BIOPHYS J, V106, P1327, DOI 10.1016/j.bpj.2013.12.055; van der Velde JHM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10144; Voelz VA, 2012, J AM CHEM SOC, V134, P12565, DOI 10.1021/ja302528z; Vogelsang J, 2009, PHOTOCH PHOTOBIO SCI, V8, P486, DOI 10.1039/b822318c; Wang XL, 2015, NUCLEIC ACIDS RES, V43, P7566, DOI 10.1093/nar/gkv726; Weikl TR, 2014, PROTEIN SCI, V23, P1508, DOI 10.1002/pro.2539; Weiss S, 1999, SCIENCE, V283, P1676, DOI 10.1126/science.283.5408.1676; Wilson TJ, 2007, BLOOD CELL MOL DIS, V38, P8, DOI 10.1016/j.bcmd.2006.10.004; Wozniak AK, 2008, P NATL ACAD SCI USA, V105, P18337, DOI 10.1073/pnas.0800977105; Wunderlich B, 2013, NAT PROTOC, V8, P1459, DOI 10.1038/nprot.2013.082; XIE XS, 1994, SCIENCE, V265, P361, DOI 10.1126/science.265.5170.361; Xie XS, 1999, J BIOL CHEM, V274, P15967, DOI 10.1074/jbc.274.23.15967; Yang H, 2003, SCIENCE, V302, P262, DOI 10.1126/science.1086911; Yim SW, 2012, CLIN CHEM, V58, P707, DOI 10.1373/clinchem.2011.176958; Yodh JG, 2010, Q REV BIOPHYS, V43, P185, DOI 10.1017/S0033583510000107; Zewail AH, 2005, PHILOS T ROY SOC A, V363, P315, DOI 10.1098/rsta.2004.1513; Zhao R, 2009, METHODS, V49, P112, DOI 10.1016/j.ymeth.2009.04.017; Zheng QS, 2014, CHEM SOC REV, V43, P1044, DOI 10.1039/c3cs60237k; Zhuang XW, 2005, ANNU REV BIOPH BIOM, V34, P399, DOI 10.1146/annurev.biophys.34.040204.144641; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048	154	258	259	32	396	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					288	+	eaan1133	10.1126/science.aan1133	http://dx.doi.org/10.1126/science.aan1133			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6BB	29348210	Green Accepted, Green Submitted			2022-12-28	WOS:000423236700029
J	van Driel, WJ; Koole, SN; Sikorska, K; van Leeuwen, JHS; Schreuder, HWR; Hermans, RHM; de Hingh, IHJT; van der Velden, J; Arts, HJ; Massuger, LFAG; Aalbers, AGJ; Verwaal, VJ; Kieffer, JM; Van de Vijver, KK; van Tinteren, H; Aaronson, NK; Sonke, GS				van Driel, W. J.; Koole, S. N.; Sikorska, K.; van Leeuwen, J. H. Schagen; Schreuder, H. W. R.; Hermans, R. H. M.; de Hingh, I. H. J. T.; van der Velden, J.; Arts, H. J.; Massuger, L. F. A. G.; Aalbers, A. G. J.; Verwaal, V. J.; Kieffer, J. M.; Van de Vijver, K. K.; van Tinteren, H.; Aaronson, N. K.; Sonke, G. S.			Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CYTOREDUCTIVE SURGERY; GYNECOLOGIC-ONCOLOGY; PERITONEAL CARCINOMATOSIS; NEOADJUVANT CHEMOTHERAPY; CISPLATIN; PHARMACOKINETICS; OUTCOMES; TRIAL	BACKGROUND Treatment of newly diagnosed advanced-stage ovarian cancer typically involves cytoreductive surgery and systemic chemotherapy. We conducted a trial to investigate whether the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to interval cytoreductive surgery would improve outcomes among patients who were receiving neoadjuvant chemotherapy for stage III epithelial ovarian cancer. METHODS In a multicenter, open-label, phase 3 trial, we randomly assigned 245 patients who had at least stable disease after three cycles of carboplatin (area under the curve of 5 to 6 mg per milliliter per minute) and paclitaxel (175 mg per square meter of body-surface area) to undergo interval cytoreductive surgery either with or without administration of HIPEC with cisplatin (100 mg per square meter). Randomization was performed at the time of surgery in cases in which surgery that would result in no visible disease (complete cytoreduction) or surgery after which one or more residual tumors measuring 10 mm or less in diameter remain (optimal cytoreduction) was deemed to be feasible. Three additional cycles of carboplatin and paclitaxel were administered postoperatively. The primary end point was recurrence-free survival. Overall survival and the side-effect profile were key secondary end points. RESULTS In the intention-to-treat analysis, events of disease recurrence or death occurred in 110 of the 123 patients (89%) who underwent cytoreductive surgery without HIPEC (surgery group) and in 99 of the 122 patients (81%) who underwent cytoreductive surgery with HIPEC (surgery-plus-HIPEC group) (hazard ratio for disease recurrence or death, 0.66; 95% confidence interval [CI], 0.50 to 0.87; P=0.003). The median recurrence-free survival was 10.7 months in the surgery group and 14.2 months in the surgery-plus-HIPEC group. At a median follow-up of 4.7 years, 76 patients (62%) in the surgery group and 61 patients (50%) in the surgery-plus-HIPEC group had died (hazard ratio, 0.67; 95% CI, 0.48 to 0.94; P=0.02). The median overall survival was 33.9 months in the surgery group and 45.7 months in the surgery-plus-HIPEC group. The percentage of patients who had adverse events of grade 3 or 4 was similar in the two groups (25% in the surgery group and 27% in the surgery-plus-HIPEC group, P=0.76). CONCLUSIONS Among patients with stage III epithelial ovarian cancer, the addition of HIPEC to interval cytoreductive surgery resulted in longer recurrence-free survival and overall survival than surgery alone and did not result in higher rates of side effects.	[van Driel, W. J.; Koole, S. N.] Netherlands Canc Inst, Dept Gynecol, Amsterdam, Netherlands; [Sikorska, K.; van Tinteren, H.] Netherlands Canc Inst, Dept Biometr, Amsterdam, Netherlands; [Aalbers, A. G. J.] Netherlands Canc Inst, Dept Surg Oncol, Amsterdam, Netherlands; [Van de Vijver, K. K.] Netherlands Canc Inst, Dept Pathol, Amsterdam, Netherlands; [Koole, S. N.; Sonke, G. S.] Netherlands Canc Inst, Dept Med Oncol, Amsterdam, Netherlands; [Kieffer, J. M.; Aaronson, N. K.] Netherlands Canc Inst, Div Psychosocial Res & Epidemiol, Amsterdam, Netherlands; [van Driel, W. J.; Koole, S. N.; van der Velden, J.] Ctr Gynecol Oncol Amsterdam, Amsterdam, Netherlands; [van Driel, W. J.; van Leeuwen, J. H. Schagen; Schreuder, H. W. R.; Hermans, R. H. M.; van der Velden, J.; Arts, H. J.; Massuger, L. F. A. G.; Sonke, G. S.] Dutch Gynecol Oncol Grp, Amsterdam, Netherlands; [van der Velden, J.] Acad Med Ctr, Dept Obstet & Gynecol, Amsterdam, Netherlands; [van Leeuwen, J. H. Schagen] St Antonius Hosp, Dept Obstet & Gynecol, Nieuwegein, Netherlands; [Schreuder, H. W. R.] Univ Med Ctr Utrecht, Dept Gynecol Oncol, UMC Utrecht Canc Ctr, Utrecht, Netherlands; [Hermans, R. H. M.] Catharina Hosp, Dept Gynecol & Obstet, Eindhoven, Netherlands; [de Hingh, I. H. J. T.] Catharina Hosp, Dept Surg, Eindhoven, Netherlands; [de Hingh, I. H. J. T.; Aalbers, A. G. J.] Dutch Peritoneal Oncol Grp, Groningen, Netherlands; [Arts, H. J.] Univ Groningen, Univ Med Ctr Groningen, Dept Gynecol Oncol, Groningen, Netherlands; [Massuger, L. F. A. G.] Radboud Univ Nijmegen, Med Ctr, Dept Gynecol Oncol, Nijmegen, Netherlands; [Verwaal, V. J.] Aarhus Univ Hosp, Dept Surg, Aarhus, Denmark	Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; Netherlands Cancer Institute; University of Amsterdam; Academic Medical Center Amsterdam; St. Antonius Hospital Utrecht; Utrecht University; Utrecht University Medical Center; Catharina Hospital; Catharina Hospital; University of Groningen; Radboud University Nijmegen; Aarhus University	van Driel, WJ (corresponding author), U1 14 Netherlands Canc Inst, Dept Gynecol, NL-1006 BE Amsterdam, Netherlands.	w.v.driel@nki.nl	Aaronson, Neil K/AAV-8194-2021; Van de Vijver, Koen/N-7895-2019; 1, 1/L-6277-2019; Koole, Simone/W-3091-2019; Schreuder, Henk/AAG-4737-2020	Van de Vijver, Koen/0000-0002-2026-9790; Koole, Simone/0000-0002-8909-1935; van der Velden, Jacobus/0000-0002-5985-1163; /0000-0001-9564-0622; Verwaal, Victor Jilbert/0000-0003-2643-3560; van Driel, Willemien Johanna/0000-0003-2246-1994; van Tinteren, Harm/0000-0002-4626-8702; Sonke, Gabe/0000-0001-8088-9628	Dutch Cancer Society; EudraCT [2006-003466-34]	Dutch Cancer Society(KWF Kankerbestrijding); EudraCT	Funded by the Dutch Cancer Society; ClinicalTrials.gov number, NCT00426257; EudraCT number, 2006-003466-34.	Armstrong DK, 2006, NEW ENGL J MED, V354, P34, DOI 10.1056/NEJMoa052985; Chua TC, 2013, J SURG ONCOL, V107, P566, DOI 10.1002/jso.23189; Cowan RA, 2017, INT J HYPERTHER, V33, P548, DOI 10.1080/02656736.2017.1283066; Esquivel J, 2016, J GASTROINTEST ONCOL, V7, P72, DOI 10.3978/j.issn.2078-6891.2015.114; Harter P, 2017, INT J GYNECOL CANCER, V27, P246, DOI 10.1097/IGC.0000000000000864; Jaaback K, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005340.pub4; OHNO S, 1994, CANCER CHEMOTH PHARM, V34, P302, DOI 10.1007/BF00686037; Panteix G, 2002, ANTICANCER RES, V22, P1329; Rose PG, 2004, NEW ENGL J MED, V351, P2489, DOI 10.1056/NEJMoa041125; Rustin GJS, 2010, LANCET, V376, P1155, DOI 10.1016/S0140-6736(10)61268-8; Rustin GJS, 2011, INT J GYNECOL CANCER, V21, P419, DOI 10.1097/IGC.0b013e3182070f17; Spiliotis J, 2015, ANN SURG ONCOL, V22, P1570, DOI 10.1245/s10434-014-4157-9; SPRATT JS, 1980, CANCER RES, V40, P256; Tewari D, 2015, J CLIN ONCOL, V33, P1460, DOI 10.1200/JCO.2014.55.9898; van de Vaart PJM, 1998, EUR J CANCER, V34, P148, DOI 10.1016/S0959-8049(97)00370-5; van Driel WJ, 2015, CURR TREAT OPTION ON, V16, DOI 10.1007/s11864-015-0329-5; VANDERBURG MEL, 1995, NEW ENGL J MED, V332, P629, DOI 10.1056/NEJM199503093321002; Vanounou T, 2016, ANN SURG ONCOL, V23, P2556, DOI 10.1245/s10434-016-5096-4; Vergote I, 2010, NEW ENGL J MED, V363, P943, DOI 10.1056/NEJMoa0908806; Verwaal VJ, 2003, J CLIN ONCOL, V21, P3737, DOI 10.1200/JCO.2003.04.187; Walker JL, 2006, GYNECOL ONCOL, V100, P27, DOI 10.1016/j.ygyno.2005.11.013; Wright AA, 2016, GYNECOL ONCOL, V143, P3, DOI 10.1016/j.ygyno.2016.05.022; Wright AA, 2015, J CLIN ONCOL, V33, P2841, DOI 10.1200/JCO.2015.61.4776	23	683	690	6	112	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2018	378	3					230	240		10.1056/NEJMoa1708618	http://dx.doi.org/10.1056/NEJMoa1708618			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT1IJ	29342393	Bronze, Green Published			2022-12-28	WOS:000422888400007
J	Zambrano, JA; Herman, TN				Zambrano, John A.; Herman, Talia N.			Rib Fracture Associated with Bordetella pertussis Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Zambrano, John A.; Herman, Talia N.] Harvard Vanguard Med Associates, Boston, MA 02215 USA	Harvard Vanguard Medical Associates	Zambrano, JA (corresponding author), Harvard Vanguard Med Associates, Boston, MA 02215 USA.	john_zambrano@atriushealth.org		Zambrano, John/0000-0002-2398-4618					0	2	5	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2018	378	3					E4	E4		10.1056/NEJMicm1701940	http://dx.doi.org/10.1056/NEJMicm1701940			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT1IJ	29342383				2022-12-28	WOS:000422888400001
J	Bereczky, T				Bereczky, Tamas			Commentary: Let's talk about sex	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bereczky, Tamas] European AIDS Treatment Grp, Brussels, Belgium		Bereczky, T (corresponding author), European AIDS Treatment Grp, Brussels, Belgium.	tamas.bereczky@eatg.org	Bereczky, Tamás/AGX-0476-2022						0	1	1	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 17	2018	360								k76	10.1136/bmj.k76	http://dx.doi.org/10.1136/bmj.k76			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT5QK	29343488				2022-12-28	WOS:000423208100004
J	Ma, R; Dixon, M				Ma, Richard; Dixon, Michael			Should all patients be asked about their sexual orientation?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Ma, Richard] Imperial Coll London, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London, England	Imperial College London	Ma, R (corresponding author), Imperial Coll London, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London, England.	r.ma@imperial.ac.uk; christine@pitchblack.eclipse.co.uk	Ma, Richard/Z-6047-2019	Ma, Richard/0000-0001-6877-2785				Bodkin H., 2017, TELEGRAPH; Hunt R, 2008, PRESCRIPTIN CHANGE L; LGBT Foundation. NHS England, 2017, SEX OR MON FULL SPEC; Mercer CH, 2013, LANCET, V382, P1781, DOI 10.1016/S0140-6736(13)62035-8; Somerville C., 2015, STONEWALL UNHEALTHY; Stonewall Guasp A., 2013, GAY BISEXUAL MENS HL	6	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 17	2018	360								k52	10.1136/bmj.k52	http://dx.doi.org/10.1136/bmj.k52			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT5QK	29343481	Green Published			2022-12-28	WOS:000423208100003
J	Horton, R				Horton, Richard			Offline: Time to act on minimum unit pricing of alcohol	LANCET			English	Editorial Material												richard.horton@lancet.com							0	3	3	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 13	2018	391	10116					106	106		10.1016/S0140-6736(18)30059-X	http://dx.doi.org/10.1016/S0140-6736(18)30059-X			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT0EG	29353606	Bronze			2022-12-28	WOS:000422793400009
J	Cohen, J				Cohen, Jon			HOW A HORROR STORY HAUNTS SCIENCE	SCIENCE			English	Editorial Material																			0	4	4	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					148	150		10.1126/science.359.6372.148	http://dx.doi.org/10.1126/science.359.6372.148			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS5EO	29326254				2022-12-28	WOS:000419816600018
J	Jones, PM; Cherry, RA; Allen, BN; Jenkyn, KMB; Shariff, SZ; Flier, S; Vogt, KN; Wijeysundera, DN				Jones, Philip M.; Cherry, Richard A.; Allen, Britney N.; Jenkyn, Krista M. Bray; Shariff, Salimah Z.; Flier, Suzanne; Vogt, Kelly N.; Wijeysundera, Duminda N.			Association Between Handover of Anesthesia Care and Adverse Postoperative Outcomes Among Patients Undergoing Major Surgery	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							TRANSITIONS; RISK; IMPACT	IMPORTANCE Handing over the care of a patient from one anesthesiologist to another occurs during some surgeries and might increase the risk of adverse outcomes. OBJECTIVE To assess whether complete handover of intraoperative anesthesia care is associated with higher likelihood of mortality or major complications compared with no handover of care. DESIGN, SETTING, AND PARTICIPANTS A retrospective population-based cohort study (April 1, 2009-March 31, 2015 set in the Canadian province of Ontario) of adult patients aged 18 years and older undergoing major surgeries expected to last at least 2 hours and requiring a hospital stay of at least 1 night. EXPOSURE Complete intraoperative handover of anesthesia care from one physician anesthesiologist to another compared with no handover of anesthesia care. MAIN OUTCOMES AND MEASURES The primary outcome was a composite of all-cause death, hospital readmission, or major postoperative complications, all within 30 postoperative days. Secondary outcomes were the individual components of the primary outcome. Inverse probability of exposure weighting based on the propensity score was used to estimate adjusted exposure effects. RESULTS Of the 313 066 patients in the cohort, 56% were women; the mean (SD) age was 60 (16) years; 49% of surgeries were performed in academic centers; 72% of surgeries were elective; and the median duration of surgery was 182 minutes (interquartile [IQR] range, 124-255). A total of 5941 (1.9%) patients underwent surgery with complete handover of anesthesia care. The percentage of patients undergoing surgery with a handover of anesthesiology care progressively increased each year of the study, reaching 2.9% in 2015. In the unweighted sample, the primary outcome occurred in 44% of the complete handover group compared with 29% of the no handover group. After adjustment, complete handovers were statistically significantly associated with an increased risk of the primary outcome (adjusted risk difference [aRD], 6.8%[95% CI, 4.5% to 9.1%]; P<.001), all-cause death (aRD, 1.2%[95% CI, 0.5% to 2%]; P=.002), and major complications (aRD, 5.8% [95% CI, 3.6% to 7.9%]; P<.001), but not with hospital readmission within 30 days of surgery (aRD, 1.2%[95% CI, -0.3% to 2.7%]; P=.11). CONCLUSIONS AND RELEVANCE Among adults undergoing major surgery, complete handover of intraoperative anesthesia care compared with no handover was associated with a higher risk of adverse postoperative outcomes. These findings may support limiting complete anesthesia handovers.	[Jones, Philip M.; Cherry, Richard A.; Flier, Suzanne] Univ Western Ontario, Dept Anesthesia & Perioperat Med, London, ON, Canada; [Jones, Philip M.] Univ Western Ontario, Dept Epidemiol & Biostat, London, ON, Canada; [Allen, Britney N.; Jenkyn, Krista M. Bray; Shariff, Salimah Z.] Western Site ICES Western, Inst Clin Evaluat Sci, London, ON, Canada; [Shariff, Salimah Z.] Univ Western Ontario, Arthur Labatt Sch Nursing, London, ON, Canada; [Vogt, Kelly N.] Univ Western Ontario, Dept Surg, London, ON, Canada; [Wijeysundera, Duminda N.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Toronto, ON, Canada; [Wijeysundera, Duminda N.] Toronto Gen Hosp, Dept Anesthesia & Pain Management, Toronto, ON, Canada; [Wijeysundera, Duminda N.] Univ Toronto, Dept Anesthesia, Toronto, ON, Canada; [Wijeysundera, Duminda N.] Cent Site ICES Cent, Inst Clin Evaluat Sci, Toronto, ON, Canada; [Wijeysundera, Duminda N.] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University of Toronto; University of Toronto	Jones, PM (corresponding author), Univ Hosp London, Hlth Sci Ctr, Room C3-110,339 Windermere Rd, London, ON N6A 5A5, Canada.	philip.jones@lhsc.on.ca	Flier, Suzanne/ABA-5167-2020; Wijeysundera, Duminda/L-3350-2018; Jones, Philip/AAI-5640-2020	Flier, Suzanne/0000-0001-8667-6439; Wijeysundera, Duminda/0000-0002-5897-8605; Jones, Philip/0000-0003-2296-6327; Shariff, Salimah/0000-0002-1219-6763	Canadian Institutes of Health Research; Department of Anesthesia at the University of Toronto; Department of Anesthesia and Perioperative Medicine at the University of Western Ontario; Ontario Ministry of Health and Long-term Care (MOHLTC); Academic Medical Organization of Southwestern Ontario (AMOSO); Schulich School of Medicine and Dentistry (SSMD), The University of Western Ontario; Lawson Health Research Institute (LHRI)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Department of Anesthesia at the University of Toronto(University of Toronto); Department of Anesthesia and Perioperative Medicine at the University of Western Ontario; Ontario Ministry of Health and Long-term Care (MOHLTC)(Ministry of Health and Long-Term Care, Ontario); Academic Medical Organization of Southwestern Ontario (AMOSO); Schulich School of Medicine and Dentistry (SSMD), The University of Western Ontario; Lawson Health Research Institute (LHRI)	Dr Wijeysundera is supported in part by a New Investigator Award from the Canadian Institutes of Health Research and a Merit Award from the Department of Anesthesia at the University of Toronto. This study was supported by the Department of Anesthesia and Perioperative Medicine at the University of Western Ontario. This project was conducted at the Institute for Clinical Evaluative Sciences (ICES) Western Site. ICES is funded by annual grants from the Ontario Ministry of Health and Long-term Care (MOHLTC). Core funding for ICES Western is provided by the Academic Medical Organization of Southwestern Ontario (AMOSO), the Schulich School of Medicine and Dentistry (SSMD), The University of Western Ontario, and the Lawson Health Research Institute (LHRI).	Abraham J, 2014, J AM MED INFORM ASSN, V21, P154, DOI 10.1136/amiajnl-2012-001351; Ahmed N, 2014, ANN SURG, V259, P1041, DOI 10.1097/SLA.0000000000000595; Austin PC, 2015, STAT MED, V34, P3661, DOI 10.1002/sim.6607; Austin PC, 2010, STAT MED, V29, P2137, DOI 10.1002/sim.3854; Benchimol EI, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001885; Haukoos JS, 2015, JAMA-J AM MED ASSOC, V314, P1637, DOI 10.1001/jama.2015.13480; Howard SK, 2002, ANESTHESIOLOGY, V97, P1281; Hudson CCC, 2015, J CARDIOTHOR VASC AN, V29, P11, DOI 10.1053/j.jvca.2014.05.018; Hyder JA, 2016, ANESTH ANALG, V122, P134, DOI 10.1213/ANE.0000000000000692; Irony TZ, 2017, JAMA-J AM MED ASSOC, V318, P1820, DOI 10.1001/jama.2017.14001; Saager L, 2014, ANESTHESIOLOGY, V121, P695, DOI 10.1097/ALN.0000000000000401; Sterne Jonathan A C, 2009, BMJ, V338, pb2393, DOI 10.1136/bmj.b2393; Tenedios CN, 2016, J ANESTH HIST, V2, P120, DOI [10.1016/j.janh.2016.03.019, DOI 10.1016/J.JANH.2016.03.019]; Terekhov MA, 2016, ANESTHESIOLOGY, V125, P690, DOI 10.1097/ALN.0000000000001246; Ukoumunne OC, 2010, STAT MED, V29, P3126, DOI 10.1002/sim.3935; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Weir E, 2010, CAN J PUBLIC HEALTH, V101, P396, DOI 10.1007/BF03404860; Weiser TG, 2015, LANCET, V385, P11, DOI 10.1016/S0140-6736(15)60806-6	18	71	71	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2018	319	2					143	153		10.1001/jama.2017.20040	http://dx.doi.org/10.1001/jama.2017.20040			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS4PR	29318277	Bronze, Green Published			2022-12-28	WOS:000419775500014
J	Kim, Y; Chen, J				Kim, Youngjin; Chen, Jue			Molecular structure of human P-glycoprotein in the ATP-bound, outward-facing conformation	SCIENCE			English	Article							NUCLEOTIDE-BINDING DOMAINS; MULTIDRUG-RESISTANCE; CATALYTIC CYCLE; DRUG-BINDING; MEMBRANE GLYCOPROTEIN; GLUTAMATE RESIDUES; ALTERNATING ACCESS; ABC TRANSPORTERS; CELLS; HYDROLYSIS	The multidrug transporter permeability (P)-glycoprotein is an adenosine triphosphate (ATP)-binding cassette exporter responsible for clinical resistance to chemotherapy. P-glycoprotein extrudes toxic molecules and drugs from cells through ATP-powered conformational changes. Despite decades of effort, only the structures of the inward-facing conformation of P-glycoprotein are available. Here we present the structure of human P-glycoprotein in the outward-facing conformation, determined by cryo-electron microscopy at 3.4-angstrom resolution. The two nucleotide-binding domains form a closed dimer occluding two ATP molecules. The drug-binding cavity observed in the inward-facing structures is reorientated toward the extracellular space and compressed to preclude substrate binding. This observation indicates that ATP binding, not hydrolysis, promotes substrate release. The structure evokes a model in which the dynamic nature of P-glycoprotein enables translocation of a large variety of substrates.	[Kim, Youngjin; Chen, Jue] Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	Chen, J (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10065 USA.	juechen@rockefeller.edu		kim, youngjin/0000-0001-6505-9212	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750; ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; Ambudkar SV, 1998, METHOD ENZYMOL, V292, P504; AZZARIA M, 1989, MOL CELL BIOL, V9, P5289, DOI 10.1128/MCB.9.12.5289; Barsony O, 2016, SCI REP-UK, V6, DOI 10.1038/srep24810; Carrier I, 2008, FEBS J, V275, P3312, DOI 10.1111/j.1742-4658.2008.06479.x; Chen L, 2012, DRUG DISCOV TODAY, V17, P343, DOI 10.1016/j.drudis.2011.11.003; DANO K, 1973, BIOCHIM BIOPHYS ACTA, V323, P466, DOI 10.1016/0005-2736(73)90191-0; Esser L, 2017, J BIOL CHEM, V292, P446, DOI 10.1074/jbc.M116.755884; Frank GA, 2016, MOL PHARMACOL, V90, P35, DOI 10.1124/mol.116.104190; Gottesman MM, 2006, FEBS LETT, V580, P998, DOI 10.1016/j.febslet.2005.12.060; HAMADA H, 1988, CANCER RES, V48, P4926; HAMADA H, 1988, J BIOL CHEM, V263, P1454; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; Hrycyna CA, 1998, J BIOL CHEM, V273, P16631, DOI 10.1074/jbc.273.27.16631; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kerr KM, 2001, J BIOL CHEM, V276, P8657, DOI 10.1074/jbc.M010044200; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Kodan A, 2014, P NATL ACAD SCI USA, V111, P4049, DOI 10.1073/pnas.1321562111; Loo TW, 2017, BIOCHEM BIOPH RES CO, V483, P366, DOI 10.1016/j.bbrc.2016.12.137; Lotsch J, 2002, CLIN PHARMACOKINET, V41, P31, DOI 10.2165/00003088-200241010-00004; Martin C, 2000, BIOCHEMISTRY-US, V39, P11901, DOI 10.1021/bi000559b; Martin C, 2001, BIOCHEMISTRY-US, V40, P15733, DOI 10.1021/bi011211z; Mechetner EB, 1997, P NATL ACAD SCI USA, V94, P12908, DOI 10.1073/pnas.94.24.12908; Mizuno N, 2003, PHARMACOL REV, V55, P425, DOI 10.1124/pr.55.3.1; Moeller A, 2015, STRUCTURE, V23, P450, DOI 10.1016/j.str.2014.12.013; RONINSON IB, 1984, NATURE, V309, P626, DOI 10.1038/309626a0; RONINSON IB, 1986, P NATL ACAD SCI USA, V83, P4538, DOI 10.1073/pnas.83.12.4538; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Sankaran B, 1997, BIOCHEMISTRY-US, V36, P6847, DOI 10.1021/bi970034s; SARKADI B, 1992, J BIOL CHEM, V267, P4854; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7; SHAROM FJ, 1995, BIOCHEM J, V308, P381, DOI 10.1042/bj3080381; SHEN DW, 1986, SCIENCE, V232, P643, DOI 10.1126/science.3457471; Sonveaux N, 1999, J BIOL CHEM, V274, P17649, DOI 10.1074/jbc.274.25.17649; Sun J, 2004, MED SCI MONITOR, V10, pRA5; THIEBAUT F, 1987, P NATL ACAD SCI USA, V84, P7735, DOI 10.1073/pnas.84.21.7735; Tombline G, 2005, BIOCHEMISTRY-US, V44, P12879, DOI 10.1021/bi0509797; Tombline G, 2004, J BIOL CHEM, V279, P31212, DOI 10.1074/jbc.M404689200; Tombline G, 2004, J BIOL CHEM, V279, P46518, DOI 10.1074/jbc.M408052200; UEDA K, 1986, BIOCHEM BIOPH RES CO, V141, P956, DOI 10.1016/S0006-291X(86)80136-X; Urbatsch IL, 2000, BIOCHEMISTRY-US, V39, P11921, DOI 10.1021/bi001220s; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Verhalen B, 2017, NATURE, V543, P738, DOI 10.1038/nature21414; Wang Z, 2011, J CHEM INF MODEL, V51, P1447, DOI 10.1021/ci2001583; Zoghbi ME, 2017, J BIOL CHEM, V292, P20412, DOI 10.1074/jbc.M117.814186; Zolnerciks JK, 2007, FASEB J, V21, P3937, DOI 10.1096/fj.07-8610com; Zolnerciks JK, 2014, FASEB J, V28, P4335, DOI 10.1096/fj.13-245639	52	237	242	3	90	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2018	359	6378					915	919		10.1126/science.aar7389	http://dx.doi.org/10.1126/science.aar7389			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX0QX	29371429				2022-12-28	WOS:000425752600045
J	Kong, A; Thorleifsson, G; Frigge, ML; Vilhjalmsson, BJ; Young, AI; Thorgeirsson, TE; Benonisdottir, S; Oddsson, A; Halldorsson, BV; Masson, G; Gudbjartsson, DF; Helgason, A; Bjornsdottir, G; Thorsteinsdottir, U; Stefansson, K				Kong, Augustine; Thorleifsson, Gudmar; Frigge, Michael L.; Vilhjalmsson, Bjarni J.; Young, Alexander I.; Thorgeirsson, Thorgeir E.; Benonisdottir, Stefania; Oddsson, Asmundur; Halldorsson, Bjarni V.; Masson, Gisli; Gudbjartsson, Daniel F.; Helgason, Agnar; Bjornsdottir, Gyda; Thorsteinsdottir, Unnur; Stefansson, Kari			The nature of nurture: Effects of parental genotypes	SCIENCE			English	Article							GENOME-WIDE ASSOCIATION; ADULT HUMAN HEIGHT; SEQUENCE VARIANTS; LINKAGE DISEQUILIBRIUM; EDUCATIONAL-ATTAINMENT; TRAITS; HERITABILITY; DISEASE; LOCI; ACHIEVEMENT	Sequence variants in the parental genomes that are not transmitted to a child (the proband) are often ignored in genetic studies. Here we show that nontransmitted alleles can affect a child through their impacts on the parents and other relatives, a phenomenon we call "genetic nurture." Using results from a meta-analysis of educational attainment, we find that the polygenic score computed for the nontransmitted alleles of 21,637 probands with at least one parent genotyped has an estimated effect on the educational attainment of the proband that is 29.9% (P = 1.6 x 10(-14)) of that of the transmitted polygenic score. Genetic nurturing effects of this polygenic score extend to other traits. Paternal and maternal polygenic scores have similar effects on educational attainment, but mothers contribute more than fathers to nutrition-and heath-related traits.	[Kong, Augustine; Thorleifsson, Gudmar; Frigge, Michael L.; Young, Alexander I.; Thorgeirsson, Thorgeir E.; Benonisdottir, Stefania; Oddsson, Asmundur; Halldorsson, Bjarni V.; Masson, Gisli; Gudbjartsson, Daniel F.; Helgason, Agnar; Bjornsdottir, Gyda; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet Amgen, IS-101 Reykjavik, Iceland; [Kong, Augustine; Young, Alexander I.] Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Big Data Inst, Oxford OX3 7LF, England; [Kong, Augustine; Gudbjartsson, Daniel F.] Univ Iceland, Sch Engn & Nat Sci, IS-101 Reykjavik, Iceland; [Vilhjalmsson, Bjarni J.] Aarhus Univ, Bioinformat Res Ctr, DK-8000 Aarhus, Denmark; [Vilhjalmsson, Bjarni J.] Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Young, Alexander I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Helgason, Agnar] Univ Iceland, Dept Anthropol, IS-101 Reykjavik, Iceland; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland	University of Oxford; University of Iceland; Aarhus University; Harvard University; Harvard T.H. Chan School of Public Health; University of Oxford; Wellcome Centre for Human Genetics; University of Iceland; University of Iceland	Kong, A; Stefansson, K (corresponding author), deCODE Genet Amgen, IS-101 Reykjavik, Iceland.; Kong, A (corresponding author), Univ Oxford, Li Ka Shing Ctr Hlth Informat & Discovery, Big Data Inst, Oxford OX3 7LF, England.; Kong, A (corresponding author), Univ Iceland, Sch Engn & Nat Sci, IS-101 Reykjavik, Iceland.	augustine.kong@bdi.ox.ac.uk; kstefans@decode.is	Stefansson, Kari/AAE-7187-2019; Vilhjálmsson, Bjarni/ABC-1369-2020	Vilhjálmsson, Bjarni/0000-0003-2277-9249; Kong, Augustine/0000-0001-8193-5438; Masson, Gisli/0000-0003-0493-8242; Bjornsdottir, Gyda/0000-0002-8100-0306; Helgason, Agnar/0000-0002-8545-3767				Allison DB, 1997, AM J HUM GENET, V60, P676; Barban N, 2016, NAT GENET, V48, P1462, DOI 10.1038/ng.3698; Benonisdottir S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13490; Bulik-Sullivan B, 2015, NAT GENET, V47, P1236, DOI 10.1038/ng.3406; Bulik-Sullivan BK, 2015, NAT GENET, V47, P291, DOI 10.1038/ng.3211; Dawkins R., 1982, pi; Falconer DS, 1996, INTRO QUANTITATIVE G; Flannick J, 2014, NAT GENET, V46, P357, DOI 10.1038/ng.2915; GRIFFING B, 1967, AUST J BIOL SCI, V20, P127, DOI 10.1071/BI9670127; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Helgadottir A, 2016, NAT GENET, V48, P634, DOI 10.1038/ng.3561; Hill NE, 2009, DEV PSYCHOL, V45, P740, DOI 10.1037/a0015362; Kong A, 2009, NATURE, V462, P868, DOI 10.1038/nature08625; Krapohl E, 2014, P NATL ACAD SCI USA, V111, P15273, DOI 10.1073/pnas.1408777111; Locke AE, 2015, NATURE, V518, P197, DOI 10.1038/nature14177; Lynch M., 1998, GENETICS ANAL QUANTI; MEYER K, 1992, LIVEST PROD SCI, V31, P179, DOI 10.1016/0301-6226(92)90017-X; Nicoletti Cheti, 2014, 8615 IZA; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Plomin R, 2014, BEHAV GENET, V44, P629, DOI 10.1007/s10519-014-9673-7; Polderman TJC, 2015, NAT GENET, V47, P702, DOI 10.1038/ng.3285; Richmond RC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002221; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Rietveld MJH, 2003, BEHAV GENET, V33, P247, DOI 10.1023/A:1023490307170; Robinson MR, 2017, NAT HUM BEHAV, V1, DOI 10.1038/s41562-016-0016; SPIELMAN RS, 1993, AM J HUM GENET, V52, P506; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; Vilhjalmsson BJ, 2015, AM J HUM GENET, V97, P576, DOI 10.1016/j.ajhg.2015.09.001; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Wray NR, 2007, GENOME RES, V17, P1520, DOI 10.1101/gr.6665407; Yang JA, 2011, AM J HUM GENET, V88, P76, DOI 10.1016/j.ajhg.2010.11.011; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Young A., BIORXIV; Zhang G, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001865	35	357	359	9	89	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					424	428		10.1126/science.aan6877	http://dx.doi.org/10.1126/science.aan6877			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6SD	29371463	Green Submitted			2022-12-28	WOS:000423283200039
J	Gupta, A; Jain, P				Gupta, Ankur; Jain, Priyanka			Calcified Spleen and Gallstones	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gupta, Ankur; Jain, Priyanka] Max Super Specialty Hosp, Dehra Dun, Uttar Pradesh, India		Gupta, A (corresponding author), Max Super Specialty Hosp, Dehra Dun, Uttar Pradesh, India.	mail.guptaankur@gmail.com		Gupta, Ankur/0000-0001-5917-2382					0	0	0	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 25	2018	378	4					380	380		10.1056/NEJMicm1703915	http://dx.doi.org/10.1056/NEJMicm1703915			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT5ZX	29365300				2022-12-28	WOS:000423233400011
J	Haselbach, D; Komarov, I; Agafonov, DE; Hartmuth, K; Graf, B; Dybkov, O; Urlaub, H; Kastner, B; Luhrmann, R; Stark, H				Haselbach, David; Komarov, Ilya; Agafonov, Dmitry E.; Hartmuth, Klaus; Graf, Benjamin; Dybkov, Olexandr; Urlaub, Henning; Kastner, Berthold; Luehrmann, Reinhard; Stark, Holger			Structure and Conformational Dynamics of the Human Spliceosomal B-act Complex	CELL			English	Article							CRYO-EM STRUCTURE; MOLECULAR ARCHITECTURE; CATALYTIC ACTIVATION; STEP; SNRNP; MODEL	The spliceosome is a highly dynamic macromolecular complex that precisely excises introns from pre-mRNA. Here we report the cryo-EM 3D structure of the human B-act spliceosome at 3.4 angstrom resolution. In the B-act state, the spliceosome is activated but not catalytically primed, so that it is functionally blocked prior to the first catalytic step of splicing. The spliceosomal core is similar to the yeast B-act spliceosome; important differences include the presence of the RNA helicase aquarius and peptidyl prolyl isomerases. To examine the overall dynamic behavior of the purified spliceosome, we developed a principal component analysis-based approach. Calculating the energy landscape revealed eight major conformational states, which we refined to higher resolution. Conformational differences of the highly flexible structural components between these eight states reveal how spliceosomal components contribute to the assembly of the spliceosome, allowing it to generate a dynamic interaction network required for its subsequent catalytic activation.	[Haselbach, David; Graf, Benjamin; Stark, Holger] Max Planck Inst Biophys Chem, Dept Struct Dynam, Fassberg 11, D-37077 Gottingen, Germany; [Komarov, Ilya; Agafonov, Dmitry E.; Hartmuth, Klaus; Dybkov, Olexandr; Kastner, Berthold; Luehrmann, Reinhard] Max Planck Inst Biophys Chem, Dept Cellular Biochem, Fassberg 11, D-37077 Gottingen, Germany; [Urlaub, Henning] Max Planck Inst Biophys Chem, Bioanalyt Mass Spectrometry Grp, Fassberg 11, D-37077 Gottingen, Germany; [Urlaub, Henning] Univ Med Ctr Gottingen, Inst Clin Chem, Bioanalyt Grp, Robert Koch Str 40, D-37073 Gottingen, Germany; [Haselbach, David] Res Inst Mol Pathol, Campus Vienna Bioctr 1, A-1030 Vienna, Austria	Max Planck Society; Max Planck Society; Max Planck Society; University of Gottingen; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Stark, H (corresponding author), Max Planck Inst Biophys Chem, Dept Struct Dynam, Fassberg 11, D-37077 Gottingen, Germany.; Luhrmann, R (corresponding author), Max Planck Inst Biophys Chem, Dept Cellular Biochem, Fassberg 11, D-37077 Gottingen, Germany.	reinhard.luehrmann@mpi-bpc.mpg.de; hstark1@gwdg.de		Haselbach, David/0000-0002-5276-5633				Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Agafonov DE, 2016, SCIENCE, V351, P1416, DOI 10.1126/science.aad2085; Agafonov DE, 2011, MOL CELL BIOL, V31, P2667, DOI 10.1128/MCB.05266-11; Bai R, 2017, CELL, V171, P1589, DOI 10.1016/j.cell.2017.10.038; Bertram K, 2017, CELL, V170, P701, DOI 10.1016/j.cell.2017.07.011; Bertram K, 2017, NATURE, V542, P318, DOI 10.1038/nature21079; Bessonov S, 2010, RNA, V16, P2384, DOI 10.1261/rna.2456210; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Chan SP, 2003, SCIENCE, V302, P279, DOI 10.1126/science.1086602; Cretu C, 2016, MOL CELL, V64, P307, DOI 10.1016/j.molcel.2016.08.036; De I, 2015, NAT STRUCT MOL BIOL, V22, P138, DOI 10.1038/nsmb.2951; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fabrizio P, 2009, MOL CELL, V36, P593, DOI 10.1016/j.molcel.2009.09.040; Fica SM, 2017, NATURE, V542, P377, DOI 10.1038/nature21078; Fica SM, 2014, NAT STRUCT MOL BIOL, V21, P464, DOI 10.1038/nsmb.2815; Fica SM, 2013, NATURE, V503, P229, DOI 10.1038/nature12734; Fischer N, 2010, NATURE, V466, P329, DOI 10.1038/nature09206; Galej WP, 2016, NATURE, V537, P197, DOI 10.1038/nature19316; Goddard TD, 2007, J STRUCT BIOL, V157, P281, DOI 10.1016/j.jsb.2006.06.010; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hang J, 2015, SCIENCE, V349, P1191, DOI 10.1126/science.aac8159; Haselbach D, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15578; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Kastner B, 2008, NAT METHODS, V5, P53, DOI 10.1038/NMETH1139; Kim SH, 1996, MOL CELL BIOL, V16, P6810; Korneta I, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002641; Kuwasako K, 2006, STRUCTURE, V14, P1677, DOI 10.1016/j.str.2006.09.009; Leitner A, 2014, NAT PROTOC, V9, P120, DOI 10.1038/nprot.2013.168; Lin PC, 2012, EMBO J, V31, P1579, DOI 10.1038/emboj.2012.7; Liu SH, 2017, SCIENCE, V358, P1278, DOI 10.1126/science.aar3462; Macias S, 2008, MOL CELL, V30, P732, DOI 10.1016/j.molcel.2008.05.002; Makarov EM, 2002, SCIENCE, V298, P2205, DOI 10.1126/science.1077783; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plaschka C, 2017, NATURE, V546, P617, DOI 10.1038/nature22799; Rauhut R, 2016, SCIENCE, V353, P1399, DOI 10.1126/science.aag1906; Scheres SHW, 2012, J STRUCT BIOL, V180, P519, DOI 10.1016/j.jsb.2012.09.006; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Nguyen THD, 2016, NATURE, V530, P298, DOI 10.1038/nature16940; Nguyen THD, 2015, NATURE, V523, P47, DOI 10.1038/nature14548; Ulrich A, 2014, ACTA CRYSTALLOGR D, V70, P3110, DOI 10.1107/S1399004714021695; Van Roon AMM, 2017, RNA, V23, P968, DOI 10.1261/rna.059378.116; Wan RX, 2017, CELL, V171, P120, DOI 10.1016/j.cell.2017.08.029; Wan RX, 2016, SCIENCE, V353, P895, DOI 10.1126/science.aag2235; Wilkinson ME, 2017, SCIENCE, V358, P1283, DOI 10.1126/science.aar3729; Xu C, 2006, J BIOL CHEM, V281, P15900, DOI 10.1074/jbc.M511155200; Yan CY, 2017, SCIENCE, V355, P149, DOI 10.1126/science.aak9979; Yan CY, 2016, SCIENCE, V353, P904, DOI 10.1126/science.aag0291; Yang B, 2012, NAT METHODS, V9, P904, DOI 10.1038/nmeth.2099; Yean SL, 2000, NATURE, V408, P881, DOI 10.1038/35048617; Zhang K, 2016, J STRUCT BIOL, V193, P1, DOI 10.1016/j.jsb.2015.11.003; Zhang XF, 2017, CELL, V169, P918, DOI 10.1016/j.cell.2017.04.033; Zheng SQ, 2017, NAT METHODS, V14, P331, DOI 10.1038/nmeth.4193	53	113	114	1	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2018	172	3					454	+		10.1016/j.cell.2018.01.010	http://dx.doi.org/10.1016/j.cell.2018.01.010			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FT9BS	29361316	Bronze, Green Published			2022-12-28	WOS:000423447600007
J	Robinson, F				Robinson, Fran			From cost cutting to conversation: how two CCGs and a hospitals trust turned financial deficit into communication bonus	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												fran.robinson8@gmail.com							0	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 23	2018	360								k306	10.1136/bmj.k306	http://dx.doi.org/10.1136/bmj.k306			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU2WS	29363501				2022-12-28	WOS:000423711300009
J	Rana, MS; Kumar, P; Lee, CJ; Verardi, R; Rajashankar, KR; Banerjee, A				Rana, Mitra S.; Kumar, Pramod; Lee, Chul-Jin; Verardi, Raffaello; Rajashankar, Kanagalaghatta R.; Banerjee, Anirban			Fatty acyl recognition and transfer by an integral membrane S-acyltransferase	SCIENCE			English	Article							CYSTEINE-RICH DOMAIN; PALMITOYL ACYLTRANSFERASE; DUAL PALMITOYLATION; ACYLATION; PROTEINS; ACID; LOCALIZATION; PALMITOYLTRANSFERASE; IDENTIFICATION; SELECTIVITY	DHHC (Asp-His-His-Cys) palmitoyltransferases are eukaryotic integral membrane enzymes that catalyze protein palmitoylation, which is important in a range of physiological processes, including small guanosine triphosphatase (GTPase) signaling, cell adhesion, and neuronal receptor scaffolding. We present crystal structures of two DHHC palmitoyltransferases and a covalent intermediate mimic. The active site resides at the membrane-cytosol interface, which allows the enzyme to catalyze thioester-exchange chemistry by using fatty acyl-coenzyme A and explains why membrane-proximal cysteines are candidates for palmitoylation. The acyl chain binds in a cavity formed by the transmembrane domain. We propose a mechanism for acyl chain-length selectivity in DHHC enzymes on the basis of cavity mutants with preferences for shorter and longer acyl chains.	[Rana, Mitra S.; Kumar, Pramod; Lee, Chul-Jin; Verardi, Raffaello; Banerjee, Anirban] NICHHD, Cell Biol & Neurobiol Branch, NIH, Bethesda, MD 20892 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, Northeastern Collaborat Access Team NE CAT, Bldg 436E,9700 South Cass Ave, Argonne, IL 60439 USA; [Rajashankar, Kanagalaghatta R.] Cornell Univ, Argonne Natl Lab, Dept Chem & Chem Biol, Bldg 436E,9700 South Cass Ave, Argonne, IL 60439 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Cornell University; United States Department of Energy (DOE); Argonne National Laboratory; Cornell University; United States Department of Energy (DOE); Argonne National Laboratory	Banerjee, A (corresponding author), NICHHD, Cell Biol & Neurobiol Branch, NIH, Bethesda, MD 20892 USA.	anirban.banerjee@nih.gov	Banerjee, Anirban/AAC-4286-2020	Banerjee, Anirban/0000-0002-9314-2862; banerjee, anirban/0000-0003-1494-6801; Rana, Mitra/0000-0002-0915-8141; Lee, Chul-Jin/0000-0003-2905-3379; Verardi, Raffaello/0000-0002-2613-1223; Kumar, Pramod/0000-0003-3869-9067	Intramural Research Program of the NIH; National Institutes of Child Health and Human Development [1ZIAHD008928]; National Institute of Neurological Disorders and Stroke; National Institute of General Medical Sciences from the NIH [P41 GM103403]; NIH-ORIP HEI grant [S10RR029205]; National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; NIH, Office of Research Infrastructure Programs, High-End Instrumentation Grant [1S10OD012289-01A1]; DOE Office of Science [DE-AC02-06CH11357]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008928] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD012289] Funding Source: NIH RePORTER	Intramural Research Program of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of General Medical Sciences from the NIH; NIH-ORIP HEI grant; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH, Office of Research Infrastructure Programs, High-End Instrumentation Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE Office of Science(United States Department of Energy (DOE)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank M. Machner (NIH) for the GobX protein expression plasmid, E. Gouaux (Oregon Health & Science University) for the pEG-Bacmam vector, Y. Li (NIH) for mass spectrometry, C. Williamson (NIH) for help with confocal microscopy, and J. Swan (NIH) for help with the figure accompanying the print version of the manuscript. The authors thank J. Bonifacino (NIH), S. Buchanan (NIH), W. Prinz (NIH), G. Storz (NIH), K. Swartz (NIH), and W. Yang (NIH) for comments on the manuscript. This work was supported by the Intramural Research Program of the NIH, the National Institutes of Child Health and Human Development (1ZIAHD008928 to M.S.R., P.K., C.-J.L., R.V., and A.B.), and the National Institute of Neurological Disorders and Stroke (to R.V. and A.B.). Crystals for this project were screened and data sets collected at various stages at the following beamlines: NE-CAT, GM/CA, and SER-CAT (22-ID) at the Advanced Photon Source, Argonne National Laboratory. NE-CAT is funded by the National Institute of General Medical Sciences from the NIH (P41 GM103403). The Pilatus 6M detector on 24-ID-C beamline (NE-CAT) is funded by a NIH-ORIP HEI grant (S10RR029205). GM/CA has been funded in whole or in part with federal funds from the National Cancer Institute (ACB-12002) and the National Institute of General Medical Sciences (AGM-12006). The Eiger 16M detector (GM/CA) was funded by an NIH, Office of Research Infrastructure Programs, High-End Instrumentation Grant (1S10OD012289-01A1). This research used resources of the Advanced Photon Source, a U.S. Department of Energy (DOE), Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under contract no. DE-AC02-06CH11357. The structures have been deposited to the Protein Data Bank (PDB) with the accession codes 6BML (hDHHC20-2-BP treated), 6BMM (hDHHC20, P2<INF>1</INF> form), 6BMN (hDHHC20, P6<INF>3</INF> form), and 6BMS (zfDHHS15). All data needed to evaluate the conclusions in the paper are present in the main text or supplementary materials. A.B. conceived the project. A.B., M.S.R., and P.K. designed experiments. M.R. performed expression, purification, crystallization, data collection, and biochemical and imaging experiments of DHHC20. P.K. performed expression, purification, crystallization, data collection, crystallography, and imaging experiments of zfDHHC15. C.-J.L. performed crystallography of hDHHC20, and R.V. performed biochemical assays of zfDHHC15. K.R.R. assisted with crystallography. A.B. contributed to crystallization, data collection, and crystallography. M. S. R., P.K., C.-J.L., R.V., K.R.R., and A.B. analyzed data. A.B. wrote the manuscript with help from M.S.R., C.-J.L., and P.K. helped in figure preparation. The authors declare no competing financial interests.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Banhegyi G, 1996, BIOCHEM J, V320, P343, DOI 10.1042/bj3200343; Baud MGJ, 2014, SCIENCE, V346, P638, DOI 10.1126/science.1249830; BERTHIAUME L, 1995, J BIOL CHEM, V270, P22399, DOI 10.1074/jbc.270.38.22399; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Blanc Mathieu, 2015, F1000Res, V4, P261, DOI 10.12688/f1000research.6464.1; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chamberlain LH, 2015, PHYSIOL REV, V95, P341, DOI 10.1152/physrev.00032.2014; COLEMAN RA, 1992, BIOCHIM BIOPHYS ACTA, V1125, P203, DOI 10.1016/0005-2760(92)90046-X; Daniotti JL, 2017, TRAFFIC, V18, P699, DOI 10.1111/tra.12510; Davda D, 2013, ACS CHEM BIOL, V8, P1912, DOI 10.1021/cb400380s; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; Draper JM, 2010, MOL MEMBR BIOL, V27, P123, DOI 10.3109/09687681003616854; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; El-Husseini AE, 2000, J CELL BIOL, V148, P159, DOI 10.1083/jcb.148.1.159; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fukata M, 2004, NEURON, V44, P987, DOI 10.1016/j.neuron.2004.12.005; Gamsjaeger R, 2007, TRENDS BIOCHEM SCI, V32, P63, DOI 10.1016/j.tibs.2006.12.007; Goehring A, 2014, NAT PROTOC, V9, P2574, DOI 10.1038/nprot.2014.173; Gonzalez Montoro A, 2013, BIOCHEM J, V454, P427, DOI 10.1042/BJ20121693; Montoro AG, 2009, BIOCHEM J, V419, P301, DOI 10.1042/BJ20080921; Gottlieb CD, 2015, J BIOL CHEM, V290, P29259, DOI 10.1074/jbc.M115.691147; Greaves J, 2017, P NATL ACAD SCI USA, V114, pE1365, DOI 10.1073/pnas.1612254114; Hamel LD, 2014, ANAL BIOCHEM, V460, P1, DOI 10.1016/j.ab.2014.05.013; Hayashi T, 2009, NEURON, V64, P213, DOI 10.1016/j.neuron.2009.08.017; Hentschel A, 2016, PROTEOMICS, V16, P759, DOI 10.1002/pmic.201500353; Hernandez JL, 2017, CELL CHEM BIOL, V24, P87, DOI 10.1016/j.chembiol.2016.12.007; Hicks SW, 2011, CELL HOST MICROBE, V10, P9, DOI 10.1016/j.chom.2011.06.003; Huang K, 2004, NEURON, V44, P977, DOI 10.1016/j.neuron.2004.11.027; Jennings BC, 2012, J BIOL CHEM, V287, P7236, DOI 10.1074/jbc.M111.337246; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; Khoury GA, 2011, SCI REP-UK, V1, DOI 10.1038/srep00090; Kordyukova LV, 2008, J VIROL, V82, P9288, DOI 10.1128/JVI.00704-08; Krishna SS, 2003, NUCLEIC ACIDS RES, V31, P532, DOI 10.1093/nar/gkg161; Liang XQ, 2001, J BIOL CHEM, V276, P30987, DOI 10.1074/jbc.M104018200; Lin YH, 2015, J BIOL CHEM, V290, P25766, DOI 10.1074/jbc.M115.637397; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Lobo S, 2002, J BIOL CHEM, V277, P41268, DOI 10.1074/JBC.M206573200; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Longo PA, 2013, METHOD ENZYMOL, V529, P227, DOI 10.1016/B978-0-12-418687-3.00018-5; Lorenz H, 2006, NAT METHODS, V3, P205, DOI 10.1038/nmeth857; Manglik A, 2014, CURR OPIN CELL BIOL, V27, P136, DOI 10.1016/j.ceb.2014.01.008; Martin BR, 2012, NAT METHODS, V9, P84, DOI [10.1038/NMETH.1769, 10.1038/nmeth.1769]; Mill P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000748; Mitchell DA, 2010, J BIOL CHEM, V285, P38104, DOI 10.1074/jbc.M110.169102; Muszbek L, 1999, LIPIDS, V34, pS331, DOI 10.1007/BF02562334; MYERS LC, 1995, J BIOL CHEM, V270, P6664, DOI 10.1074/jbc.270.12.6664; OBRIEN PJ, 1987, J BIOL CHEM, V262, P5210; Ohno Y, 2006, BBA-MOL CELL BIOL L, V1761, P474, DOI 10.1016/j.bbalip.2006.03.010; Oswald C, 2016, NATURE, V540, P462, DOI 10.1038/nature20606; Politis EG, 2005, J BIOL CHEM, V280, P10156, DOI 10.1074/jbc.M411946200; Rayment I, 1997, METHOD ENZYMOL, V276, P171, DOI 10.1016/S0076-6879(97)76058-0; Reddy KD, 2017, J BIOMOL STRUCT DYN, V35, P2337, DOI 10.1080/07391102.2016.1217275; REQUERO MA, 1995, FEBS LETT, V357, P75; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Rocks O, 2005, SCIENCE, V307, P1746, DOI 10.1126/science.1105654; Roth AF, 2002, J CELL BIOL, V159, P23, DOI 10.1083/jcb.200206120; Runkle KB, 2016, MOL CELL, V62, P385, DOI 10.1016/j.molcel.2016.04.003; Sanders SS, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004405; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SCHLESINGER MJ, 1980, J BIOL CHEM, V255, P21; SCHMIDT MFG, 1979, CELL, V17, P813, DOI 10.1016/0092-8674(79)90321-0; Senyilmaz D, 2015, NATURE, V525, P124, DOI 10.1038/nature14601; Shah K, 1997, P NATL ACAD SCI USA, V94, P3565, DOI 10.1073/pnas.94.8.3565; STANLEY CJ, 1980, BIOCHEM J, V191, P147, DOI 10.1042/bj1910147; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Word JM, 1999, J MOL BIOL, V285, P1711, DOI 10.1006/jmbi.1998.2400	67	110	114	2	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					176	+	eaao6326	10.1126/science.aao6326	http://dx.doi.org/10.1126/science.aao6326			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS5EO	29326245	Green Accepted			2022-12-28	WOS:000419816600038
J	Pastuzyn, ED; Day, CE; Kearns, RB; Kyrke-Smith, M; Taibi, AV; McCormick, J; Yoder, N; Belnap, DM; Erlendsson, S; Morado, DR; Briggs, JAG; Feschotte, C; Shepherd, JD				Pastuzyn, Elissa D.; Day, Cameron E.; Kearns, Rachel B.; Kyrke-Smith, Madeleine; Taibi, Andrew V.; McCormick, John; Yoder, Nathan; Belnap, David M.; Erlendsson, Simon; Morado, Dustin R.; Briggs, John A. G.; Feschotte, Cedric; Shepherd, Jason D.			The Neuronal Gene Arc Encodes a Repurposed Retrotransposon Gag Protein that Mediates Intercellular RNA Transfer	CELL			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; EXTRACELLULAR VESICLES; SYNAPTIC PLASTICITY; MESSENGER-RNAS; TRANSPOSABLE ELEMENTS; ANGELMAN SYNDROME; NERVOUS-SYSTEM; VISUAL-CORTEX; ARC/ARG3.1; SCHIZOPHRENIA	The neuronal gene Arc is essential for long-lasting information storage in the mammalian brain, mediates various forms of synaptic plasticity, and has been implicated in neurodevelopmental disorders. However, little is known about Arc's molecular function and evolutionary origins. Here, we show that Arc self-assembles into virus-like capsids that encapsulate RNA. Endogenous Arc protein is released from neurons in extracellular vesicles that mediate the transfer of Arc mRNA into new target cells, where it can undergo activity-dependent translation. Purified Arc capsids are endocytosed and are able to transfer Arc mRNA into the cytoplasm of neurons. These results showthat Arc exhibits similar molecular properties to retroviral Gag proteins. Evolutionary analysis indicates that Arc is derived from a vertebrate lineage of Ty3/gypsy retrotransposons, which are also ancestors to retroviruses. These findings suggest that Gag retroelements have been repurposed during evolution to mediate intercellular communication in the nervous system.	[Pastuzyn, Elissa D.; Day, Cameron E.; Kearns, Rachel B.; Kyrke-Smith, Madeleine; Taibi, Andrew V.; Yoder, Nathan; Shepherd, Jason D.] Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA; [McCormick, John; Feschotte, Cedric] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Belnap, David M.; Shepherd, Jason D.] Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA; [Belnap, David M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Erlendsson, Simon; Morado, Dustin R.; Briggs, John A. G.] Univ Copenhagen, Dept Biol, Copenhagen, Denmark; [Erlendsson, Simon] MRC Lab Mol Biol, Cambridge, England	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Copenhagen; MRC Laboratory Molecular Biology	Shepherd, JD (corresponding author), Univ Utah, Dept Neurobiol & Anat, Salt Lake City, UT 84112 USA.; Shepherd, JD (corresponding author), Univ Utah, Dept Biochem, Salt Lake City, UT 84112 USA.	jason.shepherd@neuro.utah.edu	Shepherd, Jason/N-8555-2018	Shepherd, Jason/0000-0001-7384-8289; Erlendsson, Simon/0000-0002-6378-870X	NIH [R00 NS076364, R01 MH112766, R01 GM77582, R01 GM112972]; University of Utah; MRC [MC_UP_1201/16] Funding Source: UKRI; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112972, P50GM082545, R35GM122550] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH112766] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Utah; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank Adam Frost and Raghav Kalia for technical assistance in the initial stages of this project. We thank Wesley Sundquist for helpful discussions and the Sundquist/Bass labs for experimental help and support. We thank Vivian Budnik for helpful discussions and sharing of unpublished data. We thank Kristen Keefe for experimental help with the FISH assay. We thank Jenifer Einstein and all members of the Shepherd lab for technical help and support. This work was supported by the NIH (R00 NS076364 and R01 MH112766 to J.D.S.; R01 GM77582 and R01 GM112972 to C.F.) and startup funds from the University of Utah (to J.D.S.).	Becker A, 2016, CANCER CELL, V30, P836, DOI 10.1016/j.ccell.2016.10.009; Bramham CR, 2010, EXP BRAIN RES, V200, P125, DOI 10.1007/s00221-009-1959-2; Budnik V, 2016, NAT REV NEUROSCI, V17, P160, DOI 10.1038/nrn.2015.29; Campbell S, 1999, J VIROL, V73, P2270, DOI 10.1128/JVI.73.3.2270-2279.1999; Campillos M, 2006, TRENDS GENET, V22, P585, DOI 10.1016/j.tig.2006.09.006; Carlson LA, 2016, ELIFE, V5, DOI 10.7554/eLife.14663; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Chuong EB, 2017, NAT REV GENET, V18, P71, DOI 10.1038/nrg.2016.139; Cornelis G, 2015, P NATL ACAD SCI USA, V112, pE487, DOI 10.1073/pnas.1417000112; Daberkow DP, 2007, EUR J NEUROSCI, V26, P228, DOI 10.1111/j.1460-9568.2007.05630.x; de Solis CA, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00314; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Feschotte C, 2012, NAT REV GENET, V13, P283, DOI 10.1038/nrg3199; Freed EO, 2015, NAT REV MICROBIOL, V13, P484, DOI 10.1038/nrmicro3490; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Ganser BK, 1999, SCIENCE, V283, P80, DOI 10.1126/science.283.5398.80; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Guzowski JF, 1999, NAT NEUROSCI, V2, P1120, DOI 10.1038/16046; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hamann M. V., 2016, VIRUSES, V8, P8; HANSEN LJ, 1992, J VIROL, V66, P1414, DOI 10.1128/JVI.66.3.1414-1424.1992; Heraud-Farlow JE, 2014, TRENDS NEUROSCI, V37, P470, DOI 10.1016/j.tins.2014.05.009; Irie M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005521; Kaneko-Ishino T, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00262; Korkut C, 2013, NEURON, V77, P1039, DOI 10.1016/j.neuron.2013.01.013; Kraft AW, 2017, P NATL ACAD SCI USA, V114, pE9952, DOI 10.1073/pnas.1711789114; Kutluay SB, 2014, CELL, V159, P1096, DOI 10.1016/j.cell.2014.09.057; Lachenal G, 2011, MOL CELL NEUROSCI, V46, P409, DOI 10.1016/j.mcn.2010.11.004; Lefebvre FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep27680; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mailler E, 2016, VIRUSES, P8; Malik HS, 2000, GENOME RES, V10, P1307, DOI 10.1101/gr.145000; Manago F, 2016, CELL REP, V16, P2116, DOI 10.1016/j.celrep.2016.07.044; Mattei S, 2016, CURR OPIN VIROL, V18, P27, DOI 10.1016/j.coviro.2016.02.008; McCurry CL, 2010, NAT NEUROSCI, V13, P450, DOI 10.1038/nn.2508; Mikuni T, 2013, NEURON, V78, P1024, DOI 10.1016/j.neuron.2013.04.036; Mouland AJ, 2000, J VIROL, V74, P5441, DOI 10.1128/JVI.74.12.5441-5451.2000; Myrum C, 2015, BIOCHEM J, V468, P145, DOI 10.1042/BJ20141446; Nolte-'t Hoen E, 2016, P NATL ACAD SCI USA, V113, P9155, DOI 10.1073/pnas.1605146113; Okuno H, 2012, CELL, V149, P886, DOI 10.1016/j.cell.2012.02.062; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Pastuzyn ED, 2017, FRONT MOL NEUROSCI, V10, DOI 10.3389/fnmol.2017.00234; Pinkstaff JK, 2001, P NATL ACAD SCI USA, V98, P2770, DOI 10.1073/pnas.051623398; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Purcell SM, 2014, NATURE, V506, P185, DOI 10.1038/nature12975; Purdy JG, 2008, J VIROL, V82, P5951, DOI 10.1128/JVI.00214-08; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Shepherd J. D., 2017, SEMIN CELL DEV BIOL; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Smit AFA, 1999, CURR OPIN GENET DEV, V9, P657, DOI 10.1016/S0959-437X(99)00031-3; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Taylor WR, 2017, BMC STRUCT BIOL, V17, DOI 10.1186/s12900-017-0073-0; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Tsai B, 2007, ANNU REV CELL DEV BI, V23, P23, DOI 10.1146/annurev.cellbio.23.090506.123454; Ufer F, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aaf8665; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Wang KH, 2006, CELL, V126, P389, DOI 10.1016/j.cell.2006.06.038; Waung MW, 2008, NEURON, V59, P84, DOI 10.1016/j.neuron.2008.05.014; Wu J, 2011, CELL, V147, P615, DOI 10.1016/j.cell.2011.09.036; Zappulli V, 2016, J CLIN INVEST, V126, P1198, DOI 10.1172/JCI81134; Zhang WC, 2015, NEURON, V86, P490, DOI 10.1016/j.neuron.2015.03.030; Zhou K, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-18	64	226	234	3	122	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					275	+		10.1016/j.cell.2017.12.024	http://dx.doi.org/10.1016/j.cell.2017.12.024			32	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29328916	Green Submitted, Green Accepted, Bronze			2022-12-28	WOS:000419840100025
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: When a crisis is the predictable outcome of poor policy making	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				Barr B, 2016, J EPIDEMIOL COMMUN H, V70, P339, DOI 10.1136/jech-2015-206209; BMA, 2017, STAT HLTH SYST BEDS; Burstow P., TELEHEALTH TELECARE; Full Fact, 2014, MUCH IS NHS MARK COS; HENDERSON C, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F1035; Institute for Fiscal Studies, 2017, NAT STAND LOC RISKS; King's Fund, 2017, NHS HOSP BED NUMB PA; McCartney M., 2013, PRICEWATERHOUSECOOPE; Taylor K., 2017, VIRGIN CARE JUST SUE	9	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2018	360								k90	10.1136/bmj.k90	http://dx.doi.org/10.1136/bmj.k90			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS9MW	29321153	Bronze, Green Published			2022-12-28	WOS:000422743300006
J	Green, A				Green, Andrew			Zimbabwe post-Mugabe era: reconstructing a health system	LANCET			English	Editorial Material																			0	9	9	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 6	2018	391	10115					17	18		10.1016/S0140-6736(18)30007-2	http://dx.doi.org/10.1016/S0140-6736(18)30007-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR9ZB	29323642				2022-12-28	WOS:000419432300013
J	Tu, YH; Cooper, AJ; Teng, BC; Chang, RB; Artiga, DJ; Turner, HN; Mulhall, EM; Ye, WL; Smith, AD; Liman, ER				Tu, Yu-Hsiang; Cooper, Alexander J.; Teng, Bochuan; Chang, Rui B.; Artiga, Daniel J.; Turner, Heather N.; Mulhall, Eric M.; Ye, Wenlei; Smith, Andrew D.; Liman, Emily R.			An evolutionarily conserved gene family encodes proton-selective ion channels	SCIENCE			English	Article							CELLS; TASTE; PROTEIN; DOMAIN; MICE; PH	Ion channels form the basis for cellular electrical signaling. Despite the scores of genetically identified ion channels selective for other monatomic ions, only one type of proton-selective ion channel has been found in eukaryotic cells. By comparative transcriptome analysis of mouse taste receptor cells, we identified Otopetrin1 (OTOP1), a protein required for development of gravity-sensing otoconia in the vestibular system, as forming a proton-selective ion channel. We found that murine OTOP1 is enriched in acid-detecting taste receptor cells and is required for their zinc-sensitive proton conductance. Two related murine genes, Otop2 and Otop3, and a Drosophila ortholog also encode proton channels. Evolutionary conservation of the gene family and its widespread tissue distribution suggest a broad role for proton channels in physiology and pathophysiology.	[Tu, Yu-Hsiang; Cooper, Alexander J.; Teng, Bochuan; Chang, Rui B.; Artiga, Daniel J.; Turner, Heather N.; Mulhall, Eric M.; Ye, Wenlei; Liman, Emily R.] Univ Southern Calif, Sect Neurobiol, Dept Biol Sci, Los Angeles, CA 90089 USA; [Smith, Andrew D.] Univ Southern Calif, Dept Biol Sci, Sect Mol & Computat Biol, Los Angeles, CA 90089 USA; [Liman, Emily R.] Univ Southern Calif, Bridge Inst, Los Angeles, CA 90089 USA; [Cooper, Alexander J.] Univ Southern Calif, Keck Sch Med, Dept Cell & Neurobiol, Zilkha Neurogenet Inst, Los Angeles, CA 90089 USA; [Chang, Rui B.] Yale Univ, Sch Med, Dept Neurosci, New Haven, CT 06520 USA; [Chang, Rui B.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Mulhall, Eric M.] Harvard Med Sch, Dept Neurobiol, Boston, MA 20115 USA; [Ye, Wenlei] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of Southern California; University of Southern California; University of Southern California; University of Southern California; Yale University; Yale University; Harvard University; Harvard Medical School; University of California System; University of California San Francisco	Liman, ER (corresponding author), Univ Southern Calif, Sect Neurobiol, Dept Biol Sci, Los Angeles, CA 90089 USA.; Liman, ER (corresponding author), Univ Southern Calif, Bridge Inst, Los Angeles, CA 90089 USA.	liman@usc.edu	Ye, Wenlei/S-1012-2016; Liman, Emily/AAC-7383-2021; Smith, Andrew D./G-4104-2013	Smith, Andrew D./0000-0002-3337-1970; Cooper, Alexander/0000-0002-2016-5502; Teng, Bochuan/0000-0001-7918-484X; Chang, Rui/0000-0001-6953-2943; liman, emily/0000-0003-4765-5496; Tu, Yu-Hsiang/0000-0003-3507-9938; Ye, Wenlei/0000-0002-4694-1493; Artiga, Daniel/0000-0002-5330-9496	NIH [R01DC013741, R21DC012747, R01HG006015]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG006015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013741, R21DC012747] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	E.R.L. and the University of Southern California have filed a provisional patent application no. 62/537,900 that claims methods of screening molecules that modulate Otopetrin-dependent ion channel activities. We thank S. Rao, L. Goggins, A. Bernanke, P. Uren, and members of the Nuzhdin lab for technical assistance; J. Bushman for assistance with electrophysiology; and D. Arnold, B. Bean, B. Herring, and R. Kramer for careful reading of the manuscript. Funding was provided by the NIH grants R01DC013741 and R21DC012747 (to E.R.L.) and R01HG006015 (to A.D.S.).	Bushman JD, 2015, FASEB J, V29, P3014, DOI 10.1096/fj.14-265694; Catterall WA, 2017, NAT CHEM BIOL, V13, P455, DOI [10.1038/NCHEMBIO.2353, 10.1038/nchembio.2353]; Chang RB, 2010, P NATL ACAD SCI USA, V107, P22320, DOI 10.1073/pnas.1013664107; Chizhmakov IV, 1996, J PHYSIOL-LONDON, V494, P329, DOI 10.1113/jphysiol.1996.sp021495; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DECOURSEY TE, 1991, BIOPHYS J, V60, P1243, DOI 10.1016/S0006-3495(91)82158-0; Gouaux E, 2005, SCIENCE, V310, P1461, DOI 10.1126/science.1113666; Hille B., 2001, IONIC CHANNELS EXCIT, P814; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Hughes I, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-41; Hurle B, 2003, HUM MOL GENET, V12, P777, DOI 10.1093/hmg/ddg087; Kim E, 2011, MOL CELL NEUROSCI, V46, P655, DOI 10.1016/j.mcn.2011.01.005; Liman ER, 2014, NEURON, V81, P984, DOI 10.1016/j.neuron.2014.02.022; Morgan D, 2009, P NATL ACAD SCI USA, V106, P18022, DOI 10.1073/pnas.0905565106; PINTO LH, 1992, CELL, V69, P517, DOI 10.1016/0092-8674(92)90452-I; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Reinhold AK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123342; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; Wang GX, 2014, DIABETES, V63, P1340, DOI 10.2337/db13-1139; Wu C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r130	20	108	119	13	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2018	359	6379					1047	+		10.1126/science.aao3264	http://dx.doi.org/10.1126/science.aao3264			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8SV	29371428	Green Accepted			2022-12-28	WOS:000426366200045
J	Fry, MY; Clemons, WM				Fry, Michelle Y.; Clemons, William M., Jr.			Complexity in targeting membrane proteins	SCIENCE			English	Editorial Material							TAIL-ANCHORED PROTEINS; ENDOPLASMIC-RETICULUM; INSERTION; PATHWAY; ER		[Fry, Michelle Y.; Clemons, William M., Jr.] CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA	California Institute of Technology	Clemons, WM (corresponding author), CALTECH, Div Chem & Chem Engn, Pasadena, CA 91125 USA.	clemons@caltech.edu	Clemons, William M/D-1026-2009	Clemons, William M/0000-0002-0021-889X	NIGMS NIH HHS [R01 GM097572] Funding Source: Medline	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aviram N, 2016, NATURE, V540, P134, DOI 10.1038/nature20169; Christianson JC, 2012, NAT CELL BIOL, V14, P93, DOI 10.1038/ncb2383; Costa EA, 2018, SCIENCE, V359, P689, DOI 10.1126/science.aar3607; Guna A, 2018, SCIENCE, V359, P470, DOI 10.1126/science.aao3099; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Lahiri S, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001969; Louie RJ, 2012, GENOME MED, V4, DOI 10.1186/gm404; Rivera-Monroy J, 2016, SCI REP-UK, V6, DOI 10.1038/srep39464; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Shao SC, 2017, SCIENCE, V355, P298, DOI 10.1126/science.aah6130; Shao SC, 2011, CELL, V147, P1576, DOI 10.1016/j.cell.2011.11.048; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Wang F, 2010, MOL CELL, V40, P159, DOI 10.1016/j.molcel.2010.08.038; Wideman Jeremy G, 2015, F1000Res, V4, P624, DOI 10.12688/f1000research.6944.1	15	7	7	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					390	391		10.1126/science.aar5992	http://dx.doi.org/10.1126/science.aar5992			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT6SD	29371455				2022-12-28	WOS:000423283200027
J	Caggiano, V; Leiras, R; Goni-Erro, H; Masini, D; Bellardita, C; Bouvier, J; Caldeira, V; Fisone, G; Kiehn, O				Caggiano, V.; Leiras, R.; Goni-Erro, H.; Masini, D.; Bellardita, C.; Bouvier, J.; Caldeira, V.; Fisone, G.; Kiehn, O.			Midbrain circuits that set locomotor speed and gait selection	NATURE			English	Article							BRAIN-STEM; BASAL GANGLIA; NEURONS; INITIATION; PEDUNCULOPONTINE; ORGANIZATION; PATHWAYS; REGION	Locomotion is a fundamental motor function common to the animal kingdom. It is implemented episodically and adapted to behavioural needs, including exploration, which requires slow locomotion, and escape behaviour, which necessitates faster speeds. The control of these functions originates in brainstem structures, although the neuronal substrate(s) that support them have not yet been elucidated. Here we show in mice that speed and gait selection are controlled by glutamatergic excitatory neurons (GlutNs) segregated in two distinct midbrain nuclei: the cuneiform nucleus (CnF) and the pedunculopontine nucleus (PPN). GlutNs in both of these regions contribute to the control of slower, alternating-gait locomotion, whereas only GlutNs in the CnF are able to elicit high-speed, synchronous-gait locomotion. Additionally, both the activation dynamics and the input and output connectivity matrices of GlutNs in the PPN and the CnF support explorative and escape locomotion, respectively. Our results identify two regions in the midbrain that act in conjunction to select context-dependent locomotor behaviours.	[Caggiano, V.; Leiras, R.; Goni-Erro, H.; Bellardita, C.; Bouvier, J.; Caldeira, V.; Kiehn, O.] Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, S-17177 Stockholm, Sweden; [Leiras, R.; Goni-Erro, H.; Bellardita, C.; Kiehn, O.] Univ Copenhagen, Dept Neurosci, Blegdamsvej 3, DK-2200 Copenhagen, Denmark; [Masini, D.; Fisone, G.] Karolinska Inst, Dept Neurosci, Lab Mol Neuropharmacol, S-17177 Stockholm, Sweden; [Caggiano, V.] IBM TJ Watson Res Ctr, Computat Biol Ctr, 1101 Kitchawan Rd,Route 134, Yorktown Hts, NY 10598 USA; [Bouvier, J.] CENS, UMR9197, Paris Saclay Inst Neurosci, F-91190 Gif Sur Yvette, France; [Bouvier, J.] Univ Paris 11, F-91190 Gif Sur Yvette, France	Karolinska Institutet; University of Copenhagen; Karolinska Institutet; International Business Machines (IBM); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Caggiano, V; Leiras, R; Kiehn, O (corresponding author), Karolinska Inst, Dept Neurosci, Mammalian Locomotor Lab, S-17177 Stockholm, Sweden.; Leiras, R; Kiehn, O (corresponding author), Univ Copenhagen, Dept Neurosci, Blegdamsvej 3, DK-2200 Copenhagen, Denmark.; Caggiano, V (corresponding author), IBM TJ Watson Res Ctr, Computat Biol Ctr, 1101 Kitchawan Rd,Route 134, Yorktown Hts, NY 10598 USA.	caggiano@gmail.com; Roberto.Leiras@sund.ku.dk; Ole.Kiehn@ki.se	kiehn, ole/AAT-7881-2021; Bellardita, Carmelo/N-5467-2019; Masini, Débora/ABE-3756-2021; kiehn, ole/AAB-1262-2019; Bouvier, Julien/C-1018-2017; Core, Vector/CAF-4832-2022	Bellardita, Carmelo/0000-0001-6198-243X; Masini, Débora/0000-0003-1467-2388; Bouvier, Julien/0000-0002-1307-4426; Leiras, Roberto/0000-0001-7232-2904; Fisone, Gilberto/0000-0002-0719-8000; Goni Erro, Haizea/0000-0003-3923-5299; Caggiano, Vittorio/0000-0002-2186-1550; Kiehn, Ole/0000-0002-5954-469X	European Research Council [ERC-693038]; NINDs [NS 090919]; Swedish Medical Research Council; StratNeuro; Novo Nordisk Foundation Laureate Research grant [NNF 150C0014186]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS090919] Funding Source: NIH RePORTER	European Research Council(European Research Council (ERC)European Commission); NINDs(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); StratNeuro; Novo Nordisk Foundation Laureate Research grant; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by European Research Council grant ERC-693038 (O.K.), NINDs NS 090919 (O.K.), The Swedish Medical Research Council ( O.K., G.F.), StratNeuro ( O.K.) and Novo Nordisk Foundation Laureate Research grant NNF 150C0014186 (O.K.). We thank P. Low for assistance with viral work and K. Deisseroth for providing viral ChR2 vectors.	Bellardita C, 2015, CURR BIOL, V25, P1426, DOI 10.1016/j.cub.2015.04.005; Borgius L, 2010, MOL CELL NEUROSCI, V45, P245, DOI 10.1016/j.mcn.2010.06.016; Bouvier J, 2015, CELL, V163, P1191, DOI 10.1016/j.cell.2015.10.074; Brandao ML, 1999, NEUROSCI BIOBEHAV R, V23, P863, DOI 10.1016/S0149-7634(99)00038-X; Brownstone RM, 2008, BRAIN RES REV, V57, P64, DOI 10.1016/j.brainresrev.2007.06.025; Callaway EM, 2015, J NEUROSCI, V35, P8979, DOI 10.1523/JNEUROSCI.0409-15.2015; Capelli P, 2017, NATURE, V551, P373, DOI 10.1038/nature24064; Costa RM, 2007, ANN NY ACAD SCI, V1104, P172, DOI 10.1196/annals.1390.015; DREW T, 1986, J NEUROPHYSIOL, V55, P375, DOI 10.1152/jn.1986.55.2.375; Dubuc R, 2008, BRAIN RES REV, V57, P172, DOI 10.1016/j.brainresrev.2007.07.016; FILE SE, 1975, PSYCHOPHARMACOLOGIA, V44, P53, DOI 10.1007/BF00421184; Franklin K. B. J., 2013, MOUSE BRAIN STEREOTA; Friend DM, 2014, TRENDS NEUROSCI, V37, P301, DOI 10.1016/j.tins.2014.04.004; Garcia-Rill E, 2015, J NEURAL TRANSM, V122, P225, DOI 10.1007/s00702-014-1243-x; Goulding M, 2009, NAT REV NEUROSCI, V10, P507, DOI 10.1038/nrn2608; Graybiel AM, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a021691; Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137; Grillner S, 2013, J PHYSIOL-LONDON, V591, P5425, DOI 10.1113/jphysiol.2012.246660; Grillner S, 2009, CURR OPIN NEUROBIOL, V19, P572, DOI 10.1016/j.conb.2009.10.011; Jordan LM, 2008, BRAIN RES REV, V57, P183, DOI 10.1016/j.brainresrev.2007.07.019; Kiehn O, 2016, NAT REV NEUROSCI, V17, P224, DOI 10.1038/nrn.2016.9; Kliethermes CL, 2006, PHARMACOL BIOCHEM BE, V85, P57, DOI 10.1016/j.pbb.2006.07.007; Lemieux M, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00042; Liang HZ, 2012, BRAIN STRUCT FUNCT, V217, P211, DOI 10.1007/s00429-011-0337-6; LOVICK TA, 1993, BEHAV BRAIN RES, V58, P19, DOI 10.1016/0166-4328(93)90087-7; Machado AS, 2015, ELIFE, V4, DOI 10.7554/eLife.07892; Martinez-Gonzalez C, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00022; Noga BR, 2003, J NEUROPHYSIOL, V90, P1464, DOI 10.1152/jn.00034.2003; Quiroga RQ, 2004, NEURAL COMPUT, V16, P1661, DOI 10.1162/089976604774201631; Roseberry TK, 2016, CELL, V164, P526, DOI 10.1016/j.cell.2015.12.037; Roth BL, 2016, NEURON, V89, P683, DOI 10.1016/j.neuron.2016.01.040; Ryczko D, 2013, P NATL ACAD SCI USA, V110, pE3235, DOI 10.1073/pnas.1301125110; Ryczko D, 2013, CURR PHARM DESIGN, V19, P4448, DOI 10.2174/1381612811319240011; Shik M L, 1969, Electroencephalogr Clin Neurophysiol, V26, P549; SINNAMON HM, 1993, PROG NEUROBIOL, V41, P323, DOI 10.1016/0301-0082(93)90003-B; Skinner R D, 1990, Neuroreport, V1, P207, DOI 10.1097/00001756-199011000-00008; Sternson SM, 2014, ANNU REV NEUROSCI, V37, DOI 10.1146/annurev-neuro-071013-014048; Takakusaki K, 2016, J NEURAL TRANSM, V123, P695, DOI 10.1007/s00702-015-1475-4; Tovote P, 2016, NATURE, V534, P206, DOI 10.1038/nature17996; Wall NR, 2010, P NATL ACAD SCI USA, V107, P21848, DOI 10.1073/pnas.1011756107; Wang HL, 2009, EUR J NEUROSCI, V29, P340, DOI 10.1111/j.1460-9568.2008.06576.x	41	192	192	9	58	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2018	553	7689					455	+		10.1038/nature25448	http://dx.doi.org/10.1038/nature25448			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU6OE	29342142	Green Submitted, Green Accepted			2022-12-28	WOS:000423971100032
J	Fink, D; Wani, RS; Johnston, V				Fink, Doug; Wani, Robert Serafino; Johnston, Victoria			Fever in the returning traveller	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							GEOSENTINEL SURVEILLANCE; INTERNATIONAL TRAVELERS; TROPICAL DISEASES; VISITING FRIENDS; IMPORTED MALARIA; HEALTH-PROBLEMS; QSOFA SCORE; ILLNESS; INFECTIONS; MANAGEMENT		[Fink, Doug; Johnston, Victoria] Mortimer Market Ctr, Hosp Trop Dis, London, England; [Fink, Doug] UCL, Div Infect & Immun, London, England; [Wani, Robert Serafino] Barts Hlth NHS Trust, Royal London Hosp, Dept Infect, London, England; [Johnston, Victoria] London Sch Hyg & Trop Med, London, England	University College London Hospitals NHS Foundation Trust; University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; Barts Health NHS Trust; Royal London Hospital; University of London; London School of Hygiene & Tropical Medicine	Fink, D (corresponding author), Mortimer Market Ctr, Hosp Trop Dis, London, England.; Fink, D (corresponding author), UCL, Div Infect & Immun, London, England.	douglas.fink@nhs.net	Serafino Wani Swaka, Robert/GWM-8225-2022					[Anonymous], ANN REP UNWTO; Antinori S, 2004, J TRAVEL MED, V11, P135, DOI 10.2310/7060.2004.18557; Arcilla MS, 2017, LANCET INFECT DIS, V17, P78, DOI 10.1016/S1473-3099(16)30319-X; Arcilla MS, 2016, LANCET INFECT DIS, V16, P147, DOI 10.1016/S1473-3099(15)00541-1; Askling HH, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-328; Barnett ED, 2003, J TRAVEL MED, V10, P11, DOI 10.2310/7060.2003.30663; Basnyat B, 2005, CLIN INFECT DIS, V41, P1467, DOI 10.1086/497136; Blanton LS, 2013, CURR OPIN INFECT DIS, V26, P435, DOI 10.1097/QCO.0b013e328363811b; Boggild AK, 2010, VACCINE, V28, P7389, DOI 10.1016/j.vaccine.2010.09.009; Bottieau E, 2007, MEDICINE, V86, P18, DOI 10.1097/MD.0b013e3180305c48; Bottieau E, 2006, ARCH INTERN MED, V166, P1642, DOI 10.1001/archinte.166.15.1642; Brett-Major DM, 2012, COCHRANE DB SYST REV, V2; Bruni, 1997, J Travel Med, V4, P61, DOI 10.1111/j.1708-8305.1997.tb00781.x; Buscher P, 2017, LANCET, V390, P2397, DOI 10.1016/S0140-6736(17)31510-6; CDC, TRANSM BAS PREC; Centers for Disease Control and Prevention, DIAGN MAN TICKB RICK; Centers for Disease Control and Prevention guidance for control of carbapenem-resistant enterobacteriaceae, 2012 CRE TOOKL CRE G; Checkley AM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2116; Cullen KA, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6502a1; D'Acremont V, 2002, AM J TROP MED HYG, V66, P481, DOI 10.4269/ajtmh.2002.66.481; DOHERTY JF, 1995, QJM-INT J MED, V88, P277; Faber MS, 2009, EMERG INFECT DIS, V15, P1760, DOI 10.3201/eid1511.090214; Fenner L, 2007, EMERG INFECT DIS, V13, P217, DOI 10.3201/eid1302.060847; Fhogartaigh CN, 2008, QJM-INT J MED, V101, P649, DOI 10.1093/qjmed/hcn072; Fhogartaigh CN, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e7179; Fleck S, 2006, EUR J PUBLIC HEALTH, V16, P96, DOI 10.1093/eurpub/cki144; Gautret P, 2009, EMERG INFECT DIS, V15, P1783, DOI 10.3201/eid1511.091147; Guidelines WHO, INF PREV CONTR EP PA; Haas WH, 2003, CLIN INFECT DIS, V36, P1254, DOI 10.1086/374853; Hill DR, 2000, J TRAVEL MED, V7, P259, DOI 10.2310/7060.2000.00075; Hochberg NS, 2013, MAYO CLIN PROC, V88, P1231, DOI 10.1016/j.mayocp.2013.07.018; Howell MD, 2017, JAMA-J AM MED ASSOC, V317, P847, DOI 10.1001/jama.2017.0131; Huson MAM, 2017, INFECTION, V45, P893, DOI 10.1007/s15010-017-1057-5; Jensenius M, 2003, LANCET INFECT DIS, V3, P557, DOI 10.1016/S1473-3099(03)00739-4; Jensenius M, 2013, AM J TROP MED HYG, V88, P397, DOI 10.4269/ajtmh.12-0551; Lalloo DG, 2007, J INFECTION, V54, P111, DOI 10.1016/j.jinf.2006.12.003; Leder K, 2006, CLIN INFECT DIS, V43, P1185, DOI 10.1086/507893; Leder K, 2013, ANN INTERN MED, V158, P456, DOI 10.7326/0003-4819-158-6-201303190-00005; Logan S, 2013, AM J TROP MED HYG, V88, P1032, DOI 10.4269/ajtmh.12-0646; Mendelson M, 2014, EMERG INFECT DIS, V20, P532, DOI 10.3201/eid2004.131128; Mizuno Y, 2009, TRAVEL MED INFECT DI, V7, P296, DOI 10.1016/j.tmaid.2009.03.002; Mogasale V, 2016, ANN CLIN MICROB ANTI, V15, DOI 10.1186/s12941-016-0147-z; National Institute for Health and Care Excellence, GUID; Neave PE, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-17; Newman-Klee C, 2007, AM J TROP MED HYG, V77, P764, DOI 10.4269/ajtmh.2007.77.764; Office for National Statistics, TRAV TRENDS; Parola Philippe, 2006, Travel Med Infect Dis, V4, P61, DOI 10.1016/j.tmaid.2005.01.002; Price VA, 2011, J TRAVEL MED, V18, P271, DOI 10.1111/j.1708-8305.2011.00521.x; Public Health England, 2017, GUID MAL PREV TRAV U; Public Health England, 2017, NOT DIS CAUS ORG REP; Public Health England, 2017, VIR HAEM FEV RISK AS; Public Health England, 2017, MAN HAZ GROUP 4 VIR; Rack J, 2005, J TRAVEL MED, V12, P248, DOI 10.2310/7060.2005.12502; Rahi M, 2015, INDIAN J MED RES, V141, P417, DOI 10.4103/0971-5916.159279; Reed, 1994, J Travel Med, V1, P192, DOI 10.1111/j.1708-8305.1994.tb00594.x; Riddle MS, 2016, AM J GASTROENTEROL, V111, P602, DOI 10.1038/ajg.2016.126; Ross AG, 2007, LANCET INFECT DIS, V7, P218, DOI 10.1016/S1473-3099(07)70053-1; Roukens AHE, 2007, CLIN TRANSPLANT, V21, P567, DOI 10.1111/j.1399-0012.2007.00691.x; Salit IE, 2005, CAN MED ASSOC J, V172, P884, DOI 10.1503/cmaj.1040877; Scheer CS, 2017, JAMA-J AM MED ASSOC, V317, P1909, DOI 10.1001/jama.2017.3504; Schlagenhauf P, 2015, LANCET INFECT DIS, V15, P55, DOI 10.1016/S1473-3099(14)71000-X; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Siikamaki HM, 2011, J TRAVEL MED, V18, P239, DOI 10.1111/j.1708-8305.2011.00532.x; Smith SM, 2005, EUR J EMERG MED, V12, P230, DOI 10.1097/00063110-200510000-00006; STEFFEN R, 1987, J INFECT DIS, V156, P84, DOI 10.1093/infdis/156.1.84; Stienlauf S, 2005, J TRAVEL MED, V12, P136, DOI 10.2310/7060.2005.12308; Stienlauf S, 2014, TRAVEL MED INFECT DI, V12, P757, DOI 10.1016/j.tmaid.2014.10.004; Tomasello D, 2013, TRAVEL MED INFECT DI, V11, P274, DOI 10.1016/j.tmaid.2013.07.006; Torresi J, 2009, NAT REV MICROBIOL, V7, P895, DOI 10.1038/nrmicro2238; UK Government, ENT FEV SURV 2015 20; UK Government, 2016, MAL UK ANN REP; UK Government, MAL UK ANN REP; UK Government, 2016, ENT FEV SURV 2014 20; Van Bortel W, 2014, EUROSURVEILLANCE, V19, P17, DOI 10.2807/1560-7917.ES2014.19.13.20759; Wagner KS, 2015, J TRAVEL MED, V22, P87, DOI 10.1111/jtm.12178; WHO, 2017, CLIN MAN PAT VIR HAE; Wichmann O, 2007, J INFECT DIS, V195, P1089, DOI 10.1086/512680; Wilson ME, 2007, CLIN INFECT DIS, V44, P1560, DOI 10.1086/518173; Winer L, 2002, J TRAVEL MED, V9, P227, DOI 10.2310/7060.2002.24202; World Health Organization, 2012, AM GIARD WHO MOD PRE	80	11	11	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2018	360								j5773	10.1136/bmj.j5773	http://dx.doi.org/10.1136/bmj.j5773			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU2XA	29371218				2022-12-28	WOS:000423712100001
J	Brigo, F				Brigo, Francesco			Orpheus' Descent Into the Neurointensive Care Unit	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Brigo, Francesco] Univ Verona, Dept Neurosci Biomed & Movement Sci, Verona, Italy	University of Verona	Brigo, F (corresponding author), Univ Verona, Ple LA Scuro 8, I-37134 Verona, Italy.	dr.francescobrigo@gmail.com	Brigo, Francesco/H-6513-2013	Brigo, Francesco/0000-0003-0928-1577					0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					328	328		10.1001/jama.2017.16521	http://dx.doi.org/10.1001/jama.2017.16521			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362771	Bronze			2022-12-28	WOS:000423405300002
J	Kreijkamp-Kaspers, S; Hawke, KL; van Driel, ML				Kreijkamp-Kaspers, Sanne; Hawke, Kate L.; van Driel, Mieke L.			Oral Medications to Treat Toenail Fungal Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							QUALITY-OF-LIFE; ONYCHOMYCOSIS	CLINICAL QUESTION Which oral antifungal medication is associated with the highest clinical (ie, normal appearance of the toenail) andmycological (negative culture, microscopy, or both) cure rates vs placebo or other antifungals when used to treat fungal infections? BOTTOM LINE Both terbinafine and azole-based medications were associated with higher clinical andmycological cure rates compared with placebo (high-quality evidence). Azoles were associated with lower cure rates than terbinafine when compared directly.	[Kreijkamp-Kaspers, Sanne; van Driel, Mieke L.] Univ Queensland, Fac Med, Primary Care Clin Unit, Brisbane, Qld, Australia; [Hawke, Kate L.] Univ Queensland, Fac Med, Brisbane, Qld, Australia; [Hawke, Kate L.] Princess Alexandra Hosp, Brisbane, Qld, Australia	University of Queensland; University of Queensland	van Driel, ML (corresponding author), Univ Queensland, Brisbane, Qld 4029, Australia.	m.vandriel@uq.edu.au	van Driel, Mieke/D-1167-2011; Hawke, Kate L/B-9511-2017	van Driel, Mieke/0000-0003-1711-9553; Hawke, Kate L/0000-0001-6871-4737				Ameen M, 2014, BRIT J DERMATOL, V171, P937, DOI 10.1111/bjd.13358; Drake LA, 1998, J AM ACAD DERMATOL, V38, P702, DOI 10.1016/S0190-9622(98)70199-9; Kreijkamp-Kaspers S, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010031.pub2; Reich A, 2011, AM J CLIN DERMATOL, V12, P313, DOI 10.2165/11592120-000000000-00000; Schunemann H, 2013, GRADE HDB GRADING QU; United States Food and Drug Administration, 2013, FDA LIM US NIZ KET O; Westerberg DP, 2013, AM FAM PHYSICIAN, V88, P762	7	8	8	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					397	398		10.1001/jama.2017.20160	http://dx.doi.org/10.1001/jama.2017.20160			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362778				2022-12-28	WOS:000423405300025
J	Rubin, R				Rubin, Rita			Possible Racial Disparities in NICU Breast Milk Use	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					334	334		10.1001/jama.2017.20797	http://dx.doi.org/10.1001/jama.2017.20797			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362802				2022-12-28	WOS:000423405300011
J	Wadhera, RK; Yeh, RW; Maddox, KEJ				Wadhera, Rishi K.; Yeh, Robert W.; Maddox, Karen E. Joynt			The Rise and Fall of Mandatory Cardiac Bundled Payments	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Wadhera, Rishi K.] Harvard Med Sch, Brigham & Womens Hosp, Heart & Vasc Ctr, Boston, MA USA; [Wadhera, Rishi K.; Yeh, Robert W.] Beth Israel Deaconess Med, Div Cardiol, Richard & Susan Smith Ctr Outcomes Res Cardiol, Boston, MA USA; [Wadhera, Rishi K.; Yeh, Robert W.] Harvard Med Sch, Boston, MA USA; [Maddox, Karen E. Joynt] Washington Univ, Sch Med, Dept Med, Cardiovasc Div, 660 S Euclid Ave, St Louis, MO 63110 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Washington University (WUSTL)	Maddox, KEJ (corresponding author), Washington Univ, Sch Med, Dept Med, Cardiovasc Div, 660 S Euclid Ave, St Louis, MO 63110 USA.	kjoyntmaddox@wustl.edu	Yeh, Robert/AAJ-3463-2020	Wadhera, Rishi/0000-0003-1089-3896	National Institutes of Health [T32HL007604-32]; Brigham and Women's Hospital, Division of Cardiovascular Medicine; National Heart, Lung, and Blood Institute [K23HL118138, R01HL136708, K23HL109177-03]; Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL118138, K23HL109177, T32HL007604, R01HL136708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Brigham and Women's Hospital, Division of Cardiovascular Medicine; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Wadhera is supported by the National Institutes of Health (training grant T32HL007604-32); Brigham and Women's Hospital, Division of Cardiovascular Medicine; and by the Jerome H. Grossman, MD, Fellowship in Healthcare Delivery Policy at the Harvard Kennedy School's Healthcare Policy Program. Dr Yeh receives research support from the National Heart, Lung, and Blood Institute (K23HL118138 and R01HL136708) and the Richard A. and Susan F. Smith Center for Outcomes Research in Cardiology. Dr Joynt Maddox receives research support from the National Heart, Lung, and Blood Institute (K23HL109177-03).	[Anonymous], EP PAYM MOD GEN INF; [Anonymous], 2017, MODERN HEALTHCARE; Bundled Payments for Care Improvement (BPCI), BUNDL PAYM CAR IMPR; Casale AS, 2007, ANN SURG, V246, P613, DOI 10.1097/SLA.0b013e318155a996; Centers for Medicare & Medicaid Services, NAT HLTH EXP FACT SH; Centers for Medicare & Medicaid Services, EV MED AC CAR EP DEM; Cromwell J, 1997, HEALTH CARE FINANC R, V19, P41; Lewin Group, 2018, CMS BUNDL PAYM CAR I; Maddox KEJ, 2018, JAMA-J AM MED ASSOC, V319, P191, DOI 10.1001/jama.2017.14771	9	21	21	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					335	336		10.1001/jama.2017.19205	http://dx.doi.org/10.1001/jama.2017.19205			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29327034	Green Accepted			2022-12-28	WOS:000423405300013
J	Delgado-Baquerizo, M; Oliverio, AM; Brewer, TE; Benavent-Gonzalez, A; Eldridge, DJ; Bardgett, RD; Maestre, FT; Singh, BK; Fierer, N				Delgado-Baquerizo, Manuel; Oliverio, Angela M.; Brewer, Tess E.; Benavent-Gonzalez, Alberto; Eldridge, David J.; Bardgett, Richard D.; Maestre, Fernando T.; Singh, Brajesh K.; Fierer, Noah			A global atlas of the dominant bacteria found in soil	SCIENCE			English	Article							16S RIBOSOMAL-RNA; SPECIES DEFINITION; PLANT DIVERSITY; GRASSLANDS; MICROBES	The immense diversity of soil bacterial communities has stymied efforts to characterize individual taxa and document their global distributions. We analyzed soils from 237 locations across six continents and found that only 2% of bacterial phylotypes (similar to 500 phylotypes) consistently accounted for almost half of the soil bacterial communities worldwide. Despite the overwhelming diversity of bacterial communities, relatively few bacterial taxa are abundant in soils globally. We clustered these dominant taxa into ecological groups to build the first global atlas of soil bacterial taxa. Our study narrows down the immense number of bacterial taxa to a "most wanted" list that will be fruitful targets for genomic and cultivation-based efforts aimed at improving our understanding of soil microbes and their contributions to ecosystem functioning.	[Delgado-Baquerizo, Manuel; Oliverio, Angela M.; Brewer, Tess E.; Fierer, Noah] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Delgado-Baquerizo, Manuel; Maestre, Fernando T.] Univ Rey Juan Carlos, Dept Biol & Geol, Fis & Quim Inorgan, Escuela Super Ciencias Expt & Tecnol, C Tulipan S-N, Mostoles 28933, Spain; [Oliverio, Angela M.; Fierer, Noah] Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA; [Brewer, Tess E.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Benavent-Gonzalez, Alberto] Univ Complutense Madrid, Fac Farm, Dept Biol Vegetal 2, E-28040 Madrid, Spain; [Eldridge, David J.] Univ New South Wales, Sch Biol Earth & Environm Sci, Ctr Ecosyst Sci, Sydney, NSW 2052, Australia; [Bardgett, Richard D.] Univ Manchester, Sch Earth & Environm Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England; [Singh, Brajesh K.] Western Sydney Univ, Hawkesbury Inst Environm, Penrith, NSW 2751, Australia; [Singh, Brajesh K.] Western Sydney Univ, Global Ctr Land Based Innovat, Penrith, NSW 2751, Australia	University of Colorado System; University of Colorado Boulder; Universidad Rey Juan Carlos; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Complutense University of Madrid; University of New South Wales Sydney; University of Manchester; Western Sydney University; Western Sydney University	Delgado-Baquerizo, M; Fierer, N (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA.; Delgado-Baquerizo, M (corresponding author), Univ Rey Juan Carlos, Dept Biol & Geol, Fis & Quim Inorgan, Escuela Super Ciencias Expt & Tecnol, C Tulipan S-N, Mostoles 28933, Spain.; Fierer, N (corresponding author), Univ Colorado, Dept Ecol & Evolutionary Biol, Boulder, CO 80309 USA.	m.delgadobaquerizo@gmail.com; noah.fierer@colorado.edu	Wingate, Lisa/M-9673-2019; Eldridge, David/H-3532-2019; Maestre, Fernando T./A-6825-2008; Singh, Brajesh/R-6321-2019; Wingate, Lisa/G-5575-2015; Oliverio, Angela/ABG-2089-2021; Delgado-Baquerizo, Manuel/L-3653-2017; DELGADO-BAQUERIZO, MANUEL/GLS-0346-2022	Wingate, Lisa/0000-0003-1921-1556; Eldridge, David/0000-0002-2191-486X; Maestre, Fernando T./0000-0002-7434-4856; Singh, Brajesh/0000-0003-4413-4185; Wingate, Lisa/0000-0003-1921-1556; Delgado-Baquerizo, Manuel/0000-0002-6499-576X; DELGADO-BAQUERIZO, MANUEL/0000-0002-6499-576X; FIERER, NOAH/0000-0002-6432-4261; Brewer, Tess/0000-0001-7855-5610; Oliverio, Angela/0000-0002-0261-0393; BENAVENT GONZALEZ, ALBERTO/0000-0002-3374-8379	Marie Sklodowska-Curie Actions of the Horizon 2020 Framework Programme H2020-MSCA-IF under Research Executive Agency [702057]; U.S. National Science Foundation [EAR 1331828, DEB 1554415]; Australian Research Council [DP170104634]; Hermon Slade Foundation; UK Department of Environment, Food and Rural Affairs [BD5003]; Biotechnology and Biological Sciences Research Council International Exchange Grant [B/L026406/1]; Formacion de Personal Investigador (FPI) PhD fellowship [BES-2013-062945]; Spanish Ministerio de Economia y Competitividad [CTM2015-64728-C2-1-R, CTM2012-38222-CO2-01]; European Research Council [ERC Grant] [242658, 647038]; Spanish Ministry of Economy and Competitiveness (BIOMOD project) [CGL2013-44661-R]; BBSRC [BB/L026406/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/L026406/1] Funding Source: researchfish; Division Of Environmental Biology [1556090] Funding Source: National Science Foundation	Marie Sklodowska-Curie Actions of the Horizon 2020 Framework Programme H2020-MSCA-IF under Research Executive Agency; U.S. National Science Foundation(National Science Foundation (NSF)); Australian Research Council(Australian Research Council); Hermon Slade Foundation; UK Department of Environment, Food and Rural Affairs(Department for Environment, Food & Rural Affairs (DEFRA)); Biotechnology and Biological Sciences Research Council International Exchange Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Formacion de Personal Investigador (FPI) PhD fellowship(National Health and Medical Research Council (NHMRC) of Australia); Spanish Ministerio de Economia y Competitividad(Spanish Government); European Research Council [ERC Grant](European Research Council (ERC)); Spanish Ministry of Economy and Competitiveness (BIOMOD project); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank V. Ochoa and B. Gozalo for help with soil analyses. We also thank S. Karunaratne for advice on mapping analyses, and T. Hartshorn and B. Turner for providing soil samples from Montana and Panama. M.D.-B. acknowledges support from the Marie Sklodowska-Curie Actions of the Horizon 2020 Framework Programme H2020-MSCA-IF-2016 under Research Executive Agency grant agreement no. 702057. N.F. was supported by grants from the U.S. National Science Foundation (EAR 1331828 and DEB 1554415). B.K.S. and M.D.-B were supported by the Australian Research Council project (DP170104634). D.J.E. was supported by the Hermon Slade Foundation, and R.D.B. was supported by the UK Department of Environment, Food and Rural Affairs project no. BD5003 and a Biotechnology and Biological Sciences Research Council International Exchange Grant (BB/L026406/1). A.B.-G. was supported by a Formacion de Personal Investigador (FPI) PhD fellowship (BES-2013-062945) and two research grants (CTM2015-64728-C2-1-R and CTM2012-38222-CO2-01) from the Spanish Ministerio de Economia y Competitividad. The work of F.T.M. and the global drylands database were supported by the European Research Council [ERC Grant Agreements 242658 (BIOCOM) and 647038 (BIODESERT)] and by the Spanish Ministry of Economy and Competitiveness (BIOMOD project, ref. CGL2013-44661-R). M.D.-B. and N.F. designed the study. Field sampling was conducted by N.F., M.D.-B., F.T.M., A. B.-G., D.J.E., and R.D.B. Lab analyses were done by F.T.M. and B.K.S. Bioinformatic analyses were done by T.E.B. Statistical modeling and mapping were done by M.D.-B. Network analyses were done by A.M.O. The manuscript was written by M.D.-B. and N.F. with contributions from all coauthors. All data used in this study are publicly available in Figshare (https://figshare.com/s/82a2d3f5d38ace925492; DOI:10.6084/m9.figshare.5611321).	Barberan A., 2017, MSPHERE, V2; Bardgett RD, 2014, NATURE, V515, P505, DOI 10.1038/nature13855; Bodelier PLE, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00080; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brewer TE, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.198; de Menezes AB, 2015, ENVIRON MICROBIOL, V17, P2677, DOI 10.1111/1462-2920.12559; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fierer N, 2013, SCIENCE, V342, P621, DOI 10.1126/science.1243768; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Konstantinidis KT, 2006, PHILOS T R SOC B, V361, P1929, DOI 10.1098/rstb.2006.1920; Land M, 2015, FUNCT INTEGR GENOMIC, V15, P141, DOI 10.1007/s10142-015-0433-4; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Leff JW, 2015, P NATL ACAD SCI USA, V112, P10967, DOI 10.1073/pnas.1508382112; Lok C, 2015, NATURE, V522, P270, DOI 10.1038/522270a; Maestre FT, 2015, P NATL ACAD SCI USA, V112, P15684, DOI 10.1073/pnas.1516684112; Prober SM, 2015, ECOL LETT, V18, P85, DOI 10.1111/ele.12381; Quinlan J.R., 1993, C4 5 PROGRAMS MACHIN; Ramirez KS, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1988; Schloss PD, 2016, MBIO, V7, DOI 10.1128/mBio.00201-16; Soliveres S, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0269; STACKEBRANDT E, 1994, INT J SYST BACTERIOL, V44, P846, DOI 10.1099/00207713-44-4-846; Swartz TH, 2005, EXTREMOPHILES, V9, P345, DOI 10.1007/s00792-005-0451-6; Thompson C, 2017, NATURE, V551, P33, DOI 10.1038/551033a; Tiedje JM, 1999, APPL SOIL ECOL, V13, P109, DOI 10.1016/S0929-1393(99)00026-8; VanInsberghe D, 2015, ISME J, V9, P2435, DOI 10.1038/ismej.2015.54; Whitford W., 2002, ECOLOGY DESERT SYSTE; Zhou JZ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12083	28	833	872	112	880	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					320	+		10.1126/science.aap9516	http://dx.doi.org/10.1126/science.aap9516			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6BB	29348236	Green Submitted			2022-12-28	WOS:000423236700037
J	Fox, GJ; Nhung, NV; Sy, DN; Hoa, NLP; Anh, LTN; Anh, NT; Hoa, NB; Dung, NH; Buu, TN; Loi, NT; Nhung, LT; Hung, NV; Lieu, PT; Cuong, NK; Cuong, PD; Bestrashniy, J; Britton, WJ; Marks, GB				Fox, Greg J.; Nhung, Nguyen V.; Sy, Dinh N.; Hoa, Nghiem L. P.; Anh, Le T. N.; Anh, Nguyen T.; Hoa, Nguyen B.; Dung, Nguyen H.; Buu, Tran N.; Loi, Nguyen T.; Nhung, Le T.; Hung, Nguyen V.; Lieu, Phan T.; Cuong, Nguyen K.; Cuong, Pham D.; Bestrashniy, Jessica; Britton, Warwick J.; Marks, Guy B.			Household-Contact Investigation for Detection of Tuberculosis in Vietnam	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RANDOMIZED TRIAL; DIAGNOSIS; STRATEGIES; BENEFITS; DISEASE; AFRICA; ENOUGH; IMPACT	BACKGROUND Active case finding is a top priority for the global control of tuberculosis, but robust evidence for its effectiveness in high-prevalence settings is lacking. We sought to evaluate the effectiveness of household-contact investigation, as compared with standard, passive measures alone, in Vietnam. METHODS We performed a cluster-randomized, controlled trial at clinics in 70 districts (local government areas with an average population of approximately 500,000 in urban areas and 100,000 in rural areas) in eight provinces of Vietnam. Health workers at each district clinic or hospital were assigned to perform either household-contact intervention plus standard passive case finding (intervention group) or passive case finding alone (control group). In the intervention districts, household contacts of patients with positive results for tuberculosis on sputum smear microscopy (smear-positive tuberculosis) were invited for clinical assessment and chest radiography at baseline and at 6, 12, and 24 months. The primary outcome was the cumulative incidence of registered cases of tuberculosis among household contacts of patients with tuberculosis during a 2-year period. RESULTS In 70 selected districts, we enrolled 25,707 household contacts of 10,964 patients who had smear-positive pulmonary tuberculosis. In the 36 districts that were included in the intervention group, 180 of 10,069 contacts were registered as having tuberculosis (1788 cases per 100,000 population), as compared with 110 of 15,638 contacts (703 per 100,000) in the control group (relative risk of the primary outcome in the intervention group, 2.5; 95% confidence interval [CI], 2.0 to 3.2; P<0.001); the relative risk of smear-positive disease among household contacts in the intervention group was 6.4 (95% CI, 4.5 to 9.0; P<0.001). CONCLUSIONS Household-contact investigation plus standard passive case finding was more effective than standard passive case finding alone for the detection of tuberculosis in a high-prevalence setting at 2 years.	[Fox, Greg J.; Anh, Nguyen T.; Britton, Warwick J.] Univ Sydney, Sydney Med Sch, Camperdown, NSW, Australia; [Britton, Warwick J.] Univ Sydney, Centenary Inst Canc Med & Cell Biol, Camperdown, NSW, Australia; [Fox, Greg J.; Hoa, Nghiem L. P.; Anh, Nguyen T.; Buu, Tran N.; Loi, Nguyen T.; Nhung, Le T.; Hung, Nguyen V.; Lieu, Phan T.; Cuong, Pham D.; Bestrashniy, Jessica; Marks, Guy B.] Woolcock Inst Med Res, Glebe, NSW, Australia; [Marks, Guy B.] Univ New South Wales, South Western Sydney Clin Sch, Kensington, NSW, Australia; [Nhung, Nguyen V.; Sy, Dinh N.; Anh, Le T. N.; Hoa, Nguyen B.; Cuong, Nguyen K.] Natl Lung Hosp, Hanoi, Vietnam; [Nhung, Nguyen V.; Cuong, Nguyen K.] Hanoi Med Univ, Hanoi, Vietnam; [Dung, Nguyen H.] Pham Ngoc Thach Hosp, Ho Chi Minh City, Vietnam; [Hoa, Nguyen B.] Int Union TB & Lung Dis, Ctr Operat Res, Paris, France	University of Sydney; University of Sydney; Centenary Institute; University of Sydney; Woolcock Institute of Medical Research; University of New South Wales Sydney; Hanoi Medical University	Fox, GJ (corresponding author), Univ Sydney, Woolcock Inst Med Res, 431 Glebe Point Rd, Glebe, NSW 2037, Australia.	greg.fox@sydney.edu.au	B, Hoa/AAF-4933-2020; Marks, Guy B./F-5058-2013	Marks, Guy B./0000-0002-8976-8053; Britton, Warwick/0000-0001-6721-9646	Australian National Health and Medical Research Council; ACT2 Australian New Zealand	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); ACT2 Australian New Zealand	Funded by the Australian National Health and Medical Research Council; ACT2 Australian New Zealand Clinical Trials Registry number, ACTRN12610000600044.	Adetifa IMO, 2016, B WORLD HEALTH ORGAN, V94, P433, DOI 10.2471/BLT.14.151670; [Anonymous], 2014, GUID MAN LAT TUB INF; [Anonymous], 2012, REC INV CONTR PERS I; Ayles H, 2013, LANCET, V382, P1183, DOI 10.1016/S0140-6736(13)61131-9; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Centers for Disease Control and Prevention (US), 2007, LINK PLUS VERS 2 0; Claassens M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058689; Corbett EL, 2010, LANCET, V376, P1244, DOI 10.1016/S0140-6736(10)61425-0; Dowdy DW, 2013, AM J RESP CRIT CARE, V187, P543, DOI 10.1164/rccm.201207-1217OC; Fox GJ, 2011, COCHRANE DB SYST REV, V9; Fox GJ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-342; Fox GJ, 2013, EUR RESPIR J, V41, P140, DOI 10.1183/09031936.00070812; Fox GJ, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0816-0; General Statistics Office of Vietnam, 2010, 2009 VIETN POP HOUS; Ho J, 2016, INT J MYCOBACT, V5, P374, DOI 10.1016/j.ijmyco.2016.09.023; Hoa NB, 2011, EMERG INFECT DIS, V17, P562, DOI 10.3201/eid1703.101468; Houben RMGJ, 2016, LANCET GLOB HEALTH, V4, pE806, DOI [10.1016/s2214-109x(16)30199-1, 10.1016/S2214-109X(16)30199-1]; Hwang TJ, 2011, INT J TUBERC LUNG D, V15, P1620, DOI 10.5588/ijtld.11.0222; Kasaie P, 2014, AM J RESP CRIT CARE, V189, P845, DOI 10.1164/rccm.201310-1846OC; Kato M, 2014, CURR HIV-AIDS REP, V11, P487, DOI 10.1007/s11904-014-0235-7; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Lonnroth K, 2013, INT J TUBERC LUNG D, V17, P289, DOI 10.5588/ijtld.12.0797; Lonnroth K, 2016, T ROY SOC TROP MED H, V110, P148, DOI 10.1093/trstmh/trv108; Miller AC, 2010, INT J TUBERC LUNG D, V14, P720; National Institute for Health and Care Excellence, 2016, TUB NICE GUID NG33; Nguyen BH, 2010, B WORLD HEALTH ORGAN, V88, P273, DOI 10.2471/BLT.09.067801; Taylor Zachary, 2005, Morbidity and Mortality Weekly Report, V54, P1; WHO, 2010, TREATMENT OF TUBERCULOSIS: GUIDELINES, FOURTH EDITION, P1; WHO, 2016, GLOB TUB REP; World Bank Group, 2013, PREV HIV TOT POP AG; World Health Organization, 2013, SYST SCREEN ACT TUB	31	116	120	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2018	378	3					221	229		10.1056/NEJMoa1700209	http://dx.doi.org/10.1056/NEJMoa1700209			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT1IJ	29342390	Bronze			2022-12-28	WOS:000422888400006
J	Armstrong, S				Armstrong, Stephen			TECHNOLOGY IN HEALTHCARE The apps attempting to transfer NHS 111 online	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												stephen.armstrong@me.com						[Anonymous], 2017, LIST ALL 111 SITES P; [Anonymous], 2017, SUNDAY TIMES; [Anonymous], IND CLIN REV PAN MEM; [Anonymous], FINANCIAL TIMES; [Anonymous], 2017, WIRED; Armstrong R., 2017, DIGITAL HLTH AG 1124; Banfi F, 2013, HIGHER SATISFACTION; Bhattie N, 2017, GUARDIAN; Bodkin H, 2017, DAILY TELEGRAPH; Crouch H., 2017, DIGITALHEALTH   1221; Department of Health, 2017, GOV MAND NHS ENGL; Digital NHS, NHS PATHW; GP at Hand, FAQS CAN AN REG; Gutierrez-Gutierrez B, 2016, ANTIMICROB AGENTS CH, V60, P4159, DOI 10.1128/AAC.00365-16; Ham C, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j1678; Heather B, 2016, DIGITAL HLTH; Lomas N, 2017, TECHCRUNCH; Matthews-King A., 2017, INDEPENDENT; Middleton K, 2016, SORTING OUT SYMPTOMS; Murgia M, 2017, FINANCIAL TIMES; NHS England, 2017, NHS 111 ONL EV; NHS England, DEV INT URG CAR NHS; O'Hear S., 2017, BABYLON HLTH RAISES; Rimmer A, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5698; Wickware C, 2017, PULSE; Willlet K, 2017, NEXT STEPS URGENT EM	26	4	4	1	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 15	2018	360								k156	10.1136/bmj.k156	http://dx.doi.org/10.1136/bmj.k156			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT5PG	29335297				2022-12-28	WOS:000423205100006
J	Wu, ZX; Ahmad, R; Yin, BL; Sandlobes, S; Curtin, WA				Wu, Zhaoxuan; Ahmad, Rasool; Yin, Binglun; Sandloebes, Stefanie; Curtin, W. A.			Mechanistic origin and prediction of enhanced ductility in magnesium alloys	SCIENCE			English	Article							SOLID-SOLUTION ALLOYS; RARE EARTH ALLOYS; STRETCH FORMABILITY; MG-ZN; ROOM-TEMPERATURE; ZR ALLOYS; MN ALLOY; CE ALLOY; TEXTURE; CA	Pure magnesium exhibits poor ductility owing to pyramidal < c + a > dislocation transformations to immobile structures, making this lowest-density structural metal unusable for many applications where it could enhance energy efficiency. We show why magnesium can be made ductile by specific dilute solute additions, which increase the < c + a > cross-slip and multiplication rates to levels much faster than the deleterious < c + a > transformation, enabling both favorable texture during processing and continued plastic straining during deformation. A quantitative theory establishes the conditions for ductility as a function of alloy composition in very good agreement with experiments on many existing magnesium alloys, and the solute-enhanced cross-slip mechanism is confirmed by transmission electron microscopy observations in magnesium-yttrium. The mechanistic theory can quickly screen for alloy compositions favoring conditions for high ductility and may help in the development of high-formability magnesium alloys.	[Wu, Zhaoxuan; Ahmad, Rasool; Yin, Binglun; Curtin, W. A.] Ecole Polytech Fed Lausanne, Inst Mech Engn, CH-1015 Lausanne, Switzerland; [Wu, Zhaoxuan] Inst High Performance Comp, 1 Fusionopolis Way,16-16 Connexis, Singapore 138632, Singapore; [Sandloebes, Stefanie] RWTH Rheinisch Westfal TH Aachen Univ, Inst Met & Met Phys, Kopernikusstr 14, D-52074 Aachen, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of High Performance Computing (IHPC); RWTH Aachen University	Curtin, WA (corresponding author), Ecole Polytech Fed Lausanne, Inst Mech Engn, CH-1015 Lausanne, Switzerland.	william.curtin@epfl.ch	Yin, Binglun/M-5323-2015; Wu, Zhaoxuan/A-2097-2012	Yin, Binglun/0000-0002-3384-4758; Wu, Zhaoxuan/0000-0002-4739-1139; Ahmad, Rasool/0000-0002-4154-6902	Swiss National Science Foundation [162350]; EPFL	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EPFL	The authors acknowledge financial support of this work through a grant from the Swiss National Science Foundation entitled "Control of atomistic mechanisms of flow in magnesium alloys to achieve high ductility" (project #162350). The authors also acknowledge support from EPFL to the Laboratory for Multiscale Mechanics Modeling that enabled the required high-performance computing provided by Scientific and IT Application Support (SCITAS) at EPFL. All data are reported in the main paper and supplementary materials.	Agnew SR, 2006, JOM-US, V58, P62, DOI 10.1007/s11837-006-0026-8; Agnew SR, 2001, ACTA MATER, V49, P4277, DOI 10.1016/S1359-6454(01)00297-X; AKHTAR A, 1969, ACTA METALL MATER, V17, P1351, DOI 10.1016/0001-6160(69)90152-7; Ando Shinji, 2014, Materials Science Forum, V783-786, P341, DOI 10.4028/www.scientific.net/MSF.783-786.341; Arroyave R, 2005, CALPHAD, V29, P230, DOI 10.1016/j.calphad.2005.07.004; Caceres C.H., 2001, J LIGHT MET, V1, P151; Caceres CH, 2002, PHYS STATUS SOLIDI A, V194, P147, DOI 10.1002/1521-396X(200211)194:1<147::AID-PSSA147>3.0.CO;2-L; Chang SY, 1997, MATER T JIM, V38, P526, DOI 10.2320/matertrans1989.38.526; Chen TJ, 2013, MATER DESIGN, V44, P555, DOI 10.1016/j.matdes.2012.08.040; Chino Y, 2008, MAT SCI ENG A-STRUCT, V494, P343, DOI 10.1016/j.msea.2008.04.059; Chino Y, 2008, ACTA MATER, V56, P387, DOI 10.1016/j.actamat.2007.09.036; Chino Y, 2011, MATER TRANS, V52, P1477, DOI 10.2320/matertrans.M2011048; Chino Y, 2011, J JPN I MET, V75, P35, DOI 10.2320/jinstmet.75.35; Chino Y, 2011, METALL MATER TRANS A, V42A, P1965, DOI 10.1007/s11661-010-0563-1; Chino Y, 2010, MAT SCI ENG A-STRUCT, V528, P566, DOI 10.1016/j.msea.2010.09.081; Chino Y, 2009, MAT SCI ENG A-STRUCT, V513-14, P394, DOI 10.1016/j.msea.2009.01.074; Chino Y, 2008, MATER TRANS, V49, P2916, DOI 10.2320/matertrans.MEP2008257; Gao L, 2013, J MAGNES ALLOY, V1, P283, DOI 10.1016/j.jma.2013.11.005; Hadorn JP, 2012, METALL MATER TRANS A, V43A, P1347, DOI 10.1007/s11661-011-0923-5; Hantzsche K, 2010, SCRIPTA MATER, V63, P725, DOI 10.1016/j.scriptamat.2009.12.033; Huang XS, 2015, MAT SCI ENG A-STRUCT, V633, P144, DOI 10.1016/j.msea.2015.03.018; Huang XS, 2015, J ALLOY COMPD, V632, P94, DOI 10.1016/j.jallcom.2015.01.148; Imandoust A, 2017, ACTA MATER, V138, P27, DOI 10.1016/j.actamat.2017.07.038; Luo AA, 2011, SCRIPTA MATER, V64, P410, DOI 10.1016/j.scriptamat.2010.10.045; Mishra RK, 2008, SCRIPTA MATER, V59, P562, DOI 10.1016/j.scriptamat.2008.05.019; Nakata T, 2017, ACTA MATER, V130, P261, DOI 10.1016/j.actamat.2017.03.046; Nakata T, 2016, MAT SCI ENG A-STRUCT, V673, P443, DOI 10.1016/j.msea.2016.07.098; Qian M, 2006, SCRIPTA MATER, V54, P881, DOI 10.1016/j.scriptamat.2005.11.002; Sandlobes S, 2014, ACTA MATER, V70, P92, DOI 10.1016/j.actamat.2014.02.011; Sandlobes S, 2011, ACTA MATER, V59, P429, DOI 10.1016/j.actamat.2010.08.031; Sandlobes S, 2013, MAT SCI ENG A-STRUCT, V576, P61, DOI 10.1016/j.msea.2013.03.006; Somekawa H, 2017, MAT SCI ENG A-STRUCT, V697, P217, DOI 10.1016/j.msea.2017.05.012; Tang WN, 2008, MATER TRANS, V49, P957, DOI 10.2320/matertrans.MC200707; Wu D, 2011, J ALLOY COMPD, V509, P2856, DOI 10.1016/j.jallcom.2010.11.141; Wu ZX, 2016, P NATL ACAD SCI USA, V113, P11137, DOI 10.1073/pnas.1603966113; Wu ZX, 2015, NATURE, V526, P62, DOI 10.1038/nature15364; Yang L, 2013, ACTA BIOMATER, V9, P8499, DOI 10.1016/j.actbio.2013.03.017; Yin BL, 2017, ACTA MATER, V136, P249, DOI 10.1016/j.actamat.2017.06.062; Zhang EL, 2009, MAT SCI ENG C-BIO S, V29, P987, DOI 10.1016/j.msec.2008.08.024	39	301	309	48	357	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					447	451		10.1126/science.aap8716	http://dx.doi.org/10.1126/science.aap8716			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6SD	29371467				2022-12-28	WOS:000423283200044
J	Pace, L; Goudot, C; Zueva, E; Gueguen, P; Burgdorf, N; Waterfall, JJ; Quivy, JP; Almouzni, G; Amigorena, S				Pace, Luigia; Goudot, Christel; Zueva, Elina; Gueguen, Paul; Burgdorf, Nina; Waterfall, Joshua J.; Quivy, Jean-Pierre; Almouzni, Genevieve; Amigorena, Sebastian			The epigenetic control of stemness in CD8(+) T cell fate commitment	SCIENCE			English	Article							HETEROCHROMATIN MAINTENANCE; MEMORY; EFFECTOR; DIFFERENTIATION; EXPRESSION; GENES	After priming, naive CD8(+) T lymphocytes establish specific heritable transcription programs that define progression to long-lasting memory cells or to short-lived effector cells. Although lineage specification is critical for protection, it remains unclear how chromatin dynamics contributes to the control of gene expression programs. We explored the role of gene silencing by the histone methyltransferase Suv39h1. In murine CD8(+) T cells activated after Listeria monocytogenes infection, Suv39h1-dependent trimethylation of histone H3 lysine 9 controls the expression of a set of stem cell-related memory genes. Single-cell RNA sequencing revealed a defect in silencing of stem/memory genes selectively in Suv39h1-defective T cell effectors. As a result, Suv39h1-defective CD8(+) T cells show sustained survival and increased long-term memory reprogramming capacity. Thus, Suv39h1 plays a critical role in marking chromatin to silence stem/memory genes during CD8(+) T effector terminal differentiation.	[Pace, Luigia; Goudot, Christel; Zueva, Elina; Gueguen, Paul; Burgdorf, Nina; Waterfall, Joshua J.; Quivy, Jean-Pierre; Almouzni, Genevieve; Amigorena, Sebastian] PSL Res Univ, Inst Curie, F-75005 Paris, France; [Pace, Luigia; Goudot, Christel; Zueva, Elina; Gueguen, Paul; Burgdorf, Nina; Amigorena, Sebastian] INSERM U932, Equipes Labellisees Ligue Canc, F-75005 Paris, France; [Pace, Luigia] Italian Inst Genom Med, Armenise Harvard Lab, Turin, Italy; [Waterfall, Joshua J.] INSERM U830, F-75005 Paris, France; [Waterfall, Joshua J.] Inst Curie, Translat Res Dept, F-75005 Paris, France; [Quivy, Jean-Pierre; Almouzni, Genevieve] CNRS, Equipe Labellisee Ligue Canc, UMR3664, F-75005 Paris, France; [Quivy, Jean-Pierre; Almouzni, Genevieve] UPMC Univ Paris 06, Sorbonne Univ, CNRS, UMR3664, F-75005 Paris, France; [Pace, Luigia] Italian Inst Genom Med, Turin, Italy	UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; Italian Institute for Genomic Medicine (IIGM); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Italian Institute for Genomic Medicine (IIGM)	Pace, L; Almouzni, G; Amigorena, S (corresponding author), PSL Res Univ, Inst Curie, F-75005 Paris, France.; Pace, L; Amigorena, S (corresponding author), INSERM U932, Equipes Labellisees Ligue Canc, F-75005 Paris, France.; Pace, L (corresponding author), Italian Inst Genom Med, Armenise Harvard Lab, Turin, Italy.; Almouzni, G (corresponding author), CNRS, Equipe Labellisee Ligue Canc, UMR3664, F-75005 Paris, France.; Almouzni, G (corresponding author), UPMC Univ Paris 06, Sorbonne Univ, CNRS, UMR3664, F-75005 Paris, France.	luigia.pace@iigm.it; genevieve.almouzni@curie.fr; sebastian.amigorena@curie.fr	Almouzni, Genevieve/ABG-1029-2021	Almouzni, Genevieve/0000-0001-5570-0723; quivy, jean-pierre/0000-0001-6557-7204; Waterfall, Joshua/0000-0002-3762-5050; Amigorena, Sebastian/0000-0001-8583-8416; Gueguen, Paul/0000-0003-2930-6073; Zueva, Elina/0000-0002-6276-5127	Institute Curie; Institut National de la Sante et de la Recherche Medicale; Centre National de la Recherche Scientifique; ANR [ANR-10-BLAN-1326-03, ANR-14-CE16-0009]; Ligue Contre le Cancer (Equipe labelisee Ligue) [EL2014.LNCC/SA]; Association de Recherche Contre le Cancer grant ERC (AdG) [340046 DCBIOX]; Ligue Nationale contre le Cancer (Equipe labelisee Ligue); European Commission Network of Excellence EpiGeneSys [HEALTH-F4-2010-257082]; ERC Advanced Grant "Eccentric" [2009-AdG_20090506]; European Commission [FP7_HEALTH-2010-259743]; ANR "CHAPINHIB" [ANR-12-BSV5- 0022-02]; ANR "CELLECTCHIP" [ANR-14-CE10-0013]; Aviesan-ITMO cancer project "Epigenomics of breast cancer"; SiRIC/INCa grant [INCa-DGOS-4654]; grants SESAME (region Ile-de-France) [ANR-10-EQPX-03, ANR-10-INBS-09-08];  [ANR-11-LABX-0044_DEEP];  [ANR-10-IDEX-0001-02 PSL]	Institute Curie; Institut National de la Sante et de la Recherche Medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); ANR(French National Research Agency (ANR)); Ligue Contre le Cancer (Equipe labelisee Ligue); Association de Recherche Contre le Cancer grant ERC (AdG); Ligue Nationale contre le Cancer (Equipe labelisee Ligue)(Ligue nationale contre le cancer); European Commission Network of Excellence EpiGeneSys; ERC Advanced Grant "Eccentric"; European Commission(European CommissionEuropean Commission Joint Research Centre); ANR "CHAPINHIB"(French National Research Agency (ANR)); ANR "CELLECTCHIP"(French National Research Agency (ANR)); Aviesan-ITMO cancer project "Epigenomics of breast cancer"; SiRIC/INCa grant; grants SESAME (region Ile-de-France); ; 	We thank all the U932 and UMR3664 members; C. Maison, N. Lacoste, and F. X. Gobert for helpful discussions; A. Cros and V. Mondin for technical help; B. Amati and J. Sedat for critical reading of the manuscript; the flow cytometry platform, the genomic and animal facilities, the Nikon Imaging Center of Curie Institute; and the PICT-IBISA@Pasteur Imaging facility. We thank T. Jenuwein for providing the SUV39H1 gene and the Suv39h1-KO mice. LM-OVA was kindly provided by H. Shen. Supported by the Institute Curie, Institut National de la Sante et de la Recherche Medicale, Centre National de la Recherche Scientifique, ANR "ChromaTin" grant ANR-10-BLAN-1326-03, and "EPICURE" grant ANR-14-CE16-0009 (S.A. and G.A.); la Ligue Contre le Cancer (Equipe labelisee Ligue, EL2014.LNCC/SA) and Association de Recherche Contre le Cancer grant ERC (2013-AdG No 340046 DCBIOX) (S.A.); la Ligue Nationale contre le Cancer (Equipe labelisee Ligue), the European Commission Network of Excellence EpiGeneSys (HEALTH-F4-2010-257082), ERC Advanced Grant 2009-AdG_20090506 "Eccentric," the European Commission large-scale integrating project FP7_HEALTH-2010-259743 "MODHEP," ANR-11-LABX-0044_DEEP, ANR-10-IDEX-0001-02 PSL, ANR "CHAPINHIB" ANR-12-BSV5- 0022-02, ANR "CELLECTCHIP" ANR-14-CE10-0013, and the Aviesan-ITMO cancer project "Epigenomics of breast cancer" (G.A.); and SiRIC/INCa grant INCa-DGOS-4654 (J.J.W.). High-throughput sequencing was performed by the ICGex NGS platform of the Institut Curie supported by the grants SESAME (region Ile-de-France), ANR-10-EQPX-03, and ANR-10-INBS-09-08. The bioinformatics data are available in the Gene Expression Omnibus (GEO) database under accession numbers GSE105163 (microarrays) and SuperSeries GSE106268 for ChIP-seq and scRNA-seq data (linked to subseries GSE106264, GSE106265, and GSE106267). The authors have no conflicting financial interests. The data are tabulated in the main paper and in the supplementary materials. Author contributions: L.P. conceived and designed the project, carried out experimental work, and wrote the manuscript; C.G. contributed to bioinformatics design, carried out bioinformatics work, and interpreted data; E.Z. contributed to project design, carried out experimental work, and interpreted data; P.G. carried out bioinformatics work and participated in data interpretation; N. B. carried out experimental work; J.J.W. participated in bioinformatics data analysis and interpretation; J.-P.Q. participated in project design and data interpretation and wrote the manuscript; G.A. designed the project and wrote the manuscript; and S.A. conceived and designed the project and wrote the manuscript. L.P., C.G., and S.A. are inventors on patent application EP17305757.1 submitted by Institut Curie that covers the targeting of Suv39h1 in the context of T cell adoptive transfer.	Ahmed R, 2009, NAT REV IMMUNOL, V9, P662, DOI 10.1038/nri2619; Allan RS, 2012, NATURE, V487, P249, DOI 10.1038/nature11173; Allis CD, 2016, NAT REV GENET, V17, P487, DOI 10.1038/nrg.2016.59; Almouzni G, 2011, NUCLEUS-PHILA, V2, P332, DOI 10.4161/nucl.2.5.17707; Bevan MJ, 2011, NAT IMMUNOL, V12, P463, DOI 10.1038/ni.2041; Bradley SP, 2006, J IMMUNOL, V177, P1179, DOI 10.4049/jimmunol.177.2.1179; Chang JT, 2014, NAT IMMUNOL, V15, P1104, DOI 10.1038/ni.3031; Fodor BD, 2010, ANNU REV CELL DEV BI, V26, P471, DOI 10.1146/annurev.cellbio.042308.113225; Gattinoni L, 2011, NAT MED, V17, P1290, DOI 10.1038/nm.2446; Graef P, 2014, IMMUNITY, V41, P116, DOI 10.1016/j.immuni.2014.05.018; Hoebeke I, 2007, LEUKEMIA, V21, P311, DOI 10.1038/sj.leu.2404488; Kaech SM, 2003, NAT IMMUNOL, V4, P1191, DOI 10.1038/ni1009; Kaech SM, 2012, NAT REV IMMUNOL, V12, P749, DOI 10.1038/nri3307; Kamphorst AO, 2015, VACCINE, V33, pB21, DOI 10.1016/j.vaccine.2014.12.082; Luckey CJ, 2006, P NATL ACAD SCI USA, V103, P3304, DOI 10.1073/pnas.0511137103; Maison C, 2004, NAT REV MOL CELL BIO, V5, P296, DOI 10.1038/nrm1355; Maison C, 2010, COLD SH Q B, V75, P155, DOI 10.1101/sqb.2010.75.013; Miller ML, 2014, P NATL ACAD SCI USA, V111, P7397, DOI 10.1073/pnas.1315398111; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Probst AV, 2009, NAT REV MOL CELL BIO, V10, P192, DOI 10.1038/nrm2640; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Shih HY, 2014, IMMUNOL REV, V261, P23, DOI 10.1111/imr.12208; Spinelli L, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2012-4; Wei G, 2009, IMMUNITY, V30, P155, DOI 10.1016/j.immuni.2008.12.009; Weng NP, 2012, NAT REV IMMUNOL, V12, P306, DOI 10.1038/nri3173; Wherry EJ, 2007, IMMUNITY, V27, P670, DOI 10.1016/j.immuni.2007.09.006; Yu BF, 2017, NAT IMMUNOL, V18, P573, DOI 10.1038/ni.3706	29	117	122	4	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					177	+		10.1126/science.aah6499	http://dx.doi.org/10.1126/science.aah6499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS5EO	29326266				2022-12-28	WOS:000419816600039
J	Shi, YH; Sun, Y; Hao, CF; Zhang, HP; Wei, DM; Zhang, YS; Zhu, YM; Deng, XH; Qi, XJ; Li, H; Ma, X; Ren, HQ; Wang, YQ; Zhang, D; Wang, B; Liu, FH; Wu, QF; Wang, Z; Bai, HY; Li, Y; Zhou, Y; Sun, M; Liu, H; Li, J; Zhang, L; Chen, XL; Zhang, SY; Sun, XX; Legro, RS; Chen, ZJ				Shi, Yuhua; Sun, Yun; Hao, Cuifang; Zhang, Heping; Wei, Daimin; Zhang, Yunshan; Zhu, Yimin; Deng, Xiaohui; Qi, Xiujuan; Li, Hong; Ma, Xiang; Ren, Haiqin; Wang, Yaqin; Zhang, Dan; Wang, Bo; Liu, Fenghua; Wu, Qiongfang; Wang, Ze; Bai, Haiyan; Li, Yuan; Zhou, Yi; Sun, Mei; Liu, Hong; Li, Jing; Zhang, Lin; Chen, Xiaoli; Zhang, Songying; Sun, Xiaoxi; Legro, Richard S.; Chen, Zi-Jiang			Transfer of Fresh versus Frozen Embryos in Ovulatory Women	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IN-VITRO FERTILIZATION; IMPAIRED ENDOMETRIAL RECEPTIVITY; TRIAL COMPARING FRESH; OVARIAN STIMULATION; PERINATAL OUTCOMES; BIRTH; IVF; RISK	BACKGROUND Elective frozen-embryo transfer has been shown to result in a higher live-birth rate than fresh-embryo transfer among anovulatory women with the polycystic ovary syndrome. It is uncertain whether frozen-embryo transfer increases live-birth rates among ovulatory women with infertility. METHODS In this multicenter, randomized trial, we randomly assigned 2157 women who were undergoing their first in vitro fertilization cycle to undergo either freshembryo transfer or embryo cryopreservation followed by frozen-embryo transfer. Up to two cleavage-stage embryos were transferred in each participant. The primary outcome was a live birth after the first embryo transfer. RESULTS The live-birth rate did not differ significantly between the frozen-embryo group and the fresh-embryo group (48.7% and 50.2%, respectively; relative risk, 0.97; 95% confidence interval [CI], 0.89 to 1.06; P = 0.50). There were also no significant between-group differences in the rates of implantation, clinical pregnancy, overall pregnancy loss, and ongoing pregnancy. Frozen-embryo transfer resulted in a significantly lower risk of the ovarian hyperstimulation syndrome than fresh-embryo transfer (0.6% vs. 2.0%; relative risk, 0.32; 95% CI, 0.14 to 0.74; P = 0.005). The risks of obstetrical and neonatal complications and other adverse outcomes did not differ significantly between the two groups. CONCLUSIONS The live-birth rate did not differ significantly between fresh-embryo transfer and frozen-embryo transfer among ovulatory women with infertility, but frozen-embryo transfer resulted in a lower risk of the ovarian hyperstimulation syndrome.	[Shi, Yuhua; Wei, Daimin; Wang, Ze; Sun, Mei; Liu, Hong; Li, Jing; Zhang, Lin; Chen, Zi-Jiang] Shandong Univ, Shandong Prov Hosp, Minist Educ, Key Lab Reprod Endocrinol,Ctr Reprod Med, Jinan, Shandong, Peoples R China; [Shi, Yuhua; Wei, Daimin; Wang, Ze; Sun, Mei; Liu, Hong; Li, Jing; Zhang, Lin; Chen, Zi-Jiang] Natl Res Ctr Assisted Reprod Technol & Reprod Gen, Jinan, Shandong, Peoples R China; [Deng, Xiaohui] Shandong Univ, Qilu Hosp, Ctr Reprod Med, Jinan, Shandong, Peoples R China; [Sun, Yun; Chen, Zi-Jiang] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Ctr Reprod Med, Shanghai, Peoples R China; [Sun, Yun; Chen, Zi-Jiang] Shanghai Key Lab Assisted Reprod & Reprod Genet, Shanghai, Peoples R China; [Sun, Xiaoxi] Fudan Univ, Obstet & Gynecol Hosp, Shanghai Jiai Genet & IVF Ctr, Shanghai, Peoples R China; [Hao, Cuifang] Yantai Yuhuangding Hosp, Ctr Reprod Med, Yantai, Peoples R China; [Zhang, Yunshan] Tianjin Cent Hosp Obstet & Gynecol, Ctr Reprod Med, Tianjin, Peoples R China; [Zhang, Dan; Zhou, Yi] Zhejiang Univ, Sch Med, Womens Hosp, Dept Reprod Endocrinol, Hangzhou, Zhejiang, Peoples R China; [Zhang, Songying] Zhejiang Univ, Sch Med, Ctr Reprod Med, Hangzhou, Zhejiang, Peoples R China; [Qi, Xiujuan] Qingdao Univ, Affiliated Hosp, Qingdao, Peoples R China; [Zhou, Yi] Qingdao Univ, Qingdao Women & Childrens Hosp, Ctr Reprod Med, Qingdao, Peoples R China; [Li, Hong] Suzhou Municipal Hosp, Ctr Reprod & Genet, Suzhou, Peoples R China; [Ma, Xiang] Nanjing Med Univ, Jiangsu Prov Hosp, Affiliated Hosp 1, Dept Reprod Med, Nanjing, Jiangsu, Peoples R China; [Ren, Haiqin] Jinghua Hosp, Reprod Med Ctr, Shenyang, Liaoning, Peoples R China; [Wang, Yaqin] Wuhan Univ, Ctr Reprod Med, Wuhan, Hubei, Peoples R China; [Wang, Bo] Sun Yat Sen Univ, Affiliated Hosp 6, Reprod Med Res Ctr, Guangzhou, Guangdong, Peoples R China; [Liu, Fenghua] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Ctr Reprod Med, Women & Childrens Hosp Guangdong Prov, Guangzhou, Guangdong, Peoples R China; [Chen, Xiaoli] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Ctr Reprod Med, Guangzhou, Guangdong, Peoples R China; [Wu, Qiongfang] Maternal & Child Hlth Care Hosp Jiangxi Prov, Ctr Reprod Med, Nanchang, Jiangxi, Peoples R China; [Bai, Haiyan] Northwest Women & Childrens Hosp, Ctr Assisted Reprod, Xian, Shaanxi, Peoples R China; [Li, Yuan] Beijing Chaoyang Hosp, Ctr Reprod Med, Beijing, Peoples R China; [Zhang, Heping] Yale Univ, Sch Publ Hlth, Dept Biostat, New Haven, CT USA; [Legro, Richard S.] Penn State Coll Med, Dept Obstet & Gynecol, Hershey, PA USA	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University; Shanghai Jiao Tong University; Fudan University; Zhejiang University; Zhejiang University; Qingdao University; Qingdao University; Nanjing Medical University; Wuhan University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Yale University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Chen, ZJ (corresponding author), Shandong Univ, Shandong Prov Hosp, Ctr Reprod Med, 324 Jingwu Rd, Jinan 250021, Shandong, Peoples R China.	chenzijiang@hotmail.com	Chen, Zi-Jiang/GOE-6119-2022; Yan, Junhao/AAH-8310-2019; Li, Yuan/GXV-1310-2022; Zhang, He/GXN-0028-2022; Zhang, Lin/H-5542-2017	Chen, Zi-Jiang/0000-0001-6637-6631; Wu, Qiongfang/0000-0002-8432-7240; ZHU, YM/0000-0002-9667-3677	National Key Research and Development Program of China [2017YFC1001000]; National Natural Science Foundation of China [81490743, 81430029]; Ogeda; Kin-Dex Pharmaceuticals; Fractyl Laboratories; Bayer; AbbVie; Ferring Pharmaceuticals	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ogeda; Kin-Dex Pharmaceuticals; Fractyl Laboratories(Randox Laboratories); Bayer(Bayer AG); AbbVie(AbbVie); Ferring Pharmaceuticals(Ferring Pharmaceuticals)	Supported by grants from the National Key Research and Development Program of China (2017YFC1001000), the Major Program of the National Natural Science Foundation of China (81490743), and the State Key Program of the National Natural Science Foundation of China (81430029).r Dr. Legro reports receiving consulting fees from Ogeda, Kin-Dex Pharmaceuticals, Fractyl Laboratories, Bayer, and AbbVie and receiving grant support from Ferring Pharmaceuticals. No other potential conflict of interest relevant to this article was reported.	Amer Soc Reprod Med, 2013, FERTIL STERIL, V99, P44, DOI 10.1016/j.fertnstert.2012.09.038; [Anonymous], 2012, ASS REPR TECHN NAT S; Chen ZJ, 2016, NEW ENGL J MED, V375, P523, DOI 10.1056/NEJMoa1513873; Coates A, 2017, FERTIL STERIL, V107, P723, DOI [10.1016/.fertnstert.2016.12.022, 10.1016/j.fertnstert.2016.12.022]; Diamond MP, 2012, OBSTET GYNECOL, V119, P902, DOI 10.1097/AOG.0b013e31824da35c; Evans J, 2014, HUM REPROD UPDATE, V20, P808, DOI 10.1093/humupd/dmu027; Ferraretti AP, 1999, HUM REPROD, V14, P1457, DOI 10.1093/humrep/14.6.1457; Glujovsky D, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002118.pub4, 10.1002/14651858.CD002118.pub5]; Golan A, 1989, Obstet Gynecol Surv, V44, P430, DOI 10.1097/00006254-198906000-00004; Heijnen EMEW, 2006, HUM REPROD UPDATE, V12, P13, DOI 10.1093/humupd/dmi036; Hu XL, 2014, J CLIN ENDOCR METAB, V99, P2217, DOI 10.1210/jc.2013-3362; Kalra SK, 2011, OBSTET GYNECOL, V118, P863, DOI 10.1097/AOG.0b013e31822be65f; Legro RS, 2013, J CLIN ENDOCR METAB, V98, P4565, DOI 10.1210/jc.2013-2350; Maheshwari A, 2016, FERTIL STERIL, V106, P1703, DOI 10.1016/j.fertnstert.2016.08.047; Maheshwari A, 2012, FERTIL STERIL, V98, P368, DOI 10.1016/j.fertnstert.2012.05.019; PUISSANT F, 1987, HUM REPROD, V2, P705, DOI 10.1093/oxfordjournals.humrep.a136618; Roque M, 2017, J ASSIST REPROD GEN, V34, P179, DOI 10.1007/s10815-016-0834-x; Shapiro BS, 2016, FERTIL STERIL, V106, P317, DOI 10.1016/j.fertnstert.2016.03.049; Shapiro BS, 2011, FERTIL STERIL, V96, P516, DOI 10.1016/j.fertnstert.2011.02.059; Shapiro BS, 2011, FERTIL STERIL, V96, P344, DOI 10.1016/j.fertnstert.2011.05.050; Vidal M, 2017, FERTIL STERIL, V107, DOI 10.1016/j.fertnstert.2017.01.021; Wei DM, 2017, HUM REPROD, V32, P354, DOI 10.1093/humrep/dew325; Weinerman R, 2014, FERTIL STERIL, V102, P10, DOI 10.1016/j.fertnstert.2014.05.019	23	255	276	19	131	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 11	2018	378	2					126	136		10.1056/NEJMoa1705334	http://dx.doi.org/10.1056/NEJMoa1705334			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS7IR	29320646	Bronze			2022-12-28	WOS:000419971600006
J	Seibert, TM; Fan, CC; Wang, YP; Zuber, V; Karunamuni, R; Parsons, JK; Eeles, RA; Easton, DF; Kote-Jarai, Z; Al Olama, AA; Garcia, SB; Muir, K; Gronberg, H; Wiklund, F; Aly, M; Schleutker, J; Sipeky, C; Tammela, TLJ; Nordestgaard, BG; Nielsen, SF; Weischer, M; Bisbjerg, R; Roder, MA; Iversen, P; Key, TJ; Travis, RC; Neal, DE; Donovan, JL; Hamdy, FC; Pharoah, P; Pashayan, N; Khaw, KT; Maier, C; Vogel, W; Luedeke, M; Herkommer, K; Kibel, AS; Cybulski, C; Wokolorczyk, D; Kluzniak, W; Cannon-Albright, L; Brenner, H; Cuk, K; Saum, KU; Park, JY; Sellers, TA; Slavov, C; Kaneva, R; Mitev, V; Batra, J; Clements, JA; Spurdle, A; Teixeira, MR; Paulo, P; Maia, S; Pandha, H; Michael, A; Kierzek, A; Karow, DS; Mills, IG; Andreassen, OA; Dale, AM				Seibert, Tyler M.; Fan, Chun Chieh; Wang, Yunpeng; Zuber, Verena; Karunamuni, Roshan; Parsons, J. Kellogg; Eeles, Rosalind A.; Easton, Douglas F.; Kote-Jarai, ZSofia; Al Olama, Ali Amin; Garcia, Sara Benlloch; Muir, Kenneth; Gronberg, Henrik; Wiklund, Fredrik; Aly, Markus; Schleutker, Johanna; Sipeky, Csilla; Tammela, Teuvo L. J.; Nordestgaard, Borge G.; Nielsen, Sune F.; Weischer, Maren; Bisbjerg, Rasmus; Roder, M. Andreas; Iversen, Peter; Key, Tim J.; Travis, Ruth C.; Neal, David E.; Donovan, Jenny L.; Hamdy, Freddie C.; Pharoah, Paul; Pashayan, Nora; Khaw, Kay-Tee; Maier, Christiane; Vogel, Walther; Luedeke, Manuel; Herkommer, Kathleen; Kibel, Adam S.; Cybulski, Cezary; Wokolorczyk, Dominika; Kluzniak, Wojciech; Cannon-Albright, Lisa; Brenner, Hermann; Cuk, Katarina; Saum, Kai-Uwe; Park, Jong Y.; Sellers, Thomas A.; Slavov, Chavdar; Kaneva, Radka; Mitev, Vanio; Batra, Jyotsna; Clements, Judith A.; Spurdle, Amanda; Teixeira, Manuel R.; Paulo, Paula; Maia, Sofia; Pandha, Hardev; Michael, Agnieszka; Kierzek, Andrzej; Karow, David S.; Mills, Ian G.; Andreassen, Ole A.; Dale, Anders M.		PRACTICAL Consortium	Polygenic hazard score to guide screening for aggressive - prostate cancer: development and validation in large scale - cohorts	BMJ-BRITISH MEDICAL JOURNAL			English	Article							RISK PREDICTION; SUSCEPTIBILITY; STATISTICS; PREVENTION; OUTCOMES; IMPACT	OBJECTIVES To develop and validate a genetic tool to predict age of onset of aggressive prostate cancer (PCa) and to guide decisions of who to screen and at what age. DESIGN Analysis of genotype, PCa status, and age to select single nucleotide polymorphisms (SNPs) associated with diagnosis. These polymorphisms were incorporated into a survival analysis to estimate their effects on age at diagnosis of aggressive PCa (that is, not eligible for surveillance according to National Comprehensive Cancer Network guidelines; any of Gleason score >= 7, stage T3-T4, PSA (prostate specific antigen) concentration >= 10 ng/L, nodal metastasis, distant metastasis). The resulting polygenic hazard score is an assessment of individual genetic risk. The final model was applied to an independent dataset containing genotype and PSA screening data. The hazard score was calculated for these men to test prediction of survival free from PCa. SETTING Multiple institutions that were members of international PRACTICAL consortium. PARTICIPANTS All consortium participants of European ancestry with known age, PCa status, and quality assured custom (iCOGS) array genotype data. The development dataset comprised 31 747 men; the validation dataset comprised 6411 men. MAIN OUTCOME MEASURES Prediction with hazard score of age of onset of aggressive cancer in validation set. RESULTS In the independent validation set, the hazard score calculated from 54 single nucleotide polymorphisms was a highly significant predictor of age at diagnosis of aggressive cancer (z= 11.2, P< 10(-16)). When men in the validation set with high scores (>98th centile) were compared with those with average scores (30th-70th centile), the hazard ratio for aggressive cancer was 2.9 (95% confidence interval 2.4 to 3.4). Inclusion of family history in a combined model did not improve prediction of onset of aggressive PCa (P= 0.59), and polygenic hazard score performance remained high when family history was accounted for. Additionally, the positive predictive value of PSA screening for aggressive PCa was increased with increasing polygenic hazard score. CONCLUSIONS Polygenic hazard scores can be used for personalised genetic risk estimates that can predict for age at onset of aggressive PCa.	[Seibert, Tyler M.; Fan, Chun Chieh; Karunamuni, Roshan; Karow, David S.; Dale, Anders M.] Univ Calif San Diego, Ctr Multimodal Imaging & Genet, La Jolla, CA 92093 USA; [Seibert, Tyler M.; Karunamuni, Roshan] Univ Calif San Diego, Dept Radiat Med & Appl Sci, La Jolla, CA 92093 USA; [Fan, Chun Chieh] Univ Calif San Diego, Dept Cognit Sci, La Jolla, CA 92093 USA; [Wang, Yunpeng; Zuber, Verena; Mills, Ian G.; Andreassen, Ole A.] Oslo Univ Hosp, KG Jebsen Ctr, NORMENT, Oslo, Norway; [Wang, Yunpeng; Zuber, Verena; Mills, Ian G.; Andreassen, Ole A.] Univ Oslo, Oslo, Norway; [Zuber, Verena] MRC, Biostat Unit, Cambridge Biomed Campus, Cambridge, England; [Parsons, J. Kellogg] Univ Calif San Diego, Dept Surg, La Jolla, CA 92093 USA; [Eeles, Rosalind A.; Kote-Jarai, ZSofia] Inst Canc Res, Sutton SM2 5NG, Surrey, England; [Eeles, Rosalind A.] Royal Marsden NHS Fdn Trust, London SW3 6JJ, England; [Easton, Douglas F.; Al Olama, Ali Amin; Garcia, Sara Benlloch] Univ Cambridge, Dept Publ Hlth & Primary Care, Ctr Canc Genet Epidemiol, Strangeways Res Lab, Cambridge CB1 8RN, England; [Al Olama, Ali Amin] Univ Cambridge, Stroke Res Grp, Dept Clin Neurosci, R3,Box 83,Cambridge Biomed Campus, Cambridge CB2 0QQ, England; [Muir, Kenneth] Univ Manchester, Inst Populat Hlth, Manchester, Lancs, England; [Muir, Kenneth] Univ Warwick, Warwick Med Sch, Coventry, W Midlands, England; [Gronberg, Henrik; Wiklund, Fredrik; Aly, Markus] Karolinska Inst, Dept Med Epidemiol & Biostat, Stockholm, Sweden; [Aly, Markus] Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Aly, Markus] Karolinska Univ Hosp, Dept Urol, S-17176 Stockholm, Sweden; [Schleutker, Johanna; Sipeky, Csilla] Univ Turku, Inst Biomed, Dept Med Biochem & Genet, Kiinamyllynkatu 10, FI-20014 Turku, Finland; [Schleutker, Johanna; Sipeky, Csilla] Turku Univ Hosp, Dept Med Genet, Tyks Microbiol & Genet, Turku, Finland; [Schleutker, Johanna] Univ Tampere, BioMediTech, Tampere 30014, Finland; [Tammela, Teuvo L. J.] Tampere Univ Hosp, Dept Urol, Tampere, Finland; [Tammela, Teuvo L. J.] Univ Tampere, Sch Med, Tampere, Finland; [Nordestgaard, Borge G.; Nielsen, Sune F.; Iversen, Peter] Univ Copenhagen, Fac Hlth & Med Sci, Copenhagen, Denmark; [Nordestgaard, Borge G.; Nielsen, Sune F.; Weischer, Maren] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Clin Biochem, Herlev, Denmark; [Bisbjerg, Rasmus] Copenhagen Univ Hosp, Herlev & Gentofte Hosp, Dept Urol, Herlev, Denmark; [Roder, M. Andreas; Iversen, Peter] Copenhagen Univ Hosp, Rigshosp, Dept Urol, Copenhagen Prostate Canc Ctr, Copenhagen, Denmark; [Key, Tim J.; Travis, Ruth C.] Univ Oxford, Nuffield Dept Populat Hlth, Canc Epidemiol Unit, Oxford OX3 7LF, England; [Neal, David E.; Hamdy, Freddie C.; Mills, Ian G.] Univ Oxford, Fac Med Sci, Nuffield Dept Surg Sci, John Radcliffe Hosp, Oxford, England; [Neal, David E.] Univ Cambridge, Dept Oncol, Addenbrookes Hosp, Box 279, Cambridge CB2 0QQ, England; [Donovan, Jenny L.] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England; [Pharoah, Paul; Pashayan, Nora] Univ Cambridge, Strangeways Res Lab, Dept Oncol, Ctr Canc Genet Epidemiol, Cambridge, England; [Pashayan, Nora] UCL, Dept Appl Hlth Res, London WC1E 7HB, England; [Khaw, Kay-Tee] Univ Cambridge, Clin Gerontol Unit, Cambridge, England; [Maier, Christiane; Vogel, Walther; Luedeke, Manuel] Univ Hosp Ulm, Inst Human Genet, Ulm, Germany; [Herkommer, Kathleen] Tech Univ Muenchen, Klinikum Rechts Isar, Dept Urol, Munich, Germany; [Kibel, Adam S.] Brigham & Womens Hosp, Dana Farber Canc Inst, Div Urol Surg, 75 Francis St, Boston, MA 02115 USA; [Cybulski, Cezary; Wokolorczyk, Dominika; Kluzniak, Wojciech] Pomeranian Med Univ, Dept Genet & Pathol, Int Hereditary Canc Ctr, Szczecin, Poland; [Cannon-Albright, Lisa] Univ Utah, Sch Med, Dept Med, Div Genet Epidemiol, Salt Lake City, UT USA; [Cannon-Albright, Lisa] George E Wahlen Dept Vet Affairs Med Ctr, Salt Lake City, UT USA; [Brenner, Hermann; Cuk, Katarina; Saum, Kai-Uwe] German Canc Res Ctr, Div Clin Epidemiol & Aging Res, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, Div Prevent Oncol, Heidelberg, Germany; [Brenner, Hermann] Natl Ctr Tumor Dis NCT, Heidelberg, Germany; [Brenner, Hermann] German Canc Res Ctr, German Canc Consortium DKTK, Heidelberg, Germany; [Park, Jong Y.] H Lee Moffitt Canc Ctr & Res Inst, Dept Canc Epidemiol, 12902 Magnolia Dr, Tampa, FL 33612 USA; [Sellers, Thomas A.] H Lee Moffitt Canc Ctr & Res Inst, Off Ctr Director, 12902 Magnolia Dr, Tampa, FL 33612 USA; [Slavov, Chavdar] Med Univ, Dept Urol, Sofia, Bulgaria; [Slavov, Chavdar] Med Univ, Alexandrovska Univ Hosp, Sofia, Bulgaria; [Kaneva, Radka; Mitev, Vanio] Med Univ, Mol Med Ctr, Dept Med Chem & Biochem, 2 Zdrave Str, Sofia 1431, Bulgaria; [Batra, Jyotsna; Clements, Judith A.; Spurdle, Amanda] Queensland Univ Technol, Australian Prostate Canc Res Ctr Qld, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Batra, Jyotsna; Clements, Judith A.; Spurdle, Amanda] Queensland Univ Technol, Sch Biomed Sci, Brisbane, Qld, Australia; [Spurdle, Amanda] Queensland Inst Med Res, Mol Canc Epidemiol Lab, Brisbane, Qld, Australia; [Spurdle, Amanda] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Australian Prostate Canc BioResource, Brisbane, Qld, Australia; [Teixeira, Manuel R.; Paulo, Paula; Maia, Sofia] Portuguese Oncol Inst, Dept Genet, Oporto, Portugal; [Teixeira, Manuel R.] Univ Porto, Biomed Sci Inst ICBAS, Oporto, Portugal; [Pandha, Hardev; Michael, Agnieszka; Kierzek, Andrzej] Univ Surrey, Guildford GU2 7XH, Surrey, England; [Karow, David S.; Dale, Anders M.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA; [Mills, Ian G.] Queens Univ Belfast, Ctr Canc Res & Cell Biol, Belfast, Antrim, North Ireland; [Dale, Anders M.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of Oslo; University of Oslo; MRC Biostatistics Unit; University of California System; University of California San Diego; University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of Cambridge; University of Cambridge; University of Manchester; University of Warwick; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Turku; University of Turku; Tampere University; Tampere University; Tampere University Hospital; Tampere University; University of Copenhagen; University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Oxford; University of Oxford; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; University of Bristol; University of Cambridge; University of London; University College London; University of Cambridge; Ulm University; Technical University of Munich; Harvard University; Brigham & Women's Hospital; Dana-Farber Cancer Institute; Pomeranian Medical University; Utah System of Higher Education; University of Utah; US Department of Veterans Affairs; Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; Medical University Sofia; Medical University Sofia; Medical University Sofia; Queensland University of Technology (QUT); Queensland University of Technology (QUT); QIMR Berghofer Medical Research Institute; Queensland University of Technology (QUT); Portuguese Institute of Oncology; Universidade do Porto; University of Surrey; University of California System; University of California San Diego; Queens University Belfast; University of California System; University of California San Diego	Seibert, TM (corresponding author), Univ Calif San Diego, Ctr Multimodal Imaging & Genet, La Jolla, CA 92093 USA.; Seibert, TM (corresponding author), Univ Calif San Diego, Dept Radiat Med & Appl Sci, La Jolla, CA 92093 USA.	tseibert@ucsd.edu; amdale@ucsd.edu	Røder, M. Andreas/H-7701-2019; Teixeira, Manuel António Rodrigues/E-4885-2011; Nordestgaard, Borge Gronne/ABF-1310-2020; Brenner, Hermann/B-4627-2017; Brenner, Hermann/ABE-6383-2020; Kaneva, Radka P/AGS-5076-2022; Wang, Yunpeng/W-8871-2018; Pharoah, Paul/V-6658-2019; Kaneva, Radka/AAT-5322-2021; Teixeira, Manuel AC/AAZ-7251-2020; Kaneva, Radka P/V-6535-2017; Spurdle, Amanda B/A-4978-2011; Andreassen, Ole A./AAY-7531-2020; Mills, Ian/AAK-9292-2020; Khaw, Kay-Tee/AAZ-3209-2021; /F-1441-2016	Røder, M. Andreas/0000-0002-0019-5333; Teixeira, Manuel António Rodrigues/0000-0002-4896-5982; Brenner, Hermann/0000-0002-6129-1572; Brenner, Hermann/0000-0002-6129-1572; Kaneva, Radka P/0000-0002-1437-1393; Wang, Yunpeng/0000-0001-9831-1090; Pharoah, Paul/0000-0001-8494-732X; Teixeira, Manuel AC/0000-0002-1959-0624; Kaneva, Radka P/0000-0002-1437-1393; Spurdle, Amanda B/0000-0003-1337-7897; Mills, Ian/0000-0001-5347-5083; Nordestgaard, Borge/0000-0002-1954-7220; Pashayan, Nora/0000-0003-0843-2468; Hamdy, Freddie/0000-0003-2627-2154; Schleutker, Johanna/0000-0002-1863-0305; Seibert, Tyler/0000-0002-4089-7399; Eeles, Rosalind/0000-0002-3698-6241; Zuber, Verena/0000-0001-9827-1877; Mitev, Vanyo/0000-0001-7528-590X; Michael, Agnieszka/0000-0002-7262-6227; batra, Jyotsna/0000-0003-4646-6247; /0000-0001-8387-2127	US Department of Defense [W81XWH-13-1-0391]; Prostate Cancer Foundation; Research Council of Norway [223273]; KG Jebsen Stiftelsen; South East Norway Health Authority; MRC [MC_UU_00002/7, MR/N003284/1] Funding Source: UKRI; Cancer Research UK [14136, 16491, 15007, 10118, 13065, 17528, 16561] Funding Source: researchfish; Medical Research Council [MC_UU_00002/7, MR/N003284/1, G1000143, G0401527] Funding Source: researchfish; National Institute for Health Research [NF-SI-0509-10242, NF-SI-0512-10114, NF-SI-0513-10121] Funding Source: researchfish; The Danish Cancer Society [R130-A8338] Funding Source: researchfish; The Francis Crick Institute [10119] Funding Source: researchfish	US Department of Defense(United States Department of Defense); Prostate Cancer Foundation; Research Council of Norway(Research Council of Norway); KG Jebsen Stiftelsen; South East Norway Health Authority; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); The Danish Cancer Society(Danish Cancer Society); The Francis Crick Institute	This study was funded in part by grants from the US Department of Defense (W81XWH-13-1-0391), Prostate Cancer Foundation, the Research Council of Norway (223273), KG Jebsen Stiftelsen, and South East Norway Health Authority. Funding for the PRACTICAL consortium member studies is detailed in appendix 2.	Al Olama AA, 2015, CANCER EPIDEM BIOMAR, V24, P1121, DOI 10.1158/1055-9965.EPI-14-0317; Carroll PR, 2016, J NATL COMPR CANC NE, V14, P509, DOI 10.6004/jnccn.2016.0060; Chatterjee N, 2016, NAT REV GENET, V17, P392, DOI 10.1038/nrg.2016.27; Desikan RS, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002258; Eeles R, 2014, NAT REV UROL, V11, P18, DOI 10.1038/nrurol.2013.266; Eeles RA, 2013, NAT GENET, V45, P385, DOI 10.1038/ng.2560; Fleshner NE, 2012, LANCET, V379, P1103, DOI 10.1016/S0140-6736(11)61619-X; GASTWIRTH JL, 1971, ECONOMETRICA, V39, P1037, DOI 10.2307/1909675; Goh CL, 2012, J INTERN MED, V271, P353, DOI 10.1111/j.1365-2796.2012.02511.x; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Hamdy FC, 2016, NEW ENGL J MED, V375, P1415, DOI 10.1056/NEJMoa1606220; Horwich A, 2013, ANN ONCOL, V24, P1141, DOI 10.1093/annonc/mds624; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Kader AK, 2012, EUR UROL, V62, P953, DOI 10.1016/j.eururo.2012.05.006; Kranse R, 2008, PROSTATE, V68, P1674, DOI 10.1002/pros.20840; Lane JA, 2014, LANCET ONCOL, V15, P1109, DOI 10.1016/S1470-2045(14)70361-4; Lilja H, 2007, J CLIN ONCOL, V25, P431, DOI 10.1200/JCO.2006.06.9351; Loeb S, 2014, EUR UROL, V65, P1046, DOI 10.1016/j.eururo.2013.12.062; Loeb S, 2012, EUR UROL, V61, P1, DOI 10.1016/j.eururo.2011.07.067; Mikropoulos C, 2014, FUTURE ONCOL, V10, P1679, DOI [10.2217/fon.14.72, 10.2217/FON.14.72]; Mohler JL, 2016, J NATL COMPR CANC NE, V14, P19, DOI 10.6004/jnccn.2016.0004; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pashayan N, 2011, BRIT J CANCER, V104, P1656, DOI 10.1038/bjc.2011.118; Pashayan N, 2015, GENET MED, V17, P789, DOI 10.1038/gim.2014.192; Pashayan N, 2011, INT J CANCER, V128, P1462, DOI 10.1002/ijc.25471; Pharoah PDP, 2008, NEW ENGL J MED, V358, P2796, DOI 10.1056/NEJMsa0708739; Preston MA, 2016, J CLIN ONCOL, V34, P2705, DOI 10.1200/JCO.2016.66.7527; Qaseem A, 2013, ANN INTERN MED, V158, P761, DOI 10.7326/0003-4819-158-10-201305210-00633; Schroder FH, 2014, LANCET, V384, P2027, DOI 10.1016/S0140-6736(14)60525-0; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Siegel RL, 2022, CA-CANCER J CLIN, V72, P7, DOI [10.3322/caac.21708, 10.3322/caac.21332, 10.3322/caac.21590]; Thompson IM, 2006, J NATL CANCER I, V98, P529, DOI 10.1093/jnci/djj131; Vickers AJ, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2023; Vickers AJ, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4521; Witte JS, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001861; Wolf AMD, 2010, CA-CANCER J CLIN, V60, P70, DOI 10.3322/caac.20066	36	96	96	2	20	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2018	360								j5757	10.1136/bmj.j5757	http://dx.doi.org/10.1136/bmj.j5757			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS9MW	29321194	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000422743300012
J	Plevritis, SK; Munoz, D; Kurian, AW; Stout, NK; Alagoz, O; Near, AM; Lee, SJ; van den Broek, JJ; Huang, XL; Schechter, CB; Sprague, BL; Song, J; de Koning, HJ; Trentham-Dietz, A; van Ravesteyn, NT; Gangnon, R; Chandler, Y; Li, YS; Xu, C; Ergun, MA; Huang, H; Berry, DA; Mandelblatt, JS				Plevritis, Sylvia K.; Munoz, Diego; Kurian, Allison W.; Stout, Natasha K.; Alagoz, Oguzhan; Near, Aimee M.; Lee, Sandra J.; van den Broek, Jeroen J.; Huang, Xuelin; Schechter, Clyde B.; Sprague, Brian L.; Song, Juhee; de Koning, Harry J.; Trentham-Dietz, Amy; van Ravesteyn, Nicolien T.; Gangnon, Ronald; Chandler, Young; Li, Yisheng; Xu, Cong; Ergun, Mehmet Ali; Huang, Hui; Berry, Donald A.; Mandelblatt, Jeanne S.			Association of Screening and Treatment With Breast Cancer Mortality by Molecular Subtype in US Women, 2000-2012	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; TUMOR SIZE; MAMMOGRAPHY; TRENDS; SURVIVAL; AGE; TOMOSYNTHESIS; THERAPY; COHORT	IMPORTANCE Given recent advances in screening mammography and adjuvant therapy (treatment), quantifying their separate and combined effects on US breast cancer mortality reductions by molecular subtype could guide future decisions to reduce disease burden. OBJECTIVE To evaluate the contributions associated with screening and treatment to breast cancer mortality reductions by molecular subtype based on estrogen-receptor (ER) and human epidermal growth factor receptor 2 (ERBB2, formerly HER2 or HER2/neu). DESIGN, SETTING, AND PARTICIPANTS Six Cancer Intervention and Surveillance Network (CISNET) models simulated US breast cancer mortality from 2000 to 2012 using national data on plain-film and digital mammography patterns and performance, dissemination and efficacy of ER/ERBB2-specific treatment, and competing mortality. Multiple US birth cohorts were simulated. EXPOSURES Screening mammography and treatment. MAIN OUTCOMES AND MEASURES The models compared age-adjusted, overall, and ER/ERBB2-specific breast cancer mortality rates from 2000 to 2012 for women aged 30 to 79 years relative to the estimated mortality rate in the absence of screening and treatment (baseline rate); mortality reductions were apportioned to screening and treatment. RESULTS In 2000, the estimated reduction in overall breast cancer mortality rate was 37% (model range, 27%-42%) relative to the estimated baseline rate in 2000 of 64 deaths (model range, 56-73) per 100 000 women: 44%(model range, 35%-60%) of this reduction was associated with screening and 56%(model range, 40%-65%) with treatment. In 2012, the estimated reduction in overall breast cancer mortality rate was 49% (model range, 39%-58%) relative to the estimated baseline rate in 2012 of 63 deaths (model range, 54-73) per 100 000 women: 37%(model range, 26%-51%) of this reduction was associated with screening and 63%(model range, 49%-74%) with treatment. Of the 63% associated with treatment, 31% (model range, 22%-37%) was associated with chemotherapy, 27%(model range, 18%-36%) with hormone therapy, and 4%(model range, 1%-6%) with trastuzumab. The estimated relative contributions associated with screening vs treatment varied by molecular subtype: for ER+/ERBB2-, 36%(model range, 24%-50%) vs 64%(model range, 50%-76%); for ER+/ERBB2+, 31% (model range, 23%-41%) vs 69%(model range, 59%-77%); for ER-/ERBB2+, 40% (model range, 34%-47%) vs 60% (model range, 53%-66%); and for ER-/ERBB2-, 48%(model range, 38%-57%) vs 52%(model range, 44%-62%). CONCLUSIONS AND RELEVANCE In this simulation modeling study that projected trends in breast cancer mortality rates among US women, decreases in overall breast cancer mortality from 2000 to 2012 were associated with advances in screening and in adjuvant therapy, although the associations varied by breast cancer molecular subtype.	[Plevritis, Sylvia K.; Munoz, Diego; Xu, Cong] Stanford Univ, Dept Radiol, Sch Med, Stanford, CA 94305 USA; [Plevritis, Sylvia K.; Munoz, Diego; Xu, Cong] Stanford Univ, Sch Med, Dept Biomed Data Sci, Stanford, CA 94305 USA; [Kurian, Allison W.] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA; [Kurian, Allison W.] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA; [Stout, Natasha K.] Harvard Med Sch, Dept Populat Med, Boston, MA USA; [Stout, Natasha K.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Alagoz, Oguzhan; Ergun, Mehmet Ali] Univ Wisconsin, Dept Ind & Syst Engn, Madison, WI USA; [Alagoz, Oguzhan; Trentham-Dietz, Amy; Gangnon, Ronald] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA; [Near, Aimee M.; Chandler, Young; Mandelblatt, Jeanne S.] Georgetown Univ, Med Ctr, Dept Oncol, Washington, DC 20007 USA; [Near, Aimee M.; Chandler, Young; Mandelblatt, Jeanne S.] Georgetown Lombardi Comprehens Canc Ctr, Canc Prevent & Control Program, Washington, DC USA; [Lee, Sandra J.; Huang, Hui] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Lee, Sandra J.; Huang, Hui] Harvard Med Sch, Boston, MA USA; [van den Broek, Jeroen J.; de Koning, Harry J.; van Ravesteyn, Nicolien T.] Erasmus MC Univ, Med Ctr, Dept Publ Hlth, Rotterdam, Netherlands; [Huang, Xuelin; Song, Juhee; Li, Yisheng; Berry, Donald A.] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Schechter, Clyde B.] Albert Einstein Coll Med, Dept Family & Social Med, Bronx, NY 10467 USA; [Schechter, Clyde B.] Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10467 USA; [Sprague, Brian L.] Univ Vermont, Coll Med, Dept Surg, Burlington, VT USA; [Gangnon, Ronald] Univ Wisconsin, Sch Med & Publ Hlth, Dept Biostat & Med Informat & Populat Hlth Sci, Madison, WI USA	Stanford University; Stanford University; Stanford University; Stanford University; Harvard University; Harvard Medical School; Harvard Pilgrim Health Care; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Georgetown University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Erasmus University Rotterdam; Erasmus MC; University of Texas System; UTMD Anderson Cancer Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; University of Vermont; University of Wisconsin System; University of Wisconsin Madison	Plevritis, SK (corresponding author), James H Clark Ctr, Dept Radiol, Room S255,318 Campus Dr, Stanford, CA 94305 USA.; Plevritis, SK (corresponding author), James H Clark Ctr, Dept Biomed Data Sci, Room S255,318 Campus Dr, Stanford, CA 94305 USA.	sylvia.plevritis@stanford.edu	de+Koning, Harry/AAF-9062-2019; Ergun, Mehmet/AAB-9782-2019; Kurian, Allison/A-4560-2019	de+Koning, Harry/0000-0003-4682-3646; Ergun, Mehmet/0000-0002-2480-8077; Alagoz, Oguzhan/0000-0002-5133-1382; Xu, Cong/0000-0002-8047-0488; LI, Yisheng/0000-0001-9847-8544; Gangnon, Ronald/0000-0003-2587-6714; Kurian, Allison/0000-0002-6175-9470	National Cancer Institute of the National Institutes of Health [U01 CA152958]; American Cancer Society [MRSG 14-027-01 CPHPS]; Breast Cancer Surveillance Consortium (BCSC) [P01CA154292, U54CA163303]; National Cancer Institute [HHSN261201100031C]; NATIONAL CANCER INSTITUTE [U01CA199218, P01CA154292, U01CA152958, U54CA163303] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000371] Funding Source: NIH RePORTER	National Cancer Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society(American Cancer Society); Breast Cancer Surveillance Consortium (BCSC); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported by grant U01 CA152958 from the National Cancer Institute of the National Institutes of Health, in part by grant MRSG 14-027-01 CPHPS from the American Cancer Society (Dr Chandler). The Collection of Breast Cancer Surveillance Consortium (BCSC) data used in this study was supported by grants P01CA154292 and U54CA163303 and contract HHSN261201100031C from the National Cancer Institute. The collection of cancer and vital status data from the BCSC was supported in part by several state public health departments and cancer registries throughout the United States. For a full description of these sources, please see http://www.bcsc-research.org/work/acknowledgement.html.	Alagoz O, 2018, MED DECIS MAKING, V38, DOI [10.1177/O272989X17711927, DOI 10.1177/O272989X17711927]; Albain K, 2012, LANCET, V379, P432, DOI 10.1016/S0140-6736(11)61625-5; Berry DA, 2005, NEW ENGL J MED, V353, P1784, DOI 10.1056/NEJMoa050518; Cronin KA, 2005, CANCER CAUSE CONTROL, V16, P701, DOI 10.1007/s10552-005-0693-8; Cronin Kathleen A, 2006, J Natl Cancer Inst Monogr, P26, DOI 10.1093/jncimonographs/lgj005; Elkin EB, 2005, CANCER-AM CANCER SOC, V104, P1149, DOI 10.1002/cncr.21285; Friedewald SM, 2014, JAMA-J AM MED ASSOC, V311, P2499, DOI 10.1001/jama.2014.6095; Gangnon RE, 2018, MED DECIS MAKING, V38, p24S, DOI 10.1177/0272989X17717981; Gangnon RE, 2015, CANCER EPIDEM BIOMAR, V24, P905, DOI 10.1158/1055-9965.EPI-14-1286; Giordano SH, 2014, J CLIN ONCOL, V32, P2078, DOI 10.1200/JCO.2013.54.0948; Hermon C, 1996, BRIT J CANCER, V73, P955, DOI 10.1038/bjc.1996.171; Holford Theodore R, 2006, J Natl Cancer Inst Monogr, P19, DOI 10.1093/jncimonographs/lgj016; Howlader N, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju055; Huang X, 2018, MED DECIS MAKINA, V38, DOI [10.1177/O272989X17714473, DOI 10.1177/O272989X17714473]; Iqbal J, 2015, JAMA-J AM MED ASSOC, V313, P165, DOI 10.1001/jama.2014.17322; Jatoi I, 2007, J CLIN ONCOL, V25, P1683, DOI 10.1200/JCO.2006.09.2106; Kerlikowske K, 2015, ANN INTERN MED, V162, P673, DOI 10.7326/M14-1465; Kerlikowske K, 2011, ANN INTERN MED, V155, P493, DOI 10.7326/0003-4819-155-8-201110180-00005; Lee CI, 2013, J AM COLL RADIOL, V10, P913, DOI 10.1016/j.jacr.2013.09.010; Lee SJ, 2018, MED DECIS MAKING, V38, p44S, DOI [10.1177/0272989X17741634, 10.1177/0272989x17741634]; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; Mandelblatt JS, AHRQ PUBLICATION; Mandelblatt JS, 2018, MED DECIS MAKING, V38, DOI [10.1177/O272989X17700624, DOI 10.1177/O272989X17700624]; Mariotto A, 2002, J NATL CANCER I, V94, P1626; Mariotto Angela B, 2006, J Natl Cancer Inst Monogr, P7, DOI 10.1093/jncimonographs/lgj003; Munoz D, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju289; Munoz DF, 2018, MED DECIS MAKING, V38, p32S, DOI 10.1177/0272989X17743236; Munoz DF, 2018, MED DECIS MAKING, V38, p89S, DOI 10.1177/0272989X17737508; National Cancer Institute, BREAST CANC STAT; National Center for Health Statistics, COMPR MORT FIL; Park JH, 2015, J CLIN ONCOL, V33, P2870, DOI 10.1200/JCO.2014.59.9191; Peto R, 2000, LANCET, V355, P1822, DOI 10.1016/S0140-6736(00)02277-7; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Schechter CB, 2018, MED DECIS MAKING, V38, p66S, DOI 10.1177/0272989X17698685; Stout NK, 2014, JNCI-J NATL CANCER I, V106, DOI 10.1093/jnci/dju092; Sung HN, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv107; Surveillance Epidemiology and End Results (SEER) Program, SEER STAT DAT MORT A; US Bureau of the Census, 1996, POP PROJ US AG SEX R, pP25; van den Broek JJ, 2018, MED DECIS MAKING, V38, p54S, DOI 10.1177/0272989X17711928	39	139	143	1	31	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2018	319	2					154	164		10.1001/jama.2017.19130	http://dx.doi.org/10.1001/jama.2017.19130			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS4PR	29318276	Green Published, Bronze			2022-12-28	WOS:000419775500015
J	Teutsch, SM; Naimi, TS				Teutsch, Steven M.; Naimi, Timothy S.			Eliminating Alcohol-Impaired Driving Fatalities: What Can Be Done?	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Teutsch, Steven M.] Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA; Univ Southern Calif, Los Angeles, CA USA; Publ Hlth Inst, Oakland, CA USA; Boston Univ, Sch Med, Boston, MA 02118 USA; Boston Univ, Sch Publ Hlth, Boston, MA USA; [Naimi, Timothy S.] Boston Med Ctr, Sect Gen Internal Med, Crosstown Ctr, 801 Massachusetts Ave,Room 2046, Boston, MA 02118 USA	University of California System; University of California Los Angeles; University of Southern California; Public Health Institute; Boston University; Boston University; Boston Medical Center	Teutsch, SM (corresponding author), Univ Calif Los Angeles, Fielding Sch Publ Hlth, Los Angeles, CA USA.	teutsch@comcast.net		Naimi, Timothy/0000-0001-9849-4413				Elder RW, 2011, AM J PREV MED, V40, P362, DOI 10.1016/j.amepre.2010.11.012; Elder RW, 2010, AM J PREV MED, V38, P217, DOI 10.1016/j.amepre.2009.11.005; Fell JC, 2017, ALCOHOL CLIN EXP RES, V41, P2128, DOI 10.1111/acer.13501; Mann RE, 2001, ACCIDENT ANAL PREV, V33, P569, DOI 10.1016/S0001-4575(00)00077-4; National Academies of Sciences Engineering and Medicine, 2017, GETT ZER ALC IMP DRI; Rosencrantz H, 2007, TRANSPORT RES A-POL, V41, P559, DOI 10.1016/j.tra.2006.11.002; U. S. Preventive Services Task Force, 2013, FIN REC STAT ALC MIS	7	0	0	0	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 17	2018	168	8					587	+		10.7326/M18-0069	http://dx.doi.org/10.7326/M18-0069			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GC8XZ	29344617				2022-12-28	WOS:000430083100021
J	Yang, B; Guo, QH; Tremain, B; Liu, RJ; Barr, LE; Yan, QH; Gao, WL; Liu, HC; Xiang, YJ; Chen, J; Fang, C; Hibbins, A; Lu, L; Zhang, S				Yang, Biao; Guo, Qinghua; Tremain, Ben; Liu, Rongjuan; Barr, Lauren E.; Yan, Qinghui; Gao, Wenlong; Liu, Hongchao; Xiang, Yuanjiang; Chen, Jing; Fang, Chen; Hibbins, Alastair; Lu, Ling; Zhang, Shuang			Ideal Weyl points and helicoid surface states in artificial photonic crystal structures	SCIENCE			English	Article							SEMIMETAL	Weyl points are the crossings of linearly dispersing energy bands of three-dimensional crystals, providing the opportunity to explore a variety of intriguing phenomena such as topologically protected surface states and chiral anomalies. However, the lack of an ideal Weyl system in which the Weyl points all exist at the same energy and are separated from any other bands poses a serious limitation to the further development of Weyl physics and potential applications. By experimentally characterizing a microwave photonic crystal of saddle-shaped metallic coils, we observed idealWeyl points that are related to each other through symmetry operations. Topological surface states exhibiting helicoidal structure have also been demonstrated. Our system provides a photonic platform for exploring idealWeyl systems and developing possible topological devices.	[Yang, Biao; Guo, Qinghua; Gao, Wenlong; Liu, Hongchao; Zhang, Shuang] Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; [Guo, Qinghua; Xiang, Yuanjiang] Shenzhen Univ, Int Collaborat Lab Mat Optoelect Sci & Tech 2D, Minist Educ, Shenzhen 518060, Peoples R China; [Tremain, Ben; Barr, Lauren E.; Hibbins, Alastair] Univ Exeter, Dept Phys & Astron, Electromagnet & Acoust Mat Grp, Stocker Rd, Exeter EX4 4QL, Devon, England; [Liu, Rongjuan; Yan, Qinghui; Fang, Chen; Lu, Ling] Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Inst Phys, Beijing 100190, Peoples R China; [Chen, Jing] Nankai Univ, Sch Phys, Tianjin 300071, Peoples R China	University of Birmingham; Shenzhen University; University of Exeter; Chinese Academy of Sciences; Institute of Physics, CAS; Nankai University	Zhang, S (corresponding author), Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England.; Hibbins, A (corresponding author), Univ Exeter, Dept Phys & Astron, Electromagnet & Acoust Mat Grp, Stocker Rd, Exeter EX4 4QL, Devon, England.; Lu, L (corresponding author), Chinese Acad Sci, Beijing Natl Lab Condensed Matter Phys, Inst Phys, Beijing 100190, Peoples R China.	a.p.hibbins@exeter.ac.uk	Fang, Chen/C-8263-2011; Fang, Chen/AAC-4032-2019; Lu, Ling/E-1324-2017; Xiang, Yuanjiang/F-9600-2011; Liu, Hongchao/N-2654-2016; Chen, Jing/B-8479-2009; Liu, Rongjuan/AAF-5229-2019; zhang, shuang/G-5224-2011	Xiang, Yuanjiang/0000-0002-7225-5411; Liu, Hongchao/0000-0003-1313-4000; Chen, Jing/0000-0001-5637-1829; Gao, Wenlong/0000-0002-3446-7157; Guo, Qinghua/0000-0002-6311-4510; Barr, Lauren E/0000-0001-7087-5193; Yang, Biao/0000-0002-5839-7261; Zhang, Shuang/0000-0003-4556-2333; Hibbins, Alastair/0000-0001-5406-0162; Liu, Rongjuan/0000-0003-0247-9871	European Research Council Consolidator Grant (Topological), Horizon Action Project grant [734578]; Leverhulme Trust [RPG-2012-674]; Royal Society and Wolfson Foundation; China Scholarship Council [201306110041]; National Natural Science Foundation of China [11604216, 61490713]; Engineering and Physical Sciences Research Council of the United Kingdom [EP/L015331/1]; National Key Research and Development Program of China [2016YFA0302400]; National Natural Science Foundation of China (NSFC) [11674370]; National Key RAMP;D Program of China [2016YFA0302400, 2017YFA0303800]; NSFC [11721404]; Engineering and Physical Sciences Research Council [1469872] Funding Source: researchfish	European Research Council Consolidator Grant (Topological), Horizon Action Project grant; Leverhulme Trust(Leverhulme Trust); Royal Society and Wolfson Foundation; China Scholarship Council(China Scholarship Council); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Engineering and Physical Sciences Research Council of the United Kingdom(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); National Key Research and Development Program of China; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key RAMP;D Program of China; NSFC(National Natural Science Foundation of China (NSFC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was financially supported by the European Research Council Consolidator Grant (Topological), Horizon 2020 Action Project grant 734578 (D-SPA), and Leverhulme Trust (grant RPG-2012-674). S.Z. acknowledges support from the Royal Society and Wolfson Foundation. B.Y. acknowledges support from China Scholarship Council (grant 201306110041). Q.G. acknowledges the financial support of the National Natural Science Foundation of China (grant 11604216). Y.X. acknowledges support from the National Natural Science Foundation of China (grant 61490713). L.E.B. and A.H. acknowledge financial support from the Engineering and Physical Sciences Research Council of the United Kingdom (grant EP/L015331/1). C.F. was supported by the National Key Research and Development Program of China under grant 2016YFA0302400 and by the National Natural Science Foundation of China (NSFC) under grant 11674370. L.L. was supported by the National Key R&D Program of China under grants 2017YFA0303800 and 2016YFA0302400 and by NSFC under project 11721404. Near-field scanning data were collected by a vector network analyzer controlled with xyz-stage at G31 at the Department of Physics and Astronomy, University of Exeter, UK. All data created during this research are openly available from the University of Exeter's institutional repository at http://hdl.handle.net/10871/30744.	Armitage N. P., 2017, ARXIV170501111CONDMA; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Chen WJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13038; Fang C, 2016, NAT PHYS, V12, P936, DOI [10.1038/NPHYS3782, 10.1038/nphys3782]; Guo QH, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.067402; Kaelberer T, 2010, SCIENCE, V330, P1510, DOI 10.1126/science.1197172; Lu L, 2015, SCIENCE, V349, P622, DOI 10.1126/science.aaa9273; Ma Q, 2017, NAT PHYS, V13, P842, DOI [10.1038/nphys4146, 10.1038/NPHYS4146]; Noh J, 2017, NAT PHYS, V13, P611, DOI [10.1038/NPHYS4072, 10.1038/nphys4072]; Onoda M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.083901; Ruan JW, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.226801; Ruan JW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11136; Soluyanov AA, 2015, NATURE, V527, P495, DOI 10.1038/nature15768; Wan XG, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.205101; Wang LY, 2016, PHYS REV A, V93, DOI 10.1103/PhysRevA.93.061801; Weng HM, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.011029; Xiao M, 2016, PHYS REV LETT, V117, DOI 10.1103/PhysRevLett.117.057401; Xu G, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.186806; Xu SY, 2015, SCIENCE, V349, P613, DOI 10.1126/science.aaa9297; Yang BA, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00134-1; Zhang T., 2017, ARXIV170507244CONDMA; Zhou M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01533-0	24	190	191	15	190	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2018	359	6379					1013	1016		10.1126/science.aaq1221	http://dx.doi.org/10.1126/science.aaq1221			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8SV	29326117	Green Published, Green Accepted			2022-12-28	WOS:000426366200037
J	Desai, S; McWilliams, JM				Desai, Sunita; McWilliams, J. Michael			Consequences of the 340B Drug Pricing Program	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REGRESSION DISCONTINUITY DESIGNS; INTEGRATION; CARE; HOSPITALS; COST	BACKGROUND The 340B Drug Pricing Program entitles qualifying hospitals to discounts on outpatient drugs, increasing the profitability of drug administration. By tying the program eligibility of hospitals to their Disproportionate Share Hospital (DSH) adjustment percentage, which reflects the proportion of hospitalized patients who are low-income, the program is intended to expand resources for underserved populations but provides no direct incentives for hospitals to use financial gains to enhance care for low-income patients. METHODS We used Medicare claims and a regression-discontinuity design, taking advantage of the threshold for program eligibility among general acute care hospitals (DSH percentage, >11.75%), to isolate the effects of the program on hospital-physician consolidation (i.e., acquisition of physician practices or employment of physicians by hospitals) and on the outpatient administration of parenteral drugs by hospital-owned facilities in three specialties in which parenteral drugs are frequently used. For low-income patients, we also assessed the effects of the program on the provision of care by hospitals and on mortality. RESULTS Hospital eligibility for the 340B Program was associated with 2.3 more hematologist-oncologists practicing in facilities owned by the hospital, or 230% more hematologist-oncologists than expected in the absence of the program (P = 0.02), and with 0.9 (or 900%) more ophthalmologists per hospital (P = 0.08) and 0.1 (or 33%) more rheumatologists per hospital (P = 0.84). Program eligibility was associated with significantly higher numbers of parenteral drug claims billed by hospitals for Medicare patients in hematology-oncology (90% higher, P = 0.001) and ophthalmology (177% higher, P = 0.03) but not rheumatology (77% higher, P = 0.12). Program eligibility was associated with lower proportions of low-income patients in hematology-oncology and ophthalmology and with no significant differences in hospital provision of safety-net or inpatient care for low-income groups or in mortality among low-income residents of the hospitals' local service areas. CONCLUSIONS The 340B Program has been associated with hospital-physician consolidation in hematology-oncology and with more hospital-based administration of parenteral drugs in hematology-oncology and ophthalmology. Financial gains for hospitals have not been associated with clear evidence of expanded care or lower mortality among low-income patients.	[Desai, Sunita] NYU, Dept Populat Hlth, 227 E 30th St, New York, NY 10016 USA; [Desai, Sunita; McWilliams, J. Michael] Harvard Med Sch, Dept Hlth Care Policy, Boston, MA USA; [McWilliams, J. Michael] Brigham & Womens Hosp, Div Gen Internal Med & Primary Care, 75 Francis St, Boston, MA 02115 USA	New York University; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital	Desai, S (corresponding author), NYU, Dept Populat Hlth, 227 E 30th St, New York, NY 10016 USA.	sunita.desai@nyu.edu			Agency for Healthcare Research and Quality [U19HS024072]; Robert Wood Johnson Foundation [71408]; Marshall J. Seidman Center for Studies in Health Economics and Health Care Policy at Harvard Medical School; Agency for Healthcare Research and Quality; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U19HS024072] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Marshall J. Seidman Center for Studies in Health Economics and Health Care Policy at Harvard Medical School; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Supported by grants from the Agency for Healthcare Research and Quality (U19HS024072) and the Robert Wood Johnson Foundation (71408) and by the Marshall J. Seidman Center for Studies in Health Economics and Health Care Policy at Harvard Medical School.r Funded by the Agency for Healthcare Research and Quality and others.	[Anonymous], 1999, HOSPITAL OWNERSHIP O; [Anonymous], 2017, 340B DRUG PRICING PR; [Anonymous], 2015, REP C OV 340B DRUG P; [Anonymous], 2017, 340B HOT TOP OFF PHA; [Anonymous], 2011, DRUG PRICING MANUFAC; [Anonymous], 340B EL REG EL ORG; Baker LC, 2014, HEALTH AFFAIR, V33, P756, DOI 10.1377/hlthaff.2013.1279; Barreca AI, 2016, ECON INQ, V54, P268, DOI 10.1111/ecin.12225; Clark BL, 2014, HEALTH AFFAIR, V33, P2012, DOI 10.1377/hlthaff.2014.0833; Conti RM, 2014, HEALTH AFFAIR, V33, P1786, DOI 10.1377/hlthaff.2014.0540; Conti RM, 2013, JAMA-J AM MED ASSOC, V309, P1995, DOI 10.1001/jama.2013.4156; Conti RM, 2016, IMPACT PROVIDER CONS; Dranove D, 2016, EMPLOYED HIGHER PAY; Koch TG, 2017, J HEALTH ECON, V52, P19, DOI 10.1016/j.jhealeco.2016.12.007; Lee DS, 2010, J ECON LIT, V48, P281, DOI 10.1257/jel.48.2.281; Marchetti-Bowick E, 2016, MEDICARE B; MedPAC, 2015, REP C MED HLTH CAR D; Mulcahy AW, 2014, 340B PRESCRIPTION DR; Neprash HT, 2015, JAMA INTERN MED, V175, P1932, DOI 10.1001/jamainternmed.2015.4610; Provider consolidation: the role of Medicare policy, 2017, REP C MED HLTH CAR D; Sankoh AJ, 1997, STAT MED, V16, P2529, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2529::AID-SIM692>3.0.CO;2-J; Scott KW, 2017, ANN INTERN MED, V166, P1, DOI 10.7326/M16-0125; Song ZR, 2015, JAMA INTERN MED, V175, P1229, DOI 10.1001/jamainternmed.2015.2017; Venkataramani AS, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1216; Wooldridge JM, 2002, ECONOMETRIC ANAL, V58; OVERVIEW OF THE 340B	26	38	38	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2018	378	6					539	548		10.1056/NEJMsa1706475	http://dx.doi.org/10.1056/NEJMsa1706475			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV1OX	29365282	Green Accepted			2022-12-28	WOS:000424335200009
J	Chen, YE; Fischbach, MA; Belkaid, Y				Chen, Y. Erin; Fischbach, Michael A.; Belkaid, Yasmine			Skin microbiota-host interactions	NATURE			English	Review							INNATE LYMPHOID-CELLS; REGULATORY T-CELLS; LOW-OXYGEN TENSION; STAPHYLOCOCCUS-AUREUS; MYCOBACTERIUM-TUBERCULOSIS; PROPIONIBACTERIUM-ACNES; ANTIMICROBIAL PEPTIDES; BARRIER FUNCTION; HELICOBACTER-PYLORI; TEMPORAL STABILITY	The skin is a complex and dynamic ecosystem that is inhabited by bacteria, archaea, fungi and viruses. These microbes-collectively referred to as the skin microbiota- are fundamental to skin physiology and immunity. Interactions between skin microbes and the host can fall anywhere along the continuum between mutualism and pathogenicity. In this Review, we highlight how host-microbe interactions depend heavily on context, including the state of immune activation, host genetic predisposition, barrier status, microbe localization, and microbe-microbe interactions. We focus on how context shapes the complex dialogue between skin microbes and the host, and the consequences of this dialogue for health and disease.	[Chen, Y. Erin] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA 94143 USA; [Chen, Y. Erin; Fischbach, Michael A.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Chen, Y. Erin; Fischbach, Michael A.] Stanford Univ, ChEM H, Stanford, CA 94305 USA; [Belkaid, Yasmine] NIAID, NIAID Microbiome Program, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Belkaid, Yasmine] NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA	University of California System; University of California San Francisco; Stanford University; Stanford University; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Fischbach, MA (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.; Fischbach, MA (corresponding author), Stanford Univ, ChEM H, Stanford, CA 94305 USA.; Belkaid, Y (corresponding author), NIAID, NIAID Microbiome Program, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.; Belkaid, Y (corresponding author), NIAID, Mucosal Immunol Sect, Parasit Dis Lab, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	fischbach@fischbachgroup.org; YBelkaid@niaid.nih.gov		Fischbach, Michael/0000-0003-3079-8247; Chen, Yiyin Erin/0000-0001-9452-1402	Division of Intramural Research, National Institute of Allergy and Infectious Diseases [DP1 DK113598, R01 DK110174]; HHMI-Simons Faculty Scholars Award; David and Lucile Packard Foundation; Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award; Dermatology Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZICAI001233, ZIAAI001115] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [DP1DK113598, R01DK110174] Funding Source: NIH RePORTER	Division of Intramural Research, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); HHMI-Simons Faculty Scholars Award; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award(Burroughs Wellcome Fund); Dermatology Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We apologize for not having cited all papers relevant to this expanding field of research (in particular, older literature) because of space constraints and editorial limits. This work was supported by the Division of Intramural Research, National Institute of Allergy and Infectious Diseases (Y.B.), DP1 DK113598 (M.A.F.), R01 DK110174 (M.A.F.), an HHMI-Simons Faculty Scholars Award (M.A.F.), a Fellowship for Science and Engineering from the David and Lucile Packard Foundation (M.A.F.), a Burroughs Wellcome Investigators in the Pathogenesis of Infectious Disease Award (M.A.F.) and the Dermatology Foundation (Y.E.C.).	Adams KN, 2011, CELL, V145, P39, DOI 10.1016/j.cell.2011.02.022; Afonso-Barroso A, 2013, CELL MICROBIOL, V15, P660, DOI 10.1111/cmi.12065; Agak GW, 2014, J INVEST DERMATOL, V134, P366, DOI 10.1038/jid.2013.334; Albenberg L, 2014, GASTROENTEROLOGY, V147, P1055, DOI 10.1053/j.gastro.2014.07.020; Arnold IC, 2011, J CLIN INVEST, V121, P3088, DOI 10.1172/JCI45041; Barnard E, 2016, SCI REP-UK, V6, DOI 10.1038/srep39491; Bartek IL, 2014, MBIO, V5, DOI 10.1128/mBio.01106-14; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Bek-Thomsen M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107908; Belkaid Y, 2014, SCIENCE, V346, P954, DOI 10.1126/science.1260144; Bellono NW, 2017, CELL, V170, DOI 10.1016/j.cell.2017.05.034; Bomar L, 2016, MBIO, V7, DOI 10.1128/mBio.01725-15; Boncheva M, 2014, INT J COSMETIC SCI, V36, P505, DOI 10.1111/ics.12162; Brandner JM, 2016, CURR PROBL DERMATOL, V49, P27, DOI 10.1159/000441541; Briken V, 2004, MOL MICROBIOL, V53, P391, DOI 10.1111/j.1365-2958.2004.04183.x; Byrd AL, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aal4651; Capell BC, 2009, J INVEST DERMATOL, V129, P2340, DOI 10.1038/jid.2009.103; Carbone FR, 2015, J IMMUNOL, V195, P17, DOI 10.4049/jimmunol.1500515; Cardoso V, 2017, NATURE, V549, P277, DOI 10.1038/nature23469; Cassler NM, 2017, BRIT J DERMATOL, V176, P18, DOI 10.1111/bjd.14828; Cebra JJ, 1999, AM J CLIN NUTR, V69, p1046S, DOI 10.1093/ajcn/69.5.1046s; Chatterjee D, 1998, GLYCOBIOLOGY, V8, P113, DOI 10.1093/glycob/8.2.113; Chehoud C, 2013, P NATL ACAD SCI USA, V110, P15061, DOI 10.1073/pnas.1307855110; Cheng BL, 2017, HUM VACC IMMUNOTHER, V13, P1609, DOI 10.1080/21645515.2017.1304334; Cheung GYC, 2010, CURR OPIN INFECT DIS, V23, P208, DOI 10.1097/QCO.0b013e328337fecb; Chiu IM, 2013, NATURE, V501, P52, DOI 10.1038/nature12479; Christensen GJM, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2489-5; Chu DM, 2017, NAT MED, V23, P314, DOI 10.1038/nm.4272; Clark RA, 2006, J IMMUNOL, V176, P4431, DOI 10.4049/jimmunol.176.7.4431; Cleaver JE, 2000, J DERMATOL SCI, V23, P1, DOI 10.1016/S0923-1811(99)00088-2; Cogen AL, 2010, J INVEST DERMATOL, V130, P192, DOI 10.1038/jid.2009.243; Conti F, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1079-x; CROMPTON DW, 1965, J EXP BIOL, V43, P473; Cunningham AF, 1998, J BACTERIOL, V180, P801, DOI 10.1128/JB.180.4.801-808.1998; Cush SS, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005493; Dao DN, 2004, INFECT IMMUN, V72, P2067, DOI 10.1128/IAI.72.4.2067-2074.2004; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; de Haas CJC, 2004, J EXP MED, V199, P687, DOI 10.1084/jem.20031636; De Luca C, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/321494; Donaldson GP, 2016, NAT REV MICROBIOL, V14, P20, DOI 10.1038/nrmicro3552; Doz E, 2007, J BIOL CHEM, V282, P26014, DOI 10.1074/jbc.M702690200; Drake DR, 2008, J LIPID RES, V49, P4, DOI 10.1194/jlr.R700016-JLR200; Due VL, 2003, ACTA ANAESTH SCAND, V47, P372, DOI 10.1034/j.1399-6576.2003.00542.x; Eoh H, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2017.84; Evensen K, 2014, ATHEROSCLEROSIS, V237, P499, DOI 10.1016/j.atherosclerosis.2014.10.008; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Falchook GS, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0176-3; Feingold KR, 2009, J LIPID RES, V50, pS417, DOI 10.1194/jlr.R800039-JLR200; Fitz-Gibbon S, 2013, J INVEST DERMATOL, V133, P2152, DOI 10.1038/jid.2013.21; Foster TJ, 2005, NAT REV MICROBIOL, V3, P948, DOI 10.1038/nrmicro1289; Fukuda T, 2013, MBIO, V4, DOI 10.1128/mBio.00472-12; Fung TC, 2016, IMMUNITY, V44, P634, DOI 10.1016/j.immuni.2016.02.019; Galagan JE, 2013, NATURE, V499, P178, DOI 10.1038/nature12337; Gallo RL, 2012, NAT REV IMMUNOL, V12, P503, DOI 10.1038/nri3228; GBD, 2016, LANCET, V390; Geherin SA, 2012, J IMMUNOL, V188, P6027, DOI 10.4049/jimmunol.1102639; Golden JB, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0738-z; Grice EA, 2009, SCIENCE, V324, P1190, DOI 10.1126/science.1171700; Haley CA, 2017, MICROBIOL SPECTR, V5; Hannigan GD, 2015, MBIO, V6, DOI 10.1128/mBio.01578-15; Has C, 2014, ANNU REV GENOM HUM G, V15, P245, DOI 10.1146/annurev-genom-090413-025540; Hickman HD, 2013, CELL HOST MICROBE, V13, P155, DOI 10.1016/j.chom.2013.01.004; Horsburgh CR, 2004, NEW ENGL J MED, V350, P2060, DOI 10.1056/NEJMsa031667; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Huang JT, 2009, PEDIATRICS, V123, pE808, DOI 10.1542/peds.2008-2217; Iguchi A, 2015, DNA RES, V22, P101, DOI 10.1093/dnares/dsu043; Ishikawa E, 2017, TRENDS IMMUNOL, V38, P66, DOI 10.1016/j.it.2016.10.009; Joshi GS, 2011, MOL MICROBIOL, V82, P9, DOI 10.1111/j.1365-2958.2011.07809.x; Kalan L., 2016, MBIO, V7; KALISPERATI P, 2017, FRONT GENET, V8; Kallenius G, 2016, TUBERCULOSIS, V96, P120, DOI 10.1016/j.tube.2015.09.005; Kashem SW, 2015, IMMUNITY, V43, P515, DOI 10.1016/j.immuni.2015.08.016; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Kienesberger S, 2016, CELL REP, V14, P1395, DOI 10.1016/j.celrep.2016.01.017; Kobayashi T, 2015, IMMUNITY, V42, P756, DOI 10.1016/j.immuni.2015.03.014; Kong HDH, 2012, GENOME RES, V22, P850, DOI 10.1101/gr.131029.111; Lai YP, 2009, NAT MED, V15, P1377, DOI 10.1038/nm.2062; Lanas A, 2017, LANCET, V390, P613, DOI 10.1016/S0140-6736(16)32404-7; Lee DY, 2008, J INVEST DERMATOL, V128, P1863, DOI 10.1038/sj.jid.5701235; Lehman H, 2014, CLIN REV ALLERG IMMU, V46, P112, DOI 10.1007/s12016-013-8377-8; LEYDEN JJ, 1974, BRIT J DERMATOL, V90, P525, DOI 10.1111/j.1365-2133.1974.tb06447.x; Lin PL, 2014, NAT MED, V20, P75, DOI 10.1038/nm.3412; Linehan JL, CELL; Liu HY, 2017, CELL HOST MICROBE, V22, P653, DOI 10.1016/j.chom.2017.10.006; Loesche M, 2017, J INVEST DERMATOL, V137, P237, DOI 10.1016/j.jid.2016.08.009; Luong TT, 2002, INFECT IMMUN, V70, P3389, DOI 10.1128/IAI.70.7.3389-3395.2002; Macpherson AJ, 2004, SCIENCE, V303, P1662, DOI 10.1126/science.1091334; Macpherson AJ, 2001, MICROBES INFECT, V3, P1021, DOI 10.1016/S1286-4579(01)01460-5; Madison KC, 2003, J INVEST DERMATOL, V121, P231, DOI 10.1046/j.1523-1747.2003.12359.x; Mahoney KM, 2015, CLIN THER, V37, P764, DOI 10.1016/j.clinthera.2015.02.018; Marion E, 2014, CELL, V157, P1565, DOI 10.1016/j.cell.2014.04.040; Martincorena I, 2015, SCIENCE, V348, P880, DOI 10.1126/science.aaa6806; Martinez-Barricarte R, 2018, SCI IMMUNOL, V3, DOI 10.1126/sciimmunol.aau6759; Matard B, 2013, J EUR ACAD DERMATOL, V27, P853, DOI 10.1111/j.1468-3083.2012.04591.x; McLean WHI, 2016, BRIT J DERMATOL, V175, P4, DOI 10.1111/bjd.14997; Merritt RW, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000911; METZE D, 1989, J INVEST DERMATOL, V92, P13, DOI 10.1111/1523-1747.ep13070402; Morris VK, 2017, LANCET ONCOL, V18, P446, DOI 10.1016/S1470-2045(17)30104-3; Mueller SN, 2013, ANNU REV IMMUNOL, V31, P137, DOI 10.1146/annurev-immunol-032712-095954; Nagy I, 2006, MICROBES INFECT, V8, P2195, DOI 10.1016/j.micinf.2006.04.001; Naik S, 2015, NATURE, V520, P104, DOI 10.1038/nature14052; Nakagawa S, 2017, CELL HOST MICROBE, V22, P667, DOI 10.1016/j.chom.2017.10.008; Nakatsuji T, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah4680; Nakatsuji T, 2010, J INVEST DERMATOL, V130, P985, DOI 10.1038/jid.2009.384; Natsuga K, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a018218; NICOLAIDES N, 1974, SCIENCE, V186, P19, DOI 10.1126/science.186.4158.19; Nithya S, 2015, J Oral Maxillofac Pathol, V19, P64, DOI 10.4103/0973-029X.157204; Niyonsaba F, 2017, EXP DERMATOL, V26, P989, DOI 10.1111/exd.13314; O'Riordan K, 2004, CLIN MICROBIOL REV, V17, P218, DOI 10.1128/CMR.17.1.218-234.2004; Oh J, 2016, CELL, V165, P854, DOI 10.1016/j.cell.2016.04.008; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Oh J, 2012, GENOME MED, V4, DOI 10.1186/gm378; OKADA T, 1988, J INVEST DERMATOL, V90, P648, DOI 10.1111/1523-1747.ep12560807; Otto M, 2010, ANNU REV MICROBIOL, V64, P143, DOI 10.1146/annurev.micro.112408.134309; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Palmqvist N, 2004, MICROBES INFECT, V6, P188, DOI 10.1016/j.micinf.2003.11.005; Panigrahi P, 2017, NATURE, V548, P407, DOI 10.1038/nature23480; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Perry S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008804; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; PUHVEL SM, 1975, J INVEST DERMATOL, V64, P406, DOI 10.1111/1523-1747.ep12512337; PUHVEL SM, 1975, J INVEST DERMATOL, V65, P525, DOI 10.1111/1523-1747.ep12610239; Ramsey MM, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.01230; Ring HC, 2017, JAMA DERMATOL, V153, P897, DOI 10.1001/jamadermatol.2017.0904; Rittershaus ESC, 2013, CELL HOST MICROBE, V13, P643, DOI 10.1016/j.chom.2013.05.012; Rohlke F, 2012, THER ADV GASTROENTER, V5, P403, DOI 10.1177/1756283X12453637; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Sanford JA, 2016, SCI IMMUNOL, V1, DOI 10.1126/sciimmunol.aah4609; Santilli S, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0947-0; Scharschmidt TC, 2017, CELL HOST MICROBE, V21, P467, DOI 10.1016/j.chom.2017.03.001; Scharschmidt TC, 2015, IMMUNITY, V43, P1011, DOI 10.1016/j.immuni.2015.10.016; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Scholz CFP, 2016, INT J SYST EVOL MICR, V66, P4422, DOI 10.1099/ijsem.0.001367; SEHGAL VN, 1994, DERMATOL CLIN, V12, P629, DOI 10.1016/S0733-8635(18)30127-X; SHROFF KE, 1995, INFECT IMMUN, V63, P3904, DOI 10.1128/IAI.63.10.3904-3913.1995; Shu MY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055380; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Sonesson A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08046-2; Sonnenberg GF, 2012, SCIENCE, V336, P1321, DOI 10.1126/science.1222551; STRAUSS JS, 1976, J INVEST DERMATOL, V67, P90, DOI 10.1111/1523-1747.ep12512506; Talhari C, 2015, CLIN DERMATOL, V33, P26, DOI 10.1016/j.clindermatol.2014.07.002; Thurlow LR, 2013, CELL HOST MICROBE, V13, P100, DOI 10.1016/j.chom.2012.11.012; Tomura M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06030; Tomura M, 2010, J CLIN INVEST, V120, P883, DOI 10.1172/JCI40926; Totte JEE, 2016, EUR J CLIN MICROBIOL, V35, P1069, DOI 10.1007/s10096-016-2647-3; Totte JEE, 2016, BRIT J DERMATOL, V175, P687, DOI 10.1111/bjd.14566; UHLEN M, 1984, J BIOL CHEM, V259, P1695; van Smeden J, 2016, CURR PROBL DERMATOL, V49, P8, DOI 10.1159/000441540; vanderWaaij LA, 1996, GUT, V38, P348, DOI 10.1136/gut.38.3.348; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Vossenkamper A, 2013, J EXP MED, V210, P1665, DOI 10.1084/jem.20122465; Wang YM, 2012, J INVEST DERMATOL, V132, P2067, DOI 10.1038/jid.2012.112; Wansbrough-Jones M, 2006, LANCET, V367, P1849, DOI 10.1016/S0140-6736(06)68807-7; Wentworth AB, 2013, MAYO CLIN PROC, V88, P38, DOI 10.1016/j.mayocp.2012.06.029; Wollenberg MS, 2014, MBIO, V5, DOI 10.1128/mBio.01286-14; World Health Organization, GLOB TUB REP 2016; Wyatt MA, 2010, SCIENCE, V329, P294, DOI 10.1126/science.1188888; Yager EJ, 2009, VIRAL IMMUNOL, V22, P67, DOI 10.1089/vim.2008.0086; Zhang LJ, 2015, SCIENCE, V347, P67, DOI 10.1126/science.1260972; Zimmermann M, 2010, CHEM BIOL, V17, P925, DOI 10.1016/j.chembiol.2010.08.006	161	275	288	52	280	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 25	2018	553	7689					427	436		10.1038/nature25177	http://dx.doi.org/10.1038/nature25177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU6OE	29364286	Green Accepted			2022-12-28	WOS:000423971100029
J	Lee, S; Choi, J; Mohanty, J; Sousa, LP; Tome, F; Pardon, E; Steyaert, J; Lemmon, MA; Lax, I; Schlessinger, J				Lee, Sangwon; Choi, Jungyuen; Mohanty, Jyotidarsini; Sousa, Leiliane P.; Tome, Francisco; Pardon, Els; Steyaert, Jan; Lemmon, Mark A.; Lax, Irit; Schlessinger, Joseph			Structures of beta-klotho reveal a 'zip code'-like mechanism for endocrine FGF signalling	NATURE			English	Article							FIBROBLAST; RECEPTOR; BINDING	Canonical fibroblast growth factors (FGFs) activate FGF receptors (FGFRs) through paracrine or autocrine mechanisms in a process that requires cooperation with heparan sulfate proteoglycans, which function as co-receptors for FGFR activation(1,2). By contrast, endocrine FGFs (FGF19, FGF21 and FGF23) are circulating hormones that regulate critical metabolic processes in a variety of tissues(3,4). FGF19 regulates bile acid synthesis and lipogenesis, whereas FGF21 stimulates insulin sensitivity, energy expenditure and weight loss(5). Endocrine FGFs signal through FGFRs in a manner that requires klothos, which are cell-surface proteins that possess tandem glycosidase domains(3,4). Here we describe the crystal structures of free and ligand-bound beta-klotho extracellular regions that reveal the molecular mechanism that underlies the specificity of FGF21 towards beta-klotho and demonstrate how the FGFR is activated in a klotho-dependent manner. beta-Klotho serves as a primary 'zip code'-like receptor that acts as a targeting signal for FGF21, and FGFR functions as a catalytic subunit that mediates intracellular signalling. Our structures also show how the sugar-cutting enzyme glycosidase has evolved to become a specific receptor for hormones that regulate metabolic processes, including the lowering of blood sugar levels. Finally, we describe an agonistic variant of FGF21 with enhanced biological activity and present structural insights into the potential development of therapeutic agents for diseases linked to endocrine FGFs.	[Lee, Sangwon; Choi, Jungyuen; Mohanty, Jyotidarsini; Sousa, Leiliane P.; Tome, Francisco; Lemmon, Mark A.; Lax, Irit; Schlessinger, Joseph] Yale Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA; [Lee, Sangwon; Choi, Jungyuen; Mohanty, Jyotidarsini; Sousa, Leiliane P.; Tome, Francisco; Lemmon, Mark A.; Lax, Irit; Schlessinger, Joseph] Yale Sch Med, Yale Canc Biol Inst, 333 Cedar St, New Haven, CT 06520 USA; [Pardon, Els; Steyaert, Jan] Vrije Univ Brussel VIB, Ctr Struct Biol, Pl Laan 2, B-1050 Brussels, Belgium	Yale University; Yale University; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel	Schlessinger, J (corresponding author), Yale Sch Med, Dept Pharmacol, 333 Cedar St, New Haven, CT 06520 USA.; Schlessinger, J (corresponding author), Yale Sch Med, Yale Canc Biol Inst, 333 Cedar St, New Haven, CT 06520 USA.	joseph.schlessinger@yale.edu	steyaert, jan/GQP-7811-2022; Steyaert, Jan/H-4662-2011	Steyaert, Jan/0000-0002-3825-874X; Lee, Sangwon/0000-0002-9441-6546; Pardon, Els/0000-0002-2466-0172; Lemmon, Mark/0000-0002-3379-5319	NE-CAT [P41 GM103403]; APS [DE-AC02-06CH11357]; NIH [1S10OD018007, S10RR026992-0110]; INSTRUCT (ESFRI, FWO);  [P41GM111244];  [P41GM103393];  [DE-SC0012704];  [DE-AC02-76SF00515]; NATIONAL CANCER INSTITUTE [U54CA193417] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, P41GM103403, P41GM111244] Funding Source: NIH RePORTER	NE-CAT; APS; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); INSTRUCT (ESFRI, FWO); ; ; ; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The NSLS-SSRL is supported by P41GM111244, P41GM103393, DE-SC0012704 and by DE-AC02-76SF00515. We thank NE-CAT (P41 GM103403) and APS (DE-AC02-06CH11357). This research was also supported by NIH grant 1S10OD018007 and NIH Award S10RR026992-0110. J.St. thanks INSTRUCT (ESFRI, FWO) for financial support and I. Aboutaleb for technical assistance.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Belov AA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015958; Chuenchor W, 2011, J STRUCT BIOL, V173, P169, DOI 10.1016/j.jsb.2010.09.021; Coppage AL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151269; Degirolamo C, 2016, NAT REV DRUG DISCOV, V15, P51, DOI 10.1038/nrd.2015.9; Dunshee DR, 2016, J BIOL CHEM, V291, P5986, DOI 10.1074/jbc.M115.710582; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Foltz IN, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004690; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Hecht R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049345; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang J, 2013, J PHARMACOL EXP THER, V346, P270, DOI 10.1124/jpet.113.204420; Huang ZF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020669; Isorna P, 2007, J MOL BIOL, V371, P1204, DOI 10.1016/j.jmb.2007.05.082; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kharitonenkov A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058575; Kolumam G, 2015, EBIOMEDICINE, V2, P730, DOI 10.1016/j.ebiom.2015.05.028; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; Luo J, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009098; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Micanovic R, 2009, J CELL PHYSIOL, V219, P227, DOI 10.1002/jcp.21675; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Owen BM, 2015, TRENDS ENDOCRIN MET, V26, P22, DOI 10.1016/j.tem.2014.10.002; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Yie JM, 2009, FEBS LETT, V583, P19, DOI 10.1016/j.febslet.2008.11.023; Zhen EY, 2016, BIOCHEM J, V473, P605, DOI 10.1042/BJ20151085	32	110	117	3	46	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2018	553	7689					501	+		10.1038/nature25010	http://dx.doi.org/10.1038/nature25010			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU6OE	29342135	Green Submitted, Green Accepted			2022-12-28	WOS:000423971100040
J	McInnes, MDF; Moher, D; Thombs, BD; McGrath, TA; Bossuyt, PM				McInnes, Matthew D. F.; Moher, David; Thombs, Brett D.; McGrath, Trevor A.; Bossuyt, Patrick M.		PRISMA-DTA Grp	Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies The PRISMA-DTA Statement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							BIAS; PUBLICATION; QUALITY; TOOL	IMPORTANCE Systematic reviews of diagnostic test accuracy synthesize data from primary diagnostic studies that have evaluated the accuracy of 1 or more index tests against a reference standard, provide estimates of test performance, allow comparisons of the accuracy of different tests, and facilitate the identification of sources of variability in test accuracy. OBJECTIVE To develop the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) diagnostic test accuracy guideline as a stand-alone extension of the PRISMA statement. Modifications to the PRISMA statement reflect the specific requirements for reporting of systematic reviews and meta-analyses of diagnostic test accuracy studies and the abstracts for these reviews. DESIGN Established standards from the Enhancing the Quality and Transparency of Health Research (EQUATOR) Network were followed for the development of the guideline. The original PRISMA statement was used as a framework on which to modify and add items. A group of 24 multidisciplinary experts used a systematic review of articles on existing reporting guidelines and methods, a 3-round Delphi process, a consensus meeting, pilot testing, and iterative refinement to develop the PRISMA diagnostic test accuracy guideline. The final version of the PRISMA diagnostic test accuracy guideline checklist was approved by the group. FINDINGS The systematic review (produced 64 items) and the Delphi process (provided feedback on 7 proposed items; 1 item was later split into 2 items) identified 71 potentially relevant items for consideration. The Delphi process reduced these to 60 items that were discussed at the consensus meeting. Following the meeting, pilot testing and iterative feedback were used to generate the 27-item PRISMA diagnostic test accuracy checklist. To reflect specific or optimal contemporary systematic review methods for diagnostic test accuracy, 8 of the 27 original PRISMA items were left unchanged, 17 were modified, 2 were added, and 2 were omitted. CONCLUSIONS AND RELEVANCE The 27-item PRISMA diagnostic test accuracy checklist provides specific guidance for reporting of systematic reviews. The PRISMA diagnostic test accuracy guideline can facilitate the transparent reporting of reviews, and may assist in the evaluation of validity and applicability, enhance replicability of reviews, and make the results from systematic reviews of diagnostic test accuracy studies more useful.	[McInnes, Matthew D. F.] Univ Ottawa, Dept Radiol, Ottawa, ON, Canada; [McInnes, Matthew D. F.; Moher, David] Ottawa Hosp Res Inst, Clin Epidemiol Program, Ottawa, ON, Canada; [Thombs, Brett D.] Jewish Gen Hosp, Lady Davis Inst, Montreal, PQ, Canada; [Thombs, Brett D.] McGill Univ, Dept Psychiat, Montreal, PQ, Canada; [McGrath, Trevor A.] Univ Ottawa, Dept Radiol, Ottawa, ON, Canada; [Bossuyt, Patrick M.] Univ Amsterdam, Acad Med Ctr, Dept Clin Epidemiol Biostat & Bioinformat, Amsterdam, Netherlands	University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute; Lady Davis Institute; McGill University; McGill University; University of Ottawa; University of Amsterdam; Academic Medical Center Amsterdam	McInnes, MDF (corresponding author), Ottawa Hosp Civ Campus, 1053 Carling Ave, Ottawa, ON K1E 4Y9, Canada.	mmcinnes@toh.ca	Willis, Brian/AAX-6446-2020; Bossuyt, Patrick M/AAR-1183-2021; Cohen, Jérémie/H-4707-2019; Deeks, Jon/AAV-5745-2020; Rutjes, Anne/L-8750-2017; McGrath, Trevor/AAV-8238-2020; Bossuyt, Patrick M./B-4557-2016; McInnes, Matthew/D-4532-2013	Willis, Brian/0000-0002-0821-8624; Bossuyt, Patrick M/0000-0003-4427-0128; Cohen, Jérémie/0000-0003-3572-8985; Deeks, Jon/0000-0002-8850-1971; Rutjes, Anne/0000-0001-9782-779X; Bossuyt, Patrick M./0000-0003-4427-0128; Christopher, Hyde/0000-0002-7349-0616; Salameh, Jean-Paul/0000-0002-4105-2056; Takwoingi, Yemisi/0000-0002-5828-9746; Reitsma, Johannes/0000-0003-4026-4345; Whiting, Penny/0000-0003-1138-5682; McInnes, Matthew/0000-0001-8404-4075; McGrath, Trevor/0000-0001-8063-289X; Hunt, Harriet/0000-0003-1254-0568	Canadian Institute for Health Research [375751]; Canadian Agency for Drugs and Technologies in Health; Standards for Reporting of Diagnostic Accuracy Studies Group; University of Ottawa Department of Radiology Research Stipend Program; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care South West Peninsula; MRC [G0701649, MR/N007999/1] Funding Source: UKRI; Medical Research Council [G0701649, MR/N007999/1] Funding Source: researchfish; National Institute for Health Research [PDF-2017-10-059, CL-2011-09-003] Funding Source: researchfish	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Agency for Drugs and Technologies in Health; Standards for Reporting of Diagnostic Accuracy Studies Group; University of Ottawa Department of Radiology Research Stipend Program; National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care South West Peninsula; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	The research was supported by grant 375751 from the Canadian Institute for Health Research; funding from the Canadian Agency for Drugs and Technologies in Health; funding from the Standards for Reporting of Diagnostic Accuracy Studies Group; funding from the University of Ottawa Department of Radiology Research Stipend Program; and funding from the National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care South West Peninsula.	Alldred SK, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009925; Bastian H, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000326; Beller EM, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001419; Bossuyt PM, 2015, BMJ-BRIT MED J, V351, DOI [10.1136/bmj.h5527, 10.1373/clinchem.2015.246280, 10.1148/radiol.2015151516]; Boulkedid R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020476; Cohen JF, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3751; Cohen JF, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-012799; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Dinnes J, 2016, J CLIN EPIDEMIOL, V80, P77, DOI 10.1016/j.jclinepi.2016.07.011; Equator Network, REP GUID DEV; Glasziou P, 2014, LANCET, V383, P267, DOI 10.1016/S0140-6736(13)62228-X; Hong PJ, 2018, J MAGN RESON IMAGING, V47, P523, DOI 10.1002/jmri.25797; IRWIG L, 1995, J CLIN EPIDEMIOL, V48, P119, DOI 10.1016/0895-4356(94)00099-C; Korevaar Daniel A, 2016, Res Integr Peer Rev, V1, P7, DOI 10.1186/s41073-016-0014-7; Korevaar DA, 2016, J CLIN EPIDEMIOL, V79, P96, DOI 10.1016/j.jclinepi.2016.06.002; Korevaar DA, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004596; Liberati Alessandro, 2009, J Clin Epidemiol, V62, pe1, DOI 10.1016/j.jclinepi.2009.06.006; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Macaskill P, 2010, COCHRANE HDB SYSTEMA; McGrath TA, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0590-8; McGrath TA, 2017, CLIN CHEM, V63, P1353, DOI 10.1373/clinchem.2017.271544; McGrath TA, 2017, EUR J RADIOL, V93, P59, DOI 10.1016/j.ejrad.2017.05.032; McGrath TA, 2016, RADIOLOGY, V281, P78, DOI 10.1148/radiol.2016152229; McInnes MDF, 2015, RADIOLOGY, V277, P13, DOI 10.1148/radiol.2015142779; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Moher D, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000217; Naaktgeboren CA, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0108-4; Naaktgeboren CA, 2014, J CLIN EPIDEMIOL, V67, P1200, DOI 10.1016/j.jclinepi.2014.05.018; Ochodo EA, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-33; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Staal JB, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001824.pub3; Tunis AS, 2013, RADIOLOGY, V269, P413, DOI 10.1148/radiol.13130273; van Enst WA, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-70; Whiting P, 2016, J CLIN EPIDEMIOL, V69, P225, DOI 10.1016/j.jclinepi.2015.06.005; Whiting PF, 2011, ANN INTERN MED, V155, P529, DOI 10.7326/0003-4819-155-8-201110180-00009; Willis BH, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-163; Willis BH, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-27; Zwinderman AH, 2008, BIOSTATISTICS, V9, P513, DOI 10.1093/biostatistics/kxm052	40	1177	1187	6	65	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					388	396		10.1001/jama.2017.19163	http://dx.doi.org/10.1001/jama.2017.19163			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362800	Green Published, Bronze			2022-12-28	WOS:000423405300024
J	Teijaro, JR; Burton, DR				Teijaro, John R.; Burton, Dennis R.			Taking down defenses to improve vaccines	SCIENCE			English	Editorial Material							TYPE-1 INTERFERONS; INFLUENZA; VIRUSES		[Teijaro, John R.; Burton, Dennis R.] Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA; [Burton, Dennis R.] Ragon Inst MGH Harvard & MIT, Cambridge, MA 02139 USA	Scripps Research Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute	Teijaro, JR (corresponding author), Scripps Res Inst, Dept Immunol & Microbiol, La Jolla, CA 92037 USA.	teijaro@scripps.edu; burton@scripps.edu			NIAID NIH HHS [R01 AI123210] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123210] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Amanna IJ, 2011, VIROLOGY, V411, P206, DOI 10.1016/j.virol.2010.12.016; Beachboard DC, 2016, CURR OPIN MICROBIOL, V32, P113, DOI 10.1016/j.mib.2016.05.015; Burton DR, 2017, CSH PERSPECT BIOL, V9, DOI 10.1101/cshperspect.a030262; Dorshkind K, 2009, NAT REV IMMUNOL, V9, P57, DOI 10.1038/nri2471; Du YS, 2018, SCIENCE, V359, P290, DOI 10.1126/science.aan8806; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hanley Kathryn A, 2011, Evolution (N Y), V4, P635; Krammer F, 2015, NAT REV DRUG DISCOV, V14, P167, DOI 10.1038/nrd4529; McElhaney JE, 2008, J INFECT DIS, V198, P632, DOI 10.1086/590435; Teijaro JR, 2016, ADV IMMUNOL, V132, P135, DOI 10.1016/bs.ai.2016.08.001; Wu NC, 2014, J VIROL, V88, P10157, DOI 10.1128/JVI.01494-14; Wu Nicholas C, 2014, Sci Rep, V4, P4942, DOI 10.1038/srep04942	13	3	3	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					277	278		10.1126/science.aar5421	http://dx.doi.org/10.1126/science.aar5421			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT6BB	29348225				2022-12-28	WOS:000423236700021
J	Bemma, A				Bemma, Adam			Malaysia: a refugee conundrum	LANCET			English	Editorial Material																			0	0	0	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 13	2018	391	10116					107	108		10.1016/S0140-6736(18)30052-7	http://dx.doi.org/10.1016/S0140-6736(18)30052-7			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT0EG	29353607				2022-12-28	WOS:000422793400010
J	Mulvey, B; Dougherty, JD				Mulvey, Bernard; Dougherty, Joseph D.			Weaving New Insights for the Genetic Regulation of Human Cognitive Phenotypes	CELL			English	Editorial Material							NEOCORTEX; NEUROGENESIS; EVOLUTION	Psychiatric genetic studies have drawn associations between human cognitive traits and noncoding genomic variants. However, the mechanistic effects of these variants are unclear. By weaving in strands of genomic data from developing human brains, de la Torre-Ubieta et al. tie disease-associated loci to functional enhancers, target genes, and putatively affected cell types.	[Mulvey, Bernard; Dougherty, Joseph D.] Washington Univ, Sch Med, Dept Psychiat, Dept Genet, St Louis, MO 63110 USA; [Mulvey, Bernard; Dougherty, Joseph D.] Washington Univ, Sch Med, Hope Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Dougherty, JD (corresponding author), Washington Univ, Sch Med, Dept Psychiat, Dept Genet, St Louis, MO 63110 USA.; Dougherty, JD (corresponding author), Washington Univ, Sch Med, Hope Ctr, St Louis, MO 63110 USA.	jdougherty@genetics.wustl.edu		Dougherty, Joseph/0000-0002-6385-3997; Mulvey, Bernard/0000-0003-0815-0436	Hope Center; Simons Foundation; NARSAD Independent Investigator grant from the Brain and Behavior Research Foundation; NIH [1R01NS102272, 1R01MH107515, 5U01MH109133, 5R01HG008687, 1R21DA041883]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG008687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH109133, R01MH107515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS102272] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA041883] Funding Source: NIH RePORTER	Hope Center; Simons Foundation; NARSAD Independent Investigator grant from the Brain and Behavior Research Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The Dougherty lab is supported by the Hope Center, the Simons Foundation, a NARSAD Independent Investigator grant from the Brain and Behavior Research Foundation, and the NIH (1R01NS102272, 1R01MH107515, 5U01MH109133, 5R01HG008687, 1R21DA041883). We thank K. Lyall for figure generation.	Arnold SJ, 2008, GENE DEV, V22, P2479, DOI 10.1101/gad.475408; Baala L, 2007, NAT GENET, V39, P454, DOI 10.1038/ng1993; de la Torre-Ubieta L, 2018, CELL, V172, P289, DOI 10.1016/j.cell.2017.12.014; Lui JH, 2011, CELL, V146, P18, DOI 10.1016/j.cell.2011.06.030; Pollard KS, 2006, NATURE, V443, P167, DOI 10.1038/nature05113; Rakic P, 2009, NAT REV NEUROSCI, V10, P724, DOI 10.1038/nrn2719; Reilly SK, 2015, SCIENCE, V347, P1155, DOI 10.1126/science.1260943; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Stevens HE, 2010, J NEUROSCI, V30, P5590, DOI 10.1523/JNEUROSCI.5837-09.2010; Won HJ, 2016, NATURE, V538, P523, DOI 10.1038/nature19847	10	3	3	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					10	13		10.1016/j.cell.2017.12.037	http://dx.doi.org/10.1016/j.cell.2017.12.037			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29328907	Bronze			2022-12-28	WOS:000419840100005
J	Rubin, R				Rubin, Rita			Nearly 15% of US HIV Infections Undiagnosed in 2015	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2018	319	2					114	114		10.1001/jama.2017.20149	http://dx.doi.org/10.1001/jama.2017.20149			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS4PR	29318285				2022-12-28	WOS:000419775500005
J	Samkharadze, N; Zheng, G; Kalhor, N; Brousse, D; Sammak, A; Mendes, UC; Blais, A; Scappucci, G; Vandersypen, LMK				Samkharadze, N.; Zheng, G.; Kalhor, N.; Brousse, D.; Sammak, A.; Mendes, U. C.; Blais, A.; Scappucci, G.; Vandersypen, L. M. K.			Strong spin-photon coupling in silicon	SCIENCE			English	Article							CIRCUIT QUANTUM ELECTRODYNAMICS; QUBIT; CAVITY; DOT	Long coherence times of single spins in silicon quantum dots make these systems highly attractive for quantum computation, but how to scale up spin qubit systems remains an open question. As a first step to address this issue, we demonstrate the strong coupling of a single electron spin and a single microwave photon. The electron spin is trapped in a silicon double quantum dot, and the microwave photon is stored in an on-chip high-impedance superconducting resonator. The electric field component of the cavity photon couples directly to the charge dipole of the electron in the double dot, and indirectly to the electron spin, through a strong local magnetic field gradient from a nearby micromagnet. Our results provide a route to realizing large networks of quantum dot-based spin qubit registers.	[Samkharadze, N.; Zheng, G.; Kalhor, N.; Scappucci, G.; Vandersypen, L. M. K.] Delft Univ Technol, QuTech, Lorentzweg 1, NL-2628 CJ Delft, Netherlands; [Samkharadze, N.; Zheng, G.; Kalhor, N.; Scappucci, G.; Vandersypen, L. M. K.] Delft Univ Technol, Kavli Inst Nanosci, Lorentzweg 1, NL-2628 CJ Delft, Netherlands; [Brousse, D.; Sammak, A.] QuTech, Stieltjesweg 1, NL-2628 CK Delft, Netherlands; [Brousse, D.; Sammak, A.] Netherlands Org Appl Sci Res TNO, Stieltjesweg 1, NL-2628 CK Delft, Netherlands; [Mendes, U. C.; Blais, A.] Univ Sherbrooke, Inst Quant, Sherbrooke, PQ J1K 2R1, Canada; [Mendes, U. C.; Blais, A.] Univ Sherbrooke, Dept Phys, Sherbrooke, PQ J1K 2R1, Canada; [Blais, A.] Canadian Inst Adv Res, Toronto, ON, Canada	Delft University of Technology; Delft University of Technology; Netherlands Organization Applied Science Research; University of Sherbrooke; University of Sherbrooke; Canadian Institute for Advanced Research (CIFAR)	Vandersypen, LMK (corresponding author), Delft Univ Technol, QuTech, Lorentzweg 1, NL-2628 CJ Delft, Netherlands.; Vandersypen, LMK (corresponding author), Delft Univ Technol, Kavli Inst Nanosci, Lorentzweg 1, NL-2628 CJ Delft, Netherlands.	l.m.k.vandersypen@tudelft.nl	Mendes, Udson C/C-3434-2013; Blais, Alexandre/E-3315-2010	Mendes, Udson C/0000-0002-1230-8366; Sammak, Amir/0000-0002-9776-9099; Vandersypen, Lieven/0000-0003-4346-7877; Blais, Alexandre/0000-0002-0591-2012; Kalhor, Nima/0000-0002-0378-9209; Scappucci, Giordano/0000-0003-2512-0079; Zheng, Guoji/0000-0003-1688-7040	European Research Council (ERC Synergy Quantum Computer Lab); Netherlands Organisation for Scientific Research (NWO/OCW) as part of the Frontiers of Nanoscience (NanoFront) program; Intel Corporation; Canada First Research Excellence Fund; Natural Sciences and Engineering Research Council of Canada	European Research Council (ERC Synergy Quantum Computer Lab)(European Research Council (ERC)); Netherlands Organisation for Scientific Research (NWO/OCW) as part of the Frontiers of Nanoscience (NanoFront) program; Intel Corporation(Intel Corporation); Canada First Research Excellence Fund; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	We thank J. Taylor, P. Scarlino, A. Yacoby, J. Kroll, A. Bruno, and members of the spin qubit team at QuTech for useful discussions and L. Kouwenhoven and his team for access to NbTiN films. This research was undertaken thanks in part to funding from the European Research Council (ERC Synergy Quantum Computer Lab), the Netherlands Organisation for Scientific Research (NWO/OCW) as part of the Frontiers of Nanoscience (NanoFront) program, Intel Corporation, the Canada First Research Excellence Fund, and the Natural Sciences and Engineering Research Council of Canada. Data reported in this paper are archived at http://doi.org/10.4121/uuid:1483c28e-c1d5-45d5-971c-8e660f01f768.	Beaudoin F, 2016, NANOTECHNOLOGY, V27, DOI 10.1088/0957-4484/27/46/464003; Benito M, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.235434; Bruhat L. E., 2016, ARXIV161205214CONDMA; Brune M, 1996, PHYS REV LETT, V76, P1800, DOI 10.1103/PhysRevLett.76.1800; Burkard G, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.041307; Childress L, 2004, PHYS REV A, V69, DOI 10.1103/PhysRevA.69.042302; Chiorescu I, 2004, NATURE, V431, P159, DOI 10.1038/nature02831; Cottet A, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.160502; Frey T, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.046807; Haikka P, 2017, PHYS REV A, V95, DOI 10.1103/PhysRevA.95.022306; Haroche S., 2006, EXPLORING QUANTUM; Hayashi T, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.226804; Hu XD, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.035314; Kawakami E, 2014, NAT NANOTECHNOL, V9, P666, DOI [10.1038/nnano.2014.153, 10.1038/NNANO.2014.153]; Kloeffel C, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.241405; Landig A. J., ARXIV171101932CONDMA; Mi X, 2017, SCIENCE, V355, P156, DOI 10.1126/science.aal2469; Mi X., 2017, ARXIV171003265CONDMA; Petersson KD, 2012, NATURE, V490, P380, DOI 10.1038/nature11559; Pioro-Ladriere M, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2430906; Reithmaier JP, 2004, NATURE, V432, P197, DOI 10.1038/nature02969; Rochette S., 2017, ARXIV170703895CONDMA; Samkharadze N, 2016, PHYS REV APPL, V5, DOI 10.1103/PhysRevApplied.5.044004; Shulman MD, 2012, SCIENCE, V336, P202, DOI 10.1126/science.1217692; Stockklauser A, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.011030; THOMPSON RJ, 1992, PHYS REV LETT, V68, P1132, DOI 10.1103/PhysRevLett.68.1132; Trif M, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.045434; Vandersypen LMK, 2017, NPJ QUANTUM INFORM, V3, DOI 10.1038/s41534-017-0038-y; Veldhorst M, 2015, NATURE, V526, P410, DOI 10.1038/nature15263; Viennot JJ, 2015, SCIENCE, V349, P408, DOI 10.1126/science.aaa3786; Wallraff A, 2004, NATURE, V431, P162, DOI 10.1038/nature02851; Watson T. F., 2017, ARXIV170804214CONDMA; Yoshie T, 2004, NATURE, V432, P200, DOI 10.1038/nature03119; Zajac DM, 2018, SCIENCE, V359, P439, DOI 10.1126/science.aao5965	34	203	203	9	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 9	2018	359	6380					1123	1126		10.1126/science.aar4054	http://dx.doi.org/10.1126/science.aar4054			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FY4ZM	29371427	Green Submitted, Green Published			2022-12-28	WOS:000426835900038
J	Madeo, F; Eisenberg, T; Pietrocola, F; Kroemer, G				Madeo, Frank; Eisenberg, Tobias; Pietrocola, Federico; Kroemer, Guido			Spermidine in health and disease	SCIENCE			English	Review							CALORIC RESTRICTION MIMETICS; DIETARY POLYAMINE INTAKE; BLOOD-BRAIN-BARRIER; LIFE-SPAN; HISTONE DEACETYLASE; NATURAL POLYAMINE; ACETYL-COENZYME; MOUSE MODEL; AUTOPHAGY; MEMORY		[Madeo, Frank; Eisenberg, Tobias] Karl Franzens Univ Graz, NAWI Graz, Inst Mol Biosci, Graz, Austria; [Madeo, Frank; Eisenberg, Tobias] BioTechMed Graz, Graz, Austria; [Pietrocola, Federico; Kroemer, Guido] Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc 11, Paris, France; [Pietrocola, Federico; Kroemer, Guido] Gustave Roussy Comprehens Canc Ctr, Cell Biol & Metabol Platforms, Villejuif, France; [Pietrocola, Federico; Kroemer, Guido] INSERM, U1138, Paris, France; [Pietrocola, Federico; Kroemer, Guido] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Pietrocola, Federico; Kroemer, Guido] Univ Paris 06, Paris, France; [Kroemer, Guido] Hop Europeen Georges Pompidou, Pole Biol, Paris, France; [Kroemer, Guido] Karolinska Inst, Karolinska Univ Hosp, Dept Womens & Childrens Hlth, Stockholm, Sweden	University of Graz; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UNICANCER; Gustave Roussy; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Karolinska Institutet; Karolinska University Hospital	Madeo, F (corresponding author), Karl Franzens Univ Graz, NAWI Graz, Inst Mol Biosci, Graz, Austria.; Madeo, F (corresponding author), BioTechMed Graz, Graz, Austria.; Kroemer, G (corresponding author), Ctr Rech Cordeliers, Equipe Labellisee Ligue Canc 11, Paris, France.; Kroemer, G (corresponding author), Gustave Roussy Comprehens Canc Ctr, Cell Biol & Metabol Platforms, Villejuif, France.; Kroemer, G (corresponding author), INSERM, U1138, Paris, France.; Kroemer, G (corresponding author), Univ Paris 05, Sorbonne Paris Cite, Paris, France.; Kroemer, G (corresponding author), Univ Paris 06, Paris, France.; Kroemer, G (corresponding author), Hop Europeen Georges Pompidou, Pole Biol, Paris, France.; Kroemer, G (corresponding author), Karolinska Inst, Karolinska Univ Hosp, Dept Womens & Childrens Hlth, Stockholm, Sweden.	frank.madeo@uni-graz.at; kroemer@orange.fr	Eisenberg, Tobias/AAV-7806-2021; Kroemer, Guido/AAY-9859-2020; Pietrocola, Federico/AAW-9621-2020; KROEMER, Guido/B-4263-2013	Pietrocola, Federico/0000-0002-2930-234X; KROEMER, Guido/0000-0002-9334-4405; Madeo, Frank/0000-0002-5070-1329; Eisenberg, Tobias/0000-0003-3559-1130	Austrian Science Fund FWF (Austria) [P23490-B20, P29262, P24381, P29203 P27893, I1000]; "SFB Lipotox" [F3012]; Bundesministerium fur Wissenschaft, Forschung und Wirtschaft; Karl-Franzens University; grant DKplus Metabolic and Cardiovascular Diseases [W1226]; NAWI Graz; BioTechMed-Graz flagship project "EPIAge"; Ligue contre le Cancer Comite de Charente-Maritime; Agence National de la Recherche (ANR)-Projets blancs; ANR; ERA-Net for Research on Rare Diseases; Association pour la recherche sur le cancer (ARC); Canceropole Ile-de-France; Institut National du Cancer (INCa); Institut Universitaire de France; Fondation pour la Recherche Medicale (FRM); European Commission (ArtForce); European Research Council (ERC); LeDucq Foundation; LabEx Immuno-Oncology; Recherche Hospitalo-Universitaire Torino Lumiere; Site de Recherche Integree sur le Cancer (SIRIC) Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI); FFG COIN [855987]	Austrian Science Fund FWF (Austria)(Austrian Science Fund (FWF)); "SFB Lipotox"(German Research Foundation (DFG)); Bundesministerium fur Wissenschaft, Forschung und Wirtschaft; Karl-Franzens University; grant DKplus Metabolic and Cardiovascular Diseases; NAWI Graz; BioTechMed-Graz flagship project "EPIAge"; Ligue contre le Cancer Comite de Charente-Maritime(Ligue nationale contre le cancer); Agence National de la Recherche (ANR)-Projets blancs(French National Research Agency (ANR)); ANR(French National Research Agency (ANR)); ERA-Net for Research on Rare Diseases; Association pour la recherche sur le cancer (ARC)(Fondation ARC pour la Recherche sur le Cancer); Canceropole Ile-de-France(Region Ile-de-France); Institut National du Cancer (INCa)(Institut National du Cancer (INCA) France); Institut Universitaire de France; Fondation pour la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); European Commission (ArtForce)(European CommissionEuropean Commission Joint Research Centre); European Research Council (ERC)(European Research Council (ERC)European Commission); LeDucq Foundation(Leducq Foundation); LabEx Immuno-Oncology; Recherche Hospitalo-Universitaire Torino Lumiere; Site de Recherche Integree sur le Cancer (SIRIC) Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); SIRIC Cancer Research and Personalized Medicine (CARPEM); Paris Alliance of Cancer Research Institutes (PACRI); FFG COIN	F.M., T.E., and G.K. are inventors on a patent application (WO2010081204 A3) submitted by Katholieke Universiteit Leuven that covers the use of spermidine for life-span extension. F.P. and G.K. are inventors on a patent application (WO2015049365 A3) submitted by INSERM (Institut National de la Sante et de la Recherche Medicale), Assistance Publique-Hopitaux De Paris (APHP), Universite Paris Descartes, Universite Pierre et Marie Curie (Paris 6), Universite Paris Diderot-Paris 7, Universite Paris-Sud, Institut Gustave Roussy, that covers the medical use of CRMs. We thank D. Carmona-Gutierrez and P. Royer for critical reading and support. F.M. is grateful to the Austrian Science Fund FWF (Austria) for grants P23490-B20, P29262, P24381, P29203 P27893, I1000, and "SFB Lipotox" (F3012), as well as to Bundesministerium fur Wissenschaft, Forschung und Wirtschaft and the Karl-Franzens University for grant "Unkonventionelle Forschung" and grant DKplus Metabolic and Cardiovascular Diseases (W1226). We acknowledge support from NAWI Graz and the BioTechMed-Graz flagship project "EPIAge." G.K. is supported by the Ligue contre le Cancer Comite de Charente-Maritime (equipe labelisee); Agence National de la Recherche (ANR)-Projets blancs; ANR under the frame of E-Rare-2, the ERA-Net for Research on Rare Diseases; Association pour la recherche sur le cancer (ARC); Canceropole Ile-de-France; Institut National du Cancer (INCa); Institut Universitaire de France; Fondation pour la Recherche Medicale (FRM); the European Commission (ArtForce); the European Research Council (ERC); the LeDucq Foundation; the LabEx Immuno-Oncology; the Recherche Hospitalo-Universitaire Torino Lumiere, the Site de Recherche Integree sur le Cancer (SIRIC) Stratified Oncology Cell DNA Repair and Tumor Immune Elimination (SOCRATE); the SIRIC Cancer Research and Personalized Medicine (CARPEM); and the Paris Alliance of Cancer Research Institutes (PACRI). T.E. is supported by the FFG COIN-project 855987. F. M. and T.E. have equity interests in TLL (The Longevity Labs), a company founded in 2016 that will develop natural food extracts.	Ali MA, 2011, FOOD NUTR RES, V55, DOI [10.3402/fnr.v55i0.5455, 10.3402/fnr.v55i0.5572]; Anson RM, 2003, P NATL ACAD SCI USA, V100, P6216, DOI 10.1073/pnas.1035720100; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; BARDOCZ S, 1995, BRIT J NUTR, V73, P819, DOI 10.1079/BJN19950087; Barger JL, 2017, AGING CELL, V16, P750, DOI 10.1111/acel.12608; Bennetzen MV, 2012, CELL CYCLE, V11, P1827, DOI 10.4161/cc.20233; Bonhoure N, 2015, GENE DEV, V29, P934, DOI 10.1101/gad.258350.115; Buttner S, 2014, CELL CYCLE, V13, P3903, DOI 10.4161/15384101.2014.973309; Chen TT, 2011, AGING CELL, V10, P908, DOI 10.1111/j.1474-9726.2011.00722.x; Cheng ML, 2015, J AM COLL CARDIOL, V65, P1509, DOI 10.1016/j.jacc.2015.02.018; Chrisam M, 2015, AUTOPHAGY, V11, P2142, DOI 10.1080/15548627.2015.1108508; de Cabo R, 2014, CELL, V157, P1515, DOI 10.1016/j.cell.2014.05.031; Deng KW, 2009, J NEUROSCI, V29, P9545, DOI 10.1523/JNEUROSCI.1175-09.2009; Di Biase S, 2016, CANCER CELL, V30, P136, DOI 10.1016/j.ccell.2016.06.005; Diler AS, 2002, NEUROSCI RES, V43, P335, DOI 10.1016/S0168-0102(02)00059-7; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Eisenberg T, 2016, NAT MED, V22, P1428, DOI 10.1038/nm.4222; Eisenberg T, 2014, CELL METAB, V19, P431, DOI 10.1016/j.cmet.2014.02.010; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Eiyama A, 2015, CURR OPIN CELL BIOL, V33, P95, DOI 10.1016/j.ceb.2015.01.002; Fan JJ, 2017, ONCOTARGET, V8, P17475, DOI [10.18632/oncotarget.15420, 10.18632/oncotarget.15728]; Fernandez AF, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.373; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Frake RA, 2015, J CLIN INVEST, V125, P65, DOI 10.1172/JCI73944; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Freedman ND, 2012, NEW ENGL J MED, V366, P1891, DOI 10.1056/NEJMoa1112010; Galluzzi L, 2017, NAT REV IMMUNOL, V17, P97, DOI 10.1038/nri.2016.107; Galluzzi L, 2015, CANCER CELL, V28, P690, DOI 10.1016/j.ccell.2015.10.012; Garcia-Prat L, 2016, NATURE, V529, P37, DOI 10.1038/nature16187; Gerner EW, 2004, NAT REV CANCER, V4, P781, DOI 10.1038/nrc1454; Ghosh HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009199; Graham SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119452; Guerra GP, 2016, PHARMACOL RES, V112, P99, DOI 10.1016/j.phrs.2016.03.023; Guo XL, 2011, INVEST OPHTH VIS SCI, V52, P2696, DOI 10.1167/iovs.10-6015; Gupta VK, 2016, PLOS BIOL, V14, DOI 10.1371/journal.pbio.1002563; Gupta VK, 2013, NAT NEUROSCI, V16, P1453, DOI 10.1038/nn.3512; Hai Y, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15368; Hayashi T, 2002, HYPERTENS RES, V25, P787; Hiasa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep06836; Igarashi K, 2006, AMINO ACIDS, V31, P477, DOI 10.1007/s00726-006-0264-7; Igarashi K, 2009, INT J BIOCHEM CELL B, V42, P39, DOI DOI 10.1016/J.BI0CEL.2009.07.009;PMID:19643201; Jell J, 2007, J BIOL CHEM, V282, P8404, DOI 10.1074/jbc.M610265200; Jo S, 2014, NAT MED, V20, P886, DOI 10.1038/nm.3639; Junnila RK, 2013, NAT REV ENDOCRINOL, V9, P366, DOI 10.1038/nrendo.2013.67; Kano Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056056; Kee K, 2004, J BIOL CHEM, V279, P40076, DOI 10.1074/jbc.M406002200; Kibe R, 2014, SCI REP-UK, V4, DOI 10.1038/srep04548; Knott AB, 2010, DIABETES OBES METAB, V12, P126, DOI 10.1111/j.1463-1326.2010.01267.x; Kraus D, 2014, NATURE, V508, P258, DOI 10.1038/nature13198; LaRocca TJ, 2013, MECH AGEING DEV, V134, P314, DOI 10.1016/j.mad.2013.04.004; Lee C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003293; Lee CH, 2010, CANCER RES, V70, P1564, DOI 10.1158/0008-5472.CAN-09-3228; Lee IH, 2009, J BIOL CHEM, V284, P6322, DOI 10.1074/jbc.M807135200; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Liu P, 2008, NEUROSCIENCE, V155, P789, DOI 10.1016/j.neuroscience.2008.06.033; Longo VD, 2016, CELL METAB, V23, P1048, DOI 10.1016/j.cmet.2016.06.001; Lopez-Otin C, 2016, CELL, V166, P802, DOI 10.1016/j.cell.2016.07.031; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Ma Y, 2013, IMMUNITY, V38, P729, DOI 10.1016/j.immuni.2013.03.003; Mackeh R, 2014, J BIOL CHEM, V289, P11816, DOI 10.1074/jbc.M113.507400; Madeo F, 2014, NAT REV DRUG DISCOV, V13, P727, DOI 10.1038/nrd4391; Magnes C, 2014, J CHROMATOGR A, V1331, P44, DOI 10.1016/j.chroma.2013.12.061; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Marino G, 2014, AUTOPHAGY, V10, P1879, DOI 10.4161/auto.36413; Marino G, 2014, MOL CELL, V53, P710, DOI 10.1016/j.molcel.2014.01.016; Masuko T, 2003, J NEUROCHEM, V84, P610, DOI 10.1046/j.1471-4159.2003.01558.x; Matsumoto M, 2007, MICROBIOL IMMUNOL, V51, P25, DOI 10.1111/j.1348-0421.2007.tb03887.x; Matsumoto M, 2012, SCI REP-UK, V2, DOI 10.1038/srep00233; Matsumoto M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023652; Miao HM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11716; Michaud M, 2011, SCIENCE, V334, P1573, DOI 10.1126/science.1208347; Michiels CF, 2016, ATHEROSCLEROSIS, V251, P319, DOI 10.1016/j.atherosclerosis.2016.07.899; Milovic V, 2001, EUR J GASTROEN HEPAT, V13, P1021, DOI 10.1097/00042737-200109000-00004; Minois N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.139; Minois N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102435; Morselli E, 2011, J CELL BIOL, V192, P615, DOI 10.1083/jcb.201008167; Nishimura K, 2006, J BIOCHEM, V139, P81, DOI 10.1093/jb/mvj003; Nishimura K, 2009, J PARASITOL, V95, P781, DOI 10.1645/GE-1883.1; Noro T, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.93; Noro T, 2015, INVEST OPHTH VIS SCI, V56, P5012, DOI 10.1167/iovs.15-17142; Nowotarski SL, 2013, EXPERT REV MOL MED, V15, DOI 10.1017/erm.2013.3; Oehme I, 2013, P NATL ACAD SCI USA, V110, pE2592, DOI 10.1073/pnas.1300113110; Ost M, 2015, FASEB J, V29, P1314, DOI 10.1096/fj.14-261503; Pan XB, 2016, NEUROBIOL AGING, V38, P151, DOI 10.1016/j.neurobiolaging.2015.11.014; Park MH, 2013, BIOMOL THER, V21, P1, DOI 10.4062/biomolther.2012.097; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pegg AE, 2016, J BIOL CHEM, V291, P14904, DOI 10.1074/jbc.R116.731661; Pegg AE, 2009, IUBMB LIFE, V61, P880, DOI 10.1002/iub.230; Phadwal K, 2012, AUTOPHAGY, V8, P677, DOI 10.4161/auto.18935; Phan Nguyen Thanh Binh, 2010, Health, V2, P1390, DOI 10.4236/health.2010.212206; Pietrocola F, 2015, CELL DEATH DIFFER, V22, P509, DOI 10.1038/cdd.2014.215; Pietrocola F, 2016, CANCER CELL, V30, P147, DOI 10.1016/j.ccell.2016.05.016; Pietrocola F, 2015, CELL METAB, V21, P805, DOI 10.1016/j.cmet.2015.05.014; Pietrocola F, 2014, CELL CYCLE, V13, P1987, DOI 10.4161/cc.28929; Pless M, 2004, CLIN CANCER RES, V10, P1299, DOI 10.1158/1078-0432.CCR-0977-03; Pucciarelli S, 2012, REJUV RES, V15, P590, DOI 10.1089/rej.2012.1349; Puleston DJ, 2015, MICROB CELL, V2, P91, DOI 10.15698/mic2015.03.195; Puleston DJ, 2014, ELIFE, V3, DOI 10.7554/eLife.03706; Qi YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24700; Ramot Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022564; Rao S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4056; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Sadasivan SK, 2014, EUR J PHARMACOL, V729, P94, DOI 10.1016/j.ejphar.2014.01.073; Sahin E, 2014, J IMMUNOL, V193, P1717, DOI 10.4049/jimmunol.1302167; Sansbury BE, 2014, CIRC-HEART FAIL, V7, P634, DOI 10.1161/CIRCHEARTFAILURE.114.001151; SAURA J, 1994, NEUROSCIENCE, V62, P15, DOI 10.1016/0306-4522(94)90311-5; SCALABRINO G, 1984, MECH AGEING DEV, V26, P149, DOI 10.1016/0047-6374(84)90090-3; Schwarz C, 2018, AGING-US, V10, P19, DOI 10.18632/aging.101354; Sebti S, 2014, P NATL ACAD SCI USA, V111, P4115, DOI 10.1073/pnas.1313618111; SHIN WW, 1985, J NEUROCHEM, V44, P1056, DOI 10.1111/j.1471-4159.1985.tb08724.x; Soda K, 2005, J IMMUNOL, V175, P237, DOI 10.4049/jimmunol.175.1.237; Soda K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064357; Soda Kuniyasu, 2012, Glob J Health Sci, V4, P170, DOI 10.5539/gjhs.v4n6p170; Soda K, 2009, EXP GERONTOL, V44, P727, DOI 10.1016/j.exger.2009.08.013; Soda K, 2009, J NUTR SCI VITAMINOL, V55, P361, DOI 10.3177/jnsv.55.361; Takeuchi T, 2017, J BIOL CHEM, V292, P3909, DOI 10.1074/jbc.M116.756197; Vacchelli E, 2015, SCIENCE, V350, P972, DOI 10.1126/science.aad0779; Vargas AJ, 2015, AM J CLIN NUTR, V102, P411, DOI 10.3945/ajcn.114.103895; Vargas AJ, 2012, AM J CLIN NUTR, V96, P133, DOI 10.3945/ajcn.111.030353; Velloso NA, 2009, NEUROBIOL LEARN MEM, V92, P574, DOI 10.1016/j.nlm.2009.07.006; Wang IF, 2012, P NATL ACAD SCI USA, V109, P15024, DOI 10.1073/pnas.1206362109; Wing RR, 2005, AM J CLIN NUTR, V82, p222S, DOI 10.1093/ajcn/82.1.222S; Yamamoto T, 2012, BRIT J PHARMACOL, V166, P1084, DOI 10.1111/j.1476-5381.2012.01856.x; Yang Q, 2016, CELL DEATH DIFFER, V23, P1850, DOI 10.1038/cdd.2016.71; Yue F, 2017, CANCER RES, V77, P2938, DOI 10.1158/0008-5472.CAN-16-3462; Zhang C, 2008, NAT MED, V14, P959, DOI 10.1038/nm.1851; Zhang Y, 2017, NEUROL RES, V39, P248, DOI 10.1080/01616412.2017.1283830; Zhong Z, 2016, CLIN EXP RHEUMATOL, V34, pS12; Zhu S, 2009, MOL MED, V15, P275, DOI 10.2119/molmed.2009.00062; Zoumas-Morse C, 2007, J AM DIET ASSOC, V107, P1024, DOI 10.1016/j.jada.2007.03.012; Zwighaft Z, 2015, CELL METAB, V22, P874, DOI 10.1016/j.cmet.2015.09.011	131	393	410	22	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					410	+	eaan2788	10.1126/science.aan2788	http://dx.doi.org/10.1126/science.aan2788			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6SD	29371440				2022-12-28	WOS:000423283200036
J	Green, DR				Green, Douglas R.			An Element of Life	CELL			English	Editorial Material							SELENOCYSTEINE; FERROPTOSIS; GENE	While it has been known for decades that the essential function of selenium was in the form of its incorporation as selenocysteine into selenoproteins-including the enzyme glutathione peroxidase-4-now, Ingold et al. (2018) reveal the precise role of selenolate-based catalysis by this enzyme.	[Green, Douglas R.] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Green, DR (corresponding author), St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA.	douglas.green@stjude.org	Green, Douglas R/N-8083-2018	Green, Douglas R/0000-0002-7332-1417	NATIONAL CANCER INSTITUTE [R01CA169291] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA169291] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BOCK A, 1991, MOL MICROBIOL, V5, P515, DOI 10.1111/j.1365-2958.1991.tb00722.x; Bosl MR, 1997, P NATL ACAD SCI USA, V94, P5531, DOI 10.1073/pnas.94.11.5531; Hangauer MJ, 2017, NATURE, V551, P247, DOI 10.1038/nature24297; Ingold I, 2018, CELL, V172, P409, DOI 10.1016/j.cell.2017.11.048; Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049; Rose AH, 2015, THROMB HAEMOSTASIS, V113, P494, DOI 10.1160/TH14-07-0603; Stockwell BR, 2017, CELL, V171, P273, DOI 10.1016/j.cell.2017.09.021	9	14	14	1	39	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2018	172	3					389	390		10.1016/j.cell.2018.01.003	http://dx.doi.org/10.1016/j.cell.2018.01.003			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FT9BS	29373826	Bronze			2022-12-28	WOS:000423447600001
J	Tzoneva, G; Dieck, CL; Oshima, K; Ambesi-Impiombato, A; Sanchez-Martin, M; Madubata, CJ; Khiabanian, H; Yu, JY; Waanders, E; Iacobucci, I; Sulis, ML; Kato, M; Koh, K; Paganin, M; Basso, G; Gastier-Foster, JM; Loh, ML; Kirschner-Schwabe, R; Mullighan, CG; Abadan, RR; Ferrando, AA				Tzoneva, Gannie; Dieck, Chelsea L.; Oshima, Koichi; Ambesi-Impiombato, Alberto; Sanchez-Martin, Marta; Madubata, Chioma J.; Khiabanian, Hossein; Yu, Jiangyan; Waanders, Esme; Iacobucci, Ilaria; Sulis, Maria Luisa; Kato, Motohiro; Koh, Katsuyoshi; Paganin, Maddalena; Basso, Giuseppe; Gastier-Foster, Julie M.; Loh, Mignon L.; Kirschner-Schwabe, Renate; Mullighan, Charles G.; Abadan, Raul R.; Ferrando, Adolfo A.			Clonal evolution mechanisms in NT5C2 mutant/relapsed acute lymphoblastic leukaemia	NATURE			English	Article							PYRIMIDINE HOMEOSTASIS; CREBBP MUTATIONS; CELL; RESISTANCE; RELAPSE; 5'-NUCLEOTIDASE; METABOLISM; EXPRESSION; ORIGINS	Relapsed acute lymphoblastic leukaemia (ALL) is associated with resistance to chemotherapy and poor prognosis1. Gain-of-function mutations in the 5'-nucleotidase, cytosolic II (NT5C2) gene induce resistance to 6-mercaptopurine and are selectively present in relapsed ALL2,3. Yet, the mechanisms involved in NT5C2 mutation-driven clonal evolution during the initiation of leukaemia, disease progression and relapse remain unknown. Here we use a conditional-and-inducible leukaemia model to demonstrate that expression of NT5C2(R367Q), a highly prevalent relapsed-ALL NT5C2 mutation, induces resistance to chemotherapy with 6-mercaptopurine at the cost of impaired leukaemia cell growth and leukaemia-initiating cell activity. The loss-of-fitness phenotype of NT5C2+/R367Q mutant cells is associated with excess export of purines to the extracellular space and depletion of the intracellular purine-nucleotide pool. Consequently, blocking guanosine synthesis by inhibition of inosine-5'-monophosphate dehydrogenase (IMPDH) induced increased cytotoxicity against NT5C2-mutant leukaemia lymphoblasts. These results identify the fitness cost of NT5C2 mutation and resistance to chemotherapy as key evolutionary drivers that shape clonal evolution in relapsed ALL and support a role for IMPDH inhibition in the treatment of ALL.	[Tzoneva, Gannie; Dieck, Chelsea L.; Oshima, Koichi; Ambesi-Impiombato, Alberto; Sanchez-Martin, Marta; Ferrando, Adolfo A.] Columbia Univ, Inst Canc Genet, New York, NY 10032 USA; [Madubata, Chioma J.; Abadan, Raul R.; Ferrando, Adolfo A.] Columbia Univ, Dept Syst Biol, New York, NY 10032 USA; [Khiabanian, Hossein] Rutgers State Univ, Rutgers Canc Inst, New Brunswick, NJ 08903 USA; [Yu, Jiangyan; Waanders, Esme] Princess Maxima Ctr Pediat Oncol, NL-3584 CT Utrecht, Netherlands; [Yu, Jiangyan] Radboud Univ Nijmegen, Med Ctr, Dept Human Genet, NL-6525 GA Nijmegen, Netherlands; [Yu, Jiangyan] Radboud Inst Mol Life Sci, NL-6525 GA Nijmegen, Netherlands; [Iacobucci, Ilaria; Mullighan, Charles G.] St Jude Childrens Res Hosp, Dept Pathol, 332 N Lauderdale St, Memphis, TN 38105 USA; [Sulis, Maria Luisa; Ferrando, Adolfo A.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10032 USA; [Kato, Motohiro; Koh, Katsuyoshi] Saitama Childrens Med Ctr, Dept Hematol Oncol, Saitama 3398551, Japan; [Paganin, Maddalena; Basso, Giuseppe] Univ Padua, Oncohematol Div, Dept SDB, I-35128 Padua, Italy; [Gastier-Foster, Julie M.] Nationwide Childrens Hosp, Dept Pathol & Lab Med, Columbus, OH 43205 USA; [Gastier-Foster, Julie M.] Ohio State Univ, Dept Pathol, Sch Med, Columbus, OH 43210 USA; [Gastier-Foster, Julie M.] Ohio State Univ, Dept Pediat, Sch Med, Columbus, OH 43210 USA; [Gastier-Foster, Julie M.] Childrens Oncol Grp, Arcadia, CA 91006 USA; [Loh, Mignon L.] Univ Calif San Francisco, Dept Pediat, San Francisco, CA 94143 USA; [Loh, Mignon L.] Helen Diller Family Comprehens Canc Ctr, San Francisco, CA 94115 USA; [Kirschner-Schwabe, Renate] Charite, Dept Pediat Oncol Hematol, D-10117 Berlin, Germany; [Abadan, Raul R.] Columbia Univ, Dept Biomed Informat, New York, NY 10032 USA; [Ferrando, Adolfo A.] Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10032 USA; [Tzoneva, Gannie] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA; [Ambesi-Impiombato, Alberto] PsychoGenics, Paramus, NJ 07652 USA	Columbia University; Columbia University; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers Cancer Institute of New Jersey; Radboud University Nijmegen; St Jude Children's Research Hospital; Columbia University; Saitama Children's Medical Center; University of Padua; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Children's Oncology Group (COG); University of California System; University of California San Francisco; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Helen Diller Family Comprehensive Cancer Center; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Columbia University; Columbia University; Regeneron	Ferrando, AA (corresponding author), Columbia Univ, Inst Canc Genet, New York, NY 10032 USA.; Ferrando, AA (corresponding author), Columbia Univ, Dept Syst Biol, New York, NY 10032 USA.; Ferrando, AA (corresponding author), Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10032 USA.; Ferrando, AA (corresponding author), Columbia Univ, Dept Pathol & Cell Biol, Med Ctr, New York, NY 10032 USA.	af2196@columbia.edu	Khiabanian, Hossein/N-7207-2019; Rabadan, Raul/AAZ-7367-2020; Oshima, Koichi/AAT-5670-2020; Mullighan, Charles/H-3253-2011	Khiabanian, Hossein/0000-0003-1446-4394; Mullighan, Charles/0000-0002-1871-1850; Kirschner-Schwabe, Renate/0000-0001-6335-3274; Kato, Motohiro/0000-0001-5145-1774; BASSO, GIUSEPPE/0000-0002-2634-9302; Tzoneva, Gannie/0000-0001-5784-7796; Rabadan, Raul/0000-0001-7946-9255	Leukemia & Lymphoma Society Quest for Cures award [R0749-14]; Alex Lemonade Stand Foundation; Chemotherapy Foundation; National Institutes of Health (NIH) [R35 CA210065, R01 CA206501, U54 CA193313, R01 CA185486, U54 CA209997, U10 CA98543, P30 CA013696]; Human Specimen Banking Grant [U24 CA114766]; Stewart Foundation; American Lebanese Syrian Associated Charities of St Jude Children's Research Hospital; HHMI International Student Research Fellowship; Rally Foundation fellowship; NIH/NCI [T32-CA09503]; China Scholarship Council [CSC 201304910347]; Ter Meulen Grant of the Royal Netherlands Academy of Arts and Sciences; Dutch Cancer Society [KUN2012-5366]; Leukemia & Lymphoma Society Translational Research award [6455-15, 6531-18]; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA216981, R01CA200651, T32CA009503, F31CA210607, U10CA098543, U54CA209997, P30CA013696, R01CA185486, U54CA193313, P30CA021765, R35CA210065, U24CA114766] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008224] Funding Source: NIH RePORTER	Leukemia & Lymphoma Society Quest for Cures award; Alex Lemonade Stand Foundation; Chemotherapy Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Human Specimen Banking Grant; Stewart Foundation; American Lebanese Syrian Associated Charities of St Jude Children's Research Hospital(American Lebanese Syrian Associated Charities (ALSAC)); HHMI International Student Research Fellowship; Rally Foundation fellowship; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); China Scholarship Council(China Scholarship Council); Ter Meulen Grant of the Royal Netherlands Academy of Arts and Sciences; Dutch Cancer Society(KWF Kankerbestrijding); Leukemia & Lymphoma Society Translational Research award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to R. Kopan for the Delta E -NOTCH1 construct and T. Ludwig for the ROSA26<SUP>Cre-ERT2/+</SUP> mouse. This work was supported by the Leukemia & Lymphoma Society Quest for Cures (R0749-14) and Translational Research (6455-15; 6531-18) awards (A.A.F.), an Innovative Research Award from the Alex Lemonade Stand Foundation (A.A.F.), the Chemotherapy Foundation (A.A.F.), National Institutes of Health (NIH) grants R35 CA210065 (A.A.F.), R01 CA206501 (A.A.F.), U54 CA193313 (R.R.), R01 CA185486 (R.R.), U54 CA209997 (R.R.), U10 CA98543 (J.M.G., M.L.L.), P30 CA013696, the Human Specimen Banking Grant U24 CA114766 (J.M.G.), the Stewart Foundation (R. R.) and the American Lebanese Syrian Associated Charities of St Jude Children's Research Hospital. G.T. was supported by a HHMI International Student Research Fellowship. M.S.M. was supported by a Rally Foundation fellowship. C.L.D. was supported by NIH/NCI T32-CA09503. J.Y. was supported by the China Scholarship Council (CSC 201304910347) and the Ter Meulen Grant of the Royal Netherlands Academy of Arts and Sciences. E.W. was supported by the Dutch Cancer Society (KUN2012-5366).	Andersson DI, 2010, NAT REV MICROBIOL, V8, P260, DOI 10.1038/nrmicro2319; Brouwer C, 2005, CLIN CHIM ACTA, V361, P95, DOI 10.1016/j.cccn.2005.05.006; Clappier E, 2011, J EXP MED, V208, P653, DOI 10.1084/jem.20110105; Cox CV, 2009, BLOOD, V113, P3287, DOI 10.1182/blood-2008-04-154187; Ferrando AA, 2017, NAT MED, V23, P1135, DOI 10.1038/nm.4410; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Gan L, 2003, BIOCHEMISTRY-US, V42, P857, DOI 10.1021/bi0271401; Gazziola C, 2001, J BIOL CHEM, V276, P6185, DOI 10.1074/jbc.M007623200; Gerby B, 2011, LEUKEMIA, V25, P1249, DOI 10.1038/leu.2011.93; Greaves M, 2012, NATURE, V481, P306, DOI 10.1038/nature10762; Guo KY, 2007, ENDOCRINOLOGY, V148, P3987, DOI 10.1210/en.2007-0261; Hawkins ED, 2016, NATURE, V538, P518, DOI 10.1038/nature19801; Herranz D, 2015, NAT MED, V21, P1182, DOI 10.1038/nm.3955; Herranz D, 2014, NAT MED, V20, P1130, DOI 10.1038/nm.3665; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hunger SP, 2015, NEW ENGL J MED, V373, P1541, DOI 10.1056/NEJMra1400972; Iacobucci I, 2016, CANCER CELL, V29, P186, DOI 10.1016/j.ccell.2015.12.013; Kennedy SR, 2014, NAT PROTOC, V9, P2586, DOI 10.1038/nprot.2014.170; Kimbrel EA, 2009, BLOOD, V114, P4804, DOI 10.1182/blood-2009-04-217794; Konopleva M, 2002, LEUKEMIA, V16, P1713, DOI 10.1038/sj.leu.2402608; Li BS, 2015, NAT MED, V21, P563, DOI 10.1038/nm.3840; Ma XT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7604; Malinowska-Ozdowy K, 2015, LEUKEMIA, V29, P1656, DOI 10.1038/leu.2015.107; Meyer JA, 2013, NAT GENET, V45, P290, DOI 10.1038/ng.2558; Mullighan CG, 2008, SCIENCE, V322, P1377, DOI 10.1126/science.1164266; Mullighan CG, 2011, NATURE, V471, P235, DOI 10.1038/nature09727; Oshima K, 2016, P NATL ACAD SCI USA, V113, P11306, DOI 10.1073/pnas.1608420113; Palomero T, 2006, LEUKEMIA, V20, P1279, DOI 10.1038/sj.leu.2404258; Reaves ML, 2013, NATURE, V500, P237, DOI 10.1038/nature12445; Schmitt MW, 2012, P NATL ACAD SCI USA, V109, P14508, DOI 10.1073/pnas.1208715109; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Ser Z, 2016, CELL REP, V15, P2367, DOI 10.1016/j.celrep.2016.05.035; Shlush LI, 2017, NATURE, V547, P104, DOI 10.1038/nature22993; SPYCHALA J, 1988, J BIOL CHEM, V263, P18759; Tzoneva G, 2013, NAT MED, V19, P368, DOI 10.1038/nm.3078; Van Vlierberghe P, 2012, J CLIN INVEST, V122, P3398, DOI 10.1172/JCI61269; Wang J, 2014, ELIFE, V3, DOI 10.7554/eLife.03496; Wong TN, 2016, BLOOD, V127, P893, DOI 10.1182/blood-2015-10-677021; Zhang JH, 2011, BLOOD, V118, P3080, DOI 10.1182/blood-2011-03-341412	39	72	74	1	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2018	553	7689					511	+		10.1038/nature25186	http://dx.doi.org/10.1038/nature25186			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU6OE	29342136	Green Accepted, Green Submitted			2022-12-28	WOS:000423971100042
J	Cestari, DM; Cunnane, ME; Rizzo, JF; Stone, JH				Cestari, Dean M.; Cunnane, Mary E.; Rizzo, Joseph F., III; Stone, John H.			Case 2-2018: A 41-Year-Old Woman with Vision Disturbances and Headache	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDIOPATHIC INTRACRANIAL HYPERTENSION; OPTIC DISK EDEMA; PRESSURE; PATHOGENESIS; EXPERIENCE	A 41-year-old woman with systemic lupus erythematosus presented with worsening headache, pulsatile tinnitus, and transient vision loss. Ophthalmologic examination revealed bilateral optic-disk edema with splinter and subretinal hemorrhages. A diagnosis was made.	[Cestari, Dean M.; Rizzo, Joseph F., III] Massachusetts Eye & Ear, Dept Ophthalmol, Boston, MA 02114 USA; [Cunnane, Mary E.] Massachusetts Eye & Ear, Dept Radiol, Boston, MA USA; [Stone, John H.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Cestari, Dean M.; Rizzo, Joseph F., III] Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA; [Cunnane, Mary E.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Stone, John H.] Harvard Med Sch, Dept Med, Boston, MA USA	Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts Eye & Ear Infirmary; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Cestari, DM (corresponding author), Massachusetts Eye & Ear, Dept Ophthalmol, Boston, MA 02114 USA.; Cestari, DM (corresponding author), Harvard Med Sch, Dept Ophthalmol, Boston, MA 02115 USA.				Roche-Genentech; Xencor	Roche-Genentech(Roche HoldingGenentech); Xencor	Dr. Stone reports receiving grant support and consulting fees from Roche-Genentech and Xencor. No other potential conflict of interest relevant to this article was reported.	Binder DK, 2004, NEUROSURGERY, V54, P538, DOI 10.1227/01.NEU.0000109042.87246.3C; Dave Sarita, 2008, Semin Ophthalmol, V23, P127, DOI 10.1080/08820530801888188; Friedman DI, 2004, J NEURO-OPHTHALMOL, V24, P138, DOI 10.1097/00041327-200406000-00009; Friedman DI, 2002, NEUROLOGY, V59, P1492, DOI 10.1212/01.WNL.0000029570.69134.1B; Hale N, 2014, MED CLIN N AM, V98, P505, DOI 10.1016/j.mcna.2014.01.006; HAYREH MS, 1977, ARCH OPHTHALMOL-CHIC, V95, P1237, DOI 10.1001/archopht.1977.04450070135013; HAYREH SS, 1977, ARCH OPHTHALMOL-CHIC, V95, P1566, DOI 10.1001/archopht.1977.04450090088007; HAYREH SS, 1977, ARCH OPHTHALMOL-CHIC, V95, P1553, DOI 10.1001/archopht.1977.04450090075006; Hershko AY, 2008, SEMIN ARTHRITIS RHEU, V38, P110, DOI 10.1016/j.semarthrit.2007.09.007; Morris PP, 2017, AM J NEURORADIOL, V38, P471, DOI 10.3174/ajnr.A5055; SADUN AA, 1984, ANN NEUROL, V16, P489, DOI 10.1002/ana.410160410; Sismanis A, 1998, AM J OTOL, V19, P472	12	2	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2018	378	3					282	289		10.1056/NEJMcpc1701763	http://dx.doi.org/10.1056/NEJMcpc1701763			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT1IJ	29342391				2022-12-28	WOS:000422888400013
J	Voelker, R				Voelker, Rebecca			Monthly Buprenorphine Injection Approved for Opioid Use Disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2018	319	3					220	220		10.1001/jama.2017.20647	http://dx.doi.org/10.1001/jama.2017.20647			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT3BY	29340663				2022-12-28	WOS:000423022300007
J	Georges, A				Georges, Antoine			Coherent excitations revealed and calculated	SCIENCE			English	Editorial Material							INFINITE DIMENSIONS; HUBBARD-MODEL; LATTICE		[Georges, Antoine] Coll France, 11 Pl Marcelin Berthelot, F-75005 Paris, France; [Georges, Antoine] Flatiron Inst, Ctr Computat Quantum Phys, 162 Fifth Ave, New York, NY 10010 USA; [Georges, Antoine] Univ Paris Saclay, CNRS, Ctr Phys Theor, Ecole Polytech, F-91128 Palaiseau, France; [Georges, Antoine] Univ Geneva, DQMP, 24 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland	UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; UDICE-French Research Universities; Universite Paris Saclay; University of Geneva	Georges, A (corresponding author), Coll France, 11 Pl Marcelin Berthelot, F-75005 Paris, France.; Georges, A (corresponding author), Flatiron Inst, Ctr Computat Quantum Phys, 162 Fifth Ave, New York, NY 10010 USA.; Georges, A (corresponding author), Univ Paris Saclay, CNRS, Ctr Phys Theor, Ecole Polytech, F-91128 Palaiseau, France.; Georges, A (corresponding author), Univ Geneva, DQMP, 24 Quai Ernest Ansermet, CH-1211 Geneva, Switzerland.	antoine.georges@polytechnique.edu	Georges, Antoine/H-4855-2012	Georges, Antoine/0000-0001-9479-9682				Burdin S, 2000, PHYS REV LETT, V85, P1048, DOI 10.1103/PhysRevLett.85.1048; Coleman P., 2007, HEAVY FERMIONS ELECT; Georges A, 1996, REV MOD PHYS, V68, P13, DOI 10.1103/RevModPhys.68.13; GEORGES A, 1992, PHYS REV B, V45, P6479, DOI 10.1103/PhysRevB.45.6479; Goremychkin EA, 2018, SCIENCE, V359, P186, DOI 10.1126/science.aan0593; Hewson A C, 1993, KONDO PROBLEM HEAVY; Hoffman JE, 2002, SCIENCE, V297, P1148, DOI 10.1126/science.1072640; JARRELL M, 1992, PHYS REV LETT, V69, P168, DOI 10.1103/PhysRevLett.69.168; Kunes J, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.085102; Lin N, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.106401; METZNER W, 1989, PHYS REV LETT, V62, P324, DOI 10.1103/PhysRevLett.62.324; Park H, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.137007; Rohringer G, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.125114	13	0	0	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					162	163		10.1126/science.aar2325	http://dx.doi.org/10.1126/science.aar2325			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS5EO	29326262				2022-12-28	WOS:000419816600024
J	Ashley, J; Cordy, B; Lucia, D; Fradkin, LG; Budnik, V; Thomson, T				Ashley, James; Cordy, Benjamin; Lucia, Diandra; Fradkin, Lee G.; Budnik, Vivian; Thomson, Travis			Retrovirus-like Gag Protein Arc1 Binds RNA and Traffics across Synaptic Boutons	CELL			English	Article							DROSOPHILA; GENE; LOCALIZATION; PLASTICITY; MUTATIONS; STABILITY; ALIGNMENT; MEMBRANE	Arc/Arg3.1 is required for synaptic plasticity and cognition, and mutations in this gene are linked to autism and schizophrenia. Arc bears a domain resembling retroviral/retrotransposon Gag-like proteins, which multimerize into a capsid that packages viral RNA. The significance of such a domain in a plasticity molecule is uncertain. Here, we report that the Drosophila Arc1 protein forms capsid-like structures that bind darc1 mRNA in neurons and is loaded into extracellular vesicles that are transferred from motorneurons to muscles. This loading and transfer depends on the darc1-mRNA 3' untranslated region, which contains retrotransposon-like sequences. Disrupting transfer blocks synaptic plasticity, suggesting that transfer of dArc1 complexed with its mRNA is required for this function. Notably, cultured cells also release extracellular vesicles containing the Gag region of the Copia retrotransposon complexed with its own mRNA. Taken together, our results point to a trans-synaptic mRNA transport mechanism involving retrovirus-like capsids and extracellular vesicles.	[Ashley, James; Cordy, Benjamin; Lucia, Diandra; Fradkin, Lee G.; Budnik, Vivian; Thomson, Travis] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Budnik, V; Thomson, T (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA.	vivian.budnik@umassmed.edu; travis.thomson@umassmed.edu		Ashley, James/0000-0002-6693-1014	NIH [R37MH070000]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070000, R37MH070000] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [P40OD018537] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank the Bloomington Drosophila Stock Center and flybase (NIH P40OD018537) for providing stocks and managing the fly database and the Vienna Drosophila Resource Center (VDRC). We thank Melissa Moore for valuable discussions and methodological guidance, Emiliano Riccio for help in library preparation in the initial stages of this project, and Franz Wendler for exosome preparation. We also thank Jason Shepherd for helpful discussions. This work was supported by NIH grant R37MH070000 to V.B.	Abrusan G, 2013, NUCLEIC ACIDS RES, V41, P3190, DOI 10.1093/nar/gkt011; Alenquer M, 2015, VIRUSES-BASEL, V7, P5066, DOI 10.3390/v7092862; Alhowikan AM, 2016, MED PRIN PRACT, V25, P350, DOI 10.1159/000445351; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Ataman B, 2006, P NATL ACAD SCI USA, V103, P7841, DOI 10.1073/pnas.0600387103; Berkovits BD, 2015, NATURE, V522, P363, DOI 10.1038/nature14321; Budnik V, 1996, CURR OPIN NEUROBIOL, V6, P858, DOI 10.1016/S0959-4388(96)80038-9; Budnik V, 1996, NEURON, V17, P627, DOI 10.1016/S0896-6273(00)80196-8; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Campillos M, 2006, TRENDS GENET, V22, P585, DOI 10.1016/j.tig.2006.09.006; Cao C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001478; Chen B, 2016, BIOCHEMISTRY-US, V55, P2539, DOI 10.1021/acs.biochem.6b00159; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Comas-Garcia M, 2016, VIRUSES-BASEL, V8, DOI 10.3390/v8090246; Deutsch EW, 2017, NUCLEIC ACIDS RES, V45, pD1100, DOI 10.1093/nar/gkw936; Farris S, 2014, J NEUROSCI, V34, P4481, DOI 10.1523/JNEUROSCI.4944-13.2014; Faure J, 2006, MOL CELL NEUROSCI, V31, P642, DOI 10.1016/j.mcn.2005.12.003; Fromer M, 2014, NATURE, V506, P179, DOI 10.1038/nature12929; Fruhbeis C, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001604; Gratz SJ, 2014, GENETICS, V196, P961, DOI 10.1534/genetics.113.160713; Harris KP, 2016, J NEUROSCI, V36, P5820, DOI 10.1523/JNEUROSCI.4279-15.2016; JAN LY, 1982, P NATL ACAD SCI-BIOL, V79, P2700, DOI 10.1073/pnas.79.8.2700; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koh YH, 1999, CELL, V98, P353, DOI 10.1016/S0092-8674(00)81964-9; Koles K, 2012, J BIOL CHEM, V287, P16820, DOI 10.1074/jbc.M112.342667; Korkut C, 2013, NEURON, V77, P1039, DOI 10.1016/j.neuron.2013.01.013; Korkut C, 2009, CELL, V139, P393, DOI 10.1016/j.cell.2009.07.051; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lefebvre FA, 2016, SCI REP-UK, V6, DOI 10.1038/srep27680; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mattaliano MD, 2007, MOL CELL NEUROSCI, V36, P211, DOI 10.1016/j.mcn.2007.06.008; Meckes DG, 2015, J VIROL, V89, P5200, DOI 10.1128/JVI.02470-14; Myrum C, 2015, BIOCHEM J, V468, P145, DOI 10.1042/BJ20141446; Nallamsetty S, 2005, PROTEIN SCI, V14, P2964, DOI 10.1110/ps.051718605; Nefedova LN, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9040081; Nishida KM, 2013, MOL CELL, V49, P680, DOI 10.1016/j.molcel.2012.12.024; Pastuzyn ED, 2018, CELL, V172, P275, DOI 10.1016/j.cell.2017.12.024; Peebles CL, 2010, P NATL ACAD SCI USA, V107, P18173, DOI 10.1073/pnas.1006546107; Port F, 2016, METHODS MOL BIOL, V1478, P145, DOI 10.1007/978-1-4939-6371-3_7; Ramachandran P, 2009, DEV NEUROBIOL, V69, P583, DOI 10.1002/dneu.20728; Roberts A, 2013, NAT METHODS, V10, P71, DOI [10.1038/NMETH.2251, 10.1038/nmeth.2251]; Satoh AK, 2005, DEVELOPMENT, V132, P1487, DOI 10.1242/dev.01704; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Speese SD, 2012, CELL, V149, P832, DOI 10.1016/j.cell.2012.03.032; STEWART BA, 1994, J COMP PHYSIOL A, V175, P179, DOI 10.1007/BF00215114; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Viola H, 2014, PROG MOL BIOL TRANSL, V122, P391, DOI 10.1016/B978-0-12-420170-5.00013-1; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Zhang WC, 2015, NEURON, V86, P490, DOI 10.1016/j.neuron.2015.03.030	51	203	207	5	81	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					262	+		10.1016/j.cell.2017.12.022	http://dx.doi.org/10.1016/j.cell.2017.12.022			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29328915	Bronze, Green Accepted			2022-12-28	WOS:000419840100024
J	Christ, A; Gunther, P; Lauterbach, MAR; Duewell, P; Biswas, D; Pelka, K; Scholz, CJ; Oosting, M; Haendler, K; Bassler, K; Klee, K; Schulte-Schrepping, J; Ulas, T; Moorlag, SJCFM; Kumar, V; Park, MH; Joosten, LAB; Groh, LA; Riksen, NP; Espevik, T; Schlitzer, A; Li, Y; Fitzgerald, ML; Netea, MG; Schultze, JL; Latz, E				Christ, Anette; Guenther, Patrick; Lauterbach, Mario A. R.; Duewell, Peter; Biswas, Debjani; Pelka, Karin; Scholz, Claus J.; Oosting, Marije; Haendler, Kristian; Bassler, Kevin; Klee, Kathrin; Schulte-Schrepping, Jonas; Ulas, Thomas; Moorlag, Simone J. C. F. M.; Kumar, Vinod; Park, Min Hi; Joosten, Leo A. B.; Groh, Laszlo A.; Riksen, Niels P.; Espevik, Terje; Schlitzer, Andreas; Li, Yang; Fitzgerald, Michael L.; Netea, Mihai G.; Schultze, Joachim L.; Latz, Eicke			Western Diet Triggers NLRP3-Dependent Innate Immune Reprogramming	CELL			English	Article							STEM-CELL PROLIFERATION; HEMATOPOIETIC STEM; FAMILIAL HYPERCHOLESTEROLEMIA; MYOCARDIAL-INFARCTION; NLRP3 INFLAMMASOME; NALP3 INFLAMMASOME; GENE-EXPRESSION; ATHEROSCLEROSIS; DISEASE; INTERLEUKIN-1	Long-term epigenetic reprogramming of innate immune cells in response to microbes, also termed "trained immunity,'' causes prolonged altered cellular functionality to protect from secondary infections. Here, we investigated whether sterile triggers of inflammation induce trained immunity and thereby influence innate immune responses. Western diet (WD) feeding of Ldlr(-/-) mice induced systemic inflammation, which was undetectable in serum soon after mice were shifted back to a chow diet (CD). In contrast, myeloid cell responses toward innate stimuli remained broadly augmented. WD-induced transcriptomic and epigenomic reprogramming of myeloid progenitor cells led to increased proliferation and enhanced innate immune responses. Quantitative trait locus (QTL) analysis in human monocytes trained with oxidized low-density lipoprotein (oxLDL) and stimulated with lipopolysaccharide (LPS) suggested inflammasome-mediated trained immunity. Consistently, Nlrp3(-/-)/Ldlr(-/-) mice lacked WD-induced systemic inflammation, myeloidprogenitor proliferation, and re-programming. Hence, NLRP3 mediates trained immunity following WD and could thereby mediate the potentially deleterious effects of trained immunity in inflammatory diseases.	[Christ, Anette; Lauterbach, Mario A. R.; Latz, Eicke] Univ Bonn, Univ Hosp Bonn, Inst Innate Immun, D-53127 Bonn, Germany; [Christ, Anette; Biswas, Debjani; Latz, Eicke] UMass Med Sch, Dept Infect Dis & Immunol, Worcester, MA 01605 USA; [Guenther, Patrick; Scholz, Claus J.; Haendler, Kristian; Bassler, Kevin; Klee, Kathrin; Schulte-Schrepping, Jonas; Ulas, Thomas; Schlitzer, Andreas; Netea, Mihai G.; Schultze, Joachim L.] Univ Bonn, Life & Med Sci Inst LIMES, Dept Genom & Immunoregulat & Myeloid Cell, D-53115 Bonn, Germany; [Duewell, Peter] Klinikum Univ Munchen, Med Klin & Poliklin 4, Ctr Integrated Prot Sci Munich, D-80337 Munich, Germany; [Duewell, Peter] Klinikum Univ Munchen, Med Klin & Poliklin 4, Div Clin Pharmacol, D-80337 Munich, Germany; [Pelka, Karin] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA; [Oosting, Marije; Moorlag, Simone J. C. F. M.; Joosten, Leo A. B.; Groh, Laszlo A.; Riksen, Niels P.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 GA Nijmegen, Netherlands; [Oosting, Marije; Moorlag, Simone J. C. F. M.; Joosten, Leo A. B.; Groh, Laszlo A.; Riksen, Niels P.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, NL-6525 GA Nijmegen, Netherlands; [Kumar, Vinod; Li, Yang] Univ Groningen, Univ Med Ctr Groningen, Dept Genet, NL-9700 RB Groningen, Netherlands; [Park, Min Hi; Fitzgerald, Michael L.] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Lipid Metab Unit, Boston, MA 02114 USA; [Park, Min Hi] Texas A&M Univ, Irma Lerma Rangel Coll Pharm, Dept Pharmaceut Sci, College Stn, TX 77845 USA; [Espevik, Terje; Latz, Eicke] Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, N-7491 Trondheim, Norway; [Schultze, Joachim L.; Latz, Eicke] German Ctr Neurodegenerat Dis DZNE, D-53127 Bonn, Germany	University of Bonn; University of Massachusetts System; University of Massachusetts Worcester; University of Bonn; University of Munich; University of Munich; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Radboud University Nijmegen; Radboud University Nijmegen; University of Groningen; Harvard University; Harvard Medical School; Massachusetts General Hospital; Texas A&M University System; Texas A&M University College Station; Norwegian University of Science & Technology (NTNU); Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Latz, E (corresponding author), Univ Bonn, Univ Hosp Bonn, Inst Innate Immun, D-53127 Bonn, Germany.; Latz, E (corresponding author), UMass Med Sch, Dept Infect Dis & Immunol, Worcester, MA 01605 USA.; Latz, E (corresponding author), Norwegian Univ Sci & Technol, Ctr Mol Inflammat Res, N-7491 Trondheim, Norway.; Latz, E (corresponding author), German Ctr Neurodegenerat Dis DZNE, D-53127 Bonn, Germany.	eicke.latz@uni-bonn.de	Park, Min Hi/AAL-9880-2020; Li, Yang/HGT-8446-2022; Moorlag, Simone JCFM/F-4519-2018; Latz, Eicke/H-3951-2014; Netea, Mihai/N-5155-2014; Joosten, Leo AB/H-3138-2015; Schultze, Joachim L./ABA-8176-2020; Kumar, Vinod/ABC-4866-2020; Scholz, Claus Jürgen/H-3202-2019; Riksen, Niels P/G-8260-2015; Oosting, Marije/H-7437-2015	Li, Yang/0000-0003-4022-7341; Moorlag, Simone JCFM/0000-0001-8884-8417; Latz, Eicke/0000-0003-1488-5666; Joosten, Leo AB/0000-0001-6166-9830; Schultze, Joachim L./0000-0003-2812-9853; Kumar, Vinod/0000-0002-2775-6049; Scholz, Claus Jürgen/0000-0002-6406-7859; Riksen, Niels P/0000-0001-9197-8124; Duewell, Peter/0000-0003-0836-6448; Gunther, Patrick/0000-0002-9135-7819; Handler, Kristian/0000-0001-5273-5277; Klee, Kathrin/0000-0003-2408-1282	NIH [1R01HL112661, R01HL101274]; DFG [SFB670, TRR 83, 57, SFB1123, SFB645, SFB704]; ERC Consolidator grant (InflammAct); European Union's Horizon research and innovation program [733100, 667837]; Federal Ministry for Economic Affairs and Energy (BMWi Project FASTGENOMICS); ERC Consolidator grant [310372]; Spinoza grant of the Netherlands Organization for Scientific Research (NWO); Netherlands Heart Foundation [2012T051]; IN-CONTROL CVON grant from the Netherlands Heart Foundation [CVON2012-03]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL101274, R01HL131624, R01HL112661] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DFG(German Research Foundation (DFG)); ERC Consolidator grant (InflammAct); European Union's Horizon research and innovation program; Federal Ministry for Economic Affairs and Energy (BMWi Project FASTGENOMICS); ERC Consolidator grant(European Research Council (ERC)); Spinoza grant of the Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Netherlands Heart Foundation(Netherlands Heart Foundation); IN-CONTROL CVON grant from the Netherlands Heart Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	E.L., M.L.F., and A.C. are supported by grants from the NIH (1R01HL112661 and R01HL101274). E.L. is supported by the DFG (SFB670 and TRR 83, 57) and an ERC Consolidator grant (InflammAct). E.L. and P.D. are supported by the DFG (SFB1123). J.L.S. is supported by the DFG (SFB645 and SFB704), the European Union's Horizon 2020 research and innovation program under grant agreement 733100 (SYSCID), and a grant from the Federal Ministry for Economic Affairs and Energy (BMWi Project FASTGENOMICS). E.L. is a cofounder of IFM-Therapeutics and a member of its scientific advisory board. M.G.N. is supported by an ERC Consolidator grant (310372) and a Spinoza grant of the Netherlands Organization for Scientific Research (NWO). N.P.R. is supported by a Dr. Dekker grant from the Netherlands Heart Foundation (2012T051). N.P.R., M.G.N., and L.A.B.J. received funding from the European Union's Horizon 2020 research and innovation program under grant agreement 667837. M.G.N., L.A.B.J., and N.P.R. are supported by the IN-CONTROL CVON grant from the Netherlands Heart Foundation (CVON2012-03). M.G.N., J.L.S., and E.L. are members of the Excellence Cluster ImmunoSensation.	[Anonymous], CELL; Bekkering S, 2018, CELL, V172, P135, DOI 10.1016/j.cell.2017.11.025; Bekkering S, 2014, ARTERIOSCL THROM VAS, V34, P1731, DOI 10.1161/ATVBAHA.114.303887; Boettcher S, 2017, TRENDS IMMUNOL, V38, P345, DOI 10.1016/j.it.2017.01.004; Brasacchio D, 2009, DIABETES, V58, P1229, DOI 10.2337/db08-1666; Cao XT, 2016, NAT REV IMMUNOL, V16, P35, DOI 10.1038/nri.2015.8; CLINTON SK, 1991, AM J PATHOL, V138, P1005; Dorrestein PC, 2014, IMMUNITY, V40, P824, DOI 10.1016/j.immuni.2014.05.015; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; El Messal M, 2006, CLIN CHIM ACTA, V366, P185, DOI 10.1016/j.cca.2005.09.027; FLEET JC, 1992, J NUTR, V122, P294, DOI 10.1093/jn/122.2.294; FRIEDMAN GD, 1974, NEW ENGL J MED, V290, P1275, DOI 10.1056/NEJM197406062902302; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Khera AV, 2016, NEW ENGL J MED, V375, P2349, DOI 10.1056/NEJMoa1605086; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Labzin LI, 2016, J ALLERGY CLIN IMMUN, V138, P37, DOI 10.1016/j.jaci.2016.05.010; Li Y, 2016, NAT MED, V22, P952, DOI 10.1038/nm.4139; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mega JL, 2015, LANCET, V385, P2264, DOI 10.1016/S0140-6736(14)61730-X; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Nagareddy PR, 2014, CELL METAB, V19, P821, DOI 10.1016/j.cmet.2014.03.029; Narverud I, 2011, ATHEROSCLEROSIS, V214, P163, DOI 10.1016/j.atherosclerosis.2010.10.002; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Olsson A, 2016, NATURE, V537, P698, DOI 10.1038/nature19348; Rhoads JP, 2017, J IMMUNOL, V198, P2105, DOI 10.4049/jimmunol.1601563; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Seijkens T, 2014, FASEB J, V28, P2202, DOI 10.1096/fj.13-243105; Sheedy FJ, 2013, NAT IMMUNOL, V14, P812, DOI 10.1038/ni.2639; Singer K, 2014, MOL METAB, V3, P664, DOI 10.1016/j.molmet.2014.06.005; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Swirski FK, 2013, SCIENCE, V339, P161, DOI 10.1126/science.1230719; Thorburn AN, 2014, IMMUNITY, V40, P833, DOI 10.1016/j.immuni.2014.05.014; van Kampen E, 2014, J LEUKOCYTE BIOL, V96, P833, DOI 10.1189/jlb.1A0114-017R; VANDERMEER JWM, 1988, P NATL ACAD SCI USA, V85, P1620; Wang HD, 2016, LANCET, V388, P1459, DOI 10.1016/S0140-6736(16)31012-1; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zimmer S, 2015, CIRC RES, V116, P323, DOI 10.1161/CIRCRESAHA.116.301135	40	457	468	11	160	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					162	+		10.1016/j.cell.2017.12.013	http://dx.doi.org/10.1016/j.cell.2017.12.013			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29328911	Bronze, Green Accepted			2022-12-28	WOS:000419840100017
J	Norman, JE; Stock, SJ				Norman, Jane E.; Stock, Sarah J.			Birth options after a caesarean section	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							VAGINAL BIRTH; NEONATAL-OUTCOMES; DELIVERY; SUCCESS; METAANALYSIS; LABOR		[Norman, Jane E.; Stock, Sarah J.] Univ Edinburgh, MRC Ctr Reprod Hlth, Tommys Ctr Maternal & Fetal Hlth, Edinburgh, Midlothian, Scotland; Royal Infirm Edinburgh NHS Trust, Edinburgh, Midlothian, Scotland	University of Edinburgh; Royal Infirmary of Edinburgh; University of Edinburgh	Norman, JE (corresponding author), Univ Edinburgh, MRC Ctr Reprod Hlth, Tommys Ctr Maternal & Fetal Hlth, Edinburgh, Midlothian, Scotland.	jane.norman@ed.ac.uk		Norman, Jane/0000-0001-6031-6953				Bager P, 2008, CLIN EXP ALLERGY, V38, P634, DOI 10.1111/j.1365-2222.2008.02939.x; Crowther CA, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001192; Dodd JM, 2013, COCHRANE DB SYST REV; Grobman WA, 2007, OBSTET GYNECOL, V109, P806, DOI 10.1097/01.AOG.0000259312.36053.02; Guise JM, 2010, OBSTET GYNECOL, V115, P1267, DOI 10.1097/AOG.0b013e3181df925f; Knight HE, 2014, BJOG-INT J OBSTET GY, V121, P183, DOI 10.1111/1471-0528.12508; Kuhle S, 2015, OBES REV, V16, P295, DOI 10.1111/obr.12267; Landon MB, 2005, AM J OBSTET GYNECOL, V193, P1016, DOI 10.1016/j.ajog.2005.05.066; Macones GA, 2005, AM J OBSTET GYNECOL, V193, P1656, DOI 10.1016/j.ajog.2005.04.002; Marshall NE, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.035; Mylonas I, 2015, DTSCH ARZTEBL INT, V112, P489, DOI 10.3238/arztebl.2015.0489; National Collaborating Centre for Women and Children's Health, 2008, IND LAB CLIN GUID; National Institute for Clinical Excellence, 2011, NICE CLIN GUID; Smith GCS, 2005, PLOS MED, V2, P871, DOI 10.1371/journal.pmed.0020252; Stock SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060404; Tahseen S, 2010, BJOG-INT J OBSTET GY, V117, P5, DOI 10.1111/j.1471-0528.2009.02351.x; Zhang J, 2010, OBSTET GYNECOL, V116, P1281, DOI 10.1097/AOG.0b013e3181fdef6e	17	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 11	2018	360								j5737	10.1136/bmj.j5737	http://dx.doi.org/10.1136/bmj.j5737			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS9NC	29326175	Green Published			2022-12-28	WOS:000422743900012
J	Parrish, NF; Tomonaga, K				Parrish, Nicholas F.; Tomonaga, Keizo			A Viral (Arc)hive for Metazoan Memory	CELL			English	Editorial Material								Arc, a master regulator of synaptic plasticity, contains sequence elements that are evolutionarily related to retrotransposon Gag genes. Two related papers in this issue of Cell show that Arc retains retroviral-like capsid-forming ability and can transmit mRNA between cells in the nervous system, a process that may be important for synaptic function.	[Parrish, Nicholas F.] Vanderbilt Univ, Med Ctr, Sect Surg Sci, Nashville, TN USA; [Tomonaga, Keizo] Kyoto Univ, Inst Frontier Life & Med Sci, Dept Virus Res, Kyoto, Japan; [Tomonaga, Keizo] Kyoto Univ, Grad Sch Biostudies, Dept Mammalian Regulatory Network, Kyoto, Japan	Vanderbilt University; Kyoto University; Kyoto University	Tomonaga, K (corresponding author), Kyoto Univ, Inst Frontier Life & Med Sci, Dept Virus Res, Kyoto, Japan.; Tomonaga, K (corresponding author), Kyoto Univ, Grad Sch Biostudies, Dept Mammalian Regulatory Network, Kyoto, Japan.	tomonaga@infront.kyoto-u.ac.jp		Parrish, Nicholas/0000-0002-6971-8016	Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan [JP16H06429, JP16K21723, JP16H06430]; Japan Agency for Medical Research and Development (AMED) [JP17fm0208014]	Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	K.T. receives research funding support from the Ministry of Education, Culture, Science, Sports, and Technology (MEXT) of Japan (grant no. JP16H06429, JP16K21723 and JP16H06430), and by the Japan Agency for Medical Research and Development (AMED) (grant no. JP17fm0208014).	Ashley J, 2018, CELL, V172, P262, DOI 10.1016/j.cell.2017.12.022; Campillos M, 2006, TRENDS GENET, V22, P585, DOI 10.1016/j.tig.2006.09.006; Grechishnikova D, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3344-4; Imakawa K, 2015, GENES CELLS, V20, P771, DOI 10.1111/gtc.12278; Irie M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005521; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Parrish NF, 2016, CURR OPIN MICROBIOL, V31, P176, DOI 10.1016/j.mib.2016.03.002; Pastuzyn ED, 2018, CELL, V172, P275, DOI 10.1016/j.cell.2017.12.024; Schlesinger S, 2015, MOL CELL BIOL, V35, P770, DOI 10.1128/MCB.01293-14	9	6	7	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					8	10		10.1016/j.cell.2017.12.029	http://dx.doi.org/10.1016/j.cell.2017.12.029			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29328922	Bronze			2022-12-28	WOS:000419840100004
J	Wilt, TJ; Kansagara, D; Qaseem, A				Wilt, Timothy J.; Kansagara, Devan; Qaseem, Amir			Hypertension Limbo: Balancing Benefits, Harms, and Patient Preferences Before We Lower the Bar on Blood Pressure	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							AMERICAN-COLLEGE; OLDER		[Wilt, Timothy J.] Minneapolis VA Hlth Care Syst, 1 Vet Dr,111-0, Minneapolis, MN 55417 USA; [Kansagara, Devan] Portland VA Med Ctr, Mailcode RD71,3710 SW US Vet Hosp Rd, Portland, OR 97239 USA; [Qaseem, Amir] Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center; American College of Physicians	Qaseem, A (corresponding author), Amer Coll Physicians, 190 N Independence Mall West, Philadelphia, PA 19106 USA.	aqaseem@acponline.org						Carey RM, 2018, ANN INTERN MED, V168, P351, DOI 10.7326/M17-3203; Doust J, 2017, JAMA INTERN MED, V177, P1020, DOI 10.1001/jamainternmed.2017.1302; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Hansson L, 1998, LANCET, V351, P1755, DOI 10.1016/S0140-6736(98)04311-6; HAYNES RB, 1978, NEW ENGL J MED, V299, P741, DOI 10.1056/NEJM197810052991403; Lonn EM, 2016, NEW ENGL J MED, V374, P2009, DOI 10.1056/NEJMoa1600175; Qaseem A, 2017, ANN INTERN MED, V166, P430, DOI 10.7326/M16-1785; SPRINT Research Group, 2015, N Engl J Med, V373, P2103, DOI 10.1056/NEJMoa1511939; Wei Y, 2013, J CLIN HYPERTENS, V15, P420, DOI 10.1111/jch.12094; Welch HG, 2011, OVERDIAGNOSED MAKING, P1	10	35	35	1	5	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 6	2018	168	5					369	+		10.7326/M17-3293	http://dx.doi.org/10.7326/M17-3293			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY2GD	29357397				2022-12-28	WOS:000426632600014
J	Wong, YC; Ysselstein, D; Krainc, D				Wong, Yvette C.; Ysselstein, Daniel; Krainc, Dimitri			Mitochondria-lysosome contacts regulate mitochondrial fission via RAB7 GTP hydrolysis	NATURE			English	Article							PARKINSONS-DISEASE; SITES; ER; PROTEINS; DIVISION; ACTIN; NEURODEGENERATION; DYSFUNCTION; ORGANELLES; DYNAMICS	Both mitochondria and lysosomes are essential for maintaining cellular homeostasis, and dysfunction of both organelles has been observed in multiple diseases(1-4). Mitochondria are highly dynamic and undergo fission and fusion to maintain a functional mitochondrial network, which drives cellular metabolism(5). Lysosomes similarly undergo constant dynamic regulation by the RAB7 GTPase(1), which cycles from an active GTP-bound state into an inactive GDP-bound state upon GTP hydrolysis. Here we have identified the formation and regulation of mitochondrialysosome membrane contact sites using electron microscopy, structured illumination microscopy and high spatial and temporal resolution confocal live cell imaging. Mitochondria-lysosome contacts formed dynamically in healthy untreated cells and were distinct from damaged mitochondria that were targeted into lysosomes for degradation(6,7). Contact formation was promoted by active GTP-bound lysosomal RAB7, and contact untethering was mediated by recruitment of the RAB7 GTPase-activating protein TBC1D15 to mitochondria by FIS1 to drive RAB7 GTP hydrolysis and thereby release contacts. Functionally, lysosomal contacts mark sites of mitochondrial fission, allowing regulation of mitochondrial networks by lysosomes, whereas conversely, mitochondrial contacts regulate lysosomal RAB7 hydrolysis via TBC1D15. Mitochondrialysosome contacts thus allow bidirectional regulation of mitochondrial and lysosomal dynamics, and may explain the dysfunction observed in both organelles in various human diseases.	[Wong, Yvette C.; Ysselstein, Daniel; Krainc, Dimitri] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Krainc, D (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA.	dkrainc@nm.org			NCI [CCSG P30 CA060553]; NIH [1S10OD016342-01]; NCRR shared instrumentation grant [S10 RR031680-01]; NIH/NINDS [T32 NS041234, F32 NS101778, R01 NS076054]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031680] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS041234, F32NS101778, R01NS076054] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD016342] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCRR shared instrumentation grant; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank K. Trajkovic and all members of the Krainc laboratory for advice, F. Korobova for electron microscopy assistance and J. Z. Rappoport and D. Kirchenbuechler for N-SIM assistance. All imaging work was performed at the Northwestern University Center for Advanced Microscopy, supported by NCI CCSG P30 CA060553 awarded to the Robert H Lurie Comprehensive Cancer Center. Structured illumination microscopy was performed on a Nikon N-SIM system, purchased with the support of NIH 1S10OD016342-01. The spinning disk confocal system was acquired through a NCRR shared instrumentation grant awarded to V. Gelfand (S10 RR031680-01). TBC1D15 and FIS1 constructs were gifts from N. Ishihara. HCT116 wildtype and knockout cells were gifts from R. Youle. This work was supported by NIH/NINDS grants to Y.C.W. (T32 NS041234 and F32 NS101778) and D.K. (R01 NS076054).	Bajar BT, 2016, SCI REP-UK, V6, DOI 10.1038/srep20889; Burbulla LF, 2017, SCIENCE, V357, P1255, DOI 10.1126/science.aam9080; Burte F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228; Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Daniele T, 2014, CURR BIOL, V24, P393, DOI 10.1016/j.cub.2014.01.007; Eisenberg-Bord M, 2016, DEV CELL, V39, P395, DOI 10.1016/j.devcel.2016.10.022; Elbaz-Alon Y, 2014, DEV CELL, V30, P95, DOI 10.1016/j.devcel.2014.06.007; Falcon-Perez JM, 2005, J CELL SCI, V118, P5243, DOI 10.1242/jcs.02633; Friedman JR, 2011, SCIENCE, V334, P358, DOI 10.1126/science.1207385; Honscher C, 2014, DEV CELL, V30, P86, DOI 10.1016/j.devcel.2014.06.006; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Itakura E, 2010, AUTOPHAGY, V6, P764, DOI 10.4161/auto.6.6.12709; Jackson WT, 2005, PLOS BIOL, V3, P861, DOI 10.1371/journal.pbio.0030156; Ji WK, 2015, ELIFE, V4, DOI [10.7554/eLife.11553.001, 10.7554/eLife.11553]; Jofuku A, 2005, BIOCHEM BIOPH RES CO, V333, P650, DOI 10.1016/j.bbrc.2005.05.154; Korobova F, 2013, SCIENCE, V339, P464, DOI 10.1126/science.1228360; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Lawe DC, 2000, J BIOL CHEM, V275, P3699, DOI 10.1074/jbc.275.5.3699; Lee JE, 2016, NATURE, V540, P139, DOI 10.1038/nature20555; Lewis SC, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5549; Li SA, 2015, J CELL BIOL, V208, P109, DOI 10.1083/jcb.201404050; Mandell MA, 2014, DEV CELL, V30, P394, DOI 10.1016/j.devcel.2014.06.013; Manor U, 2015, ELIFE, V4, DOI 10.7554/eLife.08828; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; Mc Donald JM, 2017, ANNU REV MED, V68, P445, DOI 10.1146/annurev-med-050715-104432; Mishra P, 2016, J CELL BIOL, V212, P379, DOI 10.1083/jcb.201511036; Moore AS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12886; Onoue K, 2013, J CELL SCI, V126, P176, DOI 10.1242/jcs.111211; Peralta ER, 2010, J BIOL CHEM, V285, P16814, DOI 10.1074/jbc.M110.111633; Phillips MJ, 2016, NAT REV MOL CELL BIO, V17, P69, DOI 10.1038/nrm.2015.8; Pickrell AM, 2015, NEURON, V85, P257, DOI 10.1016/j.neuron.2014.12.007; Plotegher N, 2017, TRENDS MOL MED, V23, P116, DOI 10.1016/j.molmed.2016.12.003; Rowland AA, 2014, CELL, V159, P1027, DOI 10.1016/j.cell.2014.10.023; Sherer NM, 2003, TRAFFIC, V4, P785, DOI 10.1034/j.1600-0854.2003.00135.x; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Soubannier V, 2012, CURR BIOL, V22, P135, DOI 10.1016/j.cub.2011.11.057; Subach OM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028674; Sugiura A, 2014, EMBO J, V33, P2142, DOI 10.15252/embj.201488104; Sun QM, 2010, P NATL ACAD SCI USA, V107, P19338, DOI 10.1073/pnas.1010554107; Yamano K, 2014, ELIFE, V3, DOI 10.7554/eLife.01612; Zhang XM, 2005, BIOCHEM BIOPH RES CO, V335, P154, DOI 10.1016/j.bbrc.2005.07.070; Zhen Y, 2015, J CELL SCI, V128, P3171, DOI 10.1242/jcs.166074	43	356	362	21	238	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2018	554	7692					382	+		10.1038/nature25486	http://dx.doi.org/10.1038/nature25486			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW0PD	29364868	Green Accepted			2022-12-28	WOS:000424996300043
J	Koellinger, PD; Harden, KP				Koellinger, Philipp D.; Harden, K. Paige			Using nature to understand nurture	SCIENCE			English	Editorial Material							GENOME-WIDE ASSOCIATION; EDUCATIONAL-ATTAINMENT		[Koellinger, Philipp D.] De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands; [Harden, K. Paige] 108 E Dean Keeton Stop A8000, Austin, TX 78704 USA		Koellinger, PD (corresponding author), De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	p.d.koellinger@vu.nl; harden@utexas.edu		Koellinger, Philipp/0000-0001-7413-0412; Harden, Kathryn/0000-0002-1557-6737	European Research Council [647648] Funding Source: Medline	European Research Council(European Research Council (ERC)European Commission)		Benjamin DJ, 2012, ANNU REV ECON, V4, P627, DOI 10.1146/annurev-economics-080511-110939; D'Onofrio BM, 2003, J CHILD PSYCHOL PSYC, V44, P1130, DOI 10.1111/1469-7610.00196; de Vlaming R, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006495; Hamer D, 2000, MOL PSYCHIATR, V5, P11, DOI 10.1038/sj.mp.4000662; HORN JM, 1979, BEHAV GENET, V9, P177, DOI 10.1007/BF01071300; Hunt J, 2002, P NATL ACAD SCI USA, V99, P6828, DOI 10.1073/pnas.092676199; JENCKS C, 1980, AM SOCIOL REV, V45, P723, DOI 10.2307/2094892; Kong A, 2018, SCIENCE, V359, P424, DOI 10.1126/science.aan6877; Lawlor DA, 2008, STAT MED, V27, P1133, DOI 10.1002/sim.3034; Okbay A, 2016, NATURE, V533, P539, DOI 10.1038/nature17671; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Rietveld CA, 2013, SCIENCE, V340, P1467, DOI 10.1126/science.1235488; Tucker-Drob EM, 2013, CURR DIR PSYCHOL SCI, V22, P349, DOI 10.1177/0963721413485087; Wolf JB, 1998, TRENDS ECOL EVOL, V13, P64, DOI 10.1016/S0169-5347(97)01233-0	14	25	25	1	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					386	387		10.1126/science.aar6429	http://dx.doi.org/10.1126/science.aar6429			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT6SD	29371452	Green Published, Green Accepted			2022-12-28	WOS:000423283200024
J	Appleby, J				Appleby, John			How Europe copes with flu	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Appleby, John] Nuffield Trust, London, England		Appleby, J (corresponding author), Nuffield Trust, London, England.							[Anonymous], 2018, IRISH NEWS      0104; [Anonymous], 2018, EP GRIPP GASTR NALL; [Anonymous], 2017, ADVERTISER; [Anonymous], 2017, GRIPP PLAN EP HIV RE; [Anonymous], 2015, THE LOCAL; [Anonymous], 2018, INDEPENDENT; [Anonymous], 2017, THE LOCAL; Clarke O., 2018, BBC NEWS; Hardy C., 2017, EURONEWS; NHS England, WINT DAIL SITREP 201; NHS England, 2018, A E ATT EM ADM MONTH; OECD, 2017, HLTH DAT SEP; Public Health England, PHE WEEKL NAT INFL R	13	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2018	360								k266	10.1136/bmj.k266	http://dx.doi.org/10.1136/bmj.k266			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU2XA	29371180				2022-12-28	WOS:000423712100005
J	Martin, EG; Schackman, BR				Martin, Erika G.; Schackman, Bruce R.			Treating and Preventing HIV with Generic Drugs - Barriers in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SAVINGS; THERAPY		[Martin, Erika G.] SUNY Albany, Rockefeller Inst Govt, Albany, NY 12222 USA; [Martin, Erika G.] SUNY Albany, Dept Publ Adm & Policy, Albany, NY 12222 USA; [Schackman, Bruce R.] Weill Cornell Med Coll, Dept Healthcare Policy & Adm, New York, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Cornell University	Martin, EG (corresponding author), SUNY Albany, Rockefeller Inst Govt, Albany, NY 12222 USA.; Martin, EG (corresponding author), SUNY Albany, Dept Publ Adm & Policy, Albany, NY 12222 USA.		Schackman, Bruce R./J-8208-2019	Schackman, Bruce R./0000-0002-1132-2932; Martin, Erika/0000-0003-2607-8933				Colgan S, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-008915; Jacomet C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117214; Mollan KR, 2014, ANN INTERN MED, V161, P1, DOI 10.7326/M14-0293; Schackman BR, 2015, MED CARE, V53, P293, DOI 10.1097/MLR.0000000000000308; Walensky RP, 2013, ANN INTERN MED, V158, P84, DOI 10.7326/0003-4819-158-2-201301150-00002	5	9	9	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 25	2018	378	4					316	319		10.1056/NEJMp1710914	http://dx.doi.org/10.1056/NEJMp1710914			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT5ZX	29365306	Bronze			2022-12-28	WOS:000423233400004
J	Rubin, R				Rubin, Rita			African Countries Move Closer to Eradicating Guinea Worm Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item													Rubin, Rita/AAD-1259-2020						0	0	0	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					334	334		10.1001/jama.2017.21121	http://dx.doi.org/10.1001/jama.2017.21121			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362803				2022-12-28	WOS:000423405300012
J	Slomski, A				Slomski, Anita			New Combination Therapy for Cystic Fibrosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					333	333		10.1001/jama.2017.20792	http://dx.doi.org/10.1001/jama.2017.20792			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362790				2022-12-28	WOS:000423405300007
J	McCartney, M				McCartney, Margaret			NO HOLDS BARRED Margaret McCartney: Hiding and seeking doctors' conflicts of interest	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												margaret@margaretmccartney.com	mccartney, margaret/AAR-4727-2020	McCartney, Margaret/0000-0002-7238-6358				[Anonymous], 2016, BMJ; Association of the British Pharmaceutical Industry, DISCL UK; Department of Health, 2017, PROM PROF REF REG PA; General Medical Council, DEV ONL REG; House of Commons Health Committee, 2005, INFL PHARM IND 4 REP; McCartney Margaret, 2016, BMJ, V354, pi3692, DOI 10.1136/bmj.i3692; Rimmer A, 2017, BMJ-BRIT MED J, V357, DOI 10.1136/bmj.j2055	7	4	4	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2018	360								k135	10.1136/bmj.k135	http://dx.doi.org/10.1136/bmj.k135			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU2WP	29358366	Bronze, Green Published			2022-12-28	WOS:000423711000001
J	Wade, L				Wade, Lizzie			THE BELIEVER	SCIENCE			English	Editorial Material																			0	0	0	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					264	268		10.1126/science.359.6373.264	http://dx.doi.org/10.1126/science.359.6373.264			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT6BB	29348220				2022-12-28	WOS:000423236700016
J	Devi, S				Devi, Sharmila			Iranian protests and Rouhanicare	LANCET			English	Editorial Material																			0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 13	2018	391	10116					109	109		10.1016/S0140-6736(18)30053-9	http://dx.doi.org/10.1016/S0140-6736(18)30053-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT0EG	29353608				2022-12-28	WOS:000422793400011
J	Milner, JJ; Toma, C; Yu, BF; Zhang, K; Omilusik, K; Phan, AT; Wang, DP; Getzler, AJ; Nguyen, T; Crotty, S; Wang, W; Pipkin, ME; Goldrath, AW				Milner, J. Justin; Toma, Clara; Yu, Bingfei; Zhang, Kai; Omilusik, Kyla; Phan, Anthony T.; Wang, Dapeng; Getzler, Adam J.; Nguyen, Toan; Crotty, Shane; Wang, Wei; Pipkin, Matthew E.; Goldrath, Ananda W.			Runx3 programs CD8(+) T cell residency in non-lymphoid tissues and tumours (vol 552, pg 253, 2017)	NATURE			English	Correction													Crotty, Shane/AAE-8446-2019; Wang, Dapeng/HGD-4818-2022; Crotty, Shane/AAC-6703-2019	Crotty, Shane/0000-0002-6484-6262				Milner JJ, 2017, NATURE, V552, P253, DOI 10.1038/nature24993	1	8	8	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2018	554	7692					393	393		10.1038/nature25445	http://dx.doi.org/10.1038/nature25445			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW0PD	29320476	Bronze			2022-12-28	WOS:000424996300046
J	Inohara, T; Xian, Y; Liang, L; Matsouaka, RA; Saver, JL; Smith, EE; Schwamm, LH; Reeves, MJ; Hernandez, AF; Bhatt, DL; Peterson, ED; Fonarow, GC				Inohara, Taku; Xian, Ying; Liang, Li; Matsouaka, Roland A.; Saver, Jeffrey L.; Smith, Eric E.; Schwamm, Lee H.; Reeves, Mathew J.; Hernandez, Adrian F.; Bhatt, Deepak L.; Peterson, Eric D.; Fonarow, Gregg C.			Association of Intracerebral Hemorrhage Among Patients Taking Non-Vitamin K Antagonist vs Vitamin K Antagonist Oral Anticoagulants With In-Hospital Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATRIAL-FIBRILLATION PATIENTS; INTRACRANIAL HEMORRHAGE; ANTIPLATELET THERAPY; WARFARIN; STROKE; DABIGATRAN; RIVAROXABAN; PREVENTION; OUTCOMES	IMPORTANCE Although non-vitamin K antagonist oral anticoagulants (NOACs) are increasingly used to prevent thromboembolic disease, there are limited data on NOAC-related intracerebral hemorrhage (ICH). OBJECTIVE To assess the association between preceding oral anticoagulant use (warfarin, NOACs, and no oral anticoagulants [OACs]) and in-hospital mortality among patients with ICH. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study of 141 311 patients with ICH admitted from October 2013 to December 2016 to 1662 Get With The Guidelines-Stroke hospitals. EXPOSURES Anticoagulation therapy before ICH, defined as any use of OACs within 7 days prior to hospital arrival. MAIN OUTCOMES AND MEASURES In-hospital mortality. RESULTS Among 141 311 patients with ICH (mean [SD] age, 68.3 [15.3] years; 48.1% women), 15 036 (10.6%) were taking warfarin and 4918 (3.5%) were taking NOACs preceding ICH, and 39 585 (28.0%) and 5783 (4.1%) were taking concomitant single and dual antiplatelet agents, respectively. Patients with prior use of warfarin or NOACs were older and had higher prevalence of atrial fibrillation and prior stroke. Acute ICH stroke severity (measured by the National Institutes of Health Stroke Scale) was not significantly different across the 3 groups (median, 9 [interquartile range, 2-21] for warfarin, 8 [2-20] for NOACs, and 8 [2-19] for no OACs). The unadjusted in-hospital mortality rates were 32.6% for warfarin, 26.5% for NOACs, and 22.5% for no OACs. Compared with patients without prior use of OACs, the risk of in-hospital mortality was higher among patients with prior use of warfarin (adjusted risk difference [ARD], 9.0% [97.5% CI, 7.9% to 10.1%]; adjusted odds ratio [AOR], 1.62 [97.5% CI, 1.53 to 1.71]) and higher among patients with prior use of NOACs (ARD, 3.3% [97.5% CI, 1.7% to 4.8%]; AOR, 1.21 [97.5% CI, 1.11-1.32]). Compared with patients with prior use of warfarin, patients with prior use of NOACs had a lower risk of in-hospital mortality (ARD, -5.7%[97.5% CI, -7.3% to -4.2%]; AOR, 0.75 [97.5% CI, 0.69 to 0.81]). The difference in mortality between NOAC-treated patients and warfarin-treated patients was numerically greater among patients with prior use of dual antiplatelet agents (32.7% vs 47.1%; ARD, -15.0%[95.5% CI, -26.3% to -3.8%]; AOR, 0.50 [97.5% CI, 0.29 to 0.86]) than among those taking these agents without prior antiplatelet therapy (26.4% vs 31.7%; ARD, -5.0% [97.5% CI, -6.8% to -3.2%]; AOR, 0.77 [97.5% CI, 0.70 to 0.85]), although the interaction P value (. 07) was not statistically significant. CONCLUSIONS AND RELEVANCE Among patients with ICH, prior use of NOACs or warfarin was associated with higher in-hospital mortality compared with no OACs. Prior use of NOACs, compared with prior use of warfarin, was associated with lower risk of in-hospital mortality.	[Inohara, Taku; Xian, Ying; Liang, Li; Matsouaka, Roland A.; Hernandez, Adrian F.; Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Xian, Ying] Duke Univ, Med Ctr, Dept Neurol, Durham, NC USA; [Matsouaka, Roland A.] Duke Univ, Dept Biostat & Bioinformat, Durham, NC USA; [Saver, Jeffrey L.] Univ Calif Los Angeles, Dept Neurol, Los Angeles, CA 90024 USA; [Smith, Eric E.] Univ Calgary, Dept Clin Neurosci, Hotchkiss Brain Inst, Calgary, AB, Canada; [Schwamm, Lee H.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA USA; [Schwamm, Lee H.; Bhatt, Deepak L.] Harvard Med Sch, Boston, MA USA; [Reeves, Mathew J.] Michigan State Univ, Dept Epidemiol, E Lansing, MI 48824 USA; [Bhatt, Deepak L.] Brigham & Womens Hosp, Heart & Vasc Ctr, 75 Francis St, Boston, MA 02115 USA; [Fonarow, Gregg C.] Ronald Reagan Univ Calif, Div Cardiol, Los Angeles Med Ctr, 10833 LeConte Ave,Room A2-237 CHS, Los Angeles, CA 90095 USA	Duke University; Duke University; Duke University; University of California System; University of California Los Angeles; University of Calgary; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Michigan State University; Harvard University; Brigham & Women's Hospital; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Ronald Reagan UCLA Medical Center	Fonarow, GC (corresponding author), Ronald Reagan Univ Calif, Div Cardiol, Los Angeles Med Ctr, 10833 LeConte Ave,Room A2-237 CHS, Los Angeles, CA 90095 USA.	gfonarow@mednet.ucla.edu	Peterson, Eric David/ABF-5033-2021; Xian, Ying/O-1956-2019; Fonarow, Gregg C/D-5988-2014; Matsouaka, Roland/K-6730-2019; Smith, Eric E/C-5443-2012; Hernandez, Adrian F/A-7818-2016	Fonarow, Gregg C/0000-0002-3192-8093; Matsouaka, Roland/0000-0002-0271-5400; Smith, Eric E/0000-0003-3956-1668; Hernandez, Adrian F/0000-0003-3387-9616; Xian, Ying/0000-0002-1237-1162	ARAMIS registry; Daiichi Sankyo; Genentech; Janssen; Alberta Innovates [201300690] Funding Source: researchfish	ARAMIS registry; Daiichi Sankyo(Daiichi Sankyo Company Limited); Genentech(Roche HoldingGenentech); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Alberta Innovates	The GWTG-Stroke program is provided by the American Heart Association/American Stroke Association. This study is in part supported by the ARAMIS registry with research funding from Daiichi Sankyo, Genentech, and Janssen.	Akiyama H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132900; Alonso A, 2014, STROKE, V45, P2286, DOI 10.1161/STROKEAHA.114.006016; Bhatt DL, 2017, CIRCULATION, V135, P334, DOI 10.1161/CIRCULATIONAHA.116.025923; Cannon CP, 2017, NEW ENGL J MED, V377, P1513, DOI 10.1056/NEJMoa1708454; Cheung YB, 2007, AM J EPIDEMIOL, V166, P1337, DOI 10.1093/aje/kwm223; Connolly SJ, 2016, NEW ENGL J MED, V375, P1131, DOI 10.1056/NEJMoa1607887; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cucchiara B, 2008, STROKE, V39, P2993, DOI 10.1161/STROKEAHA.108.520668; Dowlatshahi D, 2012, STROKE, V43, P1812, DOI 10.1161/STROKEAHA.112.652065; Flaherty ML, 2008, NEUROLOGY, V71, P1084, DOI 10.1212/01.wnl.0000326895.58992.27; Fonarow GC, 2010, CIRC-CARDIOVASC QUAL, V3, P291, DOI 10.1161/CIRCOUTCOMES.109.921858; Gadsboll K, 2017, EUR HEART J, V38, P899, DOI 10.1093/eurheartj/ehw658; Gibson CM, 2017, CIRCULATION, V135, P323, DOI 10.1161/CIRCULATIONAHA.116.025783; Gibson CM, 2016, NEW ENGL J MED, V375, P2423, DOI 10.1056/NEJMoa1611594; Giugliano RP, 2013, NEW ENGL J MED, V369, P2093, DOI 10.1056/NEJMoa1310907; Granger CB, 2011, NEW ENGL J MED, V365, P981, DOI 10.1056/NEJMoa1107039; Hagii J, 2014, STROKE, V45, P2805, DOI 10.1161/STROKEAHA.114.006661; Hankey GJ, 2014, STROKE, V45, P1304, DOI 10.1161/STROKEAHA.113.004506; Hart RG, 2012, STROKE, V43, P1511, DOI 10.1161/STROKEAHA.112.650614; Hemphill JC, 2001, STROKE, V32, P891, DOI 10.1161/01.STR.32.4.891; Khan NI, 2017, STROKE, V48, P1810, DOI 10.1161/STROKEAHA.117.016290; Levine GN, 2016, J AM COLL CARDIOL, V68, P1082, DOI 10.1016/j.jacc.2016.03.513; Lopes RD, 2017, BLOOD, V129, P2980, DOI 10.1182/blood-2016-08-731638; Marzec LN, 2017, J AM COLL CARDIOL, V69, P2475, DOI 10.1016/j.jacc.2017.03.540; Patel MR, 2011, NEW ENGL J MED, V365, P883, DOI 10.1056/NEJMoa1009638; Pedroza C, 2016, BMC MED RES METHODOL, V16, DOI 10.1186/s12874-016-0217-0; Pollack Jr CV, 2015, NEW ENGL J MED, V373, P511, DOI 10.1056/NEJMoa1502000; Reeves MJ, 2012, STROKE, V43, P44, DOI 10.1161/STROKEAHA.111.626978; Rosand J, 2004, ARCH INTERN MED, V164, P880, DOI 10.1001/archinte.164.8.880; Shah A, 2016, STROKE, V47, P1555, DOI 10.1161/STROKEAHA.115.012325; Shireman TI, 2004, STROKE, V35, P2362, DOI 10.1161/01.STR.0000141933.75462.c2; Thompson BB, 2010, NEUROLOGY, V75, P1333, DOI 10.1212/WNL.0b013e3181f735e5; Valgimigli M, 2018, EUR HEART J, V39, P213, DOI 10.1093/eurheartj/ehx419; Wilson D, 2017, NEUROLOGY, V88, P1693, DOI 10.1212/WNL.0000000000003886; Wilson D, 2016, NEUROLOGY, V86, P360, DOI 10.1212/WNL.0000000000002310; Xian Y, 2017, JAMA-J AM MED ASSOC, V317, P1057, DOI 10.1001/jama.2017.1371; Xian Y, 2012, AM HEART J, V163, P392, DOI 10.1016/j.ahj.2011.12.012	37	135	136	2	22	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	2018	319	5					463	473		10.1001/jama.2017.21917	http://dx.doi.org/10.1001/jama.2017.21917			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV0CW	29372247	Green Published, Bronze			2022-12-28	WOS:000424224500016
J	Gulland, A				Gulland, Anne			QUALITY OF HEALTHCARE Is THIS the way to better improvement?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												annecgulland@yahoo.co.uk						Chazapis M, 2018, BRIT J ANAESTH, V120, P51, DOI 10.1016/j.bja.2017.10.001; Dixon-Woods Mary, 2016, Future Hosp J, V3, P191, DOI 10.7861/futurehosp.3-3-191	2	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2018	360								k287	10.1136/bmj.k287	http://dx.doi.org/10.1136/bmj.k287			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU2XE	29374050				2022-12-28	WOS:000423712500004
J	Hershkovitz, I; Weber, GW; Quam, R; Duval, M; Grun, R; Kinsley, L; Ayalon, A; Bar-Matthews, M; Valladas, H; Mercier, N; Arsuaga, JL; Martinon-Torres, M; Bermudez de Castro, JM; Fornai, C; Martin-Frances, L; Sarig, R; May, H; Krenn, VA; Slon, V; Rodriguez, L; Garcia, R; Lorenzo, C; Carretero, JM; Frumkin, A; Shahack-Gross, R; Mayer, DEBY; Cui, YM; Wu, XZ; Peled, N; Groman-Yaroslavski, I; Weissbrod, L; Yeshurun, R; Tsatskin, A; Zaidner, Y; Weinstein-Evron, M				Hershkovitz, Israel; Weber, Gerhard W.; Quam, Rolf; Duval, Mathieu; Gruen, Rainer; Kinsley, Leslie; Ayalon, Avner; Bar-Matthews, Miryam; Valladas, Helene; Mercier, Norbert; Luis Arsuaga, Juan; Martinon-Torres, Maria; Bermudez de Castro, Jose Maria; Fornai, Cinzia; Martin-Frances, Laura; Sarig, Rachel; May, Hila; Krenn, Viktoria A.; Slon, Viviane; Rodriguez, Laura; Garcia, Rebeca; Lorenzo, Carlos; Miguel Carretero, Jose; Frumkin, Amos; Shahack-Gross, Ruth; Mayer, Daniella E. Bar-Yosef; Cui, Yaming; Wu, Xinzhi; Peled, Natan; Groman-Yaroslavski, Iris; Weissbrod, Lior; Yeshurun, Reuven; Tsatskin, Alexander; Zaidner, Yossi; Weinstein-Evron, Mina			The earliest modern humans outside Africa	SCIENCE			English	Article							HOMINID BURIAL SITE; MORPHOMETRIC-ANALYSIS; JEBEL IRHOUD; ESR DATES; CAVE; AGE; MOROCCO; FOSSILS; SKHUL; SIMA	To date, the earliest modern human fossils found outside of Africa are dated to around 90,000 to 120,000 years ago at the Levantine sites of Skhul and Qafzeh. A maxilla and associated dentition recently discovered at Misliya Cave, Israel, was dated to 177,000 to 194,000 years ago, suggesting that members of the Homo sapiens clade left Africa earlier than previously thought. This finding changes our view on modern human dispersal and is consistent with recent genetic studies, which have posited the possibility of an earlier dispersal of Homo sapiens around 220,000 years ago. The Misliyamaxilla is associated with full-fledged Levallois technology in the Levant, suggesting that the emergence of this technology is linked to the appearance of Homo sapiens in the region, as has been documented in Africa.	[Hershkovitz, Israel; Slon, Viviane] Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, POB 39040, IL-6997801 Tel Aviv, Israel; [Hershkovitz, Israel; Sarig, Rachel; May, Hila] Tel Aviv Univ, Steinhardt Museum Nat Hist, Dan David Ctr Human Evolut & Biohist Res, POB 39040, IL-6997801 Tel Aviv, Israel; [Hershkovitz, Israel; Sarig, Rachel; May, Hila] Tel Aviv Univ, Steinhardt Museum Nat Hist, Shmunis Family Anthropol Inst, POB 39040, IL-6997801 Tel Aviv, Israel; [Weber, Gerhard W.; Fornai, Cinzia; Krenn, Viktoria A.] Univ Vienna, Dept Anthropol, Althanstr 14, A-1090 Vienna, Austria; [Weber, Gerhard W.; Fornai, Cinzia; Krenn, Viktoria A.] Univ Vienna, Core Facil Micro Computed Tomog, Althanstr 14, A-1090 Vienna, Austria; [Quam, Rolf] SUNY Binghamton, Dept Anthropol, Binghamton, NY 13902 USA; [Quam, Rolf; Luis Arsuaga, Juan; Rodriguez, Laura; Garcia, Rebeca; Miguel Carretero, Jose] Ctr UCM ISCIII Evoluc & Comportamiento Humanos, Avda Monforte Lemos,5, Madrid 28029, Spain; [Quam, Rolf] Amer Museum Nat Hist, Div Anthropol, Cent Pk West 79th St, New York, NY 10024 USA; [Duval, Mathieu; Gruen, Rainer] Griffith Univ, Environm Futures Res Inst, ARCHE, Nathan, Qld 4111, Australia; [Duval, Mathieu; Martinon-Torres, Maria] Natl Res Ctr Human Evolut CENIEH, Paseo Sierra Atapuerca 3, Burgos 09002, Spain; [Gruen, Rainer; Kinsley, Leslie] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 2601, Australia; [Ayalon, Avner; Bar-Matthews, Miryam] Geol Survey Israel, 30 Malkhe Israel St, IL-9550161 Jerusalem, Israel; [Valladas, Helene] Univ Paris Saclay, CEA, CNRS, LSCE IPSL,UVSQ, Ave Terrasse, F-91198 Gif Sur Yvette, France; [Mercier, Norbert] Univ Bordeaux Montaigne, Ctr Rech Phys Appli Archeol CRP2A, CNRS, Inst Rech Archeomat,UMR 5060, F-33607 Pessac, France; [Luis Arsuaga, Juan] Univ Complutense Madrid, Fac Ciencias Geol, Dept Geodinam Estratig & Paleontol, Ciudad Univ S-N, Madrid 28040, Spain; [Martinon-Torres, Maria; Bermudez de Castro, Jose Maria] UCL, Dept Anthropol, 14 Taviton St, London WC1H 0BW, England; [Fornai, Cinzia; Krenn, Viktoria A.] Univ Zurich, Inst Evolut Med, Winterthurerstr 190, CH-8057 Zurich, Switzerland; [Martin-Frances, Laura] Univ Bordeaux, CNRS MCC, PACEA, UMR5189, Bordeaux, France; [Sarig, Rachel] Tel Aviv Univ, Sackler Fac Med, Maurice & Gabriela Goldschleger Sch Dent Med, Dept Oral Biol & Orthodont, IL-6997801 Tel Aviv, Israel; [Rodriguez, Laura; Garcia, Rebeca; Miguel Carretero, Jose] Univ Burgos, Fac Humanidades & Comunicac, Dept Hist Geog & Comunicac, Burgos 09001, Spain; [Rodriguez, Laura] Univ Isabel I, Fac Humanidades, Burgos, Spain; [Lorenzo, Carlos] Univ Rovira i Virgili, Avinguda Catalunya 35, Tarragona 43002, Spain; [Lorenzo, Carlos] Inst Catala Paleoecol Humana & Evolucio Social IP, Marcel Li Domingo S-N, Tarragona 43007, Spain; [Frumkin, Amos] Hebrew Univ Jerusalem, Inst Earth Sci, IL-9190401 Jerusalem, Israel; [Shahack-Gross, Ruth] Univ Haifa, Recanati Inst Maritime Studies, Dept Maritime Civilizat, IL-3498838 Haifa, Israel; [Mayer, Daniella E. Bar-Yosef] Tel Aviv Univ, Sonia & Marco Nadler Inst Archaeol, IL-69978 Tel Aviv, Israel; [Mayer, Daniella E. Bar-Yosef] Harvard Univ, Peabody Museum Archaeol & Ethnol, 11 Div Ave, Cambridge, MA 02138 USA; [Cui, Yaming; Wu, Xinzhi] Chinese Acad Sci, Inst Paleontol & Paleoanthropol, Dept Paleoanthropol, Str Xizhimenwai No 144, Beijing 100044, Peoples R China; [Peled, Natan] Carmel Hosp, Dept Radiol, IL-3436212 Haifa, Israel; [Groman-Yaroslavski, Iris; Weissbrod, Lior; Yeshurun, Reuven; Tsatskin, Alexander; Zaidner, Yossi; Weinstein-Evron, Mina] Univ Haifa, Zinman Inst Archaeol, IL-3498838 Haifa, Israel; [Zaidner, Yossi] Hebrew Univ Jerusalem, Inst Archaeol, IL-9190501 Jerusalem, Israel	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Tel Aviv University; University of Vienna; University of Vienna; State University of New York (SUNY) System; State University of New York (SUNY) Binghamton; American Museum of Natural History (AMNH); Griffith University; Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); Australian National University; Geological Survey Israel; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); CEA; Centre National de la Recherche Scientifique (CNRS); Universite Bordeaux-Montaigne; Universite de Orleans; Universite de Technologie de Belfort-Montbeliard (UTBM); CNRS - Institute for Humanities & Social Sciences (INSHS); Complutense University of Madrid; University of London; University College London; University of Zurich; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Humanities & Social Sciences (INSHS); UDICE-French Research Universities; Universite de Bordeaux; Tel Aviv University; Sackler Faculty of Medicine; Universidad de Burgos; Universitat Rovira i Virgili; Universitat Rovira i Virgili; Catalan Institute of Human Paleo-Ecology & Social Evolution (IPHES); Hebrew University of Jerusalem; University of Haifa; Tel Aviv University; Harvard University; Chinese Academy of Sciences; Clalit Health Services; Carmel Medical Center; University of Haifa; Hebrew University of Jerusalem	Hershkovitz, I (corresponding author), Tel Aviv Univ, Sackler Fac Med, Dept Anat & Anthropol, POB 39040, IL-6997801 Tel Aviv, Israel.; Hershkovitz, I (corresponding author), Tel Aviv Univ, Steinhardt Museum Nat Hist, Dan David Ctr Human Evolut & Biohist Res, POB 39040, IL-6997801 Tel Aviv, Israel.	anatom2@tauex.tau.ac.il	Weber, Gerhard W/F-2583-2010; Fornai, Cinzia/AAB-6451-2020; Rodriguez, Laura/H-4774-2015; Yeshurun, Reuven/A-3182-2013; Carretero, José-Miguel/AAN-1926-2020; Duval, Mathieu/U-9446-2018; Rodriguez, Laura/AAO-4864-2020; Hershkovitz, Israel/ABH-4511-2020; Díaz, José-Miguel Carretero/L-1703-2018; Lorenzo, Carlos/E-4290-2015	Weber, Gerhard W/0000-0002-8542-6259; Rodriguez, Laura/0000-0002-5090-1582; Carretero, José-Miguel/0000-0003-0409-8087; Duval, Mathieu/0000-0003-3181-7753; Rodriguez, Laura/0000-0002-5090-1582; Hershkovitz, Israel/0000-0001-5841-6090; Díaz, José-Miguel Carretero/0000-0003-0409-8087; Lorenzo, Carlos/0000-0001-5706-293X; Sarig, Rachel/0000-0002-9323-5014; Yeshurun, Reuven/0000-0002-1734-0138; Bermudez de Castro, Jose Maria/0000-0003-1314-3273; Weinstein-Evron, Mina/0000-0001-7699-5647; Quam, Rolf/0000-0002-1140-5615; Martin-Frances Martin de la Fuente, Laura/0000-0001-5853-5014; Krenn, Viktoria/0000-0002-4707-5435; Arsuaga, Juan Luis/0000-0001-5361-2295; Peled, Nir/0000-0003-3714-4377; Mercier, Norbert/0000-0002-6375-9108; Zaidner, Yossi/0000-0002-4247-4824; Fornai, Cinzia/0000-0002-0911-0164	Dan David Foundation; Irene Levi-Sala CARE Archaeological Foundation; Leakey Foundation; Thyssen Foundation; Faculty of Humanities of the University of Haifa; Israel Science Foundation [1104/12]; Ministerio de Economia y Competitividad of Spain [CGL2015-65387-C3-2-3-P MINECO/FEDER]; Fundacion Atapuerca; Marie Curie International Outgoing Fellowship (IOF) [626474]; Australian Research Council Future Fellowship [FT150100215]; LaScArBx [ANR-10-LABX-52]; Life Science Faculty University of Vienna; Oesterreichische Nationalbank, Anniversary Fund [16121]; Swiss National Science Foundation [31003A 156299/1, 31003A 176319]; A.E.R.S. Dental Medicine Organizations GmbH, Vienna, Austria [FA547014]; Siegfried Ludwig-Rudolf Slavicek Foundation, Vienna, Austria [FA547016]	Dan David Foundation; Irene Levi-Sala CARE Archaeological Foundation; Leakey Foundation; Thyssen Foundation; Faculty of Humanities of the University of Haifa; Israel Science Foundation(Israel Science Foundation); Ministerio de Economia y Competitividad of Spain(Spanish Government); Fundacion Atapuerca; Marie Curie International Outgoing Fellowship (IOF); Australian Research Council Future Fellowship(Australian Research Council); LaScArBx; Life Science Faculty University of Vienna; Oesterreichische Nationalbank, Anniversary Fund; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); A.E.R.S. Dental Medicine Organizations GmbH, Vienna, Austria; Siegfried Ludwig-Rudolf Slavicek Foundation, Vienna, Austria	Field work in Misliya Cave was supported by the Dan David Foundation, the Irene Levi-Sala CARE Archaeological Foundation, the Leakey Foundation, the Thyssen Foundation, and the Faculty of Humanities of the University of Haifa. Laboratory work and dating were supported by the Israel Science Foundation (grant no. 1104/12). The anthropological study was supported by the Dan David Foundation, Ministerio de Economia y Competitividad of Spain (CGL2015-65387-C3-2-3-P MINECO/FEDER), Fundacion Atapuerca, and The Leakey Foundation. The ESR dating study received funding from the Marie Curie International Outgoing Fellowship (IOF) 626474 and the Australian Research Council Future Fellowship FT150100215. N.M. is grateful to LaScArBx ANR-10-LABX-52 for support. Work on the virtual specimens was supported by the Life Science Faculty University of Vienna; Oesterreichische Nationalbank, Anniversary Fund, project no. 16121; the Swiss National Science Foundation grant nos. 31003A 156299/1 and 31003A 176319; A.E.R.S. Dental Medicine Organizations GmbH, Vienna, Austria, project no. FA547014; and the Siegfried Ludwig-Rudolf Slavicek Foundation, Vienna, Austria, project no. FA547016. Special thanks are due to the late Dan David and his son, Ariel David, for their inspiration and financial support throughout the years. Thanks also go to O. Bar-Yosef (Harvard University) and A.M. Tillier (University of Bordeaux), who read and commented on a previous version of this paper. All data generated in this study are in the supplementary materials. Permission to study the fossil (Misliya-1) can be obtained from the corresponding author. Micro-CT images are available from G.W.W. under a material transfer agreement with I.H. of Tel Aviv University (Misliya-1). Full acknowledgments are in the supplementary materials. I.H. and M.W.-E. direct the Misliya Cave research project; I.H., G.W.W., R.Q., J.L.A., M.M.-T., J.M.B.dC., L.M.-F., P.S., R.S., H.M., V.S., L.R., R.G., C.L., J.M.C., Y.C., X.W., and N.P. carried out various aspects of the anthropological study of the Misliya human remains; G.W.W., C.F., V.A.K., and R.S carried out the virtual image manipulation and geometric morphometric investigations; Y.Z. and M.W.-E. conducted the archaeological studies at the cave; A. A and M.B.-M. conducted the U/Th analysis; H.V. and N.M. conducted the TL dating of the archaeological layers; M.D., R.G., and L.K. conducted the U-series and ESR dating of the fossil remains; A.F., R.S.-G., and A.T. conducted the geoarchaeological and geomorphological studies of the cave; L.W. and R.Y. conducted the study of the faunal remains; D.B.-Y.M. studied the mollusc shells; and I.G.-Y. carried out the use-wear analysis. All authors participated in compiling the manuscript. The authors declare no competing financial interests.	Arsuaga JL, 2014, SCIENCE, V344, P1358, DOI 10.1126/science.1253958; Bailey SE, 2004, J HUM EVOL, V47, P183, DOI 10.1016/j.jhevol.2004.07.001; Bailey SE, 2013, ANTHR PERSPECTIVES T, P222, DOI DOI 10.1017/CBO9780511984464.010; Bailey SE, 2017, VERTEBR PALEOBIOL PA, P215, DOI 10.1007/978-3-319-46646-0_16; DECASTRO JMB, 1995, AM J PHYS ANTHROPOL, V96, P335, DOI 10.1002/ajpa.1330960403; Douze K, 2016, J HUM EVOL, V91, P93, DOI 10.1016/j.jhevol.2015.11.006; Freidline SE, 2012, J HUM EVOL, V62, P225, DOI 10.1016/j.jhevol.2011.11.005; Gomez-Robles A, 2013, P NATL ACAD SCI USA, V110, P18196, DOI 10.1073/pnas.1302653110; Hershkovitz I, 2015, NATURE, V520, P216, DOI 10.1038/nature14134; Hershkovitz I, 2011, AM J PHYS ANTHROPOL, V144, P575, DOI 10.1002/ajpa.21446; Hublin JJ, 2017, NATURE, V546, P289, DOI 10.1038/nature22336; Johnson CR, 2010, J HUM EVOL, V58, P193, DOI 10.1016/j.jhevol.2009.10.001; [刘武 LIU Wu], 2006, [人类学学报, Acta Anthropologica Sinica], V25, P177; Liu W, 2015, NATURE, V526, P696, DOI 10.1038/nature15696; Martinon-Torres M, 2007, P NATL ACAD SCI USA, V104, P13279, DOI 10.1073/pnas.0706152104; Martinon-Torres M, 2012, J HUM EVOL, V62, P7, DOI 10.1016/j.jhevol.2011.08.007; McDougall I, 2005, NATURE, V433, P733, DOI 10.1038/nature03258; Mercier N, 2007, J ARCHAEOL SCI, V34, P1064, DOI 10.1016/j.jas.2006.09.021; Mercier N, 2003, J HUM EVOL, V45, P401, DOI 10.1016/j.jhevol.2003.09.004; MERCIER N, 1993, J ARCHAEOL SCI, V20, P169, DOI 10.1006/jasc.1993.1012; Porat N, 2010, J ARCHAEOL SCI, V37, P269, DOI 10.1016/j.jas.2009.09.038; Posth C, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms16046; Richter D, 2017, NATURE, V546, P293, DOI 10.1038/nature22335; Sahle Y, 2014, QUATERN INT, V331, P6, DOI 10.1016/j.quaint.2013.03.010; SCHWARCZ HP, 1988, J HUM EVOL, V17, P733, DOI 10.1016/0047-2484(88)90063-2; Shen GJ, 2002, J HUM EVOL, V43, P817, DOI 10.1006/jhev.2002.0601; Stringer C., 2016, PHILOS T R SOC LON B, V371, P1698; STRINGER CB, 1989, NATURE, V338, P756, DOI 10.1038/338756a0; Tryon C. A., 2005, AFR ARCHAEOL REV, V22, P199, DOI [10.1007/s10437-006-9002-5, DOI 10.1007/S10437-006-9002-5]; Valladas H, 2013, J HUM EVOL, V65, P585, DOI 10.1016/j.jhevol.2013.07.005; Weber GW, 2016, QUATERN INT, V398, P159, DOI 10.1016/j.quaint.2015.10.027; Weidenreich F., 1937, PALAEONTOL SINICA; Weinstein-Evron M., 2017, QUATERNARY LEVANT EN, P225; White TD, 2003, NATURE, V423, P742, DOI 10.1038/nature01669; Zaidner Y., 2012, FARMING, V2012, P1, DOI [DOI 10.3828/BFARM.2012.4.1, 10.3828/bfarm.2012.4.1]	35	209	216	8	140	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					456	459		10.1126/science.aap8369	http://dx.doi.org/10.1126/science.aap8369			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT6SD	29371468	Green Submitted			2022-12-28	WOS:000423283200046
J	Slomski, A				Slomski, Anita			Opioid Agonist and Antagonist Therapies Prevent Opioid Relapse	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					333	333		10.1001/jama.2017.21382	http://dx.doi.org/10.1001/jama.2017.21382			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362793				2022-12-28	WOS:000423405300010
J	Hohr, AIC; Lindau, C; Wirth, C; Qiu, J; Stroud, DA; Kutik, S; Guiard, B; Hunte, C; Becker, T; Pfanner, N; Wiedemann, N				Hohr, Alexandra I. C.; Lindau, Caroline; Wirth, Christophe; Qiu, Jian; Stroud, David A.; Kutik, Stephan; Guiard, Bernard; Hunte, Carola; Becker, Thomas; Pfanner, Nikolaus; Wiedemann, Nils			Membrane protein insertion through a mitochondrial beta-barrel gate	SCIENCE			English	Article							OUTER-MEMBRANE; ASSEMBLY MACHINERY; STRUCTURAL BASIS; PERIPLASMIC CHAPERONES; ESSENTIAL COMPONENT; CRYSTAL-STRUCTURE; BIOGENESIS; BAMA; COMPLEX; TRANSLOCATION	The biogenesis of mitochondria, chloroplasts, and Gram-negative bacteria requires the insertion of beta-barrel proteins into the outer membranes. Homologous Omp85 proteins are essential for membrane insertion of beta-barrel precursors. It is unknown if precursors are threaded through the Omp85-channel interior and exit laterally or if they are translocated into the membrane at the Omp85-lipid interface. We have mapped the interaction of a precursor in transit with the mitochondrial Omp85-channel Sam50 in the native membrane environment. The precursor is translocated into the channel interior, interacts with an internal loop, and inserts into the lateral gate by beta-signal exchange. Transport through the Omp85-channel interior followed by release through the lateral gate into the lipid phase may represent a basic mechanism for membrane insertion of beta-barrel proteins.	[Hohr, Alexandra I. C.; Lindau, Caroline; Wirth, Christophe; Qiu, Jian; Stroud, David A.; Kutik, Stephan; Hunte, Carola; Becker, Thomas; Pfanner, Nikolaus; Wiedemann, Nils] Univ Freiburg, Inst Biochem & Mol Biol, Fac Med, Ctr Biochem & Mol Cell Res ZBMZ, D-79104 Freiburg, Germany; [Hohr, Alexandra I. C.; Lindau, Caroline] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Guiard, Bernard] CNRS, Ctr Genet Mol, F-91190 Gif Sur Yvette, France; [Hunte, Carola; Becker, Thomas; Pfanner, Nikolaus; Wiedemann, Nils] Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany; [Qiu, Jian] Swiss Fed Inst Technol EPFL, CH-1015 Lausanne, Switzerland; [Stroud, David A.] Univ Melbourne, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia; [Stroud, David A.] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia	University of Freiburg; University of Freiburg; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Freiburg; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; University of Melbourne; University of Melbourne	Pfanner, N; Wiedemann, N (corresponding author), Univ Freiburg, Inst Biochem & Mol Biol, Fac Med, Ctr Biochem & Mol Cell Res ZBMZ, D-79104 Freiburg, Germany.; Pfanner, N; Wiedemann, N (corresponding author), Univ Freiburg, BIOSS Ctr Biol Signalling Studies, D-79104 Freiburg, Germany.	nikolaus.pfanner@biochemie.uni-freiburg.de; nils.wiedemann@biochemie.uni-freiburg.de	Stroud, David Arthur/HGB-4331-2022; Qiu, Jian/ABD-2260-2020; Becker, Thomas/AAS-9404-2020; Pfanner, Nikolaus/AAV-7878-2021; Hunte, Carola/E-4071-2015	Stroud, David Arthur/0000-0002-2048-3383; Qiu, Jian/0000-0001-7873-0722; Hunte, Carola/0000-0002-0826-3986; Wirth, Christophe/0000-0001-8864-6508; guiard, bernard/0000-0001-5774-7867; Kutik, Stephan/0000-0002-4241-109X; Wiedemann, Nils/0000-0001-8305-6728	European Research Council [648235]; Deutsche Forschungsgemeinschaft [PF 202/8-1, BE 4679/2-1]; Sonderforschungsbereiche grants [746, 1140]; Excellence Initiative of the German federal and state governments grants [EXC 294 BIOSS, GSC-4]	European Research Council(European Research Council (ERC)European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Sonderforschungsbereiche grants; Excellence Initiative of the German federal and state governments grants	We thank C. Meisinger for discussion. This work was supported by the European Research Council Consolidator Grant no. 648235, the Deutsche Forschungsgemeinschaft grants PF 202/8-1 and BE 4679/2-1, the Sonderforschungsbereiche grants 746 and 1140, and the Excellence Initiative of the German federal and state governments grants EXC 294 BIOSS and GSC-4 Spemann Graduate School). Work included in this study has also been performed in partial fulfillment of the requirements for the doctoral theses of A.I.C.H. and C.L. and the diploma thesis of A.I.C.H. at the University of Freiburg. The data presented in this paper are tabulated in the main paper and the supplementary materials.	Albrecht R, 2014, ACTA CRYSTALLOGR D, V70, P1779, DOI 10.1107/S1399004714007482; Bakelar J, 2016, SCIENCE, V351, P180, DOI 10.1126/science.aad3460; Bamert RS, 2017, MOL MICROBIOL, V106, P142, DOI 10.1111/mmi.13757; Baud C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6271; Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105; BONNEAUD N, 1991, YEAST, V7, P609, DOI 10.1002/yea.320070609; Bos MP, 2007, EMBO REP, V8, P1149, DOI 10.1038/sj.embor.7401092; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5; Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860; Danoff EJ, 2015, BIOCHEMISTRY-US, V54, P97, DOI 10.1021/bi501443p; Delattre AS, 2010, FEBS J, V277, P4755, DOI 10.1111/j.1742-4658.2010.07881.x; Doerner PA, 2017, BIOCHEMISTRY-US, V56, P3142, DOI 10.1021/acs.biochem.7b00281; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fairman JW, 2011, CURR OPIN STRUC BIOL, V21, P523, DOI 10.1016/j.sbi.2011.05.005; Gatzeva-Topalova PZ, 2008, STRUCTURE, V16, P1873, DOI 10.1016/j.str.2008.09.014; Gentle I, 2004, J CELL BIOL, V164, P19, DOI 10.1083/jcb.200310092; Gessmann D, 2014, P NATL ACAD SCI USA, V111, P5878, DOI 10.1073/pnas.1322473111; Gruss F, 2013, NAT STRUCT MOL BIOL, V20, P1318, DOI 10.1038/nsmb.2689; Gu YH, 2017, BIOCHEM J, V474, P3951, DOI 10.1042/BCJ20170636; Gu YH, 2016, NATURE, V531, P64, DOI 10.1038/nature17199; Habib SJ, 2007, J CELL BIOL, V176, P77, DOI 10.1083/jcb.200602050; Hagan CL, 2011, ANNU REV BIOCHEM, V80, P189, DOI 10.1146/annurev-biochem-061408-144611; Han L, 2016, NAT STRUCT MOL BIOL, V23, P192, DOI 10.1038/nsmb.3181; Hildebrand A, 2009, PROTEINS, V77, P128, DOI 10.1002/prot.22499; Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302; Hohr AIC, 2015, BBA-MOL CELL RES, V1853, P74, DOI 10.1016/j.bbamcr.2014.10.006; Hoppins SC, 2004, J BIOL CHEM, V279, P12396, DOI 10.1074/jbc.M313037200; Iadanza MG, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12865; Ishikawa D, 2004, J CELL BIOL, V166, P621, DOI 10.1083/jcb.200405138; Jores T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12036; Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993; Klein A, 2012, J CELL BIOL, V199, P599, DOI 10.1083/jcb.201207161; Kleinschmidt JH, 2015, BBA-BIOMEMBRANES, V1848, P1927, DOI 10.1016/j.bbamem.2015.05.004; Knowles TJ, 2008, MOL MICROBIOL, V68, P1216, DOI 10.1111/j.1365-2958.2008.06225.x; Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200; Kutik S, 2008, CELL, V132, P1011, DOI 10.1016/j.cell.2008.01.028; Lee J, 2016, P NATL ACAD SCI USA, V113, P8717, DOI 10.1073/pnas.1604100113; Leonard-Rivera M, 2012, J BACTERIOL, V194, P4662, DOI 10.1128/JB.00825-12; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Maier T, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8452; Mallarino LE, 2015, BIOCHEMISTRY-US, V54, P844, DOI 10.1021/bi5011305; Meisinger Chris, 2006, Methods Mol Biol, V313, P33; Milenkovic D, 2004, J BIOL CHEM, V279, P22781, DOI 10.1074/jbc.C400120200; Ni DC, 2014, FASEB J, V28, P2677, DOI 10.1096/fj.13-248450; Noinaj N, 2017, NAT REV MICROBIOL, V15, DOI 10.1038/nrmicro.2016.191; Noinaj N, 2015, CURR OPIN STRUC BIOL, V31, P35, DOI 10.1016/j.sbi.2015.02.012; Noinaj N, 2014, STRUCTURE, V22, P1055, DOI 10.1016/j.str.2014.05.008; Noinaj N, 2013, NATURE, V501, P385, DOI 10.1038/nature12521; Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208; Patel GJ, 2013, BIOCHEMISTRY-US, V52, P3974, DOI 10.1021/bi400103t; Pfitzner AK, 2016, SCI REP-UK, V6, DOI 10.1038/srep39053; Qiu J, 2013, CELL, V154, P596, DOI 10.1016/j.cell.2013.06.033; Rigel NW, 2013, P NATL ACAD SCI USA, V110, P5151, DOI 10.1073/pnas.1302662110; Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schiffrin B, 2017, J MOL BIOL, V429, P3776, DOI 10.1016/j.jmb.2017.09.008; Selkrig J, 2012, NAT STRUCT MOL BIOL, V19, P506, DOI 10.1038/nsmb.2261; Shiota T, 2015, SCIENCE, V349, P1544, DOI 10.1126/science.aac6428; Sikdar R, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01246-4; SIKORSKI RS, 1989, GENETICS, V122, P19; Sklar JG, 2007, GENE DEV, V21, P2473, DOI 10.1101/gad.1581007; Stojanovski D, 2007, METHOD CELL BIOL, V80, P783, DOI 10.1016/S0091-679X(06)80036-1; Stroud DA, 2011, MOL BIOL CELL, V22, P2823, DOI 10.1091/mbc.E11-02-0148; Stubenrauch C, 2016, NAT MICROBIOL, V1, DOI [10.1038/NMICROBIOL.2016.64, 10.1038/nmicrobiol.2016.64]; Ujwal R, 2008, P NATL ACAD SCI USA, V105, P17742, DOI 10.1073/pnas.0809634105; Ulrich T, 2015, INT J MED MICROBIOL, V305, P259, DOI 10.1016/j.ijmm.2014.12.009; van den Berg B, 2013, NAT STRUCT MOL BIOL, V20, P1237, DOI 10.1038/nsmb.2709; Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973; Waizenegger T, 2004, EMBO REP, V5, P704, DOI 10.1038/sj.embor.7400183; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]; Wenz LS, 2015, J CELL BIOL, V210, P1047, DOI 10.1083/jcb.201504119; Wiedemann N, 2003, NATURE, V424, P565, DOI 10.1038/nature01753; Wiedemann N, 2004, J BIOL CHEM, V279, P18188, DOI 10.1074/jbc.M400050200; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Zhang XJC, 2016, PROTEIN CELL, V7, P471, DOI 10.1007/s13238-016-0273-6	77	81	82	2	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					289	+	eaah6834	10.1126/science.aah6834	http://dx.doi.org/10.1126/science.aah6834			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6BB	29348211	Green Accepted			2022-12-28	WOS:000423236700030
J	Chatterjee, P				Chatterjee, Patralekha			Doctors disagree with proposed medical bill in India	LANCET			English	Editorial Material																			0	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 13	2018	391	10116					110	110		10.1016/S0140-6736(18)30054-0	http://dx.doi.org/10.1016/S0140-6736(18)30054-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT0EG	29353609				2022-12-28	WOS:000422793400012
J	Joblin, C; Cernicharo, J				Joblin, Christine; Cernicharo, Jose			Detecting the building blocks of aromatics	SCIENCE			English	Editorial Material							INTERSTELLAR-MEDIUM; HYDROCARBONS; DISCOVERY; BENZENE		[Joblin, Christine] Univ Toulouse UPS, CNRS, Inst Rech Astrophys & Planetol, F-31028 Toulouse 4, France; [Cernicharo, Jose] CSIC, ICMM, Mol Astrophys Grp, Madrid 28049, Spain	Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Federale Toulouse Midi-Pyrenees (ComUE); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencia de Materiales de Madrid (ICMM)	Joblin, C (corresponding author), Univ Toulouse UPS, CNRS, Inst Rech Astrophys & Planetol, F-31028 Toulouse 4, France.	christine.joblin@irap.omp.eu	Joblin, Christine/ABD-5154-2020; Cernicharo, Jose/G-3059-2015	Joblin, Christine/0000-0003-1561-6118; Cernicharo, Jose/0000-0002-3518-2524				Cernicharo J, 2001, ASTROPHYS J, V546, pL123, DOI 10.1086/318871; FRENKLACH M, 1989, ASTROPHYS J, V341, P372, DOI 10.1086/167501; Herbst E, 2009, ANNU REV ASTRON ASTR, V47, P427, DOI 10.1146/annurev-astro-082708-101654; Hudgins DM, 2005, ASTROPHYS J, V632, P316, DOI 10.1086/432495; Jones BM, 2011, P NATL ACAD SCI USA, V108, P452, DOI 10.1073/pnas.1012468108; Kaiser RI, 2015, ANNU REV PHYS CHEM, V66, P43, DOI 10.1146/annurev-physchem-040214-121502; Kalenskii S. V., 2017, P RUSS IND WORKSH RA, V43; McGuire BA, 2018, SCIENCE, V359, P202, DOI 10.1126/science.aao4890; McGuire BA, 2016, SCIENCE, V352, P1449, DOI 10.1126/science.aae0328; Merino P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4054; Pilleri P, 2015, ASTRON ASTROPHYS, V577, DOI 10.1051/0004-6361/201425590; Sellgren K, 2010, ASTROPHYS J LETT, V722, pL54, DOI 10.1088/2041-8205/722/1/L54; Zhao TQ, 2016, PHYS CHEM CHEM PHYS, V18, P3489, DOI 10.1039/c5cp06425b	14	12	12	0	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					156	157		10.1126/science.aar4541	http://dx.doi.org/10.1126/science.aar4541			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FS5EO	29326258				2022-12-28	WOS:000419816600020
J	Barraclough, K; Bradbury, A				Barraclough, Kevin; Bradbury, Andrew			Chronic limb threatening ischaemia	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISEASE		[Barraclough, Kevin] Hoyland House, Painswick, England; [Bradbury, Andrew] Univ Birmingham, Birmingham, W Midlands, England	University of Birmingham	Barraclough, K (corresponding author), Hoyland House, Painswick, England.	k.barraclough@btinternet.com						Bradbury AW, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14140; Brearley S, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2681; Criqui MH, 2015, CIRC RES, V116, P1509, DOI 10.1161/CIRCRESAHA.116.303849; Humphreys W, 1999, BMJ-BRIT MED J, V318, P925, DOI 10.1136/bmj.318.7188.925; McGee SR, 1998, ARCH INTERN MED, V158, P1357, DOI 10.1001/archinte.158.12.1357; National Institute for Health and Care Excellence, 2012, PER ART DIS DIAGN MA, V147; Olin JW, 2000, NEW ENGL J MED, V343, P864, DOI 10.1056/NEJM200009213431207; Peach G, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5208	8	1	1	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 11	2018	360								j5460	10.1136/bmj.j5460	http://dx.doi.org/10.1136/bmj.j5460			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS9NC	29326105				2022-12-28	WOS:000422743900009
J	Hibbert, KA; Shepard, JAO; Lane, RJ; Azar, MM				Hibbert, Kathryn A.; Shepard, Jo-Anne O.; Lane, Rebekah J.; Azar, Marwan M.			Case 1-2018: A 39-Year-Old Woman with Rapidly Progressive Respiratory Failure	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							STEM-CELL TRANSPLANTATION; ADENOVIRUS INFECTIONS; PULMONARY TOXICITY; THERAPY; DISEASE		[Hibbert, Kathryn A.; Lane, Rebekah J.] Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA; [Shepard, Jo-Anne O.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Azar, Marwan M.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Hibbert, Kathryn A.; Lane, Rebekah J.] Harvard Med Sch, Dept Med, Boston, MA 02115 USA; [Shepard, Jo-Anne O.] Harvard Med Sch, Dept Radiol, Boston, MA USA; [Azar, Marwan M.] Harvard Med Sch, Dept Pathol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Hibbert, KA (corresponding author), Massachusetts Gen Hosp, Dept Med, Boston, MA 02114 USA.; Hibbert, KA (corresponding author), Harvard Med Sch, Dept Med, Boston, MA 02115 USA.		Azar, Marwan/AAE-9784-2020					Akasheh MS, 2000, BONE MARROW TRANSPL, V26, P1107, DOI 10.1038/sj.bmt.1702664; [Anonymous], 2017, TICKB DIS US REF MAN; Chakrabarti S, 2002, BLOOD, V100, P1619, DOI 10.1182/blood-2002-02-0377; Chi AK, 2013, CHEST, V144, P1913, DOI 10.1378/chest.12-1708; FLOMENBERG P, 1994, J INFECT DIS, V169, P775, DOI 10.1093/infdis/169.4.775; Florescu DF, 2012, BIOL BLOOD MARROW TR, V18, P731, DOI 10.1016/j.bbmt.2011.09.007; Forghieri F, 2007, HAEMATOLOGICA, V92, pE85, DOI 10.3324/haematol.11697; Grimley M, 1 INTERVENTIONAL TRI; Gurjal A, 1999, LUNG CANCER-J IASLC, V26, P109, DOI 10.1016/S0169-5002(99)00081-1; Helman DL, 2002, CHEST, V122, P785, DOI 10.1378/chest.122.3.785; Ison MG, 2006, CLIN INFECT DIS, V43, P331, DOI 10.1086/505498; Jain S, 2015, NEW ENGL J MED, V373, P2382; Lacy SA, 1998, TOXICOL SCI, V44, P97, DOI 10.1093/toxsci/44.2.97; Lerner PI, 1996, CLIN INFECT DIS, V22, P891, DOI 10.1093/clinids/22.6.891; Ljungman P, 2017, CLIN INFECT DIS, V64, P87, DOI 10.1093/cid/ciw668; MATSUKAWA Y, 1993, ACTA HAEMATOL-BASEL, V90, P155, DOI 10.1159/000204399; Matthes-Martin S, 2012, TRANSPL INFECT DIS, V14, P555, DOI 10.1111/tid.12022; Musher DM, 2014, NEW ENGL J MED, V371, P1619, DOI 10.1056/NEJMra1312885; Robin M, 2007, HAEMATOLOGICA, V92, P1254, DOI 10.3324/haematol.11279; Rocholl C, 2004, PEDIATRICS, V113, pE51, DOI 10.1542/peds.113.1.e51; SCHWARZMANN SW, 1971, ARCH INTERN MED, V127, P1037, DOI 10.1001/archinte.127.6.1037; SPACH DH, 1993, NEW ENGL J MED, V329, P936, DOI 10.1056/NEJM199309233291308; Thomas CF, 2004, NEW ENGL J MED, V350, P2487, DOI 10.1056/NEJMra032588	23	2	2	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 11	2018	378	2					182	190		10.1056/NEJMcpc1712222	http://dx.doi.org/10.1056/NEJMcpc1712222			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS7IR	29320657				2022-12-28	WOS:000419971600013
J	Jain, Y; Jain, P				Jain, Yogesh; Jain, Priyank			ESSAY Communitisation of healthcare: peer support groups for chronic disease care in rural India	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IMPACT		[Jain, Yogesh; Jain, Priyank] Jan Swasthya Sahyog, Bilaspur, Chhattisgarh, India; [Jain, Priyank] Cambridge Hlth Alliance, Cambridge, MA USA	Harvard University; Cambridge Health Alliance	Jain, Y (corresponding author), Jan Swasthya Sahyog, Bilaspur, Chhattisgarh, India.	yogeshjain.jssbilaspur@gmail.com						[Anonymous], 2016, CHHATTISGARH BUDGET; Batalden M, 2016, BMJ QUAL SAF, V25, P509, DOI 10.1136/bmjqs-2015-004315; Bateganya MH, 2015, JAIDS-J ACQ IMM DEF, V68, pS368, DOI 10.1097/QAI.0000000000000519; Cameron LD, 2007, PSYCHO-ONCOLOGY, V16, P171, DOI 10.1002/pon.1050; Cohen A, 2012, INT J MENT HEALTH SY, V6, DOI 10.1186/1752-4458-6-1; Davis T, 2014, J BURN CARE RES, V35, P416, DOI 10.1097/BCR.0000000000000011; Institute of Applied Manpower Research Planning Commission Government of India, 2012, IND HUM DEV REP 2011; Jain Y, 2015, INDIAN J MED RES, V141, P663; Joshi Ankur, 2016, J Family Med Prim Care, V5, P270; Malini MH, 2015, AUST J RURAL HEALTH, V23, P95, DOI 10.1111/ajr.12126; MULLEY A, 2015, BMJ-BRIT MED J, V351, DOI DOI 10.1136/BMJ.H4448; Mulley A, 2017, BMJ-BRIT MED J, V356, DOI 10.1136/bmj.j1401; National Voices, 2015, PEER SUPP WHAT IS DO; Pandey RS, 2010, COMMUNITISATION 3 WA; Pate T, 2015, ZDRAV VARST, V54, P79, DOI 10.1515/sjph-2015-0012; Reserve Bank of India, 2015, HDB STAT INDIAN EC; SabatU E., 2003, ADHERENCE LONG TERM; Sahyog Jan Swasthya, 2017, HYPERTENSION PEER SU; Sahyog Jan Swasthya, 2017, SICKLE CELL PEER SUP; Willis E, 2016, DEMENTIA	20	3	3	2	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 10	2018	360								k85	10.1136/bmj.k85	http://dx.doi.org/10.1136/bmj.k85			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS9MW	29321150				2022-12-28	WOS:000422743300005
J	Nussbaum, S; McClellan, M; Metlay, G				Nussbaum, Sam; McClellan, Mark; Metlay, Grischa			Principles for a Framework for Alternative Payment Models	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Nussbaum, Sam] USC Schaeffer Ctr Hlth Policy & Econ, Los Angeles, CA USA; [McClellan, Mark] Duke Univ, Margolis Ctr Hlth Policy, Washington, DC USA; [Metlay, Grischa] Mitre Corp, 2275 Rolling Run Dr, Windsor Mill, MD 21244 USA	Duke University; MITRE Corporation	Metlay, G (corresponding author), Mitre Corp, 2275 Rolling Run Dr, Windsor Mill, MD 21244 USA.	gmetlay@mitre.org			Guiding Committee for LAN	Guiding Committee for LAN	The authors were supported by their respective organizations for the research and time spent in preparing the manuscript. Dr McClellan receives funding as co-chair of the Guiding Committee for LAN.	[Anonymous], 2017, THE APM FRAM; Health Care Payment Learning & Action Network, APM MEAS EFF; Health Care Payment Learning and Action Network, 2017, ALT PAYM MOD APM FRA; Health Care Payment Learning and Action Network Alternative Payment Model Framework and Progress Tracking (APM FPT) Work Group, 2016, ALT PAYM MOD APM FRA; Rajkumar R, 2014, JAMA-J AM MED ASSOC, V311, P1967, DOI 10.1001/jama.2014.3703	5	25	25	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 20	2018	319	7					653	654		10.1001/jama.2017.20226	http://dx.doi.org/10.1001/jama.2017.20226			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW7MQ	29379954				2022-12-28	WOS:000425508400011
J	Dehaene, S; Lau, H; Kouider, S				Dehaene, Stanislas; Lau, Hakwan; Kouider, Sid			Conscious machines: Robot rights Response	SCIENCE			English	Letter							PERCEPTION		[Dehaene, Stanislas] Coll France, Chair Expt Cognit Psychol, F-75005 Paris, France; [Dehaene, Stanislas] Univ Paris Saclay, Univ Paris Sud, Commissariat Energie Atom & Energies Alternat CEA, INSERM,NeuroSpin Ctr,Cognit Neuroimaging Unit, F-91191 Gif Sur Yvette, France; [Lau, Hakwan] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA; [Lau, Hakwan] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90095 USA; [Lau, Hakwan] Univ Hong Kong, Dept Psychol, Hong Kong, Hong Kong, Peoples R China; [Kouider, Sid] Paris Sci & Lettres Res Univ, CNRS, Ecole Normale Super,Brain & Consciousness Grp, Ecole Hautes Etud Sci Sociales,Dept Etudes Cognit, Paris, France	UDICE-French Research Universities; PSL Research University Paris; College de France; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Hong Kong; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS)	Dehaene, S (corresponding author), Coll France, Chair Expt Cognit Psychol, F-75005 Paris, France.; Dehaene, S (corresponding author), Univ Paris Saclay, Univ Paris Sud, Commissariat Energie Atom & Energies Alternat CEA, INSERM,NeuroSpin Ctr,Cognit Neuroimaging Unit, F-91191 Gif Sur Yvette, France.	stanislas.dehaene@cea.fr						Dehaene S., 2020, WE LEARN NEW SCI ED; Dennett D, 2001, COGNITION, V79, P221, DOI 10.1016/S0010-0277(00)00130-X; Dennett D., 1988, CONSCIOUSNESS CONT S, P42, DOI DOI 10.1093/ACPROF:OSO/9780198522379.003.0003; Fletcher PC, 2009, NAT REV NEUROSCI, V10, P48, DOI 10.1038/nrn2536; Ko Y, 2012, PHILOS T R SOC B, V367, P1401, DOI 10.1098/rstb.2011.0380; Kouider S, 2007, PHILOS T R SOC B, V362, P857, DOI 10.1098/rstb.2007.2093; Odegaard B, 2017, J NEUROSCI, V37, P9593, DOI 10.1523/JNEUROSCI.3217-16.2017; Panagiotaropoulos TI, 2012, NEURON, V74, P924, DOI 10.1016/j.neuron.2012.04.013; Pontifical Academy of Sciences, 2016, FIN STAT WORKSH POW; Ullman TD, 2017, TRENDS COGN SCI, V21, P649, DOI 10.1016/j.tics.2017.05.012; Wang MG, 2013, P NATL ACAD SCI USA, V110, pE3350, DOI 10.1073/pnas.1221945110; Weiss Y, 2002, NAT NEUROSCI, V5, P598, DOI 10.1038/nn858	12	2	2	8	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					400	402		10.1126/science.aar8639	http://dx.doi.org/10.1126/science.aar8639			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6SD	29371461				2022-12-28	WOS:000423283200035
J	Ni, AM; Ruff, DA; Alberts, JJ; Symmonds, J; Cohen, MR				Ni, A. M.; Ruff, D. A.; Alberts, J. J.; Symmonds, J.; Cohen, M. R.			Learning and attention reveal a general relationship between population activity and behavior	SCIENCE			English	Article							DECISION-RELATED ACTIVITY; SPIKE COUNT CORRELATIONS; VISUAL-CORTEX; INTERNEURONAL CORRELATIONS; FLUCTUATIONS; PERFORMANCE; INFORMATION	Prior studies have demonstrated that correlated variability changes with cognitive processes that improve perceptual performance. We tested whether correlated variability covaries with subjects' performance-whether performance improves quickly with attention or slowly with perceptual learning. We found a single, consistent relationship between correlated variability and behavioral performance, regardless of the time frame of correlated variability change. This correlated variability was oriented along the dimensions in population space used by the animal on a trial-by-trial basis to make decisions. That subjects' choices were predicted by specific dimensions that were aligned with the correlated variability axis clarifies long-standing paradoxes about the relationship between shared variability and behavior.	[Cohen, M. R.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA; Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Cohen, MR (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA 15260 USA.	cohenm@pitt.edu		Symmonds, Jen/0000-0002-2030-7005; Ni, Amy/0000-0002-1746-9206; Ruff, Douglas/0000-0001-7228-8822; Cohen, Marlene/0000-0001-8583-4300	U.S. NIH [4R00EY020844-03, R01 EY022930, P30 EY008098s]; Whitehall Foundation grant; Klingenstein-Simons Fellowship; Sloan Research Fellowship; McKnight Scholar Award; Simons Foundation; NATIONAL EYE INSTITUTE [R01EY022930, P30EY008098, R00EY020844] Funding Source: NIH RePORTER	U.S. NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Whitehall Foundation grant; Klingenstein-Simons Fellowship; Sloan Research Fellowship(Alfred P. Sloan Foundation); McKnight Scholar Award; Simons Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	M.R.C. is supported by U.S. NIH grants 4R00EY020844-03, R01 EY022930, and Core Grant P30 EY008098s; a Whitehall Foundation grant; a Klingenstein-Simons Fellowship; a Sloan Research Fellowship; a McKnight Scholar Award; and a grant from the Simons Foundation. A.M.N. is supported by a fellowship from the Simons Foundation. We thank K. McCracken for technical assistance and J.H.R. Maunsell and A. Kohn for comments on a previous version of this manuscript. A.M.N., D.A.R., and M.R.C. designed the experiments; A.M.N., D.A.R., J.J.A., and J.S. collected the data; A.M.N. performed the analyses; and A.M.N. and M.R.C. wrote the paper. The authors declare no competing financial interests. Data analyzed in this manuscript are available at https://pitt.box.com/v/NiRuffAlbertsSymmondsCohen2017.	Chandrasekaran C, 2017, CURR OPIN NEUROBIOL, V43, P25, DOI 10.1016/j.conb.2016.11.002; Cohen MR, 2011, NAT NEUROSCI, V14, P811, DOI 10.1038/nn.2842; Cohen MR, 2009, NAT NEUROSCI, V12, P1594, DOI 10.1038/nn.2439; Ecker AS, 2016, J NEUROSCI, V36, P1775, DOI 10.1523/JNEUROSCI.2044-15.2016; Gu Y, 2011, NEURON, V71, P750, DOI 10.1016/j.neuron.2011.06.015; Jeanne JM, 2013, NEURON, V78, P352, DOI 10.1016/j.neuron.2013.02.023; Jehee JFM, 2012, J NEUROSCI, V32, P16747, DOI 10.1523/JNEUROSCI.6112-11.2012; Kanashiro T, 2017, ELIFE, V6, DOI 10.7554/eLife.23978; Kohn A, 2016, ANNU REV NEUROSCI, V39, P237, DOI 10.1146/annurev-neuro-070815-013851; Kwon SE, 2016, NAT NEUROSCI, V19, P1243, DOI 10.1038/nn.4356; Maunsell JHR, 2015, ANNU REV VIS SCI, V1, P373, DOI 10.1146/annurev-vision-082114-035431; Mitchell JF, 2009, NEURON, V63, P879, DOI 10.1016/j.neuron.2009.09.013; Moreno-Bote R, 2014, NAT NEUROSCI, V17, P1410, DOI 10.1038/nn.3807; Nienborg H, 2009, NATURE, V459, P89, DOI 10.1038/nature07821; Rabinowitz NC, 2015, ELIFE, V4, DOI 10.7554/eLife.08998; Ruff DA, 2016, J NEUROSCI, V36, P7523, DOI 10.1523/JNEUROSCI.0610-16.2016; Ruff DA, 2014, NAT NEUROSCI, V17, P1591, DOI 10.1038/nn.3835; Watanabe T, 2015, ANNU REV PSYCHOL, V66, P197, DOI 10.1146/annurev-psych-010814-015214; Yan Y, 2014, NAT NEUROSCI, V17, P1380, DOI 10.1038/nn.3805; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	20	84	84	3	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					463	465		10.1126/science.aao0284	http://dx.doi.org/10.1126/science.aao0284			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6SD	29371470	Green Accepted			2022-12-28	WOS:000423283200048
J	Perera, D; Tucker, JW; Brahmbhatt, S; Helal, CJ; Chong, A; Farrell, W; Richardson, P; Sach, NW				Perera, Damith; Tucker, Joseph W.; Brahmbhatt, Shalini; Helal, Christopher J.; Chong, Ashley; Farrell, William; Richardson, Paul; Sach, Neal W.			A platform for automated nanomole-scale reaction screening and micromole-scale synthesis in flow	SCIENCE			English	Article							LIGAND KNOWLEDGE-BASE; REACTION OPTIMIZATION; REACTORS; INHIBITORS; COUPLINGS; EXPANSION; SELECTION; DESIGN	The scarcity of complex intermediates in pharmaceutical research motivates the pursuit of reaction optimization protocols on submilligram scales. We report here the development of an automated flow-based synthesis platform, designed from commercially available components, that integrates both rapid nanomole-scale reaction screening and micromole-scale synthesis into a single modular unit. This system was validated by exploring a diverse range of reaction variables in a Suzuki-Miyaura coupling on nanomole scale at elevated temperatures, generating liquid chromatography-mass spectrometry data points for 5760 reactions at a rate of >1500 reactions per 24 hours. Through multiple injections of the same segment, the system directly produced micromole quantities of desired material. The optimal conditions were also replicated in traditional flow and batch mode at 50- to 200-milligram scale to provide good to excellent yields.	[Perera, Damith; Brahmbhatt, Shalini; Chong, Ashley; Farrell, William; Richardson, Paul; Sach, Neal W.] La Jolla Labs, Pfizer Worldwide Res & Dev, 10770 Sci Ctr Dr, San Diego, CA 92121 USA; [Tucker, Joseph W.; Helal, Christopher J.] Pfizer Worldwide Res & Dev, Eastern Point Rd, Groton, CT 06340 USA	Pfizer; Pfizer	Perera, D; Richardson, P; Sach, NW (corresponding author), La Jolla Labs, Pfizer Worldwide Res & Dev, 10770 Sci Ctr Dr, San Diego, CA 92121 USA.	sanjeewadamith.perera@pfizer.com; paul.f.richardson@pfizer.com; neal.sach@pfizer.com		Perera, Damith/0000-0002-0326-5958; Brahmbhatt, Shalini/0000-0002-8949-9789; Chong, Ashley/0000-0001-5142-133X	Pfizer	Pfizer(Pfizer)	We thank L. Bernier, J. Braganza, M. Collins, K. Dress, J. Lafontaine, G. Ng, U. Reilly, D. Richter, T. Long, G. Steeno, C. Subramanyam, and D. Truong for helpful discussions. D. P. was supported by postdoctoral research fellowship from Pfizer. Additional data supporting the conclusion are available in the supplementary materials.	Barder TE, 2005, J AM CHEM SOC, V127, P4685, DOI 10.1021/ja042491j; Brow DG, 2016, J MED CHEM, V59, P4443, DOI 10.1021/acs.jmedchem.5b01409; Cernak T, 2017, J MED CHEM, V60, P3594, DOI 10.1021/acs.jmedchem.6b01543; DiMasi JA, 2016, J HEALTH ECON, V47, P20, DOI 10.1016/j.jhealeco.2016.01.012; Farrant E, 2011, RSC DRUG DISCOV, V11, P1, DOI 10.1039/9781849733052-00001; Fitzpatrick DE, 2016, ACS CENTRAL SCI, V2, P131, DOI 10.1021/acscentsci.6b00015; Gildner PG, 2015, ORGANOMETALLICS, V34, P5497, DOI 10.1021/acs.organomet.5b00567; Gunther A, 2005, LANGMUIR, V21, P1547, DOI 10.1021/la0482406; Gunther A, 2006, LAB CHIP, V6, P1487, DOI 10.1039/b609851g; Hawbaker N, 2016, ORG PROCESS RES DEV, V20, P465, DOI 10.1021/op500360w; Holmes N, 2016, REACT CHEM ENG, V1, P96, DOI 10.1039/c5re00083a; Huang QH, 2011, ORG PROCESS RES DEV, V15, P556, DOI 10.1021/op100286g; Huang XH, 2003, J AM CHEM SOC, V125, P6653, DOI 10.1021/ja035483w; Jouyban A, 2004, INT J PHARM, V269, P353, DOI 10.1016/j.ijpharm.2003.09.010; Jover J, 2012, ORGANOMETALLICS, V31, P5302, DOI 10.1021/om300312t; Jover J, 2010, ORGANOMETALLICS, V29, P6245, DOI 10.1021/om100648v; Kamer PCJ, 2001, ACCOUNTS CHEM RES, V34, P895, DOI 10.1021/ar000060+; Lennox AJJ, 2014, CHEM SOC REV, V43, P412, DOI 10.1039/c3cs60197h; Lennox AJJ, 2013, ANGEW CHEM INT EDIT, V52, P7362, DOI 10.1002/anie.201301737; Magano J, 2011, CHEM REV, V111, P2177, DOI 10.1021/cr100346g; Mohamed DKB, 2016, TETRAHEDRON LETT, V57, P3965, DOI 10.1016/j.tetlet.2016.07.072; Murray PM, 2016, ORG BIOMOL CHEM, V14, P2373, DOI 10.1039/c5ob01892g; Naber JR, 2010, ANGEW CHEM INT EDIT, V49, P9469, DOI 10.1002/anie.201004425; Plutschack MB, 2017, CHEM REV, V117, P11796, DOI 10.1021/acs.chemrev.7b00183; Reizman BJ, 2016, ACCOUNTS CHEM RES, V49, P1786, DOI 10.1021/acs.accounts.6b00261; Reizman BJ, 2015, CHEM COMMUN, V51, P13290, DOI 10.1039/c5cc03651h; Roughley SD, 2011, J MED CHEM, V54, P3451, DOI 10.1021/jm200187y; Santanilla AB, 2015, SCIENCE, V347, P49, DOI 10.1126/science.1259203; Zapf A, 2000, ANGEW CHEM INT EDIT, V39, P4153, DOI 10.1002/1521-3773(20001117)39:22<4153::AID-ANIE4153>3.0.CO;2-T	29	166	168	18	159	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					429	434		10.1126/science.aap9112	http://dx.doi.org/10.1126/science.aap9112			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6SD	29371464				2022-12-28	WOS:000423283200040
J	Markmiller, S; Soltanieh, S; Server, KL; Mak, R; Jin, WH; Fang, MY; Luo, EC; Krach, F; Yang, DJ; Sen, A; Fulzele, A; Wozniak, JM; Gonzalez, DJ; Kankel, MW; Gao, FB; Bennett, EJ; Lecuyer, E; Yeo, GW				Markmiller, Sebastian; Soltanieh, Sahar; Server, Kari L.; Mak, Raymond; Jin, Wenhao; Fang, Mark Y.; Luo, En-Ching; Krach, Florian; Yang, Dejun; Sen, Anindya; Fulzele, Amit; Wozniak, Jacob M.; Gonzalez, David J.; Kankel, Mark W.; Gao, Fen-Biao; Bennett, Eric J.; Lecuyer, Eric; Yeo, Gene W.			Context-Dependent and Disease-Specific Diversity in Protein Interactions within Stress Granules	CELL			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; PLURIPOTENT STEM-CELLS; RNA-BINDING PROTEINS; PHASE-SEPARATION; DROSOPHILA MODEL; TDP-43; MUTATIONS; SYSTEM; ALS; DYNAMICS	Stress granules (SGs) are transient ribonucleoprotein (RNP) aggregates that form during cellular stress and are increasingly implicated in human neurodegeneration. To study the proteome and compositional diversity of SGs in different cell types and in the context of neurodegeneration-linked mutations, we used ascorbate peroxidase (APEX) proximity labeling, mass spectrometry, and immunofluorescence to identify similar to 150 previously unknown human SG components. A highly integrated, pre-existing SG protein interaction network in unstressed cells facilitates rapid coalescence into larger SGs. Approximately 20% of SG diversity is stress or cell-type dependent, with neuronal SGs displaying a particularly complex repertoire of proteins enriched in chaperones and autophagy factors. Strengthening the link between SGs and neurodegeneration, we demonstrate aberrant dynamics, composition, and subcellular distribution of SGs in cells from amyotrophic lateral sclerosis (ALS) patients. Using three Drosophila ALS/FTD models, we identify SG-associated modifiers of neurotoxicity in vivo. Altogether, our results highlight SG proteins as central to understanding and ultimately targeting neurodegeneration.	[Markmiller, Sebastian; Server, Kari L.; Fang, Mark Y.; Luo, En-Ching; Krach, Florian; Yeo, Gene W.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Markmiller, Sebastian; Server, Kari L.; Fang, Mark Y.; Luo, En-Ching; Krach, Florian; Yeo, Gene W.] Univ Calif San Diego, Stem Cell Program, La Jolla, CA 92093 USA; [Markmiller, Sebastian; Server, Kari L.; Fang, Mark Y.; Luo, En-Ching; Krach, Florian; Yeo, Gene W.] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92039 USA; [Soltanieh, Sahar; Lecuyer, Eric] Inst Rech Clin Montreal, Montreal, PQ H2W 1R7, Canada; [Mak, Raymond; Fulzele, Amit; Bennett, Eric J.] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Jin, Wenhao; Yeo, Gene W.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117593, Singapore; [Yang, Dejun; Gao, Fen-Biao] Univ Massachusetts, Med Sch, Dept Neurol, Worcester, MA 01605 USA; [Sen, Anindya; Kankel, Mark W.] Biogen Inc, Neuromuscular & Movement Disorders, Cambridge, MA 02142 USA; [Wozniak, Jacob M.; Gonzalez, David J.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Wozniak, Jacob M.; Gonzalez, David J.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Lecuyer, Eric] Univ Montreal, Dept Biochim & Med Mol, Montreal, PQ H3C 3J7, Canada; [Lecuyer, Eric] McGill Univ, Divis Expt Med, Montreal, PQ H3A 1A3, Canada; [Yeo, Gene W.] ASTAR, Mol Engn Lab, Singapore 138673, Singapore	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal; University of California System; University of California San Diego; National University of Singapore; University of Massachusetts System; University of Massachusetts Worcester; Biogen; University of California System; University of California San Diego; University of California System; University of California San Diego; Universite de Montreal; McGill University; Agency for Science Technology & Research (A*STAR)	Yeo, GW (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.; Yeo, GW (corresponding author), Univ Calif San Diego, Stem Cell Program, La Jolla, CA 92093 USA.; Yeo, GW (corresponding author), Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92039 USA.; Yeo, GW (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117593, Singapore.; Yeo, GW (corresponding author), ASTAR, Mol Engn Lab, Singapore 138673, Singapore.	geneyeo@ucsd.edu	Jin, Wenhao/AAA-3365-2019; Yeo, Gene/AAE-7676-2019; Yang, Dejun/L-9865-2016	Yeo, Gene/0000-0002-0799-6037; Yang, Dejun/0000-0001-5118-0652; Markmiller, Sebastian/0000-0002-5399-047X; Wozniak, Jacob/0000-0002-2453-0861; Jin, Wenhao/0000-0002-7885-3527; Mak, Raymond/0000-0002-7081-8671; Fulzele, Amit/0000-0003-1255-6981; LUO, EN-CHING/0000-0001-7941-4924	Larry L. Hillblom Foundation [2014-A-027-FEL]; IRCM Angelo Pizzagalli fellowship; NIH Graduate Training in Cellular and Molecular Pharmacology Training Grant [T32 GM007752]; ALS Canada/Brain Canada Discovery Grant; NIH [R01NS101986, DP2GM119132, NS103172, HG004659]; Packard Center for ALS Research; Target ALS Foundation; Hellman Fellowship; ALS Association; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM119132, T32GM007752, T32GM007198] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS101986, R01NS103172, R01NS066586] Funding Source: NIH RePORTER	Larry L. Hillblom Foundation; IRCM Angelo Pizzagalli fellowship; NIH Graduate Training in Cellular and Molecular Pharmacology Training Grant; ALS Canada/Brain Canada Discovery Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Center for ALS Research; Target ALS Foundation; Hellman Fellowship; ALS Association; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge members of the G.W.Y. lab for critical comments. We thank Shashank Sathe for help with bioinformatics analyses and K.G. Guruharsha and Maria D. Lalioti for valuable comments on the manuscript. S.M. was supported by a postdoctoral fellowship from the Larry L. Hillblom Foundation (2014-A-027-FEL). S.S. was supported by the IRCM Angelo Pizzagalli fellowship. J.M.W. was supported by an NIH Graduate Training in Cellular and Molecular Pharmacology Training Grant T32 GM007752. G.W.Y. is an Alfred P. Sloan Research Fellow, and E.L. is an FRQS Junior 2 Scholar. Work in the Lecuyer lab was supported by an ALS Canada/Brain Canada Discovery Grant. Work in the Gao lab was supported by the NIH (R01NS101986), the Packard Center for ALS Research, and the Target ALS Foundation. Work in the Bennett lab was supported by a Hellman Fellowship and the NIH (DP2GM119132). This work was partially supported by grants from the NIH (NS103172 and HG004659) and the ALS Association (to G.W.Y.).	AINGER K, 1993, J CELL BIOL, V123, P431, DOI 10.1083/jcb.123.2.431; Alami NH, 2014, NEURON, V81, P536, DOI 10.1016/j.neuron.2013.12.018; Aulas A, 2017, J CELL SCI, V130, P927, DOI 10.1242/jcs.199240; Becker LA, 2017, NATURE, V544, P367, DOI 10.1038/nature22038; Beckmann BM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10127; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Blokhuis AM, 2016, ACTA NEUROPATHOL, V132, P175, DOI 10.1007/s00401-016-1575-8; Boeynaems S, 2017, MOL CELL, V65, P1044, DOI 10.1016/j.molcel.2017.02.013; Brannan KW, 2016, MOL CELL, V64, P282, DOI 10.1016/j.molcel.2016.09.003; Buchan JR, 2013, CELL, V153, P1461, DOI 10.1016/j.cell.2013.05.037; Ciechanover A, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00185; Conrad T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11212; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Du ZW, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7626; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Freibaum BD, 2010, J PROTEOME RES, V9, P1104, DOI 10.1021/pr901076y; Gendron JM, 2016, MOL CELL PROTEOMICS, V15, P2576, DOI 10.1074/mcp.M116.058420; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Hung V, 2014, MOL CELL, V55, P332, DOI 10.1016/j.molcel.2014.06.003; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Kammers Kai, 2015, EuPA Open Proteom, V7, P11; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kuleshov MV, 2016, NUCLEIC ACIDS RES, V44, pW90, DOI 10.1093/nar/gkw377; Lagier-Tourenne C, 2013, P NATL ACAD SCI USA, V110, pE4530, DOI 10.1073/pnas.1318835110; Lam SS, 2015, NAT METHODS, V12, P51, DOI 10.1038/nmeth.3179; Lanson NA, 2011, HUM MOL GENET, V20, P2510, DOI 10.1093/hmg/ddr150; Lee KH, 2016, CELL, V167, P774, DOI 10.1016/j.cell.2016.10.002; Lin Y, 2016, CELL, V167, P789, DOI 10.1016/j.cell.2016.10.003; Mackenzie IR, 2017, NEURON, V95, P808, DOI 10.1016/j.neuron.2017.07.025; March ZM, 2016, BRAIN RES, V1647, P9, DOI 10.1016/j.brainres.2016.02.037; Margolin AA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007454; Martinez FJ, 2016, NEURON, V92, P780, DOI 10.1016/j.neuron.2016.09.050; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Murakami T, 2015, NEURON, V88, P678, DOI 10.1016/j.neuron.2015.10.030; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Perez-Gonzalez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090957; Periz G, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002114; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Reinhardt P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059252; Rhee HW, 2013, SCIENCE, V339, P1328, DOI 10.1126/science.1230593; Ritson GP, 2010, J NEUROSCI, V30, P7729, DOI 10.1523/JNEUROSCI.5894-09.2010; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smith BN, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aad9157; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Sundararaman B, 2016, MOL CELL, V61, P903, DOI 10.1016/j.molcel.2016.02.012; Yang DJ, 2015, ACTA NEUROPATHOL, V130, P525, DOI 10.1007/s00401-015-1448-6; Yasuda K, 2016, WIRES RNA, V7, P589, DOI 10.1002/wrna.1352	52	385	387	17	143	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2018	172	3					590	+		10.1016/j.cell.2017.12.032	http://dx.doi.org/10.1016/j.cell.2017.12.032			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FT9BS	29373831	Bronze, Green Accepted, Green Submitted			2022-12-28	WOS:000423447600017
J	Woloshin, S; Schwartz, LM; Bagley, PJ; Blunt, HB; White, B				Woloshin, Steven; Schwartz, Lisa M.; Bagley, Pamela J.; Blunt, Heather B.; White, Brian			Characteristics of Interim Publications of Randomized Clinical Trials and Comparison With Final Publications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Woloshin, Steven; Schwartz, Lisa M.] Dartmouth Inst Hlth Policy & Clin Practice, Ctr Med Media, Lebanon, NH USA; [Bagley, Pamela J.; Blunt, Heather B.] Dartmouth Coll, Biomed Lib, Hanover, NH 03755 USA; [White, Brian] Atlanticare Reg Med Ctr, Pomona, NJ USA	Dartmouth College; Dartmouth College	Schwartz, LM (corresponding author), Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH 03756 USA.	lisa.schwartz@dartmouth.edu	Bagley, Pamela J/N-1906-2015	Bagley, Pamela J/0000-0002-1214-7814; Blunt, Heather/0000-0001-8620-0166	Agency for Healthcare Research and Quality's Comparative Health System Performance Initiative [1U19HS024075]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U19HS024075] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality's Comparative Health System Performance Initiative; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	Drs Woloshin and Schwartz were supported in part by the Agency for Healthcare Research and Quality's Comparative Health System Performance Initiative under grant 1U19HS024075, which studies how health care delivery systems promote evidence-based practices and patient-centered outcomes research in delivering care.	Bassler D, 2010, JAMA-J AM MED ASSOC, V303, P1180, DOI 10.1001/jama.2010.310; Counsell N, 2017, CLIN TRIALS, V14, P67, DOI 10.1177/1740774516664689; Petzer AL, 2012, HAEMATOL-HEMATOL J, V97, P1562, DOI 10.3324/haematol.2011.060087; Petzer AL, 2010, HAEMATOL-HEMATOL J, V95, P908, DOI 10.3324/haematol.2009.013979; Stephens RJ, 2014, LUNG CANCER, V85, P116, DOI 10.1016/j.lungcan.2014.05.012; Wang H, 2016, CLIN TRIALS, V13, P621, DOI 10.1177/1740774516649595	6	12	12	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					404	406		10.1001/jama.2017.20653	http://dx.doi.org/10.1001/jama.2017.20653			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362786	Green Published, Bronze			2022-12-28	WOS:000423405300028
J	Burke, MA; Heiland, FW				Burke, Mary A.; Heiland, Frank W.			Evolving Societal Norms of Obesity What Is the Appropriate Response?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Burke, Mary A.] Fed Reserve Bank Boston, 600 Atlantic Ave, Boston, MA 02210 USA; [Heiland, Frank W.] CUNY, Baruch Coll, Inst Demog Res, Marxe Sch Publ & Int Affairs,Grad Ctr, New York, NY 10021 USA	Federal Reserve System - USA; Federal Reserve Bank - Boston; City University of New York (CUNY) System; Baruch College (CUNY)	Burke, MA (corresponding author), Fed Reserve Bank Boston, 600 Atlantic Ave, Boston, MA 02210 USA.	mary.burke@bos.frb.org						Blanchflower DG, 2009, J EUR ECON ASSOC, V7, P528, DOI 10.1162/JEEA.2009.7.2-3.528; Burke MA, 2007, ECON INQ, V45, P571, DOI 10.1111/j.1465-7295.2007.00025.x; Burke MA, 2010, OBESITY, V18, P1226, DOI 10.1038/oby.2009.369; Cruwys T, 2015, APPETITE, V86, P3, DOI 10.1016/j.appet.2014.08.035; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Jensen MD, 2014, OBESITY, V22, pS5, DOI 10.1002/oby.20821; Jensen MD, 2014, JAMA-J AM MED ASSOC, V311, P23, DOI 10.1001/jama.2013.282546; McNeill LH, 2006, SOC SCI MED, V63, P1011, DOI 10.1016/j.socscimed.2006.03.012; Puhl RM, 2010, AM J PUBLIC HEALTH, V100, P1019, DOI 10.2105/AJPH.2009.159491	9	15	16	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2018	319	3					221	222		10.1001/jama.2017.18947	http://dx.doi.org/10.1001/jama.2017.18947			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT3BY	29340684				2022-12-28	WOS:000423022300008
J	Friedrich, MJ				Friedrich, M. J.			Combination Strategy Associated With Reduced HIV Incidence in Uganda	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2018	319	3					219	219		10.1001/jama.2017.21296	http://dx.doi.org/10.1001/jama.2017.21296			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT3BY	29340692				2022-12-28	WOS:000423022300004
J	Hirsch, C				Hirsch, Calvin			In postmenopausal women with osteoporosis, romosozumab followed by alendronate reduced fractures vs alendronate alone	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Hirsch, Calvin] UC Davis Med Ctr, Sacramento, CA 95817 USA	University of California System; University of California Davis	Hirsch, C (corresponding author), UC Davis Med Ctr, Sacramento, CA 95817 USA.							Anagnostis P, 2017, MATURITAS, V101, P23, DOI 10.1016/j.maturitas.2017.04.008; Blankesteijn WM, 2015, EUR J PHARMACOL, V763, P122, DOI 10.1016/j.ejphar.2015.05.023; He XW, 2016, ATHEROSCLEROSIS, V253, P22, DOI 10.1016/j.atherosclerosis.2016.08.003; Langdahl Bente L, 2017, Lancet, V390, P1585, DOI 10.1016/S0140-6736(17)31613-6	4	3	3	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2018	168	2					JC3	JC3		10.7326/ACPJC-2018-168-2-003	http://dx.doi.org/10.7326/ACPJC-2018-168-2-003			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU8IN	29335715				2022-12-28	WOS:000424096600003
J	Salminen, P; Helmio, M; Ovaska, J; Juuti, A; Leivonen, M; Peromaa-Haavisto, P; Hurme, S; Soinio, M; Nuutila, P; Victorzon, M				Salminen, Paulina; Helmio, Mika; Ovaska, Jari; Juuti, Anne; Leivonen, Marja; Peromaa-Haavisto, Pipsa; Hurme, Saija; Soinio, Minna; Nuutila, Pirjo; Victorzon, Mikael			Effect of Laparoscopic Sleeve Gastrectomy vs Laparoscopic Roux-en-Y Gastric Bypass on Weight Loss at 5 Years Among Patients With Morbid Obesity The SLEEVEPASS Randomized Clinical Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GASTROESOPHAGEAL-REFLUX DISEASE; INTENSIVE MEDICAL-MANAGEMENT; TYPE-2 DIABETES-MELLITUS; TERM-FOLLOW-UP; BARIATRIC SURGERY; LIFE-STYLE; OUTCOMES; COMPLICATIONS; METAANALYSIS; MULTICENTER	IMPORTANCE Laparoscopic sleeve gastrectomy for treatment of morbid obesity has increased substantially despite the lack of long-term results compared with laparoscopic Roux-en-Y gastric bypass. OBJECTIVE To determine whether laparoscopic sleeve gastrectomy and laparoscopic Roux-en-Y gastric bypass are equivalent for weight loss at 5 years in patients with morbid obesity. DESIGN, SETTING, AND PARTICIPANTS The Sleeve vs Bypass (SLEEVEPASS) multicenter, multisurgeon, open-label, randomized clinical equivalence trial was conducted from March 2008 until June 2010 in Finland. The trial enrolled 240 morbidly obese patients aged 18 to 60 years, who were randomly assigned to sleeve gastrectomy or gastric bypass with a 5-year follow-up period (last follow-up, October 14, 2015). INTERVENTIONS Laparoscopic sleeve gastrectomy (n = 121) or laparoscopic Roux-en-Y gastric bypass (n = 119). MAIN OUTCOMES AND MEASURES The primary end point was weight loss evaluated by percentage excess weight loss. Prespecified equivalence margins for the clinical significance of weight loss differences between gastric bypass and sleeve gastrectomy were -9% to +9% excess weight loss. Secondary end points included resolution of comorbidities, improvement of quality of life (QOL), all adverse events (overall morbidity), and mortality. RESULTS Among 240 patients randomized (mean age, 48 [SD, 9] years; mean baseline body mass index, 45.9, [SD, 6.0]; 69.6% women), 80.4% completed the 5-year follow-up. At baseline, 42.1% had type 2 diabetes, 34.6% dyslipidemia, and 70.8% hypertension. The estimated mean percentage excess weight loss at 5 years was 49%(95% CI, 45%-52%) after sleeve gastrectomy and 57%(95% CI, 53%-61%) after gastric bypass (difference, 8.2 percentage units [95% CI, 3.2%-13.2%], higher in the gastric bypass group) and did not meet criteria for equivalence. Complete or partial remission of type 2 diabetes was seen in 37%(n = 15/41) after sleeve gastrectomy and in 45%(n = 18/40) after gastric bypass (P > .99). Medication for dyslipidemia was discontinued in 47%(n = 14/30) after sleeve gastrectomy and 60%(n = 24/40) after gastric bypass (P = .15) and for hypertension in 29% (n = 20/68) and 51%(n = 37/73) (P = .02), respectively. There was no statistically significant difference in QOL between groups (P = .85) and no treatment-related mortality. At 5 years the overall morbidity rate was 19% (n = 23) for sleeve gastrectomy and 26%(n = 31) for gastric bypass (P = .19). CONCLUSIONS AND RELEVANCE Among patients with morbid obesity, use of laparoscopic sleeve gastrectomy compared with use of laparoscopic Roux-en-Y gastric bypass did not meet criteria for equivalence in terms of percentage excess weight loss at 5 years. Although gastric bypass compared with sleeve gastrectomy was associated with greater percentage excess weight loss at 5 years, the difference was not statistically significant, based on the prespecified equivalence margins.	[Salminen, Paulina; Helmio, Mika; Ovaska, Jari] Turku Univ Hosp, Div Digest Surg & Urol, Turku, Finland; [Salminen, Paulina; Helmio, Mika; Ovaska, Jari; Victorzon, Mikael] Univ Turku, Dept Surg, Turku, Finland; [Juuti, Anne; Leivonen, Marja] Helsinki Univ Hosp, Abdominal Ctr, Dept Abdominal Surg, Helsinki, Finland; [Juuti, Anne; Leivonen, Marja] Univ Helsinki, Helsinki, Finland; [Leivonen, Marja] Seinajoki Cent Hosp, Seinajoki, Finland; [Peromaa-Haavisto, Pipsa; Victorzon, Mikael] Vaasa Cent Hosp, Vaasa, Finland; [Peromaa-Haavisto, Pipsa] Hatanpaa City Hosp, Tampere, Finland; [Hurme, Saija] Univ Turku, Dept Biostat, Turku, Finland; [Soinio, Minna; Nuutila, Pirjo] Turku Univ Hosp, Dept Endocrinol, Turku, Finland; [Nuutila, Pirjo] Univ Turku, Turku PET Ctr, Turku, Finland	University of Turku; University of Turku; University of Helsinki; Helsinki University Central Hospital; University of Helsinki; Seinajoki Central Hospital; Vaasa Central Hospital; University of Turku; University of Turku; University of Turku	Salminen, P (corresponding author), POB 52, Turku 20520, Finland.	paulina.salminen@tyks.fi	Salminen, Paulina Taru Pipsa (T.P.)/ABB-8883-2020	Salminen, Paulina Taru Pipsa (T.P.)/0000-0001-6435-9264; Nuutila, Pirjo/0000-0001-9597-338X	Mary and Georg C. Ehrnrooth Foundation; EVO Foundation; Gastroenterological Research Foundation	Mary and Georg C. Ehrnrooth Foundation; EVO Foundation; Gastroenterological Research Foundation	The SLEEVEPASS trial was supported by the Mary and Georg C. Ehrnrooth Foundation (Dr Salminen), by a government research grant from the EVO Foundation awarded to Turku University Hospital (Dr Salminen, Dr Helmio), and by the Gastroenterological Research Foundation (Dr Helmio).	Arman GA, 2016, SURG OBES RELAT DIS, V12, P1778, DOI 10.1016/j.soard.2016.01.013; Brethauer SA, 2015, OBES SURG, V25, P587, DOI 10.1007/s11695-015-1645-3; Brethauer SA, 2013, ANN SURG, V258, P628, DOI 10.1097/SLA.0b013e3182a5034b; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Catapano AL, 2011, ATHEROSCLEROSIS, V217, P3, DOI 10.1016/j.atherosclerosis.2011.06.028; Chang SH, 2014, JAMA SURG, V149, P275, DOI 10.1001/jamasurg.2013.3654; COTTON PB, 1991, GASTROINTEST ENDOSC, V37, P383, DOI 10.1016/S0016-5107(91)70740-2; Courcoulas AP, 2015, JAMA SURG, V150, P931, DOI 10.1001/jamasurg.2015.1534; DeMaria J, 2002, ANN SURG, V235, P640, DOI 10.1097/00000658-200205000-00005; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Dixon JB, 2013, DIABETES CARE, V36, P20, DOI 10.2337/dc12-0779; DuPree CE, 2014, JAMA SURG, V149, P328, DOI 10.1001/jamasurg.2013.4323; Felsenreich DM, 2017, OBES SURG, V27, P3092, DOI 10.1007/s11695-017-2748-9; Flegal KM, 2016, JAMA-J AM MED ASSOC, V315, P2284, DOI 10.1001/jama.2016.6458; Halperin F, 2014, JAMA SURG, V149, P716, DOI 10.1001/jamasurg.2014.514; Helmio M, 2014, SCAND J SURG, V103, P175, DOI 10.1177/1457496913509984; Helmio M, 2012, SURG ENDOSC, V26, P2521, DOI 10.1007/s00464-012-2225-4; Higa KD, 2001, J LAPAROENDOSC ADV A, V11, P377, DOI 10.1089/10926420152761905; Himpens J, 2006, OBES SURG, V16, P1450, DOI 10.1381/096089206778869933; Ikramuddin S, 2013, JAMA-J AM MED ASSOC, V309, P2240, DOI 10.1001/jama.2013.5835; Jimenez A, 2012, ANN SURG, V256, P1023, DOI 10.1097/SLA.0b013e318262ee6b; Karamanakos SN, 2008, ANN SURG, V247, P401, DOI 10.1097/SLA.0b013e318156f012; Kehagias I, 2011, OBES SURG, V21, P1650, DOI 10.1007/s11695-011-0479-x; Keidar A, 2013, DIABETOLOGIA, V56, P1914, DOI 10.1007/s00125-013-2965-2; Lauffenburger JC, 2017, ANN INTERN MED, V166, P81, DOI 10.7326/M15-2659; Li JF, 2016, OBES SURG, V26, P429, DOI 10.1007/s11695-015-1996-9; Melissas J, 2015, OBES SURG, V25, P2430, DOI 10.1007/s11695-015-1906-1; Moorehead MK, 2003, OBES SURG, V13, P684, DOI 10.1381/096089203322509237; Oor JE, 2016, AM J SURG, V211, P250, DOI 10.1016/j.amjsurg.2015.05.031; Peterli R, 2018, JAMA-J AM MED ASSOC, V319, P255, DOI 10.1001/jama.2017.20897; Peterli R, 2017, ANN SURG, V265, P466, DOI 10.1097/SLA.0000000000001929; Puzziferri N, 2014, JAMA-J AM MED ASSOC, V312, P934, DOI 10.1001/jama.2014.10706; Schauer PR, 2017, NEW ENGL J MED, V376, P641, DOI 10.1056/NEJMoa1600869; Sjostrom L, 2014, JAMA-J AM MED ASSOC, V311, P2297, DOI 10.1001/jama.2014.5988; Stenberg E, 2017, BRIT J SURG, V104, P562, DOI 10.1002/bjs.10448; Stenberg E, 2016, LANCET, V387, P1397, DOI 10.1016/S0140-6736(15)01126-5; Zhang Y, 2014, OBES SURG, V24, P1617, DOI 10.1007/s11695-014-1258-2	37	480	491	5	46	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2018	319	3					241	254		10.1001/jama.2017.20313	http://dx.doi.org/10.1001/jama.2017.20313			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT3BY	29340676	Green Published, Bronze			2022-12-28	WOS:000423022300017
J	Patten, DA; Shetty, S				Patten, Daniel A.; Shetty, Shishir			Chronic liver disease: scavenger hunt for novel therapies	LANCET			English	Editorial Material							HEPATOCELLULAR-CARCINOMA; HEPATITIS-C		[Patten, Daniel A.; Shetty, Shishir] Univ Birmingham, Inst Immunol & Immunotherapy, Liver Res Ctr, Birmingham B15 2TT, W Midlands, England; [Shetty, Shishir] Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp Birmingham, Liver Unit, Birmingham, W Midlands, England	University of Birmingham; University of Birmingham	Shetty, S (corresponding author), Univ Birmingham, Inst Immunol & Immunotherapy, Liver Res Ctr, Birmingham B15 2TT, W Midlands, England.; Shetty, S (corresponding author), Univ Hosp Birmingham NHS Fdn Trust, Queen Elizabeth Hosp Birmingham, Liver Unit, Birmingham, W Midlands, England.	s.shetty@bham.ac.uk	Shetty, Shishir/AAU-4047-2021	Shetty, Shishir/0000-0002-4729-2173; Patten, Daniel/0000-0002-8745-0578	Faron Pharmaceuticals; Bayer Pharmaceuticals	Faron Pharmaceuticals; Bayer Pharmaceuticals(Bayer AG)	DAP declares no competing interests. SS has received a research grant from Faron Pharmaceuticals to design a phase 1/2 trial of the drug clevegen in patients with liver cancer, travel fees from Bayer Pharmaceuticals, and the provision of equipment from Tosoh Bioscience. SS was a winner of The Academy of Medical Sciences-Lancet Young Investigator Prize in 2017.	Bieghs V, 2010, GASTROENTEROLOGY, V138, P2477, DOI 10.1053/j.gastro.2010.02.051; Busch CJL, 2017, HEPATOLOGY, V65, P1181, DOI 10.1002/hep.28970; Canton J, 2013, NAT REV IMMUNOL, V13, P621, DOI 10.1038/nri3515; Chung RT, 2014, NEW ENGL J MED, V370, P1576, DOI 10.1056/NEJMp1400986; Felmlee DJ, 2016, LANCET INFECT DIS, V16, P735, DOI 10.1016/S1473-3099(16)00120-1; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.18, 10.1038/nrdp.2016.19]; Patten DA, 2017, HEPATOLOGY, V65, P294, DOI 10.1002/hep.28879; Ramachandran P, 2016, LANCET GASTROENTEROL, V1, P328, DOI 10.1016/S2468-1253(16)30110-8; Rantakari P, 2016, P NATL ACAD SCI US; Shetty S, 2011, J IMMUNOL, V186, P4147, DOI 10.4049/jimmunol.1002961; Tsuchida T, 2017, NAT REV GASTRO HEPAT, V14, P397, DOI 10.1038/nrgastro.2017.38; Williams R, 2014, LANCET, V384, P1953, DOI 10.1016/S0140-6736(14)61838-9	13	7	8	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 13	2018	391	10116					104	105		10.1016/S0140-6736(17)32671-5	http://dx.doi.org/10.1016/S0140-6736(17)32671-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT0EG	29353605	Green Submitted			2022-12-28	WOS:000422793400008
J	Sarwark, JF; Davis, MM				Sarwark, John F.; Davis, Matthew M.			Evolving Recommendations for Scoliosis Screening A Compelling Need for Further Research	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Sarwark, John F.] Ann & Robert H Lurie Childrens Hosp Chicago, Orthopaed Surg & Sports Med, 225 E Chicago Ave,POB 69, Chicago, IL 60611 USA; [Davis, Matthew M.] Ann & Robert H Lurie Childrens Hosp Chicago, Stanley Manne Childrens Res Inst, Acad Gen Pediat & Primary Care, Chicago, IL 60611 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Ann & Robert H. Lurie Children's Hospital of Chicago	Sarwark, JF (corresponding author), Ann & Robert H Lurie Childrens Hosp Chicago, Orthopaed Surg & Sports Med, 225 E Chicago Ave,POB 69, Chicago, IL 60611 USA.	jsarwark@luriechildrens.org						Dunn J, 2018, JAMA-J AM MED ASSOC, V319, P173, DOI 10.1001/jama.2017.11669; Grivas TB, 2013, SCOLIOSIS SPINAL DIS, V8, DOI 10.1186/1748-7161-8-16; Hresko MT, 2015, COMMUNICATION	3	9	9	1	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2018	319	2					127	129		10.1001/jama.2017.20190	http://dx.doi.org/10.1001/jama.2017.20190			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS4PR	29318262				2022-12-28	WOS:000419775500012
J	Dubay, LC; Kenney, GM				Dubay, Lisa C.; Kenney, Genevieve M.			When the CHIPs Are Down - Health Coverage and Care at Risk for US Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Dubay, Lisa C.; Kenney, Genevieve M.] Urban Inst, Washington, DC 20037 USA	Urban Institute	Dubay, LC (corresponding author), Urban Inst, Washington, DC 20037 USA.							Gardner B., 2017, MEDICAID IS GOOD CHI, DOI [10.1056/NEJMp1716920, DOI 10.1056/NEJMP1716920]; Hackman M., 2017, WALL STREET J; Harrington M, 2014, CHIPRA MANDATED EVAL; Kaiser Family Foundation, 2017, STAT PLANS CHIP FED; MACPAC, 2017, MARCH 2017 REPORT C	5	1	1	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 15	2018	378	7					597	599		10.1056/NEJMp1716920	http://dx.doi.org/10.1056/NEJMp1716920			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FW0QK	29320308				2022-12-28	WOS:000425000000004
J	Lin, QY; Mason, JA; Li, ZY; Zhou, WJ; O'Brien, MN; Brown, KA; Jones, MR; Butun, S; Lee, B; Dravid, VP; Aydin, K; Mirkin, CA				Lin, Qing-Yuan; Mason, Jarad A.; Li, Zhongyang; Zhou, Wenjie; O'Brien, Matthew N.; Brown, Keith A.; Jones, Matthew R.; Butun, Serkan; Lee, Byeongdu; Dravid, Vinayak P.; Aydin, Koray; Mirkin, Chad A.			Building superlattices from individual nanoparticles via template-confined DNA-mediated assembly	SCIENCE			English	Article							PHOTONIC METAMATERIALS; ARRAYS; BONDS	DNA programmable assembly has been combined with top-down lithography to construct superlattices of discrete, reconfigurable nanoparticle architectures on a gold surface over large areas. Specifically, the assembly of individual colloidal plasmonic nanoparticles with different shapes and sizes is controlled by oligonucleotides containing "locked" nucleic acids and confined environments provided by polymer pores to yield oriented architectures that feature tunable arrangements and independently controllable distances at both nanometer-and micrometer-length scales. These structures, which would be difficult to construct by other common assembly methods, provide a platform to systematically study and control light-matter interactions in nanoparticle-based optical materials. The generality and potential of this approach are explored by identifying a broadband absorber with a solvent polarity response that allows dynamic tuning of visible light absorption.	[Lin, Qing-Yuan; Mason, Jarad A.; Zhou, Wenjie; O'Brien, Matthew N.; Brown, Keith A.; Jones, Matthew R.; Dravid, Vinayak P.; Mirkin, Chad A.] Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA; [Mason, Jarad A.; Zhou, Wenjie; O'Brien, Matthew N.; Brown, Keith A.; Mirkin, Chad A.] Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA; [Lin, Qing-Yuan; Jones, Matthew R.; Dravid, Vinayak P.; Mirkin, Chad A.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Li, Zhongyang; Butun, Serkan; Aydin, Koray] Northwestern Univ, Dept Elect Engn & Comp Sci, Evanston, IL 60208 USA; [Lee, Byeongdu] Argonne Natl Lab, Xray Sci Div, 9700 South Cass Ave, Argonne, IL 60439 USA	Northwestern University; Northwestern University; Northwestern University; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory	Dravid, VP; Mirkin, CA (corresponding author), Northwestern Univ, Int Inst Nanotechnol, Evanston, IL 60208 USA.; Mirkin, CA (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.; Dravid, VP; Mirkin, CA (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA.; Aydin, K (corresponding author), Northwestern Univ, Dept Elect Engn & Comp Sci, Evanston, IL 60208 USA.	v-dravid@northwestern.edu; aydin@northwestern.edu; chadnano@northwestern.edu	Aydin, Koray/D-5100-2009; Aydin, Koray/G-2537-2011; Zhou, Wenjie/GRF-5653-2022; Lee, Byeongdu/AAO-8096-2020; Dravid, Vinayak/B-6688-2009; Zhou, Wenjie/GRF-5753-2022; Mirkin, Chad A/E-3911-2010; O'Brien, Matthew/G-9998-2016; Brown, Keith/A-9780-2010	Aydin, Koray/0000-0002-3268-2216; Zhou, Wenjie/0000-0002-7626-4032; Lee, Byeongdu/0000-0003-2514-8805; O'Brien, Matthew/0000-0002-1721-0464; Jones, Matthew/0000-0002-9289-291X; Brown, Keith/0000-0002-2379-2018; Mirkin, Chad/0000-0002-6634-7627	Center for Bio-Inspired Energy Science, an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Basic Energy Sciences [DE-SC0000989]; Air Force Office of Scientific Research [FA9550-12-1-0280, FA9550-14-1-0274, FA9550-17-1-0348]; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource [NSF NNCI-1542205]; Materials Research Science and Engineering Center program at the Materials Research Center [NSF DMR-1121262]; International Institute for Nanotechnology (IIN); Keck Foundation; State of Illinois, through the IIN; Ryan Fellowship at Northwestern University; National Science Foundation	Center for Bio-Inspired Energy Science, an Energy Frontier Research Center - U.S. Department of Energy, Office of Science, Basic Energy Sciences(United States Department of Energy (DOE)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource; Materials Research Science and Engineering Center program at the Materials Research Center; International Institute for Nanotechnology (IIN); Keck Foundation(W.M. Keck Foundation); State of Illinois, through the IIN; Ryan Fellowship at Northwestern University; National Science Foundation(National Science Foundation (NSF))	This material is based on work supported by the Center for Bio-Inspired Energy Science, an Energy Frontier Research Center funded by the U.S. Department of Energy, Office of Science, Basic Energy Sciences, under award DE-SC0000989 and the Air Force Office of Scientific Research under awards FA9550-12-1-0280, FA9550-14-1-0274, and FA9550-17-1-0348. Use of the Center for Nanoscale Materials, an Office of Science user facility at Argonne National Laboratory, and GISAXS experiments at beamline 12-ID-B at the Advanced Photon Source at Argonne National Laboratory were supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract DE-AC02-06CH11357. This work made use of the Electron Probe Instrumentation Center (EPIC) facility of the Northwestern University Atomic and Nanoscale Characterization Experimental Center (NUANCE) at Northwestern University, which has received support from the Soft and Hybrid Nanotechnology Experimental (SHyNE) Resource (NSF NNCI-1542205); the Materials Research Science and Engineering Center program (NSF DMR-1121262) at the Materials Research Center; the International Institute for Nanotechnology (IIN); the Keck Foundation; and the State of Illinois, through the IIN. Q.-Y. L., Z.L., and M.R.J. gratefully acknowledge support from the Ryan Fellowship at Northwestern University, and M.N.O. gratefully acknowledges the National Science Foundation for a Graduate Research Fellowship. We thank C. Laramy and H. Lin for assistance with some nanoparticle syntheses. The authors declare no competing financial interests. All data are reported in the main text and the supplementary materials.	Akselrod GM, 2015, ADV MATER, V27, P8028, DOI 10.1002/adma.201503281; Bloomfield V.A., 2000, NUCL ACIDS STRUCTURE, V1st ed.; Boles MA, 2016, CHEM REV, V116, P11220, DOI 10.1021/acs.chemrev.6b00196; Ding T, 2016, P NATL ACAD SCI USA, V113, P5503, DOI 10.1073/pnas.1524209113; Flauraud V, 2017, NAT NANOTECHNOL, V12, P73, DOI [10.1038/nnano.2016.179, 10.1038/NNANO.2016.179]; Halas NJ, 2011, CHEM REV, V111, P3913, DOI 10.1021/cr200061k; Henzie J, 2013, P NATL ACAD SCI USA, V110, P6640, DOI 10.1073/pnas.1218616110; Hughes RA, 2017, NANOTECHNOLOGY, V28, DOI 10.1088/1361-6528/aa77ce; Jones MR, 2015, SCIENCE, V347, DOI 10.1126/science.1260901; Koshkin AA, 1998, TETRAHEDRON, V54, P3607, DOI 10.1016/S0040-4020(98)00094-5; Lin QY, 2015, NANO LETT, V15, P4699, DOI 10.1021/acs.nanolett.5b01548; Liu N, 2008, NAT MATER, V7, P31, DOI 10.1038/nmat2072; Liu WY, 2016, SCIENCE, V351, P582, DOI 10.1126/science.aad2080; Liu XY, 2015, ADV MATER, V27, P7314, DOI 10.1002/adma.201503336; Macfarlane RJ, 2011, SCIENCE, V334, P204, DOI 10.1126/science.1210493; Mason JA, 2016, J AM CHEM SOC, V138, P8722, DOI 10.1021/jacs.6b05430; Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0; Moreau A, 2012, NATURE, V492, P86, DOI 10.1038/nature11615; Nykypanchuk D, 2008, NATURE, V451, P549, DOI 10.1038/nature06560; O'Brien MN, 2016, J AM CHEM SOC, V138, P14562, DOI 10.1021/jacs.6b09704; O'Brien MN, 2014, ANGEW CHEM INT EDIT, V53, P9532, DOI 10.1002/anie.201405317; Owczarzy R, 2011, BIOCHEMISTRY-US, V50, P9352, DOI 10.1021/bi200904e; Pryce IM, 2010, NANO LETT, V10, P4222, DOI 10.1021/nl102684x; Qian ZX, 2017, J AM CHEM SOC, V139, P5266, DOI 10.1021/jacs.7b00711; Rogers WB, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.8; Urbas AM, 2016, J OPTICS-UK, V18, DOI 10.1088/2040-8978/18/9/093005; Valentine J, 2008, NATURE, V455, P376, DOI 10.1038/nature07247; Wang MX, 2017, ACS NANO, V11, P180, DOI 10.1021/acsnano.6b06584; Wang YF, 2012, NATURE, V491, P51, DOI 10.1038/nature11564; Zheludev NI, 2016, NAT NANOTECHNOL, V11, P16, DOI [10.1038/nnano.2015.302, 10.1038/NNANO.2015.302]	30	143	144	15	326	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					669	672		10.1126/science.aaq0591	http://dx.doi.org/10.1126/science.aaq0591			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2FH	29348364				2022-12-28	WOS:000425117700036
J	Burlingame, Q; Coburn, C; Che, XZ; Panda, A; Qu, Y; Forrest, SR				Burlingame, Quinn; Coburn, Caleb; Che, Xiaozhou; Panda, Anurag; Qu, Yue; Forrest, Stephen R.			Centimetre-scale electron diffusion in photoactive organic heterostructures	NATURE			English	Article							FIELD-EFFECT TRANSISTORS; THIN-FILMS; CHARGE-TRANSPORT; SOLAR-CELLS; MOBILITY; SEMICONDUCTOR; C-60; C-70	The unique properties of organic semiconductors, such as flexibility and lightness, are increasingly important for information displays, lighting and energy generation. But organics suffer from both static and dynamic disorder, and this can lead to variable-range carrier hopping(1,2), which results in notoriously poor electrical properties, with low electron and hole mobilities and correspondingly short charge-diffusion lengths of less than a micrometre(3,4). Here we demonstrate a photoactive (light-responsive) organic heterostructure comprising a thin fullerene channel sandwiched between an electron-blocking layer and a blended donor: C-70 fullerene heterojunction that generates charges by dissociating excitons. Centimetre-scale diffusion of electrons is observed in the fullerene channel, and this can be fitted with a simple electron diffusion model. Our experiments enable the direct measurement of charge diffusivity in organic semiconductors, which is as high as 0.83 +/- 0.07 square centimetres per second in a C-60 channel at room temperature. The high diffusivity of the fullerene combined with the extraordinarily long charge-recombination time yields diffusion lengths of more than 3.5 centimetres, orders of magnitude larger than expected for an organic system.				stevefor@umich.edu	Panda, Anurag/HCJ-0145-2022	Burlingame, Quinn/0000-0002-4511-2271	United States Department of Energy SunShot Program [DE-EE0006708, DE-EE0005310]; Air Force Office of Scientific Research [FA9550-14-1-0245]	United States Department of Energy SunShot Program; Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by the United States Department of Energy SunShot Program under awards DE-EE0006708 and DE-EE0005310, and the Air Force Office of Scientific Research under award FA9550-14-1-0245. We thank M. Ware for discussions regarding numerical simulations.	Anthopoulos TD, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2387892; BASSLER H, 1993, PHYS STATUS SOLIDI B, V175, P15, DOI 10.1002/pssb.2221750102; Burgi L, 2003, APPL PHYS LETT, V82, P1482, DOI 10.1063/1.1556564; Burlingame Q, 2016, ADV ENERGY MATER, V6, DOI 10.1002/aenm.201601094; Cheyns D, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4867261; Coropceanu V, 2007, CHEM REV, V107, P926, DOI 10.1021/cr050140x; Griffith OL, 2015, PHYS REV B, V92, DOI 10.1103/PhysRevB.92.085404; Haddon RC, 1996, J AM CHEM SOC, V118, P3041, DOI 10.1021/ja953881w; Itaka K, 2006, ADV MATER, V18, P1713, DOI 10.1002/adma.200502752; Jarrett CP, 1996, SYNTHETIC MET, V77, P35, DOI 10.1016/0379-6779(96)80052-X; Jurchescu OD, 2007, ADV MATER, V19, P688, DOI 10.1002/adma.200600929; Kim M, 2015, ADV ENERGY MATER, V5, DOI 10.1002/aenm.201401317; Kwiatkowski JJ, 2009, NANO LETT, V9, P1085, DOI 10.1021/nl803504q; Leijtens T, 2013, ADV MATER, V25, P3227, DOI 10.1002/adma.201300947; Liu X, 2016, ACS NANO, V10, P7619, DOI 10.1021/acsnano.6b02865; Nunomura S, 2014, ADV MATER, V26, P7555, DOI 10.1002/adma.201403198; Olthof S, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.176601; Roichman Y, 2002, APPL PHYS LETT, V80, P1948, DOI 10.1063/1.1461419; Sakanoue T, 2010, NAT MATER, V9, P736, DOI [10.1038/NMAT2825, 10.1038/nmat2825]; SARKAR D, 1994, SOLID STATE COMMUN, V90, P261, DOI 10.1016/0038-1098(94)90472-3; Ting HC, 2014, CHEMSUSCHEM, V7, P457, DOI 10.1002/cssc.201301090; Torricelli F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10550; Tripathi AK, 2011, PHYS REV B, V84, DOI 10.1103/PhysRevB.84.041201; Tummala NR, 2015, J PHYS CHEM LETT, V6, P3657, DOI 10.1021/acs.jpclett.5b01709; Wang NN, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4754690; Xiao X, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301557; Xue JG, 2005, ADV MATER, V17, P66, DOI 10.1002/adma.200400617	27	55	55	2	170	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2018	554	7690					77	+		10.1038/nature25148	http://dx.doi.org/10.1038/nature25148			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7QX	29342132				2022-12-28	WOS:000424048900034
J	Brantley, SL; Vidic, RD; Brasier, K; Yoxtheimer, D; Pollak, J; Wilderman, C; Wen, T				Brantley, S. L.; Vidic, R. D.; Brasier, K.; Yoxtheimer, D.; Pollak, J.; Wilderman, C.; Wen, T.			Engaging over data on fracking and water quality	SCIENCE			English	Editorial Material							SHALE-GAS DEVELOPMENT; OIL; CONTAMINATION; PENNSYLVANIA; IMPACTS; NETWORK		[Brantley, S. L.; Wen, T.] Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA; [Brantley, S. L.] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Vidic, R. D.] Univ Pittsburgh, Dept Civil & Environm Engn, Pittsburgh, PA USA; [Brasier, K.] Penn State Univ, Dept Agr Econ Sociol & Educ, University Pk, PA 16802 USA; [Yoxtheimer, D.] Penn State Univ, Marcellus Ctr Outreach & Res, University Pk, PA 16802 USA; [Pollak, J.] Consortium Univ Advancement Hydrol Sci Inc, Cambridge, MA 02140 USA; [Wilderman, C.] Dickinson Coll, Dept Environm Studies, Carlisle, PA 17013 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Dickinson College	Brantley, SL (corresponding author), Penn State Univ, Earth & Environm Syst Inst, University Pk, PA 16802 USA.; Brantley, SL (corresponding author), Penn State Univ, Dept Geosci, University Pk, PA 16802 USA.	brantley@eesi.psu.edu	Brantley, Susan L/ABE-4479-2020; Wen, Tao/P-6733-2018	Wen, Tao/0000-0002-6113-7532; Pollak, Jon/0000-0001-9088-437X	National Science Foundation [OCE-11-40159, EAR-13-31726, IIS-16-39150]	National Science Foundation(National Science Foundation (NSF))	Funding derived from National Science Foundation grants OCE-11-40159, EAR-13-31726, and IIS-16-39150 to S.L.B.	Brantley SL, 2014, INT J COAL GEOL, V126, P140, DOI 10.1016/j.coal.2013.12.017; Brasier KJ, 2017, J ENVIRON PLANN MAN, V60, P2103, DOI 10.1080/09640568.2016.1276435; Burgos WD, 2017, ENVIRON SCI TECHNOL, V51, P8851, DOI 10.1021/acs.est.7b01696; Fischer F., 2000, CITIZENS EXPERTS ENV, VIllustrated edn; Heilweil VM, 2015, ENVIRON SCI TECHNOL, V49, P4057, DOI 10.1021/es503882b; Konschnik K, 2014, NAT RESOUR J, V54, P319; Li ZH, 2017, J CONTAM HYDROL, V207, P50, DOI 10.1016/j.jconhyd.2017.09.009; Llewellyn GT, 2015, P NATL ACAD SCI USA, V112, P6325, DOI 10.1073/pnas.1420279112; Maloney KO, 2017, SCI TOTAL ENVIRON, V581, P369, DOI [10.1016/j.scitotenv2016.12.142, 10.1016/j.scitotenv.2016.12.142]; Niu XZ, 2018, ENVIRON GEOCHEM HLTH, V40, P865, DOI 10.1007/s10653-017-0031-6; Osborn SG, 2011, P NATL ACAD SCI USA, V108, P8172, DOI 10.1073/pnas.1100682108; Pielke R.A.J., 2007, HONEST BROKER MAKING; Vidic RD, 2013, SCIENCE, V340, DOI 10.1126/science.1235009; Weber ER, 2008, PUBLIC ADMIN REV, V68, P334, DOI 10.1111/j.1540-6210.2007.00866.x; Wilderman CC., 2016, CITIZ SCI THEORY PRA, V1, P7, DOI [10.5334/cstp.20, DOI 10.5334/CSTP.20/>, DOI 10.5334/CSTP.20]	15	28	28	6	88	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					395	397		10.1126/science.aan6520	http://dx.doi.org/10.1126/science.aan6520			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT6SD	29371458				2022-12-28	WOS:000423283200030
J	Vo, LT; Kinney, MA; Liu, X; Zhang, YY; Barragan, J; Sousa, PM; Jha, DK; Han, A; Cesana, M; Shao, Z; North, TE; Orkin, SH; Doulatov, S; Xu, J; Daley, GQ				Vo, Linda T. l; Kinney, Melissa A.; Liu, Xin; Zhang, Yuannyu; Barragan, Jessica; Sousa, Patricia M.; Jha, Deepak K.; Han, Areum; Cesana, Marcella; Shao, Zhen; North, Trista E.; Orkin, Stuart H.; Doulatov, Sergei; Xu, Jian; Daley, George Q.			Regulation of embryonic haematopoietic multipotency by EZH1	NATURE			English	Article							PLURIPOTENT STEM-CELLS; MOUSE EMBRYO; DEFINED FACTORS; BLOOD-CELLS; CHROMATIN; LINEAGE; ENDOTHELIUM; PROGENITORS; RESISTANCE; LEUKEMIA	All haematopoietic cell lineages that circulate in the blood of adult mammals derive from multipotent haematopoietic stem cells (HSCs) 1. By contrast, in the blood of mammalian embryos, lineage-restricted progenitors arise first, independently of HSCs, which only emerge later in gestation2,3. As best defined in the mouse, 'primitive' progenitors first appear in the yolk sac at 7.5 days post-coitum2,3. Subsequently, erythroid-myeloid progenitors that express fetal haemoglobin4, as well as fetal lymphoid progenitors5, develop in the yolk sac and the embryo proper, but these cells lack HSC potential. Ultimately, 'definitive' HSCs with long-term, multilineage potential and the ability to engraft irradiated adults emerge at 10.5 days post-coitum from arterial endothelium in the aorta-gonad-mesonephros and other haemogenic vasculature3. The molecular mechanisms of this reverse progression of haematopoietic ontogeny remain unexplained. We hypothesized that the definitive haematopoietic program might be actively repressed in early embryogenesis through epigenetic silencing6, and that alleviating this repression would elicit multipotency in otherwise lineage-restricted haematopoietic progenitors. Here we show that reduced expression of the Polycomb group protein EZH1 enhances multi-lymphoid output from human pluripotent stem cells. In addition, Ezh1 deficiency in mouse embryos results in precocious emergence of functional definitive HSCs in vivo. Thus, we identify EZH1 as a repressor of haematopoietic multipotency in the early mammalian embryo.	[Vo, Linda T. l; Kinney, Melissa A.; Barragan, Jessica; Sousa, Patricia M.; Jha, Deepak K.; Han, Areum; Cesana, Marcella; Daley, George Q.] Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA; [Vo, Linda T. l; Kinney, Melissa A.; Barragan, Jessica; Sousa, Patricia M.; Jha, Deepak K.; Han, Areum; Cesana, Marcella; Orkin, Stuart H.; Daley, George Q.] Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Vo, Linda T. l; Kinney, Melissa A.; Barragan, Jessica; Sousa, Patricia M.; Jha, Deepak K.; Han, Areum; Cesana, Marcella; Orkin, Stuart H.; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Vo, Linda T. l; Orkin, Stuart H.; Daley, George Q.] Harvard Med Sch, Boston, MA 02115 USA; [Liu, Xin; Zhang, Yuannyu; Xu, Jian] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, Childrens Med Ctr, Res Inst, Dallas, TX USA; [Zhang, Yuannyu; Shao, Zhen] Chinese Acad Sci, Shanghai Inst Biol Sci, CAS MPG Partner Inst Computat Biol, Key Lab Computat Biol, Shanghai, Peoples R China; [North, Trista E.] Beth Israel Deaconess Med Ctr, Dept Pathol, 330 Brookline Ave, Boston, MA 02215 USA; [Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Doulatov, Sergei] Univ Washington, Dept Med, Div Hematol, Seattle, WA 98195 USA	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; University of Texas System; University of Texas Southwestern Medical Center Dallas; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; Harvard University; Beth Israel Deaconess Medical Center; Howard Hughes Medical Institute; University of Washington; University of Washington Seattle	Daley, GQ (corresponding author), Boston Childrens Hosp, Stem Cell Program, Boston, MA 02115 USA.; Daley, GQ (corresponding author), Boston Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.; Daley, GQ (corresponding author), Dana Farber Canc Inst, Boston, MA 02115 USA.; Daley, GQ (corresponding author), Harvard Med Sch, Boston, MA 02115 USA.	George.Daley@childrens.harvard.edu	North, Trista/ABG-4789-2020; Kinney, Melissa A./ABC-3025-2020; Jha, Deepak/AAK-2279-2020; Cesana, Marcella/AAC-2697-2022	North, Trista/0000-0003-1249-563X; Jha, Deepak/0000-0002-6657-5662; Cesana, Marcella/0000-0002-9099-8681; Liu, Xin/0000-0003-0847-182X; Kinney, Melissa/0000-0003-1528-6163; Shao, Zhen/0000-0002-4934-4360	NIH NIDDK [R24-DK092760, R24-DK49216]; NHLBI Progenitor Cell Biology Consortium [U01-HL100001]; NHLBI [R01HL04880]; NIH [R24OD017870-01, K01DK093543, R01DK111430]; NSF Graduate Research Fellowship; T32 NIH Training Grant from BWH Hematology; Leukemia and Lymphoma Society; K99 NIH NHLBI award [1K99HL123484]; Cancer Prevention and Research Institute of Texas (CPRIT) New Investigator award [RR140025]; Howard Hughes Medical Institute; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL123484, U01HL100001, U01HL134812, K99HL123484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK111430, P30DK049216, K01DK093543, U54DK110805, R01DK098241, R24DK092760] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD017870] Funding Source: NIH RePORTER	NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI Progenitor Cell Biology Consortium; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); T32 NIH Training Grant from BWH Hematology; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); K99 NIH NHLBI award; Cancer Prevention and Research Institute of Texas (CPRIT) New Investigator award; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank T. Jenuwein for sharing the Ezh1 mutant mice, which were generated at the Research Institute of Molecular Pathology (IMP, Vienna) in 2000 by D. O'Carroll (laboratory of T. Jenuwein) with the help of M. Sibilia (laboratory of E. Wagner). We also thank T. Schlaeger and the hESC Core Facility at Boston Children's Hospital for providing pluripotent stem-cell lines, R. Mathieu from BCH Flow Cytometry Core, and M. J. Chen for technical advice. This work was supported by grants from the NIH NIDDK (R24-DK092760, R24-DK49216) and NHLBI Progenitor Cell Biology Consortium (U01-HL100001); NHLBI R01HL04880 and NIH R24OD017870-01. L.T.V. is supported by the NSF Graduate Research Fellowship. M.A.K. is supported by T32 NIH Training Grant from BWH Hematology. M.C. is supported by a fellowship from the Leukemia and Lymphoma Society. S.D. is supported by K99 NIH NHLBI award (1K99HL123484). S.H.O. is an Investigator of the Howard Hughes Medical Institute. J.X. is supported by NIH grants (K01DK093543 and R01DK111430) and a Cancer Prevention and Research Institute of Texas (CPRIT) New Investigator award (RR140025). G.Q.D. was supported by the Howard Hughes Medical Institute, and is an associate member of the Broad Institute and an investigator of the Manton Center for Orphan Disease Research.	Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Boiers C, 2013, CELL STEM CELL, V13, P535, DOI 10.1016/j.stem.2013.08.012; Boisset JC, 2010, NATURE, V464, P116, DOI 10.1038/nature08764; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Cahan P, 2014, CELL, V158, P903, DOI 10.1016/j.cell.2014.07.020; Cai ZL, 2000, IMMUNITY, V13, P423, DOI 10.1016/S1074-7613(00)00042-X; Cedar H, 2011, NAT REV IMMUNOL, V11, P478, DOI 10.1038/nri2991; Chadwick K, 2003, BLOOD, V102, P906, DOI 10.1182/blood-2003-03-0832; Ditadi A, 2015, NAT CELL BIOL, V17, P580, DOI 10.1038/ncb3161; Doulatov S, 2013, CELL STEM CELL, V13, P459, DOI 10.1016/j.stem.2013.09.002; Doulatov S, 2010, NAT IMMUNOL, V11, P585, DOI 10.1038/ni.1889; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Hohmann AF, 2016, NAT CHEM BIOL, V12, P672, DOI 10.1038/nchembio.2115; Holmes R, 2009, COLD SPRING HARB PRO, V2009; Huang JL, 2016, DEV CELL, V36, P9, DOI 10.1016/j.devcel.2015.12.014; Jang IH, 2015, BLOOD, V125, P1418, DOI 10.1182/blood-2014-04-568170; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Kim J, 2009, NAT PROTOC, V4, P506, DOI 10.1038/nprot.2009.23; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Laurenti E, 2013, NAT IMMUNOL, V14, P756, DOI 10.1038/ni.2615; Lee SCW, 2015, BLOOD, V126, P167, DOI 10.1182/blood-2014-12-615898; Majewski IJ, 2008, PLOS BIOL, V6, P796, DOI 10.1371/journal.pbio.0060093; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; McGrath KE, 2015, CELL REP, V11, P1892, DOI 10.1016/j.celrep.2015.05.036; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Medvinsky A, 2011, DEVELOPMENT, V138, P1017, DOI 10.1242/dev.040998; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; Onder TT, 2012, NATURE, V483, P598, DOI 10.1038/nature10953; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Papaemmanuil E, 2009, NAT GENET, V41, P1006, DOI 10.1038/ng.430; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; Riddell J, 2014, CELL, V157, P549, DOI 10.1016/j.cell.2014.04.006; Rybtsov S, 2011, J EXP MED, V208, P1305, DOI 10.1084/jem.20102419; Shao Z, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r16; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shin HJ, 2009, BIOINFORMATICS, V25, P2605, DOI 10.1093/bioinformatics/btp479; Sugimura R, 2017, NATURE, V545, P432, DOI 10.1038/nature22370; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Vo L. T., 2018, PROTOC EXCH; Xie HF, 2014, CELL STEM CELL, V14, P68, DOI 10.1016/j.stem.2013.10.001; Xu J, 2015, MOL CELL, V57, P304, DOI 10.1016/j.molcel.2014.12.009; Yoder MC, 1997, IMMUNITY, V7, P335, DOI 10.1016/S1074-7613(00)80355-6; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	45	49	51	6	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2018	553	7689					506	+		10.1038/nature25435	http://dx.doi.org/10.1038/nature25435			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU6OE	29342143	Green Accepted			2022-12-28	WOS:000423971100041
J	Slomski, A				Slomski, Anita			Social Media Intervention Improves Vaccine Acceptance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	2	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					333	333		10.1001/jama.2017.21378	http://dx.doi.org/10.1001/jama.2017.21378			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362791				2022-12-28	WOS:000423405300008
J	Hogberg, B				Hogberg, Bjorn			Remote control of nanoscale devices	SCIENCE			English	Editorial Material							DNA-ORIGAMI; SHAPES		[Hogberg, Bjorn] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Karolinska Institutet	Hogberg, B (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.	bjorn.hogberg@ki.se						Benson E, 2015, NATURE, V523, P441, DOI 10.1038/nature14586; Douglas SM, 2009, NUCLEIC ACIDS RES, V37, P5001, DOI 10.1093/nar/gkp436; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Gopinath A, 2016, NATURE, V535, P401, DOI 10.1038/nature18287; Kassem S, 2016, NAT CHEM, V8, P138, DOI [10.1038/nchem.2410, 10.1038/NCHEM.2410]; Klapper Y, 2010, SMALL, V6, P44, DOI 10.1002/smll.200901106; Kopperger E, 2018, SCIENCE, V359, P296, DOI 10.1126/science.aao4284; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; SEEMAN NC, 1982, J THEOR BIOL, V99, P237, DOI 10.1016/0022-5193(82)90002-9; Thubagere AJ, 2017, SCIENCE, V357, DOI 10.1126/science.aan6558	10	1	1	1	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					279	279		10.1126/science.aar6580	http://dx.doi.org/10.1126/science.aar6580			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT6BB	29348226				2022-12-28	WOS:000423236700022
J	Smakowska-Luzan, E; Mott, GA; Parys, K; Stegmann, M; Howton, TC; Layeghifard, M; Neuhold, J; Lehner, A; Kong, JX; Grunwald, K; Weinberger, N; Satbhai, SB; Mayer, D; Busch, W; Madalinski, M; Stolt-Bergner, P; Provart, NJ; Mukhtar, MS; Zipfel, C; Desveaux, D; Guttman, DS; Belkhadir, Y				Smakowska-Luzan, Elwira; Mott, G. Adam; Parys, Katarzyna; Stegmann, Martin; Howton, Timothy C.; Layeghifard, Mehdi; Neuhold, Jana; Lehner, Anita; Kong, Jixiang; Gruenwald, Karin; Weinberger, Natascha; Satbhai, Santosh B.; Mayer, Dominik; Busch, Wolfgang; Madalinski, Mathias; Stolt-Bergner, Peggy; Provart, Nicholas J.; Mukhtar, M. Shahid; Zipfel, Cyril; Desveaux, Darrell; Guttman, David S.; Belkhadir, Youssef			An extracellular network of Arabidopsis leucine-rich repeat receptor kinases	NATURE			English	Article							STRUCTURAL BASIS; PATTERN; ACTIVATION; PROTEIN; RECOGNITION; PEPTIDE; PERCEPTION; INTERACTOME; RESISTANCE; INSIGHTS	The cells of multicellular organisms receive extracellular signals using surface receptors. The extracellular domains (ECDs) of cell surface receptors function as interaction platforms, and as regulatory modules of receptor activation(1,2). Understanding how interactions between ECDs produce signal-competent receptor complexes is challenging because of their low biochemical tractability(3,4). In plants, the discovery of ECD interactions is complicated by the massive expansion of receptor families, which creates tremendous potential for changeover in receptor interactions(5). The largest of these families in Arabidopsis thaliana consists of 225 evolutionarily related leucine-rich repeat receptor kinases (LRR-RKs)(5), which function in the sensing of microorganisms, cell expansion, stomata development and stem-cell maintenance(6-9). Although the principles that govern LRR-RK signalling activation are emerging(1,10), the systems-level organization of this family of proteins is unknown. Here, to address this, we investigated 40,000 potential ECD interactions using a sensitized high-throughput interaction assay(3), and produced an LRR-based cell surface interaction network (CSILRR) that consists of 567 interactions. To demonstrate the power of CSILRR for detecting biologically relevant interactions, we predicted and validated the functions of uncharacterized LRR-RKs in plant growth and immunity. In addition, we show that CSILRR operates as a unified regulatory network in which the LRR-RKs most crucial for its overall structure are required to prevent the aberrant signalling of receptors that are several network-steps away. Thus, plants have evolved LRR-RK networks to process extracellular signals into carefully balanced responses.	[Smakowska-Luzan, Elwira; Parys, Katarzyna; Kong, Jixiang; Gruenwald, Karin; Weinberger, Natascha; Satbhai, Santosh B.; Mayer, Dominik; Busch, Wolfgang; Madalinski, Mathias; Belkhadir, Youssef] Austrian Acad Sci, Vienna Bioctr VBC, GMI, Dr Bohr Gasse 3, A-1030 Vienna, Austria; [Mott, G. Adam; Layeghifard, Mehdi; Provart, Nicholas J.; Desveaux, Darrell; Guttman, David S.] Univ Toronto, Dept Cell & Syst Biol, 25 Willcocks St, Toronto, ON, Canada; [Stegmann, Martin; Zipfel, Cyril] Sainsbury Lab, Norwich Res Pk, Norwich NR4 7UH, Norfolk, England; [Howton, Timothy C.; Mukhtar, M. Shahid] Univ Alabama Birmingham, Dept Biol, Birmingham, AL 35294 USA; [Neuhold, Jana; Lehner, Anita; Stolt-Bergner, Peggy] VBCF, Prot Technol Facil, Vienna, Austria; [Satbhai, Santosh B.; Busch, Wolfgang] Salk Inst Biol Studies, Plant Mol & Cellular Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Mayer, Dominik; Madalinski, Mathias] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Campus Vienna Bioctr 1, A-1030 Vienna, Austria; [Mayer, Dominik; Madalinski, Mathias] Inst Mol Biotechnol GmbH IMBA, Vienna Bioctr VBC, Dr Bohr Gasse 3, A-1030 Vienna, Austria; [Provart, Nicholas J.; Desveaux, Darrell; Guttman, David S.] Univ Toronto, Ctr Anal Genome Evolut & Funct, 25 Willcocks St, Toronto, ON, Canada	Austrian Academy of Sciences; Vienna Biocenter (VBC); Gregor Mendel Institute of Molecular Plant Biology (GMI); University of Toronto; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of Alabama System; University of Alabama Birmingham; Salk Institute; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Vienna Biocenter (VBC); University of Toronto	Belkhadir, Y (corresponding author), Austrian Acad Sci, Vienna Bioctr VBC, GMI, Dr Bohr Gasse 3, A-1030 Vienna, Austria.; Desveaux, D; Guttman, DS (corresponding author), Univ Toronto, Dept Cell & Syst Biol, 25 Willcocks St, Toronto, ON, Canada.; Desveaux, D; Guttman, DS (corresponding author), Univ Toronto, Ctr Anal Genome Evolut & Funct, 25 Willcocks St, Toronto, ON, Canada.	darrell.desveaux@utoronto.ca; david.guttman@utoronto.ca; youssef.belkhadir@gmi.oeaw.ac.at	ZIPFEL, CYRIL/ABD-5076-2021; Satbhai, Santosh/HDM-9121-2022; Guttman, David S/A-7839-2011; Busch, Wolfgang/B-8593-2008; Belkhadir, Youssef/GXM-6743-2022; ZIPFEL, CYRIL B/D-7103-2011; Satbhai, Santosh/A-5499-2016	ZIPFEL, CYRIL/0000-0003-4935-8583; Guttman, David S/0000-0001-8479-3869; Busch, Wolfgang/0000-0003-2042-7290; ZIPFEL, CYRIL B/0000-0003-4935-8583; Mott, Adam/0000-0001-9803-103X; Satbhai, Santosh/0000-0002-2770-656X; Mukhtar, Shahid/0000-0002-1104-6931; Belkhadir, Youssef/0000-0001-7149-7139; Stolt-Bergner, Peggy/0000-0002-5887-2915; Parys, Katarzyna/0000-0002-0141-0349	Austrian Academy of Sciences through Gregor Mendel Institute; Natural Sciences and Engineering Research Council of Canada Discovery Grants; Canada Research Chair in Plant-Microbe Systems Biology Comparative Genomics; Centre for the Analysis of Genome Evolution and Function; Gatsby Charitable Foundation; European Research Council (grant 'PHOSPHinnATE'); Hertha Firnberg Programme post-doctoral fellowship from FWF Austrian Science Fund [T-947]; Deutsche Forschungsgemeinschaft (DFG) [STE 2448/1]; National Science Foundation [IOS-1557796]; Austrian Federal Ministry of Science, Research Economy; City of Vienna through Vienna Biocenter Core Facilities (VBCF); BBSRC [BBS/E/J/000PR9795, BBS/E/J/000PR9796] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000PR9796, BBS/E/J/000PR9795] Funding Source: researchfish; Direct For Biological Sciences [1557796] Funding Source: National Science Foundation	Austrian Academy of Sciences through Gregor Mendel Institute; Natural Sciences and Engineering Research Council of Canada Discovery Grants(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chair in Plant-Microbe Systems Biology Comparative Genomics; Centre for the Analysis of Genome Evolution and Function; Gatsby Charitable Foundation; European Research Council (grant 'PHOSPHinnATE'); Hertha Firnberg Programme post-doctoral fellowship from FWF Austrian Science Fund; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); National Science Foundation(National Science Foundation (NSF)); Austrian Federal Ministry of Science, Research Economy; City of Vienna through Vienna Biocenter Core Facilities (VBCF); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank A. Pasha for uploading the CSI<SUP>LRR</SUP> interaction dataset to the Bio-Analytic Resource for Plant Biology, Y. Dagdas for comments on the manuscript, C. K. Garcia for the pECIA2/14 vectors, E. Ozkan for his protocols, Y. Saijo, K. Tori and M. Butenko for the pepr1/2, erl2 and hsl2 mutant lines, respectively, and A. Bindeus for help with programming software. This work was supported by grants from the Austrian Academy of Sciences through the Gregor Mendel Institute (Y.B. and W.B.); the Natural Sciences and Engineering Research Council of Canada Discovery Grants to D.S.G. and D.D.; a Canada Research Chair in Plant-Microbe Systems Biology (D.D.) or Comparative Genomics (D.S.G.); and the Centre for the Analysis of Genome Evolution and Function (D.D. and D.S.G.). This research was also funded by the Gatsby Charitable Foundation (C.Z.) and the European Research Council (grant 'PHOSPHinnATE') (C.Z.). E.S.-L. is supported by a Hertha Firnberg Programme post-doctoral fellowship (T-947) from the FWF Austrian Science Fund. M.S. is supported by a post-doctoral fellowship (STE 2448/1) from the Deutsche Forschungsgemeinschaft (DFG). This work was supported by the National Science Foundation (IOS-1557796) to M.S.M. P.S.-B. acknowledges funding from the Austrian Federal Ministry of Science, Research & Economy, and the City of Vienna through the Vienna Biocenter Core Facilities (VBCF). We would like to thank P. Serrano Drozdowskyj, A. Aszodi and A. Gyenesei from the VBCF Biocomputing facility for developing the Platero software. We also thank the VBCF Plant Sciences facilities for the plant growth chambers.	Agusti J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001312; Albert I, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.140, 10.1038/nplants.2015.140]; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Belkhadirl Y, 2014, TRENDS BIOCHEM SCI, V39, P447, DOI 10.1016/j.tibs.2014.06.006; Belkhadir Y, 2012, P NATL ACAD SCI USA, V109, P297, DOI 10.1073/pnas.1112840108; Boutrot F, 2017, ANNU REV PHYTOPATHOL, V55, P257, DOI 10.1146/annurev-phyto-080614-120106; Braun P, 2012, PROTEOMICS, V12, P1499, DOI 10.1002/pmic.201100598; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; CHANG C, 1992, PLANT CELL, V4, P1263, DOI 10.1105/tpc.4.10.1263; Cole SJ, 2013, NEW PHYTOL, V200, P172, DOI 10.1111/nph.12368; Couto D, 2016, NAT REV IMMUNOL, V16, P537, DOI 10.1038/nri.2016.77; Eyuboglu B, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-16; Gou XP, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-19; Halter T, 2014, CURR BIOL, V24, P134, DOI 10.1016/j.cub.2013.11.047; Hazak O, 2017, EMBO REP, V18, P1367, DOI 10.15252/embr.201643535; Hohmann U, 2017, ANNU REV PLANT BIOL, V68, P109, DOI 10.1146/annurev-arplant-042916-040957; Igarashi D, 2012, PLANT J, V71, P194, DOI 10.1111/j.1365-313X.2012.04950.x; Jaillais Y, 2011, P NATL ACAD SCI USA, V108, P8503, DOI 10.1073/pnas.1103556108; Jorda L, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.00897; Kang YH, 2016, EMBO REP, V17, P1145, DOI 10.15252/embr.201642450; Li XQ, 2016, CURR ISSUES MOL BIOL, V20, P13; Liu W, 2014, SCI REP-UK, V4, DOI 10.1038/srep05739; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; McWilliam H, 2013, NUCLEIC ACIDS RES, V41, pW597, DOI 10.1093/nar/gkt376; Meng XZ, 2016, CELL REP, V14, P1330, DOI 10.1016/j.celrep.2016.01.023; Meng XZ, 2015, CURR BIOL, V25, P2361, DOI 10.1016/j.cub.2015.07.068; Mosher S, 2013, PLANT J, V73, P469, DOI 10.1111/tpj.12050; Mott GA, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0955-7; Mukhtar MS, 2011, SCIENCE, V333, P596, DOI 10.1126/science.1203659; Nimchuk ZL, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006681; Nodine MD, 2007, DEV CELL, V12, P943, DOI 10.1016/j.devcel.2007.04.003; Ozkan E, 2013, CELL, V154, P228, DOI 10.1016/j.cell.2013.06.006; Postel S, 2010, EUR J CELL BIOL, V89, P169, DOI 10.1016/j.ejcb.2009.11.001; Roux M, 2011, PLANT CELL, V23, P2440, DOI 10.1105/tpc.111.084301; Russinova E, 2004, PLANT CELL, V16, P3216, DOI 10.1105/tpc.104.025387; Sakamoto T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-229; Santiago J, 2016, ELIFE, V5, DOI 10.7554/eLife.15075; Santiago J, 2013, SCIENCE, V341, P889, DOI 10.1126/science.1242468; Schwessinger B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002046; Shinohara H, 2016, P NATL ACAD SCI USA, V113, P3897, DOI 10.1073/pnas.1522639113; Shiu SH, 2004, PLANT CELL, V16, P1220, DOI 10.1105/tpc.020834; Song W, 2017, CURR OPIN STRUC BIOL, V43, P18, DOI 10.1016/j.sbi.2016.09.012; Soyars CL, 2016, CURR OPIN PLANT BIOL, V29, P163, DOI 10.1016/j.pbi.2015.12.002; Sun JM, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-4155-y; Sun WX, 2012, PLANT CELL, V24, P1096, DOI 10.1105/tpc.112.095919; Sun YD, 2013, CELL RES, V23, P1326, DOI 10.1038/cr.2013.131; Sun YD, 2013, SCIENCE, V342, P624, DOI 10.1126/science.1243825; Tang J, 2015, CELL RES, V25, P110, DOI 10.1038/cr.2014.161; Tarutani Y, 2004, BIOSCI BIOTECH BIOCH, V68, P1935, DOI 10.1271/bbb.68.1935; Tian L., 2017, ARTICULATION POINTS, V8, P14223, DOI [10.1038/ncomms14223, DOI 10.1038/NCOMMS14223]; VALON C, 1993, PLANT MOL BIOL, V23, P415, DOI 10.1007/BF00029017; Wang JZ, 2015, NATURE, V525, P265, DOI 10.1038/nature14858; Wang T, 2016, NATURE, V531, P241, DOI 10.1038/nature16975; Wang X, 2017, PLANT J, V89, P250, DOI 10.1111/tpj.13380; Xiao D, 2015, PLANT PHYSIOL, V169, P1275, DOI 10.1104/pp.15.01112; Yeh YH, 2016, PLANT CELL, V28, P1701, DOI 10.1105/tpc.16.00313; Zipfel C, 2017, NATURE, V543, P328, DOI 10.1038/nature22009	58	144	150	6	145	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2018	553	7688					342	+		10.1038/nature25184	http://dx.doi.org/10.1038/nature25184			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT9MB	29320478	Green Accepted			2022-12-28	WOS:000423475100052
J	Chen, XJ; Baumal, CR				Chen, Xuejing; Baumal, Caroline R.			Iris Abscess	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chen, Xuejing; Baumal, Caroline R.] Tufts Med Ctr, Boston, MA 02111 USA	Tufts Medical Center	Baumal, CR (corresponding author), Tufts Med Ctr, Boston, MA 02111 USA.	cbaumal@tuftsmedicalcenter.org	Chen, Xuejing/AAR-4248-2021	chen, xuejing/0000-0001-6827-0152					0	0	0	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 11	2018	378	2					E3	E3		10.1056/NEJMicm1705033	http://dx.doi.org/10.1056/NEJMicm1705033			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FS7IR	29320659				2022-12-28	WOS:000419971600012
J	Maddox, KEJ; Orav, EJ; Zheng, J; Epstein, AM				Maddox, Karen E. Joynt; Orav, E. John; Zheng, Jie; Epstein, Arnold M.			Participation and Dropout in the Bundled Payments for Care Improvement Initiative	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Maddox, Karen E. Joynt] Washington Univ, Sch Med, 660 S Euclid Ave, St Louis, MO 63110 USA; [Orav, E. John] Brigham & Womens Hosp, 75 Francis St, Boston, MA 02115 USA; [Zheng, Jie; Epstein, Arnold M.] Harvard TH Chan Sch Publ Hlth, Boston, MA USA	Washington University (WUSTL); Harvard University; Brigham & Women's Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Maddox, KEJ (corresponding author), Washington Univ, Sch Med, 660 S Euclid Ave, St Louis, MO 63110 USA.	kjoyntmaddox@wustl.edu			Commonwealth Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL109177] Funding Source: NIH RePORTER	Commonwealth Fund; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was funded by the Commonwealth Fund.	[Anonymous], FED REG; Centers for Medicare and Medicaid Services, 2016, QUAL PAYM PROGR DEL; Centers for Medicare and Medicaid Services, BUNDL PAYM CAR IMPR; Centers for Medicare & Medicaid Services, EP PAYM MOD; Dummit L, CMS BUNDLED PAYMENTS, P2; PRICE T, COMMUNICATION	6	22	22	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2018	319	2					191	193		10.1001/jama.2017.14771	http://dx.doi.org/10.1001/jama.2017.14771			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS4PR	29318267	Bronze, Green Published			2022-12-28	WOS:000419775500019
J	Zaffran, M; McGovern, M; Hossaini, R; Martin, R; Wenger, J				Zaffran, Michel; McGovern, Michael; Hossaini, Reza; Martin, Rebecca; Wenger, Jay			The polio endgame: securing a world free of all polioviruses	LANCET			English	Editorial Material									[Zaffran, Michel] WHO, CH-1211 Geneva 27, Switzerland; [McGovern, Michael] Rotary Int, Int PolioPlus Comm, Evanston, IL USA; [Hossaini, Reza] UNICEF, New York, NY USA; [Martin, Rebecca] US Ctr Dis Control & Prevent, Ctr Global Hlth, Atlanta, GA USA; [Wenger, Jay] Bill & Melinda Gates Fdn, Seattle, WA USA	World Health Organization; UNICEF; Centers for Disease Control & Prevention - USA; Bill & Melinda Gates Foundation	Zaffran, M (corresponding author), WHO, CH-1211 Geneva 27, Switzerland.	zaffranm@who.int			World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		[Anonymous], 2018, POLIO TODAY; Global Polio Eradication Initiative, 2013, GLOB POL ER IN POL E; Global Polio Eradication Initiative, POL THIS WEEK 27 DEC; Global Polio Eradication Initiative, 2016, GLOB POL ER IN ANN R; Global Polio Eradication Initiative, 2015, POL ER ENDG MIDT REV; Tebbens RJD, 2010, VACCINE, V29, P334, DOI 10.1016/j.vaccine.2010.10.026; UNICEF, 2017, MOR 350 000 CHILDR 5; WHO, 2017, POL REP SECR 70 WORL	8	14	15	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 6	2018	391	10115					11	13		10.1016/S0140-6736(17)32442-X	http://dx.doi.org/10.1016/S0140-6736(17)32442-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR9ZB	29323639				2022-12-28	WOS:000419432300010
J	Costa, EA; Subramanian, K; Nunnari, J; Weissman, JS				Costa, Elizabeth A.; Subramanian, Kelly; Nunnari, Jodi; Weissman, Jonathan S.			Defining the physiological role of SRP in protein-targeting efficiency and specificity	SCIENCE			English	Article							SIGNAL RECOGNITION PARTICLE; ENDOPLASMIC-RETICULUM; SACCHAROMYCES-CEREVISIAE; MEMBRANE; COMPLEX; ER; TRANSLOCATION; MITOCHONDRIA; INSERTION; SYSTEM	The signal recognition particle (SRP) enables cotranslational delivery of proteins for translocation into the endoplasmic reticulum (ER), but its full in vivo role remains incompletely explored. We combined rapid auxin-induced SRP degradation with proximity-specific ribosome profiling to define SRP's in vivo function in yeast. Despite the classic view that SRP recognizes amino-terminal signal sequences, we show that SRP was generally essential for targeting transmembrane domains regardless of their position relative to the amino terminus. By contrast, many proteins containing cleavable amino-terminal signal peptides were efficiently cotranslationally targeted in SRP's absence. We also reveal an unanticipated consequence of SRP loss: Transcripts normally targeted to the ER were mistargeted to mitochondria, leading to mitochondrial defects. These results elucidate SRP's essential roles in maintaining the efficiency and specificity of protein targeting.	[Costa, Elizabeth A.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Subramanian, Kelly; Nunnari, Jodi] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA; [Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California Davis; Howard Hughes Medical Institute; University of California System; University of California San Francisco	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA.; Weissman, JS (corresponding author), Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA.	jonathan.weissman@ucsf.edu		Costa, Elizabeth/0000-0001-8365-0436; Weissman, Jonathan/0000-0003-2445-670X	Howard Hughes Medical Institute; NIH [R01AG041826, P50GM102706, R01GM062942, R01GM097432, R01GM106019]; NSF Graduate Research Fellowship [1144247]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM097432, R01GM097432, P50GM102706, R01GM062942, T32GM007377, R01GM106019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG041826] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Graduate Research Fellowship(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank members of the Weissman and Nunnari labs for discussion; C. Jan, M. Jost, and M. Shurtleff for critical reading of the manuscript; and the University of California, San Francisco, Center for Advanced Technology for technical assistance. This work was supported by the Howard Hughes Medical Institute (J.S.W.) and NIH grants R01AG041826 (J.S.W.), P50GM102706 (J.S.W.), R01GM062942 (J.N.), R01GM097432 (J.N.), and R01GM106019 (J.N.). E.A.C. was supported by NSF Graduate Research Fellowship 1144247. J.N. serves on the scientific advisory board of Mitobridge, Inc. Data are deposited in the Gene Expression Omnibus under accession number GSE106329.	Ast T, 2013, CELL, V152, P1134, DOI 10.1016/j.cell.2013.02.003; Aviram N, 2016, NATURE, V540, P134, DOI 10.1038/nature20169; Chartron JW, 2016, NATURE, V536, P224, DOI 10.1038/nature19309; FELDHEIM D, 1994, J CELL BIOL, V126, P935, DOI 10.1083/jcb.126.4.935; FELICI F, 1989, MOL CELL BIOL, V9, P3260, DOI 10.1128/MCB.9.8.3260; Gamerdinger M, 2015, SCIENCE, V348, P201, DOI 10.1126/science.aaa5335; HANN BC, 1991, CELL, V67, P131, DOI 10.1016/0092-8674(91)90577-L; HANSEN W, 1988, J CELL BIOL, V106, P1075, DOI 10.1083/jcb.106.4.1075; Jan CH, 2014, SCIENCE, V346, P716, DOI 10.1126/science.1257521; Kornmann B, 2009, SCIENCE, V325, P477, DOI 10.1126/science.1175088; Miller C, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2010.112; Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269; Nishimura K, 2009, NAT METHODS, V6, P917, DOI 10.1038/nmeth.1401; PANZNER S, 1995, CELL, V81, P561, DOI 10.1016/0092-8674(95)90077-2; Ruan LH, 2017, NATURE, V543, P443, DOI 10.1038/nature21695; Schibich D, 2016, NATURE, V536, P219, DOI 10.1038/nature19070; Schuldiner M, 2008, CELL, V134, P634, DOI 10.1016/j.cell.2008.06.025; Stefanovic S, 2007, CELL, V128, P1147, DOI 10.1016/j.cell.2007.01.036; Voorhees RM, 2015, ELIFE, V4, DOI 10.7554/eLife.07975; WATERS MG, 1986, J CELL BIOL, V102, P1543, DOI 10.1083/jcb.102.5.1543; Williams CC, 2014, SCIENCE, V346, P748, DOI 10.1126/science.1257522; Zhang X, 2014, ANNU REV BIOPHYS, V43, P381, DOI 10.1146/annurev-biophys-051013-022653	22	110	110	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 9	2018	359	6376					689	692		10.1126/science.aar3607	http://dx.doi.org/10.1126/science.aar3607			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW2FH	29348368	Green Accepted			2022-12-28	WOS:000425117700041
J	Bakris, G; Sorrentino, M				Bakris, George; Sorrentino, Matthew			Redefining Hypertension - Assessing the New Blood-Pressure Guidelines	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Bakris, George] Univ Chicago Med, ASH Comprehens Hypertens Ctr, Dept Med, Chicago, IL 60637 USA; [Bakris, George] Univ Chicago Med, Sect Endocrinol Diabet & Metab, Chicago, IL 60637 USA; [Sorrentino, Matthew] Univ Chicago Med, Sect Cardiol, Chicago, IL USA		Bakris, G (corresponding author), Univ Chicago Med, ASH Comprehens Hypertens Ctr, Dept Med, Chicago, IL 60637 USA.; Bakris, G (corresponding author), Univ Chicago Med, Sect Endocrinol Diabet & Metab, Chicago, IL 60637 USA.							[Anonymous], 2017, HYPERTENSION; Bakris GaS, 2018, HYPERTENSION COMPANI, P281; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; de Boer IH, 2017, DIABETES CARE, V40, P1273, DOI 10.2337/dci17-0026; Muntner P, 2018, CIRCULATION, V137, P109, DOI 10.1161/CIRCULATIONAHA.117.032582	5	70	73	2	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2018	378	6					497	499		10.1056/NEJMp1716193	http://dx.doi.org/10.1056/NEJMp1716193			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV1OX	29341841				2022-12-28	WOS:000424335200002
J	Wright, AA; Katz, IT				Wright, Alexi A.; Katz, Ingrid T.			Beyond Burnout - Redesigning Care to Restore Meaning and Sanity for Physicians	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SATISFACTION						Wright, Alexi/T-5793-2019					[Anonymous], 2017, HLTH AFFAIRS BLOG; Shanafelt TD, 2015, MAYO CLIN PROC, V90, P1600, DOI 10.1016/j.mayocp.2015.08.023; Shanafelt TD, 2015, MAYO CLIN PROC, V90, P432, DOI 10.1016/j.mayocp.2015.01.012; Sinsky C, 2016, ANN INTERN MED, V165, P753, DOI 10.7326/M16-0961	4	109	110	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 25	2018	378	4					309	311		10.1056/NEJMp1716845	http://dx.doi.org/10.1056/NEJMp1716845			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT5ZX	29365301				2022-12-28	WOS:000423233400001
J	Chessman, AW				Chessman, Alexander W.			Guideline: Experts recommend a single dose of oral steroids for pain relief in acute sore throat	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Chessman, Alexander W.] Med Univ South Carolina, Charleston, SC 29401 USA	Medical University of South Carolina	Chessman, AW (corresponding author), Med Univ South Carolina, Charleston, SC 29401 USA.							Gehanno P, 2003, CLIN DRUG INVEST, V23, P263, DOI 10.2165/00044011-200323040-00006; Pierce CA, 2010, ANN PHARMACOTHER, V44, P489, DOI 10.1345/aph.1M332; Siemieniuk RAC, 2015, ANN INTERN MED, V163, P519, DOI 10.7326/M15-0715; Spinks A, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000023.pub4; WALJEE AK, 2017, BMJ-BRIT MED J, V357, DOI DOI 10.1136/BMJ.J1415	5	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2018	168	2					JC2	JC2		10.7326/ACPJC-2018-168-2-002	http://dx.doi.org/10.7326/ACPJC-2018-168-2-002			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU8IN	29335714				2022-12-28	WOS:000424096600002
J	Oliver, D				Oliver, David			ACUTE PERSPECTIVE David Oliver: Will we now see a serious attempt to tackle social care funding?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												davidoliver372@googlemail.com						Carers UK, 2014, CAR ACT FAQ; Charlesworth A, 2017, SOCIAL CARE FUNDING; Department of Health and Social Care, 2017, HLTH SECR URG PEOPL; Eaton G, 2010, NEW STATESMAN, V10; Elgot J., 2017, GUARDIAN; Gelb B., 2017, GUARDIAN; Green D, 2017, GOVT SET OUT PROPOSA; Health Education England, WORKF STRAT; King's Fund, 2011, DILN COMM REP SOC CA; King's Fund, 2016, SOC CAR OLD PEOPL HO; King's Fund, 2014, ILL SUMM BARK COMM R; King's Fund, 2017, THER MAY IS RIGHT DR; Merrick R., 2018, JEREMY HUNT KEEPS HE; Naylor C., 2017, IS THERE PARITY ESTE; Oliver D, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3623; Paine D., 2017, GOVT DITCHES CAP SOC; RAVEN R J, 1988, American Museum Novitates, P1; Social Care Institute for Excellence, 1999, RESP OLD AG LONG TER; Watt N., 2010, GUARDIAN	19	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 16	2018	360								k136	10.1136/bmj.k136	http://dx.doi.org/10.1136/bmj.k136			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT5PN	29339361	Bronze, Green Published			2022-12-28	WOS:000423205800001
J	Bonekamp, NA; Larsson, NG				Bonekamp, Nina A.; Larsson, Nils-Goeran			SnapShot: Mitochondrial Nucleoid	CELL			English	Editorial Material							DNA NUCLEOIDS; TRANSCRIPTION; MAINTENANCE; REVEALS; MTDNA; TFAM		[Bonekamp, Nina A.; Larsson, Nils-Goeran] Max Planck Inst Biol Ageing, Dept Mitochondrial Biol, D-50931 Cologne, Germany; [Larsson, Nils-Goeran] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	Max Planck Society; Karolinska Institutet	Bonekamp, NA (corresponding author), Max Planck Inst Biol Ageing, Dept Mitochondrial Biol, D-50931 Cologne, Germany.		Larsson, Nils-Göran/GVS-5578-2022; Bonekamp, Nina/AAX-3670-2020	Larsson, Nils-Göran/0000-0001-5100-996X; Bonekamp, Nina/0000-0001-9748-8089	Max Planck Society; Swedish Research Council [2015-00418]; Knut and Alice Wallenberg foundation	Max Planck Society(Max Planck SocietyFoundation CELLEX); Swedish Research Council(Swedish Research CouncilEuropean Commission); Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation)	We thank the Max Planck Society, the Swedish Research Council (2015-00418), and the Knut and Alice Wallenberg foundation for funding our research. Images of the mitochondrial nucleoid are from Kukat et al. (2015).	Bogenhagen DF, 2014, CELL METAB, V19, P618, DOI 10.1016/j.cmet.2014.03.013; Brown TA, 2011, MOL CELL BIOL, V31, P4994, DOI 10.1128/MCB.05694-11; Farge G, 2014, CELL REP, V8, P66, DOI 10.1016/j.celrep.2014.05.046; Gustafsson CM, 2016, ANNU REV BIOCHEM, V85, P133, DOI 10.1146/annurev-biochem-060815-014402; Ishihara T, 2015, MOL CELL BIOL, V35, P211, DOI 10.1128/MCB.01054-14; Kaufman BA, 2007, MOL BIOL CELL, V18, P3225, DOI 10.1091/mbc.E07-05-0404; Kukat C, 2015, P NATL ACAD SCI USA, V112, P11288, DOI 10.1073/pnas.1512131112; Kukat C, 2011, P NATL ACAD SCI USA, V108, P13534, DOI 10.1073/pnas.1109263108; Lewis SC, 2016, SCIENCE, V353, DOI 10.1126/science.aaf5549; Nicholls T. J., 2018, MOL CELL	10	32	34	0	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					388	+		10.1016/j.cell.2017.12.039	http://dx.doi.org/10.1016/j.cell.2017.12.039			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29328920	Bronze			2022-12-28	WOS:000419840100033
J	Smit, R; Bouwens, RJ; Carniani, S; Oesch, PA; Labbe, I; Illingworth, GD; van der Werf, P; Bradley, LD; Gonzalez, V; Hodge, JA; Holwerda, BW; Maiolino, R; Zheng, W				Smit, Renske; Bouwens, Rychard J.; Carniani, Stefano; Oesch, Pascal A.; Labbe, Ivo; Illingworth, Garth D.; van der Werf, Paul; Bradley, Larry D.; Gonzalez, Valentino; Hodge, Jacqueline A.; Holwerda, Benne W.; Maiolino, Roberto; Zheng, Wei			Rotation in [C II]-emitting gas in two galaxies at a redshift of 6.8	NATURE			English	Article							STAR-FORMATION RATE; SIMILAR-TO 7; C II EMISSION; SPECTROSCOPIC SURVEY; FORMING GALAXY; ALMA OBSERVATIONS; NEBULAR EMISSION; ANGULAR-MOMENTUM; TYPICAL GALAXIES; DUST EMISSION	The earliest galaxies are thought to have emerged during the first billion years of cosmic history, initiating the ionization of the neutral hydrogen that pervaded the Universe at this time. Studying this 'epoch of reionization' involves looking for the spectral signatures of ancient galaxies that are, owing to the expansion of the Universe, now very distant from Earth and therefore exhibit large redshifts. However, finding these spectral fingerprints is challenging. One spectral characteristic of ancient and distant galaxies is strong hydrogen-emission lines (known as Lyman-alpha lines), but the neutral intergalactic medium that was present early in the epoch of reionization scatters such Lyman-alpha photons. Another potential spectral identifier is the line at wavelength 157.4 micrometres of the singly ionized state of carbon (the [C II] lambda = 157.74 mu m line), which signifies cooling gas and is expected to have been bright in the early Universe. However, so far Lyman-alpha-emitting galaxies from the epoch of reionization have demonstrated much fainter [C II] luminosities than would be expected from local scaling relations1-5, and searches for the [C II] line in sources without Lyman-a emission but with photometric redshifts greater than 6 (corresponding to the first billion years of the Universe) have been unsuccessful. Here we identify [C II]. = 157.74 mu m emission from two sources that we selected as high-redshift candidates on the basis of near-infrared photometry; we confirm that these sources are two galaxies at redshifts of z = 6.8540 +/- 0.0003 and z = 6.8076 +/- 0.0002. Notably, the luminosity of the [C II] line from these galaxies is higher than that found previously in star-forming galaxies with redshifts greater than 6.5. The luminous and extended [C II] lines reveal clear velocity gradients that, if interpreted as rotation, would indicate that these galaxies have similar dynamic properties to the turbulent yet rotation-dominated disks that have been observed in Ha-emitting galaxies two billion years later, at 'cosmic noon'.	[Smit, Renske; Carniani, Stefano; Maiolino, Roberto] Univ Cambridge, Cavendish Lab, 19 JJ Thomson Ave, Cambridge CB3 0HE, England; [Smit, Renske; Carniani, Stefano; Maiolino, Roberto] Univ Cambridge, Kavli Inst Cosmol, Madingley Rd, Cambridge CB3 0HA, England; [Bouwens, Rychard J.; Labbe, Ivo; van der Werf, Paul; Hodge, Jacqueline A.] Leiden Univ, Leiden Observ, NL-2300 RA Leiden, Netherlands; [Oesch, Pascal A.] Univ Geneva, Observ Geneve, Chemin Maillettes 51, CH-1290 Versoix, Switzerland; [Illingworth, Garth D.] Univ Calif Santa Cruz, UCO Lick Observ, 1156 High St, Santa Cruz, CA 95064 USA; [Bradley, Larry D.] Space Telescope Sci Inst, 3700 San Martin Dr, Baltimore, MD 21218 USA; [Gonzalez, Valentino] Univ Chile, Dept Astron, Casilla 36-D, Santiago 7591245, Chile; [Gonzalez, Valentino] CATA, Camino Observ 1515, Santiago 7591245, Chile; [Holwerda, Benne W.] Univ Louisville, Dept Phys & Astron, Louisville, KY 40292 USA; [Zheng, Wei] Johns Hopkins Univ, Dept Phys & Astron, 3400 North Charles St, Baltimore, MD 21218 USA	University of Cambridge; University of Cambridge; Leiden University; Leiden University - Excl LUMC; University of Geneva; University of California System; University of California Santa Cruz; Space Telescope Science Institute; Universidad de Chile; University of Louisville; Johns Hopkins University	Smit, R (corresponding author), Univ Cambridge, Cavendish Lab, 19 JJ Thomson Ave, Cambridge CB3 0HE, England.; Smit, R (corresponding author), Univ Cambridge, Kavli Inst Cosmol, Madingley Rd, Cambridge CB3 0HA, England.	rs940@cam.ac.uk	Labbe, Ivo/B-1408-2016; Labbe, Ivo/AAZ-2544-2020; Carniani, Stefano/AAS-2822-2020; Carniani, Stefano/AAZ-5487-2020	Labbe, Ivo/0000-0002-2057-5376; Carniani, Stefano/0000-0002-6719-380X; Carniani, Stefano/0000-0002-6719-380X; Hodge, Jacqueline/0000-0001-6586-8845; Oesch, Pascal/0000-0001-5851-6649; Smit, Renske/0000-0001-8034-7802; Maiolino, Roberto/0000-0002-4985-3819; Illingworth, Garth/0000-0002-8096-2837	Netherlands Organisation for Scientific Research (NWO) [680-50-1518]; ERC Advanced Grant [695671]; Science and Technology Facilities Council (STFC); STFC [ST/M001172/1, ST/K003119/1] Funding Source: UKRI; Science and Technology Facilities Council [ST/M001172/1, ST/K003119/1] Funding Source: researchfish	Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); ERC Advanced Grant; Science and Technology Facilities Council (STFC)(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)Science and Technology Development Fund (STDF)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	This paper makes use of the following ALMA data: ADS/JAO.ALMA#2015.1.01111.S (http://almascience.org/aq?project_code=2015.1.01111.S). ALMA is a partnership of the European Southern Observatory (ESO, UK), the National Science Foundation (NSF, USA) and the National Institute of Natural Sciences (NINS, Japan), together with the National Research Council (NRC, Canada), the National Security Council (NSC) and Academia Sinica Institute of Astronomy and Astrophysics (ASIAA, Taiwan), and the Korea Astronomy and Space Science Institute (KASI, South Korea), in cooperation with Chile. The Joint ALMA Observatory is operated by ESO, Associated Universities Inc. (AUI)/National Radio Astronomy Observatory (NRAO), and the National Astronomical Observatory of Japan (NAOJ). This work is part of a Rubicon programme, 'A multi-wavelength view of the first galaxies', with project number 680-50-1518, which is financed by the Netherlands Organisation for Scientific Research (NWO). R.M. and S.C. acknowledge ERC Advanced Grant 695671 'QUENCH' and support by the Science and Technology Facilities Council (STFC).	Aravena M, 2016, ASTROPHYS J, V833, DOI 10.3847/1538-4357/833/1/71; Bowler RAA, 2017, MON NOT R ASTRON SOC, V466, P3612, DOI 10.1093/mnras/stw3296; Brammer GB, 2012, ASTROPHYS J SUPPL S, V200, DOI 10.1088/0067-0049/200/2/13; Burkert A, 2016, ASTROPHYS J, V826, DOI 10.3847/0004-637X/826/2/214; Burkert A, 2010, ASTROPHYS J, V725, P2324, DOI 10.1088/0004-637X/725/2/2324; Capak PL, 2015, NATURE, V522, P455, DOI 10.1038/nature14500; Carniani S, 2013, ASTRON ASTROPHYS, V559, DOI 10.1051/0004-6361/201322320; Chabrier G, 2003, PUBL ASTRON SOC PAC, V115, P763, DOI 10.1086/376392; da Cunha E, 2015, ASTROPHYS J, V806, DOI 10.1088/0004-637X/806/1/110; da Cunha E, 2008, MON NOT R ASTRON SOC, V388, P1595, DOI 10.1111/j.1365-2966.2008.13535.x; De Looze I, 2014, ASTRON ASTROPHYS, V568, DOI 10.1051/0004-6361/201322489; Dunlop JS, 2017, MON NOT R ASTRON SOC, V466, P861, DOI 10.1093/mnras/stw3088; Feng Y, 2015, ASTROPHYS J LETT, V808, DOI 10.1088/2041-8205/808/1/L17; Fiacconi D, 2017, MON NOT R ASTRON SOC, V467, P4080, DOI 10.1093/mnras/stx335; Gnerucci A, 2011, ASTRON ASTROPHYS, V528, DOI 10.1051/0004-6361/201015465; Herrera-Camus R, 2015, ASTROPHYS J, V800, DOI 10.1088/0004-637X/800/1/1; Katz H, 2017, MON NOT R ASTRON SOC, V468, P4831, DOI 10.1093/mnras/stx608; Kennicutt RC, 2012, ANNU REV ASTRON ASTR, V50, P531, DOI 10.1146/annurev-astro-081811-125610; Knudsen KK, 2016, MON NOT R ASTRON SOC, V462, pL6, DOI 10.1093/mnrasl/slw114; Koprowski MP, 2016, ASTROPHYS J LETT, V828, DOI 10.3847/2041-8205/828/2/L21; Laporte N, 2017, ASTROPHYS J LETT, V837, DOI 10.3847/2041-8213/aa62aa; Leroy AK, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/1/3; Maiolino R, 2015, MON NOT R ASTRON SOC, V452, P54, DOI 10.1093/mnras/stv1194; Mason CA, 2017, ASTROPHYS J, V838, DOI 10.3847/1538-4357/aa60c4; McMullin JP, 2007, ASTR SOC P, V376, P127; Meurer GR, 1999, ASTROPHYS J, V521, P64, DOI 10.1086/307523; Narayanan D., 2017, PREPRINT; Newman SF, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/2/104; OKE JB, 1983, ASTROPHYS J, V266, P713, DOI 10.1086/160817; Ota K, 2014, ASTROPHYS J, V792, DOI 10.1088/0004-637X/792/1/34; Ouchi M, 2013, ASTROPHYS J, V778, DOI 10.1088/0004-637X/778/2/102; Pallottini A, 2017, MON NOT R ASTRON SOC, V465, P2540, DOI 10.1093/mnras/stw2847; Pavesi R, 2016, ASTROPHYS J, V832, DOI 10.3847/0004-637X/832/2/151; Pentericci L, 2016, ASTROPHYS J LETT, V829, DOI 10.3847/2041-8205/829/1/L11; PREVOT ML, 1984, ASTRON ASTROPHYS, V132, P389; Riechers DA, 2014, ASTROPHYS J, V796, DOI 10.1088/0004-637X/796/2/84; Riechers DA, 2013, NATURE, V496, P329, DOI 10.1038/nature12050; Schaerer D, 2015, ASTRON ASTROPHYS, V574, DOI 10.1051/0004-6361/201424649; Schreiber NMF, 2009, ASTROPHYS J, V706, P1364, DOI 10.1088/0004-637X/706/2/1364; Smit R, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/1/58; Smit R, 2016, ASTROPHYS J, V833, DOI 10.3847/1538-4357/833/2/254; Smit R, 2015, ASTROPHYS J, V801, DOI 10.1088/0004-637X/801/2/122; Smith JDT, 2017, ASTROPHYS J, V834, DOI 10.3847/1538-4357/834/1/5; Stark DP, 2017, MON NOT R ASTRON SOC, V464, P469, DOI 10.1093/mnras/stw2233; Stark DP, 2016, ANNU REV ASTRON ASTR, V54, P761, DOI 10.1146/annurev-astro-081915-023417; Stark DP, 2013, ASTROPHYS J, V763, DOI 10.1088/0004-637X/763/2/129; Stott JP, 2016, MON NOT R ASTRON SOC, V457, P1888, DOI 10.1093/mnras/stw129; Strandet ML, 2017, ASTROPHYS J LETT, V842, DOI 10.3847/2041-8213/aa74b0; Vallini L, 2017, MON NOT R ASTRON SOC, V467, P1300, DOI 10.1093/mnras/stx180; Watson D, 2015, NATURE, V519, P327, DOI 10.1038/nature14164; Williams RJ, 2014, MON NOT R ASTRON SOC, V439, P2096, DOI 10.1093/mnras/stu119; Willott CJ, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/2/180; Wuyts S, 2016, ASTROPHYS J, V831, DOI 10.3847/0004-637X/831/2/149	53	107	107	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2018	553	7687					178	+		10.1038/nature24631	http://dx.doi.org/10.1038/nature24631			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4WL	29323299	Green Submitted, Green Accepted			2022-12-28	WOS:000419794800030
J	Fitzgerald, B; Boyle, C; Honein, MA				Fitzgerald, Brenda; Boyle, Coleen; Honein, Margaret A.			Birth Defects Potentially Related to Zika Virus Infection During Pregnancy in the United States	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFANTS; BRAZIL; BORN		[Fitzgerald, Brenda; Boyle, Coleen; Honein, Margaret A.] Ctr Dis Control & Prevent, Atlanta, GA USA	Centers for Disease Control & Prevention - USA	Honein, MA (corresponding author), Ctr Dis Control & Prevent, Birth Defects Branch, 1600 Clifton Rd,Mailstop E-86, Atlanta, GA 30333 USA.	mrh7@cdc.gov			Intramural CDC HHS [CC999999] Funding Source: Medline	Intramural CDC HHS		Center for Disease Control and Prevention, 2015, PREGN WOM AN LAB EV; Delaney A, 2016, MMWR MORB MORTAL WKL; Honein MA, 2017, JAMA-J AM MED ASSOC, V317, P59, DOI 10.1001/jama.2016.19006; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Reynolds MR, 2017, MMWR-MORBID MORTAL W, V66, P366, DOI 10.15585/mmwr.mm6613e1; Satterfield-Nash A, 2017, MMWR-MORBID MORTAL W, V66, P1347, DOI 10.15585/mmwr.mm6649a2; Shapiro-Mendoza CK, 2017, MMWR-MORBID MORTAL W, V66, P615, DOI 10.15585/mmwr.mm6623e1; van der Linden V, 2016, MMWR-MORBID MORTAL W, V65, P1343, DOI 10.15585/mmwr.mm6547e2	8	19	19	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 27	2018	319	12					1195	1196		10.1001/jama.2018.0126	http://dx.doi.org/10.1001/jama.2018.0126			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GA5VW	29372233	Green Accepted			2022-12-28	WOS:000428403000007
J	Chin, XY; Chan, DKL; Chong, JH				Chin, Xinyi; Chan, Daisy Kwai Lin; Chong, Jin Ho			CASE REVIEW A rash that's more than skin deep	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							NEONATAL LUPUS-ERYTHEMATOSUS; MANIFESTATIONS		[Chin, Xinyi; Chong, Jin Ho] KK Womens & Childrens Hosp, Singapore, Singapore; [Chan, Daisy Kwai Lin] Singapore Gen Hosp, Singapore, Singapore	KK Women's & Children's Hospital; Singapore General Hospital	Chin, XY (corresponding author), KK Womens & Childrens Hosp, Singapore, Singapore.	chin.xinyi@singhealth.com.sg		Chin, Xinyi/0000-0002-6010-0930				Buyon JP, 2003, CURR OPIN RHEUMATOL, V15, P535, DOI 10.1097/00002281-200309000-00003; Eichenfield LF, 2015, NEONATAL INFANT DERM, V3; Hon KL, 2012, AUTOIMMUN DIS, V2012, DOI 10.1155/2012/301274; Inzinger M, 2012, J DTSCH DERMATOL GES, V10, P407, DOI 10.1111/j.1610-0387.2012.07940.x; Izmirly PM, 2010, ARTHRITIS RHEUM-US, V62, P1153, DOI 10.1002/art.27333; Laurinaviciene R, 2012, EUR J PEDIATR, V171, P801, DOI 10.1007/s00431-011-1618-z; Rivera TL, 2009, ANN RHEUM DIS, V68, P828, DOI 10.1136/ard.2008.088054; Silverman E, 2010, SCAND J IMMUNOL, V72, P223, DOI 10.1111/j.1365-3083.2010.02443.x; Wisuthsarewong W, 2011, PEDIATR DERMATOL, V28, P115, DOI 10.1111/j.1525-1470.2011.01300.x; Zuppa AA, 2017, AUTOIMMUN REV, V16, P427, DOI 10.1016/j.autrev.2017.02.010	10	2	2	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2018	360								k8	10.1136/bmj.k8	http://dx.doi.org/10.1136/bmj.k8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU2XA	29371179				2022-12-28	WOS:000423712100011
J	Blomstedt, Y; Bhutta, ZA; Dahlstrand, J; Friberg, P; Gostin, LO; Nilsson, M; Sewankambo, NK; Tomson, G; Alfven, T				Blomstedt, Yulia; Bhutta, Zulfiqar A.; Dahlstrand, Johan; Friberg, Peter; Gostin, Lawrence O.; Nilsson, Mans; Sewankambo, Nelson K.; Tomson, Goran; Alfven, Tobias			Partnerships for child health: capitalising on links between the sustainable development goals	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							SYSTEMS; INCOME		[Blomstedt, Yulia] Umea Univ, Dept Publ Hlth & Clin Med, Epidemiol & Global Hlth Unit, Umea, Sweden; [Bhutta, Zulfiqar A.] Aga Khan Univ, Ctr Excellence Women & Child Hlth, Karachi, Pakistan; [Bhutta, Zulfiqar A.] Hosp Sick Children, Ctr Global Child Hlth, Toronto, ON, Canada; [Dahlstrand, Johan; Friberg, Peter; Tomson, Goran; Alfven, Tobias] Royal Swedish Acad Sci, SIGHT, Stockholm, Sweden; [Friberg, Peter] Univ Gothenburg, Sahlgrenska Acad, Inst Med, Gothenburg, Sweden; [Gostin, Lawrence O.] Georgetown Univ, Ctr Law, ONeill Inst Natl & Global Hlth Law, Washington, DC USA; [Nilsson, Mans] Stockholm Environm Inst, Stockholm, Sweden; [Nilsson, Mans] KTH Royal Inst Technol, Stockholm, Sweden; [Sewankambo, Nelson K.] Makerere Univ, Sch Med, Coll Hlth Sci, Kampala, Uganda; [Tomson, Goran] Karolinska Inst, Dept Learning, Stockholm, Sweden; [Tomson, Goran] Karolinska Inst, Dept Informat, Stockholm, Sweden; [Tomson, Goran] Karolinska Inst, Dept Management, Stockholm, Sweden; [Tomson, Goran] Karolinska Inst, Dept Eth, Stockholm, Sweden; [Tomson, Goran; Alfven, Tobias] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Alfven, Tobias] Sachs Children & Youth Hosp, Stockholm, Sweden	Umea University; Aga Khan University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Royal Swedish Academy of Sciences; University of Gothenburg; Georgetown University; Stockholm Environment Institute; Royal Institute of Technology; Makerere University; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet	Alfven, T (corresponding author), Royal Swedish Acad Sci, SIGHT, Stockholm, Sweden.; Alfven, T (corresponding author), Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden.; Alfven, T (corresponding author), Sachs Children & Youth Hosp, Stockholm, Sweden.	tobias.alfven@ki.se	Nilsson, Mans/HGU-9139-2022; Bhutta, Zulfiqar/L-7822-2015	Nilsson, Mans/0000-0003-2157-1083; Gostin, Lawrence/0000-0001-5286-4044; Bhutta, Zulfiqar/0000-0003-0637-599X				Cutter A, 2015, SUSTAINABLE DEV GOAL; Every Woman Every Child, 2015, GLOBAL STRATEGY WOME; Fehling M, 2013, GLOB PUBLIC HEALTH, V8, P1109, DOI 10.1080/17441692.2013.845676; Gantner L., 2007, PROGRESA INTEGRATED; Ghaffar A, 2017, B WORLD HEALTH ORGAN, V95, P87, DOI 10.2471/BLT.16.189126; International Council of Science, 2015, REV TARG SUST DEV GO; Kickbusch I, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3519; LeBlanc D., 2015, INTEGRATION LAST SUS; Marmot M, 2012, PUBLIC HEALTH, V126, pS4, DOI 10.1016/j.puhe.2012.05.014; Marmot M, 2008, LANCET, V372, P1661, DOI 10.1016/S0140-6736(08)61690-6; Nilsson M., 2017, IMPORTANT INTERACTIO; Nilsson M, 2016, NATURE, V534, P320, DOI 10.1038/534320a; Owusu-Addo E, 2014, INT J PUBLIC HEALTH, V59, P609, DOI 10.1007/s00038-014-0570-x; Partnership for Maternal Newborn and Child Health, 2014, KNOWL SUMM 30 WAT SA; Plan, 2014, MULT ED WASH PROGR L; Rasanathan K, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4213; Ryman TK, 2012, J INFECT DIS, V205, pS65, DOI 10.1093/infdis/jir777; Stenberg K, 2017, LANCET GLOB HEALTH, V5, pE875, DOI [10.1016/S2214-109X(17)30263-2, 10.1016/s2214-109x(17)30263-2]; Taylor S, 2015, LANCET, V386, P1213, DOI 10.1016/S0140-6736(15)00300-1; United Nations, 2016, NEX APPR SDGS INT GO; United Nations, 2015, TRANSF OUR WORLD 203; United Nations, 2015, ADD AB ACT AG 3 INT; Waage J, 2015, LANCET GLOB HEALTH, V3, pE251, DOI 10.1016/S2214-109X(15)70112-9; WHO, 2013, HLTH ALL POL HELS ST	24	18	18	3	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 23	2018	360								k125	10.1136/bmj.k125	http://dx.doi.org/10.1136/bmj.k125			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU2WS	29363500	Green Published			2022-12-28	WOS:000423711300001
J	Stein, J; Shapiro, S				Stein, Jason; Shapiro, Susan			Inpatient Notes: Modernizing Rounds-Why It's Time to Redesign Our Hospital Practice	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							CARE		[Stein, Jason] 1Unit, 1579 Monroe Dr NE,Suite F506, Atlanta, GA 30324 USA; Emory Univ, Nell Hodgson Woodruff Sch Nursing, Atlanta, GA 30322 USA	Emory University	Stein, J (corresponding author), 1Unit, 1579 Monroe Dr NE,Suite F506, Atlanta, GA 30324 USA.	jason.stein@1unit.com						Gausvik C, 2015, J MULTIDISCIP HEALTH, V8, P33, DOI 10.2147/JMDH.S72623; Manheim J, 2015, J HOSP MED, V10; Mueller SK, 2016, J HOSP MED, V11, P620, DOI 10.1002/jhm.2566; O'Leary KJ, 2016, J HOSP MED, V11, P524, DOI 10.1002/jhm.2587; Stein J, 2015, J HOSP MED, V10, P36, DOI 10.1002/jhm.2284	5	2	2	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2018	168	2					HO2	HO3		10.7326/M17-3334	http://dx.doi.org/10.7326/M17-3334			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU8IN	29335736				2022-12-28	WOS:000424096600001
J	Ferenchick, EK; Rasanathan, K; Polanco, NT; Bornemisza, O; Kelley, E; Mangiaterra, V				Ferenchick, Erin K.; Rasanathan, Kumanan; Polanco, Nuria Toro; Bornemisza, Olga; Kelley, Edward; Mangiaterra, Viviana			Scaling up integration of health services	LANCET			English	Editorial Material							INCOME COUNTRIES; ANTENATAL CARE; MIDDLE-INCOME; HIV		[Ferenchick, Erin K.; Bornemisza, Olga; Mangiaterra, Viviana] Global Fund Fight AIDS TB & Malaria, Geneva, Switzerland; [Rasanathan, Kumanan] UNICEF, New York, NY 10017 USA; [Polanco, Nuria Toro; Kelley, Edward] World Hlth Org, Geneva, Switzerland	UNICEF; World Health Organization	Rasanathan, K (corresponding author), UNICEF, New York, NY 10017 USA.	krasanathan@unicef.org		MANGIATERRA, VIVIANA/0000-0002-8815-0841	World Health Organization [001] Funding Source: Medline	World Health Organization(World Health Organization)		Briggs CJ, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003318.pub2; Callaghan M, 2010, HUM RESOUR HEALTH, V8, DOI 10.1186/1478-4491-8-8; de Jongh TE, 2016, BJOG-INT J OBSTET GY, V123, P549, DOI 10.1111/1471-0528.13898; George A, 2015, HEALTH POLICY PLANN, V30, P3, DOI 10.1093/heapol/czv096; Ghaffar A, 2017, B WORLD HEALTH ORGAN, V95, P87, DOI 10.2471/BLT.16.189126; Global Technical Assistance Project, 2011, 110130302 GLOB TECHN; Gunguwo H, 2013, PUBLIC HEALTH ACTION, V3, P282, DOI 10.5588/pha.13.0053; Hermans SM, 2012, JAIDS-J ACQ IMM DEF, V60, pE29, DOI 10.1097/QAI.0b013e318251aeb4; The Global Fund to Fight AIDS Tuberculosis and Malaria, 2016, GLOB FUND STRAT 2017; Tomlinson M, 2014, TROP MED INT HEALTH, V19, P256, DOI 10.1111/tmi.12257; UNICEF, 2016, STRAT HLTH 2016 2030; WHO UNICEF, 1978, INT C PRIMARY HLTH C; World Health Organisation Secretariat, 2016, FRAM INT PEOPL CTR H	13	4	4	1	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 13	2018	391	10116					102	103		10.1016/S0140-6736(18)30020-5	http://dx.doi.org/10.1016/S0140-6736(18)30020-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT0EG	29353604				2022-12-28	WOS:000422793400007
J	Giovannoni, J				Giovannoni, James			Tomato Multiomics Reveals Consequences of Crop Domestication and Improvement	CELL			English	Editorial Material							BIOSYNTHESIS; ALKALOIDS	Genome-scale analyses of variation, gene expression, and metabolite accumulation in ancestral, early domesticates, and modern tomatoes by Zhu et al. identify genes underlying fruit chemistry and demonstrate that alleles affecting metabolic quality have been bred into modern varieties as a result of linkage drag. Similar metabolic hitchhikers are likely ubiquitous in other domesticated species.	[Giovannoni, James] Cornell Univ, USDA, Ithaca, NY 14853 USA; [Giovannoni, James] Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA	Cornell University; United States Department of Agriculture (USDA); Cornell University; Boyce Thompson Institute for Plant Research	Giovannoni, J (corresponding author), Cornell Univ, USDA, Ithaca, NY 14853 USA.; Giovannoni, J (corresponding author), Cornell Univ, Boyce Thompson Inst Plant Res, Tower Rd, Ithaca, NY 14853 USA.	jjg33@cornell.edu						Cardenas PD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10654; Giovannoni J, 2017, ANNU REV PLANT BIOL, V68, P61, DOI 10.1146/annurev-arplant-042916-040906; Itkin M, 2013, SCIENCE, V341, P175, DOI 10.1126/science.1240230; Lin T, 2014, NAT GENET, V46, P1220, DOI 10.1038/ng.3117; Mu Q, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006930; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Yin KQ, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.107; Zhu GT, 2018, CELL, V172, P249, DOI 10.1016/j.cell.2017.12.019	8	25	25	4	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					6	8		10.1016/j.cell.2017.12.036	http://dx.doi.org/10.1016/j.cell.2017.12.036			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29328921	Bronze			2022-12-28	WOS:000419840100003
J	Lee, YS; Wollam, J; Olefsky, JM				Lee, Yun Sok; Wollam, Joshua; Olefsky, Jerrold M.			An Integrated View of Immunometabolism	CELL			English	Review							NECROSIS-FACTOR-ALPHA; DIET-INDUCED OBESITY; INDUCED INSULIN-RESISTANCE; ISLET-ASSOCIATED MACROPHAGES; BETA-CELL DEDIFFERENTIATION; ADIPOSE-TISSUE MACROPHAGES; ACTIVATED RECEPTOR-GAMMA; GLUCAGON-LIKE PEPTIDE-1; SATURATED FATTY-ACID; FARNESOID-X-RECEPTOR	The worldwide obesity epidemic has emerged as a major cause of insulin resistance and Type 2 diabetes. Chronic tissue inflammation is a well-recognized feature of obesity, and the field of immunometabolism has witnessed many advances in recent years. Here, we review the major features of our current understanding with respect to chronic obesity-related inflammation in metabolic tissues and focus on how these inflammatory changes affect insulin sensitivity, insulin secretion, food intake, and glucose homeostasis. There is a growing appreciation of the varied and sometimes integrated crosstalk between cells within a tissue (intraorgan) and tissues within an organism (interorgan) that supports inflammation in the context of metabolic dysregulation. Understanding these pathways and modes of communication has implications for translational studies. We also briefly summarize the state of this field with respect to potential current and developing therapeutics.	[Lee, Yun Sok; Wollam, Joshua; Olefsky, Jerrold M.] Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA; [Lee, Yun Sok] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon 34141, South Korea	University of California System; University of California San Diego; Korea Advanced Institute of Science & Technology (KAIST)	Olefsky, JM (corresponding author), Univ Calif San Diego, Dept Med, Div Endocrinol & Metab, La Jolla, CA 92093 USA.	jolefsky@ucsd.edu	Lee, Yun Sok/B-3265-2015; Lee, Yun Sok/ABC-9195-2021	Lee, Yun Sok/0000-0001-7967-4734; Lee, Yun Sok/0000-0001-7967-4734	US National Institute of Diabetes and Digestive and Kidney Diseases [DK074868, DK063491, DK101395]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491, R01DK101395, P01DK074868] Funding Source: NIH RePORTER	US National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was funded by the US National Institute of Diabetes and Digestive and Kidney Diseases (DK074868, DK063491, and DK101395).	Accili D, 2016, DIABETES OBES METAB, V18, P117, DOI 10.1111/dom.12723; Amar J, 2011, EMBO MOL MED, V3, P559, DOI 10.1002/emmm.201100159; Appleton SL, 2013, DIABETES CARE, V36, P2388, DOI 10.2337/dc12-1971; Ardestani A., 2011, J BIOL CHEM, V290, P27532; Asterholm IW, 2014, CELL METAB, V20, P103, DOI 10.1016/j.cmet.2014.05.005; Austin RL, 2008, DIABETES, V57, P2066, DOI 10.2337/db07-0763; Backhed F, 2007, P NATL ACAD SCI USA, V104, P979, DOI 10.1073/pnas.0605374104; Bapat SP, 2015, NATURE, V528, P137, DOI 10.1038/nature16151; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Baufeld C, 2016, ACTA NEUROPATHOL, V132, P361, DOI 10.1007/s00401-016-1595-4; Bell JA, 2015, J AM COLL CARDIOL, V65, P101, DOI 10.1016/j.jacc.2014.09.077; Bernstein LE, 2006, ARCH INTERN MED, V166, P902, DOI 10.1001/archinte.166.8.902; Bigornia SJ, 2012, NUTR DIABETES, V2, DOI 10.1038/nutd.2012.3; BonDurant LD, 2017, CELL METAB, V25, P935, DOI 10.1016/j.cmet.2017.03.005; Bonny C, 2001, DIABETES, V50, P77, DOI 10.2337/diabetes.50.1.77; Boulenouar S, 2017, IMMUNITY, V46, P273, DOI 10.1016/j.immuni.2017.01.008; BOUWENS L, 1986, HEPATOLOGY, V6, P718, DOI 10.1002/hep.1840060430; Bouzakri K, 2008, DIABETES, V57, P1195, DOI 10.2337/db07-1469; Brenner DA, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-S1-S17; Brufau G, 2010, HEPATOLOGY, V52, P1455, DOI 10.1002/hep.23831; Butler AE, 2016, J CLIN ENDOCR METAB, V101, P523, DOI 10.1210/jc.2015-3566; Caesar R, 2015, CELL METAB, V22, P658, DOI 10.1016/j.cmet.2015.07.026; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Calori G, 2011, DIABETES CARE, V34, P210, DOI 10.2337/dc10-0665; Canfora EE, 2015, NAT REV ENDOCRINOL, V11, P577, DOI 10.1038/nrendo.2015.128; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Cardozo AK, 2001, J BIOL CHEM, V276, P48879, DOI 10.1074/jbc.M108658200; Carey AL, 2006, DIABETES, V55, P2688, DOI 10.2337/db05-1404; Cariou B, 2006, J BIOL CHEM, V281, P11039, DOI 10.1074/jbc.M510258200; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Cavelti-Weder C, 2012, DIABETES CARE, V35, P1654, DOI 10.2337/dc11-2219; Cazettes F, 2011, BRAIN RES, V1373, P101, DOI 10.1016/j.brainres.2010.12.008; Chambers ES, 2015, GUT, V64, P1744, DOI 10.1136/gutjnl-2014-307913; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chiang SH, 2009, CELL, V138, P961, DOI 10.1016/j.cell.2009.06.046; Ciaraldi TP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158209; Cinti F, 2016, J CLIN ENDOCR METAB, V101, P1044, DOI 10.1210/jc.2015-2860; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Cipriani S, 2010, J LIPID RES, V51, P771, DOI 10.1194/jlr.M001602; Correa RO, 2016, CLIN TRANSL IMMUNOL, V5, DOI 10.1038/cti.2016.17; Corvera S, 2014, BBA-MOL BASIS DIS, V1842, P463, DOI 10.1016/j.bbadis.2013.06.003; Czech MP, 2017, NAT MED, V23, P804, DOI 10.1038/nm.4350; de La Serre CB, 2010, AM J PHYSIOL-GASTR L, V299, pG440, DOI 10.1152/ajpgi.00098.2010; De Souza CT, 2005, ENDOCRINOLOGY, V146, P4192, DOI 10.1210/en.2004-1520; DeFronzo RA, 2009, DIABETES, V58, P773, DOI 10.2337/db09-9028; Deng YF, 2010, ANN NY ACAD SCI, V1212, pE1, DOI 10.1111/j.1749-6632.2010.05875.x; Di Meo S, 2017, J ENDOCRINOL, V233, pR15, DOI 10.1530/JOE-16-0598; Dietze D, 2002, DIABETES, V51, P2369, DOI 10.2337/diabetes.51.8.2369; Dominguez H, 2005, J VASC RES, V42, P517, DOI 10.1159/000088261; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Dror E, 2017, NAT IMMUNOL, V18, P283, DOI 10.1038/ni.3659; Dumortier O, 2013, CELL METAB, V18, P312, DOI 10.1016/j.cmet.2013.06.004; Ebstein W, 1876, BERLINER KLIN WOCHEN, V13, P337; Eguchi K, 2017, J CLIN INVEST, V127, P14, DOI 10.1172/JCI88877; Eguchi K, 2012, CELL METAB, V15, P518, DOI 10.1016/j.cmet.2012.01.023; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; Erridge C, 2007, AM J CLIN NUTR, V86, P1286, DOI 10.1093/ajcn/86.5.1286; Esteves JV, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/7267910; Fabbrini E, 2015, J CLIN INVEST, V125, P787, DOI 10.1172/JCI78425; Fabbrini E, 2013, GASTROENTEROLOGY, V145, P366, DOI 10.1053/j.gastro.2013.04.010; FEINGOLD KR, 1989, J CLIN INVEST, V83, P1116, DOI 10.1172/JCI113991; Feuerer M, 2009, NAT MED, V15, P930, DOI 10.1038/nm.2002; Fink LN, 2013, DIABETOLOGIA, V56, P1623, DOI 10.1007/s00125-013-2897-x; Fink LN, 2014, OBESITY, V22, P747, DOI 10.1002/oby.20615; Franckhauser S, 2008, DIABETOLOGIA, V51, P1306, DOI 10.1007/s00125-008-0998-8; Gaich G, 2013, CELL METAB, V18, P333, DOI 10.1016/j.cmet.2013.08.005; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Glass CK, 2012, CELL METAB, V15, P635, DOI 10.1016/j.cmet.2012.04.001; Goldfine AB, 2017, J CLIN INVEST, V127, P83, DOI 10.1172/JCI88884; Goldfine AB, 2010, ANN INTERN MED, V152, P346, DOI 10.7326/0003-4819-152-6-201003160-00004; Goldfine AB, 2008, CTS-CLIN TRANSL SCI, V1, P36, DOI 10.1111/j.1752-8062.2008.00026.x; Gonzalez-Gay MA, 2006, CLIN EXP RHEUMATOL, V24, P83; Guillemot-Legris O, 2017, TRENDS NEUROSCI, V40, P237, DOI 10.1016/j.tins.2017.02.005; Guo SH, 2013, AM J PATHOL, V182, P375, DOI 10.1016/j.ajpath.2012.10.014; Haeusler RA, 2013, DIABETES, V62, P4184, DOI 10.2337/db13-0639; Halban PA, 2014, DIABETES CARE, V37, P1751, DOI 10.2337/dc14-0396; Han KH, 2000, J CLIN INVEST, V106, P793, DOI 10.1172/JCI10052; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hellerbrand C, 1999, J HEPATOL, V30, P77, DOI 10.1016/S0168-8278(99)80010-5; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Holland WL, 2011, J CLIN INVEST, V121, P1858, DOI 10.1172/JCI43378; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Hotamisligil G. S., 2016, COLD SPRING HARB PER, V8; Hotamisligil GS, 2017, NATURE, V542, P177, DOI 10.1038/nature21363; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Huh JY, 2013, MOL CELL BIOL, V33, P328, DOI 10.1128/MCB.00552-12; Hwang I, 2015, FASEB J, V29, P2397, DOI 10.1096/fj.14-265983; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Igoillo-Esteve M, 2010, DIABETOLOGIA, V53, P1395, DOI 10.1007/s00125-010-1707-y; Ivan M, 2017, MOL CELL, V66, P772, DOI 10.1016/j.molcel.2017.06.002; Jais A, 2017, J CLIN INVEST, V127, P24, DOI 10.1172/JCI88878; Jiang CT, 2011, DIABETES, V60, P2484, DOI 10.2337/db11-0174; Johnson AMF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122195; Jonas JC, 1999, J BIOL CHEM, V274, P14112, DOI 10.1074/jbc.274.20.14112; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Josefowicz SZ, 2012, NATURE, V482, P395, DOI 10.1038/nature10772; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Kamada N, 2013, NAT REV IMMUNOL, V13, P321, DOI 10.1038/nri3430; Kamata K, 2014, AMYLOID, V21, P191, DOI 10.3109/13506129.2014.937857; Kaneto H, 2002, J BIOL CHEM, V277, P30010, DOI 10.1074/jbc.M202066200; Kawamori D, 2006, J BIOL CHEM, V281, P1091, DOI 10.1074/jbc.M508510200; Kayali AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038721; Khan T, 2009, MOL CELL BIOL, V29, P1575, DOI 10.1128/MCB.01300-08; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Kiortsis DN, 2005, ANN RHEUM DIS, V64, P765, DOI 10.1136/ard.2004.026534; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Kumar H, 2011, INT REV IMMUNOL, V30, P16, DOI 10.3109/08830185.2010.529976; Kusminski CM, 2016, NAT REV DRUG DISCOV, V15, P639, DOI 10.1038/nrd.2016.75; Lackey DE, 2016, NAT REV ENDOCRINOL, V12, P15, DOI 10.1038/nrendo.2015.189; Lalia AZ, 2016, NUTRIENTS, V8, DOI 10.3390/nu8060329; Lee BC, 2016, CELL METAB, V23, P685, DOI 10.1016/j.cmet.2016.03.002; Lee KY, 2011, CELL METAB, V14, P491, DOI 10.1016/j.cmet.2011.08.006; Lee YS, 2006, DIABETES, V55, P2256, DOI 10.2337/db06-0006; Lee YS, 2014, CELL, V157, P1339, DOI 10.1016/j.cell.2014.05.012; Lee YS, 2013, CELL, V153, P413, DOI 10.1016/j.cell.2013.03.001; Lee YS, 2011, DIABETES, V60, P2474, DOI 10.2337/db11-0194; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Li PP, 2016, CELL, V167, P973, DOI 10.1016/j.cell.2016.10.025; Li PP, 2015, NAT MED, V21, P239, DOI 10.1038/nm.3800; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; Lofgren P, 2000, DIABETES, V49, P688, DOI 10.2337/diabetes.49.5.688; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Lynch L, 2014, IMMUNOLOGY, V142, P337, DOI 10.1111/imm.12269; Ma K, 2006, J CLIN INVEST, V116, P1102, DOI 10.1172/JCI25604; Ma YJ, 2013, PHARM RES-DORDR, V30, P1447, DOI 10.1007/s11095-013-0986-7; Maedler K, 2002, J CLIN INVEST, V110, P851, DOI 10.1172/JCI200215318; Magkos F, 2016, CELL METAB, V23, P591, DOI 10.1016/j.cmet.2016.02.005; Martinez SC, 2008, DIABETES, V57, P846, DOI 10.2337/db07-0595; Mayoral R, 2015, MOL METAB, V4, P378, DOI 10.1016/j.molmet.2015.02.007; McNelis JC, 2015, DIABETES, V64, P3203, DOI 10.2337/db14-1938; McNelis JC, 2014, IMMUNITY, V41, P36, DOI 10.1016/j.immuni.2014.05.010; Meex RCR, 2017, NAT REV ENDOCRINOL, V13, P508, DOI 10.1038/nrendo.2017.56; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Mighiu PI, 2012, DIABETES, V61, P1350, DOI 10.2337/db12-0330; Molofsky AB, 2013, J EXP MED, V210, P535, DOI 10.1084/jem.20121964; Morinaga H, 2015, DIABETES, V64, P1120, DOI 10.2337/db14-1238; NAITO M, 1989, J LEUKOCYTE BIOL, V46, P1; Neal MD, 2006, J IMMUNOL, V176, P3070, DOI 10.4049/jimmunol.176.5.3070; Newgard CB, 2017, CELL METAB, V25, P43, DOI 10.1016/j.cmet.2016.09.018; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Nordmann TM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06731-w; Nussbaum JC, 2013, NATURE, V502, P245, DOI 10.1038/nature12526; O'Neill LAJ, 2016, NAT REV IMMUNOL, V16, P553, DOI 10.1038/nri.2016.70; Obstfeld AE, 2010, DIABETES, V59, P916, DOI 10.2337/db09-1403; Ofei F, 1996, DIABETES, V45, P881, DOI 10.2337/diabetes.45.7.881; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Olefsky JM, 2000, J CLIN INVEST, V106, P467, DOI 10.1172/JCI10843; Oral EA, 2017, CELL METAB, V26, P157, DOI 10.1016/j.cmet.2017.06.006; Pajunen P, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-754; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Paquot N, 2000, J CLIN ENDOCR METAB, V85, P1316, DOI 10.1210/jc.85.3.1316; Pardo Marques Virginia, 2016, Anales de la Real Academia Nacional de Farmacia, V82, P200; Patsouris D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110653; Pedersen BK, 2007, J APPL PHYSIOL, V102, P814, DOI 10.1152/japplphysiol.01208.2006; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Pham CTN, 2006, NAT REV IMMUNOL, V6, P541, DOI 10.1038/nri1841; Pols TWH, 2011, J HEPATOL, V54, P1263, DOI 10.1016/j.jhep.2010.12.004; Puig J, 2015, J CLIN ENDOCR METAB, V100, pE276, DOI 10.1210/jc.2014-2682; Puleston DJ, 2017, CELL METAB, V26, P131, DOI 10.1016/j.cmet.2017.06.019; Qi L, 2009, CELL METAB, V9, P277, DOI 10.1016/j.cmet.2009.01.006; Rahier J, 2008, DIABETES OBES METAB, V10, P32, DOI 10.1111/j.1463-1326.2008.00969.x; Rai M, 2016, ANNU REV PHYSIOL, V78, P85, DOI 10.1146/annurev-physiol-021115-105305; Ramkhelawon B, 2014, NAT MED, V20, P377, DOI 10.1038/nm.3467; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Reyna SM, 2008, DIABETES, V57, P2595, DOI 10.2337/db08-0038; Richardson SJ, 2009, DIABETOLOGIA, V52, P1143, DOI 10.1007/s00125-009-1276-0; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Ridker PM, 2017, NEW ENGL J MED, V377, P1119, DOI 10.1056/NEJMoa1707914; Rissanen A, 2012, DIABETES OBES METAB, V14, P1088, DOI 10.1111/j.1463-1326.2012.01637.x; Romanatto T, 2007, PEPTIDES, V28, P1050, DOI 10.1016/j.peptides.2007.03.006; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Sabio G, 2009, CELL METAB, V10, P491, DOI 10.1016/j.cmet.2009.09.007; Samuel VT, 2016, J CLIN INVEST, V126, P12, DOI 10.1172/JCI77812; Schur EA, 2015, OBESITY, V23, P2142, DOI 10.1002/oby.21248; Shabalina IG, 2006, BIOCHEM J, V399, P405, DOI 10.1042/BJ20060706; Shea JL, 2011, OBESITY, V19, P624, DOI 10.1038/oby.2010.174; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sloan-Lancaster J, 2013, DIABETES CARE, V36, P2239, DOI 10.2337/dc12-1835; Smith U, 2016, J INTERN MED, V280, P465, DOI 10.1111/joim.12540; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Son G, 2007, AM J PHYSIOL-GASTR L, V293, pG631, DOI 10.1152/ajpgi.00185.2007; Stefan N, 2006, DIABETES CARE, V29, P853, DOI 10.2337/diacare.29.04.06.dc05-1938; Stevens CE, 1998, PHYSIOL REV, V78, P393, DOI 10.1152/physrev.1998.78.2.393; Subramanian M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135842; Suhre K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013953; Sun K, 2013, MOL CELL BIOL, V33, P904, DOI 10.1128/MCB.00951-12; Sun K, 2012, P NATL ACAD SCI USA, V109, P5874, DOI 10.1073/pnas.1200447109; Sung HK, 2013, CELL METAB, V17, P61, DOI 10.1016/j.cmet.2012.12.010; Talukdar S, 2012, NAT MED, V18, P1407, DOI 10.1038/nm.2885; Tanoue T, 2012, SEMIN IMMUNOL, V24, P50, DOI 10.1016/j.smim.2011.11.009; Tao C, 2017, ENDOCRINOLOGY, V158, P1260, DOI 10.1210/en.2017-00024; Thaler JP, 2012, J CLIN INVEST, V122, P153, DOI 10.1172/JCI59660; Thaler JP, 2010, ENDOCRINOLOGY, V151, P4109, DOI 10.1210/en.2010-0336; Theurich S, 2017, CELL METAB, V26, P171, DOI 10.1016/j.cmet.2017.05.018; Thomou T, 2017, NATURE, V542, P450, DOI 10.1038/nature21365; Tkach M, 2016, CELL, V164, P1226, DOI 10.1016/j.cell.2016.01.043; Tsuda Y, 2004, IMMUNITY, V21, P215, DOI 10.1016/j.immuni.2004.07.006; Turnbaugh PJ, 2008, CELL HOST MICROBE, V3, P213, DOI 10.1016/j.chom.2008.02.015; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; van Asseldonk EJP, 2011, J CLIN ENDOCR METAB, V96, P2119, DOI 10.1210/jc.2010-2992; van Vliet-Ostaptchouk JV, 2014, BMC ENDOCR DISORD, V14, DOI 10.1186/1472-6823-14-9; Varma V, 2009, AM J PHYSIOL-ENDOC M, V296, pE1300, DOI 10.1152/ajpendo.90885.2008; Vrieze A, 2012, GASTROENTEROLOGY, V143, P913, DOI 10.1053/j.gastro.2012.06.031; Wan JH, 2014, HEPATOLOGY, V59, P130, DOI 10.1002/hep.26607; Wascher TC, 2011, MOL MED, V17, P189, DOI 10.2119/molmed.2010.00221; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Weiskirchen Ralf, 2014, Hepatobiliary Surg Nutr, V3, P344, DOI 10.3978/j.issn.2304-3881.2014.11.03; Winer DA, 2017, J CLIN INVEST, V127, P33, DOI 10.1172/JCI88879; Winer S, 2009, NAT MED, V15, P921, DOI 10.1038/nm.2001; Wollam J, 2011, ANNU REV BIOCHEM, V80, P885, DOI 10.1146/annurev-biochem-081308-165917; Wu D, 2011, SCIENCE, V332, P243, DOI 10.1126/science.1201475; Wu HZ, 2017, J CLIN INVEST, V127, P43, DOI [10.1172/JCI88880, 10.1172/jci88880]; Xing H, 1997, ENDOCRINOLOGY, V138, P2776, DOI 10.1210/en.138.7.2776; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Yano T, 2007, DIABETES, V56, P2946, DOI 10.2337/db07-0291; Ying W, 2017, CELL, V171, P372, DOI 10.1016/j.cell.2017.08.035; Ying W, 2017, J CLIN INVEST, V127, P1019, DOI 10.1172/JCI90350; Yoshimoto S, 2013, NATURE, V499, P97, DOI 10.1038/nature12347; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Zhang YQ, 2006, P NATL ACAD SCI USA, V103, P1006, DOI 10.1073/pnas.0506982103; Zhao HL, 2003, DIABETES, V52, P2759, DOI 10.2337/diabetes.52.11.2759	235	229	239	8	149	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					22	40		10.1016/j.cell.2017.12.025	http://dx.doi.org/10.1016/j.cell.2017.12.025			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29328913	Green Accepted, Bronze			2022-12-28	WOS:000419840100007
J	Gellad, WF; James, AE				Gellad, Walid F.; James, A. Everette			Discounted Drugs for Needy Patients and Hospitals - Understanding the 340B Debate	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Gellad, Walid F.] Univ Pittsburgh, Div Gen Med, Pittsburgh, PA 15260 USA; [Gellad, Walid F.] Univ Pittsburgh, Ctr Pharmaceut Policy & Prescribing, Pittsburgh, PA 15260 USA; [James, A. Everette] Univ Pittsburgh, Hlth Policy Inst, Pittsburgh, PA 15260 USA; [James, A. Everette] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Hlth Policy & Management, Pittsburgh, PA USA; [Gellad, Walid F.] Vet Affairs Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA 15213 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System	Gellad, WF (corresponding author), Univ Pittsburgh, Div Gen Med, Pittsburgh, PA 15260 USA.; Gellad, WF (corresponding author), Univ Pittsburgh, Ctr Pharmaceut Policy & Prescribing, Pittsburgh, PA 15260 USA.; Gellad, WF (corresponding author), Vet Affairs Pittsburgh Healthcare Syst, Ctr Hlth Equ Res & Promot, Pittsburgh, PA 15213 USA.							Conti RM, 2014, HEALTH AFFAIR, V33, P1786, DOI 10.1377/hlthaff.2014.0540; Department of Health and Human Services, 2017, EXAM HRSAS OV 340B D; MedPAC, 2015, C OV 340B DRUG PRIC; Mulcahy AW, 2014, PERSPECTIVE 340B PRE	4	3	3	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 8	2018	378	6					501	503		10.1056/NEJMp1716139	http://dx.doi.org/10.1056/NEJMp1716139			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FV1OX	29365283				2022-12-28	WOS:000424335200004
J	Janes, MR; Zhang, JC; Li, LS; Hansen, R; Peters, U; Guo, X; Chen, YC; Babbar, A; Firdaus, SJ; Darjania, L; Feng, J; Chen, JH; Li, SW; Li, SS; Long, YO; Thach, C; Liu, Y; Zarieh, A; Ely, T; Kucharski, JM; Kessler, LV; Wu, T; Yu, K; Wang, Y; Yao, Y; Deng, XH; Zarrinkar, PP; Brehmer, D; Dhanak, D; Lorenzi, MV; Hu-Lowe, D; Patricelli, MP; Ren, PD; Liu, Y				Janes, Matthew R.; Zhang, Jingchuan; Li, Lian-Sheng; Hansen, Rasmus; Peters, Ulf; Guo, Xin; Chen, Yuching; Babbar, Anjali; Firdaus, Sarah J.; Darjania, Levan; Feng, Jun; Chen, Jeffrey H.; Li, Shuangwei; Li, Shisheng; Long, Yun O.; Thach, Carol; Liu, Yuan; Zarieh, Ata; Ely, Tess; Kucharski, Jeff M.; Kessler, Linda V.; Wu, Tao; Yu, Ke; Wang, Yi; Yao, Yvonne; Deng, Xiaohu; Zarrinkar, Patrick P.; Brehmer, Dirk; Dhanak, Dashyant; Lorenzi, Matthew V.; Hu-Lowe, Dana; Patricelli, Matthew P.; Ren, Pingda; Liu, Yi			Targeting KRAS Mutant Cancers with a Covalent G12C-Specific Inhibitor	CELL			English	Article							MEDIATED NUCLEOTIDE EXCHANGE; ONCOGENIC KRAS; K-RAS; PANCREATIC-CANCER; SMALL MOLECULES; LUNG ADENOCARCINOMAS; PATHWAY SIGNATURES; CELL-LINES; SOS; ACTIVATION	KRAS(G12C) was recently identified to be potentially druggable by allele-specific covalent targeting of Cys-12 in vicinity to an inducible allosteric switch II pocket (S-IIP). Success of this approach requires active cycling of KRAS(G12C) between its active-GTP and inactive-GDP conformations as accessibility of the S-IIP is restricted only to the GDP-bound state. This strategy proved feasible for inhibiting mutant KRAS in vitro; however, it is uncertain whether this approach would translate to in vivo. Here, we describe structure-based design and identification of ARS-1620, a covalent compound with high potency and selectivity for KRAS(G12C). ARS-1620 achieves rapid and sustained in vivo target occupancy to induce tumor regression. We use ARS-1620 to dissect oncogenic KRAS dependency and demonstrate that monolayer culture formats significantly underestimate KRAS dependency in vivo. This study provides in vivo evidence that mutant KRAS can be selectively targeted and reveals ARS-1620 as representing a new generation of KRAS(G12C)-specific inhibitors with promising therapeutic potential.	[Janes, Matthew R.; Zhang, Jingchuan; Li, Lian-Sheng; Hansen, Rasmus; Peters, Ulf; Guo, Xin; Chen, Yuching; Babbar, Anjali; Firdaus, Sarah J.; Darjania, Levan; Feng, Jun; Chen, Jeffrey H.; Li, Shuangwei; Li, Shisheng; Long, Yun O.; Thach, Carol; Liu, Yuan; Zarieh, Ata; Ely, Tess; Kucharski, Jeff M.; Kessler, Linda V.; Wu, Tao; Yu, Ke; Wang, Yi; Yao, Yvonne; Deng, Xiaohu; Zarrinkar, Patrick P.; Hu-Lowe, Dana; Patricelli, Matthew P.; Ren, Pingda; Liu, Yi] Wellspring Biosci, San Diego, CA 92121 USA; [Brehmer, Dirk] Janssen Res & Dev, Oncol Discovery, Beerse, Belgium; [Dhanak, Dashyant; Lorenzi, Matthew V.] Janssen Res & Dev, Spring House, PA USA; [Ren, Pingda; Liu, Yi] Kura Oncol, San Diego, CA 92121 USA	Johnson & Johnson; Janssen Pharmaceuticals; Johnson & Johnson; Janssen Pharmaceuticals	Liu, Y (corresponding author), Wellspring Biosci, San Diego, CA 92121 USA.; Liu, Y (corresponding author), Kura Oncol, San Diego, CA 92121 USA.	yi@kuraoncology.com	Li, Shuangwei/E-3099-2010	Li, Shuangwei/0000-0003-2880-5508; Peters, Ulf/0000-0003-4664-8198; Li, Liansheng/0000-0002-8187-2876	DOE Office of Science User Facility [DE-AC02-05CH11231]	DOE Office of Science User Facility(United States Department of Energy (DOE))	We thank K. Shokat and N. Rosen for discussions and for revising the paper. We thank A. Borum for compound management and technical assistance with chemistry. We thank N. Khanna for technical assistance and sharing reagents. We thank Shanghai Langtze Biomedical Technology for chemistry support. We thank the NCI for providing the MEFs used in this work. This work used resources of the Advanced Light Source (beamline 5.0.3), which is a DOE Office of Science User Facility under contract DE-AC02-05CH11231.	Athuluri-Divakar SK, 2016, CELL, V165, P643, DOI 10.1016/j.cell.2016.03.045; Bailey P, 2016, NATURE, V531, P47, DOI 10.1038/nature16965; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Burns MC, 2014, P NATL ACAD SCI USA, V111, P3401, DOI 10.1073/pnas.1315798111; Campbell JD, 2016, NAT GENET, V48, P607, DOI 10.1038/ng.3564; Chiaradonna F, 2006, ONCOGENE, V25, P5391, DOI 10.1038/sj.onc.1209528; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Dry JR, 2010, CANCER RES, V70, P2264, DOI 10.1158/0008-5472.CAN-09-1577; Ekert JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092248; Evelyn CR, 2014, CHEM BIOL, V21, P1618, DOI 10.1016/j.chembiol.2014.09.018; Fujita-Sato S, 2015, CANCER RES, V75, P2851, DOI 10.1158/0008-5472.CAN-14-1623; Giannakis M, 2016, CELL REP, V15, P857, DOI 10.1016/j.celrep.2016.03.075; Hayes TK, 2016, CANCER CELL, V29, P75, DOI 10.1016/j.ccell.2015.11.011; Howes AL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108283; Johnson KA, 2009, METHOD ENZYMOL, V467, P601, DOI 10.1016/S0076-6879(09)67023-3; Jordan EJ, 2017, CANCER DISCOV, V7, P596, DOI 10.1158/2159-8290.CD-16-1337; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Kwong LN, 2015, J CLIN INVEST, V125, P1459, DOI 10.1172/JCI78954; Lamba S, 2014, CELL REP, V8, P1475, DOI 10.1016/j.celrep.2014.07.033; Lannine BR, 2014, NAT CHEM BIOL, V10, P760, DOI [10.1038/NCHEMBIO.1582, 10.1038/nchembio.1582]; Leshchiner ES, 2015, P NATL ACAD SCI USA, V112, P1761, DOI 10.1073/pnas.1413185112; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Lim SM, 2014, ANGEW CHEM INT EDIT, V53, P199, DOI 10.1002/anie.201307387; Lito P, 2016, SCIENCE, V351, P604, DOI 10.1126/science.aad6204; Liu QS, 2013, CHEM BIOL, V20, P146, DOI 10.1016/j.chembiol.2012.12.006; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Margarit SM, 2003, CELL, V112, P685, DOI 10.1016/S0092-8674(03)00149-1; Maurer T, 2012, P NATL ACAD SCI USA, V109, P5299, DOI 10.1073/pnas.1116510109; McDonald ER, 2017, CELL, V170, P577, DOI 10.1016/j.cell.2017.07.005; Ostrem JM, 2013, NATURE, V503, P548, DOI 10.1038/nature12796; Patgiri A, 2011, NAT CHEM BIOL, V7, P585, DOI [10.1038/NCHEMBIO.612, 10.1038/nchembio.612]; Patricelli MP, 2016, CANCER DISCOV, V6, P316, DOI 10.1158/2159-8290.CD-15-1105; Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394; Pylayeva-Gupta Y, 2011, NAT REV CANCER, V11, P761, DOI 10.1038/nrc3106; Selby M, 2017, SLAS DISCOV, V22, P473, DOI 10.1177/2472555217697434; Shao DD, 2014, CELL, V158, P171, DOI 10.1016/j.cell.2014.06.004; Shima Fumi, 2013, Enzymes, V34 Pt. B, P1, DOI 10.1016/B978-0-12-420146-0.00001-9; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Strelow JM, 2017, SLAS DISCOV, V22, P3, DOI 10.1177/1087057116671509; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun Q, 2012, ANGEW CHEM INT EDIT, V51, P6140, DOI 10.1002/anie.201201358; Sunaga N, 2011, MOL CANCER THER, V10, P336, DOI 10.1158/1535-7163.MCT-10-0750; Sweet-Cordero A, 2005, NAT GENET, V37, P48, DOI 10.1038/ng1490; Vallejo A, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14294; Vartanian S, 2013, J BIOL CHEM, V288, P2403, DOI 10.1074/jbc.M112.394130; Weigelt B, 2010, BREAST CANCER RES TR, V122, P35, DOI 10.1007/s10549-009-0502-2; Welsch ME, 2017, CELL, V168, P878, DOI 10.1016/j.cell.2017.02.006; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu T., 2015, PCT Int. Appl. WO, Patent No. [2015054572, A1, 2015054572]; Xiong Y, 2017, ACS MED CHEM LETT, V8, P61, DOI 10.1021/acsmedchemlett.6b00373	51	576	613	22	182	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2018	172	3					578	+		10.1016/j.cell.2018.01.006	http://dx.doi.org/10.1016/j.cell.2018.01.006			29	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FT9BS	29373830	Bronze			2022-12-28	WOS:000423447600016
J	Kwong, JC; Schwartz, KL; Campitelli, MA; Chung, H; Crowcroft, NS; Karnauchow, T; Katz, K; Ko, DT; McGeer, AJ; McNally, D; Richardson, DC; Rosella, LC; Simor, A; Smieja, M; Zahariadis, G; Gubbay, JB				Kwong, Jeffrey C.; Schwartz, Kevin L.; Campitelli, Michael A.; Chung, Hannah; Crowcroft, Natasha S.; Karnauchow, Timothy; Katz, Kevin; Ko, Dennis T.; McGeer, Allison J.; McNally, Dayre; Richardson, David C.; Rosella, Laura C.; Simor, Andrew; Smieja, Marek; Zahariadis, George; Gubbay, Jonathan B.			Acute Myocardial Infarction after Laboratory-Confirmed Influenza Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ISCHEMIC-HEART-DISEASE; CONTROLLED CASE SERIES; UNITED-STATES; SEASONAL INFLUENZA; EXCESS MORTALITY; RISK-FACTORS; VACCINATION; ENGLAND; VIRUS; DEATH	BACKGROUND Acute myocardial infarction can be triggered by acute respiratory infections. Previous studies have suggested an association between influenza and acute myocardial infarction, but those studies used nonspecific measures of influenza infection or study designs that were susceptible to bias. We evaluated the association between laboratory-confirmed influenza infection and acute myocardial infarction. METHODS We used the self-controlled case-series design to evaluate the association between laboratory-confirmed influenza infection and hospitalization for acute myocardial infarction. We used various high-specificity laboratory methods to confirm influenza infection in respiratory specimens, and we ascertained hospitalization for acute myocardial infarction from administrative data. We defined the "risk interval" as the first 7 days after respiratory specimen collection and the "control interval" as 1 year before and 1 year after the risk interval. RESULTS We identified 364 hospitalizations for acute myocardial infarction that occurred within 1 year before and 1 year after a positive test result for influenza. Of these, 20 (20.0 admissions per week) occurred during the risk interval and 344 (3.3 admissions per week) occurred during the control interval. The incidence ratio of an admission for acute myocardial infarction during the risk interval as compared with the control interval was 6.05 (95% confidence interval [CI], 3.86 to 9.50). No increased incidence was observed after day 7. Incidence ratios for acute myocardial infarction within 7 days after detection of influenza B, influenza A, respiratory syncytial virus, and other viruses were 10.11 (95% CI, 4.37 to 23.38), 5.17 (95% CI, 3.02 to 8.84), 3.51 (95% CI, 1.11 to 11.12), and 2.77 (95% CI, 1.23 to 6.24), respectively. CONCLUSIONS We found a significant association between respiratory infections, especially influenza, and acute myocardial infarction.	[Kwong, Jeffrey C.; Schwartz, Kevin L.; Campitelli, Michael A.; Chung, Hannah; Ko, Dennis T.; Rosella, Laura C.] Univ Toronto, Inst Clin Evaluat Sci, Toronto, ON, Canada; [Kwong, Jeffrey C.; Schwartz, Kevin L.; Crowcroft, Natasha S.; Rosella, Laura C.; Gubbay, Jonathan B.] Univ Toronto, Publ Hlth Ontario, Toronto, ON, Canada; [Kwong, Jeffrey C.; Schwartz, Kevin L.; Crowcroft, Natasha S.; McGeer, Allison J.; Rosella, Laura C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Toronto, Dept Family & Community Med, Toronto, ON, Canada; [Crowcroft, Natasha S.; Katz, Kevin; McGeer, Allison J.; Simor, Andrew; Gubbay, Jonathan B.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Kwong, Jeffrey C.] Univ Hlth Network, Toronto, ON, Canada; [Katz, Kevin] North York Gen Hosp, Toronto, ON, Canada; [Ko, Dennis T.] Sunnybrook Hlth Sci Ctr, Toronto, ON, Canada; [McGeer, Allison J.] Sinai Hlth Syst, Toronto, ON, Canada; [Gubbay, Jonathan B.] Hosp Sick Children, Toronto, ON, Canada; [Karnauchow, Timothy; McNally, Dayre] Childrens Hosp Eastern Ontario, Ottawa, ON, Canada; [Karnauchow, Timothy] Univ Ottawa, Dept Pathol & Lab Med, Ottawa, ON, Canada; [Richardson, David C.] William Osler Hlth Syst, Brampton, ON, Canada; [Smieja, Marek] McMaster Univ, Hamilton, ON, Canada; [Zahariadis, George] London Hlth Sci Ctr, London, ON, Canada; [Zahariadis, George] Newfoundland & Labrador Publ Hlth Lab, St John, NF, Canada	University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; North York General Hospital; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Ottawa; Children's Hospital of Eastern Ontario; University of Ottawa; McMaster University; London Health Sciences Centre	Kwong, JC (corresponding author), Inst Clin Evaluat Sci, G1 06,2075 Bayview Ave, Toronto, ON M4N 3M5, Canada.	jeff.kwong@utoronto.ca	ortiz, alberto/Y-7582-2018; Gubbay, Jonathan/Q-8580-2019; McGeer, Allison/AAB-6885-2020; Cuervo, Guillermo/B-1883-2012	ortiz, alberto/0000-0002-9805-9523; Gubbay, Jonathan/0000-0003-0026-3786; McGeer, Allison/0000-0001-5647-6137; Cuervo, Guillermo/0000-0002-7075-943X; Ko, Dennis/0000-0001-6840-8051	Canadian Institutes of Health Research [CIHR MOP 130568]; Public Health Ontario; Institute for Clinical Evaluative Sciences - Ontario Ministry of Health and Long-Term Care	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Public Health Ontario; Institute for Clinical Evaluative Sciences - Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario)	Supported by an operating grant (CIHR MOP 130568) from the Canadian Institutes of Health Research, by Public Health Ontario, and by the Institute for Clinical Evaluative Sciences, which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care.	ALLING DW, 1981, AM J EPIDEMIOL, V113, P30, DOI 10.1093/oxfordjournals.aje.a113063; Aull L, 2007, SOUTH MED J, V100, P873, DOI 10.1097/SMJ.0b013e31813c6b34; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Buchan Sarah A, 2016, CMAJ Open, V4, pE455; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; COLLINS S. D., 1932, Public Health Reports, V47, P2159, DOI 10.2307/4580606; Corrales-Medina VF, 2012, CIRCULATION, V125, P773, DOI 10.1161/CIRCULATIONAHA.111.040766; Corrales-Medina VF, 2010, LANCET INFECT DIS, V10, P83, DOI 10.1016/S1473-3099(09)70331-7; Darvishian M, 2014, LANCET INFECT DIS, V14, P1228, DOI 10.1016/S1473-3099(14)70960-0; Foster ED, 2013, EPIDEMIOL INFECT, V141, P735, DOI 10.1017/S0950268812002890; Grohskopf LA, 2016, MMWR RECOMM REP, V65, P1, DOI 10.15585/mmwr.rr6505a1; Guan XR, 2012, INFLAMM RES, V61, P591, DOI 10.1007/s00011-012-0449-3; HOUSWORTH J, 1974, AM J EPIDEMIOL, V100, P40, DOI 10.1093/oxfordjournals.aje.a112007; Ip DKM, 2016, CLIN INFECT DIS, V62, P431, DOI 10.1093/cid/civ909; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; MacIntyre CR, 2013, HEART, V99, P1843, DOI 10.1136/heartjnl-2013-304320; Madjid M, 2007, EUR HEART J, V28, P1205, DOI 10.1093/eurheartj/ehm035; MANTON KG, 1982, DEMOGRAPHY, V19, P527, DOI 10.2307/2061017; Osterholm MT, 2012, LANCET INFECT DIS, V12, P36, DOI 10.1016/S1473-3099(11)70295-X; PONKA A, 1981, ANN CLIN RES, V13, P429; Redelmeier DA, 2013, J CLIN EPIDEMIOL, V66, P955, DOI 10.1016/j.jclinepi.2013.05.003; Rees K, 2015, COCHRANE DB SYST REV, V5, DOI DOI 10.1002/14651858.CD005050.PUB3; Reichert TA, 2004, AM J EPIDEMIOL, V160, P492, DOI 10.1093/aje/kwh227; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; STERN MP, 1978, CIRCULATION, V58, P537, DOI 10.1161/01.CIR.58.3.537; TILLETT HE, 1983, INT J EPIDEMIOL, V12, P344, DOI 10.1093/ije/12.3.344; Warren-Gash C, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-002604; Warren-Gash C, 2012, J INFECT DIS, V206, P1652, DOI 10.1093/infdis/jis597; Warren-Gash C, 2011, J INFECT DIS, V203, P1710, DOI 10.1093/infdis/jir171; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302; Williams WW, 2016, MMWR SURVEILL SUMM, V65, P1, DOI 10.15585/mmwr.ss6501a1	32	567	590	3	46	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 25	2018	378	4					345	353		10.1056/NEJMoa1702090	http://dx.doi.org/10.1056/NEJMoa1702090			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT5ZX	29365305	Bronze			2022-12-28	WOS:000423233400007
J	Ortega, R; Brull, SJ; Prielipp, R; Gutierrez, A; De la Cruz, R; Conley, CM				Ortega, Rafael; Brull, Sorin J.; Prielipp, Richard; Gutierrez, Alexander; De la Cruz, Rossemary; Conley, Christopher M.			Monitoring Neuromuscular Function	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ortega, Rafael; De la Cruz, Rossemary; Conley, Christopher M.] Boston Med Ctr, Dept Anesthesiol, Boston, MA 02118 USA; [Ortega, Rafael; De la Cruz, Rossemary; Conley, Christopher M.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Gutierrez, Alexander] Boston Univ, Boston, MA 02215 USA; [Brull, Sorin J.] Mayo Clin, Jacksonville, FL 32224 USA; [Prielipp, Richard] Univ Minnesota, Med Sch Twin Cities, Minneapolis, MN USA	Boston Medical Center; Boston University; Boston University; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities	Ortega, R (corresponding author), Boston Med Ctr, Dept Anesthesiol, Boston, MA 02118 USA.; Ortega, R (corresponding author), Boston Univ, Sch Med, Boston, MA 02118 USA.		Brull, Sorin Joseph/E-8578-2010	Brull, Sorin Joseph/0000-0003-2607-2590; Conley, Christopher/0000-0002-6446-2832				Brull SJ, 2017, ANESTHESIOLOGY, V126, P173, DOI 10.1097/ALN.0000000000001409; Hemmerling TM, 2007, CAN J ANAESTH, V54, P58, DOI 10.1007/BF03021901; Murphy GS, 2011, ANESTHESIOLOGY, V115, P946, DOI 10.1097/ALN.0b013e3182342840; Naguib M, 2017, ANAESTHESIA, V72, P16, DOI 10.1111/anae.13738; Thilen SR, 2012, ANESTHESIOLOGY, V117, P964, DOI 10.1097/ALN.0b013e31826f8fdd	5	2	3	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 25	2018	378	4							e6	10.1056/NEJMvcm1603741	http://dx.doi.org/10.1056/NEJMvcm1603741			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT5ZX	29365307				2022-12-28	WOS:000423233400010
J	Pasqual, G; Chudnovskiy, A; Tas, JMJ; Agudelo, M; Schweitzer, LD; Cui, A; Hacohen, N; Victora, GD				Pasqual, Giulia; Chudnovskiy, Aleksey; Tas, Jeroen M. J.; Agudelo, Marianna; Schweitzer, Lawrence D.; Cui, Ang; Hacohen, Nir; Victora, Gabriel D.			Monitoring T cell-dendritic cell interactions in vivo by intercellular enzymatic labelling	NATURE			English	Article							PROTEIN-PROTEIN INTERACTIONS; ONE-STEP GENERATION; IMMUNE-RESPONSES; RNA-SEQ; MICE; EXPRESSION; AFFINITY; LIGAND; GENES; CD40L	Interactions between different cell types are essential for multiple biological processes, including immunity, embryonic development and neuronal signalling. Although the dynamics of cell-cell interactions can be monitored in vivo by intravital microscopy(1), this approach does not provide any information on the receptors and ligands involved or enable the isolation of interacting cells for downstream analysis. Here we describe a complementary approach that uses bacterial sortase A-mediated cell labelling across synapses of immune cells to identify receptor-ligand interactions between cells in living mice, by generating a signal that can subsequently be detected ex vivo by flow cytometry. We call this approach for the labelling of 'kiss-and-run' interactions between immune cells 'Labelling Immune Partnerships by SorTagging Intercellular Contacts' (LIPSTIC). Using LIPSTIC, we show that interactions between dendritic cells and CD4(+) T cells during T-cell priming in vivo occur in two distinct modalities: an early, cognate stage, during which CD40-CD40L interactions occur specifically between T cells and antigen-loaded dendritic cells; and a later, non-cognate stage during which these interactions no longer require prior engagement of the T-cell receptor. Therefore, LIPSTIC enables the direct measurement of dynamic cell-cell interactions both in vitro and in vivo. Given its flexibility for use with different receptor-ligand pairs and a range of detectable labels, we expect that this approach will be of use to any field of biology requiring quantification of intercellular communication.	[Pasqual, Giulia; Chudnovskiy, Aleksey; Tas, Jeroen M. J.; Agudelo, Marianna; Victora, Gabriel D.] Rockefeller Univ, Lab Lymphocyte Dynam, 1230 York Ave, New York, NY 10021 USA; [Schweitzer, Lawrence D.; Cui, Ang; Hacohen, Nir] Broad Inst MIT & Harvard, Cambridge, MA USA; [Schweitzer, Lawrence D.; Cui, Ang; Hacohen, Nir] Massachusetts Gen Hosp, Dept Med, Ctr Canc Res, Boston, MA 02114 USA	Rockefeller University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital	Victora, GD (corresponding author), Rockefeller Univ, Lab Lymphocyte Dynam, 1230 York Ave, New York, NY 10021 USA.	victora@rockefeller.edu	Pasqual, Giulia/AAD-8378-2022	Pasqual, Giulia/0000-0002-1476-2669; Victora, Gabriel/0000-0001-8807-348X	NIH grants [DP5OD012146, R01AI119006]; Starr Cancer Consortium grant; Swiss National Science Foundation Postdoctoral fellowship; Cancer Research Institute Irvington Postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI119006, T32AI070084] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP5OD012146] Funding Source: NIH RePORTER	NIH grants(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Starr Cancer Consortium grant; Swiss National Science Foundation Postdoctoral fellowship(Swiss National Science Foundation (SNSF)); Cancer Research Institute Irvington Postdoctoral fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. Ploegh for introducing us to sortase A; H. Yang, S. Markoulaki and R. Jaenisch for generating gene- targeted mice; A. Ting for NLG-and NRX-expressing constructs; and L. Mesin and C.F. Opel for technical advice. This work was funded by NIH grants DP5OD012146 and R01AI119006 to G.D.V. and a Starr Cancer Consortium grant to G.D.V. and N.H. G.P. was supported by the Swiss National Science Foundation Postdoctoral fellowship and the Cancer Research Institute Irvington Postdoctoral fellowship. G.V. is a Searle Scholar.	An HJ, 2011, J BIOL CHEM, V286, P11226, DOI 10.1074/jbc.M110.208215; Barnden MJ, 1998, IMMUNOL CELL BIOL, V76, P34, DOI 10.1046/j.1440-1711.1998.00709.x; Behrens GMN, 2004, J IMMUNOL, V172, P5420, DOI 10.4049/jimmunol.172.9.5420; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Chen I, 2011, P NATL ACAD SCI USA, V108, P11399, DOI 10.1073/pnas.1101046108; Eickhoff S, 2015, CELL, V162, P1322, DOI 10.1016/j.cell.2015.08.004; Engels B, 2003, HUM GENE THER, V14, P1155, DOI 10.1089/104303403322167993; Ghiotto M, 2010, INT IMMUNOL, V22, P651, DOI 10.1093/intimm/dxq049; Greene JAL, 1996, J BIOL CHEM, V271, P26762, DOI 10.1074/jbc.271.43.26762; GU H, 1993, CELL, V73, P1155, DOI 10.1016/0092-8674(93)90644-6; Hadjantonakis Anna-Katerina, 2002, BMC Biotechnol, V2, P11, DOI 10.1186/1472-6750-2-11; Haswell LE, 2001, EUR J IMMUNOL, V31, P3094, DOI 10.1002/1521-4141(2001010)31:10<3094::AID-IMMU3094>3.0.CO;2-F; Kang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029800; KAWABE T, 1994, IMMUNITY, V1, P167, DOI 10.1016/1074-7613(94)90095-7; Kretschmer B, 2011, IMMUNOL LETT, V136, P221, DOI 10.1016/j.imlet.2011.01.013; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee PP, 2001, IMMUNITY, V15, P763, DOI 10.1016/S1074-7613(01)00227-8; Lesley R, 2006, P NATL ACAD SCI USA, V103, P10717, DOI 10.1073/pnas.0601539103; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Liu DS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052823; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Madsen L, 1999, P NATL ACAD SCI USA, V96, P10338, DOI 10.1073/pnas.96.18.10338; Martell JD, 2016, NAT BIOTECHNOL, V34, P774, DOI 10.1038/nbt.3563; Maruyama T, 2015, NAT BIOTECHNOL, V33, P538, DOI 10.1038/nbt.3190; Mempel TR, 2004, NATURE, V427, P154, DOI 10.1038/nature02238; Picelli S, 2014, NAT PROTOC, V9, P171, DOI 10.1038/nprot.2014.006; Popp MWL, 2011, ANGEW CHEM INT EDIT, V50, P5024, DOI 10.1002/anie.201008267; RENSHAW BR, 1994, J EXP MED, V180, P1889, DOI 10.1084/jem.180.5.1889; Shalek AK, 2014, NATURE, V510, P363, DOI 10.1038/nature13437; Shih TAY, 2002, NAT IMMUNOL, V3, P399, DOI 10.1038/ni776; Singh J, 1998, PROTEIN SCI, V7, P1124, DOI 10.1002/pro.5560070506; Slavoff SA, 2011, J AM CHEM SOC, V133, P19769, DOI 10.1021/ja206435e; Southern E, 2006, NAT PROTOC, V1, P518, DOI 10.1038/nprot.2006.73; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Swee LK, 2015, ACS CHEM BIOL, V10, P460, DOI 10.1021/cb500462t; vanderMerwe PA, 1997, J EXP MED, V185, P393, DOI 10.1084/jem.185.3.393; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; WHITLOW M, 1993, PROTEIN ENG, V6, P989, DOI 10.1093/protein/6.8.989; Yang H, 2013, CELL, V154, P1370, DOI 10.1016/j.cell.2013.08.022	39	87	88	4	95	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 25	2018	553	7689					496	+		10.1038/nature25442	http://dx.doi.org/10.1038/nature25442			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU6OE	29342141	Green Submitted, Green Accepted			2022-12-28	WOS:000423971100039
J	She, R; Jarosz, DF				She, Richard; Jarosz, Daniel F.			Mapping Causal Variants with Single-Nucleotide Resolution Reveals Biochemical Drivers of Phenotypic Change	CELL			English	Article							GENETIC-LINKAGE MAP; SACCHAROMYCES-CEREVISIAE; DROSOPHILA-MELANOGASTER; MISSING HERITABILITY; RECOMBINATION RATES; QUANTITATIVE TRAITS; SECONDARY STRUCTURE; COMPLEX TRAITS; HUMAN GENOME; PROTEIN	Understanding the sequence determinants that give rise to diversity among individuals and species is the central challenge of genetics. However, despite ever greater numbers of sequenced genomes, most genome-wide association studies cannot distinguish causal variants from linked passenger mutations spanning many genes. We report that this inherent challenge can be overcome in model organisms. By pushing the advantages of inbred crossing to its practical limit in Saccharomyces cerevisiae, we improved the statistical resolution of linkage analysis to single nucleotides. This "super-resolution'' approach allowed us to map 370 causal variants across 26 quantitative traits. Missense, synonymous, and cis-regulatory mutations collectively gave rise to phenotypic diversity, providing mechanistic insight into the basis of evolutionary divergence. Our data also systematically unmasked complex genetic architectures, revealing that multiple closely linked driver mutations frequently act on the same quantitative trait. Single-nucleotide mapping thus complements traditional deletion and overexpression screening paradigms and opens new frontiers in quantitative genetics.	[She, Richard; Jarosz, Daniel F.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Jarosz, Daniel F.] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Jarosz, DF (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.; Jarosz, DF (corresponding author), Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA.	jarosz@stanford.edu		Jarosz, Daniel/0000-0003-3497-5888	NIH [DP2-GM119140, GM098600]; Searle Scholar Award [14-SSP-210]; Kimmel Scholar Award [SKF-15-154]; David and Lucile Packard Foundation; Gerald J. Lieberman Fellowship; Stanford Graduate Fellowship; NATIONAL CANCER INSTITUTE [P30CA124435] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [DP2GM119140, R00GM098600] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Searle Scholar Award; Kimmel Scholar Award; David and Lucile Packard Foundation(The David & Lucile Packard Foundation); Gerald J. Lieberman Fellowship; Stanford Graduate Fellowship(Stanford University); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH New Innovator (DP2-GM119140) and R00 (GM098600) Awards, a Searle Scholar Award (14-SSP-210), a Kimmel Scholar Award (SKF-15-154), a Science and Engineering Fellowship from the David and Lucile Packard Foundation (to D.F.J.), and the Gerald J. Lieberman Fellowship and the Stanford Graduate Fellowship (to R.S.). We thank R. Matt for modifying the Sky1 crystal structure, M. Desai (Harvard) for advice with sequencing protocols, J. McCusker (Duke) for guiding the selection of the clinical parent, and L. Steinmetz, M. Snyder, D. Petrov, and M. Feldman (Stanford) for critically reading the manuscript.	Abrusan G, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005242; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Bari VK, 2015, SCI REP-UK, V5, DOI 10.1038/srep09685; Bartoszewski RA, 2010, J BIOL CHEM, V285, P28741, DOI 10.1074/jbc.M110.154575; BENZER S, 1955, P NATL ACAD SCI USA, V41, P344, DOI 10.1073/pnas.41.6.344; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Buhr F, 2016, MOL CELL, V61, P341, DOI 10.1016/j.molcel.2016.01.008; CHAGANTI RS, 1974, P NATL ACAD SCI USA, V71, P4508, DOI 10.1073/pnas.71.11.4508; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; CRICK FH, 1961, NATURE, V192, P1227, DOI 10.1038/1921227a0; Cubillos FA, 2009, FEMS YEAST RES, V9, P1217, DOI 10.1111/j.1567-1364.2009.00583.x; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; DONISKELLER H, 1987, CELL, V51, P319, DOI 10.1016/0092-8674(87)90158-9; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Ehrenreich IM, 2010, NATURE, V464, P1039, DOI 10.1038/nature08923; Firnberg E, 2014, MOL BIOL EVOL, V31, P1581, DOI 10.1093/molbev/msu081; Flint J, 2005, NAT REV GENET, V6, P271, DOI 10.1038/nrg1576; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ghannoum MA, 1999, CLIN MICROBIOL REV, V12, P501, DOI 10.1128/CMR.12.4.501; HALL JM, 1990, SCIENCE, V250, P1684, DOI 10.1126/science.2270482; Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021; Huang RY, 2005, CANCER RES, V65, P5890, DOI 10.1158/0008-5472.CAN-04-4093; Iraqi FA, 2012, GENETICS, V190, P389, DOI 10.1534/genetics.111.132639; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; King EG, 2012, GENETICS, V191, P935, DOI 10.1534/genetics.112.138537; Kryazhimskiy S, 2014, SCIENCE, V344, P1519, DOI 10.1126/science.1250939; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lehner B, 2013, NAT REV GENET, V14, P168, DOI 10.1038/nrg3404; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; Lukasiewicz R, 2007, J MOL BIOL, V367, P249, DOI 10.1016/j.jmb.2006.12.031; Martens K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11512; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; McCullough MJ, 1998, J CLIN MICROBIOL, V36, P557, DOI 10.1128/JCM.36.2.557-562.1998; Millot GA, 2012, HUM MUTAT, V33, P1526, DOI 10.1002/humu.22150; NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156; Osbourn AE, 2009, CELL MOL LIFE SCI, V66, P3755, DOI 10.1007/s00018-009-0114-3; Parts L, 2011, GENOME RES, V21, P1131, DOI 10.1101/gr.116731.110; Pena-Castillo L, 2007, GENETICS, V176, P7, DOI 10.1534/genetics.107.074468; Robinson JA, 2016, CURR BIOL, V26, P1183, DOI 10.1016/j.cub.2016.02.062; Sadhu MJ, 2016, SCIENCE, V352, P1113, DOI 10.1126/science.aaf5124; Sauna ZE, 2011, NAT REV GENET, V12, P683, DOI 10.1038/nrg3051; Segura J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1945; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sigala I, 2016, TUMOR BIOL, V37, P8699, DOI 10.1007/s13277-015-4738-7; Slot JC, 2010, P NATL ACAD SCI USA, V107, P10136, DOI 10.1073/pnas.0914418107; Steinmetz LM, 2002, NATURE, V416, P326, DOI 10.1038/416326a; Strope PK, 2015, GENOME RES, V25, P762, DOI 10.1101/gr.185538.114; Tiley GP, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0473-3; Torok T, 1996, J IND MICROBIOL, V17, P303, DOI 10.1007/BF01574705; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Vizoso-Vazquez A, 2012, APPL MICROBIOL BIOT, V94, P173, DOI 10.1007/s00253-011-3785-2; Warringer J, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002111; Wilfert L, 2007, HEREDITY, V98, P189, DOI 10.1038/sj.hdy.6800950; Yalcin B, 2004, P NATL ACAD SCI USA, V101, P9734, DOI 10.1073/pnas.0401189101; Yang H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7129; Yang H, 2007, NAT GENET, V39, P1100, DOI 10.1038/ng2087	62	34	34	0	15	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2018	172	3					478	+		10.1016/j.cell.2017.12.015	http://dx.doi.org/10.1016/j.cell.2017.12.015			28	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FT9BS	29373829	Bronze, Green Accepted			2022-12-28	WOS:000423447600009
J	Clery, D				Clery, Daniel			ASTRONOMY Newborn exoplanet eyed for moons and rings	SCIENCE			English	News Item														Clery, Daniel/0000-0002-8742-3596					0	0	0	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					258	258		10.1126/science.359.6373.258	http://dx.doi.org/10.1126/science.359.6373.258			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6BB	29348214				2022-12-28	WOS:000423236700010
J	Kitson, PJ; Marie, G; Francoia, JP; Zalesskiy, SS; Sigerson, RC; Mathieson, JS; Cronin, L				Kitson, Philip J.; Marie, Guillaume; Francoia, Jean-Patrick; Zalesskiy, Sergey S.; Sigerson, Ralph C.; Mathieson, Jennifer S.; Cronin, Leroy			Digitization of multistep organic synthesis in reactionware for on-demand pharmaceuticals	SCIENCE			English	Article							CHEMICAL-SYNTHESIS; 3D; BACLOFEN; CHEMISTRY	Chemical manufacturing is often done at large facilities that require a sizable capital investment and then produce key compounds for a finite period. We present an approach to the manufacturing of fine chemicals and pharmaceuticals in a self-contained plastic reactionware device. The device was designed and constructed by using a chemical to computer-automated design (ChemCAD) approach that enables the translation of traditional bench-scale synthesis into a platform-independent digital code. This in turn guides production of a three-dimensional printed device that encloses the entire synthetic route internally via simple operations. We demonstrate the approach for the g-aminobutyric acid receptor agonist, (+/-)-baclofen, establishing a concept that paves the way for the local manufacture of drugs outside of specialist facilities.	[Kitson, Philip J.; Marie, Guillaume; Francoia, Jean-Patrick; Zalesskiy, Sergey S.; Sigerson, Ralph C.; Mathieson, Jennifer S.; Cronin, Leroy] Univ Glasgow, Sch Chem, WestCHEM, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Cronin, L (corresponding author), Univ Glasgow, Sch Chem, WestCHEM, Glasgow G12 8QQ, Lanark, Scotland.	lee.cronin@glasgow.ac.uk	Cronin, Leroy/AAW-8067-2020; Cronin, Leroy/B-7752-2008	Cronin, Leroy/0000-0001-8035-5757; Cronin, Leroy/0000-0001-8035-5757; Kitson, Philip/0000-0003-1826-1869	Engineering and Physical Sciences Research Council [EP/H024107/1, EP/J015156/1, EP/K021966/1, EP/L015668/1, EP/L023652/1]; European Research Council [670467 SMART-POM]; Defense Advanced Research Projects Agency (DARPA); EPSRC [EP/H024107/1, EP/K021966/1, EP/R01308X/1, EP/L015668/1, EP/J015156/1, EP/L023652/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Research Council(European Research Council (ERC)European Commission); Defense Advanced Research Projects Agency (DARPA)(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We acknowledge the help of S. Marshall in compiling our analysis of the economic impact of our methodology. Supplementary materials include a PDF document detailing the materials and methods used in this article; the STL and OpenSCAD files used to generate all 3D printed objects mentioned; a schematic movie illustrating the process of baclofen synthesis in the monolithic cartridge; and Python code that can be used to automate the stirrer- hotplate operations for the baclofen synthesis. We gratefully acknowledge financial support from the Engineering and Physical Sciences Research Council (grant nos. EP/H024107/1, EP/J015156/1, EP/K021966/1, EP/L015668/1, EP/L023652/1) and European Research Council (project 670467 SMART-POM). This research was developed with funding from the Defense Advanced Research Projects Agency (DARPA). The views, opinions and/or findings expressed are those of the author and should not be interpreted as representing the official views or policies of the Department of Defense or the U.S. Government. L.C. is the founder and director of CroninGroupPLC and is listed as an inventor on a patent application filed by The University of Glasgow (GB 1800299.8). L.C. conceived the initial concept and the design approach; P.J.K. designed the reactionware with help from J.P.F. and S.Z.; G.M. and R.C.S. telescoped the methods, porting them from glass to plastic; and P.J.K. developed the monolithic cartridges with help from S.Z. J.S.M. helped evaluate the purity of the products, and P.J.K. coordinated the team with help from L.C.	Adamo A, 2016, SCIENCE, V352, P61, DOI 10.1126/science.aaf1337; Addolorato G, 2002, ALCOHOL ALCOHOLISM, V37, P504, DOI 10.1093/alcalc/37.5.504; ALMIRANTE L, 1965, J MED CHEM, V8, P305, DOI 10.1021/jm00327a007; Applequist GE, 2000, COMPUT CHEM ENG, V24, P2211, DOI 10.1016/S0098-1354(00)00585-8; Bogers M, 2016, TECHNOL FORECAST SOC, V102, P225, DOI 10.1016/j.techfore.2015.07.024; Bogue R, 2013, ASSEMBLY AUTOM, V33, P307, DOI 10.1108/AA-06-2013-055; Camps P, 2004, TETRAHEDRON-ASYMMETR, V15, P2039, DOI 10.1016/j.tetasy.2004.05.021; Coakley M, 2016, JALA-J LAB AUTOM, V21, P489, DOI 10.1177/2211068216649578; Crowl D. A., 2019, CHEM PROCESS SAFETY, V4th; DAPRADA M, 1976, LIFE SCI, V19, P1253, DOI 10.1016/0024-3205(76)90261-7; Dimitrov D, 2006, RAPID PROTOTYPING J, V12, P136, DOI 10.1108/13552540610670717; Ehlen MA, 2014, COMPUT CHEM ENG, V60, P102, DOI 10.1016/j.compchemeng.2013.07.014; FITTON A, 1995, DRUGS, V50, P691, DOI 10.2165/00003495-199550040-00008; Gross B, 2017, ANAL CHEM, V89, P57, DOI 10.1021/acs.analchem.6b04344; Gross BC, 2014, ANAL CHEM, V86, P3240, DOI 10.1021/ac403397r; Hayashi Y, 2016, CHEM SCI, V7, P866, DOI 10.1039/c5sc02913a; Hollister SJ, 2005, NAT MATER, V4, P518, DOI 10.1038/nmat1421; Hong SM, 2015, ADV MATER, V27, P4035, DOI [10.1002/adma.201501099, 10.1002/adma.201570182]; Kitson PJ, 2016, BEILSTEIN J ORG CHEM, V12, P2776, DOI 10.3762/bjoc.12.276; Kitson PJ, 2016, NAT PROTOC, V11, P920, DOI 10.1038/nprot.2016.041; Kitson PJ, 2014, ANGEW CHEM INT EDIT, V53, P12723, DOI 10.1002/anie.201402654; Kitson PJ, 2013, CHEM SCI, V4, P3099, DOI 10.1039/c3sc51253c; Kockmann N, 2008, CHEM-EUR J, V14, P7470, DOI 10.1002/chem.200800707; Ley SV, 2015, ANGEW CHEM INT EDIT, V54, P3449, DOI 10.1002/anie.201410744; LI XM, 2014, INT J POLYM SCI, DOI DOI 10.1155/2014/829145; MANN A, 1991, J MED CHEM, V34, P1307, DOI 10.1021/jm00108a011; Okafor O, 2017, REACT CHEM ENG, V2, P129, DOI 10.1039/c6re00210b; Pearce J.M, 2014, OPEN SOURCE LAB, P1, DOI [10.1016/B978-0-12-410462-4.00001-9, DOI 10.1016/B978-0-12-410462-4.00001-9]; Rengier F, 2010, INT J COMPUT ASS RAD, V5, P335, DOI 10.1007/s11548-010-0476-x; Roberge DM, 2005, CHEM ENG TECHNOL, V28, P318, DOI 10.1002/ceat.200407128; Symes MD, 2012, NAT CHEM, V4, P349, DOI [10.1038/NCHEM.1313, 10.1038/nchem.1313]; Vaxelaire C, 2011, ANGEW CHEM INT EDIT, V50, P3605, DOI 10.1002/anie.201100059	32	106	107	9	118	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					314	319		10.1126/science.aao3466	http://dx.doi.org/10.1126/science.aao3466			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6BB	29348235	Green Accepted			2022-12-28	WOS:000423236700036
J	Daskin, JH; Pringle, RM				Daskin, Joshua H.; Pringle, Robert M.			Warfare and wildlife declines in Africa's protected areas	NATURE			English	Article							ARMED-CONFLICT; SPATIAL AUTOCORRELATION; POPULATION DECLINES; EXTINCTION RISK; WAR; DROUGHT; CONSERVATION; RAINFALL; MODELS; IMPACT	Large-mammal populations are ecological linchpins(1), and their worldwide decline(2) and extinction(3) disrupts many ecosystem functions and services(4). Reversal of this trend will require an understanding of the determinants of population decline, to enable more accurate predictions of when and where collapses will occur and to guide the development of effective conservation and restoration policies(2,5). Many correlates of large-mammal declines are known, including low reproductive rates, overhunting, and habitat destruction(2,6,7). However, persistent uncertainty about the effects of one widespread factor-armed conflict-complicates conservation-planning and priority-setting efforts(5,8). Case studies have revealed that conflict can have either positive or negative local impacts on wildlife(8-10), but the direction and magnitude of its net effect over large spatiotemporal scales have not previously been quantified(5). Here we show that conflict frequency predicts the occurrence and severity of population declines among wild large herbivores in African protected areas from 1946 to 2010. Conflict was extensive during this period, occurring in 71% of protected areas, and conflict frequency was the single most important predictor of wildlife population trends among the variables that we analysed. Population trajectories were stable in peacetime, fell significantly below replacement with only slight increases in conflict frequency (one conflict-year per two-to-five decades), and were almost invariably negative in high-conflict sites, both in the full 65-year dataset and in an analysis restricted to recent decades (1989-2010). Yet total population collapse was infrequent, indicating that war-torn faunas can often recover. Human population density was also correlated (positively) with wildlife population trajectories in recent years; however, we found no significant effect, in either timespan, of species body mass, protected-area size, conflict intensity (human fatalities), drought frequency, presence of extractable mineral resources, or various metrics of development and governance. Our results suggest that sustained conservation activity in conflict zones-and rapid interventions following ceasefires-may help to save many at-risk populations and species.	[Daskin, Joshua H.; Pringle, Robert M.] Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA; [Daskin, Joshua H.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA; [Daskin, Joshua H.] Yale Univ, Yale Inst Biospher Studies, New Haven, CT 06520 USA	Princeton University; Yale University; Yale University	Daskin, JH; Pringle, RM (corresponding author), Princeton Univ, Dept Ecol & Evolut Biol, Princeton, NJ 08544 USA.; Daskin, JH (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA.; Daskin, JH (corresponding author), Yale Univ, Yale Inst Biospher Studies, New Haven, CT 06520 USA.	joshua.daskin@yale.edu; rpringle@princeton.edu			US NSF DDIG grant [DEB-1501306]; NSF [DEB-1355122, DEB-1457697]; Princeton Environmental Institute; Direct For Biological Sciences [1457697] Funding Source: National Science Foundation	US NSF DDIG grant; NSF(National Science Foundation (NSF)); Princeton Environmental Institute; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	We thank E. Angus, C. Baker, C. Buoncore, J. Castillo Vardaro, B. Lin, A. Tilman, and the Princeton University libraries staff for assistance with data collection and analysis; D. Wilcove, S. Pacala, S. Morris, S. Budischak, J. Socolar, K. Gaynor, J. Edmond, T. Coverdale, R. Long, and U. Srinivasan provided comments. I. Craigie provided access to raw data from ref. 19, and we acknowledge the use of publically available data sources, especially from R. East, the IUCN African Elephant Specialist Group, the World Database of Protected Areas, PRIO-GRID, and GED. This work is a product of US NSF DDIG grant DEB-1501306 to J.H.D. and R.M.P. Additional support was provided by NSF DEB-1355122, DEB-1457697, and the Princeton Environmental Institute.	Ali S. H., 2007, PEACE PARKS CONSERVA, P109; Anderson D. R., 2008, MODEL BASED INFERENC; [Anonymous], 2015, MUMIN MULTIMODEL INF; Augustine DJ, 2010, AFR J ECOL, V48, P1009, DOI 10.1111/j.1365-2028.2010.01207.x; Barnes MD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12747; Begueria S, 2014, INT J CLIMATOL, V34, P3001, DOI 10.1002/joc.3887; Begueria S, 2010, B AM METEOROL SOC, V91, P1351, DOI 10.1175/2010BAMS2988.1; Beyers RL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027129; Blanc J. Julian, 2005, Pachyderm, V38, P19; Bontemps S., 2011, GLOBCOVER 2009 PRODU; Bouche P, 2012, ENVIRON MONIT ASSESS, V184, P7001, DOI 10.1007/s10661-011-2475-y; Brashares JS, 2003, CONSERV BIOL, V17, P733, DOI 10.1046/j.1523-1739.2003.01592.x; Brashares JS, 2001, P ROY SOC B-BIOL SCI, V268, P2473, DOI 10.1098/rspb.2001.1815; Breheny, 2020, PACKAGE VISREGR PACK; Burke MB, 2009, P NATL ACAD SCI USA, V106, P20670, DOI 10.1073/pnas.0907998106; Butsic V, 2015, BIOL CONSERV, V191, P266, DOI 10.1016/j.biocon.2015.06.037; Cade BS, 2015, ECOLOGY, V96, P2370, DOI 10.1890/14-1639.1; Campos J., 2005, GEN SPECIFIC MODELIN; Cardillo M, 2005, SCIENCE, V309, P1239, DOI 10.1126/science.1116030; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Center for International Earth Science Information Network & International Center for Tropical Agriculture, 2005, GRIDD POP WORLD V 3; Charles-Dominique T, 2016, P NATL ACAD SCI USA, V113, pE5572, DOI 10.1073/pnas.1607493113; Craigie ID, 2010, BIOL CONSERV, V143, P2221, DOI 10.1016/j.biocon.2010.06.007; CROICU MIHAI, 2012, UCDP GED CONFLICT PO; Davidson AD, 2009, P NATL ACAD SCI USA, V106, P10702, DOI 10.1073/pnas.0901956106; de Merode E, 2007, BIOL LETTERS, V3, P299, DOI 10.1098/rsbl.2007.0010; Diniz JAF, 2003, GLOBAL ECOL BIOGEOGR, V12, P53, DOI 10.1046/j.1466-822X.2003.00322.x; Dirzo R, 2014, SCIENCE, V345, P401, DOI 10.1126/science.1251817; Dormann CF, 2013, ECOGRAPHY, V36, P27, DOI 10.1111/j.1600-0587.2012.07348.x; Draper NR., 1998, WILEY SERIES PROBABI, V3rd ed.; Dudley JP, 2002, CONSERV BIOL, V16, P319, DOI 10.1046/j.1523-1739.2002.00306.x; Eck K, 2012, COOP CONFL, V47, P124, DOI 10.1177/0010836711434463; Esteban J, 2012, SCIENCE, V336, P858, DOI 10.1126/science.1222240; Fritz SA, 2009, ECOL LETT, V12, P538, DOI 10.1111/j.1461-0248.2009.01307.x; Gaynor KM, 2016, FRONT ECOL ENVIRON, V14, P533, DOI 10.1002/fee.1433; Grueber CE, 2011, J EVOLUTION BIOL, V24, P699, DOI 10.1111/j.1420-9101.2010.02210.x; Hallagan J.B., 1981, Oryx, V16, P161; Hammill E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11042; Hanson T, 2009, CONSERV BIOL, V23, P578, DOI 10.1111/j.1523-1739.2009.01166.x; IUCN & UNEP-WCMC, 2014, WORLD DAT PROT AR WD; Jones Kate E., 2009, Ecology (Washington D C), V90, P2648, DOI 10.1890/08-1494.1; Kanyamibwa S, 1998, BIODIVERS CONSERV, V7, P1399, DOI 10.1023/A:1008880113990; Kuhn I, 2012, J BIOGEOGR, V39, P995, DOI 10.1111/j.1365-2699.2012.02707.x; Lichstein JW, 2002, ECOL MONOGR, V72, P445, DOI 10.1890/0012-9615(2002)072[0445:SAAAMI]2.0.CO;2; Mcdonald RI, 2008, BIOL CONSERV, V141, P1695, DOI 10.1016/j.biocon.2008.04.025; Oglethorpe J., 2002, CONSERVING PEACE RES, P361; Ogutu JO, 2008, J ANIM ECOL, V77, P814, DOI 10.1111/j.1365-2656.2008.01392.x; Ogutu JO, 2003, ECOL LETT, V6, P412, DOI 10.1046/j.1461-0248.2003.00447.x; Ogutu JO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163249; ORIANS GH, 1970, SCIENCE, V168, P544, DOI 10.1126/science.168.3931.544; P.R.S. Group, 2006, INT COUNTR RISK GUID; Pettersson T, 2015, J PEACE RES, V52, P536, DOI 10.1177/0022343315595927; Pretis F., 2017, GETS GENERAL TO SPEC; Pringle RM, 2017, NATURE, V546, P91, DOI 10.1038/nature22902; R Development Core Team, 2009, R LANG ENV STAT COMP; Raleigh C, 2010, J PEACE RES, V47, P651, DOI 10.1177/0022343310378914; Ripple WJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1400103; Schleussner CF, 2016, P NATL ACAD SCI USA, V113, P9216, DOI 10.1073/pnas.1601611113; Smith RJ, 2003, NATURE, V426, P67, DOI 10.1038/nature02025; Sundberg R, 2013, J PEACE RES, V50, P523, DOI 10.1177/0022343313484347; Tollefsen A. F., 2015, PRIO GRID CODEBOOK V; Tollefsen AF, 2012, J PEACE RES, V49, P363, DOI 10.1177/0022343311431287; Transparency International, 2016, CORRUPTION PERCEPTIO; Turner M., 2015, LANDSCAPE ECOLOGY TH, DOI [10.1007/978-1-4939-2794-4, DOI 10.1007/978-1-4939-2794-4]; Uchida H., 2010, AGGLOMERATION INDEX; von Uexkull N, 2016, P NATL ACAD SCI USA, V113, P12391, DOI 10.1073/pnas.1607542113; Wittemyer G, 2014, P NATL ACAD SCI USA, V111, P13117, DOI 10.1073/pnas.1403984111; Woodroffe R, 1998, SCIENCE, V280, P2126, DOI 10.1126/science.280.5372.2126; Zuur Alain F., 2009, P1	69	90	92	9	120	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 18	2018	553	7688					328	+		10.1038/nature25194	http://dx.doi.org/10.1038/nature25194			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT9MB	29320475				2022-12-28	WOS:000423475100049
J	Liu, XK; Li, J				Liu, Xiao Ke; Li, Jun			SPOT DIAGNOSIS Hyperpigmentation in the skin folds	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Li, Jun] Peking Union Med Coll Hosp, Chinese Acad Med Sci, Dept Dermatol, Beijing, Peoples R China; Peking Union Med Coll, Beijing, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, J (corresponding author), Peking Union Med Coll Hosp, Chinese Acad Med Sci, Dept Dermatol, Beijing, Peoples R China.	lijun35@hotmail.com						Chung VQ, 2006, J AM ACAD DERMATOL, V54, P745, DOI 10.1016/j.jaad.2004.06.051; Torley D, 2002, BRIT J DERMATOL, V147, P1096, DOI 10.1046/j.1365-2133.2002.05150.x	2	2	2	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 18	2018	360								j5729	10.1136/bmj.j5729	http://dx.doi.org/10.1136/bmj.j5729			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT5QZ	29348270				2022-12-28	WOS:000423209600002
J	Ikramuddin, S; Korner, J; Lee, WJ; Thomas, AJ; Connett, JE; Bantle, JP; Leslie, DB; Wang, Q; Inabnet, WB; Jeffery, RW; Chong, K; Chuang, LM; Jensen, MD; Vella, A; Ahmed, L; Belani, K; Billington, CJ				Ikramuddin, Sayeed; Korner, Judith; Lee, Wei-Jei; Thomas, Avis J.; Connett, John E.; Bantle, John P.; Leslie, Daniel B.; Wang, Qi; Inabnet, William B., III; Jeffery, Robert W.; Chong, Keong; Chuang, Lee-Ming; Jensen, Michael D.; Vella, Adrian; Ahmed, Leaque; Belani, Kumar; Billington, Charles J.			Lifestyle Intervention and Medical Management With vs Without Roux-en-Y Gastric Bypass and Control of Hemoglobin A(1c), LDL Cholesterol, and Systolic Blood Pressure at 5 Years in the Diabetes Surgery Study	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BARIATRIC SURGERY; TYPE-2; OUTCOMES; ADULTS; HYPERTENSION; REMISSION; MELLITUS; WEIGHT; 5-YEAR; GOALS	IMPORTANCE The Roux-en-Y gastric bypass is effective in achieving established diabetes treatment targets, but durability is unknown. OBJECTIVE To compare durability of Roux-en-Y gastric bypass added to intensive lifestyle and medical management in achieving diabetes control targets. DESIGN, SETTING, AND PARTICIPANTS Observational follow-up of a randomized clinical trial at 4 sites in the United States and Taiwan, involving 120 participants who had a hemoglobin A(1c) (HbA(1c)) level of 8.0% or higher and a body mass index between 30.0 and 39.9 (enrolled between April 2008 and December 2011) were followed up for 5 years, ending in November 2016. INTERVENTIONS Lifestyle-intensive medical management intervention based on the Diabetes Prevention Program and Look AHEAD trials for 2 years, with and without (60 participants each) Roux-en-Y gastric bypass surgery followed by observation to year 5. MAIN OUTCOMES AND MEASURES The American Diabetes Association composite triple end point of hemoglobin A(1c) less than 7.0%, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg at 5 years. RESULTS Of 120 participants who were initially randomized (mean age, 49 years [SD, 8 years], 72 women [60%]), 98 (82%) completed 5 years of follow-up. Baseline characteristics were similar between groups: mean (SD) body mass index 34.4 (3.2) for the lifestyle-medical management group and 34.9 (3.0) for the gastric bypass group and had hemoglobin A(1c) levels of 9.6%(1.2) and 9.6%(1.0), respectively. At 5 years, 13 participants (23%) in the gastric bypass group and 2 (4%) in the lifestyle-intensive medical management group had achieved the composite triple end point (difference, 19%; 95% CI, 4%-34%; P = .01). In the fifth year, 31 patients (55%) in the gastric bypass group vs 8 (14%) in the lifestyle-medical management group achieved an HbA(1c) level of less than 7.0%(difference, 41%; 95% CI, 19%-63%; P = .002). Gastric bypass had more serious adverse events than did the lifestyle-medical management intervention, 66 events vs 38 events, most frequently gastrointestinal events and surgical complications such as strictures, small bowel obstructions, and leaks. Gastric bypass had more parathyroid hormone elevation but no difference in B-12 deficiency. CONCLUSIONS AND RELEVANCE In extended follow-up of obese adults with type 2 diabetes randomized to adding gastric bypass compared with lifestyle and intensive medical management alone, there remained a significantly better composite triple end point in the surgical group at 5 years. However, because the effect size diminished over 5 years, further follow-up is needed to understand the durability of the improvement.	[Ikramuddin, Sayeed; Leslie, Daniel B.] Univ Minnesota, Dept Surg, Minneapolis, MN 55455 USA; [Korner, Judith] Columbia Univ, Med Ctr, Div Endocrinol, Dept Med, New York, NY USA; [Lee, Wei-Jei] Natl Taiwan Univ Hosp, Surg Dept, Taipei, Taiwan; [Thomas, Avis J.; Connett, John E.; Wang, Qi] Univ Minnesota, Sch Publ Hlth, Div Biostat, Minneapolis, MN 55455 USA; [Thomas, Avis J.] Optum, Eden Prairie, MN USA; [Bantle, John P.; Billington, Charles J.] Univ Minnesota, Div Endocrinol & Diabet, Dept Med, Minneapolis, MN 55455 USA; [Inabnet, William B., III] Mt Sinai Med Ctr, Div Metab Endocrine & Minimally Invas Surg, New York, NY 10029 USA; [Jeffery, Robert W.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN 55455 USA; [Chong, Keong] Min Sheng Gen Hosp, Dept Endocrinol, Taoyuan, Taiwan; [Chuang, Lee-Ming] Natl Taiwan Univ Hosp, Div Metab & Endocrinol, Internal Med Dept, Taipei, Taiwan; [Jensen, Michael D.; Vella, Adrian] Mayo Clin, Div Endocrinol & Diabet, Dept Med, Rochester, MN USA; [Ahmed, Leaque] Harlem Hosp Med Ctr, Dept Surg, New York, NY USA; [Belani, Kumar] Univ Minnesota, Dept Anesthesiol, Minneapolis, MN 55455 USA; [Billington, Charles J.] Minneapolis VA Hlth Care Syst, Sect Endocrinol & Metab, Dept Med, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; Columbia University; National Taiwan University; National Taiwan University Hospital; University of Minnesota System; University of Minnesota Twin Cities; Optum; University of Minnesota System; University of Minnesota Twin Cities; Icahn School of Medicine at Mount Sinai; University of Minnesota System; University of Minnesota Twin Cities; National Taiwan University; National Taiwan University Hospital; Mayo Clinic; University of Minnesota System; University of Minnesota Twin Cities; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System	Billington, CJ (corresponding author), Univ Minnesota, Dept Med, 516 Delaware St Southeast,MMC 101, Minneapolis, MN 55455 USA.	billi005@umn.edu	Chuang, Lee-Ming/AAF-3324-2019; Belani, Kumar G/H-9536-2019	Wang, Qi/0000-0001-6341-6087; CHUANG, LEE-MING/0000-0003-0978-2662; BELANI, KUMAR/0000-0003-1784-136X	Medtronic Inc; University of Minnesota; Mayo Clinic; Columbia University; National Taiwan University Hospital; Min-Sheng General Hospital, Taoyuan, Taiwan; National Center for Advancing Translational Sciences, National Institutes of Health [UL1 TR000040, UL1 RR024156]; NIH [P30 DK50456]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000040, UL1TR002494] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024156] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050456, P30DK026687] Funding Source: NIH RePORTER	Medtronic Inc(Medtronic); University of Minnesota(University of Minnesota System); Mayo Clinic; Columbia University; National Taiwan University Hospital(National Taiwan University); Min-Sheng General Hospital, Taoyuan, Taiwan; National Center for Advancing Translational Sciences, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The Diabetes Surgery Study was supported by Medtronic Inc, formerly Covidien, Mansfield, Massachusetts. Medtronic provided funds for University of Minnesota, Mayo Clinic, Columbia University, National Taiwan University Hospital, and Min-Sheng General Hospital, Taoyuan, Taiwan. This study was supported in part by grants UL1 TR000040 and UL1 RR024156 to Columbia University both from the National Center for Advancing Translational Sciences, National Institutes of Health, formerly the National Center for Research Resources. Support was provided by NIH grant P30 DK50456 to the Minnesota Obesity Center at the University of Minnesota and the Mayo Clinic.	Adams TD, 2017, NEW ENGL J MED, V377, P1143, DOI 10.1056/NEJMoa1700459; Ali MK, 2013, NEW ENGL J MED, V368, P1613, DOI 10.1056/NEJMsa1213829; Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; American Diabetes Association, 2017, Clin Diabetes, V35, P5, DOI 10.2337/cd16-0067; Bertoni AG, 2008, J DIABETES COMPLICAT, V22, P1, DOI 10.1016/j.jdiacomp.2006.10.003; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Courcoulas AP, 2015, JAMA SURG, V150, P931, DOI 10.1001/jamasurg.2015.1534; DPP Res Grp, 2002, DIABETES CARE, V25, P2165; Halperin F, 2014, JAMA SURG, V149, P716, DOI 10.1001/jamasurg.2014.514; Ikramuddin S, 2016, DIABETES CARE, V39, P1510, DOI 10.2337/dc15-2481; Ikramuddin S, 2015, LANCET DIABETES ENDO, V3, P413, DOI 10.1016/S2213-8587(15)00089-3; Ikramuddin S, 2013, JAMA-J AM MED ASSOC, V309, P2240, DOI 10.1001/jama.2013.5835; Liang ZW, 2013, DIABETES RES CLIN PR, V101, P50, DOI 10.1016/j.diabres.2013.04.005; Lipska KJ, 2017, JAMA-J AM MED ASSOC, V317, P1017, DOI 10.1001/jama.2017.0029; Mingrone G, 2015, LANCET, V386, P964, DOI 10.1016/S0140-6736(15)00075-6; Nguyen KT, 2015, DIABETES, V64, P3104, DOI 10.2337/db14-1870; Purnell JQ, 2016, DIABETES CARE, V39, P1101, DOI 10.2337/dc15-2138; Saydah SH, 2004, JAMA-J AM MED ASSOC, V291, P335, DOI 10.1001/jama.291.3.335; Schauer PR, 2017, NEW ENGL J MED, V376, P1997, DOI 10.1056/NEJMc1703377; Sjostrom L, 2014, JAMA-J AM MED ASSOC, V311, P2297, DOI 10.1001/jama.2014.5988; Thomas AJ, 2014, OBES SURG, V24, P1875, DOI 10.1007/s11695-014-1280-4; VANTHOF MA, 1977, HUM BIOL, V49, P165; Wadden TA, 2006, OBESITY, V14, P737; Wong KL, 2012, J DIABETES COMPLICAT, V26, P169, DOI 10.1016/j.jdiacomp.2012.03.006	25	146	155	2	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2018	319	3					266	278		10.1001/jama.2017.20813	http://dx.doi.org/10.1001/jama.2017.20813			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT3BY	29340678	Green Published, Bronze			2022-12-28	WOS:000423022300019
J	Stockier, MR				Stockier, Martin R.			Pooled RCTs: Reanalysis accounting for screening intensity suggests that screening reduces prostate cancer mortality	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Stockier, Martin R.] Univ Sydney, Sydney, NSW, Australia	University of Sydney	Stockier, MR (corresponding author), Univ Sydney, Sydney, NSW, Australia.							US Preventive Services Task Force, 2017, PROST CANC SCREEN DR	1	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2018	168	2					JC5	JC5		10.7326/ACPJC-2018-168-2-005	http://dx.doi.org/10.7326/ACPJC-2018-168-2-005			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU8IN	29335717				2022-12-28	WOS:000424096600005
J	Voelker, R				Voelker, Rebecca			Second Cancer Biosimilar Approved	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2018	319	3					220	220		10.1001/jama.2017.20642	http://dx.doi.org/10.1001/jama.2017.20642			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT3BY	29340661				2022-12-28	WOS:000423022300005
J	Dunn, J; Henrikson, NB; Morrison, CC; Blasi, PR; Nguyen, M; Lin, JS				Dunn, John; Henrikson, Nora B.; Morrison, Caitlin C.; Blasi, Paula R.; Nguyen, Matt; Lin, Jennifer S.			Screening for Adolescent Idiopathic Scoliosis Evidence Report and Systematic Review for the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							QUALITY-OF-LIFE; RANDOMIZED CONTROLLED-TRIAL; LONG-TERM TREATMENT; NATURAL-HISTORY; FOLLOW-UP; CURVE PROGRESSION; BRACING PATIENTS; CHILDREN; RECOMMENDATIONS; PREVALENCE	IMPORTANCE Adolescent idiopathic scoliosis (AIS), a spinal curvature of 10 degrees or more, is the most common form of scoliosis, with a prevalence of 1% to 3%. Curves progress in approximately two-thirds of patients with AIS before skeletal maturity, and large curves (>50 degrees) may be associated with adverse health outcomes. OBJECTIVE To systematically review evidence on benefits and harms of AIS screening for the US Preventive Services Task Force (USPSTF). DATA SOURCES Cochrane Central Register of Controlled Trials, MEDLINE, ERIC, PubMed, CINAHL, and relevant systematic reviews were searched for studies published from January 1966 to October 20, 2016; studies included in a previous USPSTF report were also reviewed. Surveillance was conducted through July 24, 2017. STUDY SELECTION Fair-and good-quality studies that evaluated the accuracy of screening children and adolescents aged 10 to 18 years for AIS, the benefits of AIS treatment, the harms of AIS screening or treatment, or long-term health outcomes. DATA EXTRACTION AND SYNTHESIS Two investigators independently reviewed abstracts and full-text articles and extracted data into evidence tables. Results were qualitatively summarized. MAIN OUTCOMES AND MEASURES Health outcomes and spinal curvature in adolescence and adulthood, accuracy of screening for AIS, any harm of AIS screening or treatment. RESULTS Fourteen studies (N = 448 276) in 26 articles were included. Accuracy of AIS screening was highest (93.8% sensitivity; 99.2% specificity) in a cohort study of a clinic-based program using forward bend test, scoliometer, and Moire topography screening (n = 306 082); accuracy was lower in cohort studies of 6 programs using fewer modalities (n = 141 161). Four controlled studies (n = 587) found evidence for benefit of bracing on curve progression compared with controls. A randomized clinical trial and a nonrandomized trial of exercise treatment (N = 184) found favorable reductions in Cobb angle of 0.67 degrees to 4.9 degrees in the intervention group compared with increases of 1.38 degrees to 2.8 degrees in the control group. Two cohort studies (n = 339) on long-term outcomes found that braced participants reported more negative treatment experience and body appearance compared with surgically treated or untreated participants. A study that combined a randomized clinical trial and cohort design (n = 242) reported harms of bracing, which included skin problems on the trunk and nonback body pains. There was no evidence on the effect of AIS screening on adult health outcomes. CONCLUSIONS AND RELEVANCE Screening can detect AIS. Bracing and possibly exercise treatment can interrupt or slow progression of curvature in adolescence. However, there is little or no evidence on long-term outcomes for AIS treated in adolescence, the association between curvature at skeletal maturity and adult health outcomes, the harms of AIS screening or treatment, or the effect of AIS screening on adult health outcomes.	[Dunn, John; Henrikson, Nora B.; Morrison, Caitlin C.; Blasi, Paula R.; Nguyen, Matt] Kaiser Permanente Washington Hlth Res Inst, Kaiser Permanente Res Affiliates Evidence Based P, Seattle, WA 98101 USA; [Lin, Jennifer S.] Kaiser Permanente Ctr Hlth Res, Kaiser Permanente Res Affiliates Evidence Based P, Portland, OR USA	Kaiser Permanente; Kaiser Permanente	Dunn, J (corresponding author), Kaiser Permanente Washington Hlth Res Inst, 1730 Minor Ave, Seattle, WA 98101 USA.	dunn.jb@ghc.org	Kehoe, Clare/ABC-7984-2020	Blasi, Paula/0000-0002-7094-706X	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services [HHSA-290-2012-00015-I-357 EPC4]	Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services	This research was funded under contract HHSA-290-2012-00015-I-357 EPC4, Task Order 6, from the Agency for Healthcare Research and Quality (AHRQ), US Department of Health and Human Services, under a contract to support the USPSTF.	Adobor RD, 2011, SCOLIOSIS SPINAL DIS, V6, DOI 10.1186/1748-7161-6-23; ASCANI E, 1986, SPINE, V11, P784, DOI 10.1097/00007632-198610000-00007; Asher MA, 2006, SCOLIOSIS SPINAL DIS, V1, DOI 10.1186/1748-7161-1-2; Atkins D, 2004, BMC HEALTH SERV RES, V4, DOI 10.1186/1472-6963-4-38; BERKMAN ND, 2014, AHRQ PUBLICATION, V10; Bunge EM, 2010, EUR SPINE J, V19, P747, DOI 10.1007/s00586-010-1337-6; Bunge EM, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-57; BUNNELL WP, 1986, SPINE, V11, P773, DOI 10.1097/00007632-198610000-00003; Canavese F, 2011, INDIAN J ORTHOP, V45, P7, DOI 10.4103/0019-5413.73655; Cobb J. R., 1947, INSTRUCTIONAL COURSE, V5; Coillard C, 2014, EUR J PHYS REHAB MED, V50, P479; Danielsson AJ, 2012, SPINE, V37, P755, DOI 10.1097/BRS.0b013e318231493c; Danielsson AJ, 2010, SPINE, V35, P199, DOI 10.1097/BRS.0b013e3181c89f4a; Danielsson AJ, 2001, SPINE, V26, P516; Danielsson AJ, 2001, EUR SPINE J, V10, P278, DOI 10.1007/s005860100309; Danielsson AJ, 2001, SPINE, V26, P1449, DOI 10.1097/00007632-200107010-00015; Doody MM, 2000, SPINE, V25, P2052; DUNN J, 2017, SCREENING ADOLESCENT; Fong DYT, 2015, SPINE J, V15, P825, DOI 10.1016/j.spinee.2015.01.019; Fong DYT, 2010, SPINE, V35, P1061, DOI 10.1097/BRS.0b013e3181bcc835; Goldberg C J, 1993, Eur Spine J, V2, P29, DOI 10.1007/BF00301052; GOLDBERG CJ, 1995, SPINE, V20, P1368, DOI 10.1097/00007632-199506000-00007; GOLDBERG CJ, 1993, SPINE, V18, P902, DOI 10.1097/00007632-199306000-00015; GOLDSTEIN LA, 1973, CLIN ORTHOP RELAT R, P10; Himmetoglu S, 2015, MINERVA PEDIATR, V67, P245; Hresko MT, 2015, POSITION STATEMENT S; Karachalios T, 1999, SPINE, V24, P2318, DOI 10.1097/00007632-199911150-00006; Konieczny MR, 2013, J CHILD ORTHOP, V7, P3, DOI 10.1007/s11832-012-0457-4; Lee CF, 2010, SPINE, V35, pE1492, DOI 10.1097/BRS.0b013e3181ecf3fe; Levy AR, 1996, SPINE, V21, P1540, DOI 10.1097/00007632-199607010-00011; Luk KDK, 2010, SPINE, V35, P1607, DOI 10.1097/BRS.0b013e3181c7cb8c; MCALISTER WH, 1975, RADIOL CLIN N AM, V13, P113; Monticone M, 2014, EUR SPINE J, V23, P1204, DOI 10.1007/s00586-014-3241-y; NACHEMSON AL, 1995, J BONE JOINT SURG AM, V77A, P815, DOI 10.2106/00004623-199506000-00001; NASH CL, 1979, J BONE JOINT SURG AM, V61, P371, DOI 10.2106/00004623-197961030-00009; NEGRINI S, 2015, COCHRANE DB SYST REV, V6; Negrini S, 2008, J REHABIL MED, V40, P451, DOI 10.2340/16501977-0195; Negrini S, 2012, SCOLIOSIS SPINAL DIS, V7, DOI 10.1186/1748-7161-7-3; Pehrsson K, 2001, THORAX, V56, P388, DOI 10.1136/thorax.56.5.388; PETERSON LE, 1995, J BONE JOINT SURG AM, V77A, P823, DOI 10.2106/00004623-199506000-00002; Richards BS, 2005, SPINE, V30, P2068, DOI 10.1097/01.brs.0000178819.90239.d0; RISEBOROUGH EJ, 1973, J BONE JOINT SURG AM, VA 55, P974, DOI 10.2106/00004623-197355050-00006; Soucacos P N, 1998, Eur Spine J, V7, P270, DOI 10.1007/s005860050074; Soucacos PN, 2000, ORTHOPEDICS, V23, P833; Soucacos PN, 1997, J BONE JOINT SURG AM, V79A, P1498, DOI 10.2106/00004623-199710000-00006; THULBOURNE T, 1976, J BONE JOINT SURG BR, V58, P64, DOI 10.1302/0301-620X.58B1.1270497; U.S. Preventive Services Task Force (USPSTF), 2015, US PREV SERV TASK FO; US Preventive Services Task Force, 2004, SCREEN ID SCOL AD RE; WEINSTEIN SL, 1983, J BONE JOINT SURG AM, V65, P447, DOI 10.2106/00004623-198365040-00004; WEINSTEIN SL, 1981, J BONE JOINT SURG AM, V63, P702, DOI 10.2106/00004623-198163050-00003; Weinstein SL, 1999, SPINE, V24, P2592, DOI 10.1097/00007632-199912150-00006; Weinstein SL, 2013, SPINE, V38, P1832, DOI 10.1097/01.brs.0000435048.23726.3e; Weinstein SL, 2013, NEW ENGL J MED, V369, P1512, DOI 10.1056/NEJMoa1307337; Wiemann JM, 2014, J PEDIATR ORTHOPED, V34, P603, DOI 10.1097/BPO.0000000000000221; Wong HK, 2005, SPINE, V30, P1188, DOI 10.1097/01.brs.0000162280.95076.bb; Yawn BP, 1999, JAMA-J AM MED ASSOC, V282, P1427, DOI 10.1001/jama.282.15.1427	56	64	70	4	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2018	319	2					173	187		10.1001/jama.2017.11669	http://dx.doi.org/10.1001/jama.2017.11669			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS4PR	29318283	Bronze			2022-12-28	WOS:000419775500017
J	Nowoshilow, S; Schloissnig, S; Fei, JF; Dahl, A; Pang, AWC; Pippel, M; Winkler, S; Hastie, AR; Young, G; Roscito, JG; Falcon, F; Knapp, D; Powell, S; Cruz, A; Cao, H; Habermann, B; Hiller, M; Tanaka, EM; Myers, EW				Nowoshilow, Sergej; Schloissnig, Siegfried; Fei, Ji-Feng; Dahl, Andreas; Pang, Andy W. C.; Pippel, Martin; Winkler, Sylke; Hastie, Alex R.; Young, George; Roscito, Juliana G.; Falcon, Francisco; Knapp, Dunja; Powell, Sean; Cruz, Alfredo; Cao, Han; Habermann, Bianca; Hiller, Michael; Tanaka, Elly M.; Myers, Eugene W.			The axolotl genome and the evolution of key tissue formation regulators	NATURE			English	Article							LIMB REGENERATION; NEURAL CREST; APPENDAGE REGENERATION; PAX3; SALAMANDERS; ELEMENTS; GENES; IDENTIFICATION; CHOREOGRAPHY; ROLES	Salamanders serve as important tetrapod models for developmental, regeneration and evolutionary studies. An extensive molecular toolkit makes the Mexican axolotl (Ambystoma mexicanum) a key representative salamander for molecular investigations. Here we report the sequencing and assembly of the 32-gigabase-pair axolotl genome using an approach that combined long-read sequencing, optical mapping and development of a new genome assembler (MARVEL). We observed a size expansion of introns and intergenic regions, largely attributable to multiplication of long terminal repeat retroelements. We provide evidence that intron size in developmental genes is under constraint and that species-restricted genes may contribute to limb regeneration. The axolotl genome assembly does not contain the essential developmental gene Pax3. However, mutation of the axolotl Pax3 paralogue Pax7 resulted in an axolotl phenotype that was similar to those seen in Pax3(-/-) and Pax7(-/-) mutant mice. The axolotl genome provides a rich biological resource for developmental and evolutionary studies.	[Nowoshilow, Sergej; Winkler, Sylke; Roscito, Juliana G.; Hiller, Michael; Tanaka, Elly M.; Myers, Eugene W.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Nowoshilow, Sergej; Tanaka, Elly M.] Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Campus Vienna Bioctr 1, A-1030 Vienna, Austria; [Nowoshilow, Sergej; Dahl, Andreas; Knapp, Dunja; Tanaka, Elly M.] Tech Univ Dresden, DFG Res Ctr Regenerat Therapies, Dresden, Germany; [Schloissnig, Siegfried] Heidelberg Inst Theoret Studies, Heidelberg, Germany; [Fei, Ji-Feng] South China Normal Univ, Inst Brain Res & Rehabil, Guangzhou, Guangdong, Peoples R China; [Dahl, Andreas] Tech Univ Dresden, Biotechnol Ctr Biotec, Deep Sequencing Grp, Dresden, Germany; [Pang, Andy W. C.; Hastie, Alex R.] Bionano Genom, San Diego, CA USA; [Young, George] Francis Crick Inst, London, England; [Roscito, Juliana G.; Hiller, Michael] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Roscito, Juliana G.; Hiller, Michael; Myers, Eugene W.] Ctr Syst Biol, Dresden, Germany; [Falcon, Francisco; Cruz, Alfredo] Langebio Cinvestav, Unidad Genom Avanzada, Mol & Dev Complex Grp, Irapuato, Mexico; [Habermann, Bianca] CNRS, IBDM, Marseille, France; [Habermann, Bianca] Aix Marseille Univ, Marseille, France	Max Planck Society; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP); Technische Universitat Dresden; Heidelberg Institute for Theoretical Studies; South China Normal University; Technische Universitat Dresden; Francis Crick Institute; Max Planck Society; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite	Hiller, M; Tanaka, EM; Myers, EW (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.; Tanaka, EM (corresponding author), Vienna Bioctr VBC, Res Inst Mol Pathol IMP, Campus Vienna Bioctr 1, A-1030 Vienna, Austria.; Tanaka, EM (corresponding author), Tech Univ Dresden, DFG Res Ctr Regenerat Therapies, Dresden, Germany.; Hiller, M (corresponding author), Max Planck Inst Phys Komplexer Syst, Dresden, Germany.; Hiller, M; Myers, EW (corresponding author), Ctr Syst Biol, Dresden, Germany.	hiller@mpi-cbg.de; elly.tanaka@imp.ac.at; siegfried.schloissnig@h-its.org	Dahl, Andreas/E-3783-2017; Cruz-Ramirez, Luis Alfredo/B-7588-2009; Ramírez, Luis Alfredo Cruz/K-2548-2019; Powell, Sean/B-2374-2009; Pippel, Martin/AGA-8156-2022; roscito, juliana gusson/AAI-8461-2021; Young, George/C-6733-2009; Fei, Ji-Feng/O-5160-2015; Habermann, Bianca/N-4886-2016	Dahl, Andreas/0000-0002-2668-8371; Cruz-Ramirez, Luis Alfredo/0000-0001-9973-5784; Ramírez, Luis Alfredo Cruz/0000-0001-9973-5784; Powell, Sean/0000-0002-0994-5911; Pippel, Martin/0000-0002-8134-5929; roscito, juliana gusson/0000-0003-1494-1162; Young, George/0000-0002-1203-588X; Fei, Ji-Feng/0000-0003-2426-9402; Cao, Han/0000-0003-3612-6169; Habermann, Bianca/0000-0002-2457-7504; Nowoshilow, Sergej/0000-0001-8360-5010; /0000-0002-3014-1248; Tanaka, Elly/0000-0003-4240-2158	Max Planck Society President's fund; BMBF [01IS14014C, 031L0102, 01IH11003C]; MPI-CBG; DFG [FZ111, TA 274/3-3]; IMP; NSFC [31771611]; SCNU [S82111-E2]; CONACYT Masters Fellowship; Swedish IRLG GRANT [2014-9040-114152-32]; CONACYT [FOINS-301]; Ciencia Basica [I0017-CB-2015-01-000000000252126]; Crick Institute [FC001162]; CRUK; MRC; Wellcome Trust; The Francis Crick Institute [10162] Funding Source: researchfish	Max Planck Society President's fund; BMBF(Federal Ministry of Education & Research (BMBF)); MPI-CBG; DFG(German Research Foundation (DFG)); IMP; NSFC(National Natural Science Foundation of China (NSFC)); SCNU; CONACYT Masters Fellowship; Swedish IRLG GRANT; CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Ciencia Basica; Crick Institute; CRUK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); The Francis Crick Institute	E.W.M. was supported by the Max Planck Society President's fund and BMBF grants 01IS14014C and 031L0102. E.M.T., S.N. and J.-F.F. were supported by MPI-CBG, DFG FZ111 and IMP. E.M.T. and J.-F.F. were supported by DFG TA 274/3-3. J.-F.F. is supported by NSFC grant 31771611 and a Research Starting Grant S82111-E2 from SCNU. F.F. was supported by a CONACYT Masters Fellowship. A.C. was supported by The Swedish IRLG GRANT 2014-9040-114152-32, CONACYT FOINS-301 and Ciencia Basica I0017-CB-2015-01-000000000252126. G.Y. was supported by the Crick Institute award FC001162 (to J.P. Stoye). The Crick receives its core funding from CRUK, the MRC and the Wellcome Trust. B.H. was supported by BMBF grant 01IH11003C. We thank W. Bonacci, E. Gromberg, A. Tazaki and I. Stutzer for sample preparation; S. Clausing, N. Gscheidel, Y. Duport, A. Sommer and the VBCF NGS facility for sequencing; A. Kavirayani and T. Engelmaier at VBCF for histology; E. Heude for confirmation of Pax7 mutant immunofluorescence; T. Anantharaman for optimizing assembly and scaffolding parameters for Bionano data; and G. Papoutsoglou for advice.	AUERBACH R, 1954, J EXP ZOOL, V127, P305, DOI 10.1002/jez.1401270206; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Bryant DM, 2017, CELL REP, V18, P762, DOI 10.1016/j.celrep.2016.12.063; Calve S, 2010, DEV BIOL, V344, P259, DOI 10.1016/j.ydbio.2010.05.007; Currie JD, 2016, DEV CELL, V39, P411, DOI 10.1016/j.devcel.2016.10.013; da Silva SM, 2002, DEV CELL, V3, P547, DOI 10.1016/S1534-5807(02)00288-5; DAVIS AP, 1995, NATURE, V375, P791, DOI 10.1038/375791a0; Degenhardt KR, 2010, DEV BIOL, V339, P519, DOI 10.1016/j.ydbio.2009.12.030; Feiner N, 2014, GENOME BIOL EVOL, V6, P1635, DOI 10.1093/gbe/evu135; Gaj T, 2013, TRENDS BIOTECHNOL, V31, P397, DOI 10.1016/j.tibtech.2013.04.004; Garza-Garcia AA, 2010, INTEGR COMP BIOL, V50, P528, DOI 10.1093/icb/icq022; Jiang P, 2017, DEV BIOL, V426, P143, DOI 10.1016/j.ydbio.2016.05.024; Keinath MC, 2015, SCI REP-UK, V5, DOI 10.1038/srep16413; King BL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157106; Knapp D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061352; Kuang S, 2006, J CELL BIOL, V172, P103, DOI 10.1083/jcb.200508001; Kumar A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9684; Llorens C, 2011, NUCLEIC ACIDS RES, V39, pD70, DOI 10.1093/nar/gkq1061; Mansouri A, 1996, DEVELOPMENT, V122, P831; Mansouri A, 1996, CURR OPIN CELL BIOL, V8, P851, DOI 10.1016/S0955-0674(96)80087-1; Milewski RC, 2004, DEVELOPMENT, V131, P829, DOI 10.1242/dev.00975; Nord H, 2016, MOL BIOL CELL, V27, P1853, DOI 10.1091/mbc.E15-12-0821; Parra G, 2007, BIOINFORMATICS, V23, P1061, DOI 10.1093/bioinformatics/btm071; Relaix F, 2004, GENE DEV, V18, P1088, DOI 10.1101/gad.301004; Roensch K, 2013, SCIENCE, V342, P1375, DOI 10.1126/science.1241796; Smith JJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-19; Spemann H, 1924, ARCH MIKROSK ANAT EN, V100, P599, DOI 10.1007/BF02108133; Sperry RW, 1943, J EXP ZOOL, V92, P263, DOI 10.1002/jez.1400920303; Stewart R, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002936; Sugiura T, 2016, NATURE, V531, P237, DOI 10.1038/nature16974; Sun C, 2014, GENOME BIOL EVOL, V6, P1818, DOI 10.1093/gbe/evu143; Sun C, 2012, GENOME BIOL EVOL, V4, P168, DOI 10.1093/gbe/evr139; Sun YB, 2015, P NATL ACAD SCI USA, V112, pE1257, DOI 10.1073/pnas.1501764112; Tanaka EM, 2016, CELL, V165, P1598, DOI 10.1016/j.cell.2016.05.038; Tassava Roy A., 1996, Wound Repair and Regeneration, V4, P75, DOI 10.1046/j.1524-475X.1996.40113.x; Voss S. R., 2009, COLD SPRING HARB PRO; Voss SR, 2013, HUM GENOMICS, V7, DOI 10.1186/1479-7364-7-9; Warren RL, 2015, PLANT J, V83, P189, DOI 10.1111/tpj.12886; Zimin AV, 2017, GIGASCIENCE, V6, DOI 10.1093/gigascience/giw016	39	264	270	43	228	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2018	554	7690					50	+		10.1038/nature25458	http://dx.doi.org/10.1038/nature25458			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7QX	29364872	hybrid, Green Published			2022-12-28	WOS:000424048900029
J	Schreiber, LR; Bluhm, H				Schreiber, Lars R.; Bluhm, Hendrik			Toward a silicon-based quantum computer	SCIENCE			English	Editorial Material									[Schreiber, Lars R.] Rhein Westfal TH Aachen, Inst Quantum Informat, JARA, Aachen, Germany; Forschungszentrum Julich, Julich, Germany	RWTH Aachen University; Helmholtz Association; Research Center Julich	Schreiber, LR (corresponding author), Rhein Westfal TH Aachen, Inst Quantum Informat, JARA, Aachen, Germany.	lars.schreiber@physik.rwth-aachen.de	Bluhm, Hendrik/D-3422-2014	Schreiber, Lars/0000-0003-0904-9612				Cerfontaine P, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.150501; Chekhovich EA, 2013, NAT MATER, V12, P494, DOI [10.1038/NMAT3652, 10.1038/nmat3652]; Mi X., 2017, ARXIV171003265CONDMA; Muhonen JT, 2014, NAT NANOTECHNOL, V9, P986, DOI [10.1038/nnano.2014.211, 10.1038/NNANO.2014.211]; Samkharadze N., 2017, ARXIV171102040CONDMA; Vandersypen LMK, 2017, NPJ QUANTUM INFORM, V3, DOI 10.1038/s41534-017-0038-y; Veldhorst M, 2015, NATURE, V526, P410, DOI 10.1038/nature15263; Watson T. F., 2017, ARXIV170804214CONDMA; Yoneda J., 2017, ARXIV170801454CONDMA; Zajac DM, 2018, SCIENCE, V359, P439, DOI 10.1126/science.aao5965; Zajac DM, 2016, PHYS REV APPL, V6, DOI 10.1103/PhysRevApplied.6.054013	12	19	19	0	43	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					393	394		10.1126/science.aar6209	http://dx.doi.org/10.1126/science.aar6209			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT6SD	29371457				2022-12-28	WOS:000423283200029
J	Chen, GZ; Liu, Y; Goetz, R; Fu, LL; Jayaraman, S; Hu, MC; Moe, OW; Liang, G; Li, XK; Mohammadi, M				Chen, Gaozhi; Liu, Yang; Goetz, Regina; Fu, Lili; Jayaraman, Seetharaman; Hu, Ming-Chang; Moe, Orson W.; Liang, Guang; Li, Xiaokun; Mohammadi, Moosa			alpha-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling	NATURE			English	Article							FIBROBLAST-GROWTH-FACTOR; TRANSCRIPTS ENCODING MEMBRANE; C-TERMINAL TAIL; STRUCTURAL BASIS; BETA-KLOTHO; FIBROBLAST-GROWTH-FACTOR-1 FGF1; METABOLIC-ACTIVITY; CRYSTAL-STRUCTURE; RECEPTOR; HEPARIN	The ageing suppressor alpha-klotho binds to the fibroblast growth factor receptor (FGFR). This commits FGFR to respond to FGF23, a key hormone in the regulation of mineral ion and vitamin D homeostasis. The role and mechanism of this co-receptor are unknown. Here we present the atomic structure of a 1:1:1 ternary complex that consists of the shed extracellular domain of alpha-klotho, the FGFR1c ligand-binding domain, and FGF23. In this complex, alpha-klotho simultaneously tethers FGFR1c by its D3 domain and FGF23 by its C-terminal tail, thus implementing FGF23-FGFR1c proximity and conferring stability. Dimerization of the stabilized ternary complexes and receptor activation remain dependent on the binding of heparan sulfate, a mandatory cofactor of paracrine FGF signalling. The structure of alpha-klotho is incompatible with its purported glycosidase activity. Thus, shed alpha-klotho functions as an on-demand non-enzymatic scaffold protein that promotes FGF23 signalling.	[Chen, Gaozhi; Fu, Lili; Liang, Guang; Li, Xiaokun] Wenzhou Med Univ, Sch Pharmaceut Sci, Chem Biol Res Ctr, Wenzhou 325035, Zhejiang, Peoples R China; [Chen, Gaozhi; Liu, Yang; Goetz, Regina; Fu, Lili; Mohammadi, Moosa] NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA; [Jayaraman, Seetharaman] New York Struct Biol Ctr, New York, NY 10027 USA; [Hu, Ming-Chang; Moe, Orson W.] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Hu, Ming-Chang; Moe, Orson W.] Univ Texas Southwestern Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Hu, Ming-Chang; Moe, Orson W.] Univ Texas Southwestern Med Ctr Dallas, Charles & Jane Pak Ctr Mineral Metab & Clin Res, Dallas, TX 75390 USA	Wenzhou Medical University; New York University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Li, XK (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Chem Biol Res Ctr, Wenzhou 325035, Zhejiang, Peoples R China.; Mohammadi, M (corresponding author), NYU, Sch Med, Dept Biochem & Mol Pharmacol, New York, NY 10016 USA.	xiaokunli@wzmu.edu.cn; moosa.mohammadi@nyumc.org	kasaei, fahime/T-7197-2018; Mohammadi, Moosa/ABA-6745-2020; Goetz, Regina/M-2411-2019	Mohammadi, Moosa/0000-0003-2434-9437; Goetz, Regina/0000-0003-3681-4703	NIH grant [R01 DE13686]; National Key R&D Program of China [2017YFA0506000]; NIH NIGMS;  [R01 DK092461];  [P30 DK079328];  [R01 DK091392]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE013686] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091392, R01DK092461, P30DK079328] Funding Source: NIH RePORTER	NIH grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Key R&D Program of China; NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); ; ; ; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank N. J. Cowan for critically reading and editing the manuscript, and C.-S. Huang for help with diffraction data processing with XDS. This work was primarily supported by NIH grant R01 DE13686 (to M.M.). Support was also provided by National Key R&D Program of China (#2017YFA0506000 to X.L.). Funding for mouse studies was provided by R01 DK092461, P30 DK079328 (to O.W.M.), and R01 DK091392 (to M.C.H). Beamlines at the Northeastern Collaborative Access Team (NE-CAT) facility at the Advanced Photon Source of Argonne National Laboratory are primarily funded by NIH NIGMS and member institutions.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Andrukhova O, 2017, J BONE MINER RES, V32, P2049, DOI 10.1002/jbmr.3195; Beenken A, 2012, J BIOL CHEM, V287, P3067, DOI 10.1074/jbc.M111.275891; Belov AA, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015958; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; Chen CD, 2007, P NATL ACAD SCI USA, V104, P19796, DOI 10.1073/pnas.0709805104; Dunshee DR, 2016, J BIOL CHEM, V291, P5986, DOI 10.1074/jbc.M115.710582; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Gattineni J, 2009, AM J PHYSIOL-RENAL, V297, pF282, DOI 10.1152/ajprenal.90742.2008; Goetz R, 2007, MOL CELL BIOL, V27, P3417, DOI 10.1128/MCB.02249-06; Goetz R, 2013, NAT REV MOL CELL BIO, V14, P166, DOI 10.1038/nrm3528; Goetz R, 2012, MOL CELL BIOL, V32, P1944, DOI 10.1128/MCB.06603-11; Goetz R, 2010, P NATL ACAD SCI USA, V107, P407, DOI 10.1073/pnas.0902006107; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; Harmer NJ, 2004, J MOL BIOL, V339, P821, DOI 10.1016/j.jmb.2004.04.031; Hayashi Y, 2007, J BIOL CHEM, V282, P30889, DOI 10.1074/jbc.M700832200; Henrissat B, 1997, CURR OPIN STRUC BIOL, V7, P637, DOI 10.1016/S0959-440X(97)80072-3; Holt JA, 2003, GENE DEV, V17, P1581, DOI 10.1101/gad.1083503; Hu MC, 2013, ANNU REV PHYSIOL, V75, P503, DOI 10.1146/annurev-physiol-030212-183727; Hu MC, 2010, FASEB J, V24, P3438, DOI 10.1096/fj.10-154765; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Imura A, 2007, SCIENCE, V316, P1615, DOI 10.1126/science.1135901; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Kurosu H, 2007, J BIOL CHEM, V282, P26687, DOI 10.1074/jbc.M704165200; Lemmon MA, 2010, CELL, V141, P1117, DOI 10.1016/j.cell.2010.06.011; Li SA, 2004, CELL STRUCT FUNCT, V29, P91, DOI 10.1247/csf.29.91; Lindberg K, 2014, J AM SOC NEPHROL, V25, P2169, DOI 10.1681/ASN.2013111209; Liu Y, 2017, STRUCTURE, V25, P1325, DOI 10.1016/j.str.2017.06.016; Matsumura Y, 1998, BIOCHEM BIOPH RES CO, V242, P626, DOI 10.1006/bbrc.1997.8019; Mohammadi M, 2005, CYTOKINE GROWTH F R, V16, P107, DOI 10.1016/j.cytogfr.2005.01.008; Ogawa Y, 2007, P NATL ACAD SCI USA, V104, P7432, DOI 10.1073/pnas.0701600104; Olsen SK, 2006, GENE DEV, V20, P185, DOI 10.1101/gad.1365406; ORNITZ DM, 1992, MOL CELL BIOL, V12, P240, DOI 10.1128/MCB.12.1.240; ORNITZ DM, 1995, SCIENCE, V268, P432, DOI 10.1126/science.7536345; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Pitteloud N, 2007, J CLIN INVEST, V117, P457, DOI 10.1172/JCI29884; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Potthoff MJ, 2009, P NATL ACAD SCI USA, V106, P10853, DOI 10.1073/pnas.0904187106; Robinson CJ, 2005, J BIOL CHEM, V280, P42274, DOI 10.1074/jbc.M505720200; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shiraki-Iida T, 1998, FEBS LETT, V424, P6, DOI 10.1016/S0014-5793(98)00127-6; Suzuki M, 2008, MOL ENDOCRINOL, V22, P1006, DOI 10.1210/me.2007-0313; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; van Loon EPM, 2015, AM J PHYSIOL-RENAL, V309, pF359, DOI 10.1152/ajprenal.00240.2014; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu XL, 2008, J BIOL CHEM, V283, P33304, DOI 10.1074/jbc.M803319200	53	222	241	16	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2018	553	7689					461	+		10.1038/nature25451	http://dx.doi.org/10.1038/nature25451			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU6OE	29342138	Green Submitted, Green Accepted			2022-12-28	WOS:000423971100033
J	Smalley, DE; Nygaard, E; Squire, K; Van Wagoner, J; Rasmussen, J; Gneiting, S; Qaderi, K; Goodsell, J; Rogers, W; Lindsey, M; Costner, K; Monk, A; Pearson, M; Haymore, B; Peatross, J				Smalley, D. E.; Nygaard, E.; Squire, K.; Van Wagoner, J.; Rasmussen, J.; Gneiting, S.; Qaderi, K.; Goodsell, J.; Rogers, W.; Lindsey, M.; Costner, K.; Monk, A.; Pearson, M.; Haymore, B.; Peatross, J.			A photophoretic-trap volumetric display	NATURE			English	Article							MANIPULATION; BEAMS; PARTICLES; AIR	Free-space volumetric displays, or displays that create luminous image points in space, are the technology that most closely resembles the three-dimensional displays of popular fiction(1). Such displays are capable of producing images in 'thin air' that are visible from almost any direction and are not subject to clipping. Clipping restricts the utility of all three-dimensional displays that modulate light at a two-dimensional surface with an edge boundary; these include holographic displays, nanophotonic arrays, plasmonic displays, lenticular or lenslet displays and all technologies in which the light scattering surface and the image point are physically separate. Here we present a free-space volumetric display based on photophoretic optical trapping(2) that produces full-colour graphics in free space with ten-micrometre image points using persistence of vision. This display works by first isolating a cellulose particle in a photophoretic trap created by spherical and astigmatic aberrations. The trap and particle are then scanned through a display volume while being illuminated with red, green and blue light. The result is a three-dimensional image in free space with a large colour gamut, fine detail and low apparent speckle. This platform, named the Optical Trap Display, is capable of producing image geometries that are currently unobtainable with holographic and light-field technologies, such as long-throw projections, tall sandtables and 'wrap-around' displays(1).	[Smalley, D. E.; Nygaard, E.; Squire, K.; Van Wagoner, J.; Rasmussen, J.; Gneiting, S.; Qaderi, K.; Goodsell, J.; Rogers, W.; Lindsey, M.; Costner, K.; Monk, A.; Pearson, M.; Haymore, B.] Brigham Young Univ, Dept Elect & Comp Engn, Provo, UT 84602 USA; [Peatross, J.] Brigham Young Univ, Dept Phys & Astron, Provo, UT 84602 USA	Brigham Young University; Brigham Young University	Smalley, DE (corresponding author), Brigham Young Univ, Dept Elect & Comp Engn, Provo, UT 84602 USA.	smalley@byu.edu						ASHKIN A, 1987, NATURE, V330, P769, DOI 10.1038/330769a0; Blundell B. G, 2000, VOLUMETRIC 3 DIMENSI, V1, P330; Blundell BG, 2017, 3D RES, V8, DOI 10.1007/s13319-017-0122-2; BOWEN RW, 1974, VISION RES, V14, P295, DOI 10.1016/0042-6989(74)90079-0; Bowman RW, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/2/026401; CLIFTON TE, 1993, IEEE COMPUT GRAPH, V13, P57, DOI 10.1109/38.219452; Davis EJ, 1997, AEROSOL SCI TECH, V26, P212, DOI 10.1080/02786829708965426; Desyatnikov AS, 2009, OPT EXPRESS, V17, P8201, DOI 10.1364/OE.17.008201; Ehrenhaft F., 1910, MESSUNG ELEKTRIZITAT; Galstian T, 2001, US patent, Patent No. [6,180,940, 6180940]; Gupta JK, 2010, INDOOR AIR, V20, P31, DOI 10.1111/j.1600-0668.2009.00623.x; HE H, 1995, J MOD OPTIC, V42, P217, DOI 10.1080/09500349514550171; Horvath H, 2014, KONA POWDER PART J, P181; Inaba H., 1994, US patent, Patent No. [5,363,190, 5363190]; JENNINGS SG, 1988, J AEROSOL SCI, V19, P159, DOI 10.1016/0021-8502(88)90219-4; Kimura H., 2006, P ACM SIGGRAPH 2006; McDonald G., 2017, WHY DONT WE HAVE PRI; Neukirch LP, 2013, OPT LETT, V38, P2976, DOI 10.1364/OL.38.002976; Ochiai Y, 2016, ACM T GRAPHIC, V35, DOI 10.1145/2850414; Perlin K., 2006, US patent, Patent No. [6,997,558, 6997558]; ROHATSCHEK H, 1985, J AEROSOL SCI, V16, P29, DOI 10.1016/0021-8502(85)90018-7; Ruiz-Avila Jaime, 2016, HOLOVECT HOLOGRAPHIC; Sahoo DR, 2016, UIST 2016: PROCEEDINGS OF THE 29TH ANNUAL SYMPOSIUM ON USER INTERFACE SOFTWARE AND TECHNOLOGY, P437, DOI 10.1145/2984511.2984549; Saito H, 2008, PROC SPIE, V6803, DOI 10.1117/12.768068; Shvedov VG, 2011, OPT EXPRESS, V19, P17350, DOI 10.1364/OE.19.017350; Smalley D. E., 2015, OSA DISPLAY TECHNICA; van Eymeren J, 2012, MON NOT R ASTRON SOC, V420, P183, DOI 10.1111/j.1365-2966.2011.20020.x; Wilson S. D., 1992, US patent, Patent No. [5,170,890, 5170890]	28	138	145	19	119	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2018	553	7689					486	+		10.1038/nature25176	http://dx.doi.org/10.1038/nature25176			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU6OE	29368704	hybrid			2022-12-28	WOS:000423971100037
J	Bergeris, A; Tse, T; Zarin, DA				Bergeris, Annice; Tse, Tony; Zarin, Deborah A.			Trialists' Intent to Share Individual Participant Data as Disclosed at ClinicalTrials.gov	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Bergeris, Annice; Tse, Tony; Zarin, Deborah A.] NIH, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM)	Zarin, DA (corresponding author), Natl Lib Med, ClinicalTrials Gov, 8600 Rockville Pike,Bldg 38A,Room 07N719, Bethesda, MD 20894 USA.	dzarin@mail.nih.gov		Tse, Tony/0000-0002-9906-6864	Intramural Research Program of the National Institutes of Health, National Library of Medicine; NATIONAL LIBRARY OF MEDICINE [ZIHLM200888] Funding Source: NIH RePORTER	Intramural Research Program of the National Institutes of Health, National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	The authors are supported by the Intramural Research Program of the National Institutes of Health, National Library of Medicine.	Bauchner H, 2016, JAMA-J AM MED ASSOC, V315, P1237, DOI 10.1001/jama.2016.2420; Boutron I, 2016, JAMA-J AM MED ASSOC, V315, P2729, DOI 10.1001/jama.2016.6310; Taichman DB, 2017, JAMA-J AM MED ASSOC, V317, P2491, DOI 10.1001/jama.2017.6514; Zarin DA, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001946	4	12	12	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					406	408		10.1001/jama.2017.20581	http://dx.doi.org/10.1001/jama.2017.20581			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362784	Green Accepted, Green Published, Bronze			2022-12-28	WOS:000423405300029
J	Yeom, J; Santos, US; Chekini, M; Cha, M; de Moura, AF; Kotov, NA				Yeom, Jihyeon; Santos, Uallisson S.; Chekini, Mahshid; Cha, Minjeong; de Moura, Andre F.; Kotov, Nicholas A.			Chiromagnetic nanoparticles and gels	SCIENCE			English	Article							MAGNETO-CHIRAL DICHROISM; CIRCULARLY-POLARIZED LUMINESCENCE; OPTICAL-ACTIVITY; SILVER NANOCLUSTERS; MCD SPECTROSCOPY; FARADAY-ROTATION; COBALT OXIDE; QUANTUM DOTS; NANOCRYSTALS; MOLECULES	Chiral inorganic nanostructures have high circular dichroism, but real-time control of their optical activity has so far been achieved only by irreversible chemical changes. Field modulation is a far more desirable path to chiroptical devices. We hypothesized that magnetic field modulation can be attained for chiral nanostructures with large contributions of the magnetic transition dipole moments to polarization rotation. We found that dispersions and gels of paramagnetic Co3O4 nanoparticles with chiral distortions of the crystal lattices exhibited chiroptical activity in the visible range that was 10 times as strong as that of nonparamagnetic nanoparticles of comparable size. Transparency of the nanoparticle gels to circularly polarized light beams in the ultraviolet range was reversibly modulated by magnetic fields. These phenomena were also observed for other nanoscale metal oxides with lattice distortions from imprinted amino acids and other chiral ligands. The large family of chiral ceramic nanostructures and gels can be pivotal for new technologies and knowledge at the nexus of chirality and magnetism.	[Yeom, Jihyeon; Kotov, Nicholas A.] Univ Michigan, Dept Macromol Sci & Engn, Ann Arbor, MI 48109 USA; [Yeom, Jihyeon; Chekini, Mahshid; Cha, Minjeong; Kotov, Nicholas A.] Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA; [Santos, Uallisson S.; de Moura, Andre F.] Univ Fed Sao Carlos, Dept Chem, BR-13565905 Sao Carlos, SP, Brazil; [Chekini, Mahshid; Kotov, Nicholas A.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Cha, Minjeong; Kotov, Nicholas A.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; [Kotov, Nicholas A.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Universidade Federal de Sao Carlos; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kotov, NA (corresponding author), Univ Michigan, Dept Macromol Sci & Engn, Ann Arbor, MI 48109 USA.; Kotov, NA (corresponding author), Univ Michigan, Biointerfaces Inst, Ann Arbor, MI 48109 USA.; de Moura, AF (corresponding author), Univ Fed Sao Carlos, Dept Chem, BR-13565905 Sao Carlos, SP, Brazil.; Kotov, NA (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.; Kotov, NA (corresponding author), Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA.; Kotov, NA (corresponding author), Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA.	moura@ufscar.br; kotov@umich.edu	de Moura, André F/E-8810-2012; Kotov, Nicholas/AAZ-4204-2021; Yeom, Jihyeon/P-8080-2018	Kotov, Nicholas/0000-0002-6864-5804; Santos, Uallisson Silva/0000-0002-3394-2817; Yeom, Jihyeon/0000-0002-3032-8301; Cha, Minjeong/0000-0001-8721-7111; Chekini, Mahshid/0000-0002-7406-0095; Farias de Moura, Andre/0000-0003-1974-4803	NSF Ceramics program through project "Ceramics quasicrystals" [1411014]; NSF [1463474]; Air Force Office of Scientific Research [FA9550-16-1-0265]; Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2012/15147-4, 2013/07296-2]; Ministerio da Educacao/Programa de Educacao Tutorial; Swiss National Science Foundation Early Postdoc Mobility Fellowship [P2GEP2-165061]	NSF Ceramics program through project "Ceramics quasicrystals"; NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Ministerio da Educacao/Programa de Educacao Tutorial; Swiss National Science Foundation Early Postdoc Mobility Fellowship	All data are reported in the main text and supplementary materials. The central part of this work was supported by the NSF Ceramics program through the project "Ceramics quasicrystals" (grant no. 1411014). Partial support of this work was also provided by the NSF-funded project "Energy- and cost-efficient manufacturing employing nano-particles" (grant no. 1463474) and the Air Force Office of Scientific Research-funded project "Nanocomposite ion conductors from branched aramid nanofibers" (grant no. FA9550-16-1-0265). We also thank the Brazilian funding agencies Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP; grants 2012/15147-4 and 2013/07296-2) for financial support. The authors acknowledge the National Laboratory for Scientific Computing (LNCC/MCTI, Brazil) for providing the high-performance computing resources of the SDumont supercomputer (http://sdumont.lncc.br), which have contributed to the results reported in this paper. A.F.d.M. thanks Ministerio da Educacao/Programa de Educacao Tutorial for a fellowship. U.S.S. thanks CNPq for a scholarship. M. Che. acknowledges the support of the Swiss National Science Foundation Early Postdoc Mobility Fellowship (grant no. P2GEP2-165061).	Alonso-Gomez JL, 2009, ANGEW CHEM INT EDIT, V48, P5545, DOI 10.1002/anie.200901240; Barron LD, 2008, NAT MATER, V7, P691, DOI 10.1038/nmat2263; BARRON LD, 1984, MOL PHYS, V51, P715, DOI 10.1080/00268978400100481; Ben-Moshe A, 2013, CHEM SOC REV, V42, P7028, DOI 10.1039/c3cs60139k; Bordacs S, 2012, NAT PHYS, V8, P734, DOI [10.1038/NPHYS2387, 10.1038/nphys2387]; Bruhn T, 2014, ANGEW CHEM INT EDIT, V53, P14592, DOI 10.1002/anie.201408398; BUDA AB, 1992, J AM CHEM SOC, V114, P6006, DOI 10.1021/ja00041a016; Chen W, 2009, NANO LETT, V9, P2153, DOI 10.1021/nl900726s; Crassous J, 2009, CHEM SOC REV, V38, P830, DOI 10.1039/b806203j; Fasman G.D., 1996, CIRCULAR DICHROISM C; Fujioka Y, 2016, INORG CHEM, V55, P9436, DOI 10.1021/acs.inorgchem.6b01693; Gansel JK, 2009, SCIENCE, V325, P1513, DOI 10.1126/science.1177031; Goto T, 2017, ANGEW CHEM INT EDIT, V56, P2989, DOI 10.1002/anie.201612331; Govorov AO, 2010, NANO LETT, V10, P1374, DOI 10.1021/nl100010v; Guerrero-Martinez A, 2011, ANGEW CHEM INT EDIT, V50, P5499, DOI 10.1002/anie.201007536; Haffer S, 2013, J PHYS CHEM C, V117, P24471, DOI 10.1021/jp409058t; Han B, 2017, NANO LETT, V17, P6083, DOI 10.1021/acs.nanolett.7b02583; HARMAN B, 1983, INORG CHIM A-BIOINOR, V80, P75, DOI 10.1016/S0020-1693(00)91264-7; Hochepied JF, 2001, J MAGN MAGN MATER, V231, P315, DOI 10.1016/S0304-8853(01)00182-2; Ikedo Y, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.054424; Jain PK, 2009, NANO LETT, V9, P1644, DOI 10.1021/nl900007k; Kim Y, 2016, NAT MATER, V15, P461, DOI [10.1038/NMAT4525, 10.1038/nmat4525]; Kitagawa Y, 2011, ANGEW CHEM INT EDIT, V50, P9133, DOI 10.1002/anie.201101809; Kumar J, 2017, CHEM COMMUN, V53, P1269, DOI 10.1039/c6cc09476g; Kuzmin DA, 2016, NANO LETT, V16, P4391, DOI 10.1021/acs.nanolett.6b01517; Kuzyk A, 2014, NAT MATER, V13, P862, DOI [10.1038/NMAT4031, 10.1038/nmat4031]; Kuzyk A, 2012, NATURE, V483, P311, DOI 10.1038/nature10889; Lee JH, 2011, NAT NANOTECHNOL, V6, P418, DOI [10.1038/nnano.2011.95, 10.1038/NNANO.2011.95]; Lee N, 2012, CHEM SOC REV, V41, P2575, DOI 10.1039/c1cs15248c; Li J, 2012, OPT MATER EXPRESS, V2, P1760, DOI 10.1364/OME.2.001760; Mark AG, 2013, NAT MATER, V12, P802, DOI [10.1038/NMAT3685, 10.1038/nmat3685]; McPeak KM, 2014, NANO LETT, V14, P2934, DOI 10.1021/nl501032j; MOFFITT W, 1959, J CHEM PHYS, V30, P648, DOI 10.1063/1.1730025; Moloney MP, 2015, NAT PROTOC, V10, P558, DOI 10.1038/nprot.2015.028; Mukhina MV, 2015, NANO LETT, V15, P2844, DOI 10.1021/nl504439w; Naaman R, 2015, ANNU REV PHYS CHEM, V66, P263, DOI 10.1146/annurev-physchem-040214-121554; Nafie LA, 1996, CHEM PHYS, V205, P309, DOI 10.1016/0301-0104(95)00400-9; Nakanishi K., 2000, CIRCULAR DICHROISM P; Nakashima T, 2009, J AM CHEM SOC, V131, P10342, DOI 10.1021/ja902800f; Nishida N, 2007, CHEM MATER, V19, P2831, DOI 10.1021/cm0700192; Norberg NS, 2006, J APPL PHYS, V99, DOI 10.1063/1.2151818; Pfleiderer C, 2010, J PHYS-CONDENS MAT, V22, DOI 10.1088/0953-8984/22/16/164207; Pineider F, 2013, NANO LETT, V13, P4785, DOI 10.1021/nl402394p; Rikken GLJA, 2000, NATURE, V405, P932, DOI 10.1038/35016043; Rikken GLJA, 1997, NATURE, V390, P493, DOI 10.1038/37323; Risthaus T, 2014, PHYS CHEM CHEM PHYS, V16, P14408, DOI 10.1039/c3cp54517b; Roman-Velazquez CE, 2003, J PHYS CHEM B, V107, P12035, DOI 10.1021/jp0356315; Salabas EL, 2006, NANO LETT, V6, P2977, DOI 10.1021/nl060528n; Sessoli R, 2015, NAT PHYS, V11, P69, DOI [10.1038/NPHYS3152, 10.1038/nphys3152]; Singh G, 2014, SCIENCE, V345, P1149, DOI 10.1126/science.1254132; Sun SH, 2004, J AM CHEM SOC, V126, P273, DOI 10.1021/ja0380852; Train C, 2008, NAT MATER, V7, P729, DOI 10.1038/nmat2256; Train C, 2011, CHEM SOC REV, V40, P3297, DOI 10.1039/c1cs15012j; Wang GX, 2009, J PHYS CHEM C, V113, P4357, DOI 10.1021/jp8106149; Yannopapas V, 2015, ACS PHOTONICS, V2, P1030, DOI 10.1021/acsphotonics.5b00237; Yao H, 2016, NANOSCALE, V8, P11264, DOI 10.1039/c6nr00631k; Yao H, 2015, J PHYS CHEM C, V119, P13224, DOI 10.1021/acs.jpcc.5b03131; Yu JH, 2010, NAT MATER, V9, P47, DOI [10.1038/NMAT2572, 10.1038/nmat2572]; Zhou YL, 2011, ANGEW CHEM INT EDIT, V50, P11456, DOI 10.1002/anie.201103762; Zubritskaya I., 2017, NANO LETT, DOI [10.1021/acs.nanolett.7b04139, DOI 10.1021/ACS.NAN0LETT.7B04139]	60	135	136	36	386	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					309	+		10.1126/science.aao7172	http://dx.doi.org/10.1126/science.aao7172			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6BB	29348234				2022-12-28	WOS:000423236700035
J	Dunbar, CE; High, KA; Joung, JK; Kohn, DB; Ozawa, K; Sadelain, M				Dunbar, Cynthia E.; High, Katherine A.; Joung, J. Keith; Kohn, Donald B.; Ozawa, Keiya; Sadelain, Michel			Gene therapy comes of age	SCIENCE			English	Review							ADENOASSOCIATED VIRAL VECTORS; CHIMERIC ANTIGEN RECEPTORS; HEMATOPOIETIC STEM-CELLS; HEMOPHILIA-B DOGS; FACTOR-IX; T-CELLS; PARKINSONS-DISEASE; RETROVIRAL VECTORS; IMMUNE-RESPONSES; MOUSE MODEL	After almost 30 years of promise tempered by setbacks, gene therapies are rapidly becoming a critical component of the therapeutic armamentarium for a variety of inherited and acquired human diseases. Gene therapies for inherited immune disorders, hemophilia, eye and neurodegenerative disorders, and lymphoid cancers recently progressed to approved drug status in the United States and Europe, or are anticipated to receive approval in the near future. In this Review, we discuss milestones in the development of gene therapies, focusing on direct in vivo administration of viral vectors and adoptive transfer of genetically engineered T cells or hematopoietic stem cells. We also discuss emerging genome editing technologies that should further advance the scope and efficacy of gene therapy approaches.	[Dunbar, Cynthia E.] NHLBI, Hematol Branch, Bethesda, MD 20892 USA; [High, Katherine A.] Spark Therapeut, Philadelphia, PA USA; [Joung, J. Keith] Massachusetts Gen Hosp, Boston, MA 02114 USA; [Joung, J. Keith] Harvard Med Sch, Boston, MA USA; [Kohn, Donald B.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Ozawa, Keiya] Univ Tokyo, Inst Med Sci, Tokyo, Japan; [Sadelain, Michel] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Tokyo; Memorial Sloan Kettering Cancer Center	Dunbar, CE (corresponding author), NHLBI, Hematol Branch, Bethesda, MD 20892 USA.; Sadelain, M (corresponding author), Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA.	dunbarc@nhlbi.nih.gov; m-sadelain@ski.mskcc.org	High, Katherine A./AAB-9322-2020; Kohn, Donald/N-5085-2016	High, Katherine/0000-0002-0805-6223; Kohn, Donald/0000-0003-1840-6087; Dunbar, Cynthia/0000-0002-7645-838X	Takara Bio; Beam Therapeutics; Editas Medicine; Pairwise Plants; BioMarin Pharmaceutical; Juno Therapeutics; Fate Therapeutics	Takara Bio; Beam Therapeutics; Editas Medicine; Pairwise Plants; BioMarin Pharmaceutical(Johnson & Johnson); Juno Therapeutics; Fate Therapeutics	K.A.H. is President and Head of Research and Development at Spark Therapeutics, a biotechnology company involved in discovering, developing, and delivering AAV gene therapies for genetic diseases. K.O. has a sponsored research agreement with Takara Bio for CAR-T gene therapy. J.K.J. is a paid scientific adviser for Beam Therapeutics, Editas Medicine, and Pairwise Plants and holds equity in Beam Therapeutics, Editas Medicine, Monitor Biotechnologies, Pairwise Plants, Poseida Therapeutics, and Transposagen Biopharmaceuticals. These financial interests were reviewed and are managed by Massachusetts General Hospital and Partners HealthCare in accordance with their conflict of interest policies. J.K.J. has sponsored research agreements with AstraZeneca and Takeda Pharmaceuticals and is an inventor on patent applications and issued patents that cover genome editing technologies. D.B.K. is on the Scientific Advisory Boards of Orchard Therapeutics and Kite Pharma, companies developing gene therapies, and has a Sponsored Research Agreement from BioMarin Pharmaceutical on lentiviral vectors for sickle cell disease. D.B.K. is an inventor on intellectual property licensed to Orchard Therapeutics from the University of California Los Angeles, on lentiviral vector gene therapy for adenosine deaminase-deficient SCID. M.S. has sponsored research agreements with Juno Therapeutics and Fate Therapeutics. M.S. is an inventor on patents related to CAR therapies that are licensed by Memorial Sloan-Kettering Cancer Center.	Abina SHB, 2015, JAMA-J AM MED ASSOC, V313, P1550, DOI 10.1001/jama.2015.3253; Aiuti A, 2002, SCIENCE, V296, P2410, DOI 10.1126/science.1070104; Aiuti A, 2013, SCIENCE, V341, P865, DOI 10.1126/science.1233151; Aiuti A, 2009, NEW ENGL J MED, V360, P447, DOI 10.1056/NEJMoa0805817; Ali SA, 2016, BLOOD, V128, P1688, DOI 10.1182/blood-2016-04-711903; [Anonymous], 1996, B MED ETHICS; Asokan A, 2012, MOL THER, V20, P699, DOI 10.1038/mt.2011.287; Bainbridge JWB, 2015, NEW ENGL J MED, V372, P1887, DOI 10.1056/NEJMoa1414221; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Baum C, 2011, STEM CELLS, V29, P1479, DOI 10.1002/stem.716; Bennett J, 2016, LANCET, V388, P661, DOI 10.1016/S0140-6736(16)30371-3; Berns K, 2013, FIELDS VIROLOGY, V6th, P2437; Biffi A, 2013, SCIENCE, V341, P864, DOI 10.1126/science.1233158; Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Braun CJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007280; Brentjens RJ, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005930; Brentjens RJ, 2011, BLOOD, V118, P4817, DOI 10.1182/blood-2011-04-348540; Brentjens RJ, 2003, NAT MED, V9, P279, DOI 10.1038/nm827; BUNNELL BA, 1995, P NATL ACAD SCI USA, V92, P7739, DOI 10.1073/pnas.92.17.7739; Busch DH, 2016, SEMIN IMMUNOL, V28, P28, DOI 10.1016/j.smim.2016.02.001; Canver MC, 2015, NATURE, V527, P192, DOI 10.1038/nature15521; Carroll D, 2014, ANNU REV BIOCHEM, V83, P409, DOI 10.1146/annurev-biochem-060713-035418; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Chen JS, 2017, NATURE, V550, P407, DOI 10.1038/nature24268; Chew WL, 2016, NAT METHODS, V13, P868, DOI 10.1038/nmeth.3993; Christian M, 2010, GENETICS, V186, P757, DOI 10.1534/genetics.110.120717; Christine CW, 2009, NEUROLOGY, V73, P1662, DOI 10.1212/WNL.0b013e3181c29356; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Couzin-Frankel J, 2013, SCIENCE, V342, P1432, DOI 10.1126/science.342.6165.1432; DANOS O, 1988, P NATL ACAD SCI USA, V85, P6460, DOI 10.1073/pnas.85.17.6460; Davila ML, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008226; De Ravin SS, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3480; De Ravin SS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad8856; Doudna J. A., SCIENCE, V346; Dunbar CE, 1996, ANNU REV MED, V47, P11; Eichler F, 2017, NEW ENGL J MED, V377, P1630, DOI 10.1056/NEJMoa1700554; Ellebrecht CT, 2016, SCIENCE, V353, P179, DOI 10.1126/science.aaf6756; Eshhar Z, 2014, CANCER J, V20, P123, DOI 10.1097/PPO.0000000000000027; Eyquem J, 2017, NATURE, V543, P113, DOI 10.1038/nature21405; FRIEDMANN T, 1972, SCIENCE, V175, P949, DOI 10.1126/science.175.4025.949; Friedmann T, 2015, MOL THER, V23, P1282, DOI 10.1038/mt.2015.118; Gallardo HF, 1997, BLOOD, V90, P952, DOI 10.1182/blood.V90.3.952.952_952_957; Gattinoni L, 2012, NAT REV CANCER, V12, P671, DOI 10.1038/nrc3322; Gaudelli NM, 2017, NATURE, V551, P464, DOI 10.1038/nature24644; Gaudet D, 2013, GENE THER, V20, P361, DOI 10.1038/gt.2012.43; Genovese P, 2014, NATURE, V510, P235, DOI 10.1038/nature13420; George LA, 2017, NEW ENGL J MED, V377, P2215, DOI 10.1056/NEJMoa1708538; Gilbert LA, 2013, CELL, V154, P442, DOI 10.1016/j.cell.2013.06.044; Gill S, 2016, BEST PRACT RES CL HA, V29, P329, DOI 10.1016/j.beha.2016.10.004; Hacein-Bey-Abina S, 2002, NEW ENGL J MED, V346, P1185, DOI 10.1056/NEJMoa012616; Hacein-Bey-Abina S, 2014, NEW ENGL J MED, V371, P1407, DOI 10.1056/NEJMoa1404588; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Halene S, 1999, BLOOD, V94, P3349, DOI 10.1182/blood.V94.10.3349.422k05_3349_3357; Hauswirth WW, 2008, HUM GENE THER, V19, P979, DOI 10.1089/hum.2008.107; Herzog RW, 1997, P NATL ACAD SCI USA, V94, P5804, DOI 10.1073/pnas.94.11.5804; High KA, 2016, HUM MOL GENET, V25, pR36, DOI 10.1093/hmg/ddv475; Hoban MD, 2015, BLOOD, V125, P2597, DOI 10.1182/blood-2014-12-615948; Hwu WL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003640; Imai C, 2004, LEUKEMIA, V18, P676, DOI 10.1038/sj.leu.2403302; Jacobson SG, 2015, NEW ENGL J MED, V372, P1920, DOI 10.1056/NEJMoa1412965; Jenks S, 2000, J NATL CANCER I, V92, P98, DOI 10.1093/jnci/92.2.98; Jensen MC, 2015, CURR OPIN IMMUNOL, V33, P9, DOI 10.1016/j.coi.2015.01.002; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Joung JK, 2013, NAT REV MOL CELL BIO, V14, P49, DOI 10.1038/nrm3486; Kay MA, 2000, NAT GENET, V24, P257, DOI 10.1038/73464; Kessler PD, 1996, P NATL ACAD SCI USA, V93, P14082, DOI 10.1073/pnas.93.24.14082; Klebanoff CA, 2016, NAT MED, V22, P26, DOI 10.1038/nm.4015; Kleinstiver BP, 2016, NATURE, V529, P490, DOI 10.1038/nature16526; Kochenderfer JN, 2015, J CLIN ONCOL, V33, P540, DOI 10.1200/JCO.2014.56.2025; Kochenderfer JN, 2010, BLOOD, V116, P4099, DOI 10.1182/blood-2010-04-281931; Komor AC, 2017, CELL, V168, P20, DOI 10.1016/j.cell.2016.10.044; Komor AC, 2016, NATURE, V533, P420, DOI 10.1038/nature17946; Korin YD, 1998, J VIROL, V72, P3161, DOI 10.1128/JVI.72.4.3161-3168.1998; Kotterman MA, 2015, ANNU REV BIOMED ENG, V17, P63, DOI 10.1146/annurev-bioeng-071813-104938; Lee DW, 2015, LANCET, V385, P517, DOI 10.1016/S0140-6736(14)61403-3; Lee DW, 2014, BLOOD, V124, P188, DOI 10.1182/blood-2014-05-552729; LeWitt PA, 2011, LANCET NEUROL, V10, P309, DOI 10.1016/S1474-4422(11)70039-4; Li LJ, 2013, MOL THER, V21, P1259, DOI 10.1038/mt.2013.65; Li T, 2011, NUCLEIC ACIDS RES, V39, P359, DOI 10.1093/nar/gkq704; Liang PP, 2015, PROTEIN CELL, V6, P363, DOI 10.1007/s13238-015-0153-5; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Maguire AM, 2009, LANCET, V374, P1597, DOI 10.1016/S0140-6736(09)61836-5; Maher J, 2002, NAT BIOTECHNOL, V20, P70, DOI 10.1038/nbt0102-70; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; Manno CS, 2006, NAT MED, V12, P342, DOI 10.1038/nm1358; Mansilla-Soto J, 2016, HUM GENE THER, V27, P295, DOI 10.1089/hum.2016.037; Marks WJ, 2010, LANCET NEUROL, V9, P1164, DOI 10.1016/S1474-4422(10)70254-4; Maude SL, 2014, NEW ENGL J MED, V371, P1507, DOI 10.1056/NEJMoa1407222; MAVILIO F, 1994, BLOOD, V83, P1988; May C, 2000, NATURE, V406, P82, DOI 10.1038/35017565; Mendell JR, 2017, NEW ENGL J MED, V377, P1713, DOI 10.1056/NEJMoa1706198; Miller AD, 2014, HUM GENE THER, V25, P989, DOI 10.1089/hum.2014.2542; MILLER AD, 1991, J VIROL, V65, P2220, DOI 10.1128/JVI.65.5.2220-2224.1991; Mimuro J, 2014, J MED VIROL, V86, P1990, DOI 10.1002/jmv.23818; Mingozzi F, 2007, NAT MED, V13, P419, DOI 10.1038/nm1549; Mingozzi F, 2013, BLOOD, V122, P23, DOI 10.1182/blood-2013-01-306647; Mingozzi F, 2011, CURR GENE THER, V11, P321, DOI 10.2174/156652311796150354; Montini E, 2009, J CLIN INVEST, V119, P964, DOI 10.1172/JCI37630; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Mount JD, 2002, BLOOD, V99, P2670, DOI 10.1182/blood.V99.8.2670; Muramatsu S, 2010, MOL THER, V18, P1731, DOI 10.1038/mt.2010.135; Muramatsu SI, 2002, HUM GENE THER, V13, P345, DOI 10.1089/10430340252792486; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Naldini L, 2016, SCIENCE, V353, P1101, DOI 10.1126/science.aah6192; Naldini L, 2015, NATURE, V526, P351, DOI 10.1038/nature15818; Nathwani AC, 2014, NEW ENGL J MED, V371, P1994, DOI 10.1056/NEJMoa1407309; Nathwani AC, 2011, NEW ENGL J MED, V365, P2357, DOI 10.1056/NEJMoa1108046; National Academies of Sciences Engineering and Medicine, 2017, HUM GEN ED SCI ETH G; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Niemeyer GP, 2009, BLOOD, V113, P797, DOI 10.1182/blood-2008-10-181479; Nienhuis AW, 2006, MOL THER, V13, P1031, DOI 10.1016/j.ymthe.2006.03.001; Orkin SH, 2016, SCIENCE, V352, P1059, DOI 10.1126/science.aaf4770; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Porter DL, 2011, NEW ENGL J MED, V365, P725, DOI 10.1056/NEJMoa1103849; Qasim W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaj2013; Qi LS, 2013, CELL, V152, P1173, DOI 10.1016/j.cell.2013.02.022; Rangarajan S, 2017, NEW ENGL J MED, V377, P2519, DOI 10.1056/NEJMoa1708483; Reyon D, 2012, NAT BIOTECHNOL, V30, P460, DOI 10.1038/nbt.2170; Ribeil JA, 2017, NEW ENGL J MED, V376, P848, DOI 10.1056/NEJMoa1609677; RIVIERE I, 1995, P NATL ACAD SCI USA, V92, P6733, DOI 10.1073/pnas.92.15.6733; Riviere I, 2017, MOL THER, V25, P1117, DOI 10.1016/j.ymthe.2017.03.034; Robbins PF, 2011, J CLIN ONCOL, V29, P917, DOI 10.1200/JCO.2010.32.2537; Rogers GL, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-25; ROUET P, 1994, P NATL ACAD SCI USA, V91, P6064, DOI 10.1073/pnas.91.13.6064; Russell DW, 1996, J VIROL, V70, P217, DOI 10.1128/JVI.70.1.217-222.1996; Russell S, 2017, LANCET, V390, P849, DOI 10.1016/S0140-6736(17)31868-8; Sadelain M, 2003, NAT REV CANCER, V3, P35, DOI 10.1038/nrc971; Sadelain M., 1992, 9 INT IMM C BUD, V88, P34; Sadelain M, 2017, NATURE, V545, P423, DOI 10.1038/nature22395; Sadelain M, 2013, CANCER DISCOV, V3, P388, DOI 10.1158/2159-8290.CD-12-0548; Sagonowsky E, 2017, FIERCEPHARMA; Sander JD, 2014, NAT BIOTECHNOL, V32, P347, DOI 10.1038/nbt.2842; Sessa M, 2016, LANCET, V388, P476, DOI 10.1016/S0140-6736(16)30374-9; Sharma R, 2015, BLOOD, V126, P1777, DOI 10.1182/blood-2014-12-615492; Silva G, 2011, CURR GENE THER, V11, P11, DOI 10.2174/156652311794520111; Slaymaker IM, 2016, SCIENCE, V351, P84, DOI 10.1126/science.aad5227; Stein S, 2010, NAT MED, V16, P198, DOI 10.1038/nm.2088; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Talbot K, 2017, GENE THER, V24, P529, DOI 10.1038/gt.2017.52; Tebas P, 2014, NEW ENGL J MED, V370, P901, DOI 10.1056/NEJMoa1300662; Traxler EA, 2016, NAT MED, V22, P987, DOI 10.1038/nm.4170; Tsai SQ, 2016, NAT REV GENET, V17, P300, DOI 10.1038/nrg.2016.28; Turtle CJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8621; Urnov FD, 2010, NAT REV GENET, V11, P636, DOI 10.1038/nrg2842; WATANABE S, 1983, MOL CELL BIOL, V3, P2241, DOI 10.1128/MCB.3.12.2241; WILLIAMS DA, 1984, NATURE, V310, P476, DOI 10.1038/310476a0; Wright AF, 2015, NEW ENGL J MED, V372, P1954, DOI 10.1056/NEJMe1503419; Wright JF, 2011, HUM GENE THER, V22, P913, DOI 10.1089/hum.2011.2514; Wu Chuanfeng, 2011, Front Med, V5, P356, DOI 10.1007/s11684-011-0159-1; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Xiao XA, 1996, J VIROL, V70, P8098, DOI 10.1128/JVI.70.11.8098-8108.1996; YU SF, 1986, P NATL ACAD SCI USA, V83, P3194, DOI 10.1073/pnas.83.10.3194; Zhong L, 2008, P NATL ACAD SCI USA, V105, P7827, DOI 10.1073/pnas.0802866105	155	627	660	47	485	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					175	+	eaan4672	10.1126/science.aan4672	http://dx.doi.org/10.1126/science.aan4672			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS5EO	29326244				2022-12-28	WOS:000419816600037
J	Omer, DB; Maimon, SR; Las, L; Ulanovsky, N				Omer, David B.; Maimon, Shir R.; Las, Liora; Ulanovsky, Nachum			Social place-cells in the bat hippocampus	SCIENCE			English	Article							ENTORHINAL CORTEX; REPRESENTATION; MEMORY; EXPERIENCE; RESPONSES; DYNAMICS; LOCATION; NEURONS; BRAIN; SPACE	Social animals have to know the spatial positions of conspecifics. However, it is unknown how the position of others is represented in the brain. We designed a spatial observational-learning task, in which an observer bat mimicked a demonstrator bat while we recorded hippocampal dorsal-CA1 neurons from the observer bat. A neuronal subpopulation represented the position of the other bat, in allocentric coordinates. About half of these "social placecells" represented also the observer's own position-that is, were place cells. The representation of the demonstrator bat did not reflect self-movement or trajectory planning by the observer. Some neurons represented also the position of inanimate moving objects; however, their representation differed from the representation of the demonstrator bat. This suggests a role for hippocampal CA1 neurons in social-spatial cognition.	[Omer, David B.; Maimon, Shir R.; Las, Liora; Ulanovsky, Nachum] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Las, L; Ulanovsky, N (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	liora.las@weizmann.ac.il; nachum.ulanovsky@weizmann.ac.il	LAS, LIORA/AGF-2249-2022; Omer, David/AAF-1960-2019	Omer, David/0000-0001-7402-9453	European Research Council (ERC-CoG-NATURAL_BAT_NAV); Israel Science Foundation [ISF 1319/13]; Minerva Foundation	European Research Council (ERC-CoG-NATURAL_BAT_NAV); Israel Science Foundation(Israel Science Foundation); Minerva Foundation	We thank K. Haroush, S. Romani, O. Forkosh, A. Rubin, M. Geva-Sagiv, A. Finkelstein, T. Eliav, G. Ginosar, A. Sarel, and D. Blum for comments on the manuscript; S. Kaufman, O. Gobi, and S. Futerman for bat training; A. Tuval for veterinary support; C. Ra'anan and R. Eilam for histology; B. Pasmantirer and G. Ankaoua for mechanical designs; and G. Brodsky for graphics. This study was supported by research grants to N.U. from the European Research Council (ERC-CoG-NATURAL_BAT_NAV), Israel Science Foundation (ISF 1319/13), and Minerva Foundation. The data are archived on the Weizmann Institute of Science servers and will be made available on request.	Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Dudek SM, 2016, NAT REV NEUROSCI, V17, P89, DOI 10.1038/nrn.2015.22; Eichenbaum H, 2014, NEURON, V83, P764, DOI 10.1016/j.neuron.2014.07.032; Ferbinteanu J, 2003, NEURON, V40, P1227, DOI 10.1016/S0896-6273(03)00752-9; Finkelstein A, 2015, NATURE, V517, P159, DOI 10.1038/nature14031; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Henriksen EJ, 2010, NEURON, V68, P127, DOI 10.1016/j.neuron.2010.08.042; Hitti FL, 2014, NATURE, V508, P88, DOI 10.1038/nature13028; Ho SA, 2008, NEUROSCIENCE, V157, P254, DOI 10.1016/j.neuroscience.2008.09.004; Knierim JJ, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0369; Lever C, 2009, J NEUROSCI, V29, P9771, DOI 10.1523/JNEUROSCI.1319-09.2009; MARKUS EJ, 1995, J NEUROSCI, V15, P7079; Moita MAP, 2003, NEURON, V37, P485, DOI 10.1016/S0896-6273(03)00033-3; Mou X, 2016, ELIFE, V5, DOI 10.7554/eLife.18022; Neuweiler G., 2000, BIOL BATS; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Okuyama T, 2016, SCIENCE, V353, P1536, DOI 10.1126/science.aaf7003; Peyrache A, 2015, NAT NEUROSCI, V18, P569, DOI 10.1038/nn.3968; Pfeiffer BE, 2015, SCIENCE, V349, P180, DOI 10.1126/science.aaa9633; Rizzolatti G, 2016, NAT REV NEUROSCI, V17, P757, DOI 10.1038/nrn.2016.135; Sarel A, 2017, SCIENCE, V355, P176, DOI 10.1126/science.aak9589; Savelli F, 2008, HIPPOCAMPUS, V18, P1270, DOI 10.1002/hipo.20511; Solstad T, 2008, SCIENCE, V322, P1865, DOI 10.1126/science.1166466; TAUBE JS, 1990, J NEUROSCI, V10, P420; Tsao A, 2013, CURR BIOL, V23, P399, DOI 10.1016/j.cub.2013.01.036; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; von Heimendahl M, 2012, J NEUROSCI, V32, P2129, DOI 10.1523/JNEUROSCI.3812-11.2012; WILSON MA, 1993, SCIENCE, V261, P1055, DOI 10.1126/science.8351520; Yartsev MM, 2013, SCIENCE, V340, P367, DOI 10.1126/science.1235338; Yartsev MM, 2011, NATURE, V479, P103, DOI 10.1038/nature10583; Zynyuk L, 2012, HIPPOCAMPUS, V22, P1405, DOI 10.1002/hipo.20977	32	97	99	1	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					218	+		10.1126/science.aao3474	http://dx.doi.org/10.1126/science.aao3474			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS5EO	29326274				2022-12-28	WOS:000419816600047
J	Voosen, P				Voosen, Paul			EARTH SCIENCE Earth scientists list top priorities for space missions	SCIENCE			English	News Item																			0	1	1	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					143	143		10.1126/science.359.6372.143	http://dx.doi.org/10.1126/science.359.6372.143			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS5EO	29326250				2022-12-28	WOS:000419816600014
J	Michilli, D; Seymour, A; Hessels, JWT; Spitler, LG; Gajjar, V; Archibald, AM; Bower, GC; Chatterjee, S; Cordes, JM; Gourdji, K; Heald, GH; Kaspi, VM; Law, CJ; Sobey, C; Adams, EAK; Bassa, CG; Bogdanov, S; Brinkman, C; Demorest, P; Fernandez, F; Hellbourg, G; Lazio, TJW; Lynch, RS; Maddox, N; Marcote, B; McLaughlin, MA; Paragi, Z; Ransom, SM; Scholz, P; Siemion, APV; Tendulkar, SP; Van Rooy, P; Wharton, RS; Whitlow, D				Michilli, D.; Seymour, A.; Hessels, J. W. T.; Spitler, L. G.; Gajjar, V.; Archibald, A. M.; Bower, G. C.; Chatterjee, S.; Cordes, J. M.; Gourdji, K.; Heald, G. H.; Kaspi, V. M.; Law, C. J.; Sobey, C.; Adams, E. A. K.; Bassa, C. G.; Bogdanov, S.; Brinkman, C.; Demorest, P.; Fernandez, F.; Hellbourg, G.; Lazio, T. J. W.; Lynch, R. S.; Maddox, N.; Marcote, B.; McLaughlin, M. A.; Paragi, Z.; Ransom, S. M.; Scholz, P.; Siemion, A. P. V.; Tendulkar, S. P.; Van Rooy, P.; Wharton, R. S.; Whitlow, D.			An extreme magneto-ionic environment associated with the fast radio burst source FRB 121102	NATURE			English	Article							SAGITTARIUS-A-ASTERISK; FARADAY-ROTATION; GAMMA-RAY; SUPERNOVA REMNANT; BLACK-HOLE; X-RAY; FIELDS; POLARIZATION; NEBULA; GALAXY	Fast radio bursts are millisecond-duration, extragalactic radio flashes of unknown physical origin(1-3). The only known repeating fast radio burst source(4-6)-FRB 121102-has been localized to a star-forming region in a dwarf galaxy(7-9) at redshift 0.193 and is spatially coincident with a compact, persistent radio source(7,10). The origin of the bursts, the nature of the persistent source and the properties of the local environment are still unclear. Here we report observations of FRB 121102 that show almost 100 per cent linearly polarized emission at a very high and variable Faraday rotation measure in the source frame (varying from + 1.46 x 10(5) radians per square metre to + 1.33 x 10(5) radians per square metre at epochs separated by seven months) and narrow (below 30 microseconds) temporal structure. The large and variable rotation measure demonstrates that FRB 121102 is in an extreme and dynamic magneto-ionic environment, and the short durations of the bursts suggest a neutron star origin. Such large rotation measures have hitherto been observed(11,12) only in the vicinities of massive black holes (larger than about 10,000 solar masses). Indeed, the properties of the persistent radio source are compatible with those of a low-luminosity, accreting massive black hole(10). The bursts may therefore come from a neutron star in such an environment or could be explained by other models, such as a highly magnetized wind nebula(13) or supernova remnant(14) surrounding a young neutron star.	[Michilli, D.; Hessels, J. W. T.; Archibald, A. M.; Adams, E. A. K.; Bassa, C. G.; Maddox, N.] Netherlands Inst Radio Astron, ASTRON, Postbus 2, NL-7990 AA Dwingeloo, Netherlands; [Michilli, D.; Hessels, J. W. T.; Archibald, A. M.; Gourdji, K.] Univ Amsterdam, Anton Pannekoek Inst Astron, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands; [Seymour, A.; Fernandez, F.; Whitlow, D.] Natl Astron & Ionosphere Ctr, Arecibo Observ, PR 00612 USA; [Spitler, L. G.; Wharton, R. S.] Max Planck Inst Radioastron, Hugel 69, D-53121 Bonn, Germany; [Gajjar, V.] Univ Calif Berkeley, Space Sci Lab, 7 Gauss Way, Albany, CA 94710 USA; [Gajjar, V.] Chinese Acad Sci, Xinjiang Astron Observ, 150 Sci 1 St, Urumqi 830011, Xinjiang, Peoples R China; [Gajjar, V.] Chinese Acad Sci, Key Lab Radio Astron, Nanjing 210008, Peoples R China; [Bower, G. C.] Acad Sinica, Inst Astron & Astrophys, 645 N Aohoku Pl, Hilo, HI 96720 USA; [Chatterjee, S.; Cordes, J. M.] Cornell Univ, Cornell Ctr Astrophys & Planetary Sci, Ithaca, NY 14853 USA; [Chatterjee, S.; Cordes, J. M.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [Heald, G. H.; Sobey, C.] CSIRO Astron & Space Sci, 26 Dick Perry Ave, Kensington, WA 6151, Australia; [Kaspi, V. M.; Tendulkar, S. P.] McGill Univ, Dept Phys, 3600 Univ, Montreal, PQ H3A 2T8, Canada; [Kaspi, V. M.; Tendulkar, S. P.] McGill Univ, McGill Space Inst, 3600 Univ, Montreal, PQ H3A 2T8, Canada; [Law, C. J.; Hellbourg, G.; Siemion, A. P. V.] Univ Calif Berkeley, Dept Astron, Berkeley, CA 94720 USA; [Law, C. J.; Hellbourg, G.; Siemion, A. P. V.] Univ Calif Berkeley, Radio Astron Lab, Berkeley, CA 94720 USA; [Sobey, C.] Curtin Univ, Int Ctr Radio Astron Res, GPO Box U1987, Perth, WA 6845, Australia; [Adams, E. A. K.] Univ Groningen, Kapteyn Astron Inst, Postbus 800, NL-9700 AA Groningen, Netherlands; [Bogdanov, S.] Columbia Univ, Columbia Astrophys Lab, 538 W 120th St, New York, NY 10027 USA; [Brinkman, C.] Univ Vermont, Dept Phys, Burlington, VT 05401 USA; [Demorest, P.] Natl Radio Astron Observ, POB O, Socorro, NM 87801 USA; [Lazio, T. J. W.] CALTECH, Jet Prop Lab, 4800 Oak Grove Dr, Pasadena, CA 91109 USA; [Lynch, R. S.] Green Bank Observ, POB 2, Green Bank, WV 24944 USA; [Lynch, R. S.; McLaughlin, M. A.] Ctr Gravitat Waves & Cosmol, Chestnut Ridge Res Bldg, Morgantown, WV 26505 USA; [Marcote, B.; Paragi, Z.] Joint Inst VLBI ERIC, Postbus 2, NL-7990 AA Dwingeloo, Netherlands; [McLaughlin, M. A.] West Virginia Univ, Dept Phys & Astron, Morgantown, WV 26506 USA; [Ransom, S. M.] Natl Radio Astron Observ, Charlottesville, VA 22903 USA; [Scholz, P.] Dominion Radio Astrophys Observ, Herzberg Astron & Astrophys, Natl Res Council Canada, POB 248, Penticton, BC V2A 6J9, Canada; [Siemion, A. P. V.] Radboud Univ Nijmegen, Comeniuslaan 4, NL-6525 HP Nijmegen, Netherlands; [Siemion, A. P. V.] SETI Inst, 189 North Bernardo Ave 200, Mountain View, CA 94043 USA; [Van Rooy, P.] Case Western Reserve Univ, Dept Elect Engn & Comp Sci, Cleveland, OH 44106 USA	University of Amsterdam; National Aeronautics & Space Administration (NASA); Max Planck Society; University of California System; University of California Berkeley; Chinese Academy of Sciences; Xinjiang Astronomy Observatory, NACO, CAS; Chinese Academy of Sciences; Academia Sinica - Taiwan; Cornell University; Cornell University; Commonwealth Scientific & Industrial Research Organisation (CSIRO); McGill University; McGill University; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Curtin University; University of Groningen; Columbia University; University of Vermont; National Radio Astronomy Observatory (NRAO); California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); National Radio Astronomy Observatory (NRAO); West Virginia University; National Radio Astronomy Observatory (NRAO); National Research Council Canada; Radboud University Nijmegen; Case Western Reserve University	Hessels, JWT (corresponding author), Netherlands Inst Radio Astron, ASTRON, Postbus 2, NL-7990 AA Dwingeloo, Netherlands.; Hessels, JWT (corresponding author), Univ Amsterdam, Anton Pannekoek Inst Astron, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.	J.W.T.Hessels@uva.nl	Gajjar, Vishal/AAK-4813-2021; Sobey, Charlotte/AAN-6948-2020; Hessels, Jason/GTO-3261-2022; Bower, Geoffrey/ABC-8386-2020; Gourdji, Kelly/T-3060-2017; Chatterjee, Shami/AAE-8374-2022; Law, Casey/AAW-3133-2021	Gajjar, Vishal/0000-0002-8604-106X; Sobey, Charlotte/0000-0002-8950-7873; Hessels, Jason/0000-0003-2317-1446; Bower, Geoffrey/0000-0003-4056-9982; Gourdji, Kelly/0000-0002-0152-1129; hellbourg, gregory/0000-0002-8191-3885; Brinkman, Casey/0000-0002-4480-310X; Marcote, Benito/0000-0001-9814-2354; McLaughlin, Maura/0000-0001-7697-7422; Wharton, Robert/0000-0002-7416-5209; Chatterjee, Shami/0000-0002-2878-1502; Ransom, Scott/0000-0001-5799-9714; Heald, George/0000-0002-2155-6054; Maddox, Natasha/0000-0001-8312-5260; Law, Casey/0000-0002-4119-9963; Spitler, Laura G/0000-0002-3775-8291; Archibald, Anne/0000-0003-0638-3340; Bogdanov, Slavko/0000-0002-9870-2742	National Science Foundation [AST-1100968]; Breakthrough Prize Foundation; European Research Council (ERC) under European Union's Seventh Framework Programme; ERC Starting Grant DRAGNET [337062]; ERC Starting Grant BEACON [279702]; Max Planck Society; NANOGrav Physics Frontiers Center (NSF) [1430284]; NSERC Discovery Grant; R. Howard Webster Foundation Fellowship from Canadian Institute for Advanced Research (CIFAR); FRQNT Centre de Recherche en Astrophysique du Quebec; NSF [1611606]; Spanish Ministerio de Economia y Competitividad (MINECO) of ICCUB (Unidad de Excelencia 'Maria de Maeztu') [AYA2016-76012-C3-1-P, MDM-2014-0369]; Division Of Astronomical Sciences [1611606] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Breakthrough Prize Foundation; European Research Council (ERC) under European Union's Seventh Framework Programme(European Research Council (ERC)); ERC Starting Grant DRAGNET; ERC Starting Grant BEACON; Max Planck Society(Max Planck SocietyFoundation CELLEX); NANOGrav Physics Frontiers Center (NSF)(National Science Foundation (NSF)); NSERC Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC)); R. Howard Webster Foundation Fellowship from Canadian Institute for Advanced Research (CIFAR); FRQNT Centre de Recherche en Astrophysique du Quebec; NSF(National Science Foundation (NSF)); Spanish Ministerio de Economia y Competitividad (MINECO) of ICCUB (Unidad de Excelencia 'Maria de Maeztu'); Division Of Astronomical Sciences(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	We thank the staff of the Arecibo Observatory and the Green Bank Observatory for their help with our observations. We also thank B. Adebahr, L. Connor, G. Desvignes, R. Eatough, R. Fender, M. Haverkorn, A. Karastergiou, R. Morganti, E. Petroff, F. Vieyro and J. Weisberg for suggestions and comments on the manuscript. The Arecibo Observatory is operated by SRI International under a cooperative agreement with the National Science Foundation (AST-1100968), and in alliance with Ana G. Mendez-Universidad Metropolitana and the Universities Space Research Association. The Green Bank Observatory is a facility of the National Science Foundation operated under cooperative agreement by Associated Universities, Inc. Breakthrough Listen (BL) is managed by the Breakthrough Initiatives, sponsored by the Breakthrough Prize Foundation (http://www.breakthroughinitiatives.org). The research leading to these results received funding from the European Research Council (ERC) under the European Union's Seventh Framework Programme (FP7/2007-2013). J.W.T.H. is a Netherlands Organisation for Scientific Research (NWO) Vidi Fellow and, together with D.M., K.G. and C.G.B., acknowledges funding for this work from ERC Starting Grant DRAGNET under contract number 337062. L.G.S. acknowledges financial support from the ERC Starting Grant BEACON under contract number 279702, as well as the Max Planck Society. A.M.A. is an NWO Veni Fellow. S.C., J.M.C., P.D., T.J.W.L., M. A. M. and S.M.R. are partially supported by the NANOGrav Physics Frontiers Center (NSF award 1430284). V.M.K. holds the Lorne Trottier Chair in Astrophysics & Cosmology and a Canada Research Chair and receives support from an NSERC Discovery Grant and Herzberg Prize, from an R. Howard Webster Foundation Fellowship from the Canadian Institute for Advanced Research (CIFAR), and from the FRQNT Centre de Recherche en Astrophysique du Quebec. C.J.L. acknowledges support from NSF award 1611606. Part of this research was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with the National Aeronautics and Space Administration. B. M. acknowledges support from the Spanish Ministerio de Economia y Competitividad (MINECO) under grants AYA2016-76012-C3-1-P and MDM-2014-0369 of ICCUB (Unidad de Excelencia 'Maria de Maeztu'). S.M.R. is a CIFAR Senior Fellow. P.S. holds a Covington Fellowship at DRAO.	Akahori T, 2016, ASTROPHYS J, V824, DOI 10.3847/0004-637X/824/2/105; Anderson CS, 2015, ASTROPHYS J, V815, DOI 10.1088/0004-637X/815/1/49; Anderson C. S., 2016, ASTROPHYS J, V820, P144; Barsdell BR, 2012, MON NOT R ASTRON SOC, V422, P379, DOI 10.1111/j.1365-2966.2012.20622.x; Bassa CG, 2017, ASTROPHYS J LETT, V843, DOI 10.3847/2041-8213/aa7a0c; Bower GC, 2003, ASTROPHYS J, V588, P331, DOI 10.1086/373989; Brentjens MA, 2005, ASTRON ASTROPHYS, V441, P1217, DOI 10.1051/0004-6361:20052990; Chatterjee S, 2017, NATURE, V541, P58, DOI 10.1038/nature20797; Cordes JM, 2017, ASTROPHYS J, V842, DOI 10.3847/1538-4357/aa74da; Cordes J. M., 2016, RADIO WAVE PROPAGATI; Cordes J. M., 2002, NE2001 NEW MODEL GAL; DAVIDSON K, 1985, ANNU REV ASTRON ASTR, V23, P119; Eatough RP, 2013, NATURE, V501, P391, DOI 10.1038/nature12499; Frail DA, 1999, NATURE, V398, P127, DOI 10.1038/18163; Gaensler BM, 2005, NATURE, V434, P1104, DOI 10.1038/nature03498; Gajjar V., 2017, ASTRON TELEGR, V10675; Harvey-Smith L, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/2/83; Harvey-Smith L, 2010, ASTROPHYS J, V712, P1157, DOI 10.1088/0004-637X/712/2/1157; Haverkorn M, 2015, ASTROPHYS SPACE SC L, V407, P483, DOI 10.1007/978-3-662-44625-6_17; Heald G, 2009, ASTRON ASTROPHYS, V503, P409, DOI 10.1051/0004-6361/200912240; Hester JJ, 2008, ANNU REV ASTRON ASTR, V46, P127, DOI 10.1146/annurev.astro.45.051806.110608; Hunt LK, 2009, ASTRON ASTROPHYS, V507, P1327, DOI 10.1051/0004-6361/200912020; Kashiyama K, 2017, ASTROPHYS J LETT, V839, DOI 10.3847/2041-8213/aa68e1; Lorimer DR, 2007, SCIENCE, V318, P777, DOI 10.1126/science.1147532; MacMahon D. H. E., 2017, PUBL ASTRON IN PRESS; Manchester RN, 2005, ASTRON J, V129, P1993, DOI 10.1086/428488; Marcote B, 2017, ASTROPHYS J LETT, V834, DOI 10.3847/2041-8213/834/2/L8; Marrone DP, 2007, ASTROPHYS J, V654, pL57, DOI 10.1086/510850; Masui K, 2015, NATURE, V528, P523, DOI 10.1038/nature15769; McCray R, 2016, ANNU REV ASTRON ASTR, V54, P19, DOI 10.1146/annurev-astro-082615-105405; MCKEE CF, 1995, PHYS REP, V256, P157, DOI 10.1016/0370-1573(94)00106-D; Metzger BD, 2017, ASTROPHYS J, V841, DOI 10.3847/1538-4357/aa633d; O'Sullivan SP, 2012, MON NOT R ASTRON SOC, V421, P3300, DOI 10.1111/j.1365-2966.2012.20554.x; Oppermann N, 2015, ASTRON ASTROPHYS, V575, DOI 10.1051/0004-6361/201423995; Orlando S, 2016, ASTROPHYS J, V822, DOI 10.3847/0004-637X/822/1/22; Pen UL, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/2/179; Petroff E, 2016, PUBL ASTRON SOC AUST, V33, DOI 10.1017/pasa.2016.35; Petroff E, 2015, MON NOT R ASTRON SOC, V454, P457, DOI 10.1093/mnras/stv1953; Petroff E, 2015, MON NOT R ASTRON SOC, V447, P246, DOI 10.1093/mnras/stu2419; Piro AL, 2016, ASTROPHYS J LETT, V824, DOI 10.3847/2041-8205/824/2/L32; Quataert E, 1999, ASTROPHYS J, V517, pL101, DOI 10.1086/312035; Ransom S. M., 2001, THESIS; Reines AE, 2015, ASTROPHYS J, V813, DOI 10.1088/0004-637X/813/2/82; Reynolds SP, 2017, SPACE SCI REV, V207, P175, DOI 10.1007/s11214-017-0356-6; Scholz P, 2017, ASTROPHYS J, V846, DOI 10.3847/1538-4357/aa8456; Scholz P, 2016, ASTROPHYS J, V833, DOI 10.3847/1538-4357/833/2/177; Shannon RM, 2013, MON NOT R ASTRON SOC, V435, pL29, DOI 10.1093/mnrasl/slt088; Sicheneder E, 2017, MON NOT R ASTRON SOC, V467, P3642, DOI 10.1093/mnras/stx103; Spitler LG, 2016, NATURE, V531, P202, DOI 10.1038/nature17168; Spitler LG, 2014, ASTROPHYS J, V790, DOI 10.1088/0004-637X/790/2/101; Tendulkar SP, 2017, ASTROPHYS J LETT, V834, DOI 10.3847/2041-8213/834/2/L7; Thornton D, 2013, SCIENCE, V341, P53, DOI 10.1126/science.1236789; van Straten W, 2011, PUBL ASTRON SOC AUST, V28, P1, DOI 10.1071/AS10021; van Straten W., 2012, AR T, V9, P237; Vieyro FL, 2017, ASTRON ASTROPHYS, V602, DOI 10.1051/0004-6361/201730556; Zhang B, 2017, ASTROPHYS J LETT, V836, DOI 10.3847/2041-8213/aa5ded	56	255	257	0	32	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 11	2018	553	7687					182	+		10.1038/nature25149	http://dx.doi.org/10.1038/nature25149			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4WL	29323297	Green Submitted, Green Published			2022-12-28	WOS:000419794800031
J	Schnaitmann, C; Haikala, V; Abraham, E; Oberhauser, V; Thestrup, T; Griesbeck, O; Reiff, DF				Schnaitmann, Christopher; Haikala, Vaeinoe; Abraham, Eva; Oberhauser, Vitus; Thestrup, Thomas; Griesbeck, Oliver; Reiff, Dierk F.			Color Processing in the Early Visual System of Drosophila	CELL			English	Article							PIERIS-RAPAE-CRUCIVORA; PHYSIOLOGICAL CHARACTERIZATION; PHOTORECEPTOR SYNAPSE; SPECTRAL SENSITIVITY; BUTTERFLY PAPILIO; COMPOUND EYES; CELL-TYPES; RETINA; VISION; EXPRESSION	Color vision extracts spectral information by comparing signals from photoreceptors with different visual pigments. Such comparisons are encoded by color-opponent neurons that are excited at one wavelength and inhibited at another. Here, we examine the circuit implementation of color-opponent processing in the Drosophila visual system by combining two-photon calcium imaging with genetic dissection of visual circuits. We report that coloropponent processing of UVshort/blue and UVlong/green is already implemented in R7/R8 inner photoreceptor terminals of "pale'' and "yellow'' ommatidia, respectively. R7 and R8 photoreceptors of the same type of ommatidia mutually inhibit each other directly via HisCl1 histamine receptors and receive additional feedback inhibition that requires the second histamine receptor Ort. Color-opponent processing at the first visual synapse represents an unexpected commonality between Drosophila and vertebrates; however, the differences in the molecular and cellular implementation suggest that the same principles evolved independently.	[Schnaitmann, Christopher; Haikala, Vaeinoe; Abraham, Eva; Oberhauser, Vitus; Reiff, Dierk F.] Albert Ludwigs Univ Freiburg, Dept Anim Physiol & Neurobiol, Inst Biol 1, D-79104 Freiburg, Germany; [Thestrup, Thomas; Griesbeck, Oliver] Max Planck Inst Neurobiol, Tools Bioimaging, D-82152 Martinsried, Germany	University of Freiburg; Max Planck Society	Reiff, DF (corresponding author), Albert Ludwigs Univ Freiburg, Dept Anim Physiol & Neurobiol, Inst Biol 1, D-79104 Freiburg, Germany.	dierk.reiff@biologie.uni-freiburg.de		Griesbeck, Oliver/0000-0001-5883-5594; Schnaitmann, Christopher/0000-0001-7715-9333	German Research Foundation [DFG - INST 39/902-1, 91b GG]; state of Baden-Wurttemberg	German Research Foundation(German Research Foundation (DFG)); state of Baden-Wurttemberg	We thank B. Ziser, K. Eschbach, L. Gladis, and A. Laurenco for excellent technical assistance; the mechanics workshop of the Institute of Biology I, especially H. Noeske; and the Life Imaging Center Freiburg (LIC), especially R. Nitschke. We thank C. Desplan, R. Hardie, and H. Bellen for fly stocks and C.-H. Lee for fly stocks and DNA. We are grateful to R. Menzel, M. Heisenberg, R. Friedrich, and A. Straw for comments on an early version and to M. Dickinson for his thorough comments on the final manuscript. This work was supported by a grant for major instrumentation (91b GG to D.F.R.) funded by the German Research Foundation (DFG - INST 39/902-1) and the state of Baden-Wurttemberg.	ABRAMOV I, 1994, ANNU REV PSYCHOL, V45, P451, DOI 10.1146/annurev.ps.45.020194.002315; Arikawa K, 2005, J NEUROSCI, V25, P5935, DOI 10.1523/JNEUROSCI.1364-05.2005; Ascoli GA, 2007, J NEUROSCI, V27, P9247, DOI 10.1523/JNEUROSCI.2055-07.2007; Behnia R, 2015, CURR OPIN NEUROBIOL, V34, P125, DOI 10.1016/j.conb.2015.03.010; Chapot CA, 2017, J PHYSIOL-LONDON, V595, P5495, DOI 10.1113/JP274177; Chen PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062240; Clarke SE, 2015, NAT REV NEUROSCI, V16, P733, DOI 10.1038/nrn4037; Dacey DM, 2003, CURR OPIN NEUROBIOL, V13, P421, DOI 10.1016/S0959-4388(03)00103-X; Demb JB, 2015, ANNU REV VIS SCI, V1, P263, DOI 10.1146/annurev-vision-082114-035334; Gao SY, 2008, NEURON, V60, P328, DOI 10.1016/j.neuron.2008.08.010; Gegenfurtner KR, 2003, ANNU REV NEUROSCI, V26, P181, DOI 10.1146/annurev.neuro.26.041002.131116; Gordon MD, 2009, NEURON, V61, P373, DOI 10.1016/j.neuron.2008.12.033; HARDIE RC, 1989, NATURE, V339, P704, DOI 10.1038/339704a0; HARDIE RC, 1984, J COMP PHYSIOL, V154, P157, DOI 10.1007/BF00604981; HARDIE RC, 1977, Z NATURFORSCH C, V32, P887; Hardie RC, 2015, CURR OPIN NEUROBIOL, V34, P37, DOI 10.1016/j.conb.2015.01.008; HEISENBERG M, 1977, J COMP PHYSIOL, V117, P127, DOI 10.1007/BF00612784; HORRIDGE GA, 1983, J COMP PHYSIOL, V150, P271, DOI 10.1007/BF00605018; Jagadish S, 2014, NEURON, V83, P630, DOI 10.1016/j.neuron.2014.06.025; Jones PL, 2017, ANNU REV ENTOMOL, V62, P53, DOI 10.1146/annurev-ento-031616-034903; Karuppudurai T, 2014, NEURON, V81, P603, DOI 10.1016/j.neuron.2013.12.010; Kelber A, 2003, BIOL REV, V78, P81, DOI 10.1017/S1464793102005985; Kelber A, 2016, CURR OPIN NEUROBIOL, V41, P106, DOI 10.1016/j.conb.2016.09.007; KIEN J, 1977, J COMP PHYSIOL, V113, P35, DOI 10.1007/BF00610452; Mank M, 2006, BIOPHYS J, V90, P1790, DOI 10.1529/biophysj.105.073536; Markstein M, 2008, NAT GENET, V40, P476, DOI 10.1038/ng.101; MATIC T, 1983, J COMP PHYSIOL, V152, P169, DOI 10.1007/BF00611182; Melnattur KV, 2014, J NEUROGENET, V28, P374, DOI 10.3109/01677063.2014.891590; MENZEL R, 1986, J COMP PHYSIOL A, V158, P165, DOI 10.1007/BF01338560; Oh Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068269; Olsen SR, 2008, NATURE, V452, P956, DOI 10.1038/nature06864; Pantazis A, 2008, J NEUROSCI, V28, P7250, DOI 10.1523/JNEUROSCI.1654-08.2008; Paulk AC, 2009, J COMP NEUROL, V513, P441, DOI 10.1002/cne.21993; PEITSCH D, 1992, J COMP PHYSIOL A, V170, P23, DOI 10.1007/BF00190398; Pfeiffer BD, 2010, GENETICS, V186, P735, DOI 10.1534/genetics.110.119917; Qiu X, 2003, J COMP PHYSIOL A, V189, P81, DOI 10.1007/s00359-002-0380-0; Reiff DF, 2010, NAT NEUROSCI, V13, P973, DOI 10.1038/nn.2595; Rushton WA, 1972, J PHYSL, V220, p1P; Salcedo E, 1999, J NEUROSCI, V19, P10716, DOI 10.1523/JNEUROSCI.19-24-10716.1999; Sarov M, 2016, ELIFE, V5, DOI 10.7554/eLife.12068; Schmeling F, 2014, J EXP BIOL, V217, P3557, DOI 10.1242/jeb.108514; Schnaitmann C, 2013, CURR BIOL, V23, P2375, DOI 10.1016/j.cub.2013.10.037; Skorupski P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012049; SMOLA U, 1979, J COMP PHYSIOL, V133, P41, DOI 10.1007/BF00663108; Takemura S, 2013, NATURE, V500, P175, DOI 10.1038/nature12450; Takemura SY, 2011, CURR BIOL, V21, P2077, DOI 10.1016/j.cub.2011.10.053; Tan LM, 2015, CELL, V163, P1756, DOI 10.1016/j.cell.2015.11.021; Thestrup T, 2014, NAT METHODS, V11, P175, DOI [10.1038/NMETH.2773, 10.1038/nmeth.2773]; TROJE N, 1993, Z NATURFORSCH C, V48, P96; Venken KJT, 2006, SCIENCE, V314, P1747, DOI 10.1126/science.1134426; Wardill TJ, 2012, SCIENCE, V336, P925, DOI 10.1126/science.1215317; Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497; Weir PT, 2016, J NEUROSCI, V36, P5397, DOI 10.1523/JNEUROSCI.0310-16.2016; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Witte I, 2002, J NEUROCHEM, V83, P504, DOI 10.1046/j.1471-4159.2002.01076.x; Yamaguchi S, 2008, P NATL ACAD SCI USA, V105, P4910, DOI 10.1073/pnas.0711484105; Yamaguchi S, 2010, P NATL ACAD SCI USA, V107, P5634, DOI 10.1073/pnas.0809398107	57	64	64	6	37	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					318	+		10.1016/j.cell.2017.12.018	http://dx.doi.org/10.1016/j.cell.2017.12.018			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29328919	Bronze, Green Published			2022-12-28	WOS:000419840100028
J	Song, WM; Colonna, M				Song, Wilbur M.; Colonna, Marco			Immune Training Unlocks Innate Potential	CELL			English	Editorial Material							MEMORY; CELLS; HUMANS	Trained immunity is a form of innate immune memory with distinct features from classical adaptive immune memory. In the current issues of Cell and Cell Host & Microbe, five studies from the International Trained Immunity Consortium shed light on mechanisms and functional consequences of this phenomenon on cellular and whole-organism levels.	[Song, Wilbur M.; Colonna, Marco] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	Washington University (WUSTL)	Colonna, M (corresponding author), Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA.	mcolonna@wustl.edu						Arts RJW, 2018, CELL HOST MICROBE, V23, P89, DOI 10.1016/j.chom.2017.12.010; Bekkering S, 2018, CELL, V172, P135, DOI 10.1016/j.cell.2017.11.025; Christ A, 2018, CELL, V172, P162, DOI 10.1016/j.cell.2017.12.013; Geary CD, 2017, SEMIN IMMUNOL, V31, P11, DOI 10.1016/j.smim.2017.08.012; Kaufmann E, 2018, CELL, V172, P176, DOI 10.1016/j.cell.2017.12.031; Laidlaw BJ, 2016, NAT REV IMMUNOL, V16, P102, DOI 10.1038/nri.2015.10; Mitroulis I, 2018, CELL, V172, P147, DOI 10.1016/j.cell.2017.11.034; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Weisel F, 2017, ANNU REV IMMUNOL, V35, P255, DOI 10.1146/annurev-immunol-041015-055531	9	22	22	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					3	5		10.1016/j.cell.2017.12.034	http://dx.doi.org/10.1016/j.cell.2017.12.034			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29328917	Bronze			2022-12-28	WOS:000419840100002
J	Zhou, HY; Peng, C; Yoon, Y; Hsu, CW; Nelson, KA; Fu, L; Joannopoulos, JD; Soljacic, M; Zhen, B				Zhou, Hengyun; Peng, Chao; Yoon, Yoseob; Hsu, Chia Wei; Nelson, Keith A.; Fu, Liang; Joannopoulos, John D.; Soljacic, Marin; Zhen, Bo			Observation of bulk Fermi arc and polarization half charge from paired exceptional points	SCIENCE			English	Article							PHOTONICS; SYMMETRY; LASERS	The ideas of topology have found tremendous success in closed physical systems, but even richer properties exist in the more general open or dissipative framework. We theoretically propose and experimentally demonstrate a bulk Fermi arc that develops from non-Hermitian radiative losses in an open system of photonic crystal slabs. Moreover, we discover half-integer topological charges in the polarization of far-field radiation around the bulk Fermi arc. Both phenomena are shown to be direct consequences of the non-Hermitian topological properties of exceptional points, where resonances coincide in their frequencies and linewidths. Our work connects the fields of topological photonics, non-Hermitian physics, and singular optics, providing a framework to explore more complex non-Hermitian topological systems.	[Zhou, Hengyun; Peng, Chao; Fu, Liang; Joannopoulos, John D.; Soljacic, Marin] MIT, Dept Phys, Cambridge, MA 02139 USA; [Peng, Chao] Peking Univ, Dept Elect, State Key Lab Adv Opt Commun Syst & Networks, Beijing 100871, Peoples R China; [Yoon, Yoseob; Nelson, Keith A.] MIT, Dept Chem, Cambridge, MA 02139 USA; [Hsu, Chia Wei] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA; [Zhen, Bo] Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA; [Zhou, Hengyun] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Massachusetts Institute of Technology (MIT); Peking University; Massachusetts Institute of Technology (MIT); Yale University; University of Pennsylvania; Harvard University	Zhen, B (corresponding author), Univ Penn, Dept Phys & Astron, Philadelphia, PA 19104 USA.	bozhen@sas.upenn.edu	Soljacic, Marin/AAA-4868-2019; Yoon, Yoseob/D-5400-2013; Hsu, Chia Wei (Wade)/G-5486-2011; Joannopoulos, John D/E-6401-2013	Yoon, Yoseob/0000-0002-8832-897X; Hsu, Chia Wei (Wade)/0000-0002-9609-7155; 	Army Research Office through the Institute for Soldier Nanotechnologies [W911NF-13-D-0001]; S3TEC, an Energy Frontier Research Center - U.S. Department of Energy [DE-SC0001299]; Air Force Research Lab [FA8650-16-D-5403]; Undergraduate Research Opportunities Program at Massachusetts Institute of Technology; Air Force Office of Scientific Research Young Investigator Program [FA9550-18-1-0133]; National Natural Science Foundation of China [61575002, 61320106001]; China Scholarship Council; National Science Foundation [NSF DMR-1307632]; Skoltech, Skoltech Next Generation Program	Army Research Office through the Institute for Soldier Nanotechnologies; S3TEC, an Energy Frontier Research Center - U.S. Department of Energy(United States Department of Energy (DOE)); Air Force Research Lab(United States Department of DefenseUS Air Force Research Laboratory); Undergraduate Research Opportunities Program at Massachusetts Institute of Technology; Air Force Office of Scientific Research Young Investigator Program(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council); National Science Foundation(National Science Foundation (NSF)); Skoltech, Skoltech Next Generation Program	We thank T. Savas for fabrication of the samples. We also thank S. Johnson, E. Mele, L. Lu, Y. Shen, S. Skirlo, S. Liu, J. Y. Lee, F. Machado, N. Rivera, G. Zhang, and S. Moore for helpful discussions. Research was supported in part by the Army Research Office through the Institute for Soldier Nanotechnologies under contract no. W911NF-13-D-0001 [photon management for developing nuclear-thermophotovoltaic (TPV) and fuel-TPV mm-scale systems]. Research was also supported as part of the S3TEC, an Energy Frontier Research Center funded by the U.S. Department of Energy under grant no. DE-SC0001299 (for fundamental photon transport related to solar TPVs and solar thermoelectrics), and by the Air Force Research Lab under contract FA8650-16-D-5403. H.Z. acknowledges support from the Undergraduate Research Opportunities Program at Massachusetts Institute of Technology. B.Z. acknowledges the Air Force Office of Scientific Research Young Investigator Program under award number FA9550-18-1-0133. C.P. acknowledges support from the National Natural Science Foundation of China under grant nos. 61575002 and 61320106001, and the China Scholarship Council. C.W.H. acknowledges support from the National Science Foundation under grant NSF DMR-1307632. Y. Y. and K.A.N. were supported in part by Skoltech as part of the Skoltech Next Generation Program. H.Z. and B.Z. conceived the idea. H.Z. performed the analytical calculations and numerical simulations. H.Z., B.Z., C.P., and Y. Y. conducted the experiments and analyzed the data. H.Z. and B.Z. wrote the manuscript, with input from all authors. B.Z., M.S., and J.D.J. supervised the research. All authors contributed to the analysis and discussion of the results. All data needed to evaluate the conclusions are present in the paper and/or the supplementary materials. Additional data related to this paper may be requested from the authors.	Armitage NP, 2018, REV MOD PHYS, V90, DOI 10.1103/RevModPhys.90.015001; Bauer T, 2015, SCIENCE, V347, P964, DOI 10.1126/science.1260635; Bender CM, 1998, PHYS REV LETT, V80, P5243, DOI 10.1103/PhysRevLett.80.5243; Berry MV, 2003, P ROY SOC A-MATH PHY, V459, P1261, DOI 10.1098/rspa.2003.1155; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Chen WJ, 2017, NATURE, V548, P192, DOI 10.1038/nature23281; Chong YD, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.235125; Dembowski C, 2001, PHYS REV LETT, V86, P787, DOI 10.1103/PhysRevLett.86.787; Doppler J, 2016, NATURE, V537, P76, DOI 10.1038/nature18605; Feng L, 2014, SCIENCE, V346, P972, DOI 10.1126/science.1258479; Fu L., 2017, ARXIV170805841; Hasan MZ, 2010, REV MOD PHYS, V82, P3045, DOI 10.1103/RevModPhys.82.3045; Heiss WD, 2012, J PHYS A-MATH THEOR, V45, DOI 10.1088/1751-8113/45/44/444016; Hodaei H, 2017, NATURE, V548, P187, DOI 10.1038/nature23280; Hodaei H, 2014, SCIENCE, V346, P975, DOI 10.1126/science.1258480; Kirillov ON, 2005, J PHYS A-MATH GEN, V38, P5531, DOI 10.1088/0305-4470/38/24/007; Leykam D, 2017, PHYS REV LETT, V118, DOI 10.1103/PhysRevLett.118.040401; Lin Z, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.213901; Lu L, 2014, NAT PHOTONICS, V8, P821, DOI [10.1038/nphoton.2014.248, 10.1038/NPHOTON.2014.248]; Miyai E, 2006, NATURE, V441, P946, DOI 10.1038/441946a; Moiseyev N., 2011, NONHERMITIAN QUANTUM; Qi XL, 2011, REV MOD PHYS, V83, DOI 10.1103/RevModPhys.83.1057; Regan EC, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601591; Shen H, 2017, ARXIV170607435; Shi L, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3524520; Xu H, 2016, NATURE, V537, P80, DOI 10.1038/nature18604; Zhen B, 2015, NATURE, V525, P354, DOI 10.1038/nature14889; Zhen B, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.257401; Zhou HX, 2016, THESIS	29	315	317	26	143	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 2	2018	359	6379					1009	1012		10.1126/science.aap9859	http://dx.doi.org/10.1126/science.aap9859			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX8SV	29326118	Green Submitted, Green Published			2022-12-28	WOS:000426366200036
J	Bakhoum, SF; Ngo, B; Laughney, AM; Cavallo, JA; Murphy, CJ; Ly, P; Shah, P; Sriram, RK; Watkins, TBK; Taunk, NK; Duran, M; Pauli, C; Shaw, C; Chadalavada, K; Rajasekhar, VK; Genovese, G; Venkatesan, S; Birkbak, NJ; McGranahan, N; Lundquist, M; LaPlant, Q; Healey, JH; Elemento, O; Chung, CH; Lee, NY; Imielenski, M; Nanjangud, G; Pe'er, D; Cleveland, DW; Powell, SN; Lammerding, J; Swanton, C; Cantley, LC				Bakhoum, Samuel F.; Ngo, Bryan; Laughney, Ashley M.; Cavallo, Julie-Ann; Murphy, Charles J.; Ly, Peter; Shah, Pragya; Sriram, Roshan K.; Watkins, Thomas B. K.; Taunk, Neil K.; Duran, Mercedes; Pauli, Chantal; Shaw, Christine; Chadalavada, Kalyani; Rajasekhar, Vinagolu K.; Genovese, Giulio; Venkatesan, Subramanian; Birkbak, Nicolai J.; McGranahan, Nicholas; Lundquist, Mark; LaPlant, Quincey; Healey, John H.; Elemento, Olivier; Chung, Christine H.; Lee, Nancy Y.; Imielenski, Marcin; Nanjangud, Gouri; Pe'er, Dana; Cleveland, Don W.; Powell, Simon N.; Lammerding, Jan; Swanton, Charles; Cantley, Lewis C.			Chromosomal instability drives metastasis through a cytosolic DNA response	NATURE			English	Article							BREAST-CANCER; ANEUPLOIDY; CELLS; SENSITIVITY; PROGNOSIS; EVOLUTION; CGAS; TOOL	Chromosomal instability is a hallmark of cancer that results from ongoing errors in chromosome segregation during mitosis. Although chromosomal instability is a major driver of tumour evolution, its role in metastasis has not been established. Here we show that chromosomal instability promotes metastasis by sustaining a tumour cell-autonomous response to cytosolic DNA. Errors in chromosome segregation create a preponderance of micronuclei whose rupture spills genomic DNA into the cytosol. This leads to the activation of the cGAS-STING (cyclic GMP-AMP synthase-stimulator of interferon genes) cytosolic DNA-sensing pathway and downstream noncanonical NF-kappa B signalling. Genetic suppression of chromosomal instability markedly delays metastasis even in highly aneuploid tumour models, whereas continuous chromosome segregation errors promote cellular invasion and metastasis in a STING-dependent manner. By subverting lethal epithelial responses to cytosolic DNA, chromosomally unstable tumour cells co-opt chronic activation of innate immune pathways to spread to distant organs.	[Bakhoum, Samuel F.; Cavallo, Julie-Ann; Taunk, Neil K.; Duran, Mercedes; LaPlant, Quincey; Lee, Nancy Y.; Powell, Simon N.] Mem Sloan Kettering Canc Ctr, Dept Radiat Oncol, New York, NY 10065 USA; [Bakhoum, Samuel F.; Ngo, Bryan; Cavallo, Julie-Ann; Murphy, Charles J.; Sriram, Roshan K.; Duran, Mercedes; Lundquist, Mark; Elemento, Olivier; Imielenski, Marcin; Cantley, Lewis C.] Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA; [Laughney, Ashley M.] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Ly, Peter; Cleveland, Don W.] Univ Calif San Diego, Ludwig Inst Canc Res, La Jolla, CA 92093 USA; [Shah, Pragya; Lammerding, Jan] Cornell Univ, Nancy E & Peter C Meinig Sch Biomed Engn, Ithaca, NY 14850 USA; [Shah, Pragya; Lammerding, Jan] Cornell Univ, Weill Inst Cell & Mol Biol, Ithaca, NY 14850 USA; [Watkins, Thomas B. K.; Birkbak, Nicolai J.; McGranahan, Nicholas; Swanton, Charles] Francis Crick Inst, London NW1 1AT, England; [Pauli, Chantal] Univ Hosp Zurich, Inst Pathol & Mol Pathol, CH-8091 Zurich, Switzerland; [Shaw, Christine; Chadalavada, Kalyani; Nanjangud, Gouri] Mem Sloan Kettering Canc Ctr, Mol Cytogenet Core, New York, NY 10065 USA; [Rajasekhar, Vinagolu K.; Healey, John H.] Mem Sloan Kettering Canc Ctr, Dept Surg, New York, NY 10065 USA; [Genovese, Giulio] Broad Inst Harvard & MIT, Cambridge, MA 02142 USA; [Venkatesan, Subramanian; Birkbak, Nicolai J.; McGranahan, Nicholas; Swanton, Charles] UCL Canc Inst, London WC1E 6BT, England; [Chung, Christine H.] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA; [Pe'er, Dana] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; Ludwig Institute for Cancer Research; University of California System; University of California San Diego; Cornell University; Cornell University; Francis Crick Institute; University of Zurich; University Zurich Hospital; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of London; University College London; H Lee Moffitt Cancer Center & Research Institute; Memorial Sloan Kettering Cancer Center	Cantley, LC (corresponding author), Weill Cornell Med, Sandra & Edward Meyer Canc Ctr, New York, NY 10065 USA.	lcantley@med.cornell.edu	durán, mercedes/H-9240-2015; Lammerding, Jan/A-9498-2016; McGranahan, Nicholas/ABD-6561-2021; Cleveland, Don/AAN-9783-2021	Lammerding, Jan/0000-0003-4335-8611; McGranahan, Nicholas/0000-0001-9537-4045; Swanton, Charles/0000-0002-4299-3018; Laughney, Ashley/0000-0001-9435-953X; Birkbak, Nicolai/0000-0003-1613-9587; Cleveland, Don/0000-0002-1934-3682; Healey, John/0000-0002-0802-1186; Vinagolu, Rajasekhar/0000-0002-7364-2675; Pauli, Chantal/0000-0001-9621-8511; Ngo, Bryan/0000-0002-7733-2658; Pe'er, Dana/0000-0002-9259-8817; Ly, Peter/0000-0001-8946-7069	DoD Breast Cancer Research Breakthrough Award (BCRBA) [W81XWH-16-1-0315]; Elsa Pardee Foundation; MSKCC Cytogenetics Core [P30-CA008748]; NSF Graduate Research Fellowship [DGE1257284]; NIH [R01-HL082792, U54-CA210184, R35-CA197588]; DoD BCRBA [BC150580, W81XWH-16-1-0316]; NSF [CBET-1254846]; NCI [K99-CA218871]; Breast Cancer Research Foundation; Gray Foundation Basser Initiative; MRC [G0701935, MR/P014712/1] Funding Source: UKRI; Cancer Research UK [19310, 17786, 20466] Funding Source: researchfish; Medical Research Council [G0701935, MR/P014712/1] Funding Source: researchfish; Rosetrees Trust [M445, M391, M640, M231-CD1, M179] Funding Source: researchfish; The Francis Crick Institute [C28575/A25223, C60895/A23896, 10169, 10170, 10172, VEG 108844, A1278, 10467, 10485, 10359] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [K99CA218871, R01CA187069, U54CA210184, R35CA197588, P30CA008748, R01CA169306] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM122476] Funding Source: NIH RePORTER	DoD Breast Cancer Research Breakthrough Award (BCRBA)(United States Department of Defense); Elsa Pardee Foundation; MSKCC Cytogenetics Core; NSF Graduate Research Fellowship(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD BCRBA; NSF(National Science Foundation (NSF)); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breast Cancer Research Foundation; Gray Foundation Basser Initiative; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Rosetrees Trust(Rosetrees Trust); The Francis Crick Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Massague, R. Benezra, X. Cai, J. Leeman, M. Bakhoum, B. Hopkins and D. Landau for feedback. Grant support: S.F.B. ( DoD Breast Cancer Research Breakthrough Award ( BCRBA) W81XWH-16-1-0315, Elsa Pardee Foundation, MSKCC Cytogenetics Core ( P30-CA008748) and Core ( P30-CA008748) grants); B.N. ( NSF Graduate Research Fellowship DGE1257284); J.L. ( NIH R01-HL082792, U54-CA210184, DoD BCRBA BC150580, NSF CBET-1254846); P.L. ( NCI K99-CA218871); G.G. ( DoD BCRBA W81XWH-16-1-0316); L.C.C. ( NIH R35-CA197588, U54-CA210184, Breast Cancer Research Foundation, Gray Foundation Basser Initiative).	Abe T, 2014, J VIROL, V88, P5328, DOI 10.1128/JVI.00037-14; Ahn J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4723; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bakhoum SF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6990; Bakhoum SF, 2014, CURR BIOL, V24, pR148, DOI 10.1016/j.cub.2014.01.019; Bakhoum SF, 2011, CLIN CANCER RES, V17, P7704, DOI 10.1158/1078-0432.CCR-11-2049; Bakhoum SF, 2009, NAT CELL BIOL, V11, P27, DOI 10.1038/ncb1809; Brastianos PK, 2015, CANCER DISCOV, V5, P1164, DOI 10.1158/2159-8290.CD-15-0369; Burrell RA, 2013, NATURE, V494, P492, DOI 10.1038/nature11935; Chen Q, 2016, NATURE, V533, P493, DOI 10.1038/nature18268; Chung CH, 2004, CANCER CELL, V5, P489, DOI 10.1016/S1535-6108(04)00112-6; Cimini D, 2001, J CELL BIOL, V153, P517, DOI 10.1083/jcb.153.3.517; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; Davidson PM, 2014, CELL MOL BIOENG, V7, P293, DOI 10.1007/s12195-014-0342-y; De Preter K, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn114; Denais CM, 2016, SCIENCE, V352, P353, DOI 10.1126/science.aad7297; Di Tommaso P, 2017, NAT BIOTECHNOL, V35, P316, DOI 10.1038/nbt.3820; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; Ems-McClung SC, 2010, SEMIN CELL DEV BIOL, V21, P276, DOI 10.1016/j.semcdb.2010.01.016; Gu ZG, 2014, BIOINFORMATICS, V30, P2811, DOI 10.1093/bioinformatics/btu393; Gulen MF, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00573-w; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Harding SM, 2017, NATURE, V548, P466, DOI 10.1038/nature23470; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Hatzis C, 2011, JAMA-J AM MED ASSOC, V305, P1873, DOI 10.1001/jama.2011.593; Jamal-Hanjani M, 2017, NEW ENGL J MED, V376, P2109, DOI 10.1056/NEJMoa1616288; Kis-Toth K, 2011, J IMMUNOL, V187, P1222, DOI 10.4049/jimmunol.1100469; Lan YY, 2014, CELL REP, V9, P180, DOI 10.1016/j.celrep.2014.08.074; Lau L, 2015, SCIENCE, V350, P568, DOI 10.1126/science.aab3291; Levine JH, 2015, CELL, V162, P184, DOI 10.1016/j.cell.2015.05.047; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ly P, 2017, NAT CELL BIOL, V19, P68, DOI 10.1038/ncb3450; Mackenzie KJ, 2017, NATURE, V548, P461, DOI 10.1038/nature23449; McGranahan N, 2016, SCIENCE, V351, P1463, DOI 10.1126/science.aaf1490; Mitelman F., 2017, MITELMAN DATABASE OF; Moore AT, 2005, J CELL BIOL, V169, P391, DOI 10.1083/jcb.200411089; Robinson DR, 2017, NATURE, V548, P297, DOI 10.1038/nature23306; Rowald K, 2016, CELL REP, V15, P2679, DOI 10.1016/j.celrep.2016.05.048; Sheltzer JM, 2017, CANCER CELL, V31, P240, DOI 10.1016/j.ccell.2016.12.004; Sheltzer JM, 2013, CANCER RES, V73, P6401, DOI 10.1158/0008-5472.CAN-13-0749; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Stetson DB, 2008, CELL, V134, P587, DOI 10.1016/j.cell.2008.06.032; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Sun SC, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.3123pe18; Thompson SL, 2008, J CELL BIOL, V180, P665, DOI 10.1083/jcb.200712029; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Turajlic S, 2016, SCIENCE, V352, P169, DOI 10.1126/science.aaf2784; van Dijk D., 2017, BIORXIV, P111591; Wang J, 2016, INT J ONCOL, V49, P381, DOI 10.3892/ijo.2016.3500; Wang XB, 2007, NAT CELL BIOL, V9, P470, DOI 10.1038/ncb1559; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Yang C, 2013, CANCER DISCOV, V3, P212, DOI 10.1158/2159-8290.CD-12-0271; Yang H, 2017, P NATL ACAD SCI USA, V114, pE4612, DOI 10.1073/pnas.1705499114; Zaki BI, 2014, CANCER-AM CANCER SOC, V120, P1733, DOI 10.1002/cncr.28656; Zheng GXY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14049	59	595	617	8	184	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 25	2018	553	7689					467	+		10.1038/nature25432	http://dx.doi.org/10.1038/nature25432			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GA1CA	29342134	Green Accepted, Green Submitted			2022-12-28	WOS:000428051800001
J	Yan, X; Shi, QY; Bracher, A; Milicic, G; Singh, AK; Hartl, FU; Hayer-Hartl, M				Yan, Xiao; Shi, Qiaoyun; Bracher, Andreas; Milicic, Goran; Singh, Amit K.; Hartl, F. Ulrich; Hayer-Hartl, Manajit			GroEL Ring Separation and Exchange in the Chaperonin Reaction	CELL			English	Article							FOLDING FUNCTIONAL FORM; CRYSTAL-STRUCTURE; ATP HYDROLYSIS; REACTION CYCLE; IN-VIVO; POLYPEPTIDE BINDING; ESCHERICHIA-COLI; HEAT-SHOCK; NANO-CAGE; PROTEIN	The bacterial chaperonin GroEL and its cofactor, GroES, form a nano-cage for a single molecule of substrate protein (SP) to fold in isolation. GroEL and GroES undergo an ATP-regulated interaction cycle to close and open the folding cage. GroEL consists of two heptameric rings stacked back to back. Here, we show that GroEL undergoes transient ring separation, resulting in ring exchange between complexes. Ring separation occurs upon ATP-binding to the trans ring of the asymmetric GroEL:7ADP:GroES complex in the presence or absence of SP and is a consequence of inter-ring negative allostery. We find that a GroEL mutant unable to perform ring separation is folding active but populates symmetric GroEL: GroES(2) complexes, where both GroEL rings function simultaneously rather than sequentially. As a consequence, SP binding and release from the folding chamber is inefficient, and E. coli growth is impaired. We suggest that transient ring separation is an integral part of the chaperonin mechanism.	[Yan, Xiao; Shi, Qiaoyun; Bracher, Andreas; Milicic, Goran; Singh, Amit K.; Hartl, F. Ulrich; Hayer-Hartl, Manajit] Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany; [Shi, Qiaoyun] ShanghaiTech Univ, IHuman Inst, Shanghai 201210, Peoples R China	Max Planck Society; ShanghaiTech University	Hartl, FU; Hayer-Hartl, M (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de; mhartl@biochem.mpg.de	Hayer-Hartl, Manajit/V-8078-2017; Hartl, F. Ulrich/Y-8206-2019	Hayer-Hartl, Manajit/0000-0001-8213-6742; 	Minerva Foundation; Munich Center for Integrated Protein Science (CiPSM); Deutsche Forschungsgemeinschaft [SFB 1035]	Minerva Foundation; Munich Center for Integrated Protein Science (CiPSM); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank N. Wischnewski, R. Lange, A. Jungclaus, and A. Ries for technical help. The crystallization experiments were carried out by the MPIB crystallization facility. We are also grateful to A.J. Gupta, S. Haldar, D. Balchin, J.Y. Bhat, and H. Aigner for experimental help and productive discussions. X-ray diffraction data were collected at the European Synchrotron Radiation Facility (ESRF) in Grenoble, France. We thank the staff at the beamline MASSIF-1 for their support. We acknowledge funding by the Minerva Foundation, the Munich Center for Integrated Protein Science (CiPSM) and the Deutsche Forschungsgemeinschaft (SFB 1035).	Bowler MW, 2015, J SYNCHROTRON RADIAT, V22, P1540, DOI 10.1107/S1600577515016604; Burston SG, 1996, NATURE, V383, P96, DOI 10.1038/383096a0; Cabo-Bilbao A, 2006, J STRUCT BIOL, V155, P482, DOI 10.1016/j.jsb.2006.06.008; Chaudhry C, 2003, EMBO J, V22, P4877, DOI 10.1093/emboj/cdg477; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Danziger O, 2003, P NATL ACAD SCI USA, V100, P13797, DOI 10.1073/pnas.2333925100; Ellis RJ, 1996, FASEB J, V10, P20, DOI 10.1096/fasebj.10.1.8566542; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ewalt KL, 1997, CELL, V90, P491, DOI 10.1016/S0092-8674(00)80509-7; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; Fei X, 2014, P NATL ACAD SCI USA, V111, P12775, DOI 10.1073/pnas.1412922111; Fei X, 2013, P NATL ACAD SCI USA, V110, pE2958, DOI 10.1073/pnas.1311996110; FENTON WA, 1994, NATURE, V371, P614, DOI 10.1038/371614a0; Figueiredo L, 2004, J BIOL CHEM, V279, P1090, DOI 10.1074/jbc.M310914200; Genevaux P, 2004, EMBO REP, V5, P195, DOI 10.1038/sj.embor.7400067; Georgescauld F, 2014, CELL, V157, P922, DOI 10.1016/j.cell.2014.03.038; Gruber R, 2016, CHEM REV, V116, P6588, DOI 10.1021/acs.chemrev.5b00556; Gupta AJ, 2014, J MOL BIOL, V426, P2739, DOI 10.1016/j.jmb.2014.04.018; Haldar S, 2015, J MOL BIOL, V427, P2244, DOI 10.1016/j.jmb.2015.04.009; Hayer-Hartl M, 2016, TRENDS BIOCHEM SCI, V41, P62, DOI 10.1016/j.tibs.2015.07.009; HAYERHARTL MK, 1995, SCIENCE, V269, P836, DOI 10.1126/science.7638601; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Kerner MJ, 2005, CELL, V122, P209, DOI 10.1016/j.cell.2005.05.028; Koike-Takeshita A, 2008, J BIOL CHEM, V283, P23774, DOI 10.1074/jbc.M802542200; Koike-Takeshita A, 2014, J MOL BIOL, V426, P3634, DOI 10.1016/j.jmb.2014.08.017; Leichert LI, 2004, PLOS BIOL, V2, P1723, DOI 10.1371/journal.pbio.0020333; Levy-Rimler G, 2001, EUR J BIOCHEM, V268, P3465, DOI 10.1046/j.1432-1327.2001.02243.x; Llorca O, 1998, J BIOL CHEM, V273, P32587, DOI 10.1074/jbc.273.49.32587; Lopez T, 2015, J MOL BIOL, V427, P2919, DOI 10.1016/j.jmb.2015.04.013; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; Martin J, 1997, P NATL ACAD SCI USA, V94, P1107, DOI 10.1073/pnas.94.4.1107; Mayhew M, 1996, NATURE, V379, P420, DOI 10.1038/379420a0; Meyer AS, 2003, CELL, V113, P369, DOI 10.1016/S0092-8674(03)00307-6; Motojima F, 2000, BIOCHEM BIOPH RES CO, V267, P842, DOI 10.1006/bbrc.1999.2020; Motojima F, 2010, EMBO J, V29, P4008, DOI 10.1038/emboj.2010.262; Murai N, 1996, J BIOL CHEM, V271, P28229, DOI 10.1074/jbc.271.45.28229; Nisemblat S, 2015, P NATL ACAD SCI USA, V112, P6044, DOI 10.1073/pnas.1411718112; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poso D, 2004, J MOL BIOL, V338, P969, DOI 10.1016/j.jmb.2004.03.010; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Radaev S, 2002, J APPL CRYSTALLOGR, V35, P674, DOI 10.1107/S0021889802013973; Ranson NA, 2006, NAT STRUCT MOL BIOL, V13, P147, DOI 10.1038/nsmb1046; RANSON NA, 1995, J MOL BIOL, V250, P581, DOI 10.1006/jmbi.1995.0399; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Rye HS, 1999, CELL, V97, P325, DOI 10.1016/S0092-8674(00)80742-4; Rye HS, 1997, NATURE, V388, P792, DOI 10.1038/42047; Saibil HR, 2013, J MOL BIOL, V425, P1476, DOI 10.1016/j.jmb.2012.11.028; Sameshima T, 2008, J BIOL CHEM, V283, P23765, DOI 10.1074/jbc.M802541200; Sewell BT, 2004, NAT STRUCT MOL BIOL, V11, P1128, DOI 10.1038/nsmb844; Sharma S, 2008, CELL, V133, P142, DOI 10.1016/j.cell.2008.01.048; Shiseki K, 2001, J BIOL CHEM, V276, P11335, DOI 10.1074/jbc.M010348200; Sot B, 2002, J BIOL CHEM, V277, P34024, DOI 10.1074/jbc.M205733200; Taguchi H, 1997, J BIOL CHEM, V272, P18155, DOI 10.1074/jbc.272.29.18155; Taguchi H, 2015, J MOL BIOL, V427, P2912, DOI 10.1016/j.jmb.2015.04.007; Tang YC, 2008, EMBO J, V27, P1458, DOI 10.1038/emboj.2008.77; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Theillet FX, 2014, CHEM REV, V114, P6661, DOI 10.1021/cr400695p; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; Weber F, 2000, METH MOL B, V140, P117; WEISSMAN JS, 1994, CELL, V78, P693, DOI 10.1016/0092-8674(94)90533-9; White HE, 1997, NAT STRUCT BIOL, V4, P690, DOI 10.1038/nsb0997-690; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yang D, 2013, P NATL ACAD SCI USA, V110, pE4298, DOI 10.1073/pnas.1318862110; YBARRA J, 1995, J BIOL CHEM, V270, P22962, DOI 10.1074/jbc.270.39.22962; Ye X, 2013, P NATL ACAD SCI USA, V110, pE4289, DOI 10.1073/pnas.1317702110; YIFRACH O, 1995, BIOCHEMISTRY-US, V34, P5303, DOI 10.1021/bi00016a001; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	67	33	33	2	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2018	172	3					605	+		10.1016/j.cell.2017.12.010	http://dx.doi.org/10.1016/j.cell.2017.12.010			24	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FT9BS	29336887	Green Submitted, Bronze			2022-12-28	WOS:000423447600018
J	Zeuzem, S; Foster, GR; Wang, S; Asatryan, A; Gane, E; Feld, JJ; Asselah, T; Bourliere, M; Ruane, PJ; Wedemeyer, H; Pol, S; Flisiak, R; Poordad, F; Chuang, WL; Stedman, CA; Flamm, S; Kwo, P; Dore, GJ; Sepulveda-Arzola, G; Roberts, SK; Soto-Malave, R; Kaita, K; Puoti, M; Vierling, J; Tam, E; Vargas, HE; Bruck, R; Fuster, F; Paik, SW; Felizarta, F; Kort, J; Fu, B; Liu, R; Ng, TI; Pilot-Matias, T; Lin, CW; Trinh, R; Mensa, FJ				Zeuzem, S.; Foster, G. R.; Wang, S.; Asatryan, A.; Gane, E.; Feld, J. J.; Asselah, T.; Bourliere, M.; Ruane, P. J.; Wedemeyer, H.; Pol, S.; Flisiak, R.; Poordad, F.; Chuang, W. -L.; Stedman, C. A.; Flamm, S.; Kwo, P.; Dore, G. J.; Sepulveda-Arzola, G.; Roberts, S. K.; Soto-Malave, R.; Kaita, K.; Puoti, M.; Vierling, J.; Tam, E.; Vargas, H. E.; Bruck, R.; Fuster, F.; Paik, S. -W.; Felizarta, F.; Kort, J.; Fu, B.; Liu, R.; Ng, T. I.; Pilot-Matias, T.; Lin, C. -W.; Trinh, R.; Mensa, F. J.			Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHRONIC HEPATITIS-C; PEGYLATED INTERFERON; NATURAL PREVALENCE; VIRUS-INFECTION; DOUBLE-BLIND; SOFOSBUVIR; CIRRHOSIS; SAFETY; ABT-493/ABT-530; SIMEPREVIR	BACKGROUND Glecaprevir and pibrentasvir are direct-acting antiviral agents with pangenotypic activity and a high barrier to resistance. We evaluated the efficacy and safety of 8-week and 12-week courses of treatment with 300 mg of glecaprevir plus 120 mg of pibrentasvir in patients without cirrhosis who had hepatitis C virus (HCV) genotype 1 or 3 infection. METHODS We conducted two phase 3, randomized, open-label, multicenter trials. Patients with genotype 1 infection were randomly assigned in a 1:1 ratio to receive oncedaily glecaprevir-pibrentasvir for either 8 or 12 weeks. Patients with genotype 3 infection were randomly assigned in a 2:1 ratio to receive 12 weeks of treatment with either glecaprevir-pibrentasvir or sofosbuvir-daclatasvir. Additional patients with genotype 3 infection were subsequently enrolled and nonrandomly assigned to receive 8 weeks of treatment with glecaprevir-pibrentasvir. The primary end point was the rate of sustained virologic response 12 weeks after the end of treatment. RESULTS In total, 1208 patients were treated. The rate of sustained virologic response at 12 weeks among genotype 1-infected patients was 99.1% (95% confidence interval [CI], 98 to 100) in the 8-week group and 99.7% (95% CI, 99 to 100) in the 12-week group. Genotype 3-infected patients who were treated for 12 weeks had a rate of sustained virologic response at 12 weeks of 95% (95% CI, 93 to 98; 222 of 233 patients) with glecaprevir-pibrentasvir and 97% (95% CI, 93 to 99.9; 111 of 115) with sofosbuvir-daclatasvir; 8 weeks of treatment with glecaprevir-pibrentasvir yielded a rate of 95% (95% CI, 91 to 98; 149 of 157 patients). Adverse events led to discontinuation of treatment in no more than 1% of patients in any treatment group. CONCLUSIONS Once-daily treatment with glecaprevir-pibrentasvir for either 8 weeks or 12 weeks achieved high rates of sustained virologic response among patients with HCV genotype 1 or 3 infection who did not have cirrhosis.	[Zeuzem, S.] Goethe Univ Hosp, Frankfurt, Germany; [Wedemeyer, H.] Hannover Med Sch, Hannover, Germany; [Foster, G. R.] Queen Mary Univ London, Barts Hlth, London, England; [Wang, S.; Asatryan, A.; Kort, J.; Fu, B.; Liu, R.; Ng, T. I.; Pilot-Matias, T.; Lin, C. -W.; Trinh, R.; Mensa, F. J.] AbbVie, N Chicago, IL USA; [Flamm, S.] Northwestern Feinberg Sch Med, Chicago, IL USA; [Gane, E.] Auckland City Hosp, Liver Unit, Auckland, New Zealand; [Stedman, C. A.] Christchurch Hosp, Christchurch, New Zealand; [Stedman, C. A.] Univ Otago, Christchurch, New Zealand; [Feld, J. J.] Univ Toronto, Toronto Ctr Liver Dis, Toronto, ON, Canada; [Kaita, K.] Univ Manitoba, Winnipeg, MB, Canada; [Tam, E.] LAIR Ctr, Vancouver, BC, Canada; [Asselah, T.] Univ Paris Diderot, Hop Beaujon, AP HP, Serv Hepatol,Ctr Rech Inflammat,INSERM,UMR 1149, Clichy, France; [Bourliere, M.] Hop St Joseph, Marseille, France; [Pol, S.] Grp Hosp Cochin St Vincent Paul, Paris, France; [Ruane, P. J.] Ruane Med & Liver Hlth Inst, Los Angeles, CA USA; [Kwo, P.] Stanford Univ, Div Gastroenterol & Hepatol, Palo Alto, CA 94304 USA; [Felizarta, F.] Private Practice, Bakersfield, CA USA; [Flisiak, R.] UM Bialymstoku, Klin Chorob Zakaznych & Hepatol, Bialystok, Poland; [Poordad, F.] Univ Texas Hlth, Texas Liver Inst, San Antonio, TX USA; [Vierling, J.] Baylor Coll Med, Houston, TX USA; [Chuang, W. -L.] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan; [Dore, G. J.] Univ New South Wales Sydney, Kirby Inst, Sydney, NSW, Australia; [Dore, G. J.] St Vincents Hosp, Sydney, NSW, Australia; [Roberts, S. K.] Alfred Hosp, Melbourne, Vic, Australia; [Sepulveda-Arzola, G.] Inst Invest Cientif Sur, Ponce, PR USA; [Soto-Malave, R.] Univ Puerto Rico, San Juan, PR 00936 USA; [Puoti, M.] Azienda Ospedaliera Ospedale Niguarda Ca Granda, Milan, Italy; [Vargas, H. E.] Mayo Clin, Phoenix, AZ USA; [Bruck, R.] Tel Aviv Univ, Tel Aviv Med Ctr, Tel Aviv, Israel; [Bruck, R.] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel; [Fuster, F.] Ctr Invest Clin Vina Mar, Vina Del Mar, Chile; [Paik, S. -W.] Samsung Med Ctr, Seoul, South Korea	Goethe University Frankfurt; Goethe University Frankfurt Hospital; Hannover Medical School; Barts Health NHS Trust; University of London; Queen Mary University London; AbbVie; Northwestern University; Feinberg School of Medicine; Auckland City Hospital; Christchurch Hospital New Zealand; University of Otago; University of Toronto; University of Manitoba; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Stanford University; University of Texas System; University of Texas Health San Antonio; Baylor College of Medicine; Kaohsiung Medical University; Kaohsiung Medical University Hospital; University of New South Wales Sydney; Kirby Institute; St Vincents Hospital Sydney; Florey Institute of Neuroscience & Mental Health; University of Puerto Rico; Ospedale Niguarda Ca' Granda; Mayo Clinic; Mayo Clinic Phoenix; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Sackler Faculty of Medicine; Sungkyunkwan University (SKKU); Samsung Medical Center	Zeuzem, S (corresponding author), Univ Hosp Frankfurt, Dept Med, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.	zeuzem@em.uni-frankfurt.de	Chuang, Wan-Long/ABF-7427-2021; Vargas, Hugo E./K-1562-2019; Dore, Gregory John/ABD-5665-2021; Zeuzem, Stefan/AAE-7435-2019; Feld, Jordan/AAH-5628-2020; Puoti, Massimo/AAA-6580-2020; Flisiak, Robert/S-5356-2018	Chuang, Wan-Long/0000-0002-2376-421X; Vargas, Hugo E./0000-0002-7802-688X; Dore, Gregory John/0000-0002-4741-2622; Feld, Jordan/0000-0003-2640-2211; Flisiak, Robert/0000-0003-3394-1635; Foster, Graham/0000-0002-3704-386X; FUSTER GARCIA, FRANCISCO/0000-0002-2528-6143; Ng, Teresa/0000-0001-8333-2446; Puoti, Massimo/0000-0003-3278-7138	AbbVie	AbbVie(AbbVie)	Supported by AbbVie.	American Association for the Study of Liver Disease; Infectious Dis- eases Society of America, 2017, HCV GUID REC TEST MA; Ampuero J, 2014, ALIMENT PHARM THER, V39, P686, DOI 10.1111/apt.12646; [Anonymous], 1998, STAT PRINCIPLES CLIN; [Anonymous], 2015, DAKL DACL; [Anonymous], 2016, ZEP ELB GRAZ; [Anonymous], 2015, HARV LED SOF; [Anonymous], 2015, EPCL SOF VELP; [Anonymous], 2015, VIEK PAK OMB PAR RIT; Asselah T, 2016, HEPATOLOGY, V64, p63A; Asselah T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150569; Banerjee D, 2016, ALIMENT PHARM THER, V43, P674, DOI 10.1111/apt.13514; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Cavalcante LN, 2015, WORLD J HEPATOL, V7, P1617, DOI 10.4254/wjh.v7.i12.1617; European Ass Study Liver, 2017, J HEPATOL, V66, P153, DOI 10.1016/j.jhep.2016.09.001; Food and Drug Administration, 2010, NON CLIN TRIALS EST; Foster GR, 2015, NEW ENGL J MED, V373, P2608, DOI 10.1056/NEJMoa1512612; Fried MW, 2013, HEPATOLOGY, V58, P1918, DOI 10.1002/hep.26641; Gigi E, 2007, Hippokratia, V11, P196; Gower E, 2014, J HEPATOL, V61, pS45, DOI 10.1016/j.jhep.2014.07.027; Harder J, 2004, CLIN MICROBIOL INFEC, V10, P768, DOI 10.1111/j.1469-0691.2004.00934.x; Hassanein TI, 2016, HEPATOLOGY, V64, p1128A; Hernandez D, 2013, J CLIN VIROL, V57, P13, DOI 10.1016/j.jcv.2012.12.020; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Kowdley KV, 2016, HEPATOLOGY, V64, p39A; Kwo PY, 2017, J HEPATOL, V67, P263, DOI 10.1016/j.jhep.2017.03.039; Manns M, 2014, LANCET, V384, P414, DOI 10.1016/S0140-6736(14)60538-9; Nelson DR, 2015, HEPATOLOGY, V61, P1127, DOI 10.1002/hep.27726; Ng TI, 2018, ANTIMICROB AGENTS CH, V62, DOI 10.1128/AAC.01620-17; Ng TI, 2017, ANTIMICROB AGENTS CH, V61, DOI [10.1128/AAC.02558-16, 10.1128/aac.02558-16]; Ng TI, 2016, 2016 INT LIV C EASL; Pawlotsky JM, 2015, J HEPATOL, V63, P199, DOI 10.1016/j.jhep.2015.03.025; PAWLOTSKY JM, 1995, J INFECT DIS, V171, P1607, DOI 10.1093/infdis/171.6.1607; Schinazi RF, 2017, LIVER INT, V37, P73, DOI 10.1111/liv.13324; The European Agency for the Evaluation of Medicinal Products, 2000, POINTS CONS SWITCH S; Townsend K, 2016, AIDS, V30, P261, DOI 10.1097/QAD.0000000000000903; Walker A, 2015, J CLIN VIROL, V70, P43, DOI 10.1016/j.jcv.2015.07.008	36	258	273	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 25	2018	378	4					354	369		10.1056/NEJMoa1702417	http://dx.doi.org/10.1056/NEJMoa1702417			16	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT5ZX	29365309	Green Published, Bronze			2022-12-28	WOS:000423233400008
J	Serghiou, S; Ioannidis, JPA				Serghiou, Stylianos; Ioannidis, John P. A.			Altmetric Scores, Citations, and Publication of Studies Posted as Preprints	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Serghiou, Stylianos] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA; [Ioannidis, John P. A.] Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, 1265 Welch Rd, Stanford, CA 94305 USA	Stanford University; Stanford University	Ioannidis, JPA (corresponding author), Stanford Univ, Meta Res Innovat Ctr Stanford METRICS, 1265 Welch Rd, Stanford, CA 94305 USA.	jioannid@stanford.edu	Ioannidis, John P. A./G-9836-2011; Serghiou, Stelios/Q-6773-2017	Serghiou, Stelios/0000-0002-2477-6060; Ioannidis, John P./0000-0003-3118-6859	Laura and John Arnold Foundation	Laura and John Arnold Foundation	METRICS is funded by a grant from the Laura and John Arnold Foundation. The work of Dr Ioannidis is supported by an unrestricted gift from Sue and Bob O'Donnell.	Annesley T, 2017, CLIN CHEM, V63, P453, DOI 10.1373/clinchem.2016.268227; Benjamin DJ, 2018, NAT HUM BEHAV, V2, P6, DOI 10.1038/s41562-017-0189-z; Bourne PE, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005473; Butler D, 2003, NATURE, V425, P548, DOI 10.1038/425548b; Inglis JR, BIORXIV PROGR REPORT; US National Library of Medicine, YEARL CIT TOT 2017 M	6	48	49	5	26	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					402	403		10.1001/jama.2017.21168	http://dx.doi.org/10.1001/jama.2017.21168			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362788	Bronze, Green Published			2022-12-28	WOS:000423405300027
J	White, H; Barrett, M; Gooding, C				White, Heather; Barrett, Michael; Gooding, Christopher			CASE REVIEW Chronic hip pain	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CANCER		[White, Heather] Univ Cambridge, Cambridge, England; [Barrett, Michael; Gooding, Christopher] Cambridge Univ Hosp NHS Trust, Addenbrookes Hosp, Cambridge, England	University of Cambridge; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	White, H (corresponding author), Univ Cambridge, Cambridge, England.	htw28@cam.ac.uk						Anract P, 2017, ORTHOP TRAUMATOL-SUR, V103, pS41, DOI 10.1016/j.otsr.2016.11.001; Di Lascio S, 2014, BREAST CARE, V9, P7, DOI 10.1159/000358750; Gravalos C, 2016, CLIN TRANSL ONCOL, V18, P1243, DOI 10.1007/s12094-016-1590-1; Hamilton W, 2015, BRIT J GEN PRACT, V65, pE516, DOI 10.3399/bjgp15X686077; Henschke N, 2013, COCHRANE DB SYST REV; MIRELS H, 1989, CLIN ORTHOP RELAT R, P256; Weidle UH, 2016, CANCER GENOM PROTEOM, V13, P1	7	1	1	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 19	2018	360								j5882	10.1136/bmj.j5882	http://dx.doi.org/10.1136/bmj.j5882			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT5RJ	29351915				2022-12-28	WOS:000423210600001
J	Gibeaux, R; Acker, R; Kitaoka, M; Georgiou, G; van Kruijsbergen, I; Ford, B; Marcotte, EM; Nomura, DK; Kwon, T; Veenstra, GJC; Heald, R				Gibeaux, Romain; Acker, Rachael; Kitaoka, Maiko; Georgiou, Georgios; van Kruijsbergen, Ila; Ford, Breanna; Marcotte, Edward M.; Nomura, Daniel K.; Kwon, Taejoon; Veenstra, Gert Jan C.; Heald, Rebecca			Paternal chromosome loss and metabolic crisis contribute to hybrid inviability in Xenopus	NATURE			English	Article							MITOTIC SPINDLE; EGG EXTRACTS; GENE-EXPRESSION; NUCLEAR; LAEVIS; TROPICALIS; INCOMPATIBILITY; ELIMINATION; GENOMICS	Hybridization of eggs and sperm from closely related species can give rise to genetic diversity, or can lead to embryo inviability owing to incompatibility. Although central to evolution, the cellular and molecular mechanisms underlying post-zygotic barriers that drive reproductive isolation and speciation remain largely unknown(1,2). Species of the African clawed frog Xenopus provide an ideal system to study hybridization and genome evolution. Xenopus laevis is an allotetraploid with 36 chromosomes that arose through interspecific hybridization of diploid progenitors, whereas Xenopus tropicalis is a diploid with 20 chromosomes that diverged from a common ancestor approximately 48 million years ago(3). Differences in genome size between the two species are accompanied by organism size differences, and size scaling of the egg and subcellular structures such as nuclei and spindles formed in egg extracts(4). Nevertheless, early development transcriptional programs, gene expression patterns, and protein sequences are generally conserved(5,6). Whereas the hybrid produced when X. laevis eggs are fertilized by X. tropicalis sperm is viable, the reverse hybrid dies before gastrulation(7,8). Here we apply cell biological tools and high-throughput methods to study the mechanisms underlying hybrid inviability. We reveal that two specific X. laevis chromosomes are incompatible with the X. tropicalis cytoplasm and are mis-segregated during mitosis, leading to unbalanced gene expression at the maternal to zygotic transition, followed by cell-autonomous catastrophic embryo death. These results reveal a cellular mechanism underlying hybrid incompatibility that is driven by genome evolution and contributes to the process by which biological populations become distinct species.	[Gibeaux, Romain; Acker, Rachael; Kitaoka, Maiko; Heald, Rebecca] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Georgiou, Georgios; van Kruijsbergen, Ila; Veenstra, Gert Jan C.] Radboud Univ Nijmegen, Radboud Inst Mol Life Sci, Fac Sci, Dept Mol Dev Biol, NL-6500 HB Nijmegen, Netherlands; [Ford, Breanna; Nomura, Daniel K.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Ford, Breanna; Nomura, Daniel K.] Univ Calif Berkeley, Dept Nutr Sci, Berkeley, CA 94720 USA; [Ford, Breanna; Nomura, Daniel K.] Univ Calif Berkeley, Dept Toxicol, Berkeley, CA 94720 USA; [Marcotte, Edward M.] Univ Texas Austin, Inst Cellular & Mol Biol, Ctr Syst & Synthet Biol, Dept Mol Biosci, Austin, TX 78712 USA; [Kwon, Taejoon] Ulsan Natl Inst Sci & Technol, Dept Biomed Engn, Ulsan 44919, South Korea	University of California System; University of California Berkeley; Radboud University Nijmegen; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of Texas System; University of Texas Austin; Ulsan National Institute of Science & Technology (UNIST)	Heald, R (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA.	bheald@berkeley.edu	Kwon, Taejoon/AAR-9814-2020; Kwon, Taejoon/S-3835-2016; Veenstra, Gert Jan C./D-4963-2012; Gibeaux, Romain/E-2920-2019; Ford, Breanna/P-7236-2019	Kwon, Taejoon/0000-0002-9794-6112; Veenstra, Gert Jan C./0000-0002-7787-4940; Gibeaux, Romain/0000-0001-5081-1985; Ford, Breanna/0000-0001-8277-9406; Kitaoka, Maiko/0000-0002-1240-7903; Heald, Rebecca/0000-0001-6671-6528; Marcotte, Edward/0000-0001-8808-180X	National Institutes of Health (NIH) [S10 OD018174, R35 GM118183, R01 CA172667, R01 HD069344]; National Science Foundation [DBI-1041078]; EMBO long-term fellowship [ALTF 836-2013]; Human Frontier Science Program long-term fellowship [LT 0004252014-L]; National Science Foundation REU Summer Fellowship; Flora Lamson Hewlett Chair; UC Berkeley Department of Molecular and Cell Biology NIH training grant [4T32GM007232-40]; Basic Science Research Program through National Research Foundation of Korea - Ministry of Science, ICT and Future Planning [NRF-2016R1C1B2009302]; UNIST Research Fund [1.160060.01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD069344] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [R01CA172667] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007232, R35GM122480, DP1GM106408, R35GM118183] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018174] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); EMBO long-term fellowship(European Molecular Biology Organization (EMBO)); Human Frontier Science Program long-term fellowship(Human Frontier Science Program); National Science Foundation REU Summer Fellowship; Flora Lamson Hewlett Chair; UC Berkeley Department of Molecular and Cell Biology NIH training grant; Basic Science Research Program through National Research Foundation of Korea - Ministry of Science, ICT and Future Planning; UNIST Research Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank members of the Heald laboratory, present and past, for support and discussions. We thank the students who helped with some of the experiments: B. Castellano, J. Chen, S. Ramos, A. Sabillo, and K. Shih. We are also grateful to the Marine Biological Laboratory and the National Xenopus Resource for organizing the 2013 Advanced Imaging in Xenopus Workshop where several techniques used here were taught to R.G., and to J. Wallingford and A. Shindo for subsequent support. We thank the Welch, King, Harland, Rokhsar, Barton, and Fletcher laboratories at the University of California, Berkeley (UC Berkeley) for sharing reagents, materials, and expertise, as well as T. Stukenberg and A. Straight for providing us with the Ndc80 and CENP-A antibodies, respectively. We especially thank A. Mudd and D. Rokhsar for providing early access to the X. borealis genome assembly. This work used the Functional Genomics Laboratory, a QB3-Berkeley Core Research Facility at UC Berkeley as well as the Vincent J. Coates Genomics Sequencing Laboratory at UC Berkeley, supported by National Institutes of Health (NIH) S10 OD018174 Instrumentation Grant. The confocal microscopy performed in this work was done at the UC Berkeley CRL Molecular Imaging Center, supported by National Science Foundation DBI-1041078. R.G. was initially supported by EMBO long-term fellowship ALTF 836-2013 and for most of this project by Human Frontier Science Program long-term fellowship LT 0004252014-L. R.A. was supported in part by a National Science Foundation REU Summer Fellowship in 2014. R.H. was supported by NIH R35 GM118183 and the Flora Lamson Hewlett Chair. D.K.N. was supported by NIH R01 CA172667. M.K. was supported by UC Berkeley Department of Molecular and Cell Biology NIH training grant 4T32GM007232-40. T.K. was supported by Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Science, ICT and Future Planning (NRF-2016R1C1B2009302), and the UNIST Research Fund (grant number 1.160060.01). G.J.C.V., I.V.K., and G.G. were supported by NIH R01 HD069344.	Brown KS, 2007, J CELL BIOL, V176, P765, DOI 10.1083/jcb.200610043; BURKI E, 1985, BIOCHEM GENET, V23, P73, DOI 10.1007/BF00499114; Cheeseman IM, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a015826; Crasta K, 2012, NATURE, V482, P53, DOI 10.1038/nature10802; Edelstein Arthur D, 2014, J Biol Methods, V1; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Ferree PM, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000234; Fujiwara A, 1997, CHROMOSOMA, V106, P44, DOI 10.1007/s004120050223; Goda T, 2006, PLOS GENET, V2, P811, DOI 10.1371/journal.pgen.0020091; HAMILTON L, 1957, NATURE, V179, P159, DOI 10.1038/179159a0; Hannak E, 2006, NAT PROTOC, V1, P2305, DOI 10.1038/nprot.2006.396; Hatch EM, 2013, CELL, V154, P47, DOI 10.1016/j.cell.2013.06.007; Hensey C, 1997, MECH DEVELOP, V69, P183, DOI 10.1016/S0925-4773(97)00191-3; Hirsch N, 2002, DEV DYNAM, V225, P422, DOI 10.1002/dvdy.10178; Kalitsis P, 2012, CHROMOSOMA, V121, P327, DOI 10.1007/s00412-012-0369-6; Lee C., 2008, CSH PROTOC; Lee HY, 2008, CELL, V135, P1065, DOI 10.1016/j.cell.2008.10.047; Levy DL, 2010, CELL, V143, P288, DOI 10.1016/j.cell.2010.09.012; Louie SM, 2016, CELL CHEM BIOL, V23, P567, DOI 10.1016/j.chembiol.2016.03.017; Ma H, 2016, CELL METAB, V24, P283, DOI 10.1016/j.cmet.2016.06.012; Maresca Thomas J., 2006, V322, P459; Mi HY, 2016, NUCLEIC ACIDS RES, V44, pD336, DOI 10.1093/nar/gkv1194; MURRAY AW, 1991, METHOD CELL BIOL, V36, P581; Narbonne P, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001197; Presgraves DC, 2010, NAT REV GENET, V11, P175, DOI 10.1038/nrg2718; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sakai C, 2007, CHROMOSOME RES, V15, P697, DOI 10.1007/s10577-007-1155-9; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmid M, 2015, CYTOGENET GENOME RES, V145, P201, DOI 10.1159/000433481; Seehausen O, 2014, NAT REV GENET, V15, P176, DOI 10.1038/nrg3644; Session AM, 2016, NATURE, V538, P336, DOI 10.1038/nature19840; Terradas M, 2009, DNA REPAIR, V8, P1225, DOI 10.1016/j.dnarep.2009.07.004; Vastag Livia, 2011, PLoS One, V6, pe16881, DOI 10.1371/journal.pone.0016881; Wuhr M, 2008, CURR BIOL, V18, P1256, DOI 10.1016/j.cub.2008.07.092; Yanai I, 2011, DEV CELL, V20, P483, DOI 10.1016/j.devcel.2011.03.015	36	36	36	2	29	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2018	553	7688					337	+		10.1038/nature25188	http://dx.doi.org/10.1038/nature25188			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT9MB	29320479	Green Accepted, Green Submitted			2022-12-28	WOS:000423475100051
J	Devi, S				Devi, Sharmila			Syria: 7 years into a civil war	LANCET			English	Editorial Material																			0	5	5	0	14	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 6	2018	391	10115					15	16		10.1016/S0140-6736(18)30006-0	http://dx.doi.org/10.1016/S0140-6736(18)30006-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR9ZB	29323641				2022-12-28	WOS:000419432300012
J	McLeod, AF; Reiter, M; Kuiper, R; Klaassen, PD; Evans, CJ				McLeod, Anna F.; Reiter, Megan; Kuiper, Rolf; Klaassen, Pamela D.; Evans, Christopher J.			A parsec-scale optical jet from a massive young star in the Large Magellanic Cloud	NATURE			English	Article							RADIATION; OUTFLOW	Highly collimated parsec-scale jets, which are generally linked to the presence of an accretion disk, are commonly observed in lowmass young stellar objects(1),(2). In the past two decades, a few of these jets have been directly (or indirectly) observed from higher-mass (larger than eight solar masses) young stellar objects(3-7), adding to the growing evidence that disk-mediated accretion also occurs in high-mass stars(8-11), the formation mechanism of which is still poorly understood. Of the observed jets from massive young stars, none is in the optical regime (massive young stars are typically highly obscured by their natal material), and none is found outside of the Milky Way. Here we report observations of HH 1177, an optical ionized jet that originates from a massive young stellar object located in the Large Magellanic Cloud. The jet is highly collimated over its entire measured length of at least ten parsecs and has a bipolar geometry. The presence of a jet indicates ongoing, disk-mediated accretion and, together with the high degree of collimation, implies that this system is probably formed through a scaled-up version of the formation mechanism of low-mass stars. We conclude that the physics that govern jet launching and collimation is independent of stellar mass.	[McLeod, Anna F.] Univ Canterbury, Sch Phys & Chem Sci, Christchurch, New Zealand; [Reiter, Megan] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA; [Kuiper, Rolf] Univ Tubingen, Inst Astron & Astrophys, Tubingen, Germany; [Klaassen, Pamela D.; Evans, Christopher J.] Royal Observ Edinburgh, UK Astron Technol Ctr, Edinburgh, Midlothian, Scotland	University of Canterbury; University of Michigan System; University of Michigan; Eberhard Karls University of Tubingen; University of Edinburgh	McLeod, AF (corresponding author), Univ Canterbury, Sch Phys & Chem Sci, Christchurch, New Zealand.	anna.mcleod@canterbury.ac.nz	Kuiper, Rolf/AAS-1266-2020	Kuiper, Rolf/0000-0003-2309-8963; McLeod, Anna Faye/0000-0002-5456-523X	Emmy Noether Research Program - German Research Foundation (DFG) [KU 2849/3-1]	Emmy Noether Research Program - German Research Foundation (DFG)	R.K. acknowledges financial support from the Emmy Noether Research Program, funded by the German Research Foundation (DFG) under grant number KU 2849/3-1.	Bacon R., 2014, MSNGR, V157, P13; Bally J, 2006, ASTRON J, V131, P473, DOI 10.1086/498265; Bally J., 1997, IAU S, V182, P29; Bally J., 2007, PROTOSTARS PLANETS, VV, P215; Beltran MT, 2016, ASTRON ASTROPHYS REV, V24, DOI 10.1007/s00159-015-0089-z; Caratti o Garatti A., 2015, ASTRON ASTROPHYS, V573, pL4; Caulet A, 2008, ASTROPHYS J, V678, P200, DOI 10.1086/528923; Chu YH, 2005, ASTROPHYS J, V634, pL189, DOI 10.1086/498943; Frank A., 2014, PROTOSTARS PLANETS, VVI, P451, DOI [DOI 10.2458/AZU_UAPRESS_9780816531240-CH020, 10.2458/azu_uapress_9780816531240-ch020]; Fukui Y, 2015, ASTROPHYS J LETT, V807, DOI 10.1088/2041-8205/807/1/L4; Garatti ACO, 2017, NAT PHYS, V13, P276, DOI [10.1038/nphys3942, 10.1038/NPHYS3942]; Ginsburg A., 2011, ASTROPHYS SOURCE COD; Guzman AE, 2014, ASTROPHYS J, V781, DOI 10.1088/0004-637X/781/1/56; Hirota T, 2017, NAT ASTRON, V1, DOI 10.1038/s41550-017-0146; ISRAEL FP, 1986, ASTROPHYS J, V303, P186, DOI 10.1086/164065; Konigl A., 2000, Protostars and planets 4, P759; Kuiper R, 2011, ASTROPHYS J, V732, DOI 10.1088/0004-637X/732/1/20; Kuiper R, 2010, ASTROPHYS J, V722, P1556, DOI 10.1088/0004-637X/722/2/1556; MARTI J, 1993, ASTROPHYS J, V416, P208, DOI 10.1086/173227; Masque JM, 2015, ASTROPHYS J, V814, DOI 10.1088/0004-637X/814/1/44; Maud LT, 2015, MON NOT R ASTRON SOC, V453, P645, DOI 10.1093/mnras/stv1635; McLeod AF, 2016, MON NOT R ASTRON SOC, V462, P3537, DOI 10.1093/mnras/stw1864; McLeod AF, 2015, MON NOT R ASTRON SOC, V450, P1057, DOI 10.1093/mnras/stv680; Meyer DMA, 2017, MON NOT R ASTRON SOC, V464, pL90, DOI 10.1093/mnrasl/slw187; MUNDT R, 1993, ASTROPHYS SPACE SC L, V186, P91; Osterbrock DE, 1996, PUBL ASTRON SOC PAC, V108, P277, DOI 10.1086/133722; Pudritz R. E., 2007, PROTOSTARS PLANETS, P277; Reipurth B, 1997, ASTRON J, V114, P2708, DOI 10.1086/118681; Reipurth B, 1998, NATURE, V396, P343, DOI 10.1038/24562; Reipurth B, 2001, ANNU REV ASTRON ASTR, V39, P403, DOI 10.1146/annurev.astro.39.1.403; Shimonishi T, 2016, ASTROPHYS J, V827, DOI 10.3847/0004-637X/827/1/72; Shu FH, 1999, NATO ADV SCI I C-MAT, V540, P193; Smith N, 2010, MON NOT R ASTRON SOC, V405, P1153, DOI 10.1111/j.1365-2966.2010.16520.x; Tomisaka K, 1998, ASTROPHYS J, V502, pL163, DOI 10.1086/311504; Weilbacher PM, 2012, PROC SPIE, V8451, DOI 10.1117/12.925114	35	18	18	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 15	2018	554	7692					334	+		10.1038/nature25189	http://dx.doi.org/10.1038/nature25189			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW0PD	29364870	Green Submitted			2022-12-28	WOS:000424996300032
J	Calo, E; Gu, B; Bowen, ME; Aryan, F; Zalc, A; Liang, JL; Flynn, RA; Swigut, T; Chang, HY; Attardi, LD; Wysocka, J				Calo, Eliezer; Gu, Bo; Bowen, Margot E.; Aryan, Fardin; Zalc, Antoine; Liang, Jialiang; Flynn, Ryan A.; Swigut, Tomek; Chang, Howard Y.; Attardi, Laura D.; Wysocka, Joanna			Tissue-selective effects of nucleolar stress and rDNA damage in developmental disorders	NATURE			English	Article							TREACHER-COLLINS-SYNDROME; RNA HELICASE DDX21; NEURAL CREST; P53; DNA; PREVENTION; PROTEIN; CELLS; ENDONUCLEASE; PATHOGENESIS	Many craniofacial disorders are caused by heterozygous mutations in general regulators of housekeeping cellular functions such as transcription or ribosome biogenesis(1,2). Although it is understood that many of these malformations are a consequence of defects in cranial neural crest cells, a cell type that gives rise to most of the facial structures during embryogenesis(3,4), the mechanism underlying cell-type selectivity of these defects remains largely unknown. By exploring molecular functions of DDX21, a DEAD-box RNA helicase involved in control of both RNA polymerase (Pol) I-and II-dependent transcriptional arms of ribosome biogenesis(5), we uncovered a previously unappreciated mechanism linking nucleolar dysfunction, ribosomal DNA (rDNA) damage, and craniofacial malformations. Here we demonstrate that genetic perturbations associated with Treacher Collins syndrome, a craniofacial disorder caused by heterozygous mutations in components of the Pol I transcriptional machinery or its cofactor TCOF1 (ref.1), lead to relocalization of DDX21 from the nucleolus to the nucleoplasm, its loss from the chromatin targets, as well as inhibition of rRNA processing and downregulation of ribosomal protein gene transcription. These effects are cell-type-selective, cell-autonomous, and involve activation of p53 tumour-suppressor protein. We further show that cranial neural crest cells are sensitized to p53-mediated apoptosis, but blocking DDX21 loss from the nucleolus and chromatin rescues both the susceptibility to apoptosis and the craniofacial phenotypes associated with Treacher Collins syndrome. This mechanism is not restricted to cranial neural crest cells, as blood formation is also hypersensitive to loss of DDX21 functions. Accordingly, ribosomal gene perturbations associated with Diamond-Blackfan anaemia disrupt DDX21 localization. At the molecular level, we demonstrate that impaired rRNA synthesis elicits a DNA damage response, and that rDNA damage results in tissue-selective and dosage-dependent effects on craniofacial development. Taken together, our findings illustrate how disruption in general regulators that compromise nucleolar homeostasis can result in tissue-selective malformations.				wysocka@stanford.edu	Zalc, Antoine/GOH-1122-2022	Zalc, Antoine/0000-0001-6077-0996; Swigut, Tomek/0000-0002-7649-6781; Bowen, Margot/0000-0001-6391-5775	Howard Hughes Medical Institute [R01 GM112720]; March of Dimes Birth Defects Foundation; March of Dimes Foundation [6-FY15-189, RC35CA197591]; Ludwig Foundation; Stanford Medical Scientist Training Program [T32CA09302]; Helen Hay Whitney Foundation; EMBO [ALTF 275-2015]; European Commission [GA-2013-609409]; Marie Curie Actions; Jane Coffin Childs Memorial Fund; Stanford Graduate Student Fellowship; National Institutes of Health [P50-HG007735, R01-ES023168]; NATIONAL CANCER INSTITUTE [T32CA009302, R35CA197591] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG007735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM112720] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); March of Dimes Birth Defects Foundation(March of Dimes); March of Dimes Foundation(March of Dimes); Ludwig Foundation; Stanford Medical Scientist Training Program; Helen Hay Whitney Foundation; EMBO(European Molecular Biology Organization (EMBO)); European Commission(European CommissionEuropean Commission Joint Research Centre); Marie Curie Actions(European Commission); Jane Coffin Childs Memorial Fund; Stanford Graduate Student Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Stack and J. Wu for providing the endothelial and cardiomyocyte cells, J. Chen for Xenopus splicing morpholino validations, C. Santoriello and L. Zon for ddx21 zebrafish morpholino, the Swanson Biotechnology Center at the Koch Institute for Integrative Cancer Research, especially E. Vasile for microscopy and A. Amsterdam for zebrafish work, and K. Cimprich and members of the Wysocka, Calo, and Chang laboratories for discussions. This work was supported by the Howard Hughes Medical Institute (J.W.), R01 GM112720 (J.W.), the March of Dimes Birth Defects Foundation (J.W.), March of Dimes Foundation grants 6-FY15-189 and RC35CA197591 (L.D.A.), Ludwig Foundation (J.W.), Stanford Medical Scientist Training Program and T32CA09302 (R.A.F.), the Helen Hay Whitney Foundation (E.C.), EMBO (ALTF 275-2015), the European Commission (LTFCOFUND2013, GA-2013-609409), and the Marie Curie Actions (A.Z.), Jane Coffin Childs Memorial Fund postdoctoral fellowship (M.E.B.), Stanford Graduate Student Fellowship (B.G.) and National Institutes of Health P50-HG007735 and R01-ES023168 (H.Y.C.).	Bajpai R, 2010, NATURE, V463, P958, DOI 10.1038/nature08733; Berdasco M, 2013, HUM GENET, V132, P359, DOI 10.1007/s00439-013-1271-x; Berkson RG, 2005, INT J CANCER, V115, P701, DOI 10.1002/ijc.20968; Bronner ME, 2012, DEV BIOL, V366, P2, DOI 10.1016/j.ydbio.2011.12.042; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Burridge PW, 2014, NAT METHODS, V11, P855, DOI [10.1038/NMETH.2999, 10.1038/nmeth.2999]; Calo E, 2015, NATURE, V518, P249, DOI 10.1038/nature13923; Carey M. F., 2009, COLD SPRING HARB PRO, V2009; Chailleux C, 2014, NAT PROTOC, V9, P517, DOI 10.1038/nprot.2014.031; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Dixon J, 2000, HUM MOL GENET, V9, P1473, DOI 10.1093/hmg/9.10.1473; Dixon J, 2006, P NATL ACAD SCI USA, V103, P13403, DOI 10.1073/pnas.0603730103; Dolma S, 2003, CANCER CELL, V3, P285, DOI 10.1016/S1535-6108(03)00050-3; Faber J., 1994, NORMAL TABLE XENOPUS, P2; Flick KE, 1998, NATURE, V394, P96, DOI 10.1038/27952; Flynn RA, 2015, RNA, V21, P135, DOI 10.1261/rna.047803.114; Gonzales B, 2005, HUM MOL GENET, V14, P2035, DOI 10.1093/hmg/ddi208; Grier JD, 2002, GENESIS, V32, P145, DOI 10.1002/gene.10066; Hu SJ, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85558; Jones NC, 2008, NAT MED, V14, P125, DOI 10.1038/nm1725; Kadakia S, 2014, INT J PEDIATR OTORHI, V78, P893, DOI 10.1016/j.ijporl.2014.03.006; Lau MCC, 2016, BBA-MOL BASIS DIS, V1862, P1147, DOI 10.1016/j.bbadis.2016.03.005; MUSCARELLA DE, 1990, MOL CELL BIOL, V10, P3386, DOI 10.1128/MCB.10.7.3386; Narla A, 2010, BLOOD, V115, P3196, DOI 10.1182/blood-2009-10-178129; Prescott SL, 2015, CELL, V163, P68, DOI 10.1016/j.cell.2015.08.036; Rinon A, 2011, DEVELOPMENT, V138, P1827, DOI 10.1242/dev.053645; Sakai D, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10328; Sloan KE, 2015, NUCLEIC ACIDS RES, V43, P553, DOI 10.1093/nar/gku1291; Song CL, 2017, GENE DEV, V31, P1370, DOI 10.1101/gad.300624.117; Trainor PA, 2010, AM J MED GENET A, V152A, P2984, DOI 10.1002/ajmg.a.33454; Truett GE, 2000, BIOTECHNIQUES, V29, P52, DOI 10.2144/00291bm09; Valdez BC, 1997, EUR J BIOCHEM, V250, P800, DOI 10.1111/j.1432-1033.1997.00800.x; Van Nostrand JL, 2014, NATURE, V514, P228, DOI 10.1038/nature13585; Watt KEN, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006187; Weiner AMJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029574; Yelick PC, 2015, RARE DIS, V3, DOI 10.1080/21675511.2015.1025185; Zarnegar BJ, 2016, NAT METHODS, V13, P489, DOI [10.1038/NMETH.3840, 10.1038/nmeth.3840]; Zhang ZJ, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-896	38	80	81	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2018	554	7690					112	+		10.1038/nature25449	http://dx.doi.org/10.1038/nature25449			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7QX	29364875	Green Accepted, Green Published			2022-12-28	WOS:000424048900041
J	Fan, JW; Rosenfeld, D; Zhang, YW; Giangrande, SE; Li, ZQ; Machado, LAT; Martin, ST; Yang, Y; Wang, J; Artaxo, P; Barbosa, HMJ; Braga, RC; Comstock, JM; Feng, Z; Gao, WH; Gomes, HB; Mei, F; Pohlker, C; Pohlker, ML; Poschl, U; de Souza, RAF				Fan, Jiwen; Rosenfeld, Daniel; Zhang, Yuwei; Giangrande, Scott E.; Li, Zhanqing; Machado, Luiz A. T.; Martin, Scot T.; Yang, Yan; Wang, Jian; Artaxo, Paulo; Barbosa, Henrique M. J.; Braga, Ramon C.; Comstock, Jennifer M.; Feng, Zhe; Gao, Wenhua; Gomes, Helber B.; Mei, Fan; Poehlker, Christopher; Poehlker, Mira L.; Poeschl, Ulrich; de Souza, Rodrigo A. F.			Substantial convection and precipitation enhancements by ultrafine aerosol particles	SCIENCE			English	Article							AMAZON RAIN-FOREST; SIZE DISTRIBUTION; MICROPHYSICAL PROCESSES; VERTICAL VELOCITY; PART I; CLOUDS; INVIGORATION; IMPACTS; MODEL; POLLUTION	Aerosol-cloud interactions remain the largest uncertainty in climate projections. Ultrafine aerosol particles smaller than 50 nanometers (UAP(<50)) can be abundant in the troposphere but are conventionally considered too small to affect cloud formation. Observational evidence and numerical simulations of deep convective clouds (DCCs) over the Amazon show that DCCs forming in a low-aerosol environment can develop very large vapor supersaturation because fast droplet coalescence reduces integrated droplet surface area and subsequent condensation. UAP(<50) from pollution plumes that are ingested into such clouds can be activated to form additional cloud droplets on which excess supersaturation condenses and forms additional cloud water and latent heating, thus intensifying convective strength. This mechanism suggests a strong anthropogenic invigoration of DCCs in previously pristine regions of the world.	[Fan, Jiwen; Zhang, Yuwei; Yang, Yan; Comstock, Jennifer M.; Feng, Zhe; Gao, Wenhua; Mei, Fan] Pacific Northwest Natl Lab, Atmospher Sci & Global Change Div, Richland, WA 99352 USA; [Rosenfeld, Daniel] Hebrew Univ Jerusalem, Inst Earth Sci, IL-91904 Jerusalem, Israel; [Zhang, Yuwei; Li, Zhanqing] Univ Maryland, Dept Atmospher & Ocean Sci, College Pk, MD 20742 USA; [Zhang, Yuwei; Li, Zhanqing] Univ Maryland, ESSIC, College Pk, MD 20742 USA; [Giangrande, Scott E.; Wang, Jian] Brookhaven Natl Lab, Environm & Climate Sci Dept, Upton, NY 11973 USA; [Li, Zhanqing] Beijing Normal Univ, GCESS, State Lab Earth Surface Proc & Resource Ecol, Beijing, Peoples R China; [Machado, Luiz A. T.; Braga, Ramon C.] Inst Nacl Pesquisas Espaciais, Ctr Previsao Tempo & Estudos Climat, Cachoeira Paulista, Brazil; [Giangrande, Scott E.] Harvard Univ, Sch Engn & Appl Sci, Boston, MA 02115 USA; [Martin, Scot T.] Harvard Univ, Dept Earth & Planetary Sci, Boston, MA 02115 USA; [Yang, Yan] Beijing Municipal Weather Modificat Off, Beijing 100089, Peoples R China; [Artaxo, Paulo; Barbosa, Henrique M. J.] Univ Sao Paulo, Inst Fis, Rua Matao 1371, BR-05508090 Sao Paulo, Brazil; [Barbosa, Henrique M. J.] Univ Maryland Baltimore Cty, Dept Phys, Baltimore, MD 21228 USA; [Gao, Wenhua] Chinese Acad Meteorol Sci, State Key Lab Severe Weather, Beijing 100086, Peoples R China; [Gomes, Helber B.] Univ Fed Alagoas, Inst Atmospher Sci, Atmospher & Climate Dynam Lab, Maceio, Brazil; [Poehlker, Christopher; Poehlker, Mira L.; Poeschl, Ulrich] Max Planck Inst Chem, Multiphase Chem Dept, D-55020 Mainz, Germany; [Poeschl, Ulrich] Max Planck Inst Chem, Biogeochem Dept, D-55020 Mainz, Germany; [Poeschl, Ulrich] Johannes Gutenberg Univ Mainz, D-55122 Mainz, Germany; [de Souza, Rodrigo A. F.] Amazonas State Univ UEA, Sch Technol, Dept Meteorol, Manaus, AM, Brazil	United States Department of Energy (DOE); Pacific Northwest National Laboratory; Hebrew University of Jerusalem; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; United States Department of Energy (DOE); Brookhaven National Laboratory; Beijing Normal University; Instituto Nacional de Pesquisas Espaciais (INPE); Harvard University; Harvard University; Universidade de Sao Paulo; University System of Maryland; University of Maryland Baltimore County; Chinese Academy of Meteorological Sciences (CAMS); Chinese Academy of Sciences; Universidade Federal de Alagoas; Max Planck Society; Max Planck Society; Johannes Gutenberg University of Mainz; Universidade do Estado do Amazonas	Fan, JW (corresponding author), Pacific Northwest Natl Lab, Atmospher Sci & Global Change Div, Richland, WA 99352 USA.	jiwen.fan@pnnl.gov	Rosenfeld, Daniel/AAJ-4617-2021; Barbosa, H. M. J./F-3499-2012; Martin, Scot/G-1094-2015; Gao, Wenhua/AAA-4698-2022; Wang, Jian/G-9344-2011; Ferreira de Souza, Rodrigo/B-8453-2013; Pöschl, Ulrich/A-6263-2010; Artaxo, Paulo/E-8874-2010; Mei, Fan/D-9953-2013; Feng, Zhe/E-1877-2015; Machado, Luiz/C-4314-2012; Gomes, Helber Barros/E-3845-2012; Pöhlker, Mira L/N-2835-2017; Li, Zhanqing/F-4424-2010; Pöhlker, Christopher/S-5207-2016; Fan, Jiwen/E-9138-2011; Rosenfeld, Daniel/F-6077-2016	Rosenfeld, Daniel/0000-0002-0784-7656; Barbosa, H. M. J./0000-0002-4027-1855; Martin, Scot/0000-0002-8996-7554; Gao, Wenhua/0000-0003-2478-5917; Ferreira de Souza, Rodrigo/0000-0003-0838-3723; Pöschl, Ulrich/0000-0003-1412-3557; Artaxo, Paulo/0000-0001-7754-3036; Mei, Fan/0000-0003-4285-2749; Feng, Zhe/0000-0002-7540-9017; Machado, Luiz/0000-0002-8243-1706; Gomes, Helber Barros/0000-0001-9972-9990; Pöhlker, Mira L/0000-0001-6852-0756; Li, Zhanqing/0000-0001-6737-382X; Pöhlker, Christopher/0000-0001-6958-425X; Fan, Jiwen/0000-0001-5280-4391; Rosenfeld, Daniel/0000-0002-0784-7656; Yang, Yan/0000-0002-4844-4378; Zhang, Yuwei/0000-0002-3260-6782	U.S. DOE, Office of Science, Atmospheric System Research Program; DOE by Battelle Memorial Institute [DE-AC06-76RLO1830]; NSF [AGS1534670]; National Science Foundation of China [91544217]; project BACCHUS European Commission [FP7-603445]; Brookhaven Science Associates LLC under DOE [DE-SC0012704]; CHUVA project; Central Office of the Large Scale Biosphere Atmosphere Experiment in Amazonia (LBA), Instituto Nacional de Pesquisas da Amazonia (INPA), Universidade do Estado do Amazonas (UEA); local Research Foundation (FAPEAM); FAPESP [2009/15235-8, 2013/05014-0, 2013/50510-5]; Brazilian National Council for Scientific and Technological Development (CNPq) [001030/2012-4]; German Federal Ministry of Education and Research (BMBF) [01LB1001A]; Brazilian Ministerio da Ciencia, Tecnologia e Inovacao (MCTI/FINEP) [01.11.01248.00]; Amazon State University (UEA); FAPEAM; LBA/INPA; SDS/CEUC/RDS-Uatuma	U.S. DOE, Office of Science, Atmospheric System Research Program(United States Department of Energy (DOE)); DOE by Battelle Memorial Institute(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); project BACCHUS European Commission; Brookhaven Science Associates LLC under DOE; CHUVA project; Central Office of the Large Scale Biosphere Atmosphere Experiment in Amazonia (LBA), Instituto Nacional de Pesquisas da Amazonia (INPA), Universidade do Estado do Amazonas (UEA); local Research Foundation (FAPEAM); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Brazilian National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Brazilian Ministerio da Ciencia, Tecnologia e Inovacao (MCTI/FINEP); Amazon State University (UEA); FAPEAM; LBA/INPA; SDS/CEUC/RDS-Uatuma	This study was supported by the U.S. DOE, Office of Science, Atmospheric System Research Program. The Pacific Northwest National Laboratory (PNNL) is operated for DOE by Battelle Memorial Institute under contract DE-AC06-76RLO1830. This research used PNNL Institutional Computing resources. Y.Z. and Z.L. were supported by NSF grant AGS1534670 and National Science Foundation of China grant 91544217. D.R. was supported by project BACCHUS European Commission FP7-603445. S.E.G. represents Brookhaven Science Associates LLC under DOE contract DE-SC0012704. The DOE Atmospheric Radiation Measurement (ARM) Climate Research Facility's GoAmazon field campaign data were used. The x-band and s-band (SIPAM) radar data were supported by the CHUVA project. We thank the GoAmazon team and the CHUVA team for their effort to produce the observational data. We acknowledge support from the Central Office of the Large Scale Biosphere Atmosphere Experiment in Amazonia (LBA), Instituto Nacional de Pesquisas da Amazonia (INPA), Universidade do Estado do Amazonas (UEA), and the local Research Foundation (FAPEAM). L.A.T.M., P.A., and H.M.J.B. were supported by FAPESP grants 2009/15235-8, 2013/05014-0, and 2013/50510-5. The work was conducted under authorization 001030/2012-4 of the Brazilian National Council for Scientific and Technological Development (CNPq). For the operation of the ATTO site, we acknowledge support by the German Federal Ministry of Education and Research (BMBF contract 01LB1001A), the Brazilian Ministerio da Ciencia, Tecnologia e Inovacao (MCTI/FINEP contract 01.11.01248.00), and the Amazon State University (UEA), FAPEAM, LBA/INPA, and SDS/CEUC/RDS-Uatuma. We thank C. Schumacher and A. Funk at Texas A&M University for the SIPAM data, T. Biscaro for the x-band data, S. Tang at Lawrence Livermore National Laboratory for the input of local convective system selection, S. Hagos at PNNL for the input of model configuration, and C. Kuang at Brookhaven National Laboratory for help in understanding the uncertainty of Scanning Mobility Particle Sizer data. The observational data including x-band and SIPAM radar data from CHUVA can be obtained from DOE ARM data archive www.archive.arm.gov/discovery/#v/results/s/fiop::amf2014goamazon, which is available to the community. The model simulation data are archived at PNNL PIC and are available at https://dtn2.pnl.gov/data/jiwen/GoAmazon_simulations_sci/.	Andreae MO, 2007, SCIENCE, V315, P50, DOI 10.1126/science.1136529; Andreae MO, 2004, SCIENCE, V303, P1337, DOI 10.1126/science.1092779; [Anonymous], 2013, CLIMATE CHANGE 2013; [Anonymous], 2017, P 31 C NEUR INF PROC, DOI [10.5194/acp-2017-694, DOI 10.5194/ACP-2017-694]; Barnes HC, 2016, J GEOPHYS RES-ATMOS, V121, P8269, DOI 10.1002/2016JD025074; Cecchini MA, 2016, ATMOS CHEM PHYS, V16, P7029, DOI 10.5194/acp-16-7029-2016; Chen Q, 2017, ATMOS CHEM PHYS, V17, P9585, DOI 10.5194/acp-17-9585-2017; Fan JW, 2016, J ATMOS SCI, V73, P4221, DOI 10.1175/JAS-D-16-0037.1; Fan JW, 2013, P NATL ACAD SCI USA, V110, pE4581, DOI 10.1073/pnas.1316830110; Fan JW, 2012, J GEOPHYS RES-ATMOS, V117, DOI 10.1029/2011JD016537; Giangrande SE, 2016, J GEOPHYS RES-ATMOS, V121, P12891, DOI 10.1002/2016JD025303; Giangrande SE, 2013, J APPL METEOROL CLIM, V52, P2278, DOI 10.1175/JAMC-D-12-0185.1; Houze R.A, 2014, CLOUD DYNAMICS, V104; Khain A, 2004, J ATMOS SCI, V61, P2963, DOI 10.1175/JAS-3350.1; Khain AP, 2012, J ATMOS SCI, V69, P2787, DOI 10.1175/2011JAS3649.1; Khain AP, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/1/015004; Koren I, 2008, SCIENCE, V321, P946, DOI 10.1126/science.1159185; Koren I, 2014, SCIENCE, V344, P1143, DOI 10.1126/science.1252595; Kulmala M, 2011, ATMOS CHEM PHYS, V11, P13061, DOI 10.5194/acp-11-13061-2011; Lebo ZJ, 2011, ATMOS CHEM PHYS, V11, P5407, DOI 10.5194/acp-11-5407-2011; Lee SS, 2008, J GEOPHYS RES-ATMOS, V113, DOI 10.1029/2007JD009224; Li ZQ, 2011, NAT GEOSCI, V4, P888, DOI [10.1038/ngeo1313, 10.1038/NGEO1313]; Lin JC, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006884; Lohmann U, 2005, ATMOS CHEM PHYS, V5, P715, DOI 10.5194/acp-5-715-2005; Marengo JA, 2017, ATMOS CHEM PHYS, V17, P7671, DOI 10.5194/acp-17-7671-2017; Martin ST, 2017, B AM METEOROL SOC, V98, P981, DOI 10.1175/BAMS-D-15-00221.1; Martin ST, 2016, ATMOS CHEM PHYS, V16, P4785, DOI 10.5194/acp-16-4785-2016; Martin ST, 2010, ATMOS CHEM PHYS, V10, P11415, DOI 10.5194/acp-10-11415-2010; Pikridas M, 2015, ATMOS CHEM PHYS, V15, P10219, DOI 10.5194/acp-15-10219-2015; Pohlker ML, 2016, ATMOS CHEM PHYS, V16, P15709, DOI 10.5194/acp-16-15709-2016; Poschl U, 2010, SCIENCE, V329, P1513, DOI 10.1126/science.1191056; Pohlker M. L, 2017, ATMOS CHEM PHYS DISC, DOI [10.5194/acp-2017-847, DOI 10.5194/ACP-2017-847]; Rosenfeld D, 2008, SCIENCE, V321, P1309, DOI 10.1126/science.1160606; Shrivastava M, 2017, REV GEOPHYS, V55, P509, DOI 10.1002/2016RG000540; Skamarock W.C., 2008, NCARTN475STR, DOI [10.5065/D68S4MVH, DOI 10.5065/D68S4MVH]; Storer RL, 2013, J ATMOS SCI, V70, P430, DOI 10.1175/JAS-D-12-076.1; Tang SQ, 2016, ATMOS CHEM PHYS, V16, P14249, DOI 10.5194/acp-16-14249-2016; Tao WK, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000369; Thornton JA, 2017, GEOPHYS RES LETT, V44, P9102, DOI 10.1002/2017GL074982; van den Heever SC, 2011, J ATMOS SCI, V68, P699, DOI 10.1175/2010JAS3603.1; Wang J, 2017, J AEROSOL SCI, V108, P44, DOI 10.1016/j.jaerosci.2017.02.012; Wang J, 2016, NATURE, V539, P416, DOI 10.1038/nature19819; Wang Y, 2014, P NATL ACAD SCI USA, V111, P6894, DOI 10.1073/pnas.1403364111; Yang X, 2014, J GEOPHYS RES-ATMOS, V119, P1835, DOI 10.1002/2013JD021224; Zhang RY, 2007, P NATL ACAD SCI USA, V104, P5295, DOI 10.1073/pnas.0700618104; Zhang RY, 2012, CHEM REV, V112, P1957, DOI 10.1021/cr2001756; Zhou JC, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2000JD000203	47	204	209	31	240	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					411	+		10.1126/science.aan8461	http://dx.doi.org/10.1126/science.aan8461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6SD	29371462				2022-12-28	WOS:000423283200037
J	Lamb, JB; Willis, BL; Fiorenza, EA; Couch, CS; Howard, R; Rader, DN; True, JD; Kelly, LA; Ahmad, A; Jompa, J; Harvell, CD				Lamb, Joleah B.; Willis, Bette L.; Fiorenza, Evan A.; Couch, Courtney S.; Howard, Robert; Rader, Douglas N.; True, James D.; Kelly, Lisa A.; Ahmad, Awaludinnoer; Jompa, Jamaluddin; Harvell, C. Drew			Plastic waste associated with disease on coral reefs	SCIENCE			English	Article							MARINE; OCEAN; BIODIVERSITY; VIRULENCE; BACTERIA; ECOLOGY; DEBRIS; LIFE; BAND	Plastic waste can promote microbial colonization by pathogens implicated in outbreaks of disease in the ocean. We assessed the influence of plastic waste on disease risk in 124,000 reef-building corals from 159 reefs in the Asia-Pacific region. The likelihood of disease increases from 4% to 89% when corals are in contact with plastic. Structurally complex corals are eight times more likely to be affected by plastic, suggesting that microhabitats for reef-associated organisms and valuable fisheries will be disproportionately affected. Plastic levels on coral reefs correspond to estimates of terrestrial mismanaged plastic waste entering the ocean. We estimate that 11.1 billion plastic items are entangled on coral reefs across the Asia-Pacific and project this number to increase 40% by 2025. Plastic waste management is critical for reducing diseases that threaten ecosystem health and human livelihoods.	[Lamb, Joleah B.; Fiorenza, Evan A.; Couch, Courtney S.; Harvell, C. Drew] Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA; [Lamb, Joleah B.; Willis, Bette L.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Lamb, Joleah B.; Willis, Bette L.; Kelly, Lisa A.] James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia; [Fiorenza, Evan A.] Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA; [Couch, Courtney S.] Univ Hawaii Manoa, HIMB, Kaneohe, HI 96744 USA; [Couch, Courtney S.] NOAA, Ecosyst Sci Div, Pacific Isl Fisheries Sci Ctr, Honolulu, HI 96818 USA; [Howard, Robert] Fauna & Flora Int, Marine Programme, Yangon, Myanmar; [Rader, Douglas N.] Environm Def Fund, Oceans Program, New York, NY 10010 USA; [True, James D.] Prince Songkla Univ, Ctr Biodivers Peninsular Thailand, Hat Yai, Songkhla, Thailand; [Kelly, Lisa A.] Carleton Univ, Fish Ecol & Conservat Physiol Lab, Dept Biol, Ottawa, ON, Canada; [Kelly, Lisa A.] Carleton Univ, Inst Environm Sci, Ottawa, ON, Canada; [Ahmad, Awaludinnoer] Nature Conservancy, Raja Ampat Field Off, North Sorong, West Papua, Indonesia; [Ahmad, Awaludinnoer; Jompa, Jamaluddin] Hasanuddin Univ, Fac Marine Sci & Fisheries, Makassar, South Sulawesi, Indonesia	Cornell University; James Cook University; James Cook University; University of Washington; University of Washington Seattle; University of Hawaii System; University of Hawaii Manoa; National Oceanic Atmospheric Admin (NOAA) - USA; Environmental Defense Fund; Prince of Songkla University; Carleton University; Carleton University; The Nature Conservancy Indonesia; Universitas Hasanuddin	Lamb, JB (corresponding author), Cornell Univ, Dept Ecol & Evolutionary Biol, Ithaca, NY 14853 USA.; Lamb, JB (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.; Lamb, JB (corresponding author), James Cook Univ, Coll Sci & Engn, Townsville, Qld, Australia.	joleah.lamb@cornell.edu	Lamb, Joleah/D-1994-2018; Jompa, Jamaluddin/AAD-9280-2021; kelly, Lisa/GWU-9804-2022; Fiorenza, Evan/AAN-1069-2020	Lamb, Joleah/0000-0002-7005-9994; Jompa, Jamaluddin/0000-0001-9740-333X; Couch, Courtney/0000-0002-5642-8765; Kelly, Lisa/0000-0003-2830-6493; Fiorenza, Evan/0000-0002-5421-0148	Nature Conservancy NatureNet Science Fellowship; AIMS@JCU (Australian Institute of Marine Science at James Cook University) Postgraduate Scholarship; NSF Ecology of Infectious Marine Disease Research Coordination Network [Division of Ocean Sciences (OCE) award] [1215977]; Capturing Coral Reef and Ecosystem Related Services (CCRES) Project - Global Environment Facility; World Bank [P123933]; NOAA/National Ocean Service (NOS)-HIMB [MOA-2009-039]; Australian Research Council [CEO561435]; Environmental Defense Fund Innovation for Impact; Atkinson Center for a Sustainable Future at Cornell University	Nature Conservancy NatureNet Science Fellowship; AIMS@JCU (Australian Institute of Marine Science at James Cook University) Postgraduate Scholarship; NSF Ecology of Infectious Marine Disease Research Coordination Network [Division of Ocean Sciences (OCE) award]; Capturing Coral Reef and Ecosystem Related Services (CCRES) Project - Global Environment Facility; World Bank(The World Bank India); NOAA/National Ocean Service (NOS)-HIMB; Australian Research Council(Australian Research Council); Environmental Defense Fund Innovation for Impact; Atkinson Center for a Sustainable Future at Cornell University	We thank S. Atto, S. Beveridge, F. J. Pollock, G. Torda, A. Tracy, A. Wenger, C. Wood, S. Yusuf, and S. Piromvaragorn for their assistance. This research was supported by The Nature Conservancy NatureNet Science Fellowship, an AIMS@JCU (Australian Institute of Marine Science at James Cook University) Postgraduate Scholarship, the NSF Ecology of Infectious Marine Disease Research Coordination Network [Division of Ocean Sciences (OCE) award 1215977], the Capturing Coral Reef and Ecosystem Related Services (CCRES) Project funded by the Global Environment Facility and the World Bank (project ID P123933), NOAA/National Ocean Service (NOS)-HIMB agreement code MOA-2009-039, Australian Research Council (grant CEO561435), and the Environmental Defense Fund Innovation for Impact partnership with the Atkinson Center for a Sustainable Future at Cornell University. Surveys in Australia were conducted under Great Barrier Reef Marine Park Authority permits G10/33393.1 and G12/35232.1. All data and code to understand and assess the conclusions of this research are available in the main text, supplementary materials, and via the Dryad Digital Repository (https://doi.org/10.5061/dryad.mp480).	Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; Barnes DKA, 2002, NATURE, V416, P808, DOI 10.1038/416808a; Bourne DG, 2015, CORAL REEFS, V34, P233, DOI 10.1007/s00338-014-1239-x; Burke L, 2011, REEFS RISK REVISTED; Dang HY, 2008, APPL ENVIRON MICROB, V74, P52, DOI 10.1128/AEM.01400-07; De Tender CA, 2015, ENVIRON SCI TECHNOL, V49, P9629, DOI 10.1021/acs.est.5b01093; Fazey FMC, 2016, ENVIRON POLLUT, V210, P354, DOI 10.1016/j.envpol.2016.01.026; Glas MS, 2012, ISME J, V6, P1526, DOI 10.1038/ismej.2012.2; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Jambeck JR, 2015, SCIENCE, V347, P768, DOI 10.1126/science.1260352; Kirstein IV, 2016, MAR ENVIRON RES, V120, P1, DOI 10.1016/j.marenvres.2016.07.004; Lamb JB, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0210; Lamb JB, 2015, ECOLOGY, V96, P2555, DOI 10.1890/14-1952.1; Maynard J, 2015, NAT CLIM CHANGE, V5, P688, DOI 10.1038/nclimate2625; Morrow KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044859; Mydlarz LD, 2006, ANNU REV ECOL EVOL S, V37, P251, DOI 10.1146/annurev.ecolsys.37.091305.110103; Nugues MM, 2004, ECOL LETT, V7, P919, DOI 10.1111/j.1461-0248.2004.00651.x; Oberbeckmann S, 2015, ENVIRON CHEM, V12, P551, DOI 10.1071/EN15069; Page CA, 2008, CORAL REEFS, V27, P257, DOI 10.1007/s00338-007-0317-8; Richardson LE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08109-4; Rogers A, 2014, CURR BIOL, V24, P1000, DOI 10.1016/j.cub.2014.03.026; Smith JE, 2006, ECOL LETT, V9, P835, DOI 10.1111/j.1461-0248.2006.00937.x; Soffer N, 2015, ENVIRON MICROBIOL, V17, P1203, DOI 10.1111/1462-2920.12553; Sweet MJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069717; Worm B, 2006, SCIENCE, V314, P787, DOI 10.1126/science.1132294; Zettler ER, 2013, ENVIRON SCI TECHNOL, V47, P7137, DOI 10.1021/es401288x	26	349	357	40	583	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					460	462		10.1126/science.aar3320	http://dx.doi.org/10.1126/science.aar3320			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6SD	29371469				2022-12-28	WOS:000423283200047
J	Bahr, C; von Paleske, L; Slu, VVU; Emeseiro, SR; Takayama, N; Ng, SW; Murison, A; Langenfeld, K; Petretich, M; Scognamiglio, R; Zeisberger, P; Benk, AS; Amit, I; Zandstra, PW; Lupien, M; Dick, JE; Trumpp, A; Spitz, F				Bahr, Carsten; von Paleske, Lisa; Slu, Veli V. U.; Emeseiro, Silvia R.; Takayama, Naoya; Ng, Stanley W.; Murison, Alex; Langenfeld, Katja; Petretich, Massimo; Scognamiglio, Roberta; Zeisberger, Petra; Benk, Amelie S.; Amit, Ido; Zandstra, Peter W.; Lupien, Mathieu; Dick, John E.; Trumpp, Andreas; Spitz, Francois			A Myc enhancer cluster regulates normal and leukaemic haematopoietic stem cell hierarchies	NATURE			English	Article							GENE-EXPRESSION; IDENTIFICATION; TRANSFORMATION; TRANSCRIPTION; SPECIFICITY; NETWORKS; REVEALS; DOMAINS; TISSUE; RISK	The transcription factor Myc is essential for the regulation of haematopoietic stem cells and progenitors and has a critical function in haematopoietic malignancies(1). Here we show that an evolutionarily conserved region located 1.7 megabases downstream of the Myc gene that has previously been labelled as a 'superenhancer'(2) is essential for the regulation of Myc expression levels in both normal haematopoietic and leukaemic stem cell hierarchies in mice and humans. Deletion of this region in mice leads to a complete loss of Myc expression in haematopoietic stem cells and progenitors. This caused an accumulation of differentiation-arrested multipotent progenitors and loss of myeloid and B cells, mimicking the phenotype caused by Mx1-Cre-mediated conditional deletion of the Myc gene in haematopoietic stem cells(3). This super-enhancer comprises multiple enhancer modules with selective activity that recruits a compendium of transcription factors, including GFI1b, RUNX1 and MYB. Analysis of mice carrying deletions of individual enhancer modules suggests that specific Myc expression levels throughout most of the haematopoietic hierarchy are controlled by the combinatorial and additive activity of individual enhancer modules, which collectively function as a ` blood enhancer cluster' (BENC). We show that BENC is also essential for the maintenance of MLL-AF9-driven leukaemia in mice. Furthermore, a BENC module, which controls Myc expression in mouse haematopoietic stem cells and progenitors, shows increased chromatin accessibility in human acute myeloid leukaemia stem cells compared to blasts. This difference correlates with MYC expression and patient outcome. We propose that clusters of enhancers, such as BENC, form highly combinatorial systems that allow precise control of gene expression across normal cellular hierarchies and which also can be hijacked in malignancies.	[Bahr, Carsten; von Paleske, Lisa; Scognamiglio, Roberta; Zeisberger, Petra; Benk, Amelie S.; Trumpp, Andreas] German Canc Res Ctr, Div Stem Cells & Canc, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Bahr, Carsten; von Paleske, Lisa; Scognamiglio, Roberta; Zeisberger, Petra; Benk, Amelie S.; Trumpp, Andreas] DKFZ ZMBH Alliance, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Bahr, Carsten; von Paleske, Lisa; Scognamiglio, Roberta; Zeisberger, Petra; Benk, Amelie S.; Trumpp, Andreas] Heidelberg Inst Stem Cell Technol & Expt Med HI S, Neuenheimer Feld 280, D-69120 Heidelberg, Germany; [Bahr, Carsten; von Paleske, Lisa; Scognamiglio, Roberta; Benk, Amelie S.; Trumpp, Andreas] Heidelberg Univ, Fac Biosci, D-69120 Heidelberg, Germany; [Slu, Veli V. U.; Emeseiro, Silvia R.; Langenfeld, Katja; Petretich, Massimo; Spitz, Francois] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Takayama, Naoya; Murison, Alex; Lupien, Mathieu; Dick, John E.] Univ Hlth Network, Princess Margaret Canc Ctr, Toronto, ON M5G 2M9, Canada; [Takayama, Naoya; Dick, John E.] Univ Toronto, Dept Mol Genet, Toronto, ON M5G 1A1, Canada; [Ng, Stanley W.; Zandstra, Peter W.] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON M5G 1A1, Canada; [Murison, Alex; Lupien, Mathieu] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada; [Amit, Ido] Weizmann Inst Sci, Dept Immunol, IL-76100 Rehovot, Israel; [Trumpp, Andreas] German Canc Consortium DKTK, D-69120 Heidelberg, Germany; [Trumpp, Andreas] Natl Zentrum Tumorerkrankungen NCT, D-69120 Heidelberg, Germany; [Spitz, Francois] CNRS, UMR3738, 25 Rue Dr Roux, F-75015 Paris, France; [Spitz, Francois] Inst Pasteur, Dev & Stem Cell Biol Dept, Epi Genom Anim Dev Unit, F-75015 Paris, France; [Zandstra, Peter W.] Univ British Columbia, Sch Biomed Engn, Michael Smith Labs, 301-2185 East Mall, Vancouver, BC V6T 1Z4, Canada	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; European Molecular Biology Laboratory (EMBL); University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University of Toronto; University of Toronto; Weizmann Institute of Science; Helmholtz Association; German Cancer Research Center (DKFZ); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; University of British Columbia	Trumpp, A (corresponding author), German Canc Res Ctr, Div Stem Cells & Canc, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.; Trumpp, A (corresponding author), DKFZ ZMBH Alliance, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.; Trumpp, A (corresponding author), Heidelberg Inst Stem Cell Technol & Expt Med HI S, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.; Trumpp, A (corresponding author), Heidelberg Univ, Fac Biosci, D-69120 Heidelberg, Germany.; Spitz, F (corresponding author), European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany.; Trumpp, A (corresponding author), German Canc Consortium DKTK, D-69120 Heidelberg, Germany.; Trumpp, A (corresponding author), Natl Zentrum Tumorerkrankungen NCT, D-69120 Heidelberg, Germany.; Spitz, F (corresponding author), CNRS, UMR3738, 25 Rue Dr Roux, F-75015 Paris, France.; Spitz, F (corresponding author), Inst Pasteur, Dev & Stem Cell Biol Dept, Epi Genom Anim Dev Unit, F-75015 Paris, France.	a.trumpp@dkfz.de; francois.spitz@pasteur.fr	Trumpp, Andreas/Z-2141-2019	Trumpp, Andreas/0000-0002-6212-3466; Remeseiro, Silvia/0000-0001-5343-007X; Dick, John/0000-0002-9527-8317; Spitz, Francois/0000-0002-1960-829X	Jeff Schell Darwin Trust; EMBL international PhD program; Helmholtz International Graduate School for Cancer Research; EMBL (EIPOD) under Marie Curie Actions COFUND; Medicine by Design program (Toronto University); Ontario Institute for Cancer Research; Cancer Stem Cell Consortium [OGI-047]; Canadian Institutes of Health Research; CIHR-Japan Epigenetics in Stem Cells Program; Canadian Cancer Society; Terry Fox Foundation; Canada Research Chair; Deutsche Forschungsgemeinschaft [SFB 873, FOR 2674]; SyTASC consortium (Deutsche Krebshilfe); Dietmar Hopp Foundation	Jeff Schell Darwin Trust; EMBL international PhD program; Helmholtz International Graduate School for Cancer Research; EMBL (EIPOD) under Marie Curie Actions COFUND; Medicine by Design program (Toronto University); Ontario Institute for Cancer Research; Cancer Stem Cell Consortium; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); CIHR-Japan Epigenetics in Stem Cells Program; Canadian Cancer Society(Canadian Cancer Society (CCS)); Terry Fox Foundation; Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); SyTASC consortium (Deutsche Krebshilfe)(Deutsche Krebshilfe); Dietmar Hopp Foundation	We thank members of the Spitz and Trumpp laboratories and colleagues for sharing reagents and helpful comments; A. Przybylla, M. Sohn and M. Neubauer for technical assistance; L. Alfaro and W. Zhang for sample preparation for RNA sequencing; M. Milsom for critical reading of the manuscript; R. Grosschedl and S. Boller for help with B cell development analysis; and the DKFZ Flow Cytometry Core facility and the EMBL and DKFZ Laboratory Animal Resource Facilities. Support was provided by PhD fellowships to V.V.U. (Jeff Schell Darwin Trust); M.P. (EMBL international PhD program), C.B. (Helmholtz International Graduate School for Cancer Research) and post-doctoral fellowship to S. R. (EMBL (EIPOD) under Marie Curie Actions COFUND). The J.E.D. and M.L. laboratories were supported in part by the Medicine by Design program (Toronto University), the Ontario Institute for Cancer Research, Cancer Stem Cell Consortium (OGI-047), the Canadian Institutes of Health Research and the CIHR-Japan Epigenetics in Stem Cells Program, Canadian Cancer Society, Terry Fox Foundation, and a Canada Research Chair to J.E.D. The A.T. laboratory was supported by the SFB 873 and FOR 2674 (Deutsche Forschungsgemeinschaft), the SyTASC consortium (Deutsche Krebshilfe) and the Dietmar Hopp Foundation.	Ahmadiyeh N, 2010, P NATL ACAD SCI USA, V107, P9742, DOI 10.1073/pnas.0910668107; Bradner JE, 2017, CELL, V168, P629, DOI 10.1016/j.cell.2016.12.013; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; Corces MR, 2016, NAT GENET, V48, P1193, DOI 10.1038/ng.3646; Delgado M Dolores, 2010, Genes Cancer, V1, P605, DOI 10.1177/1947601910377495; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Eppert K, 2011, NAT MED, V17, P1086, DOI 10.1038/nm.2415; Fulco CP, 2016, SCIENCE, V354, P769, DOI 10.1126/science.aag2445; Guo W., 2008, NAT PROTOC EXCH; Guo YS, 2009, BLOOD, V114, P2097, DOI 10.1182/blood-2009-01-197947; Heng TSP, 2008, NAT IMMUNOL, V9, P1091, DOI 10.1038/ni1008-1091; Herranz D, 2014, NAT MED, V20, P1130, DOI 10.1038/nm.3665; Hsu PD, 2013, NAT BIOTECHNOL, V31, P827, DOI 10.1038/nbt.2647; Kieffer-Kwon KR, 2013, CELL, V155, P1507, DOI 10.1016/j.cell.2013.11.039; Kim J, 2010, CELL, V143, P313, DOI 10.1016/j.cell.2010.09.010; Krivtsov AV, 2006, NATURE, V442, P818, DOI 10.1038/nature04980; Kuhn MWM, 2012, BLOOD, V119, pE67, DOI 10.1182/blood-2011-09-380444; Lara-Astiaso D, 2014, SCIENCE, V345, P943, DOI 10.1126/science.1256271; Laurenti E, 2013, NAT IMMUNOL, V14, P756, DOI 10.1038/ni.2615; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li QL, 2002, BLOOD, V100, P3077, DOI 10.1182/blood-2002-04-1104; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Marinic M, 2013, DEV CELL, V24, P530, DOI 10.1016/j.devcel.2013.01.025; Mifsud B, 2015, NAT GENET, V47, P598, DOI 10.1038/ng.3286; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nalls MA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002113; Ng SWK, 2016, NATURE, V540, P433, DOI 10.1038/nature20598; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Okada Y, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002067; Qiao WL, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002838; Radtke I, 2009, P NATL ACAD SCI USA, V106, P12944, DOI 10.1073/pnas.0903142106; Rathert P, 2015, NATURE, V525, P543, DOI 10.1038/nature14898; Schuhmacher M, 2001, NUCLEIC ACIDS RES, V29, P397, DOI 10.1093/nar/29.2.397; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Shi J, 2013, GENE DEV, V27, P2648, DOI 10.1101/gad.232710.113; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sur IK, 2012, SCIENCE, V338, P1360, DOI 10.1126/science.1228606; Therneau TM, 2000, MODELING SURVIVAL DA; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Uslu VV, 2014, NAT GENET, V46, P753, DOI 10.1038/ng.2971; Wang HY, 2013, CELL, V153, P910, DOI 10.1016/j.cell.2013.04.025; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; Yashiro-Ohtani Y, 2014, P NATL ACAD SCI USA, V111, pE4946, DOI 10.1073/pnas.1407079111; Zhang XY, 2016, NAT GENET, V48, P176, DOI 10.1038/ng.3470; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	48	154	157	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2018	553	7689					515	+		10.1038/nature25193	http://dx.doi.org/10.1038/nature25193			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU6OE	29342133				2022-12-28	WOS:000423971100043
J	Gorg, F; Messer, M; Sandholzer, K; Jotzu, G; Desbuquois, R; Esslinger, T				Goerg, Frederik; Messer, Michael; Sandholzer, Kilian; Jotzu, Gregor; Desbuquois, Remi; Esslinger, Tilman			Enhancement and sign change of magnetic correlations in a driven quantum many-body system	NATURE			English	Article							OPTICAL LATTICES; HIGH-TEMPERATURE; ULTRAFAST; ELECTRONS; ATOMS	Periodic driving can be used to control the properties of a many-body state coherently and to realize phases that are not accessible in static systems. For example, exposing materials to intense laser pulses makes it possible to induce metal-insulator transitions, to control magnetic order and to generate transient superconducting behaviour well above the static transition temperature(1-6). However, pinning down the mechanisms underlying these phenomena is often difficult because the response of a material to irradiation is governed by complex, many-body dynamics. For static systems, extensive calculations have been performed to explain phenomena such as high-temperature superconductivity(7). Theoretical analyses of driven many-body Hamiltonians are more challenging, but approaches have now been developed, motivated by recent observations(8-10). Here we report an experimental quantum simulation in a periodically modulated hexagonal lattice and show that antiferromagnetic correlations in a fermionic many-body system can be reduced, enhanced or even switched to ferromagnetic correlations (sign reversal). We demonstrate that the description of the many-body system using an effective Floquet-Hamiltonian with a renormalized tunnelling energy remains valid in the high-frequency regime by comparing the results to measurements in an equivalent static lattice. For near-resonant driving, the enhancement and sign reversal of correlations is explained by a microscopic model of the system in which the particle tunnelling and magnetic exchange energies can be controlled independently. In combination with the observed sufficiently long lifetimes of the correlations in this system, periodic driving thus provides an alternative way of investigating unconventional pairing in strongly correlated systems experimentally(7,9,10).	[Goerg, Frederik; Messer, Michael; Sandholzer, Kilian; Jotzu, Gregor; Desbuquois, Remi; Esslinger, Tilman] Swiss Fed Inst Technol, Inst Quantum Elect, CH-8093 Zurich, Switzerland; [Jotzu, Gregor] Max Planck Inst Struct & Dynam Matter, D-22761 Hamburg, Germany	Swiss Federal Institutes of Technology Domain; ETH Zurich; Max Planck Society	Esslinger, T (corresponding author), Swiss Fed Inst Technol, Inst Quantum Elect, CH-8093 Zurich, Switzerland.	esslinger@phys.ethz.ch	Esslinger, Tilman/M-9022-2016	Esslinger, Tilman/0000-0002-8333-107X; Sandholzer, Kilian/0000-0002-9435-877X; Jotzu, Gregor/0000-0003-4421-5874; Desbuquois, Remi/0000-0003-3726-0538	SNF [200020_169320]; SNF (NCCR-QSIT); Swiss State Secretary for Education, Research and Innovation [15.0019]; ERC advanced grant TransQ [742579]	SNF; SNF (NCCR-QSIT); Swiss State Secretary for Education, Research and Innovation; ERC advanced grant TransQ	We thank D. Abanin, D. Greif, D. Jaksch, M. Landini, Y. Murakami, N. Tsuji, P. Werner and W. Zwerger for discussions. We acknowledge SNF (Project Number 200020_169320 and NCCR-QSIT), Swiss State Secretary for Education, Research and Innovation Contract No. 15.0019 (QUIC) and ERC advanced grant TransQ (Project Number 742579) for funding.	Bermudez A, 2015, NEW J PHYS, V17, DOI 10.1088/1367-2630/17/10/103021; Bukov M, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.125301; Bukov M, 2015, ADV PHYS, V64, P139, DOI 10.1080/00018732.2015.1055918; Chen YA, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.210405; Coulthard JR, 2017, PHYS REV B, V96, DOI 10.1103/PhysRevB.96.085104; DAGOTTO E, 1994, REV MOD PHYS, V66, P763, DOI 10.1103/RevModPhys.66.763; Desbuquois R, 2017, PHYS REV A, V96, DOI 10.1103/PhysRevA.96.053602; Eckardt A, 2017, REV MOD PHYS, V89, DOI 10.1103/RevModPhys.89.011004; Goldman N, 2014, PHYS REV X, V4, DOI 10.1103/PhysRevX.4.031027; Greif D, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.260401; Greif D, 2013, SCIENCE, V340, P1307, DOI 10.1126/science.1236362; Ho WW, 2017, PHYS REV B, V95, DOI 10.1103/PhysRevB.95.094302; Imriska J, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.115301; Jotzu G, 2015, PHYS REV LETT, V115, DOI 10.1103/PhysRevLett.115.073002; Kirilyuk A, 2010, REV MOD PHYS, V82, P2731, DOI 10.1103/RevModPhys.82.2731; Kitamura S, 2016, PHYS REV B, V94, DOI 10.1103/PhysRevB.94.174503; Kuwahara T, 2016, ANN PHYS-NEW YORK, V367, P96, DOI 10.1016/j.aop.2016.01.012; Li TQ, 2013, NATURE, V496, P69, DOI 10.1038/nature11934; Ma RC, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.095301; Mariager SO, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.087201; Meinert F, 2016, PHYS REV LETT, V116, DOI 10.1103/PhysRevLett.116.205301; Mentink JH, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7708; Mitrano M, 2016, NATURE, V530, P461, DOI 10.1038/nature16522; Nicoletti D, 2016, ADV OPT PHOTONICS, V8, P401, DOI 10.1364/AOP.8.000401; Parker CV, 2013, NAT PHYS, V9, P769, DOI [10.1038/nphys2789, 10.1038/NPHYS2789]; Rini M, 2007, NATURE, V449, P72, DOI 10.1038/nature06119; Sciolla B, 2013, PHYS REV A, V88, DOI 10.1103/PhysRevA.88.063629; Struck J, 2011, SCIENCE, V333, P996, DOI 10.1126/science.1207239; Tarruell L, 2012, NATURE, V483, P302, DOI 10.1038/nature10871; Trotzky S, 2008, SCIENCE, V319, P295, DOI 10.1126/science.1150841; Uehlinger T, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.185307; Zenesini A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.100403	33	86	87	1	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2018	553	7689					481	+		10.1038/nature25135	http://dx.doi.org/10.1038/nature25135			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU6OE	29368703	Green Submitted			2022-12-28	WOS:000423971100036
J	[Anonymous]				[Anonymous]			Vaccine boosters (vol 553, pg 259, 2018)	NATURE			English	Correction																		*NATURE, 2018, NATURE, V553, P259	1	2	2	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2018	553	7689					392	392		10.1038/d41586-018-01073-7	http://dx.doi.org/10.1038/d41586-018-01073-7			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU6OE	29368736	Bronze			2022-12-28	WOS:000423971100010
J	Tregoning, J				Tregoning, John			From parade ground to PI	SCIENCE			English	Editorial Material								At the end of my postdoc, I excelled at moving tiny amounts of colorless fluid from one tube to another at strange times of day, and I had a vague sense of where I wanted to go scientifically. But my experience in the lab wasn't sufficient to equip me to run my own group. That preparation came from my double life as a British Army Reserve officer. Admittedly, I learned several things in the army that have not been so useful in a research lab, including how to march in time with others, shout very loudly, and swear with an unrivaled range of colorful expletives. Critically, though, my time in the army taught me how to be a leader-for good and ill.	[Tregoning, John] Imperial Coll London, London, England	Imperial College London	Tregoning, J (corresponding author), Imperial Coll London, London, England.			Tregoning, John/0000-0001-8093-8741					0	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					362	362		10.1126/science.359.6373.362	http://dx.doi.org/10.1126/science.359.6373.362			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT6BB	29348239	Bronze			2022-12-28	WOS:000423236700043
J	Friedrich, MJ				Friedrich, M. J.			Dangers of Substandard or Falsified Medicines	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	0	0	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2018	319	3					219	219		10.1001/jama.2017.21291	http://dx.doi.org/10.1001/jama.2017.21291			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT3BY	29340691				2022-12-28	WOS:000423022300003
J	Mitroulis, I; Ruppova, K; Wang, BM; Chen, LS; Grzybek, M; Grinenko, T; Eugster, A; Troullinaki, M; Palladini, A; Kourtzelis, I; Chatzigeorgiou, A; Schlitzer, A; Beyer, M; Joosten, LAB; Isermann, B; Lesche, M; Petzold, A; Simons, K; Henry, I; Dahl, A; Schultze, JL; Wielockx, B; Zamboni, N; Mirtschink, P; Coskun, U; Hajishengallis, G; Netea, MG; Chavakis, T				Mitroulis, Ioannis; Ruppova, Klara; Wang, Baomei; Chen, Lan-Sun; Grzybek, Michal; Grinenko, Tatyana; Eugster, Anne; Troullinaki, Maria; Palladini, Alessandra; Kourtzelis, Ioannis; Chatzigeorgiou, Antonios; Schlitzer, Andreas; Beyer, Marc; Joosten, Leo A. B.; Isermann, Berend; Lesche, Mathias; Petzold, Andreas; Simons, Kai; Henry, Ian; Dahl, Andreas; Schultze, Joachim L.; Wielockx, Ben; Zamboni, Nicola; Mirtschink, Peter; Coskun, Unal; Hajishengallis, George; Netea, Mihai G.; Chavakis, Triantafyllos			Modulation of Myelopoiesis Progenitors Is an Integral Component of Trained Immunity	CELL			English	Article							HEMATOPOIETIC STEM-CELLS; HIGH-THROUGHPUT; SELF-RENEWAL; LINEAGE COMMITMENT; GLOBAL ANALYSIS; DORMANCY; DIFFERENTIATION; PROLIFERATION; ACCUMULATION; QUIESCENCE	Trained innate immunity fosters a sustained favorable response of myeloid cells to a secondary challenge, despite their short lifespan in circulation. We thus hypothesized that trained immunity acts via modulation of hematopoietic stem and progenitor cells (HSPCs). Administration of beta-glucan (prototypical trained-immunity-inducing agonist) to mice induced expansion of progenitors of the myeloid lineage, which was associated with elevated signaling by innate immune mediators, such as IL-1 beta and granulocyte-macrophage colony-stimulating factor (GM-CSF), and with adaptations in glucose metabolism and cholesterol biosynthesis. The trained-immunity-related increase in myelopoiesis resulted in a beneficial response to secondary LPS challenge and protection from chemotherapy-induced myelosuppression in mice. Therefore, modulation of myeloid progenitors in the bone marrow is an integral component of trained immunity, which to date, was considered to involve functional changes of mature myeloid cells in the periphery.	[Mitroulis, Ioannis; Ruppova, Klara; Chen, Lan-Sun; Grinenko, Tatyana; Troullinaki, Maria; Palladini, Alessandra; Kourtzelis, Ioannis; Chatzigeorgiou, Antonios; Wielockx, Ben; Mirtschink, Peter; Chavakis, Triantafyllos] Tech Univ Dresden, Inst Clin Chem & Lab Med, Dresden, Germany; [Wang, Baomei; Hajishengallis, George] Univ Penn, Sch Dent Med, Dept Microbiol, Philadelphia, PA 19104 USA; [Grzybek, Michal; Palladini, Alessandra; Coskun, Unal] Tech Univ Dresden, Univ Hosp, Helmholtz Zentrum Munchen, Paul Langerhans Inst Dresden, Dresden, Germany; [Grzybek, Michal; Palladini, Alessandra; Coskun, Unal] Tech Univ Dresden, Fac Med Carl Gustav Carus, Dresden, Germany; [Grzybek, Michal; Palladini, Alessandra; Coskun, Unal] German Ctr Diabet Res DZD eV, Neuherberg, Germany; [Eugster, Anne] DFG Ctr Regenerat Therapies Dresden, Dresden, Germany; [Schlitzer, Andreas] Univ Bonn, LIMES Inst, Myeloid Cell Biol, Bonn, Germany; [Beyer, Marc; Netea, Mihai G.] Univ Bonn, Life & Med Sci Inst, Dept Genom & Immunoregulat, Bonn, Germany; [Beyer, Marc] German Ctr Neurodegenerat Dis DZNE, Mol Immunol Neurodegenerat, Bonn, Germany; [Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 GA Nijmegen, Netherlands; [Joosten, Leo A. B.; Netea, Mihai G.] Radboud Univ Nijmegen, Med Ctr, Radboud Ctr Infect Dis, NL-6525 GA Nijmegen, Netherlands; [Isermann, Berend] Otto Von Guericke Univ, Inst Clin Chem & Pathobiochem, Magdeburg, Germany; [Lesche, Mathias; Petzold, Andreas; Dahl, Andreas] Tech Univ Dresden, Deep Sequencing Grp, Biotechnol Ctr, Dresden, Germany; [Simons, Kai; Henry, Ian] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany; [Simons, Kai] Lipotype GmbH, Dresden, Germany; [Schultze, Joachim L.] German Ctr Neurodegenerat Dis, PRECISE Platform Single Cell Genom & Epigenom, Bonn, Germany; [Schultze, Joachim L.] Univ Bonn, Bonn, Germany; [Zamboni, Nicola] Swiss Fed Inst Technol, Inst Mol Syst Biol, Zurich, Switzerland; [Mitroulis, Ioannis] Tech Univ Dresden, Inst Clin Chem & Lab Med, Dresden, Germany; [Mitroulis, Ioannis] Natl Ctr Tumor Dis, Dresden, Germany	Technische Universitat Dresden; University of Pennsylvania; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; German Research Foundation (DFG); Technische Universitat Dresden; University of Bonn; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Radboud University Nijmegen; Radboud University Nijmegen; Otto von Guericke University; Technische Universitat Dresden; Max Planck Society; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; Swiss Federal Institutes of Technology Domain; ETH Zurich; Technische Universitat Dresden	Mitroulis, I; Chavakis, T (corresponding author), Tech Univ Dresden, Inst Clin Chem & Lab Med, Dresden, Germany.; Mitroulis, I (corresponding author), Tech Univ Dresden, Inst Clin Chem & Lab Med, Dresden, Germany.; Mitroulis, I (corresponding author), Natl Ctr Tumor Dis, Dresden, Germany.	ioannis.mitroulis@uniklinikum-dresden.de; triantafyllos.chavakis@uniklinikum-dresden.de	Henry, Ian/J-7328-2019; Hajishengallis, George N./K-1117-2019; Netea, Mihai/N-5155-2014; Zamboni, Nicola/K-3042-2012; Palladini, Alessandra/AAV-7838-2021; Chavakis, Triantafyllos/ABE-8845-2020; Joosten, Leo AB/H-3138-2015; Mitroulis, Ioannis/AAB-7915-2021; Schultze, Joachim L./ABA-8176-2020; Beyer, Marc/ABE-1408-2021; Dahl, Andreas/E-3783-2017; Wielockx, Ben/AAC-6854-2020; Grzybek, Michal/D-3802-2017; Coskun, Unal/F-4683-2011	Henry, Ian/0000-0002-7134-3110; Hajishengallis, George N./0000-0001-7392-8852; Zamboni, Nicola/0000-0003-1271-1021; Palladini, Alessandra/0000-0001-5307-8643; Joosten, Leo AB/0000-0001-6166-9830; Mitroulis, Ioannis/0000-0002-9991-2362; Schultze, Joachim L./0000-0003-2812-9853; Beyer, Marc/0000-0001-9704-148X; Dahl, Andreas/0000-0002-2668-8371; Wielockx, Ben/0000-0002-4923-2596; Grinenko, Tatyana/0000-0002-2582-1417; Chatzigeorgiou, Antonios/0000-0002-7039-4223; Chen, Lan-Sun/0000-0002-5917-3083; Kourtzelis, Ioannis/0000-0003-3006-8885; Grzybek, Michal/0000-0003-2083-0506; Coskun, Unal/0000-0003-4375-3144	ERC (Consolidator grant DEMETINL); Deutsche Forschungsgemeinschaft [CH279/5-1, TR-SFB127, SFB 854/B26N]; NIH [DE024716, DE026152]; German Federal Ministry of Education and Research grant; ERC Consolidator Grant [310372]; Spinoza Grant of the Netherlands Association for Scientific Research; IN-CONTROL CVON grant from the Netherlands Heart Foundation [CVON2012-03]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE026152, R01DE024716] Funding Source: NIH RePORTER	ERC (Consolidator grant DEMETINL); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Federal Ministry of Education and Research grant; ERC Consolidator Grant(Estonian Research Council); Spinoza Grant of the Netherlands Association for Scientific Research; IN-CONTROL CVON grant from the Netherlands Heart Foundation; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by grants from the ERC (Consolidator grant DEMETINL to T.C.), the Deutsche Forschungsgemeinschaft (CH279/5-1 and TR-SFB127 to T.C. and SFB 854/B26N to B.I.), and from the NIH (DE024716 to G.H. and DE026152 to G.H. and T.C.). A.S., M.B., and J.L.S. are members of the Excellence Cluster ImmunoSensation. U.C. was supported by the German Federal Ministry of Education and Research grant to the German Center for Diabetes Research (DZD e.V.). M.G.N. was supported by an ERC Consolidator Grant (#310372) and a Spinoza Grant of the Netherlands Association for Scientific Research. MGN and LABJ were partly supported by an IN-CONTROL CVON grant from the Netherlands Heart Foundation (CVON2012-03).	Arts RJW, 2016, CELL METAB, V24, P807, DOI 10.1016/j.cmet.2016.10.008; Arts RJW, 2016, CELL REP, V17, P2562, DOI 10.1016/j.celrep.2016.11.011; Bonifacio E, 2015, JAMA-J AM MED ASSOC, V313, P1541, DOI 10.1001/jama.2015.2928; Chen C, 2010, J CLIN INVEST, V120, P4091, DOI 10.1172/JCI43873; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Coskun U, 2011, STRUCTURE, V19, P1543, DOI 10.1016/j.str.2011.10.010; Cutando L, 2013, J CLIN INVEST, V123, P2816, DOI 10.1172/JCI67569; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Frelin C, 2013, NAT IMMUNOL, V14, P1037, DOI 10.1038/ni.2692; Fuhrer T, 2011, ANAL CHEM, V83, P7074, DOI 10.1021/ac201267k; Gekas C, 2013, BLOOD, V121, P4463, DOI 10.1182/blood-2012-09-457929; Goodridge HS, 2016, NAT REV IMMUNOL, V16, P392, DOI 10.1038/nri.2016.43; Herzog R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029851; Herzog R, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-1-r8; Hosoya T, 2009, J EXP MED, V206, P2987, DOI 10.1084/jem.20090934; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Jensen KJ, 2015, J INFECT DIS, V211, P956, DOI 10.1093/infdis/jiu508; Kaul S, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.004401; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liebisch G, 2006, BBA-MOL CELL BIOL L, V1761, P121, DOI 10.1016/j.bbalip.2005.12.007; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mills EL, 2016, EUR J IMMUNOL, V46, P13, DOI 10.1002/eji.201445427; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Murphy AJ, 2011, J CLIN INVEST, V121, P4138, DOI 10.1172/JCI57559; Musso G, 2015, GENOM DATA, V6, P199, DOI 10.1016/j.gdata.2015.09.015; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; Netea MG, 2016, SCIENCE, V352, DOI 10.1126/science.aaf1098; Netea MG, 2014, SEMIN IMMUNOL, V26, P512, DOI 10.1016/j.smim.2014.09.006; Nimmo RA, 2015, TRENDS CELL BIOL, V25, P459, DOI 10.1016/j.tcb.2015.04.004; Norata GD, 2015, IMMUNITY, V43, P421, DOI 10.1016/j.immuni.2015.08.023; Novershtern N, 2011, CELL, V144, P296, DOI 10.1016/j.cell.2011.01.004; Passegue E, 2005, J EXP MED, V202, P1599, DOI 10.1084/jem.20050967; Pietras EM, 2016, NAT CELL BIOL, V18, P607, DOI 10.1038/ncb3346; Pietras EM, 2015, CELL STEM CELL, V17, P35, DOI 10.1016/j.stem.2015.05.003; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; R Development Core Team, 2016, R LANG ENV STAT COMP; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Sarrazin S, 2011, SEMIN IMMUNOL, V23, P326, DOI 10.1016/j.smim.2011.08.011; Sezgin E, 2017, NAT REV MOL CELL BIO, V18, P361, DOI 10.1038/nrm.2017.16; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; Suda T, 2011, CELL STEM CELL, V9, P298, DOI 10.1016/j.stem.2011.09.010; Surma MA, 2015, EUR J LIPID SCI TECH, V117, P1540, DOI 10.1002/ejlt.201500145; Takizawa H, 2017, CELL STEM CELL, V21, P225, DOI 10.1016/j.stem.2017.06.013; Takubo K, 2013, CELL STEM CELL, V12, P49, DOI 10.1016/j.stem.2012.10.011; Trumpp A, 2010, NAT REV IMMUNOL, V10, P201, DOI 10.1038/nri2726; VANDERMEER JWM, 1988, P NATL ACAD SCI USA, V85, P1620; Walter D, 2015, NATURE, V520, P549, DOI 10.1038/nature14131; Wang YH, 2014, CELL, V158, P1309, DOI 10.1016/j.cell.2014.07.048; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2007, J STAT SOFTW, V21, P1; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Winkler IG, 2012, NAT MED, V18, P1651, DOI 10.1038/nm.2969; Wu TD, 2010, BIOINFORMATICS, V26, P873, DOI 10.1093/bioinformatics/btq057; Yamada T, 2013, CELL CYCLE, V12, P2376, DOI 10.4161/cc.25416; Yanez A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024761; Yang J, 2017, NUCLEIC ACIDS RES, V45, P1281, DOI 10.1093/nar/gkw1214; Yvan-Charvet L, 2010, SCIENCE, V328, P1689, DOI 10.1126/science.1189731; Zhang HJ, 2016, STEM CELL REP, V6, P940, DOI 10.1016/j.stemcr.2016.05.002; Zhao JL, 2015, CURR OPIN HEMATOL, V22, P286, DOI 10.1097/MOH.0000000000000149	62	456	473	15	88	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	2018	172	1-2					147	+		10.1016/j.cell.2017.11.034	http://dx.doi.org/10.1016/j.cell.2017.11.034			27	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FS5MI	29328910	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000419840100016
J	Moreno-Mayar, JV; Potter, BA; Vinner, L; Steinrucken, M; Rasmussen, S; Terhorst, J; Kamm, JA; Albrechtsen, A; Malaspinas, AS; Sikora, M; Reuther, JD; Irish, JD; Malhi, RS; Orlando, L; Song, YS; Nielsen, R; Meltzer, DJ; Willerslev, E				Moreno-Mayar, J. Victor; Potter, Ben A.; Vinner, Lasse; Steinrucken, Matthias; Rasmussen, Simon; Terhorst, Jonathan; Kamm, John A.; Albrechtsen, Anders; Malaspinas, Anna-Sapfo; Sikora, Martin; Reuther, Joshua D.; Irish, Joel D.; Malhi, Ripan S.; Orlando, Ludovic; Song, Yun S.; Nielsen, Rasmus; Meltzer, David J.; Willerslev, Eske			Terminal Pleistocene Alaskan genome reveals first founding population of Native Americans	NATURE			English	Article							GENERATION SEQUENCING DATA; ADMIXTURE; ANCESTRY; HISTORY; BERINGIA; BURIAL	Despite broad agreement that the Americas were initially populated via Beringia, the land bridge that connected far northeast Asia with northwestern North America during the Pleistocene epoch, when and how the peopling of the Americas occurred remains unresolved(1-5). Analyses of human remains from Late Pleistocene Alaska are important to resolving the timing and dispersal of these populations. The remains of two infants were recovered at Upward Sun River (USR), and have been dated to around 11.5 thousand years ago (ka)(6). Here, by sequencing the USR1 genome to an average coverage of approximately 17 times, we show that USR1 is most closely related to Native Americans, but falls basal to all previously sequenced contemporary and ancient Native Americans(1,7,8). As such, USR1 represents a distinct Ancient Beringian population. Using demographic modelling, we infer that the Ancient Beringian population and ancestors of other Native Americans descended from a single founding population that initially split from East Asians around 36 +/- 1.5 ka, with gene flow persisting until around 25 +/- 1.1 ka. Gene flow from ancient north Eurasians into all Native Americans took place 25-20 ka, with Ancient Beringians branching off around 22-18.1 ka. Our findings support a long-term genetic structure in ancestral Native Americans, consistent with the Beringian 'standstill model'(9). We show that the basal northern and southern Native American branches, to which all other Native Americans belong, diverged around 17.5-14.6 ka, and that this probably occurred south of the North American ice sheets. We also show that after 11.5 ka, some of the northern Native American populations received gene flow from a Siberian population most closely related to Koryaks, but not Palaeo-Eskimos(1), Inuits or Kets(10), and that Native American gene flow into Inuits was through northern and not southern Native American groups(1). Our findings further suggest that the far-northern North American presence of northern Native Americans is from a back migration that replaced or absorbed the initial founding population of Ancient Beringians.	[Moreno-Mayar, J. Victor; Vinner, Lasse; Malaspinas, Anna-Sapfo; Sikora, Martin; Orlando, Ludovic; Nielsen, Rasmus; Meltzer, David J.; Willerslev, Eske] Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark; [Potter, Ben A.; Reuther, Joshua D.] Univ Alaska, Dept Anthropol, Fairbanks, AK 99775 USA; [Steinrucken, Matthias] Univ Massachusetts, Dept Biostat & Epidemiol, Amherst, MA 01003 USA; [Steinrucken, Matthias] Univ Chicago, Dept Ecol & Evolut, 940 E 57Th St, Chicago, IL 60637 USA; [Rasmussen, Simon] Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Terhorst, Jonathan; Kamm, John A.; Song, Yun S.; Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Terhorst, Jonathan] Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA; [Kamm, John A.; Willerslev, Eske] Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England; [Albrechtsen, Anders] Univ Copenhagen, Dept Biol, Bioinformat Ctr, DK-2200 Copenhagen, Denmark; [Malaspinas, Anna-Sapfo] Univ Lausanne, Dept Computat Biol, Lausanne, Switzerland; [Malaspinas, Anna-Sapfo] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Irish, Joel D.] Liverpool John Moores Univ, Res Ctr Evolutionary Anthropol & Palaeoecol, Liverpool L3 3AF, Merseyside, England; [Malhi, Ripan S.] Univ Illinois, Dept Anthropol, Urbana, IL 61801 USA; [Malhi, Ripan S.] Univ Illinois, Carle R Woese Inst Genom Biol, Urbana, IL 61801 USA; [Song, Yun S.] Univ Calif Berkeley, Div Comp Sci, Berkeley, CA 94720 USA; [Song, Yun S.] Chan Zuckerberg Biohub, San Francisco, CA 94158 USA; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Meltzer, David J.] Southern Methodist Univ, Dept Anthropol, Dallas, TX 75275 USA; [Willerslev, Eske] Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England	University of Copenhagen; University of Alaska System; University of Alaska Fairbanks; University of Massachusetts System; University of Massachusetts Amherst; University of Chicago; Technical University of Denmark; University of California System; University of California Berkeley; University of Michigan System; University of Michigan; Wellcome Trust Sanger Institute; University of Copenhagen; University of Lausanne; Swiss Institute of Bioinformatics; Liverpool John Moores University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Southern Methodist University; University of Cambridge	Willerslev, E (corresponding author), Univ Copenhagen, Ctr GeoGenet, Nat Hist Museum Denmark, DK-1350 Copenhagen, Denmark.; Willerslev, E (corresponding author), Wellcome Trust Sanger Inst, Wellcome Genome Campus, Cambridge CB10 1SA, England.; Willerslev, E (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	ewillerslev@snm.ku.dk	Nielsen, Rasmus/D-4405-2009; Willerslev, Eske/A-9619-2011; Rasmussen, Simon/G-6258-2016; Albrechtsen, Anders/K-4281-2013; Orlando, Ludovic/A-8932-2013; Sikora, Martin/C-8609-2015; Rasmussen, Simon/AAA-2308-2020; Moreno-Mayar, J. Víctor/AAB-3732-2022; Willerslev, Eske/AAA-5686-2019	Nielsen, Rasmus/0000-0003-0513-6591; Willerslev, Eske/0000-0002-7081-6748; Rasmussen, Simon/0000-0001-6323-9041; Albrechtsen, Anders/0000-0001-7306-031X; Orlando, Ludovic/0000-0003-3936-1850; Sikora, Martin/0000-0003-2818-8319; Rasmussen, Simon/0000-0001-6323-9041; Moreno-Mayar, J. Víctor/0000-0002-7712-4496; Meltzer, David/0000-0001-8084-9802; Potter, Ben/0000-0002-4749-0428; Vinner, Lasse/0000-0002-3081-3702; Kamm, Jack/0000-0003-2412-756X; Irish, Joel D./0000-0001-7857-8847; Malaspinas, Anna-Sapfo/0000-0003-1001-7511	Lundbeck Foundation; Danish National Research Foundation [DNRF94]; Conacyt (Mexico); NSF [1138811, 1223119]; NIH [R01-GM094402]; Packard Fellowship for Science and Engineering; Quest Archaeological Research Fund; Swiss National Science Foundation; ERC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094402] Funding Source: NIH RePORTER; Directorate For Geosciences [1223119] Funding Source: National Science Foundation; Lundbeck Foundation [R155-2013-16338, R38-2008-3048, R109-2012-9995, R24-2008-2527, R215-2015-4174, R70-2010-6286] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Danish National Research Foundation(Danmarks Grundforskningsfond); Conacyt (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Packard Fellowship for Science and Engineering; Quest Archaeological Research Fund; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ERC(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO)); Lundbeck Foundation(Lundbeckfonden)	The Upward Sun River excavations and analysis were conducted under a Memorandum of Agreement (MOA) signed by the State of Alaska, the National Science Foundation, the Healy Lake Tribal Council and the Tanana Chiefs Conference. We appreciate the cooperation of all parties. We thank M. Allentoft, S. Gopalakrishnan, T. Korneliussen, P. Librado, J. Ramos-Madrigal, G. Renaud and F. Vieira for discussions, and the Danish National High-throughput Sequencing Centre for assistance with data generation. GeoGenetics members were supported by the Lundbeck Foundation and the Danish National Research Foundation (DNRF94) and KU2016. J.V.M.-M. was supported by Conacyt (Mexico). Samples were recovered during excavations by B.A.P. supported by NSF Grants 1138811 and 1223119. Research was supported in part by NIH grant R01-GM094402 (M.St., J.T., J.A.K. and Y.S.S.) and a Packard Fellowship for Science and Engineering (Y.S.S.). Y.S.S. is a Chan Zuckerberg Biohub investigator. D.J.M. is supported by the Quest Archaeological Research Fund. A.-S.M. is supported by the Swiss National Science Foundation and the ERC.	Albrechtsen A, 2009, GENET EPIDEMIOL, V33, P266, DOI 10.1002/gepi.20378; Alexander DH, 2009, GENOME RES, V19, P1655, DOI 10.1101/gr.094052.109; Allentoft ME, 2015, NATURE, V522, P167, DOI 10.1038/nature14507; Delaneau O, 2013, NAT METHODS, V10, P5, DOI 10.1038/nmeth.2307; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Dillehay TD, 2008, SCIENCE, V320, P784, DOI 10.1126/science.1156533; Dyke A., 2003, DEGLACIATION N AM; Flegontov P., 2016, PREPRINT; Fu QM, 2013, CURR BIOL, V23, P553, DOI 10.1016/j.cub.2013.02.044; Goebel T., 2002, ARCHAEOLOGICAL PAPER, V12, P117, DOI 10.1525/ap3a.2002.12.1.117; Goebel Ted., 2016, HDB ARCTIC ARCHAEOLO, P223; Green RE, 2008, CELL, V134, P416, DOI 10.1016/j.cell.2008.06.021; Green RE, 2010, SCIENCE, V328, P710, DOI 10.1126/science.1188021; Hoffecker JF, 2016, EVOL ANTHROPOL, V25, P64, DOI 10.1002/evan.21478; Kamm JA, 2017, J COMPUT GRAPH STAT, V26, P182, DOI 10.1080/10618600.2016.1159212; Kari J. M., 2011, DENE YENISEIAN CONNE; Korneliussen TS, 2015, BIOINFORMATICS, V31, P4009, DOI 10.1093/bioinformatics/btv509; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Leppala K, 2017, BIOINFORMATICS, V33, P1738, DOI 10.1093/bioinformatics/btx048; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindgreen Stinus, 2012, BMC Res Notes, V5, P337, DOI 10.1186/1756-0500-5-337; Llamas B, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501385; Malaspinas AS, 2014, BIOINFORMATICS, V30, P2962, DOI 10.1093/bioinformatics/btu410; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Patterson N, 2012, GENETICS, V192, P1065, DOI 10.1534/genetics.112.145037; Pedersen MW, 2016, NATURE, V537, P45, DOI 10.1038/nature19085; Pickrell JK, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002967; Potter BA, 2014, P NATL ACAD SCI USA, V111, P17060, DOI 10.1073/pnas.1413131111; Racimo F, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005972; Raghavan M, 2015, SCIENCE, V349, DOI 10.1126/science.aab3884; Raghavan M, 2014, SCIENCE, V345, P1020, DOI 10.1126/science.1255832; Raghavan M, 2014, NATURE, V505, P87, DOI 10.1038/nature12736; Rasmussen M, 2015, NATURE, V523, P455, DOI 10.1038/nature14625; Rasmussen M, 2014, NATURE, V506, P225, DOI 10.1038/nature13025; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich D, 2012, NATURE, V488, P370, DOI 10.1038/nature11258; Schubert M, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-178; Skoglund P, 2015, NATURE, V525, P104, DOI 10.1038/nature14895; Skotte L, 2013, GENETICS, V195, P693, DOI 10.1534/genetics.113.154138; Steinrucken M., 2015, PREPRINT; Tackney JC, 2015, P NATL ACAD SCI USA, V112, P13833, DOI 10.1073/pnas.1511903112; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; Terhorst J, 2017, NAT GENET, V49, P303, DOI 10.1038/ng.3748; Verdu P, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004530; von Cramon-Taubadel N, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602289	46	146	153	4	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2018	553	7687					203	+		10.1038/nature25173	http://dx.doi.org/10.1038/nature25173			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4WL	29323294	Green Submitted, Green Accepted			2022-12-28	WOS:000419794800036
J	Jewkes, R				Jewkes, Rachel			Renewing the focus on health care for sexually assaulted children and adolescents	LANCET			English	Editorial Material							SOUTH-AFRICA; PREVALENCE		[Jewkes, Rachel] South African Med Res Council, Private Bag X385, ZA-0001 Pretoria, South Africa	South African Medical Research Council	Jewkes, R (corresponding author), South African Med Res Council, Private Bag X385, ZA-0001 Pretoria, South Africa.	rjewkes@mrc.ac.za		Jewkes, Rachel/0000-0002-4330-6267	South African Medical Research Council	South African Medical Research Council(South African Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	I am a former Director of the Gender and Health Research Unit of the South African Medical Research Council and have worked for many years in different contexts with Claudia Garcia-Moreno who led the development process for the WHO clinical guidelines on responding to children and adolescents who have been sexually abused, including co-authoring publications. I have been instrumental in trying to improve post-rape health care in South Africa, including developing the national curriculum, and in this co-authored with Neil McKerrow who was a member of the Guidelines Development Group for the WHO clinical guidelines. I am funded by the South African Medical Research Council.	A. World Health, 2012, GLOB BURD MENT DIS N; Gavey Nicola, 2005, JUST SEX CULTURAL SC; Jewkes R, 2013, LANCET GLOB HEALTH, V1, pE208, DOI 10.1016/S2214-109X(13)70069-X; Jina R., 2008, PARTICIPANTS MANUAL; Jina R, 2014, INT J GYNECOL OBSTET, V126, P187, DOI 10.1016/j.ijgo.2014.02.011; Jina R, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-257; Mathews S, 2013, J CHILD SEX ABUS, V22, P639, DOI 10.1080/10538712.2013.811137; Oshodi Y, 2016, J INTERPERS VIOLENCE; World Health Organisation, 2013, RESPONDING INTIMATE; World Health Organization, 2017, RESP CHILDR AD WHO H; World Health Organization, 2016, PROBLEM MANAGEMENT P; Zinzow HM, 2012, SOC PSYCH PSYCH EPID, V47, P893, DOI 10.1007/s00127-011-0397-1	12	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 6	2018	391	10115					9	11		10.1016/S0140-6736(17)33362-7	http://dx.doi.org/10.1016/S0140-6736(17)33362-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FR9ZB	29323657				2022-12-28	WOS:000419432300009
J	Boussinesq, M				Boussinesq, Michel			A new powerful drug to combat river blindness	LANCET			English	Editorial Material							ONCHOCERCIASIS; IVERMECTIN; AREA		[Boussinesq, Michel] Montpellier Univ, Inst Rech Dev, F-34394 Montpellier, France	Institut de Recherche pour le Developpement (IRD); Universite de Montpellier	Boussinesq, M (corresponding author), Montpellier Univ, Inst Rech Dev, F-34394 Montpellier, France.	michel.boussinesq@ird.fr						Awadzi K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002953; Gardon J, 1997, LANCET, V350, P18, DOI 10.1016/S0140-6736(96)11094-1; Geary TG, 2005, TRENDS PARASITOL, V21, P530, DOI 10.1016/j.pt.2005.08.014; Kamgno J, 2017, NEW ENGL J MED, V377, P2044, DOI [10.1056/NEJMoa1705026, 10.1056/nejmoa1705026]; Opoku NO, 2018, LANCET, V392, P1207, DOI 10.1016/S0140-6736(17)32844-1; Tekle AH, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0160-7; Turner HC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0779-4; Wanji S, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1283-6; WHITWORTH JAG, 1992, T ROY SOC TROP MED H, V86, P281, DOI 10.1016/0035-9203(92)90309-Z	9	10	10	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2018	392	10154					1170	1172		10.1016/S0140-6736(18)30101-6	http://dx.doi.org/10.1016/S0140-6736(18)30101-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GV9SO	29361336	hybrid			2022-12-28	WOS:000446500900006
J	Kasinath, V; Faini, M; Poepsel, S; Reif, D; Feng, XA; Stjepanovic, G; Aebersold, R; Nogales, E				Kasinath, Vignesh; Faini, Marco; Poepsel, Simon; Reif, Dvir; Feng, Xinyu Ashlee; Stjepanovic, Goran; Aebersold, Ruedi; Nogales, Eva			Structures of human PRC2 with its cofactors AEBP2 and JARID2	SCIENCE			English	Article							REPRESSIVE COMPLEX 2; POLYCOMB PROTEIN; GENE-EXPRESSION; TARGET GENES; RNA-BINDING; CHROMATIN; RECRUITMENT; METHYLATION; SUZ12; DIFFERENTIATION	Transcriptionally repressive histone H3 lysine 27 methylation by Polycomb repressive complex 2 (PRC2) is essential for cellular differentiation and development. Here we report cryo-electron microscopy structures of human PRC2 in a basal state and two distinct active states while in complex with its cofactors JARID2 and AEBP2. Both cofactors mimic the binding of histone H3 tails. JARID2, methylated by PRC2, mimics a methylated H3 tail to stimulate PRC2 activity, whereas AEBP2 interacts with the RBAP48 subunit, mimicking an unmodified H3 tail. SUZ12 interacts with all other subunits within the assembly and thus contributes to the stability of the complex. Our analysis defines the complete architecture of a functionally relevant PRC2 and provides a structural framework to understand its regulation by cofactors, histone tails, and RNA.	[Kasinath, Vignesh; Poepsel, Simon; Reif, Dvir; Stjepanovic, Goran; Nogales, Eva] Univ Calif Berkeley, Dept Mol & Cell Biol, Inst QB3, Berkeley, CA 94720 USA; [Kasinath, Vignesh; Poepsel, Simon; Stjepanovic, Goran; Nogales, Eva] Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA; [Faini, Marco; Aebersold, Ruedi] Swiss Fed Inst Technol, Inst Mol Syst Biol, Dept Biol, CH-8093 Zurich, Switzerland; [Feng, Xinyu Ashlee] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Aebersold, Ruedi] Univ Zurich, Fac Sci, Zurich, Switzerland; [Nogales, Eva] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA	University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; Swiss Federal Institutes of Technology Domain; ETH Zurich; University of California System; University of California Berkeley; University of Zurich; Howard Hughes Medical Institute; University of California System; University of California Berkeley	Nogales, E (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Inst QB3, Berkeley, CA 94720 USA.; Nogales, E (corresponding author), Lawrence Berkeley Natl Lab, Mol Biophys & Integrated Bioimaging Div, Berkeley, CA 94720 USA.; Nogales, E (corresponding author), Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	enogales@lbl.gov	Poepsel, Simon/AAG-2009-2019; Kasinath, Vignesh/P-8024-2019; Stjepanovic, Goran/A-7902-2010	Kasinath, Vignesh/0000-0003-2686-0546; Stjepanovic, Goran/0000-0002-4841-9949; Faini, Marco/0000-0001-8131-7648; Poepsel, Simon/0000-0002-8304-4062; Reif, Dvir/0000-0001-7054-2751	Eli Lilly through the Lilly Research Award Program; Helen Hay Whitney Foundation; Alexander von Humboldt Foundation (Germany); European Molecular Biology Organization; European Union [HEALTH-F4-2008-201648]; European Research Council (ERC) [233226, 670821]; Innovative Medicines Initiative Joint Undertaking (ULTRA-DD) [115766]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM127018] Funding Source: NIH RePORTER	Eli Lilly through the Lilly Research Award Program; Helen Hay Whitney Foundation; Alexander von Humboldt Foundation (Germany)(Alexander von Humboldt Foundation); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); European Union(European Commission); European Research Council (ERC)(European Research Council (ERC)European Commission); Innovative Medicines Initiative Joint Undertaking (ULTRA-DD); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was in part funded by Eli Lilly through the Lilly Research Award Program. V.K. was supported by a postdoctoral fellowship from Helen Hay Whitney Foundation. S.P. was supported by the Alexander von Humboldt Foundation (Germany) as a Feodor-Lynen postdoctoral fellow. M.F. was supported by a Long-Term Fellowship from the European Molecular Biology Organization. R.A. was supported by the European Union 7th Framework Program (PROSPECTS, HEALTH-F4-2008-201648), the European Research Council (ERC Advanced Grants 233226 and 670821), and the Innovative Medicines Initiative Joint Undertaking (ULTRA-DD, grant 115766). E.N. is a Howard Hughes Medical Institute Investigator.	Betancur JG, 2015, RNA BIOL, V12, P959, DOI 10.1080/15476286.2015.1069463; Brecqueville M, 2011, BLOOD CANCER J, V1, DOI 10.1038/bcj.2011.31; Brooun A, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11384; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Ciferri C, 2012, ELIFE, V1, DOI 10.7554/eLife.00005; Davidovich C, 2015, RNA, V21, P2007, DOI 10.1261/rna.053918.115; Grijzenhout A, 2016, DEVELOPMENT, V143, P2716, DOI 10.1242/dev.123935; Hauri S, 2016, CELL REP, V17, P583, DOI 10.1016/j.celrep.2016.08.096; Jiao LY, 2015, SCIENCE, V350, DOI 10.1126/science.aac4383; Justin N, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11316; Kaneko S, 2014, MOL CELL, V53, P290, DOI 10.1016/j.molcel.2013.11.012; Kaneko S, 2010, GENE DEV, V24, P2615, DOI 10.1101/gad.1983810; Kanhere A, 2010, MOL CELL, V38, P675, DOI 10.1016/j.molcel.2010.03.019; Kim H, 2009, NUCLEIC ACIDS RES, V37, P2940, DOI 10.1093/nar/gkp149; Li G, 2010, GENE DEV, V24, P368, DOI 10.1101/gad.1886410; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x; Mouradov D, 2014, CANCER RES, V74, P3238, DOI 10.1158/0008-5472.CAN-14-0013; Pasini D, 2010, NATURE, V464, P306, DOI 10.1038/nature08788; Poepsel S, 2018, NAT STRUCT MOL BIOL, V25, P154, DOI 10.1038/s41594-018-0023-y; Sanulli S, 2015, MOL CELL, V57, P769, DOI 10.1016/j.molcel.2014.12.020; Schmitges FW, 2011, MOL CELL, V42, P330, DOI 10.1016/j.molcel.2011.03.025; Son J, 2013, GENE DEV, V27, P2663, DOI 10.1101/gad.225888.113; Talbert PB, 2006, NAT REV GENET, V7, P793, DOI 10.1038/nrg1920; Walker E, 2010, CELL STEM CELL, V6, P153, DOI 10.1016/j.stem.2009.12.014; Wang XY, 2017, NAT STRUCT MOL BIOL, V24, P1028, DOI 10.1038/nsmb.3487; Zhang Z, 2011, STEM CELLS, V29, P229, DOI 10.1002/stem.578	29	109	112	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	2018	359	6378					940	944		10.1126/science.aar5700	http://dx.doi.org/10.1126/science.aar5700			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FX0QX	29348366	Green Accepted, Green Submitted			2022-12-28	WOS:000425752600050
J	Zabala-Letona, A; Arruabarrena-Aristorena, A; Martin-Martin, N; Fernandez-Ruiz, S; Sutherland, JD; Clasquin, M; Tomas-Cortazar, J; Jimenez, J; Torres, I; Quang, P; Ximenez-Embun, P; Bago, R; Ugalde-Olano, A; Loizaga-Iriarte, A; Lacasa-Viscasillas, I; Unda, M; Torrano, V; Cabrera, D; van Liempd, SM; Cendon, Y; Castro, E; Murray, S; Revandkar, A; Alimonti, A; Zhang, YN; Barnett, A; Lein, G; Pirman, D; Cortazar, AR; Arreal, L; Prudkin, L; Astobiza, I; Valcarcel-Jimenez, L; Zuniga-Garcia, P; Fernandez-Dominguez, I; Piva, M; Caro-Maldonado, A; Sanchez-Mosquera, P; Castillo-Martin, M; Serra, V; Beraza, N; Gentilella, A; Thomas, G; Azkargorta, M; Elortza, F; Farras, R; Olmos, D; Efeyan, A; Anguita, J; Munoz, J; Falcon-Perez, JM; Barrio, R; Macarulla, T; Mato, JM; Martinez-Chantar, ML; Cordon-Cardo, C; Aransay, AM; Marks, K; Baselga, J; Tabernero, J; Nuciforo, P; Manning, BD; Marjon, K; Carracedo, A				Zabala-Letona, Amaia; Arruabarrena-Aristorena, Amaia; Martin-Martin, Natalia; Fernandez-Ruiz, Sonia; Sutherland, James D.; Clasquin, Michelle; Tomas-Cortazar, Julen; Jimenez, Jose; Torres, Ines; Phong Quang; Ximenez-Embun, Pilar; Bago, Ruzica; Ugalde-Olano, Aitziber; Loizaga-Iriarte, Ana; Lacasa-Viscasillas, Isabel; Unda, Miguel; Torrano, Veronica; Cabrera, Diana; van Liempd, Sebastiaan M.; Cendon, Ylenia; Castro, Elena; Murray, Stuart; Revandkar, Ajinkya; Alimonti, Andrea; Zhang, Yinan; Barnett, Amelia; Lein, Gina; Pirman, David; Cortazar, Ana R.; Arreal, Leire; Prudkin, Ludmila; Astobiza, Ianire; Valcarcel-Jimenez, Lorea; Zuniga-Garcia, Patricia; Fernandez-Dominguez, Itziar; Piva, Marco; Caro-Maldonado, Alfredo; Sanchez-Mosquera, Pilar; Castillo-Martin, Mireia; Serra, Violeta; Beraza, Naiara; Gentilella, Antonio; Thomas, George; Azkargorta, Mikel; Elortza, Felix; Farras, Rosa; Olmos, David; Efeyan, Alejo; Anguita, Juan; Munoz, Javier; Falcon-Perez, Juan M.; Barrio, Rosa; Macarulla, Teresa; Mato, Jose M.; Martinez-Chantar, Maria L.; Cordon-Cardo, Carlos; Aransay, Ana M.; Marks, Kevin; Baselga, Jose; Tabernero, Josep; Nuciforo, Paolo; Manning, Brendan D.; Marjon, Katya; Carracedo, Arkaitz			mTORC1-dependent AMD1 regulation sustains polyamine metabolism in prostate cancer (vol 547, pg 109, 2017)	NATURE			English	Correction									[Serra, Violeta] Inst Salud Carlos III, CIBERONC, C Monforte de Lemos 3-5,Pabellon 11,Planta 0, Madrid 28029, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Instituto de Salud Carlos III			Aransay, Ana M./F-8086-2011; Tomás-Cortázar, Julen/AAN-8237-2021; Chantar, Maria Luz Martinez/F-5190-2011; Falcon-Perez, Juan M/F-5920-2011; Macarulla, Teresa/AAG-9230-2019; Piva, Marco/F-2748-2019; Cortazar, Ana Rosa/AAA-4463-2019; Barrio, Rosa/F-8712-2011; García, Patricia Zúñiga/G-4756-2016; Serra, Violeta/AAG-8328-2019; Munoz, Javier/I-4891-2012; Tabernero, Josep/AAG-5026-2019; Manning, Brendan/ABD-6528-2021; unda, miguel/AAP-8322-2021; Gentilella, Antonio/AAA-9864-2020	Aransay, Ana M./0000-0002-8271-612X; Chantar, Maria Luz Martinez/0000-0002-6446-9911; Cortazar, Ana Rosa/0000-0002-7082-5695; Barrio, Rosa/0000-0002-9663-0669; García, Patricia Zúñiga/0000-0002-6167-4063; Munoz, Javier/0000-0003-3288-3496; Tabernero, Josep/0000-0002-2495-8139; Manning, Brendan/0000-0003-3895-5956; unda, miguel/0000-0003-2849-9459; Piva, Marco/0000-0001-6906-6065; Cendon Florez, Ylenia/0000-0001-7525-7407; Nuciforo, Paolo/0000-0003-1380-0990; Ximenez-Embun, Pilar/0000-0002-2582-9443; Olmos Hidalgo, David/0000-0002-7003-4826; Beraza, Naiara/0000-0003-0718-0940; Falcon-Perez, Juan M/0000-0003-3133-0670; Elortza, Felix/0000-0001-8839-5438				Zabala-Letona A, 2017, NATURE, V547, P109, DOI 10.1038/nature22964	1	2	2	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	2018	554	7693								10.1038/nature25470	http://dx.doi.org/10.1038/nature25470			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FW8PA	29342137	Bronze			2022-12-28	WOS:000425597400052
J	Hu, WQ; Lum, GZ; Mastrangeli, M; Sitti, M				Hu, Wenqi; Lum, Guo Zhan; Mastrangeli, Massimo; Sitti, Metin			Small-scale soft-bodied robot with multimodal locomotion	NATURE			English	Article							MICROROBOTS; FABRICATION; INSECTS; DESIGN	Untethered small-scale (from several millimetres down to a few micrometres in all dimensions) robots that can non-invasively access confined, enclosed spaces may enable applications in microfactories such as the construction of tissue scaffolds by robotic assembly(1), in bioengineering such as single-cell manipulation and biosensing(2), and in healthcare(3-6) such as targeted drug delivery(4) and minimally invasive surgery(3,5). Existing small-scale robots, however, have very limited mobility because they are unable to negotiate obstacles and changes in texture or material in unstructured environments(7-13). Of these small-scale robots, soft robots have greater potential to realize high mobility via multimodal locomotion, because such machines have higher degrees of freedom than their rigid counterparts(14-16). Here we demonstrate magneto-elastic soft millimetre-scale robots that can swim inside and on the surface of liquids, climb liquid menisci, roll and walk on solid surfaces, jump over obstacles, and crawl within narrow tunnels. These robots can transit reversibly between different liquid and solid terrains, as well as switch between locomotive modes. They can additionally execute pick-and-place and cargo-release tasks. We also present theoretical models to explain how the robots move. Like the large-scale robots that can be used to study locomotion(17), these soft small-scale robots could be used to study soft-bodied locomotion produced by small organisms.				sitti@is.mpg.de	Sitti, Metin/AGP-6288-2022; Hu, wenqi/GSI-7291-2022; Hu, Wenqi/W-9200-2019	Hu, wenqi/0000-0003-0813-6001; Hu, Wenqi/0000-0002-3457-821X; Lum, Guo Zhan/0000-0002-3368-0175; Sitti, Metin/0000-0001-8249-3854	Alexander von Humboldt Foundation; Max Planck Society	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Max Planck Society(Max Planck Society)	W.H. thanks the Alexander von Humboldt Foundation for financial support. This work is funded by the Max Planck Society. We thank Z. Burghard and A. Diem from the University of Stuttgart for evaluating the Young's modulus of our robots, K. Suppelt and S. Meyer from Fujifilm Visualsonics for their help with the ultrasound-guided experiments, and the members from Physical Intelligence Department at the Max Planck Institute for Intelligent Systems for their comments.	Abbott JJ, 2009, INT J ROBOT RES, V28, P1434, DOI 10.1177/0278364909341658; Aguilar J, 2016, REP PROG PHYS, V79, DOI 10.1088/0034-4885/79/11/110001; Aguilar J, 2016, NAT PHYS, V12, P278, DOI 10.1038/NPHYS3568; Amjadi M, 2015, NANOTECHNOLOGY, V26, DOI 10.1088/0957-4484/26/37/375501; Brackenbury J, 1997, NATURE, V390, P453, DOI 10.1038/37253; Campbell JF, 1999, NATURE, V397, P485, DOI 10.1038/17254; Ceylan H, 2017, LAB CHIP, V17, P1705, DOI 10.1039/c7lc00064b; Chung SE, 2015, LAB CHIP, V15, P1667, DOI 10.1039/c5lc00009b; Diller E, 2016, INT J ROBOT RES, V35, P114, DOI 10.1177/0278364915583539; Diller E, 2014, ADV FUNCT MATER, V24, P4397, DOI 10.1002/adfm.201400275; Diller E, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4874306; Gemmell BJ, 2013, P NATL ACAD SCI USA, V110, P17904, DOI 10.1073/pnas.1306983110; Hines L, 2017, ADV MATER, V29, DOI 10.1002/adma.201603483; Hu DL, 2005, NATURE, V437, P733, DOI 10.1038/nature03995; Huang HW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12263; Koh JS, 2015, SCIENCE, V349, P517, DOI 10.1126/science.aab1637; Kummer MP, 2010, IEEE T ROBOT, V26, P1006, DOI 10.1109/TRO.2010.2073030; Lum GZ, 2016, P NATL ACAD SCI USA, V113, pE6007, DOI 10.1073/pnas.1608193113; Maeda S, 2007, ADV MATER, V19, P3480, DOI 10.1002/adma.200700625; Miyashita S, 2015, IEEE INT CONF ROBOT, P1490, DOI 10.1109/ICRA.2015.7139386; Nelson BJ, 2010, ANNU REV BIOMED ENG, V12, P55, DOI 10.1146/annurev-bioeng-010510-103409; Rus D, 2015, NATURE, V521, P467, DOI 10.1038/nature14543; Sitti M., 2017, MOBILE MICROROBOTICS; Sitti M, 2015, P IEEE, V103, P205, DOI 10.1109/JPROC.2014.2385105; Sitti M, 2009, NATURE, V458, P1121, DOI 10.1038/4581121a; TAYLOR G, 1951, PROC R SOC LON SER-A, V209, P447, DOI 10.1098/rspa.1951.0218; Wang W, 2014, BIOINSPIR BIOMIM, V9, DOI 10.1088/1748-3182/9/4/046006; Wehner M, 2016, NATURE, V536, P451, DOI 10.1038/nature19100; Yuk H, 2011, BIOINSPIR BIOMIM, V6, DOI 10.1088/1748-3182/6/4/046002; Zhang XD, 2016, IEEE-ASME T MECH, V21, P1129, DOI 10.1109/TMECH.2015.2479404	30	989	1011	227	1667	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2018	554	7690					81	85		10.1038/nature25443	http://dx.doi.org/10.1038/nature25443			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7QX	29364873				2022-12-28	WOS:000424048900035
J	Pasca, SP				Pasca, Sergiu P.			The rise of three-dimensional human brain cultures	NATURE			English	Review							PLURIPOTENT STEM-CELLS; BIOENGINEERED ORGAN GERM; CENTRAL-NERVOUS-SYSTEM; CEREBRAL ORGANOIDS; SELF-ORGANIZATION; IN-VITRO; CORTICAL DEVELOPMENT; HUMAN ES; NEURAL DIFFERENTIATION; INTERNEURON MIGRATION	Pluripotent stem cells show a remarkable ability to self-organize and differentiate in vitro in three-dimensional aggregates, known as organoids or organ spheroids, and to recapitulate aspects of human brain development and function. Regionspecific 3D brain cultures can be derived from any individual and assembled to model complex cell-cell interactions and to generate circuits in human brain assembloids. Here I discuss how this approach can be used to understand unique features of the human brain and to gain insights into neuropsychiatric disorders. In addition, I consider the challenges faced by researchers in further improving and developing methods to probe and manipulate patient-derived 3D brain cultures.	[Pasca, Sergiu P.] Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA	Stanford University	Pasca, SP (corresponding author), Stanford Univ, Dept Psychiat & Behav Sci, Stanford, CA 94305 USA.	spasca@stanford.edu	Pasca, Sergiu/AAY-3949-2021	Pasca, Sergiu/0000-0002-3216-3248	National Institute of Mental Health (NIMH); California Institute of Regenerative Medicine (CIRM); MQ Fellow Award; Donald E. and Delia B. Baxter Foundation Award; Stanford Neurosciences Institute's Brain Rejuvenation Project; Kwan Research Fund; Brain & Behavior Research Foundation (BBRF, NARSAD)	National Institute of Mental Health (NIMH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); MQ Fellow Award; Donald E. and Delia B. Baxter Foundation Award; Stanford Neurosciences Institute's Brain Rejuvenation Project; Kwan Research Fund; Brain & Behavior Research Foundation (BBRF, NARSAD)	The author thanks B. A. Barres, K. Deisseroth, R. Reimer, J. A. Bernstein, H. B. Fraser, J. R. Huguenard and members of the Pasca laboratory, and acknowledges funding support from the National Institute of Mental Health (NIMH), California Institute of Regenerative Medicine (CIRM), the MQ Fellow Award, the Donald E. and Delia B. Baxter Foundation Award, the Stanford Neurosciences Institute's Brain Rejuvenation Project, the Kwan Research Fund and the Brain & Behavior Research Foundation (BBRF, NARSAD).	Aach J, 2017, ELIFE, V6, DOI 10.7554/eLife.20674; Agasse F, 2004, EUR J NEUROSCI, V19, P1459, DOI 10.1111/j.1460-9568.2004.03259.x; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Arora N, 2017, DEVELOPMENT, V144, P1128, DOI 10.1242/dev.142919; Bagley JA, 2017, NAT METHODS, V14, P743, DOI 10.1038/nmeth.4304; Bartolini G, 2013, NEURON, V79, P849, DOI 10.1016/j.neuron.2013.08.014; Bershteyn M, 2017, CELL STEM CELL, V20, P435, DOI 10.1016/j.stem.2016.12.007; Birey F, 2017, NATURE, V545, P54, DOI 10.1038/nature22330; BOLZ J, 1992, J NEUROSCI, V12, P3054, DOI 10.1523/JNEUROSCI.12-08-03054.1992; BOX GEP, 1976, J AM STAT ASSOC, V71, P791, DOI 10.2307/2286841; Callaway EM, 2015, J NEUROSCI, V35, P8979, DOI 10.1523/JNEUROSCI.0409-15.2015; Camp JG, 2015, P NATL ACAD SCI USA, V112, P15672, DOI 10.1073/pnas.1520760112; Carcamo-Orive I, 2017, CELL STEM CELL, V20, P518, DOI 10.1016/j.stem.2016.11.005; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Chen YW, 2017, NAT CELL BIOL, V19, P542, DOI 10.1038/ncb3510; Chiang MY, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600964; Choi SH, 2014, NATURE, V515, P274, DOI 10.1038/nature13800; Chun S, 2014, SCIENCE, V344, P1178, DOI 10.1126/science.1253895; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/nmeth.2481, 10.1038/NMETH.2481]; Cugola FR, 2016, NATURE, V534, P267, DOI 10.1038/nature18296; DeFelipe J, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00029; DeForest CA, 2010, CHEM MATER, V22, P4783, DOI 10.1021/cm101391y; Deglincerti A, 2016, CURR TOP DEV BIOL, V116, P99, DOI 10.1016/bs.ctdb.2015.11.010; Eiraku M, 2008, CELL STEM CELL, V3, P519, DOI 10.1016/j.stem.2008.09.002; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Elkabetz Y, 2008, GENE DEV, V22, P152, DOI 10.1101/gad.1616208; Erecinska M, 2004, PROG NEUROBIOL, V73, P397, DOI 10.1016/j.pneurobio.2004.06.003; Espuny-Camacho I, 2013, NEURON, V77, P440, DOI 10.1016/j.neuron.2012.12.011; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Fietz SA, 2012, P NATL ACAD SCI USA, V109, P11836, DOI 10.1073/pnas.1209647109; Gabriel E, 2017, CELL STEM CELL, V20, P397, DOI 10.1016/j.stem.2016.12.005; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; GIERER A, 1972, NATURE-NEW BIOL, V239, P98, DOI 10.1038/newbio239098a0; Harrison RG, 1907, P SOC EXP BIOL MED, V4, P140; HEFFNER RS, 1983, BRAIN BEHAV EVOLUT, V23, P165, DOI 10.1159/000121494; Heidenreich M, 2016, NAT REV NEUROSCI, V17, P36, DOI 10.1038/nrn.2015.2; HENSCHEN A, 1985, EXP BRAIN RES, V60, P38; Hirano M, 2003, DEV DYNAM, V228, P664, DOI 10.1002/dvdy.10425; Hirayama M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3497; Holtfreter J, 1944, J EXP ZOOL, V95, P307, DOI 10.1002/jez.1400950303; Huch M, 2013, EMBO J, V32, P2708, DOI 10.1038/emboj.2013.204; Humpel C, 2015, NEUROSCIENCE, V305, P86, DOI 10.1016/j.neuroscience.2015.07.086; Hutter-Schmid B, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00052; Iefremova V, 2017, CELL REP, V19, P50, DOI 10.1016/j.celrep.2017.03.047; Jo J, 2016, CELL STEM CELL, V19, P248, DOI 10.1016/j.stem.2016.07.005; Kadoshima T, 2013, P NATL ACAD SCI USA, V110, P20284, DOI 10.1073/pnas.1315710110; Kant I, 1997, CRITIQUE OFJUDGMENT; Kawaguchi K, 2017, NATURE, V545, P327, DOI 10.1038/nature22321; Kepecs A, 2014, NATURE, V505, P318, DOI 10.1038/nature12983; Kilpinen H, 2017, NATURE, V546, P370, DOI 10.1038/nature22403; Kim SY, 2013, TRENDS COGN SCI, V17, P596, DOI 10.1016/j.tics.2013.10.005; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Lancaster MA, 2017, NAT BIOTECHNOL, V35, P659, DOI 10.1038/nbt.3906; Lancaster MA, 2013, NATURE, V501, P373, DOI 10.1038/nature12517; Li Y, 2017, CELL STEM CELL, V20, P385, DOI 10.1016/j.stem.2016.11.017; Lin MZ, 2016, NAT NEUROSCI, V19, P1142, DOI 10.1038/nn.4359; Luo CY, 2017, SCIENCE, V357, P600, DOI 10.1126/science.aan3351; Ma Z, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8413; Macosko EZ, 2015, CELL, V161, P1202, DOI 10.1016/j.cell.2015.05.002; Mariani J, 2015, CELL, V162, P375, DOI 10.1016/j.cell.2015.06.034; Mariani J, 2012, P NATL ACAD SCI USA, V109, P12770, DOI 10.1073/pnas.1202944109; Marin O, 2012, NAT REV NEUROSCI, V13, P107, DOI 10.1038/nrn3155; Marton RM, 2016, CELL STEM CELL, V19, P145, DOI 10.1016/j.stem.2016.07.017; Mason C, 2009, REGEN MED, V4, P329, DOI 10.2217/RME.09.20; McCracken KW, 2014, NATURE, V516, P400, DOI 10.1038/nature13863; Mora-Bermudez F, 2016, ELIFE, V5, DOI 10.7554/eLife.18683; Muguruma K, 2015, CELL REP, V10, P537, DOI 10.1016/j.celrep.2014.12.051; Munsie M, 2017, DEVELOPMENT, V144, P942, DOI 10.1242/dev.140111; Nakano T, 2012, CELL STEM CELL, V10, P771, DOI 10.1016/j.stem.2012.05.009; Ogawa M, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3498; Otani T, 2016, CELL STEM CELL, V18, P467, DOI 10.1016/j.stem.2016.03.003; Pankratz MT, 2007, STEM CELLS, V25, P1511, DOI 10.1634/stemcells.2006-0707; Paredes MF, 2016, SCIENCE, V354, DOI 10.1126/science.aaf7073; Pasca AM, 2015, NAT METHODS, V12, P671, DOI [10.1038/NMETH.3415, 10.1038/nmeth.3415]; Pasca SP, 2014, ANNU REV NEUROSCI, V37, P479, DOI 10.1146/annurev-neuro-062012-170328; Pasca SP, 2011, NAT MED, V17, P1657, DOI 10.1038/nm.2576; Pera MF, 2015, NAT METHODS, V12, P917, DOI 10.1038/nmeth.3586; Phan DTT, 2017, EXP BIOL MED, V242, P1669, DOI 10.1177/1535370217694100; Pickl M, 2009, ONCOGENE, V28, P461, DOI 10.1038/onc.2008.394; Prescott SL, 2015, CELL, V163, P68, DOI 10.1016/j.cell.2015.08.036; Qian XY, 2016, CELL, V165, P1238, DOI 10.1016/j.cell.2016.04.032; Quadrato G, 2017, NATURE, V545, P48, DOI 10.1038/nature22047; Reddington AE, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00398; Renner M, 2017, EMBO J, V36, P1316, DOI 10.15252/embj.201694700; REYNOLDS BA, 1992, J NEUROSCI, V12, P4565, DOI 10.1523/jneurosci.12-11-04565.1992; Rigamonti A, 2016, STEM CELL REP, V6, P993, DOI 10.1016/j.stemcr.2016.05.010; Rouhani F, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004432; Rubenstein JLR, 2003, GENES BRAIN BEHAV, V2, P255, DOI 10.1034/j.1601-183X.2003.00037.x; Sachs N, 2017, DEVELOPMENT, V144, P1107, DOI 10.1242/dev.143933; Sakaguchi H, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9896; Sato T, 2011, GASTROENTEROLOGY, V141, P1762, DOI 10.1053/j.gastro.2011.07.050; Sato T, 2009, NATURE, V459, P262, DOI 10.1038/nature07935; Schwartz MP, 2015, P NATL ACAD SCI USA, V112, P12516, DOI 10.1073/pnas.1516645112; Silbereis JC, 2016, NEURON, V89, P248, DOI 10.1016/j.neuron.2015.12.008; Sloan SA, 2017, NEURON, V95, P779, DOI 10.1016/j.neuron.2017.07.035; Sorg BA, 2016, J NEUROSCI, V36, P11459, DOI 10.1523/JNEUROSCI.2351-16.2016; Sousa AMM, 2017, CELL, V170, P226, DOI 10.1016/j.cell.2017.06.036; Stein JL, 2014, NEURON, V83, P69, DOI 10.1016/j.neuron.2014.05.035; Sternfeld MJ, 2017, ELIFE, V6, DOI 10.7554/eLife.21540; Stevens KR, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah5505; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; Sun T, 2014, NAT REV NEUROSCI, V15, P217, DOI 10.1038/nrn3707; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takasato M, 2015, NATURE, V526, P564, DOI 10.1038/nature15695; Thomas CA, 2017, CELL STEM CELL, V21, P319, DOI 10.1016/j.stem.2017.07.009; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; TOWNES PL, 1955, J EXP ZOOL, V128, P53, DOI 10.1002/jez.1401280105; Tsiairis CD, 2016, CELL, V164, P656, DOI 10.1016/j.cell.2016.01.028; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Turner DA, 2016, BIOESSAYS, V38, P181, DOI 10.1002/bies.201500111; Vierbuchen T, 2010, NATURE, V463, P1035, DOI 10.1038/nature08797; Warmflash A, 2014, NAT METHODS, V11, P847, DOI [10.1038/NMETH.3016, 10.1038/nmeth.3016]; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954; WOOLSEY TA, 1970, BRAIN RES, V17, P205, DOI 10.1016/0006-8993(70)90079-X; Workman MJ, 2017, NAT MED, V23, P49, DOI 10.1038/nm.4233; Xiang YF, 2017, CELL STEM CELL, V21, P383, DOI 10.1016/j.stem.2017.07.007; YAMAMOTO N, 1992, NEURON, V9, P217, DOI 10.1016/0896-6273(92)90161-6; Zecca L, 2003, J NEURAL TRANSM-SUPP, P145; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129; Zhang YS, 2013, NEURON, V78, P785, DOI 10.1016/j.neuron.2013.05.029	121	257	263	24	231	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2018	553	7689					437	445		10.1038/nature25032	http://dx.doi.org/10.1038/nature25032			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU6OE	29364288				2022-12-28	WOS:000423971100030
J	Boden, I; Skinner, EH; Browning, L; Reeve, J; Anderson, L; Hill, C; Robertson, IK; Story, D; Denehy, L				Boden, Ianthe; Skinner, Elizabeth H.; Browning, Laura; Reeve, Julie; Anderson, Lesley; Hill, Cat; Robertson, Iain K.; Story, David; Denehy, Linda			Preoperative physiotherapy for the prevention of respiratory complications after upper abdominal surgery: pragmatic, double blinded, multicentre randomised controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							POSTOPERATIVE PULMONARY COMPLICATIONS; GENERAL-ANESTHESIA; ENHANCED RECOVERY; THORACIC-SURGERY; PATIENT OUTCOMES; MOBILIZATION; PRESSURE; CARE; ASSOCIATION; EXPERIENCE	OBJECTIVE (PPCs) after upper abdominal surgery. DESIGN Prospective, pragmatic, multicentre, patient and assessor blinded, parallel group, randomised placebo controlled superiority trial. SETTING Multidisciplinary preadmission clinics at three tertiary public hospitals in Australia and New Zealand. PARTICIPANTS 441 adults aged 18 years or older who were within six weeks of elective major open upper abdominal surgery were randomly assigned through concealed allocation to receive either an information booklet (n=219; control) or preoperative physiotherapy (n=222; intervention) and followed for 12 months. 432 completed the trial. INTERVENTIONS Preoperatively, participants received an information booklet (control) or an additional 30 minute physiotherapy education and breathing exercise training session (intervention). Education focused on PPCs and their prevention through early ambulation and self directed breathing exercises to be initiated immediately on regaining consciousness after surgery. Postoperatively, all participants received standardised early ambulation, and no additional respiratory physiotherapy was provided. MAIN OUTCOME MEASURES The primary outcome was a PPC within 14 postoperative hospital days assessed daily using the Melbourne group score. Secondary outcomes were hospital acquired pneumonia, length of hospital stay, utilisation of intensive care unit services, and hospital costs. Patient reported health related quality of life, physical function, and post-discharge complications were measured at six weeks, and all cause mortality was measured to 12 months. RESULTS The incidence of PPCs within 14 postoperative hospital days, including hospital acquired pneumonia, was halved (adjusted hazard ratio 0.48, 95% confidence interval 0.30 to 0.75, P=0.001) in the intervention group compared with the control group, with an absolute risk reduction of 15% (95% confidence interval 7% to 22%) and a number needed to treat of 7 (95% confidence interval 5 to 14). No significant differences in other secondary outcomes were detected. CONCLUSION In a general population of patients listed for elective upper abdominal surgery, a 30 minute preoperative physiotherapy session provided within existing hospital multidisciplinary preadmission clinics halves the incidence of PPCs and specifically hospital acquired pneumonia. Further research is required to investigate benefits to mortality and length of stay.	[Boden, Ianthe] Launceston Gen Hosp, Dept Physiotherapy, Launceston, Tas 7250, Australia; [Boden, Ianthe; Skinner, Elizabeth H.; Browning, Laura] Univ Melbourne, Dept Physiotherapy, Melbourne, Vic 3010, Australia; [Skinner, Elizabeth H.; Browning, Laura] Western Hlth, Allied Hlth & Serv Planning, Community Integrat, Melbourne, Vic, Australia; [Reeve, Julie] Auckland Univ Technol, Sch Clin Sci, Fac Hlth & Environm Sci, Auckland, New Zealand; [Reeve, Julie; Anderson, Lesley] North Shore Hosp, Physiotherapy Dept, Waitemata Dist Hlth Board, Auckland, New Zealand; [Hill, Cat] North West Reg Hosp, Physiotherapy Dept, Burnie, Tas, Australia; [Robertson, Iain K.] Launceston Gen Hosp, Clifford Craig Fdn, Launceston, Tas, Australia; [Robertson, Iain K.] Univ Tasmania, Sch Hlth Sci, Launceston, Tas, Australia; [Story, David] Univ Melbourne, Melbourne Med Sch, Anaesthesia Perioperat & Pain Med Unit, Melbourne, Vic, Australia; [Denehy, Linda] Univ Melbourne, Melbourne Sch Hlth Sci, Melbourne, Vic, Australia; [Denehy, Linda] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia	University of Melbourne; Auckland University of Technology; University of Tasmania; University of Melbourne; University of Melbourne; Peter Maccallum Cancer Center	Boden, I (corresponding author), Launceston Gen Hosp, Dept Physiotherapy, Launceston, Tas 7250, Australia.; Boden, I (corresponding author), Univ Melbourne, Dept Physiotherapy, Melbourne, Vic 3010, Australia.	ianthe.boden@ths.tas.gov.au	Boden, Ianthe/CAG-9148-2022; Reeve, Julie/I-2005-2019	Browning, Laura/0000-0002-8666-9076; Story, David/0000-0002-6479-1310; Reeve, Julie/0000-0001-8234-3119	Clifford Craig Foundation, Launceston, Australia; University of Tasmania (virtual Tasmanian Academic Health Science Precinct), Tasmania, Australia; Waitemata District Health Board; Three Harbours Health Foundation, Auckland, New Zealand; Launceston General Hospital; North West Regional Hospital; North Shore Hospital; Tasmanian Health Service-North	Clifford Craig Foundation, Launceston, Australia; University of Tasmania (virtual Tasmanian Academic Health Science Precinct), Tasmania, Australia; Waitemata District Health Board; Three Harbours Health Foundation, Auckland, New Zealand; Launceston General Hospital; North West Regional Hospital; North Shore Hospital; Tasmanian Health Service-North	This study was an investigator initiated trial funded by competitive research grants from the Clifford Craig Foundation, Launceston, Australia, the University of Tasmania (virtual Tasmanian Academic Health Science Precinct), Tasmania, Australia, and the Awhina Contestable Research Grant from the Waitemata District Health Board and Three Harbours Health Foundation, Auckland, New Zealand, Support was provided from departmental sources at each participating study centre (Launceston General Hospital, North West Regional Hospital, North Shore Hospital) and through sponsorship by the Tasmanian Health Service-North to support IB for the period of the trial. The funding sources had no controlling role in the study design, data collection, analysis, interpretation, or report writing. All authors had full access to the data on trial completion and had final responsibility for publication submission.	Ball L, 2017, INTENS CARE MED, V43, P119, DOI 10.1007/s00134-016-4627-6; Boden I, 2017, PHYSIOTHERAPY; Boden I, 2015, TRIALS, V16, DOI 10.1186/s13063-015-1090-6; Brooks D, 2002, CHEST, V121, P488, DOI 10.1378/chest.121.2.488; Browning L, 2007, AUST J PHYSIOTHER, V53, P47, DOI 10.1016/S0004-9514(07)70061-2; Castelino T, 2016, SURGERY, V159, P991, DOI 10.1016/j.surg.2015.11.029; CASTILLO R, 1985, ARCH PHYS MED REHAB, V66, P376; Clark L, 2016, BMJ-BRIT MED J, V355, DOI 10.1136/bmj.i5663; Condie E, 1993, PHYSIOTHERAPY, V79, P547, DOI [10.1016/S0031-9406(10)60295-7, DOI 10.1016/S0031-9406(10)60295-7]; Fernandez-Bustamante A, 2017, JAMA SURG, V152, P157, DOI 10.1001/jamasurg.2016.4065; Fiore JF, 2013, WORLD J SURG, V37, P2927, DOI 10.1007/s00268-013-2208-1; Fleisher LA, 2014, PERIOPER MED, V3, DOI 10.1186/2047-0525-3-7; Grabitz Stephanie D, 2017, Crit Care Med, V45, pe30; Gustafsson UO, 2012, CLIN NUTR, V31, P783, DOI [10.1007/s00268-012-1772-0, 10.1016/j.clnu.2012.08.013]; Haines KJ, 2013, PHYSIOTHERAPY, V99, P119, DOI 10.1016/j.physio.2012.05.013; Hall Miranda, 2008, Physiotherapy Theory and Practice, V24, P167, DOI 10.1080/09593980701588326; Hemmes SNT, 2014, LANCET, V384, P495, DOI 10.1016/S0140-6736(14)60416-5; Hughes M, 2015, J SURG RES, V193, P102, DOI 10.1016/j.jss.2014.06.032; Katsura M, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010356.pub2; Keulers BJ, 2008, WORLD J SURG, V32, P964, DOI 10.1007/s00268-008-9581-1; Khuri SF, 2005, ANN SURG, V242, P326, DOI 10.1097/01.sla.0000179621.33268.83; Mackay MR, 2005, AUST J PHYSIOTHER, V51, P151, DOI 10.1016/S0004-9514(05)70021-0; Mans CM, 2015, CLIN REHABIL, V29, P426, DOI 10.1177/0269215514545350; MCHORNEY CA, 1994, MED CARE, V32, P40, DOI 10.1097/00005650-199401000-00004; Miskovic A, 2017, BRIT J ANAESTH, V118, P317, DOI 10.1093/bja/aex002; Neto AS, 2016, LANCET RESP MED, V4, P272, DOI 10.1016/S2213-2600(16)00057-6; Olsen MF, 1997, BRIT J SURG, V84, P1535, DOI 10.1002/bjs.1800841111; Parry S, 2014, PHYSIOTHERAPY, V100, P47, DOI 10.1016/j.physio.2013.05.002; Pasquina P, 2006, CHEST, V130, P1887, DOI 10.1378/chest.130.6.1887; Patman S, 2017, ARCH PHYSIOTHERAPY, P7; Rankin SL, 1996, AM J CARDIOL, V77, P1220, DOI 10.1016/S0002-9149(97)89157-6; Samnani Sunil Sadruddin, 2014, Int Sch Res Notices, V2014, P250536, DOI 10.1155/2014/250536; Schaller SJ, 2016, LANCET, V388, P1377, DOI 10.1016/S0140-6736(16)31637-3; Schmidt CM, 2010, ARCH SURG-CHICAGO, V145, P634, DOI 10.1001/archsurg.2010.118; Scholes RL, 2009, AUST J PHYSIOTHER, V55, P191, DOI 10.1016/S0004-9514(09)70081-9; Schultz MJ, 2017, EUR J ANAESTH, V34, P492, DOI [10.1097/EJA.0000000000000646, DOI 10.1097/EJA.0000000000000646]; Neto AS, 2014, LANCET RESP MED, V2, P1007, DOI 10.1016/S2213-2600(14)70228-0; Silva YR, 2013, PHYSIOTHERAPY, V99, P187, DOI 10.1016/j.physio.2012.09.006; Sopena N, 2005, CHEST, V127, P213, DOI 10.1378/chest.127.1.213; Stern C, 2005, INT J EVID-BASED HEA, V3, P45, DOI 10.1111/j.1479-6988.2005.00021.x; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8	41	114	119	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2018	360								j5916	10.1136/bmj.j5916	http://dx.doi.org/10.1136/bmj.j5916			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU2WT	29367198	Green Published, hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000423711400002
J	Morgan, M				Morgan, Matt			Poor hospital design has an impact on staff, patients, and healthcare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Morgan, Matt] Cardiff Univ, Cardiff, S Glam, Wales; Univ Hosp Wales, Cardiff, S Glam, Wales	Cardiff University; Cardiff University	Morgan, M (corresponding author), Cardiff Univ, Cardiff, S Glam, Wales.	mmorgan@bmj.com		Morgan, Matt/0000-0002-2357-7190					0	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 23	2018	360								k288	10.1136/bmj.k288	http://dx.doi.org/10.1136/bmj.k288			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU2WS	29363497				2022-12-28	WOS:000423711300006
J	Thongsomboon, W; Serra, DO; Possling, A; Hadjineophytou, C; Hengge, R; Cegelski, L				Thongsomboon, Wiriya; Serra, Diego O.; Possling, Alexandra; Hadjineophytou, Chris; Hengge, Regine; Cegelski, Lynette			Phosphoethanolamine cellulose: A naturally produced chemically modified cellulose	SCIENCE			English	Article							ESCHERICHIA-COLI; CURLI; IDENTIFICATION; TYPHIMURIUM; ACTIVATION; RESISTANCE; PROTEINS; SYNTHASE; SYSTEM; MATRIX	Cellulose is a major contributor to the chemical and mechanical properties of plants and assumes structural roles in bacterial communities termed biofilms. We find that Escherichia coli produces chemically modified cellulose that is required for extracellular matrix assembly and biofilm architecture. Solid-state nuclear magnetic resonance spectroscopy of the intact and insoluble material elucidates the zwitterionic phosphoethanolamine modification that had evaded detection by conventional methods. Installation of the phosphoethanolamine group requires BcsG, a proposed phosphoethanolamine transferase, with biofilm-promoting cyclic diguanylate monophosphate input through a BcsE-BcsF-BcsG transmembrane signaling pathway. The bcsEFG operon is present in many bacteria, including Salmonella species, that also produce the modified cellulose. The discovery of phosphoethanolamine cellulose and the genetic and molecular basis for its production offers opportunities to modulate its production in bacteria and inspires efforts to biosynthetically engineer alternatively modified cellulosic materials.	[Thongsomboon, Wiriya; Cegelski, Lynette] Stanford Univ, Dept Chem, Stanford, CA 94305 USA; [Serra, Diego O.; Possling, Alexandra; Hadjineophytou, Chris; Hengge, Regine] Humboldt Univ, Inst Biol, Microbiol, D-10115 Berlin, Germany; [Hadjineophytou, Chris] Univ Gothenburg, Dept Chem & Mol Biol, S-41296 Gothenburg, Sweden; [Hadjineophytou, Chris] Univ Oslo, Dept Biosci, N-0371 Oslo, Norway	Stanford University; Humboldt University of Berlin; University of Gothenburg; University of Oslo	Cegelski, L (corresponding author), Stanford Univ, Dept Chem, Stanford, CA 94305 USA.; Hengge, R (corresponding author), Humboldt Univ, Inst Biol, Microbiol, D-10115 Berlin, Germany.	regine.hengge@hu-berlin.de; cegelski@stanford.edu	Hengge, Regine/AAE-7092-2021	Thongsomboon, Wiriya/0000-0002-9359-6119; Hengge, Regine/0000-0002-3969-8018; Hadjineophytou, Chris/0000-0003-2015-021X	NSF CAREER award [1453247]; Precourt Institute for Energy Seed Grant; Deutsche Forschungsgemeinschaft [He1556/17-1, He1556/21-1]; ERASMUS fellowship from European Union	NSF CAREER award(National Science Foundation (NSF)NSF - Office of the Director (OD)); Precourt Institute for Energy Seed Grant; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ERASMUS fellowship from European Union	We thank J. Schaefer for assistance with <SUP>31</SUP>P NMR measurements; S. Lynch and A. Banerjee for assistance with solution-state NMR; and the Vincent Coates Foundation Mass Spectrometry Laboratory, Stanford University Mass Spectrometry (T. McLaughlin) for mass spectrometry assistance. We thank F. Yildiz and D. Zamorano-Sanchez for providing the pMMB956 plasmid; J. Rolff (Freie Universitat Berlin) for the ability to use the scanning electron microscope in his laboratories; and C. Tukel for the Salmonella enterica serovar Typhimurium strain IR715 Delta csgBA. Financial support was provided by the NSF CAREER award 1453247 (to L.C.), the Precourt Institute for Energy Seed Grant (to L.C.), and the Deutsche Forschungsgemeinschaft grants He1556/17-1 and He1556/21-1 (to R.H.). C.H. was supported by an ERASMUS fellowship from the European Union. W.T. and L.C. have filed a U.S. patent application relating to the work in this manuscript, no. PCT/US2017/047511 filed 18 August 2017 (production and applications of pEtN cellulose).	Anderson GG, 2008, CURR TOP MICROBIOL, V322, P85; Bian Z, 2000, J INFECT DIS, V181, P602, DOI 10.1086/315233; Cegelski L, 2009, NAT CHEM BIOL, V5, P913, DOI 10.1038/nchembio.242; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; Fage CD, 2014, ACTA CRYSTALLOGR D, V70, P2730, DOI 10.1107/S1399004714017623; Fang X, 2014, MOL MICROBIOL, V93, P439, DOI 10.1111/mmi.12672; Hung C, 2013, MBIO, V4, DOI 10.1128/mBio.00645-13; Jenal U, 2017, NAT REV MICROBIOL, V15, P271, DOI 10.1038/nrmicro.2016.190; Kai-Larsen Y, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001010; Karch H, 2012, EMBO MOL MED, V4, P841, DOI 10.1002/emmm.201201662; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Klemm D, 2005, ANGEW CHEM INT EDIT, V44, P3358, DOI 10.1002/anie.200460587; MANOIL C, 1986, SCIENCE, V233, P1403, DOI 10.1126/science.3529391; McCrate OA, 2013, J MOL BIOL, V425, P4286, DOI 10.1016/j.jmb.2013.06.022; Morgan JLW, 2014, NAT STRUCT MOL BIOL, V21, P489, DOI 10.1038/nsmb.2803; Nilsson J, 2005, PROTEINS, V60, P606, DOI 10.1002/prot.20583; Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w; Omadjela O, 2013, P NATL ACAD SCI USA, V110, P17856, DOI 10.1073/pnas.1314063110; Pultz IS, 2012, MOL MICROBIOL, V86, P1424, DOI 10.1111/mmi.12066; Reichhardt C, 2016, ANAL BIOANAL CHEM, V408, P7709, DOI 10.1007/s00216-016-9868-2; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; Richter AM, 2014, EMBO MOL MED, V6, P1622, DOI 10.15252/emmm.201404309; Romling U, 2005, CELL MOL LIFE SCI, V62, P1234, DOI 10.1007/s00018-005-4557-x; Romling U, 2015, TRENDS MICROBIOL, V23, P545, DOI 10.1016/j.tim.2015.05.005; Serra DO, 2013, J BACTERIOL, V195, P5540, DOI 10.1128/JB.00946-13; Serra DO, 2013, MBIO, V4, DOI 10.1128/mBio.00103-13; Stewart PS, 2008, NAT REV MICROBIOL, V6, P199, DOI 10.1038/nrmicro1838; Tukel C, 2005, MOL MICROBIOL, V58, P289, DOI 10.1111/j.1365-2958.2005.04825.x; Tukel C, 2010, CELL MICROBIOL, V12, P1495, DOI 10.1111/j.1462-5822.2010.01485.x; UPDEGRAFF DM, 1969, ANAL BIOCHEM, V32, P420, DOI 10.1016/S0003-2697(69)80009-6; Wang X, 2006, CELL MOL LIFE SCI, V63, P2352, DOI 10.1007/s00018-006-6222-4; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	32	128	131	15	207	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					334	338		10.1126/science.aao4096	http://dx.doi.org/10.1126/science.aao4096			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6BB	29348238				2022-12-28	WOS:000423236700040
J	Reges, O; Greenland, P; Dicker, D; Leibowitz, M; Hoshen, M; Gofer, I; Rasmussen-Torvik, LJ; Balicer, RD				Reges, Orna; Greenland, Philip; Dicker, Dror; Leibowitz, Morton; Hoshen, Moshe; Gofer, Ilan; Rasmussen-Torvik, Laura J.; Balicer, Ran D.			Association of Bariatric Surgery Using Laparoscopic Banding, Roux-en-Y Gastric Bypass, or Laparoscopic Sleeve Gastrectomy vs Usual Care Obesity Management With All-Cause Mortality	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OUTCOMES	IMPORTANCE Bariatric surgery is an effective and safe approach for weight loss and short-term improvement in metabolic disorders such as diabetes. However, studies have been limited in most settings by lack of a nonsurgical group, losses to follow-up, missing data, and small sample sizes in clinical trials and observational studies. OBJECTIVE To assess the association of 3 common types of bariatric surgery compared with nonsurgical treatment with mortality and other clinical outcomes among obese patients. DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study in a large Israeli integrated health fund covering 54% of Israeli citizens with less than 1% turnover of members annually. Obese adult patients who underwent bariatric surgery between January 1, 2005, and December 31, 2014, were selected and compared with obese nonsurgical patients matched on age, sex, body mass index (BMI), and diabetes, with a final follow-up date of December 31, 2015. A total of 33 540 patients were included in this study. EXPOSURES Bariatric surgery (laparoscopic banding, Roux-en-Y gastric bypass, or laparoscopic sleeve gastrectomy) or usual care obesity management only (provided by a primary care physician and which may include dietary counseling and behavior modification). MAIN OUTCOMES AND MEASURES The primary outcome, all-cause mortality, matched and adjusted for BMI prior to surgery, age, sex, socioeconomic status, diabetes, hyperlipidemia, hypertension, cardiovascular disease, and smoking. RESULTS The study population included 8385 patients who underwent bariatric surgery (median age, 46 [IQR, 37-54] years; 5490[65.5%] women; baseline median BMI, 40.6 [IQR, 38.5-43.7]; laparoscopic banding [n = 3635], gastric bypass [n = 1388], laparoscopic sleeve gastrectomy [n = 3362], and 25 155 nonsurgical matched patients (median age, 46 [IQR, 37-54] years; 16 470 [65.5%] women; baseline median BMI, 40.5 [IQR, 37.0-43.5]). The availability of follow-up data was 100% for all-cause mortality. There were 105 deaths (1.3%) among surgical patients during a median follow-up of 4.3 (IQR, 2.8-6.6) years (including 61 [1.7%] who underwent laparoscopic banding, 18 [1.3%] gastric bypass, and 26 [0.8%] sleeve gastrectomy), and 583 deaths (2.3%) among nonsurgical patients during a median follow-up of 4.0(IQR, 2.6-6.2) years. The absolute difference was 2.51 (95% CI, 1.86-3.15) fewer deaths/1000 person-years in the surgical vs nonsurgical group. Adjusted hazard ratios (HRs) for mortality among nonsurgical vs surgical patients were 2.02 (95% CI, 1.63-2.52) for the entire study population; by surgical type, HRs were 2.01 (95% CI, 1.50-2.69) for laparoscopic banding, 2.65 (95% CI, 1.55-4.52) for gastric bypass, and 1.60 (95% CI, 1.02-2.51) for laparoscopic sleeve gastrectomy. CONCLUSIONS AND RELEVANCE Among obese patients in a large integrated health fund in Israel, bariatric surgery using laparoscopic banding, gastric bypass, or laparoscopic sleeve gastrectomy, compared with usual care nonsurgical obesity management, was associated with lower all-cause mortality over a median follow-up of approximately 4.5 years. The evidence of this association adds to the limited literature describing beneficial outcomes of these 3 types of bariatric surgery compared with usual care obesity management alone.	[Reges, Orna; Leibowitz, Morton; Hoshen, Moshe; Gofer, Ilan; Balicer, Ran D.] Clalit Res Inst, Clalit Hlth Serv, Tel Aviv, Israel; [Reges, Orna] Ariel Univ, Dept Hlth Syst Management, Ariel, Israel; [Greenland, Philip; Rasmussen-Torvik, Laura J.] Northwestern Univ, Feinberg Sch Med, Dept Prevent Med, Chicago, IL 60611 USA; [Greenland, Philip] Northwestern Univ, Feinberg Sch Med, Dept Med, Chicago, IL 60611 USA; [Dicker, Dror] Rabin Med Ctr, Hasharon Hosp, Internal Med Dept D, Petah Tiqwa, Israel; [Dicker, Dror] Hasharon Hosp, Rabin Med Ctr, EASO Collaborating Ctr Obes Management, Petah Tiqwa, Israel; [Dicker, Dror] Tel Aviv Univ, Sackler Sch Med, Tel Aviv, Israel; [Dicker, Dror] Herzliya Med Ctr, Bariatr Ctr, Herzliyya, Israel; [Leibowitz, Morton] NYU, Sch Med, Dept Med, New York, NY USA; [Balicer, Ran D.] Ben Gurion Univ Negev, Sch Publ Hlth, Publ Hlth Dept, Beer Sheva, Israel	Clalit Health Services; Ariel University; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Rabin Medical Center; Rabin Medical Center; Tel Aviv University; Sackler Faculty of Medicine; New York University; Ben Gurion University	Reges, O (corresponding author), Clalit Res Inst, Chief Phys Off, Clalit Hlth Serv, 101 Arlozorov St, IL-62098 Tel Aviv, Israel.	ornare@clalit.org.il	Greenland, Philip/ABD-5528-2021; Reges, Orna/AAD-4072-2021	Reges, Orna/0000-0002-5384-005X; Rasmussen-Torvik, Laura/0000-0002-0820-7300; Balicer, Ran/0000-0002-7783-6362				Adams TD, 2017, NEW ENGL J MED, V377, P1143, DOI 10.1056/NEJMoa1700459; Arterburn DE, 2015, JAMA-J AM MED ASSOC, V313, P62, DOI 10.1001/jama.2014.16968; Arterburn DE, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g3961; Dicker D, 2016, OBES SURG, V26, P1814, DOI 10.1007/s11695-015-2025-8; Karpati T, 2014, POPUL HEALTH METR, V12, DOI 10.1186/s12963-014-0032-y; Kim J, 2016, SURG OBES RELAT DIS, V12, P453, DOI 10.1016/j.soard.2015.11.021; Pontiroli AE, 2016, CARDIOVASC DIABETOL, V15, DOI 10.1186/s12933-016-0347-z; Puzziferri N, 2014, JAMA-J AM MED ASSOC, V312, P934, DOI 10.1001/jama.2014.10706; Schaubel DE, 2006, BIOMETRICS, V62, P910, DOI 10.1111/j.1541-0420.2006.00527.x; Torgersen Z, 2014, CURR OPIN ENDOCRINOL, V21, P352, DOI 10.1097/MED.0000000000000099; Zhou X, 2016, OBES SURG, V26, P2590, DOI 10.1007/s11695-016-2144-x	11	131	135	2	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2018	319	3					279	290		10.1001/jama.2017.20513	http://dx.doi.org/10.1001/jama.2017.20513			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT3BY	29340677	Green Published, Bronze			2022-12-28	WOS:000423022300020
J	Bodewits, D; Farnham, TL; Kelley, MSP; Knight, MM				Bodewits, Dennis; Farnham, Tony L.; Kelley, Michael S. P.; Knight, Matthew M.			A rapid decrease in the rotation rate of comet 41P/Tuttle-Giacobini-Kresak	NATURE			English	Article							PERIOD; 67P/CHURYUMOV-GERASIMENKO; MORPHOLOGY; STATE	Cometary outgassing can produce torques that change the spin state of the cometary nucleus, which in turn influences the evolution and lifetime of the comet(1,2). If these torques increase the rate of rotation to the extent that centripetal forces exceed the material strength of the nucleus, the comet can fragment(3). Torques that slow down the rotation can cause the spin state to become unstable, but if the torques persist the nucleus can eventually reorient itself and the rotation rate can increase again(4). Simulations predict that most comets go through a short phase of rapid changes in spin state, after which changes occur gradually over longer times(5). Here we report observations of comet 41P/Tuttle-Giacobini-Kresak during its close approach to Earth (0.142 astronomical units, approximately 21 million kilometres, on 1 April 2017) that reveal a rapid decrease in rotation rate. Between March and May 2017, the apparent rotation period of the nucleus increased from 20 hours to more than 46 hours-a rate of change of more than an order of magnitude larger than has hitherto been measured. This phenomenon must have been caused by the gas emission from the comet aligning in such a way that it produced an anomalously strong torque that slowed the spin rate of the nucleus. The behaviour of comet 41P/Tuttle-Giacobini-Kresak suggests that it is in a distinct evolutionary state and that its rotation may be approaching the point of instability.	[Bodewits, Dennis; Farnham, Tony L.; Kelley, Michael S. P.; Knight, Matthew M.] Univ Maryland, Dept Astron, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Bodewits, D (corresponding author), Univ Maryland, Dept Astron, College Pk, MD 20742 USA.	dennis@astro.umd.edu			Swift Guest Investigator Program [1316125]; National Science Foundation [AST-1005313]	Swift Guest Investigator Program; National Science Foundation(National Science Foundation (NSF))	We thank M. Siegel and the Swift team for planning the observations of 41P. This research was supported by Swift Guest Investigator Program grant 1316125. We thank A. Thirouin, C. Trujillo and N. Moskovitz for observing and/or donating telescope time to acquire images used to determine rotation periods from morphology. We thank N. Eisner and D. Schleicher for sharing their preliminary results with us. We thank N. Samarasinha for calculating the zeta parameter for 41P and 67P. This work made use of the Discovery Channel Telescope at Lowell Observatory. Lowell is a private, non-profit institution dedicated to astrophysical research and public appreciation of astronomy and operates the DCT in partnership with Boston University, the University of Maryland, the University of Toledo, Northern Arizona University and Yale University. The Large Monolithic Imager was built by Lowell Observatory using funds provided by the National Science Foundation (AST-1005313). This work also made use of NASA's Astrophysics Data System and of the JPL/Horizons ephemerides service, maintained by the JPL Solar System Dynamics group.	A'Hearn MF, 2005, SCIENCE, V310, P258, DOI 10.1126/science.1118923; A'Hearn MF, 2011, SCIENCE, V332, P1396, DOI 10.1126/science.1204054; AHearn MF, 1995, ICARUS, V118, P223, DOI 10.1006/icar.1995.1190; AHEARN MF, 1986, NATURE, V324, P649, DOI 10.1038/324649a0; Belton MJS, 2012, CAN J PHYS, V90, P807, DOI 10.1139/p11-123; Bodewits D, 2014, ASTROPHYS J, V786, DOI 10.1088/0004-637X/786/1/48; Combi M., 2017, NASA PLANETARY DATA; COWAN JJ, 1979, MOON PLANETS, V21, P155, DOI 10.1007/BF00897085; Davidsson BJR, 2001, ICARUS, V149, P375, DOI 10.1006/icar.2000.6540; ESA Flight Dynamics Team, 2017, COM ROT PER; Farnham T. L., 2017, CBET, V4375; Farnham TL, 2000, ICARUS, V147, P180, DOI 10.1006/icar.2000.6420; FELDMAN PD, 1992, ICARUS, V95, P65, DOI 10.1016/0019-1035(92)90191-9; Fernandez YR, 2013, ICARUS, V226, P1138, DOI 10.1016/j.icarus.2013.07.021; FESTOU MC, 1981, ASTRON ASTROPHYS, V95, P69; Gutierrez PJ, 2003, ASTRON ASTROPHYS, V406, P1123, DOI 10.1051/0004-6361:20030845; Jewitt D, 1997, EARTH MOON PLANETS, V79, P35, DOI 10.1023/A:1006272914117; Keller HU, 2015, ASTRON ASTROPHYS, V579, DOI 10.1051/0004-6361/201526421; Knight M. M, 2017, CBET, V4377; Knight MM, 2012, ASTRON J, V144, DOI 10.1088/0004-6256/144/5/153; Knight MM, 2011, ASTRON J, V141, DOI 10.1088/0004-6256/141/6/183; Kronk G. W., 2017, GW KRONKS COMETOGRAP; Lamy PL, 2004, SPACE SCI S, P223; Mottola S, 2014, ASTRON ASTROPHYS, V569, DOI 10.1051/0004-6361/201424590; Mueller B. E. A., 2017, AST COM MET 2017 M; Mueller BEA, 1996, ICARUS, V123, P463, DOI 10.1006/icar.1996.0172; Mueller BEA, 2010, ICARUS, V209, P745, DOI 10.1016/j.icarus.2010.05.004; Samarasinha NH, 2013, ASTROPHYS J LETT, V775, DOI 10.1088/2041-8205/775/1/L10; Samarasinha NH, 2004, SPACE SCI S, P281; Schleicher D., 2010, LOWELL OBSERVATORY; SCHLEICHER DG, 1988, ASTROPHYS J, V331, P1058, DOI 10.1086/166622; Schleicher DG, 2004, SPACE SCI S, P449; SCHLEICHER DG, 1991, ICARUS, V94, P511, DOI 10.1016/0019-1035(91)90244-N; Sierks H, 2015, SCIENCE, V347, DOI 10.1126/science.aaa1044; Steckloff JK, 2016, ICARUS, V272, P60, DOI 10.1016/j.icarus.2016.02.026; Yoshida S., 2017, 41P TUTTLE GIACOBINI	37	20	20	1	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2018	553	7687					186	+		10.1038/nature25150	http://dx.doi.org/10.1038/nature25150			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4WL	29323296	Green Submitted			2022-12-28	WOS:000419794800032
J	Garaycoechea, JI; Crossan, GP; Langevin, F; Mulderrig, L; Louzada, S; Yang, FT; Guilbaud, G; Park, N; Roerink, S; Nik-Zainal, S; Stratton, MR; Patel, KJ				Garaycoechea, Juan I.; Crossan, Gerry P.; Langevin, Frederic; Mulderrig, Lee; Louzada, Sandra; Yang, Fentang; Guilbaud, Guillaume; Park, Naomi; Roerink, Sophie; Nik-Zainal, Serena; Stratton, Michael R.; Patel, Ketan J.			Alcohol and endogenous aldehydes damage chromosomes and mutate stem cells	NATURE			English	Article							FANCONI-ANEMIA PATHWAY; BONE-MARROW FAILURE; DNA-REPAIR; HOMOLOGOUS RECOMBINATION; GENOME; MICE; IDENTIFICATION; REPLICATION; PROGRESSION; EXPRESSION	Haematopoietic stem cells renew blood. Accumulation of DNA damage in these cells promotes their decline, while misrepair of this damage initiates malignancies. Here we describe the features and mutational landscape of DNA damage caused by acetaldehyde, an endogenous and alcohol-derived metabolite. This damage results in DNA double-stranded breaks that, despite stimulating recombination repair, also cause chromosome rearrangements. We combined transplantation of single haematopoietic stem cells with whole-genome sequencing to show that this damage occurs in stem cells, leading to deletions and rearrangements that are indicative of microhomology-mediated end-joining repair. Moreover, deletion of p53 completely rescues the survival of aldehyde-stressed and mutated haematopoietic stem cells, but does not change the pattern or the intensity of genome instability within individual stem cells. These findings characterize the mutation of the stem-cell genome by an alcohol-derived and endogenous source of DNA damage. Furthermore, we identify how the choice of DNA-repair pathway and a stringent p53 response limit the transmission of aldehyde-induced mutations in stem cells.	[Garaycoechea, Juan I.; Crossan, Gerry P.; Langevin, Frederic; Mulderrig, Lee; Guilbaud, Guillaume; Patel, Ketan J.] MRC, Lab Mol Biol, Cambridge Biomed Campus,Francis Crick Ave, Cambridge CB2 0QH, England; [Louzada, Sandra; Yang, Fentang; Park, Naomi; Roerink, Sophie; Nik-Zainal, Serena; Stratton, Michael R.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Patel, Ketan J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Hills Rd, Cambridge CB2 0QQ, England	MRC Laboratory Molecular Biology; Wellcome Trust Sanger Institute; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Garaycoechea, JI (corresponding author), MRC, Lab Mol Biol, Cambridge Biomed Campus,Francis Crick Ave, Cambridge CB2 0QH, England.	kjp@mrc-lmb.cam.ac.uk	Yang, Fan/GYU-4249-2022; Nik-Zainal, Serena/ABD-4437-2020	Nik-Zainal, Serena/0000-0001-5054-1727; Crossan, Gerry/0000-0002-7974-009X; Louzada Gomes Pereira, Sandra/0000-0003-2245-8453; Yang, Fengtang/0000-0002-3573-2354	NIHR Cambridge Biomedical Research Centre; MRC; Jeffrey Cheah Foundation; CRUK; Wellcome Trust; King's College, Cambridge; Cancer Research UK [23433, 22932, 23273, 23916] Funding Source: researchfish; Medical Research Council [MC_U105178811] Funding Source: researchfish; Medical Research Foundation [MRF-104-0006-S-MULDE] Funding Source: researchfish; Wellcome Trust [106202/Z/14/Z] Funding Source: researchfish; MRC [MC_U105178811] Funding Source: UKRI	NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Jeffrey Cheah Foundation; CRUK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); King's College, Cambridge; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Foundation(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank D. Kent for technical advice with single-HSC transplants; R. Berks, A. Middleton, J. Wiles, C. Knox, X. Gong, J. Roe, J. Willems, the ARES staff and Biomed for their help with mouse work; M. Daly, F. Zhang, V. Romashova and M. Balmont for help with flow cytometry; and J. Sale, C. Rada, M. Taylor, Y. L. Wu and members of the Patel laboratory for critical reading of the manuscript. The Human Research Tissue Bank (supported by the NIHR Cambridge Biomedical Research Centre) processed histology. K.J.P. is supported by the MRC and the Jeffrey Cheah Foundation. G.P.C. and L.M. were supported by CRUK. J.I.G. is supported by the Wellcome Trust and King's College, Cambridge.	Adamo A, 2010, MOL CELL, V39, P25, DOI 10.1016/j.molcel.2010.06.026; Behjati S, 2014, NATURE, V513, P422, DOI 10.1038/nature13448; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Cabezas-Wallscheid N, 2014, CELL STEM CELL, V15, P507, DOI 10.1016/j.stem.2014.07.005; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Dykstra B, 2011, J EXP MED, V208, P2691, DOI 10.1084/jem.20111490; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Garaycoechea JI, 2014, BLOOD, V123, P26, DOI 10.1182/blood-2013-09-427740; Garaycoechea JI, 2012, NATURE, V489, P571, DOI 10.1038/nature11368; Garcia-Rubio ML, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005674; Geigl JB, 2006, NAT PROTOC, V1, P1172, DOI 10.1038/nprot.2006.160; Ghezraoui H, 2014, MOL CELL, V55, P829, DOI 10.1016/j.molcel.2014.08.002; Giri SD, 1998, MUTAT RES-GEN TOX EN, V413, P227; Gribble SM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060482; Gu YS, 1997, IMMUNITY, V7, P653, DOI 10.1016/S1074-7613(00)80386-6; Hira A, 2013, BLOOD, V122, P3206, DOI 10.1182/blood-2013-06-507962; Jaber S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11091; Kawashima N, 2015, BRIT J HAEMATOL, V168, P460, DOI 10.1111/bjh.13122; Kent D., 2007, CURR PROTOC STEM CEL; KRISHNA G, 1992, MUTAT RES, V282, P159, DOI 10.1016/0165-7992(92)90090-5; Lai CL, 2014, ALCOHOL CLIN EXP RES, V38, P44, DOI 10.1111/acer.12215; Langevin F, 2011, NATURE, V475, P53, DOI 10.1038/nature10192; Long DT, 2011, SCIENCE, V333, P84, DOI 10.1126/science.1204258; Milyavsky M, 2010, CELL STEM CELL, V7, P186, DOI 10.1016/j.stem.2010.05.016; Mohrin M, 2010, CELL STEM CELL, V7, P174, DOI 10.1016/j.stem.2010.06.014; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Nijnik A, 2007, NATURE, V447, P686, DOI 10.1038/nature05875; Nik-Zainal S, 2015, MUTAGENESIS, V30, P763, DOI 10.1093/mutage/gev073; Oberbeck N, 2014, MOL CELL, V55, P807, DOI 10.1016/j.molcel.2014.07.010; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Orsburn B, 2010, MOL CELL BIOL, V30, P2341, DOI 10.1128/MCB.00091-10; Osawa M, 1996, SCIENCE, V273, P242, DOI 10.1126/science.273.5272.242; Pace P, 2010, SCIENCE, V329, P219, DOI 10.1126/science.1192277; Pang WW, 2011, P NATL ACAD SCI USA, V108, P20012, DOI 10.1073/pnas.1116110108; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Reinholdt Laura, 2004, Methods Mol Biol, V262, P87; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Roswall Nina, 2015, J Prev Med Public Health, V48, P1, DOI 10.3961/jpmph.14.052; Schwab RA, 2015, MOL CELL, V60, P351, DOI 10.1016/j.molcel.2015.09.012; Shen ZY, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-143; Tan SLW, 2017, CELL, V169, P1105, DOI 10.1016/j.cell.2017.05.010; Wang M, 2000, CHEM RES TOXICOL, V13, P1149, DOI 10.1021/tx000118t; Wyatt DW, 2016, MOL CELL, V63, P662, DOI 10.1016/j.molcel.2016.06.020; Yokoyama A, 2003, JPN J CLIN ONCOL, V33, P111, DOI 10.1093/jjco/hyg026	46	195	204	4	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2018	553	7687					171	+		10.1038/nature25154	http://dx.doi.org/10.1038/nature25154			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4WL	29323295	Green Accepted			2022-12-28	WOS:000419794800029
J	Opoku, NO; Bakajika, DK; Kanza, EM; Howard, H; Mambandu, GL; Nyathirombo, A; Nigo, MM; Kasonia, K; Masembe, SL; Mumbere, M; Kataliko, K; Larbelee, JP; Kpawor, M; Bolay, KM; Bolay, F; Asare, S; Attah, SK; Olipoh, G; Vaillant, M; Halleux, CM; Kuesel, AC				Opoko, Nicholas O.; Bakajika, Didier K.; Kanza, Eric M.; Howard, Hayford; Mambandu, Germain L.; Nyathirombo, Amos; Nigo, Maurice M.; Kasonia, Kambale; Masembe, Safari L.; Mumbere, Mupenzi; Kataliko, Kambale; Larbelee, Jemmah P.; Kpawor, Mawolo; Bolay, Kpehe M.; Bolay, Fatorma; Asare, Sampson; Attah, Simon K.; Olipoh, George; Vaillant, Michel; Halleux, Christine M.; Kuesel, Annette C.			Single dose moxidectin versus ivermectin for Onchocerca volvulus infection in Ghana, Liberia, and the Democratic Republic of the Congo: a randomised, controlled, double-blind phase 3 trial	LANCET			English	Article							ANTIPARASITIC MOXIDECTIN; MULTIPLE TREATMENTS; ADVERSE REACTIONS; ENDEMIC FOCI; PHARMACOKINETICS; ELIMINATION; CHEMOTHERAPY; MICROFILARICIDES; AFRICA	Background The morbidity and socioeconomic effects of onchocerciasis, a parasitic disease that is primarily endemic in sub-Saharan Africa, have motivated large morbidity and transmission control programmes. Annual community-directed ivermectin treatment has substantially reduced prevalence. Elimination requires intensified efforts, including more efficacious treatments. We compared parasitological efficacy and safety of moxidectin and ivermectin. Methods This double-blind, parallel group, superiority trial was done in four sites in Ghana, Liberia, and the Democratic Republic of the Congo. We enrolled participants (aged >= 12 years) with at least 10 Onchocerca volvulus microfilariae per mg skin who were not co-infected with Loa loa or lymphatic filariasis microfilaraemic. Participants were randomly allocated, stratified by sex and level of infection, to receive a single oral dose of 8 mg moxidectin or 150 mu g/kg ivermectin as overencapsulated oral tablets. The primary efficacy outcome was skin microfilariae density 12 months post treatment. We used a mixed-effects model to test the hypothesis that the primary efficacy outcome in the moxidectin group was 50% or less than that in the ivermectin group. The primary efficacy analysis population were all participants who received the study drug and completed 12-month follow-up (modified intention to treat). This study is registered with ClinicalTrials.gov, number NCT00790998. Findings Between April 22, 2009, and Jan 23, 2011, we enrolled and allocated 998 participants to moxidectin and 501 participants to ivermectin. 978 received moxidectin and 494 ivermectin, of which 947 and 480 were included in primary efficacy outcome analyses. At 12 months, skin microfilarial density (microfilariae per mg of skin) was lower in the moxidectin group (adjusted geometric mean 0.6 [95% CI 0.3-1.0]) than in the ivermectin group (4.5 [3 .5-5 9]; difference 3.9 [3. 2-4. 9], p<0.0001; treatment difference 86%). Mazzotti (ie, efficacy-related) reactions occurred in 967 (99%) of 978 moxidectin-treated participants and in 478 (97%) of 494 ivermectin-treated participants, including ocular reactions (moxidectin 113 112%1 participants and ivermectin 47 [10%] participants), laboratory reactions (788[81%]and 415 [84%]), and clinical reactions (944 [97%] and 446 [90%]). No serious adverse events were considered to be related to treatment. Interpretation Skin microfilarial loads (ie, parasite transmission reservoir) are lower after moxidectin treatment than after ivermectin treatment. Moxidectin would therefore be expected to reduce parasite transmission between treatment rounds more than ivermectin could, thus accelerating progress towards elimination. Copyright (C) 2018 World Health Organization; licensee Elsevier.	[Opoko, Nicholas O.] Univ Hlth & Allied Sci, Sch Publ Hlth, Dept Epidemiol & Biostat, Hohoe, Ghana; [Bakajika, Didier K.] WHO AFRO, Brazzaville, Rep Congo; [Kanza, Eric M.; Kasonia, Kambale; Masembe, Safari L.; Mumbere, Mupenzi; Kataliko, Kambale] UCG, Dept Rech Clin Graben, CRCB, Butembo, DEM REP CONGO; [Howard, Hayford] Kolahun Hosp, Kolahun, Liberia; [Mambandu, Germain L.] Minist Prov Sante, Kisangani, DEM REP CONGO; [Nyathirombo, Amos] Gulu Univ, Fac Med, Dept Ophthalmol, Gulu, Uganda; [Nigo, Maurice M.] Univ Hosp Basel, CLINAM, Nanomed Res Lab, Basel, Switzerland; [Larbelee, Jemmah P.] Cooper Adventist Hosp, Eye Care Serv, Monrovia, CA, Liberia; [Kpawor, Mawolo; Bolay, Kpehe M.; Bolay, Fatorma] LIBR, Monrovia, Liberia; [Asare, Sampson] South Dakota State Univ, Dept Chem & Biochem, Brookings, SD USA; [Attah, Simon K.] Univ Ghana, Sch Med, Dept Microbiol, Accra, Ghana; [Olipoh, George] Ghana Inst Management & Publ Adm, Ctr Management Dev, Accra, Ghana; [Vaillant, Michel] Luxembourg Inst Hlth, Competence Ctr Methodol & Stat, Strassen, Luxembourg; [Halleux, Christine M.; Kuesel, Annette C.] WHO, Special Programme Res & Training Trop Dis TDR, UNICEF, UNDP,World Bank, CH-1211 Geneva, Switzerland	University of Basel; South Dakota State University; University of Ghana; Luxembourg Institute of Health; The World Bank; World Health Organization	Kuesel, AC (corresponding author), WHO, Special Programme Res & Training Trop Dis TDR, UNICEF, UNDP,World Bank, CH-1211 Geneva, Switzerland.	kuesela@who.int	Mumbere, Mupenzi/AAG-4924-2019; Mumbere, Mupenzi/ADG-7720-2022; Kuesel, Annette C./ABB-0050-2022; vaillant, michel/H-5635-2019	Mumbere, Mupenzi/0000-0003-2035-7165; Kuesel, Annette C./0000-0002-1696-1784; vaillant, michel/0000-0003-4714-8128; Halleux, Christine/0000-0002-3230-5541	UNICEF; UNDP; World Bank; WHO Special Programme for Research and Training in Tropical Diseases	UNICEF; UNDP; World Bank(The World Bank India); WHO Special Programme for Research and Training in Tropical Diseases	UNICEF/UNDP/World Bank/WHO Special Programme for Research and Training in Tropical Diseases.	African Programme for Onchocerciasis Control, 2015, AFRICAN PROGRAMME ON; [Anonymous], 2015, Wkly Epidemiol Rec, V90, P661; Awadzi K, 2004, ANN TROP MED PARASIT, V98, P231, DOI 10.1179/000349804225003253; Awadzi K, 2004, ANN TROP MED PARASIT, V98, P359, DOI 10.1179/000349804225003442; AWADZI K, 1980, ANN TROP MED PARASIT, V74, P189, DOI 10.1080/00034983.1980.11687330; AWADZI K, 1995, TROP MED PARASITOL, V46, P131; Awadzi K, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002953; Basanez MG, 2008, LANCET INFECT DIS, V8, P310, DOI 10.1016/S1473-3099(08)70099-9; Botto C, 2016, PARASITE VECTOR, V9, DOI 10.1186/s13071-016-1313-z; Cotreau MM, 2003, J CLIN PHARMACOL, V43, P1108, DOI 10.1177/0091270003257456; D'Ambrosio MV, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa3480; DESOLE G, 1989, TROP MED PARASITOL, V40, P375; DESOLE G, 1989, B WORLD HEALTH ORGAN, V67, P707; Eberhard M, 2013, MMWR-MORBID MORTAL W, V62, P405; Frempong KK, 2016, CLIN INFECT DIS, V62, P1338, DOI 10.1093/cid/ciw144; HERO M, 1992, EYE, V6, P93, DOI 10.1038/eye.1992.19; Korth-Bradley JM, 2014, CLIN PHARM DRUG DEV, V3, P151, DOI 10.1002/cpdd.81; Korth-Bradley JM, 2012, CLIN PHARM DRUG DEV, V1, P32, DOI 10.1177/2160763X11432508; Korth-Bradley JM, 2012, AM J TROP MED HYG, V86, P122, DOI 10.4269/ajtmh.2012.11-0415; Korth-Bradley JM, 2011, ANTIMICROB AGENTS CH, V55, P5200, DOI 10.1128/AAC.00311-11; Kuesel AC, 2016, INT J PARASITOL-DRUG, V6, P272, DOI 10.1016/j.ijpddr.2016.04.002; Mounsey KE, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004389; Osei-Atweneboana MY, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000998; Osei-Atweneboano MY, 2007, LANCET, V369, P2021, DOI 10.1016/S0140-6736(07)60942-8; Pion SDS, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002084; Prichard R, 2012, INT J PARASITOL-DRUG, V2, P134, DOI 10.1016/j.ijpddr.2012.04.001; Remme JHF., 2017, INT ENCY PUBLIC HLTH, V2 nd edition, P576; Tekle AH, 2016, INFECT DIS POVERTY, V5, DOI 10.1186/s40249-016-0160-7; Turner HC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0779-4	29	74	75	0	13	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 6	2018	392	10154					1207	1216		10.1016/S0140-6736(17)32844-1	http://dx.doi.org/10.1016/S0140-6736(17)32844-1			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GV9SO	29361335	Green Published, hybrid			2022-12-28	WOS:000446500900026
J	McMahon, GT; Skochelak, SE				McMahon, Graham T.; Skochelak, Susan E.			Evolution of Continuing Medical Education Promoting Innovation Through Regulatory Alignment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[McMahon, Graham T.] Accreditat Council Continuing Med Educ, 401 N Michigan Ave,Ste 1850, Chicago, IL 60611 USA; [Skochelak, Susan E.] Amer Med Assoc, Med Educ, 515 N State St, Chicago, IL 60610 USA	American Medical Association	McMahon, GT (corresponding author), Accreditat Council Continuing Med Educ, 401 N Michigan Ave,Ste 1850, Chicago, IL 60611 USA.	gmcmahon@accme.org	McMahon, Graham/D-3740-2009	McMahon, Graham/0000-0003-4288-6535	Accreditation Council for Continuing Medical Education	Accreditation Council for Continuing Medical Education	Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr McMahon is a salaried employee of the Accreditation Council for Continuing Medical Education. Dr Skochelak is the group vice president for medical education at the American Medical Association.	Accreditation Council for Continuing Medical Education, AMA ACCME AL; American Medical Association, AMA ACCME AL; McMahon GT, 2017, ACAD MED, V92, P1075, DOI 10.1097/ACM.0000000000001619; National Academy of Medicine, LEARN HLTH SYST SER; Shanafelt TD, 2016, MAYO CLIN PROC, V91, P422, DOI 10.1016/j.mayocp.2016.02.001	5	10	10	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 13	2018	319	6					545	546		10.1001/jama.2017.19954	http://dx.doi.org/10.1001/jama.2017.19954			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FV9LD	29356818				2022-12-28	WOS:000424908400010
J	Lioy, VS; Cournac, A; Marbouty, M; Duigou, S; Mozziconacci, J; Espeli, O; Boccard, F; Koszul, R				Lioy, Virginia S.; Cournac, Axel; Marbouty, Martial; Duigou, Stephane; Mozziconacci, Julien; Espeli, Olivier; Boccard, Frederic; Koszul, Romain			Multiscale Structuring of the E. coli Chromosome by Nucleoid-Associated and Condensin Proteins	CELL			English	Article							ESCHERICHIA-COLI; BACTERIAL CHROMOSOME; BACILLUS-SUBTILIS; TOPOISOMERASE-IV; GENE-EXPRESSION; MOLECULAR-BASIS; DNA-BINDING; 3D GENOME; H-NS; ORGANIZATION	As in eukaryotes, bacterial genomes are not randomly folded. Bacterial genetic information is generally carried on a circular chromosome with a single origin of replication from which two replication forks proceed bidirectionally toward the opposite terminus region. Here, we investigate the higher-order architecture of the Escherichia coli genome, showing its partition into two structurally distinct entities by a complex and intertwined network of contacts: the replication terminus (ter) region and the rest of the chromosome. Outside of ter, the condensin MukBEF and the ubiquitous nucleoid-associated protein (NAP) HU promote DNA contacts in the megabase range. Within ter, the MatP protein prevents MukBEF activity, and contacts are restricted to similar to 280 kb, creating a domain with distinct structural properties. We also show how other NAPs contribute to nucleoid organization, such as H-NS, which restricts short-range interactions. Combined, these results reveal the contributions of major evolutionarily conserved proteins in a bacterial chromosome organization.	[Lioy, Virginia S.; Duigou, Stephane; Boccard, Frederic] Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Biol Integrat Cellule,CEA, F-91198 Gif Sur Yvette, France; [Cournac, Axel; Marbouty, Martial; Koszul, Romain] Inst Pasteur, Dept Genomes & Genet, Grp Regulat Spatiale Genomes, F-75015 Paris, France; [Cournac, Axel; Marbouty, Martial; Koszul, Romain] CNRS, UMR 3525, F-75015 Paris, France; [Mozziconacci, Julien] Univ Paris 06, UMR 7600, Lab Phys Theoret Mat Condensee, Sorbonne Univ, F-75005 Paris, France; [Espeli, Olivier] Coll France, UMR CNRS 7241, INSERM U1050, Ctr Interdisciplinaire Rech Biol, Paris, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; PSL Research University Paris; College de France; Ecole Normale Superieure (ENS); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm)	Boccard, F (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Biol Integrat Cellule,CEA, F-91198 Gif Sur Yvette, France.; Koszul, R (corresponding author), Inst Pasteur, Dept Genomes & Genet, Grp Regulat Spatiale Genomes, F-75015 Paris, France.; Koszul, R (corresponding author), CNRS, UMR 3525, F-75015 Paris, France.	frederic.boccard@i2bc.paris-saclay.fr; romain.koszul@pasteur.fr	Lioy, Vicky S./AAL-9782-2021; Mozziconacci, Julien/M-4731-2019; Lioy, Vicky/AAE-4039-2022	Lioy, Vicky S./0000-0002-5366-0462; Lioy, Vicky/0000-0002-5366-0462; Koszul, Romain/0000-0002-3086-1173; COURNAC, Axel/0000-0003-3523-2453; Boccard, Frederic/0000-0002-1866-2489; marbouty, martial/0000-0002-1668-8423	European Research Council (ERC) [260822]; Agence Nationale pour la Recherche [HiResBac ANR-15-CE11-0023-03, ANR-12-BSV8-0020-01]; Fondation pour la Recherche Medicale	European Research Council (ERC)(European Research Council (ERC)); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale)	We thank Charlotte Cockram, Matthew McNeil, and Benedicte Michel for careful reading of the manuscript; Michele Valens for microscopy analyses; and the members of the R.K., O.E., and F.B. laboratories for fruitful discussions and advice. We thank the I2BC genomic facility for high-throughput sequencing. This research was supported by funding from the European Research Council under the 7th Framework Program (FP7/2007-2013, ERC Grant Agreement 260822 to R.K.), by the Agence Nationale pour la Recherche (HiResBac ANR-15-CE11-0023-03 to R.K., O.E., and J.M.), by the Fondation pour la Recherche Medicale (to V.S.L.), and by the Agence Nationale pour la Recherche (ANR-12-BSV8-0020-01 to F.B.).	Alipour E, 2012, NUCLEIC ACIDS RES, V40, P11202, DOI 10.1093/nar/gks925; Booker BM, 2010, MOL MICROBIOL, V78, P1348, DOI 10.1111/j.1365-2958.2010.07394.x; Brezellec P, 2006, BIOINFORMATICS, V22, P1935, DOI 10.1093/bioinformatics/btl336; Cho BK, 2008, GENOME RES, V18, P900, DOI 10.1101/gr.070276.107; Claret L, 1997, J MOL BIOL, V273, P93, DOI 10.1006/jmbi.1997.1310; Corrales M, 2017, GENOME RES, V27, P1153, DOI 10.1101/gr.211433.116; Cournac A, 2016, METHODS MOL BIOL, V1361, P227, DOI 10.1007/978-1-4939-3079-1_13; Cournac A, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-436; Dekker J, 2002, SCIENCE, V295, P1306, DOI 10.1126/science.1067799; Dekker J, 2016, CELL, V164, P1110, DOI 10.1016/j.cell.2016.02.007; Dillon SC, 2010, NAT REV MICROBIOL, V8, P185, DOI 10.1038/nrmicro2261; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dupaigne P, 2012, MOL CELL, V48, P560, DOI 10.1016/j.molcel.2012.09.009; Espeli O, 2008, MOL MICROBIOL, V68, P1418, DOI 10.1111/j.1365-2958.2008.06239.x; Espeli O, 2012, EMBO J, V31, P3198, DOI 10.1038/emboj.2012.128; Hardy CD, 2005, MOL MICROBIOL, V57, P1636, DOI 10.1111/j.1365-2958.2005.04799.x; Hess BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066104; Higgins NP, 1996, J BACTERIOL, V178, P2825, DOI 10.1128/jb.178.10.2825-2835.1996; Javer A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4854; Kahramanoglou C, 2011, NUCLEIC ACIDS RES, V39, P2073, DOI 10.1093/nar/gkq934; Kleckner N, 2014, CURR OPIN MICROBIOL, V22, P127, DOI 10.1016/j.mib.2014.10.001; Lang B, 2007, NUCLEIC ACIDS RES, V35, P6330, DOI 10.1093/nar/gkm712; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Le TBK, 2016, EMBO J, V35, P1582, DOI 10.15252/embj.201593561; Le TBK, 2013, SCIENCE, V342, P731, DOI 10.1126/science.1242059; Lesne A, 2014, NAT METHODS, V11, P1141, DOI [10.1038/nmeth.3104, 10.1038/NMETH.3104]; Marbouty M, 2015, MOL CELL, V59, P588, DOI 10.1016/j.molcel.2015.07.020; Marbouty M, 2014, ELIFE, V3, DOI 10.7554/eLife.03318; Moffitt JR, 2016, ELIFE, V5, DOI 10.7554/eLife.13065; Niki H, 2000, GENE DEV, V14, P212; Nolivos S, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10466; Nolivos S, 2014, FEMS MICROBIOL REV, V38, P380, DOI 10.1111/1574-6976.12045; Prieto AI, 2012, NUCLEIC ACIDS RES, V40, P3524, DOI 10.1093/nar/gkr1236; Skoko D, 2006, J MOL BIOL, V364, P777, DOI 10.1016/j.jmb.2006.09.043; Staczek P, 1998, MOL MICROBIOL, V29, P1435, DOI 10.1046/j.1365-2958.1998.01025.x; Tjaden B, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0572-2; Trussart M, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14665; Umbarger MA, 2011, MOL CELL, V44, P252, DOI 10.1016/j.molcel.2011.09.010; Val ME, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501914; Valens M, 2004, EMBO J, V23, P4330, DOI 10.1038/sj.emboj.7600434; Vickridge E, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14618; Vora T, 2009, MOL CELL, V35, P247, DOI 10.1016/j.molcel.2009.06.035; Wang WQ, 2011, SCIENCE, V333, P1445, DOI 10.1126/science.1204697; Wang XD, 2006, GENE DEV, V20, P1727, DOI 10.1101/gad.388406; Wang XD, 2017, SCIENCE, V355, P524, DOI 10.1126/science.aai8982; Wang XD, 2015, GENE DEV, V29, P1661, DOI 10.1101/gad.265876.115; Wang XD, 2013, NAT REV GENET, V14, P191, DOI 10.1038/nrg3375; Zawadzki P, 2015, CELL REP, V13, P2587, DOI 10.1016/j.celrep.2015.11.034	48	139	140	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 8	2018	172	4					771	+		10.1016/j.cell.2017.12.027	http://dx.doi.org/10.1016/j.cell.2017.12.027			31	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FV5UV	29358050	Bronze			2022-12-28	WOS:000424648800017
J	Tetarenko, BE; Lasota, JP; Heinke, CO; Dubus, G; Sivakoff, GR				Tetarenko, B. E.; Lasota, J. -P.; Heinke, C. O.; Dubus, G.; Sivakoff, G. R.			Strong disk winds traced throughout outbursts in black-hole X-ray binaries	NATURE			English	Article							LIGHT CURVES; MAGNETOROTATIONAL TURBULENCE; LOCAL SIMULATIONS; INSTABILITY MODEL; MAGNETIC-FLUX; TRANSIENTS; SYSTEMS; IRRADIATION; VISCOSITY; DECAYS	Recurring outbursts associated with matter flowing onto compact stellar remnants (such as black holes, neutron stars and white dwarfs) in close binary systems provide a way of constraining the poorly understood accretion process. The light curves of these outbursts are shaped by the efficiency of angular-momentum (and thus mass) transport in the accretion disks, which has traditionally been encoded in a viscosity parameter, a. Numerical simulations(1-3) of the magneto-rotational instability that is believed to be the physical mechanism behind this transport yield values of a of roughly 0.1-0.2, consistent with values determined from observations of accreting white dwarfs(4). Equivalent viscosity parameters have hitherto not been estimated for disks around neutron stars or black holes. Here we report the results of an analysis of archival X-ray light curves of 21 outbursts in black-hole X-ray binaries. By applying a Bayesian approach to a model of accretion, we determine corresponding values of a of around 0.2-1.0. These high values may be interpreted as an indication either of a very high intrinsic rate of angular-momentum transport in the disk, which could be sustained by the magneto-rotational instability only if a large-scale magnetic field threads the disk(5-7), or that mass is being lost from the disk through substantial outflows, which strongly shape the outburst in the black-hole X-ray binary. The lack of correlation between our estimates of a and the accretion state of the binaries implies that such outflows can remove a substantial fraction of the disk mass in all accretion states and therefore suggests that the outflows correspond to magnetically driven disk winds rather than thermally driven ones, which require specific radiative conditions(8).				btetaren@ualberta.ca	Sivakoff, Gregory R/G-9602-2011; Lasota, Jean-Pierre/AAD-2940-2022	Sivakoff, Gregory R/0000-0001-6682-916X; Lasota, Jean-Pierre/0000-0002-6171-8396; Tetarenko, Bailey/0000-0003-2636-6644; Dubus, Guillaume/0000-0002-5130-2514	NSERC; Discovery Accelerator Supplement; National Science Foundation [NSF PHY-1125915]; Polish National Science Centre OPUS grant [2015/19/B/ST9/01099]; French Space Agency CNES	NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); Discovery Accelerator Supplement; National Science Foundation(National Science Foundation (NSF)); Polish National Science Centre OPUS grant; French Space Agency CNES(Centre National D'etudes Spatiales)	B.E.T. thanks participants of the 'disks17: Confronting MHD Theories of Accretion Disks with Observations' programme, held at the Kavli Institute for Theoretical Physics (KITP), for their feedback and comments on this project, especially A. Veledina for advice regarding the analysis of the X-ray light curves and P. Charles for comments on the manuscript. B.E.T., G.R.S. and C.O.H. acknowledge support by NSERC Discovery Grants, and C.O.H. by a Discovery Accelerator Supplement. This research was supported in part by the National Science Foundation under grant number NSF PHY-1125915, via support for KITP. J.-P.L. acknowledges support by the Polish National Science Centre OPUS grant 2015/19/B/ST9/01099. J.-P.L. and G.D. also acknowledge support from the French Space Agency CNES. This research has made use of data, software, and/or web tools obtained from the High Energy Astrophysics Science Archive Research Center (HEASARC), a service of the Astrophysics Science Division at NASA/GSFC and of the Smithsonian Astrophysical Observatory's High Energy Astrophysics Division, data supplied by the UK Swift Science Data Centre at the University of Leicester, and data provided by RIKEN, JAXA and the MAXI team. This work has also made extensive use of NASA's Astrophysics Data System (ADS).	Bai XN, 2013, ASTROPHYS J, V767, DOI 10.1088/0004-637X/767/1/30; Balbus SA, 1998, REV MOD PHYS, V70, P1, DOI 10.1103/RevModPhys.70.1; Bianchi S, 2017, MON NOT R ASTRON SOC, V472, P2454, DOI 10.1093/mnras/stx2173; Campana S, 2013, MON NOT R ASTRON SOC, V432, P1695, DOI 10.1093/mnras/stt604; CANNIZZO JK, 1993, ACCRETION DISKS COMP; Chakravorty S, 2013, MON NOT R ASTRON SOC, V436, P560, DOI 10.1093/mnras/stt1593; Coleman MSB, 2016, MON NOT R ASTRON SOC, V462, P3710, DOI 10.1093/mnras/stw1908; Davis SW, 2010, ASTROPHYS J, V713, P52, DOI 10.1088/0004-637X/713/1/52; deJong JA, 1996, ASTRON ASTROPHYS, V314, P484; Dubus G, 1999, MON NOT R ASTRON SOC, V303, P139, DOI 10.1046/j.1365-8711.1999.02212.x; Dubus G, 2001, ASTRON ASTROPHYS, V373, P251, DOI 10.1051/0004-6361:20010632; Evans PA, 2007, ASTRON ASTROPHYS, V469, P379, DOI 10.1051/0004-6361:20077530; Evans PA, 2009, MON NOT R ASTRON SOC, V397, P1177, DOI 10.1111/j.1365-2966.2009.14913.x; FAULKNER J, 1983, MON NOT R ASTRON SOC, V205, P359, DOI 10.1093/mnras/205.2.359; Foreman-Mackey D, 2013, PUBL ASTRON SOC PAC, V125, P306, DOI 10.1086/670067; Geem ZW, 2001, SIMULATION, V76, P60, DOI 10.1177/003754970107600201; Goodman J, 2010, COMM APP MATH COM SC, V5, P65, DOI 10.2140/camcos.2010.5.65; Heinke CO, 2015, MON NOT R ASTRON SOC, V447, P3034, DOI 10.1093/mnras/stu2652; Higginbottom N, 2015, ASTROPHYS J, V807, DOI 10.1088/0004-637X/807/1/107; Hirose S, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/1; HUANG M, 1989, ASTROPHYS J, V343, P229, DOI 10.1086/167700; King AR, 2007, MON NOT R ASTRON SOC, V376, P1740, DOI 10.1111/j.1365-2966.2007.11556.x; King AR, 1998, MON NOT R ASTRON SOC, V293, pL42, DOI 10.1046/j.1365-8711.1998.01295.x; Kotko I, 2012, ASTRON ASTROPHYS, V545, DOI 10.1051/0004-6361/201219618; Lasota JP, 2015, ASTROPHYS J LETT, V801, DOI 10.1088/2041-8205/801/1/L4; Lasota JP, 2001, NEW ASTRON REV, V45, P449, DOI 10.1016/S1387-6473(01)00112-9; Lesur G, 2013, ASTRON ASTROPHYS, V550, DOI 10.1051/0004-6361/201220395; Lipunova GV, 2017, MON NOT R ASTRON SOC, V468, P4735, DOI 10.1093/mnras/stx768; Menou K, 2000, MON NOT R ASTRON SOC, V314, P498, DOI 10.1046/j.1365-8711.2000.03357.x; MEYER F, 1981, ASTRON ASTROPHYS, V104, pL10; Migliari S, 2006, MON NOT R ASTRON SOC, V366, P79, DOI 10.1111/j.1365-2966.2005.09777.x; Miller JM, 2006, ASTROPHYS J, V646, P394, DOI 10.1086/504673; Neilsen J, 2013, ADV SPACE RES, V52, P732, DOI 10.1016/j.asr.2013.04.021; Ozel F, 2010, ASTROPHYS J, V725, P1918, DOI 10.1088/0004-637X/725/2/1918; Ohsuga K, 2011, ASTROPHYS J, V736, DOI 10.1088/0004-637X/736/1/2; OSAKI Y, 1974, PUBL ASTRON SOC JPN, V26, P429; Ponti G, 2012, MON NOT R ASTRON SOC, V422, pL11, DOI 10.1111/j.1745-3933.2012.01224.x; Powell CR, 2007, MON NOT R ASTRON SOC, V374, P466, DOI 10.1111/j.1365-2966.2006.11144.x; Salvesen G, 2016, MON NOT R ASTRON SOC, V457, P857, DOI 10.1093/mnras/stw029; Scepi N., 2017, ASTRON ASTROPHYS; Shahbaz T, 1998, MON NOT R ASTRON SOC, V301, P382, DOI 10.1046/j.1365-8711.1998.01991.x; SHAKURA NI, 1973, ASTRON ASTROPHYS, V24, P337; Simon JB, 2012, MON NOT R ASTRON SOC, V422, P2685, DOI 10.1111/j.1365-2966.2012.20835.x; Simon V, 2006, MON NOT R ASTRON SOC, V369, P355, DOI 10.1111/j.1365-2966.2006.10300.x; Smak J., 1984, Acta Astronomica, V34, P161; Tetarenko BE, 2016, ASTROPHYS J SUPPL S, V222, DOI 10.3847/0067-0049/222/2/15; TOOR A, 1974, ASTRON J, V79, P995, DOI 10.1086/111643; Torres MAP, 2008, ASTROPHYS J, V672, P1079, DOI 10.1086/523831; Truss MR, 2002, MON NOT R ASTRON SOC, V337, P1329, DOI 10.1046/j.1365-8711.2002.05986.x; vanParadijs J, 1996, ASTROPHYS J, V464, pL139, DOI 10.1086/310100; Warner B, 1995, CATACLYSMIC VARIABLE, P126; Yan Z, 2015, ASTROPHYS J, V805, DOI 10.1088/0004-637X/805/2/87	52	53	53	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	2018	554	7690					69	+		10.1038/nature25159	http://dx.doi.org/10.1038/nature25159			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU7QX	29364880	Green Submitted			2022-12-28	WOS:000424048900032
J	Khin, MO; Bromham, N; Harrison, M; Eadon, H				Khin, May Oo; Bromham, Nathan; Harrison, Mark; Eadon, Hilary		Guideline Comm	Assessment and management of oesophago-gastric cancer: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Khin, May Oo; Bromham, Nathan; Eadon, Hilary] Royal Coll Obstetricians & Gynaecologists, Natl Guideline Alliance, London NW1 4RG, England; [Harrison, Mark] Mt Vernon Canc Ctr, Northwood HA6 2RN, Middx, England	Mount Vernon Cancer Centre	Eadon, H (corresponding author), Royal Coll Obstetricians & Gynaecologists, Natl Guideline Alliance, London NW1 4RG, England.	HEadon@rcog.org.uk			NICE	NICE	The National Guideline Alliance was commissioned and funded by NICE to develop this guideline and write this BMJ summary.	National Institute for Health and Care Excellence, 2017, OES GASTR CANC ASS M; National Institute of Health and Care Excellence, 2004, IMPR SUPP PALL CAR A; National Institute of Health and Care Excellence, 2017, NUTR SUPP AD OR NUTR; National Institute of Health and Care Excellence, 2012, PAT EXP AD NHS SERV; NHS Digital, 2016, NAT OES GASTR CANC A	5	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 29	2018	360								k213	10.1136/bmj.k213	http://dx.doi.org/10.1136/bmj.k213			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU4TD	29378685				2022-12-28	WOS:000423844600001
J	Gong, SH; Alpeggiani, F; Sciacca, B; Garnett, EC; Kuipers, L				Gong, Su-Hyun; Alpeggiani, Filippo; Sciacca, Beniamino; Garnett, Erik C.; Kuipers, L.			Nanoscale chiral valley-photon interface through optical spin-orbit coupling	SCIENCE			English	Article							NANOPHOTONIC WAVE-GUIDE; POLARIZATION; MOS2; OPTOELECTRONICS; COHERENCE; MOMENTUM; LOCKING	The emergence of two-dimensional transition metal dichalcogenide materials has sparked intense activity in valleytronics, as their valley information can be encoded and detected with the spin angular momentum of light. We demonstrate the valley-dependent directional coupling of light using a plasmonic nanowire-tungsten disulfide (WS2) layers system. We show that the valley pseudospin in WS2 couples to transverse optical spin of the same handedness with a directional coupling efficiency of 90 +/- 1%. Our results provide a platform for controlling, detecting, and processing valley and spin information with precise optical control at the nanoscale.	[Gong, Su-Hyun; Alpeggiani, Filippo; Kuipers, L.] Delft Univ Technol, Dept Quantum Nanosci, Kavli Inst Nanosci, POB 5046, NL-2600 GA Delft, Netherlands; [Gong, Su-Hyun; Alpeggiani, Filippo; Sciacca, Beniamino; Garnett, Erik C.; Kuipers, L.] AMOLF, Ctr Nanophoton, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands	Delft University of Technology; AMOLF	Kuipers, L (corresponding author), Delft Univ Technol, Dept Quantum Nanosci, Kavli Inst Nanosci, POB 5046, NL-2600 GA Delft, Netherlands.; Kuipers, L (corresponding author), AMOLF, Ctr Nanophoton, Sci Pk 104, NL-1098 XG Amsterdam, Netherlands.	l.kuipers@tudelft.nl	Kuipers, Laurens/A-9378-2014; Garnett, Erik C/A-6847-2009	Garnett, Erik C/0000-0002-9158-8326; Gong, Su-Hyun/0000-0002-8652-714X; Sciacca, Beniamino/0000-0003-1113-1391; Kuipers, L./0000-0003-0556-8167	European Research Council (ERC) Advanced Investigator Grant [340438-CONSTANS]; Marie Sklodowska-Curie individual fellowship BISTRO-LIGHT [748950]; ERC under the European Union's Seventh Framework Programme (FP)/ERC [337328]	European Research Council (ERC) Advanced Investigator Grant; Marie Sklodowska-Curie individual fellowship BISTRO-LIGHT; ERC under the European Union's Seventh Framework Programme (FP)/ERC	S.-H.G., F.A., and L.K. acknowledge funding from European Research Council (ERC) Advanced Investigator Grant no. 340438-CONSTANS. This work is part of the research program of The Netherlands Organization for Scientific Research (NWO). F.A. acknowledges support from the Marie Sklodowska-Curie individual fellowship BISTRO-LIGHT (no. 748950). B.S. and E.C.G. were supported by funding from the ERC under the European Union's Seventh Framework Programme (FP/2007-2013)/ERC grant agreement no. 337328, "NanoEnabledPV." All data are reported in the main text and supplementary materials.	Aiello A, 2015, NAT PHOTONICS, V9, P789, DOI 10.1038/nphoton.2015.203; Bliokh KY, 2015, NAT PHOTONICS, V9, P796, DOI 10.1038/nphoton.2015.201; Bliokh KY, 2015, SCIENCE, V348, P1448, DOI 10.1126/science.aaa9519; Bliokh KY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4300; Cao T, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1882; Chervy T., 2017, ARXIV170107972CONDMA; Coles RJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11183; Jones AM, 2014, NAT PHYS, V10, P130, DOI [10.1038/NPHYS2848, 10.1038/nphys2848]; Jones AM, 2013, NAT NANOTECHNOL, V8, P634, DOI [10.1038/NNANO.2013.151, 10.1038/nnano.2013.151]; Mak KF, 2014, SCIENCE, V344, P1489, DOI 10.1126/science.1250140; Mak KF, 2016, NAT PHOTONICS, V10, P216, DOI [10.1038/NPHOTON.2015.282, 10.1038/nphoton.2015.282]; Mak KF, 2012, NAT NANOTECHNOL, V7, P494, DOI [10.1038/nnano.2012.96, 10.1038/NNANO.2012.96]; O'Connor D, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6327; Rodriguez-Fortuno FJ, 2014, ACS PHOTONICS, V1, P762, DOI 10.1021/ph500084b; Rodriguez-Fortuno FJ, 2013, SCIENCE, V340, P328, DOI 10.1126/science.1233739; Sayrin C, 2015, PHYS REV X, V5, DOI 10.1103/PhysRevX.5.041036; Schaibley JR, 2016, NAT REV MATER, V1, DOI 10.1038/natrevmats.2016.55; Schmidt R, 2016, NANO LETT, V16, P2945, DOI 10.1021/acs.nanolett.5b04733; Van Mechelen T, 2016, OPTICA, V3, P118, DOI 10.1364/OPTICA.3.000118; Wang QH, 2012, NAT NANOTECHNOL, V7, P699, DOI [10.1038/nnano.2012.193, 10.1038/NNANO.2012.193]; Xiao D, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.196802; Xiao D, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.236809; Xu XD, 2014, NAT PHYS, V10, P343, DOI [10.1038/NPHYS2942, 10.1038/nphys2942]; Zeng HL, 2012, NAT NANOTECHNOL, V7, P490, DOI [10.1038/nnano.2012.95, 10.1038/NNANO.2012.95]; Zhang YJ, 2014, SCIENCE, V344, P725, DOI 10.1126/science.1251329; Zhu BR, 2014, P NATL ACAD SCI USA, V111, P11606, DOI 10.1073/pnas.1406960111	29	164	166	27	222	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					443	+		10.1126/science.aan8010	http://dx.doi.org/10.1126/science.aan8010			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6SD	29371466	Green Submitted			2022-12-28	WOS:000423283200043
J	Diver, MM; Pedi, L; Koide, A; Koide, S; Long, SB				Diver, Melinda M.; Pedi, Leanne; Koide, Akiko; Koide, Shohei; Long, Stephen B.			Atomic structure of the eukaryotic intramembrane RAS methyltransferase ICMT	NATURE			English	Article							ISOPRENYLCYSTEINE CARBOXYL METHYLTRANSFERASE; CRYSTAL-STRUCTURE; PROTEIN PRENYLATION; MUTATIONAL ANALYSIS; MODEL; CARBOXYLMETHYLTRANSFERASE; RECOGNITION; METHYLATION; TOPOLOGY	The maturation of RAS GTPases and approximately 200 other cellular CAAX proteins involves three enzymatic steps: addition of a farnesyl or geranylgeranyl prenyl lipid to the cysteine (C) in the C-terminal CAAX motif, proteolytic cleavage of the AAX residues and methylation of the exposed prenylcysteine residue at its terminal carboxylate1. This final step is catalysed by isoprenylcysteine carboxyl methyltransferase (ICMT), a eukaryote-specific integral membrane enzyme that resides in the endoplasmic reticulum2. ICMT is the only cellular enzyme that is known to methylate prenylcysteine substrates; methylation is important for the biological functions of these substrates, such as the membrane localization and subsequent activity of RAS1, prelamin A3 and RAB4. Inhibition of ICMT has potential for combating progeria3 and cancer5-8. Here we present an X-ray structure of ICMT, in complex with its cofactor, an ordered lipid molecule and a monobody inhibitor, at 2.3 A resolution. The active site spans cytosolic and membrane-exposed regions, indicating distinct entry routes for the cytosolic methyl donor, S-adenosyl-l-methionine, and for prenylcysteine substrates, which are associated with the endoplasmic reticulum membrane. The structure suggests how ICMT overcomes the topographical challenge and unfavourable energetics of bringing two reactants that have different cellular localizations together in a membrane environment-a relatively uncharacterized but defining feature of many integral membrane enzymes.	[Diver, Melinda M.; Pedi, Leanne; Long, Stephen B.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10065 USA; [Diver, Melinda M.] Weill Cornell Med Grad Sch Med Sci, Grad Program Biochem & Struct Biol Cell & Dev Bio, 1300 York Ave, New York, NY 10065 USA; [Koide, Akiko; Koide, Shohei] NYU, Perlmutter Canc Ctr, Langone Med Ctr, 430 East 29th St, New York, NY 10016 USA; [Koide, Akiko] NYU, Dept Med, Langone Med Ctr, 430 East 29th St, New York, NY 10016 USA; [Koide, Shohei] NYU, Dept Biochem & Mol Pharmacol, Langone Med Ctr, 430 East 29th St, New York, NY 10016 USA; [Diver, Melinda M.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	Memorial Sloan Kettering Cancer Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; New York University; NYU Langone Medical Center; University of California System; University of California San Francisco	Long, SB (corresponding author), Mem Sloan Kettering Canc Ctr, Struct Biol Program, 1275 York Ave, New York, NY 10065 USA.	Longs@mskcc.org		Koide, Shohei/0000-0001-5473-4358; Long, Stephen/0000-0002-8144-1398; Diver, Melinda/0000-0001-5037-7322	NIH [ACB-12002, AGM-12006, P41 GM103403, S10 RR029205, U54-GM087519]; DOE [DE-AC02-06CH11357]; American Heart Association Pre-doctoral Fellowship; Burroughs Wellcome Career Award; Geoffrey Beene Cancer Research Center at MSKCC;  [P30 CA008748]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR029205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103403, U54GM087519] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); American Heart Association Pre-doctoral Fellowship(American Heart Association); Burroughs Wellcome Career Award(Burroughs Wellcome Fund); Geoffrey Beene Cancer Research Center at MSKCC; ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Julius, C. D. Lima, M. Luo, N. P. Pavletich, R. K. Hite, S. Shuman and members of the Long laboratory for discussions. Beamlines 24-ID and 23-ID at the Advanced Photon Source are supported by NIH grants ACB-12002, AGM-12006, P41 GM103403 and S10 RR029205, under DOE contract DE-AC02-06CH11357. This work was supported, in part, by an American Heart Association Pre-doctoral Fellowship (M.M.D.), a Burroughs Wellcome Career Award (S.B.L), the Geoffrey Beene Cancer Research Center at MSKCC (S.B.L.), a core-facilities support grant to MSKCC (P30 CA008748) and NIH grant U54-GM087519 (S.K.).	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Anderson JL, 2005, J BIOL CHEM, V280, P29454, DOI 10.1074/jbc.M504982200; Baron Rudi A., 2004, BMC Biochemistry, V5, P19, DOI 10.1186/1471-2091-5-19; Berndt N, 2011, NAT REV CANCER, V11, P775, DOI 10.1038/nrc3151; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Caffrey M, 2009, NAT PROTOC, V4, P706, DOI 10.1038/nprot.2009.31; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Court H, 2017, J CELL BIOL, V216, P4165, DOI 10.1083/jcb.201701053; Cox AD, 2014, NAT REV DRUG DISCOV, V13, P828, DOI 10.1038/nrd4389; Dai Q, 1998, J BIOL CHEM, V273, P15030, DOI 10.1074/jbc.273.24.15030; Dharmaiah S, 2016, P NATL ACAD SCI USA, V113, pE6766, DOI 10.1073/pnas.1615316113; Diver MM, 2014, J BIOL CHEM, V289, P26007, DOI 10.1074/jbc.M114.585125; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Gordon LB, 2014, CELL, V156, P400, DOI 10.1016/j.cell.2013.12.028; Griggs AM, 2010, J BIOL CHEM, V285, P13380, DOI 10.1074/jbc.M109.061366; Horowitz S, 2013, J AM CHEM SOC, V135, P15536, DOI 10.1021/ja407140k; Ibrahim MX, 2013, SCIENCE, V340, P1330, DOI 10.1126/science.1238880; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kawate T, 2006, STRUCTURE, V14, P673, DOI 10.1016/j.str.2006.01.013; KILMARTIN JV, 1982, J CELL BIOL, V93, P576, DOI 10.1083/jcb.93.3.576; Koide A, 2012, J MOL BIOL, V415, P393, DOI 10.1016/j.jmb.2011.12.019; Koide A, 2009, PROTEIN ENG DES SEL, V22, P685, DOI 10.1093/protein/gzp053; Koide S, 2012, METHOD ENZYMOL, V503, P135, DOI 10.1016/B978-0-12-396962-0.00006-9; Koide S, 2009, CURR OPIN STRUC BIOL, V19, P449, DOI 10.1016/j.sbi.2009.04.008; Lau HY, 2017, ONCOGENE, V36, P3934, DOI 10.1038/onc.2016.508; LEMMON MA, 1994, NAT STRUCT BIOL, V1, P157, DOI 10.1038/nsb0394-157; Li XC, 2015, NATURE, V517, P104, DOI 10.1038/nature13797; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2002, NATURE, V419, P645, DOI 10.1038/nature00986; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; PEREZSALA D, 1992, BIOCHEM J, V284, P835, DOI 10.1042/bj2840835; Romano JD, 2001, MOL BIOL CELL, V12, P1957, DOI 10.1091/mbc.12.7.1957; Sha F, 2013, P NATL ACAD SCI USA, V110, P14924, DOI 10.1073/pnas.1303640110; Stockbridge RB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6120; Strong M, 2006, P NATL ACAD SCI USA, V103, P8060, DOI 10.1073/pnas.0602606103; TAN EW, 1991, J BIOL CHEM, V266, P10719; Wang M, 2016, NAT REV MOL CELL BIO, V17, P110, DOI 10.1038/nrm.2015.11; Wang T, 2017, CELL, V168, P890, DOI 10.1016/j.cell.2017.01.013; Wright LP, 2009, MOL CELL BIOL, V29, P1826, DOI 10.1128/MCB.01719-08; Yang J, 2011, MOL CELL, V44, P997, DOI 10.1016/j.molcel.2011.10.020	42	24	25	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 25	2018	553	7689					526	+		10.1038/nature25439	http://dx.doi.org/10.1038/nature25439			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FU6OE	29342140	Green Accepted			2022-12-28	WOS:000423971100045
J	Pitman, B				Pitman, Bonnie			Pharma Art-Abstract Medication in the Work of Beverly Fishman	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Pitman, Bonnie] Edith ODonnell Inst Art Hist, Residence, Dallas, TX USA; [Pitman, Bonnie] Univ Texas Dallas, Ctr Brain Hlth, Art Brain Initiat, Richardson, TX 75080 USA	University of Texas System; University of Texas Dallas	Pitman, B (corresponding author), Univ Texas Dallas, 800 W Campbell Rd,ATC 11,Off ATC 3-602, Richardson, TX 75080 USA.	bpitman@utdallas.edu							0	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	2018	319	4					326	328		10.1001/jama.2017.18675	http://dx.doi.org/10.1001/jama.2017.18675			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT8LW	29362772				2022-12-28	WOS:000423405300001
J	Hawkes, N				Hawkes, Nigel			NHS PRIVATISATION Carillion's toll on NHS	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						National Audit Office, 2018, PFI PF2 REP COMPTR A; O'Dowd A, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.k273	2	0	0	0	8	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 22	2018	360								k298	10.1136/bmj.k298	http://dx.doi.org/10.1136/bmj.k298			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU2WP	29358230				2022-12-28	WOS:000423711000008
J	Galperin, MY; Shalaeva, DN				Galperin, Michael Y.; Shalaeva, Daria N.			A bacterial coat that is not pure cotton	SCIENCE			English	Editorial Material							CYCLIC-DI-GMP; CELLULOSE BIOSYNTHESIS; 2ND-MESSENGER; NANOCELLULOSE		[Galperin, Michael Y.] NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA; [Shalaeva, Daria N.] Moscow MV Lomonosov State Univ, Sch Bioengn & Bioinformat, Moscow 119992, Russia; [Shalaeva, Daria N.] Univ Osnabruck, Sch Phys, D-49069 Osnabruck, Germany	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); Lomonosov Moscow State University; University Osnabruck	Galperin, MY (corresponding author), NIH, Natl Ctr Biotechnol Informat, Natl Lib Med, Bethesda, MD 20894 USA.	galperin@ncbi.nlm.nih.gov; dshalaeva@uos.de	Galperin, Michael Y./B-5859-2013	Galperin, Michael Y./0000-0002-2265-5572	U.S. National Institutes of Health Intramural Research Program at the National Library of Medicine; German Academic Exchange Service (DAAD)	U.S. National Institutes of Health Intramural Research Program at the National Library of Medicine; German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD))	M.Y.G. is supported by the U.S. National Institutes of Health Intramural Research Program at the National Library of Medicine. D.N.S. is supported by the German Academic Exchange Service (DAAD).	Abitbol T, 2016, CURR OPIN BIOTECH, V39, P76, DOI 10.1016/j.copbio.2016.01.002; Fang X, 2014, MOL MICROBIOL, V93, P439, DOI 10.1111/mmi.12672; Galperin MY, 1998, PROTEIN SCI, V7, P1829, DOI 10.1002/pro.5560070819; Krasteva PV, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01523-2; Lin N, 2014, EUR POLYM J, V59, P302, DOI 10.1016/j.eurpolymj.2014.07.025; Lomize MA, 2012, NUCLEIC ACIDS RES, V40, pD370, DOI 10.1093/nar/gkr703; Morgan JLW, 2016, NATURE, V531, P329, DOI 10.1038/nature16966; Orr MW, 2016, CURR OPIN MICROBIOL, V34, P119, DOI 10.1016/j.mib.2016.08.010; Richter AM, 2014, EMBO MOL MED, V6, P1622, DOI 10.15252/emmm.201404309; Romling U, 2015, TRENDS MICROBIOL, V23, P545, DOI 10.1016/j.tim.2015.05.005; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; ROSS P, 1991, MICROBIOL REV, V55, P35, DOI 10.1128/MMBR.55.1.35-58.1991; Serra DO, 2013, J BACTERIOL, V195, P5540, DOI 10.1128/JB.00946-13; Thongsomboon W, 2018, SCIENCE, V359, P334, DOI 10.1126/science.aao4096; Zogaj X, 2001, MOL MICROBIOL, V39, P1452, DOI 10.1046/j.1365-2958.2001.02337.x	15	7	7	0	53	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					276	277		10.1126/science.aar5253	http://dx.doi.org/10.1126/science.aar5253			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT6BB	29348224				2022-12-28	WOS:000423236700020
J	Weiss, DJ; Nelson, A; Gibson, HS; Temperley, W; Peedell, S; Lieber, A; Hancher, M; Poyart, E; Belchior, S; Fullman, N; Mappin, B; Dalrymple, U; Rozier, J; Lucas, TCD; Howes, RE; Tusting, LS; Kang, SY; Cameron, E; Bisanzio, D; Battle, KE; Bhatt, S; Gething, PW				Weiss, D. J.; Nelson, A.; Gibson, H. S.; Temperley, W.; Peedell, S.; Lieber, A.; Hancher, M.; Poyart, E.; Belchior, S.; Fullman, N.; Mappin, B.; Dalrymple, U.; Rozier, J.; Lucas, T. C. D.; Howes, R. E.; Tusting, L. S.; Kang, S. Y.; Cameron, E.; Bisanzio, D.; Battle, K. E.; Bhatt, S.; Gething, P. W.			A global map of travel time to cities to assess inequalities in accessibility in 2015	NATURE			English	Article							AFRICA	The economic and man-made resources that sustain human wellbeing are not distributed evenly across the world, but are instead heavily concentrated in cities. Poor access to opportunities and services offered by urban centres (a function of distance, transport infrastructure, and the spatial distribution of cities) is a major barrier to improved livelihoods and overall development. Advancing accessibility worldwide underpins the equity agenda of 'leaving no one behind' established by the Sustainable Development Goals of the United Nations(1). This has renewed international efforts to accurately measure accessibility and generate a metric that can inform the design and implementation of development policies. The only previous attempt to reliably map accessibility worldwide, which was published nearly a decade ago(2), predated the baseline for the Sustainable Development Goals and excluded the recent expansion in infrastructure networks, particularly in lower-resource settings. In parallel, new data sources provided by Open Street Map and Google now capture transportation networks with unprecedented detail and precision. Here we develop and validate a map that quantifies travel time to cities for 2015 at a spatial resolution of approximately one by one kilometre by integrating ten global-scale surfaces that characterize factors affecting human movement rates and 13,840 high-density urban centres within an established geospatial-modelling framework. Our results highlight disparities in accessibility relative to wealth as 50.9% of individuals living in low-income settings (concentrated in sub-Saharan Africa) reside within an hour of a city compared to 90.7% of individuals in high-income settings. By further triangulating this map against socioeconomic datasets, we demonstrate how access to urban centres stratifies the economic, educational, and health status of humanity.	[Weiss, D. J.; Gibson, H. S.; Dalrymple, U.; Rozier, J.; Lucas, T. C. D.; Howes, R. E.; Tusting, L. S.; Kang, S. Y.; Cameron, E.; Bisanzio, D.; Battle, K. E.; Gething, P. W.] Univ Oxford, Malaria Atlas Project, Big Data Inst, Nuffield Dept Med, Roosevelt Dr, Oxford OX3 7FY, England; [Nelson, A.] Univ Twente, Dept Nat Resources, Fac Geoinformat Sci & Earth Observat ITC, POB 217, NL-7500 AE Enschede, Netherlands; [Temperley, W.; Peedell, S.] European Commiss, Joint Res Ctr, Unit Knowledge Sustainable Dev & Food Secur D6, Via Fermi 2749, I-21027 Ispra, Varese, Italy; [Lieber, A.; Hancher, M.; Poyart, E.] Google Inc, 1600 Amphitheatre Pkwy, Mountain View, CA 94043 USA; [Belchior, S.] Vizzuality, Off D, Gwydir St, Cambridge CB1 2LJ, England; [Fullman, N.] Univ Washington, Inst Hlth Metr & Evaluat, 2301 5th Ave,Suite 600, Seattle, WA 98121 USA; [Mappin, B.] Univ Queensland, Ctr Biodivers & Conservat Sci, Sch Biol Sci, St Lucia, Qld 4072, Australia; [Bhatt, S.] Imperial Coll London, Dept Infect Dis Epidemiol, London W2 1PG, England	University of Oxford; University of Twente; European Commission Joint Research Centre; EC JRC ISPRA Site; Google Incorporated; Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; University of Queensland; Imperial College London	Weiss, DJ (corresponding author), Univ Oxford, Malaria Atlas Project, Big Data Inst, Nuffield Dept Med, Roosevelt Dr, Oxford OX3 7FY, England.	daniel.weiss@bdi.ox.ac.uk	Gething, Peter/ABD-2110-2020; Nelson, Andy/G-3649-2012; Bhatt, Samir/ABE-7938-2020; Gething, Peter/GQR-1884-2022	Nelson, Andy/0000-0002-7249-3778; Gething, Peter/0000-0001-6759-5449; Belchior de Castro, Simao/0000-0002-3002-5239; Rozier, Jennifer/0000-0002-2610-7557; Cameron, Ewan/0000-0002-8842-3811; Kang, Su Yun/0000-0003-4648-9844; Bhatt, Samir/0000-0002-0891-4611; Mappin, Bonnie/0000-0002-1205-719X; Lucas, Tim/0000-0003-4694-8107; Gibson, Harry/0000-0001-6779-3250; /0000-0002-6175-5648	Google Earth Engine Research Award; European Parliament/European Commission Directorate General for Climate Action; Medical Research Council [MR/K00669X/1, MR/R015600/1, MR/N011570/1, MR/K010174/1B] Funding Source: researchfish; MRC [MR/R015600/1, MR/K00669X/1, MR/N011570/1] Funding Source: UKRI	Google Earth Engine Research Award(Google Incorporated); European Parliament/European Commission Directorate General for Climate Action; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank J. C. Alonso, G. Pacheco, E. Brett, A. Arenzana, and B. A. Laken for the development of http://roadlessforest.eu/map.html and D. Pfeffer and K. Twohig for formatting of the figures and references. Funding was provided by a Google Earth Engine Research Award entitled "Developing and validating an online accessibility mapping tool powered by Google Earth Engine" and the "Roadless Forest" project "Making efficient use of EU climate finance: Using roads as an early performance indicator for REDD+ projects" (European Parliament/European Commission Directorate General for Climate Action).	Allan JR, 2017, BIOL CONSERV, V206, P47, DOI 10.1016/j.biocon.2016.12.011; Bhatt S, 2015, NATURE, V526, P207, DOI 10.1038/nature15535; Bloom DE, 2008, SCIENCE, V319, P772, DOI 10.1126/science.1153057; Center for International Earth Science Information Network Columbia University Institute for Demographic Research International Food Policy Research Institute The World Bank & Centro Internacional de Agricultura Tropical, 2016, GLOB RUR URB MAPP PR; Central Intelligence Agency Office of Geographic and Cartographic Research, WORLD DAT BANK 2 N A; Chambers J. M., 1983, GRAPHICAL METHODS DA, DOI DOI 10.1201/9781351072304; Danielson J.J., 2010, GLOBAL MULTIRESOLUTI; Dijkstra E., 1959, NUMER MATH, V1, P269, DOI [10.1007/BF01386390, DOI 10.1007/BF01386390]; Fotso JC, 2007, HEALTH PLACE, V13, P205, DOI 10.1016/j.healthplace.2006.01.004; Frelat R, 2016, P NATL ACAD SCI USA, V113, P458, DOI 10.1073/pnas.1518384112; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; Gaughan AE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055882; Gilbert M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5116; Google Earth Engine Developers, 2017, CUM COST MAPP; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Ibisch PL, 2016, SCIENCE, V354, P1423, DOI 10.1126/science.aaf7166; Laurance WF, 2017, SCIENCE, V358, P442, DOI 10.1126/science.aao0312; Laurance WF, 2014, NATURE, V513, P229, DOI 10.1038/nature13717; Lehner B., 2008, EOS T AM GEOPHYS UN, V89, P93, DOI [10.1029/2008EO100001, DOI 10.1029/2008EO100001, DOI 10.1111/j.1469-8137.2009.03092.x]; Linard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031743; National Imagery and Mapping Agency, 1997, VECT MAP LEV 0 VMAPO; Nelson A., 2008, TRAVEL TIME MAJOR CI; Nelson A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022722; Pekel JF, 2016, NATURE, V540, P418, DOI 10.1038/nature20584; Pesaresi M., 2016, GHS SETTLEMENT GRID; Schmitz C, 2012, GLOBAL ENVIRON CHANG, V22, P189, DOI 10.1016/j.gloenvcha.2011.09.013; Sorichetta A, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.45; The World Bank, 2016, GDP CURR US; Tobler W, 1993, 931 NCGIA; UN, 2015, UN TRANSF OUR WORLD, DOI [10.1201/b20466-7, DOI 10.1201/B20466-7]; United Nations, 2014, REV WORLD URB PROSP; van Etten J, 2017, J STAT SOFTW, V76, P1, DOI 10.18637/jss.v076.i13; Walbridge S., 2013, THESIS; Wehrlin JP, 2006, EUR J APPL PHYSIOL, V96, P404, DOI 10.1007/s00421-005-0081-9; Young A, 2013, Q J ECON, V128, P1727, DOI 10.1093/qje/qjt025	36	406	427	68	387	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 18	2018	553	7688					333	+		10.1038/nature25181	http://dx.doi.org/10.1038/nature25181			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT9MB	29320477	Green Submitted			2022-12-28	WOS:000423475100050
J	Yanovski, SZ; Yanovski, JA				Yanovski, Susan Z.; Yanovski, Jack A.			Toward Precision Approaches for the Prevention and Treatment of Obesity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Yanovski, Susan Z.] NIDDK, NIH, Bethesda, MD 20892 USA; [Yanovski, Jack A.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Intramural Res, NIH, Bethesda, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Yanovski, SZ (corresponding author), NIDDK, Off Obes Res, NIH, 6707 Democracy Blvd,Room 6025, Bethesda, MD 20892 USA.	sy29f@nih.gov		Yanovski, Jack/0000-0001-8542-1637	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the United States National Institutes of Health; Zafgen; Rhythm Pharmaceuticals; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD000641] Funding Source: NIH RePORTER	Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the United States National Institutes of Health; Zafgen; Rhythm Pharmaceuticals; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Both authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr J. A. Yanovski reports receiving grant funding from the Intramural Research Program of the Eunice Kennedy Shriver National Institute of Child Health and Human Development of the United States National Institutes of Health, Zafgen, and Rhythm Pharmaceuticals. No other disclosures were reported.	Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Hales CM, 2017, PREVALENCE OBESITY A, V288, P1; Kuhnen P, 2016, NEW ENGL J MED, V375, P240, DOI 10.1056/NEJMoa1512693; Nicoletti CF, 2017, NUTRIENTS, V9, DOI 10.3390/nu9090974; Rask-Andersen M, 2017, PLOS GENET, V13, DOI 10.1371/journal.pgen.1006977; Schulz LO, 2006, DIABETES CARE, V29, P1866, DOI 10.2337/dc06-0138; Stubbs J, 2011, OBES REV, V12, P688, DOI 10.1111/j.1467-789X.2011.00883.x; Unick JL, 2015, OBESITY, V23, P1353, DOI 10.1002/oby.21112; Yanovski SZ, 2014, JAMA-J AM MED ASSOC, V311, P74, DOI 10.1001/jama.2013.281361	10	52	54	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	2018	319	3					223	224		10.1001/jama.2017.20051	http://dx.doi.org/10.1001/jama.2017.20051			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FT3BY	29340687	Green Accepted			2022-12-28	WOS:000423022300009
J	Zhao, WJ; Caro, F; Robins, W; Mekalanos, JJ				Zhao, Wenjing; Caro, Florence; Robins, William; Mekalanos, John J.			Antagonism toward the intestinal microbiota and its effect on Vibrio cholerae virulence	SCIENCE			English	Article							VI SECRETION SYSTEM; HOST; INFECTION; MODEL; GUT	The bacterial type VI secretion system (T6SS) is a nanomachine that delivers toxic effector proteins into target cells, killing them. In mice, we found that the Vibrio cholerae T6SS attacks members of the host commensal microbiota in vivo, facilitating the pathogen's colonization of the gut. This microbial antagonistic interaction drives measurable changes in the pathogenicity of V. cholerae through enhanced intestinal colonization, expression of bacterial virulence genes, and activation of host innate immune genes. Because ablation of mouse commensals by this enteric pathogen correlated with more severe diarrheal symptoms, we conclude that antagonism toward the gut microbiota could improve the fitness of V. cholerae as a pathogen by elevating its transmission to new susceptible hosts.	[Zhao, Wenjing; Caro, Florence; Robins, William; Mekalanos, John J.] Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Mekalanos, JJ (corresponding author), Harvard Med Sch, Dept Microbiol & Immunobiol, Boston, MA 02115 USA.	john_mekalanos@hms.harvard.edu		Caro, Florence/0000-0002-1617-1563; Zhao, Wenjing/0000-0003-1706-6324; Robins, William/0000-0003-4786-399X	National Institute of Allergy and Infectious Diseases [AI-01845]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018045, R37AI018045] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank M. Gack and J. Chiang for assistance with luciferase assays and for a kind gift of reporter. We thank all Mekalanos lab members for helpful comments. Supported by National Institute of Allergy and Infectious Diseases grant AI-01845 (J. J. M.). The authors declare no competing financial interests. All authors helped to design and analyze experiments; W.Z., F.C., and W.R. performed experiments; and W.Z., F.C., W.R., and J. J. M. wrote the paper. All data generated or analyzed during this study are included in this published article and its supplementary materials.	Anderson MC, 2017, CELL HOST MICROBE, V21, P769, DOI 10.1016/j.chom.2017.05.004; Bachmann V, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0004031; Basler M, 2012, NATURE, V483, P182, DOI 10.1038/nature10846; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Bishop AL, 2014, INFECT IMMUN, V82, P2434, DOI 10.1128/IAI.00054-14; Borgeaud S, 2015, SCIENCE, V347, P63, DOI 10.1126/science.1260064; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Fu Y, 2013, CELL HOST MICROBE, V14, P652, DOI 10.1016/j.chom.2013.11.001; Harris AM, 2008, AM J TROP MED HYG, V79, P708, DOI 10.4269/ajtmh.2008.79.708; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; Heidelberg JF, 2000, NATURE, V406, P477, DOI 10.1038/35020000; Higgins DA, 2007, NATURE, V450, P883, DOI 10.1038/nature06284; Hsiao A, 2014, NATURE, V515, P423, DOI 10.1038/nature13738; MacIntyre DL, 2010, P NATL ACAD SCI USA, V107, P19520, DOI 10.1073/pnas.1012931107; Mandlik A, 2011, CELL HOST MICROBE, V10, P165, DOI 10.1016/j.chom.2011.07.007; Mutreja A, 2011, NATURE, V477, P462, DOI 10.1038/nature10392; Newman MA, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00139; Pukatzki S, 2006, P NATL ACAD SCI USA, V103, P1528, DOI 10.1073/pnas.0510322103; Sana TG, 2016, P NATL ACAD SCI USA, V113, pE5044, DOI 10.1073/pnas.1608858113	19	98	102	7	76	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					210	+		10.1126/science.aap8775	http://dx.doi.org/10.1126/science.aap8775			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS5EO	29326272	Green Accepted			2022-12-28	WOS:000419816600045
J	Qiao, JJ; Zhou, S; Fang, H				Qiao, Jianjun; Zhou, Sha; Fang, Hong			An ulcer on the nipple	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DISEASES; BREAST		[Qiao, Jianjun; Zhou, Sha; Fang, Hong] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Dermatol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Fang, H (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Dermatol, Hangzhou, Zhejiang, Peoples R China.	fanghongzy@zju.edu.cn	Qiao, Jianjun/AAE-7199-2022	Zhou, Sha/0000-0002-7468-1924; Fang, Hong/0000-0002-5917-2283; Hong, Fang/0000-0002-4940-9662				Barrett ME, 2013, DERMATOL THER, V26, P331, DOI 10.1111/dth.12071; Davies GLS, 2004, ANN ROY COLL SURG, V86, P146; Eccleston K, 2008, INT J STD AIDS, V19, P145, DOI 10.1258/ijsa.2007.007258; Hartman-Adams H, 2014, AM FAM PHYSICIAN, V90, P229; LeGoff J, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-83; Linares MA, 2015, PRIMARY CARE, V42, P645, DOI 10.1016/j.pop.2015.07.006; Qiao JJ, 2011, CAN MED ASSOC J, V183, P2015, DOI 10.1503/cmaj.110664; Sandoval-Leon AC, 2013, BREAST CANCER RES TR, V141, P1, DOI 10.1007/s10549-013-2661-4; Whitaker-Worth DL, 2000, J AM ACAD DERMATOL, V43, P733, DOI 10.1067/mjd.2000.109303; Workowski KA, 2015, MMWR RECOMM REP, V64, P1, DOI 10.15585/mmwr.rr7004a1	10	2	2	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 11	2018	360								j5850	10.1136/bmj.j5850	http://dx.doi.org/10.1136/bmj.j5850			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS9NC	29326237				2022-12-28	WOS:000422743900013
J	Joffe, S; Lynch, HF				Joffe, Steven; Lynch, Holly Fernandez			Federal Right-to-Try Legislation - Threatening the FDA's Public Health Mission	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EXPANDED ACCESS; DRUGS		[Joffe, Steven; Lynch, Holly Fernandez] Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Philadelphia, PA 19104 USA; [Joffe, Steven; Lynch, Holly Fernandez] Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Joffe, Steven] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Joffe, S (corresponding author), Univ Penn, Dept Med Eth & Hlth Policy, Perelman Sch Med, Philadelphia, PA 19104 USA.; Joffe, S (corresponding author), Univ Penn, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA.; Joffe, S (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.		Joffe, Steven/H-3941-2019	Joffe, Steven/0000-0002-0667-7384				Darrow JJ, 2015, NEW ENGL J MED, V372, P279, DOI 10.1056/NEJMhle1409465; Goldwater Institute, RIGHT TRY MOD LEG; Gottlieb S, 2017, EXAMINING PATIENT AC; McKee AE, 2017, J CLIN PHARMACOL, V57, pS136, DOI 10.1002/jcph.960	4	29	29	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 22	2018	378	8					695	697		10.1056/NEJMp1714054	http://dx.doi.org/10.1056/NEJMp1714054			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FW8VA	29320302				2022-12-28	WOS:000425613900006
J	Cartlidge, E				Cartlidge, Edwin			THE LIGHT FANTASTIC	SCIENCE			English	Editorial Material																			0	54	55	1	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					382	385		10.1126/science.359.6374.382	http://dx.doi.org/10.1126/science.359.6374.382			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT6SD	29371451				2022-12-28	WOS:000423283200023
J	Brumbaugh, J; Di Stefano, B; Wang, XY; Borkent, M; Forouzmand, E; Clowers, KJ; Ji, F; Schwarz, BA; Kalocsay, M; Elledge, SJ; Chen, Y; Sadreyev, RI; Gygi, SP; Hu, G; Shi, YS; Hochedlinger, K				Brumbaugh, Justin; Di Stefano, Bruno; Wang, Xiuye; Borkent, Marti; Forouzmand, Elmira; Clowers, Katie J.; Ji, Fei; Schwarz, Benjamin A.; Kalocsay, Marian; Elledge, Stephen J.; Chen, Yue; Sadreyev, Ruslan I.; Gygi, Steven P.; Hu, Guang; Shi, Yongsheng; Hochedlinger, Konrad			Nudt21 Controls Cell Fate by Connecting Alternative Polyadenylation to Chromatin Signaling (vol 172, pg 106, 2018)	CELL			English	Correction												yongshes@uci.edu; khochedlinger@mgh.harvard.edu	Kalocsay, Marian/ABH-5959-2020	Kalocsay, Marian/0000-0002-4187-5829; WANG, XIUYE/0000-0002-7756-3974	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD058013] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102745] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099134] Funding Source: NIH RePORTER; NICHD NIH HHS [R01 HD058013] Funding Source: Medline; NIGMS NIH HHS [P01 GM099134] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Brumbaugh J, 2018, CELL, V172, P106, DOI 10.1016/j.cell.2017.11.023	1	19	21	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2018	172	3					629	631		10.1016/j.cell.2017.12.035	http://dx.doi.org/10.1016/j.cell.2017.12.035			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FT9BS	29373832	Green Accepted, Bronze			2022-12-28	WOS:000423447600020
J	Joshi, HJ; Narimatsu, Y; Schjoldager, KT; Tytgat, HLP; Aebi, M; Clausen, H; Halim, A				Joshi, Hiren J.; Narimatsu, Yoshiki; Schjoldager, Katrine T.; Tytgat, Hanne L. P.; Aebi, Markus; Clausen, Henrik; Halim, Adnan			SnapShot: O-Glycosylation Pathways across Kingdoms	CELL			English	Editorial Material									[Joshi, Hiren J.; Narimatsu, Yoshiki; Schjoldager, Katrine T.; Clausen, Henrik; Halim, Adnan] Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, Copenhagen, Denmark; [Tytgat, Hanne L. P.; Aebi, Markus] ETH, Inst Microbiol, Zurich, Switzerland	University of Copenhagen; Swiss Federal Institutes of Technology Domain; ETH Zurich	Joshi, HJ (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Cellular & Mol Med, Copenhagen Ctr Glyc, Copenhagen, Denmark.		clausen, henrik/AAD-8016-2021; Tytgat, Hanne L.P./B-4388-2013; Narimatsu, Yoshiki/G-8388-2019; Joshi, Hiren/B-5739-2016	Tytgat, Hanne L.P./0000-0001-6270-2110; Halim, Adnan/0000-0003-1629-187X; Narimatsu, Yoshiki/0000-0003-1428-5695; Joshi, Hiren/0000-0002-8192-2829	Lundbeck Foundation; Danish National Research Foundation [DNRF107]; Novo Nordisk Foundation; European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant [704228]; Lundbeck Foundation [R5-2006-542, R223-2016-563] Funding Source: researchfish; Novo Nordisk Fonden [NNF17OC0026030] Funding Source: researchfish	Lundbeck Foundation(Lundbeckfonden); Danish National Research Foundation(Danmarks Grundforskningsfond); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant; Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported The Lundbeck Foundation, The Danish National Research Foundation (DNRF107), The Novo Nordisk Foundation, and the European Union's Horizon 2020 research and innovation program under the Marie Sklodowska-Curie grant agreement No 704228.	Bennett EP, 2012, GLYCOBIOLOGY, V22, P736, DOI 10.1093/glycob/cwr182; Halim A, 2015, P NATL ACAD SCI USA, V112, P15648, DOI 10.1073/pnas.1511743112; Larsen ISB, 2017, P NATL ACAD SCI USA, V114, P11163, DOI 10.1073/pnas.1708319114; Mikami T, 2013, BBA-GEN SUBJECTS, V1830, P4719, DOI 10.1016/j.bbagen.2013.06.006; Sheikh MO, 2017, GLYCOBIOLOGY, V27, P806, DOI 10.1093/glycob/cwx062; Takeuchi H, 2014, BIOCHEM BIOPH RES CO, V453, P235, DOI 10.1016/j.bbrc.2014.05.115; Tytgat HLP, 2016, TRENDS MICROBIOL, V24, P853, DOI 10.1016/j.tim.2016.06.004; Varki A., 2009, ESSENTIALS GLYCOBIOL	8	48	51	9	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	2018	172	3					632	+		10.1016/j.cell.2018.01.016	http://dx.doi.org/10.1016/j.cell.2018.01.016			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	FT9BS	29373833	Bronze			2022-12-28	WOS:000423447600021
J	Kopperger, E; List, J; Madhira, S; Rothfischer, F; Lamb, DC; Simmel, FC				Kopperger, Enzo; List, Jonathan; Madhira, Sushi; Rothfischer, Florian; Lamb, Don C.; Simmel, Friedrich C.			A self-assembled nanoscale robotic arm controlled by electric fields	SCIENCE			English	Article							STRAND-DISPLACEMENT-REACTIONS; DNA ORIGAMI; MOLECULE; TRANSPORT; SURFACE; MOTOR; MECHANISMS; OPERATION; MOVEMENT; MACHINE	The use of dynamic, self-assembled DNA nanostructures in the context of nanorobotics requires fast and reliable actuation mechanisms. We therefore created a 55-nanometer-by-55-nanometer DNA-based molecular platform with an integrated robotic arm of length 25 nanometers, which can be extended to more than 400 nanometers and actuated with externally applied electrical fields. Precise, computer-controlled switching of the arm between arbitrary positions on the platform can be achieved within milliseconds, as demonstrated with single-pair Forster resonance energy transfer experiments and fluorescence microscopy. The arm can be used for electrically driven transport of molecules or nanoparticles over tens of nanometers, which is useful for the control of photonic and plasmonic processes. Application of piconewton forces by the robot arm is demonstrated in force-induced DNA duplex melting experiments.	[Kopperger, Enzo; List, Jonathan; Rothfischer, Florian; Simmel, Friedrich C.] Tech Univ Munich, Phys Dept E14, D-85748 Garching, Germany; [Madhira, Sushi; Lamb, Don C.] Ludwig Maximilians Univ Munchen, Dept Chem, D-81377 Munich, Germany; [Lamb, Don C.] Ludwig Maximilians Univ Munchen, Ctr Integrated Prot Sci Munich, D-81377 Munich, Germany; [Lamb, Don C.; Simmel, Friedrich C.] Nanosyst Initiat Munich, D-80539 Munich, Germany	Technical University of Munich; University of Munich; University of Munich	Simmel, FC (corresponding author), Tech Univ Munich, Phys Dept E14, D-85748 Garching, Germany.; Simmel, FC (corresponding author), Nanosyst Initiat Munich, D-80539 Munich, Germany.	simmel@tum.de	Simmel, Friedrich/G-3281-2010; Lamb, Don C/G-9501-2014	Simmel, Friedrich/0000-0003-3829-3446; Lamb, Don C/0000-0002-0232-1903; Rothfischer, Florian/0000-0003-0764-520X; List, Jonathan/0000-0001-8408-0877	Deutsche Forschungsgemeinschaft through Collaborative Research Centre [SFB1032]; Technical University Munich (TUM) through TUM International Graduate School of Science and Engineering; Ludwig-Maximilians University through Center for NanoScience and the BioImaging Network	Deutsche Forschungsgemeinschaft through Collaborative Research Centre(German Research Foundation (DFG)); Technical University Munich (TUM) through TUM International Graduate School of Science and Engineering; Ludwig-Maximilians University through Center for NanoScience and the BioImaging Network	We gratefully acknowledge the support of the Deutsche Forschungsgemeinschaft through the Collaborative Research Centre (grants SFB1032 Project A2 to F.C.S and SFB1032 Project B3 to D.C.L.). E.K. acknowledges support by the Technical University Munich (TUM) through the TUM International Graduate School of Science and Engineering. D.C.L. acknowledges the additional support of the Ludwig-Maximilians University through the Center for NanoScience and the BioImaging Network. We thank J. Muller and F. Wilde for help with the design of the operational amplifier, F. Praetorius for providing the M13 scaffold strands, and S. Krishnan for help with TEM imaging. All data are reported in the main text and the supplementary materials. Contributions: E.K., J.L., and F.C.S. conceived the study. E.K. and J.L. designed the structure and built the electrical setup. E.K., J.L., S.M., and F.R. performed the experiments. D.C.L. guided the single-molecule fluorescence experiments. E.K., J.L., S.M., D.C.L., and F.C.S. interpreted and discussed the experiments. All authors commented on and wrote the paper. Competing interests: E.K., J.L., and F.C.S. have filed a patent covering electrically driven molecular machines (EPA 17 165 250.6). We declare no competing financial interests.	Badjic JD, 2004, SCIENCE, V303, P1845, DOI 10.1126/science.1094791; Barish RD, 2009, P NATL ACAD SCI USA, V106, P6054, DOI 10.1073/pnas.0808736106; Bockelmann U, 2002, BIOPHYS J, V82, P1537, DOI 10.1016/S0006-3495(02)75506-9; Douglas SM, 2009, NATURE, V459, P414, DOI 10.1038/nature08016; Dudko OK, 2008, P NATL ACAD SCI USA, V105, P15755, DOI 10.1073/pnas.0806085105; EssevazRoulet B, 1997, P NATL ACAD SCI USA, V94, P11935, DOI 10.1073/pnas.94.22.11935; Gopinath A, 2016, NATURE, V535, P401, DOI 10.1038/nature18287; Gopinath A, 2014, ACS NANO, V8, P12030, DOI 10.1021/nn506014s; Green SJ, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.238101; Gu HZ, 2010, NATURE, V465, P202, DOI 10.1038/nature09026; Kapanidis AN, 2005, ACCOUNTS CHEM RES, V38, P523, DOI 10.1021/ar0401348; Kassem S, 2016, NAT CHEM, V8, P138, DOI [10.1038/nchem.2410, 10.1038/NCHEM.2410]; Kauert DJ, 2011, NANO LETT, V11, P5558, DOI 10.1021/nl203503s; Ketterer P, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501209; Klapper Y, 2010, SMALL, V6, P44, DOI 10.1002/smll.200901106; Kopperger E, 2015, NANO LETT, V15, P2693, DOI 10.1021/acs.nanolett.5b00351; Kudernac T, 2011, NATURE, V479, P208, DOI 10.1038/nature10587; Kufer SK, 2008, SCIENCE, V319, P594, DOI 10.1126/science.1151424; Kuzyk A, 2014, NAT MATER, V13, P862, DOI [10.1038/NMAT4031, 10.1038/nmat4031]; Lewandowski B, 2013, SCIENCE, V339, P189, DOI 10.1126/science.1229753; Li XY, 2004, ANGEW CHEM INT EDIT, V43, P4848, DOI 10.1002/anie.200400656; Lund K, 2010, NATURE, V465, P206, DOI 10.1038/nature09012; Marras AE, 2015, P NATL ACAD SCI USA, V112, P713, DOI 10.1073/pnas.1408869112; McKinney SA, 2006, BIOPHYS J, V91, P1941, DOI 10.1529/biophysj.106.082487; Omabegho T, 2009, SCIENCE, V324, P67, DOI 10.1126/science.1170336; Rothemund PWK, 2006, NATURE, V440, P297, DOI 10.1038/nature04586; Sauer-Budge AF, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.238101; Scheible MB, 2014, NANO LETT, V14, P1627, DOI 10.1021/nl500092j; Shin JS, 2004, J AM CHEM SOC, V126, P10834, DOI 10.1021/ja047543j; Soong RK, 2000, SCIENCE, V290, P1555, DOI 10.1126/science.290.5496.1555; Tomaru T, 2017, CHEM COMMUN, V53, P7716, DOI 10.1039/c7cc03214e; Tomov TE, 2017, ACS NANO, V11, P4002, DOI 10.1021/acsnano.7b00547; Viovy JL, 2000, REV MOD PHYS, V72, P813, DOI 10.1103/RevModPhys.72.813; Wang ZG, 2012, ANGEW CHEM INT EDIT, V51, P4322, DOI 10.1002/anie.201107855; Wei F, 2006, LANGMUIR, V22, P6280, DOI 10.1021/la060602h; Wickham SFJ, 2011, NAT NANOTECHNOL, V6, P166, DOI [10.1038/nnano.2010.284, 10.1038/NNANO.2010.284]; Yang YY, 2017, CHEM-EUR J, V23, P3979, DOI 10.1002/chem.201605616; Yurke B, 2000, NATURE, V406, P605, DOI 10.1038/35020524; Zhang DY, 2011, NAT CHEM, V3, P103, DOI 10.1038/NCHEM.957; Zhang TS, 2015, J PHYS CHEM LETT, V6, P2043, DOI 10.1021/acs.jpclett.5b00747	40	194	196	27	354	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					296	300		10.1126/science.aao4284	http://dx.doi.org/10.1126/science.aao4284			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6BB	29348232				2022-12-28	WOS:000423236700032
J	Schultz, R; Atkinson, G; Eaton, DW; Gu, YJ; Kao, H				Schultz, R.; Atkinson, G.; Eaton, D. W.; Gu, Y. J.; Kao, H.			Hydraulic fracturing volume is associated with induced earthquake productivity in the Duvernay play	SCIENCE			English	Article							INDUCED SEISMICITY; WESTERN CANADA; CROOKED LAKE; ALBERTA; GAS; INJECTION; NETWORKS; INSIGHTS; BASIN	A sharp increase in the frequency of earthquakes near Fox Creek, Alberta, began in December 2013 in response to hydraulic fracturing. Using a hydraulic fracturing database, we explore relationships between injection parameters and seismicity response. We show that induced earthquakes are associated with completions that used larger injection volumes (104 to 105 cubic meters) and that seismic productivity scales linearly with injection volume. Injection pressure and rate have an insignificant association with seismic response. Further findings suggest that geological factors play a prominent role in seismic productivity, as evidenced by spatial correlations. Together, volume and geological factors account for similar to 96% of the variability in the induced earthquake rate near Fox Creek. This result is quantified by a seismogenic index-modified frequency-magnitude distribution, providing a framework to forecast induced seismicity.	[Schultz, R.] Alberta Geol Survey, 4999 98 Ave, Edmonton, AB, Canada; [Atkinson, G.] Western Univ, 1151 Richmond St, London, ON, Canada; [Eaton, D. W.] Univ Calgary, 2500 Univ Dr, Calgary, AB, Canada; [Gu, Y. J.] Univ Alberta, 116 St & 85 Ave, Edmonton, AB, Canada; [Kao, H.] Nat Resources Canada, 9860 West Saanich Rd, Sidney, BC, Canada	Western University (University of Western Ontario); University of Calgary; University of Alberta; Natural Resources Canada	Schultz, R (corresponding author), Alberta Geol Survey, 4999 98 Ave, Edmonton, AB, Canada.	ryan.schultz@aer.ca	Eaton, David/AAR-5939-2021	Schultz, Ryan/0000-0002-1796-9622; Kao, Honn/0000-0001-9150-9416				Alberta Energy Regulator, 2015, AER B; Atkinson GM, 2016, SEISMOL RES LETT, V87, P631, DOI 10.1785/0220150263; Atkinson GM, 2015, SEISMOL RES LETT, V86, P1009, DOI 10.1785/0220140204; Bao XW, 2016, SCIENCE, V354, P1406, DOI 10.1126/science.aag2583; Chen H, 2016, J ENVIRON MANAGE, V170, P152, DOI 10.1016/j.jenvman.2016.01.023; Clarke H, 2014, GEOPHYS RES LETT, V41, P8308, DOI 10.1002/2014GL062047; Dinske C, 2013, J SEISMOL, V17, P13, DOI 10.1007/s10950-012-9292-9; Eaton D., 2017, 79 EAGE C EXH 2017 W; Efron B., 1986, STAT SCI, V1, P54, DOI [10.1214/ss/1177013815, DOI 10.1214/SS/1177013815]; Farahbod Amir Mansour, 2015, Leading Edge, V34, P658, DOI 10.1190/tle34060658.1; Farahbod AM, 2015, CAN J EARTH SCI, V52, P112, DOI 10.1139/cjes-2014-0162; Ghofrani H, 2016, GEOPHYS RES LETT, V43, P10164, DOI 10.1002/2016GL070042; Gibbons J. D., 2011, NONPARAMETRIC STAT I; Hajati T, 2015, GEOPHYS RES LETT, V42, P10601, DOI 10.1002/2015GL066652; Ishimoto M., 1939, B EARTHQ RES I TOKYO, V17, P391; King G. E., 2010, SPE ANN TECHN C EXH; Langenbruch C, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1601542; Mahani AB, 2017, B SEISMOL SOC AM, V107, P542, DOI 10.1785/0120160175; Marzocchi W, 2003, ANN GEOPHYS-ITALY, V46, P1271; MASSEY FJ, 1951, J AM STAT ASSOC, V46, P68, DOI 10.2307/2280095; Maxwell S. C., 2009, SEG TECHN PROGR EXP, V2009, P1552, DOI [10.1190/1.3255145, DOI 10.1190/1.3255145]; McGarr A, 2014, J GEOPHYS RES-SOL EA, V119, P1008, DOI 10.1002/2013JB010597; Petersen M. D, 2015, 20151070 US GEOL SUR; RALEIGH CB, 1976, SCIENCE, V191, P1230, DOI 10.1126/science.191.4233.1230; Scanlon BR, 2014, ENVIRON SCI TECHNOL, V48, P12386, DOI 10.1021/es502506v; Schultz R, 2017, J GEOPHYS RES-SOL EA, V122, P492, DOI 10.1002/2016JB013570; Schultz R, 2016, GEOPHYS RES LETT, V43, P2534, DOI 10.1002/2015GL067514; Schultz R, 2015, B SEISMOL SOC AM, V105, P2871, DOI 10.1785/0120150131; Schultz R, 2015, GEOPHYS RES LETT, V42, P2750, DOI 10.1002/2015GL063455; Schultz R, 2014, J GEOPHYS RES-SOL EA, V119, P3410, DOI 10.1002/2013JB010836; Segall P, 2015, J GEOPHYS RES-SOL EA, V120, P5082, DOI 10.1002/2015JB012060; Shapiro Serge A., 2010, Leading Edge, V29, P304, DOI 10.1190/1.3353727; Shapiro S.A., 2015, FLUID INDUCED SEISMI; Skoumal RJ, 2015, B SEISMOL SOC AM, V105, P189, DOI 10.1785/0120140168; Stern VH, 2013, 201315 ALB GEOL SURV; Wang R., 2016, GEOPHYS RES LETT; Wang RJ, 2017, GEOPHYS J INT, V210, P979, DOI 10.1093/gji/ggx204; Weingarten M, 2015, SCIENCE, V348, P1336, DOI 10.1126/science.aab1345; Westwood RF, 2017, FUEL, V203, P843, DOI 10.1016/j.fuel.2017.05.004	39	126	128	8	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					304	308		10.1126/science.aao0159	http://dx.doi.org/10.1126/science.aao0159			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6BB	29348233				2022-12-28	WOS:000423236700034
J	Trivedi, AN; Leyva, B; Lee, Y; Panagiotou, OA; Dahabreh, IJ				Trivedi, Amal N.; Leyva, Bryan; Lee, Yoojin; Panagiotou, Orestis A.; Dahabreh, Issa J.			Elimination of Cost Sharing for Screening Mammography in Medicare Advantage Plans	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PREVENTIVE SERVICES; CARE; INSURANCE; BREAST; IMPACT	BACKGROUND The Affordable Care Act (ACA) required most insurers and the Medicare program to eliminate cost sharing for screening mammography. METHODS We conducted a difference-in-differences study of biennial screening mammography among 15,085 women 65 to 74 years of age in 24 Medicare Advantage plans that eliminated cost sharing to provide full coverage for screening mammography, as compared with 52,035 women in 48 matched control plans that had and maintained full coverage. RESULTS In plans that eliminated cost sharing, adjusted rates of biennial screening mammography increased from 59.9% (95% confidence interval [CI], 54.9 to 65.0) in the 2-year period before cost-sharing elimination to 65.4% (95% CI, 61.8 to 69.0) in the 2-year period thereafter. In control plans, the rates of biennial mammography were 73.1% (95% CI, 69.2 to 77.0) and 72.8% (95% CI, 69.7 to 76.0) during the same periods, yielding a difference in differences of 5.7 percentage points (95% CI, 3.0 to 8.4). The difference in differences was 9.8 percentage points (95% CI, 4.5 to 15.2) among women living in the areas with the highest quartile of educational attainment versus 4.3 percentage points (95% CI, 0.2 to 8.4) among women in the lowest quartile. As indicated by the difference-in-differences estimates, after the elimination of cost sharing, the rate of biennial mammography increased by 6.5 percentage points (95% CI, 3.7 to 9.4) for white women and 8.4 percentage points (95% CI, 2.5 to 14.4) for black women but was almost unchanged for Hispanic women (0.4 percentage points; 95% CI, -7.3 to 8.1). CONCLUSIONS The elimination of cost sharing for screening mammography under the ACA was associated with an increase in rates of use of this service among older women for whom screening is recommended. The effect was attenuated among women living in areas with lower educational attainment and was negligible among Hispanic women.	[Trivedi, Amal N.; Leyva, Bryan; Lee, Yoojin; Panagiotou, Orestis A.; Dahabreh, Issa J.] Brown Univ, Dept Hlth Serv Policy & Practice, Sch Publ Hlth, Providence, RI 02912 USA; [Dahabreh, Issa J.] Brown Univ, Dept Epidemiol, Sch Publ Hlth, Providence, RI 02912 USA; [Trivedi, Amal N.] Providence Vet Affairs Med Ctr, Providence, RI USA	Brown University; Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center	Trivedi, AN (corresponding author), 121 S Main St, Providence, RI 02903 USA.	amal_trivedi@brown.edu	Panagiotou, Orestis/AAI-1268-2021	Leyva, Bryan/0000-0003-1929-4910	National Institute on Aging; NATIONAL INSTITUTE ON AGING [R01AG044374, P01AG027296] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funded by the National Institute on Aging.	[Anonymous], 2010, HLTH AFFAIRS POLICY; [Anonymous], COST SHARING EFFECTS; Barcellos SH, 2014, P NATL ACAD SCI USA, V111, P5497, DOI 10.1073/pnas.1320488111; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; BLUSTEIN J, 1995, NEW ENGL J MED, V332, P1138, DOI 10.1056/NEJM199504273321706; Brodie, 2014, KAISER HLTH TRACKING; Centers for Disease Control and Prevention, BREAST CANC SCREEN G; Cooper GS, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv374; Eicheldinger C, 2008, HEALTH CARE FINANC R, V29, P27; Fedewa SA, 2015, CANCER-AM CANCER SOC, V121, P3272, DOI 10.1002/cncr.29494; Garcia Mosqueira A, 2015, INQUIRY; Gornick ME, 1996, NEW ENGL J MED, V335, P791, DOI 10.1056/NEJM199609123351106; Han XS, 2015, PREV MED, V78, P85, DOI 10.1016/j.ypmed.2015.07.012; Healthcare. gov, BALT CENT MED MED SE; Jacobson G, 2016, MED ADVANTAGE 2016 S; Jena AB, 2017, HEALTH SERV RES, V52, P191, DOI 10.1111/1475-6773.12486; Jensen GA, 2015, PREV MED, V76, P37, DOI 10.1016/j.ypmed.2015.03.023; Loewenstein G, 2013, J HEALTH ECON, V32, P850, DOI 10.1016/j.jhealeco.2013.04.004; Long S., 2014, HLTH REFORM MONITORI; LURIE N, 1987, AM J PUBLIC HEALTH, V77, P801, DOI 10.2105/AJPH.77.7.801; Mehta SJ, 2015, AM J MANAG CARE, V21, P511; Nardin R, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0397-6; NEWHOUSE JP, 1981, NEW ENGL J MED, V305, P1501, DOI 10.1056/NEJM198112173052504; Patel MR, 2017, J RACIAL ETHN HLTH D; Rice T, 2004, MED CARE RES REV, V61, P415, DOI 10.1177/1077558704269498; RUBIN RJ, 1995, NEW ENGL J MED, V333, P733; Rustgi SD, 2009, WOMEN RISK WHY MANY; Sabatino SA, 2016, MED CARE, V54, P394, DOI 10.1097/MLR.0000000000000495; Shoemaker ML, 2016, CANCER CAUSE CONTROL, V27, P453, DOI 10.1007/s10552-016-0718-5; Siu AL, 2016, ANN INTERN MED, V164, P279, DOI 10.7326/M15-2886; Solanki G, 2000, HEALTH SERV RES, V34, P1331; Solanki G, 1999, AM J PREV MED, V17, P127, DOI 10.1016/S0749-3797(99)00057-4; Stecker EC, 2015, CIRCULATION, V132, P1580, DOI 10.1161/CIRCULATIONAHA.114.012584; Trivedi AN, 2008, NEW ENGL J MED, V358, P375, DOI 10.1056/NEJMsa070929; TVERSKY A, 1991, Q J ECON, V106, P1039, DOI 10.2307/2937956; United States Cancer Statistics Working Group, 2017, US CANC STAT 1999 20; Zambrana RE, 1999, PREV MED, V29, P466, DOI 10.1006/pmed.1999.0566	37	21	21	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 18	2018	378	3					262	269		10.1056/NEJMsa1706808	http://dx.doi.org/10.1056/NEJMsa1706808			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT1IJ	29342379	Green Accepted, Bronze			2022-12-28	WOS:000422888400010
J	Cho, A				Cho, Adrian			COMPUTATION DOE pushes for useful quantum computing	SCIENCE			English	News Item																			0	9	11	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					141	142		10.1126/science.359.6372.141	http://dx.doi.org/10.1126/science.359.6372.141			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS5EO	29326248				2022-12-28	WOS:000419816600012
J	Dundas, CM; Bramson, AM; Ojha, L; Wray, JJ; Mellon, MT; Byrne, S; McEwen, AS; Putzig, NE; Viola, D; Sutton, S; Clark, E; Holt, JW				Dundas, Colin M.; Bramson, Ali M.; Ojha, Lujendra; Wray, James J.; Mellon, Michael T.; Byrne, Shane; McEwen, Alfred S.; Putzig, Nathaniel E.; Viola, Donna; Sutton, Sarah; Clark, Erin; Holt, John W.			Exposed subsurface ice sheets in the Martian mid-latitudes	SCIENCE			English	Article							GROUND ICE; MARS; STABILITY; DEPOSITS; PLANITIA; METER; AGES	Thick deposits cover broad regions of the Martian mid-latitudes with a smooth mantle; erosion in these regions creates scarps that expose the internal structure of the mantle. We investigated eight of these locations and found that they expose deposits of water ice that can be >100 meters thick, extending downward from depths as shallow as 1 to 2 meters below the surface. The scarps are actively retreating because of sublimation of the exposed water ice. The ice deposits likely originated as snowfall during Mars' high-obliquity periods and have now compacted into massive, fractured, and layered ice. We expect the vertical structure of Martian ice-rich deposits to preserve a record of ice deposition and past climate.	[Dundas, Colin M.] US Geol Survey, Astrogeol Sci Ctr, 2255 N Gemini Dr, Flagstaff, AZ 86001 USA; [Bramson, Ali M.; Byrne, Shane; McEwen, Alfred S.; Viola, Donna; Sutton, Sarah; Clark, Erin] Univ Arizona, Lunar & Planetary Lab, Tucson, AZ 85721 USA; [Ojha, Lujendra] Johns Hopkins Univ, Dept Earth & Planetary Sci, Baltimore, MD 21218 USA; [Wray, James J.] Georgia Inst Technol, Sch Earth & Atmospher Sci, Atlanta, GA 30332 USA; [Mellon, Michael T.] Johns Hopkins Univ, Appl Phys Lab, Laurel, MD USA; [Putzig, Nathaniel E.] Planetary Sci Inst, 1546 Cole Blvd,Suite 120, Lakewood, CO 80401 USA; [Holt, John W.] Univ Texas Austin, Inst Geophys, Jackson Sch Geosci, Austin, TX 78758 USA	United States Department of the Interior; United States Geological Survey; University of Arizona; Johns Hopkins University; University System of Georgia; Georgia Institute of Technology; Johns Hopkins University; Johns Hopkins University Applied Physics Laboratory; University of Texas System; University of Texas Austin	Dundas, CM (corresponding author), US Geol Survey, Astrogeol Sci Ctr, 2255 N Gemini Dr, Flagstaff, AZ 86001 USA.	cdundas@usgs.gov	Wray, James J/B-8457-2008	Wray, James J/0000-0001-5559-2179; Viola, Donna/0000-0003-4447-2184; Bramson, Ali/0000-0003-4903-0916; Putzig, Nathaniel/0000-0003-4485-6321; Ojha, Lujendra/0000-0003-2086-4546	MRO project; NASA [NNH13AV85I, NNX16AP09H]; Blaustein Postdoctoral Fellowship at Johns Hopkins University	MRO project; NASA(National Aeronautics & Space Administration (NASA)); Blaustein Postdoctoral Fellowship at Johns Hopkins University	Observation planning was funded by the MRO project, and analysis was funded by NASA grants NNH13AV85I (to C.M.D.) and NNX16AP09H (to A.M.B.). L.O. was supported by the Blaustein Postdoctoral Fellowship at Johns Hopkins University. We thank NASA/ Jet Propulsion Laboratory and the instrument teams for their efforts collecting and processing data. The SHARAD instrument was provided to NASA's MRO mission by the Italian Space Agency (ASI). We thank M. Christoffersen for help with the HRSC-based clutter simulations, which are available at https://doi.org/10.6084/m9.figshare.5537893. The authors declare no competing financial interests. All of the primary spacecraft data used in this study are available via the Planetary Data System. HiRISE and CTX data are at https://pds-imaging.jpl.nasa.gov/volumes/mro.html, SHARAD data are at http://pds-geosciences.wustl.edu/missions/mro/sharad.htm, CRISM data are at http://pdsgeosciences.wustl.edu/missions/mro/crism.htm, and THEMIS data and derived products are at http://viewer.mars.asu.edu/viewer/themis#T=0; observation ID numbers are listed in tables S2 to S5. Derived thermal inertia data are available via https://se.psi.edu/similar to than/inertia and dust cover index and albedo via www.mars.asu.edu/data.	Abbud-Madrid A., 2016, REPORT MARS WATER IN; Bandfield JL, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003007; Boynton WV, 2002, SCIENCE, V297, P81, DOI 10.1126/science.1073722; Bramson AM, 2015, GEOPHYS RES LETT, V42, P6566, DOI 10.1002/2015GL064844; Byrne S, 2009, SCIENCE, V325, P1674, DOI 10.1126/science.1175307; CLARK RN, 1981, J GEOPHYS RES, V86, P3087, DOI 10.1029/JB086iB04p03087; Conway SJ, 2014, GEOPHYS RES LETT, V41, P5402, DOI 10.1002/2014GL060314; Cull S, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL045372; Diez B, 2008, ICARUS, V196, P409, DOI 10.1016/j.icarus.2008.02.006; Dundas C. M., 2014, J GEOPHYS RES, V119; Dundas CM, 2015, ICARUS, V262, P154, DOI 10.1016/j.icarus.2015.07.033; Dundas CM, 2010, ICARUS, V206, P716, DOI 10.1016/j.icarus.2009.09.007; Feldman W. C., 2008, THE MARTIAN SURFACE; Fisher DA, 2005, ICARUS, V179, P387, DOI 10.1016/j.icarus.2005.07.024; Head JW, 2003, NATURE, V426, P797, DOI 10.1038/nature02114; Herkenhoff KE, 2007, SCIENCE, V317, P1711, DOI 10.1126/science.1143544; Holt JW, 2008, SCIENCE, V322, P1235, DOI 10.1126/science.1164246; Kokaly R.F., 2017, USGS SPECTRAL LIB VE, DOI [10.3133/ds1035, DOI 10.3133/DS1035]; LEIGHTON RB, 1966, SCIENCE, V153, P136, DOI 10.1126/science.153.3732.136; Madeleine JB, 2009, ICARUS, V203, P390, DOI 10.1016/j.icarus.2009.04.037; Mellon MT, 2009, J GEOPHYS RES-PLANET, V114, DOI 10.1029/2009JE003417; Mellon MT, 2008, J GEOPHYS RES-PLANET, V113, DOI 10.1029/2007JE003039; Mellon MT, 2004, ICARUS, V169, P324, DOI 10.1016/j.icarus.2003.10.022; MELLON MT, 1993, J GEOPHYS RES-PLANET, V98, P3345, DOI 10.1029/92JE02355; Mouginot J, 2010, ICARUS, V210, P612, DOI 10.1016/j.icarus.2010.07.003; Plaut JJ, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036379; Putzig N. E., 2014, J GEOPHYS RES, V119; Schorghofer N, 2007, NATURE, V449, P192, DOI 10.1038/nature06082; Schorghofer N, 2012, ICARUS, V220, P1112, DOI 10.1016/j.icarus.2012.07.003; Sizemore HG, 2015, ICARUS, V251, P191, DOI 10.1016/j.icarus.2014.04.013; Stuurman CM, 2016, GEOPHYS RES LETT, V43, P9484, DOI 10.1002/2016GL070138; WELLS EN, 1984, ICARUS, V58, P331, DOI 10.1016/0019-1035(84)90079-4	32	108	112	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					199	201		10.1126/science.aao1619	http://dx.doi.org/10.1126/science.aao1619			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS5EO	29326269				2022-12-28	WOS:000419816600042
J	Vaidya, J; Massarut, S; Vaidya, HJ; Alexander, EC; Richards, T; Caris, JA; Sirohi, B; Tobias, JS				Vaidya, Jayant; Massarut, Samuele; Vaidya, Hrisheekesh J.; Alexander, Emma C.; Richards, Thomas; Caris, Jochem A.; Sirohi, Bhawna; Tobias, Jeffrey S.			Rethinking neoadjuvant chemotherapy for breast cancer	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							DOSE-INTENSIFIED CHEMOTHERAPY; III RANDOMIZED GEPARTRIO; OPEN-LABEL; PHASE-3 TRIAL; PREOPERATIVE CHEMOTHERAPY; ADJUVANT TRASTUZUMAB; DARBEPOETIN ALPHA; PREPARE TRIAL; CYCLOPHOSPHAMIDE; METAANALYSIS		[Vaidya, Jayant] UCL, Div Surg & Intervent Sci, London, England; [Vaidya, Jayant] Royal Free Hosp, Whittington Hosp, Dept Surg, London, England; [Vaidya, Jayant] Univ Coll London Hosp, London, England; [Massarut, Samuele] Ctr Riferimento Oncol Aviano, Aviano, Italy; [Vaidya, Hrisheekesh J.] Imperial Coll London, Imperial Coll Sch Med, London, England; [Alexander, Emma C.] Kings Coll London, GKT Sch Med Educ, London, England; [Richards, Thomas; Tobias, Jeffrey S.] Univ Coll London Hosp, Dept Clin Oncol, London, England; [Caris, Jochem A.] Whittington Hosp, Dept Surg, London, England; [Sirohi, Bhawna] Barts Hlth NHS Trust, Dept Med Oncol, London, England	University of London; University College London; University of London; University College London; Royal Free London NHS Foundation Trust; UCL Medical School; University College London Hospitals NHS Foundation Trust; University of London; University College London; IRCCS Aviano (CRO); Imperial College London; University of London; King's College London; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; Barts Health NHS Trust	Vaidya, J (corresponding author), UCL, Div Surg & Intervent Sci, London, England.; Vaidya, J (corresponding author), Royal Free Hosp, Whittington Hosp, Dept Surg, London, England.	jayant.vaidya@ucl.ac.uk	Massarut, Samuele/J-2995-2018; Vaidya, Jayant S/A-7218-2008	Massarut, Samuele/0000-0003-4717-0544; Vaidya, Jayant S/0000-0003-1760-1278; Vaidya, Hrisheekesh/0000-0003-0885-9859; Alexander, Emma/0000-0001-7063-6846				Alberro JA, 2018, LANCET ONCOL, V19, P27, DOI 10.1016/S1470-2045(17)30777-5; Badwe R, 2015, LANCET ONCOL, V16, P1380, DOI 10.1016/S1470-2045(15)00135-7; Baselga J, 2012, LANCET, V379, P633, DOI 10.1016/S0140-6736(11)61847-3; Bonnefoi H, 2011, LANCET ONCOL, V12, P527, DOI 10.1016/S1470-2045(11)70094-8; Cameron D, 2013, LANCET ONCOL, V14, P933, DOI 10.1016/S1470-2045(13)70335-8; Cancer Research UK, 2017, CANC STAT; Cify A S, 2015, ENDING MED REVERSALS; Cortazar P, 2014, LANCET, V384, P164, DOI 10.1016/S0140-6736(13)62422-8; Dowsett M, 2015, LANCET, V386, P1341, DOI 10.1016/S0140-6736(15)61074-1; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Gianni L, 2016, LANCET ONCOL, V17, P791, DOI 10.1016/S1470-2045(16)00163-7; Gianni L, 2012, LANCET ONCOL, V13, P25, DOI 10.1016/S1470-2045(11)70336-9; Gianni L, 2010, LANCET, V375, P377, DOI 10.1016/S0140-6736(09)61964-4; Gianni L, 2009, J CLIN ONCOL, V27, P2474, DOI 10.1200/JCO.2008.19.2567; Kim C, 2016, MAYO CLIN P, DOI [10.1016/j.mayocp.2016.02.012.27236424, DOI 10.1016/J.MAYOCP.2016.02.012.27236424]; Mauri D, 2005, JNCI-J NATL CANCER I, V97, P188, DOI 10.1093/jnci/dji021; Mieog JSD, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005002.pub2; Miller KD, 2017, NEW ENGL J MED, V377, P186, DOI 10.1056/NEJMe1706150; Moja L, 2012, COCHRANE DB SYST REV; O'Sullivan CC, 2015, J CLIN ONCOL, V33, P2600, DOI 10.1200/JCO.2015.60.8620; Piccart-Gebhart M, 2016, J CLIN ONCOL, V34, P1034, DOI 10.1200/JCO.2015.62.1797; Piccart-Gebhart MJ, 2005, NEW ENGL J MED, V353, P1659, DOI 10.1056/NEJMoa052306; Rastogi P, 2008, J CLIN ONCOL, V26, P778, DOI 10.1200/JCO.2007.15.0235; Spring LM, 2016, JAMA ONCOL, V2, P1477, DOI 10.1001/jamaoncol.2016.1897; Untch M, 2011, ANN ONCOL, V22, P1988, DOI 10.1093/annonc/mdq709; Untch M, 2011, ANN ONCOL, V22, P1999, DOI 10.1093/annonc/mdq713; Untch M, 2010, J CLIN ONCOL, V28, P2024, DOI 10.1200/JCO.2009.23.8451; Untch M, 2009, J CLIN ONCOL, V27, P2938, DOI 10.1200/JCO.2008.20.3133; Valachis A, 2011, BREAST, V20, P485, DOI 10.1016/j.breast.2011.06.009; von Minckwitz G, 2005, J CLIN ONCOL, V23, P2676, DOI 10.1200/JCO.2005.05.078; von Minckwitz G, 2008, JNCI-J NATL CANCER I, V100, P552, DOI 10.1093/jnci/djn089; von Minckwitz G, 2008, JNCI-J NATL CANCER I, V100, P542, DOI 10.1093/jnci/djn085; von Minckwitz G, 2017, NEW ENGL J MED, V377, P122, DOI 10.1056/NEJMoa1703643; von Minckwitz G, 2012, NEW ENGL J MED, V366, P299, DOI 10.1056/NEJMoa1111065	34	60	65	3	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 11	2018	360								j5913	10.1136/bmj.j5913	http://dx.doi.org/10.1136/bmj.j5913			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS9NC	29326104	Green Published			2022-12-28	WOS:000422743900014
J	Bagian, JP; Paull, DE				Bagian, James P.; Paull, Douglas E.			Handovers During Anesthesia Care Patient Safety Risk or Opportunity for Improvement?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							IMPLEMENTATION		[Bagian, James P.] Univ Michigan, Ctr Healthcare Engn & Patient Safety, 1205 Beal Ave,2753 IOE Bldg, Ann Arbor, MI 48109 USA; [Paull, Douglas E.] Natl Ctr Patient Safety, Dept Vet Affairs, Ann Arbor, MI USA	University of Michigan System; University of Michigan	Bagian, JP (corresponding author), Univ Michigan, Ctr Healthcare Engn & Patient Safety, 1205 Beal Ave,2753 IOE Bldg, Ann Arbor, MI 48109 USA.	jbagian@umich.edu		Bagian, James/0000-0003-1792-6099; Paull, Douglas/0000-0001-8876-2824				[Anonymous], 2017, Sentinel Event Alert, P1; Cohen MD, HANDOFFS HOSP REV LI; Gross TK, 2016, AM PEDIAT NEWS; Jones PM, 2018, JAMA-J AM MED ASSOC, V319, P143, DOI 10.1001/jama.2017.20040; Manser T, 2012, P HUM FACT ERG SOC 2, V862; National Patient Safety Foundation, 2015, RCA2 IMPR ROOT CAUS; Neily J, 2010, JAMA-J AM MED ASSOC, V304, P1693, DOI 10.1001/jama.2010.1506; Sathishkumar S, 2015, ANESTHESIOLOGY, V123, P29, DOI 10.1097/ALN.0000000000000699; Starmer AJ, 2013, JAMA-J AM MED ASSOC, V310, P2262, DOI 10.1001/jama.2013.281961; The Accreditation Council for Graduate Medical Education, 2014, CLIN LEARN ENV REV C; The Joint Commission, TRANS CAR NEED MOR E; Weiss KB, 2013, JAMA-J AM MED ASSOC, V309, P1687, DOI 10.1001/jama.2013.1931	12	10	10	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	2018	319	2					125	127		10.1001/jama.2017.20602	http://dx.doi.org/10.1001/jama.2017.20602			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS4PR	29318263				2022-12-28	WOS:000419775500011
J	McTighe, K				McTighe, Kristen			SCIENTIFIC COMMUNITY Crackdown threatens science in Turkey	SCIENCE			English	News Item																			0	0	0	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	2018	359	6374					378	379		10.1126/science.359.6374.378	http://dx.doi.org/10.1126/science.359.6374.378			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT6SD	29371448				2022-12-28	WOS:000423283200020
J	Boatin, AA; Schlotheuber, A; Betran, AP; Moller, AB; Barros, AJD; Boerma, T; Torloni, MR; Victora, CG; Hosseinpoor, AR				Boatin, Adeline Adwoa; Schlotheuber, Anne; Betran, Ana Pilar; Moller, Ann-Beth; Barros, Aluisio J. D.; Boerma, Ties; Torloni, Maria Regina; Victora, Cesar G.; Hosseinpoor, Ahmad Reza			Within country inequalities in caesarean section rates: observational study of 72 low and middle income countries	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DELIVERY; PREFERENCES; MORTALITY; SERVICES; ACCESS; TRENDS; ASIA	OBJECTIVE To provide an update on economic related inequalities in caesarean section rates within countries. DESIGN Secondary analysis of demographic and health surveys and multiple indicator cluster surveys. SETTING 72 low and middle income countries with a survey conducted between 2010 and 2014 for analysis of the latest situation of inequality, and 28 countries with a survey also conducted between 2000 and 2004 for analysis of the change in inequality over time. PARTICIPANTS Women aged 15-49 years with a live birth during the two or three years preceding the survey. MAIN OUTCOME MEASURES Data on caesarean section were disaggregated by asset based household wealth status and presented separately for five subgroups, ranging from the poorest to the richest fifth. Absolute and relative inequalities were measured using difference and ratio measures. The pace of change in the poorest and richest fifths was compared using a measure of excess change. RESULTS National caesarean section rates ranged from 0.6% in South Sudan to 58.9% in the Dominican Republic. Within countries, caesarean section rates were lowest in the poorest fifth (median 3.7%) and highest in the richest fifth (median 18.4%). 18 out of 72 study countries reported a difference of 20 percentage points or higher between the richest and poorest fifth. The highest caesarean section rates and greatest levels of absolute inequality were observed in countries from the region of the Americas, whereas countries from the African region had low levels of caesarean use and comparatively lower levels of absolute inequality, although relative inequality was quite high in some countries. 26 out of 28 countries reported increases in caesarean section rates over time. Rates tended to increase faster in the richest fifth (median 0.9 percentage points per year) compared with the poorest fifth (median 0.2 percentage points per year), indicating an increase in inequality over time in most of these countries. CONCLUSIONS Substantial within country economic inequalities in caesarean deliveries remain. These inequalities might be due to a combination of inadequate access to emergency obstetric care among the poorest subgroups and high levels of caesarean use without medical indication in the richest subgroups, especially in middle income countries. Country specific strategies should address these inequalities to improve maternal and newborn health.	[Boatin, Adeline Adwoa] Harvard Med Sch, Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA USA; [Schlotheuber, Anne; Hosseinpoor, Ahmad Reza] WHO, Dept Informat Evidence & Res, CH-1211 Geneva, Switzerland; [Betran, Ana Pilar; Moller, Ann-Beth] WHO, HRP UNDP UNFPA UNICEF WHO World Bank Special Prog, Dept Reprod Hlth & Res, Geneva, Switzerland; [Barros, Aluisio J. D.; Victora, Cesar G.] Univ Fed Pelotas, Int Ctr Equ Hlth, Pelotas, Brazil; [Boerma, Ties] Univ Manitoba, Countdown Womens Childrens & Adolescents Hlth 203, Winnipeg, MB, Canada; [Boerma, Ties] Univ Manitoba, Rady Fac Hlth Sci, Ctr Global Publ Hlth, Winnipeg, MB, Canada; [Torloni, Maria Regina] Sao Paulo Fed Univ, Evidence Based Healthcare Post Grad Program, Sao Paulo, Brazil	Harvard University; Harvard Medical School; Massachusetts General Hospital; World Health Organization; United Nations Population Fund; World Health Organization; Universidade Federal de Pelotas; University of Manitoba; University of Manitoba; Universidade Federal de Sao Paulo (UNIFESP)	Hosseinpoor, AR (corresponding author), WHO, Dept Informat Evidence & Res, CH-1211 Geneva, Switzerland.	hosseinpoora@who.int	Hosseinpoor, Ahmad Reza/AFP-8422-2022; Victora, Cesar Gomes/Y-2455-2019; Barros, Aluisio JD/A-7417-2008	Hosseinpoor, Ahmad Reza/0000-0001-7322-672X; Victora, Cesar Gomes/0000-0002-2465-2180; Barros, Aluisio JD/0000-0002-2022-8729; Schlotheuber, Anne/0000-0001-6393-4095				Adua E, 2017, EPMA J, V8, P197, DOI 10.1007/s13167-017-0109-3; Allin S, 2015, 21022 NBER; Betran AP, 2016, BJOG-INT J OBSTET GY, V123, P667, DOI 10.1111/1471-0528.13526; Betran AP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148343; Betran AP, 2015, REPROD HEALTH, V12, DOI 10.1186/s12978-015-0043-6; Betran AP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097769; Boatin AA, 2017, BJOG; Brooks MI, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2028-3; Cavallaro FL, 2013, B WORLD HEALTH ORGAN, V91, P914, DOI 10.2471/BLT.13.117598; Chigbu CO, 2007, BJOG-INT J OBSTET GY, V114, P1261, DOI 10.1111/j.1471-0528.2007.01440.x; Cresswell JA, 2015, TROP MED INT HEALTH, V20, P607, DOI 10.1111/tmi.12466; Dingle A, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-51; Dumont A, 2001, LANCET, V358, P1328, DOI 10.1016/S0140-6736(01)06414-5; Edmonds JK, 2015, J PERINAT EDUC, V24, P93, DOI 10.1891/1058-1243.24.2.93; El-Khoury M, 2012, INT J EQUITY HEALTH, V11, DOI 10.1186/1475-9276-11-49; FARMER PE, 2013, BMJ-BRIT MED J, V346, DOI DOI 10.1136/BMJ.F65; FIGO Working Grp Challenges Care M, 2016, INT J GYNECOL OBSTET, V135, P232, DOI 10.1016/j.ijgo.2016.08.001; Gebremedhin S, 2014, REPROD HEALTH, V11, DOI 10.1186/1742-4755-11-14; Hancioglu A, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001391; Holmer H, 2015, LANCET GLOB HEALTH, V3, pS9, DOI 10.1016/S2214-109X(14)70349-3; Klemetti R, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.032; Lee K, 2009, GLOB INST, P1; Leone T, 2014, INT J GYNECOL OBSTET, V127, P157, DOI 10.1016/j.ijgo.2014.05.018; Lindquist SAI, 2017, JAMA SURG, V152, P1148, DOI 10.1001/jamasurg.2017.2825; Lumbiganon P, 2010, LANCET, V375, P490, DOI 10.1016/S0140-6736(09)61870-5; Mazzoni A, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0824-0; Mi J, 2014, LANCET, V383, P1463, DOI 10.1016/S0140-6736(14)60716-9; Ministry of Health, 2010, FAST TRACK IN ROAD M; Ministry of Health, 2008, NAT HLTH STRAT PLAN; Ministry of Health and Family Welfare, 2014, HLTH B, V2013; Molina G, 2015, JAMA-J AM MED ASSOC, V314, P2263, DOI 10.1001/jama.2015.15553; National Cancer Institute, 2013, HLTH DISP CALC VERS; Ologunde R, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.05.022; Ortiz I., 2011, GLOBAL INEQUALITY BO; Prakash KC, 2014, ARCH GYNECOL OBSTET, V289, P421, DOI 10.1007/s00404-013-2976-8; Rahnama P, 2016, REPROD HEALTH, V13, DOI 10.1186/s12978-016-0120-5; Requejo J, 2014, INT J EPIDEMIOL, V43, P586, DOI 10.1093/ije/dyu034; Ronsmans C, 2004, BJOG-INT J OBSTET GY, V111, P1027, DOI 10.1111/j.1471-0528.2004.00247.x; Ronsmans C, 2003, TROP MED INT HEALTH, V8, P940, DOI 10.1046/j.1365-3156.2003.01111.x; Ronsmans C, 2006, LANCET, V368, P1516, DOI 10.1016/S0140-6736(06)69639-6; Roy A., 2016, DIVERS EQUAL HLTH CA, V13, DOI [DOI 10.21767/2049-5471.100076, 10.21767/2049-5471.100076]; Royal Government of Cambodia, 2011, NAT SOC PROT STRAT P; Say L, 2007, B WORLD HEALTH ORGAN, V85, P812, DOI 10.2471/BLT.06.035659; Souza JP, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-71; Speybroeck N, 2010, INT J PUBLIC HEALTH, V55, P347, DOI 10.1007/s00038-009-0105-z; Stanton CK, 2005, B WORLD HEALTH ORGAN, V83, P449; Tomeo CA, 1999, EPIDEMIOLOGY, V10, P774, DOI 10.1097/00001648-199911000-00022; Torloni MR, 2013, BMC PREGNANCY CHILDB, V13, DOI 10.1186/1471-2393-13-78; Torloni MR, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d276; Torloni MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014566; UNICEF, 2014, STAT MON MULT IND CL; UNICEF WHO UN Population Fund, 1997, GUID MON AV US OBST; USAID, 2013, DHS PROGR DEM HLTH S; USAID, 2014, DHS PROGR WEALTH IND; Vogel JP, 2015, LANCET GLOB HEALTH, V3, pE260, DOI 10.1016/S2214-109X(15)70094-X; WHO, 2010, WOR HEALT REP, P1; WHO, 2016, WHO REG OFF; WHO, 2016, GLOB HLTH OBS HLTH E; WHO, 1996, MAT HLTH SAF MOTH PR; WHO, 2015, STAT IN REPR MAT NEW; Witter S, 2009, GLOBAL HEALTH ACTION, V2, DOI 10.3402/gha.v2i0.1881; World Bank, 2017, WORLD DEV IND GINI I; World Bank, 2017, WORLD BANK COUNTR LE; World Health Organization, 2017, NAT HLTH IN MON STEP; World Health Organization Human Reproduction Programme 10 April 2015, 2015, Reprod Health Matters, V23, P149, DOI 10.1016/j.rhm.2015.07.007; Worley H, 2015, RWANDAS SUCCESS IMPR; Ye J, 2016, BJOG-INT J OBSTET GY, V123, P745, DOI 10.1111/1471-0528.13592; Ye JF, 2014, BIRTH-ISS PERINAT C, V41, P237, DOI 10.1111/birt.12104	68	120	120	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2018	360								k55	10.1136/bmj.k55	http://dx.doi.org/10.1136/bmj.k55			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU2WT	29367432	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000423711400017
J	Hornung, CH				Hornung, Christian H.			The art of manufacturing molecules	SCIENCE			English	Editorial Material									[Hornung, Christian H.] CSIRO Mfg, Private Bag 10, Clayton, Vic 3169, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Hornung, CH (corresponding author), CSIRO Mfg, Private Bag 10, Clayton, Vic 3169, Australia.	christian.hornung@csiro.au	Hornung, Christian/AAI-5276-2020; Hornung, Christian H/H-4808-2012	Hornung, Christian/0000-0002-3678-6565; 				Fitzpatrick DE, 2018, TETRAHEDRON, V74, P3087, DOI 10.1016/j.tet.2017.08.050; Gutmann B, 2015, ANGEW CHEM INT EDIT, V54, P6688, DOI 10.1002/anie.201409318; Hessel V, 2013, CHEMSUSCHEM, V6, P746, DOI 10.1002/cssc.201200766; Hornung CH, 2017, ORG PROCESS RES DEV, V21, P1311, DOI 10.1021/acs.oprd.7b00180; Kitson PJ, 2018, SCIENCE, V359, P314, DOI 10.1126/science.aao3466; Mohammed MI, 2015, PROC TECH, V20, P54, DOI 10.1016/j.protcy.2015.07.010; Parra-Cabrera C, 2018, CHEM SOC REV, V47, P209, DOI 10.1039/c7cs00631d; Peters W, 2015, ENERG ENVIRON SCI, V8, P641, DOI 10.1039/c4ee03461a; Rauch E, 2016, J CLEAN PROD, V135, P127, DOI 10.1016/j.jclepro.2016.06.106; Whitesides GM, 2006, NATURE, V442, P368, DOI 10.1038/nature05058; Yetisen AK, 2013, LAB CHIP, V13, P2210, DOI 10.1039/c3lc50169h	11	7	8	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 19	2018	359	6373					273	274		10.1126/science.aar4543	http://dx.doi.org/10.1126/science.aar4543			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FT6BB	29348222				2022-12-28	WOS:000423236700018
J	Eroglu, Z; Zaretsky, JM; Hu-Lieskovan, S; Kim, DW; Algazi, A; Johnson, DB; Liniker, E; Kong, B; Munhoz, R; Rapisuwon, S; Gherardini, PF; Chmielowski, B; Wang, XY; Shintaku, IP; Wei, C; Sosman, JA; Joseph, RW; Postow, MA; Carlino, MS; Hwu, WJ; Scolyer, RA; Messina, J; Cochran, AJ; Long, GV; Ribas, A				Eroglu, Zeynep; Zaretsky, Jesse M.; Hu-Lieskovan, Siwen; Kim, Dae Won; Algazi, Alain; Johnson, Douglas B.; Liniker, Elizabeth; Kong, Ben; Munhoz, Rodrigo; Rapisuwon, Suthee; Gherardini, Pier Federico; Chmielowski, Bartosz; Wang, Xiaoyan; Shintaku, I. Peter; Wei, Cody; Sosman, Jeffrey A.; Joseph, Richard W.; Postow, Michael A.; Carlino, Matteo S.; Hwu, Wen-Jen; Scolyer, Richard A.; Messina, Jane; Cochran, Alistair J.; Long, Georgina V.; Ribas, Antoni			High response rate to PD-1 blockade in desmoplastic melanomas	NATURE			English	Article							CELL LUNG-CANCER; METASTATIC MELANOMA; MUTATIONS; EXPRESSION; PEMBROLIZUMAB; RESISTANCE; IMMUNOTHERAPY; DISRUPTION; ANTI-PD-1; PATHWAY	Desmoplastic melanoma is a rare subtype of melanoma characterized by dense fibrous stroma, resistance to chemotherapy and a lack of actionable driver mutations, and is highly associated with ultraviolet light-induced DNA damage(1). We analysed sixty patients with advanced desmoplastic melanoma who had been treated with antibodies to block programmed cell death 1 (PD-1) or PD-1 ligand (PD-L1). Objective tumour responses were observed in forty-two of the sixty patients (70%; 95% confidence interval 57-81%), including nineteen patients (32%) with a complete response. Whole-exome sequencing revealed a high mutational load and frequent NF1 mutations (fourteen out of seventeen cases) in these tumours. Immunohistochemistry analysis from nineteen desmoplastic melanomas and thirteen non-desmoplastic melanomas revealed a higher percentage of PD-L1-positive cells in the tumour parenchyma in desmoplastic melanomas (P = 0.04); these cells were highly associated with increased CD8 density and PD-L1 expression in the tumour invasive margin. Therefore, patients with advanced desmoplastic melanoma derive substantial clinical benefit from PD-1 or PD-L1 immune checkpoint blockade therapy, even though desmoplastic melanoma is defined by its dense desmoplastic fibrous stroma. The benefit is likely to result from the high mutational burden and a frequent pre-existing adaptive immune response limited by PD-L1 expression.	[Eroglu, Zeynep; Zaretsky, Jesse M.; Hu-Lieskovan, Siwen; Chmielowski, Bartosz; Wang, Xiaoyan; Shintaku, I. Peter; Wei, Cody; Cochran, Alistair J.; Ribas, Antoni] Univ Calif Los Angeles, Los Angeles, CA 90095 USA; [Eroglu, Zeynep; Kim, Dae Won; Messina, Jane] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA; [Eroglu, Zeynep; Kim, Dae Won; Messina, Jane] Univ S Florida, Tampa, FL USA; [Kim, Dae Won; Hwu, Wen-Jen] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA; [Algazi, Alain] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Johnson, Douglas B.; Sosman, Jeffrey A.] Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Liniker, Elizabeth; Carlino, Matteo S.; Scolyer, Richard A.; Long, Georgina V.] Melanoma Inst Australia, Sydney, NSW, Australia; [Kong, Ben; Carlino, Matteo S.] Westmead Hosp, Sydney, NSW, Australia; [Munhoz, Rodrigo; Postow, Michael A.] Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; [Munhoz, Rodrigo; Postow, Michael A.] Weill Cornell Med Coll, New York, NY USA; [Rapisuwon, Suthee] Georgetown Lombardi Canc Ctr, Washington, DC USA; [Gherardini, Pier Federico] Parker Inst Canc Immunotherapy, San Francisco, CA USA; [Joseph, Richard W.] Mayo Clin, Jacksonville, FL 32224 USA; [Carlino, Matteo S.; Scolyer, Richard A.; Long, Georgina V.] Univ Sydney, Sydney, NSW, Australia; [Scolyer, Richard A.] Royal Prince Alfred Hosp, Sydney, NSW, Australia; [Long, Georgina V.] Royal North Shore Hosp, Sydney, NSW, Australia; [Sosman, Jeffrey A.] Northwestern Univ, Med Ctr, Chicago, IL 60611 USA	University of California System; University of California Los Angeles; H Lee Moffitt Cancer Center & Research Institute; State University System of Florida; University of South Florida; University of Texas System; UTMD Anderson Cancer Center; University of California System; University of California San Francisco; Vanderbilt University; Melanoma Institute Australia; University of Sydney; Memorial Sloan Kettering Cancer Center; Cornell University; Mayo Clinic; University of Sydney; University of Sydney; Royal North Shore Hospital; Northwestern University	Hu-Lieskovan, S; Ribas, A (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.	shu-lieskovan@mednet.ucla.edu; aribas@mednet.ucla.edu	Carlino, Matteo/GRS-7198-2022; Scolyer, Richard/AAE-8511-2019; Long, Georgina V/C-1771-2013	Scolyer, Richard/0000-0002-8991-0013; Long, Georgina V/0000-0001-8894-3545; Carlino, Matteo/0000-0002-7861-4104; Rapisuwon, Suthee/0000-0002-1389-925X	Grimaldi Family Fund; Parker Institute for Cancer Immunotherapy; National Institutes of Health (NIH) [R35 CA197633, P01 CA168585]; Ressler Family Fund; Samuels Family Fund; Garcia-Corsini Family Fund; Moffitt Cancer Center NCI Skin SPORE [5P50CA168536]; Moffitt's Total Cancer Care Initiative and Collaborative Data Services [P30-CA076292]; NIH training grant [GM08042]; American Society of Clinical Oncology (ASCO); Tower Cancer Research Foundation Grant; Dr. Charles Coltman Fellowship Award from the Hope Foundation; NHMRC Fellowship; University of Sydney Medical Foundation; NATIONAL CANCER INSTITUTE [P01CA168585, R35CA197633, P30CA008748, P30CA076292, P50CA168536] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008042] Funding Source: NIH RePORTER	Grimaldi Family Fund; Parker Institute for Cancer Immunotherapy; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ressler Family Fund; Samuels Family Fund; Garcia-Corsini Family Fund; Moffitt Cancer Center NCI Skin SPORE; Moffitt's Total Cancer Care Initiative and Collaborative Data Services; NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Society of Clinical Oncology (ASCO); Tower Cancer Research Foundation Grant; Dr. Charles Coltman Fellowship Award from the Hope Foundation; NHMRC Fellowship(National Health and Medical Research Council (NHMRC) of Australia); University of Sydney Medical Foundation(University of Sydney); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was funded in part by the Grimaldi Family Fund, the Parker Institute for Cancer Immunotherapy, National Institutes of Health (NIH) grants R35 CA197633 and P01 CA168585, the Ressler Family Fund, the Samuels Family Fund and the Garcia-Corsini Family Fund (to A.R.). Z.E. was supported in part by the Moffitt Cancer Center NCI Skin SPORE (5P50CA168536) and Moffitt's Total Cancer Care Initiative and Collaborative Data Services (P30-CA076292) for this work. J.M.Z. is part of the UCLA Medical Scientist Training Program supported by NIH training grant GM08042. S.H.-L. was supported by a Young Investigator Award and a Career Development Award from the American Society of Clinical Oncology (ASCO), a Tower Cancer Research Foundation Grant, and a Dr. Charles Coltman Fellowship Award from the Hope Foundation. We acknowledge the Translational Pathology Core Laboratory (TPCL) and R. Guo, W. Li, J. Pang and M. H. Macabali from UCLA for blood and biopsy processing, and X. Li, L. Dong, J. Yoshizawa, and J. Zhou from the UCLA Clinical Microarray Core for sequencing expertise. G.V.L. is supported by an NHMRC Fellowship and The University of Sydney Medical Foundation. R.A.S. is supported by an NHMRC Fellowship.	Akbani R, 2015, CELL, V161, P1681, DOI 10.1016/j.cell.2015.05.044; Akbay EA, 2013, CANCER DISCOV, V3, P1355, DOI 10.1158/2159-8290.CD-13-0310; Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Ansell SM, 2015, NEW ENGL J MED, V372, P311, DOI 10.1056/NEJMoa1411087; Busam KJ, 2004, AM J SURG PATHOL, V28, P1518, DOI 10.1097/01.pas.0000141391.91677.a4; Casey SC, 2016, SCIENCE, V352, P227, DOI 10.1126/science.aac9935; Daud AI, 2016, J CLIN ONCOL, V34, P4102, DOI 10.1200/JCO.2016.67.2477; Dorand RD, 2016, SCIENCE, V353, P399, DOI 10.1126/science.aae0477; Frydenlund N, 2017, MODERN PATHOL, V30, P357, DOI 10.1038/modpathol.2016.210; Hamid O, 2013, NEW ENGL J MED, V369, P134, DOI 10.1056/NEJMoa1305133; Han DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119716; Hayward NK, 2017, NATURE, V545, P175, DOI 10.1038/nature22071; Hugo W, 2016, CELL, V165, P35, DOI 10.1016/j.cell.2016.02.065; Jiang H, 2016, NAT MED, V22, P851, DOI 10.1038/nm.4123; Kataoka K, 2016, NATURE, V534, P402, DOI 10.1038/nature18294; Krauthammer M, 2015, NAT GENET, V47, P996, DOI 10.1038/ng.3361; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Nghiem PT, 2016, NEW ENGL J MED, V374, P2542, DOI 10.1056/NEJMoa1603702; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Ribas A, 2016, JAMA-J AM MED ASSOC, V315, P1600, DOI 10.1001/jama.2016.4059; Rittmeyer A, 2017, LANCET, V389, P255, DOI 10.1016/S0140-6736(16)32517-X; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Roh W, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aah3560; Rosenberg JE, 2016, LANCET, V387, P1909, DOI 10.1016/S0140-6736(16)00561-4; Shain AH, 2015, NAT GENET, V47, P1194, DOI 10.1038/ng.3382; Shin DS, 2017, CANCER DISCOV, V7, P188, DOI 10.1158/2159-8290.CD-16-1223; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Van Allen EM, 2015, SCIENCE, V350, P207, DOI 10.1126/science.aad0095; Wiesner T, 2015, AM J SURG PATHOL, V39, P1357, DOI 10.1097/PAS.0000000000000451; Zaretsky JM, 2016, NEW ENGL J MED, V375, P819, DOI 10.1056/NEJMoa1604958	30	176	186	4	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 18	2018	553	7688					347	+		10.1038/nature25187	http://dx.doi.org/10.1038/nature25187			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FT9MB	29320474	Green Submitted, Green Accepted			2022-12-28	WOS:000423475100053
J	Genere, N; Montori, VM				Genere, Natalia; Montori, Victor M.			Review: Newer second-line drugs for diabetes are not more cost-effective than sulfonylureas	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Genere, Natalia; Montori, Victor M.] Mayo Clin, Rochester, MN 55905 USA	Mayo Clinic	Genere, N (corresponding author), Mayo Clin, Rochester, MN 55905 USA.							Huang ES, 2014, JAMA INTERN MED, V174, P251, DOI 10.1001/jamainternmed.2013.12956; Rodriguez-Gutierrez R, 2016, CIRC-CARDIOVASC QUAL, V9, P504, DOI 10.1161/CIRCOUTCOMES.116.002901	2	5	5	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2018	168	2					JC8	JC8		10.7326/ACPJC-2018-168-2-008	http://dx.doi.org/10.7326/ACPJC-2018-168-2-008			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU8IN	29335720				2022-12-28	WOS:000424096600008
J	Johnson, BE; Johnson, CA				Johnson, Bruce E.; Johnson, Cynda Ann			Pooled RCTs: In postmenopausal women, hormone therapy for 6 to 7 years did not affect mortality at 18 years	ANNALS OF INTERNAL MEDICINE			English	Editorial Material									[Johnson, Bruce E.; Johnson, Cynda Ann] Virginia Tech, Carilion Sch Med, Roanoke, VA 24016 USA	Virginia Polytechnic Institute & State University	Johnson, BE (corresponding author), Virginia Tech, Carilion Sch Med, Roanoke, VA 24016 USA.							Boardman HM, 2015, COCHRANE DB SYST REV, V3, DOI [10.1002/14651858, DOI 10.1002/14651858.CD002229.PUB4]; Pinkerton JV, 2017, MENOPAUSE, V24, P728, DOI 10.1097/GME.0000000000000921; STAMPFER MJ, 1985, NEW ENGL J MED, V313, P1044, DOI 10.1056/NEJM198510243131703; WILSON PWF, 1985, NEW ENGL J MED, V313, P1038, DOI 10.1056/NEJM198510243131702	4	0	0	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 16	2018	168	2					JC4	JC4		10.7326/ACPJC-2018-168-2-004	http://dx.doi.org/10.7326/ACPJC-2018-168-2-004			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FU8IN	29335716				2022-12-28	WOS:000424096600004
J	Chappuis, F				Chappuis, Francois			Oral fexinidazole for human African trypanosomiasis	LANCET			English	Editorial Material							BRUCEI-GAMBIENSE; EMERGING STRATEGIES; EFLORNITHINE; CONTEMPORARY		[Chappuis, Francois] Geneva Univ Hosp, Div Trop & Humanitarian Med, CH-1211 Geneva 14, Switzerland; [Chappuis, Francois] Univ Geneva, CH-1211 Geneva 14, Switzerland	University of Geneva	Chappuis, F (corresponding author), Geneva Univ Hosp, Div Trop & Humanitarian Med, CH-1211 Geneva 14, Switzerland.; Chappuis, F (corresponding author), Univ Geneva, CH-1211 Geneva 14, Switzerland.	francois.chappuis@hcuge.ch		Chappuis, Francois/0000-0003-0442-7610				Boelaert M, 2017, EBIOMEDICINE; Buscher P, 2017, LANCET; Eperon G, 2014, EXPERT REV ANTI-INFE, V12, P1407, DOI 10.1586/14787210.2014.959496; Jacobs RT, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001151; Mesu VKBK, 2018, LANCET, V391, P144, DOI 10.1016/S0140-6736(17)32758-7; Priotto G, 2008, BMJ-BRIT MED J, V336, P705, DOI 10.1136/bmj.39485.592674.BE; Priotto G, 2009, LANCET, V374, P56, DOI 10.1016/S0140-6736(09)61117-X; Steinmann P, 2015, TROP MED INT HEALTH, V20, P707, DOI 10.1111/tmi.12483; Sutherland CS, 2017, LANCET GLOB HEALTH, V5, pE69, DOI 10.1016/S2214-109X(16)30237-6; Torreele E, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000923; WHO, 2012, ACC WORK OV GL IMP N	11	25	25	1	10	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 13	2018	391	10116					100	102		10.1016/S0140-6736(18)30019-9	http://dx.doi.org/10.1016/S0140-6736(18)30019-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FT0EG	29353603				2022-12-28	WOS:000422793400006
J	McGuire, BA; Burkhardt, AM; Kalenskii, S; Shingledecker, CN; Remijan, AJ; Herbst, E; McCarthy, MC				McGuire, Brett A.; Burkhardt, Andrew M.; Kalenskii, Sergei; Shingledecker, Christopher N.; Remijan, Anthony J.; Herbst, Eric; McCarthy, Michael C.			Detection of the aromatic molecule benzonitrile (c-C6H5CN) in the interstellar medium	SCIENCE			English	Article							LOW-TEMPERATURE; CHEMICAL-COMPOSITION; BENZENE; CHEMISTRY; TMC-1; CN; HYDROCARBONS; SPECTRA	Polycyclic aromatic hydrocarbons and polycyclic aromatic nitrogen heterocycles are thought to be widespread throughout the universe, because these classes of molecules are probably responsible for the unidentified infrared bands, a set of emission features seen in numerous Galactic and extragalactic sources. Despite their expected ubiquity, astronomical identification of specific aromatic molecules has proven elusive. We present the discovery of benzonitrile (c-C6H5CN), one of the simplest nitrogen-bearing aromatic molecules, in the interstellar medium. We observed hyperfine-resolved transitions of benzonitrile in emission from the molecular cloud TMC-1. Simple aromatic molecules such as benzonitrile may be precursors for polycyclic aromatic hydrocarbon formation, providing a chemical link to the carriers of the unidentified infrared bands.	[McGuire, Brett A.; Remijan, Anthony J.] Natl Radio Astron Observ, Edgemont Rd, Charlottesville, VA 22903 USA; [McGuire, Brett A.; McCarthy, Michael C.] Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA; [Burkhardt, Andrew M.; Herbst, Eric] Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; [Kalenskii, Sergei] Russian Acad Sci, Lebedev Phys Inst, Astro Space Ctr, Moscow, Russia; [Shingledecker, Christopher N.; Herbst, Eric] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA; [McCarthy, Michael C.] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA	National Radio Astronomy Observatory (NRAO); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Virginia; Russian Academy of Sciences; Russian Academy of Science Lebedev Physical Institute; University of Virginia; Harvard University	McGuire, BA (corresponding author), Natl Radio Astron Observ, Edgemont Rd, Charlottesville, VA 22903 USA.; McGuire, BA (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	bmcguire@nrao.edu	Kalenskii, Sergei/M-3822-2015; Shingledecker, Christopher N./U-6402-2019	Kalenskii, Sergei/0000-0002-4294-3643; Shingledecker, Christopher N./0000-0002-5171-7568; McGuire, Brett/0000-0003-1254-4817; McCarthy, Michael/0000-0001-9142-0008	NASA through Hubble Fellowship - Space Telescope Science Institute [HST-HF2-51396]; NASA [NAS5-26555]; NSF through Grote Reber Fellowship Program; Basic Research Program of the Presidium of the Russian Academy of Sciences [P-7]; NSF [AST 15-14844, AST-1615847]	NASA through Hubble Fellowship - Space Telescope Science Institute; NASA(National Aeronautics & Space Administration (NASA)); NSF through Grote Reber Fellowship Program; Basic Research Program of the Presidium of the Russian Academy of Sciences(Russian Academy of Sciences); NSF(National Science Foundation (NSF))	Supported by NASA through Hubble Fellowship grant HST-HF2-51396 awarded by the Space Telescope Science Institute, which is operated by the Association of Universities for Research in Astronomy Inc. for NASA under contract NAS5-26555 (B.A.M.); NSF through the Grote Reber Fellowship Program administered by Associated Universities Inc./National Radio Astronomy Observatory (A.M.B.); Basic Research Program P-7 of the Presidium of the Russian Academy of Sciences (S.V.K.); NSF grant AST 15-14844 (E.H. and C.N.S.); and NSF grant AST-1615847 (M.C.M.). We thank G.A. Blake for a critical reading of the manuscript and J. Mangum for helpful discussions. The National Radio Astronomy Observatory and the Green Bank Observatory are facilities of the National Science Foundation operated under cooperative agreement by Associated Universities Inc. The Nobeyama observations are archived at www.cv.nrao.edu/PRIMOS/datasummary.html, and the GBT observations at https://archive.nrao.edu/archive/advquery.jsp under project codes AGBT02C_012, AGBT17A_164, and AGBT17A_434. Laboratory data are tabulated in the supplementary materials. The modifications we applied to KIDA and the output of our chemical model are available at doi:10.18130/V3/4IFDBP.	Abplanalp MJ, 2016, P NATL ACAD SCI USA, V113, P7727, DOI 10.1073/pnas.1604426113; Berne O, 2015, ASTRON ASTROPHYS, V577, DOI 10.1051/0004-6361/201425338; Boersma C, 2014, ASTROPHYS J SUPPL S, V211, DOI 10.1088/0067-0049/211/1/8; Campbell EK, 2015, NATURE, V523, P322, DOI 10.1038/nature14566; Cernicharo J, 2001, ASTROPHYS J, V546, pL123, DOI 10.1086/318871; Chiar JE, 2013, ASTROPHYS J, V770, DOI 10.1088/0004-637X/770/1/78; CRUTCHER RM, 1984, ASTROPHYS J, V283, P668, DOI 10.1086/162352; CSASZAR AG, 1989, SPECTROCHIM ACTA A, V45, P845, DOI 10.1016/0584-8539(89)80222-3; Draine BT, 2016, ASTROPHYS J, V831, DOI 10.3847/0004-637X/831/1/109; FIELD FH, 1964, J PHYS CHEM-US, V68, P1039, DOI 10.1021/j100787a011; Garcia-Hernandez DA, 2016, J PHYS CONF SER, V728, DOI 10.1088/1742-6596/728/5/052003; Gratier P, 2016, ASTROPHYS J SUPPL S, V225, DOI 10.3847/0067-0049/225/2/25; GREEN JHS, 1976, SPECTROCHIM ACTA A, V32, P1279, DOI 10.1016/0584-8539(76)80166-3; Hincelin U, 2011, ASTRON ASTROPHYS, V530, DOI 10.1051/0004-6361/201016328; Hudgins DM, 2005, ASTROPHYS J, V632, P316, DOI 10.1086/432495; Jochims HW, 1999, ASTROPHYS J, V512, P500, DOI 10.1086/306752; Kaifu N, 2004, PUBL ASTRON SOC JPN, V56, P69, DOI 10.1093/pasj/56.1.69; Kaiser RI, 2015, ANNU REV PHYS CHEM, V66, P43, DOI 10.1146/annurev-physchem-040214-121502; Kalenskii S. V., 2016, P RUSS IND WORKSH RA; Kofman V, 2017, MOL ASTROPHYS, V7, P19, DOI 10.1016/j.molap.2017.04.002; Kraemer KE, 2006, ASTROPHYS J, V652, pL25, DOI 10.1086/509778; Loomis RA, 2016, MON NOT R ASTRON SOC, V463, P4175, DOI 10.1093/mnras/stw2302; Lovas FJ, 2005, J AM CHEM SOC, V127, P4345, DOI 10.1021/ja0426239; LOW FJ, 1984, ASTROPHYS J, V278, pL19, DOI 10.1086/184213; Malek SE, 2012, ASTROPHYS J, V744, DOI 10.1088/0004-637X/744/1/16; McGuire BA, 2017, ASTROPHYS J LETT, V843, DOI 10.3847/2041-8213/aa7ca3; Pilleri P, 2009, MON NOT R ASTRON SOC, V397, P1053, DOI 10.1111/j.1365-2966.2009.15067.x; Regan MW, 2004, ASTROPHYS J SUPPL S, V154, P204, DOI 10.1086/423204; Ribeiro FD, 2015, PHYS CHEM CHEM PHYS, V17, P27473, DOI 10.1039/c5cp05040e; Ruaud M, 2016, MON NOT R ASTRON SOC, V459, P3756, DOI 10.1093/mnras/stw887; Thorwirth S, 2007, ASTROPHYS J, V662, P1309, DOI 10.1086/518026; Tielens AGGM, 2008, ANNU REV ASTRON ASTR, V46, P289, DOI 10.1146/annurev.astro.46.060407.145211; Trevitt AJ, 2010, J PHYS CHEM A, V114, P1749, DOI 10.1021/jp909633a; Wakelam V, 2015, ASTROPHYS J SUPPL S, V217, DOI 10.1088/0067-0049/217/2/20; Wishart J.F., 1998, PHOTOCHEMISTRY RAD C; Wohlfart K, 2008, J MOL SPECTROSC, V247, P119, DOI 10.1016/j.jms.2007.10.006; Woon DE, 2006, CHEM PHYS, V331, P67, DOI 10.1016/j.chemphys.2006.09.028; Zhou L, 2010, ASTROPHYS J, V718, P1243, DOI 10.1088/0004-637X/718/2/1243	38	263	264	15	91	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 12	2018	359	6372					202	205		10.1126/science.aao4890	http://dx.doi.org/10.1126/science.aao4890			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS5EO	29326270	Green Submitted			2022-12-28	WOS:000419816600043
J	Zhu, WH; Winter, MG; Byndloss, MX; Spiga, L; Duerkop, BA; Hughes, ER; Buttner, L; Romao, ED; Behrendt, CL; Lopez, CA; Sifuentes-Dominguez, L; Huff-Hardy, K; Wilson, RP; Gillis, CC; Tukel, C; Koh, AY; Burstein, E; Hooper, LV; Baumler, AJ; Winter, SE				Zhu, Wenhan; Winter, Maria G.; Byndloss, Mariana X.; Spiga, Luisella; Duerkop, Breck A.; Hughes, Elizabeth R.; Buttner, Lisa; Romao, Everton de Lima; Behrendt, Cassie L.; Lopez, Christopher A.; Sifuentes-Dominguez, Luis; Huff-Hardy, Kayci; Wilson, R. Paul; Gillis, Caroline C.; Tukel, Cagla; Koh, Andrew Y.; Burstein, Ezra; Hooper, Lora V.; Baumler, Andreas J.; Winter, Sebastian E.			Precision editing of the gut microbiota ameliorates colitis	NATURE			English	Article							ENTERICA SEROTYPE TYPHIMURIUM; ESCHERICHIA-COLI; INFLAMMATORY RESPONSES; SEROVAR TYPHIMURIUM; ULCERATIVE-COLITIS; ELECTRON-ACCEPTOR; CROHNS-DISEASE; CD-HIT; GROWTH; ENTEROBACTERIACEAE	Inflammatory diseases of the gastrointestinal tract are frequently associated with dysbiosis(1-8), characterized by changes in gut microbial communities that include an expansion of facultative anaerobic bacteria of the Enterobacteriaceae family (phylum Proteobacteria). Here we show that a dysbiotic expansion of Enterobacteriaceae during gut inflammation could be prevented by tungstate treatment, which selectively inhibited molybdenum-cofactor-dependent microbial respiratory pathways that are operational only during episodes of inflammation. By contrast, we found that tungstate treatment caused minimal changes in the microbiota composition under homeostatic conditions. Notably, tungstate-mediated microbiota editing reduced the severity of intestinal inflammation in mouse models of colitis. We conclude that precision editing of the microbiota composition by tungstate treatment ameliorates the adverse effects of dysbiosis in the inflamed gut.	[Zhu, Wenhan; Winter, Maria G.; Spiga, Luisella; Hughes, Elizabeth R.; Buttner, Lisa; Gillis, Caroline C.; Koh, Andrew Y.; Winter, Sebastian E.] Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Byndloss, Mariana X.; Romao, Everton de Lima; Lopez, Christopher A.; Baumler, Andreas J.] Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, One Shields Ave, Davis, CA 95616 USA; [Duerkop, Breck A.; Behrendt, Cassie L.; Hooper, Lora V.] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Sifuentes-Dominguez, Luis; Koh, Andrew Y.] Univ Texas Southwestern Med Ctr Dallas, Dept Pediat, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Huff-Hardy, Kayci; Burstein, Ezra] Univ Texas Southwestern Med Ctr Dallas, Div Digest & Liver Dis, Dept Internal Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Wilson, R. Paul; Tukel, Cagla] Temple Univ, Lewis Katz Sch Med, Dept Microbiol & Immunol, 1801 North Broad St, Philadelphia, PA 19122 USA; [Hooper, Lora V.] Univ Texas Southwestern Med Ctr Dallas, Howard Hughes Med Inst, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Wilson, R. Paul] GlaxoSmithKline, 1250 South Collegeville Rd, Collegeville, PA 19426 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of California System; University of California Davis; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; GlaxoSmithKline	Winter, SE (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Microbiol, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.; Baumler, AJ (corresponding author), Univ Calif Davis, Sch Med, Dept Med Microbiol & Immunol, One Shields Ave, Davis, CA 95616 USA.	ajbaumler@ucdavis.edu; Sebastian.Winter@UTSouthwestern.edu	Byndloss, Mariana Xavier/ABD-5506-2021; Baumler, Andreas J/H-2301-2011; Koh, Andrew/R-6837-2019; Byndloss, Mariana X/D-9890-2014; Duerkop, Breck/I-2460-2019; Winter, Sebastian E/A-4118-2009	Byndloss, Mariana Xavier/0000-0002-2122-4156; Baumler, Andreas J/0000-0001-9152-7809; Koh, Andrew/0000-0003-2172-5126; Byndloss, Mariana X/0000-0002-2122-4156; Duerkop, Breck/0000-0003-4030-9822; Winter, Sebastian E/0000-0003-1532-9178; Hughes, Elizabeth R/0000-0003-4967-8819; Sifuentes-Dominguez, Luis/0000-0002-9525-071X; Spiga, Luisella/0000-0002-4770-7156; Zhu, Wenhan/0000-0003-3771-0842	NIH [AI112445, AI118807, AI128151, DK070855, DK102436, 5K12HD-068369]; Welch Foundation [I-1858, I-1874]; American Cancer Society Research Scholar Grant [MPC-130347]; Crohn's and Colitis Foundation of America [454921]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI123163, R21AI128151, R01AI112445, R01AI118807, T32AI007520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK102436, T32DK007745, R01DK070855] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); American Cancer Society Research Scholar Grant(American Cancer Society); Crohn's and Colitis Foundation of America; Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIH grants AI112445 (A.J.B.), AI118807 (S.E.W.), AI128151 (S.E.W.), DK070855 (L.V.H.), DK102436 (B.A.D.) and 5K12HD-068369 (L.S.-D.), Welch Foundation grants I-1858 (S.E.W.) and I-1874 (L.V.H.), American Cancer Society Research Scholar Grant MPC-130347 (S.E.W.) and a Crohn's and Colitis Foundation of America postdoctoral fellowship no. 454921 (W.Z.). Work in the L.V.H. laboratory is supported by the Howard Hughes Medical Institute. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. Any opinions, findings, and conclusions or recommendations expressed in this material are those of the authors and do not necessarily reflect the views of the funders. We thank B. Sartor for the E. coli NC101 strain.	Barman M, 2008, INFECT IMMUN, V76, P907, DOI 10.1128/IAI.01432-07; Brugiroux S, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.215; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Collins S, 2009, DIGEST DIS, V27, P85, DOI 10.1159/000268126; Davis R., 1980, ADV BACTERIAL GENETI; De Gregoris TB, 2011, J MICROBIOL METH, V86, P351, DOI 10.1016/j.mimet.2011.06.010; Eaves-Pyles T, 2008, INT J MED MICROBIOL, V298, P397, DOI 10.1016/j.ijmm.2007.05.011; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Garrett WS, 2010, CELL HOST MICROBE, V8, P292, DOI 10.1016/j.chom.2010.08.004; Gates AJ, 2003, FEMS MICROBIOL LETT, V220, P261, DOI 10.1016/S0378-1097(03)00122-8; Godinez I, 2008, INFECT IMMUN, V76, P2008, DOI 10.1128/IAI.01691-07; Hans W, 2000, EUR J GASTROEN HEPAT, V12, P267, DOI 10.1097/00042737-200012030-00002; Hughes ER, 2017, CELL HOST MICROBE, V21, P208, DOI 10.1016/j.chom.2017.01.005; Kamada N, 2012, SCIENCE, V336, P1325, DOI 10.1126/science.1222195; Keestra AM, 2011, MBIO, V2, DOI 10.1128/mBio.00266-11; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Kruis W, 2004, GUT, V53, P1617, DOI 10.1136/gut.2003.037747; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Lupp C, 2007, CELL HOST MICROBE, V2, P119, DOI 10.1016/j.chom.2007.06.010; Mshvildadze M, 2010, J PEDIATR-US, V156, P20, DOI 10.1016/j.jpeds.2009.06.063; Overbergh L, 2003, J Biomol Tech, V14, P33; Pal D, 2005, J BACTERIOL, V187, P7167, DOI 10.1128/JB.187.21.7167-7175.2005; Prantera C, 1996, AM J GASTROENTEROL, V91, P328; Price-Carter M, 2001, J BACTERIOL, V183, P2463, DOI 10.1128/JB.183.8.2463-2475.2001; Raetz M, 2013, NAT IMMUNOL, V14, P136, DOI 10.1038/ni.2508; Rodriguez MS, 1999, J BIOL CHEM, V274, P9108, DOI 10.1074/jbc.274.13.9108; RUTGEERTS P, 1995, GASTROENTEROLOGY, V108, P1617, DOI 10.1016/0016-5085(95)90121-3; Sambrook J, 1989, MOL CLONING; Sassone-Corsi M, 2016, NATURE, V540, P280, DOI 10.1038/nature20557; Shavit Y, 2014, BIOINFORMATICS, V30, P3120, DOI 10.1093/bioinformatics/btu491; Shin NR, 2015, TRENDS BIOTECHNOL, V33, P496, DOI 10.1016/j.tibtech.2015.06.011; SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784; Stecher B, 2007, PLOS BIOL, V5, P2177, DOI 10.1371/journal.pbio.0050244; STEWART V, 1988, J BACTERIOL, V170, P1589, DOI 10.1128/jb.170.4.1589-1597.1988; Vujkovic-Cvijin I, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006438; WANG RF, 1991, GENE, V100, P195, DOI 10.1016/0378-1119(91)90366-J; Wilson RP, 2008, CELL MICROBIOL, V10, P876, DOI 10.1111/j.1462-5822.2007.01090.x; Winter SE, 2013, EMBO REP, V14, P319, DOI 10.1038/embor.2013.27; Winter SE, 2013, SCIENCE, V339, P708, DOI 10.1126/science.1232467; Winter SE, 2010, NATURE, V467, P426, DOI 10.1038/nature09415; Winter SE, 2009, INFECT IMMUN, V77, P1904, DOI 10.1128/IAI.01341-08	44	252	264	11	194	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 11	2018	553	7687					208	+		10.1038/nature25172	http://dx.doi.org/10.1038/nature25172			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FS4WL	29323293	Green Accepted			2022-12-28	WOS:000419794800037
J	Postow, MA; Sidlow, R; Hellmann, MD				Postow, Michael A.; Sidlow, Robert; Hellmann, Matthew D.			Immune-Related Adverse Events Associated with Immune Checkpoint Blockade	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							ADVANCED MELANOMA; ALLOGRAFT-REJECTION; TUMOR-REGRESSION; SINGLE-ARM; IPILIMUMAB; IMMUNOTHERAPY; NIVOLUMAB; SAFETY; INHIBITORS; CTLA-4		Mem Sloan Kettering Canc Ctr, 1275 York Ave, New York, NY 10021 USA; Weill Cornell Med Coll, New York, NY USA	Memorial Sloan Kettering Cancer Center; Cornell University	Postow, MA (corresponding author), 300 East 66th St, New York, NY 10065 USA.	postowm@mskcc.org		Knaack, Aaron/0000-0001-7712-1415	Bristol-Myers Squibb; Novartis; Ono Pharmaceutical; Array BioPharma; Merck; Incyte; NewLink Genetics; Genentech; AstraZeneca; Janssen; Mirati Therapeutics; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	Bristol-Myers Squibb(Bristol-Myers Squibb); Novartis(Novartis); Ono Pharmaceutical; Array BioPharma(Pfizer); Merck(Merck & Company); Incyte; NewLink Genetics; Genentech(Roche HoldingGenentech); AstraZeneca(AstraZeneca); Janssen(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc); Mirati Therapeutics; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Dr. Postow reports receiving grant support, paid to his institution, and consulting fees from Bristol-Myers Squibb, honoraria from Merck and Bristol-Myers Squibb, and consulting fees and advisory board fees from Novartis, Ono Pharmaceutical, Array BioPharma, Merck, Incyte, and NewLink Genetics; and Dr. Hellmann, receiving consulting fees and advisory board fees from Genentech, Merck, AstraZeneca, Novartis, Janssen, and Mirati Therapeutics and grant support, consulting fees, and advisory board fees from Bristol-Myers Squibb. No other potential conflict of interest relevant to this article was reported.	Abdel-Rahman O, 2016, FUTURE ONCOL, V12, P413, DOI 10.2217/fon.15.222; Arriola E, 2015, ONCOIMMUNOLOGY, V4, DOI 10.1080/2162402X.2015.1040218; Attia P, 2005, J CLIN ONCOL, V23, P6043, DOI 10.1200/JCO.2005.06.205; Balar AV, 2017, LANCET, V389, P67, DOI 10.1016/S0140-6736(16)32455-2; Bashey A, 2009, BLOOD, V113, P1581, DOI 10.1182/blood-2008-07-168468; Bergqvist V, 2017, CANCER IMMUNOL IMMUN, V66, P581, DOI 10.1007/s00262-017-1962-6; Betof AS, 2017, ONCOLOGIST, V22, P963, DOI 10.1634/theoncologist.2016-0450; Boussiotis VA, 2016, NEW ENGL J MED, V375, P1767, DOI 10.1056/NEJMra1514296; Boutros C, 2016, NAT REV CLIN ONCOL, V13, P473, DOI 10.1038/nrclinonc.2016.58; BREWERTON DA, 1973, LANCET, V2, P996, DOI 10.1016/S0140-6736(73)91091-X; BURDICK KH, 1964, CANCER, V17, P708, DOI 10.1002/1097-0142(196406)17:6<708::AID-CNCR2820170604>3.0.CO;2-3; Burke MM, 2011, J CLIN ONCOL, V29, pE792, DOI 10.1200/JCO.2011.36.9199; Byrne EH, 2017, CANCER-AM CANCER SOC, V123, P2143, DOI 10.1002/cncr.30444; Callahan MK, 2011, ASCO M, V29, P2505, DOI DOI 10.1200/JC0.2011.29.15_; Carli L, 2013, CLIN RHEUMATOL, V32, P1071, DOI 10.1007/s10067-013-2214-6; Caturegli P, 2016, AM J PATHOL, V186, P3225, DOI 10.1016/j.ajpath.2016.08.020; Chaput N, 2017, ANN ONCOL, V28, P1368, DOI 10.1093/annonc/mdx108; Davar D, 2015, CASE REP ONCOL MED, V2015, DOI 10.1155/2015/737389; Del Castillo M, 2016, CLIN INFECT DIS, V63, P1490, DOI 10.1093/cid/ciw539; Ding W, 2017, BLOOD, V129, P3419, DOI 10.1182/blood-2017-02-765685; Dittmar M, 2005, THYROID, V15, P239, DOI 10.1089/thy.2005.15.239; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Downey SG, 2007, CLIN CANCER RES, V13, P6681, DOI 10.1158/1078-0432.CCR-07-0187; Dubin K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10391; El-Khoueiry AB, 2017, LANCET, V389, P2492, DOI 10.1016/S0140-6736(17)31046-2; Esfahani K, 2017, NEW ENGL J MED, V376, P1989, DOI 10.1056/NEJMc1703047; Friedman CF, 2016, JAMA ONCOL, V2, P1346, DOI 10.1001/jamaoncol.2016.1051; Haanen JBAG, 2017, ANN ONCOL, V28, P119, DOI 10.1093/annonc/mdx225; Harbour SN, 2015, P NATL ACAD SCI USA, V112, P7061, DOI 10.1073/pnas.1415675112; Horvat TZ, 2015, J CLIN ONCOL, V33, P3193, DOI 10.1200/JCO.2015.60.8448; Hua C, 2016, JAMA DERMATOL, V152, P45, DOI 10.1001/jamadermatol.2015.2707; Huscher D, 2009, ANN RHEUM DIS, V68, P1119, DOI 10.1136/ard.2008.092163; Iwama S, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008002; Johnpulle RAN, 2016, ONCOIMMUNOLOGY, V5, DOI 10.1080/2162402X.2016.1234572; Johnson DB, 2017, CANCER-AM CANCER SOC, V123, P1904, DOI 10.1002/cncr.30642; Johnson DB, 2016, JAMA ONCOL, V2, P234, DOI 10.1001/jamaoncol.2015.4368; Johnson DB, 2016, NEW ENGL J MED, V375, P1749, DOI 10.1056/NEJMoa1609214; Kanz BA, 2016, J IMMUNOTHER CANCER, V4, DOI 10.1186/s40425-016-0166-5; Khoja L, 2017, ANN ONCOL, V28, P2377, DOI 10.1093/annonc/mdx286; Krummel MF, 1996, J EXP MED, V183, P2533, DOI 10.1084/jem.183.6.2533; Kyi C, 2014, J IMMUNOTHER CANCER, V2, DOI 10.1186/2051-1426-2-19; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Larkin J, 2015, NEW ENGL J MED, V373, P23, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Lesokhin AM, 2016, J CLIN ONCOL, V34, P2698, DOI 10.1200/JCO.2015.65.9789; Lipson EJ, 2016, NEW ENGL J MED, V374, P896, DOI 10.1056/NEJMc1509268; Menzies AM, 2017, ANN ONCOL, V28, P368, DOI 10.1093/annonc/mdw443; Morales RE, 2015, J IMMUNOTHER CANCER, V3, DOI 10.1186/s40425-015-0066-0; Morganstein DL, 2017, CLIN ENDOCRINOL, V86, P614, DOI 10.1111/cen.13297; Naidoo J, 2017, J CLIN ONCOL, V35, P709, DOI 10.1200/JCO.2016.68.2005; National Comprehensive Cancer Network, 2018, PREV TREATM CANC REL; Nishijima TF, 2016, CANCER TREAT REV, V45, P30, DOI 10.1016/j.ctrv.2016.02.006; Nishimura H, 1999, IMMUNITY, V11, P141, DOI 10.1016/S1074-7613(00)80089-8; Osorio JC, 2017, ANN ONCOL, V28, P583, DOI 10.1093/annonc/mdw640; Owonikoko TK, 2017, CANCER IMMUNOL IMMUN, V66, P45, DOI 10.1007/s00262-016-1918-2; Reck M, 2016, NEW ENGL J MED, V375, P1823, DOI 10.1056/NEJMoa1606774; Renton AE, 2015, JAMA NEUROL, V72, P396, DOI 10.1001/jamaneurol.2014.4103; Robert C, 2015, NEW ENGL J MED, V372, P2521, DOI 10.1056/NEJMoa1503093; Robert C, 2015, NEW ENGL J MED, V372, P320, DOI 10.1056/NEJMoa1412082; Santini F, 2017, J CLIN ONCOL, V35; Schadendorf D, 2017, J CLIN ONCOL, V35, P3807, DOI 10.1200/JCO.2017.73.2289; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Spain L, 2016, ANN ONCOL, V27, P1135, DOI 10.1093/annonc/mdw130; Teulings HE, 2015, J CLIN ONCOL, V33, P773, DOI 10.1200/JCO.2014.57.4756; TIVOL EA, 1995, IMMUNITY, V3, P541, DOI 10.1016/1074-7613(95)90125-6; Topalian SL, 2014, J CLIN ONCOL, V32, P1020, DOI 10.1200/JCO.2013.53.0105; Uslu U, 2015, J IMMUNOTHER, V38, P212, DOI 10.1097/CJI.0000000000000081; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Weber JS, 2017, J CLIN ONCOL, V35, P785, DOI 10.1200/JCO.2015.66.1389; Weber JS, 2015, J CLIN ONCOL, V33, P2092, DOI 10.1200/JCO.2014.60.0379; Weber JS, 2012, J CLIN ONCOL, V30, P2691, DOI 10.1200/JCO.2012.41.6750; Wightman F, 2015, AIDS, V29, P504, DOI 10.1097/QAD.0000000000000562; Wolchok Jedd D, 2010, Cancer Immun, V10, P9; YANAGAWA T, 1995, J CLIN ENDOCR METAB, V80, P41, DOI 10.1210/jc.80.1.41; Yanai S, 2017, CLIN GASTROENTEROL H, V15, pE80, DOI 10.1016/j.cgh.2016.09.017; Younes A, 2016, LANCET ONCOL, V17, P1283, DOI 10.1016/S1470-2045(16)30167-X	76	1990	2078	28	313	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 11	2018	378	2					158	168		10.1056/NEJMra1703481	http://dx.doi.org/10.1056/NEJMra1703481			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FS7IR	29320654				2022-12-28	WOS:000419971600009
J	Hackshaw, A; Morris, JK; Boniface, S; Tang, JL; Milenkovic, D				Hackshaw, Allan; Morris, Joan K.; Boniface, Sadie; Tang, Jin-Ling; Milenkovic, Dusan			Low cigarette consumption and risk of coronary heart disease and stroke: meta-analysis of 141 cohort studies in 55 study reports	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALL-CAUSE MORTALITY; SMOKE-FREE LEGISLATION; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; FOLLOW-UP; HEALTH CONSEQUENCES; LONG-TERM; LOW-INTENSITY; LUNG-CANCER; MEN	OBJECTIVE To use the relation between cigarette consumption and cardiovascular disease to quantify the risk of coronary heart disease and stroke for light smoking (one to five cigarettes/day). DESIGN Systematic review and meta-analysis. DATA SOURCES Medline 1946 to May 2015, with manual searches of references. ELIGIBILITY CRITERIA FOR SELECTING STUDIES Prospective cohort studies with at least 50 events, reporting hazard ratios or relative risks (both hereafter referred to as relative risk) compared with never smokers or age specific incidence in relation to risk of coronary heart disease or stroke. DATA EXTRACTION/SYNTHESIS MOOSE guidelines were followed. For each study, the relative risk was estimated for smoking one, five, or 20 cigarettes per day by using regression modelling between risk and cigarette consumption. Relative risks were adjusted for at least age and often additional confounders. The main measure was the excess relative risk for smoking one cigarette per day (RR1_per_day-1) expressed as a proportion of that for smoking 20 cigarettes per day (RR20_per_day-1), expected to be about 5% assuming a linear relation between risk and consumption (as seen with lung cancer). The relative risks for one, five, and 20 cigarettes per day were also pooled across all studies in a random effects meta-analysis. Separate analyses were done for each combination of sex and disorder. RESULTS The meta-analysis included 55 publications containing 141 cohort studies. Among men, the pooled relative risk for coronary heart disease was 1.48 for smoking one cigarette per day and 2.04 for 20 cigarettes per day, using all studies, but 1.74 and 2.27 among studies in which the relative risk had been adjusted for multiple confounders. Among women, the pooled relative risks were 1.57 and 2.84 for one and 20 cigarettes per day (or 2.19 and 3.95 using relative risks adjusted for multiple factors). Men who smoked one cigarette per day had 46% of the excess relative risk for smoking 20 cigarettes per day (53% using relative risks adjusted for multiple factors), and women had 31% of the excess risk (38% using relative risks adjusted for multiple factors). For stroke, the pooled relative risks for men were 1.25 and 1.64 for smoking one or 20 cigarettes per day (1.30 and 1.56 using relative risks adjusted for multiple factors). In women, the pooled relative risks were 1.31 and 2.16 for smoking one or 20 cigarettes per day (1.46 and 2.42 using relative risks adjusted for multiple factors). The excess risk for stroke associated with one cigarette per day (in relation to 20 cigarettes per day) was 41% for men and 34% for women (or 64% and 36% using relative risks adjusted for multiple factors). Relative risks were generally higher among women than men. CONCLUSIONS Smoking only about one cigarette per day carries a risk of developing coronary heart disease and stroke much greater than expected: around half that for people who smoke 20 per day. No safe level of smoking exists for cardiovascular disease. Smokers should aim to quit instead of cutting down to significantly reduce their risk of these two common major disorders.	[Hackshaw, Allan] UCL, Canc Res UK & UCL Canc Trials Ctr, London W1T 4TJ, England; [Morris, Joan K.] Queen Mary Univ London, Wolfson Inst Prevent Med, London, England; [Boniface, Sadie] Kings Coll London, Addict Dept, London, England; [Tang, Jin-Ling] Chinese Univ Hong Kong, JC Sch Publ Hlth & Primary Care, Hong Kong, Hong Kong, Peoples R China; [Milenkovic, Dusan] Evidera, Meta Res, London, England	Cancer Research UK; University of London; University College London; University of London; Queen Mary University London; University of London; King's College London; Chinese University of Hong Kong; Evidera	Hackshaw, A (corresponding author), UCL, Canc Res UK & UCL Canc Trials Ctr, London W1T 4TJ, England.	a.hackshaw@ucl.ac.uk	Morris, Joan/AAT-9211-2020; Tang, Jin-Ling/AAJ-4090-2021; Boniface, Sadie/J-8713-2015	Morris, Joan/0000-0002-7164-612X; Boniface, Sadie/0000-0003-3492-6402	Cancer Research UK [C444/A15953]	Cancer Research UK(Cancer Research UK)	This study was supported by a core grant from Cancer Research UK (C444/A15953).	ABBOTT RD, 1986, NEW ENGL J MED, V315, P717, DOI 10.1056/NEJM198609183151201; Agaku IT, 2015, TOB CONTROL, V24, pE233, DOI 10.1136/tobaccocontrol-2014-051922; Alkerwi A, 2017, CLIN NUTR, V36, P1275, DOI 10.1016/j.clnu.2016.08.013; Amrock SM, 2015, PEDIATRICS, V135, P246, DOI 10.1542/peds.2014-2502; [Anonymous], 1978, J Chronic Dis, V31, P201; Barnoya J, 2005, CIRCULATION, V111, P2684, DOI 10.1161/CIRCULATIONAHA.104.492215; Barr CD, 2012, AM J EPIDEMIOL, V176, P642, DOI 10.1093/aje/kws267; Beard E, 2016, BMJ-BRIT MED J, V354, DOI 10.1136/bmj.i4645; Bhatnagar A, 2014, CIRCULATION, V130, P1418, DOI 10.1161/CIR.0000000000000107; Bhatnagar P, 2015, HEART, V101, P1182, DOI 10.1136/heartjnl-2015-307516; Bjartveit K, 2005, TOB CONTROL, V14, P315, DOI 10.1136/tc.2005.011932; Britton J, 2007, HARM REDUCTION NICOT; Burns DM, 1997, USITC PUBL; BUSH TL, 1983, AM J EPIDEMIOL, V118, P480, DOI 10.1093/oxfordjournals.aje.a113653; Carnevale R, 2016, CHEST, V150, P606, DOI 10.1016/j.chest.2016.04.012; Centers for Disease Control and Prevention, 2017, STROK FACTS; Centers for Disease Control and Prevention, 2017, HEART DIS FACTS; Chen ZM, 2015, LANCET, V386, P1447, DOI 10.1016/S0140-6736(15)00340-2; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Cronin EM, 2012, CLIN CARDIOL, V35, P205, DOI 10.1002/clc.21014; Csabai D, 2016, BEHAV BRAIN RES, V302, P44, DOI 10.1016/j.bbr.2016.01.022; Denlinger-Apte RL, 2017, NICOTINE TOB RES, V19, P1149, DOI 10.1093/ntr/ntw320; DOLL R, 1980, BRIT MED J, V280, P967, DOI 10.1136/bmj.280.6219.967; DOLL R, 2004, BMJ-BRIT MED J, V328, P1519, DOI DOI 10.1136/BMJ.38142.554479.AE; Ehteshami-Afshar S, 2014, ANN HUM BIOL, V41, P249, DOI 10.3109/03014460.2013.853834; Eriksen M, 2015, TOBACCO ATLAS; Fischer F, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2489-4; Fish LJ, 2015, NICOTINE TOB RES, V17, P546, DOI 10.1093/ntr/ntu169; Freund K M, 1993, Ann Epidemiol, V3, P417, DOI 10.1016/1047-2797(93)90070-K; FULLER JH, 1983, BMJ-BRIT MED J, V287, P867, DOI 10.1136/bmj.287.6396.867; Garfinkel L, 1985, Natl Cancer Inst Monogr, V67, P49; Gellert C, 2013, EUR J EPIDEMIOL, V28, P649, DOI 10.1007/s10654-013-9776-0; Giovino GA, 2012, LANCET, V380, P668, DOI 10.1016/S0140-6736(12)61085-X; Godtfredsen NS, 2003, J EPIDEMIOL COMMUN H, V57, P412, DOI 10.1136/jech.57.6.412; Godtfredsen NS, 2005, JAMA-J AM MED ASSOC, V294, P1505, DOI 10.1001/jama.294.12.1505; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Greiller L, 2015, ANN ONCOL, V26, pi57, DOI [10.1093/annonc/mdv128.01, DOI 10.1093/ANNONC/MDV128.01]; Gun RT, 2006, AUST NZ J PUBL HEAL, V30, P318, DOI 10.1111/j.1467-842X.2006.tb00842.x; Hamilton G, 2000, ADDICT RES, V8, P419, DOI 10.3109/16066350009005588; Hart CL, 2000, STROKE, V31, P1893, DOI 10.1161/01.STR.31.8.1893; Herbec A, 2014, SMOKING BRITAIN, V1; Hippisley-Cox J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2573; Hirayama T, 1990, LIFE STYLE MORTALITY; Ho MG, 2010, TOB CONTROL, V19, P13, DOI 10.1136/tc.2009.030981; Honjo K, 2010, TOB CONTROL, V19, P50, DOI 10.1136/tc.2009.029751; Huxley RR, 2012, AM J EPIDEMIOL, V175, P816, DOI 10.1093/aje/kwr391; Huxley RR, 2011, LANCET, V378, P1297, DOI 10.1016/S0140-6736(11)60781-2; Inoue-Choi M, 2017, JAMA INTERN MED, V177, P87, DOI 10.1001/jamainternmed.2016.7511; Iredale JM, 2016, PREV MED, V83, P70, DOI 10.1016/j.ypmed.2015.11.020; Iversen B, 2013, EUR J EPIDEMIOL, V28, P659, DOI 10.1007/s10654-013-9785-z; Jacobs DR, 1999, ARCH INTERN MED, V159, P733, DOI 10.1001/archinte.159.7.733; Jamal A, 2015, MMWR-MORBID MORTAL W, V64, P1233, DOI 10.15585/mmwr.mm6444a2; Jamrozik K, 2011, TOB CONTROL, V20, P258, DOI 10.1136/tc.2010.039172; Jee SH, 1999, JAMA-J AM MED ASSOC, V282, P2149, DOI 10.1001/jama.282.22.2149; Ji JF, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-497; Jonsdottir LS, 2002, J CARDIOVASC RISK, V9, P67, DOI 10.1097/00043798-200204000-00001; KAHN HAROLD A., 1966, NAT CANCER INST MONOGR, V19, P1; KAWACHI I, 1994, ARCH INTERN MED, V154, P169, DOI 10.1001/archinte.154.2.169; KAWACHI I, 1993, JAMA-J AM MED ASSOC, V269, P232, DOI 10.1001/jama.269.2.232; Kelly TN, 2008, STROKE, V39, P1688, DOI 10.1161/STROKEAHA.107.505305; Khang YH, 2008, HEART, V94, P75, DOI 10.1136/hrt.2007.117747; Kondo T, 2011, CIRC J, V75, P2885, DOI 10.1253/circj.CJ-11-0416; KONO S, 1985, J CANCER RES CLIN, V110, P161, DOI 10.1007/BF00402732; Kotz D, 2012, ADDICTION, V107, P995, DOI 10.1111/j.1360-0443.2011.03739.x; Kropp RY, 2004, PEDIATRICS, V114, pE445, DOI 10.1542/peds.2004-0893; KULLER LH, 1991, PREV MED, V20, P638, DOI 10.1016/0091-7435(91)90060-H; LACROIX AZ, 1991, NEW ENGL J MED, V324, P1619, DOI 10.1056/NEJM199106063242303; Lam TH, 2007, TOB CONTROL, V16, P182, DOI 10.1136/tc.2006.019505; Lam TH, 2002, ANN EPIDEMIOL, V12, P316, DOI 10.1016/S1047-2797(01)00258-7; Law MR, 1997, BRIT J CANCER, V75, P1690, DOI 10.1038/bjc.1997.287; Law MR, 1997, BMJ-BRIT MED J, V315, P973, DOI 10.1136/bmj.315.7114.973; Lawlor DA, 2008, STROKE, V39, P760, DOI 10.1161/STROKEAHA.107.494823; Liaw KM, 1998, TOB CONTROL, V7, P141, DOI 10.1136/tc.7.2.141; Lindson-Hawley Nicola, 2016, Cochrane Database Syst Rev, V10, pCD005231; Liu A, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2013-003307; Liu SW, 2017, J EPIDEMIOL COMMUN H, V71, P154, DOI 10.1136/jech-2016-207805; Luoto R, 2000, Nicotine Tob Res, V2, P133, DOI 10.1080/713688127; Mackay DF, 2010, HEART, V96, P1525, DOI 10.1136/hrt.2010.199026; Ng M, 2014, JAMA-J AM MED ASSOC, V311, P183, DOI 10.1001/jama.2013.284692; McNeill A., 2015, REPORT COMMISSIONED; Merry AHH, 2011, BMC CARDIOVASC DISOR, V11, DOI 10.1186/1471-2261-11-13; Meyers DG, 2009, J AM COLL CARDIOL, V54, P1249, DOI 10.1016/j.jacc.2009.07.022; MiYang Jeon, 2014, Med Sci Monit, V20, P601, DOI 10.12659/MSM.890367; Molshatzki N, 2013, INT J CARDIOL, V168, P2278, DOI 10.1016/j.ijcard.2013.01.200; Mons U, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1551; National Cancer Institute (NCI), 1997, NAT CANC I NCI MON, V8; Nilsson S, 2001, J EPIDEMIOL COMMUN H, V55, P825, DOI 10.1136/jech.55.11.825; PATRICK DL, 1994, AM J PUBLIC HEALTH, V84, P1086, DOI 10.2105/AJPH.84.7.1086; Pechacek TF, 2004, BRIT MED J, V328, P980, DOI 10.1136/bmj.328.7446.980; Pham TM, 2007, EUR J EPIDEMIOL, V22, P599, DOI 10.1007/s10654-007-9161-y; Pirie K, 2013, LANCET, V381, P133, DOI 10.1016/S0140-6736(12)61720-6; Pope CA, 2011, ENVIRON HEALTH PERSP, V119, P1616, DOI 10.1289/ehp.1103639; Pope CA, 2011, AIR QUAL ATMOS HLTH, V4, P5, DOI 10.1007/s11869-010-0082-7; Pope CA, 2009, CIRCULATION, V120, P941, DOI 10.1161/CIRCULATIONAHA.109.857888; Prescott E, 1998, BMJ-BRIT MED J, V316, P1043; Prescott E, 2002, J EPIDEMIOL COMMUN H, V56, P702, DOI 10.1136/jech.56.9.702; RAGLAND DR, 1988, AM J EPIDEMIOL, V127, P462, DOI 10.1093/oxfordjournals.aje.a114823; ROSENGREN A, 1992, J INTERN MED, V231, P357, DOI 10.1111/j.1365-2796.1992.tb00944.x; Royal College of Physicians, 2005, GOING SMOK FREE MED; Royal College of Physicians, 2016, NIC SMOK TOB HARM RE; Rutten LJF, 2015, NICOTINE TOB RES, V17, P1228, DOI 10.1093/ntr/ntv003; Sargent RP, 2004, BMJ-BRIT MED J, V328, P977, DOI 10.1136/bmj.38055.715683.55; Shaper AG, 2003, INT J EPIDEMIOL, V32, P802, DOI 10.1093/ije/dyg206; SHAPIRO S, 1969, AM J PUBLIC HEALTH N, V59, P1, DOI 10.2105/AJPH.59.Suppl_6.1; Sims M, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c2161; Song YM, 2008, J CLIN ONCOL, V26, P5101, DOI 10.1200/JCO.2008.17.0498; Song YM, 2008, STROKE, V39, P2432, DOI 10.1161/STROKEAHA.107.512632; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; Tan CE, 2012, CIRCULATION, V126, P2177, DOI 10.1161/CIRCULATIONAHA.112.121301; Tang J, 1992, J SMOKING RELATED DI, V3, P203; Teasdale JE, 2016, DRUG ALCOHOL DEPEN, V163, P256, DOI 10.1016/j.drugalcdep.2016.04.020; Thun MJ, 2013, NEW ENGL J MED, V368, P351, DOI 10.1056/NEJMsa1211127; Tverdal A, 2006, TOB CONTROL, V15, P472, DOI 10.1136/tc.2006.016246; Tverdal A, 2011, TOB CONTROL, V20, P123, DOI 10.1136/tc.2010.036780; U.S. Department of Health and Human Services, 2006, HLTH CONS INV EXP TO; US Department of Health and Human Services, 2010, TOB SMOK CAUS DIS BI; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; WATT GCM, 1995, SCOT MED J, V40, P108, DOI 10.1177/003693309504000403; WEIR JM, 1970, CANCER, V25, P105, DOI 10.1002/1097-0142(197001)25:1<105::AID-CNCR2820250115>3.0.CO;2-Z; Wells G.A., 2009, NEWCASTLE OTTAWA SCA; Wen CP, 2004, PREV MED, V39, P528, DOI 10.1016/j.ypmed.2004.02.010; Woodward M, 2005, INT J EPIDEMIOL, V34, P1036, DOI 10.1093/ije/dyi104; Woodward M, 1999, J Epidemiol Biostat, V4, P285; Xu WH, 2007, PREV MED, V45, P313, DOI 10.1016/j.ypmed.2007.05.015; Yong HH, 2016, NICOTINE TOB RES, V18, P2115, DOI 10.1093/ntr/ntw107; Zhang QL, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-273	126	256	271	7	47	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 24	2018	360								j5855	10.1136/bmj.j5855	http://dx.doi.org/10.1136/bmj.j5855			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	FU2WT	29643098	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000423711400001
J	O'Keeffe, LM; Ramond, A; Oliver-Williams, C; Willeit, P; Paige, E; Trotter, P; Evans, J; Wadstrom, J; Nicholson, M; Collett, D; Di Angelantonio, E				O'Keeffe, Linda M.; Ramond, Anna; Oliver-Williams, Clare; Willeit, Peter; Paige, Ellie; Trotter, Patrick; Evans, Jonathan; Wadstrom, Jonas; Nicholson, Michael; Collett, Dave; Di Angelantonio, Emanuele			Mid- and Long-Term Health Risks in Living Kidney Donors A Systematic Review and Meta-analysis	ANNALS OF INTERNAL MEDICINE			English	Review							SELECTING APPROPRIATE CONTROLS; CARDIOVASCULAR-DISEASE; MEDICAL RISKS; FOLLOW-UP; DONATION; HYPERTENSION; MORTALITY; OUTCOMES; PREGNANCY; CARE	Background: Long-term health risks for adults who donate kidneys are unclear. Purpose: To summarize evidence about mid-and long-term health risks associated with living kidney donation in adults. Data Sources: PubMed, Embase, Scopus, and PsycINFO without language restriction from April 1964 to July 2017. Study Selection: Observational studies with at least 1 year of follow-up that compared health outcomes in adult living kidney donors versus nondonor populations. Data Extraction: Two investigators independently extracted study data and assessed study quality. Data Synthesis: 52 studies, comprising 118 426 living kidney donors and 117656 nondonors, were included. Average follow-up was 1 to 24 years. No evidence suggested higher risk for all-cause mortality, cardiovascular disease, hypertension, type 2 diabetes, or adverse psychosocial health outcomes in living kidney donors than in nondonor populations. Donors had higher diastolic blood pressure, lower estimated glomerular filtration rates, and higher risk for end-stage renal disease (ESRD) (relative risk [RR], 8.83 [95% CI, 1.02 to 20.93]) and preeclampsia in female donors (RR, 2.12 [CI, 1.06 to 4.27]). Despite the increased RR, donors had low absolute risk for ESRD (incidence rate, 0.5 event [CI, 0.1 to 4.9 events] per 1000 person-years) and preeCIampsia (incidence rate, 5.9 events [CI, 2.9 to 8.9 events] per 100 pregnancies). Limitation: Generalizability was limited by selected control populations, few studies reported pregnancy-related outcomes, and few studies were from low-and middle-income countries. Conclusion: Although living kidney donation is associated with higher RRs for ESRD and preeclampsia, the absolute risk for these outcomes remains low. Compared with nondonor populations, living kidney donors have no increased risk for other major chronic diseases, such as type 2 diabetes, or for adverse psychosocial outcomes.	[Di Angelantonio, Emanuele] Univ Bristol, Bristol, Avon, England; [Trotter, Patrick; Nicholson, Michael] Univ Cambridge, Dept Surg, Addenbrookes Hosp, Box 202,Level E9,Hills Rd, Cambridge CB2 0QQ, England; Natl Inst Hlth Res Blood & Transplant Res Unit Do, Cambridge, England; [Willeit, Peter] Med Univ Innsbruck, Dept Neurol, Christoph Probst Pl 1,Innrain 52, A-6020 Innsbruck, Austria; [Paige, Ellie] Australian Natl Univ, Res Sch Populat Hlth, Natl Ctr Epidemiol & Populat Hlth, Canberra, ACT 0200, Australia; [Wadstrom, Jonas] Karolinska Univ Hosp, Dept Transplantat Surg, SE-14186 Stockholm, Sweden; [Collett, Dave] Natl Hlth Serv Blood & Transplant, Bristol BS34 8RR, Avon, England	University of Bristol; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Medical University of Innsbruck; Australian National University; Karolinska Institutet; Karolinska University Hospital; NHS Blood & Transplant (NHSBT)	Di Angelantonio, E (corresponding author), Univ Bristol, Bristol, Avon, England.	ed303@medschl.cam.ac.uk	DiAngelantonio, Emanuele/ABE-6852-2020; Willeit, Peter/HCI-7091-2022	Willeit, Peter/0000-0002-1866-7159; O'Keeffe, Linda/0000-0002-0003-0774; Ramond, Anna/0000-0002-9958-3693; Di Angelantonio, Emanuele/0000-0001-8776-6719; Paige, Ellie/0000-0003-0855-9872	National Health Service Blood and Transplant; National Institute for Health Research [PROSPERO: CRD42017072284]; British Heart Foundation [RG/08/014/24067] Funding Source: researchfish; Medical Research Council [MR/M014509/1, MR/L003120/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0512-10165] Funding Source: researchfish; MRC [MR/L003120/1, MR/M014509/1] Funding Source: UKRI	National Health Service Blood and Transplant; National Institute for Health Research(National Institute for Health Research (NIHR)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	National Health Service Blood and Transplant and National Institute for Health Research. (PROSPERO: CRD42017072284)	Andrews PA, 2012, TRANSPLANTATION, V93, P666, DOI 10.1097/TP.0b013e318247a7b7; Berger JC, 2011, CLIN J AM SOC NEPHRO, V6, P2887, DOI 10.2215/CJN.04160511; Borenstein M., 2009, INTRO METAANALYSIS; Boudville N, 2006, ANN INTERN MED, V145, P185, DOI 10.7326/0003-4819-145-3-200608010-00006; British Transplantation Society/The Renal Association, 2011, UK GUID LIV DON KIDN; Brown MA, 2001, HYPERTENS PREGNANCY, V20, pIX, DOI 10.1081/PRG-100104165; Chen TK, 2016, CURR OPIN NEPHROL HY, V25, P217, DOI 10.1097/MNH.0000000000000222; Clemens KK, 2006, AM J TRANSPLANT, V6, P2965, DOI 10.1111/j.1600-6143.2006.01567.x; Cornell JE, 2014, ANN INTERN MED, V160, P267, DOI 10.7326/M13-2886; Doshi MD, 2013, AM J TRANSPLANT, V13, P111, DOI 10.1111/j.1600-6143.2012.04303.x; Garg AX, 2006, KIDNEY INT, V70, P1801, DOI 10.1038/sj.ki.5001819; Garg AX, 2008, TRANSPLANTATION, V86, P399, DOI 10.1097/TP.0b013e31817ba9e3; Garg AX, 2015, NEW ENGL J MED, V372, P124, DOI 10.1056/NEJMoa1408932; Garg AX, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e1203; Hostetter TH, 2003, J AM SOC NEPHROL, V14, pS144, DOI 10.1097/01.ASN.0000070150.60928.06; Ibrahim HN, 2009, NEW ENGL J MED, V360, P459, DOI 10.1056/NEJMoa0804883; Kasiske BL, 2015, AM J KIDNEY DIS, V66, P114, DOI 10.1053/j.ajkd.2015.01.019; Lam N, 2012, NEPHROL DIAL TRANSPL, V27, P3291, DOI 10.1093/ndt/gfr802; Lam NN, 2015, NAT REV NEPHROL, V11, P411, DOI 10.1038/nrneph.2015.58; Lam NN, 2015, AM J KIDNEY DIS, V65, P925, DOI 10.1053/j.ajkd.2015.01.017; Lentine KL, 2017, TRANSPLANTATION, V101, pS7, DOI 10.1097/TP.0000000000001769; Lentine KL, 2013, TRANSPL INT, V26, P853, DOI 10.1111/tri.12088; Lentine KL, 2012, TRANSPLANTATION, V94, P139, DOI 10.1097/TP.0b013e318254757d; Li SS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003847; Mjoen G, 2015, AM J TRANSPLANT, V15, P286, DOI 10.1111/ajt.13016; Mjoen G, 2014, KIDNEY INT, V86, P162, DOI 10.1038/ki.2013.460; Mjoen G, 2012, NEPHROL DIAL TRANSPL, V27, P443, DOI 10.1093/ndt/gfr303; Moody WE, 2016, HYPERTENSION, V67, P368, DOI 10.1161/HYPERTENSIONAHA.115.06608; Muzaale AD, 2014, JAMA-J AM MED ASSOC, V311, P579, DOI 10.1001/jama.2013.285141; OConnell D, 2012, NEWCASTLE OTTAWA SCA; Ommen ES, 2011, AM J TRANSPLANT, V11, P2575, DOI 10.1111/j.1600-6143.2011.03815.x; Ommen ES, 2006, CLIN J AM SOC NEPHRO, V1, P885, DOI 10.2215/CJN.00840306; Reese PP, 2015, AM J TRANSPLANT, V15, P287, DOI 10.1111/ajt.13015; Reese PP, 2014, AM J TRANSPLANT, V14, P1853, DOI 10.1111/ajt.12822; Reese PP, 2015, LANCET, V385, P2003, DOI 10.1016/S0140-6736(14)62484-3; Reisaeter AV, 2009, AM J TRANSPLANT, V9, P820, DOI 10.1111/j.1600-6143.2008.02427.x; Reule S, 2013, AM J KIDNEY DIS, V61, P194, DOI 10.1053/j.ajkd.2012.07.013; Rizvi SAH, 2016, TRANSPLANTATION, V100, P1284, DOI 10.1097/TP.0000000000001075; Segev DL, 2010, JAMA-J AM MED ASSOC, V303, P959, DOI 10.1001/jama.2010.237; Seyahi N, 2007, AM J KIDNEY DIS, V49, P143, DOI 10.1053/j.ajkd.2006.10.016; Shehab-Eldin W, 2009, AM J NEPHROL, V30, P371, DOI 10.1159/000232577; Thomas SM, 2013, AM J TRANSPLANT, V13, P2935, DOI 10.1111/ajt.12446; Weng FL, 2012, CLIN TRANSPLANT, V26, pE300, DOI 10.1111/j.1399-0012.2012.01660.x; Young A, 2012, AM J KIDNEY DIS, V59, P761, DOI 10.1053/j.ajkd.2011.09.019	44	86	89	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 20	2018	168	4					276	+		10.7326/M17-1235	http://dx.doi.org/10.7326/M17-1235			14	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FW6NB	30128524	Green Submitted			2022-12-28	WOS:000425434000016
